Citrus Sinensis ID: 043136
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FII5 | 1041 | Leucine-rich repeat recep | yes | no | 0.926 | 0.803 | 0.638 | 0.0 | |
| Q9M0G7 | 1013 | Leucine-rich repeat recep | no | no | 0.924 | 0.823 | 0.443 | 0.0 | |
| O49545 | 1003 | Leucine-rich repeat recep | no | no | 0.937 | 0.843 | 0.421 | 0.0 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.916 | 0.825 | 0.417 | 1e-179 | |
| Q9FRS6 | 1029 | Leucine-rich repeat recep | no | no | 0.957 | 0.839 | 0.412 | 1e-178 | |
| O65440 | 992 | Leucine-rich repeat recep | no | no | 0.923 | 0.839 | 0.410 | 1e-170 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.911 | 0.838 | 0.396 | 1e-163 | |
| Q9SGP2 | 996 | Receptor-like protein kin | no | no | 0.906 | 0.821 | 0.384 | 1e-155 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.951 | 0.755 | 0.356 | 1e-147 | |
| C0LGX3 | 993 | LRR receptor-like serine/ | no | no | 0.903 | 0.820 | 0.362 | 1e-140 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1078 bits (2788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/852 (63%), Positives = 665/852 (78%), Gaps = 16/852 (1%)
Query: 43 NSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLT 102
++F DW P + + + VWCSWSG+ C+ ++Q+ SLDLS R+LSG IP +IRYL+
Sbjct: 51 SAFQDW-KVPV----NGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLS 105
Query: 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF 162
SL +LNLS N+ +G +I +LTKL T+DIS NSF+S+FPPGISKL+FL++FNA+SN+F
Sbjct: 106 SLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNF 165
Query: 163 TGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLT 222
G LP + +L L++LN GGSYF+GEIP+ Y L L+F+ LAGN L G LPP+LGLLT
Sbjct: 166 EGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLT 225
Query: 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282
+L+ +EIGYN+ G +P EFA L NLKY D+S C+LSG+LP E+ NL+ LE L LF+N F
Sbjct: 226 ELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGF 285
Query: 283 TGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLA 342
TGEIP SY NL++L++LD S NQLSG IP+ ++LK LT LSL++N L GE+P+ I L
Sbjct: 286 TGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELP 345
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402
+L TL LWNN+ TGVLP KLGSNGKL T+DVS+NS TG IP ++C G++L+KLILFSN F
Sbjct: 346 ELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMF 405
Query: 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQ 462
+P++L C SL R R Q+N+LNG+IP GFG L NLTF+D+S N + +IP D A
Sbjct: 406 EGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAP 465
Query: 463 KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522
L+YLN+S N F LP NIW APNL+I SAS S L G+IP+++GCKS Y+IEL N LN
Sbjct: 466 VLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVGCKSFYRIELQGNSLN 525
Query: 523 GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCST 582
G+IPWDIGHCEKLL LNLS+N L GIIPWEIS LPSI DVDLSHN LTGTIPS+F + T
Sbjct: 526 GTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKT 585
Query: 583 LESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNH 642
+ +FNVSYN L GPIP+ F +L+PS F NEGLCG ++ KPC +D AG+ ++ H
Sbjct: 586 ITTFNVSYNQLIGPIPSGS--FAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGH 643
Query: 643 --QQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFS----NDREIGPWKLTA 696
+++PKKTAGAIVWI+AAA G+G FVLVA TRCF+ +Y N +IGPWKLTA
Sbjct: 644 HKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTA 703
Query: 697 FQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN--IRRRR 754
FQRLNFTADDV+ECLS +D ILGMGSTGTVYKAEMP GEIIAVKKLWGK+KEN IRRR+
Sbjct: 704 FQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRK 763
Query: 755 -GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW 813
GVLAEVDVLGNVRHRNIVRLLGCC+NR+CTMLLYEYMPNG+LDDLLH +K A+W
Sbjct: 764 SGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEW 823
Query: 814 VTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
Y+IA+GVAQGICYLHHDCDPVIVHRDLKPSNILLD + EARVADFGVAKLIQ+DESM
Sbjct: 824 TALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESM 883
Query: 874 SVIAGSYGYIAP 885
SV+AGSYGYIAP
Sbjct: 884 SVVAGSYGYIAP 895
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9M0G7|PXL2_ARATH Leucine-rich repeat receptor-like protein kinase PXL2 OS=Arabidopsis thaliana GN=PXL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 660 bits (1702), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/864 (44%), Positives = 532/864 (61%), Gaps = 30/864 (3%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
LLS+K++L DP N DW S+ S C+W+G++CN + + LDL+ +
Sbjct: 34 LLSVKSTLVDPLN-FLKDW----KLSDTSDH-----CNWTGVRCN-SNGNVEKLDLAGMN 82
Query: 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKL 149
L+G I I L+SL N+S N F+ L +I L++IDIS NSF+ + ++
Sbjct: 83 LTGKISDSISQLSSLVSFNISCNGFESLLPKSI---PPLKSIDISQNSFSGSLFLFSNES 139
Query: 150 RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNS 209
L NA N+ +G L + L SL+ L+L G++F G +PS ++NL LRFL L+GN+
Sbjct: 140 LGLVHLNASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGNN 199
Query: 210 LTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNL 269
LTG LP LG L LE +GYN +G +P EF ++ +LKY+D++ LSG +PSE+ L
Sbjct: 200 LTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGKL 259
Query: 270 TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329
LE LLL++N+FTG IP G++ L+VLD SDN L+G IP + LK L L+LM N
Sbjct: 260 KSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRNK 319
Query: 330 LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
L G IP I LA L L LWNN L+G LP LG N L +DVSSNS +G IP T+C+
Sbjct: 320 LSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCNK 379
Query: 390 DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNS 449
L KLILF+N FT IP L C SL R+R+Q+N LNGSIP GFG L L ++++ N
Sbjct: 380 GNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGNR 439
Query: 450 LSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGC 508
LSG IP D+ ++ L +++ S N ++SLPS I S NL+ + + ++G++PD F C
Sbjct: 440 LSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQDC 499
Query: 509 KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNF 568
S+ ++L +N L G+IP I CEKL+ LNL N+LTG IP +I+ + ++ +DLS+N
Sbjct: 500 PSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNNS 559
Query: 569 LTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCP 628
LTG +P + LE NVSYN LTGP+P +G ++P GN GLCG VL PC
Sbjct: 560 LTGVLPESIGTSPALELLNVSYNKLTGPVPING-FLKTINPDDLRGNSGLCGGVL-PPCS 617
Query: 629 ADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSNDRE 688
A + + AG ++ I A+ +G+ +V T ++ YS GF D
Sbjct: 618 KFQRATSS---HSSLHGKRIVAGWLIGI-ASVLALGILTIVTRT-LYKKWYSNGFCGDET 672
Query: 689 IG----PWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLW 743
PW+L AF RL FTA D+L C+ S+ I GMG+TG VYKAEM ++AVKKLW
Sbjct: 673 ASKGEWPWRLMAFHRLGFTASDILACIKESNMI-GMGATGIVYKAEMSRSSTVLAVKKLW 731
Query: 744 GKHKENIRRRRG-VLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA 802
+ G + EV++LG +RHRNIVRLLG N + M++YE+M NGNL D +H
Sbjct: 732 RSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIHG 791
Query: 803 KNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862
KN L+ DWV+RY IALGVA G+ YLHHDC P ++HRD+K +NILLD ++AR+ADFG
Sbjct: 792 KNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADFG 851
Query: 863 VAKLI-QSDESMSVIAGSYGYIAP 885
+A+++ + E++S++AGSYGYIAP
Sbjct: 852 LARMMARKKETVSMVAGSYGYIAP 875
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49545|BAME1_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM1 OS=Arabidopsis thaliana GN=BAM1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 637 bits (1642), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/882 (42%), Positives = 521/882 (59%), Gaps = 36/882 (4%)
Query: 13 HLLVVFSANTLPLPLVSLLSIKASLK---DPFNNSFHDWDATPAFSNPSSEQEPVWCSWS 69
H+ F+A+ +LLS+K SL D N+ W + +F C+W
Sbjct: 12 HISHTFTASRPISEFRALLSLKTSLTGAGDDKNSPLSSWKVSTSF-----------CTWI 60
Query: 70 GIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLR 129
G+ C+ +TSLDLS +LSG + P++ +L L +L+L+ N GP+ P I L+ LR
Sbjct: 61 GVTCDVSRRHVTSLDLSGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLR 120
Query: 130 TIDISHNSFNSTFPPGISK-LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG 188
+++S+N FN +FP IS L LR+ + Y+N+ TG LP+ L L+ L+LGG+YF G
Sbjct: 121 HLNLSNNVFNGSFPDEISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAG 180
Query: 189 EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVN 247
+IP Y + + +L ++GN L G +PP++G LT L + IGY N + +P E +L
Sbjct: 181 KIPPSYGSWPVIEYLAVSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSE 240
Query: 248 LKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307
L D + C L+G +P EI L KL+ L L N F+G + G L +L+ +DLS+N +
Sbjct: 241 LVRFDGANCGLTGEIPPEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFT 300
Query: 308 GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGK 367
G IPAS A LK LT L+L N L GEIP+ I L +L+ L LW N+ TG +PQKLG NGK
Sbjct: 301 GEIPASFAELKNLTLLNLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGK 360
Query: 368 LLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLN 427
L VD+SSN LTG +PP +C G++L LI N SIP++L C SL+R+R+ +N LN
Sbjct: 361 LNLVDLSSNKLTGTLPPNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLN 420
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPN 487
GSIP+G LP LT +++ N LSGE+P G + L +++S N LP I +
Sbjct: 421 GSIPKGLFGLPKLTQVELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTG 480
Query: 488 LKILSASSSKLTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
++ L +K G IP +G + + KI+ +NL +G I +I C+ L ++LSRN L+
Sbjct: 481 VQKLLLDGNKFQGPIPSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELS 540
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPN 606
G IP EI+ + + ++LS N L G+IP + + +L S + SYN L+G +P +G F
Sbjct: 541 GEIPNEITAMKILNYLNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQ-FSY 599
Query: 607 LHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLF 666
+ +SF+GN LCG L PC DG+A G HQ K A + ++ +
Sbjct: 600 FNYTSFLGNPDLCGPYL-GPC-KDGVAKG-----GHQSHSKGPLSASMKLLLVLGLLVCS 652
Query: 667 VLVAGTRCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTV 726
+ A +A R E W+LTAFQRL+FT DDVL+ L D I+G G G V
Sbjct: 653 IAFAVVAIIKA---RSLKKASESRAWRLTAFQRLDFTCDDVLDSLK-EDNIIGKGGAGIV 708
Query: 727 YKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786
YK MP G+++AVK+L + + G AE+ LG +RHR+IVRLLG CSN E +L
Sbjct: 709 YKGVMPNGDLVAVKRLAAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLL 767
Query: 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846
+YEYMPNG+L ++LH K G W TRYKIAL A+G+CYLHHDC P+IVHRD+K +
Sbjct: 768 VYEYMPNGSLGEVLHGKKGGH---LHWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSN 824
Query: 847 NILLDGEMEARVADFGVAKLIQ---SDESMSVIAGSYGYIAP 885
NILLD EA VADFG+AK +Q + E MS IAGSYGYIAP
Sbjct: 825 NILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 628 bits (1620), Expect = e-179, Method: Compositional matrix adjust.
Identities = 362/867 (41%), Positives = 519/867 (59%), Gaps = 40/867 (4%)
Query: 27 LVSLLSIKASLK-DPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDL 85
L +LLS+K+S D + W+ + F CSW+G+ C+ +TSLDL
Sbjct: 28 LHALLSLKSSFTIDEHSPLLTSWNLSTTF-----------CSWTGVTCDVSLRHVTSLDL 76
Query: 86 SRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPG 145
S +LSG + ++ +L L +L+L+AN GP+ P I L +LR +++S+N FN +FP
Sbjct: 77 SGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGSFPDE 136
Query: 146 ISK-LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLD 204
+S L LR+ + Y+N+ TG LP+ L L+ L+LGG+YF G+IP+ Y L +L
Sbjct: 137 LSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVLEYLA 196
Query: 205 LAGNSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLP 263
++GN LTG +PP++G LT L + IGY N + +P E +L L D + C L+G +P
Sbjct: 197 VSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLTGEIP 256
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
EI L KL+ L L N FTG I G + +L+ +DLS+N +G IP S + LK LT L
Sbjct: 257 PEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKNLTLL 316
Query: 324 SLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIP 383
+L N L+G IP+ I + +L+ L LW N+ TG +PQKLG NG+L+ +D+SSN LTG +P
Sbjct: 317 NLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLTGTLP 376
Query: 384 PTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFM 443
P +C G+RL LI N SIP++L C SL+R+R+ +N LNGSIP+ LP L+ +
Sbjct: 377 PNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGLPKLSQV 436
Query: 444 DMSRNSLSGEIPRDLGNAQ-KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKI 502
++ N L+GE+P G L +++S N SLP+ I + ++ L +K +G I
Sbjct: 437 ELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSI 496
Query: 503 PDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITD 561
P IG + + K++ +NL +G I +I C+ L ++LSRN L+G IP E++G+ +
Sbjct: 497 PPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGMKILNY 556
Query: 562 VDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGR 621
++LS N L G+IP + +L S + SYN L+G +P++G F + +SF+GN LCG
Sbjct: 557 LNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQ-FSYFNYTSFVGNSHLCGP 615
Query: 622 VLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSR 681
L PC G ++H +P ++ ++ F +F +VA + +R
Sbjct: 616 YL-GPC-------GKGTHQSH-VKPLSATTKLLLVLGLLFCSMVFAIVAIIK------AR 660
Query: 682 GFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKK 741
N E W+LTAFQRL+FT DDVL+ L D I+G G G VYK MP G+++AVK+
Sbjct: 661 SLRNASEAKAWRLTAFQRLDFTCDDVLDSLK-EDNIIGKGGAGIVYKGTMPKGDLVAVKR 719
Query: 742 LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLH 801
L G AE+ LG +RHR+IVRLLG CSN E +L+YEYMPNG+L ++LH
Sbjct: 720 L-ATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH 778
Query: 802 AKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861
K G W TRYKIAL A+G+CYLHHDC P+IVHRD+K +NILLD EA VADF
Sbjct: 779 GKKGGH---LHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADF 835
Query: 862 GVAKLIQ---SDESMSVIAGSYGYIAP 885
G+AK +Q + E MS IAGSYGYIAP
Sbjct: 836 GLAKFLQDSGTSECMSAIAGSYGYIAP 862
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FRS6|PXL1_ARATH Leucine-rich repeat receptor-like protein kinase PXL1 OS=Arabidopsis thaliana GN=PXL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 624 bits (1610), Expect = e-178, Method: Compositional matrix adjust.
Identities = 379/919 (41%), Positives = 542/919 (58%), Gaps = 55/919 (5%)
Query: 1 MKLPLFFLTFFLHLLVVFSANTLPLPLVS-----------LLSIKASLKDPFNNSFHDWD 49
M +P F F+ +F P VS LL+ K+ L DP NN DW
Sbjct: 1 MAIPRLFFLFYYIGFALF-------PFVSSETFQNSEQEILLAFKSDLFDPSNN-LQDWK 52
Query: 50 ATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNL 109
N ++ E V C W+G+ C+ + + L LS +LSG + +I+ SL L+L
Sbjct: 53 RP---ENATTFSELVHCHWTGVHCD-ANGYVAKLLLSNMNLSGNVSDQIQSFPSLQALDL 108
Query: 110 SANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLE 169
S NAF+ L ++ LT L+ ID+S NSF TFP G+ L NA SN+F+G LP +
Sbjct: 109 SNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMATGLTHVNASSNNFSGFLPED 168
Query: 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEI 229
+L+ L+ G YF+G +PS ++NL +L+FL L+GN+ G +P +G L+ LE I +
Sbjct: 169 LGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNNFGGKVPKVIGELSSLETIIL 228
Query: 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS 289
GYN GE+P EF L L+Y+D++ NL+G +PS + L +L + L++N TG++P
Sbjct: 229 GYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQLKQLTTVYLYQNRLTGKLPRE 288
Query: 290 YGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLL 349
G + +L LDLSDNQ++G IP + LK L L+LM N L G IP I L +L+ L L
Sbjct: 289 LGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQLTGIIPSKIAELPNLEVLEL 348
Query: 350 WNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN 409
W N L G LP LG N L +DVSSN L+G IP +C L KLILF+N+F+ IPE
Sbjct: 349 WQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYSRNLTKLILFNNSFSGQIPEE 408
Query: 410 LVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNI 469
+ +C +L R+RIQ N ++GSIP G G LP L +++++N+L+G+IP D+ + L +++I
Sbjct: 409 IFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNNLTGKIPDDIALSTSLSFIDI 468
Query: 470 SENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCK-SIYKIELHNNLLNGSIPWD 528
S N + S S+PNL+ AS + GKIP+ I + S+ ++L N +G IP
Sbjct: 469 SFNHLSSLSSSIF-SSPNLQTFIASHNNFAGKIPNQIQDRPSLSVLDLSFNHFSGGIPER 527
Query: 529 IGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNV 588
I EKL+ LNL N L G IP ++G+ + +DLS+N LTG IP++ TLE NV
Sbjct: 528 IASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNSLTGNIPADLGASPTLEMLNV 587
Query: 589 SYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPC------PADGLAAGDVEVRNH 642
S+N L GPIP S +F + P +GN GLCG VL PC A G G + V NH
Sbjct: 588 SFNKLDGPIP-SNMLFAAIDPKDLVGNNGLCGGVLP-PCSKSLALSAKGRNPGRIHV-NH 644
Query: 643 QQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRC-FRANYSRGF---SNDREIGPWKLTAFQ 698
+++ M F G ++ TR +N++R + RE PW+L AFQ
Sbjct: 645 AVFGFIVGTSVIVAMGMMFLAGRWIY---TRWDLYSNFAREYIFCKKPREEWPWRLVAFQ 701
Query: 699 RLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEI--IAVKKLW---------GKHK 747
RL FTA D+L + S+ I+GMG+ G VYKAE+ + +AVKKLW H
Sbjct: 702 RLCFTAGDILSHIKESN-IIGMGAIGIVYKAEVMRRPLLTVAVKKLWRSPSPQNDIEDHH 760
Query: 748 ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE 807
+ +L EV++LG +RHRNIV++LG N M++YEYMPNGNL LH+K++ +
Sbjct: 761 QEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMVYEYMPNGNLGTALHSKDE-K 819
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK-L 866
L+ DW++RY +A+GV QG+ YLH+DC P I+HRD+K +NILLD +EAR+ADFG+AK +
Sbjct: 820 FLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNNILLDSNLEARIADFGLAKMM 879
Query: 867 IQSDESMSVIAGSYGYIAP 885
+ +E++S++AGSYGYIAP
Sbjct: 880 LHKNETVSMVAGSYGYIAP 898
|
Involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65440|BAME3_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM3 OS=Arabidopsis thaliana GN=BAM3 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 598 bits (1542), Expect = e-170, Method: Compositional matrix adjust.
Identities = 357/869 (41%), Positives = 515/869 (59%), Gaps = 36/869 (4%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
L+S+K S D ++ S W+ P F++ CSW+G+ C+ + IT LDLS +
Sbjct: 38 LISLKQSF-DSYDPSLDSWN-IPNFNS--------LCSWTGVSCDNLNQSITRLDLSNLN 87
Query: 90 LSGPIPPEIRYLT-SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP-GIS 147
+SG I PEI L+ SL L++S+N+F G L I EL+ L ++IS N F G S
Sbjct: 88 ISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFS 147
Query: 148 KLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAG 207
++ L +AY NSF G LPL L L+ L+LGG+YFDGEIP Y + SL+FL L+G
Sbjct: 148 QMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSG 207
Query: 208 NSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
N L G +P +L +T L ++ +GY N+ +G +P +F L+NL ++D++ C+L G++P+E+
Sbjct: 208 NDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAEL 267
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
NL LE+L L N TG +P GN+ +L+ LDLS+N L G IP L+ L+ L +L
Sbjct: 268 GNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLF 327
Query: 327 NNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
N L GEIP+ + L DL L LW+N+ TG +P KLGSNG L+ +D+S+N LTG IP ++
Sbjct: 328 FNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESL 387
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
C G RL LILF+N +PE+L C L R R+ N L +P+G LPNL+ +++
Sbjct: 388 CFGRRLKILILFNNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLELQ 447
Query: 447 RNSLSGEIP-RDLGNAQ--KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIP 503
N L+GEIP + GNAQ L +N+S N +P +I + +L+IL +++L+G+IP
Sbjct: 448 NNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQIP 507
Query: 504 DFIGC-KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDV 562
IG KS+ KI++ N +G P + G C L L+LS N ++G IP +IS + + +
Sbjct: 508 GEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNYL 567
Query: 563 DLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRV 622
++S N ++P+ +L S + S+N +G +P SG F + +SF+GN LCG
Sbjct: 568 NVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQ-FSYFNNTSFLGNPFLCG-F 625
Query: 623 LTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRG 682
+ PC + + + Q ++ G I FG+GL +R
Sbjct: 626 SSNPCNG---SQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKNRR 682
Query: 683 FSNDREIGP--WKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVK 740
R+ P WKL FQ+L F ++ +LEC+ + ++G G G VYK MP GE +AVK
Sbjct: 683 M---RKNNPNLWKLIGFQKLGFRSEHILECVK-ENHVIGKGGRGIVYKGVMPNGEEVAVK 738
Query: 741 KLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL 800
KL K + G+ AE+ LG +RHRNIVRLL CSN++ +L+YEYMPNG+L ++L
Sbjct: 739 KLLTITKGS-SHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEVL 797
Query: 801 HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860
H K + W TR +IAL A+G+CYLHHDC P+I+HRD+K +NILL E EA VAD
Sbjct: 798 HGK---AGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVAD 854
Query: 861 FGVAKLIQSD----ESMSVIAGSYGYIAP 885
FG+AK + D E MS IAGSYGYIAP
Sbjct: 855 FGLAKFMMQDNGASECMSSIAGSYGYIAP 883
|
Necessary for male gametophyte development, as well as ovule specification and function. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 575 bits (1483), Expect = e-163, Method: Compositional matrix adjust.
Identities = 344/867 (39%), Positives = 506/867 (58%), Gaps = 45/867 (5%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
LL++K+S+ P + HDW + S+P + CS+SG+ C+ +++ SL++S
Sbjct: 31 LLNLKSSMIGPKGHGLHDWIHS---SSPDAH-----CSFSGVSCD-DDARVISLNVSFTP 81
Query: 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN-SFNSTFPPGISK 148
L G I PEI LT L +L L+AN F G L + LT L+ ++IS+N + TFP I K
Sbjct: 82 LFGTISPEIGMLTHLVNLTLAANNFTGELPLEMKSLTSLKVLNISNNGNLTGTFPGEILK 141
Query: 149 LRF-LRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAG 207
L + + Y+N+F G LP E +L L+ L+ GG++F GEIP Y ++ SL +L L G
Sbjct: 142 AMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGNFFSGEIPESYGDIQSLEYLGLNG 201
Query: 208 NSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
L+G P L L L + IGY N+ G VP EF L L+ +D+++C L+G +P+ +
Sbjct: 202 AGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFGGLTKLEILDMASCTLTGEIPTSL 261
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
SNL L L L N+ TG IP L +L+ LDLS NQL+G IP S +L +T ++L
Sbjct: 262 SNLKHLHTLFLHINNLTGHIPPELSGLVSLKSLDLSINQLTGEIPQSFINLGNITLINLF 321
Query: 327 NNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
N L+G+IP+ I L L+ +W N+ T LP LG NG L+ +DVS N LTG IP +
Sbjct: 322 RNNLYGQIPEAIGELPKLEVFEVWENNFTLQLPANLGRNGNLIKLDVSDNHLTGLIPKDL 381
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
C G++L LIL +N F IPE L C SL+++RI N LNG++P G LP +T ++++
Sbjct: 382 CRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIRIVKNLLNGTVPAGLFNLPLVTIIELT 441
Query: 447 RNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIP-DF 505
N SGE+P + + L+ + +S N F +P I + PNL+ L ++ G IP +
Sbjct: 442 DNFFSGELPVTM-SGDVLDQIYLSNNWFSGEIPPAIGNFPNLQTLFLDRNRFRGNIPREI 500
Query: 506 IGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLS 565
K + +I N + G IP I C L+ ++LSRN + G IP I+ + ++ +++S
Sbjct: 501 FELKHLSRINTSANNITGGIPDSISRCSTLISVDLSRNRINGEIPKGINNVKNLGTLNIS 560
Query: 566 HNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLC--GRVL 623
N LTG+IP+ N ++L + ++S+N L+G +P G F + +SF GN LC RV
Sbjct: 561 GNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLGGQ-FLVFNETSFAGNTYLCLPHRV- 618
Query: 624 TKPCPADGLAAGDVEVRNHQQ--QPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSR 681
CP G NH P + ++ ++AA G+ + + VA + + +
Sbjct: 619 --SCPT---RPGQTSDHNHTALFSPSRI---VITVIAAITGL-ILISVAIRQMNKKKNQK 669
Query: 682 GFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKK 741
+ WKLTAFQ+L+F ++DVLECL + I+G G G VY+ MP +A+K+
Sbjct: 670 SLA-------WKLTAFQKLDFKSEDVLECLK-EENIIGKGGAGIVYRGSMPNNVDVAIKR 721
Query: 742 LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLH 801
L G+ R G AE+ LG +RHR+IVRLLG +N++ +LLYEYMPNG+L +LLH
Sbjct: 722 LVGRGTG--RSDHGFTAEIQTLGRIRHRHIVRLLGYVANKDTNLLLYEYMPNGSLGELLH 779
Query: 802 AKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861
G W TR+++A+ A+G+CYLHHDC P+I+HRD+K +NILLD + EA VADF
Sbjct: 780 GSKGGH---LQWETRHRVAVEAAKGLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADF 836
Query: 862 GVAKLI---QSDESMSVIAGSYGYIAP 885
G+AK + + E MS IAGSYGYIAP
Sbjct: 837 GLAKFLVDGAASECMSSIAGSYGYIAP 863
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGP2|HSL1_ARATH Receptor-like protein kinase HSL1 OS=Arabidopsis thaliana GN=HSL1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 548 bits (1412), Expect = e-155, Method: Compositional matrix adjust.
Identities = 338/878 (38%), Positives = 496/878 (56%), Gaps = 60/878 (6%)
Query: 30 LLSIKASLKDP--FNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSR 87
L +K SL DP + +S++ DA+P C WSG+ C S +TS+DLS
Sbjct: 23 LQQVKLSLDDPDSYLSSWNSNDASP-------------CRWSGVSCAGDFSSVTSVDLSS 69
Query: 88 RSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGIS 147
+L+GP P I L++L HL+L N+ + L I L+T+D+S N P ++
Sbjct: 70 ANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGELPQTLA 129
Query: 148 KLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAG 207
+ L + N+F+G +P F + +L+ L+L + DG IP N+S+L+ L+L+
Sbjct: 130 DIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKMLNLSY 189
Query: 208 NSLTGS-LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
N + S +PP+ G LT LE + + +L G++P L L +D++ +L G +P +
Sbjct: 190 NPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGHIPPSL 249
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
LT + + L+ N TGEIP GNL++L++LD S NQL+G IP L + L L+L
Sbjct: 250 GGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LESLNLY 308
Query: 327 NNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
N L GE+P I L +L + ++ N LTG LP+ LG N L +DVS N +G +P +
Sbjct: 309 ENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGDLPADL 368
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
C L +L++ N+F+ IPE+L +C SL+R+R+ N+ +GS+P GF LP++ +++
Sbjct: 369 CAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVNLLELV 428
Query: 447 RNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-F 505
NS SGEI + +G A L L +S N F SLP I S NL LSAS +K +G +PD
Sbjct: 429 NNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGSLPDSL 488
Query: 506 IGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLS 565
+ + ++LH N +G + I +KL LNL+ N TG IP EI L + +DLS
Sbjct: 489 MSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLNYLDLS 548
Query: 566 HNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTK 625
N +G IP + ++ L N+SYN L+G +P S + +++ +SFIGN GLCG +
Sbjct: 549 GNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPS--LAKDMYKNSFIGNPGLCGDI--- 602
Query: 626 PCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSN 685
GL + E + VW++ + F + VL+AG F Y R F
Sbjct: 603 ----KGLCGSENEAKKR---------GYVWLLRSIFVLAAMVLLAGVAWFYFKY-RTFKK 648
Query: 686 DR--EIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLW 743
R E W L +F +L F+ ++LE L D ++G G++G VYK + GE +AVK+LW
Sbjct: 649 ARAMERSKWTLMSFHKLGFSEHEILESLD-EDNVIGAGASGKVYKVVLTNGETVAVKRLW 707
Query: 744 -GKHKENIR-----------RRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791
G KE + AEV+ LG +RH+NIV+L CCS R+C +L+YEYM
Sbjct: 708 TGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLLVYEYM 767
Query: 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD 851
PNG+L DLLH+ G + W TR+KI L A+G+ YLHHD P IVHRD+K +NIL+D
Sbjct: 768 PNGSLGDLLHSSKGG---MLGWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSNNILID 824
Query: 852 GEMEARVADFGVAKLI----QSDESMSVIAGSYGYIAP 885
G+ ARVADFGVAK + ++ +SMSVIAGS GYIAP
Sbjct: 825 GDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAP 862
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1345), Expect = e-147, Method: Compositional matrix adjust.
Identities = 346/971 (35%), Positives = 506/971 (52%), Gaps = 113/971 (11%)
Query: 6 FFLTFFLHLLVVFSANTLPLPLVS-LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPV 64
F +T L L S+ + VS L+S S P + F W+ P+ S+P
Sbjct: 18 FSITLSLFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWN--PSDSDP------- 68
Query: 65 WCSWSGIKCNPKSSQ-ITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAIL 123
C W I C+ ++ +T +++ L+ P PP I TSL L +S G + I
Sbjct: 69 -CQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIG 127
Query: 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGP------------------ 165
+ ++L ID+S NS P + KL+ L+ SN TG
Sbjct: 128 DCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFD 187
Query: 166 ------LPLEFVQLNSLQQLNLGG-SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQL 218
LPLE ++++L+ + GG S G+IP + N +L+ L LA ++GSLP L
Sbjct: 188 NYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSL 247
Query: 219 GLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLF 278
G L++L+ + + L GE+P E + L + + +LSGTLP E+ L LE +LL+
Sbjct: 248 GQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLW 307
Query: 279 KN------------------------HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL 314
+N +F+G IP S+GNL LQ L LS N ++G IP+ L
Sbjct: 308 QNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSIL 367
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
++ L + + N + G IP +I LL +L+ L W N L G +P +L L +D+S
Sbjct: 368 SNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLS 427
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGF 434
N LTG +P + L KL+L SN + IP + NC+SL RLR+ +N++ G IP+G
Sbjct: 428 QNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGI 487
Query: 435 GLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSAS 494
G L NL+F+D+S N+LSG +P ++ N ++L+ LN+S N+ Q LP ++ S L++L S
Sbjct: 488 GFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVS 547
Query: 495 SSKLTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLL---------------- 537
S+ LTGKIPD +G S+ ++ L N NG IP +GHC L L
Sbjct: 548 SNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEEL 607
Query: 538 ---------LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNV 588
LNLS NSL G IP IS L ++ +D+SHN L+G + S L S N+
Sbjct: 608 FDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDL-SALSGLENLVSLNI 666
Query: 589 SYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKK 648
S+N +G +P S +F L + GN GLC + + C + + H + +
Sbjct: 667 SHNRFSGYLPDS-KVFRQLIGAEMEGNNGLCSKGF-RSCFVSNSSQLTTQRGVHSHRLRI 724
Query: 649 TAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSNDREIGP----WKLTAFQRLNFTA 704
G ++ + A +G+ ++ + R + ND E G W+ T FQ+LNFT
Sbjct: 725 AIGLLISVTAVLAVLGVLAVIRAKQMIRDD------NDSETGENLWTWQFTPFQKLNFTV 778
Query: 705 DDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRR-------RRGVL 757
+ VL+CL + ++G G +G VYKAEMP E+IAVKKLW N+ R
Sbjct: 779 EHVLKCL-VEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFS 837
Query: 758 AEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY 817
AEV LG++RH+NIVR LGCC N+ +L+Y+YM NG+L LLH ++ +L W RY
Sbjct: 838 AEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSL--GWEVRY 895
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE---SMS 874
KI LG AQG+ YLHHDC P IVHRD+K +NIL+ + E + DFG+AKL+ + S +
Sbjct: 896 KIILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSN 955
Query: 875 VIAGSYGYIAP 885
IAGSYGYIAP
Sbjct: 956 TIAGSYGYIAP 966
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGX3|HSL2_ARATH LRR receptor-like serine/threonine-protein kinase HSL2 OS=Arabidopsis thaliana GN=HSL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 315/869 (36%), Positives = 483/869 (55%), Gaps = 54/869 (6%)
Query: 34 KASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPK---SSQITSLDLSRRSL 90
K L DP N DW T +P C+W+GI C+ + S +T++DLS ++
Sbjct: 36 KTRLFDPDGN-LQDWVITGDNRSP--------CNWTGITCHIRKGSSLAVTTIDLSGYNI 86
Query: 91 SGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILEL-TKLRTIDISHNSFNSTFPPGISKL 149
SG P + +L ++ LS N +G + A L L +KL+ + ++ N+F+ P +
Sbjct: 87 SGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSPEF 146
Query: 150 RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNS 209
R LR+ SN FTG +P + +L +LQ LNL G+ G +P+ L+ L LDLA S
Sbjct: 147 RKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYIS 206
Query: 210 LTGS-LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISN 268
S +P LG L+ L + + ++NL GE+P +LV L+ +D++ +L+G +P I
Sbjct: 207 FDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGR 266
Query: 269 LTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328
L + + L+ N +G++P S GNL L+ D+S N L+G +P +A+L+ L +L +N
Sbjct: 267 LESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDN 325
Query: 329 VLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388
G +P + L +L ++NN TG LP+ LG ++ DVS+N +G +PP +C
Sbjct: 326 FFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCY 385
Query: 389 GDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN 448
+L K+I FSN + IPE+ +C SL+ +R+ DN+L+G +P F LP LT ++++ N
Sbjct: 386 RRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELP-LTRLELANN 444
Query: 449 S-LSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIG 507
+ L G IP + A+ L L IS N+F +P + +L+++ S + G IP I
Sbjct: 445 NQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCIN 504
Query: 508 -CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSH 566
K++ ++E+ N+L+G IP + C +L LNLS N L G IP E+ LP + +DLS+
Sbjct: 505 KLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSN 564
Query: 567 NFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVL--T 624
N LTG IP+ L FNVS N L G IP+ ++ SF+GN LC L
Sbjct: 565 NQLTGEIPAELLRLK-LNQFNVSDNKLYGKIPSG--FQQDIFRPSFLGNPNLCAPNLDPI 621
Query: 625 KPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFS 684
+PC + +++ + + + A G +++ + F+ R
Sbjct: 622 RPCRS-------------KRETRYILPISILCIVALTGALVWLFIKTKPLFKRKPKR--- 665
Query: 685 NDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWG 744
K+T FQR+ FT +D+ L+ D I+G G +G VY+ ++ G+ +AVKKLWG
Sbjct: 666 ------TNKITIFQRVGFTEEDIYPQLT-EDNIIGSGGSGLVYRVKLKSGQTLAVKKLWG 718
Query: 745 KHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKN 804
+ + +EV+ LG VRH NIV+LL CC+ E L+YE+M NG+L D+LH++
Sbjct: 719 ETGQKTESESVFRSEVETLGRVRHGNIVKLLMCCNGEEFRFLVYEFMENGSLGDVLHSEK 778
Query: 805 KGENLVA-DWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
+ + DW TR+ IA+G AQG+ YLHHD P IVHRD+K +NILLD EM+ RVADFG+
Sbjct: 779 EHRAVSPLDWTTRFSIAVGAAQGLSYLHHDSVPPIVHRDVKSNNILLDHEMKPRVADFGL 838
Query: 864 AKLIQ-------SDESMSVIAGSYGYIAP 885
AK ++ SD SMS +AGSYGYIAP
Sbjct: 839 AKPLKREDNDGVSDVSMSCVAGSYGYIAP 867
|
Receptor-like serine/threonine-kinase acting on substrates that controls floral organ abscission. Regulated by the 'INFLORESCENCE DEFICIENT IN ABSCISSION' (IDA) family of ligands. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| 224071507 | 1026 | predicted protein [Populus trichocarpa] | 0.958 | 0.843 | 0.782 | 0.0 | |
| 359490050 | 1024 | PREDICTED: leucine-rich repeat receptor- | 0.964 | 0.849 | 0.726 | 0.0 | |
| 356529873 | 1187 | PREDICTED: leucine-rich repeat receptor- | 0.967 | 0.735 | 0.719 | 0.0 | |
| 356542427 | 1022 | PREDICTED: leucine-rich repeat receptor- | 0.965 | 0.852 | 0.718 | 0.0 | |
| 449519374 | 1049 | PREDICTED: leucine-rich repeat receptor- | 0.967 | 0.832 | 0.718 | 0.0 | |
| 449458421 | 1049 | PREDICTED: leucine-rich repeat receptor- | 0.967 | 0.832 | 0.718 | 0.0 | |
| 147821313 | 1034 | hypothetical protein VITISV_002859 [Viti | 0.950 | 0.828 | 0.711 | 0.0 | |
| 297797107 | 1037 | hypothetical protein ARALYDRAFT_496307 [ | 0.953 | 0.829 | 0.642 | 0.0 | |
| 15240263 | 1041 | putative leucine-rich repeat receptor-li | 0.926 | 0.803 | 0.638 | 0.0 | |
| 255539821 | 939 | Receptor protein kinase CLAVATA1 precurs | 0.818 | 0.785 | 0.715 | 0.0 |
| >gi|224071507|ref|XP_002303493.1| predicted protein [Populus trichocarpa] gi|222840925|gb|EEE78472.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1368 bits (3542), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 683/873 (78%), Positives = 754/873 (86%), Gaps = 8/873 (0%)
Query: 15 LVVFSANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSE-QEPVWCSWSGIKC 73
L+VFSA TLP PL SLLSIK LKDP +N+FHDW+ SN S QEPVWCSWSGIKC
Sbjct: 21 LLVFSATTLPPPLQSLLSIKTFLKDP-SNTFHDWN----LSNTSGLIQEPVWCSWSGIKC 75
Query: 74 NPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDI 133
NP ++QITSLDLS R+LSG IP EIRYLTSL HLNLS NAFDG LQPAI EL LR +DI
Sbjct: 76 NPATAQITSLDLSHRNLSGVIPAEIRYLTSLVHLNLSGNAFDGLLQPAIFELGDLRILDI 135
Query: 134 SHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD 193
SHN+FNSTFPPGISKL+FLR+FNAYSN+FTGPLP EFV L L++LNLGGSYF GEIP
Sbjct: 136 SHNNFNSTFPPGISKLKFLRVFNAYSNNFTGPLPKEFVWLRFLEELNLGGSYFTGEIPRS 195
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNL-QGEVPVEFASLVNLKYMD 252
Y + L++L LAGN L G LPP LG L+QLE +E+GY+ L G VP EFA L NLKY+D
Sbjct: 196 YGSFLRLKYLYLAGNELEGPLPPDLGFLSQLEHLELGYHPLLSGNVPEEFALLTNLKYLD 255
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPA 312
IS CNLSG+LP ++ NLTKLE LLLF N FTGEIPVSY NL+AL+ LDLS NQLSG IP
Sbjct: 256 ISKCNLSGSLPPQLGNLTKLENLLLFMNQFTGEIPVSYTNLKALKALDLSVNQLSGAIPE 315
Query: 313 SLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVD 372
L+SLK L RLS + N L GEIP I L LDTL LWNN+LTGVLPQKLGSNG LL +D
Sbjct: 316 GLSSLKELNRLSFLKNQLTGEIPPGIGELPYLDTLELWNNNLTGVLPQKLGSNGNLLWLD 375
Query: 373 VSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432
VS+NSL+GPIPP +C G++L+KLILFSN F +P++L NC+SLSR RIQDNQLNGSIP
Sbjct: 376 VSNNSLSGPIPPNLCQGNKLYKLILFSNKFLGKLPDSLANCTSLSRFRIQDNQLNGSIPY 435
Query: 433 GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILS 492
G GLLPNL+++D+S+N+ +GEIP DLGN++ L +LNIS NSF T+LP+NIWSAPNL+I S
Sbjct: 436 GLGLLPNLSYVDLSKNNFTGEIPDDLGNSEPLHFLNISGNSFHTALPNNIWSAPNLQIFS 495
Query: 493 ASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWE 552
ASS KL KIPDFIGC S+Y+IEL +N+ NGSIPWDIGHCE+L+ LNLSRNSLTGIIPWE
Sbjct: 496 ASSCKLVSKIPDFIGCSSLYRIELQDNMFNGSIPWDIGHCERLVSLNLSRNSLTGIIPWE 555
Query: 553 ISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF 612
IS LP+I DVDLSHN LTG+IPSNF NCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF
Sbjct: 556 ISTLPAIADVDLSHNLLTGSIPSNFGNCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF 615
Query: 613 IGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGT 672
GN+GLCG VL KPC AD L AG++EVR H+QQPK+TAGAIVWIMAAAFGIGLFVLVAGT
Sbjct: 616 SGNQGLCGGVLPKPCAADTLGAGEMEVR-HRQQPKRTAGAIVWIMAAAFGIGLFVLVAGT 674
Query: 673 RCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMP 732
RCF ANY R FS++REIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMP
Sbjct: 675 RCFHANYGRRFSDEREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMP 734
Query: 733 GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792
GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP
Sbjct: 735 GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 794
Query: 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 852
NGNL DLLH KNKG+NLV DW+TRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG
Sbjct: 795 NGNLHDLLHGKNKGDNLVGDWLTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 854
Query: 853 EMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
EMEARVADFGVAKLIQSDESMSVIAGSYGYIAP
Sbjct: 855 EMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 887
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359490050|ref|XP_002268598.2| PREDICTED: leucine-rich repeat receptor-like protein kinase TDR-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1291 bits (3340), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/876 (72%), Positives = 729/876 (83%), Gaps = 6/876 (0%)
Query: 10 FFLHLLVVFSANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWS 69
F L + +VFSA LPL L+SLL++K+SLKDP + + H WD TP+ S P+ + P+WCSWS
Sbjct: 18 FLLRITLVFSA-PLPLQLISLLALKSSLKDPLS-TLHGWDPTPSLSTPAFHR-PLWCSWS 74
Query: 70 GIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLR 129
G+KC+PK+S +TSLDLSRR+LSG IPPEIRYL++L HLNLS NAFDGP P++ EL LR
Sbjct: 75 GVKCDPKTSHVTSLDLSRRNLSGTIPPEIRYLSTLNHLNLSGNAFDGPFPPSVFELPNLR 134
Query: 130 TIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE 189
+DISHN+FNS+FPPG+SK++FLR+ +AYSNSFTGPLP + +QL L+ LNLGGSYF+G
Sbjct: 135 ALDISHNNFNSSFPPGLSKIKFLRLLDAYSNSFTGPLPQDIIQLRYLEFLNLGGSYFEGS 194
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249
IP+ Y N L+FL LAGN+L G +PP+LGL QL+R+EIGYN G VP++FA L NLK
Sbjct: 195 IPAIYGNFPRLKFLHLAGNALDGPIPPELGLNAQLQRLEIGYNAFYGGVPMQFALLSNLK 254
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309
Y+DIS NLSG LP+ + N+T L+ LLLF NHF GEIPVSY L AL+ LDLS+NQL+G
Sbjct: 255 YLDISTANLSGPLPAHLGNMTMLQTLLLFSNHFWGEIPVSYARLTALKSLDLSNNQLTGS 314
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLL 369
IP SLK LT LSLMNN L GEIPQ I L +LDTL LWNN LTG LPQ LGSN KL+
Sbjct: 315 IPEQFTSLKELTILSLMNNELAGEIPQGIGDLPNLDTLSLWNNSLTGTLPQNLGSNAKLM 374
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS 429
+DVSSN LTG IP +C G+ L KLILF N +P +L NC+SL R R+Q NQLNGS
Sbjct: 375 KLDVSSNFLTGSIPLNLCLGNHLIKLILFGNRLVSELPNSLANCTSLMRFRVQGNQLNGS 434
Query: 430 IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLK 489
IP GFG +PNLT+MD+S+N SGEIP D GNA KLEYLNISEN+F + LP NIW AP+L+
Sbjct: 435 IPYGFGQMPNLTYMDLSKNKFSGEIPEDFGNAAKLEYLNISENAFDSQLPDNIWRAPSLQ 494
Query: 490 ILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGII 549
I SASSS + GKIPDFIGC+S+YKIEL N LNGSIPWDIGHC KLL LNL NSLTGII
Sbjct: 495 IFSASSSNIRGKIPDFIGCRSLYKIELQGNELNGSIPWDIGHCMKLLSLNLRDNSLTGII 554
Query: 550 PWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHP 609
PWEIS LPSITDVDLSHNFLTGTIPSNF+NCSTLESFNVS+NLLTGPIP+SGTIFPNLHP
Sbjct: 555 PWEISTLPSITDVDLSHNFLTGTIPSNFDNCSTLESFNVSFNLLTGPIPSSGTIFPNLHP 614
Query: 610 SSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLV 669
SSF GN LCG V++KPC A AA +VR QQPKKTAGAIVWIMAAAFGIGLFVL+
Sbjct: 615 SSFTGNVDLCGGVVSKPCAAGTEAATAEDVR---QQPKKTAGAIVWIMAAAFGIGLFVLI 671
Query: 670 AGTRCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKA 729
AG+RCFRANYSRG S +RE+GPWKLTAFQRLNF+ADDV+EC+SM+DKI+GMGSTGTVYKA
Sbjct: 672 AGSRCFRANYSRGISGEREMGPWKLTAFQRLNFSADDVVECISMTDKIIGMGSTGTVYKA 731
Query: 730 EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789
EM GGE+IAVKKLWGK KE +R+RRGV+AEVDVLGNVRHRNIVRLLG CSN + TMLLYE
Sbjct: 732 EMRGGEMIAVKKLWGKQKETVRKRRGVVAEVDVLGNVRHRNIVRLLGWCSNSDSTMLLYE 791
Query: 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849
YMPNG+LDDLLH KNKG+NLVADW TRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL
Sbjct: 792 YMPNGSLDDLLHGKNKGDNLVADWYTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 851
Query: 850 LDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
LD +MEARVADFGVAKLIQ DESMSVIAGSYGYIAP
Sbjct: 852 LDADMEARVADFGVAKLIQCDESMSVIAGSYGYIAP 887
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529873|ref|XP_003533511.1| PREDICTED: leucine-rich repeat receptor-like protein kinase TDR-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1271 bits (3288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/889 (71%), Positives = 735/889 (82%), Gaps = 16/889 (1%)
Query: 5 LFFLTF-FL---HLLVVFSANT-LPLPLVSLLSIKASLKDPFNNSFHDWDATPA--FSNP 57
LF +TF FL HLL++ SA T LPL LV+LLSIK+SL DP NN HDWD +P+ FSN
Sbjct: 6 LFLITFSFLCQTHLLILLSATTTLPLQLVALLSIKSSLLDPLNN-LHDWDPSPSPTFSN- 63
Query: 58 SSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGP 117
S+ Q P+WCSW I C+PK+SQIT+LDLS +LSG I P+IR+L++L HLNLS N F G
Sbjct: 64 SNPQHPIWCSWRAITCHPKTSQITTLDLSHLNLSGTISPQIRHLSTLNHLNLSGNDFTGS 123
Query: 118 LQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQ 177
Q AI ELT+LRT+DISHNSFNSTFPPGISKL+FLR FNAYSNSFTGPLP E L ++
Sbjct: 124 FQYAIFELTELRTLDISHNSFNSTFPPGISKLKFLRHFNAYSNSFTGPLPQELTTLRFIE 183
Query: 178 QLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGE 237
QLNLGGSYF IP Y L+FLDLAGN+ G LPPQLG L +LE +EIGYNN G
Sbjct: 184 QLNLGGSYFSDGIPPSYGTFPRLKFLDLAGNAFEGPLPPQLGHLAELEHLEIGYNNFSGT 243
Query: 238 VPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ 297
+P E L NLKY+DIS+ N+SG + E+ NLTKLE LLLFKN TGEIP + G L++L+
Sbjct: 244 LPSELGLLPNLKYLDISSTNISGNVIPELGNLTKLETLLLFKNRLTGEIPSTLGKLKSLK 303
Query: 298 VLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357
LDLSDN+L+GPIP + L LT L+LMNN L GEIPQ I L LDTL L+NN LTG
Sbjct: 304 GLDLSDNELTGPIPTQVTMLTELTMLNLMNNNLTGEIPQGIGELPKLDTLFLFNNSLTGT 363
Query: 358 LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLS 417
LP++LGSNG LL +DVS+NSL GPIP +C G++L +LILF N FT S+P +L NC+SL+
Sbjct: 364 LPRQLGSNGLLLKLDVSTNSLEGPIPENVCKGNKLVRLILFLNRFTGSLPHSLANCTSLA 423
Query: 418 RLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTS 477
R+RIQ+N LNGSIPQG LLPNLTF+D+S N+ G+IP LGN L+Y N+S NSF TS
Sbjct: 424 RVRIQNNFLNGSIPQGLTLLPNLTFLDISTNNFRGQIPERLGN---LQYFNMSGNSFGTS 480
Query: 478 LPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLL 537
LP++IW+A +L I SA+SS +TG+IPDFIGC+++YK+EL N +NG+IPWDIGHC+KL+L
Sbjct: 481 LPASIWNATDLAIFSAASSNITGQIPDFIGCQALYKLELQGNSINGTIPWDIGHCQKLIL 540
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPI 597
LNLSRNSLTGIIPWEIS LPSITDVDLSHN LTGTIPSNF NCSTLE+FNVS+N L GPI
Sbjct: 541 LNLSRNSLTGIIPWEISILPSITDVDLSHNSLTGTIPSNFNNCSTLENFNVSFNSLIGPI 600
Query: 598 PASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIM 657
P+SG IFPNLHPSS+ GN+GLCG VL KPC AD LAA D +V H+QQPK+TAGAIVWI+
Sbjct: 601 PSSG-IFPNLHPSSYAGNQGLCGGVLAKPCAADALAASDNQVDVHRQQPKRTAGAIVWIV 659
Query: 658 AAAFGIGLFVLVAGTRCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKI 717
AAAFGIGLFVLVAGTRCF ANY+ F + E+GPWKLTAFQRLNFTA+DVLECLS+SDKI
Sbjct: 660 AAAFGIGLFVLVAGTRCFHANYNHRFGD--EVGPWKLTAFQRLNFTAEDVLECLSLSDKI 717
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LGMGSTGTVY+AEMPGGEIIAVKKLWGK KE NIRRRRGVLAEV+VLGNVRHRNIVRLLG
Sbjct: 718 LGMGSTGTVYRAEMPGGEIIAVKKLWGKQKENNIRRRRGVLAEVEVLGNVRHRNIVRLLG 777
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
CCSN ECTMLLYEYMPNGNLDDLLHAKNKG+NLVADW RYKIALGVAQGICYLHHDCDP
Sbjct: 778 CCSNNECTMLLYEYMPNGNLDDLLHAKNKGDNLVADWFNRYKIALGVAQGICYLHHDCDP 837
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
VIVHRDLKPSNILLD EM+ARVADFGVAKLIQ+DESMSVIAGSYGYIAP
Sbjct: 838 VIVHRDLKPSNILLDAEMKARVADFGVAKLIQTDESMSVIAGSYGYIAP 886
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356542427|ref|XP_003539668.1| PREDICTED: leucine-rich repeat receptor-like protein kinase TDR-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1270 bits (3287), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 637/886 (71%), Positives = 734/886 (82%), Gaps = 15/886 (1%)
Query: 5 LFFLTF-FL---HLLVVFSANT-LPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSS 59
LF +TF FL HLL+V SA T L L L++LLSIK+SL DP NN HDWD +P+ SNP
Sbjct: 6 LFLITFSFLCQTHLLLVLSATTPLSLQLIALLSIKSSLLDPLNN-LHDWDPSPSPSNP-- 62
Query: 60 EQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQ 119
Q P+WCSW I C+ K+SQIT+LDLS +LSG I P+IR+L++L HLNLS N F G Q
Sbjct: 63 -QHPIWCSWRAITCHSKTSQITTLDLSHLNLSGTISPQIRHLSTLNHLNLSGNDFTGSFQ 121
Query: 120 PAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQL 179
AI ELT+LRT+DISHNSFNSTFPPGISKL+FLR FNAYSNSFTGPLP E L L+QL
Sbjct: 122 YAIFELTELRTLDISHNSFNSTFPPGISKLKFLRHFNAYSNSFTGPLPQELTTLRFLEQL 181
Query: 180 NLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP 239
NLGGSYF IP Y L+FLD+AGN+L G LPPQLG L +LE +EIGYNN G +P
Sbjct: 182 NLGGSYFSDGIPPSYGTFPRLKFLDIAGNALEGPLPPQLGHLAELEHLEIGYNNFSGTLP 241
Query: 240 VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVL 299
E A L NLKY+DIS+ N+SG + E+ NLTKLE LLLFKN TGEIP + G L++L+ L
Sbjct: 242 SELALLYNLKYLDISSTNISGNVIPELGNLTKLETLLLFKNRLTGEIPSTIGKLKSLKGL 301
Query: 300 DLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP 359
DLSDN+L+GPIP + L LT L+LM+N L GEIPQ I L LDTL L+NN LTG LP
Sbjct: 302 DLSDNELTGPIPTQVTMLTELTTLNLMDNNLTGEIPQGIGELPKLDTLFLFNNSLTGTLP 361
Query: 360 QKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRL 419
Q+LGSNG LL +DVS+NSL GPIP +C G++L +LILF N FT S+P +L NC+SL+R+
Sbjct: 362 QQLGSNGLLLKLDVSTNSLEGPIPENVCKGNKLVRLILFLNRFTGSLPPSLSNCTSLARV 421
Query: 420 RIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLP 479
RIQ+N L+GSIP+G LLPNLTF+D+S N+ G+IP LGN L+Y NIS NSF TSLP
Sbjct: 422 RIQNNFLSGSIPEGLTLLPNLTFLDISTNNFRGQIPERLGN---LQYFNISGNSFGTSLP 478
Query: 480 SNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLN 539
++IW+A NL I SA+SS +TG+IPDFIGC+++YK+EL N +NG+IPWD+GHC+KL+LLN
Sbjct: 479 ASIWNATNLAIFSAASSNITGQIPDFIGCQALYKLELQGNSINGTIPWDVGHCQKLILLN 538
Query: 540 LSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPA 599
LSRNSLTGIIPWEIS LPSITDVDLSHN LTGTIPSNF NCSTLE+FNVS+N LTGPIP+
Sbjct: 539 LSRNSLTGIIPWEISALPSITDVDLSHNSLTGTIPSNFNNCSTLENFNVSFNSLTGPIPS 598
Query: 600 SGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAA 659
+G IFPNLHPSS+ GN+GLCG VL KPC AD L+A D +V +QQPK+TAGAIVWI+AA
Sbjct: 599 TG-IFPNLHPSSYSGNQGLCGGVLAKPCAADALSAADNQVDVRRQQPKRTAGAIVWIVAA 657
Query: 660 AFGIGLFVLVAGTRCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILG 719
AFGIGLFVLVAGTRCF ANY+R F + E+GPWKLTAFQRLNFTA+DVLECLSMSDKILG
Sbjct: 658 AFGIGLFVLVAGTRCFHANYNRRFGD--EVGPWKLTAFQRLNFTAEDVLECLSMSDKILG 715
Query: 720 MGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS 779
MGSTGTVY++EMPGGEIIAVKKLWGK KENIRRRRGVLAEV+VLGNVRHRNIVRLLGCCS
Sbjct: 716 MGSTGTVYRSEMPGGEIIAVKKLWGKQKENIRRRRGVLAEVEVLGNVRHRNIVRLLGCCS 775
Query: 780 NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIV 839
N+ECTMLLYEYMPNGNLDD LH KNKG+NLVADW TRYKIALGVAQGICYLHHDCDPVIV
Sbjct: 776 NKECTMLLYEYMPNGNLDDWLHGKNKGDNLVADWFTRYKIALGVAQGICYLHHDCDPVIV 835
Query: 840 HRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
HRDLKPSNILLD EMEARVADFGVAKLIQ+DESMSVIAGSYGYIAP
Sbjct: 836 HRDLKPSNILLDAEMEARVADFGVAKLIQTDESMSVIAGSYGYIAP 881
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519374|ref|XP_004166710.1| PREDICTED: leucine-rich repeat receptor-like protein kinase TDR-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1257 bits (3253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/880 (71%), Positives = 734/880 (83%), Gaps = 7/880 (0%)
Query: 9 TFFLHLLVVFSANT-LPLPLVSLLSIKASLKDPFNNSFHDWD-ATPAFSNPSSEQEPVWC 66
TF L ++V S T LPL L+SLLS+K+++KDP +++FHDWD TP F+ S Q+P+WC
Sbjct: 24 TFLLEVVVSVSTPTALPLQLLSLLSLKSTIKDP-SSTFHDWDYPTPTFTRADS-QDPIWC 81
Query: 67 SWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELT 126
SWSGI+C+ S++I+SLDLS+R+LSG IP EI+YLTSL HLNLS N+F G AI EL
Sbjct: 82 SWSGIECHRNSAEISSLDLSQRNLSGYIPSEIKYLTSLIHLNLSGNSFVGAFPTAIFELP 141
Query: 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF 186
LRT+DISHN+F+S FPPGISKL+FL +FNAYSN+FTGPLP + L+ L+ L+LGGSYF
Sbjct: 142 HLRTLDISHNNFSSIFPPGISKLKFLNVFNAYSNNFTGPLPQDLPHLHFLEWLSLGGSYF 201
Query: 187 DGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246
G IP+ Y LS L++L L GN L G +P QL L +LER+EIGYN L G +P +F L+
Sbjct: 202 SGNIPASYGGLSRLKYLHLGGNVLEGEIPGQLAYLNKLERMEIGYNTLSGGIPSKFPLLL 261
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
NLKY+DI+ NLSGTLP +I N+T L+ LLLFKN +GEIP S G L+AL+ LDLS+N+L
Sbjct: 262 NLKYLDIAEANLSGTLPQDIGNMTNLQNLLLFKNRISGEIPRSLGKLEALEELDLSENEL 321
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
+G IP+ L +LK LT LSLM N L GEIPQ + L +L +L LWNN TG LPQKLGSNG
Sbjct: 322 TGTIPSDLYNLKELTDLSLMENDLSGEIPQALGDLPNLVSLRLWNNSFTGPLPQKLGSNG 381
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
KLL VDVSSN TG IPP +C G++LFKLILFSN + +P +L NC SL R RIQ+N+L
Sbjct: 382 KLLQVDVSSNMFTGSIPPDLCHGNKLFKLILFSNKLEHELPASLANCKSLIRFRIQNNRL 441
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
NGSIP GFGLL NLTF D S N+ SGEIP D+GNA +L+YLNIS+N+F TSLP NIW++
Sbjct: 442 NGSIPYGFGLLENLTFADFSNNNFSGEIPADIGNAVRLQYLNISQNAFGTSLPENIWNST 501
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+I SASSSK+ GKIPDFI C+SIYKIEL +N LN SIPW IGHCEKL+ LNL RNSLT
Sbjct: 502 RLEIFSASSSKIIGKIPDFISCRSIYKIELQDNDLNSSIPWTIGHCEKLITLNLGRNSLT 561
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPN 606
GIIPWEIS LP IT +DLSHN LTGTIPSNF+NCST+ESFNVSYN+LTGPIP++GTIFP
Sbjct: 562 GIIPWEISTLPGITAIDLSHNSLTGTIPSNFQNCSTIESFNVSYNMLTGPIPSTGTIFPA 621
Query: 607 LHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLF 666
LHPSSFIGN+GLCG +++KPC D L AG +EVR QQP++TAGAIVWIMA AFGIGLF
Sbjct: 622 LHPSSFIGNDGLCGEIVSKPCDTDTLTAGAIEVR--PQQPRRTAGAIVWIMAGAFGIGLF 679
Query: 667 VLVAGTRCFRANYSRGF-SNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGT 725
+LVAGTRCF+ANY+R F + EIGPWKLTAFQRLNFTA++VLECL+M+DKILGMGSTGT
Sbjct: 680 ILVAGTRCFQANYNRRFGGGEEEIGPWKLTAFQRLNFTAEEVLECLTMTDKILGMGSTGT 739
Query: 726 VYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785
VYKAEMPGGEIIAVKKLWGK+KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM
Sbjct: 740 VYKAEMPGGEIIAVKKLWGKYKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 799
Query: 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 845
LLYEYMPNGNLDDLLH KNKGENL ADW+TRYKIALGVAQGICYLHHDCDPVIVHRDLKP
Sbjct: 800 LLYEYMPNGNLDDLLHGKNKGENLGADWMTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 859
Query: 846 SNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
SNILLDGEMEARVADFGVAKLIQ+DESMSVIAGSYGYIAP
Sbjct: 860 SNILLDGEMEARVADFGVAKLIQTDESMSVIAGSYGYIAP 899
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449458421|ref|XP_004146946.1| PREDICTED: leucine-rich repeat receptor-like protein kinase TDR-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1257 bits (3253), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 632/880 (71%), Positives = 734/880 (83%), Gaps = 7/880 (0%)
Query: 9 TFFLHLLVVFSANT-LPLPLVSLLSIKASLKDPFNNSFHDWD-ATPAFSNPSSEQEPVWC 66
TF L ++V S T LPL L+SLLS+K+++KDP +++FHDWD TP F+ S Q+P+WC
Sbjct: 24 TFLLEVVVSVSTPTALPLQLLSLLSLKSTIKDP-SSTFHDWDYPTPTFTRADS-QDPIWC 81
Query: 67 SWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELT 126
SWSGI+C+ S++I+SLDLS+R+LSG IP EI+YLTSL HLNLS N+F G AI EL
Sbjct: 82 SWSGIECHRNSAEISSLDLSQRNLSGYIPSEIKYLTSLIHLNLSGNSFVGAFPTAIFELP 141
Query: 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF 186
LRT+DISHN+F+S FPPGISKL+FL +FNAYSN+FTGPLP + L+ L+ L+LGGSYF
Sbjct: 142 HLRTLDISHNNFSSIFPPGISKLKFLNVFNAYSNNFTGPLPQDLPHLHFLEWLSLGGSYF 201
Query: 187 DGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246
G IP+ Y LS L++L L GN L G +P QL L +LER+EIGYN L G +P +F L+
Sbjct: 202 SGNIPASYGGLSRLKYLHLGGNVLEGEIPGQLAYLNKLERMEIGYNTLSGGIPSKFPLLL 261
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
NLKY+DI+ NLSGTLP +I N+T L+ LLLFKN +GEIP S G L+AL+ LDLS+N+L
Sbjct: 262 NLKYLDIAEANLSGTLPQDIGNMTNLQNLLLFKNRISGEIPRSLGKLEALEELDLSENEL 321
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
+G IP+ L +LK LT LSLM N L GEIPQ + L +L +L LWNN TG LPQKLGSNG
Sbjct: 322 TGTIPSDLYNLKELTDLSLMENDLSGEIPQALGDLPNLVSLRLWNNSFTGPLPQKLGSNG 381
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
KLL VDVSSN TG IPP +C G++LFKLILFSN + +P +L NC SL R RIQ+N+L
Sbjct: 382 KLLQVDVSSNMFTGSIPPDLCHGNKLFKLILFSNKLEHELPASLANCKSLIRFRIQNNRL 441
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
NGSIP GFGLL NLTF D S N+ SGEIP D+GNA +L+YLNIS+N+F TSLP NIW++
Sbjct: 442 NGSIPYGFGLLENLTFADFSNNNFSGEIPADIGNAVRLQYLNISQNAFGTSLPENIWNST 501
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+I SASSSK+ GKIPDFI C+SIYKIEL +N LN SIPW IGHCEKL+ LNL RNSLT
Sbjct: 502 RLEIFSASSSKIIGKIPDFISCRSIYKIELQDNNLNSSIPWTIGHCEKLITLNLGRNSLT 561
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPN 606
GIIPWEIS LP IT +DLSHN LTGTIPSNF+NCST+ESFNVSYN+LTGPIP++GTIFP
Sbjct: 562 GIIPWEISTLPGITAIDLSHNSLTGTIPSNFQNCSTIESFNVSYNMLTGPIPSTGTIFPA 621
Query: 607 LHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLF 666
LHPSSFIGN+GLCG +++KPC D L AG +EVR QQP++TAGAIVWIMA AFGIGLF
Sbjct: 622 LHPSSFIGNDGLCGEIVSKPCDTDTLTAGAIEVR--PQQPRRTAGAIVWIMAGAFGIGLF 679
Query: 667 VLVAGTRCFRANYSRGF-SNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGT 725
+LVAGTRCF+ANY+R F + EIGPWKLTAFQRLNFTA++VLECL+M+DKILGMGSTGT
Sbjct: 680 ILVAGTRCFQANYNRRFGGGEEEIGPWKLTAFQRLNFTAEEVLECLTMTDKILGMGSTGT 739
Query: 726 VYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785
VYKAEMPGGEIIAVKKLWGK+KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM
Sbjct: 740 VYKAEMPGGEIIAVKKLWGKYKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 799
Query: 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 845
LLYEYMPNGNLDDLLH KNKGENL ADW+TRYKIALGVAQGICYLHHDCDPVIVHRDLKP
Sbjct: 800 LLYEYMPNGNLDDLLHGKNKGENLGADWMTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 859
Query: 846 SNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
SNILLDGEMEARVADFGVAKLIQ+DESMSVIAGSYGYIAP
Sbjct: 860 SNILLDGEMEARVADFGVAKLIQTDESMSVIAGSYGYIAP 899
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147821313|emb|CAN65669.1| hypothetical protein VITISV_002859 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1249 bits (3233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/876 (71%), Positives = 717/876 (81%), Gaps = 19/876 (2%)
Query: 10 FFLHLLVVFSANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWS 69
F L + +VFSA LPL L+SLL++K+SLKDP ++ H W TP+ S P+ + P+WCSWS
Sbjct: 18 FLLRITLVFSA-PLPLQLISLLALKSSLKDPL-STLHGWXXTPSLSTPAFHR-PLWCSWS 74
Query: 70 GIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLR 129
G+KC+PK+S +TSLDLSRR+LSG IPPEIRYL++L HLNLS NAFDGP P++ EL LR
Sbjct: 75 GVKCDPKTSHVTSLDLSRRNLSGTIPPEIRYLSTLNHLNLSGNAFDGPFPPSVFELPNLR 134
Query: 130 TIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE 189
+DISHN+FNS+FPPG+SK++FLR+ +AYSNSFTGPLP + ++L L+ LNLGGSYF+G
Sbjct: 135 XLDISHNNFNSSFPPGLSKIKFLRLLDAYSNSFTGPLPQDIIRLRYLEFLNLGGSYFEG- 193
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249
+S+L + +PP+LGL QL+R+EIGYN G VP++FA L NLK
Sbjct: 194 -------ISTLSW-----ECXGXPIPPELGLNAQLQRLEIGYNAFYGGVPMQFALLSNLK 241
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309
Y+DIS NLSG LP+ + N+T L+ LLLF NHF GEIPVSY L AL+ LDLS+NQL+G
Sbjct: 242 YLDISTANLSGPLPAHLGNMTMLQTLLLFSNHFWGEIPVSYARLTALKSLDLSNNQLTGS 301
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLL 369
IP SLK LT LSLMNN L GEIPQ I L +LDTL LWNN LTG LPQ LGSN KL+
Sbjct: 302 IPEQFTSLKELTILSLMNNELAGEIPQGIGDLPNLDTLSLWNNSLTGTLPQNLGSNAKLM 361
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS 429
+DVSSN LTG IP +C G+ L KLILF N +P +L NC+SL R R+Q NQLNGS
Sbjct: 362 KLDVSSNFLTGSIPLNLCLGNHLIKLILFGNRLVSELPNSLANCTSLMRFRVQGNQLNGS 421
Query: 430 IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLK 489
IP GFG +PNLT+MD+S+N SGEIP D GNA KLEYLNISEN+F + LP NIW AP+L+
Sbjct: 422 IPYGFGQMPNLTYMDLSKNKFSGEIPGDFGNAAKLEYLNISENAFDSQLPDNIWRAPSLQ 481
Query: 490 ILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGII 549
I SASSS + GKIPDFIGC+S+YKIEL N LNGSIPWDIGHC KLL LNL NSLTGII
Sbjct: 482 IFSASSSNIRGKIPDFIGCRSLYKIELQGNELNGSIPWDIGHCMKLLSLNLRDNSLTGII 541
Query: 550 PWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHP 609
PWEIS LPSITDVDLSHNFLTGTIPSNF+NCSTLESFNVS+NLLTGPIP+SGTIFPNLHP
Sbjct: 542 PWEISTLPSITDVDLSHNFLTGTIPSNFDNCSTLESFNVSFNLLTGPIPSSGTIFPNLHP 601
Query: 610 SSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLV 669
SSF GN LCG V++KPC A AA +VR QQPKKTAGAIVWIMAAAFGIGLFVL+
Sbjct: 602 SSFTGNVDLCGGVVSKPCAAGTEAATAEDVR---QQPKKTAGAIVWIMAAAFGIGLFVLI 658
Query: 670 AGTRCFRANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKA 729
AG+RCFRANYSRG S +RE+GPWKLTAFQRLNF+ADDV+EC+SM+DKI+GMGSTGTVYKA
Sbjct: 659 AGSRCFRANYSRGISGEREMGPWKLTAFQRLNFSADDVVECISMTDKIIGMGSTGTVYKA 718
Query: 730 EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789
EM GGE+IAVKKLWGK KE +R+RRGV+AEVDVLGNVRHRNIVRLLG CSN + TMLLYE
Sbjct: 719 EMRGGEMIAVKKLWGKQKETVRKRRGVVAEVDVLGNVRHRNIVRLLGWCSNSDSTMLLYE 778
Query: 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849
YMPNG+LDDLLH KNKG+NLVADW TRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL
Sbjct: 779 YMPNGSLDDLLHGKNKGDNLVADWYTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 838
Query: 850 LDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
LD +MEARVADFGVAKLIQ DESMSVIAGSYGYIAP
Sbjct: 839 LDADMEARVADFGVAKLIQCDESMSVIAGSYGYIAP 874
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297797107|ref|XP_002866438.1| hypothetical protein ARALYDRAFT_496307 [Arabidopsis lyrata subsp. lyrata] gi|297312273|gb|EFH42697.1| hypothetical protein ARALYDRAFT_496307 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1080 bits (2792), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 566/881 (64%), Positives = 687/881 (77%), Gaps = 21/881 (2%)
Query: 18 FSANTLPLP----LVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKC 73
F+ N+L L L+SL+S+K SL P ++F DW P + PVWCSWSG+ C
Sbjct: 21 FAFNSLALKVSPQLLSLISLKTSLSGP-PSAFQDW-KVPV----DGQNVPVWCSWSGVVC 74
Query: 74 NPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDI 133
+ ++Q+ SLDLS R+LSG IP +IRYL+SL +LNLS N+ +G +I +LTKL T+DI
Sbjct: 75 DNVTAQVISLDLSHRNLSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDI 134
Query: 134 SHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD 193
SHNSF+S+FPPGISKL+FL++FNA+SN+F G LP + +L L++LN GGSYF+GEIP+
Sbjct: 135 SHNSFDSSFPPGISKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAA 194
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
Y L L+F+ LAGN L G LPP+LGLL +L+ IEIGYN+ G +P EF+ L NLKY D+
Sbjct: 195 YGGLQRLKFIHLAGNVLGGELPPRLGLLPELQHIEIGYNHFTGSIPSEFSLLSNLKYFDV 254
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPAS 313
S C+LSG+LP E+ NLT LE LLLF N FTGEIP SY NL+AL++LD S NQLSG IP+
Sbjct: 255 SNCSLSGSLPQELGNLTNLETLLLFDNGFTGEIPESYSNLKALKLLDFSINQLSGSIPSG 314
Query: 314 LASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDV 373
++LK LT LSL++N L GE+P+ I L +L TL LWNN+ TGVLPQKLGSNG L+T+DV
Sbjct: 315 FSNLKNLTWLSLISNNLSGEVPEGIGELPELTTLSLWNNNFTGVLPQKLGSNGNLVTMDV 374
Query: 374 SSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG 433
S+NS TG IP ++C G++L+KLILFSN F +P++L C SL R R Q+N+LNG+IP G
Sbjct: 375 SNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKSLTRCDSLWRFRSQNNRLNGTIPIG 434
Query: 434 FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493
FG L NLTF+D+S N + +IP D A L+YLN+S NSF LP NIW APNL+I SA
Sbjct: 435 FGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNLSTNSFHRKLPENIWKAPNLQIFSA 494
Query: 494 SSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEI 553
S S L G+IP+++GCKS Y+IEL N LNG+IPWDIGHCEKLL LNLS+N L+GIIPWEI
Sbjct: 495 SFSNLIGEIPNYVGCKSFYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLSGIIPWEI 554
Query: 554 SGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFI 613
S LPSI DVDLSHN LTGTIPS+F + T+ +FNVSYN L GPIP SG++ +L+PS F
Sbjct: 555 STLPSIADVDLSHNLLTGTIPSDFGSSKTITTFNVSYNQLIGPIP-SGSL-AHLNPSFFA 612
Query: 614 GNEGLCGRVLTKPCPADGLAAGDVEVRNH--QQQPKKTAGAIVWIMAAAFGIGLFVLVAG 671
NEGLCG V+ KPC +D AGD ++ H +++PKKTAGAIVWI+AAA G+G FVLVA
Sbjct: 613 SNEGLCGDVVGKPCNSDRFNAGDSDLDGHHNEERPKKTAGAIVWILAAAIGVGFFVLVAA 672
Query: 672 TRCFRANYSRGFS----NDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVY 727
TRCF+ +Y N +IGPWKLTAFQRLNFTADDV+ECLS +D ILGMGSTGTVY
Sbjct: 673 TRCFQKSYGNRVDGGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVY 732
Query: 728 KAEMPGGEIIAVKKLWGKHKEN--IRRRR-GVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784
KAEMP GEIIAVKKLWGK+KEN IRRR+ GVLAEVDVLGNVRHRNIVRLLGCCSNR+CT
Sbjct: 733 KAEMPNGEIIAVKKLWGKNKENGKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCSNRDCT 792
Query: 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLK 844
MLLYEYMPNG+LDDLLH +K N A+W Y+IA+GVAQGICYLHHDCDPVIVHRDLK
Sbjct: 793 MLLYEYMPNGSLDDLLHGGDKTMNAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLK 852
Query: 845 PSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
PSNILLD + EARVADFGVAKLIQ+DESMSV+AGSYGYIAP
Sbjct: 853 PSNILLDADFEARVADFGVAKLIQTDESMSVVAGSYGYIAP 893
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15240263|ref|NP_200956.1| putative leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|75333913|sp|Q9FII5.1|TDR_ARATH RecName: Full=Leucine-rich repeat receptor-like protein kinase TDR; AltName: Full=Protein PHLOEM INTERCALATED WITH XYLEM; AltName: Full=Tracheary element differentiation inhibitory factor receptor; Short=AtTDR; Short=TDIF receptor; Flags: Precursor gi|10177178|dbj|BAB10447.1| receptor protein kinase-like protein [Arabidopsis thaliana] gi|224589737|gb|ACN59400.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|332010090|gb|AED97473.1| putative leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1078 bits (2788), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 544/852 (63%), Positives = 665/852 (78%), Gaps = 16/852 (1%)
Query: 43 NSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLT 102
++F DW P + + + VWCSWSG+ C+ ++Q+ SLDLS R+LSG IP +IRYL+
Sbjct: 51 SAFQDW-KVPV----NGQNDAVWCSWSGVVCDNVTAQVISLDLSHRNLSGRIPIQIRYLS 105
Query: 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF 162
SL +LNLS N+ +G +I +LTKL T+DIS NSF+S+FPPGISKL+FL++FNA+SN+F
Sbjct: 106 SLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGISKLKFLKVFNAFSNNF 165
Query: 163 TGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLT 222
G LP + +L L++LN GGSYF+GEIP+ Y L L+F+ LAGN L G LPP+LGLLT
Sbjct: 166 EGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLT 225
Query: 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282
+L+ +EIGYN+ G +P EFA L NLKY D+S C+LSG+LP E+ NL+ LE L LF+N F
Sbjct: 226 ELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGF 285
Query: 283 TGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLA 342
TGEIP SY NL++L++LD S NQLSG IP+ ++LK LT LSL++N L GE+P+ I L
Sbjct: 286 TGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELP 345
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402
+L TL LWNN+ TGVLP KLGSNGKL T+DVS+NS TG IP ++C G++L+KLILFSN F
Sbjct: 346 ELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMF 405
Query: 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQ 462
+P++L C SL R R Q+N+LNG+IP GFG L NLTF+D+S N + +IP D A
Sbjct: 406 EGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAP 465
Query: 463 KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522
L+YLN+S N F LP NIW APNL+I SAS S L G+IP+++GCKS Y+IEL N LN
Sbjct: 466 VLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVGCKSFYRIELQGNSLN 525
Query: 523 GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCST 582
G+IPWDIGHCEKLL LNLS+N L GIIPWEIS LPSI DVDLSHN LTGTIPS+F + T
Sbjct: 526 GTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKT 585
Query: 583 LESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNH 642
+ +FNVSYN L GPIP+ F +L+PS F NEGLCG ++ KPC +D AG+ ++ H
Sbjct: 586 ITTFNVSYNQLIGPIPSGS--FAHLNPSFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGH 643
Query: 643 --QQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFS----NDREIGPWKLTA 696
+++PKKTAGAIVWI+AAA G+G FVLVA TRCF+ +Y N +IGPWKLTA
Sbjct: 644 HKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPWKLTA 703
Query: 697 FQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN--IRRRR 754
FQRLNFTADDV+ECLS +D ILGMGSTGTVYKAEMP GEIIAVKKLWGK+KEN IRRR+
Sbjct: 704 FQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRK 763
Query: 755 -GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW 813
GVLAEVDVLGNVRHRNIVRLLGCC+NR+CTMLLYEYMPNG+LDDLLH +K A+W
Sbjct: 764 SGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEW 823
Query: 814 VTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
Y+IA+GVAQGICYLHHDCDPVIVHRDLKPSNILLD + EARVADFGVAKLIQ+DESM
Sbjct: 824 TALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDESM 883
Query: 874 SVIAGSYGYIAP 885
SV+AGSYGYIAP
Sbjct: 884 SVVAGSYGYIAP 895
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255539821|ref|XP_002510975.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] gi|223550090|gb|EEF51577.1| Receptor protein kinase CLAVATA1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1075 bits (2781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 539/753 (71%), Positives = 627/753 (83%), Gaps = 15/753 (1%)
Query: 1 MKLPLFF---LTFFLHL---LVVFSA---NTLPLPLVSLLSIKASLKDPFNNSFHDWDAT 51
MK P F L+FF L LVV SA PL L +LLS+K+SL+DP +F DWD +
Sbjct: 1 MKPPFLFCLTLSFFYLLPTFLVVISAAAATAQPLQLHALLSLKSSLQDPLG-TFQDWDQS 59
Query: 52 PAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSA 111
S+ + PVWC+WSGIKC+P+++QI SLDLS R LSG IP EIR+L SL HLNLS+
Sbjct: 60 ---SSKPGFRSPVWCAWSGIKCDPRTAQIISLDLSGRGLSGLIPDEIRHLKSLIHLNLSS 116
Query: 112 NAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFV 171
NAFDGPLQP I ELT+LRTIDISHNSFNSTFPPGISKLRFLR+F+AYSN+FTGPLP EFV
Sbjct: 117 NAFDGPLQPVIFELTQLRTIDISHNSFNSTFPPGISKLRFLRVFHAYSNNFTGPLPTEFV 176
Query: 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY 231
L L++LNL GSYF+GEIP Y + L+FL LAGN+L G LPPQLG L QL+R+EIGY
Sbjct: 177 ALPYLERLNLTGSYFEGEIPLGYGSFQRLKFLGLAGNALEGLLPPQLGFLNQLQRLEIGY 236
Query: 232 NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYG 291
N G+VP EFA L NL+YMDIS C+LSG L ++ NLTKLE LLLF+N+F+GEIPVS
Sbjct: 237 NKFTGKVPEEFALLSNLRYMDISCCSLSGNLTQQLGNLTKLETLLLFQNNFSGEIPVSLT 296
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
NL++L+VLDLSDN L+G IP L+SLK LTRLSLM N L GEIP I L +++TL LWN
Sbjct: 297 NLKSLKVLDLSDNHLTGTIPVGLSSLKELTRLSLMKNQLVGEIPLGIGELPNIETLCLWN 356
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N LTG LPQKLGSNGKLL +DVS+NSL+GP+PP +C G++LFKL+LFSN S+P++L
Sbjct: 357 NRLTGFLPQKLGSNGKLLWLDVSNNSLSGPVPPNLCQGNKLFKLLLFSNKLIGSLPDSLS 416
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
NC++L+R RIQDNQLNGSIP G GLLPNL+F+D+S N+ +GEIP D+GNA +L+YLNISE
Sbjct: 417 NCTTLTRFRIQDNQLNGSIPHGIGLLPNLSFVDLSNNNFTGEIPEDIGNAPQLQYLNISE 476
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
NSF LPSNIW+APNL+I SASSSK+ G++P+FIGC+S+YKIELH+N LNG+IPWDIGH
Sbjct: 477 NSFDRKLPSNIWNAPNLQIFSASSSKIRGELPNFIGCRSVYKIELHDNSLNGTIPWDIGH 536
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
CEKL+ LNLSRNSLTGIIPWEIS LP+ITDVDLSHN LTG+IPSNF+NC+TLESFNVS+N
Sbjct: 537 CEKLICLNLSRNSLTGIIPWEISTLPAITDVDLSHNLLTGSIPSNFDNCTTLESFNVSFN 596
Query: 592 LLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAG 651
LTGPIP SGTIFPNLHPSSF GNEGLCGRVL KPC D L AG+VEV H QQPKKTAG
Sbjct: 597 RLTGPIPGSGTIFPNLHPSSFSGNEGLCGRVLAKPCAMDTLTAGEVEVHRH-QQPKKTAG 655
Query: 652 AIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSND-REIGPWKLTAFQRLNFTADDVLEC 710
AIVWIMAAAFGIGLFVLVAGTRCF ANY+R F++D REIGPWKLTAFQRLNFTADDVLEC
Sbjct: 656 AIVWIMAAAFGIGLFVLVAGTRCFHANYNRKFNDDEREIGPWKLTAFQRLNFTADDVLEC 715
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLW 743
LSM+DKI+GMGSTGTVYKAEMPGGEIIAVKKLW
Sbjct: 716 LSMTDKIIGMGSTGTVYKAEMPGGEIIAVKKLW 748
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 902 | ||||||
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.943 | 0.817 | 0.617 | 3.5e-288 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.923 | 0.822 | 0.425 | 1.8e-174 | |
| TAIR|locus:2025545 | 1029 | AT1G08590 [Arabidopsis thalian | 0.933 | 0.818 | 0.411 | 2.6e-166 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.919 | 0.826 | 0.412 | 3.1e-163 | |
| TAIR|locus:2120412 | 992 | BAM3 "BARELY ANY MERISTEM 3" [ | 0.922 | 0.838 | 0.398 | 1.3e-157 | |
| UNIPROTKB|Q5Z9N5 | 994 | P0481E08.42 "Os06g0717200 prot | 0.904 | 0.820 | 0.391 | 9e-148 | |
| TAIR|locus:2032553 | 996 | HSL1 "HAESA-like 1" [Arabidops | 0.925 | 0.838 | 0.375 | 1.3e-141 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.922 | 0.830 | 0.365 | 5.2e-136 | |
| TAIR|locus:2005540 | 999 | HAE "HAESA" [Arabidopsis thali | 0.895 | 0.808 | 0.367 | 2.7e-132 | |
| TAIR|locus:2169975 | 993 | HSL2 "HAESA-like 2" [Arabidops | 0.643 | 0.584 | 0.328 | 1.8e-129 |
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2768 (979.4 bits), Expect = 3.5e-288, P = 3.5e-288
Identities = 536/868 (61%), Positives = 654/868 (75%)
Query: 27 LVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLS 86
L+SLLS+K SL P ++F DW P + + + VWCSWSG+ C+ ++Q+ SLDLS
Sbjct: 36 LLSLLSLKTSLSGP-PSAFQDWKV-PV----NGQNDAVWCSWSGVVCDNVTAQVISLDLS 89
Query: 87 RRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGI 146
R+LSG IP +IRYL+SL +LNLS N+ +G +I +LTKL T+DIS NSF+S+FPPGI
Sbjct: 90 HRNLSGRIPIQIRYLSSLLYLNLSGNSLEGSFPTSIFDLTKLTTLDISRNSFDSSFPPGI 149
Query: 147 SKLRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLA 206
SKL+FL++FNA+SN+F G LP + YF+GEIP+ Y L L+F+ LA
Sbjct: 150 SKLKFLKVFNAFSNNFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLA 209
Query: 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
GN L G LPP+LGLLT+L+ +EIGYN+ G +P EFA L NLKY D+S C+LSG+LP E+
Sbjct: 210 GNVLGGKLPPRLGLLTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQEL 269
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
NL+ LE L LF+N FTGEIP SY NL++L++LD S NQLSG IP+ ++LK LT LSL+
Sbjct: 270 GNLSNLETLFLFQNGFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLI 329
Query: 327 NNVLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
+N L GE+P+ I WNN+ TGVLP KLGSNGKL T+DVS+NS TG IP ++
Sbjct: 330 SNNLSGEVPEGIGELPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSL 389
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
C G++L+KLILFSN F +P++L C SL R R Q+N+LNG+IP GFG L NLTF+D+S
Sbjct: 390 CHGNKLYKLILFSNMFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLS 449
Query: 447 RNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFI 506
N + +IP D A L+YLN+S N F LP NIW APNL+I SAS S L G+IP+++
Sbjct: 450 NNRFTDQIPADFATAPVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYV 509
Query: 507 GCKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSH 566
GCKS Y+IEL N LNG+IPWDIGHCEK GIIPWEIS LPSI DVDLSH
Sbjct: 510 GCKSFYRIELQGNSLNGTIPWDIGHCEKLLCLNLSQNHLNGIIPWEISTLPSIADVDLSH 569
Query: 567 NFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKP 626
N LTGTIPS+F + T+ +FNVSYN L GPIP SG+ F +L+PS F NEGLCG ++ KP
Sbjct: 570 NLLTGTIPSDFGSSKTITTFNVSYNQLIGPIP-SGS-FAHLNPSFFSSNEGLCGDLVGKP 627
Query: 627 CPADGLAAGDVEVRNH--QQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSR--- 681
C +D AG+ ++ H +++PKKTAGAIVWI+AAA G+G FVLVA TRCF+ +Y
Sbjct: 628 CNSDRFNAGNADIDGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVD 687
Query: 682 -GFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVK 740
G N +IGPWKLTAFQRLNFTADDV+ECLS +D ILGMGSTGTVYKAEMP GEIIAVK
Sbjct: 688 GGGRNGGDIGPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVK 747
Query: 741 KLWGKHKEN--IRRRR-GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLD 797
KLWGK+KEN IRRR+ GVLAEVDVLGNVRHRNIVRLLGCC+NR+CTMLLYEYMPNG+LD
Sbjct: 748 KLWGKNKENGKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLD 807
Query: 798 DLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857
DLLH +K A+W Y+IA+GVAQGICYLHHDCDPVIVHRDLKPSNILLD + EAR
Sbjct: 808 DLLHGGDKTMTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEAR 867
Query: 858 VADFGVAKLIQSDESMSVIAGSYGYIAP 885
VADFGVAKLIQ+DESMSV+AGSYGYIAP
Sbjct: 868 VADFGVAKLIQTDESMSVVAGSYGYIAP 895
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1695 (601.7 bits), Expect = 1.8e-174, P = 1.8e-174
Identities = 368/865 (42%), Positives = 512/865 (59%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
LLS+K++L DP N DW S+ S C+W+G++CN + + LDL+ +
Sbjct: 34 LLSVKSTLVDPLN-FLKDWK----LSDTSDH-----CNWTGVRCN-SNGNVEKLDLAGMN 82
Query: 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFN-STFPPGISK 148
L+G I I L+SL N+S N F+ L +I L++IDIS NSF+ S F
Sbjct: 83 LTGKISDSISQLSSLVSFNISCNGFESLLPKSI---PPLKSIDISQNSFSGSLFLFSNES 139
Query: 149 LRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAGN 208
L + + NA N+ +G L + +F G +PS ++NL LRFL L+GN
Sbjct: 140 LGLVHL-NASGNNLSGNLTEDLGNLVSLEVLDLRGNFFQGSLPSSFKNLQKLRFLGLSGN 198
Query: 209 SLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISN 268
+LTG LP LG L LE +GYN +G +P EF ++ +LKY+D++ LSG +PSE+
Sbjct: 199 NLTGELPSVLGQLPSLETAILGYNEFKGPIPPEFGNINSLKYLDLAIGKLSGEIPSELGK 258
Query: 269 LTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328
L LE LLL++N+FTG IP G++ L+VLD SDN L+G IP + LK L L+LM N
Sbjct: 259 LKSLETLLLYENNFTGTIPREIGSITTLKVLDFSDNALTGEIPMEITKLKNLQLLNLMRN 318
Query: 329 VLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388
L G IP I WNN L+G LP LG N L +DVSSNS +G IP T+C+
Sbjct: 319 KLSGSIPPAISSLAQLQVLELWNNTLSGELPSDLGKNSPLQWLDVSSNSFSGEIPSTLCN 378
Query: 389 GDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN 448
L KLILF+N FT IP L C SL R+R+Q+N LNGSIP GFG L L ++++ N
Sbjct: 379 KGNLTKLILFNNTFTGQIPATLSTCQSLVRVRMQNNLLNGSIPIGFGKLEKLQRLELAGN 438
Query: 449 SLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIG 507
LSG IP D+ ++ L +++ S N ++SLPS I S NL+ + + ++G++PD F
Sbjct: 439 RLSGGIPGDISDSVSLSFIDFSRNQIRSSLPSTILSIHNLQAFLVADNFISGEVPDQFQD 498
Query: 508 CKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSHN 567
C S+ ++L +N L G+IP I CEK TG IP +I+ + ++ +DLS+N
Sbjct: 499 CPSLSNLDLSSNTLTGTIPSSIASCEKLVSLNLRNNNLTGEIPRQITTMSALAVLDLSNN 558
Query: 568 FLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPC 627
LTG +P + LE NVSYN LTGP+P +G + ++P GN GLCG VL PC
Sbjct: 559 SLTGVLPESIGTSPALELLNVSYNKLTGPVPINGFL-KTINPDDLRGNSGLCGGVLP-PC 616
Query: 628 PADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSNDR 687
A + + AG ++ I A+ +G+ +V T ++ YS GF D
Sbjct: 617 SKFQRATSS---HSSLHGKRIVAGWLIGI-ASVLALGILTIVTRT-LYKKWYSNGFCGDE 671
Query: 688 EIG----PWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKL 742
PW+L AF RL FTA D+L C+ S+ I GMG+TG VYKAEM ++AVKKL
Sbjct: 672 TASKGEWPWRLMAFHRLGFTASDILACIKESNMI-GMGATGIVYKAEMSRSSTVLAVKKL 730
Query: 743 WGKHKENIRRRRG-VLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLH 801
W + G + EV++LG +RHRNIVRLLG N + M++YE+M NGNL D +H
Sbjct: 731 WRSAADIEDGTTGDFVGEVNLLGKLRHRNIVRLLGFLYNDKNMMIVYEFMLNGNLGDAIH 790
Query: 802 AKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861
KN L+ DWV+RY IALGVA G+ YLHHDC P ++HRD+K +NILLD ++AR+ADF
Sbjct: 791 GKNAAGRLLVDWVSRYNIALGVAHGLAYLHHDCHPPVIHRDIKSNNILLDANLDARIADF 850
Query: 862 GVAKLI-QSDESMSVIAGSYGYIAP 885
G+A+++ + E++S++AGSYGYIAP
Sbjct: 851 GLARMMARKKETVSMVAGSYGYIAP 875
|
|
| TAIR|locus:2025545 AT1G08590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1618 (574.6 bits), Expect = 2.6e-166, P = 2.6e-166
Identities = 362/879 (41%), Positives = 518/879 (58%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
LL+ K+ L DP NN DW P N ++ E V C W+G+ C+ + + L LS +
Sbjct: 34 LLAFKSDLFDPSNN-LQDWKR-P--ENATTFSELVHCHWTGVHCDA-NGYVAKLLLSNMN 88
Query: 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKL 149
LSG + +I+ SL L+LS NAF+ L ++ LT L+ ID+S NSF TFP G+
Sbjct: 89 LSGNVSDQIQSFPSLQALDLSNNAFESSLPKSLSNLTSLKVIDVSVNSFFGTFPYGLGMA 148
Query: 150 RFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAGNS 209
L NA SN+F+G LP + YF+G +PS ++NL +L+FL L+GN+
Sbjct: 149 TGLTHVNASSNNFSGFLPEDLGNATTLEVLDFRGGYFEGSVPSSFKNLKNLKFLGLSGNN 208
Query: 210 LTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNL 269
G +P +G L+ LE I +GYN GE+P EF L L+Y+D++ NL+G +PS + L
Sbjct: 209 FGGKVPKVIGELSSLETIILGYNGFMGEIPEEFGKLTRLQYLDLAVGNLTGQIPSSLGQL 268
Query: 270 TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329
+L + L++N TG++P G + +L LDLSDNQ++G IP + LK L L+LM N
Sbjct: 269 KQLTTVYLYQNRLTGKLPRELGGMTSLVFLDLSDNQITGEIPMEVGELKNLQLLNLMRNQ 328
Query: 330 LFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
L G IP I W N L G LP LG N L +DVSSN L+G IP +C
Sbjct: 329 LTGIIPSKIAELPNLEVLELWQNSLMGSLPVHLGKNSPLKWLDVSSNKLSGDIPSGLCYS 388
Query: 390 DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNS 449
L KLILF+N+F+ IPE + +C +L R+RIQ N ++GSIP G G LP L +++++N+
Sbjct: 389 RNLTKLILFNNSFSGQIPEEIFSCPTLVRVRIQKNHISGSIPAGSGDLPMLQHLELAKNN 448
Query: 450 LSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCK 509
L+G+IP D+ + L +++IS N +SL S+I+S+PNL+ AS + GKIP+ I +
Sbjct: 449 LTGKIPDDIALSTSLSFIDISFNHL-SSLSSSIFSSPNLQTFIASHNNFAGKIPNQIQDR 507
Query: 510 -SIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSHNF 568
S+ ++L N +G IP I EK G IP ++G+ + +DLS+N
Sbjct: 508 PSLSVLDLSFNHFSGGIPERIASFEKLVSLNLKSNQLVGEIPKALAGMHMLAVLDLSNNS 567
Query: 569 LTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCP 628
LTG IP++ TLE NVS+N L GPIP S +F + P +GN GLCG VL PC
Sbjct: 568 LTGNIPADLGASPTLEMLNVSFNKLDGPIP-SNMLFAAIDPKDLVGNNGLCGGVLP-PCS 625
Query: 629 ------ADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRC-FRANYSR 681
A G G + V NH +++ M F G ++ TR +N++R
Sbjct: 626 KSLALSAKGRNPGRIHV-NHAVFGFIVGTSVIVAMGMMFLAGRWIY---TRWDLYSNFAR 681
Query: 682 GF---SNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEI-- 736
+ RE PW+L AFQRL FTA D+L + S+ I+GMG+ G VYKAE+ +
Sbjct: 682 EYIFCKKPREEWPWRLVAFQRLCFTAGDILSHIKESN-IIGMGAIGIVYKAEVMRRPLLT 740
Query: 737 IAVKKLWGK---------HKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787
+AVKKLW H + +L EV++LG +RHRNIV++LG N M++
Sbjct: 741 VAVKKLWRSPSPQNDIEDHHQEEDEEDDILREVNLLGGLRHRNIVKILGYVHNEREVMMV 800
Query: 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847
YEYMPNGNL LH+K++ + L+ DW++RY +A+GV QG+ YLH+DC P I+HRD+K +N
Sbjct: 801 YEYMPNGNLGTALHSKDE-KFLLRDWLSRYNVAVGVVQGLNYLHNDCYPPIIHRDIKSNN 859
Query: 848 ILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
ILLD +EAR+ADFG+AK+ + +E++S++AGSYGYIAP
Sbjct: 860 ILLDSNLEARIADFGLAKMMLHKNETVSMVAGSYGYIAP 898
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1589 (564.4 bits), Expect = 3.1e-163, P = 3.1e-163
Identities = 358/867 (41%), Positives = 497/867 (57%)
Query: 29 SLLSIKASLK---DPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDL 85
+LLS+K SL D N+ W + +F C+W G+ C+ +TSLDL
Sbjct: 28 ALLSLKTSLTGAGDDKNSPLSSWKVSTSF-----------CTWIGVTCDVSRRHVTSLDL 76
Query: 86 SRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPG 145
S +LSG + P++ +L L +L+L+ N GP+ P I L+ LR +++S+N FN +FP
Sbjct: 77 SGLNLSGTLSPDVSHLRLLQNLSLAENLISGPIPPEISSLSGLRHLNLSNNVFNGSFPDE 136
Query: 146 ISK-LRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLD 204
IS L LR+ + Y+N+ TG LP+ YF G+IP Y + + +L
Sbjct: 137 ISSGLVNLRVLDVYNNNLTGDLPVSVTNLTQLRHLHLGGNYFAGKIPPSYGSWPVIEYLA 196
Query: 205 LAGNSLTGSLPPQLGLLTQLERIEIGYNN-LQGEVPVEFASLVNLKYMDISACNLSGTLP 263
++GN L G +PP++G LT L + IGY N + +P E +L L D + C L+G +P
Sbjct: 197 VSGNELVGKIPPEIGNLTTLRELYIGYYNAFEDGLPPEIGNLSELVRFDGANCGLTGEIP 256
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
EI L KL+ L L N F+G + G L +L+ +DLS+N +G IPAS A LK LT L
Sbjct: 257 PEIGKLQKLDTLFLQVNVFSGPLTWELGTLSSLKSMDLSNNMFTGEIPASFAELKNLTLL 316
Query: 324 SLMNNVLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIP 383
+L N L GEIP+ I W N+ TG +PQKLG NGKL VD+SSN LTG +P
Sbjct: 317 NLFRNKLHGEIPEFIGDLPELEVLQLWENNFTGSIPQKLGENGKLNLVDLSSNKLTGTLP 376
Query: 384 PTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTF 442
P +C G++L LI N SIP++L C SL+R+R+ +N LNGSIP+G FGL P LT
Sbjct: 377 PNMCSGNKLETLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKGLFGL-PKLTQ 435
Query: 443 MDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKI 502
+++ N LSGE+P G + L +++S N LP I + ++ L +K G I
Sbjct: 436 VELQDNYLSGELPVAGGVSVNLGQISLSNNQLSGPLPPAIGNFTGVQKLLLDGNKFQGPI 495
Query: 503 PDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITD 561
P +G + + KI+ +NL +G I +I C+ +G IP EI+ + +
Sbjct: 496 PSEVGKLQQLSKIDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGEIPNEITAMKILNY 555
Query: 562 VDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGR 621
++LS N L G+IP + + +L S + SYN L+G +P +G F + +SF+GN LCG
Sbjct: 556 LNLSRNHLVGSIPGSISSMQSLTSLDFSYNNLSGLVPGTGQ-FSYFNYTSFLGNPDLCGP 614
Query: 622 VLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSR 681
L PC DG+A G HQ K A + ++ +GL V +R
Sbjct: 615 YLG-PCK-DGVAKG-----GHQSHSKGPLSASMKLLLV---LGLLVCSIAFAVVAIIKAR 664
Query: 682 GFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKK 741
E W+LTAFQRL+FT DDVL+ L D I+G G G VYK MP G+++AVK+
Sbjct: 665 SLKKASESRAWRLTAFQRLDFTCDDVLDSLK-EDNIIGKGGAGIVYKGVMPNGDLVAVKR 723
Query: 742 LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLH 801
L + + G AE+ LG +RHR+IVRLLG CSN E +L+YEYMPNG+L ++LH
Sbjct: 724 LAAMSRGS-SHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSLGEVLH 782
Query: 802 AKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861
K KG +L W TRYKIAL A+G+CYLHHDC P+IVHRD+K +NILLD EA VADF
Sbjct: 783 GK-KGGHL--HWDTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVADF 839
Query: 862 GVAKLIQ---SDESMSVIAGSYGYIAP 885
G+AK +Q + E MS IAGSYGYIAP
Sbjct: 840 GLAKFLQDSGTSECMSAIAGSYGYIAP 866
|
|
| TAIR|locus:2120412 BAM3 "BARELY ANY MERISTEM 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1536 (545.8 bits), Expect = 1.3e-157, P = 1.3e-157
Identities = 347/870 (39%), Positives = 501/870 (57%)
Query: 30 LLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRS 89
L+S+K S D ++ S W+ P F++ CSW+G+ C+ + IT LDLS +
Sbjct: 38 LISLKQSF-DSYDPSLDSWNI-PNFNS--------LCSWTGVSCDNLNQSITRLDLSNLN 87
Query: 90 LSGPIPPEIRYLT-SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP-GIS 147
+SG I PEI L+ SL L++S+N+F G L I EL+ L ++IS N F G S
Sbjct: 88 ISGTISPEISRLSPSLVFLDISSNSFSGELPKEIYELSGLEVLNISSNVFEGELETRGFS 147
Query: 148 KLRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAG 207
++ L +AY NSF G LPL YFDGEIP Y + SL+FL L+G
Sbjct: 148 QMTQLVTLDAYDNSFNGSLPLSLTTLTRLEHLDLGGNYFDGEIPRSYGSFLSLKFLSLSG 207
Query: 208 NSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
N L G +P +L +T L ++ +GY N+ +G +P +F L+NL ++D++ C+L G++P+E+
Sbjct: 208 NDLRGRIPNELANITTLVQLYLGYYNDYRGGIPADFGRLINLVHLDLANCSLKGSIPAEL 267
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
NL LE+L L N TG +P GN+ +L+ LDLS+N L G IP L+ L+ L +L
Sbjct: 268 GNLKNLEVLFLQTNELTGSVPRELGNMTSLKTLDLSNNFLEGEIPLELSGLQKLQLFNLF 327
Query: 327 NNVLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
N L GEIP+ + W+N+ TG +P KLGSNG L+ +D+S+N LTG IP ++
Sbjct: 328 FNRLHGEIPEFVSELPDLQILKLWHNNFTGKIPSKLGSNGNLIEIDLSTNKLTGLIPESL 387
Query: 387 CDGDRLFKLILFSNNFTYS-IPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDM 445
C G RL LILF NNF + +PE+L C L R R+ N L +P+G LPNL+ +++
Sbjct: 388 CFGRRLKILILF-NNFLFGPLPEDLGQCEPLWRFRLGQNFLTSKLPKGLIYLPNLSLLEL 446
Query: 446 SRNSLSGEIPRD-LGNAQ--KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKI 502
N L+GEIP + GNAQ L +N+S N +P +I + +L+IL +++L+G+I
Sbjct: 447 QNNFLTGEIPEEEAGNAQFSSLTQINLSNNRLSGPIPGSIRNLRSLQILLLGANRLSGQI 506
Query: 503 PDFIGC-KSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITD 561
P IG KS+ KI++ N +G P + G C +G IP +IS + +
Sbjct: 507 PGEIGSLKSLLKIDMSRNNFSGKFPPEFGDCMSLTYLDLSHNQISGQIPVQISQIRILNY 566
Query: 562 VDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGR 621
+++S N ++P+ +L S + S+N +G +P SG F + +SF+GN LCG
Sbjct: 567 LNVSWNSFNQSLPNELGYMKSLTSADFSHNNFSGSVPTSGQ-FSYFNNTSFLGNPFLCG- 624
Query: 622 VLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGL--FVLVAGTRCFRANY 679
+ PC +G + + + Q ++ G I FG+GL F LV N
Sbjct: 625 FSSNPC--NG-SQNQSQSQLLNQNNARSRGEISAKFKLFFGLGLLGFFLVFVVLAVVKN- 680
Query: 680 SRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAV 739
R N+ + WKL FQ+L F ++ +LEC+ + ++G G G VYK MP GE +AV
Sbjct: 681 RRMRKNNPNL--WKLIGFQKLGFRSEHILECVK-ENHVIGKGGRGIVYKGVMPNGEEVAV 737
Query: 740 KKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDL 799
KKL K + G+ AE+ LG +RHRNIVRLL CSN++ +L+YEYMPNG+L ++
Sbjct: 738 KKLLTITKGS-SHDNGLAAEIQTLGRIRHRNIVRLLAFCSNKDVNLLVYEYMPNGSLGEV 796
Query: 800 LHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA 859
LH K + W TR +IAL A+G+CYLHHDC P+I+HRD+K +NILL E EA VA
Sbjct: 797 LHGK---AGVFLKWETRLQIALEAAKGLCYLHHDCSPLIIHRDVKSNNILLGPEFEAHVA 853
Query: 860 DFGVAKLIQSD----ESMSVIAGSYGYIAP 885
DFG+AK + D E MS IAGSYGYIAP
Sbjct: 854 DFGLAKFMMQDNGASECMSSIAGSYGYIAP 883
|
|
| UNIPROTKB|Q5Z9N5 P0481E08.42 "Os06g0717200 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1443 (513.0 bits), Expect = 9.0e-148, P = 9.0e-148
Identities = 333/850 (39%), Positives = 482/850 (56%)
Query: 47 DWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSL-SGPIPPEIRYLTSLT 105
DWD PA ++P+ C++SG+ C+ +S ++ +++L+ L SG +PPEI L SL
Sbjct: 47 DWD--PAATSPAH------CTFSGVTCDGRS-RVVAINLTALPLHSGYLPPEIALLDSLA 97
Query: 106 HLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP-P----GISK-LRFLRIFNAYS 159
+L ++A G + + L LR +++S+N+ + FP P G S L + +AY+
Sbjct: 98 NLTIAACCLPGHVPLELPTLPSLRHLNLSNNNLSGHFPVPDSGGGASPYFPSLELIDAYN 157
Query: 160 NSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG 219
N+ +G LP YF G IP Y +L++L +L L GN+L+G +P L
Sbjct: 158 NNLSGLLPPFSASHARLRYLHLGGNYFTGAIPDSYGDLAALEYLGLNGNTLSGHVPVSLS 217
Query: 220 LLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLF 278
LT+L + IGY N G VP EF L L +D+S+CNL+G +P E+ L +L+ L L
Sbjct: 218 RLTRLREMYIGYYNQYDGGVPPEFGDLGALLRLDMSSCNLTGPVPPELGRLQRLDTLFLQ 277
Query: 279 KNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI 338
N +GEIP G+L +L LDLS N L+G IP SLA+L L L+L N L G IP +
Sbjct: 278 WNRLSGEIPPQLGDLSSLASLDLSVNDLAGEIPPSLANLSNLKLLNLFRNHLRGSIPDFV 337
Query: 339 EXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILF 398
W+N+LTG +P LG NG+L T+D+++N LTGPIP +C G RL L+L
Sbjct: 338 AGFAQLEVLQLWDNNLTGNIPAGLGKNGRLKTLDLATNHLTGPIPADLCAGRRLEMLVLM 397
Query: 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDL 458
N IP++L +C +L+R+R+ N L G +P G LP ++++ N L+GE+P +
Sbjct: 398 ENGLFGPIPDSLGDCKTLTRVRLAKNFLTGPVPAGLFNLPQANMVELTDNLLTGELPDVI 457
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIG-CKSIYKIELH 517
G K+ L + N +P I + P L+ LS S+ +G +P IG K++ ++ +
Sbjct: 458 GG-DKIGMLLLGNNGIGGRIPPAIGNLPALQTLSLESNNFSGALPPEIGNLKNLSRLNVS 516
Query: 518 NNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSHNFLTGTIPSNF 577
N L G+IP ++ C +G IP I+ L + +++S N LTG +P
Sbjct: 517 GNALTGAIPDELIRCASLAAVDLSRNGFSGEIPESITSLKILCTLNVSRNRLTGELPPEM 576
Query: 578 ENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAAGDV 637
N ++L + +VSYN L+GP+P G F + SSF+GN GLCG + CP +A G
Sbjct: 577 SNMTSLTTLDVSYNSLSGPVPMQGQ-FLVFNESSFVGNPGLCGGPVADACPPS-MAGGGG 634
Query: 638 EVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYSRGFSNDREIGPWKLTAF 697
+ + + +V ++AA + + L A C + R + R G WK+TAF
Sbjct: 635 GAGSQLRLRWDSKKMLVALVAAFAAVAVAFLGARKGC---SAWRSAARRRS-GAWKMTAF 690
Query: 698 QRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL 757
Q+L F+A+DV+EC+ D I+G G G VY G E+ A+K+L G+ RG
Sbjct: 691 QKLEFSAEDVVECVK-EDNIIGKGGAGIVYHGVTRGAEL-AIKRLVGRGGGE--HDRGFS 746
Query: 758 AEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY 817
AEV LG +RHRNIVRLLG SNRE +LLYEYMPNG+L ++LH KG +L W R
Sbjct: 747 AEVTTLGRIRHRNIVRLLGFVSNRETNLLLYEYMPNGSLGEMLHG-GKGGHL--GWEARA 803
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI--QSDESMSV 875
++A A G+CYLHHDC P I+HRD+K +NILLD EA VADFG+AK + + E MS
Sbjct: 804 RVAAEAACGLCYLHHDCAPRIIHRDVKSNNILLDSAFEAHVADFGLAKFLGGATSECMSA 863
Query: 876 IAGSYGYIAP 885
IAGSYGYIAP
Sbjct: 864 IAGSYGYIAP 873
|
|
| TAIR|locus:2032553 HSL1 "HAESA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1385 (492.6 bits), Expect = 1.3e-141, P = 1.3e-141
Identities = 332/883 (37%), Positives = 481/883 (54%)
Query: 23 LPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITS 82
L P V L+ + S D D+ + N S++ P C WSG+ C S +TS
Sbjct: 8 LLFPTVFSLNQDGFILQQVKLSLDDPDSYLSSWN-SNDASP--CRWSGVSCAGDFSSVTS 64
Query: 83 LDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTF 142
+DLS +L+GP P I L++L HL+L N+ + L I L+T+D+S N
Sbjct: 65 VDLSSANLAGPFPSVICRLSNLAHLSLYNNSINSTLPLNIAACKSLQTLDLSQNLLTGEL 124
Query: 143 PPGISKLRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRF 202
P ++ + L + N+F+G +P F DG IP N+S+L+
Sbjct: 125 PQTLADIPTLVHLDLTGNNFSGDIPASFGKFENLEVLSLVYNLLDGTIPPFLGNISTLKM 184
Query: 203 LDLAGNSLTGS-LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGT 261
L+L+ N + S +PP+ G LT LE + + +L G++P L L +D++ +L G
Sbjct: 185 LNLSYNPFSPSRIPPEFGNLTNLEVMWLTECHLVGQIPDSLGQLSKLVDLDLALNDLVGH 244
Query: 262 LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321
+P + LT + + L+ N TGEIP GNL++L++LD S NQL+G IP L + L
Sbjct: 245 IPPSLGGLTNVVQIELYNNSLTGEIPPELGNLKSLRLLDASMNQLTGKIPDELCRVP-LE 303
Query: 322 RLSLMNNVLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGP 381
L+L N L GE+P I + N LTG LP+ LG N L +DVS N +G
Sbjct: 304 SLNLYENNLEGELPASIALSPNLYEIRIFGNRLTGGLPKDLGLNSPLRWLDVSENEFSGD 363
Query: 382 IPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLT 441
+P +C L +L++ N+F+ IPE+L +C SL+R+R+ N+ +GS+P GF LP++
Sbjct: 364 LPADLCAKGELEELLIIHNSFSGVIPESLADCRSLTRIRLAYNRFSGSVPTGFWGLPHVN 423
Query: 442 FMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGK 501
+++ NS SGEI + +G A L L +S N F SLP I S NL LSAS +K +G
Sbjct: 424 LLELVNNSFSGEISKSIGGASNLSLLILSNNEFTGSLPEEIGSLDNLNQLSASGNKFSGS 483
Query: 502 IPD-FIGCKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSIT 560
+PD + + ++LH N +G + I +K TG IP EI L +
Sbjct: 484 LPDSLMSLGELGTLDLHGNQFSGELTSGIKSWKKLNELNLADNEFTGKIPDEIGSLSVLN 543
Query: 561 DVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCG 620
+DLS N +G IP + ++ L N+SYN L+G +P S + +++ +SFIGN GLCG
Sbjct: 544 YLDLSGNMFSGKIPVSLQSLK-LNQLNLSYNRLSGDLPPS--LAKDMYKNSFIGNPGLCG 600
Query: 621 RVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYS 680
+ GL + E + VW++ + F + VL+AG F Y
Sbjct: 601 DI-------KGLCGSENEAKKR---------GYVWLLRSIFVLAAMVLLAGVAWFYFKY- 643
Query: 681 RGFSNDR--EIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIA 738
R F R E W L +F +L F+ ++LE L D ++G G++G VYK + GE +A
Sbjct: 644 RTFKKARAMERSKWTLMSFHKLGFSEHEILESLD-EDNVIGAGASGKVYKVVLTNGETVA 702
Query: 739 VKKLW-GKHKEN------IRRRRGVL-----AEVDVLGNVRHRNIVRLLGCCSNRECTML 786
VK+LW G KE + GV AEV+ LG +RH+NIV+L CCS R+C +L
Sbjct: 703 VKRLWTGSVKETGDCDPEKGYKPGVQDEAFEAEVETLGKIRHKNIVKLWCCCSTRDCKLL 762
Query: 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846
+YEYMPNG+L DLLH+ +KG L W TR+KI L A+G+ YLHHD P IVHRD+K +
Sbjct: 763 VYEYMPNGSLGDLLHS-SKGGML--GWQTRFKIILDAAEGLSYLHHDSVPPIVHRDIKSN 819
Query: 847 NILLDGEMEARVADFGVAKLI----QSDESMSVIAGSYGYIAP 885
NIL+DG+ ARVADFGVAK + ++ +SMSVIAGS GYIAP
Sbjct: 820 NILIDGDYGARVADFGVAKAVDLTGKAPKSMSVIAGSCGYIAP 862
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1332 (473.9 bits), Expect = 5.2e-136, P = 5.2e-136
Identities = 320/875 (36%), Positives = 472/875 (53%)
Query: 22 TLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQIT 81
T+ P+ L ++ SLK F H +P + S +CSW+G+ C+ +T
Sbjct: 20 TVAKPITELHAL-LSLKSSFTIDEH----SPLLT--SWNLSTTFCSWTGVTCDVSLRHVT 72
Query: 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNST 141
SLDLS +LSG + ++ +L L +L+L+AN GP+ P I L +LR +++S+N FN +
Sbjct: 73 SLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNNVFNGS 132
Query: 142 FPPGISK-LRFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSL 200
FP +S L LR+ + Y+N+ TG LP+ YF G+IP+ Y L
Sbjct: 133 FPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYGTWPVL 192
Query: 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNN-LQGEVPVEFASLVNLKYMDISACNLS 259
+L ++GN LTG +PP++G LT L + IGY N + +P E +L L D + C L+
Sbjct: 193 EYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAANCGLT 252
Query: 260 GTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKG 319
G +P EI L KL+ L L N FTG I G + +L+ +DLS+N +G IP S + LK
Sbjct: 253 GEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSFSQLKN 312
Query: 320 LTRLSLMNNVLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT 379
LT L+L N L+G IP+ I W N+ TG +PQKLG NG+L+ +D+SSN LT
Sbjct: 313 LTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLSSNKLT 372
Query: 380 GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLP 438
G +PP +C G+RL LI N SIP++L C SL+R+R+ +N LNGSIP+ FGL P
Sbjct: 373 GTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKELFGL-P 431
Query: 439 NLTFMDMSRNSLSGEIPRDLGNAQ-KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497
L+ +++ N L+GE+P G L +++S N SLP+ I + ++ L +K
Sbjct: 432 KLSQVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGNLSGVQKLLLDGNK 491
Query: 498 LTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGL 556
+G IP IG + + K++ +NL +G I +I C+ +G IP E++G+
Sbjct: 492 FSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEISRCKLLTFVDLSRNELSGDIPNELTGM 551
Query: 557 PSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNE 616
+ ++LS N L G+IP + +L S + SYN L+G +P++G F + +SF+GN
Sbjct: 552 KILNYLNLSRNHLVGSIPVTIASMQSLTSVDFSYNNLSGLVPSTGQ-FSYFNYTSFVGNS 610
Query: 617 GLCGRVLTKPCPADGLAAGDVEVRNHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFR 676
LCG L PC G ++H + P ++ ++ F +F +VA +
Sbjct: 611 HLCGPYLG-PC-------GKGTHQSHVK-PLSATTKLLLVLGLLFCSMVFAIVAIIK--- 658
Query: 677 ANYSRGFSNDREIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEI 736
+R N E W+LTAFQRL+FT DDVL+ L D I+G G G VYK MP G++
Sbjct: 659 ---ARSLRNASEAKAWRLTAFQRLDFTCDDVLDSLK-EDNIIGKGGAGIVYKGTMPKGDL 714
Query: 737 IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796
+AVK+L G AE+ LG +RHR+IVRLLG CSN E +L+YEYMPNG+L
Sbjct: 715 VAVKRL-ATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHETNLLVYEYMPNGSL 773
Query: 797 DDLLHAKNKGE-NLVADWVTRYKIALGVA--QGIC---YLHHDCDPVIVHRDLKPSNILL 850
++LH K G + + + A G+ C +H D + D +
Sbjct: 774 GEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSNNILLDSNFEAHVA 833
Query: 851 DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
D + + D G + E MS IAGSYGYIAP
Sbjct: 834 DFGLAKFLQDSGTS------ECMSAIAGSYGYIAP 862
|
|
| TAIR|locus:2005540 HAE "HAESA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1297 (461.6 bits), Expect = 2.7e-132, P = 2.7e-132
Identities = 316/860 (36%), Positives = 472/860 (54%)
Query: 49 DATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLN 108
D + S+ S + C W G+ C+ +S + S+DLS L GP P + +L SL L+
Sbjct: 37 DPAQSLSSWSDNNDVTPCKWLGVSCDA-TSNVVSVDLSSFMLVGPFPSILCHLPSLHSLS 95
Query: 109 LSANAFDGPLQPAILELT-KLRTIDISHN----SFNSTFPPGISKLRFLRIFNAYSNSFT 163
L N+ +G L + L ++D+S N S + P + L+FL I N+ +
Sbjct: 96 LYNNSINGSLSADDFDTCHNLISLDLSENLLVGSIPKSLPFNLPNLKFLEISG---NNLS 152
Query: 164 GPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAGNSLTGS-LPPQLGLLT 222
+P F + G IP+ N+++L+ L LA N + S +P QLG LT
Sbjct: 153 DTIPSSFGEFRKLESLNLAGNFLSGTIPASLGNVTTLKELKLAYNLFSPSQIPSQLGNLT 212
Query: 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282
+L+ + + NL G +P + L +L +D++ L+G++PS I+ L +E + LF N F
Sbjct: 213 ELQVLWLAGCNLVGPIPPSLSRLTSLVNLDLTFNQLTGSIPSWITQLKTVEQIELFNNSF 272
Query: 283 TGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEXXX 342
+GE+P S GN+ L+ D S N+L+G IP +L +L L L+L N+L G +P+ I
Sbjct: 273 SGELPESMGNMTTLKRFDASMNKLTGKIPDNL-NLLNLESLNLFENMLEGPLPESITRSK 331
Query: 343 XXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402
+NN LTGVLP +LG+N L VD+S N +G IP +C +L LIL N+F
Sbjct: 332 TLSELKLFNNRLTGVLPSQLGANSPLQYVDLSYNRFSGEIPANVCGEGKLEYLILIDNSF 391
Query: 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQ 462
+ I NL C SL+R+R+ +N+L+G IP GF LP L+ +++S NS +G IP+ + A+
Sbjct: 392 SGEISNNLGKCKSLTRVRLSNNKLSGQIPHGFWGLPRLSLLELSDNSFTGSIPKTIIGAK 451
Query: 463 KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLL 521
L L IS+N F S+P+ I S + +S + + +G+IP+ + K + +++L N L
Sbjct: 452 NLSNLRISKNRFSGSIPNEIGSLNGIIEISGAENDFSGEIPESLVKLKQLSRLDLSKNQL 511
Query: 522 NGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCS 581
+G IP ++ + +G IP E+ LP + +DLS N +G IP +N
Sbjct: 512 SGEIPRELRGWKNLNELNLANNHLSGEIPKEVGILPVLNYLDLSSNQFSGEIPLELQNLK 571
Query: 582 TLESFNVSYNLLTGPIPASGTIFPN-LHPSSFIGNEGLCGRVLTKPCPADGLAAGDVEVR 640
L N+SYN L+G IP ++ N ++ FIGN GLC DGL +
Sbjct: 572 -LNVLNLSYNHLSGKIPP---LYANKIYAHDFIGNPGLC-------VDLDGLCRKITRSK 620
Query: 641 NHQQQPKKTAGAIVWIMAAAFGIGLFVLVAGTRCFRANYS--RGF-SNDREIGPWKLTAF 697
N G VWI+ F + V V G F A R S+ W+ +F
Sbjct: 621 N--------IG-YVWILLTIFLLAGLVFVVGIVMFIAKCRKLRALKSSTLAASKWR--SF 669
Query: 698 QRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKL-----WG--KHKENI 750
+L+F+ ++ +CL + ++G GS+G VYK E+ GGE++AVKKL G ++ +
Sbjct: 670 HKLHFSEHEIADCLDEKN-VIGFGSSGKVYKVELRGGEVVAVKKLNKSVKGGDDEYSSDS 728
Query: 751 RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLV 810
R AEV+ LG +RH++IVRL CCS+ +C +L+YEYMPNG+L D+LH KG +V
Sbjct: 729 LNRDVFAAEVETLGTIRHKSIVRLWCCCSSGDCKLLVYEYMPNGSLADVLHGDRKG-GVV 787
Query: 811 ADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-- 868
W R +IAL A+G+ YLHHDC P IVHRD+K SNILLD + A+VADFG+AK+ Q
Sbjct: 788 LGWPERLRIALDAAEGLSYLHHDCVPPIVHRDVKSSNILLDSDYGAKVADFGIAKVGQMS 847
Query: 869 ---SDESMSVIAGSYGYIAP 885
+ E+MS IAGS GYIAP
Sbjct: 848 GSKTPEAMSGIAGSCGYIAP 867
|
|
| TAIR|locus:2169975 HSL2 "HAESA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 790 (283.2 bits), Expect = 1.8e-129, Sum P(2) = 1.8e-129
Identities = 198/603 (32%), Positives = 310/603 (51%)
Query: 34 KASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPK---SSQITSLDLSRRSL 90
K L DP N DW T + P C+W+GI C+ + S +T++DLS ++
Sbjct: 36 KTRLFDPDGN-LQDWVIT------GDNRSP--CNWTGITCHIRKGSSLAVTTIDLSGYNI 86
Query: 91 SGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILEL-TKLRTIDISHNSFNSTFPPGISKL 149
SG P + +L ++ LS N +G + A L L +KL+ + ++ N+F+ P +
Sbjct: 87 SGGFPYGFCRIRTLINITLSQNNLNGTIDSAPLSLCSKLQNLILNQNNFSGKLPEFSPEF 146
Query: 150 RFLRIFNAYSNSFTGPLPLEFVXXXXXXXXXXXXXYFDGEIPSDYRNLSSLRFLDLAGNS 209
R LR+ SN FTG +P + G +P+ L+ L LDLA S
Sbjct: 147 RKLRVLELESNLFTGEIPQSYGRLTALQVLNLNGNPLSGIVPAFLGYLTELTRLDLAYIS 206
Query: 210 LTGS-LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISN 268
S +P LG L+ L + + ++NL GE+P +LV L+ +D++ +L+G +P I
Sbjct: 207 FDPSPIPSTLGNLSNLTDLRLTHSNLVGEIPDSIMNLVLLENLDLAMNSLTGEIPESIGR 266
Query: 269 LTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328
L + + L+ N +G++P S GNL L+ D+S N L+G +P +A+L+ L +L +N
Sbjct: 267 LESVYQIELYDNRLSGKLPESIGNLTELRNFDVSQNNLTGELPEKIAALQ-LISFNLNDN 325
Query: 329 VLFGEIPQDIEXXXXXXXXXXWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388
G +P + +NN TG LP+ LG ++ DVS+N +G +PP +C
Sbjct: 326 FFTGGLPDVVALNPNLVEFKIFNNSFTGTLPRNLGKFSEISEFDVSTNRFSGELPPYLCY 385
Query: 389 GDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN 448
+L K+I FSN + IPE+ +C SL+ +R+ DN+L+G +P F LP LT ++++ N
Sbjct: 386 RRKLQKIITFSNQLSGEIPESYGDCHSLNYIRMADNKLSGEVPARFWELP-LTRLELANN 444
Query: 449 S-LSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIG 507
+ L G IP + A+ L L IS N+F +P + +L+++ S + G IP I
Sbjct: 445 NQLQGSIPPSISKARHLSQLEISANNFSGVIPVKLCDLRDLRVIDLSRNSFLGSIPSCIN 504
Query: 508 -CKSIYKIELHNNLLNGSIPWDIGHCEKXXXXXXXXXXXTGIIPWEISGLPSITDVDLSH 566
K++ ++E+ N+L+G IP + C + G IP E+ LP + +DLS+
Sbjct: 505 KLKNLERVEMQENMLDGEIPSSVSSCTELTELNLSNNRLRGGIPPELGDLPVLNYLDLSN 564
Query: 567 NFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLT-- 624
N LTG IP+ L FNVS N L G IP SG PS F+GN LC L
Sbjct: 565 NQLTGEIPAELLRLK-LNQFNVSDNKLYGKIP-SGFQQDIFRPS-FLGNPNLCAPNLDPI 621
Query: 625 KPC 627
+PC
Sbjct: 622 RPC 624
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9FII5 | TDR_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6384 | 0.9268 | 0.8030 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 902 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-144 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-39 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 6e-37 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-32 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-21 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-21 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-21 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-19 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 7e-18 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-18 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-16 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-16 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-16 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-16 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-15 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-14 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-14 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-14 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-14 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-14 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-14 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-14 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-14 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-14 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-13 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-13 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-13 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-13 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-12 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-12 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-12 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-12 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 7e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-11 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-11 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 4e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-11 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 5e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-10 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-10 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 5e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 7e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-09 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-09 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-09 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-09 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-09 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-08 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-08 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-08 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-08 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-08 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-08 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-08 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 4e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-08 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 8e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 8e-08 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 9e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-07 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-07 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 9e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-06 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-05 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-05 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-04 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 7e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-04 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 7e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 7e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 0.002 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.002 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.002 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 451 bits (1163), Expect = e-144
Identities = 304/927 (32%), Positives = 463/927 (49%), Gaps = 129/927 (13%)
Query: 4 PLFFLTFFLHLLVVFS---ANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSE 60
+ + L + FS A L L LLS K+S+ DP +W+++
Sbjct: 9 CPYLIFMLFFLFLNFSMLHAEELEL----LLSFKSSINDPLKYLS-NWNSSADV------ 57
Query: 61 QEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQP 120
C W GI CN SS++ S+DLS +++SG I I L + +NLS N GP+
Sbjct: 58 -----CLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPD 111
Query: 121 AILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180
I + S LR+L + N N+FTG +P + L+ L+
Sbjct: 112 DIFTTS--------------------SSLRYLNLSN---NNFTGSIPRGSIPN--LETLD 146
Query: 181 LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPV 240
L + GEIP+D + SSL+ LDL GN L G +P L LT LE + + N L G++P
Sbjct: 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPR 206
Query: 241 EFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLD 300
E + +LK++ + NLSG +P EI LT L L L N+ TG IP S GNL+ LQ L
Sbjct: 207 ELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLF 266
Query: 301 LSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQ 360
L N+LSGPIP S+ SL+ L L L +N L GEIP+ + L +L+ L L++N+ TG +P
Sbjct: 267 LYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPV 326
Query: 361 KLGSNGKL-----------------------LTV-DVSSNSLTGPIPPTICDGDRLFKLI 396
L S +L LTV D+S+N+LTG IP +C LFKLI
Sbjct: 327 ALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386
Query: 397 LFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPR 456
LFSN+ IP++L C SL R+R+QDN +G +P F LP + F+D+S N+L G I
Sbjct: 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINS 446
Query: 457 DLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKS-IYKIE 515
+ L+ L+++ N F LP + + + L+ L S ++ +G +P +G S + +++
Sbjct: 447 RKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLK 505
Query: 516 LHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
L N L+G IP ++ C+KL+ L+LS N L+G IP S +P ++ +DLS N L+G IP
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 576 NFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLT---KPCPADGL 632
N N +L N+S+N L G +P++G F ++ S+ GN LCG T PC
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGA-FLAINASAVAGNIDLCGGDTTSGLPPC----- 619
Query: 633 AAGDVEVRNHQQQPKKTAGAIVW--IMAAAFGIGLFVLVAGTRCFRANYSRGFSN----- 685
K+ W + G L + + F + RG +N
Sbjct: 620 --------------KRVRKTPSWWFYITCTLGAFLVLALVA---FGFVFIRGRNNLELKR 662
Query: 686 -DREIGPWKLTAFQR---LNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEI-IAVK 740
+ E G W+L F + T +D+L L + ++ G G YK + + VK
Sbjct: 663 VENEDGTWELQFFDSKVSKSITINDILSSLK-EENVISRGKKGASYKGKSIKNGMQFVVK 721
Query: 741 KLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL 800
++ +I +E+ +G ++H NIV+L+G C + + L++EY+ NL ++L
Sbjct: 722 EI--NDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774
Query: 801 HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860
NL W R KIA+G+A+ + +LH C P +V +L P I++DG+ E +
Sbjct: 775 ------RNL--SWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR- 825
Query: 861 FGVAKLIQSDESMSVIAGSYGYIAPGT 887
+ L+ +D + S Y+AP T
Sbjct: 826 LSLPGLLCTDTKCFI---SSAYVAPET 849
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 7e-39
Identities = 58/171 (33%), Positives = 92/171 (53%), Gaps = 11/171 (6%)
Query: 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG GS G VY A G+++A+K + K + R R +L E+ +L ++H NIVRL
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRER--ILREIKILKKLKHPNIVRL 62
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ + L+ EY G+L DLL + + +++ R+ + + YLH
Sbjct: 63 YDVFEDEDKLYLVMEYCEGGDLFDLLKKRGR----LSEDEARF-YLRQILSALEYLHSKG 117
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IVHRDLKP NILLD + ++ADFG+A+ + E ++ G+ Y+AP
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAP 165
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 6e-37
Identities = 66/172 (38%), Positives = 100/172 (58%), Gaps = 11/172 (6%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG GS GTVYKA+ G G+I+AVK L K E ++ + E+ +L + H NIVRL
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILK-KRSEKSKKDQTARREIRILRRLSHPNIVRL 63
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ +++ L+ EY G+L D L +++ + KIAL + +G+ YLH +
Sbjct: 64 IDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP----LSEDEAK-KIALQILRGLEYLHSNG 118
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
I+HRDLKP NILLD ++ADFG+AK ++S S++ G+ Y+AP
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 5e-36
Identities = 61/172 (35%), Positives = 93/172 (54%), Gaps = 14/172 (8%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G GTVY A G+ +A+K + K +++ +L E+++L + H NIV+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCD 835
+ L+ EY G+L DLL +I L + +G+ YLH +
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKL----SEDEILRILLQILEGLEYLHSNG-- 112
Query: 836 PVIVHRDLKPSNILLD-GEMEARVADFGVAKLIQSDES-MSVIAGSYGYIAP 885
I+HRDLKP NILLD + ++ADFG++KL+ SD+S + I G+ Y+AP
Sbjct: 113 --IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-34
Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 13/169 (7%)
Query: 715 DKILGMGSTGTVYKAE-----MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ G VYK +AVK L K + ++ L E ++ + H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--KEDASEQQIEEFLREARIMRKLDHP 61
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIV+LLG C+ E M++ EYMP G+L D L KN+ + L AL +A+G+ Y
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR-KNRPKEL--SLSDLLSFALQIARGMEY 118
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAG 878
L +HRDL N L+ + +++DFG+++ + D+ V G
Sbjct: 119 LESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG 164
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-34
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 715 DKILGMGSTGTVYKAE-----MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ G VYK + +AVK L K + ++ L E ++ + H
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--KEDASEQQIEEFLREARIMRKLDHP 61
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
N+V+LLG C+ E ++ EYM G+L L + L AL +A+G+ Y
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKL--SLSDLLSFALQIARGMEY 117
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
L +HRDL N L+ + +++DFG+++ + D+
Sbjct: 118 LESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRK 160
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 55/163 (33%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 715 DKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ G VYK + +AVK L K + R L E ++ + H
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL--KEGASEEEREEFLEEASIMKKLSHP 61
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIVRLLG C+ E ++ EYMP G+L D L GE L ++AL +A+G+ Y
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR--KHGEKL--TLKDLLQMALQIAKGMEY 117
Query: 830 LH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
L + VHRDL N L+ + +++DFG+++ I D+
Sbjct: 118 LESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDD 156
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 55/179 (30%), Positives = 92/179 (51%), Gaps = 21/179 (11%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++LG GS G+VY A GE++AVK + + + E+ +L +++H NIVR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRY 64
Query: 775 LGCCSNRECTML-LY-EYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYL 830
G + E L ++ EY+ G+L LL K E ++ + + + +G+ YL
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPVIRKYTRQ------ILEGLAYL 117
Query: 831 H-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAP 885
H + IVHRD+K +NIL+D + ++ADFG AK + E + G+ ++AP
Sbjct: 118 HSNG----IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-31
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
K LG G+ G VYK ++ G + +AVK L K + R+ L E V+ + H N+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL--KEDASEEERKDFLKEARVMKKLGHPNV 58
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVAD----WVTRYKIALGVAQGI 827
VRLLG C+ E L+ EYM G+L D L A+ +A+G+
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL VHRDL N L+ ++ +++DFG+++ + D+
Sbjct: 119 EYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 47/173 (27%), Positives = 91/173 (52%), Gaps = 19/173 (10%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G G VYKA G+ +A+K + K + ++ ++ E+ +L +H NIV+ G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI--KLESK-EKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLH--H 832
++ ++ E+ G+L DLL + N+ E+ +A + + +G+ YLH
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIA------YVCKELLKGLEYLHSNG 118
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+K +NILL + E ++ DFG++ + ++ + + G+ ++AP
Sbjct: 119 -----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAP 166
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 57/168 (33%), Positives = 93/168 (55%), Gaps = 17/168 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K+LG GS+G VYK P G+I A+KK+ E R++ +L E+ L + +V+
Sbjct: 7 KVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCESPYVVKC 64
Query: 775 LGC-CSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHH 832
G E +++L EYM G+L DLL K E ++A IA + +G+ YLH
Sbjct: 65 YGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLA------YIARQILKGLDYLHT 117
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY 880
I+HRD+KPSN+L++ + E ++ADFG++K++ E+ ++
Sbjct: 118 KRH--IIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTF 160
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 54/174 (31%), Positives = 97/174 (55%), Gaps = 17/174 (9%)
Query: 717 ILGMGSTGTVYKAE-MPGGEIIAVKK--LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
++G G+ G VYK + G+ +A+K+ L +E ++ ++ E+D+L N++H NIV+
Sbjct: 7 LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS---IMQEIDLLKNLKHPNIVK 63
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHH 832
+G + ++ EY NG+L ++ E+LVA +V + V QG+ YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQ------VLQGLAYLH- 116
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
+ ++HRD+K +NIL + ++ADFGVA KL + + + G+ ++AP
Sbjct: 117 --EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAP 168
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (236), Expect = 2e-21
Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
K +G GS G VY G++ +K++ E R L EV +L + H NI++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERED--ALNEVKILKKLNHPNIIK 63
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG-----ENLVADWVTRYKIALGVAQGIC 828
+ ++ EY G+L + + K E + DW ++ L +
Sbjct: 64 YYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV--QLCLAL----K 117
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
YLH I+HRD+KP NI L ++ DFG++K++ S + +V+ Y Y++P
Sbjct: 118 YLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSP 172
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 57/173 (32%), Positives = 94/173 (54%), Gaps = 18/173 (10%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G++G V K P G+I+AVK + + E I+++ +L E+D+L IV G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQ--ILRELDILHKCNSPYIVGFYG 66
Query: 777 CC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWV-TRY--KIALGVAQGICYLHH 832
+N + ++ + EYM G+LD +L V + R KIA+ V +G+ YLH
Sbjct: 67 AFYNNGDISICM-EYMDGGSLDKIL-------KEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNIL++ + ++ DFGV+ + + + + G+ Y+AP
Sbjct: 119 KHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAP 168
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 5e-21
Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 22/176 (12%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNIVR 773
LG GS G V G++ A+K L K+ I +R+ V L E ++L + H IV+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL---KKKKIIKRKEVEHTLTERNILSRINHPFIVK 57
Query: 774 LLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + + ++L EY P G L L + + + Y A + + YLH
Sbjct: 58 LH-YAFQTEEKLYLVL-EYAPGGELFSHLSKEGR---FSEERARFY--AAEIVLALEYLH 110
Query: 832 -HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
I++RDLKP NILLD + ++ DFG+AK L + G+ Y+AP
Sbjct: 111 SLG----IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.3 bits (233), Expect = 8e-21
Identities = 51/161 (31%), Positives = 81/161 (50%), Gaps = 22/161 (13%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRN 770
+ LG G+ G VYKA + GEI+A+KK+ ++E G+ L E+ +L ++H N
Sbjct: 5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEE-----GIPSTALREISLLKELKHPN 59
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGIC 828
IV+LL L++EY +L L + NL+ I + +G+
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIK------SIMYQLLRGLA 112
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
Y H I+HRDLKP NIL++ + ++ADFG+A+
Sbjct: 113 YCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-21
Identities = 55/164 (33%), Positives = 88/164 (53%), Gaps = 19/164 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEII----AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
K+LG G+ GTVYK +P GE + A+K L + + + + + +L E V+ +V H +
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVL--REETSPKANKEILDEAYVMASVDHPH 70
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGIC 828
+VRLLG C + L+ + MP G L D + H N G + +W + +A+G+
Sbjct: 71 VVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMS 123
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
YL + +VHRDL N+L+ ++ DFG+AKL+ DE
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 11/148 (7%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
+G G G V + G + +AVK L K++ + LAE V+ +RH N+V+LLG
Sbjct: 14 IGKGEFGDVMLGDYRG-QKVAVKCL----KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
++ EYM G+L D L ++ + +A + AL V +G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ---QLGFALDVCEGMEYLE---EKN 122
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAK 865
VHRDL N+L+ ++ A+V+DFG+AK
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 54/160 (33%), Positives = 89/160 (55%), Gaps = 13/160 (8%)
Query: 715 DKILGMGSTGTVYKA--EMPGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
K++G G G V++ +MPG + +A+K L + E ++R+ L+E ++G H N
Sbjct: 10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHN 67
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+RL G + + M++ EYM NG LD L + GE V + G+A G+ YL
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLR-DHDGEFSSYQLVGMLR---GIAAGMKYL 123
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
D VHRDL NIL++ +E +V+DFG++++++ D
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 53/171 (30%), Positives = 88/171 (51%), Gaps = 13/171 (7%)
Query: 715 DKILGMGSTGTVYKAEM--PGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++++G G G V + + PG +A+K L + E ++RR L+E ++G H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPN 66
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+ L G + M++ E+M NG LD L +N G+ V V + G+A G+ YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLR-QNDGQFTVIQLVGMLR---GIAAGMKYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
+ VHRDL NIL++ + +V+DFG+++ ++ D S S G
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG 170
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 1e-19
Identities = 55/160 (34%), Positives = 89/160 (55%), Gaps = 13/160 (8%)
Query: 715 DKILGMGSTGTVYKAEM--PGG-EI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+K++G G G V + PG EI +A+K L + E ++RR L+E ++G H N
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPN 66
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+ L G + + M++ EYM NG+LD L K+ G+ V V + G+A G+ YL
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-KHDGQFTVIQLVGMLR---GIASGMKYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
D VHRDL NIL++ + +V+DFG++++++ D
Sbjct: 123 ---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 52/162 (32%), Positives = 86/162 (53%), Gaps = 13/162 (8%)
Query: 715 DKILGMGSTGTVYKA--EMPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+K++G G G V + ++PG + I A+K L + +R L E ++G H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDK--QRLDFLTEASIMGQFDHPN 66
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+RL G + M++ EYM NG+LD L +N G+ V V + G+A G+ YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLR-ENDGKFTVGQLV---GMLRGIASGMKYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ VHRDL NIL++ + +V+DFG+++ ++ E+
Sbjct: 123 ---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 90.2 bits (222), Expect = 4e-19
Identities = 56/179 (31%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIVRL 774
+ LG GS G VY A +++A+K L K + + L E+ +L ++ H NIV+L
Sbjct: 6 RKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ L+ EY+ G+L+DLL + L + + YLH
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI--LSALEYLHSKG 121
Query: 835 DPVIVHRDLKPSNILLD-GEMEARVADFGVAKLIQSDES-------MSVIAGSYGYIAP 885
I+HRD+KP NILLD ++ DFG+AKL+ S S G+ GY+AP
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
|
Length = 384 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 20/176 (11%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNVRHRNIV 772
+ LG GS G+VYKA G+++A+K + + + I + E+ +L IV
Sbjct: 8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK------EISILKQCDSPYIV 61
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK--GENLVADWVTRYKIALGVAQGICYL 830
+ G ++ EY G++ D++ NK E +A I +G+ YL
Sbjct: 62 KYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA------AILYQTLKGLEYL 115
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
H +HRD+K NILL+ E +A++ADFGV+ +L + + + G+ ++AP
Sbjct: 116 H---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAP 168
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 5e-19
Identities = 56/170 (32%), Positives = 93/170 (54%), Gaps = 17/170 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ GTVYK P G + A+K ++G H++ +RR+ + E+++L +V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ--ICREIEILRDVNHPNVVKC 137
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ +L E+M G+L+ A E +AD +A + GI YLH
Sbjct: 138 HDMFDHNGEIQVLLEFMDGGSLEGTHIAD---EQFLAD------VARQILSGIAYLHRR- 187
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIA 884
IVHRD+KPSN+L++ ++ADFGV++++ ++M S G IA
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNSSVGTIA 233
|
Length = 353 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 9e-19
Identities = 50/161 (31%), Positives = 77/161 (47%), Gaps = 12/161 (7%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
++M K LG G G VY+ +AVK L KE+ L E V+ ++H
Sbjct: 8 ITMKHK-LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHP 62
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
N+V+LLG C+ ++ E+M GNL D L N+ E + V +A ++ + Y
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEY 119
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
L +HRDL N L+ +VADFG+++L+ D
Sbjct: 120 LEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 53/154 (34%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G V K GEI+A+KK + ++ L EV VL +RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT-ALREVKVLRQLRHENIVNLKE 67
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCD 835
+ L++EY+ L +LL A G L D V Y L Q I Y H H+
Sbjct: 68 AFRRKGRLYLVFEYVER-TLLELLEASPGG--LPPDAVRSYIWQL--LQAIAYCHSHN-- 120
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
I+HRD+KP NIL+ ++ DFG A+ +++
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 4e-18
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 16/162 (9%)
Query: 716 KILGMGSTGTVYKA--EMPG---GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
K LG G G V + G GE +AVK L H + R E+++L + H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 771 IVRLLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
IV+ G C L+ EY+P+G+L D L +++ + + + + + +G+
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLL---LFSSQICKGMD 123
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
YL +HRDL NIL++ E +++DFG+AK++ D
Sbjct: 124 YLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 5e-18
Identities = 57/178 (32%), Positives = 94/178 (52%), Gaps = 17/178 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLA---EVDVLGNVRHRNI 771
K+LG G+ G VY ++ G +AVK++ ++ ++ V A E+ +L N++H I
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQV-PFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+ GC + E + EYMP G++ D L K + + VTR K + +G+ YLH
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTR-KYTRQILEGVEYLH 121
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ----SDESMSVIAGSYGYIAP 885
+IVHRD+K +NIL D ++ DFG +K +Q S M + G+ +++P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (211), Expect = 6e-18
Identities = 52/164 (31%), Positives = 78/164 (47%), Gaps = 20/164 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKH--KEN----IRRRRGVLAEVDVLGNVRH 768
KI+G GS TV A E + A+K L + KE ++ + VL ++ H
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN-----GH 61
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
I++L + E + EY PNG L + K + + TR+ A + +
Sbjct: 62 PGIIKLYYTFQDEENLYFVLEYAPNGELLQYIR-KYGS---LDEKCTRFYAAE-ILLALE 116
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
YLH I+HRDLKP NILLD +M ++ DFG AK++ + S
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 6e-18
Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 16/174 (9%)
Query: 706 DVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVL 763
+VLE + G GS GTV K G+I+ K++ +G E + ++ +++EV++L
Sbjct: 3 EVLETI-------GKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE--KEKQQLVSEVNIL 53
Query: 764 GNVRHRNIVRLLGCCSNRECTMLLY---EYMPNGNLDDLL-HAKNKGENLVADWVTRYKI 819
++H NIVR +R LY EY G+L L+ K + + + +++ R
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQ-TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
L +A C+ D ++HRDLKP+NI LD ++ DFG+AK++ D S
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 57/179 (31%), Positives = 96/179 (53%), Gaps = 18/179 (10%)
Query: 714 SDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+KI G G+ G VY A + GE++AVK++ + + + + E+ VL ++H N+V
Sbjct: 5 GNKI-GGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ G +RE + EY G L++LL H + E+++ Y + L +G+ YLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR----VYTLQL--LEGLAYLH 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD-----ESMSVIAGSYGYIAP 885
IVHRD+KP+NI LD ++ DFG A ++++ E + +AG+ Y+AP
Sbjct: 117 SH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAP 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 8e-18
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 40/174 (22%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKEN------IRRRRGVLAEVDVLGNVRH 768
+G G+ G VYKA GE++A+KK+ ++++ IR E+ +L +RH
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-------EIKLLQKLRH 57
Query: 769 RNIVRLLGCCSNREC--TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG---- 822
NIVRL +++ +++EYM + +L LL + K
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE------------VKFTESQIKC 104
Query: 823 ----VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ +G+ YLH + I+HRD+K SNIL++ + ++ADFG+A+ S
Sbjct: 105 YMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 56/174 (32%), Positives = 78/174 (44%), Gaps = 17/174 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
K LG GS G V G+ A+K L K I + + V L E +L ++RH +
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALKIL---SKAKIVKLKQVEHVLNEKRILQSIRHPFL 63
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V L G + L+ EY+P G L L + Y A V + YLH
Sbjct: 64 VNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPE---PVARFY--AAQVVLALEYLH 118
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
D IV+RDLKP N+LLD + ++ DFG AK + + G+ Y+AP
Sbjct: 119 S-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRV--KGRTYTLCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 8/171 (4%)
Query: 717 ILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G+V K + +I K N ++ +L E+++ + + IV+ G
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITT-DPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 777 CCSNRECTML--LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ + + EY G+LD + K + + V KIA V +G+ YLH
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLKGLSYLH--- 122
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNILL + + ++ DFGV+ + + + + S+ Y+AP
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSF-YMAP 172
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 55/188 (29%), Positives = 102/188 (54%), Gaps = 27/188 (14%)
Query: 713 MSDKILGMGSTGTVYKA-EMPGGEIIAVKKL------WGKHKENIRRRRGVL----AEVD 761
+ +++G G+ G VY A + GE++AVK++ G+H R++ ++ +E++
Sbjct: 4 VKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS---RQKDMVKALRSEIE 60
Query: 762 VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
L ++ H NIV+ LG + E + EY+P G++ L + E + + T
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ---- 116
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK----LIQSDESMSVIA 877
V +G+ YLH I+HRDLK N+L+D + +++DFG++K + +D++MS +
Sbjct: 117 -VLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQ 171
Query: 878 GSYGYIAP 885
GS ++AP
Sbjct: 172 GSVFWMAP 179
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 26/171 (15%)
Query: 718 LGMGSTGTVYKAEM--PGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G+ G VYK E+ P +A+K L K + ++ E +++ +++H NI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTL--KENAEPKVQQEFRQEAELMSDLQHPNI 70
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYK---------IA 820
V LLG C+ + T +L+EY+ +G+L + L ++ + + T IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 821 LGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ +A G+ YL HH VHRDL N L+ + +++DFG+++ I S
Sbjct: 131 IQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 21/175 (12%)
Query: 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKH------KENIRRRRGVLAEVDVLGNVRHRN 770
LG+G G V ++ A+K + +H +E+I + +L E + H
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN------HPF 54
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
IV+L +++ +L EY G L +L + L ++ R+ IA V YL
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG----LFDEYTARFYIA-CVVLAFEYL 109
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H+ I++RDLKP N+LLD ++ DFG AK ++S + G+ Y+AP
Sbjct: 110 HNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAP 161
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 55/176 (31%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKL-----WGKHKENIRRRRGVLAEVDVLGNVRHR 769
++LG GS G+VY+ + G+ AVK++ +E +++ E+ +L ++H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQ---EIALLSKLQHP 62
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIV+ LG + + E +P G+L LL V TR +I LG+ Y
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----Y 117
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
LH D VHRD+K +NIL+D ++ADFG+AK + GS ++AP
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 22/163 (13%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++ LG G G V+ G +AVK L K L E ++ +RH +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLH---AKNKGENLVADWVTRYKIALGVAQGICYL- 830
CS E ++ EYM G+L D L K + D +A +A+G+ YL
Sbjct: 67 YAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVD------MAAQIAEGMAYLE 120
Query: 831 --HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
++ +HRDL NIL+ + ++ADFG+A+LI+ DE
Sbjct: 121 SRNY------IHRDLAARNILVGENLVCKIADFGLARLIEDDE 157
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 55/173 (31%), Positives = 92/173 (53%), Gaps = 19/173 (10%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G+V K + +P G ++A K + K ++R++ +L E+ ++ R IV G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ--ILRELQIMHECRSPYIVSFYG 70
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL---HHD 833
N + E+M G+LD + KG + + + KIA+ V +G+ YL H
Sbjct: 71 AFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILG--KIAVAVVEGLTYLYNVHR- 124
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNIL++ + ++ DFGV+ +LI S V G+ Y++P
Sbjct: 125 ----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV--GTSTYMSP 171
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G VYKA GE++A+K + + ++ + E+ +L RH NIV G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPNIVAYFG 67
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNK--GENLVADWVTRYKIALGVAQGICYLHHDC 834
R+ ++ EY G+L D+ E +A +V R +G+ YLH
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA-YVCRE-----TLKGLAYLHET- 120
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
+HRD+K +NILL + + ++ADFGV+ + +++
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIA 156
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 53/164 (32%), Positives = 87/164 (53%), Gaps = 19/164 (11%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEII----AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K+LG G+ GTVYK +P GE + A+K+L + + + + +L E V+ +V +
Sbjct: 12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNP 69
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGI 827
++ RLLG C L+ + MP G L D + H N G + +W + +A+G+
Sbjct: 70 HVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKGM 122
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL + +VHRDL N+L+ ++ DFG+AKL+ +DE
Sbjct: 123 NYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 56/179 (31%), Positives = 96/179 (53%), Gaps = 17/179 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLW--GKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K+LG G+ G VY ++ G +A K++ + E + + E+ +L N++H IV
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 773 RLLGCCSNR-ECTMLLY-EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ GC +R E T+ ++ EYMP G++ D L K + + VTR K + +G+ YL
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTR-KYTRQILEGMSYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ----SDESMSVIAGSYGYIAP 885
H + +IVHRD+K +NIL D ++ DFG +K +Q S + + G+ +++P
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 28/171 (16%)
Query: 718 LGMGSTGTVYKAEM----PGGE--IIAVKKLWGKHKENIRR--RRGVLAEVDVLGNVRHR 769
LG G+ G V+ E P + ++AVK L KE R+ E ++L N +H
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL----KETASNDARKDFEREAELLTNFQHE 68
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW------VTR---YKIA 820
NIV+ G C+ + ++++EYM +G+L+ L + + +T +IA
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 821 LGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ +A G+ YL H VHRDL N L+ ++ ++ DFG+++ + +
Sbjct: 129 VQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 8e-16
Identities = 46/153 (30%), Positives = 77/153 (50%), Gaps = 9/153 (5%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
LG G G V++ +A+K L +++ +++ EV L +RH++++ L
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKIL---KSDDLLKQQDFQKEVQALKRLRHKHLISLFAV 70
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
CS E ++ E M G+L L E V + +A VA+G+ YL +
Sbjct: 71 CSVGEPVYIITELMEKGSLLAFL---RSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
+HRDL NIL+ ++ +VADFG+A+LI+ D
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKED 157
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 55/159 (34%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLW--GKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K+LG G+ G VY + G +AVK++ +E + + E+ +L N+RH IV
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 773 RLLGCCSNRECTML--LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ GC + E L EYMP G++ D L K + + VTR + + QG+ YL
Sbjct: 68 QYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTR-RYTRQILQGVSYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
H + +IVHRD+K +NIL D ++ DFG +K IQ+
Sbjct: 123 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 48/157 (30%), Positives = 88/157 (56%), Gaps = 15/157 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENI----RRRRGVLAEVDVLGNVRHRNI 771
++LG G+ GTVY G++IAVK++ N+ + + EVD+L +++H NI
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQV-ELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 772 VRLLGCCSNRECTMLLY-EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
V+ LG C + + T+ ++ E++P G++ +L N+ L +Y + G+ YL
Sbjct: 65 VQYLGTCLD-DNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKY--TKQILDGVAYL 118
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
H++C +VHRD+K +N++L ++ DFG A+ +
Sbjct: 119 HNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 29/182 (15%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+G+G+T VY A +P E +A+K++ + +R+ EV + H N+V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRK------EVQAMSQCNHPNVV 62
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG----ENLVADWVTRYKIALGVAQGIC 828
+ + L+ Y+ G+L D++ + E ++A + V +G+
Sbjct: 63 KYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA------TVLKEVLKGLE 116
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-----VIAGSYGYI 883
YLH +HRD+K NILL + ++ADFGV+ + + G+ ++
Sbjct: 117 YLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWM 173
Query: 884 AP 885
AP
Sbjct: 174 AP 175
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-15
Identities = 52/168 (30%), Positives = 95/168 (56%), Gaps = 21/168 (12%)
Query: 713 MSDKILGMGSTGTVYKA-EMPGGEIIAVKK--LWGKHKENIRRRRGVLA----EVDVLGN 765
+ ++G GS G+VY GE++AVK+ L + R+R +L E+ +L
Sbjct: 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKE 62
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALG 822
++H NIV+ LG + + + EY+P G++ LL+ N G E LV ++V +
Sbjct: 63 LQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQ------ 114
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
+ +G+ YLH+ I+HRD+K +NIL+D + +++DFG++K ++++
Sbjct: 115 ILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 47/158 (29%), Positives = 86/158 (54%), Gaps = 12/158 (7%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G VYKA + GEI+A+KK+ + + + L E+ +L + H NI++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTA-LREIKLLKELNHPNIIKLLD 65
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCD 835
++ L++E+M + +L L+ + +G + + + + + QG+ + H H
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRG---LPESLIKS-YLYQLLQGLAFCHSHG-- 118
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
I+HRDLKP N+L++ E ++ADFG+A+ S
Sbjct: 119 --ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 3e-15
Identities = 54/165 (32%), Positives = 82/165 (49%), Gaps = 22/165 (13%)
Query: 716 KILGMGSTGTV----YKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++LG G G V Y G GE++AVK L K + + G E+++L + H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTL--KRECGQQNTSGWKKEINILKTLYHEN 67
Query: 771 IVRLLGCCSNR--ECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQG 826
IV+ GCCS + + L+ EY+P G+L D L H N + L+ A + +G
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--------FAQQICEG 119
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ YLH +HRDL N+LLD + ++ DFG+AK +
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 47/173 (27%), Positives = 79/173 (45%), Gaps = 23/173 (13%)
Query: 715 DKILGMGSTGTVYKAE------MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-R 767
K LG G+ G V KAE +AVK L K + +++E++++ + +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKML--KDDATEKDLSDLVSEMEMMKMIGK 74
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA---KNKGENLVADWVTRYKI----- 819
H+NI+ LLG C+ ++ EY +GNL D L A + + +
Sbjct: 75 HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 820 ---ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
A VA+G+ +L +HRDL N+L+ + ++ADFG+A+ I
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (189), Expect = 4e-15
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 35/166 (21%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ VYKA G I+A+KK+ + K+ I L E+ +L ++H
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFT--ALREIKLLQELKHP 62
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA----- 824
NI+ LL ++ L++E+M +L+ ++ K+ I L A
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKS--------------IVLTPADIKSY 107
Query: 825 -----QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+G+ YLH + I+HRDLKP+N+L+ + ++ADFG+A+
Sbjct: 108 MLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 7e-15
Identities = 34/78 (43%), Positives = 46/78 (58%)
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
L G +P++IS L L+ + L N G IP S G++ +L+VLDLS N +G IP SL L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 318 KGLTRLSLMNNVLFGEIP 335
L L+L N L G +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 50/172 (29%), Positives = 82/172 (47%), Gaps = 16/172 (9%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G VYKA+ G A K + + +E + + E+D+L +H NIV L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELE---DFMVEIDILSECKHPNIVGLYE 69
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDC 834
+L E+ G LD ++ +G E + +V R + + + +LH
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIR-YVCRQ-----MLEALNFLH--- 120
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
++HRDLK NILL + + ++ADFGV AK + + G+ ++AP
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 74.9 bits (185), Expect = 1e-14
Identities = 44/154 (28%), Positives = 78/154 (50%), Gaps = 24/154 (15%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIR--RRRGVLAEVDVLGNVRHRNIVRL 774
+G G++G VYKA + G+ +A+KK+ +R + ++ E+ ++ + +H NIV
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM------RLRKQNKELIINEILIMKDCKHPNIVDY 80
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLH- 831
+ ++ EYM G+L D++ + E +A + V QG+ YLH
Sbjct: 81 YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA------YVCREVLQGLEYLHS 134
Query: 832 -HDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ ++HRD+K NILL + ++ADFG A
Sbjct: 135 QN-----VIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 53/159 (33%), Positives = 79/159 (49%), Gaps = 15/159 (9%)
Query: 718 LGMGSTGTVYKA--EMPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
LG G+ G+V K M G+ + AVK L K + ++ L E V+ + H IVR
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTL--KQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L+G C E ML+ E P G L L K + E V+D ++A VA G+ YL
Sbjct: 61 LIGVCKG-EPLMLVMELAPLGPLLKYL--KKRREIPVSDLK---ELAHQVAMGMAYLE-- 112
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
VHRDL N+LL +A+++DFG+++ + +
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 51/153 (33%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VY A ++ E++A+KK+ K++ + + ++ EV L +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 777 CCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
C L+ EY G+ D+L H K E +A I G QG+ YLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIA------AICHGALQGLAYLHSHE 135
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+HRD+K NILL ++ADFG A L+
Sbjct: 136 ---RIHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 43/148 (29%), Positives = 74/148 (50%), Gaps = 9/148 (6%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
+G G+ G VYK + G +AVK +++R+ L E ++L H NIV+L+G
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRK--FLQEAEILKQYDHPNIVKLIGV 60
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
C ++ ++ E +P G+L L K K V + +++L A G+ YL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR-KKKNRLTVKKLL---QMSLDAAAGMEYLESKN--- 113
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAK 865
+HRDL N L+ +++DFG+++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-14
Identities = 51/170 (30%), Positives = 84/170 (49%), Gaps = 9/170 (5%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G V+K + A+K++ K N R R + E VL + I+R
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQI-DLSKMNRREREEAIDEARVLAKLDSSYIIRYYE 66
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
++ ++ EY NG+L LL + +G L D V R+ I + + G+ +LH
Sbjct: 67 SFLDKGKLNIVMEYAENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILL--GLAHLHSK--- 120
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-VIAGSYGYIAP 885
I+HRD+K N+ LD ++ D GVAKL+ + + + I G+ Y++P
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 44/174 (25%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+++G G+ G V+ + + + K + R E VL + H NI+
Sbjct: 6 RVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYY 65
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQGICYLHH 832
+ M++ EY P G L + + + E+ + + + +AL HH
Sbjct: 66 ENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL---------HH 116
Query: 833 DCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+I+HRDLK NILLD +M ++ DFG++K++ S + G+ YI+P
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 51/161 (31%), Positives = 85/161 (52%), Gaps = 15/161 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV--LAEVDVLGNVRHRNIV 772
K+LG G+ GTVYK +P GE + + E + V + E ++ ++ H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLH--AKNKGENLVADWVTRYKIALGVAQGICYL 830
RLLG C + L+ + MP+G L D +H N G L+ +W + +A+G+ YL
Sbjct: 73 RLLGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYL 125
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ +VHRDL N+L+ ++ DFG+A+L++ DE
Sbjct: 126 E---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE 163
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 46/161 (28%), Positives = 72/161 (44%), Gaps = 16/161 (9%)
Query: 718 LGMGSTGTVY----KAEMPGGEI--IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG GS G VY K + G +A+K + ++R R L E V+ ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN--ASMRERIEFLNEASVMKEFNCHHV 71
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAK--NKGENLVADWVTRYKI---ALGVAQG 826
VRLLG S + T+++ E M G+L L ++ N T K A +A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+ YL VHRDL N ++ ++ ++ DFG+ + I
Sbjct: 132 MAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 53/162 (32%), Positives = 82/162 (50%), Gaps = 23/162 (14%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHK---ENIRRRRGVLAEVDVLGNV-RHRN 770
K LG G+ G+VY A GE++A+KK+ K E + R EV L + H N
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-----EVKSLRKLNEHPN 59
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQGI 827
IV+L + ++EYM GNL L+ + E+++ + Y+I QG+
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSII--YQIL----QGL 112
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
++H HRDLKP N+L+ G ++ADFG+A+ I+S
Sbjct: 113 AHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-14
Identities = 56/179 (31%), Positives = 94/179 (52%), Gaps = 17/179 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLW--GKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K+LG G+ G VY + G +AVK++ + E + + E+ +L N+ H IV
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67
Query: 773 RLLGCCSN-RECTMLLY-EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ GC + E T+ ++ E+MP G++ D L K + + VTR K + +G+ YL
Sbjct: 68 QYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTR-KYTRQILEGVSYL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ----SDESMSVIAGSYGYIAP 885
H + +IVHRD+K +NIL D ++ DFG +K +Q S M + G+ +++P
Sbjct: 123 HSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 22/176 (12%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRG-----VLAEVDVLGNVRHRNI 771
+G G+ G V+KA + GE +A+KK+ +RR G L E+ L +H +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV------ALRRLEGGIPNQALREIKALQACQHPYV 61
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+LL + +L+ EYMP+ L ++L +++ L V Y L +G+ Y+H
Sbjct: 62 VKLLDVFPHGSGFVLVMEYMPSD-LSEVL--RDEERPLPEAQVKSYMRML--LKGVAYMH 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--MSVIAGSYGYIAP 885
I+HRDLKP+N+L+ + ++ADFG+A+L +E S + Y AP
Sbjct: 117 ---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 7e-14
Identities = 42/114 (36%), Positives = 60/114 (52%), Gaps = 3/114 (2%)
Query: 516 LHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
L N L G IP DI L +NLS NS+ G IP + + S+ +DLS+N G+IP
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 576 NFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF--IGNEGLCGRVLTKPC 627
+ ++L N++ N L+G +PA+ LH +SF N GLCG + C
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRL-LHRASFNFTDNAGLCGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 7e-14
Identities = 50/169 (29%), Positives = 89/169 (52%), Gaps = 8/169 (4%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G+VYK P G +A+K++ + E+ + ++ E+D+L IV G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDES--KFNQIIMELDILHKAVSPYIVDFYG 66
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ EYM G+LD L +A + + V R +I V +G+ +L + +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKL-YAGGVATEGIPEDVLR-RITYAVVKGLKFLKEEHN- 123
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+KP+N+L++G + ++ DFGV+ + + + + I G Y+AP
Sbjct: 124 -IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-GCQSYMAP 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 7e-14
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 17/178 (9%)
Query: 717 ILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRR---RGVLAEVDVLGNVRHRNIV 772
++G G+ G V + ++ A+K + +K+ + R VL E +L + H +V
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYM---NKQKCVEKGSVRNVLNERRILQELNHPFLV 63
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLD-DLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + E L+ + + G+L L E V W+ +I L + YLH
Sbjct: 64 NLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWIC--EIVLALE----YLH 117
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFC 889
I+HRD+KP NILLD + + DF +A + D + +G+ GY+AP C
Sbjct: 118 ---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 7e-14
Identities = 53/179 (29%), Positives = 82/179 (45%), Gaps = 36/179 (20%)
Query: 718 LGMGSTGTVYKAEMPG---GE---IIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVR 767
+G G+ G V++A PG E ++AVK L + + +R ++AE D
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------ 66
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--------HAKNKGENLVADWVTRY-- 817
H NIV+LLG C+ + LL+EYM G+L++ L + + +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126
Query: 818 -------KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
IA VA G+ YL + VHRDL N L+ M ++ADFG+++ I S
Sbjct: 127 LSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 182
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 49/180 (27%), Positives = 92/180 (51%), Gaps = 25/180 (13%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIR-----RRRGVLAEVDVLGNVRHRN 770
K LG GS G+VYK + ++ + + + ++ R + E+ +L +V H N
Sbjct: 6 KKLGKGSYGSVYKVKR-----LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 771 IVR-----LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
I+ L G N+ C ++ EY P G+L + + K L+ + ++I + + +
Sbjct: 61 IISYKEAFLDG---NKLCIVM--EYAPFGDLSKAISKRKKKRKLIPE-QEIWRIFIQLLR 114
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
G+ LH + I+HRDLK +NILL ++ D G++K+++ + + + I G+ Y+AP
Sbjct: 115 GLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAP 170
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 55/171 (32%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VY A E++AVKK+ K+ + + ++ EV L ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 777 CCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
C L+ EY G+ DLL H K E +A I G QG+ YLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA------AITHGALQGLAYLHSHN 141
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRD+K NILL + ++ADFG A S G+ ++AP
Sbjct: 142 ---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAP 186
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 9e-14
Identities = 44/155 (28%), Positives = 85/155 (54%), Gaps = 12/155 (7%)
Query: 717 ILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
++G GS G V K + G+I+A+KK + +++ ++ + E+ +L +RH N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHDC 834
++ L++E++ + LDDL N E+ V ++ ++I G+ C+ H+
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYL--FQILRGI--EFCHSHN-- 120
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
I+HRD+KP NIL+ ++ DFG A+ + +
Sbjct: 121 ---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 49/163 (30%), Positives = 84/163 (51%), Gaps = 12/163 (7%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
E L + K LG G G V+ G +A+K L K+ LAE +++ ++H
Sbjct: 6 ETLKLVKK-LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQH 60
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+VRL + +E ++ EYM NG+L D L +G L + +A +A+G+
Sbjct: 61 PRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT-PEGIKLTIN--KLIDMAAQIAEGMA 116
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
++ +HRDL+ +NIL+ + ++ADFG+A+LI+ +E
Sbjct: 117 FIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 47/180 (26%), Positives = 85/180 (47%), Gaps = 18/180 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKL---WGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G+ + Y+A ++ G ++AVK++ E + E+ ++ + H +I
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+R+LG L E+M G++ LL + V + Y + +G+ YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAV---IINY--TEQLLRGLSYLH 120
Query: 832 HDCDPVIVHRDLKPSNILLDGE-MEARVADFGVA-----KLIQSDESMSVIAGSYGYIAP 885
+ I+HRD+K +N+L+D R+ADFG A K + E + G+ ++AP
Sbjct: 121 ---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VY A ++ E++A+KK+ K++ + + ++ EV L ++H N + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 777 CCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
C L+ EY G+ DLL H K E +A I G QG+ YLH
Sbjct: 93 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA------AITHGALQGLAYLHSH- 144
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRD+K NILL + ++ADFG A + S G+ ++AP
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAP 190
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 53/172 (30%), Positives = 85/172 (49%), Gaps = 18/172 (10%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VY A ++ E++A+KK+ K++ + + ++ EV L +RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 777 CCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLH-HD 833
C L+ EY G+ DLL H K E +A + G QG+ YLH H+
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIA------AVTHGALQGLAYLHSHN 135
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRD+K NILL ++ DFG A ++ G+ ++AP
Sbjct: 136 ----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAP 180
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 19/176 (10%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+LG G+ G VY A ++ IA+K++ + + R + + E+ + ++HRNIV+ L
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI---PERDSRYVQPLHEEIALHSYLKHRNIVQYL 71
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAK----NKGENLVADWVTRYKIALGVAQGICYLH 831
G S + E +P G+L LL +K E + + + + +G+ YLH
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ------ILEGLKYLH 125
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEA-RVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
D IVHRD+K N+L++ +++DFG +K L + G+ Y+AP
Sbjct: 126 ---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 17/162 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVD---VLGNVRHRNI 771
K+LG G GTV+K +P G+ I + + K ++ R+ D +G++ H I
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIP-VAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICY 829
VRLLG C L+ + P G+L D + H + + +W + +A+G+ Y
Sbjct: 72 VRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYY 124
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
L +VHR+L NILL + ++ADFGVA L+ D+
Sbjct: 125 LEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD 163
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 54/166 (32%), Positives = 87/166 (52%), Gaps = 23/166 (13%)
Query: 716 KILGMGSTGTVYKAEM--------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR 767
+ LG G+ G+V E+ GE++AVKKL E++R E+++L +++
Sbjct: 10 QQLGKGNFGSV---ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE---REIEILKSLQ 63
Query: 768 HRNIVRLLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
H NIV+ G C + R L+ EY+P G+L D L K++ E L + Y A + +
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQ-KHR-ERLDHRKLLLY--ASQICK 119
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
G+ YL VHRDL NIL++ E ++ DFG+ K++ D+
Sbjct: 120 GMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK 162
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 52/169 (30%), Positives = 86/169 (50%), Gaps = 11/169 (6%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G G V+ A+ GEI+A+K++ + R VL E D+L + +V+LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ E L EY+P G+ LL+ ++++ R+ +A + LH +
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLG----VLSEDHARFYMAEMFE-AVDALH---EL 120
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+HRDLKP N L+D ++ DFG++K I + + SV+ GS Y+AP
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVV-GSPDYMAP 167
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 3e-13
Identities = 46/145 (31%), Positives = 80/145 (55%), Gaps = 21/145 (14%)
Query: 734 GEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLL 787
GE +AVK L G H ++++ E+++L N+ H NIV+ G C+ L+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKK------EIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 788 YEYMPNGNLDDLLHAKNKGE-NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846
E++P+G+L + L +NK + NL + K A+ + +G+ YL VHRDL
Sbjct: 87 MEFLPSGSLKEYL-PRNKNKINLK----QQLKYAVQICKGMDYLG---SRQYVHRDLAAR 138
Query: 847 NILLDGEMEARVADFGVAKLIQSDE 871
N+L++ E + ++ DFG+ K I++D+
Sbjct: 139 NVLVESEHQVKIGDFGLTKAIETDK 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 52/174 (29%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNI 771
++LG G G V ++ G++ A KKL K+ I++R+G L E +L V R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGESMALNEKQILEKVNSRFV 62
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V L ++ L+ M G+L H + GE + + A+ C L
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLK--FHIYHMGEAGFEE----GRAVFYAAEICCGLE 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD R++D G+A + +++ G+ GY+AP
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 17/174 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ G V+ + A+K + +++ + V E VL V H I+RL
Sbjct: 7 KTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC---YLH 831
++ +L EY+P G L L + N + ++ +C YLH
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYA--------SEIVCALEYLH 118
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD E ++ DFG AK + D + + + G+ Y+AP
Sbjct: 119 ---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT-LCGTPEYLAP 167
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 56/179 (31%), Positives = 90/179 (50%), Gaps = 25/179 (13%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRNI 771
+G G+ G VY+A + GEI+A+KK+ R G+ L E+ +L N+RH NI
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 772 VRLLGCCSNR--ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVT-RYK-IALGVAQGI 827
V L + + L+ EY +L LL +N+ + + K + L + +G+
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLL------DNMPTPFSESQVKCLMLQLLRGL 121
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DESMSVIAGSYGYIAP 885
YLH + I+HRDLK SN+LL + ++ADFG+A+ + M+ + Y AP
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAP 177
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 4e-13
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 10/156 (6%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K LG G G V+ +AVK L K + L E +++ ++H +VRL
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTL----KPGTMSVQAFLEEANLMKTLQHDKLVRLY 67
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
+ E ++ EYM G+L D L + G+ L+ + + +A+G+ Y+
Sbjct: 68 AVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI---DFSAQIAEGMAYIERKN- 123
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL+ +N+L+ + ++ADFG+A++I+ +E
Sbjct: 124 --YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 4e-13
Identities = 52/174 (29%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNI 771
++LG G G V ++ G++ A K+L K+ I++R+G L E +L V + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRL---EKKRIKKRKGESMALNEKQILEKVNSQFV 62
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V L ++ L+ M G+L H N G + A+ +C L
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGN----PGFEEERALFYAAEILCGLE 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
V+RDLKP NILLD R++D G+A I ES+ G+ GY+AP
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 53/161 (32%), Positives = 85/161 (52%), Gaps = 20/161 (12%)
Query: 708 LECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIR---RRRGVLAEVDVLG 764
L+ L++ + I G G G V + E G + +AVK NI+ + L E V+
Sbjct: 5 LQKLTLGEII-GEGEFGAVLQGEYTG-QKVAVK--------NIKCDVTAQAFLEETAVMT 54
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
+ H+N+VRLLG + +++ E M GNL + L + +G LV + + +L VA
Sbjct: 55 KLHHKNLVRLLGVILHNGLYIVM-ELMSKGNLVNFL--RTRGRALV-SVIQLLQFSLDVA 110
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+G+ YL +VHRDL NIL+ + A+V+DFG+A+
Sbjct: 111 EGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 52/161 (32%), Positives = 86/161 (53%), Gaps = 28/161 (17%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHR 769
+KI G G+ G VYKA + GEI+A+KK+ + ++ GV + E+ +L + H
Sbjct: 5 EKI-GEGTYGVVYKARDKLTGEIVALKKIRLETEDE-----GVPSTAIREISLLKELNHP 58
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLD-----DLLHAKNKGENLVADWVTRYKIALGVA 824
NIVRLL + L++E++ +LD D L+ ++ Y++ G+A
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYL--YQLLQGIA 113
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
C+ H ++HRDLKP N+L+D E ++ADFG+A+
Sbjct: 114 --YCHSHR-----VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 8e-13
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 22 TLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQ-- 79
TL + +L ++K+SL P W+ P +Q P WSG C S++
Sbjct: 369 TLLEEVSALQTLKSSLGLP---LRFGWNGDPC----VPQQHP----WSGADCQFDSTKGK 417
Query: 80 --ITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
I L L + L G IP +I L L +NLS N+ G + P++ +T L +D+S+NS
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLP 167
FN + P + +L LRI N NS +G +P
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 47/159 (29%), Positives = 81/159 (50%), Gaps = 29/159 (18%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIR---RRRGV----LAEVDVLGNVRHR 769
+G G+ G VYKA GE++A+KK IR GV + E+ +L + H
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKK--------IRLDTETEGVPSTAIREISLLKELNHP 59
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE---NLVADWVTRYKIALGVAQG 826
NIV+LL L++E++ + +L + A L+ ++ +++ G+A
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYL--FQLLQGLA-- 114
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
C+ H ++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 115 FCHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 14/156 (8%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
LG G G V++ +AVK L K + LAE ++ +RH +++L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL----KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL--HHDCD 835
C+ E ++ E M G+L + L G L +A VA G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQ-GGAGRALKLP--QLIDMAAQVASGMAYLEAQN--- 123
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL N+L+ +VADFG+A++I+ D
Sbjct: 124 --YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 54/176 (30%), Positives = 85/176 (48%), Gaps = 20/176 (11%)
Query: 721 GSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS 779
G+ G V+ A+ G+I A+K + + VL E D+L + +V+L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 780 NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCDPVI 838
++ L+ EY+P G+L LL N G +L D Y IA + + YLH + I
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLE--NVG-SLDEDVARIY-IA-EIVLALEYLHSNG----I 114
Query: 839 VHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---------IAGSYGYIAP 885
+HRDLKP NIL+D ++ DFG++K+ +++ I G+ YIAP
Sbjct: 115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
+G G G V+ +A+K + +E + E V+ + H +V+L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYGV 67
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
C+ R L++E+M +G L D L A+ +G+ + T + L V +G+ YL
Sbjct: 68 CTERSPICLVFEFMEHGCLSDYLRAQ-RGK-FSQE--TLLGMCLDVCEGMAYLESSN--- 120
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
++HRDL N L+ +V+DFG+ + + D+ S
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 49/162 (30%), Positives = 80/162 (49%), Gaps = 15/162 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENI--RRRRGVLAEVDVLGNVRHRNIV 772
K+LG G+ GTVYK +P GE + + +EN + + +L E V+ V +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYL 830
RLLG C L+ + MP G L D + + G + +W + +A+G+ YL
Sbjct: 73 RLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYL 125
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ +VHRDL N+L+ ++ DFG+A+L+ DE+
Sbjct: 126 E---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 56/172 (32%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNIVR 773
LG G G V ++ G++ A KKL K+ +++R+G L E +L V R IV
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL---DKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L ++ L+ M G+L H N GE + + AQ IC L H
Sbjct: 58 LAYAFETKDDLCLVMTLMNGGDLK--YHIYNVGEPGFPEARAIFY----AAQIICGLEHL 111
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RDLKP N+LLD R++D G+A ++ + + AG+ GY+AP
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 48/183 (26%), Positives = 81/183 (44%), Gaps = 30/183 (16%)
Query: 715 DKILGMGSTGTVYKAE------MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
K LG G G V KA G +AVK L K + R +L+E ++L V H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKML--KENASSSELRDLLSEFNLLKQVNH 62
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYK--------- 818
++++L G CS +L+ EY G+L L K G + + R
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 819 ---------IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
A +++G+ YL + +VHRDL N+L+ + +++DFG+++ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 870 DES 872
++S
Sbjct: 180 EDS 182
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 44/172 (25%), Positives = 74/172 (43%), Gaps = 31/172 (18%)
Query: 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVD------VLGNV 766
K LG G G V+ + G +A+K + R G ++E D V+ +
Sbjct: 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMI----------REGAMSEDDFIEEAKVMMKL 56
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
H N+V+L G C+ + ++ EYM NG L + L + + L +
Sbjct: 57 SHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--------KLGTEWLLDMCSD 108
Query: 827 IC----YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
+C YL + +HRDL N L+ + +V+DFG+A+ + D+ S
Sbjct: 109 VCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 45/152 (29%), Positives = 73/152 (48%), Gaps = 20/152 (13%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKEN----IRRRRGVLAEVDVLGNVRHRNIV 772
+G GS G VYKA + +++A+K + + E+ I++ E+ L R I
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ------EIQFLSQCRSPYIT 62
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
+ G ++ EY G+ DLL E +A ++ R V G+ YLH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA-FILRE-----VLLGLEYLHE 116
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ +HRD+K +NILL E + ++ADFGV+
Sbjct: 117 EGK---IHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 28/159 (17%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRNIV 772
+G G+ G VYKA + E IA+KK+ + ++ GV + E+ +L ++H NIV
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQED-----EGVPSTAIREISLLKEMQHGNIV 64
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAK-----NKGENLVADWVTRYKIALGVAQGI 827
RL + + L++EY+ +LD H K L+ ++ Y+I G+A
Sbjct: 65 RLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYL--YQILRGIA--Y 117
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEA-RVADFGVAK 865
C+ H ++HRDLKP N+L+D A ++ADFG+A+
Sbjct: 118 CHSHR-----VLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 45/175 (25%), Positives = 86/175 (49%), Gaps = 18/175 (10%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDV-LGNVRHRNIVRLL 775
LG G+ G V K +P G I+AVK++ + N + ++ +L ++D+ + +V V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRI--RATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66
Query: 776 GCCSNRECTMLLYEYMPNGNLDDL-----LHAKNKGENLVADWVTRYKIALGVAQGICYL 830
G + E M + +LD E+++ KIA+ + + + YL
Sbjct: 67 GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILG------KIAVSIVKALEYL 119
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H ++HRD+KPSN+L++ + ++ DFG++ + + ++ AG Y+AP
Sbjct: 120 HSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAP 172
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 47/150 (31%), Positives = 81/150 (54%), Gaps = 13/150 (8%)
Query: 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ TV+K ++A+K++ +H+E + EV +L N++H NIV L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--AIREVSLLKNLKHANIVTLHD 70
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL-GVAQGICYLHHDCD 835
C L++EY+ + DL + NL++ + KI + + +G+ Y H
Sbjct: 71 IIHTERCLTLVFEYLDS----DLKQYLDNCGNLMS--MHNVKIFMFQLLRGLSYCHKR-- 122
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAK 865
I+HRDLKP N+L++ + E ++ADFG+A+
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 48/175 (27%), Positives = 83/175 (47%), Gaps = 23/175 (13%)
Query: 718 LGMGSTGTVYKAEM----PGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G+ G V+ AE P + ++AVK L + R+ E ++L N++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKAL---KDPTLAARKDFQREAELLTNLQHEHI 69
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR-----------YKIA 820
V+ G C + + ++++EYM +G+L+ L A ++ D R IA
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
+A G+ YL VHRDL N L+ + ++ DFG+++ + S + V
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 59/172 (34%), Positives = 92/172 (53%), Gaps = 17/172 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G V K P G I+A K + + K IR + ++ E+ VL IV G
Sbjct: 9 LGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQ--IIRELKVLHECNSPYIVGFYG 66
Query: 777 C-CSNRECTMLLYEYMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
S+ E ++ + E+M G+LD +L A EN++ KI++ V +G+ YL
Sbjct: 67 AFYSDGEISICM-EHMDGGSLDQVLKKAGRIPENILG------KISIAVLRGLTYLREKH 119
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNIL++ E ++ DFGV+ +LI S + V G+ Y++P
Sbjct: 120 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV--GTRSYMSP 167
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 7e-12
Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 15/171 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G VYKA + GE+ AVK + + ++ + E+ ++ +H NIV G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL---IQQEIFMVKECKHCNIVAYFG 73
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+RE + EY G+L D+ H L +V R + QG+ YLH
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK- 127
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD--ESMSVIAGSYGYIAP 885
+HRD+K +NILL + ++ADFGVA I + + S I Y ++AP
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY-WMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-12
Identities = 51/171 (29%), Positives = 93/171 (54%), Gaps = 28/171 (16%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLA--EVDVLGNVRHRNIVR 773
+G G+ G VYKA + GE++A+KK+ +N + + A E+ +L + HRNIV
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 774 LLGCCSNRECTM----------LLYEYMPNGNLDDLLHAK--NKGENLVADWVTRYKIAL 821
L ++++ + L++EYM + +L LL + + E+ + ++ +
Sbjct: 71 LKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKSFMKQ----- 124
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ +G+ Y H +HRD+K SNILL+ + + ++ADFG+A+L S+ES
Sbjct: 125 -LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-11
Identities = 31/76 (40%), Positives = 44/76 (57%)
Query: 164 GPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ 223
G +P + +L LQ +NL G+ G IP +++SL LDL+ NS GS+P LG LT
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 224 LERIEIGYNNLQGEVP 239
L + + N+L G VP
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (164), Expect = 1e-11
Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 46/179 (25%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRR-----RRGVLAEVDVLGNVRHR 769
K +G G+ G V A G +A+KK+ N+ +R +L E+ +L ++RH
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-----SNVFDDLIDAKR-ILREIKLLRHLRHE 59
Query: 770 NIVRLLGCCSNRECTML----------LY---EYMPNGNLDDLLHAKNKGENLVADWVTR 816
NI+ LL +L +Y E M +L ++ + + +
Sbjct: 60 NIIGLL--------DILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL- 109
Query: 817 YKIALGVAQGICYLH--HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
Y+I G+ YLH + ++HRDLKPSNIL++ + ++ DFG+A+ + DE
Sbjct: 110 YQILRGLK----YLHSAN-----VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 52/166 (31%), Positives = 83/166 (50%), Gaps = 31/166 (18%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVR---H 768
+G G+ GTVYKA ++ G +A+KK+ E G+ L E+ +L + H
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-----GIPLSTLREIALLKQLESFEH 60
Query: 769 RNIVRLLGCC----SNRECTMLL-YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
NIVRLL C ++RE + L +E++ + +L L + I +
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL------SKCPKPGLPPETIKDLM 113
Query: 824 AQ---GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866
Q G+ +LH IVHRDLKP NIL+ + + ++ADFG+A++
Sbjct: 114 RQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/192 (31%), Positives = 89/192 (46%), Gaps = 20/192 (10%)
Query: 701 NFTADDV----LECLSMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRR- 754
FT D L M + + G GS G V A+ G GE A+K L K +E ++ ++
Sbjct: 6 MFTKPDTSSWKLSDFEMGETL-GTGSFGRVRIAKHKGTGEYYAIKCL--KKREILKMKQV 62
Query: 755 -GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW 813
V E +L + H IV ++ + L E++ G L L + N VA +
Sbjct: 63 QHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKF 122
Query: 814 VTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
Y L +A YLH D I++RDLKP N+LLD + +V DFG AK + +
Sbjct: 123 ---YHAELVLA--FEYLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRT 172
Query: 874 SVIAGSYGYIAP 885
+ G+ Y+AP
Sbjct: 173 FTLCGTPEYLAP 184
|
Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 2e-11
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNI 771
++LG G G V ++ G++ A KKL K+ I++R+G L E +L V R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVNSRFV 62
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V L ++ L+ M G+L ++ N+ + A+ C L
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHIY------NMGNPGFDEERAVFYAAEITCGLE 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD R++D G+A I E++ G+ GY+AP
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/174 (32%), Positives = 82/174 (47%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNI 771
++LG G G V ++ G++ A KKL K+ I++R+G L E +L V R +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVNSRFV 62
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V L ++ L+ M G+L H N G N D + A+ C L
Sbjct: 63 VSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMG-NPGFD---EQRAIFYAAELCCGLE 116
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD R++D G+A I E++ G+ GY+AP
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAP 170
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 48/166 (28%), Positives = 85/166 (51%), Gaps = 17/166 (10%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGV--LAEVDVLGNVRHRNIVR 773
++LG G+ G V+K + +AVK KE++ + + L+E +L H NIV+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKTC----KEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-H 832
L+G C+ R+ ++ E +P G D L + K + L + ++ AL A G+ YL
Sbjct: 57 LIGVCTQRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKF--ALDAAAGMAYLESK 112
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAG 878
+C +HRDL N L+ +++DFG+++ Q D+ + +G
Sbjct: 113 NC----IHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSSG 152
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 47/166 (28%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNV-RHRN 770
+++G G+ G VYKA G+++A+K + +E I+ E ++L H N
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIK------EEYNILRKYSNHPN 64
Query: 771 IVRLLGCCSNRECTM------LLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGV 823
I G + L+ E G++ DL+ + KG+ L +W+ Y I
Sbjct: 65 IATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-ILRET 122
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+G+ YLH + ++HRD+K NILL E ++ DFGV+ + S
Sbjct: 123 LRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS 165
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 26/159 (16%)
Query: 721 GSTGTVYKA-EMPGGEIIAVKKLWGK-HKENIRRRRGV----LAEVDVLGNVRHRNIVRL 774
G+ G VY+A + GEI+A+KKL K KE + G L E+++L ++H NIV +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKL--KMEKE----KEGFPITSLREINILLKLQHPNIVTV 69
Query: 775 ----LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+G SN + ++ EY+ + +L L+ K L ++ + L + G+ +L
Sbjct: 70 KEVVVG--SNLDKIYMVMEYVEH-DLKSLM-ETMKQPFLQSEVKC---LMLQLLSGVAHL 122
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
H D I+HRDLK SN+LL+ ++ DFG+A+ S
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 53/173 (30%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNIVR 773
LG G G V +M G++ A KKL +K+ +++R+G + E +L V R IV
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL---NKKRLKKRKGYEGAMVEKRILAKVHSRFIVS 57
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + L+ M G+L H N E + AQ I L H
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLR--YHIYNVDEE--NPGFPEPRACFYTAQIISGLEHL 113
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
I++RDLKP N+LLD + R++D G+A +L AG+ G++AP
Sbjct: 114 HQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAP 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 49/170 (28%), Positives = 86/170 (50%), Gaps = 12/170 (7%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G VYKA+ G + A K + K +E + + E+++L H IV+LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELE---DYMVEIEILATCNHPYIVKLLG 76
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
++ E+ P G +D ++ ++G +T +I + Q + L +
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRG-------LTEPQIQVICRQMLEALQYLHSM 129
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
I+HRDLK N+LL + + ++ADFGV AK +++ + G+ ++AP
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 15/171 (8%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G VYKA + GE+ A+K + + E+ V E+ ++ + +H NIV G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV---VQQEIIMMKDCKHSNIVAYFG 73
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
R+ + E+ G+L D+ H +V+R + QG+ YLH
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD--ESMSVIAGSYGYIAP 885
+HRD+K +NILL ++ADFGV+ I + + S I Y ++AP
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY-WMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 54/175 (30%), Positives = 91/175 (52%), Gaps = 26/175 (14%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
ILG G+ GTVYKA + I+AVK + + ++ +++E+++L I+
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVI--PLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 776 GC--CSNR--ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
G NR CT E+M G+LD + E+++ +IA+ V +G+ YL
Sbjct: 66 GAFFVENRISICT----EFMDGGSLDVY---RKIPEHVLG------RIAVAVVKGLTYL- 111
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSN+L++ + ++ DFGV+ +L+ S V G+ Y+AP
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV--GTNAYMAP 162
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 48/154 (31%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
LG G G V+ G +A+K L K L E V+ +RH +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 69
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
S E ++ EYM G+L D L + + V +A +A G+ Y+
Sbjct: 70 VS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV---DMAAQIASGMAYVER---MN 122
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
VHRDL+ +NIL+ + +VADFG+A+LI+ +E
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 20/166 (12%)
Query: 715 DKILGMGSTGTVYKA--EMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRN 770
+ ++G G+ G V +A + G ++ A+K L EN R E++VL + H N
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASEN--DHRDFAGELEVLCKLGHHPN 64
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLH-----------AKNKGENLVADWVTRYKI 819
I+ LLG C NR + EY P GNL D L AK G +
Sbjct: 65 IINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
A VA G+ YL + +HRDL N+L+ + +++ADFG+++
Sbjct: 125 ASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 3e-11
Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 11/156 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K LG G G V+ G +AVK L K L E ++ +RH +V+L
Sbjct: 12 KKLGNGQFGEVWMGTWNGNTKVAVKTL----KPGTMSPESFLEEAQIMKKLRHDKLVQLY 67
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
S E ++ EYM G+L D L GE +A VA G+ Y+
Sbjct: 68 AVVS-EEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIER--- 120
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL+ +NIL+ + ++ADFG+A+LI+ +E
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 55/191 (28%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN-AQK 463
ENL+N L L + N+L +I + L NLT +D+ N+++ +IP +G
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISELLEL-TNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 464 LEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNG 523
L+ L++S+N ++ LPS + + PNLK L S + L+ ++ ++L N ++
Sbjct: 142 LKELDLSDNKIES-LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583
+P +I L L+LS NS+ ++ +S L +++ ++LS+N L +P + N S L
Sbjct: 200 DLPPEIELLSALEELDLSNNSIIELLS-SLSNLKNLSGLELSNNKLE-DLPESIGNLSNL 257
Query: 584 ESFNVSYNLLT 594
E+ ++S N ++
Sbjct: 258 ETLDLSNNQIS 268
|
Length = 394 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 54/173 (31%), Positives = 85/173 (49%), Gaps = 11/173 (6%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVR 773
K++G GS G V A+ G+ AVK L K + ++ ++AE +VL NV+H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + + +Y+ G L H + E + R+ A +A + YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGEL--FFHLQR--ERSFPEPRARF-YAAEIASALGYLH-- 113
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
I++RDLKP NILLD + + DFG+ K I+ ++ S G+ Y+AP
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 55/171 (32%), Positives = 88/171 (51%), Gaps = 15/171 (8%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G V K + P G I+A K + + K IR + ++ E+ VL IV G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYG 70
Query: 777 CCSNRECTMLLYEYMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
+ + E+M G+LD +L AK E ++ K+++ V +G+ YL
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG------KVSIAVLRGLAYLREKHQ 124
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNIL++ E ++ DFGV+ +LI D + G+ Y++P
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSP 171
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 48/153 (31%), Positives = 82/153 (53%), Gaps = 16/153 (10%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRNIV 772
+G G+ G VYK G+I+A+KK+ + +E GV + E+ +L ++H NIV
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEE-----GVPSTAIREISLLKELQHPNIV 62
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
L L++E++ + +L L + KG+ + A+ V Y + QGI + H
Sbjct: 63 CLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSY--LYQILQGILFCHS 119
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
++HRDLKP N+L+D + ++ADFG+A+
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 19/154 (12%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLW-----GKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G+ TVYK GEI+A+K++ G IR E+ ++ ++H NI
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-------EISLMKELKHENI 60
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
VRL ML++EYM D + G D T + +GI + H
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDK---DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+ ++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 118 ---ENRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 5e-11
Identities = 50/173 (28%), Positives = 85/173 (49%), Gaps = 25/173 (14%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
L+M + + +G G G V + G ++ AVK + +N + LAE V+ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYRGNKV-AVKCI-----KNDATAQAFLAEASVMTQL 56
Query: 767 RHRNIVRLLGCCSNRECTM-LLYEYMPNGNLDDLLHAKNK----GENLVADWVTRYKIAL 821
RH N+V+LLG + + ++ EYM G+L D L ++ + G+ L+ K +L
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL-------KFSL 109
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
V + + YL + VHRDL N+L+ + A+V+DFG+ K S +
Sbjct: 110 DVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 50/177 (28%), Positives = 87/177 (49%), Gaps = 28/177 (15%)
Query: 718 LGMGSTGTVYKAE----MPGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G+ G V+ AE +P + ++AVK L + + R+ E ++L ++H++I
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKAL---KEASESARQDFQREAELLTVLQHQHI 69
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAK-------NKGENLVADWVT---RYKIAL 821
VR G C+ ++++EYM +G+L+ L + GE++ +T IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 822 GVAQGICY---LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
+A G+ Y LH VHRDL N L+ + ++ DFG+++ I S + V
Sbjct: 130 QIASGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 50/170 (29%), Positives = 74/170 (43%), Gaps = 19/170 (11%)
Query: 716 KILGMGSTGTVYKAEM-----PG-GEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
LG G+ G VY+ PG G I +AVK L + + ++ L E ++ N H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA--KNKGENLVADWVTRYKIALGVAQG 826
NIV+LLG C E ++ E M G+L L + + I L VA+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 827 ICYLHHDCDPVIVHRDLKPSNILL-----DGEMEARVADFGVAKLIQSDE 871
YL +HRDL N L+ D + ++ DFG+A+ I +
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD 165
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 23/170 (13%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRR--RRGVLAEVDVLGNVR 767
LG G G V+ A+ G E ++ VK L EN++ RR E+D+ +
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRR----ELDMFRKLS 66
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW----VTRYKIALGV 823
H+N+VRLLG C E ++ EY G+L L A + + + + +
Sbjct: 67 HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126
Query: 824 AQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
A G+ +L VHRDL N L+ + E +V+ ++K + + E
Sbjct: 127 ALGMDHLSNAR-----FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE 171
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 8e-11
Identities = 47/172 (27%), Positives = 76/172 (44%), Gaps = 37/172 (21%)
Query: 719 GMGSTGTVYKA---EMPGGEIIAVKKLWGKHKE-------NIRRRRGVLAEVDVLGNVRH 768
G G+ G VYKA G+ A+KK G ++ R E+ +L ++H
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-------EIALLRELKH 61
Query: 769 RNIVRLLGCCSNRE--CTMLLYEYMPNGNLDDLL-----HAKNKGENLVADWVTRYKIAL 821
N+V L+ LL++Y + DL H + K ++ V +
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQIIKFHRQAKRVSIPPSMVKS--LLW 115
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR----VADFGVAKLIQS 869
+ G+ YLH + ++HRDLKP+NIL+ GE R + D G+A+L +
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 47/179 (26%), Positives = 89/179 (49%), Gaps = 15/179 (8%)
Query: 718 LGMGSTGTVYKAEM--PGGEIIAVKKL------WGK-HKENIRRRRGVLAEVDVLG-NVR 767
LG G+ G VYK G ++A+K++ +GK +E + +++EV ++ +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGVAQG 826
H NIVR + ++ + + L + ++ K K + + + + I + +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERI--WNIFVQMVLA 125
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ YLH + IVHRDL P+NI+L + + + DFG+AK Q + ++ + G+ Y P
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP 182
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 35/86 (40%), Positives = 45/86 (52%), Gaps = 2/86 (2%)
Query: 284 GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343
G IP L+ LQ ++LS N + G IP SL S+ L L L N G IP+ + L
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 344 LDTLLLWNNHLTGVLPQKLGSNGKLL 369
L L L N L+G +P LG G+LL
Sbjct: 492 LRILNLNGNSLSGRVPAALG--GRLL 515
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-10
Identities = 33/91 (36%), Positives = 58/91 (63%), Gaps = 2/91 (2%)
Query: 229 IGYNN--LQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI 286
+G +N L+G +P + + L +L+ +++S ++ G +P + ++T LE+L L N F G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 287 PVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
P S G L +L++L+L+ N LSG +PA+L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGR 513
|
Length = 623 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 51/172 (29%), Positives = 87/172 (50%), Gaps = 18/172 (10%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K LG G+ G V +A G +AVK L K + R +++E+ ++ ++ H
Sbjct: 41 KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGNH 98
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
NIV LLG C+ +++ EY G+L + L K + + D ++ + VA+G+
Sbjct: 99 ENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS---FSYQVAKGMA 155
Query: 829 YL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGS 879
+L +C +HRDL N+LL ++ DFG+A+ I +D S V+ G+
Sbjct: 156 FLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMND-SNYVVKGN 202
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 48/168 (28%), Positives = 79/168 (47%), Gaps = 21/168 (12%)
Query: 716 KILGMGSTGTVYKAEM--PGGEI--IAVKKLWGKHKENIRRRR---GVLAEVDVLGNVRH 768
KILG G G+V + ++ G +AVK + K +I L+E + + H
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM----KLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 769 RNIVRLLGCC---SNRE---CTMLLYEYMPNGNLDDLLHAKNKGENLVADWV-TRYKIAL 821
N+++L+G C S+ + M++ +M +G+L L G + T K +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+A G+ YL + +HRDL N +L +M VADFG++K I S
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 20/164 (12%)
Query: 717 ILGMGSTGTVYKAEMPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
++G G+ G V KA + + A+K++ K + R E++VL + H NI+
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE--------NLVADWVTRYKI---AL 821
LLG C +R L EY P+GNL D L E N A ++ ++ A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
VA+G+ YL +HRDL NIL+ A++ADFG+++
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/173 (32%), Positives = 84/173 (48%), Gaps = 11/173 (6%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVR 773
K++G GS G V A+ G AVK L K + + ++AE +VL N++H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L E + +Y+ G L H + E + R+ A VA I YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL--FFHLQR--ERCFLEPRARF-YAAEVASAIGYLH-- 113
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
I++RDLKP NILLD + + DFG+ K ++ +E+ S G+ Y+AP
Sbjct: 114 -SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 49/158 (31%), Positives = 87/158 (55%), Gaps = 13/158 (8%)
Query: 718 LGMGSTGTVYKA--EMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G+ G V K +M +I +A+K L ++++++R ++ E +++ + + IVR+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDE--MMREAEIMHQLDNPYIVRM 60
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+G C E ML+ E G L+ L K K E V++ V ++ V+ G+ YL
Sbjct: 61 IGVCE-AEALMLVMEMASGGPLNKFLSGK-KDEITVSNVV---ELMHQVSMGMKYLE--- 112
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
VHRDL N+LL + A+++DFG++K + +D+S
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS 150
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 41/157 (26%), Positives = 79/157 (50%), Gaps = 11/157 (7%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+K LG G G V+ A +AVK + K LAE +V+ ++H +V+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ +E ++ E+M G+L D L + + + + + +A+G+ ++
Sbjct: 67 HAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI---DFSAQIAEGMAFIEQRN 122
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL+ +NIL+ + ++ADFG+A++I+ +E
Sbjct: 123 ---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 46/178 (25%), Positives = 82/178 (46%), Gaps = 24/178 (13%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRH--- 768
++G G+ G VY+ +P G ++A+K + +I+R EV +L +R
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR------EVALLSQLRQSQP 61
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
NI + G ++ EY G++ L+ A E ++ + R V +
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-VIIRE-----VLVALK 115
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
Y+H ++HRD+K +NIL+ ++ DFGVA L+ + S S G+ ++AP
Sbjct: 116 YIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAP 170
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 19/149 (12%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIR---RRRGVLAEVDVLGNVRHRNIVR 773
+G GSTG V A + G +AVKK+ ++R RR + EV ++ + +H NIV
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKM------DLRKQQRRELLFNEVVIMRDYQHPNIVE 80
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+ + ++ E++ G L D++ E +A + L V + + +LH
Sbjct: 81 MYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------TVCLAVLKALSFLHAQ 134
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFG 862
++HRD+K +ILL + +++DFG
Sbjct: 135 G---VIHRDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 45/178 (25%), Positives = 76/178 (42%), Gaps = 13/178 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K LG G G V + G +A+K + KE + E V+ + H +V+L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMKLSHEKLVQLY 65
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G C+ + ++ EYM NG L + L K ++ V +G+ YL
Sbjct: 66 GVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPS----QLLEMCKDVCEGMAYLE---S 118
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY--GYIAPGTFCFC 891
+HRDL N L+D + +V+DFG+++ + DE S + + + P +
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 47/160 (29%), Positives = 84/160 (52%), Gaps = 24/160 (15%)
Query: 715 DKI--LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVR 767
+K+ +G G+ GTV+KA EI+A+K++ + GV L E+ +L ++
Sbjct: 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-----EGVPSSALREICLLKELK 57
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H+NIVRL + + L++EY + +L + N G+ D + +G+
Sbjct: 58 HKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCN-GD---IDPEIVKSFMFQLLKGL 112
Query: 828 --CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
C+ H+ ++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 113 AFCHSHN-----VLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-10
Identities = 57/184 (30%), Positives = 93/184 (50%), Gaps = 19/184 (10%)
Query: 705 DDVLECLSMSDKILGMGSTGTVYK-AEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVL 763
DD E +S LG G+ G V+K + P G I+A K + + K IR + ++ E+ VL
Sbjct: 4 DDDFEKISE----LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQ--IIRELQVL 57
Query: 764 GNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALG 822
IV G + + E+M G+LD +L + E ++ K+++
Sbjct: 58 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG------KVSIA 111
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYG 881
V +G+ YL I+HRD+KPSNIL++ E ++ DFGV+ +LI D + G+
Sbjct: 112 VIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSFVGTRS 167
Query: 882 YIAP 885
Y++P
Sbjct: 168 YMSP 171
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 57/177 (32%), Positives = 95/177 (53%), Gaps = 17/177 (9%)
Query: 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVRHRNIVR 773
+G+G+ GTVYKA P G +A+K + + E+ + R V A + L H NIVR
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66
Query: 774 LLGCC----SNRECTM-LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L+ C ++RE + L++E++ + +L L K L A+ T + +G+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAE--TIKDLMRQFLRGLD 122
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+LH +C IVHRDLKP NIL+ + ++ADFG+A++ +++ + + Y AP
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAP 176
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 49/172 (28%), Positives = 86/172 (50%), Gaps = 20/172 (11%)
Query: 718 LGMGSTGTVYKAEM----PGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G+ G V+ AE P + ++AVK L + R+ E ++L N++H +I
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTL---KDASDNARKDFHREAELLTNLQHEHI 69
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADW-----VTRYK---IALGV 823
V+ G C + ++++EYM +G+L+ L A L+A+ +T+ + IA +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
A G+ YL VHRDL N L+ + ++ DFG+++ + S + V
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRV 178
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 34/197 (17%)
Query: 702 FTADDVLECLSMSDKILGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLA 758
FTA+D+ + +G G+ GTV K M P G I+AVK++ E ++R +L
Sbjct: 1 FTAEDLKDLGE-----IGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKR--LLM 51
Query: 759 EVDVLGNVRHRN---IVRLLGCCSNR-ECTMLLYEYMPNGNLDDL---LHAKNKG---EN 808
++DV+ +R + IV+ G +C + + E M + +LD ++ K E
Sbjct: 52 DLDVV--MRSSDCPYIVKFYGALFREGDCWICM-ELM-DISLDKFYKYVYEVLKSVIPEE 107
Query: 809 LVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868
++ KIA+ + + YL + I+HRD+KPSNILLD ++ DFG++ +
Sbjct: 108 ILG------KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
Query: 869 SDESMSVIAGSYGYIAP 885
+ + AG Y+AP
Sbjct: 160 DSIAKTRDAGCRPYMAP 176
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 46/174 (26%), Positives = 79/174 (45%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR-NIVR 773
K + G+ G+VY A+ G+ A+K L + V AE ++ + +
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L +++ L+ EY+ G+ L+ K G L DW +Y V G+ LH
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLI--KTLG-GLPEDWAKQY--IAEVVLGVEDLHQR 116
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGT 887
I+HRD+KP N+L+D ++ DFG+++ ++ G+ Y+AP T
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK---FVGTPDYLAPET 164
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 43/153 (28%), Positives = 84/153 (54%), Gaps = 14/153 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G V+K G+I+A+KK + + +++ ++ L E+ +L ++H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK-FVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67
Query: 777 CCSNRECTMLLYEYMPNGNLDDL-LHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDC 834
+ L++EY + L++L + + E+L+ KI Q + + H H+C
Sbjct: 68 VFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK------KIIWQTLQAVNFCHKHNC 121
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+HRD+KP NIL+ + + ++ DFG A+++
Sbjct: 122 ----IHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 53/181 (29%), Positives = 83/181 (45%), Gaps = 20/181 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+++G GS G V G+ +KKL ++ R R+ E +L ++H NIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAY 64
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLH--AKNKG----ENLVADWVTRYKIALGVAQGIC 828
+ LLY M DL H + KG EN V +W + +AL
Sbjct: 65 RESWEGEDG--LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------ 116
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAPGT 887
YLH + I+HRDLK N+ L +V D G+A+++++ M S + G+ Y++P
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173
Query: 888 F 888
F
Sbjct: 174 F 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-10
Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 16/170 (9%)
Query: 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRR---RGVLAEVDVLGNVRHRNI 771
K++G G+ G V+ G++ A+K L K ++ +R V AE D+L + I
Sbjct: 7 KVIGRGAFGEVWLVRDKDTGQVYAMKVL---RKSDMIKRNQIAHVRAERDILADADSPWI 63
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+L + E L+ EYMP G DL++ + + + Y +A+ + L
Sbjct: 64 VKLYYSFQDEEHLYLVMEYMPGG---DLMNLLIRKDVFPEETARFY-----IAELVLALD 115
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSY 880
+HRD+KP NIL+D + ++ADFG+ K+ ++ + + S+
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSH 165
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 26/182 (14%)
Query: 716 KILGMGSTGTVYKAEMPGG----EIIAVKKLWGKHKENIRRRRG----VLAEVDVLGNVR 767
K+LG G G V++ G +I A+K L K I R + AE ++L V+
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVL---KKATIVRNQKDTAHTKAERNILEAVK 58
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVA 824
H IV L+ L+ EY+ G L +H + +G E+ +++ +AL
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALE-- 114
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK-LIQSDESMSVIAGSYGYI 883
+LH I++RDLKP NILLD + ++ DFG+ K I G+ Y+
Sbjct: 115 ----HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYM 167
Query: 884 AP 885
AP
Sbjct: 168 AP 169
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-10
Identities = 40/154 (25%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 716 KILGMGSTGTVYKAEMPGG---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K +G G G V E+ G + VK+L + +++ + L E +++H N++
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKEL--RVSASVQEQMKFLEEAQPYRSLQHSNLL 58
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
+ LG C+ +L+ E+ P G+L L + K E + D T ++A +A G+ +LH
Sbjct: 59 QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866
+ +H DL N LL ++ ++ D+G++
Sbjct: 119 NN---FIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 22/180 (12%)
Query: 718 LGMGSTGTVYKAE--MPGGEIIAVKKLWGKHKE-----NIRRRRGVLAEVDVLGNVRHRN 770
+G G+ G V+KA GG +A+K++ + E + R VL ++ H N
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF---EHPN 65
Query: 771 IVRLLGCCS----NRECTM-LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+VRL C+ +RE + L++E++ DL +K T + + +
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQ----DLTTYLDKVPEPGVPTETIKDMMFQLLR 121
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
G+ +LH +VHRDLKP NIL+ + ++ADFG+A++ +++ + + Y AP
Sbjct: 122 GLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 6e-10
Identities = 45/144 (31%), Positives = 71/144 (49%), Gaps = 19/144 (13%)
Query: 736 IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGN 795
++AVK L +N R L EV +L ++ NI+RLLG C + + ++ EYM NG+
Sbjct: 48 LVAVKILRPDANKNARN--DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 796 LDDLL---HAKNKGEN-----------LVADWVTRYKIALGVAQGICYLHHDCDPVIVHR 841
L+ L H +K EN + + +AL +A G+ YL VHR
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHR 162
Query: 842 DLKPSNILLDGEMEARVADFGVAK 865
DL N L+ + ++ADFG+++
Sbjct: 163 DLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 6e-10
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 21/175 (12%)
Query: 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKH-KENIRRRRGVLAEVDV-LGNVRHRNIVRL 774
+G G+ G VYK G ++AVK++ KE +R +L ++DV L + IV+
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKR---ILMDLDVVLKSHDCPYIVKC 79
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYL-- 830
G + E M LD LL E+++ K+ + + + + YL
Sbjct: 80 YGYFITDSDVFICMELMSTC-LDKLLKRIQGPIPEDILG------KMTVAIVKALHYLKE 132
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H ++HRD+KPSNILLD ++ DFG++ + ++ + AG Y+AP
Sbjct: 133 KHG----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAP 183
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-10
Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 29/182 (15%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K+LG GS G V AE+ G GE AVK L K+++ VL + DV + + ++ L
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKAL----KKDV-----VLIDDDVECTMVEKRVLAL 51
Query: 775 ---------LGCC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
L C +E + E++ G+L + H ++KG Y+ A
Sbjct: 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGR------FDLYRATFYAA 103
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYI 883
+ +C L I++RDLK N++LD + ++ADFG+ K + D S G+ YI
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYI 163
Query: 884 AP 885
AP
Sbjct: 164 AP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 7e-10
Identities = 57/176 (32%), Positives = 87/176 (49%), Gaps = 17/176 (9%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNV-RHRN 770
K+LG GS G V AE+ G E+ AVK L K+ I + V + E VL +H
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVL---KKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ +L C ++ + EY+ G+L + H + G + R+ A + G+ +L
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQRSGR--FDEPRARF-YAAEIVLGLQFL 112
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
H + I++RDLK N+LLD E ++ADFG+ K I + S G+ YIAP
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 49/171 (28%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GSTG V A E G +AVK + + ++ RR + EV ++ + +H+N+V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
E +L E++ G L D++ E +A + V Q +CYLH
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA------TVCESVLQALCYLHSQG-- 137
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD--ESMSVIAGSYGYIAP 885
++HRD+K +ILL + +++DFG I D + S++ Y ++AP
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 44/175 (25%), Positives = 86/175 (49%), Gaps = 12/175 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G VYKA + G ++A+KK+ + + R+ L E+D+L + H N+++
Sbjct: 8 KKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKY 67
Query: 775 LGC-CSNRECTMLLYEYMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
L N E ++L E G+L ++ H K + + T +K + + + ++H
Sbjct: 68 LASFIENNELNIVL-ELADAGDLSRMIKHFKKQKRLI--PERTIWKYFVQLCSALEHMHS 124
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD--ESMSVIAGSYGYIAP 885
I+HRD+KP+N+ + ++ D G+ + S + S++ Y Y++P
Sbjct: 125 K---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 50/166 (30%), Positives = 73/166 (43%), Gaps = 22/166 (13%)
Query: 716 KILGMGSTGTVYKAE---MPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G VY+ G + +AVK L E + L E ++ H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQ 69
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLL-HAKNKGEN----LVADWVTRYKIALGVA 824
NIVRL+G R +L E M G+L L + + E + D + A VA
Sbjct: 70 NIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLL---FCARDVA 126
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA---DFGVAKLI 867
+G YL + +HRD+ N LL + RVA DFG+A+ I
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 23/166 (13%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ LG G+ + + +AVK L + R L E+ ++ +++ NI+RLL
Sbjct: 31 EFLGEGAPEFDGQPVL-----VAVKML--RADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLL----------HAKNKGENLVADWVTRYKIALGVAQ 825
G C + + ++ EYM NG+L+ L HA N +A+ + +A+ +A
Sbjct: 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL---YMAVQIAS 140
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
G+ YL VHRDL N L+ ++ADFG+++ + S +
Sbjct: 141 GMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 48/164 (29%), Positives = 73/164 (44%), Gaps = 20/164 (12%)
Query: 717 ILGMGSTGTVYKAEMPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
++G G+ G V KA + + A+K++ ++ R E++VL + H NI+
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHHPNII 59
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLH-----------AKNKGENLVADWVTRYKIAL 821
LLG C +R L EY P+GNL D L A A
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
VA+G+ YL +HRDL NIL+ A++ADFG+++
Sbjct: 120 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
LG G G V+ G +A+K L K L E ++ +RH +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL----KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
S E ++ E+M G+L D L +G+ +A +A G+ Y+
Sbjct: 70 VS-EEPIYIVTEFMGKGSLLDFL---KEGDGKYLKLPQLVDMAAQIADGMAYIER---MN 122
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL+ +NIL+ + ++ADFG+A+LI+ +E
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 54/173 (31%), Positives = 88/173 (50%), Gaps = 15/173 (8%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG---VLAEVDVLGNVRHRNIVR 773
LG G G V ++ G++ A KKL K+ ++++ G L E ++L V IV
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL---DKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE-NLVADWVTRYKIALGVAQGICYLHH 832
L ++ L+ M G+L H N GE L + V Y + + GI +LH
Sbjct: 58 LAYAFESKTHLCLVMSLMNGGDLK--YHIYNVGERGLEMERVIHY--SAQITCGILHLH- 112
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IV+RD+KP N+LLD + R++D G+A ++ ++++ AG+ GY+AP
Sbjct: 113 --SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAP 163
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 41/195 (21%)
Query: 716 KILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLA--------EVDVL 763
K LG GS G V + E GG++I AVK L + L+ E ++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL----------KSDKLSDIMDDFLKEAAIM 50
Query: 764 GNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
++ H N++RL G M++ E P G+L D L G L++ T A+ +
Sbjct: 51 HSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLIS---TLCDYAVQI 106
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYI 883
A G+ YL +HRDL NILL + + ++ DFG+ + + +E V+
Sbjct: 107 ANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME------ 157
Query: 884 APGTFCFCFSVPFCW 898
VPF W
Sbjct: 158 ------EHLKVPFAW 166
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 52/167 (31%), Positives = 79/167 (47%), Gaps = 18/167 (10%)
Query: 716 KILGMGSTGTVYKAEM---PGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+++G G G VY + G +I AVK L ++ L E ++ + H N+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 772 VRLLGCCSNRE-CTMLLYEYMPNGNLDDLLH-AKNKGEN-LVADWVTRYKIALGVAQGIC 828
+ LLG C E +++ YM +G DL + +++ N V D + L VA+G+
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHG---DLRNFIRSETHNPTVKDLIG---FGLQVAKGME 112
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
YL VHRDL N +LD +VADFG+A+ I E SV
Sbjct: 113 YL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 1e-09
Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 15/140 (10%)
Query: 751 RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNK--GE 807
+ RR L E+ +L ++H NI+ + ++ EY G L D ++ K + E
Sbjct: 41 KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEE 100
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+V ++ ++I V+ Y+H I+HRD+K NI L ++ DFG++K++
Sbjct: 101 EMVLWYL--FQIVSAVS----YIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKIL 151
Query: 868 QSDESM--SVIAGSYGYIAP 885
S+ SM +V+ Y Y++P
Sbjct: 152 GSEYSMAETVVGTPY-YMSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 11/157 (7%)
Query: 718 LGMGSTGTVYKA--EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
LG G+ GTV K +M E K+ + + +L E +V+ + + IVR++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G C E ML+ E G L+ L KNK ++ +T ++ V+ G+ YL +
Sbjct: 63 GICEA-ESWMLVMELAELGPLNKFL-QKNK--HVTEKNIT--ELVHQVSMGMKYLE---E 113
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
VHRDL N+LL + A+++DFG++K + +DE+
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 47/169 (27%), Positives = 81/169 (47%), Gaps = 10/169 (5%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
LG G+ G VYKA+ ++A K+ E + E+D+L + H NIV+LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837
+L E+ G +D ++ + +T +I + Q + L++ +
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERP-------LTEPQIRVVCKQTLEALNYLHENK 123
Query: 838 IVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
I+HRDLK NIL + + ++ADFGV AK ++ + G+ ++AP
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 172
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 44/183 (24%)
Query: 718 LGMGSTGTVYKAEMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G V A +A+KKL + I +R E+ +L ++ H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR-TYRELRLLKHMDHENVIGLLD 81
Query: 777 CCSNRECTMLLYEYMPNGNLDDL-------------LHAKNKGENLVADWVT--RYKIAL 821
+ P +L+D L+ K + L D + Y+I
Sbjct: 82 V------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL- 128
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
+G+ Y+H I+HRDLKPSNI ++ + E ++ DFG+A+ +D+ M+ G
Sbjct: 129 ---RGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLAR--HTDDEMT------G 174
Query: 882 YIA 884
Y+A
Sbjct: 175 YVA 177
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 1e-09
Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 13/152 (8%)
Query: 715 DKILGMGSTGTVYKA--EMPGGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++ILG G G + + ++P +A+ L + + ++RRG LAE LG H N
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
IVRL G + M++ EYM NG LD L K++G+ + + + G+A G+ YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLR-KHEGQLVAGQLMG---MLPGLASGMKYL 123
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862
+ VH+ L +L++ ++ +++ F
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-09
Identities = 30/88 (34%), Positives = 54/88 (61%)
Query: 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV 238
L L G IP+D L L+ ++L+GNS+ G++PP LG +T LE +++ YN+ G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 239 PVEFASLVNLKYMDISACNLSGTLPSEI 266
P L +L+ ++++ +LSG +P+ +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 85/303 (28%), Positives = 134/303 (44%), Gaps = 12/303 (3%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
L+LS N L +P+SL+ L L LS + LL L +L L
Sbjct: 45 VAVNRLALNLSSNTLLL-LPSSLSRLLSLDLLSPSGISSLDGSENLLNLL-PLPSLDLNL 102
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N L +L L ++D+ +N++T IPP I K + S+N S+P L
Sbjct: 103 NRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESLPSPLR 160
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
N +L L + N L+ +P+ L NL +D+S N +S ++P ++ LE L++S
Sbjct: 161 NLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSN 218
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
NS L S++ + NL L S++KL ++ ++L NN ++ SI +G
Sbjct: 219 NS-IIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQIS-SIS-SLGS 275
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
L L+LS NSL+ +P L L + LT + S L + N+ N
Sbjct: 276 LTNLRELDLSGNSLSNALPLIALLLLL--LELLLNLLLT-LKALELKLNSILLNNNILSN 332
Query: 592 LLT 594
T
Sbjct: 333 GET 335
|
Length = 394 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 37/181 (20%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE-----------------IIAVKKLWGKHKENIR 751
+ L+ +K LG G G V+ E G + ++AVK L + +
Sbjct: 5 QPLNFVEK-LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL--RPDASDN 61
Query: 752 RRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--CTMLLYEYMPNGNLDDLLH---AKNKG 806
R L EV +L + NI RLLG C+ C ++ EYM NG+L+ L A+ G
Sbjct: 62 AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIM--EYMENGDLNQFLQKHVAETSG 119
Query: 807 ENLVADWVTR----YKIALGVAQGICYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADF 861
+ ++ Y +A +A G+ YL + VHRDL N L+ ++ADF
Sbjct: 120 LACNSKSLSFSTLLY-MATQIASGMRYLESLN----FVHRDLATRNCLVGKNYTIKIADF 174
Query: 862 G 862
G
Sbjct: 175 G 175
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 23/164 (14%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKL----WGKHKENIRRRRG-------VLAEVDV 762
LG G+ G V KA G+I+A+KK+ R+ G L E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK-IAL 821
+ ++H NI+ L+ + L+ + M +L ++ K + ++ K I L
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK------IRLTESQVKCILL 126
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+ G+ LH +HRDL P+NI ++ + ++ADFG+A+
Sbjct: 127 QILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 3e-09
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K+LG G G V+ + G G++ A+K L K + + VL E ++L + H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
L+ +Y P G L LL + +++ V R+ A + + YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQP--GKCLSEEVARFYAAEVLL-ALEYLHLLG 123
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866
IV+RDLKP NILL ++DF ++K
Sbjct: 124 ---IVYRDLKPENILLHESGHIMLSDFDLSKQ 152
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 21/154 (13%)
Query: 737 IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796
I + K+ K +E R+ EV VL N++H NIV+ ++ +Y G+L
Sbjct: 33 INISKMSPKEREESRK------EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL 86
Query: 797 DDLLHAKNKG----ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 852
++A+ +G E+ + DW + +AL H D I+HRD+K NI L
Sbjct: 87 YKKINAQ-RGVLFPEDQILDWFVQICLAL---------KHVHDRKILHRDIKSQNIFLTK 136
Query: 853 EMEARVADFGVAKLIQSD-ESMSVIAGSYGYIAP 885
+ ++ DFG+A+++ S E G+ Y++P
Sbjct: 137 DGTIKLGDFGIARVLNSTVELARTCIGTPYYLSP 170
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 57/174 (32%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVR 773
K++G GS G V A+ G+ AVK L K N + ++ ++AE +VL NV+H +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L E + +++ G L H + E + R+ A +A + YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL--FFHLQR--ERSFPEPRARFYAA-EIASALGYLH-- 113
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAK--LIQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD + + DFG+ K + QSD + + G+ Y+AP
Sbjct: 114 -SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTTTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 35/170 (20%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+ +G G+ G V A + G+ +A+KK+ + + L E+ +L + +H NI+
Sbjct: 10 IENIGSGAYGVVCSAIDTRSGKKVAIKKI-PHAFDVPTLAKRTLRELKILRHFKHDNIIA 68
Query: 774 LLGCCSNRECTMLLYEYMPNGNL------------DDLLHAKNKGENLVADWVTR--YKI 819
+ +L P G DL H + + L + + Y++
Sbjct: 69 IR--------DIL----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+G+ Y+H ++HRDLKPSN+L++ + E R+ DFG+A+ + S
Sbjct: 117 L----RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-09
Identities = 46/173 (26%), Positives = 89/173 (51%), Gaps = 15/173 (8%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+KI G G++GTVY A ++ G+ +A+K++ + + ++ ++ E+ V+ +H NIV
Sbjct: 25 EKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVN 80
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + ++ EY+ G+L D++ E +A + Q + +LH +
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFLHSN 134
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
++HRD+K NILL + ++ DFG I ++S S + G+ ++AP
Sbjct: 135 ---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 4e-09
Identities = 47/150 (31%), Positives = 76/150 (50%), Gaps = 13/150 (8%)
Query: 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG GS TVYK + G+++A+K + + +E + E +L ++H NIV L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHANIVLLHD 70
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGEN-LVADWVTRYKIALGVAQGICYLHHDCD 835
+E L++EY+ DL +K L + V + L +G+ Y+H
Sbjct: 71 IIHTKETLTLVFEYVHT----DLCQYMDKHPGGLHPENVKLFLFQL--LRGLSYIHQR-- 122
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAK 865
I+HRDLKP N+L+ E ++ADFG+A+
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-09
Identities = 33/86 (38%), Positives = 53/86 (61%), Gaps = 1/86 (1%)
Query: 423 DNQ-LNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSN 481
DNQ L G IP L +L +++S NS+ G IP LG+ LE L++S NSF S+P +
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 482 IWSAPNLKILSASSSKLTGKIPDFIG 507
+ +L+IL+ + + L+G++P +G
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 48/180 (26%), Positives = 88/180 (48%), Gaps = 21/180 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+++G G+ G VYK + G++ A+K + G +E I++ +L + HRNI
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS-----HHRNIA 66
Query: 773 RLLGCCSNR------ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
G + + L+ E+ G++ DL+ KG L +W+ I + +G
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK-NTKGNTLKEEWIAY--ICREILRG 123
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
+ +LH ++HRD+K N+LL E ++ DFGV A+L ++ + G+ ++AP
Sbjct: 124 LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 5e-09
Identities = 52/158 (32%), Positives = 85/158 (53%), Gaps = 15/158 (9%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLL 775
LG G+ G V+KA + E++A+KK++ + +R E+ L + H NIV+LL
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQR-TFREIMFLQELGDHPNIVKLL 73
Query: 776 GC--CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
N + L++EYM + LHA + N++ D RY I + + + Y+H
Sbjct: 74 NVIKAENDKDIYLVFEYM-----ETDLHAVIR-ANILEDVHKRY-IMYQLLKALKYIH-- 124
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
++HRDLKPSNILL+ + ++ADFG+A+ + E
Sbjct: 125 -SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 49/160 (30%), Positives = 74/160 (46%), Gaps = 33/160 (20%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG GS TVYK G+++A+K + K +E + + E +L ++H NIV L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFT--AIREASLLKGLKHANIVLLHD 70
Query: 777 CCSNRECTMLLYEYM-----------PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+E ++EYM P G LH N V + L +
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYN---------VRLFMFQL--LR 114
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
G+ Y+H I+HRDLKP N+L+ E ++ADFG+A+
Sbjct: 115 GLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 51/170 (30%), Positives = 88/170 (51%), Gaps = 15/170 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+GMG+ G V A + G+ +A+KK+ + +R E+ +L ++RH NI+ L
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKR-TYRELKLLKHLRHENIISLSD 76
Query: 777 C-CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
S E + E + +L LL ++ + + ++ Y+I +G+ Y+H
Sbjct: 77 IFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYFL--YQIL----RGLKYVH---S 126
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+VHRDLKPSNIL++ + ++ DFG+A+ IQ D M+ + Y AP
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLAR-IQ-DPQMTGYVSTRYYRAP 174
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 54/177 (30%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDVLG-NVRHRN 770
K+LG GS G V AE+ G E+ A+K L K+ I + V + E +L +H
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVL---KKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ L C ++ + EY+ G DL+ + Y A V + +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGG---DLMFQIQRSRKFDEPRSRFY--AAEVTLALMFL 112
Query: 831 H-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
H H +++RDLK NILLD E ++ADFG+ K I + + + G+ YIAP
Sbjct: 113 HRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 9e-09
Identities = 45/150 (30%), Positives = 80/150 (53%), Gaps = 13/150 (8%)
Query: 718 LGMGSTGTVYKAEMPGGE-IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ TV+K E ++A+K++ +H+E + EV +L +++H NIV L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCT--AIREVSLLKDLKHANIVTLHD 71
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL-GVAQGICYLHHDCD 835
+ L++EY+ DL + N+++ + KI L + +G+ Y H
Sbjct: 72 IVHTDKSLTLVFEYLDK----DLKQYMDDCGNIMS--MHNVKIFLYQILRGLAYCHRR-- 123
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAK 865
++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 49/180 (27%), Positives = 87/180 (48%), Gaps = 21/180 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVR 773
+++G G+ G VYK + G++ A+K + E + E+++L HRNI
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE----EEEIKLEINMLKKYSHHRNIAT 77
Query: 774 LLGC------CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
G + + L+ E+ G++ DL+ KG L DW+ I + +G+
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK-NTKGNALKEDWIAY--ICREILRGL 134
Query: 828 CYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
+LH H ++HRD+K N+LL E ++ DFGV A+L ++ + G+ ++AP
Sbjct: 135 AHLHAHK----VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAP 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 29/178 (16%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGE-----------------IIAVKKLWGKHKENIRRR 753
L+ +K LG G G V+ E G E ++AVK L + N R
Sbjct: 7 LTFKEK-LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKML--REDANKNAR 63
Query: 754 RGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL------HAKNKGE 807
L E+ ++ ++ NI+RLL C + ++ EYM NG+L+ L A K +
Sbjct: 64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD 123
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+ + T +A +A G+ YL VHRDL N L+ ++ADFG+++
Sbjct: 124 VVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 45/166 (27%)
Query: 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKEN-----IRRRRGVLAEVDVLGNVRHRNI 771
LG GS TVYK G+++A+K++ +H+E IR E +L +++H NI
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-------EASLLKDLKHANI 65
Query: 772 VRLLGCCSNRECTMLLYEYM-----------PNGNLDDLLHAKNKGENLVADWVTRYKIA 820
V L ++ L++EY+ G L N ++
Sbjct: 66 VTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----LSMHN------------VRLF 108
Query: 821 L-GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
L + +G+ Y H ++HRDLKP N+L+ E ++ADFG+A+
Sbjct: 109 LFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 56/175 (32%), Positives = 81/175 (46%), Gaps = 14/175 (8%)
Query: 716 KILGMGSTGTVY---KAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
K+LG GS G V+ K P G++ A+K L K +R R E D+L V H I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVL-KKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+L L+ +++ G DL +K + V Y L +A L
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALA-----LD 112
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
H I++RDLKP NILLD E ++ DFG++K I ++ G+ Y+AP
Sbjct: 113 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAP 167
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 50/172 (29%), Positives = 83/172 (48%), Gaps = 29/172 (16%)
Query: 716 KILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV- 766
K LG G G V +AE G + +AVK L K + +++E++++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML--KDNATDKDLADLISEMELMKLIG 75
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKN-KGENLVADWVTR--------- 816
+H+NI+ LLG C+ ++ EY GNL + L A+ G + D +T+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD-ITKVPEEQLSFK 134
Query: 817 --YKIALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
A VA+G+ YL C +HRDL N+L+ + ++ADFG+A+
Sbjct: 135 DLVSCAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 18/162 (11%)
Query: 708 LECLSMSDKILGMGSTGTVYKAEMPGGE-IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
LE DK LG G+ TVYK + ++A+K++ +H+E + EV +L ++
Sbjct: 5 LETYIKLDK-LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCT--AIREVSLLKDL 61
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ- 825
+H NIV L + L++EY+ DL + N + + + L + Q
Sbjct: 62 KHANIVTLHDIIHTEKSLTLVFEYLDK----DLKQYLDDCGNSI----NMHNVKLFLFQL 113
Query: 826 --GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
G+ Y H ++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 114 LRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/175 (25%), Positives = 82/175 (46%), Gaps = 22/175 (12%)
Query: 718 LGMGSTGTVYKAEM--PG---GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
LG + G +YK + PG +++A+K L K N ++ E ++ + H NIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL------------VADWVTRYKIA 820
LLG + + +L+EY+ G+L + L ++ ++ D IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
+ +A G+ YL VH+DL NIL+ ++ +++D G+++ I S + V
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRV 182
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 45/170 (26%), Positives = 85/170 (50%), Gaps = 14/170 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GSTG V A E G+ +AVKK+ + ++ RR + EV ++ + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ---RRELLFNEVVIMRDYHHENVVDMYN 86
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ ++ E++ G L D++ E +A + L V + + YLH+
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------TVCLSVLRALSYLHNQG-- 138
Query: 837 VIVHRDLKPSNILLDGEMEARVADFG-VAKLIQSDESMSVIAGSYGYIAP 885
++HRD+K +ILL + +++DFG A++ + + G+ ++AP
Sbjct: 139 -VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 3e-08
Identities = 41/170 (24%), Positives = 88/170 (51%), Gaps = 14/170 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G++GTV+ A ++ G+ +A+K++ + + ++ ++ E+ V+ +++ NIV L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ ++ EY+ G+L D++ E +A + Q + +LH +
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA------AVCRECLQALEFLHAN--- 134
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
++HRD+K N+LL + ++ DFG I ++S S + G+ ++AP
Sbjct: 135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 53/164 (32%), Positives = 73/164 (44%), Gaps = 25/164 (15%)
Query: 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVL-- 763
CL+ +LG G G V AE GE+ A+K L K +I R V + E +
Sbjct: 3 CLA----VLGRGHFGKVLLAEYKKTGELYAIKAL---KKGDIIARDEVESLMCEKRIFET 55
Query: 764 -GNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI-AL 821
+ RH +V L C + + EY G+L +H E R A
Sbjct: 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSE-------PRAVFYAA 108
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
V G+ YLH + IV+RDLK N+LLD E ++ADFG+ K
Sbjct: 109 CVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 49/177 (27%), Positives = 85/177 (48%), Gaps = 19/177 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ G V A + G +AVKKL + +R E+ +L V H+NI+ L
Sbjct: 27 KPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA-YRELVLLKCVNHKNIISL 85
Query: 775 LGCCSNREC------TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L + ++ L+ E M + NL ++H + E +++ + Q +C
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHE----------RMSYLLYQMLC 134
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ H I+HRDLKPSNI++ + ++ DFG+A+ ++ M+ + Y AP
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 48/176 (27%), Positives = 89/176 (50%), Gaps = 18/176 (10%)
Query: 716 KILGMGSTGTV-YKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ GTV + G +A+KKL+ + + +R E+ +L +++H N++ L
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA-YRELRLLKHMKHENVIGL 79
Query: 775 LGCCS---NRECTMLLYEYMP--NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
L + + + Y MP +L L+ + E+ + V Y++ +G+ Y
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV--YQML----KGLKY 133
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+H I+HRDLKP N+ ++ + E ++ DFG+A+ Q+D M+ + Y AP
Sbjct: 134 IH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 13/170 (7%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VYK + E++A+K + + E+ + E+ VL I R G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYITRYYG 69
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
++ EY+ G+ DLL E +A I + +G+ YLH +
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA------TILREILKGLDYLHSERK- 122
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
+HRD+K +N+LL + + ++ADFGVA +L + + G+ ++AP
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-08
Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 714 SDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
S K +G G+ G+V A + GE +A+KKL + I +R E+ +L +++H N++
Sbjct: 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA-YRELTLLKHMQHENVI 77
Query: 773 RLLGCCSNRECTMLLYEY---MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
LL ++ ++ MP D K G L D K+ V Q +C
Sbjct: 78 GLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSED-----KVQYLVYQMLCG 129
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
L + I+HRDLKP N+ ++ + E ++ DFG+A+ +D M+ + Y AP
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVVTRWYRAP 183
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 4e-08
Identities = 43/170 (25%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G++GTVY A ++ G+ +A+K++ + + ++ ++ E+ V+ ++ NIV L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ ++ EY+ G+L D++ E +A + Q + +LH +
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALDFLHSN--- 134
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
++HRD+K NILL + ++ DFG I ++S S + G+ ++AP
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-08
Identities = 44/165 (26%), Positives = 66/165 (40%), Gaps = 22/165 (13%)
Query: 734 GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL--GCCSNRECTMLLYEYM 791
G +A+K L E +R E + + H NIV LL G ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPP-GLLFAVFEYV 61
Query: 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL- 850
P L ++L G + ++ L V + H + IVHRDLKP NI++
Sbjct: 62 PGRTLREVL--AADGALPAGETG---RLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113
Query: 851 --DGEMEARVADFGVAKLIQSDESMSV--------IAGSYGYIAP 885
A+V DFG+ L+ V + G+ Y AP
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAP 158
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 48/169 (28%), Positives = 80/169 (47%), Gaps = 35/169 (20%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRN 770
+ +G G+ G VYKA + G+++A+KK + E G+ L E+ +L +
Sbjct: 7 EKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-----EGIPPTALREISLLQMLSESI 61
Query: 771 -IVRLLGCCSNRE-----CTMLLYEYMPNGNLDDL-----LHAKNKGENLVADWVTR--Y 817
IVRLL E L++EY+ + DL + + G L A + Y
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDS----DLKKFMDSNGRGPGRPLPAKTIKSFMY 117
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA-RVADFGVAK 865
++ GVA C+ H ++HRDLKP N+L+D + ++AD G+ +
Sbjct: 118 QLLKGVAH--CHKHG-----VMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-08
Identities = 75/249 (30%), Positives = 118/249 (47%), Gaps = 52/249 (20%)
Query: 346 TLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYS 405
TL+L NN L LP+ L N K T+ +SN LT IP T+ D + +L S N
Sbjct: 203 TLILDNNELKS-LPENLQGNIK--TLYANSNQLTS-IPATLPDTIQEMEL---SINRITE 255
Query: 406 IPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPN-LTFMDMSRNSLSGEIPRDLGNAQKL 464
+PE L S+L L + N+++ +P+ LP L ++ + NS+ +P L + +
Sbjct: 256 LPERLP--SALQSLDLFHNKIS-CLPEN---LPEELRYLSVYDNSIRT-LPAHLPSG--I 306
Query: 465 EYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGS 524
+LN+ NS T+LP + P LK L A + LT L S
Sbjct: 307 THLNVQSNSL-TALPETL--PPGLKTLEAGENALTS--------------------LPAS 343
Query: 525 IPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLE 584
+P +L +L++S+N +T ++P + P+IT +D+S N LT +P N + L+
Sbjct: 344 LP------PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQ 391
Query: 585 SFNVSYNLL 593
S N L
Sbjct: 392 IMQASRNNL 400
|
Length = 754 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 51/162 (31%), Positives = 80/162 (49%), Gaps = 24/162 (14%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL- 775
LG G+ G VYKA ++ G ++A+KK+ H E L E+ +L ++H N+V L+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITALREIKILKKLKHPNVVPLID 74
Query: 776 -------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ--- 825
R ++ YM + +L LL N L T +I + Q
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYM-DHDLSGLLE--NPSVKL-----TESQIKCYMLQLLE 126
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
GI YLH + I+HRD+K +NIL+D + ++ADFG+A+
Sbjct: 127 GINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY 165
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 5e-08
Identities = 43/157 (27%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 712 SMSDKI--LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRG--VLAEVDVLGNV 766
SM KI +G+G+ G V ++ + A+K L + + + R + V AE D+L
Sbjct: 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTL--RKADVLMRNQAAHVKAERDILAEA 58
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
+ +V+L +++ + +Y+P G++ LL E +A R+ IA +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA----RFYIA-ELTCA 113
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
I +H +HRD+KP NIL+D + ++ DFG+
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 716 KILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV- 766
K LG G G V AE G + +AVK L K + +++E++++ +
Sbjct: 21 KPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMIG 78
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE-------NLVADWVTRYKI 819
+H+NI+ LLG C+ ++ EY GNL + L A+ V D +K
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 820 ALG----VAQGICYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ VA+G+ YL C +HRDL N+L+ ++ADFG+A+ + +
Sbjct: 139 LVSCTYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNN 189
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 6e-08
Identities = 35/116 (30%), Positives = 55/116 (47%), Gaps = 24/116 (20%)
Query: 344 LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFT 403
+D L L N L G +P + L ++++S NS+ G IPP++
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG---------------- 463
Query: 404 YSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLG 459
+ +SL L + N NGSIP+ G L +L ++++ NSLSG +P LG
Sbjct: 464 --------SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-08
Identities = 54/173 (31%), Positives = 82/173 (47%), Gaps = 11/173 (6%)
Query: 716 KILGMGSTGTVYKAEMPGGEII-AVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVR 773
K++G GS G V A E AVK L K + + +++E +VL NV+H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + + +Y+ G L H + E + R+ A +A + YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL--FYHLQR--ERCFLEPRARF-YAAEIASALGYLH-- 113
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
IV+RDLKP NILLD + + DFG+ K I+ + + S G+ Y+AP
Sbjct: 114 -SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 47/161 (29%), Positives = 79/161 (49%), Gaps = 24/161 (14%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKK-LWGKHKEN--IRRRRGVLAEVDVLGNVRHRNIV 772
+G G+ G V+KA +I+A+KK L KE I R E+ +L ++H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR----EIKILQLLKHENVV 74
Query: 773 RLLGCCSN--------RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
L+ C + L++E+ + +L LL KN L K+ +
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS----EIKKVMKMLL 129
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
G+ Y+H + I+HRD+K +NIL+ + ++ADFG+A+
Sbjct: 130 NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 32/115 (27%), Positives = 54/115 (46%), Gaps = 23/115 (20%)
Query: 443 MDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKI 502
+ + L G IP D+ + L+ +N+S NS + ++P ++ S +L++L
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471
Query: 503 PDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLP 557
+L N NGSIP +G L +LNL+ NSL+G +P + G
Sbjct: 472 ------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 1/85 (1%)
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPI 597
L L L G IP +IS L + ++LS N + G IP + + ++LE ++SYN G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 598 PASGTIFPNLHPSSFIGNEGLCGRV 622
P S +L + GN L GRV
Sbjct: 483 PESLGQLTSLRILNLNGNS-LSGRV 506
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 7e-08
Identities = 37/116 (31%), Positives = 48/116 (41%), Gaps = 24/116 (20%)
Query: 323 LSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPI 382
L L N L G IP DI L L ++ L N + G +P LGS L +D+S NS G
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG-- 480
Query: 383 PPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLP 438
SIPE+L +SL L + N L+G +P G
Sbjct: 481 ----------------------SIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 47/174 (27%), Positives = 89/174 (51%), Gaps = 18/174 (10%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G+V A + G +AVKKL + I +R E+ +L +++H N++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83
Query: 777 CCSNREC-----TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ + L ++ +L++++ K + L D V + + +G+ Y+H
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIV----KCQKLTDDHVQF--LIYQILRGLKYIH 137
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRDLKPSN+ ++ + E ++ DFG+A+ +D+ M+ + Y AP
Sbjct: 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 186
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 7e-08
Identities = 45/173 (26%), Positives = 87/173 (50%), Gaps = 20/173 (11%)
Query: 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GSTG V A + G+++AVKK+ + ++ RR + EV ++ + +H N+V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYN 84
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ ++ E++ G L D++ E +A + L V + + LH
Sbjct: 85 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA------AVCLAVLKALSVLHAQG-- 136
Query: 837 VIVHRDLKPSNILLDGEMEARVADFG----VAKLIQSDESMSVIAGSYGYIAP 885
++HRD+K +ILL + +++DFG V+K + +S+ G+ ++AP
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 55/182 (30%), Positives = 82/182 (45%), Gaps = 29/182 (15%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K+LG GS G V+ AE+ G + A+K L K+++ VL + DV + + ++ L
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKAL----KKDV-----VLMDDDVECTMVEKRVLSL 51
Query: 775 ---------LGCC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
L C +E + EY+ G DL+ T Y A +
Sbjct: 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGG---DLMFHIQSCHKFDLPRATFY--AAEII 106
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYI 883
G+ +LH IV+RDLK NILLD + ++ADFG+ K + D G+ YI
Sbjct: 107 CGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYI 163
Query: 884 AP 885
AP
Sbjct: 164 AP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 8e-08
Identities = 41/163 (25%), Positives = 71/163 (43%), Gaps = 19/163 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K LG G G V+ + +A+K + E + E V+ + H +V+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC----YLH 831
G C+ ++ ++ E+M NG L + L + +G + L + Q +C YL
Sbjct: 66 GVCTQQKPLYIVTEFMENGCLLNYLR-QRQG-------KLSKDMLLSMCQDVCEGMEYLE 117
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
+ +HRDL N L+ +V+DFG+ + + DE S
Sbjct: 118 RNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 31/176 (17%)
Query: 716 KILGMGSTGTVYKAEMPGGEI--------IAVKKLWGKHKENIRRRRGVLAEVDVLGNV- 766
K LG G G V AE G + +AVK L K + +++E++++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML--KSDATEKDLSDLISEMEMMKMIG 81
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAK-------------NKGENL-VAD 812
+H+NI+ LLG C+ ++ EY GNL + L A+ E L D
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 813 WVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868
V+ A VA+G+ YL +HRDL N+L+ + ++ADFG+A+ I
Sbjct: 142 LVS---CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K +G GS G +Y A+ V K K ++ + EV +L ++H NIV
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNK---GENLVADWVTRYKIALGVAQGICYLHH 832
++ EY G+L ++ + E+ + W +I+LG L H
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV--QISLG-------LKH 116
Query: 833 DCDPVIVHRDLKPSNILLDGE-MEARVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
D I+HRD+K NI L M A++ DFG+A+ L S E G+ Y++P
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 10/170 (5%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G+V A + + +AVKKL + I RR E+ +L +++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARR-TYRELRLLKHMKHENVIGLLD 81
Query: 777 CCSNRECTMLLYE-YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
+ E Y+ + L+ K + L + V L +G+ Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQL--LRGLKYIH---S 136
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRDLKPSN+ ++ + E R+ DFG+A+ Q+D+ M+ + Y AP
Sbjct: 137 AGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGYVATRWYRAP 184
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 8/150 (5%)
Query: 718 LGMGSTGTVYKAEMPGGEIIA---VKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G G V E G A VK+L + + L EV + H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
LG C +L+ E+ P G+L + L + +A ++A VA G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+H DL N L ++ ++ D+G+A
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 46/161 (28%), Positives = 75/161 (46%), Gaps = 16/161 (9%)
Query: 718 LGMGSTGTVYKA---EMPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG GS G VY+ ++ GE +AVK + ++R R L E V+ ++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV--NESASLRERIEFLNEASVMKGFTCHHV 71
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLH-----AKNKGENLVADWVTRYKIALGVAQG 826
VRLLG S + T+++ E M +G+L L A+N ++A +A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+ YL+ VHRDL N ++ + ++ DFG+ + I
Sbjct: 132 MAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 24/75 (32%), Positives = 39/75 (52%)
Query: 406 IPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLE 465
IP ++ L + + N + G+IP G + +L +D+S NS +G IP LG L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 466 YLNISENSFQTSLPS 480
LN++ NS +P+
Sbjct: 494 ILNLNGNSLSGRVPA 508
|
Length = 623 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 55/182 (30%), Positives = 87/182 (47%), Gaps = 29/182 (15%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K+LG GS G V AE+ G E A+K L K+++ VL + DV + R ++ L
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKAL----KKDV-----VLEDDDVECTMVERRVLAL 51
Query: 775 ---------LGCC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
L C +E + EY+ G+L + H ++ G + R+ A +
Sbjct: 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGR--FDEARARF-YAAEII 106
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYI 883
G+ +LH I++RDLK N+LLD + ++ADFG+ K + + S G+ YI
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYI 163
Query: 884 AP 885
AP
Sbjct: 164 AP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 33/174 (18%)
Query: 716 KILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV- 766
K LG G G V AE G + +AVK L K + +++E++++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML--KDDATDKDLSDLVSEMEMMKMIG 75
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKN-------------KGENLV-AD 812
+H+NI+ LLG C+ +L EY GNL + L A+ E L D
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 813 WVTRYKIALGVAQGICYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
V+ A VA+G+ YL C +HRDL N+L+ + ++ADFG+A+
Sbjct: 136 LVS---CAYQVARGMEYLASQKC----IHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.6 bits (128), Expect = 2e-07
Identities = 42/170 (24%), Positives = 87/170 (51%), Gaps = 14/170 (8%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G++GTVY A ++ G+ +A++++ + + ++ ++ E+ V+ ++ NIV L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ ++ EY+ G+L D++ E +A + Q + +LH +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFLHSN--- 135
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
++HRD+K NILL + ++ DFG I ++S S + G+ ++AP
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 40/175 (22%), Positives = 86/175 (49%), Gaps = 10/175 (5%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+K +G G VY+A + + +A+KK+ + + R+ + E+D+L + H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 774 LLGC-CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVAD-WVTRYKIALGVAQGICYLH 831
L + E ++L E G+L ++ K + L+ + V +Y + L A +
Sbjct: 67 YLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA-----VE 120
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-VIAGSYGYIAP 885
H ++HRD+KP+N+ + ++ D G+ + S + + + G+ Y++P
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 17/170 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDV 762
E ++MS + LG GS G VY+ G +A+K + ++R R L E V
Sbjct: 6 EKITMSRE-LGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASV 62
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA---KNKGENLVADWVTRYKI 819
+ ++VRLLG S + T+++ E M G+L L + + + + A + I
Sbjct: 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122
Query: 820 ALG--VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+ +A G+ YL+ + VHRDL N ++ + ++ DFG+ + I
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 169
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 53/178 (29%), Positives = 86/178 (48%), Gaps = 20/178 (11%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLA---EVDVLGNVRHRNI 771
K++G G+ G V +M G++ A+K L +K + +R E DVL N R I
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKIL---NKWEMLKRAETACFREERDVLVNGDRRWI 63
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV--AQGICY 829
L + L+ +Y G+L LL +K E+ + + + R+ +A V +
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
L + VHRD+KP N+LLD R+ADFG + +D ++ +V G+ YI+P
Sbjct: 121 LGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 47/186 (25%), Positives = 87/186 (46%), Gaps = 35/186 (18%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL-- 774
LG GS G V+ A + + +AVKK+ ++++ L E+ ++ + H NIV++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKH---ALREIKIIRRLDHDNIVKVYE 69
Query: 775 -LGCCSNRECTML--------LY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
LG + + +Y EYM DL + +G L + + L
Sbjct: 70 VLGPSGSDLTEDVGSLTELNSVYIVQEYMET----DLANVLEQGP-LSEEHARLFMYQL- 123
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYG 881
+G+ Y+H ++HRDLKP+N+ ++ E + ++ DFG+A+++ S G
Sbjct: 124 -LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHK------G 173
Query: 882 YIAPGT 887
Y++ G
Sbjct: 174 YLSEGL 179
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 18/175 (10%)
Query: 716 KILGMGSTGTVYKAEMPGGEI--IAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRN 770
+ LG GS G V A + +A+K+ K I +++ V +E +L + H
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRF---EKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
V L G + L+ E++ G L + N V AQ +
Sbjct: 93 CVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVG--------CFYAAQIVLIF 144
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ IV+RDLKP N+LLD + ++ DFG AK++ D + G+ YIAP
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV--DTRTYTLCGTPEYIAP 197
|
Length = 340 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 10/159 (6%)
Query: 715 DKILGMGSTGTVYKA--EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+ +G G G VY+ P E IAV K+ + R L E ++ H +IV
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
+L+G + ++ E P G L L NK +L D + + ++ + YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYLQ-VNK-YSL--DLASLILYSYQLSTALAYLE- 124
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
VHRD+ N+L+ ++ DFG+++ ++ +
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 18/176 (10%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL--AEVDVLGNVRHRNIVR 773
K++G G+ G V + + KL K E I+R E D++ +V+
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF-EMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + + ++ EYMP G+L +L+ + E + +AL +
Sbjct: 108 LFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG----- 162
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV----IAGSYGYIAP 885
++HRD+KP N+LLD ++ADFG ++ DE+ V G+ YI+P
Sbjct: 163 ----LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 45/168 (26%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 716 KILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRH 768
++LG G G+V +A++ + +AVK L K +I + L E + H
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKML----KADIFSSSDIEEFLREAACMKEFDH 60
Query: 769 RNIVRLLGCCSNRECT------MLLYEYMPNGNLDDLLHAKNKGEN-LVADWVTRYKIAL 821
N+++L+G M++ +M +G+L L GE T + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+A G+ YL +HRDL N +L+ M VADFG++K I S
Sbjct: 121 DIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYS 165
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 55/176 (31%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL--AEVDVLGNVRHRNIVR 773
K++G G+ G V +M E I K+ K E ++R E +VL N + I
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKW-EMLKRAETACFREERNVLVNGDCQWITT 65
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV--AQGICYLH 831
L + L+ +Y G+L LL +K E+ + + + R+ IA V I LH
Sbjct: 66 LHYAFQDENYLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
+ VHRD+KP N+LLD R+ADFG + D ++ SV G+ YI+P
Sbjct: 123 Y------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 4e-07
Identities = 54/175 (30%), Positives = 79/175 (45%), Gaps = 16/175 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
K+LG G+ G V E G+ A+K L KE I + V L E VL N RH +
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + + EY G L H E + ++ R+ A + + YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSR--ERVFSEDRARFYGA-EIVSALGYLH 112
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
CD +V+RDLK N++LD + ++ DFG+ K I +M G+ Y+AP
Sbjct: 113 -SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 39/174 (22%), Positives = 81/174 (46%), Gaps = 8/174 (4%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+K +G G VY+A + G +A+KK+ + + R + E+D+L + H N+++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVAD-WVTRYKIALGVAQGICYLHH 832
++ E G+L ++ K + L+ + V +Y + L A L H
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA-----LEH 121
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-VIAGSYGYIAP 885
++HRD+KP+N+ + ++ D G+ + S + + + G+ Y++P
Sbjct: 122 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 10/150 (6%)
Query: 717 ILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
++G G+ G V K EI+A+KK + +EN + L E+ +L ++ NIV L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK-FKDSEENEEVKETTLRELKMLRTLKQENIVELK 66
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
R L++EY+ N+ +LL G + + V Y L A C+ +
Sbjct: 67 EAFRRRGKLYLVFEYVEK-NMLELLEEMPNG--VPPEKVRSYIYQLIKAIHWCHKND--- 120
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAK 865
IVHRD+KP N+L+ ++ DFG A+
Sbjct: 121 --IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL--AEVDVLGNVRHRNIVR 773
K++G G+ G V ++ + + K+ K E ++R E DVL N ++ I
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKW-EMLKRAETACFREERDVLVNGDNQWITT 65
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA--QGICYLH 831
L + L+ +Y G+L LL +K E+ + + + R+ +A V + LH
Sbjct: 66 LHYAFQDENNLYLVMDYYVGGDLLTLL---SKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
+ VHRD+KP NIL+D R+ADFG + D ++ SV G+ YI+P
Sbjct: 123 Y------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 16/175 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
K+LG G+ G V E G+ A+K L KE I + V L E VL N RH +
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLKNTRHPFL 57
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L ++ + EY+ G L H E + ++ TR+ A + + YLH
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSR--ERVFSEDRTRFYGA-EIVSALDYLH 112
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
IV+RDLK N++LD + ++ DFG+ K I +M G+ Y+AP
Sbjct: 113 SG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 15/175 (8%)
Query: 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
++LG GS G V A + G + AVK L K+ I + V + E +L R+
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVL---KKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ L CC + L+ M N DL+ K Y A + + +LH
Sbjct: 58 LTQLYCCF--QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY--AAEITSALMFLH 113
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
D I++RDLK N+LLD E ++ADFG+ K I + ++ S G+ YIAP
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAP 165
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 9e-07
Identities = 51/196 (26%), Positives = 82/196 (41%), Gaps = 29/196 (14%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+++G G G VY A P +A+KK+ EN ++ L E + ++ H IV +
Sbjct: 8 RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWV------TRYKIALGVAQGIC 828
CS+ + Y+ L LL + + E+L + I + I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE----------------S 872
Y+H ++HRDLKP NILL E + D+G A + +E S
Sbjct: 128 YVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184
Query: 873 MSV---IAGSYGYIAP 885
M++ I G+ Y+AP
Sbjct: 185 MTIPGKIVGTPDYMAP 200
|
Length = 932 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 34/105 (32%), Positives = 53/105 (50%), Gaps = 4/105 (3%)
Query: 299 LDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVL 358
L L + L G IP ++ L+ L ++L N + G IP + + L+ L L N G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 359 PQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFT 403
P+ LG L ++++ NSL+G +P + G RL F NFT
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL--GGRLLHRASF--NFT 523
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 45/160 (28%), Positives = 78/160 (48%), Gaps = 17/160 (10%)
Query: 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRR--GVLAEVDVLGNVRHRNIV 772
K++G G+ G V + G I A+KKL + E + + + V AE D+L + +V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKL--RKSEMLEKEQVAHVRAERDILAEADNPWVV 64
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV--AQGICYL 830
+L + L+ EY+P G++ LL K+ + TR+ IA + I L
Sbjct: 65 KLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD----TFTEEETRFYIAETILAIDSIHKL 120
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
+ +HRD+KP N+LLD + +++DFG+ ++
Sbjct: 121 GY------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-06
Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 11/150 (7%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K LG+G+ G V A ++ + A+K L K N + V AE D+L + +V+L
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+++ + +Y+P G++ LL + E L ++ +A+ + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---- 122
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGV 863
+HRD+KP NIL+D + ++ DFG+
Sbjct: 123 -----IHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 1e-06
Identities = 43/165 (26%), Positives = 77/165 (46%), Gaps = 26/165 (15%)
Query: 717 ILGMGSTGTVYKA-EMPGGEIIAVKKL--WGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+G G+ G V A P G +A+KK+ + R R E+ +L +H NI+
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR----EIKILRRFKHENIIG 67
Query: 774 LLGC-CSNRECTM----LLYEYMPNGNLDDLLHAKNKGENLVADWVTR--YKIALGVAQG 826
+L + ++ E M L+ K ++L D + Y+I +G
Sbjct: 68 ILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYFLYQIL----RG 118
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ Y+H + ++HRDLKPSN+LL+ + ++ DFG+A++ +
Sbjct: 119 LKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 50/193 (25%), Positives = 82/193 (42%), Gaps = 41/193 (21%)
Query: 716 KILGMGSTGTVYKAEMPGG-EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+LG GS G V AE G E+ A+K I ++ V+ + DV + + ++ L
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIK---------ILKKDVVIQDDDVECTMVEKRVLAL 56
Query: 775 LG----------CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK------ 818
G C + + EY+ G+L + + G R+K
Sbjct: 57 SGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVG---------RFKEPHAVF 105
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIA 877
A +A G+ +LH I++RDLK N++LD E ++ADFG+ K + +
Sbjct: 106 YAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC 162
Query: 878 GSYGYIAPGTFCF 890
G+ YIAP +
Sbjct: 163 GTPDYIAPEIIAY 175
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 43/156 (27%), Positives = 78/156 (50%), Gaps = 16/156 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ G V A E +A+KK+ +N + L E+ +L ++ H N++ +
Sbjct: 11 KPIGRGAYGIVCSAKNSETNEKVAIKKI-ANAFDNRIDAKRTLREIKLLRHLDHENVIAI 69
Query: 775 LGCC--SNREC---TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
+RE ++YE M D LH + ++D +Y + + +G+ Y
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFL-YQLLRGLKY 123
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+H ++HRDLKPSN+LL+ + ++ DFG+A+
Sbjct: 124 IH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 2e-06
Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 14/182 (7%)
Query: 706 DVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLG 764
D E + ++I G GS G V+K + +++A+K + + E+ + E+ VL
Sbjct: 1 DPEELFTKLERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAED--EIEDIQQEITVLS 57
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
+ + G ++ EY+ G+ DLL A E +A + +
Sbjct: 58 QCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE------IL 111
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYI 883
+G+ YLH + +HRD+K +N+LL + + ++ADFGVA +L + + G+ ++
Sbjct: 112 KGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168
Query: 884 AP 885
AP
Sbjct: 169 AP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 37/144 (25%), Positives = 64/144 (44%), Gaps = 13/144 (9%)
Query: 725 TVYKAEMPGGEIIAVKKLWGKHKENI----RRRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780
++ + PG E A + K E++ +R G E +L + H +I++L G +
Sbjct: 95 SILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSIIQLKGTFTY 154
Query: 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVH 840
+ T L+ +P D + K + D + I V + I YLH + I+H
Sbjct: 155 NKFTCLI---LPRYKTDLYCYLAAKRNIAICDILA---IERSVLRAIQYLHENR---IIH 205
Query: 841 RDLKPSNILLDGEMEARVADFGVA 864
RD+K NI ++ + + DFG A
Sbjct: 206 RDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 3e-06
Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 14/165 (8%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G V+ + +AVK +++ + L E +L H NIVRL+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK--FLQEARILKQYSHPNIVRLIG 60
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
C+ ++ ++ E + G+ L + +G L ++ A G+ YL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVK--ELIQMVENAAAGMEYLESKH-- 114
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
+HRDL N L+ + +++DFG+++ +E V A + G
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGG 154
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 3e-06
Identities = 46/165 (27%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 716 KILGMGSTGTVYKAEMPGGEII---AVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHR 769
K LG G G+V + ++ + I AVK + K I R + L+E + H
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTM----KIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 770 NIVRLLGCC---SNRE---CTMLLYEYMPNGNLDD-LLHAKNKGENLVADWVTRYKIALG 822
N++RL+G C E +++ +M +G+L LL+++ K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
+A G+ YL +HRDL N +L+ M VADFG++K I
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 43/170 (25%), Positives = 72/170 (42%), Gaps = 16/170 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K L GS G V+ A PG V K I ++ L E +L NV H +++R+
Sbjct: 72 KTLTPGSEGRVFVATKPGQPDPVVLK--------IGQKGTTLIEAMLLQNVNHPSVIRMK 123
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
+ T ++ +P+ + D + + L D I + +G+ YLH
Sbjct: 124 DTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPID--QALIIEKQILEGLRYLHAQ-- 176
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+K NI ++ + + D G A+ + +AG+ AP
Sbjct: 177 -RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
|
Length = 357 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G V+K + +++A+K + + E+ + E+ VL + + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED--EIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
++ EY+ G+ DLL E +A I + +G+ YLH +
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLHSEKK- 122
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGYIAP 885
+HRD+K +N+LL E ++ADFGVA +L + + G+ ++AP
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 4e-06
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 21/167 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ G V A + G+ +A+KKL + +N+ + E+ ++ V H+NI+ L
Sbjct: 22 KPIGSGAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGL 80
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG-------VAQGI 827
L + P +L++ E + A+ ++ L + Q +
Sbjct: 81 LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQML 128
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
C + H I+HRDLKPSNI++ + ++ DFG+A+ + M+
Sbjct: 129 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 175
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 42/157 (26%), Positives = 74/157 (47%), Gaps = 21/157 (13%)
Query: 714 SDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGK---HKE---NIRRRRGVLAEVDVLGNV 766
S K++G G+ G V + G + A+K L KE +IR R +L E D L
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW-- 62
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
+V++ ++ L+ E++P G++ LL K D +T + +A+
Sbjct: 63 ----VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--------DTLTEEETQFYIAET 110
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
+ + +HRD+KP N+LLD + +++DFG+
Sbjct: 111 VLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 5e-06
Identities = 50/175 (28%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 718 LGMGSTGTVY----KAEMPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
LG GS GTVY K + + +K++ G+ N + E +L + H IV
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ--EAQLLSKLDHPAIV 65
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGVAQGICYLH 831
+ R+ ++ EY +LD L K+ G+ L + V + I L + G+ Y+H
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL--GVHYMH 123
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDESMSVIAGSYGYIAP 885
I+HRDLK NI L + ++ DFGV++L+ S + + G+ Y++P
Sbjct: 124 QR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSP 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 42/174 (24%), Positives = 72/174 (41%), Gaps = 14/174 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL--AEVDVLGNVRHRNIVR 773
K++G G+ G V + KL K E I+R E D++ +V+
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-EMIKRSDSAFFWEERDIMAFANSPWVVQ 107
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + ++ EYMP G+L +L+ + E + +AL + +
Sbjct: 108 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGF---- 163
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
+HRD+KP N+LLD ++ADFG + + + G+ YI+P
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 47/185 (25%), Positives = 79/185 (42%), Gaps = 37/185 (20%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G G+ G VY+ + I A+K L ++ ++A+ +V + RNI L
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVL---------SKKEIVAKKEVAHTIGERNI---LV 48
Query: 777 CCSNRECTML------------LY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
E + LY +YM G L H + +G + +
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL--FWHLQKEGR------FSEDRAKF 100
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSY 880
+A+ + L H IV+RDLKP NILLD + DFG++K + +++ + G+
Sbjct: 101 YIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160
Query: 881 GYIAP 885
Y+AP
Sbjct: 161 EYLAP 165
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 5e-06
Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 29/182 (15%)
Query: 716 KILGMGSTGTVYKAEMPGG-EIIAVKKLWGKHKENIRRRRGV---LAEVDVLG-NVRHRN 770
+LG GS G V AE G E+ A+K L K+ I + V + E VL +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKIL---KKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK------IALGVA 824
+ +L C + + EY+ G+L + H + G ++K A +A
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVG---------KFKEPHAVFYAAEIA 111
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYI 883
G+ +LH I++RDLK N++LD E ++ADFG+ K I ++ G+ YI
Sbjct: 112 IGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYI 168
Query: 884 AP 885
AP
Sbjct: 169 AP 170
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 6e-06
Identities = 43/175 (24%), Positives = 81/175 (46%), Gaps = 38/175 (21%)
Query: 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
D+ +G G+ G V+ P G+ +A+KK+ +N+ + V E+ +L +H N++
Sbjct: 5 DRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLS 63
Query: 774 LLGCCSNRECTMLLYEYMPNGNLD---------DLLHAK-----NKGENLVADWVT--RY 817
L + + ++D +L+ + + L +D V Y
Sbjct: 64 AL-------------DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLY 110
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+I G+ YLH I+HRD+KP N+L++ ++ DFG+A++ + DES
Sbjct: 111 QILRGLK----YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 40/157 (25%), Positives = 75/157 (47%), Gaps = 13/157 (8%)
Query: 710 CLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRR--GVLAEVDVLGNV 766
+ + K LG+G+ G V A ++ + A+K L + K+ + R + V AE D+L
Sbjct: 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTL--RKKDVLLRNQVAHVKAERDILAEA 58
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
+ +VRL +++ + +Y+P G++ LL +A + +A+
Sbjct: 59 DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY--------IAEL 110
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
C + +HRD+KP NIL+D + ++ DFG+
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-06
Identities = 53/180 (29%), Positives = 79/180 (43%), Gaps = 24/180 (13%)
Query: 717 ILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL- 774
I+G GS G VY+A + E +A+KK+ + R E+ ++ N+ H NI+ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFLK 125
Query: 775 ----LGCCSNRECTMLL---YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
C E + L E++P + H L V Y L + +
Sbjct: 126 DYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL--CRAL 183
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEA-RVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
Y+H I HRDLKP N+L+D ++ DFG AK L+ S+S I + Y AP
Sbjct: 184 AYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-YRAP 239
|
Length = 440 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 23/188 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+++G GS G V A + GE +A+KK+ E++ +L E+ +L +RH +IV +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 775 LGCC---SNREC--TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL-GVAQGIC 828
S RE +++E M + DL ++L + ++ L + + +
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMES----DLHQVIKANDDLTPE---HHQFFLYQLLRALK 117
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY----GYIA 884
Y+H + HRDLKP NIL + + + ++ DFG+A++ +D ++ Y Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 885 PGTFCFCF 892
P C F
Sbjct: 175 P-ELCGSF 181
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 7/108 (6%)
Query: 757 LAEVDVLGNVRHRNIVRLLGCCS-NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVT 815
L E +L + H+NI+ +L C + E +LY YM GNL L GE ++
Sbjct: 56 LQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 816 RYKI---ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860
++ A+ +A G+ YLH ++H+D+ N ++D E++ ++ D
Sbjct: 116 TQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 39/186 (20%)
Query: 717 ILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+LG GS G V AE G E+ A+K I ++ V+ + DV + + ++ L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIK---------ILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 776 ----------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
C + + EY+ G+L + H + G+ V A ++
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQAVF---YAAEISV 112
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM------SVIAGS 879
G+ +LH I++RDLK N++LD E ++ADFG+ K E M G+
Sbjct: 113 GLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRTFCGT 164
Query: 880 YGYIAP 885
YIAP
Sbjct: 165 PDYIAP 170
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 46/179 (25%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 716 KILGMGSTGTV---YKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K +G G+ G V Y A + +A+KKL + +R E+ ++ V H+NI+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNII 79
Query: 773 RLLGCCSNREC------TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
LL + ++ L+ E M + NL ++ + E +++ + Q
Sbjct: 80 SLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHE----------RMSYLLYQM 128
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+C + H I+HRDLKPSNI++ + ++ DFG+A+ + M+ + Y AP
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 15/154 (9%)
Query: 714 SDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGK---HKENIRRRRGVLAEVDVLGNVRHR 769
S K++G G+ G V + G I A+K L KE + R AE D+L
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR---AERDILVEADGA 61
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
+V++ ++ L+ E++P G++ LL K+ +++ T++ IA V I
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT----LSEEATQFYIAETVL-AIDA 116
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
+H +HRD+KP N+LLD + +++DFG+
Sbjct: 117 IHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 51/175 (29%), Positives = 76/175 (43%), Gaps = 16/175 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
K+LG G+ G V E G A+K L KE I + V + E VL N RH +
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKIL---RKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + + EY G L H E + + R+ A + + YLH
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGEL--FFHLSR--ERVFTEERARFYGA-EIVSALEYLH 112
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SMSVIAGSYGYIAP 885
+V+RD+K N++LD + ++ DFG+ K SD +M G+ Y+AP
Sbjct: 113 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 164
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 52/175 (29%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
K+LG G+ G V E G A+K L KE I + V L E VL N RH +
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHTLTENRVLQNSRHPFL 57
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + + EY G L H E + ++ R+ A + + YLH
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSR--ERVFSEDRARFYGA-EIVSALDYLH 112
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
+ + +V+RDLK N++LD + ++ DFG+ K I+ +M G+ Y+AP
Sbjct: 113 SEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 165
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 23/62 (37%), Positives = 37/62 (59%), Gaps = 1/62 (1%)
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYI 883
+ I L H + +V+RDLKP+NILLD R++D G+A + + + G++GY+
Sbjct: 104 TEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYM 162
Query: 884 AP 885
AP
Sbjct: 163 AP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 43/184 (23%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 718 LGMGSTGTVYKAEM----PG--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
LG G VYK + PG + +A+K L K K R E + ++H NI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL--KDKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL--------------VADWVTRY 817
V LLG + + +++ Y + +L + L ++ ++ AD+V
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV--- 127
Query: 818 KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
I +A G+ +L HH +VH+DL N+L+ ++ +++D G+ + + + + +
Sbjct: 128 HIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 876 IAGS 879
+ S
Sbjct: 183 MGNS 186
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 50/168 (29%), Positives = 77/168 (45%), Gaps = 28/168 (16%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV---RL 774
+G G+ G VYKA+ G+ K+ K E E+ +L ++H N++ ++
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKV 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLH---------AKNKGENLVADWVTRYKIALGVAQ 825
S+R+ LL++Y + DL H A K L V + +
Sbjct: 67 FLSHSDRK-VWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVK--SLLYQILD 119
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEAR----VADFGVAKLIQS 869
GI YLH + ++HRDLKP+NIL+ GE R +AD G A+L S
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 50/189 (26%), Positives = 83/189 (43%), Gaps = 29/189 (15%)
Query: 715 DKILGMGSTGTV-YKAEMPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
++LG G+TGTV + GE AVK + G + + R + EV L N +I
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQA---EVCCLLNCDFFSI 93
Query: 772 VRLLGCC---------SNRECTM---LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI 819
V+ C N E + L+ +Y G+L + ++ K + ++
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFRE----HEA 145
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ---SDESMSVI 876
L Q + +HH ++HRD+K +NILL ++ DFG +K+ SD+
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 877 AGSYGYIAP 885
G+ Y+AP
Sbjct: 206 CGTPYYVAP 214
|
Length = 496 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-05
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 20/161 (12%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV--LAEVDVLGNVR-HRN 770
KI G G+ V KA G+ A+K + K++ + V L E+ L + H N
Sbjct: 5 GKI-GEGTFSEVLKAQSRKTGKYYAIKCM----KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 771 IVRLLGCCSNRE--CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
I+RL+ +R+ L++E M + NL +L+ K + L V Y + Q +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELM-DMNLYELI--KGRKRPLPEKRVKSY-----MYQLLK 111
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
L H I HRD+KP NIL+ + ++ADFG + I S
Sbjct: 112 SLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYS 151
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 40/132 (30%), Positives = 65/132 (49%), Gaps = 14/132 (10%)
Query: 738 AVKKLWGKHKENIRRR---RGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794
A+KK+ +K+N+ R + V E D+L + +V + + ++ EY+ G
Sbjct: 30 AMKKI---NKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG 86
Query: 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM 854
+ LL KN G L D Y +A + YLH + IVHRDLKP N+L+
Sbjct: 87 DCATLL--KNIGA-LPVDMARMYFAETVLA--LEYLH---NYGIVHRDLKPDNLLITSMG 138
Query: 855 EARVADFGVAKL 866
++ DFG++K+
Sbjct: 139 HIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 3e-05
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 10/170 (5%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G V + + I A+K + H + LAE VL V IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
+ E L+ ++ G L H + +G + A+ +C L +
Sbjct: 61 SFQSPEKLYLVLAFINGGEL--FHHLQREGR------FDLSRARFYTAELLCALENLHKF 112
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
+++RDLKP NILLD + + DFG+ KL ++ D+ + G+ Y+AP
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAP 162
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 26/63 (41%), Positives = 38/63 (60%), Gaps = 3/63 (4%)
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDESMSVIAGSYGY 882
A+ I L H + +V+RDLKP+NILLD R++D G+A + SV G++GY
Sbjct: 104 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--GTHGY 161
Query: 883 IAP 885
+AP
Sbjct: 162 MAP 164
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 32/121 (26%), Positives = 59/121 (48%), Gaps = 16/121 (13%)
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQG 826
+ N ++L + + +L+ +Y+ +G+L DLL + K E V KI + +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK------KIIRQLVEA 121
Query: 827 ICYLH-HDCDPVIVHRDLKPSNILLDGEME-ARVADFGVAKLIQSDESMSVIAGSYGYIA 884
+ LH H+ I+H D+K N+L D + + D+G+ K+I + S G+ Y +
Sbjct: 122 LNDLHKHN----IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFS 174
Query: 885 P 885
P
Sbjct: 175 P 175
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 4e-05
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 15/155 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRR--RGVLAEVDVLGNVRHRNIV 772
K + G+ G VY + ++ AVK + K + I + V AE D L + IV
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVV--KKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH 831
L + L+ EY+ G++ LLH E + +++ +AL YLH
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLH 121
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866
I+HRDLKP N+L+ E ++ DFG++K+
Sbjct: 122 RHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 30/104 (28%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 786 LLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDL 843
L+ EY P G+L LL + E++ ++ +A+ + Y VHRD+
Sbjct: 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGY---------VHRDI 128
Query: 844 KPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
KP N+L+D ++ADFG A + +++ + + G+ YIAP
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-05
Identities = 24/59 (40%), Positives = 33/59 (55%), Gaps = 2/59 (3%)
Query: 510 SIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
++ ++L NN L IP L +L+LS N+LT I P SGLPS+ +DLS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58
|
Length = 60 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 49/168 (29%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777
+G G+ G VYKA+ G+ + K E E+ +L ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGK--DDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKV 66
Query: 778 C---SNRECTMLLYEYMPNGNLDDLLH---------AKNKGENLVADWVTRYKIALGVAQ 825
++R+ LL++Y + DL H A K L V + +
Sbjct: 67 FLSHADRK-VWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVK--SLLYQILD 119
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEAR----VADFGVAKLIQS 869
GI YLH + ++HRDLKP+NIL+ GE R +AD G A+L S
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 9e-05
Identities = 32/115 (27%), Positives = 51/115 (44%), Gaps = 10/115 (8%)
Query: 759 EVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK 818
E+D+L + HR I+ L+ + ++ MP D + G + +T
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAIT--- 189
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA-KLIQSDES 872
I + + + YLH I+HRD+K NI LD A + DFG A KL ++
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
|
Length = 392 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 34/119 (28%), Positives = 56/119 (47%), Gaps = 9/119 (7%)
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H +V L C + EY+ G DL+ + L + Y + +A +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGG---DLMFHMQRQRKLPEEHARFYSAEISLA--L 109
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
YLH + I++RDLK N+LLD E ++ D+G+ K ++ ++ S G+ YIAP
Sbjct: 110 NYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 45/162 (27%), Positives = 76/162 (46%), Gaps = 16/162 (9%)
Query: 716 KILGMGSTGTVYKA---EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNI 771
K LG G+ G V A E E +A+KK+ + I +R L E+ +L + R H+NI
Sbjct: 6 KELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNI 64
Query: 772 VRLLG---CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L + LYE + +L ++ + G+ L T + Q +C
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEADLHQIIRS---GQPL-----TDAHFQSFIYQILC 116
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
L + ++HRDLKP N+L++ + E ++ DFG+A+ +
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K++G G+ G V + G+I A+K L + V AE DVL +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ + L+ E++P G+L +L K + D VTR+ +A V I +H
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTML---IKYDTFSED-VTRFYMAECVL-AIEAVHK-- 119
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+HRD+KP NIL+D +++DFG++
Sbjct: 120 -LGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 716 KILGMGSTGTV---YKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K +G G+ G V Y A + +A+KKL + +R E+ ++ V H+NI+
Sbjct: 30 KPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRA-YRELVLMKCVNHKNII 86
Query: 773 RLLGCCSNREC------TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
LL + ++ ++ E M + NL ++ + E +++ + Q
Sbjct: 87 GLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHE----------RMSYLLYQM 135
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+C + H I+HRDLKPSNI++ + ++ DFG+A+ + M+ + Y AP
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 30/99 (30%), Positives = 49/99 (49%), Gaps = 10/99 (10%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K+LG G+ G V +A G +AVK L K + +++E+ +L ++ H
Sbjct: 13 KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKML--KEGATASEHKALMSELKILIHIGNH 70
Query: 769 RNIVRLLGCCSNRECT-MLLYEYMPNGNLDDLLHAKNKG 806
N+V LLG C+ M++ E+ GNL + L AK +
Sbjct: 71 LNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREF 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 52/184 (28%), Positives = 78/184 (42%), Gaps = 28/184 (15%)
Query: 716 KILGMGSTGTVYKAEMPGG----EIIAVKKLW-------GKHKENIRRRRGVLAEVDVLG 764
K+LG G+ G V+ G ++ A+K L K E+ R R VL
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE------ 59
Query: 765 NVRHRNIVRLLGCCSNRECTM-LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
+VR + L E + L+ +Y+ G + L+ + +N D V Y
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR---DNFSEDEVRFY-----S 111
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK--LIQSDESMSVIAGSYG 881
+ I L H IV+RD+K NILLD E + DFG++K L + E G+
Sbjct: 112 GEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 882 YIAP 885
Y+AP
Sbjct: 172 YMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 58/212 (27%), Positives = 88/212 (41%), Gaps = 9/212 (4%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
+P + L++L +L+LS N L P I L+ L +D+S+NS +S L+ L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKNLS 235
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+N LP L++L+ L+L + S +L++LR LDL+GNSL+ +
Sbjct: 236 GLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRELDLSGNSLSNA 292
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273
LP LL LE + N L +E L +I N + P +S L L
Sbjct: 293 LPLIALLLLLLELLL---NLLLTLKALELKLNSILLNNNIL-SNGETSSPEALSILESLN 348
Query: 274 MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305
L N Y + L D
Sbjct: 349 NLWTLDNALDESNLNRYIVKNPNAIGSLLDLV 380
|
Length = 394 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 28/184 (15%)
Query: 716 KILGMGSTGTVYKA-EMPG---GEIIAVKKLW-------GKHKENIRRRRGVLAEVDVLG 764
K+LG G+ G V+ ++ G G++ A+K L K E+ R R VL
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTER------QVLE 59
Query: 765 NVRHRNIVRLLGCCSNRECTM-LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
++R + L + + L+ +Y+ G L L + + ++ +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER--------FKEQEVQIYS 111
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV--IAGSYG 881
+ + L H I++RD+K NILLD + DFG++K DE G+
Sbjct: 112 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 882 YIAP 885
Y+AP
Sbjct: 172 YMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 20/178 (11%)
Query: 718 LGMGSTGTVYK-AEMPGGEIIAVKKLWGKHKENIRR-RRGVLAEVDVLGNV-RHRNIVRL 774
+G G+ G VYK G + AVK L + I + AE ++L ++ H N+V+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKIL-----DPISDVDEEIEAEYNILQSLPNHPNVVKF 84
Query: 775 LGC------CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
G + ++L E G++ +L+ + + + Y I G G+
Sbjct: 85 YGMFYKADKLVGGQLWLVL-ELCNGGSVTELVKGLLICGQRLDEAMISY-ILYGALLGLQ 142
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
+LH++ I+HRD+K +NILL E ++ DFGV A+L + + G+ ++AP
Sbjct: 143 HLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 197
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 9/116 (7%)
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+V L C L+ EY+ G DL+ + L + Y + +A + +L
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGG---DLMFHMQRQRKLPEEHARFYAAEICIA--LNFL 112
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
H + I++RDLK N+LLD + ++ D+G+ K + ++ S G+ YIAP
Sbjct: 113 H---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 7e-04
Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 14/174 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVL--AEVDVLGNVRHRNIVR 773
K++G G+ G V + + KL K E I+R E D++ + IV+
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-EMIKRSDSAFFWEERDIMAHANSEWIVQ 107
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L + + ++ EYMP G+L +L+ + E + +AL + +
Sbjct: 108 LHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGF---- 163
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIAP 885
+HRD+KP N+LLD ++ADFG + ++ + G+ YI+P
Sbjct: 164 -----IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISP 212
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 39/169 (23%), Positives = 65/169 (38%), Gaps = 30/169 (17%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIA---VKKLWGKHKE---NIRRRRGVLAEVDVLGNVRHR 769
++ G+ +Y + G + + K + +H E +RR R E +L
Sbjct: 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRY-RHPELDEKLRRERTRR-EARIL------ 53
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVAD-WVTRYKIALGVAQGIC 828
R G ++Y+ P+ L ++ +GE L R + V + +
Sbjct: 54 AKAREAGVP-----VPIVYDVDPDNGL--IVMEYIEGELLKDALEEARPDLLREVGRLVG 106
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSV 875
LH IVH DL SNI+L G R+ DFG+ + E +V
Sbjct: 107 KLHKAG---IVHGDLTTSNIILSGG---RIYFIDFGLGEFSDEVEDKAV 149
|
Length = 204 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-04
Identities = 57/281 (20%), Positives = 93/281 (33%), Gaps = 67/281 (23%)
Query: 75 PKSSQITSLDLSRRSLSGP----IPPEIRYLTSLTHLNLSAN-------AFDGPLQPAIL 123
PK + L L +L + +R SL L LS N LQ +
Sbjct: 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQ-GLT 78
Query: 124 ELTKLRTIDISHNSFNSTFPPGISKLR---FLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180
+ L+ +D+S N+ + L L+ +N G L + L+ L
Sbjct: 79 KGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGL-GDRGLRLLA-KGLKDLP 136
Query: 181 LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLL----TQLERIEIGYNNLQG 236
+L L L N L G+ L L+ + + N +
Sbjct: 137 P-----------------ALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179
Query: 237 E----VPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGN 292
+ + NL+ +D++ L+ + L L +
Sbjct: 180 AGIRALAEGLKANCNLEVLDLNNNGLTDE------GASALAETLA--------------S 219
Query: 293 LQALQVLDLSDNQLSGPIPASLAS-----LKGLTRLSLMNN 328
L++L+VL+L DN L+ A+LAS L LSL N
Sbjct: 220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCN 260
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 21/61 (34%), Positives = 34/61 (55%), Gaps = 2/61 (3%)
Query: 199 SLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+L+ LDL+ N LT +P L L+ +++ NNL P F+ L +L+ +D+S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 258 L 258
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.001
Identities = 32/139 (23%), Positives = 57/139 (41%), Gaps = 12/139 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKK--LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
K + K + P ++AVKK L KE+++ + E+ ++H NI+
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKL---LQQEIITSRQLQHPNILP 63
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+ ++ M G+ +DLL K + + + I V + Y+H
Sbjct: 64 YVTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAF-ILKDVLNALDYIHSK 120
Query: 834 CDPVIVHRDLKPSNILLDG 852
+HR +K S+ILL G
Sbjct: 121 G---FIHRSVKASHILLSG 136
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 37/152 (24%), Positives = 71/152 (46%), Gaps = 15/152 (9%)
Query: 718 LGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G G V +E+ G + VK+L K + + + L + D ++H NI++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL--KANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGICYLH- 831
LG C +L++EY G+L L ++ + + ++A +A G+ ++H
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN---SQLLLLQRMACEIAAGVTHMHK 117
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863
H+ +H DL N L ++ +V D+G+
Sbjct: 118 HN----FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.001
Identities = 42/163 (25%), Positives = 71/163 (43%), Gaps = 34/163 (20%)
Query: 751 RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML--LYEYMPNGNLDDLLHAKNK--- 805
R + ++ EV+V+ ++H+NIVR + N+ L L E+ G+L + K
Sbjct: 54 REKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFG 113
Query: 806 --GENLVADWVTRYKIALGVAQGICYLHHDCD----PVIVHRDLKPSNIL---------- 849
E+ + D +TR + + Y H+ D ++HRDLKP NI
Sbjct: 114 KIEEHAIVD-ITRQ-----LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167
Query: 850 -------LDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
L+G A++ DFG++K I + G+ Y +P
Sbjct: 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSP 210
|
Length = 1021 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 19/50 (38%), Positives = 29/50 (58%), Gaps = 2/50 (4%)
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV--IAGSYGYIAP 885
I++RD+K NILLD E + DFG++K ++E G+ Y+AP
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 29/99 (29%), Positives = 47/99 (47%), Gaps = 10/99 (10%)
Query: 716 KILGMGSTGTVYKA------EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K LG G+ G V +A + +AVK L K + ++ E+ +L ++ H
Sbjct: 13 KPLGRGAFGKVIQASAFGIEKSASCRTVAVKML--KEGATASEYKALMTELKILIHIGHH 70
Query: 769 RNIVRLLGCCSNRECT-MLLYEYMPNGNLDDLLHAKNKG 806
N+V LLG C+ M++ EY GNL + L +K +
Sbjct: 71 LNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKREC 109
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 9/119 (7%)
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H +V L C + E++ G DL+ + L + Y + +A +
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGG---DLMFHMQRQRKLPEEHARFYSAEISLA--L 109
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYGYIAP 885
+LH + I++RDLK N+LLD E ++ D+G+ K I+ ++ S G+ YIAP
Sbjct: 110 NFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAP 165
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 20/178 (11%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVR-HRNIVR 773
+G G+ G V+K G AVK L H E I AE ++L + H N+V+
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE------AEYNILKALSDHPNVVK 79
Query: 774 LLGC-----CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
G N + L+ E G++ DL+ KG + + IA + + +
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV----KGFLKRGERMEEPIIAYILHEALM 135
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDESMSVIAGSYGYIAP 885
L H +HRD+K +NILL E ++ DFGV A+L + + G+ ++AP
Sbjct: 136 GLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAP 193
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 271 KLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVL 330
L+ L L N T ++ L L+VLDLS N L+ P + + L L L L N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 13/97 (13%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVL---GNV 766
K LG G+ G V +A G +AVK L K ++ R +++E+ VL GN
Sbjct: 41 KTLGAGAFGKVVEATAYGLFKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGN- 97
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAK 803
H NIV LLG C+ T+++ EY G+L + L K
Sbjct: 98 -HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.003
Identities = 31/149 (20%), Positives = 57/149 (38%), Gaps = 20/149 (13%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV--R 773
K+L G T VY + + K + + EV +L + + + +
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYVL------KINPSREKGADREREVAILQLLARKGLPVPK 57
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+L + + LL E++ LD++ + + IA +A+ + LH
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEVSEEEKE------------DIAEQLAELLAKLHQL 105
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFG 862
V+ H DL P NIL+D + D+
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 11/102 (10%)
Query: 716 KILGMGSTGTVYKAEMPG-GE-----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K LG G+ G V +A G G+ +AVK L K + R +++E+ +L ++ +H
Sbjct: 44 KTLGAGAFGKVVEATAFGLGKEDNVLRVAVKML--KASAHTDEREALMSELKILSHLGQH 101
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLV 810
+NIV LLG C++ +++ EY G+L + L + K E +
Sbjct: 102 KNIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RKKAETFL 141
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 25/166 (15%)
Query: 715 DKILGMGSTGTVYKAEMPGGEII---AVKKLWGKHKENIRRRRGV---LAEVDVLG---- 764
DK++G G G VY+ + I AV K+ E I V + ++D +
Sbjct: 17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKN 76
Query: 765 --NVRHRNIVRLLGCCSNRECTM----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK 818
N+ H I + GC S + C M +L E + + K K + L+ +
Sbjct: 77 IHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKN------ 130
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
I + + Y+H + I H D+KP NI++DG + D+G+A
Sbjct: 131 IMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.98 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.97 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.96 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.95 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.95 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.95 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.95 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.95 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.94 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.94 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.94 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.94 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.94 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.94 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.94 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.94 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.93 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.93 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.93 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.93 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.93 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.93 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.93 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.93 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.93 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.93 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.93 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.93 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.93 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.93 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.93 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.93 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.93 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.93 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.93 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.92 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.92 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.92 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.92 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.92 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.92 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.92 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.92 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.92 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.92 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.92 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.92 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.91 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.91 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.91 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.91 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.91 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.91 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.91 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.91 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.91 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.91 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.91 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.9 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.9 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.9 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.9 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.9 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.9 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.9 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.9 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.9 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.9 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.9 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.9 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.9 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.9 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.9 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.89 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.89 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.89 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.89 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.89 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.89 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.89 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.89 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.89 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.89 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.89 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.89 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.89 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.89 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.89 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.89 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.89 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.89 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.89 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.89 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.89 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.89 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.89 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.88 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.88 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.88 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.88 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.88 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.88 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.88 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.88 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.88 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.88 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.88 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.88 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.88 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.88 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.88 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.88 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.88 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.88 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.88 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.88 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.87 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.87 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.87 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.87 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.87 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.87 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.87 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.87 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.87 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.87 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.87 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.87 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.87 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.87 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.87 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.87 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.87 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.87 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.86 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.86 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.86 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.86 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.86 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.86 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.86 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.86 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.86 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.86 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.85 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.85 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.85 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.85 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.85 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.85 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.85 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.85 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.85 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.85 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.85 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.85 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.85 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.85 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.85 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.85 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.85 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.85 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.84 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.84 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.84 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.84 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.84 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.84 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.84 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.84 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.83 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.83 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.83 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.83 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.82 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.82 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.82 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.82 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.82 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.81 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.81 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.8 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.8 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.79 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.79 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.78 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.77 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.76 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.76 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.71 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.7 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.65 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.53 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.52 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.49 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.48 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.47 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.42 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.39 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.16 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.13 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.11 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.1 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.07 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.04 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.02 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.99 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.97 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.94 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.93 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.9 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.83 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.73 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.73 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.72 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.71 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.54 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.53 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.43 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.37 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.34 | |
| KOG2120 | 419 | consensus SCF ubiquitin ligase, Skp2 component [Po | 98.3 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.29 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.24 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-109 Score=1044.50 Aligned_cols=823 Identities=35% Similarity=0.617 Sum_probs=713.1
Q ss_pred cCCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecCCCCCEEEEEcCCCCcccccCcccc
Q 043136 20 ANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIR 99 (902)
Q Consensus 20 ~~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~ 99 (902)
+...++|++||++||+++.+|.+ .+.+|+.. + +||.|.||+|+.. ++|+.|+|++++++|.+++.+.
T Consensus 24 ~~~~~~~~~~l~~~~~~~~~~~~-~~~~w~~~------~-----~~c~w~gv~c~~~-~~v~~L~L~~~~i~~~~~~~~~ 90 (968)
T PLN00113 24 SMLHAEELELLLSFKSSINDPLK-YLSNWNSS------A-----DVCLWQGITCNNS-SRVVSIDLSGKNISGKISSAIF 90 (968)
T ss_pred cCCCHHHHHHHHHHHHhCCCCcc-cCCCCCCC------C-----CCCcCcceecCCC-CcEEEEEecCCCccccCChHHh
Confidence 33378999999999999987766 78999754 2 3999999999864 4999999999999999999999
Q ss_pred CCCCCCEEEccCCCCcccCchhhh-ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 100 YLTSLTHLNLSANAFDGPLQPAIL-ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 100 ~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
.+++|++|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..++.+++|++
T Consensus 91 ~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 168 (968)
T PLN00113 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168 (968)
T ss_pred CCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCE
Confidence 999999999999999999998766 999999999999999998886 56899999999999999999999999999999
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++.+++|++|+|++|++++.+|..|+++++|++|+|++|++
T Consensus 169 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l 248 (968)
T PLN00113 169 LDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNL 248 (968)
T ss_pred EECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCcee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhh
Q 043136 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI 338 (902)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 338 (902)
++.+|..+.++++|++|+|++|++.+.+|..+.++++|++|+|++|.+++.+|..+.++++|+.|++++|.+.+.+|..+
T Consensus 249 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~ 328 (968)
T PLN00113 249 TGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVAL 328 (968)
T ss_pred ccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcE
Q 043136 339 ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSR 418 (902)
Q Consensus 339 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 418 (902)
..+++|+.|++++|.+++.+|..++.+.+|+.|++++|++++.+|..++.+.+++.|++++|++.+.+|..+..+++|+.
T Consensus 329 ~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~ 408 (968)
T PLN00113 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408 (968)
T ss_pred hcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCcc
Q 043136 419 LRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKL 498 (902)
Q Consensus 419 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 498 (902)
|++++|++++.+|..|..+++|+.|++++|++++.+|..+..+++|+.|+|++|++.+.+|..+ ..++|+.|++++|++
T Consensus 409 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l 487 (968)
T PLN00113 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQF 487 (968)
T ss_pred EECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCcc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 458999999999999
Q ss_pred CCCcccccc-cccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCC
Q 043136 499 TGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNF 577 (902)
Q Consensus 499 ~~~~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~ 577 (902)
++.+|..++ +++|+.|+|++|++.+.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+
T Consensus 488 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 567 (968)
T PLN00113 488 SGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNL 567 (968)
T ss_pred CCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhH
Confidence 999998665 8999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccceeecccCCcccccCCCCCCcCcCCCCCcccCCcccCCCCc---CCCCCCCCCCCCccccccCCCCCccccccee
Q 043136 578 ENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVL---TKPCPADGLAAGDVEVRNHQQQPKKTAGAIV 654 (902)
Q Consensus 578 ~~l~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~gn~~lcg~~~---~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~v 654 (902)
.++++|+.|++++|+++|.+|..+++.++ .+++|.||+++||.+. ..+|... .. ......++
T Consensus 568 ~~l~~L~~l~ls~N~l~~~~p~~~~~~~~-~~~~~~~n~~lc~~~~~~~~~~c~~~------------~~--~~~~~~~~ 632 (968)
T PLN00113 568 GNVESLVQVNISHNHLHGSLPSTGAFLAI-NASAVAGNIDLCGGDTTSGLPPCKRV------------RK--TPSWWFYI 632 (968)
T ss_pred hcCcccCEEeccCCcceeeCCCcchhccc-ChhhhcCCccccCCccccCCCCCccc------------cc--cceeeeeh
Confidence 99999999999999999999999888775 8899999999998652 2234210 00 00111111
Q ss_pred eeehhhhhhheeeeecceeeeeeccccC-cCCCccCCCccccccc---ccCCCHHHHHHHhccCCcEeeecCceEEEEEE
Q 043136 655 WIMAAAFGIGLFVLVAGTRCFRANYSRG-FSNDREIGPWKLTAFQ---RLNFTADDVLECLSMSDKILGMGSTGTVYKAE 730 (902)
Q Consensus 655 ~i~~~~~~i~l~~~~~~~~~~r~~~~~~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~ 730 (902)
.++++++++++++++ +++++|+++.+. .+.+.+.+.|....+. ...++.+++.+. +..++.||+|+||.||+|+
T Consensus 633 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ig~G~~g~Vy~~~ 710 (968)
T PLN00113 633 TCTLGAFLVLALVAF-GFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSS-LKEENVISRGKKGASYKGK 710 (968)
T ss_pred hHHHHHHHHHHHHHH-HHHHHHhhhcccccccccccccccccccccccchhhhHHHHHhh-CCcccEEccCCCeeEEEEE
Confidence 111111111111111 222223222111 1111122223322222 123455666554 3456789999999999997
Q ss_pred e-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCc
Q 043136 731 M-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL 809 (902)
Q Consensus 731 ~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 809 (902)
. .+++.||||++...... ..+|++++++++|||||++++++.+.+..|+||||+++|+|.++++.
T Consensus 711 ~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------- 776 (968)
T PLN00113 711 SIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------- 776 (968)
T ss_pred ECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-------
Confidence 6 57899999988432211 12468889999999999999999999999999999999999999852
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCccc
Q 043136 810 VADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 810 ~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
.+|..+.+|+.|+|+|++|+|+.++++|+|||+||+||+++.++.+++. ||.+...... ....||+.|||||++.
T Consensus 777 -l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~ 851 (968)
T PLN00113 777 -LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRE 851 (968)
T ss_pred -CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC---CCccccccccCccccc
Confidence 6788899999999999999997766779999999999999999888876 6665443222 2236899999999987
Q ss_pred ccccC
Q 043136 890 FCFSV 894 (902)
Q Consensus 890 ~~~~~ 894 (902)
+....
T Consensus 852 ~~~~~ 856 (968)
T PLN00113 852 TKDIT 856 (968)
T ss_pred CCCCC
Confidence 65433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-67 Score=664.91 Aligned_cols=519 Identities=36% Similarity=0.578 Sum_probs=498.3
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccc-cccccceeccccccccCCCchhhhcccCCcEEe
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGIS-KLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 180 (902)
.+++.|+|++|.++|.++..|..+++|++|+|++|++++.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4789999999999999999999999999999999999999998865 999999999999999998886 5689999999
Q ss_pred ccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcc
Q 043136 181 LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG 260 (902)
Q Consensus 181 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 260 (902)
|++|.+++.+|..++++++|++|+|++|.+++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSG 226 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhh
Q 043136 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL 340 (902)
Q Consensus 261 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 340 (902)
.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..+.++++|+.|++++|.+.+.+|..+..
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~ 306 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEE
Q 043136 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420 (902)
Q Consensus 341 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 420 (902)
+++|+.|++++|.+++..|..+..+++|+.|++++|++++.+|..++.+.+|+.|++++|++.+.+|..+..+++|+.|+
T Consensus 307 l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~ 386 (968)
T PLN00113 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLI 386 (968)
T ss_pred CCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCC
Q 043136 421 IQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG 500 (902)
Q Consensus 421 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 500 (902)
+++|++++.+|..++.+++|+.|+|++|++++.+|..|.+++.|+.|++++|++++.+|..++.+++|+.|++++|++.+
T Consensus 387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~ 466 (968)
T PLN00113 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466 (968)
T ss_pred CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCC
Q 043136 501 KIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENC 580 (902)
Q Consensus 501 ~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l 580 (902)
.+|...+..+|+.|||++|++++.+|..++.+++|+.|+|++|+++|.+|..++++++|++|+|++|.++|.+|..|.++
T Consensus 467 ~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 546 (968)
T PLN00113 467 GLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEM 546 (968)
T ss_pred ecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCc
Confidence 99998888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccceeecccCCcccccCCCCCCcCcCCCCCcccCCcccCCCC
Q 043136 581 STLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRV 622 (902)
Q Consensus 581 ~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~gn~~lcg~~ 622 (902)
++|+.|+|++|+++|.+|......+.+......+|+..+.-|
T Consensus 547 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p 588 (968)
T PLN00113 547 PVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLP 588 (968)
T ss_pred ccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCC
Confidence 999999999999999999876666666666777887554333
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=380.48 Aligned_cols=474 Identities=28% Similarity=0.379 Sum_probs=288.9
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccc
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAY 158 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 158 (902)
.++.|++++|.+. .+.+.+.++..|..|++++|++. ..|++++.+.+++.|+.|+|+++ .+|+.++.+.+|+.|+.+
T Consensus 46 ~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s 122 (565)
T KOG0472|consen 46 DLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCS 122 (565)
T ss_pred chhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcc
Confidence 3455666666665 34445566666666666666665 35556666666666666666654 355555555555555555
Q ss_pred cccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC
Q 043136 159 SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV 238 (902)
Q Consensus 159 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 238 (902)
+|.+. .+|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|+++ ...
T Consensus 123 ~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~------------------------~l~ 176 (565)
T KOG0472|consen 123 SNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLK------------------------ALP 176 (565)
T ss_pred cccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchh------------------------hCC
Confidence 55554 23444555555555555555554 34444444555555555555555 322
Q ss_pred ChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCcccc-cc
Q 043136 239 PVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA-SL 317 (902)
Q Consensus 239 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~-~l 317 (902)
|..+. ++.|++||..+|-++ .+|..++.+.+|+-|+|.+|+|. ..| +|.++..|.+|+++.|+|+ .+|+... ++
T Consensus 177 ~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L 251 (565)
T KOG0472|consen 177 ENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHL 251 (565)
T ss_pred HHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhccc
Confidence 22222 444444444444444 44444444444444444444444 333 4444444555555555444 2333222 44
Q ss_pred CCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCC--CccEE
Q 043136 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD--RLFKL 395 (902)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~--~L~~L 395 (902)
+++..|||..|++. +.|..+..+.+|++||+|+|.|+ ..|..++++ .|+.|-+.+|.+...--+.+...+ -|++|
T Consensus 252 ~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyL 328 (565)
T KOG0472|consen 252 NSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYL 328 (565)
T ss_pred ccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHH
Confidence 44555555555543 34444444555555555555554 234444444 455555555544311000000000 00110
Q ss_pred e-------ccCC----cCccc-ccc---cccccCCCcEEEccCCccCCCCCcccCCCCC---CcEEEccCcccCCCCCCc
Q 043136 396 I-------LFSN----NFTYS-IPE---NLVNCSSLSRLRIQDNQLNGSIPQGFGLLPN---LTFMDMSRNSLSGEIPRD 457 (902)
Q Consensus 396 ~-------l~~N----~l~~~-~p~---~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~ 457 (902)
. ++.- .-.+. .+. ....+.+.+.|+++.-+++ .+|+....... .+..+++.|++. ++|..
T Consensus 329 rs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~ 406 (565)
T KOG0472|consen 329 RSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKR 406 (565)
T ss_pred HHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhh
Confidence 0 0000 00001 111 2234567899999999998 67776544444 789999999998 78988
Q ss_pred CcccCcCce-ecccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccce
Q 043136 458 LGNAQKLEY-LNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLL 536 (902)
Q Consensus 458 ~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~ 536 (902)
+..+..+.. +.+++|.+ +.+|..++.+++|..|+|++|-+...+-++.++..|+.||+|.|+|. .+|..+-.+..|+
T Consensus 407 L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE 484 (565)
T KOG0472|consen 407 LVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE 484 (565)
T ss_pred hHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccc-cchHHHhhHHHHH
Confidence 888877764 55565655 68999999999999999999988754444555888999999999996 8998888888899
Q ss_pred EEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCccc
Q 043136 537 LLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594 (902)
Q Consensus 537 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~ 594 (902)
.+--++|++..+.|+.+++|.+|.+|||.+|.+. .||+.+++|++|++|++++|++.
T Consensus 485 tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 485 TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 9888999999888888999999999999999998 89999999999999999999998
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=384.32 Aligned_cols=449 Identities=29% Similarity=0.450 Sum_probs=324.9
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccc
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAY 158 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 158 (902)
-++.|++++|+++ ..|++++.+..++.|+.|+|+++ .+|++++.+.+|+.|+.++|.+. .+|+.++.+..|+.|+..
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~ 145 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDAT 145 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcc
Confidence 4788999999998 78999999999999999999998 68999999999999999999998 578899999999999999
Q ss_pred cccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC
Q 043136 159 SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV 238 (902)
Q Consensus 159 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 238 (902)
+|+++ ..|..+..+.+|..|++.+|++....|..+. ++.|++||+..|-++ .+|+.++.+.+|+.|||..|+|. ..
T Consensus 146 ~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~l 221 (565)
T KOG0472|consen 146 NNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FL 221 (565)
T ss_pred ccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cC
Confidence 99998 5688899999999999999999965555554 999999999999998 89999999999999999999999 66
Q ss_pred ChhccCCCCCCEEEccCccCcccCCcccc-CCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCcccccc
Q 043136 239 PVEFASLVNLKYMDISACNLSGTLPSEIS-NLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317 (902)
Q Consensus 239 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 317 (902)
| +|.+++.|++|+++.|+++ .+|.+.. +++++.+|||.+|+++ ..|+.+.-+.+|++||+|+|.|+ ..|.+++++
T Consensus 222 P-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl 297 (565)
T KOG0472|consen 222 P-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL 297 (565)
T ss_pred C-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccc
Confidence 7 8999999999999999999 6676554 9999999999999999 88999999999999999999999 578889999
Q ss_pred CCCCEEEccCccccccCChhhh------hccccceEEecCceec---c------c-cCcc---ccCCCceeEEEecCCcc
Q 043136 318 KGLTRLSLMNNVLFGEIPQDIE------LLADLDTLLLWNNHLT---G------V-LPQK---LGSNGKLLTVDVSSNSL 378 (902)
Q Consensus 318 ~~L~~L~L~~N~l~~~~p~~~~------~l~~L~~L~L~~N~l~---~------~-~~~~---~~~~~~L~~L~Ls~N~l 378 (902)
.|+.|-+.+|.+.. +-.++- -++.|+. .+..-.++ | . .+.. .....+.+.|+++.-++
T Consensus 298 -hL~~L~leGNPlrT-iRr~ii~~gT~~vLKyLrs-~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ql 374 (565)
T KOG0472|consen 298 -HLKFLALEGNPLRT-IRREIISKGTQEVLKYLRS-KIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQL 374 (565)
T ss_pred -eeeehhhcCCchHH-HHHHHHcccHHHHHHHHHH-hhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccc
Confidence 99999999999853 222221 1222222 00000110 0 0 0111 12233556666666666
Q ss_pred cCCCCCCccCCCC---ccEEeccCCcCcccccccccccCCCc-EEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCC
Q 043136 379 TGPIPPTICDGDR---LFKLILFSNNFTYSIPENLVNCSSLS-RLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEI 454 (902)
Q Consensus 379 ~~~~p~~~~~~~~---L~~L~l~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 454 (902)
+ .+|...++..+ ....+++.|++. ++|..+..++.+. .+.+++|.++ -+|..++.+++|+.|+|++|-+. .+
T Consensus 375 t-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~L 450 (565)
T KOG0472|consen 375 T-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN-DL 450 (565)
T ss_pred c-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-hc
Confidence 6 34544444333 555666666655 4555555544432 3444444443 55556666666666666666555 45
Q ss_pred CCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCccccccCCcccccccc
Q 043136 455 PRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEK 534 (902)
Q Consensus 455 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~ 534 (902)
|..++.+..|+.||++.|+|. .+|..+..+..++.+-.++|++....|+ .++++.+
T Consensus 451 P~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~-----------------------~l~nm~n 506 (565)
T KOG0472|consen 451 PEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS-----------------------GLKNMRN 506 (565)
T ss_pred chhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH-----------------------Hhhhhhh
Confidence 666666666666666666663 4555555555555554444554433333 2555555
Q ss_pred ceEEEeeCCcceecCCCCCCCCCcccEEEccCCccc
Q 043136 535 LLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT 570 (902)
Q Consensus 535 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 570 (902)
|..|||.+|.+. .+|..+++|++|+.|+|++|.+.
T Consensus 507 L~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 507 LTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred cceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 555555555555 45555666666666666666665
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.53 Aligned_cols=365 Identities=20% Similarity=0.236 Sum_probs=211.7
Q ss_pred CCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccC
Q 043136 104 LTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG 183 (902)
Q Consensus 104 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 183 (902)
-+.||+|+|.++..-+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 355777777777666666677777777777777666 4565555555666666666666666666666666666666666
Q ss_pred ccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCC
Q 043136 184 SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLP 263 (902)
Q Consensus 184 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 263 (902)
|.|+...-..|..-.++++|+|++|.|+..-...|..+.+|..|.|+.|+|+...+..|.++++|+.|||..|+|.-.-.
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 66664444455555566666666666665555556666666666666666665555555556666666666666653324
Q ss_pred ccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccc
Q 043136 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343 (902)
Q Consensus 264 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 343 (902)
-.|.+|++|+.|.|..|.+...-...|..+.++++|+|+.|+++..-..++.+++.|+.|+||+|.|...-++.+...++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 45555666666666666655444445555566666666666665555555555555666666665555555555555555
Q ss_pred cceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccc---cccccCCCcEEE
Q 043136 344 LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPE---NLVNCSSLSRLR 420 (902)
Q Consensus 344 L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~---~l~~l~~L~~L~ 420 (902)
|+.|+|++|+|+...+..|..+..|++|+|++|+++..-...|..+.+|++|+|.+|.++..+.+ .|.++++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 55555555555555555555555555555555555543333333344444444444444433322 344555666666
Q ss_pred ccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceeccc
Q 043136 421 IQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNIS 470 (902)
Q Consensus 421 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 470 (902)
|.+|+|..+...+|.++++|+.|||.+|.|..+-|.+|..+ .|+.|.+.
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~n 447 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMN 447 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhc
Confidence 66666654334455566666666666666655555555555 55555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=366.18 Aligned_cols=368 Identities=24% Similarity=0.247 Sum_probs=332.7
Q ss_pred CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc
Q 043136 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA 206 (902)
Q Consensus 127 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 206 (902)
.-++||+|+|+++..-+..|.++++|+.+++..|.++ .+|...+...+|+.|+|.+|.|+..-.+.+.-++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3467999999999999999999999999999999998 678766677779999999999997777888999999999999
Q ss_pred CCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec
Q 043136 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 207 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
.|.|+...-++|..-.++++|+|++|+|+......|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.-
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 99999766677888889999999999999988999999999999999999999777788889999999999999998544
Q ss_pred CCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCC
Q 043136 287 PVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366 (902)
Q Consensus 287 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 366 (902)
-..|.++++|+.|.|..|.++..-.+.|..+.+++.|+|+.|++...-..++.+++.|+.|+||+|.|..+.++.+...+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 56799999999999999999988888999999999999999999988888899999999999999999999999999999
Q ss_pred ceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCc---ccCCCCCCcEE
Q 043136 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ---GFGLLPNLTFM 443 (902)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L 443 (902)
+|++||||+|+|+...+..|..+..|+.|.|+.|.+.......|..+++|+.|||++|.|++.|.+ .|..|+.|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 999999999999988888888899999999999999987778899999999999999999877654 57789999999
Q ss_pred EccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCC
Q 043136 444 DMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSS 496 (902)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 496 (902)
+|.+|+|..+.-.+|.++..||+|||.+|.|...-|.+|..+ +|+.|-+..-
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSs 449 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSS 449 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhccc
Confidence 999999997767889999999999999999988888888888 8888776543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=373.13 Aligned_cols=460 Identities=26% Similarity=0.332 Sum_probs=211.6
Q ss_pred CCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccC
Q 043136 104 LTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG 183 (902)
Q Consensus 104 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 183 (902)
|+.|||++|++. ..|..+..+.+|+.|+++.|-+. ..|.+.+++++|++|.|..|.+. ..|..+..+.+|++|++++
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 445555544443 24444444444555555554444 23344444444444444444443 3444444444444444444
Q ss_pred ccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCC
Q 043136 184 SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLP 263 (902)
Q Consensus 184 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 263 (902)
|.+. .+|..+..++.++.+..++|...... +... ++.+++..|.+.+.++..+..+.. .|||.+|.+. .
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l----g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~-- 192 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRL----GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V-- 192 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhh----cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--
Confidence 4443 44444444444444444444111111 1111 444444445544444444444433 4555555544 1
Q ss_pred ccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccc
Q 043136 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343 (902)
Q Consensus 264 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 343 (902)
..+.++.+|+.|....|++.... -.-++|+.|+.++|.++...+.. .-.+|+++++++|++++ +|++++.+.+
T Consensus 193 ~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~dis~n~l~~-lp~wi~~~~n 265 (1081)
T KOG0618|consen 193 LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYLDISHNNLSN-LPEWIGACAN 265 (1081)
T ss_pred hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc--ccccceeeecchhhhhc-chHHHHhccc
Confidence 12344445555555555444211 11244555555555554221111 12345555555555542 3355555555
Q ss_pred cceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccc-ccccCC-CcEEEc
Q 043136 344 LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSS-LSRLRI 421 (902)
Q Consensus 344 L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~-l~~l~~-L~~L~L 421 (902)
|+.+...+|+|+ .+|..+...++|+.|++.+|.+. -+|+.....++|+.|+|..|++.. .|+. +..... |..|+.
T Consensus 266 le~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~-lp~~~l~v~~~~l~~ln~ 342 (1081)
T KOG0618|consen 266 LEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPS-LPDNFLAVLNASLNTLNV 342 (1081)
T ss_pred ceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccc-cchHHHhhhhHHHHHHhh
Confidence 555555555553 44444455555555555555554 344444445555555555555542 2222 222221 444555
Q ss_pred cCCccCCCCCc-ccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCC
Q 043136 422 QDNQLNGSIPQ-GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG 500 (902)
Q Consensus 422 s~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 500 (902)
+.|.+. ..|. .=..++.|+.|+|.+|.|+...-..+.+.++|++|+|++|+|.......+.++..|+.|+||+|+|+.
T Consensus 343 s~n~l~-~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~ 421 (1081)
T KOG0618|consen 343 SSNKLS-TLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTT 421 (1081)
T ss_pred hhcccc-ccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhh
Confidence 555554 2221 11123445555555555554443445555555555555555543333344555555555555555553
Q ss_pred Cccccc-ccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcC
Q 043136 501 KIPDFI-GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFEN 579 (902)
Q Consensus 501 ~~p~~~-~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 579 (902)
+|+.+ .|..|++|...+|++. ..| ++..++.|+.+|||.|+|+...-..--.-++|++|||++|.=.-.--+.|..
T Consensus 422 -Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~~d~~~l~~ 498 (1081)
T KOG0618|consen 422 -LPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLVFDHKTLKV 498 (1081)
T ss_pred -hhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccccchhhhHH
Confidence 33322 2555555555555554 344 5555555555555555555432111111145555555555521122334444
Q ss_pred CccceeecccCC
Q 043136 580 CSTLESFNVSYN 591 (902)
Q Consensus 580 l~~L~~l~ls~N 591 (902)
++++..++++-|
T Consensus 499 l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 499 LKSLSQMDITLN 510 (1081)
T ss_pred hhhhhheecccC
Confidence 444444444444
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=344.62 Aligned_cols=395 Identities=30% Similarity=0.402 Sum_probs=224.6
Q ss_pred ccccceecccccccc-CCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEE
Q 043136 149 LRFLRIFNAYSNSFT-GPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERI 227 (902)
Q Consensus 149 l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 227 (902)
|+..+-.|+++|.|+ +..|.....+++++.|.|...++. .+|..++.+.+|++|.+++|+|+ .+-..+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGEL--------- 74 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGEL--------- 74 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhh---------
Confidence 344555666666666 345555555555555555555554 44555555555555555555554 333344
Q ss_pred EeeCcccCCCCChhccCCCCCCEEEccCccCcc-cCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCC
Q 043136 228 EIGYNNLQGEVPVEFASLVNLKYMDISACNLSG-TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306 (902)
Q Consensus 228 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 306 (902)
..++.|+.+++.+|++.. -+|..+..+..|+.||||+|++. +.|..+...+++-+|+||+|+|
T Consensus 75 ---------------s~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~I 138 (1255)
T KOG0444|consen 75 ---------------SDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNI 138 (1255)
T ss_pred ---------------ccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCcc
Confidence 444445555555554431 24445555555566666666655 5555555566666666666666
Q ss_pred ccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCccc-CCCCCC
Q 043136 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT-GPIPPT 385 (902)
Q Consensus 307 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~-~~~p~~ 385 (902)
..+....|.+++.|-+||||+|++. .+|+.+..+..|++|.|++|.+....-..+..+++|+.|.+|+.+=+ ..+|.
T Consensus 139 etIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Pt- 216 (1255)
T KOG0444|consen 139 ETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPT- 216 (1255)
T ss_pred ccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCC-
Confidence 5433345556666666666666663 55666666777777777777665444444555666666666654432 23444
Q ss_pred ccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCc
Q 043136 386 ICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLE 465 (902)
Q Consensus 386 ~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 465 (902)
++..+.+|..+|||.|.+. .+|..+.++++|+.|+||+|+|+ .+.-..+...+|+
T Consensus 217 -----------------------sld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lE 271 (1255)
T KOG0444|consen 217 -----------------------SLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLE 271 (1255)
T ss_pred -----------------------chhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhh
Confidence 4444444444444444444 44444445555555555555544 2333334444555
Q ss_pred eecccccccCCCcChhhhcccccceeccCCCccCC-Ccccccc-cccccEEeccCccccccCCccccccccceEEEeeCC
Q 043136 466 YLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG-KIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543 (902)
Q Consensus 466 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N 543 (902)
.|+||.|+++ .+|++++++++|+.|.+.+|+++- -+|..+| +.+|+.+..++|.+. ..|+.+..|.+|+.|.|++|
T Consensus 272 tLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~N 349 (1255)
T KOG0444|consen 272 TLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHN 349 (1255)
T ss_pred hhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccc
Confidence 5555555552 455555555555555555555431 1344444 445555555555554 77888888999999999999
Q ss_pred cceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCC-----cccccCCCC
Q 043136 544 SLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN-----LLTGPIPAS 600 (902)
Q Consensus 544 ~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N-----~l~g~ip~~ 600 (902)
+|. .+|+.|.-|+.|+.|||..|.=--..|.--..-++|+..|+.+- +|.|..|+.
T Consensus 350 rLi-TLPeaIHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNIDFSLq~QlrlAG~~pas 410 (1255)
T KOG0444|consen 350 RLI-TLPEAIHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNIDFSLQHQLRLAGQMPAS 410 (1255)
T ss_pred cee-echhhhhhcCCcceeeccCCcCccCCCCcchhhhcceeeecceehhhHHhhccCCccc
Confidence 988 68888999999999999988755344433333356766665542 345655543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=313.13 Aligned_cols=175 Identities=31% Similarity=0.471 Sum_probs=153.3
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||+||+|+++ ++..||||.+.++.. ..+.++-+..|+++++.++|||||+++++++..+..|+|||||
T Consensus 13 ~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 13 ELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred eehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 34456999999999999764 579999999965532 4456677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC------CCEEEeecccce
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE------MEARVADFGVAK 865 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~------~~~kl~DFGla~ 865 (902)
+||||.++++.++ .+++.+...++.|+|.|+++||+++ ||||||||+|||++.. -.+||+|||+|+
T Consensus 92 ~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 9999999998775 3777888899999999999999776 9999999999999764 458999999999
Q ss_pred eccCCCCceeeccccCccccCcccccccCce
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
...++....+.||+|.|||||+++.+.++.+
T Consensus 164 ~L~~~~~a~tlcGSplYMAPEV~~~~~YdAK 194 (429)
T KOG0595|consen 164 FLQPGSMAETLCGSPLYMAPEVIMSQQYDAK 194 (429)
T ss_pred hCCchhHHHHhhCCccccCHHHHHhccccch
Confidence 9988888888999999999999987666543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=360.04 Aligned_cols=480 Identities=27% Similarity=0.355 Sum_probs=386.9
Q ss_pred EEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccc
Q 043136 83 LDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF 162 (902)
Q Consensus 83 L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 162 (902)
+|.+...+. .||..+-.-..++.|++++|-+-...-+.+.+.-+|+.||||+|++. .+|..+..+..|+.|+++.|.|
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 445555555 57777777677889999998876443445566667999999999986 6888999999999999999988
Q ss_pred cCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhc
Q 043136 163 TGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEF 242 (902)
Q Consensus 163 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 242 (902)
. ..|....++.+|++|+|.+|++. ..|..+..+.+|++|+++.|++. .+|..+..++.++.+..++|......
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~l---- 153 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRL---- 153 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhh----
Confidence 7 56788999999999999999988 77889999999999999999998 78999999999999999999322222
Q ss_pred cCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCE
Q 043136 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTR 322 (902)
Q Consensus 243 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 322 (902)
+... ++.++|..|.+.+.++..+..++. .|+|.+|.+. . ..+.++.+|+.|....|+++... -.-++|+.
T Consensus 154 g~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~ 223 (1081)
T KOG0618|consen 154 GQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTA 223 (1081)
T ss_pred cccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhhccchhhhhhhhcccceEE----ecCcchhe
Confidence 2222 888999999999888888888777 7999999987 2 45677889999999999987422 23578899
Q ss_pred EEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcC
Q 043136 323 LSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402 (902)
Q Consensus 323 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l 402 (902)
|+.++|.++...+ -....+|+++++++|++++. |.+++.+.+|+.+++.+|+|+ .+|..+....+|+++.+..|.+
T Consensus 224 L~a~~n~l~~~~~--~p~p~nl~~~dis~n~l~~l-p~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel 299 (1081)
T KOG0618|consen 224 LYADHNPLTTLDV--HPVPLNLQYLDISHNNLSNL-PEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNEL 299 (1081)
T ss_pred eeeccCcceeecc--ccccccceeeecchhhhhcc-hHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhh
Confidence 9999999873322 12346799999999999965 499999999999999999995 7888888889999999999999
Q ss_pred cccccccccccCCCcEEEccCCccCCCCCcc-cCCCCC-CcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcCh
Q 043136 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPN-LTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPS 480 (902)
Q Consensus 403 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 480 (902)
. -+|+....+++|+.|+|..|+|. ..|+. +..+.. |..|+.|.|+++...-..=..++.|+.|++.+|.++...-.
T Consensus 300 ~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p 377 (1081)
T KOG0618|consen 300 E-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFP 377 (1081)
T ss_pred h-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchh
Confidence 8 46777888999999999999997 55553 333443 78888888888843222223467899999999999988878
Q ss_pred hhhcccccceeccCCCccCCCccc-cc-ccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCc
Q 043136 481 NIWSAPNLKILSASSSKLTGKIPD-FI-GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPS 558 (902)
Q Consensus 481 ~~~~l~~L~~L~ls~N~l~~~~p~-~~-~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 558 (902)
.+.+.++|++|+|++|+|.. +|+ .. .+..|+.|+||+|+|+ .+|..+..+..|+.|..-+|+|. ..| ++.++++
T Consensus 378 ~l~~~~hLKVLhLsyNrL~~-fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~q 453 (1081)
T KOG0618|consen 378 VLVNFKHLKVLHLSYNRLNS-FPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQ 453 (1081)
T ss_pred hhccccceeeeeeccccccc-CCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCc
Confidence 88899999999999999974 454 33 3888999999999997 88999999999999999999998 667 8999999
Q ss_pred ccEEEccCCccccc-CCCCCcCCccceeecccCCc
Q 043136 559 ITDVDLSHNFLTGT-IPSNFENCSTLESFNVSYNL 592 (902)
Q Consensus 559 L~~L~Ls~N~l~g~-ip~~~~~l~~L~~l~ls~N~ 592 (902)
|+.+|+|.|+|+-. +|..... +.|++|||++|.
T Consensus 454 L~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 454 LKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred ceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 99999999999743 4544433 789999999997
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=336.03 Aligned_cols=363 Identities=27% Similarity=0.414 Sum_probs=200.4
Q ss_pred CEEEEEcCCCCcc-cccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecc
Q 043136 79 QITSLDLSRRSLS-GPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157 (902)
Q Consensus 79 ~v~~L~L~~~~l~-g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 157 (902)
-|+..|+++|.++ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++.. +-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhHHHhh
Confidence 4666777777777 456667777777777777666665 466667777777777777776653 3344555555666666
Q ss_pred ccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCC
Q 043136 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGE 237 (902)
Q Consensus 158 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 237 (902)
.+|++... -||..+..|..|+.||||+|+|+ ..|..+..-.++-.|+||+|+|..+
T Consensus 86 R~N~LKns-----------------------GiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetI 141 (1255)
T KOG0444|consen 86 RDNNLKNS-----------------------GIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETI 141 (1255)
T ss_pred hccccccC-----------------------CCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccC
Confidence 55555422 23444444555555555555555 4455555555555555555555533
Q ss_pred CChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc-cccCccccc
Q 043136 238 VPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS-GPIPASLAS 316 (902)
Q Consensus 238 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~l~~ 316 (902)
+...|.++..|-+||||+|++. .+|..+..+..|++|+|++|.+....-..+..+++|++|.+|+.+=+ .-+|.++..
T Consensus 142 Pn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~ 220 (1255)
T KOG0444|consen 142 PNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDD 220 (1255)
T ss_pred CchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhh
Confidence 3334455555555555555555 34444555555555555555544322233334555555555554432 245555666
Q ss_pred cCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEe
Q 043136 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLI 396 (902)
Q Consensus 317 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~ 396 (902)
+.+|..+|||.|.+. .+|+.+-.+.+|+.|+||+|+|+. +....+...+|++|++|.|+++ .+|..+|.+++|++|+
T Consensus 221 l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~ite-L~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy 297 (1255)
T KOG0444|consen 221 LHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITE-LNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLY 297 (1255)
T ss_pred hhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceee-eeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHH
Confidence 666666666666653 455555566666666666666552 2233344455666666666665 4555555555555555
Q ss_pred ccCCcCcc-cccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccc
Q 043136 397 LFSNNFTY-SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENS 473 (902)
Q Consensus 397 l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 473 (902)
+.+|+++. -+|+.++.+.+|+.+..++|.+. .+|..++.+..|+.|.|++|++- .+|+.+.-++.|++|||.+|.
T Consensus 298 ~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 298 ANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 55555543 24555555555555555555554 45555555555555555555554 455555555555555555553
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=301.85 Aligned_cols=179 Identities=27% Similarity=0.412 Sum_probs=153.3
Q ss_pred HHHHHhccCCcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHH----HHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIR----RRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~----~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
+.+...|...+.+|+|+||.|-+| +.++|+.||||++.++...... ......+|++||++++||+||+++++|+.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 345567888899999999999999 4567999999999765443211 23346799999999999999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEAR 857 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~k 857 (902)
.++.||||||++||+|.+.+-..+. +.+..-+.+++|++.|+.|||++| |+||||||+|||+..+ ..+|
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llK 319 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLK 319 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEE
Confidence 9999999999999999999876553 444455689999999999999776 9999999999999665 7899
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+|||+|+.......+.+.||||.|.|||++....
T Consensus 320 ItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg 354 (475)
T KOG0615|consen 320 ITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG 354 (475)
T ss_pred ecccchhhccccceehhhhcCCccccChhheecCC
Confidence 99999999988888889999999999999996643
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.20 Aligned_cols=188 Identities=44% Similarity=0.778 Sum_probs=163.4
Q ss_pred cccCCCHHHHHHHhccCC--cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEE
Q 043136 698 QRLNFTADDVLECLSMSD--KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775 (902)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~--~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~ 775 (902)
....|+++++.+++..+. ..||+|+||.||+|...++..||||++....... .++|.+|++++.+++|||+|+++
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEE
Confidence 345699999999998776 7999999999999999899999999875433221 34499999999999999999999
Q ss_pred eEEecCC-eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043136 776 GCCSNRE-CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM 854 (902)
Q Consensus 776 ~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~ 854 (902)
|||.+.+ +.++|||||++|+|.+.++..... +++|.+|++|+.++|+||+|||+...++||||||||+|||+|+++
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~ 214 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF 214 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC
Confidence 9999988 599999999999999999875432 679999999999999999999998777899999999999999999
Q ss_pred CEEEeecccceeccC-CCCceee-ccccCccccCccccc
Q 043136 855 EARVADFGVAKLIQS-DESMSVI-AGSYGYIAPGTFCFC 891 (902)
Q Consensus 855 ~~kl~DFGla~~~~~-~~~~~~~-~Gt~~y~APE~~~~~ 891 (902)
++||+|||+|+.... .....+. .||.+|+|||++...
T Consensus 215 ~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g 253 (361)
T KOG1187|consen 215 NAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTG 253 (361)
T ss_pred CEEccCccCcccCCccccceeeecCCCCccCChhhhccC
Confidence 999999999977654 4333444 899999999999653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.51 Aligned_cols=178 Identities=28% Similarity=0.405 Sum_probs=153.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
..-++||+|+||+||.++. .+++.||+|++.++......+.+...+|..|+.+++||+||+++..|++.+..|+|+||+
T Consensus 28 ~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~ 107 (357)
T KOG0598|consen 28 EILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYL 107 (357)
T ss_pred eeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEecc
Confidence 3458999999999999965 468999999997776665566778899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-cCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~ 870 (902)
.||+|...+++.+. +++....-++.+|+.||.|||+++ |||||+||+|||+|.+|+++|+|||+++.. ..+
T Consensus 108 ~GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 108 NGGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred CCccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 99999999986553 556666678889999999999776 999999999999999999999999999954 445
Q ss_pred CCceeeccccCccccCccccc-ccCceee
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC-FSVPFCW 898 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~-~~~p~~~ 898 (902)
....++|||+.|||||++.+. ++..+||
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDW 208 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDW 208 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccch
Confidence 566778999999999999774 3444444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=302.28 Aligned_cols=172 Identities=28% Similarity=0.451 Sum_probs=156.9
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
+|...+.||+|+|+.||+++. .+|+.||+|++.++.......++.+.+||+|.+.++|||||+++++|++.+.+|||.|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 466678999999999999987 7899999999988776677778889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
+|+.++|.+++++++ ++++.++..+++||+.|+.|||+.+ |||||||..|++++++.+|||+|||+|..+..
T Consensus 99 LC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred ecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 999999999998543 4777888899999999999999665 99999999999999999999999999999874
Q ss_pred C-CCceeeccccCccccCcccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~ 890 (902)
+ +...+.||||.|+|||++..
T Consensus 171 ~~Erk~TlCGTPNYIAPEVl~k 192 (592)
T KOG0575|consen 171 DGERKKTLCGTPNYIAPEVLNK 192 (592)
T ss_pred cccccceecCCCcccChhHhcc
Confidence 4 77788999999999999963
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=282.91 Aligned_cols=177 Identities=29% Similarity=0.475 Sum_probs=151.7
Q ss_pred CCHHHHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 702 FTADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 702 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
.+..|+... +.||+|..|+||+|+++ +++.+|+|.+.... ....++++.+|++++++++||+||++||.|..
T Consensus 76 i~~~dle~~-----~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERL-----GVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhh-----hhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 455566533 67999999999999764 68899999994332 33556789999999999999999999999999
Q ss_pred CC-eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEe
Q 043136 781 RE-CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA 859 (902)
Q Consensus 781 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 859 (902)
.+ ..+++||||++|+|+++++..+ .+++...-+|+.+|++||.|||+. ++||||||||+|||++..|+||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence 88 5999999999999999998653 367778889999999999999962 359999999999999999999999
Q ss_pred ecccceeccCCCCceeeccccCccccCccccccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
|||.++.+.+. ...+++||..|||||.+++..+
T Consensus 222 DFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Y 254 (364)
T KOG0581|consen 222 DFGVSGILVNS-IANTFVGTSAYMSPERISGESY 254 (364)
T ss_pred cccccHHhhhh-hcccccccccccChhhhcCCcC
Confidence 99999987665 5577899999999999998543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-34 Score=279.78 Aligned_cols=183 Identities=23% Similarity=0.380 Sum_probs=154.7
Q ss_pred ccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEe-EEecCC-eeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG-CCSNRE-CTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~-~~~~~~-~~~lv~ 788 (902)
|.+.++||+|+||+||+|. ..+|..+|.|.+. -...+.+.++++..|+.++++++|||||++++ .+.++. ..++||
T Consensus 21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 3445789999999999994 5689999999986 44455677888999999999999999999998 444444 489999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV--IVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~--ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
|||++|||..+++..+. +...+++.++|++..|++.||.++|+.- ++ |+||||||.||+++..|.||++|||+++.
T Consensus 100 E~c~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HhhcccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 99999999999987655 4456889999999999999999999742 34 99999999999999999999999999999
Q ss_pred ccCCCC-ceeeccccCccccCcccccccCcee
Q 043136 867 IQSDES-MSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 867 ~~~~~~-~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
+..... ..+.+|||+||+||.+.+..+.+.+
T Consensus 178 l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kS 209 (375)
T KOG0591|consen 178 LSSKTTFAHSLVGTPYYMSPERIHESGYNFKS 209 (375)
T ss_pred hcchhHHHHhhcCCCcccCHHHHhcCCCCcch
Confidence 865443 4678999999999999887666554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=265.27 Aligned_cols=174 Identities=28% Similarity=0.397 Sum_probs=153.5
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.+.+|.|+||+|.+++.+ +|..+|+|++.+......+..+...+|..+++.+.||+++++++.+.+....||||||++|
T Consensus 49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G 128 (355)
T KOG0616|consen 49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG 128 (355)
T ss_pred eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence 478999999999999764 5889999999777666777778889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
|.|..++++.++ ++.....-++.||+.|++|||+.+ |++||+||+|||+|.+|.+||+|||+|+..... +
T Consensus 129 GElFS~Lrk~~r-----F~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T 198 (355)
T KOG0616|consen 129 GELFSYLRKSGR-----FSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--T 198 (355)
T ss_pred ccHHHHHHhcCC-----CCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc--E
Confidence 999999987654 555666778999999999999776 999999999999999999999999999987544 6
Q ss_pred eeeccccCccccCcccc-cccCceee
Q 043136 874 SVIAGSYGYIAPGTFCF-CFSVPFCW 898 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~-~~~~p~~~ 898 (902)
.+.||||.|+|||+++. .++..+||
T Consensus 199 ~TlCGTPeYLAPEii~sk~ynkavDW 224 (355)
T KOG0616|consen 199 WTLCGTPEYLAPEIIQSKGYNKAVDW 224 (355)
T ss_pred EEecCCccccChHHhhcCCCCcchhH
Confidence 78999999999999976 44455554
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=272.19 Aligned_cols=173 Identities=24% Similarity=0.370 Sum_probs=147.7
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
.++|+|+||.||+|+++ +|+.||||++... .++....+-.++||+++++++|+|+|.++++|..+...++|+|||+.
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Es-edd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh- 85 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVES-EDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH- 85 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccC-CccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-
Confidence 46899999999999775 5999999998543 33445567788999999999999999999999999999999999976
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 873 (902)
++.+-+..... -.+.....++++|+++|+.|+|+++ +|||||||+|||++..|.+|+||||+|+... +++..
T Consensus 86 TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y 158 (396)
T KOG0593|consen 86 TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY 158 (396)
T ss_pred HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence 44444444333 2566778899999999999999766 9999999999999999999999999999887 66677
Q ss_pred eeeccccCccccCcccc--cccCcee
Q 043136 874 SVIAGSYGYIAPGTFCF--CFSVPFC 897 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~--~~~~p~~ 897 (902)
+..+.|.+|+|||.+.| .||.|+|
T Consensus 159 TDYVATRWYRaPELLvGDtqYG~pVD 184 (396)
T KOG0593|consen 159 TDYVATRWYRAPELLVGDTQYGKPVD 184 (396)
T ss_pred hhhhhhhhccChhhhcccCcCCCccc
Confidence 88999999999999998 5676765
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=287.44 Aligned_cols=175 Identities=37% Similarity=0.625 Sum_probs=149.0
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-eeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-CTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-~~~lv~e~~~~g 794 (902)
+.||+|+||+||+|.+.+...||||++......... .++|.+|+.++.+++|||||+++|++.+.. ..++||||+++|
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 459999999999999866666999999654433333 778999999999999999999999998887 799999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccCC-CC
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSD-ES 872 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~-~~ 872 (902)
+|.++++.. ....+++..+++|+.|||+||.|||+++. ||||||||+|||++.++ ++||+|||+++..... ..
T Consensus 126 sL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred cHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 999999874 22358999999999999999999996532 99999999999999998 9999999999886543 34
Q ss_pred ceeeccccCccccCcccccccCcee
Q 043136 873 MSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
.....||+.|||||++.+. ..+|+
T Consensus 201 ~~~~~GT~~wMAPEv~~~~-~~~~~ 224 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGE-KSPYT 224 (362)
T ss_pred ccCCCCCccccChhhhcCC-CCcCC
Confidence 4447899999999999976 44444
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=282.26 Aligned_cols=179 Identities=29% Similarity=0.434 Sum_probs=153.0
Q ss_pred HHHhccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCC-ee
Q 043136 708 LECLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRE-CT 784 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~-~~ 784 (902)
+..+|...++||.|+||.||+|+ ..+++.||||+++++.... +...-+||+..++++. |||||++.+++.+.+ ..
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~--ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccH--HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 44567777889999999999995 4568999999996554432 2223468999999998 999999999998887 99
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+|||||+ .+|+++++.+++ .+++..+..|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|
T Consensus 86 ~fVfE~Md-~NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLA 157 (538)
T KOG0661|consen 86 YFVFEFMD-CNLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLA 157 (538)
T ss_pred eeeHHhhh-hhHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccc
Confidence 99999994 699999987633 6888999999999999999999766 999999999999998889999999999
Q ss_pred eeccCCCCceeeccccCccccCccc--ccccCce
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFC--FCFSVPF 896 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~--~~~~~p~ 896 (902)
|.+......+..+.|.+|+|||++. +.|..|+
T Consensus 158 Rev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pv 191 (538)
T KOG0661|consen 158 REVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPV 191 (538)
T ss_pred cccccCCCcchhhhcccccchHHhhhccccCCch
Confidence 9999888889999999999999983 3444443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=271.37 Aligned_cols=177 Identities=23% Similarity=0.357 Sum_probs=160.0
Q ss_pred HhccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.+|.+.+.||+|.||.|-+|+ +..|+.||||.+.+....+....-.+.+||+||..++||||+.+|++|+..+..++||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 345566789999999999995 4679999999998777777777788999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||..+|+|++++.+++. +++.....+++||..|+.|+|.++ +||||+|.+|||+|.++.+||+|||++-.+.
T Consensus 133 EYaS~GeLYDYiSer~~-----LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS-----LSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EecCCccHHHHHHHhcc-----ccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 99999999999987654 667777899999999999999554 9999999999999999999999999999998
Q ss_pred CCCCceeeccccCccccCcccccccC
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
++....++||+|-|++||++.|..+.
T Consensus 205 ~~kfLqTFCGSPLYASPEIvNG~PY~ 230 (668)
T KOG0611|consen 205 DKKFLQTFCGSPLYASPEIVNGTPYK 230 (668)
T ss_pred cccHHHHhcCCcccCCccccCCCCCC
Confidence 88888999999999999999887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=276.61 Aligned_cols=167 Identities=26% Similarity=0.401 Sum_probs=142.0
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~e~~~ 792 (902)
++||+|+||.||+|++ .+|+.||+|++...... ........+||.||++++||||+++.+...+. ..+|+|+|||+
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd 201 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD 201 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence 5799999999999954 67999999999644322 23345577999999999999999999988766 68999999996
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 871 (902)
. ||.-++... ...++..+++.++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||+|+++....
T Consensus 202 h-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 202 H-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred c-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 5 888887542 335788899999999999999999766 9999999999999999999999999999886544
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
..+..+-|.+|+|||.+.|.
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred cccccceEEeeccChHHhcCC
Confidence 45667789999999999874
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=277.61 Aligned_cols=177 Identities=32% Similarity=0.423 Sum_probs=153.5
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+|++||+|+. .+++.||||++.++....+...+.+.+|-++|.++ .||.|++++..|+++...|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 4668999999999999954 56899999999777666656667788899999999 899999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.++|++.+. +++.....++.+|+.|++|||++| ||||||||+|||+|+||++||+|||.|+.+.+.
T Consensus 156 A~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 156 APNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred cCCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 999999999998754 666777789999999999999666 999999999999999999999999999987421
Q ss_pred CC--------------ceeeccccCccccCcccccccCcee
Q 043136 871 ES--------------MSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 871 ~~--------------~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
.. ..+++||..|++||++.+.+..|-+
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~s 268 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSS 268 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCccc
Confidence 11 1558999999999999887766543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=254.78 Aligned_cols=177 Identities=28% Similarity=0.451 Sum_probs=147.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
+|...+.+|+|+||.||+|++ .+|+.||||++......+ .......+||+.++.++|+||+.++++|...+...+|+|
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 344567899999999999954 679999999996543221 223457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||+ .||+..++.+. ..+....++.++.++.+|++|||.+. |+|||+||.|+|++.+|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 59999987643 36777888999999999999999766 99999999999999999999999999998864
Q ss_pred CCC-ceeeccccCccccCcccc--cccCce
Q 043136 870 DES-MSVIAGSYGYIAPGTFCF--CFSVPF 896 (902)
Q Consensus 870 ~~~-~~~~~Gt~~y~APE~~~~--~~~~p~ 896 (902)
... ....+-|.+|+|||.+-| .|+.++
T Consensus 154 p~~~~~~~V~TRWYRAPELLfGsr~Yg~~V 183 (318)
T KOG0659|consen 154 PNRIQTHQVVTRWYRAPELLFGSRQYGTGV 183 (318)
T ss_pred CCcccccceeeeeccChHHhccchhcCCcc
Confidence 433 333478999999999866 344443
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-30 Score=280.52 Aligned_cols=172 Identities=31% Similarity=0.421 Sum_probs=154.4
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
++.||+|+.|.|..|++ .+|+.+|||++.+...........+.+||.||+-+.||||+++|++|+++.++|+|.||++|
T Consensus 17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g 96 (786)
T KOG0588|consen 17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG 96 (786)
T ss_pred cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence 37899999999999965 57999999999776555555566788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
|.|++++..++. +++.+..++++||+.|+.|+|+.+ |+|||+||+|+|+|..+.+||+|||+|..-.++.-.
T Consensus 97 GELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 97 GELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL 168 (786)
T ss_pred chhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence 999999987653 566777899999999999999776 999999999999999999999999999987778888
Q ss_pred eeeccccCccccCcccccccC
Q 043136 874 SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.+.||+|.|+|||+++|..+.
T Consensus 169 eTSCGSPHYA~PEIV~G~pYd 189 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYD 189 (786)
T ss_pred cccCCCcccCCchhhcCCCCC
Confidence 899999999999999886554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=267.59 Aligned_cols=144 Identities=29% Similarity=0.384 Sum_probs=128.0
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
-++||+|+||.||.|+. .+|+.+|+|++.+.......+.+.+..|-.+|...++|+||++|..|++.+++|+||||++|
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 37899999999999965 46999999999877766666778889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||+..++...+ .+++....-++.+++.|++.+|..| +|||||||+|+|||..|++|++|||++..
T Consensus 226 GD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 226 GDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred ccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999998654 3555566677888999999999666 99999999999999999999999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=273.88 Aligned_cols=175 Identities=30% Similarity=0.406 Sum_probs=149.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh-h-HHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE-N-IRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~-~-~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~ 785 (902)
..|...+.||+|+||+|+.|.. .+++.||+|++.++... . ....+.+.+|+.++++++ ||||+++++++......|
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 4567789999999999999955 56899999966443111 1 123445668999999998 999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeecccc
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVA 864 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla 864 (902)
+||||+.||+|.+++...+. +.+....++++|++.|++|+|+++ |+||||||+||+++.+ +++||+|||++
T Consensus 97 ivmEy~~gGdL~~~i~~~g~-----l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKGR-----LKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEecCCccHHHHHHHcCC-----CChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 99999999999999987432 555777899999999999999766 9999999999999999 99999999999
Q ss_pred eec-cCCCCceeeccccCccccCcccccc
Q 043136 865 KLI-QSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 865 ~~~-~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
... ..+....+.|||+.|+|||++.+..
T Consensus 169 ~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~ 197 (370)
T KOG0583|consen 169 AISPGEDGLLKTFCGSPAYAAPEVLSGKG 197 (370)
T ss_pred cccCCCCCcccCCCCCcccCCHHHhCCCC
Confidence 988 4667778899999999999999865
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=271.87 Aligned_cols=175 Identities=28% Similarity=0.429 Sum_probs=150.1
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+-+.||+|+||+||+|+. .+.+.||+|.+.+.. ...++.+.+.+|++|+++++|||||.++++|+...++|+|.||+
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a 83 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYA 83 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhh
Confidence 3446799999999999965 468889999986543 44566788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
.| +|.+++...+. +++..+..|+.+++.||.|||+.+ |+|||+||+|||++..|.+|++|||+|+.+....
T Consensus 84 ~g-~L~~il~~d~~-----lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 84 VG-DLFTILEQDGK-----LPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hh-hHHHHHHhccC-----CCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 66 99999986543 677888899999999999999655 9999999999999999999999999999886544
Q ss_pred C-ceeeccccCccccCcccccccCceeeec
Q 043136 872 S-MSVIAGSYGYIAPGTFCFCFSVPFCWVD 900 (902)
Q Consensus 872 ~-~~~~~Gt~~y~APE~~~~~~~~p~~~~~ 900 (902)
. .+.+.|||.|||||.+.+. ||+...
T Consensus 155 ~vltsikGtPlYmAPElv~e~---pyd~~s 181 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQ---PYDHTS 181 (808)
T ss_pred eeeeeccCcccccCHHHHcCC---Cccchh
Confidence 4 3567899999999999854 555543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=260.21 Aligned_cols=177 Identities=27% Similarity=0.344 Sum_probs=142.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhH-----------HHHHHHHHHHHHHhcCCcCeeEeEEeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENI-----------RRRRGVLAEVDVLGNVRHRNIVRLLGCC 778 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-----------~~~~~~~~Ei~il~~l~h~nIv~l~~~~ 778 (902)
.|...+.||+|.||.|-+|+. .+++.||||++.++..... ...+...+||.||++++|||||+++++.
T Consensus 98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL 177 (576)
T KOG0585|consen 98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL 177 (576)
T ss_pred heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence 455667899999999999976 4689999999975443211 1125788999999999999999999998
Q ss_pred ecC--CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 779 SNR--ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 779 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
.+. +.+|||+|||..|.+...-. ....+...+..++.+++..||+|||.++ ||||||||+|+|++++|+|
T Consensus 178 DDP~s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 178 DDPESDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred cCcccCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcE
Confidence 764 57999999999887754211 1222778888999999999999999877 9999999999999999999
Q ss_pred EEeecccceeccCC------CCceeeccccCccccCcccccccCc
Q 043136 857 RVADFGVAKLIQSD------ESMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 857 kl~DFGla~~~~~~------~~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
||+|||.+.....+ ......+|||.|||||...++-...
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~ 294 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFS 294 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCcc
Confidence 99999998866221 1234478999999999998855433
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-28 Score=252.98 Aligned_cols=176 Identities=26% Similarity=0.383 Sum_probs=144.3
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe-eEeEEeEEecCC------eeEEE
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN-IVRLLGCCSNRE------CTMLL 787 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n-Iv~l~~~~~~~~------~~~lv 787 (902)
++||+|+||+||+|+. .+|+.||+|++...... +.......+|+.+++.++|+| ||++++++...+ ..++|
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv 95 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV 95 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence 4499999999999965 56899999999654332 123445689999999999999 999999998776 78999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
+||++ -||.+++....... ...+...++.+++|+++|++|||+++ |+||||||+||+++++|.+||+|||+|+..
T Consensus 96 fe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~ 170 (323)
T KOG0594|consen 96 FEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF 170 (323)
T ss_pred EEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence 99994 59999998755321 23455678899999999999999766 999999999999999999999999999977
Q ss_pred c-CCCCceeeccccCccccCccccc--ccCcee
Q 043136 868 Q-SDESMSVIAGSYGYIAPGTFCFC--FSVPFC 897 (902)
Q Consensus 868 ~-~~~~~~~~~Gt~~y~APE~~~~~--~~~p~~ 897 (902)
. +.......++|.+|+|||++.|. |+.++|
T Consensus 171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vD 203 (323)
T KOG0594|consen 171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVD 203 (323)
T ss_pred cCCcccccccEEEeeccCHHHhcCCCcCCCCcc
Confidence 5 34446678899999999999885 444443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-29 Score=268.44 Aligned_cols=168 Identities=27% Similarity=0.406 Sum_probs=146.9
Q ss_pred cCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
..-++||+|+.|.||.|+ ..+++.||||++..+. +..++-+.+|+.+|+..+|+|||.+++.|...+..|+|||||
T Consensus 276 ~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 276 TDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred cchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 334679999999999994 5678999999995433 234556889999999999999999999998889999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+||+|.|++... .+++.++..|++++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+....
T Consensus 353 ~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 353 EGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ 423 (550)
T ss_pred CCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence 999999998654 3778899999999999999999776 9999999999999999999999999999886555
Q ss_pred -CceeeccccCccccCcccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~~ 892 (902)
...+.+|||+|||||++.-..
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~ 445 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKP 445 (550)
T ss_pred CccccccCCCCccchhhhhhcc
Confidence 567899999999999996633
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-28 Score=272.25 Aligned_cols=177 Identities=28% Similarity=0.416 Sum_probs=150.5
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.++||+|.||+|++|..+ +++.+|||.+++......++.+..+.|.+|+... +||+++.++.+|++++++|+||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 35589999999999999764 5889999999877666666777888899998877 599999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-C
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-S 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~ 869 (902)
+.|||+..+.+.. .+++....-++..|+.||+|||+++ |||||||.+|||+|.+|++||+|||+++..- .
T Consensus 451 ~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 451 VAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred cCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999954443322 4777777889999999999999666 9999999999999999999999999999754 5
Q ss_pred CCCceeeccccCccccCccccc-ccCceee
Q 043136 870 DESMSVIAGSYGYIAPGTFCFC-FSVPFCW 898 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~-~~~p~~~ 898 (902)
+..+.++||||.|||||++.+. |+..+||
T Consensus 522 g~~TsTfCGTpey~aPEil~e~~Yt~aVDW 551 (694)
T KOG0694|consen 522 GDRTSTFCGTPEFLAPEVLTEQSYTRAVDW 551 (694)
T ss_pred CCccccccCChhhcChhhhccCcccchhhH
Confidence 6677889999999999999874 4444555
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=259.07 Aligned_cols=164 Identities=29% Similarity=0.527 Sum_probs=140.0
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhc--CCcCeeEeEEeEEecCC----eeEEEEE
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN--VRHRNIVRLLGCCSNRE----CTMLLYE 789 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~h~nIv~l~~~~~~~~----~~~lv~e 789 (902)
++||+|.||.||+|+. +++.||||++. .+.++.+..|-+|++. ++|+||++++++-.... ++++|+|
T Consensus 216 eli~~Grfg~V~KaqL-~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 216 ELIGRGRFGCVWKAQL-DNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHhhcCccceeehhhc-cCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 5789999999999988 55999999983 3445567778888765 48999999998875544 8999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC------CCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD------CDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
|.+.|+|.++++.. ..+|....+|+..|++||+|||+. +.++|+|||||++||||..|+++.|+|||+
T Consensus 289 fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999865 589999999999999999999974 356799999999999999999999999999
Q ss_pred ceeccCCCC---ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
|..+..+.. ....+||.+|||||++.|..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgai 394 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAI 394 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhc
Confidence 998864332 34478999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.5e-28 Score=253.52 Aligned_cols=167 Identities=35% Similarity=0.538 Sum_probs=140.9
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--eeEEEEEc
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--CTMLLYEY 790 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--~~~lv~e~ 790 (902)
..+.||+|+||.||++... +|+..|||.+...... ..+.+.+|+.++.+++|||||+++|.....+ .+++.|||
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4578999999999999764 4899999998543211 1566889999999999999999999855544 68999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~ 869 (902)
+++|+|.+++...+. .+++..+..+.+||++||+|||+++ ||||||||+|||++. ++.+||+|||+++....
T Consensus 98 ~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred cCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 999999999987642 3677888899999999999999666 999999999999999 69999999999987753
Q ss_pred ----CCCceeeccccCccccCcccc
Q 043136 870 ----DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ----~~~~~~~~Gt~~y~APE~~~~ 890 (902)
........||+.|||||++..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~ 195 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRN 195 (313)
T ss_pred ccccccccccccCCccccCchhhcC
Confidence 222445789999999999995
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=254.30 Aligned_cols=164 Identities=30% Similarity=0.465 Sum_probs=138.9
Q ss_pred CCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC--CcCeeEeEEeEEecCC----eeEEE
Q 043136 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV--RHRNIVRLLGCCSNRE----CTMLL 787 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l--~h~nIv~l~~~~~~~~----~~~lv 787 (902)
..+.||+|.||+||+|++ .|+.||||++..+. .+.+.+|.+|++.. +|+||+.+++.-..+. ++|+|
T Consensus 215 L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 215 LQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred EEEEecCccccceeeccc-cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 347899999999999988 67889999985433 34577899998774 9999999998754332 68999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH-----DCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
.||.+.|||+|++... +++....++++..+|.||+|||. +|.+.|.|||||+.||||..++.+.|+|+|
T Consensus 288 TdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLG 361 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 361 (513)
T ss_pred eecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeece
Confidence 9999999999999753 57888899999999999999995 467889999999999999999999999999
Q ss_pred cceeccCCCC-----ceeeccccCccccCcccc
Q 043136 863 VAKLIQSDES-----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~~-----~~~~~Gt~~y~APE~~~~ 890 (902)
+|....++.. ....+||.+|||||++..
T Consensus 362 LAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 362 LAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred eeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9988765432 345789999999999843
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=246.16 Aligned_cols=172 Identities=27% Similarity=0.358 Sum_probs=141.6
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~lv~e~~~ 792 (902)
..|++|+||.||+|++ ++++.||+|++...... ....-...+||.++.+++|||||.+-++... -+..|+|||||+
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek-~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E 160 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEK-EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE 160 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeeccccccc-CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH
Confidence 5699999999999965 56899999999654322 1222345789999999999999999988654 457999999996
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-C
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD-E 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~ 871 (902)
. ||..++..-+ ..+...+.+.++.|+++|++|||... |+|||+||+|+|+.+.|.+||+|||+||.+... .
T Consensus 161 h-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 161 H-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred h-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 5 9999987644 24667788899999999999999766 999999999999999999999999999998654 3
Q ss_pred CceeeccccCccccCccccc--ccCce
Q 043136 872 SMSVIAGSYGYIAPGTFCFC--FSVPF 896 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~--~~~p~ 896 (902)
..+..+-|.+|+|||.+.|. |++++
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~i 259 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAV 259 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcch
Confidence 45667889999999999774 44444
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=238.31 Aligned_cols=174 Identities=26% Similarity=0.380 Sum_probs=150.8
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|-||.||.|+. +++-.||+|++.+.+.......+++.+|++|.+.++||||+++|++|.+....|+++||.
T Consensus 25 eigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya 104 (281)
T KOG0580|consen 25 EIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYA 104 (281)
T ss_pred cccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEec
Confidence 3678999999999999954 568899999998777666666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
.+|+++..+...+. ..++......++.|+|.|+.|+|.. +||||||||+|+|++.++.+||+|||-+.... ..
T Consensus 105 ~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~ 177 (281)
T KOG0580|consen 105 PRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN 177 (281)
T ss_pred CCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC-CC
Confidence 99999999985432 2355566678999999999999955 49999999999999999999999999987654 55
Q ss_pred CceeeccccCccccCccccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
...+.|||..|.|||+..+...
T Consensus 178 kR~tlcgt~dyl~pEmv~~~~h 199 (281)
T KOG0580|consen 178 KRKTLCGTLDYLPPEMVEGRGH 199 (281)
T ss_pred CceeeecccccCCHhhcCCCCc
Confidence 6788999999999999977543
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=251.49 Aligned_cols=167 Identities=30% Similarity=0.441 Sum_probs=138.4
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-----eeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-----CTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-----~~~l 786 (902)
...+++|.|+||.||+|... +++.||||+++.+... --+|+++|++++|||||++..+|.... +..+
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 34589999999999999764 4699999999766543 236999999999999999998885422 3458
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~ 865 (902)
|||||+. +|.+.++.... .+..++...++-++.|+.+|+.|||+.+ |+||||||+|+|+|.+ |.+||||||.|+
T Consensus 100 VleymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 9999964 99999875322 2223556667788999999999999755 9999999999999987 899999999999
Q ss_pred eccCCCCceeeccccCccccCccccc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
....++...+...|..|+|||.+-|+
T Consensus 175 ~L~~~epniSYicSRyYRaPELifga 200 (364)
T KOG0658|consen 175 VLVKGEPNISYICSRYYRAPELIFGA 200 (364)
T ss_pred eeccCCCceeEEEeccccCHHHHcCc
Confidence 99888888888899999999999774
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.2e-28 Score=261.66 Aligned_cols=169 Identities=30% Similarity=0.536 Sum_probs=142.4
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
.+.||+|.||.||.|++.....||+|.+.... ...+.|.+|+++|++++|++||+++++|..++..|||||||+.|
T Consensus 211 ~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~----m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 211 IRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS----MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHhcCCccceEEEEEEcCCCcccceEEeccc----cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 46799999999999999888899999985442 23456779999999999999999999999988999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCce
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 874 (902)
+|.++++.. ....+...+.+.++.|||+|++||++++ +|||||.++||||+++..+||+|||+|+.+.++....
T Consensus 287 sLl~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 287 SLLDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cHHHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 999999862 2234677888999999999999999766 9999999999999999999999999999665544332
Q ss_pred eecc--ccCccccCccccccc
Q 043136 875 VIAG--SYGYIAPGTFCFCFS 893 (902)
Q Consensus 875 ~~~G--t~~y~APE~~~~~~~ 893 (902)
..-| ...|.|||++.+.-.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~F 381 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKF 381 (468)
T ss_pred cCCCCCCceecCHHHHhhCCc
Confidence 2222 346999999977543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=246.81 Aligned_cols=171 Identities=23% Similarity=0.374 Sum_probs=145.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||.|..++||+|+. +.++.||||++.-.... ...+.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 55678999999999999954 57899999998543322 3367899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS- 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~- 869 (902)
|.+|++.++++..-.. -+++..+..|.+++++||.|||.+| .||||||+.|||++.+|.|||+|||.+..+.+
T Consensus 106 Ma~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999865332 2777888899999999999999776 99999999999999999999999998766533
Q ss_pred CCCc----eeeccccCccccCcccc
Q 043136 870 DESM----SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~----~~~~Gt~~y~APE~~~~ 890 (902)
+... .+++||+.|||||+++.
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred CceeeEeeccccCcccccChHHhhh
Confidence 2221 45689999999999643
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=258.88 Aligned_cols=173 Identities=29% Similarity=0.403 Sum_probs=152.4
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~l 786 (902)
...|.+.+.||+|.||.||+|+.. +|+.+|+|.+.++........+.+.+|+++|+++. |||||.++++|++...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 345666789999999999999765 49999999997766555456678899999999998 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CCEEEeecc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE----MEARVADFG 862 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~----~~~kl~DFG 862 (902)
|||++.||+|.+.+... ..++.....+++|++.|++|+|+.+ |+|||+||+|+|+... +.+|++|||
T Consensus 114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 99999999999999765 1677788899999999999999765 9999999999999543 579999999
Q ss_pred cceeccCCCCceeeccccCccccCcccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
+|.....+......+||+.|+|||++.+
T Consensus 185 la~~~~~~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 185 LAKFIKPGERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred CceEccCCceEeeecCCccccCchhhcC
Confidence 9999888777888999999999999985
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=258.77 Aligned_cols=188 Identities=30% Similarity=0.496 Sum_probs=156.0
Q ss_pred cccCCCHHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeE
Q 043136 698 QRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777 (902)
Q Consensus 698 ~~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~ 777 (902)
+.....++|+. ..+.||+|.||+||+|++.+ .||||++...... ....+.|.+|+.++++-+|.||+-+.|+
T Consensus 385 ~~WeIp~~ev~-----l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~ 456 (678)
T KOG0193|consen 385 EEWEIPPEEVL-----LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGA 456 (678)
T ss_pred cccccCHHHhh-----ccceeccccccceeeccccc--ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehh
Confidence 33445555554 45789999999999998733 5999998655443 3478889999999999999999999999
Q ss_pred EecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEE
Q 043136 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857 (902)
Q Consensus 778 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~k 857 (902)
|..... .||..+|+|.+|+.+++..+. .++..+...|++|||+|+.|||.++ |||||+|..||++.++++||
T Consensus 457 ~~~p~~-AIiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVk 528 (678)
T KOG0193|consen 457 CMNPPL-AIITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVK 528 (678)
T ss_pred hcCCce-eeeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEE
Confidence 988877 899999999999999987542 4788888999999999999999766 99999999999999999999
Q ss_pred Eeecccceec---cCCCCceeeccccCccccCcccccccCceeeecC
Q 043136 858 VADFGVAKLI---QSDESMSVIAGSYGYIAPGTFCFCFSVPFCWVDQ 901 (902)
Q Consensus 858 l~DFGla~~~---~~~~~~~~~~Gt~~y~APE~~~~~~~~p~~~~~~ 901 (902)
|+|||++..- ..+.......|...|||||+++.....||++-.|
T Consensus 529 IgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSD 575 (678)
T KOG0193|consen 529 IGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSD 575 (678)
T ss_pred EecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccc
Confidence 9999998643 2333345567888999999999877778876543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-28 Score=235.70 Aligned_cols=170 Identities=32% Similarity=0.500 Sum_probs=148.3
Q ss_pred ccCCcEeeecCceEEEEE-EeCCCcEEEEEEeccc-----chhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGK-----HKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~-----~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
|..++.+|+|..+.|.+| ...+++.+|+|++... ......-+++-.+|+.|++++ .||+|+++.++|+.+..+
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 445678999999999988 4467899999998521 112233456678899999998 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++|+|.|+.|.|.|++... ..+++....+|++|+.+|++|+|... |||||+||+|||++++.++||+|||+|
T Consensus 99 FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred hhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999754 35777888899999999999999766 999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
..+.+++.....||||+|.|||.+.
T Consensus 171 ~~l~~GekLrelCGTPgYLAPEtik 195 (411)
T KOG0599|consen 171 CQLEPGEKLRELCGTPGYLAPETIK 195 (411)
T ss_pred eccCCchhHHHhcCCCcccChhhee
Confidence 9999999999999999999999984
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-28 Score=257.86 Aligned_cols=164 Identities=32% Similarity=0.499 Sum_probs=143.5
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||.|+||.||-|++ .+.+.||||++.-..+.....-.++.+|+..+.+++|||+|.+-|+|..+...|+||||| -|
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence 5699999999999965 568899999997555555566678999999999999999999999999999999999999 56
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCce
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 874 (902)
+..|++...++ ++.+..+..|+.+.++||+|||+.+ .||||||+.|||+++.|.||++|||.|..+.+ ..
T Consensus 111 SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---An 180 (948)
T KOG0577|consen 111 SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---AN 180 (948)
T ss_pred cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc---hh
Confidence 88888876554 4677888899999999999999766 99999999999999999999999999987543 45
Q ss_pred eeccccCccccCcccc
Q 043136 875 VIAGSYGYIAPGTFCF 890 (902)
Q Consensus 875 ~~~Gt~~y~APE~~~~ 890 (902)
+++|||+|||||++..
T Consensus 181 sFvGTPywMAPEVILA 196 (948)
T KOG0577|consen 181 SFVGTPYWMAPEVILA 196 (948)
T ss_pred cccCCccccchhHhee
Confidence 6899999999999954
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=255.66 Aligned_cols=169 Identities=26% Similarity=0.288 Sum_probs=142.8
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|+||.||+|+. .+++.||+|++.+...........+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 468999999986443333344566788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 873 (902)
+|.+++...+ .+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++... .....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~ 152 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcc
Confidence 9999887543 3677788889999999999999766 9999999999999999999999999997642 23334
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
...+||+.|||||++.+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~ 171 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDND 171 (323)
T ss_pred cceecCccccChhhhcCCC
Confidence 5578999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=249.22 Aligned_cols=175 Identities=28% Similarity=0.340 Sum_probs=146.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|.. .+++.||+|++.+...........+.+|++++.+++|++|+++++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4457899999999999965 578999999986443333333456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++..... ..+++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 83 NGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred CCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 99999988764321 24677888899999999999999665 9999999999999999999999999998765544
Q ss_pred CceeeccccCccccCccccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
......||+.|||||++.+...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~ 178 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKY 178 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCC
Confidence 4455679999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-29 Score=256.40 Aligned_cols=276 Identities=21% Similarity=0.192 Sum_probs=184.9
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccC-CCCCCCCCcccccccccceec
Q 043136 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISH-NSFNSTFPPGISKLRFLRIFN 156 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~ 156 (902)
...+.|+|..|+|+...|.+|+.+++|++||||+|+|+.+-|.+|.+|.+|..|-+.+ |+|+...-..|++|..|+.|.
T Consensus 67 ~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLl 146 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLL 146 (498)
T ss_pred CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHh
Confidence 4678999999999977777999999999999999999999999999999988876666 999977667799999999999
Q ss_pred cccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCcc------------CCCCccccCCCCC
Q 043136 157 AYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLT------------GSLPPQLGLLTQL 224 (902)
Q Consensus 157 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~------------~~~p~~~~~l~~L 224 (902)
+.-|++.-.....|..+++|..|.|..|.+...--..|..+..++.+.+..|.+- ...|-.++...-.
T Consensus 147 lNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 147 LNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred cChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 9999999999999999999999999999998554558999999999999999832 2233344444434
Q ss_pred cEEEeeCcccCCCCChhccCC-CCCCEEEccCccCcccCC-ccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecc
Q 043136 225 ERIEIGYNNLQGEVPVEFASL-VNLKYMDISACNLSGTLP-SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302 (902)
Q Consensus 225 ~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 302 (902)
.-..+.++++..+.+..|... ..+..--.+.+...+.-| ..|..+++|+.|+|++|+|+++-+.+|.++.++++|.|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 444444444443333333211 111111111122222223 345555555555555555555555555555555555555
Q ss_pred cCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCce
Q 043136 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNH 353 (902)
Q Consensus 303 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 353 (902)
.|+|...-...|.++..|+.|+|.+|+|+...|..|..+..|.+|+|-.|.
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np 357 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNP 357 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCc
Confidence 555554444455555555555555555555555555555555555555444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=237.51 Aligned_cols=172 Identities=26% Similarity=0.365 Sum_probs=144.8
Q ss_pred hccCCcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+|+.||++ ...+|+.+|+|++..+. ......+++.+|++|.+.++|||||++.+.+.+.+..|+|+|
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k-~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhh-hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 3445577999999999999 45679999999885432 233466788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEEEeeccccee
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~ 866 (902)
+|.|++|..-+-.+. ..++...-..++||++|+.|+|..+ |||||+||+|+++... -.+|++|||+|..
T Consensus 91 ~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 91 LVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred cccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999977665442 3555666788999999999999666 9999999999999533 4599999999999
Q ss_pred ccCCCCceeeccccCccccCccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
..++......+|||+|||||++...
T Consensus 163 l~~g~~~~G~~GtP~fmaPEvvrkd 187 (355)
T KOG0033|consen 163 VNDGEAWHGFAGTPGYLSPEVLKKD 187 (355)
T ss_pred eCCccccccccCCCcccCHHHhhcC
Confidence 9877777889999999999999653
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=259.52 Aligned_cols=172 Identities=24% Similarity=0.334 Sum_probs=143.5
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||+||+|+.. +++.||+|++.+...........+.+|++++.+++||+|+++++++.+....|+||||+
T Consensus 4 ~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (363)
T cd05628 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFL 83 (363)
T ss_pred eEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCC
Confidence 44578999999999999654 58899999986543333344566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++...+ .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+.+....
T Consensus 84 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 84 PGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999987543 3677888899999999999999665 9999999999999999999999999987543211
Q ss_pred ------------------------------------CceeeccccCccccCcccccc
Q 043136 872 ------------------------------------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ------------------------------------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+||+.|||||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 212 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC
Confidence 012357999999999987653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=252.92 Aligned_cols=169 Identities=25% Similarity=0.292 Sum_probs=142.1
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|+||.||+|+. .+++.||+|++.............+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999975 468999999986443333344556778999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-CCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 873 (902)
+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 152 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM 152 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCcc
Confidence 9998886543 3677888899999999999999765 99999999999999999999999999876422 2233
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
....||+.|||||++.+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~ 171 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDND 171 (323)
T ss_pred ccccCCcCcCCcccccCCC
Confidence 4567999999999997653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=253.05 Aligned_cols=169 Identities=27% Similarity=0.308 Sum_probs=142.5
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|+||.||+|+. .+++.||+|++.+...........+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999975 468999999986543333344567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-CCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~ 873 (902)
+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~ 152 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM 152 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccccc
Confidence 9998886532 3677888899999999999999665 99999999999999999999999999886432 2233
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
...+||+.|+|||++.+..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~ 171 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDND 171 (328)
T ss_pred ccccCCcCccChhhhcCCC
Confidence 4567999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-28 Score=241.26 Aligned_cols=175 Identities=26% Similarity=0.412 Sum_probs=149.2
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS 779 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~ 779 (902)
.-..+|+++.. +++|+|+||.||+|. ...|+.+|||++... ...+++.+|+.||++++.|+||++||.|.
T Consensus 28 ~K~PEEVFDi~----~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYF 98 (502)
T KOG0574|consen 28 NKPPEEVFDIV----GKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYF 98 (502)
T ss_pred cCChHHHHHHH----HHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhc
Confidence 44567776654 569999999999994 457999999998432 34567889999999999999999999999
Q ss_pred cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEe
Q 043136 780 NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA 859 (902)
Q Consensus 780 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 859 (902)
.....|+|||||..|++.++++.+++ ++.+..+..+.+..+.||+|||. .+-||||||+.|||++.+|.+|++
T Consensus 99 K~sDLWIVMEYCGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLA 171 (502)
T KOG0574|consen 99 KHSDLWIVMEYCGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLA 171 (502)
T ss_pred cCCceEeehhhcCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhh
Confidence 89999999999999999999987654 57788888999999999999994 458999999999999999999999
Q ss_pred ecccceeccCCC-CceeeccccCccccCccccc
Q 043136 860 DFGVAKLIQSDE-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 860 DFGla~~~~~~~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
|||.|....+.- ...+..|||.|||||+++..
T Consensus 172 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EI 204 (502)
T KOG0574|consen 172 DFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEI 204 (502)
T ss_pred hccccchhhhhHHhhCccccCcccccHHHHHHh
Confidence 999998775433 34668899999999999653
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=253.60 Aligned_cols=172 Identities=27% Similarity=0.325 Sum_probs=145.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 455688999999999999764 5889999998644333334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... ..++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 100 VVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999987543 3566777789999999999999765 999999999999999999999999999876433
Q ss_pred CCceeeccccCccccCccccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~ 192 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGH 192 (329)
T ss_pred --cceecCChhhcCHHHHcCCCC
Confidence 234689999999999976543
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=253.94 Aligned_cols=171 Identities=26% Similarity=0.304 Sum_probs=144.3
Q ss_pred ccCCcEeeecCceEEEEEEeCC--CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|.+.+.||+|+||.||+|.... +..||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4556889999999999996533 36899999854433333445668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 112 y~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999987543 3667778899999999999999766 99999999999999999999999999987643
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ....+||+.|||||++.+..
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~ 204 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVG 204 (340)
T ss_pred C--cceecCChhhcCHHHHhCCC
Confidence 2 34568999999999987653
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-26 Score=250.79 Aligned_cols=170 Identities=26% Similarity=0.293 Sum_probs=141.6
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|+||.||+|+. .+++.||+|++.+...........+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 468999999986543333344556778999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 873 (902)
+|.+++.... .+++.....++.|++.||+|||+. .+|+||||||+||+++.++.+||+|||+++... .....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 153 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 153 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence 9998886532 367788889999999999999961 249999999999999999999999999987643 23333
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
...+||+.|||||++.+..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDND 172 (325)
T ss_pred ccccCCcccCCHHHHccCC
Confidence 4567999999999986643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-26 Score=250.67 Aligned_cols=168 Identities=27% Similarity=0.301 Sum_probs=141.7
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+|+.. +++.||+|++.+...........+.+|++++++++||||+++++++.+.+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999764 5789999998544333344556678899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-CCCcee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DESMSV 875 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~~~~ 875 (902)
.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.... ......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 152 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence 99987543 3677788899999999999999665 99999999999999999999999999986432 223345
Q ss_pred eccccCccccCccccccc
Q 043136 876 IAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 876 ~~Gt~~y~APE~~~~~~~ 893 (902)
.+||+.|+|||++.+...
T Consensus 153 ~~gt~~y~aPE~~~~~~~ 170 (312)
T cd05585 153 FCGTPEYLAPELLLGHGY 170 (312)
T ss_pred ccCCcccCCHHHHcCCCC
Confidence 679999999999976543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=257.40 Aligned_cols=147 Identities=27% Similarity=0.356 Sum_probs=126.5
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 34557899999999999965 46889999998654433344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+++|+|.+++.... .+++.....++.|++.||+|||..+ |+||||||+||+++.++++||+|||+++.
T Consensus 83 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 83 IPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 99999999987543 3566777788999999999999665 99999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=256.78 Aligned_cols=147 Identities=26% Similarity=0.325 Sum_probs=126.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 34568899999999999965 46899999998544333334456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+++|+|.+++...+ .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 83 ~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 83 LPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999987542 3566777789999999999999766 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=252.83 Aligned_cols=175 Identities=23% Similarity=0.373 Sum_probs=152.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe-eEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC-TMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~-~~lv~e 789 (902)
|...+++|+|+||.++.++++ +++.||+|++.... .....++...+|+.++++++|||||.+.+.|..++. .+|||+
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~-~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~ 84 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEK-LTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVME 84 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccc-cCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEe
Confidence 344578999999999999654 57889999985443 334555678899999999999999999999998887 999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||+||++.+.+.+.+ ...+++.++.+++.|++.|+.|||+.+ |+|||||+.||+++.++.|||+|||+|+....
T Consensus 85 Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 85 YCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred ecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999998765 235788899999999999999999665 99999999999999999999999999999877
Q ss_pred CC-CceeeccccCccccCccccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+. ...+.+|||.||.||.+.+..+
T Consensus 159 ~~~~a~tvvGTp~YmcPEil~d~pY 183 (426)
T KOG0589|consen 159 EDSLASTVVGTPYYMCPEILSDIPY 183 (426)
T ss_pred chhhhheecCCCcccCHHHhCCCCC
Confidence 65 6678899999999999987644
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.6e-27 Score=246.60 Aligned_cols=181 Identities=28% Similarity=0.350 Sum_probs=155.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+..-++||+|+||.||.|+. .+|+.||.|++.++...........++|-.|++++..++||.+-..|++.+..++||..
T Consensus 187 F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtl 266 (591)
T KOG0986|consen 187 FRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTL 266 (591)
T ss_pred eeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEe
Confidence 34458999999999999966 46999999998766555445556678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
|.||||.-.|...+. ..+++....-++.+|+.||++||... ||+||+||+|||+|+.|+++|+|.|+|..+..+
T Consensus 267 MNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 267 MNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred ecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999887765432 34778888889999999999999655 999999999999999999999999999999888
Q ss_pred CCceeeccccCccccCccccc-ccCceee
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC-FSVPFCW 898 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~-~~~p~~~ 898 (902)
......+||.+|||||+++.. |..+.||
T Consensus 341 ~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dw 369 (591)
T KOG0986|consen 341 KPIRGRVGTVGYMAPEVLQNEVYDFSPDW 369 (591)
T ss_pred CccccccCcccccCHHHHcCCcccCCccH
Confidence 888888999999999999764 3334444
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=257.03 Aligned_cols=147 Identities=25% Similarity=0.342 Sum_probs=126.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+. .+++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 34568899999999999965 46889999998654333344556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+++|+|.+++...+ .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 83 IPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 99999999986542 3566677789999999999999766 99999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=256.34 Aligned_cols=146 Identities=23% Similarity=0.350 Sum_probs=125.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|++.+...........+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 44568899999999999975 45889999998543332333455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+++|+|.+++...+ .++......++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|.
T Consensus 83 ~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 83 IPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 99999999987543 3566677788999999999999766 9999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-26 Score=254.48 Aligned_cols=172 Identities=22% Similarity=0.269 Sum_probs=143.9
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 4566789999999999999764 578999999854333333344567789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++... ..+......++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+....
T Consensus 124 y~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 124 YMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999998643 2566777889999999999999766 99999999999999999999999999987643
Q ss_pred CCC--ceeeccccCccccCccccc
Q 043136 870 DES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
... ....+||+.|||||++.+.
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~ 218 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCceecccCCCCcccCCHHHHhcc
Confidence 322 2356799999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=250.24 Aligned_cols=175 Identities=29% Similarity=0.366 Sum_probs=152.5
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.++||+|.|+.|..|++ .++..||+|.+.+..... ..+..+.+|+++|+.++|||||+++.+.+.....|+|||
T Consensus 57 ~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 57 LYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred ceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 456678999999999999965 468999999997665443 334448899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+.+|++++++...... .......+..|+..|++|||+++ |||||||++||+++.+..+||+|||++..+..
T Consensus 136 ya~~ge~~~yl~~~gr~-----~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRM-----KEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred eccCchhHHHHHhcccc-----hhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999876542 22445578899999999999766 99999999999999999999999999999988
Q ss_pred CCCceeeccccCccccCcccccccC
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+....+.||++.|+|||+++|..++
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~ 232 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYD 232 (596)
T ss_pred cccccccCCCCCccChHhhcCcccC
Confidence 8888899999999999999986543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=255.67 Aligned_cols=148 Identities=28% Similarity=0.370 Sum_probs=127.5
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||||++.............+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 345688999999999999764 6889999998543322233445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 83 ~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 83 LPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred CCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceec
Confidence 99999999987543 3677788899999999999999766 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-26 Score=251.99 Aligned_cols=174 Identities=26% Similarity=0.382 Sum_probs=143.1
Q ss_pred CcEeeecCceEEEEEEeCC--C---cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMPG--G---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~--~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.++||+|+||.||+|++.. + ..||||..............++.+|+++|++++|||||++||++..+...|+|||
T Consensus 162 ~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmE 241 (474)
T KOG0194|consen 162 GKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVME 241 (474)
T ss_pred cceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEE
Confidence 3889999999999996543 2 2289998854333455677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
+|.||+|.+++++.+. .++..++..++.+.|.||+|||+++ +|||||.++|+|++.++.+||+|||+++.-..
T Consensus 242 l~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~ 314 (474)
T KOG0194|consen 242 LCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ 314 (474)
T ss_pred ecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcc
Confidence 9999999999987643 4788899999999999999999766 99999999999999999999999999876431
Q ss_pred CCCce-eeccccCccccCcccccccCc
Q 043136 870 DESMS-VIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 870 ~~~~~-~~~Gt~~y~APE~~~~~~~~p 895 (902)
..... ...-...|+|||.+......+
T Consensus 315 ~~~~~~~~klPirWLAPEtl~~~~~s~ 341 (474)
T KOG0194|consen 315 YVMKKFLKKLPIRWLAPETLNTGIFSF 341 (474)
T ss_pred eeeccccccCcceecChhhhccCcccc
Confidence 11111 112345899999997764443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=249.16 Aligned_cols=171 Identities=29% Similarity=0.344 Sum_probs=144.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.||+|++........+..+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345688999999999999764 6889999998544333334456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++...+ .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 83 VPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999987543 3567777889999999999999766 999999999999999999999999999876432
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|+|||++.+..
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~ 174 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKG 174 (291)
T ss_pred --cccccCChhhcCHHHHcCCC
Confidence 23467999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-26 Score=251.41 Aligned_cols=170 Identities=29% Similarity=0.389 Sum_probs=144.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|++++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 445688999999999999765 5889999998644333334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 83 VPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999997543 3567778889999999999999766 99999999999999999999999999986543
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.....+||+.|+|||++.+.
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~ 173 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGK 173 (333)
T ss_pred -ccCCcccCccccChhHhcCC
Confidence 23456799999999998765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-27 Score=249.31 Aligned_cols=170 Identities=28% Similarity=0.370 Sum_probs=144.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.+ .+++.||+|++.-.. ...+.+++++|+.++.+++++||.++|+.|.....+|++|||
T Consensus 15 ~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 15 YTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 33447899999999999954 568999999985433 334567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
|.||++.+.++.... .++..+..|++++..|+.|+|+++ .+|||||+.||++..+|.||++|||++......
T Consensus 93 ~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred hcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999975432 244555568899999999999766 999999999999999999999999999887654
Q ss_pred CC-ceeeccccCccccCccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ..+++|||.|||||++.+.
T Consensus 165 ~~rr~tfvGTPfwMAPEVI~~~ 186 (467)
T KOG0201|consen 165 VKRRKTFVGTPFWMAPEVIKQS 186 (467)
T ss_pred hhccccccccccccchhhhccc
Confidence 43 3789999999999999863
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.7e-26 Score=249.40 Aligned_cols=169 Identities=23% Similarity=0.313 Sum_probs=142.4
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
++||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++.++ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999764 6889999998654333334456678899999988 799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-cCCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QSDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~~~ 872 (902)
|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.. .....
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~ 152 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence 99998886542 3677888899999999999999766 999999999999999999999999998753 22333
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|+|||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGED 172 (329)
T ss_pred cccccCCccccCHHHHcCCC
Confidence 45578999999999997654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=235.54 Aligned_cols=144 Identities=28% Similarity=0.372 Sum_probs=126.9
Q ss_pred cEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|.-|+||+|+..+ +..+|+|++.+..........+++.|.+||+.++||.++.+|+.++.+++.|+|||||+||
T Consensus 83 k~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGG 162 (459)
T KOG0610|consen 83 KRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGG 162 (459)
T ss_pred HHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCc
Confidence 569999999999998765 5899999997766666666677889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|..+.+++.. ..++...+.-++.+|+-||+|||..| ||+||+||+||||.++|++-++||.++.
T Consensus 163 dL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 163 DLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred cHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccc
Confidence 99998876543 34666667778899999999999766 9999999999999999999999998764
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=251.20 Aligned_cols=172 Identities=25% Similarity=0.347 Sum_probs=142.4
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|+.. +++.||+|++.............+.+|++++.+++||+|+++++++.+.+..|+||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~ 83 (360)
T cd05627 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFL 83 (360)
T ss_pred eEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 34578999999999999664 68899999985433333344566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++.... .++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 84 PGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred CCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999987543 3667778889999999999999665 9999999999999999999999999987543211
Q ss_pred ------------------------------------CceeeccccCccccCcccccc
Q 043136 872 ------------------------------------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ------------------------------------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+||+.|||||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~ 212 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG 212 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC
Confidence 012357999999999986654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=252.62 Aligned_cols=175 Identities=26% Similarity=0.443 Sum_probs=144.5
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecc-cchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--eeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWG-KHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--CTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~-~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--~~~lv~ 788 (902)
.++.+||+|+|-+||+|-+ .+|..||--.+.. +........+++..|+++++.++||||+++|++|.+.. ...+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4568899999999999955 3577776332211 11233455688999999999999999999999998765 477899
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeecccceec
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLI 867 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~ 867 (902)
|.+..|+|..|.++.++ .+....+.|++||++||.|||++ .++|||||||-+||+|+.. |.|||+|.|+|+..
T Consensus 123 EL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999988765 56678889999999999999998 6899999999999999754 89999999999987
Q ss_pred cCCCCceeeccccCccccCcccccccC
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
....... .+|||.|||||+|...|..
T Consensus 197 r~s~aks-vIGTPEFMAPEmYEE~YnE 222 (632)
T KOG0584|consen 197 RKSHAKS-VIGTPEFMAPEMYEENYNE 222 (632)
T ss_pred hccccce-eccCccccChHHHhhhcch
Confidence 6665544 8999999999999765544
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=247.26 Aligned_cols=170 Identities=24% Similarity=0.301 Sum_probs=141.6
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 5789999998654333334455677899988776 799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++...+ .+++.....++.|++.|++|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~ 152 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT 152 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence 99998876532 3677888899999999999999766 9999999999999999999999999997642 2233
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDY 173 (329)
T ss_pred cccccCCccccCHHHHcCCCC
Confidence 345689999999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=245.90 Aligned_cols=170 Identities=23% Similarity=0.295 Sum_probs=143.0
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++.++ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 5789999999654433444556688899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++...+ .+++..+..++.|++.|++|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 152 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT 152 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence 99998886432 3678888899999999999999766 9999999999999999999999999997632 2333
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEY 173 (327)
T ss_pred eecccCCcccCCHHHHCCCCC
Confidence 455789999999999976543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=246.22 Aligned_cols=169 Identities=31% Similarity=0.371 Sum_probs=137.3
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHH-HHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVD-VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 58899999986443333333445556655 57888999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+.+.... .++......++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET 152 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence 99988876432 3566777789999999999999665 9999999999999999999999999987642 2233
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|+|||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEP 172 (321)
T ss_pred cccccCCcccCCHHHhcCCC
Confidence 34567999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8e-27 Score=233.88 Aligned_cols=176 Identities=27% Similarity=0.341 Sum_probs=150.0
Q ss_pred CcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
-+++|+|.||+|..|+ ..+++.||+|++++.......+...-..|-++++..+||.+..+...|+..+..|+||||+.|
T Consensus 173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG 252 (516)
T KOG0690|consen 173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG 252 (516)
T ss_pred HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence 3789999999999995 457999999998765555555556677899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee-ccCCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~-~~~~~~ 872 (902)
|.|...+.+.+ .+++....-+...|+.||.|||+.+ ||+||+|.+|.++|.||++||+|||+++. +..+..
T Consensus 253 GeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t 324 (516)
T KOG0690|consen 253 GELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT 324 (516)
T ss_pred ceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccce
Confidence 99998887543 3444555567888999999999766 99999999999999999999999999986 355666
Q ss_pred ceeeccccCccccCcccc-cccCceee
Q 043136 873 MSVIAGSYGYIAPGTFCF-CFSVPFCW 898 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~-~~~~p~~~ 898 (902)
..++||||.|.|||++.. .|+..++|
T Consensus 325 ~kTFCGTPEYLAPEVleDnDYgraVDW 351 (516)
T KOG0690|consen 325 TKTFCGTPEYLAPEVLEDNDYGRAVDW 351 (516)
T ss_pred eccccCChhhcCchhhccccccceeeh
Confidence 788999999999999966 66777776
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=239.85 Aligned_cols=169 Identities=28% Similarity=0.431 Sum_probs=143.3
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.++++|.|.||+||-|.+ ++|+.||||++.+.... .+....+.+|+.|++.++||.||.+.-.|++.+..++|||-+
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl- 645 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL- 645 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-
Confidence 368999999999999955 57999999999654332 233467889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEEEeecccceeccC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEARVADFGVAKLIQS 869 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla~~~~~ 869 (902)
.||..+++-....+ .+++...+-+..||+.||.|||.++ |||+|+||+|||+... -.+||||||+|+.+.+
T Consensus 646 ~GDMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE 719 (888)
T KOG4236|consen 646 HGDMLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE 719 (888)
T ss_pred cchHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence 66887777654332 3556666678899999999999776 9999999999999543 4699999999999988
Q ss_pred CCCceeeccccCccccCcccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.....+.+|||.|.|||+++.
T Consensus 720 ksFRrsVVGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 720 KSFRRSVVGTPAYLAPEVLRN 740 (888)
T ss_pred hhhhhhhcCCccccCHHHHhh
Confidence 888888999999999999964
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=245.50 Aligned_cols=169 Identities=28% Similarity=0.371 Sum_probs=139.2
Q ss_pred cEeeecCceEEEEEEe----CCCcEEEEEEecccch-hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 716 KILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+.||+|+||.||+|+. ..++.||+|.+..... ........+.+|++++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 3578999999854322 1223345577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS- 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~- 869 (902)
+++|+|.+++.... .+.+.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999986543 3556677788999999999999766 99999999999999999999999999976432
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......+||+.|+|||++.+..
T Consensus 154 ~~~~~~~~gt~~y~aPE~~~~~~ 176 (323)
T cd05584 154 GTVTHTFCGTIEYMAPEILMRSG 176 (323)
T ss_pred CCcccccCCCccccChhhccCCC
Confidence 22234467999999999987653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=246.24 Aligned_cols=170 Identities=29% Similarity=0.364 Sum_probs=138.3
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHH-HHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVD-VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||+||+|+.. +++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999764 68999999985443322233344555655 45778999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... ..++.....++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 152 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT 152 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence 99999886532 3667778889999999999999766 9999999999999999999999999987642 2233
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|||||++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPY 173 (323)
T ss_pred cccccCChhhcChhhhcCCCC
Confidence 445679999999999876543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=251.03 Aligned_cols=173 Identities=22% Similarity=0.257 Sum_probs=144.1
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34566789999999999999764 57899999985433333334456778999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++|+|.+++... .++......++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+...
T Consensus 123 Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 123 EYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred cCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999998643 2456667789999999999999766 9999999999999999999999999998764
Q ss_pred CCCC--ceeeccccCccccCccccc
Q 043136 869 SDES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
.... ....+||+.|||||++.+.
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~l~~~ 218 (371)
T cd05622 194 KEGMVRCDTAVGTPDYISPEVLKSQ 218 (371)
T ss_pred cCCcccccCcccCccccCHHHHhcc
Confidence 3322 2356799999999998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=244.26 Aligned_cols=178 Identities=27% Similarity=0.415 Sum_probs=143.0
Q ss_pred HHhccCCcEeeecCceEEEEEEeCC-----------------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCee
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMPG-----------------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nI 771 (902)
...|.+.+.||+|+||.||+|.+.+ +..||+|.+.... .......+.+|++++.+++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence 3456678899999999999996532 3469999885432 22345678899999999999999
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccC--------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--------------ENLVADWVTRYKIALGVAQGICYLHHDCDPV 837 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 837 (902)
+++++++.+.+..++||||+++|+|.+++...... ....+++....+++.|++.|++|||+.+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--- 158 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--- 158 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence 99999999999999999999999999998653211 1124677788899999999999999765
Q ss_pred eEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 838 ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+||||||+||+++.++.+||+|||+++....... .....++..|||||++.+.
T Consensus 159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999999987643322 1223457889999998654
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=245.18 Aligned_cols=169 Identities=28% Similarity=0.358 Sum_probs=138.4
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
++||+|+||.||+|+.. +++.||+|++...........+....|.+++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 5788999998643322233344556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-CCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~ 872 (902)
|+|.+++.... .++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.... ...
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~ 152 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence 99999886543 3667778889999999999999765 99999999999999999999999999986532 233
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|||||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQK 172 (316)
T ss_pred cccccCCccccCHHHHcCCC
Confidence 44568999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=246.37 Aligned_cols=169 Identities=27% Similarity=0.370 Sum_probs=140.2
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 5889999998543322233445677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~ 152 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT 152 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence 99999886543 3667788899999999999999666 9999999999999999999999999988643 2233
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|||||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEML 172 (320)
T ss_pred ccccccCccccCHHHHcCCC
Confidence 44567999999999997654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=246.17 Aligned_cols=170 Identities=28% Similarity=0.343 Sum_probs=140.5
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
++||+|+||.||+|+.. +++.||+|++.+.........+.+..|.+++..+ +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 5789999998644333334455677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-CCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-DES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-~~~ 872 (902)
|+|.+++...+ .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.... ...
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~ 152 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT 152 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence 99998886543 3667778889999999999999766 99999999999999999999999999986432 223
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEY 173 (321)
T ss_pred ccccccCccccCHHHHcCCCC
Confidence 345679999999999876433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=245.77 Aligned_cols=169 Identities=31% Similarity=0.367 Sum_probs=138.3
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHH-HhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDV-LGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||+||+|+. .+++.||+|++.+...........+.+|..+ ++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999965 4689999999865433333344455666654 6778999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 152 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT 152 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence 99998886432 3677788899999999999999665 9999999999999999999999999987542 2233
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|||||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQP 172 (325)
T ss_pred cccccCChhhCCHHHHcCCC
Confidence 44567999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=257.52 Aligned_cols=175 Identities=29% Similarity=0.473 Sum_probs=145.2
Q ss_pred CCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 714 SDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.||+|+||+||+|+.. +...||||.++.. ...+.+.+|.+|++.+..++|||||+++|+|..++.+|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~Mv 567 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMV 567 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEE
Confidence 4578999999999999643 3567999998433 3445678899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCC---------CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 788 YEYMPNGNLDDLLHAKNKGE---------NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~---------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
+|||..|||.++++...... +.++...+.+.|+.|||.|++||-+++ +|||||..+|+||.+...|||
T Consensus 568 FEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKI 644 (774)
T KOG1026|consen 568 FEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKI 644 (774)
T ss_pred EEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEe
Confidence 99999999999998654321 234788889999999999999999776 999999999999999999999
Q ss_pred eecccceeccCCCCcee---eccccCccccCccccccc
Q 043136 859 ADFGVAKLIQSDESMSV---IAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 859 ~DFGla~~~~~~~~~~~---~~Gt~~y~APE~~~~~~~ 893 (902)
+|||++|.+-..+.++. ..=..+|||||.+.+.-.
T Consensus 645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF 682 (774)
T KOG1026|consen 645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF 682 (774)
T ss_pred cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc
Confidence 99999997654433321 122458999999977543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=250.03 Aligned_cols=172 Identities=23% Similarity=0.271 Sum_probs=142.2
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3456688999999999999764 688999999854322222334557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++... .++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 124 y~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 124 YMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999988643 2455667788999999999999765 99999999999999999999999999987643
Q ss_pred CC--CceeeccccCccccCccccc
Q 043136 870 DE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....+||+.|||||++.+.
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~~~~~ 218 (370)
T cd05596 195 NGMVRCDTAVGTPDYISPEVLKSQ 218 (370)
T ss_pred CCcccCCCCCCCcCeECHHHhccC
Confidence 32 22346799999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=234.04 Aligned_cols=165 Identities=28% Similarity=0.473 Sum_probs=139.6
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-----CCeeEEEE
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-----RECTMLLY 788 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-----~~~~~lv~ 788 (902)
.+.||+|+||.|+.|.+ .+|+.||||++.... ......++..+|+++++.++|+||+.+.+++.. -+.+|+|+
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~ 105 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVF 105 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEeh
Confidence 47899999999999955 578999999995332 233455678899999999999999999998855 35789999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|+| +.||..+++..+ .+.......++.|+++||.|+|+.+ |+|||+||+|++++.+..+||+|||+|+...
T Consensus 106 elM-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 106 ELM-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred hHH-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecc
Confidence 999 669999997653 2566777789999999999999766 9999999999999999999999999999885
Q ss_pred C---CCCceeeccccCccccCccc
Q 043136 869 S---DESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 869 ~---~~~~~~~~Gt~~y~APE~~~ 889 (902)
. ....+..+.|.+|+|||.+.
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll 200 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLL 200 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHh
Confidence 3 44557788999999999983
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=250.06 Aligned_cols=173 Identities=29% Similarity=0.378 Sum_probs=145.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++.+...........+.+|++++..++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 445688999999999999764 6899999998644332223456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... .++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 83 MPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 99999999987642 3677788899999999999999765 999999999999999999999999999876443
Q ss_pred C------------------------------CceeeccccCccccCcccccc
Q 043136 871 E------------------------------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~------------------------------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP 206 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC
Confidence 2 223457999999999997763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-26 Score=244.27 Aligned_cols=167 Identities=28% Similarity=0.495 Sum_probs=140.9
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
..-.++|.+- +-+|.|+.|.||+|++ .++.||||++..- -..+|+-|++++||||+.+.|+|..
T Consensus 120 eiPFe~IsEL-----eWlGSGaQGAVF~Grl-~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtq 183 (904)
T KOG4721|consen 120 EIPFEEISEL-----EWLGSGAQGAVFLGRL-HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQ 183 (904)
T ss_pred cCCHHHhhhh-----hhhccCcccceeeeec-cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecC
Confidence 3445565544 4589999999999998 5688999997211 1247888999999999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
...+|||||||+.|-|+++++..+ ++.....+.|..+||.|+.|||.+ +|||||+|.-||||..+..|||+|
T Consensus 184 sPcyCIiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 184 SPCYCIIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred CceeEEeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEecc
Confidence 999999999999999999998654 345556678999999999999955 499999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||.++...+....-.++||..|||||++...
T Consensus 256 FGTS~e~~~~STkMSFaGTVaWMAPEvIrne 286 (904)
T KOG4721|consen 256 FGTSKELSDKSTKMSFAGTVAWMAPEVIRNE 286 (904)
T ss_pred ccchHhhhhhhhhhhhhhhHhhhCHHHhhcC
Confidence 9999987666556678999999999999654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.4e-25 Score=244.89 Aligned_cols=172 Identities=27% Similarity=0.285 Sum_probs=143.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.++..++|+||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 445688999999999999764 5889999998543333334456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 83 YVGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred CCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999865322 3567778889999999999999766 999999999999999999999999999876433
Q ss_pred CC--ceeeccccCccccCcccc
Q 043136 871 ES--MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~--~~~~~Gt~~y~APE~~~~ 890 (902)
.. ....+||+.|||||++..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQA 177 (331)
T ss_pred CCccccceeccccccCHHHHhh
Confidence 32 223579999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.1e-26 Score=239.80 Aligned_cols=179 Identities=27% Similarity=0.325 Sum_probs=156.1
Q ss_pred HHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+...|..++.||+|-|++|-.|++ -+|++||||++.+...+ ......+.+|++.|+-++|||||++|++.......|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 345678889999999999999954 58999999999665443 3445668899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cCCCCEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL-DGEMEARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl-~~~~~~kl~DFGla~ 865 (902)
|+|+-++|||++++-+...+ +.+....+++.||+.|+.|+|..| +||||+||+|+++ ..-|-||+.|||++-
T Consensus 95 iLELGD~GDl~DyImKHe~G----l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEG----LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred EEEecCCchHHHHHHhhhcc----ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccc
Confidence 99999999999999776543 455666789999999999999888 9999999999977 456899999999999
Q ss_pred eccCCCCceeeccccCccccCcccccccC
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.+.++....+.||+..|.|||++.|.-++
T Consensus 168 kf~PG~kL~TsCGSLAYSAPEILLGDsYD 196 (864)
T KOG4717|consen 168 KFQPGKKLTTSCGSLAYSAPEILLGDSYD 196 (864)
T ss_pred cCCCcchhhcccchhhccCchhhhcCccC
Confidence 99999999999999999999999887654
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-28 Score=249.37 Aligned_cols=375 Identities=19% Similarity=0.208 Sum_probs=172.6
Q ss_pred CCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC-ccCcccCCccccCCCCccEEec
Q 043136 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA-CNLSGTLPSEISNLTKLEMLLL 277 (902)
Q Consensus 199 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L 277 (902)
.-..++|..|+|+.+.|.+|+.+++|++|||++|+|+.+-|.+|.++.+|..|-+.+ |+|+......|.+|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 344455555555544444555555555555555555555555555555544443333 5555433344555555555555
Q ss_pred CCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccc
Q 043136 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 278 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 357 (902)
.-|++.-.....|..+++|..|.+.+|.+..+--..|..+..++.+.+..|.+... .+++.+.. +...
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icd-----CnL~wla~-------~~a~ 215 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICD-----CNLPWLAD-------DLAM 215 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccc-----cccchhhh-------HHhh
Confidence 55555544444455555555555555555422222455555555555555542100 00000000 1112
Q ss_pred cCccccCCCceeEEEecCCcccCCCCCCccCC-CCccEEeccCCcCccccc-ccccccCCCcEEEccCCccCCCCCcccC
Q 043136 358 LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIP-ENLVNCSSLSRLRIQDNQLNGSIPQGFG 435 (902)
Q Consensus 358 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~-~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~~~ 435 (902)
.|..++......-..+.++++...-+.-|... ..+..-..+.....+.-| ..|..+++|+.|+|++|+|+++-+.+|.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe 295 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE 295 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence 22222332223333333333332222111111 011111111111122222 1244445555555555555544444555
Q ss_pred CCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCC---------------
Q 043136 436 LLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG--------------- 500 (902)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--------------- 500 (902)
.+..++.|.|..|+|...-...|.++..|+.|+|.+|+|+..-|.+|..+..|..|+|-.|.+.-
T Consensus 296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~ 375 (498)
T KOG4237|consen 296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKS 375 (498)
T ss_pred chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCC
Confidence 55555555555555543333444445555555555555554445555544455555444443311
Q ss_pred --CcccccccccccEEeccCccc------------------------------------cccCCccccccccceEEEeeC
Q 043136 501 --KIPDFIGCKSIYKIELHNNLL------------------------------------NGSIPWDIGHCEKLLLLNLSR 542 (902)
Q Consensus 501 --~~p~~~~~~~l~~l~Ls~N~l------------------------------------~g~ip~~~~~l~~L~~L~Ls~ 542 (902)
..|....-..++.++++++-+ ...+|..+. ..-.+|+|.+
T Consensus 376 ~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~g 453 (498)
T KOG4237|consen 376 VVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDG 453 (498)
T ss_pred CCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhccc
Confidence 011111111222333332222 123333321 2345688888
Q ss_pred CcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCC
Q 043136 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591 (902)
Q Consensus 543 N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N 591 (902)
|.++ .+|.+ .+..| .+|||+|+++-.--..|.+++.|.+|-+|||
T Consensus 454 n~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 454 NAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred chhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 8888 56665 66777 8899999888666677888888888888887
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=243.87 Aligned_cols=172 Identities=27% Similarity=0.271 Sum_probs=143.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|.+.+...........+.+|+.++..++|++|+++++++.+.+..|+||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 445688999999999999764 5788999998543333333445577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .+++.....++.|++.||+|+|+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 83 YVGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred CCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999975322 3567777889999999999999665 999999999999999999999999999876543
Q ss_pred CCc--eeeccccCccccCcccc
Q 043136 871 ESM--SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~--~~~~Gt~~y~APE~~~~ 890 (902)
... ...+||+.|||||++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQA 177 (331)
T ss_pred CceeeccccCCcccCCHHHHhc
Confidence 322 23579999999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=243.43 Aligned_cols=167 Identities=29% Similarity=0.362 Sum_probs=140.7
Q ss_pred cEeeecCceEEEEEEe----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|+||.||+++. .+++.||+|++..... .......+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999964 3578999999854322 2233455678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD- 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~- 870 (902)
++|+|.+++.... .+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 152 (318)
T cd05582 81 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE 152 (318)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence 9999999886532 3678888999999999999999766 999999999999999999999999999876443
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......||+.|+|||++.+.
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~ 173 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRR 173 (318)
T ss_pred CceecccCChhhcCHHHHcCC
Confidence 233456899999999998654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-26 Score=229.43 Aligned_cols=166 Identities=25% Similarity=0.401 Sum_probs=139.1
Q ss_pred cCCcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
..++.||+|+|+.|--| ...++.+||||++.+. ....+.++.+|++++..++ |+||++++++|+++..+|+|||-
T Consensus 81 Lt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 81 LTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred hHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 44578999999999988 5678999999999544 3345677899999999994 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEeecccceec
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVADFGVAKLI 867 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~~ 867 (902)
|.||.|...+++++. +.+.+.-++..+|+.||.|||.++ |.|||+||+|||..... -+||+||.++.-+
T Consensus 158 m~GGplLshI~~~~~-----F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 158 MRGGPLLSHIQKRKH-----FNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred ccCchHHHHHHHhhh-----ccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 999999999987654 566677789999999999999666 99999999999996654 4899999887655
Q ss_pred cCC--------CCceeeccccCccccCccc
Q 043136 868 QSD--------ESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 868 ~~~--------~~~~~~~Gt~~y~APE~~~ 889 (902)
... ....+.+|+..|||||+..
T Consensus 230 k~~~~~spastP~L~tPvGSAEfMAPEVVd 259 (463)
T KOG0607|consen 230 KLNNDCSPASTPELLTPVGSAEFMAPEVVD 259 (463)
T ss_pred ccCCCCCCCCCccccCcccchhhcchhHHh
Confidence 321 1234578999999999974
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=243.29 Aligned_cols=172 Identities=26% Similarity=0.316 Sum_probs=141.5
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc-CeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|++++..++| ++|+++++++.+.+..|+||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45678999999999999764 578899999864433233445667889999999865 5688999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-C
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-S 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~ 869 (902)
+++|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++... .
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 83 VNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999886543 3567788889999999999999765 9999999999999999999999999987542 2
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......+||+.|+|||++.+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~ 177 (324)
T cd05587 155 GKTTRTFCGTPDYIAPEIIAYQP 177 (324)
T ss_pred CCceeeecCCccccChhhhcCCC
Confidence 33345578999999999997654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=252.24 Aligned_cols=168 Identities=27% Similarity=0.467 Sum_probs=143.2
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------eeEEE
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------CTMLL 787 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~~~lv 787 (902)
++.||+||||.||+++. .+|+.||||.+.+.. ..+.++...+|++++++++|||||+++++-++.. ...+|
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 46799999999999984 579999999885433 3455677889999999999999999999876543 56899
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCCC--CEEEeeccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL--DGEM--EARVADFGV 863 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl--~~~~--~~kl~DFGl 863 (902)
||||.||||+..+..... ..-+++.....+..+++.||.|||.++ ||||||||.||++ ..+| ..||+|||.
T Consensus 96 mEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999976432 234777888899999999999999665 9999999999998 3344 379999999
Q ss_pred ceeccCCCCceeeccccCccccCccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
|+...++....+.+||+.|.|||++.
T Consensus 171 Arel~d~s~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 171 ARELDDNSLFTSLVGTEEYLHPELYE 196 (732)
T ss_pred cccCCCCCeeeeecCchhhcChHHHh
Confidence 99999888889999999999999997
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-24 Score=273.14 Aligned_cols=346 Identities=21% Similarity=0.275 Sum_probs=180.0
Q ss_pred hhhhccCCCcEEEccCCCC------CCCCCccccccc-ccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCc
Q 043136 120 PAILELTKLRTIDISHNSF------NSTFPPGISKLR-FLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192 (902)
Q Consensus 120 ~~~~~l~~L~~L~Ls~N~l------~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 192 (902)
.+|.++++|+.|.+..+.+ ...+|..+..++ +|+.|++.+|.+. .+|..| ...+|++|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 3455566666666544432 223344444432 3555555544443 233333 2345555555555554 3344
Q ss_pred ccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCc
Q 043136 193 DYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKL 272 (902)
Q Consensus 193 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 272 (902)
.+..+++|++|+|++|.....+|. ++.+++|++|+|++|..-..+|..+..+++|++|++++|..-+.+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 444555555555554433333432 4445555555555544333455555555555555555543333444333 44555
Q ss_pred cEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCc
Q 043136 273 EMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNN 352 (902)
Q Consensus 273 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 352 (902)
+.|+|++|...+.+|.. .++|++|+|++|.++ .+|..+ .+++|++|++.++... .+. +
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~-~l~----------------~ 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSE-KLW----------------E 764 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchh-hcc----------------c
Confidence 55555554433333321 234455555555543 233332 3444444444432210 000 0
Q ss_pred eeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCc
Q 043136 353 HLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432 (902)
Q Consensus 353 ~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 432 (902)
.+....+..+...++|+.|++++|...+.+|..++++++|+.|++++|+..+.+|..+ ++++|+.|+|++|..-..+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 0111111112233456666777666666666667777777777777665555666655 567777777777654445554
Q ss_pred ccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCc
Q 043136 433 GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497 (902)
Q Consensus 433 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 497 (902)
. .++|+.|+|++|.++ .+|.++..+++|+.|+|++|+--..+|..+..+++|+.++++++.
T Consensus 844 ~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 I---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred c---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 2 356777888888777 567777778888888887743334567777777788887777653
|
syringae 6; Provisional |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=247.13 Aligned_cols=178 Identities=27% Similarity=0.378 Sum_probs=139.6
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC-
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR- 781 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~- 781 (902)
..+.+.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3456678999999999999963 235679999985332 223456688999999999 899999999988764
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccC-------------------------------------------------------
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKG------------------------------------------------------- 806 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 806 (902)
+..++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4588999999999999998753210
Q ss_pred --CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---ceeeccccC
Q 043136 807 --ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYG 881 (902)
Q Consensus 807 --~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~ 881 (902)
....+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .....+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0123667778889999999999999765 99999999999999999999999999986543221 122346678
Q ss_pred ccccCcccccc
Q 043136 882 YIAPGTFCFCF 892 (902)
Q Consensus 882 y~APE~~~~~~ 892 (902)
|||||++.+..
T Consensus 242 y~aPE~~~~~~ 252 (338)
T cd05102 242 WMAPESIFDKV 252 (338)
T ss_pred ccCcHHhhcCC
Confidence 99999986543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=238.30 Aligned_cols=175 Identities=29% Similarity=0.342 Sum_probs=145.5
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||++.. .+++.||+|++.............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 34557899999999999976 46889999998544333333345577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... ..+++.....++.|++.|++|||+.+ ++||||||+||++++++.++|+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 82 MNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred cCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 999999988864321 24678888899999999999999766 999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......+|++.|+|||++.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~ 177 (285)
T cd05605 156 ETIRGRVGTVGYMAPEVVKNER 177 (285)
T ss_pred CccccccCCCCccCcHHhcCCC
Confidence 4444567999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=238.43 Aligned_cols=171 Identities=29% Similarity=0.365 Sum_probs=141.8
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||+||+|... +++.||+|++...........+.+..|++++++++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999654 6889999998644333333445677899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC-cee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES-MSV 875 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~-~~~ 875 (902)
.+++..... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence 988754322 2235778888899999999999999765 99999999999999999999999999987644322 334
Q ss_pred eccccCccccCcccccc
Q 043136 876 IAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 876 ~~Gt~~y~APE~~~~~~ 892 (902)
..||+.|+|||++.+..
T Consensus 157 ~~g~~~y~aPE~~~~~~ 173 (280)
T cd05608 157 YAGTPGFMAPELLQGEE 173 (280)
T ss_pred cCCCcCccCHHHhcCCC
Confidence 57999999999997653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=244.08 Aligned_cols=169 Identities=29% Similarity=0.349 Sum_probs=135.9
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHH-HHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVD-VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999764 57889999986433222223334444544 46778999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .........++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~ 152 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT 152 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence 99999887533 2455667789999999999999766 9999999999999999999999999997643 2333
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|||||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQP 172 (325)
T ss_pred cccccCCccccCHHHHcCCC
Confidence 45568999999999987653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-24 Score=274.78 Aligned_cols=305 Identities=22% Similarity=0.277 Sum_probs=158.5
Q ss_pred ccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecC
Q 043136 272 LEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351 (902)
Q Consensus 272 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 351 (902)
|+.|.+.+|.+. .+|..| ...+|++|+|++|++. .++..+..+++|+.|+|+++...+.+|. +..+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 455555544444 334433 2344555555555544 2344444455555555554433333432 44444555555555
Q ss_pred ceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCC
Q 043136 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP 431 (902)
Q Consensus 352 N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 431 (902)
|..-..+|..+..+++|+.|++++|..-+.+|..+ ++.+|+.|++++|.....+|.. .++|+.|+|++|.++ .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 44333444455555555555555543333444433 4455555555555444444432 234556666666654 444
Q ss_pred cccCCCCCCcEEEccCccc-------CCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCccc
Q 043136 432 QGFGLLPNLTFMDMSRNSL-------SGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD 504 (902)
Q Consensus 432 ~~~~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 504 (902)
..+ .+++|+.|+++++.. ....|..+...++|+.|+|++|...+.+|.+++++++|+.|++++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 443 355555555554321 111111222334566666666665556666666666666666666554445555
Q ss_pred ccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccC-CcccccCCCCCcCCccc
Q 043136 505 FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSH-NFLTGTIPSNFENCSTL 583 (902)
Q Consensus 505 ~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~l~~L 583 (902)
...+++|+.|+|++|..-..+|.. ..+|+.|+|++|.++ .+|.++..+++|+.|+|++ |+|+ .+|..+..+++|
T Consensus 821 ~~~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L 895 (1153)
T PLN03210 821 GINLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHL 895 (1153)
T ss_pred CCCccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCC
Confidence 555666666666665444444432 245666666666666 4566666666666666666 4444 456666666666
Q ss_pred eeecccCC
Q 043136 584 ESFNVSYN 591 (902)
Q Consensus 584 ~~l~ls~N 591 (902)
+.++++++
T Consensus 896 ~~L~l~~C 903 (1153)
T PLN03210 896 ETVDFSDC 903 (1153)
T ss_pred CeeecCCC
Confidence 66666655
|
syringae 6; Provisional |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-25 Score=243.15 Aligned_cols=173 Identities=26% Similarity=0.313 Sum_probs=142.0
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+||.||+|+.. +++.||+|++.+.........+....|.+++..+ +|++|+++++++.+.+..|+||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 34578999999999999764 5789999998654333333445567788888777 589999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-C
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-S 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~ 869 (902)
+++|+|.+.+.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++... .
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 83 VNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999998886543 3667788899999999999999765 9999999999999999999999999998643 2
Q ss_pred CCCceeeccccCccccCccccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.......+||+.|+|||++.+...
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~ 178 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPY 178 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCC
Confidence 233345679999999999976543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=242.91 Aligned_cols=170 Identities=29% Similarity=0.349 Sum_probs=139.1
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+.........+....|.+++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999764 5889999998543222223344566788888754 899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence 99999886532 3567778889999999999999766 9999999999999999999999999987542 2233
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~ 173 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKY 173 (316)
T ss_pred eeccCCCcCccCHHHHcCCCC
Confidence 455789999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=243.58 Aligned_cols=172 Identities=25% Similarity=0.298 Sum_probs=144.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 44568899999999999965 46889999998654333334556688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 83 QPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999976422 3677778889999999999999766 999999999999999999999999999876543
Q ss_pred CCc--eeeccccCccccCcccc
Q 043136 871 ESM--SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~--~~~~Gt~~y~APE~~~~ 890 (902)
... ....||+.|+|||++..
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred CceeeecccCCccccCHHHhcc
Confidence 322 33579999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-25 Score=243.51 Aligned_cols=171 Identities=29% Similarity=0.393 Sum_probs=139.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHH---hcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVL---GNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il---~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.+.+.||+|+||.||+|.. .+++.||||++.+.........+.+.+|++++ +.++||||+++++++.+.+..|+||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 3457899999999999965 46899999998644322233345566676655 5668999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++|+|...++.. .+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 82 EYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred cCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999998887532 3678888899999999999999665 9999999999999999999999999987543
Q ss_pred C-CCCceeeccccCccccCcccccc
Q 043136 869 S-DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~-~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .......+||+.|||||++.+..
T Consensus 153 ~~~~~~~~~~g~~~y~aPE~~~~~~ 177 (324)
T cd05589 153 GFGDRTSTFCGTPEFLAPEVLTETS 177 (324)
T ss_pred CCCCcccccccCccccCHhHhcCCC
Confidence 2 22334567999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=241.49 Aligned_cols=169 Identities=29% Similarity=0.356 Sum_probs=138.7
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||+||+|+.. +++.||+|++...........+....|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999764 5789999998543222223344566788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... ..++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 152 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK 152 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence 99999987532 3667778889999999999999765 9999999999999999999999999987642 2233
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|||||++.+..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~ 172 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQK 172 (316)
T ss_pred eeeecCCccccCHHHHcCCC
Confidence 45568999999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=254.27 Aligned_cols=174 Identities=22% Similarity=0.259 Sum_probs=143.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-C-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-G-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|...+.||+|+||.||+|... + ++.||+|++... .......+.+|+++++.++|||||++++++...+..|+|||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 667789999999999999653 3 577888876432 22334557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.++++.... ....+++.....++.|++.||+|+|+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865322 2335677888889999999999999665 99999999999999999999999999987654
Q ss_pred CCC---ceeeccccCccccCcccccc
Q 043136 870 DES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
... ....+||+.|||||++.+..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 247 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKR 247 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCC
Confidence 322 34567999999999987653
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=241.55 Aligned_cols=172 Identities=26% Similarity=0.267 Sum_probs=142.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+++.. +++.||+|++.+...........+.+|+.++..++|++|+++++++.+.+..|+||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 345688999999999999764 4788999998543333333445578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 83 YVGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred cCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999975322 3667777889999999999999766 999999999999999999999999999765433
Q ss_pred CC--ceeeccccCccccCcccc
Q 043136 871 ES--MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~--~~~~~Gt~~y~APE~~~~ 890 (902)
.. ....+||+.|||||++.+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQA 177 (332)
T ss_pred CcceecccccCccccCHHHHhc
Confidence 22 223579999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=234.55 Aligned_cols=169 Identities=27% Similarity=0.356 Sum_probs=140.5
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+++.. +++.||+|++.............+..|++++++++||||+++++++.+....|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999754 5899999998543322222334456799999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVI 876 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 876 (902)
.+++..... ...++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++............
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR 154 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence 988864432 23677888889999999999999665 999999999999999999999999999877554444456
Q ss_pred ccccCccccCcccccc
Q 043136 877 AGSYGYIAPGTFCFCF 892 (902)
Q Consensus 877 ~Gt~~y~APE~~~~~~ 892 (902)
.||+.|+|||++.+..
T Consensus 155 ~~~~~y~aPE~~~~~~ 170 (277)
T cd05607 155 AGTNGYMAPEILKEEP 170 (277)
T ss_pred CCCCCccCHHHHccCC
Confidence 7999999999986654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-25 Score=241.78 Aligned_cols=172 Identities=26% Similarity=0.317 Sum_probs=141.2
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+..|++++..+. |++|+++++++.+.+..|+||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 34578999999999999754 68899999986433223334456778899988885 67888999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++.....++.|++.|++|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 83 VNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999886543 3677888999999999999999766 999999999999999999999999998864322
Q ss_pred -CCceeeccccCccccCcccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......+||+.|+|||++.+..
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~ 177 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQP 177 (323)
T ss_pred CccccCccCCccccCHHHHcCCC
Confidence 2234567999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=242.30 Aligned_cols=171 Identities=25% Similarity=0.279 Sum_probs=141.2
Q ss_pred cCCcEeeecCceEEEEEEe----CCCcEEEEEEecccch-hhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.||+|+||.||+|+. .+++.||+|++.+... ......+.+.+|+++++.+ +||+|+++++++...+..|+
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4567899999999999965 3578999999854321 1223345677899999999 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999986543 3667788899999999999999765 99999999999999999999999999986
Q ss_pred ccCCC--CceeeccccCccccCccccc
Q 043136 867 IQSDE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
..... .....+||+.|||||++.+.
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCC
Confidence 53322 23346799999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=240.50 Aligned_cols=170 Identities=29% Similarity=0.385 Sum_probs=141.3
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|+.. +++.||+|++.+...........+.+|++++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999764 5789999998644333334455677899999887 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 152 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT 152 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence 99998886542 3678888899999999999999665 9999999999999999999999999987642 2233
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|+|||++.+...
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~ 173 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPY 173 (318)
T ss_pred ccceecCccccCHHHhcCCCC
Confidence 345679999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=249.41 Aligned_cols=177 Identities=28% Similarity=0.504 Sum_probs=148.1
Q ss_pred HhccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..-.++++||.|.||+||+|+++. ...||||.++. ...++.+.+|+.|+.||.+++||||+++.|+......++
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~--GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA--GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeecc--CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 344678999999999999997642 45799999853 345577888999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
||.|||++|+|+.+++.+.. .+.+.+...+.++||.|+.||-.++ +|||||.++|||++.+..+||+|||++|
T Consensus 707 IiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSR 779 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 779 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccccee
Confidence 99999999999999987542 3677888899999999999999555 9999999999999999999999999999
Q ss_pred eccCCC-C-ceeecc--ccCccccCcccccccCc
Q 043136 866 LIQSDE-S-MSVIAG--SYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 866 ~~~~~~-~-~~~~~G--t~~y~APE~~~~~~~~p 895 (902)
.++++. . .++..| ..+|.|||.+.+--.++
T Consensus 780 vledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTs 813 (996)
T KOG0196|consen 780 VLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTS 813 (996)
T ss_pred ecccCCCccccccCCccceeecChhHhhhcccCc
Confidence 886554 2 222333 35799999997654443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=258.75 Aligned_cols=179 Identities=26% Similarity=0.332 Sum_probs=145.5
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.++||+|+||.||+|.+. +++.||+|++...........+++.+|++++++++||||+++++++.+.+..|+||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456689999999999999764 5899999998654444444566789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccC------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 791 MPNGNLDDLLHAKNKG------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++||+|.+++...... .....++...+.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|
T Consensus 84 ~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred CCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999998643211 1123456677889999999999999765 999999999999999999999999999
Q ss_pred eeccCCC-------------------CceeeccccCccccCccccccc
Q 043136 865 KLIQSDE-------------------SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 865 ~~~~~~~-------------------~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+...... .....+||+.|||||++.+...
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~ 208 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA 208 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC
Confidence 8762110 0122469999999999876543
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=245.07 Aligned_cols=179 Identities=30% Similarity=0.340 Sum_probs=147.3
Q ss_pred CCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-c-----CeeEeE
Q 043136 702 FTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H-----RNIVRL 774 (902)
Q Consensus 702 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-----~nIv~l 774 (902)
+...|.+..+|.+.++||+|+||+|.+|.+ .+++.||||+++++. ....+...|+.+|..++ | -|+|++
T Consensus 178 ~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 178 LVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred EEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 334455556888999999999999999955 569999999995443 34455677999999986 4 399999
Q ss_pred EeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-
Q 043136 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE- 853 (902)
Q Consensus 775 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~- 853 (902)
+++|..+++.|||+|.+ .-+|+++++..+.. .++......|+.||+.||.+||..+ |||+||||+|||+.+.
T Consensus 254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPK 326 (586)
T ss_pred eeccccccceeeeehhh-hhhHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCC
Confidence 99999999999999999 56999999876542 3677788899999999999999665 9999999999999654
Q ss_pred -CCEEEeecccceeccCCCCceeeccccCccccCccccccc
Q 043136 854 -MEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 854 -~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..+||+|||.|...... ..+.+-+..|+|||++.|..+
T Consensus 327 r~~vKVIDFGSSc~~~q~--vytYiQSRfYRAPEVILGlpY 365 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQR--VYTYIQSRFYRAPEVILGLPY 365 (586)
T ss_pred cCceeEEecccccccCCc--ceeeeeccccccchhhccCCC
Confidence 36999999999875433 336788999999999988543
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=241.02 Aligned_cols=166 Identities=26% Similarity=0.285 Sum_probs=135.9
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
||+|+||.||+|+.. +++.||+|++.+..............|..++.+. +||+|+++++++.+....|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999764 5899999998543332233344455677777655 699999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~ 872 (902)
|+|.+++.... .+++.....++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++... ....
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~ 152 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence 99998886532 3677888899999999999999766 9999999999999999999999999987643 2333
Q ss_pred ceeeccccCccccCccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~ 891 (902)
....+||+.|||||++.+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~ 171 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDE 171 (330)
T ss_pred ccCccCCccccCHHHHcCC
Confidence 4456899999999998653
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=235.78 Aligned_cols=169 Identities=27% Similarity=0.436 Sum_probs=138.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 455688999999999999664 6889999998543221 1234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ |+|.+++..... ..++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~ 156 (288)
T cd07871 85 LD-SDLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156 (288)
T ss_pred CC-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence 96 599988865322 3567778889999999999999765 999999999999999999999999999865322
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......||+.|+|||++.+
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 157 TKTYSNEVVTLWYRPPDVLLG 177 (288)
T ss_pred CccccCceecccccChHHhcC
Confidence 22344578999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=240.46 Aligned_cols=173 Identities=27% Similarity=0.361 Sum_probs=144.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. ++..||+|.+.... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4455688999999999999765 57889999885432 22345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... ..++..+..++.|++.|+.|||+.+ +|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 999999999987543 3677788899999999999999642 599999999999999999999999999986643
Q ss_pred CCCceeeccccCccccCccccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
. ......||+.|+|||++.+...
T Consensus 157 ~-~~~~~~g~~~y~aPE~~~~~~~ 179 (331)
T cd06649 157 S-MANSFVGTRSYMSPERLQGTHY 179 (331)
T ss_pred c-ccccCCCCcCcCCHhHhcCCCC
Confidence 2 2344679999999999976543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=232.53 Aligned_cols=173 Identities=27% Similarity=0.359 Sum_probs=144.2
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|.. .+++.||+|++...........+.+.+|+.++++++|++|+++++.+.+.+..|+||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 3457899999999999965 468899999986443333333455778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ..+++..+..++.|++.|++|+|+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 83 ~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 83 NGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred CCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 99999998864322 23677888899999999999999665 9999999999999999999999999998765444
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......||+.|||||++.+.
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~ 176 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNE 176 (285)
T ss_pred cccCCCCCccccChHHHcCC
Confidence 44456799999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-24 Score=232.02 Aligned_cols=174 Identities=27% Similarity=0.340 Sum_probs=144.7
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||+|+||+||+|.. .+++.||+|.+.............+.+|++++++++|++|+++++++..++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 457899999999999966 4688999999854433333334557789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+++|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 157 (285)
T cd05632 84 GGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES 157 (285)
T ss_pred CccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence 9999988865321 24788888999999999999999665 99999999999999999999999999977644433
Q ss_pred ceeeccccCccccCccccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.....|++.|+|||++.+...
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~ 178 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRY 178 (285)
T ss_pred ccCCCCCcCccChHHhcCCCC
Confidence 445679999999999876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8e-25 Score=249.69 Aligned_cols=176 Identities=26% Similarity=0.363 Sum_probs=142.5
Q ss_pred cCCcEeeecCceEEEEEEeCCC-cEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeE-Eec------CCe
Q 043136 713 MSDKILGMGSTGTVYKAEMPGG-EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGC-CSN------REC 783 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~-~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~-~~~------~~~ 783 (902)
.+++.|.+|||+.||.|+...+ .+||+|++... ++...+.+.+||++|++++ |+|||.+++. ... .-+
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4568999999999999987665 99999998655 3456677889999999996 9999999993 321 136
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
+++.||||+||.|-|++..+.... +.+.++++|+.|+++|+++||.. .++|||||||-||||++.+|..||||||.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~~---lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQTR---LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhcc---CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 789999999999999998765432 77889999999999999999987 68899999999999999999999999999
Q ss_pred ceeccCCC-Cc---------eeeccccCccccCcccccccCc
Q 043136 864 AKLIQSDE-SM---------SVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 864 a~~~~~~~-~~---------~~~~Gt~~y~APE~~~~~~~~p 895 (902)
|....... .. -...-|+.|+|||++.-.-+.|
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p 234 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP 234 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC
Confidence 87542221 11 1134699999999985433333
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=244.93 Aligned_cols=176 Identities=26% Similarity=0.369 Sum_probs=145.5
Q ss_pred cEeeecCceEEEEEEeCCCcE-EEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~-vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
..||.|+||.||+|..+.... .|.|.|.. ....+.++++-||+|+..++||+||++++.|..++..||+.|||.||
T Consensus 38 GELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 38 GELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred hhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 458999999999997665444 45666633 33456788999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-CCCCc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-SDESM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~~~~~ 873 (902)
-+..++-..+. ++...++..+++|++.||.|||++. |||||+|+.|||++-||.++++|||.+.... .....
T Consensus 115 AVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 115 AVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred hHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 99988876543 5778888899999999999999665 9999999999999999999999999876543 23445
Q ss_pred eeeccccCccccCccccc--ccCceeeecC
Q 043136 874 SVIAGSYGYIAPGTFCFC--FSVPFCWVDQ 901 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~--~~~p~~~~~~ 901 (902)
.++.|||+|||||+.... -..||++-.|
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaD 217 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKAD 217 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhh
Confidence 678999999999998543 3457776543
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=236.20 Aligned_cols=170 Identities=26% Similarity=0.381 Sum_probs=138.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 456689999999999999765 6889999998543221 1233467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ +++.+++..... .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 85 VH-TDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-cCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 95 688888764321 3566777889999999999999766 999999999999999999999999999765322
Q ss_pred -CCceeeccccCccccCccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......||+.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~ 178 (303)
T cd07869 157 SHTYSNEVVTLWYRPPDVLLGS 178 (303)
T ss_pred CccCCCCcccCCCCChHHHcCC
Confidence 223446789999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=239.73 Aligned_cols=174 Identities=26% Similarity=0.371 Sum_probs=144.4
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...|...+.||+|+||.||+|.+. ++..+|+|.+.... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 345666788999999999999765 57888998875432 223456688999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++|+|.+++.... ..++.....++.|++.|++|||+. .+|+||||||+||+++.++.+||+|||++...
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 82 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 99999999999987533 356777889999999999999963 24999999999999999999999999998765
Q ss_pred cCCCCceeeccccCccccCcccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
... ......||+.|+|||++.+..
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~ 178 (333)
T cd06650 155 IDS-MANSFVGTRSYMSPERLQGTH 178 (333)
T ss_pred hhh-ccccCCCCccccCHHHhcCCC
Confidence 332 223457999999999997653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.5e-26 Score=260.39 Aligned_cols=169 Identities=26% Similarity=0.294 Sum_probs=140.6
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+.++||+|+||.|..++++ +++.||+|++.+-.........-|..|-.+|.--+.+-||.++..|+++.+.|+|||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 4488999999999999764 588999999854322223334557788999998899999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
||||..++.+.. .++.....-++..|+.||.-+|+.| +|||||||+|||+|..|++|++|||.+-.+..++.
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999998654 2444445567788999999999766 99999999999999999999999999988875544
Q ss_pred c--eeeccccCccccCcccc
Q 043136 873 M--SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ~--~~~~Gt~~y~APE~~~~ 890 (902)
. ...+|||.|++||+++.
T Consensus 231 V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 231 VRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred EEeccccCCCCccCHHHHHh
Confidence 3 45789999999999953
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=243.00 Aligned_cols=176 Identities=30% Similarity=0.468 Sum_probs=141.3
Q ss_pred ccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
+.+.+.||+|+||.||+|+. .++..||||++.... .....+.+.+|++++..+ +||||+++++++...+..
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 45678999999999999953 235689999885332 223456788999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC----------------------------------------------------------
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKG---------------------------------------------------------- 806 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~---------------------------------------------------------- 806 (902)
++||||+++|+|.++++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 9999999999999998753210
Q ss_pred ------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc-
Q 043136 807 ------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM- 873 (902)
Q Consensus 807 ------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~- 873 (902)
....+++..+.+++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 1124677888999999999999999765 999999999999999999999999999876433221
Q ss_pred --eeeccccCccccCcccccc
Q 043136 874 --SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 --~~~~Gt~~y~APE~~~~~~ 892 (902)
....++..|||||++.+..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~ 292 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCV 292 (375)
T ss_pred ccCCCCCCcceeChhHhcCCC
Confidence 1233466799999987654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-26 Score=225.43 Aligned_cols=175 Identities=25% Similarity=0.394 Sum_probs=141.7
Q ss_pred ccCCcEeeecCceEEEEEEeC---C--CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP---G--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~---~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~ 785 (902)
|...+.||+|.||.||+|... + .+.+|+|++....... ..-....+|+..++.++||||+.+..++.. +..+|
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~t-GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGT-GISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCC-CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 445577999999999999322 2 3479999985432221 122345689999999999999999999877 77899
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CCEEEeec
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE----MEARVADF 861 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~----~~~kl~DF 861 (902)
+++||++. ||.++++..+......++....+.|+.||+.|+.|||+.- |+|||+||.||++..+ |.|||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999975 9999998766655567888889999999999999999776 9999999999999877 89999999
Q ss_pred ccceeccCCC----CceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+||.+.+.- .....+-|.+|+|||.+.|.
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa 214 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA 214 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhccc
Confidence 9999885432 12345679999999999774
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-25 Score=235.91 Aligned_cols=176 Identities=30% Similarity=0.456 Sum_probs=145.9
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
|+.+..-.+.++||+|.||+|..|....+.+||||+++.... ...+.+|.+|+++|.+++|||||+++|+|..++..+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 333344456789999999999999988889999999865433 344678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|+|||++|+|.+++.+..... .....-..|+.|||.|++||.+.. +||||+.++|+|++.++++||+|||+++
T Consensus 612 mI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccc
Confidence 9999999999999998764321 334455679999999999999665 9999999999999999999999999999
Q ss_pred eccCCCCcee---eccccCccccCccc
Q 043136 866 LIQSDESMSV---IAGSYGYIAPGTFC 889 (902)
Q Consensus 866 ~~~~~~~~~~---~~Gt~~y~APE~~~ 889 (902)
..-.++.... .+-..+|||||.+.
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsil 712 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESIL 712 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHH
Confidence 7655444322 34457899999884
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.3e-24 Score=242.71 Aligned_cols=165 Identities=24% Similarity=0.262 Sum_probs=137.9
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||.||+|.+ .+++.||+|+.. ...+.+|++++++++||||+++++++......++||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3466778999999999999965 468899999642 234578999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|++ +++|.+++.... .+++..++.++.|++.||+|||+++ ||||||||+||+++.++.+||+|||+|+...
T Consensus 163 e~~-~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRY-KTDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecC-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999 478988876542 3677888899999999999999765 9999999999999999999999999997543
Q ss_pred CC--CCceeeccccCccccCcccccc
Q 043136 869 SD--ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~--~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......+||+.|+|||++.+..
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 259 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDP 259 (391)
T ss_pred cccccccccccCccCCCChhhhcCCC
Confidence 21 2234468999999999997653
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.2e-24 Score=239.46 Aligned_cols=169 Identities=24% Similarity=0.380 Sum_probs=136.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----CeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~~ 785 (902)
|.+.+.||+|+||.||+|.. .+++.||+|++..... .......+.+|++++++++||||+++++++... ...|
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 45668999999999999975 4689999999853221 222345678999999999999999999987543 3579
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+ +++|.+++.... .+++.....++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecC-CCCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccc
Confidence 999999 578998886432 3677888899999999999999766 9999999999999999999999999998
Q ss_pred eccCCCC----ceeeccccCccccCcccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~ 890 (902)
....... .....||+.|+|||++.+
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhc
Confidence 6532211 234579999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-24 Score=240.46 Aligned_cols=176 Identities=28% Similarity=0.447 Sum_probs=140.1
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
+.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+++++.+ +|+||+++++++...+..
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 456789999999999998642 2457999998543322 3456688999999999 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc-----------------------------------------------------------
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK----------------------------------------------------------- 805 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 805 (902)
++||||+++|+|.+++.....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999865321
Q ss_pred ------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc---eee
Q 043136 806 ------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM---SVI 876 (902)
Q Consensus 806 ------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~---~~~ 876 (902)
.....+++....+++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++........ ...
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 01124677788899999999999999765 999999999999999999999999999876433221 122
Q ss_pred ccccCccccCcccccc
Q 043136 877 AGSYGYIAPGTFCFCF 892 (902)
Q Consensus 877 ~Gt~~y~APE~~~~~~ 892 (902)
.+++.|||||++....
T Consensus 275 ~~~~~y~aPE~~~~~~ 290 (374)
T cd05106 275 RLPVKWMAPESIFDCV 290 (374)
T ss_pred CCccceeCHHHhcCCC
Confidence 3456799999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.7e-24 Score=231.42 Aligned_cols=173 Identities=27% Similarity=0.424 Sum_probs=136.1
Q ss_pred ccCCcEeeecCceEEEEEEeC--CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEe-----cC
Q 043136 712 SMSDKILGMGSTGTVYKAEMP--GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCS-----NR 781 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~-----~~ 781 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++....... .....+.+|+++++.+ +||||+++++++. ..
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 556788999999999999763 46789999885432221 1123345677766655 6999999999885 24
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
...++||||+. ++|.+++..... ...++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 56899999995 699998865432 23677888999999999999999766 999999999999999999999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++............||+.|+|||++.+..
T Consensus 155 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 185 (290)
T cd07862 155 GLARIYSFQMALTSVVVTLWYRAPEVLLQSS 185 (290)
T ss_pred cceEeccCCcccccccccccccChHHHhCCC
Confidence 9998765554455667999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=228.99 Aligned_cols=166 Identities=15% Similarity=0.219 Sum_probs=139.5
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~lv~e~~ 791 (902)
..||+|++|.||+|.. +++.||||++...........+.+.+|++++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 788999999865444433445678899999999999999999999876 34689999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++...+ .+++.....++.|++.|++|+|+. .+++||||||+||+++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 105 TRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999997542 367788889999999999999963 138899999999999999999999999998654322
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
....||+.|+|||++.+.
T Consensus 178 --~~~~~~~~y~aPE~~~~~ 195 (283)
T PHA02988 178 --FKNVNFMVYFSYKMLNDI 195 (283)
T ss_pred --ccccCcccccCHHHhhhc
Confidence 234689999999999763
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.6e-24 Score=239.02 Aligned_cols=162 Identities=31% Similarity=0.558 Sum_probs=135.3
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.+.||+|+||.||+|++. +++.||+|++..... ....+.+.+|++++++++|+||+++++++...+..|+||||+++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 156 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDG 156 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCC
Confidence 467999999999999764 689999999854332 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-C
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-S 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~ 872 (902)
|+|.+.. .........++.||+.||+|||+++ |+||||||+||++++++.+||+|||+++.+.... .
T Consensus 157 ~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 157 GSLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred Ccccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 9986432 2345566789999999999999765 9999999999999999999999999998764332 2
Q ss_pred ceeeccccCccccCcccc
Q 043136 873 MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~ 890 (902)
.....||..|+|||++..
T Consensus 225 ~~~~~gt~~y~aPE~~~~ 242 (353)
T PLN00034 225 CNSSVGTIAYMSPERINT 242 (353)
T ss_pred ccccccCccccCcccccc
Confidence 344679999999999853
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=239.27 Aligned_cols=177 Identities=25% Similarity=0.370 Sum_probs=141.6
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~ 783 (902)
.+.+.+.||+|+||.||+|... .+..||||++..... ....+.+.+|+++++++. ||||+++++++.+.+.
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR--SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 3456689999999999999652 234799999854322 234567889999999996 9999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC---------------------------------------------------------
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG--------------------------------------------------------- 806 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~--------------------------------------------------------- 806 (902)
.|+||||+++|+|.+++......
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999999998753210
Q ss_pred ----------------------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 043136 807 ----------------------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 852 (902)
Q Consensus 807 ----------------------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~ 852 (902)
....+++..+..++.|+++|++|||+.+ |+||||||+||+++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0123567777899999999999999665 999999999999999
Q ss_pred CCCEEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 853 EMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 853 ~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.+||+|||+++....... .....+++.|||||++.+..
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 315 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL 315 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC
Confidence 99999999999987643222 22345678899999986654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=232.21 Aligned_cols=172 Identities=24% Similarity=0.318 Sum_probs=140.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 455688999999999999775 578899999854322 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++.+..+.... ...++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 82 VEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9887665543321 13677788899999999999999665 999999999999999999999999999876432
Q ss_pred C--CceeeccccCccccCcccccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~ 177 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAP 177 (287)
T ss_pred ccccccccccccccCCcHHHcCCC
Confidence 2 223457999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-24 Score=245.91 Aligned_cols=177 Identities=25% Similarity=0.302 Sum_probs=144.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-------
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------- 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------- 782 (902)
.|.+.+.||+|+||.||+|+. .+++.||||++..... .......+.+|+.++..++|++|+++++.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 566778999999999999965 5689999999854332 2344566789999999999999999988765432
Q ss_pred -eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 783 -CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 783 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
..++||||+++|+|.++++.+.. ....+++.....++.|++.||+|+|+.+ |+||||||+||+++.++.+||+||
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEec
Confidence 36899999999999999975433 2235777888899999999999999665 999999999999999999999999
Q ss_pred ccceeccCC---CCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSD---ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~---~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++.+... ......+||+.|||||++.+..
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 221 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP 221 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCC
Confidence 999876432 2234568999999999997653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=227.64 Aligned_cols=173 Identities=25% Similarity=0.368 Sum_probs=140.5
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..+.+.+.||+|+||.||+|.+. .+..||+|.+.... .....+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 34566789999999999999653 35689999885432 2234466889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++.... ..+++..++.++.|++.|++|||+++ ++||||||+||+++.++.+|++|||.+.
T Consensus 83 lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccc
Confidence 9999999999999987532 24678888999999999999999665 9999999999999999999999999876
Q ss_pred eccCCCCce--eeccccCccccCccccc
Q 043136 866 LIQSDESMS--VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~~--~~~Gt~~y~APE~~~~~ 891 (902)
......... ...++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYH 183 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhC
Confidence 543222111 22356789999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.7e-24 Score=236.59 Aligned_cols=172 Identities=29% Similarity=0.318 Sum_probs=138.9
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------ 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------ 782 (902)
..|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 3466678999999999999966 4588999999854322 2234456778999999999999999999986443
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+++ ++.+.+.. .++...+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 57999999964 67666542 2566777889999999999999766 9999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCccccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+++............||+.|+|||++.+...
T Consensus 169 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 199 (359)
T cd07876 169 LARTACTNFMMTPYVVTRYYRAPEVILGMGY 199 (359)
T ss_pred CccccccCccCCCCcccCCCCCchhccCCCC
Confidence 9987654444455679999999999977543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=242.69 Aligned_cols=169 Identities=25% Similarity=0.339 Sum_probs=134.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--------
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-------- 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-------- 781 (902)
.|...+.||+|+||.||+|.. .+++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 456678999999999999976 468899999884322 1234699999999999999999876432
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEee
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVAD 860 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~D 860 (902)
...++||||++ +++.+++..... ....+++.....++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeec
Confidence 24679999996 578777754322 2234777888899999999999999766 99999999999998665 799999
Q ss_pred cccceeccCCCCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||+|+.+..........||+.|||||++.+.
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~ 245 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCC
Confidence 9999877655555567899999999998653
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.1e-24 Score=250.70 Aligned_cols=40 Identities=20% Similarity=0.245 Sum_probs=19.6
Q ss_pred ccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCC
Q 043136 559 ITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPA 599 (902)
Q Consensus 559 L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~ 599 (902)
|+.|+|++|+|+ .+|..+.+++.|+.|+|++|+|+|.+|+
T Consensus 424 L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 424 LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 444455555554 4444444455555555555555544443
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=201.31 Aligned_cols=166 Identities=27% Similarity=0.408 Sum_probs=138.3
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
++||+|.||+||+|+. .+++.||+|++.-.... +.......+||.+++.++|.|||+++++...+....+|+|||. .
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q 85 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q 85 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence 5699999999999965 45889999998644322 2334567899999999999999999999999999999999994 5
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-Cc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 873 (902)
+|..+...... .++......++.|+++|+.|+|+++ +.|||+||+|.+++.+|++|++|||+|+.+.-.- ..
T Consensus 86 dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 86 DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 88877765432 3666777889999999999999777 9999999999999999999999999999775332 34
Q ss_pred eeeccccCccccCcccc
Q 043136 874 SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~ 890 (902)
+..+-|.+|++|.++-|
T Consensus 159 saevvtlwyrppdvlfg 175 (292)
T KOG0662|consen 159 SAEVVTLWYRPPDVLFG 175 (292)
T ss_pred eceeeeeeccCcceeee
Confidence 55677999999999865
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=223.92 Aligned_cols=170 Identities=25% Similarity=0.382 Sum_probs=137.7
Q ss_pred cEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+.||+|+||.||+|... .+..+|+|++..... ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 35899999999999654 346799998754332 2334568889999999999999999999999899999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|+|.+++...........++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+|++|||.++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~ 155 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY 155 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence 999999997654333334566777789999999999999665 99999999999999999999999999875433221
Q ss_pred ---ceeeccccCccccCcccc
Q 043136 873 ---MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ---~~~~~Gt~~y~APE~~~~ 890 (902)
.....|++.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 156 YVTPDQLWVPLRWIAPELVDE 176 (269)
T ss_pred eecCCCcCCcccccCHhHhcc
Confidence 123457888999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-25 Score=227.85 Aligned_cols=172 Identities=27% Similarity=0.328 Sum_probs=141.6
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+-.+||+|+||.|.+|+. .+.+.||||++.+.........+--+.|-+++.-. +-|.+++++.+|++-+..|+||||
T Consensus 352 nFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEy 431 (683)
T KOG0696|consen 352 NFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEY 431 (683)
T ss_pred ceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEE
Confidence 5668999999999999955 45788999998655433333334445677777666 578999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-cC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~~ 869 (902)
+.||+|...++..++ +.+....-++..||-||-|||+++ ||+||+|.+||++|.+|++||+|||+++.- .+
T Consensus 432 vnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 432 VNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred ecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999988887655 333445567889999999999666 999999999999999999999999999864 45
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+..+.++||||.|+|||++.+.+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqP 526 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQP 526 (683)
T ss_pred CcceeeecCCCcccccceEEecc
Confidence 66678899999999999998753
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=216.40 Aligned_cols=176 Identities=27% Similarity=0.367 Sum_probs=143.5
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEE
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCC 778 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~ 778 (902)
.|..-.+.+.+....++||-|-.|.|..|.. .+++++|+|++. + .....+|++..-.. .|||||.++++|
T Consensus 53 ~~k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~----D----s~KARrEVeLHw~~s~h~~iV~IidVy 124 (400)
T KOG0604|consen 53 DFKEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL----D----SPKARREVELHWMASGHPHIVSIIDVY 124 (400)
T ss_pred chhcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh----c----CHHHHhHhhhhhhhcCCCceEEeehhh
Confidence 3444445566666678999999999999954 578999999873 2 22345688876555 699999999998
Q ss_pred ec----CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--
Q 043136 779 SN----RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-- 852 (902)
Q Consensus 779 ~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-- 852 (902)
+. .....+|||.|+||+|...++.++. ..+.+.+.-.|++||+.|+.|||+.. |.||||||+|+|...
T Consensus 125 eNs~~~rkcLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~ 198 (400)
T KOG0604|consen 125 ENSYQGRKCLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTS 198 (400)
T ss_pred hhhccCceeeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCC
Confidence 54 4578899999999999999987654 35777888899999999999999665 999999999999954
Q ss_pred -CCCEEEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 853 -EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 853 -~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
+..+|++|||+|+.-.......+.|-||+|.|||++.-
T Consensus 199 ~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~ 237 (400)
T KOG0604|consen 199 PNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGP 237 (400)
T ss_pred CCcceEecccccccccCCCccccCCcccccccCHHHhCc
Confidence 45799999999998776667788899999999999854
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-25 Score=236.20 Aligned_cols=167 Identities=29% Similarity=0.387 Sum_probs=150.0
Q ss_pred cEeeecCceEEEEEEeCCCc-EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGE-IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~-~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
..||-|+||+|-++.....+ .+|+|++.+++....+..+.+..|-.||..++.|.||++|..|.+..++|+.||-|-||
T Consensus 426 aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGG 505 (732)
T KOG0614|consen 426 ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGG 505 (732)
T ss_pred hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCc
Confidence 56999999999999765433 48999998888777778888999999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCce
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 874 (902)
.+...+++++. ++..+..-++..+.+|++|||+++ ||+||+||+|.+++.+|.+|+.|||+|+.+..+..+.
T Consensus 506 ElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTw 577 (732)
T KOG0614|consen 506 ELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTW 577 (732)
T ss_pred hhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCcee
Confidence 99999988765 444555567888999999999776 9999999999999999999999999999999999999
Q ss_pred eeccccCccccCcccc
Q 043136 875 VIAGSYGYIAPGTFCF 890 (902)
Q Consensus 875 ~~~Gt~~y~APE~~~~ 890 (902)
++||||.|.|||++..
T Consensus 578 TFcGTpEYVAPEIILn 593 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILN 593 (732)
T ss_pred eecCCcccccchhhhc
Confidence 9999999999999843
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=225.42 Aligned_cols=169 Identities=24% Similarity=0.341 Sum_probs=134.8
Q ss_pred EeeecCceEEEEEEeCC---CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTGTVYKAEMPG---GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~~---~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+|+||.||+|...+ ...+|+|.+.... .......+.+|+++++.++||||+++++++......|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 58999999999996533 3568888764322 233445678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC-
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES- 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~- 872 (902)
|+|.+++...........++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence 99999997654322333456777889999999999999665 99999999999999999999999999875432221
Q ss_pred --ceeeccccCccccCcccc
Q 043136 873 --MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 --~~~~~Gt~~y~APE~~~~ 890 (902)
.....+++.|+|||++..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05042 157 ITKDCHAVPLRWLAPELVEI 176 (269)
T ss_pred eccCCCCCcccccCHHHHhh
Confidence 122345678999999754
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1e-23 Score=251.04 Aligned_cols=185 Identities=24% Similarity=0.301 Sum_probs=146.1
Q ss_pred HHHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--C
Q 043136 705 DDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--R 781 (902)
Q Consensus 705 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~ 781 (902)
.+..-..|.+.+.||+|+||.||+|+.. +++.||+|.+.... ........+..|+.++++++|||||+++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~-l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc-cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3444445667789999999999999764 56788888875332 223445678899999999999999999998854 4
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCC----CCeEEcCCCCCCEEEcC-----
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD----PVIVHRDLKPSNILLDG----- 852 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~----~~ivHrDlKp~NILl~~----- 852 (902)
..+|+||||+++|+|.+++..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 578999999999999999975322 12247888899999999999999997431 45999999999999964
Q ss_pred ------------CCCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 853 ------------EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 853 ------------~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.+.+||+|||+++.+.........+||+.|+|||++.+.
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge 216 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHE 216 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhcc
Confidence 235899999999877544444556899999999998653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=230.75 Aligned_cols=175 Identities=26% Similarity=0.296 Sum_probs=143.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHH-----HHHHHHHHHHHhcCC---cCeeEeEEeEEecCC
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRR-----RRGVLAEVDVLGNVR---HRNIVRLLGCCSNRE 782 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~-----~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~~ 782 (902)
|..-+.+|+|+||.|+.|.++ +...|+||.+.+...-.... ...+-.||+||..++ |+||+|++++|++++
T Consensus 563 yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd 642 (772)
T KOG1152|consen 563 YTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDD 642 (772)
T ss_pred ceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCC
Confidence 344578999999999999654 56788999886543221111 123456999999997 999999999999999
Q ss_pred eeEEEEEcc-CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 783 CTMLLYEYM-PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 783 ~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
++|++||-. +|-||.+++..+.. +++.....|.+||+.|+++||.++ |||||||-+|+.++.+|-+|++||
T Consensus 643 ~yyl~te~hg~gIDLFd~IE~kp~-----m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 643 YYYLETEVHGEGIDLFDFIEFKPR-----MDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred eeEEEecCCCCCcchhhhhhccCc-----cchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999976 45699999986543 677788899999999999999665 999999999999999999999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccccCc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
|.|...+. .....++||..|+|||++.|..+..
T Consensus 715 gsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~g 747 (772)
T KOG1152|consen 715 GSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLG 747 (772)
T ss_pred cchhhhcC-CCcceeeeeccccchhhhCCCccCC
Confidence 99876654 4467789999999999998875543
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=225.41 Aligned_cols=170 Identities=31% Similarity=0.385 Sum_probs=144.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 445688999999999999664 5899999998544333334556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... .++...+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 83 VPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999987542 3677788889999999999999765 999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.....|++.|+|||.+.+.
T Consensus 155 --~~~~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSK 173 (290)
T ss_pred --CCCCCCCccccChhhhcCC
Confidence 3345789999999998654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=222.51 Aligned_cols=168 Identities=24% Similarity=0.380 Sum_probs=139.1
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.+.||+|+||.||+|+..++..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 44578999999999999888888899998743221 23457889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|+|.++++.... .+++..++.++.|++.|++|||+.+ |+||||||+||++++++.+|++|||.++.......
T Consensus 83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 83 NGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999875321 3678888999999999999999766 99999999999999999999999999886543222
Q ss_pred c--eeeccccCccccCccccc
Q 043136 873 M--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~--~~~~Gt~~y~APE~~~~~ 891 (902)
. ....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~ 176 (256)
T cd05114 156 TSSSGAKFPVKWSPPEVFNFS 176 (256)
T ss_pred eccCCCCCchhhCChhhcccC
Confidence 1 122355689999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=244.61 Aligned_cols=263 Identities=29% Similarity=0.397 Sum_probs=149.8
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEc
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 253 (902)
..-..|+|++|.|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|++++|+|+. +|.. .++|+.|+|
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence 34556777777776 4565554 36777777777776 34532 3566667776666663 3432 345666666
Q ss_pred cCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccccc
Q 043136 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 254 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
++|.++ .+|.. .++|+.|++++|+++ .+|.. +++|+.|+|++|+|++ +|.. ..+|+.|++++|.+++
T Consensus 270 s~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~- 336 (788)
T PRK15387 270 FSNPLT-HLPAL---PSGLCKLWIFGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS- 336 (788)
T ss_pred cCCchh-hhhhc---hhhcCEEECcCCccc-ccccc---ccccceeECCCCcccc-CCCC---cccccccccccCcccc-
Confidence 666665 33332 234556666666665 23331 3456666666666653 3321 1234555555555542
Q ss_pred CChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccccc
Q 043136 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC 413 (902)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l 413 (902)
+|. ...+|+.|+|++|+|++ +|.. ..+|+.|++++|+++. +|.. .
T Consensus 337 LP~---lp~~Lq~LdLS~N~Ls~-------------------------LP~l---p~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 337 LPT---LPSGLQELSVSDNQLAS-------------------------LPTL---PSELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred ccc---cccccceEecCCCccCC-------------------------CCCC---Ccccceehhhcccccc-Cccc---c
Confidence 332 11244455555555443 2221 1234444444444442 3332 2
Q ss_pred CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceecc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 493 (902)
.+|+.|++++|+|++ +|.. .++|+.|++++|+|++ +|... .+|+.|++++|+|+ .+|..++.+++|+.|+|
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 356777777777773 5543 3567777777777774 56432 35677788888875 57777778888888888
Q ss_pred CCCccCCCccc
Q 043136 494 SSSKLTGKIPD 504 (902)
Q Consensus 494 s~N~l~~~~p~ 504 (902)
++|+|++..|.
T Consensus 453 s~N~Ls~~~~~ 463 (788)
T PRK15387 453 EGNPLSERTLQ 463 (788)
T ss_pred CCCCCCchHHH
Confidence 88888776554
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=223.94 Aligned_cols=168 Identities=35% Similarity=0.554 Sum_probs=141.7
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|+.. +++.||+|++....... .......+|+.++++++||||+++++++.+....++||||+
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999765 46789999986554332 22334456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-cCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~ 870 (902)
++++|.+++.... .+++..+..++.|+++||++||+.+ ++||||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN 152 (260)
T ss_dssp TTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred ccccccccccccc-----ccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 9999999998332 4688889999999999999999776 999999999999999999999999999864 223
Q ss_pred CCceeeccccCccccCccc
Q 043136 871 ESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~ 889 (902)
.......||+.|+|||++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~ 171 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQ 171 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHT
T ss_pred ccccccccccccccccccc
Confidence 3345567899999999987
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=222.30 Aligned_cols=171 Identities=25% Similarity=0.400 Sum_probs=142.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 45668899999999999988788899999875322 23456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.++++.... ...++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 84 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 84 AKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 99999999875422 24667788899999999999999766 9999999999999999999999999998764332
Q ss_pred C--ceeeccccCccccCcccccc
Q 043136 872 S--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .....++..|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~ 180 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGS 180 (261)
T ss_pred eeccCCCccceecCCHHHhccCC
Confidence 1 12234567899999986654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=233.42 Aligned_cols=166 Identities=23% Similarity=0.268 Sum_probs=138.5
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||.||+|+.. +++.||+|+.... ....|+.++++++||||+++++++...+..++||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34677789999999999999764 4678999875221 1245899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+ .+++.+++.... ..+++..+..|+.||+.||+|||+++ ||||||||+||+++.++.+||+|||.++...
T Consensus 137 e~~-~~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred Ecc-CCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 999 568888886532 24778888999999999999999765 9999999999999999999999999998654
Q ss_pred CCCCceeeccccCccccCcccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.........||+.|+|||++.+..
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~ 232 (357)
T PHA03209 209 VAPAFLGLAGTVETNAPEVLARDK 232 (357)
T ss_pred cCcccccccccccccCCeecCCCC
Confidence 444445567999999999997643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=234.82 Aligned_cols=170 Identities=27% Similarity=0.316 Sum_probs=138.3
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.. ..++.||+|++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 96 (355)
T cd07874 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQD 96 (355)
T ss_pred ceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccce
Confidence 456678999999999999965 4588999999854322 233445677899999999999999999988643 35
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+++ ++.+.+.. .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 97 VYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred eEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 7999999964 67666642 2566778889999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
++............||+.|+|||++.+..
T Consensus 166 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 194 (355)
T cd07874 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMG 194 (355)
T ss_pred cccCCCccccCCccccCCccCHHHHcCCC
Confidence 98765544445568999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.9e-25 Score=255.16 Aligned_cols=171 Identities=31% Similarity=0.481 Sum_probs=143.2
Q ss_pred CcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
...||.|.||.||.| ...+|+..|+|.+...... .+..+.+.+|..++..++|||+|++||+-.+++.++|.||||++
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 357999999999999 4567999999988543333 34456678899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC--
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-- 871 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-- 871 (902)
|+|.+++...+. .++.....+..|++.|++|||++| ||||||||+||+++..|.+|.+|||.|+.+....
T Consensus 1319 GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1319 GSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred CcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence 999999875432 344444567789999999999777 9999999999999999999999999999886542
Q ss_pred ---CceeeccccCccccCcccccccC
Q 043136 872 ---SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 872 ---~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
......|||.|||||++.|.-+.
T Consensus 1391 ~~~el~~~~GT~~YMAPEvit~t~~k 1416 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGK 1416 (1509)
T ss_pred CCHHHHhhcCCchhcCchhhcccccC
Confidence 23457899999999999876543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.2e-24 Score=248.47 Aligned_cols=173 Identities=29% Similarity=0.433 Sum_probs=142.0
Q ss_pred cCCcEeeecCceEEEEEEeCC--C----cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMPG--G----EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~--~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
...+.||+|+||.||+|...+ + ..||||.+.+. .+..+..+|.+|..+|++++|||||+++|++.+....+|
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 345889999999999996543 3 34889988543 344667889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 787 LYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++|||+||||..++++.+.. ....+.......++.|||+|+.||++++ +|||||.++|+|++....|||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999876332 2345777788999999999999999777 999999999999999999999999999
Q ss_pred eeccCCCCce-eecc--ccCccccCcccc
Q 043136 865 KLIQSDESMS-VIAG--SYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~~~~~-~~~G--t~~y~APE~~~~ 890 (902)
+.+.+.+... .-.+ ...|||||.+..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d 878 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKD 878 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhh
Confidence 9553332221 1112 247999999985
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=221.71 Aligned_cols=176 Identities=20% Similarity=0.355 Sum_probs=145.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|++.............+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 45668899999999999965 46899999987544333445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .....+....+.++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~ 159 (267)
T cd08228 84 ADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence 999999998865332 1234677788899999999999999665 999999999999999999999999998876432
Q ss_pred CC-ceeeccccCccccCccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....|++.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~ 181 (267)
T cd08228 160 TTAAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred hHHHhcCCCCccccChhhhccC
Confidence 22 2345688999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=233.96 Aligned_cols=176 Identities=26% Similarity=0.429 Sum_probs=140.8
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~ 784 (902)
+...+.||+|+||.||+|++. .++.||+|++...... ...+.+.+|++++.++. ||||+++++++...+..
T Consensus 39 ~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 39 LVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred eehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 345688999999999999753 3468999999643222 23456889999999997 99999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc-----------------------------------------------------------
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK----------------------------------------------------------- 805 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------- 805 (902)
++||||+++|+|.++++..+.
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999975421
Q ss_pred ----------------------------------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043136 806 ----------------------------------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD 851 (902)
Q Consensus 806 ----------------------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~ 851 (902)
.....+++....+++.|++.||+|||+.+ ++||||||+||+++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 01123566777889999999999999655 99999999999999
Q ss_pred CCCCEEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 852 GEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 852 ~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+++.+|++|||+++....... .....|++.|||||++.+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 317 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL 317 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC
Confidence 999999999999987533221 22345788999999986543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-24 Score=229.34 Aligned_cols=146 Identities=24% Similarity=0.331 Sum_probs=122.6
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||-|+||+|.+++. .+...||+|.+.++.............|-.||...+.+-||++|..|++++.+|+||||++
T Consensus 633 kik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIP 712 (1034)
T KOG0608|consen 633 KIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 712 (1034)
T ss_pred EEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccC
Confidence 347899999999999954 4567799999866554444445567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+..++.+.+. +++....-++.++..|+++.|.+| +|||||||+|||||.||++|+.|||++.-+
T Consensus 713 GGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 713 GGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred CccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccc
Confidence 9999999876553 444444456667999999999666 999999999999999999999999998643
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=223.43 Aligned_cols=178 Identities=24% Similarity=0.358 Sum_probs=141.4
Q ss_pred HhccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..+...+.||+|+||.||+|... .+..||+|++.... ......++.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 44666789999999999998643 25679999874322 22345568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC-----CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG-----ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
.++||||+++|+|.+++...... .....++..+..++.|+++|++|||+.+ ++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998753321 1223567788899999999999999665 999999999999999999999
Q ss_pred eecccceeccCCCCc---eeeccccCccccCcccccc
Q 043136 859 ADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 859 ~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~~ 892 (902)
+|||+++........ ....+++.|||||++.+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 197 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC
Confidence 999998765332211 1234577899999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=228.15 Aligned_cols=168 Identities=25% Similarity=0.391 Sum_probs=132.7
Q ss_pred CcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~lv~e 789 (902)
.++||+|+||.||+|+.. +++.||+|.+..... ...+.+|++++++++||||+++++++.. ....|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 467999999999999754 467899998853321 2335689999999999999999998854 456899999
Q ss_pred ccCCCCHHHHHHhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCCEEEeec
Q 043136 790 YMPNGNLDDLLHAKNK----GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVADF 861 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DF 861 (902)
|+. +++.+++..... .....+++.....++.|++.||+|||+++ |+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 984 689888764321 11234677888899999999999999766 9999999999999 45678999999
Q ss_pred ccceeccCCC----CceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+|+...... ......||+.|||||++.+.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCC
Confidence 9998764322 22346789999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=7.6e-24 Score=245.98 Aligned_cols=173 Identities=27% Similarity=0.446 Sum_probs=137.6
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------------
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-------------- 780 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-------------- 780 (902)
+.||+||||.||+|+.+ +|+.||||+|..+. .......+.+|+..+++++|||||+++..|.+
T Consensus 485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~ 562 (1351)
T KOG1035|consen 485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASD 562 (1351)
T ss_pred HHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccc
Confidence 57999999999999764 89999999996554 44556678899999999999999998754300
Q ss_pred --------------------------------------------------------------------------------
Q 043136 781 -------------------------------------------------------------------------------- 780 (902)
Q Consensus 781 -------------------------------------------------------------------------------- 780 (902)
T Consensus 563 ~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~ 642 (1351)
T KOG1035|consen 563 SESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVIL 642 (1351)
T ss_pred hhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCcccc
Confidence
Q ss_pred -----------------C--------CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCC
Q 043136 781 -----------------R--------ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835 (902)
Q Consensus 781 -----------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~ 835 (902)
+ ...||-||||+...+.++++...... .....++++++|++||+|+|.++
T Consensus 643 d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~g- 717 (1351)
T KOG1035|consen 643 DDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQG- 717 (1351)
T ss_pred CcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhCc-
Confidence 0 13578899998877777776544321 34567899999999999999666
Q ss_pred CCeEEcCCCCCCEEEcCCCCEEEeecccceecc-------------------CCCCceeeccccCccccCcccccccCce
Q 043136 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-------------------SDESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 836 ~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-------------------~~~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
||||||||.||++++++.|||+|||+|+... ++...+..+||.-|+|||++.+....+|
T Consensus 718 --iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 718 --IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred --eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 9999999999999999999999999998721 1113456789999999999988776554
Q ss_pred e
Q 043136 897 C 897 (902)
Q Consensus 897 ~ 897 (902)
+
T Consensus 796 n 796 (1351)
T KOG1035|consen 796 N 796 (1351)
T ss_pred c
Confidence 4
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=220.20 Aligned_cols=169 Identities=29% Similarity=0.382 Sum_probs=141.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++++++||||+++++++...+..|+|||
T Consensus 10 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 355668899999999999975 56888999988543222 23457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.++++... ..++..+..++.|++.|++|+|+.+ |+|||+||+||+++.++.+||+|||+++....
T Consensus 87 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 87 YCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITA 158 (267)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence 999999999886432 3677888899999999999999665 99999999999999999999999999987643
Q ss_pred CC-CceeeccccCccccCcccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
.. ......|++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~y~~PE~~~~ 180 (267)
T cd06646 159 TIAKRKSFIGTPYWMAPEVAAV 180 (267)
T ss_pred cccccCccccCccccCHhHccc
Confidence 22 2344578999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=221.22 Aligned_cols=172 Identities=26% Similarity=0.366 Sum_probs=141.8
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
..+.+.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 34566789999999999999877788899999854322 23457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... ....++.....++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999987543 224678888999999999999999766 99999999999999999999999999987653
Q ss_pred CCCc--eeeccccCccccCccccc
Q 043136 870 DESM--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~~--~~~~Gt~~y~APE~~~~~ 891 (902)
.... ....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~ 179 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYN 179 (261)
T ss_pred CcccccCCCcCceeccCccccccC
Confidence 2211 112234579999988654
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=233.89 Aligned_cols=171 Identities=26% Similarity=0.305 Sum_probs=138.7
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~ 103 (364)
T cd07875 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 103 (364)
T ss_pred ceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCe
Confidence 456678999999999999965 4588999999854322 223345677899999999999999999987543 35
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||++ +++.+.+.. ..++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 104 VYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred EEEEEeCCC-CCHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 799999996 577777642 2566778889999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCccccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
++............||+.|+|||++.+...
T Consensus 173 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 202 (364)
T cd07875 173 ARTAGTSFMMTPYVVTRYYRAPEVILGMGY 202 (364)
T ss_pred ccccCCCCcccCCcccCCcCCHHHHhCCCC
Confidence 987655444455679999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.9e-23 Score=238.16 Aligned_cols=166 Identities=25% Similarity=0.303 Sum_probs=138.2
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+|||++++++...+..++|||
T Consensus 170 gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 170 GFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4566789999999999999764 478899996421 224579999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
++ .++|.+++..... .+++..+..|+.|+++||+|||+++ ||||||||+|||++.++.+||+|||+++....
T Consensus 241 ~~-~~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~ 312 (461)
T PHA03211 241 KY-RSDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARG 312 (461)
T ss_pred cc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence 99 4789888764322 4788999999999999999999766 99999999999999999999999999987643
Q ss_pred CCC---ceeeccccCccccCccccccc
Q 043136 870 DES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
... .....||+.|||||++.+...
T Consensus 313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~ 339 (461)
T PHA03211 313 SWSTPFHYGIAGTVDTNAPEVLAGDPY 339 (461)
T ss_pred ccccccccccCCCcCCcCHHHHcCCCC
Confidence 221 234579999999999976543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-24 Score=208.87 Aligned_cols=176 Identities=24% Similarity=0.313 Sum_probs=145.1
Q ss_pred HhccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-----CCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-----REC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-----~~~ 783 (902)
.+|.+.+.+|+|+|+.||.++ ..+++.||+|++.... .+..+..++|++..++++||||++++++... ...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 467788999999999999996 4678999999995443 3556778999999999999999999987643 346
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|++++|+..|+|.+.+..... +...+++.+.+.|+.++++||++||.. .++++||||||.||++.+++.+++.|||.
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred EEEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccC
Confidence 8999999999999999986554 334688899999999999999999976 45799999999999999999999999999
Q ss_pred ceeccC----CC------CceeeccccCccccCcccc
Q 043136 864 AKLIQS----DE------SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~----~~------~~~~~~Gt~~y~APE~~~~ 890 (902)
++...- .. .......|..|+|||.|.-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV 212 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence 876521 10 1122457899999999943
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=226.99 Aligned_cols=171 Identities=29% Similarity=0.421 Sum_probs=136.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.|...+.||+|+||.||+|.+. +++ .||+|++.... .....+++.+|+.+++.++||||+++++++... ..+
T Consensus 8 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3456688999999999999753 333 48999874322 223456688999999999999999999998764 578
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|+||+++|+|.+++..... .+++...+.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccc
Confidence 99999999999999875432 3667788899999999999999665 9999999999999999999999999998
Q ss_pred eccCCCCcee---eccccCccccCccccc
Q 043136 866 LIQSDESMSV---IAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~~~---~~Gt~~y~APE~~~~~ 891 (902)
.......... ..++..|+|||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 186 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHR 186 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccC
Confidence 7754333222 2346689999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.5e-23 Score=222.23 Aligned_cols=175 Identities=24% Similarity=0.417 Sum_probs=141.0
Q ss_pred cCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
.+.+.||+|+||.||+|.. ..++.||+|.+.... .......+.+|++++++++||||+++++++......|+|
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 4557899999999999964 246789999985432 223446688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccC------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 788 YEYMPNGNLDDLLHAKNKG------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
|||+++++|.+++...... ....+++.....++.|++.|++|||+++ ++||||||+||++++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 9999999999998643210 1234677888899999999999999766 999999999999999999
Q ss_pred EEEeecccceeccCCC---CceeeccccCccccCcccccc
Q 043136 856 ARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+|++|||+++...... ......++..|+|||++.+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCC
Confidence 9999999998764322 123344677899999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=233.18 Aligned_cols=168 Identities=24% Similarity=0.394 Sum_probs=137.8
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-----eeEEE
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-----CTMLL 787 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-----~~~lv 787 (902)
..+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+++++.++||||+++++++...+ ..|+|
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 457899999999999976 4689999999854322 2234456789999999999999999999998766 78999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+. +++.+.+.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+..
T Consensus 83 ~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 83 TELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred eeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99995 68888775432 4677888899999999999999766 999999999999999999999999999865
Q ss_pred cCCC--CceeeccccCccccCccccc
Q 043136 868 QSDE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... ......+|+.|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 179 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGS 179 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCC
Confidence 4322 22345689999999998763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.1e-23 Score=225.50 Aligned_cols=176 Identities=28% Similarity=0.415 Sum_probs=137.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCc--EEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.+.||+|+||.||+|.+. ++. .+|+|++... ......+.+.+|++++.++ +||||+++++++...+..|+|
T Consensus 9 ~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 9 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred ceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 345688999999999999764 343 4577776422 2233456688899999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 788 YEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
|||+++|+|.++++..... ....+++.+++.++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 9999999999999764321 1224678889999999999999999665 9999999999999999999
Q ss_pred EEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 857 RVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 857 kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+|||+++............++..|+|||++.+..
T Consensus 164 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 164 KIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred EeCccccCcccchhhhcccCCCcccccCHHHHhccC
Confidence 999999986432211112223466799999886543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.8e-23 Score=222.01 Aligned_cols=175 Identities=28% Similarity=0.481 Sum_probs=141.3
Q ss_pred cCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.||+|+||.||+|.... ...||+|.+.... .......+.+|++++.+++||||+++++++...+..|+
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 345789999999999996533 2579999885332 22345668899999999999999999999999899999
Q ss_pred EEEccCCCCHHHHHHhhccCCC-----------cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 787 LYEYMPNGNLDDLLHAKNKGEN-----------LVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
+|||+++|+|.+++........ ..+++.....++.|++.|++|||+.+ ++||||||+||++++++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999976432111 34677888899999999999999765 999999999999999999
Q ss_pred EEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 856 ARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+||+|||+++....... .....+++.|+|||++.+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK 202 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCc
Confidence 99999999986533221 22345688999999886543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=223.44 Aligned_cols=179 Identities=25% Similarity=0.432 Sum_probs=144.1
Q ss_pred hccCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
.+.+.+.||+|+||.||+|+..+ ++.||+|++..... ....+.+.+|++++++++||||+++++++......
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 34556789999999999996532 47899999854322 23456788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc---------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK---------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
++||||+++++|.+++...+. .....+++.....++.|++.|++|+|..+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999976431 12234677888999999999999999665 999999999999999999
Q ss_pred EEEeecccceeccCCCC---ceeeccccCccccCcccccccC
Q 043136 856 ARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+|++|||.++....... .....+++.|+|||++.+....
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 202 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT 202 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcc
Confidence 99999999986533221 1233467889999998765443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-23 Score=226.56 Aligned_cols=169 Identities=25% Similarity=0.406 Sum_probs=137.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++++||||+++++++..++..++||||
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 455688999999999999764 5788999998543222 2233467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ +++.+++..... ..++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 86 LD-KDLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred CC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 96 488888765422 3567778889999999999999665 999999999999999999999999999765332
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 158 TKTYSNEVVTLWYRPPDVLLG 178 (309)
T ss_pred ccccccccccccccCCHHHhC
Confidence 2 2334568999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.3e-23 Score=218.25 Aligned_cols=167 Identities=22% Similarity=0.365 Sum_probs=136.1
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46899999999999764 68899999875332 2234466889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc-
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM- 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~- 873 (902)
+|.+++.... ...++...+.++.|+++||+|||+.+ ++||||||+||+++.++.+|++|||+++........
T Consensus 79 ~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 151 (252)
T cd05084 79 DFLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS 151 (252)
T ss_pred cHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence 9999986432 23678888899999999999999665 999999999999999999999999998765432111
Q ss_pred --eeeccccCccccCccccc
Q 043136 874 --SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 --~~~~Gt~~y~APE~~~~~ 891 (902)
....++..|+|||.+.+.
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~ 171 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYG 171 (252)
T ss_pred cCCCCCCceeecCchhhcCC
Confidence 111234569999998654
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=222.52 Aligned_cols=176 Identities=26% Similarity=0.440 Sum_probs=142.2
Q ss_pred hccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
-+.+.+.||+|+||.||+|.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 355678899999999999964 23456889987432 233456688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc--------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK--------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
++||||+++++|.+++..... .....+++..++.++.|++.||+|||+++ ++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcE
Confidence 999999999999999975432 12234788899999999999999999665 9999999999999999999
Q ss_pred EEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 857 RVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 857 kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
|++|||.++....... .....+++.|+|||++.+..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 198 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 198 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCC
Confidence 9999999986543221 12234577899999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=219.24 Aligned_cols=169 Identities=25% Similarity=0.386 Sum_probs=139.8
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||.||+|+..++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 345578999999999999887777899998853322 2345788999999999999999999999888999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
.+|+|.+++..... .+++..++.++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||.++......
T Consensus 82 ~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 82 SNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred CCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999865322 4678888999999999999999665 9999999999999999999999999988764332
Q ss_pred Cce--eeccccCccccCccccc
Q 043136 872 SMS--VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~--~~~Gt~~y~APE~~~~~ 891 (902)
... ...++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~y~~pe~~~~~ 176 (256)
T cd05113 155 YTSSVGSKFPVRWSPPEVLLYS 176 (256)
T ss_pred eeecCCCccChhhCCHHHHhcC
Confidence 211 12355679999998654
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=217.86 Aligned_cols=176 Identities=22% Similarity=0.381 Sum_probs=146.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++|++|+++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 556789999999999999765 7899999988643333344466788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... ....+++..++.++.|+++|++|||+.+ ++||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 84 ADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred CCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999865322 2234678888999999999999999665 999999999999999999999999998866432
Q ss_pred C-CceeeccccCccccCccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......|++.|+|||.+.+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~ 181 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred CcccceecCCccccCHHHhccC
Confidence 2 23445789999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=223.42 Aligned_cols=176 Identities=28% Similarity=0.393 Sum_probs=142.7
Q ss_pred hccCCcEeeecCceEEEEEEeCC-----------------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG-----------------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~-----------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~ 773 (902)
.+.+.+.||+|+||.||+|+... +..||+|++...... ...+.+.+|++++++++||||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 6 PLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCEeE
Confidence 34567889999999999986532 245899988543322 44567889999999999999999
Q ss_pred EEeEEecCCeeEEEEEccCCCCHHHHHHhhccCC------CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE------NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 774 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
+++++..++..++||||+++++|.+++....... ...+++...+.++.|++.|++|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997654211 125788889999999999999999665 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++.++.+|++|||+++....... .....+++.|||||++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG 207 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC
Confidence 9999999999999999986543221 2234567789999998664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=223.67 Aligned_cols=178 Identities=25% Similarity=0.372 Sum_probs=142.5
Q ss_pred HHhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEe
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCS 779 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~ 779 (902)
...+.+.+.||+|+||.||+|+.. ++..||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 344567789999999999999641 24578999875322 223456688999999999 8999999999999
Q ss_pred cCCeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043136 780 NRECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNI 848 (902)
Q Consensus 780 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NI 848 (902)
.....|+||||+++|+|.+++...... ....+++.++..++.|+++|++|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 999999999999999999999764321 1234677888999999999999999665 99999999999
Q ss_pred EEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 849 LLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 849 Ll~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
++++++.+||+|||.++....... .....+++.|+|||++.+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 214 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR 214 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC
Confidence 999999999999999987643221 1223456789999998664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.9e-23 Score=219.88 Aligned_cols=167 Identities=28% Similarity=0.382 Sum_probs=139.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++...+..|+||||
T Consensus 11 ~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 34457799999999999965 4688999998854322 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++...+ .+++.+...++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 88 CGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999986543 3677888899999999999999766 999999999999999999999999998765432
Q ss_pred C-CceeeccccCccccCccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~ 889 (902)
. ......|++.|+|||++.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccccccCcccccChhhhc
Confidence 2 234457999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=216.42 Aligned_cols=173 Identities=30% Similarity=0.452 Sum_probs=142.7
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh--hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE--NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
+...+.||+|++|.||+|.. .+++.||+|.+...... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 44568999999999999965 46899999988643221 2233456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... ..+......++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++...
T Consensus 84 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 84 EYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999987543 3566777899999999999999665 9999999999999999999999999998654
Q ss_pred CCCC----ceeeccccCccccCcccccc
Q 043136 869 SDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
.... .....|+..|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEG 183 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCC
Confidence 3211 13356889999999997654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=224.31 Aligned_cols=177 Identities=26% Similarity=0.398 Sum_probs=141.0
Q ss_pred HhccCCcEeeecCceEEEEEEeCC---------------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG---------------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~---------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l 774 (902)
..|.+.+.||+|+||.||+|+... ...||+|++.... .......+.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~ 82 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIRL 82 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence 456677889999999999986532 2358999885432 22345668899999999999999999
Q ss_pred EeEEecCCeeEEEEEccCCCCHHHHHHhhccC-------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG-------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 775 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
++++...+..++||||+++++|.+++...... .....++..++.++.|++.|++|||+.+ ++||||||+|
T Consensus 83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~N 159 (295)
T cd05097 83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRN 159 (295)
T ss_pred EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhh
Confidence 99999999999999999999999998653211 1123677888899999999999999665 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|++++++.+|++|||+++....... .....+++.|+|||++.+.
T Consensus 160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 206 (295)
T cd05097 160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG 206 (295)
T ss_pred EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC
Confidence 9999999999999999976543221 1223456789999987653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=217.43 Aligned_cols=172 Identities=27% Similarity=0.444 Sum_probs=140.8
Q ss_pred ccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.+.||+|+||.||+|.+.. ...||+|++.... .......+.+|+.++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 4567899999999999997642 4579999875432 233456688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++++|.+++..... .+++..+.+++.|++.|++|||+.+ |+||||||+||++++++.+|++|||+++..
T Consensus 84 ~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 84 TEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999875332 4678888999999999999999665 999999999999999999999999999877
Q ss_pred cCCCC-ce--eeccccCccccCcccccc
Q 043136 868 QSDES-MS--VIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~-~~--~~~Gt~~y~APE~~~~~~ 892 (902)
..... .. ...+++.|+|||.+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 184 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRK 184 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCC
Confidence 42211 11 123467899999987543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=5e-23 Score=223.10 Aligned_cols=173 Identities=29% Similarity=0.464 Sum_probs=135.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEec-----CC
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCSN-----RE 782 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~~-----~~ 782 (902)
|...+.||+|+||.||+|+.. +++.||+|.+....... .....+.+|+++++++ +||||+++++++.. ..
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 445688999999999999664 68899999885432221 1112344567766655 69999999998864 24
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..++||||+. +++.+++..... ..+++..+..++.|++.||+|+|+.+ |+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccC
Confidence 5799999996 589888865422 23677888899999999999999766 9999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+++............||+.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (288)
T cd07863 154 LARIYSCQMALTPVVVTLWYRAPEVLLQST 183 (288)
T ss_pred ccccccCcccCCCccccccccCchHhhCCC
Confidence 998775444445567899999999986643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=242.02 Aligned_cols=184 Identities=18% Similarity=0.181 Sum_probs=136.6
Q ss_pred HHHHHHhccCCcEeeecCceEEEEEEeCC--CcEEEEE--------------EecccchhhHHHHHHHHHHHHHHhcCCc
Q 043136 705 DDVLECLSMSDKILGMGSTGTVYKAEMPG--GEIIAVK--------------KLWGKHKENIRRRRGVLAEVDVLGNVRH 768 (902)
Q Consensus 705 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~vavK--------------~i~~~~~~~~~~~~~~~~Ei~il~~l~h 768 (902)
.+.+...|.+.+.||+|+||+||+|..+. +..+++| .+.+...........+.+|++++++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 34445567788999999999999986432 2222222 1111111222334567899999999999
Q ss_pred CeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043136 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNI 848 (902)
Q Consensus 769 ~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NI 848 (902)
|||+++++++.+.+..|+|+|++ ++++.+++..................|+.|++.||+|||+++ ||||||||+||
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NI 298 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENI 298 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHE
Confidence 99999999999999999999999 467887775432211112234456689999999999999665 99999999999
Q ss_pred EEcCCCCEEEeecccceeccCCCC--ceeeccccCccccCcccccc
Q 043136 849 LLDGEMEARVADFGVAKLIQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 849 Ll~~~~~~kl~DFGla~~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
|++.++.+||+|||+++.+..... ....+||+.|+|||++.+..
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 344 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG 344 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC
Confidence 999999999999999987754322 23467999999999997643
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=228.90 Aligned_cols=167 Identities=31% Similarity=0.470 Sum_probs=138.1
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
-++|+|.||+||.|++. +...+|||.+..+.. +..+-+..||...++++|.|||+++|.+..++++-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds---r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS---REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccc---hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence 47999999999999765 466799999864433 33455678999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCCEEEeecccceeccC-CCC
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEMEARVADFGVAKLIQS-DES 872 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~~~~-~~~ 872 (902)
+|.++++.+=. +..-.+.++-.+.+||++||.|||... |||||||-+|+||+ -.|.+||+|||.+++... ...
T Consensus 658 SLSsLLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~ 732 (1226)
T KOG4279|consen 658 SLSSLLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC 732 (1226)
T ss_pred cHHHHHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcc
Confidence 99999975422 112244566678899999999999665 99999999999996 468999999999988753 344
Q ss_pred ceeeccccCccccCcccc
Q 043136 873 MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~ 890 (902)
+.++.||..|||||++-.
T Consensus 733 TETFTGTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 733 TETFTGTLQYMAPEVIDQ 750 (1226)
T ss_pred ccccccchhhhChHhhcc
Confidence 677899999999999943
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=217.06 Aligned_cols=173 Identities=27% Similarity=0.462 Sum_probs=143.1
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccch---hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK---ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~---~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
|...+.||+|+||.||+|...+++.+|+|.+..... ...+..+.+.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (265)
T cd06631 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFM 81 (265)
T ss_pred ccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEE
Confidence 345688999999999999888899999998854321 22334456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... .+++..+..++.|++.|++|+|+.+ |+|+||||+||+++.++.+||+|||.+....
T Consensus 82 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 82 EFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred ecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 9999999999986532 3567778889999999999999665 9999999999999999999999999987642
Q ss_pred C-------CCCceeeccccCccccCcccccc
Q 043136 869 S-------DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~-------~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ........|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 184 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESG 184 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCC
Confidence 1 11123356899999999987643
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-23 Score=219.86 Aligned_cols=179 Identities=24% Similarity=0.336 Sum_probs=143.3
Q ss_pred HhccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..+.+.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34556788999999999999653 24689999975432 22334567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCC-----CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGE-----NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
.|+||||+++|+|.+++....... ....++..++.++.|++.|+.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 999999999999999997543211 124677888899999999999999665 999999999999999999999
Q ss_pred eecccceeccCCCC---ceeeccccCccccCccccccc
Q 043136 859 ADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 859 ~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+|||+++....... .....++..|+|||++.+...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 198 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF 198 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC
Confidence 99999986643321 223456789999999865443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=220.16 Aligned_cols=173 Identities=27% Similarity=0.435 Sum_probs=140.7
Q ss_pred hccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~ 783 (902)
.+...+.||+|+||.||+|+. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++... ..
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 345568899999999999963 3578899999854322 23446688999999999999999999998775 56
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.++||||+++++|.+++.... ...++..+..++.|++.||+|+|+.+ ++||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred eEEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcc
Confidence 899999999999999986432 14688888999999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCC----ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
++....... .....|+..|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~ 188 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK 188 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCC
Confidence 987643322 12345677899999986543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6e-23 Score=218.44 Aligned_cols=168 Identities=25% Similarity=0.382 Sum_probs=138.6
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.+.||+|+||.||+|++.++..+|+|++..... ..+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 45678999999999999887778899998853322 12357789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+++|.+++..... ..++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.++...+...
T Consensus 83 ~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 83 NGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999875432 4678888999999999999999765 99999999999999999999999999986643222
Q ss_pred ce--eeccccCccccCccccc
Q 043136 873 MS--VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~~--~~~Gt~~y~APE~~~~~ 891 (902)
.. ...++..|+|||.+.+.
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~ 176 (256)
T cd05059 156 TSSQGTKFPVKWAPPEVFDYS 176 (256)
T ss_pred cccCCCCCCccccCHHHhccC
Confidence 11 12234579999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=222.72 Aligned_cols=171 Identities=28% Similarity=0.367 Sum_probs=141.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.+|+|.+..... .....++.+|++++++++||||+++++++.+.+..++||||
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 345678999999999999654 578888888753322 23455688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.++++... .+++.....++.|+++||+|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 99999999997542 356777889999999999999963 24999999999999999999999999998765332
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......|++.|+|||++.+..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~ 174 (308)
T cd06615 154 -MANSFVGTRSYMSPERLQGTH 174 (308)
T ss_pred -ccccCCCCcCccChhHhcCCC
Confidence 234467899999999987654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-23 Score=217.98 Aligned_cols=185 Identities=27% Similarity=0.403 Sum_probs=148.2
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEE-EeCCCcEEEEEEecccc----hhhHHHHHHHHHHHHHHhcCCcCeeEeEE
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKH----KENIRRRRGVLAEVDVLGNVRHRNIVRLL 775 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~----~~~~~~~~~~~~Ei~il~~l~h~nIv~l~ 775 (902)
.|...-....+|..-..||+|+|++||+| +....+.||||+-.... .......+...+|.+|.+.++||.||++|
T Consensus 454 QFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY 533 (775)
T KOG1151|consen 454 QFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY 533 (775)
T ss_pred hhccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence 35555556667766788999999999999 44567888888753211 11222345577899999999999999999
Q ss_pred eEEe-cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---
Q 043136 776 GCCS-NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD--- 851 (902)
Q Consensus 776 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~--- 851 (902)
+++. +.+.+|-|+|||+|.||.-+++..+ .+++.....|+.||+.||.||... .++|||-|+||.|||+.
T Consensus 534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~Gt 607 (775)
T KOG1151|consen 534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGT 607 (775)
T ss_pred eeeeeccccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCc
Confidence 9986 4567899999999999999998654 367788889999999999999987 68899999999999994
Q ss_pred CCCCEEEeecccceeccCCCC--------ceeeccccCccccCccccc
Q 043136 852 GEMEARVADFGVAKLIQSDES--------MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 852 ~~~~~kl~DFGla~~~~~~~~--------~~~~~Gt~~y~APE~~~~~ 891 (902)
..|.+||.|||+++.+.++.. +....||.+|.+||+|.-.
T Consensus 608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg 655 (775)
T KOG1151|consen 608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG 655 (775)
T ss_pred ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecC
Confidence 457899999999998865432 2446799999999999654
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=215.18 Aligned_cols=167 Identities=26% Similarity=0.426 Sum_probs=137.9
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGN 795 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 795 (902)
++||+|+||.||+|...+++.+|+|++..... ......+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999888889999998754332 2334568899999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc--
Q 043136 796 LDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-- 873 (902)
Q Consensus 796 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 873 (902)
|.+++..... ..++..+..++.|++.|+.|+|..+ ++||||||+||+++.++.+|++|||++.........
T Consensus 79 L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (250)
T cd05085 79 FLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS 151 (250)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence 9998865321 3678888899999999999999665 999999999999999999999999998765332211
Q ss_pred eeeccccCccccCccccc
Q 043136 874 SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~ 891 (902)
....+++.|+|||++.+.
T Consensus 152 ~~~~~~~~y~aPE~~~~~ 169 (250)
T cd05085 152 GLKQIPIKWTAPEALNYG 169 (250)
T ss_pred CCCCCcccccCHHHhccC
Confidence 112345679999998654
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=217.67 Aligned_cols=173 Identities=27% Similarity=0.450 Sum_probs=140.3
Q ss_pred hccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.+.||+|+||.||+|+.. .+..+|+|.+..... ....+.+.+|+.++++++||||+++++++...+..|+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4556789999999999999653 234799998854322 2345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++.... ...++.+...++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||.++.
T Consensus 83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999987542 23677888999999999999999665 99999999999999999999999999987
Q ss_pred ccCCCCc-e---eeccccCccccCcccccc
Q 043136 867 IQSDESM-S---VIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~~-~---~~~Gt~~y~APE~~~~~~ 892 (902)
+...... . ...++..|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 185 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCc
Confidence 6433221 1 112356799999997643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.7e-23 Score=218.75 Aligned_cols=168 Identities=21% Similarity=0.338 Sum_probs=132.8
Q ss_pred EeeecCceEEEEEEeCCC---cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTGTVYKAEMPGG---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~~~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+|+||.||+|+..++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++++.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999965443 345566653322 223456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC--
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-- 871 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-- 871 (902)
|+|.+++...... ....++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 80 ~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 80 GDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999764321 223556667789999999999999665 9999999999999999999999999986432211
Q ss_pred -CceeeccccCccccCcccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~ 890 (902)
.....+|+..|+|||++..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~ 175 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGE 175 (268)
T ss_pred hcccCCcCcccccCchhccc
Confidence 1234568899999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-23 Score=234.78 Aligned_cols=169 Identities=22% Similarity=0.281 Sum_probs=139.1
Q ss_pred HHHHhccCCcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
+....|.+.+.||+|+||.||+|... .++.||+|.+... ....+|++++++++||||+++++++.....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 160 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST 160 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence 34445777889999999999999643 3578999987432 124579999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+|||++. +++.+++.... .+++..++.++.|++.||+|||+++ ||||||||+||+++.++.+||+|||+
T Consensus 161 ~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred EEEEehhcC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCcc
Confidence 999999994 68888884322 4778889999999999999999766 99999999999999999999999999
Q ss_pred ceeccCCCC---ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
++....... .....||+.|+|||++.+..
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 263 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDP 263 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCC
Confidence 987643322 23467999999999997653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=223.61 Aligned_cols=178 Identities=26% Similarity=0.376 Sum_probs=141.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~ 780 (902)
..|.+.+.||+|+||.||+|+.. +...+|+|.+.... .......+.+|+++++++ +||||+++++++..
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 45677899999999999999642 23569999885432 223445688899999999 79999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
.+..|+||||+++|+|.+++...... ....+++.++.+++.|++.||+|||+.+ ++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheE
Confidence 99999999999999999999764321 1234778889999999999999999665 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.++.+||+|||.++....... .....+++.|||||++.+..
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 218 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC
Confidence 99999999999999976543221 11123456899999886643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=219.33 Aligned_cols=176 Identities=20% Similarity=0.352 Sum_probs=146.4
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|.. .+++.+|||.+.............+.+|+++++.++||||+++++++...+..+++|||
T Consensus 4 y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08229 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLEL 83 (267)
T ss_pred hhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEe
Confidence 34557899999999999975 57899999988654434445566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... .....++...+.++.|++.|++|||+.+ ++|+||||+||+++.++.++++|||++......
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 84 ADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred cCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 999999999875322 2235778888999999999999999665 999999999999999999999999998876433
Q ss_pred CC-ceeeccccCccccCccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....|+..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~ 181 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHEN 181 (267)
T ss_pred CcccccccCCcCccCHHHhcCC
Confidence 22 2345789999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.2e-23 Score=230.49 Aligned_cols=171 Identities=23% Similarity=0.367 Sum_probs=143.0
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec-----CCeeE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN-----RECTM 785 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~-----~~~~~ 785 (902)
.+.++||+|.+|.||+++. ++++..|+|+...... ..++++.|.++++.. .|||++.+||+|.. .+..|
T Consensus 22 ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 22 EIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred EEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 4568999999999999954 5688899998754332 334566789999887 69999999999853 46899
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|||||.||+..|+++... ...++|..+..|++.++.|+.+||... ++|||||-.|||++.++.||++|||++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 9999999999999998765 235778888899999999999999665 9999999999999999999999999998
Q ss_pred eccCC-CCceeeccccCccccCccccccc
Q 043136 866 LIQSD-ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 866 ~~~~~-~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..... ....+.+|||.|||||++.-...
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~ 200 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDES 200 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccC
Confidence 77543 34567899999999999965544
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=214.91 Aligned_cols=173 Identities=25% Similarity=0.366 Sum_probs=144.8
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|++|.||+|... +++.||+|.+..... .....+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 34578999999999999764 688999998853322 2345667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++.... ....++...+.++.|++.|+.|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 82 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 82 ENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999987642 224677888899999999999999665 9999999999999999999999999998765432
Q ss_pred C-ceeeccccCccccCcccccc
Q 043136 872 S-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .....|++.|+|||++.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08529 156 NFANTIVGTPYYLSPELCEDKP 177 (256)
T ss_pred chhhccccCccccCHHHhcCCC
Confidence 2 33457899999999987654
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-23 Score=228.17 Aligned_cols=167 Identities=25% Similarity=0.379 Sum_probs=136.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.. .+++.||||++..... .....+.+.+|++++++++||||+++++++... ..
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 455668899999999999965 4678999999854322 223345577899999999999999999987543 35
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+++|++ +++|.+++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred EEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 78999988 78998887532 3677888899999999999999766 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++..... ....+||+.|+|||++.+
T Consensus 165 ~~~~~~~--~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 165 ARQADDE--MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred ceecCCC--cCCccccccccCchHhcC
Confidence 9876432 344679999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-23 Score=218.63 Aligned_cols=171 Identities=27% Similarity=0.405 Sum_probs=140.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+.+.+.||+|+||.||+|... .++.||+|++... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 8 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred eEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 345688999999999999654 5888999987432 22345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ...+++..++.++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.++.....
T Consensus 84 ~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 84 MTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999986532 224678888899999999999999665 999999999999999999999999999876543
Q ss_pred CCc--eeeccccCccccCcccccc
Q 043136 871 ESM--SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~--~~~~Gt~~y~APE~~~~~~ 892 (902)
... ....+++.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~ 181 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNK 181 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCC
Confidence 221 1123456899999886543
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=219.26 Aligned_cols=169 Identities=28% Similarity=0.352 Sum_probs=141.2
Q ss_pred eeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+|.. .+++.||+|.+...........+.+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 46889999998643332233345567899999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVI 876 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 876 (902)
.+++..... ..+++..+..++.|++.|+.|||+.+ ++||||||+||++++++.+|++|||.+............
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR 154 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence 999875432 24678888899999999999999665 999999999999999999999999999876544444456
Q ss_pred ccccCccccCcccccc
Q 043136 877 AGSYGYIAPGTFCFCF 892 (902)
Q Consensus 877 ~Gt~~y~APE~~~~~~ 892 (902)
.|+..|+|||++.+..
T Consensus 155 ~~~~~y~~PE~~~~~~ 170 (277)
T cd05577 155 AGTPGYMAPEVLQGEV 170 (277)
T ss_pred cCCCCcCCHHHhcCCC
Confidence 7889999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=226.38 Aligned_cols=177 Identities=27% Similarity=0.368 Sum_probs=139.2
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC-C
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR-E 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~-~ 782 (902)
+|.+.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++.++ +|+||+++++++... .
T Consensus 8 ~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 8 RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 4567789999999999999532 35789999885322 223445678899999999 799999999988654 5
Q ss_pred eeEEEEEccCCCCHHHHHHhhccC--------------------------------------------------------
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKG-------------------------------------------------------- 806 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 806 (902)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 688999999999999998643210
Q ss_pred CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---ceeeccccCcc
Q 043136 807 ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYI 883 (902)
Q Consensus 807 ~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~ 883 (902)
....+++..+..++.||+.|++|||+.+ |+||||||+||+++.++.+||+|||+++.+..... .....++..||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 0125688889999999999999999665 99999999999999999999999999987643221 12345677899
Q ss_pred ccCcccccc
Q 043136 884 APGTFCFCF 892 (902)
Q Consensus 884 APE~~~~~~ 892 (902)
|||++.+..
T Consensus 243 aPE~~~~~~ 251 (337)
T cd05054 243 APESIFDKV 251 (337)
T ss_pred CcHHhcCCC
Confidence 999886543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=219.97 Aligned_cols=177 Identities=25% Similarity=0.357 Sum_probs=139.7
Q ss_pred HhccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..|.+.+.||+|+||.||+|... .+..||+|.+..... ......+.+|+.++++++||||+++++++.+.+.
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45666789999999999998543 245799998753322 2334457889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCC-----CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGE-----NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
.|+||||+++|+|.+++....... .....+..+..++.|++.|++|||+++ |+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 999999999999999997543211 123456677889999999999999665 999999999999999999999
Q ss_pred eecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 859 ADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 859 ~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
+|||+++....... .....++..|+|||++.+.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 196 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG 196 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccC
Confidence 99999986533221 1122456789999998654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=216.78 Aligned_cols=161 Identities=22% Similarity=0.360 Sum_probs=132.4
Q ss_pred cEeeecCceEEEEEEeCCCc-----------EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 716 KILGMGSTGTVYKAEMPGGE-----------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~-----------~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
+.||+|+||.||+|...... .+++|.+.... .....+.+|+.++++++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 46899999999999765432 46777653222 115667889999999999999999999988 778
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-------CEE
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-------EAR 857 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-------~~k 857 (902)
++||||+++|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~k 148 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIK 148 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEE
Confidence 999999999999999876432 4677888899999999999999665 99999999999999887 799
Q ss_pred EeecccceeccCCCCceeeccccCccccCccccc
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
++|||+++.... .....++..|+|||++.+.
T Consensus 149 l~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 149 LSDPGIPITVLS---REERVERIPWIAPECIRNG 179 (259)
T ss_pred eCCCCccccccc---ccccccCCCccChhhhcCC
Confidence 999999987543 2234577889999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=224.59 Aligned_cols=179 Identities=26% Similarity=0.365 Sum_probs=142.3
Q ss_pred HHHhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEE
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCC 778 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~ 778 (902)
....+.+.+.||+|+||.||+|+.. ....||+|.+.... .....+.+.+|+++++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3345677899999999999999642 12368999875322 223456788999999999 799999999999
Q ss_pred ecCCeeEEEEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 779 SNRECTMLLYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 779 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
...+..+++|||+++|+|.+++..... .....+++.++..++.|++.|++|||..+ ++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 999999999999999999999975431 12335778888999999999999999665 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++.++.+||+|||.++....... .....++..|||||++.+.
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC
Confidence 9999999999999999987643221 1122345679999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=242.67 Aligned_cols=171 Identities=29% Similarity=0.336 Sum_probs=144.5
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|.+. +++.||+|++...........+.+.+|+.++..++||||+++++++......|+||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 445688999999999999765 6889999998654433444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++...+ .+++...+.|+.||+.||+|||.++ ||||||||+|||++.++.+||+|||+++.....
T Consensus 86 ~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~ 157 (669)
T cd05610 86 LIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNR 157 (669)
T ss_pred CCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccCC
Confidence 99999999987543 3566778899999999999999665 999999999999999999999999999876433
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......||+.|+|||...+
T Consensus 158 ~~~~~~~~~t~~~~~pe~~~~ 178 (669)
T cd05610 158 ELNMMDILTTPSMAKPKNDYS 178 (669)
T ss_pred cccccccccCccccCcccccc
Confidence 2 3345789999999997644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=216.86 Aligned_cols=175 Identities=27% Similarity=0.422 Sum_probs=142.3
Q ss_pred HHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+.+..+.+.++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. .+..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 34455667789999999999999888889999999854332 2346788999999999999999999874 456899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++.... ....++.....++.|++.|++|||+.+ ++||||||+||++++++.++++|||.+..
T Consensus 78 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 78 ITEYMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred EEEcCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceee
Confidence 999999999999986532 224677888899999999999999665 99999999999999999999999999987
Q ss_pred ccCCCC--ceeeccccCccccCcccccc
Q 043136 867 IQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
...... .....++..|+|||++.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~ 179 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGT 179 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCC
Confidence 653222 12234567899999886543
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=218.66 Aligned_cols=171 Identities=28% Similarity=0.408 Sum_probs=139.4
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
..|.+.+.||+|+||.||+|++.++..||+|++..... ..+.+.+|++++++++||||+++++++. .+..|+|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 45677889999999999999877777899999854322 2345788999999999999999999875 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... ....++..+..++.|+++||+|+|+.+ ++||||||+||++++++.+||+|||.++.+..
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 999999999997532 124577888899999999999999665 99999999999999999999999999987644
Q ss_pred CCCc--eeeccccCccccCccccc
Q 043136 870 DESM--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~~--~~~~Gt~~y~APE~~~~~ 891 (902)
.... ....++..|+|||+..+.
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~ 178 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYG 178 (262)
T ss_pred cccccccCCcccceecCHhHhccC
Confidence 3321 223466789999987543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=218.08 Aligned_cols=170 Identities=36% Similarity=0.551 Sum_probs=137.1
Q ss_pred CcEeeecCceEEEEEEeC-----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMP-----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.+.||.|+||.||+|.+. .+..|+||.+... ......+.+.+|++.+++++||||++++|++...+..++|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 468999999999999775 3678999998432 233446778999999999999999999999998888999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... ...+++..++.|+.|+++||+|||+.+ ++|+||+++||+++.++.+||+|||+++....
T Consensus 82 ~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999998762 224788999999999999999999766 99999999999999999999999999987732
Q ss_pred CCCc---eeeccccCccccCcccccc
Q 043136 870 DESM---SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~---~~~~Gt~~y~APE~~~~~~ 892 (902)
.... ....+...|+|||.+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~ 181 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGE 181 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSE
T ss_pred cccccccccccccccccccccccccc
Confidence 2221 2234677899999987654
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=216.87 Aligned_cols=164 Identities=28% Similarity=0.405 Sum_probs=137.3
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+.++||+|+||.||+|.+ .+++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 82 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMD 82 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCC
Confidence 457899999999999965 568899999885432 22344568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
++++..+. ..++.....++.|++.|++|+|+.+ |+|+||||+||+++.++.+||+|||++...... .
T Consensus 83 ~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~ 149 (279)
T cd06619 83 GGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-I 149 (279)
T ss_pred CCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-c
Confidence 99986542 2456677789999999999999665 999999999999999999999999999876433 2
Q ss_pred ceeeccccCccccCcccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|+|||++.+..
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~ 169 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQ 169 (279)
T ss_pred ccCCCCChhhcCceeecCCC
Confidence 34467999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=215.34 Aligned_cols=171 Identities=32% Similarity=0.499 Sum_probs=142.9
Q ss_pred cEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|+++++.++|+||+++++++......++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 468999999999997643 7889999986443322 4567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccC----CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 792 PNGNLDDLLHAKNKG----ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~----~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
++++|.+++...... .....++..++.++.|+++|++|||+++ ++||||||+||+++.++.+|++|||.++..
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 155 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV 155 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence 999999998764211 1235788999999999999999999665 999999999999999999999999999877
Q ss_pred cCCC---CceeeccccCccccCccccc
Q 043136 868 QSDE---SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~---~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... ......+++.|+|||++...
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (262)
T cd00192 156 YDDDYYRKKTGGKLPIRWMAPESLKDG 182 (262)
T ss_pred ccccccccccCCCcCccccCHHHhccC
Confidence 5432 23345678899999988664
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=217.17 Aligned_cols=175 Identities=24% Similarity=0.342 Sum_probs=137.0
Q ss_pred CCcEeeecCceEEEEEEeCC-C--cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Cee
Q 043136 714 SDKILGMGSTGTVYKAEMPG-G--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------ECT 784 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~-~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~~ 784 (902)
+.+.||+|+||.||+|+... + ..+|+|.+.... ......+.+.+|++++++++||||+++++++... ...
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45789999999999997644 3 268999875432 2234456788999999999999999999987432 246
Q ss_pred EEEEEccCCCCHHHHHHhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
++||||+++|+|.+++...+. .....+++.....++.|++.|++|||+++ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998754322 12334788888999999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCC---ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.+..... .....+++.|+|||++.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~ 190 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRV 190 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCC
Confidence 987643322 12234677899999987654
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=213.46 Aligned_cols=171 Identities=20% Similarity=0.286 Sum_probs=142.0
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|+||.||+++.. +++.+|+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..|+||||+
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 45688999999999999664 688999998853322 234566788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|++.+++..... ...+......++.|++.|++|||+++ |+|+||||+||++++++.++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 154 (255)
T cd08219 81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG 154 (255)
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence 99999998864322 23567778899999999999999665 9999999999999999999999999998764322
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
......|++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~ 175 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENM 175 (255)
T ss_pred cccccccCCccccCHHHHccC
Confidence 23346789999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=226.35 Aligned_cols=177 Identities=28% Similarity=0.378 Sum_probs=138.2
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC-
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR- 781 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~- 781 (902)
..|.+.+.||+|+||.||+|.+ .+++.||||++..... ......+.+|++++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 3566789999999999999963 3468899999854322 23345688899999999 689999999988654
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccC-------------------------------------------------------
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKG------------------------------------------------------- 806 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 806 (902)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998753210
Q ss_pred -------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---ceee
Q 043136 807 -------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVI 876 (902)
Q Consensus 807 -------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~ 876 (902)
....+++.....++.|+++|++|||+++ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 0123567778899999999999999665 99999999999999999999999999986533221 1223
Q ss_pred ccccCccccCccccc
Q 043136 877 AGSYGYIAPGTFCFC 891 (902)
Q Consensus 877 ~Gt~~y~APE~~~~~ 891 (902)
.+++.|+|||++.+.
T Consensus 242 ~~~~~y~aPE~~~~~ 256 (343)
T cd05103 242 RLPLKWMAPETIFDR 256 (343)
T ss_pred CCCcceECcHHhcCC
Confidence 456789999987553
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=221.86 Aligned_cols=168 Identities=25% Similarity=0.398 Sum_probs=132.1
Q ss_pred CcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~lv~e 789 (902)
.++||+|+||.||+|+.. ++..||+|.+..... ...+.+|++++++++||||+++++++.. ....|+|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 367999999999999764 357899998853321 2346689999999999999999998853 567899999
Q ss_pred ccCCCCHHHHHHhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCCEEEeec
Q 043136 790 YMPNGNLDDLLHAKNK----GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVADF 861 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DF 861 (902)
|++ +++.+++..... .....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 588888754321 12234677888899999999999999765 9999999999999 55678999999
Q ss_pred ccceeccCCC----CceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++...... ......||+.|+|||++.+.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCC
Confidence 9998764322 12345789999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=215.09 Aligned_cols=171 Identities=29% Similarity=0.449 Sum_probs=138.7
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccch--hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv 787 (902)
...+.||+|+||.||+|.. .+++.||+|++..... ......+.+.+|++++++++||||+++++++.+. ...++|
T Consensus 5 ~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (265)
T cd06652 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIF 84 (265)
T ss_pred eEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEE
Confidence 4568899999999999976 4588999998753221 2223456788899999999999999999988763 467899
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++++|.+++.... ..++.....++.|++.||+|+|+++ ++|+||||+||+++.++.+||+|||.++..
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 85 MEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 99999999999986532 2566777889999999999999766 999999999999999999999999998865
Q ss_pred cCC----CCceeeccccCccccCccccc
Q 043136 868 QSD----ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~----~~~~~~~Gt~~y~APE~~~~~ 891 (902)
... .......|+..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGE 184 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCC
Confidence 321 122345689999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.7e-22 Score=213.25 Aligned_cols=173 Identities=21% Similarity=0.332 Sum_probs=144.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||.++. .+++.+|+|++..... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 44568899999999999965 4588899998754332 234455678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ....++..+..++.|+++|++|||+.+ ++||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999987542 224677888899999999999999665 999999999999999999999999999876443
Q ss_pred C-CceeeccccCccccCccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......|++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 155 YSMAETVVGTPYYMSPELCQGV 176 (256)
T ss_pred cccccccCCCccccCHhhcCCC
Confidence 3 23446789999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-22 Score=221.06 Aligned_cols=177 Identities=27% Similarity=0.385 Sum_probs=140.5
Q ss_pred HhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~ 780 (902)
..+.+.+.||+|+||.||+|+.. ....+|+|.+..... ......+.+|+++++++ +||||+++++++..
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 34557789999999999999642 245689998754322 23455688899999999 69999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
.+..|+||||+++|+|.+++..... .....+++.+...++.|++.|++|+|+++ ++||||||+||+
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 8999999999999999999976431 11234788888999999999999999665 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
+++++.+|++|||.++....... .....+++.|||||++.+.
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 211 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR 211 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccC
Confidence 99999999999999987643221 1112345679999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=215.46 Aligned_cols=166 Identities=28% Similarity=0.408 Sum_probs=142.0
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+|+.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+....|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999764 4889999998654444344556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVI 876 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 876 (902)
.+++.... .++...+..++.|+++|++|+|+.+ ++|+||||+||+++.++.+|++|||.++...........
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~ 152 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence 99997542 2667778889999999999999665 999999999999999999999999999877554334456
Q ss_pred ccccCccccCccccc
Q 043136 877 AGSYGYIAPGTFCFC 891 (902)
Q Consensus 877 ~Gt~~y~APE~~~~~ 891 (902)
.|++.|+|||++.+.
T Consensus 153 ~~~~~~~~PE~~~~~ 167 (262)
T cd05572 153 CGTPEYVAPEIILNK 167 (262)
T ss_pred cCCcCccChhHhcCC
Confidence 789999999998654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-22 Score=218.99 Aligned_cols=176 Identities=27% Similarity=0.395 Sum_probs=141.0
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~ 783 (902)
.+...+.||+|+||.||++... ....+|+|++..... .+....+.+|++++.++ +|+||+++++++...+.
T Consensus 13 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred HeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 3456688999999999999653 236789998854322 23445688999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 852 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~ 852 (902)
.+++|||+++|+|.++++.... .....+++..++.++.|++.|++|||+.+ |+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcC
Confidence 9999999999999999975421 12335778888999999999999999665 999999999999999
Q ss_pred CCCEEEeecccceeccCCCCc---eeeccccCccccCccccc
Q 043136 853 EMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 853 ~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
++.+|++|||.++.+...... ....++..|+|||++.+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 209 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccC
Confidence 999999999999876433211 122346789999987554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=8e-23 Score=220.92 Aligned_cols=174 Identities=21% Similarity=0.333 Sum_probs=139.4
Q ss_pred CCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 714 SDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.||+|+||.||+|... .++.||+|++..... ....+.+.+|+.++.+++||||+++++++...+..+++
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 4467999999999999753 257899999854332 23346688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 788 YEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
+||+++++|.+++..... .....+++..++.++.|++.||+|+|+++ |+||||||+||++++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 999999999999863211 11234677888899999999999999665 9999999999999999999
Q ss_pred EEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 857 RVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 857 kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+|||+++....... .....+++.|+|||++.+..
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 202 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK 202 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCC
Confidence 9999999886543222 12334678999999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.4e-23 Score=195.27 Aligned_cols=171 Identities=26% Similarity=0.379 Sum_probs=140.5
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
..||+|+||.|-+.++ .+|...|+|++...- ..+..++..+|+.+..+. .+|++|.+||.+..+...|+.||.|+
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~- 128 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD- 128 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-
Confidence 4589999999988865 579999999985433 345567788999987665 79999999999999999999999994
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
-+|..+.++--. .....++...-+|+..+..||.|||++ ..+||||+||+|||++.+|+|||||||.+-...+.-..
T Consensus 129 tSldkfy~~v~~-~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk 205 (282)
T KOG0984|consen 129 TSLDKFYRKVLK-KGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK 205 (282)
T ss_pred hhHHHHHHHHHh-cCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH
Confidence 588777654322 233567777789999999999999984 46999999999999999999999999999887766655
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
+...|...|||||.+....
T Consensus 206 t~daGCkpYmaPEri~~e~ 224 (282)
T KOG0984|consen 206 TMDAGCKPYMAPERINPEL 224 (282)
T ss_pred HHhcCCCccCChhhcCccc
Confidence 6567999999999996653
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=215.51 Aligned_cols=173 Identities=25% Similarity=0.398 Sum_probs=141.8
Q ss_pred HHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
...+...+.||+|+||.||+|...++..+|+|.+... ....+.+.+|++++++++|+||+++++++.+ ...+++|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 4456678899999999999998877888999987532 2234568889999999999999999999887 7789999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... ....++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+|++|||.++...
T Consensus 80 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 9999999999987542 224677888899999999999999765 9999999999999999999999999998664
Q ss_pred CCCC--ceeeccccCccccCcccccc
Q 043136 869 SDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
.... .....++..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGS 179 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCC
Confidence 3222 12234567899999986643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=215.11 Aligned_cols=174 Identities=26% Similarity=0.392 Sum_probs=138.5
Q ss_pred CCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe------
Q 043136 714 SDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC------ 783 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~------ 783 (902)
+.+.||+|+||.||+|.... +..||+|++.... ......+.+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 45789999999999996532 4679999985432 223445678899999999999999999998865443
Q ss_pred eEEEEEccCCCCHHHHHHhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG-ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
.++||||+++|+|.+++...... .....++.....++.|++.||+|+|+.+ ++||||||+||++++++.+||+|||
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg 158 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFG 158 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCcc
Confidence 79999999999999998654322 2235778888999999999999999665 9999999999999999999999999
Q ss_pred cceeccCCCC---ceeeccccCccccCccccc
Q 043136 863 VAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
.++....... .....++..|+|||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR 190 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhcccC
Confidence 9987643321 1123356789999998654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=214.16 Aligned_cols=165 Identities=28% Similarity=0.425 Sum_probs=132.8
Q ss_pred EeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+|+||.||+|.+. ++..||+|++.... .....+.+.+|++++++++||||+++++++.. +..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999653 35579999885432 23345668899999999999999999998864 568999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
++|.+++.... ..+++..+.+++.|++.|++|+|+++ ++||||||+||+++.++.+|++|||+++........
T Consensus 79 ~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~ 151 (257)
T cd05115 79 GPLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY 151 (257)
T ss_pred CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccc
Confidence 99999986432 24778889999999999999999765 999999999999999999999999999865433221
Q ss_pred ----eeeccccCccccCccccc
Q 043136 874 ----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ----~~~~Gt~~y~APE~~~~~ 891 (902)
....+++.|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05115 152 YKARSAGKWPLKWYAPECINFR 173 (257)
T ss_pred eeccCCCCCCcccCCHHHHccC
Confidence 112235789999988654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-22 Score=216.32 Aligned_cols=169 Identities=27% Similarity=0.366 Sum_probs=141.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|++++++++||||+++++++..++..|+||||
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 445678999999999999764 4889999998543 233456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++++..++..... .+++..+..++.|++.|++|||+.+ ++|||+||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 91 CPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred CCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999888764322 3677888999999999999999655 999999999999999999999999998764322
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......|++.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~ 184 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMC 184 (292)
T ss_pred ccccceecCCccccCceeecc
Confidence 22345678999999999864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=215.83 Aligned_cols=168 Identities=27% Similarity=0.364 Sum_probs=139.5
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+++++.++||||+++++++...+..|+||||+
T Consensus 8 ~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 34577999999999999765 47788888874332 234556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD- 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~- 870 (902)
+++++.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+|++|||++......
T Consensus 85 ~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 9999998876432 24778888999999999999999665 999999999999999999999999998765322
Q ss_pred CCceeeccccCccccCcccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......|++.|+|||++..
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMC 177 (282)
T ss_pred cccccccccccccCHhhccc
Confidence 22344578999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=216.02 Aligned_cols=170 Identities=28% Similarity=0.420 Sum_probs=138.9
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.+.||+|+||.||+|...++..+|+|.+...... .+.+.+|+.++++++|++++++++++. ....|+||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 45567889999999999998888888999998543322 345788999999999999999999875 4568999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ....++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.+......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 82 MSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 99999999987532 123678889999999999999999766 999999999999999999999999999876433
Q ss_pred CCc--eeeccccCccccCccccc
Q 043136 871 ESM--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~--~~~~Gt~~y~APE~~~~~ 891 (902)
... ....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~~ 178 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALYG 178 (260)
T ss_pred ccccccCCCCCccccChHHHhcC
Confidence 221 123356689999987553
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=218.69 Aligned_cols=175 Identities=26% Similarity=0.459 Sum_probs=141.1
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+...+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..+
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 445688999999999999642 3456888887432 2234456889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043136 786 LLYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM 854 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~ 854 (902)
+||||+++++|.+++..... .....+++..++.++.|++.|++|||+++ |+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence 99999999999999975431 11124678889999999999999999666 99999999999999999
Q ss_pred CEEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 855 EARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 855 ~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
.+||+|||+++....... .....|++.|+|||++.+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 201 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK 201 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC
Confidence 999999999976543221 12345678899999987644
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=213.72 Aligned_cols=172 Identities=28% Similarity=0.385 Sum_probs=144.4
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccch--hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
|...+.||+|+||.||+|... +++.||+|.+..... ...+..+.+.+|++++++++|+||+++++++......++||
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 345688999999999999765 789999998854321 12334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... ..++..+..++.|+++|++|||+.+ ++|+||||+||+++.++.+||+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 82 ELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 9999999999986532 3567788889999999999999766 9999999999999999999999999998765
Q ss_pred CCCCceeeccccCccccCccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.........|++.|+|||.+...
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~ 176 (258)
T cd06632 154 EFSFAKSFKGSPYWMAPEVIAQQ 176 (258)
T ss_pred ccccccccCCCcceeCHHHhcCC
Confidence 44434556789999999998654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-23 Score=210.35 Aligned_cols=176 Identities=23% Similarity=0.327 Sum_probs=147.2
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
-++||+|+|++|..+++ ++.+.||+|++++.........+-.+.|-.+..+. +||.+|.++.+|+++...++|.||++
T Consensus 255 l~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ 334 (593)
T KOG0695|consen 255 LRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVN 334 (593)
T ss_pred eeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEec
Confidence 37899999999999976 46789999998655444444455567788888776 79999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-cCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QSDE 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~~~~ 871 (902)
||+|.-.++++++ +++....-+...|.-||.|||+.| ||+||+|.+|+|+|.+|++|+.|+|+++.- .++.
T Consensus 335 ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd 406 (593)
T KOG0695|consen 335 GGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD 406 (593)
T ss_pred Ccceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence 9999888776554 555666667788999999999666 999999999999999999999999999864 5566
Q ss_pred CceeeccccCccccCcccc-cccCceee
Q 043136 872 SMSVIAGSYGYIAPGTFCF-CFSVPFCW 898 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~-~~~~p~~~ 898 (902)
.++++||||.|+|||+++| .|+.-++|
T Consensus 407 ~tstfcgtpnyiapeilrgeeygfsvdw 434 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEYGFSVDW 434 (593)
T ss_pred ccccccCCCcccchhhhcccccCceehH
Confidence 7788999999999999988 45555555
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=213.54 Aligned_cols=161 Identities=24% Similarity=0.339 Sum_probs=130.5
Q ss_pred cEeeecCceEEEEEEeCC-------------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC
Q 043136 716 KILGMGSTGTVYKAEMPG-------------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE 782 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~ 782 (902)
+.||+|+||.||+|.... ...||+|.+.... ......+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 368999999999996432 2358888764332 233456778999999999999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC-------
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME------- 855 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~------- 855 (902)
..++||||+++|++..++.... ..+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~ 150 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPF 150 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCce
Confidence 9999999999999988876432 24677888899999999999999665 999999999999987664
Q ss_pred EEEeecccceeccCCCCceeeccccCccccCccc
Q 043136 856 ARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
+|++|||.+...... ....|+..|||||++.
T Consensus 151 ~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 151 IKLSDPGIPITVLSR---QECVERIPWIAPECVE 181 (262)
T ss_pred eEeCCCCCCccccCc---ccccccccccChhhhc
Confidence 899999998765322 2346888999999885
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=217.02 Aligned_cols=171 Identities=29% Similarity=0.439 Sum_probs=142.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 44567899999999999988788999999985432 223456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ...++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.+.......
T Consensus 85 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 85 EKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999975422 24678888999999999999999665 9999999999999999999999999998764332
Q ss_pred C-ceeeccccCccccCccccc
Q 043136 872 S-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~-~~~~~Gt~~y~APE~~~~~ 891 (902)
. .....++..|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~ 179 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHG 179 (261)
T ss_pred ccccCCCCceEecCHHHHccC
Confidence 2 1223456789999988653
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-23 Score=217.12 Aligned_cols=173 Identities=25% Similarity=0.355 Sum_probs=146.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.||+|.+.+.........+.+.+|++++++++||||+++++++.+....++|+||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (258)
T cd05578 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDL 81 (258)
T ss_pred ceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeC
Confidence 345688999999999999765 5899999998654433334567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++... ..++......++.|+++|++|||+.+ ++|+||||+||++++++.++|+|||.+......
T Consensus 82 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 82 LLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999998654 24677888899999999999999665 999999999999999999999999998876554
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......|+..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~y~~PE~~~~~~ 175 (258)
T cd05578 154 TLTTSTSGTPGYMAPEVLCRQG 175 (258)
T ss_pred ccccccCCChhhcCHHHHcccC
Confidence 3445567899999999986543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=215.86 Aligned_cols=161 Identities=20% Similarity=0.260 Sum_probs=128.8
Q ss_pred EeeecCceEEEEEEeCC-------------------------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCee
Q 043136 717 ILGMGSTGTVYKAEMPG-------------------------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~~-------------------------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nI 771 (902)
.||+|+||.||+|.... ...||+|++.... ......+.+|++++++++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 58999999999986321 1358888874322 2234567789999999999999
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD 851 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~ 851 (902)
+++++++......++||||+++|+|.+++.... ..+++..+.+++.|+++||+|||+.+ |+||||||+||+++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~ 151 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLA 151 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEe
Confidence 999999999999999999999999998886432 13677788899999999999999665 99999999999997
Q ss_pred CCC-------CEEEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 852 GEM-------EARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 852 ~~~-------~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.++ .+|++|||.+...... ....++..|+|||++.+
T Consensus 152 ~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 152 RLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG 194 (274)
T ss_pred ccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcC
Confidence 643 3899999988654322 22457889999998865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=219.08 Aligned_cols=176 Identities=26% Similarity=0.394 Sum_probs=140.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-----------------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-----------------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-----------------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~ 773 (902)
.+.+.+.||+|+||.||+|+.. ++..||+|++.... .......+.+|++++++++|+||++
T Consensus 6 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 6 RLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 4567789999999999998532 23468999885332 2334567889999999999999999
Q ss_pred EEeEEecCCeeEEEEEccCCCCHHHHHHhhccCC------CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGE------NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 774 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
+++++...+..++||||+++|+|.+++....... ....++.+...++.|++.|++|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999987643211 124677788999999999999999765 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++.++.+|++|||+++.+..... .....+++.|+|||+..+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 207 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG 207 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC
Confidence 9999999999999999986543221 1223346789999976543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=216.27 Aligned_cols=170 Identities=30% Similarity=0.449 Sum_probs=136.4
Q ss_pred ccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCee
Q 043136 712 SMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~ 784 (902)
+.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 44568899999999999964 357899999985332 2344668899999999999999999998754 3468
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++||||+++|+|.+++.... ...++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~ 155 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLT 155 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccc
Confidence 99999999999999986532 13678888999999999999999665 999999999999999999999999999
Q ss_pred eeccCCCCce----eeccccCccccCccccc
Q 043136 865 KLIQSDESMS----VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~~~~----~~~Gt~~y~APE~~~~~ 891 (902)
+......... ...++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (284)
T cd05081 156 KVLPQDKEYYKVREPGESPIFWYAPESLTES 186 (284)
T ss_pred ccccCCCcceeecCCCCCceEeeCHHHhccC
Confidence 8764432211 11234569999998664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=214.05 Aligned_cols=170 Identities=26% Similarity=0.407 Sum_probs=138.4
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
..+.+++.||+|+||.||+|....+..+|+|++..... ..+.+.+|++++++++||+++++++++. .+..++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 34667789999999999999887777899998753322 2345778999999999999999999875 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.++++... ....++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 81 FMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred cCCCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 999999999997532 224678888899999999999999665 99999999999999999999999999987643
Q ss_pred CCC--ceeeccccCccccCcccc
Q 043136 870 DES--MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~--~~~~~Gt~~y~APE~~~~ 890 (902)
... .....++..|+|||+..+
T Consensus 155 ~~~~~~~~~~~~~~y~~Pe~~~~ 177 (260)
T cd05069 155 NEYTARQGAKFPIKWTAPEAALY 177 (260)
T ss_pred CcccccCCCccchhhCCHHHhcc
Confidence 321 122346678999998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=215.65 Aligned_cols=169 Identities=29% Similarity=0.442 Sum_probs=136.5
Q ss_pred cCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeE
Q 043136 713 MSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTM 785 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~ 785 (902)
...+.||+|+||+||++.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 5668899999999988642 3577899998854322 23445678899999999999999999987653 4689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++++|.+++... .+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 85 lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 85 LIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 999999999999998643 3678889999999999999999765 9999999999999999999999999998
Q ss_pred eccCCCC----ceeeccccCccccCcccccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....++..|+|||++.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~ 186 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENK 186 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccC
Confidence 7643322 11234566799999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=213.77 Aligned_cols=165 Identities=28% Similarity=0.424 Sum_probs=133.9
Q ss_pred EeeecCceEEEEEEe---CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+|+||.||+|.+ .+++.+|+|++.... ......+.+.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999954 357889999875332 233455678899999999999999999998864 567899999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
|+|.+++.... ..++.....++.|++.|++|+|.++ |+||||||+||++++++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~ 151 (257)
T cd05116 80 GPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY 151 (257)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCe
Confidence 99999986432 3677888899999999999999665 999999999999999999999999999876433221
Q ss_pred ----eeeccccCccccCccccc
Q 043136 874 ----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ----~~~~Gt~~y~APE~~~~~ 891 (902)
....+++.|+|||++...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~ 173 (257)
T cd05116 152 YKAKTHGKWPVKWYAPECMNYY 173 (257)
T ss_pred eeecCCCCCCccccCHhHhccC
Confidence 122345789999988653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=221.27 Aligned_cols=170 Identities=19% Similarity=0.194 Sum_probs=136.7
Q ss_pred CcEeeec--CceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 715 DKILGMG--STGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 715 ~~~iG~G--~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.++||+| +|++||++.. .+++.||+|++..... .....+.+.+|+++++.++||||+++++++..++..|+||||+
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 3679999 7899999965 5689999999854322 2233456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|++.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.++++||+.+.......
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999865422 13677888899999999999999766 9999999999999999999999998654432111
Q ss_pred --------CceeeccccCccccCccccc
Q 043136 872 --------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 --------~~~~~~Gt~~y~APE~~~~~ 891 (902)
......++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQN 183 (327)
T ss_pred ccccccccccccccceecccChHHhhcc
Confidence 01223567889999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-24 Score=209.69 Aligned_cols=183 Identities=27% Similarity=0.388 Sum_probs=144.7
Q ss_pred ccCCCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEe
Q 043136 699 RLNFTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLG 776 (902)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~ 776 (902)
...|+.+++.+- ..||.|+||+|++-.+ +.|+..|||++..... .++.++++.|.+...+- +.|+||++||
T Consensus 58 ~~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyG 130 (361)
T KOG1006|consen 58 LHTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYG 130 (361)
T ss_pred ccccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhh
Confidence 446777766554 4689999999999855 5799999999964432 45667788899876655 7999999999
Q ss_pred EEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 777 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
.+..++..|+-||.| .-++..+.+.-..-....+++...-+|....+.||.||... ..|||||+||+|||++..|.+
T Consensus 131 a~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 131 ALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCE
Confidence 999999999999999 45777665432222223456666667788889999999874 479999999999999999999
Q ss_pred EEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 857 RVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 857 kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+||||++-...+.-..+.-+|...|||||.+...
T Consensus 208 KLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~ 242 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS 242 (361)
T ss_pred eeecccchHhHHHHHHhhhccCCccccChhccCCc
Confidence 99999999877666666667899999999998543
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=213.90 Aligned_cols=172 Identities=27% Similarity=0.464 Sum_probs=141.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh------hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE------NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~------~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
+.+.+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|++++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 44568899999999999965 45789999988543222 112335688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++||||+++++|.+++.... .+++.....++.|++.|++|+|+.+ ++||||||+||++++++.+||+|||.+
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999996542 3567778899999999999999665 999999999999999999999999999
Q ss_pred eeccCCC-------CceeeccccCccccCccccc
Q 043136 865 KLIQSDE-------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~-------~~~~~~Gt~~y~APE~~~~~ 891 (902)
+...... ......|+..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 187 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT 187 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccC
Confidence 8764221 11234688999999998654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=214.49 Aligned_cols=175 Identities=28% Similarity=0.426 Sum_probs=144.0
Q ss_pred HHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
...+.+.+.||+|+||.||+|...+++.||+|.+..... ..+++.+|++++++++|+||+++++++......++||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT 80 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence 345667789999999999999887888999999854322 2355788999999999999999999999888999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+|++|||.++...
T Consensus 81 e~~~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 81 EYMSKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred eccCCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 9999999999997542 124678888899999999999999766 9999999999999999999999999998764
Q ss_pred CCCC--ceeeccccCccccCccccccc
Q 043136 869 SDES--MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 869 ~~~~--~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.... .....++..|+|||.+.+...
T Consensus 155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~ 181 (261)
T cd05034 155 DDEYTAREGAKFPIKWTAPEAANYGRF 181 (261)
T ss_pred chhhhhhhccCCCccccCHHHhccCCc
Confidence 3221 122334678999999876433
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=217.76 Aligned_cols=174 Identities=27% Similarity=0.395 Sum_probs=138.5
Q ss_pred cCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
...+.||+|+||.||+|... ....+|+|.+..... ....+.+.+|+.++++++||||+++++.+...+..++
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 34578999999999999652 235688888753322 2344678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC-------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 787 LYEYMPNGNLDDLLHAKNKG-------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
||||+.+|+|.+++...... ....+++...+.++.|++.|++|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999998753211 1234678888999999999999999665 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|++++++.+||+|||+++....... .....++..|+|||++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 9999999999999999986533221 1223456789999987554
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.3e-22 Score=214.40 Aligned_cols=171 Identities=27% Similarity=0.497 Sum_probs=138.6
Q ss_pred ccCCcEeeecCceEEEEEEeCC-C---cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-G---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.+.||+|+||.||+|.... + ..||+|.+.... .....+++..|++++++++||||+++++++...+..++|
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 4567899999999999997643 2 369999885432 234456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++++|.+++..... ..++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||+++..
T Consensus 84 ~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 84 TEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred EecCCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccc
Confidence 999999999999875421 3677888899999999999999665 999999999999999999999999998765
Q ss_pred cCCCCce---eec---cccCccccCccccc
Q 043136 868 QSDESMS---VIA---GSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~~~~---~~~---Gt~~y~APE~~~~~ 891 (902)
....... ... ++..|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYR 186 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccC
Confidence 4322211 111 13579999998754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=214.88 Aligned_cols=171 Identities=29% Similarity=0.442 Sum_probs=133.9
Q ss_pred cEeeecCceEEEEEEeCC-Cc--EEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPG-GE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|+||.||+|...+ +. .+|+|.+.... .....+.+.+|+++++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999997643 33 46788774221 223445678899999999 7999999999999999999999999
Q ss_pred CCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 792 PNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 792 ~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
++|+|.+++..... .....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~d 155 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIAD 155 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECC
Confidence 99999999975432 11124678888999999999999999665 99999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||+++.............+..|+|||++.+.
T Consensus 156 fgl~~~~~~~~~~~~~~~~~~y~apE~~~~~ 186 (270)
T cd05047 156 FGLSRGQEVYVKKTMGRLPVRWMAIESLNYS 186 (270)
T ss_pred CCCccccchhhhccCCCCccccCChHHHccC
Confidence 9998643221111122345679999998654
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=218.60 Aligned_cols=174 Identities=27% Similarity=0.418 Sum_probs=141.3
Q ss_pred hccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~ 783 (902)
.+.+.+.||+|+||.||+|.. ..+..||+|++..... ....+.+.+|+++++++ +||||+++++++...+.
T Consensus 36 ~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH--SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC--hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 456778999999999999964 1355799998754322 23456788999999999 79999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+.+|+|.++++.... ..+++.+...++.|++.|++|+|+.+ |+|+||||+||+++.++.+|++|||+
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence 9999999999999999875332 23688889999999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCC---ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
++....... .....+++.|+|||++.+..
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 219 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCV 219 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCC
Confidence 986643322 11234577899999886543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-23 Score=201.54 Aligned_cols=167 Identities=27% Similarity=0.402 Sum_probs=138.8
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
..||.|+.|.|++++.+ +|...|||.+.... ..++.++++..+.++.+.. .|+||+.+|+|..+..+++.||.|.
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 45899999999999765 58999999986443 3456677888899887764 8999999999999999999999983
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
.-.+.+++.-.. ++++...-++...++.||.||.++| +|+|||+||+|||+|+.|.+|+||||++-++.+....
T Consensus 175 ~C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh 248 (391)
T KOG0983|consen 175 TCAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH 248 (391)
T ss_pred HHHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc
Confidence 345555554322 4666666788889999999999865 7999999999999999999999999999988877777
Q ss_pred eeeccccCccccCccccc
Q 043136 874 SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~ 891 (902)
+...|.+.|||||.+.-.
T Consensus 249 trsAGC~~YMaPERidp~ 266 (391)
T KOG0983|consen 249 TRSAGCAAYMAPERIDPP 266 (391)
T ss_pred ccccCCccccCccccCCC
Confidence 778899999999998543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=216.08 Aligned_cols=165 Identities=26% Similarity=0.314 Sum_probs=131.2
Q ss_pred EeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHH---HhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 717 ILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDV---LGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i---l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.||+|+||.||+|... +++.+|+|.+.+...........+.+|..+ +...+||+|+++++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999764 588999998864432222222223344433 333479999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|+|.+++.... .+++.....++.|++.|++|||+.+ |+||||||+||++++++.+|++|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 999999886543 3778888999999999999999766 9999999999999999999999999987654322
Q ss_pred ceeeccccCccccCcccc
Q 043136 873 MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~ 890 (902)
.....||+.|+|||++..
T Consensus 152 ~~~~~~~~~y~aPE~~~~ 169 (279)
T cd05633 152 PHASVGTHGYMAPEVLQK 169 (279)
T ss_pred ccCcCCCcCccCHHHhcC
Confidence 233579999999999853
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=220.37 Aligned_cols=175 Identities=27% Similarity=0.342 Sum_probs=144.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|.+...........+.+.+|+++++.++||||+++++++......|+||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 345578999999999999765 4899999998655443334556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ...+++.....++.|+++||+|||..+ ++||||||+||+++.++.++|+|||++......
T Consensus 83 ~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 83 CPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred cCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999986432 224677888899999999999999665 999999999999999999999999998754321
Q ss_pred C------------------------------CceeeccccCccccCcccccc
Q 043136 871 E------------------------------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~------------------------------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||..|+|||++.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 208 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG 208 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC
Confidence 1 011346899999999987653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=210.98 Aligned_cols=167 Identities=30% Similarity=0.451 Sum_probs=140.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||.||+|.. .++.||+|++..... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred ccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 34568899999999999986 478899999854322 4566889999999999999999999999889999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ...++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 99999999875432 24788889999999999999999665 9999999999999999999999999998763322
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ...++..|+|||++...
T Consensus 157 ~--~~~~~~~~~ape~~~~~ 174 (256)
T cd05039 157 D--SGKLPVKWTAPEALREK 174 (256)
T ss_pred c--cCCCcccccCchhhcCC
Confidence 2 23446679999988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-22 Score=219.41 Aligned_cols=162 Identities=21% Similarity=0.195 Sum_probs=124.7
Q ss_pred HhccCCcEeeecCceEEEEEEeC--CCcEEEEEEecccch--hhHHHHHHHHHHHHHHhcCCcCeeEe-EEeEEecCCee
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP--GGEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVRHRNIVR-LLGCCSNRECT 784 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~h~nIv~-l~~~~~~~~~~ 784 (902)
..|...+.||+|+||+||+|++. +++.||||++..... ......+.+.+|++++++++|++++. ++++ +..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCc
Confidence 45667889999999999999764 577789998753211 12234566889999999999999985 5432 457
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDL-KPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-Kp~NILl~~~~~~kl~DFGl 863 (902)
|+||||++|++|... . .. . ...++.|+++||+|+|+++ |+|||| ||+||+++.++.+||+|||+
T Consensus 94 ~LVmE~~~G~~L~~~-~--~~------~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-R--PH------G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred EEEEEccCCCCHHHh-C--cc------c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 999999999999632 1 00 1 1357889999999999765 999999 99999999999999999999
Q ss_pred ceeccCCCC---------ceeeccccCccccCcccc
Q 043136 864 AKLIQSDES---------MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~---------~~~~~Gt~~y~APE~~~~ 890 (902)
|+.+..... .....|++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997654321 134678899999999854
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=211.00 Aligned_cols=174 Identities=24% Similarity=0.345 Sum_probs=141.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~lv~e 789 (902)
|.+.+.||+|++|.||+|... +++.||+|++.... ......+.+.+|++++++++|+|++++++.+.. +...|+|||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 456689999999999999654 57889999985332 223345567889999999999999999998764 446899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++++++.+++..... ..+++.+++.++.|++.|++|+|+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 9999999999875322 24678889999999999999999665 99999999999999999999999999987643
Q ss_pred CC-CceeeccccCccccCcccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......|++.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~ 178 (257)
T cd08223 155 QCDMASTLIGTPYYMSPELFSNKP 178 (257)
T ss_pred cCCccccccCCcCccChhHhcCCC
Confidence 22 234457899999999987653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-23 Score=219.81 Aligned_cols=172 Identities=25% Similarity=0.344 Sum_probs=143.1
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+||.++||++...+.+.||+|++.-. ..+......+.+|++.|.+++ |.+||++|+|-..+++.||||||
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~ 441 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC 441 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec
Confidence 4455789999999999999888899999988433 334456778999999999995 99999999999999999999998
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
- ..||..+++.+... ..+| .++.+..||++|+.++|.++ |||.|+||.|+|+- +|.+||+|||+|..+..+
T Consensus 442 G-d~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 442 G-DIDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred c-cccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 6 56999999876432 2334 45678899999999999665 99999999999987 468999999999988765
Q ss_pred CC---ceeeccccCccccCccccccc
Q 043136 871 ES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 ~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.. ..+.+||+.|||||.+..+-.
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s 538 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSS 538 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccc
Confidence 54 355799999999999976543
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=215.11 Aligned_cols=172 Identities=25% Similarity=0.391 Sum_probs=137.3
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHH-HhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDV-LGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+||.||+|... +++.||+|++...... .....+..|+.+ ++..+||||+++++++...+..|+||||
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS--QEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc--HHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 34578999999999999764 6899999998543222 122345556665 5556899999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ |+|.+++..... ....+++..++.++.|++.|++|||++ .+++||||||+||+++.++.+||+|||.++.....
T Consensus 82 ~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 82 MD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 95 689888865332 224578889999999999999999964 14999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCcccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......|+..|+|||++.+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 158 VAKTIDAGCKPYMAPERINP 177 (283)
T ss_pred cccccccCCccccChhhcCC
Confidence 33344578999999999865
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.7e-22 Score=218.42 Aligned_cols=175 Identities=27% Similarity=0.403 Sum_probs=136.1
Q ss_pred ccCCcEeeecCceEEEEEEeCC-C--cEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-G--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+.+.||+|+||+||+|...+ + ..+|+|.+.... .....+.+.+|++++.++ +||||+++++++...+..|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 4466889999999999997643 3 346888764221 223345688899999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 788 YEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
|||+++|+|.+++...... ....+++.....++.|++.|++|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 9999999999999754311 1124677888999999999999999665 9999999999999999999
Q ss_pred EEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 857 RVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 857 kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||+|||++..............+..|+|||++.+.
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 193 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYS 193 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhccC
Confidence 99999998643221111112235579999998654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=216.71 Aligned_cols=172 Identities=27% Similarity=0.376 Sum_probs=139.4
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|++|.||+|+.. +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..|+||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFL 81 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecC
Confidence 34578999999999999764 6889999998543221 122355778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+ +++.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 82 S-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred C-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 6 689888865432 234678888899999999999999665 9999999999999999999999999997653222
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+++.|+|||++.+.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~ 176 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGS 176 (285)
T ss_pred ccccCCcccccccChHHhcCC
Confidence 12334678999999998653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=218.04 Aligned_cols=170 Identities=24% Similarity=0.386 Sum_probs=141.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++.+......|+|||
T Consensus 21 ~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 344557899999999999965 46889999988543322 23557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++... ..++.+...++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||.++....
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999988542 2567788899999999999999765 99999999999999999999999999876543
Q ss_pred CCC-ceeeccccCccccCcccccc
Q 043136 870 DES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
... .....|++.|+|||.+.+..
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~~~ 192 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTRKA 192 (296)
T ss_pred cccccCcccCCccccCHHHHcCCC
Confidence 222 23457899999999986643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.5e-22 Score=210.26 Aligned_cols=168 Identities=26% Similarity=0.432 Sum_probs=138.1
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGN 795 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 795 (902)
++||+|+||.||+|...+++.||+|++...... ...+.+.+|++++++++|+||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999998766999999988543322 345678899999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc--
Q 043136 796 LDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-- 873 (902)
Q Consensus 796 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~-- 873 (902)
|.+++..... ..++.....++.+++.|++|+|+.+ ++||||||+||+++.++.+||+|||.++........
T Consensus 79 l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 151 (251)
T cd05041 79 LLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS 151 (251)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence 9999865322 3567778899999999999999665 999999999999999999999999999865422211
Q ss_pred -eeeccccCccccCcccccc
Q 043136 874 -SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 -~~~~Gt~~y~APE~~~~~~ 892 (902)
....++..|+|||++.+..
T Consensus 152 ~~~~~~~~~y~~PE~~~~~~ 171 (251)
T cd05041 152 DGLKQIPIKWTAPEALNYGR 171 (251)
T ss_pred cccCcceeccCChHhhccCC
Confidence 1123356799999986543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=215.11 Aligned_cols=170 Identities=24% Similarity=0.395 Sum_probs=138.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC------C
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR------E 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~------~ 782 (902)
.|...+.||+|+||.||+|... +++.||+|++..... ....+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 7 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc----cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3445578999999999999664 578899998853321 234567899999998 699999999998653 4
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+++++|.+++.... ...+++..+..++.|++.|++|||+++ |+|||+||+||++++++.+||+|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 6899999999999999987532 124677888899999999999999765 9999999999999999999999999
Q ss_pred cceeccCC-CCceeeccccCccccCcccc
Q 043136 863 VAKLIQSD-ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~-~~~~~~~Gt~~y~APE~~~~ 890 (902)
+++..... .......|++.|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 185 (272)
T cd06637 157 VSAQLDRTVGRRNTFIGTPYWMAPEVIAC 185 (272)
T ss_pred CceecccccccCCcccccccccCHhHhcc
Confidence 99876432 22345679999999999863
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=216.60 Aligned_cols=169 Identities=25% Similarity=0.391 Sum_probs=142.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 20 ~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 455668899999999999975 5789999999854322 234557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++... ..++..+..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 97 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~ 167 (297)
T cd06656 97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (297)
T ss_pred ccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence 99999999998642 3567788899999999999999665 99999999999999999999999999987643
Q ss_pred CCC-ceeeccccCccccCccccc
Q 043136 870 DES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
... .....|++.|+|||.+.+.
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~ 190 (297)
T cd06656 168 EQSKRSTMVGTPYWMAPEVVTRK 190 (297)
T ss_pred CccCcCcccCCccccCHHHHcCC
Confidence 322 2345789999999998664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.1e-22 Score=213.25 Aligned_cols=173 Identities=27% Similarity=0.409 Sum_probs=141.2
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh-------hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE-------NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~-------~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
|...+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|++++++++|||++++++++...+.
T Consensus 3 ~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 82 (272)
T cd06629 3 WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEY 82 (272)
T ss_pred eeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCc
Confidence 45678999999999999965 46889999987432111 11223567889999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.++||||+++++|.+++.... .+++..+..++.|++.|+.|+|+.+ ++||||||+||+++.++.+|++|||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 83 LSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred eEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999987542 3677778889999999999999665 99999999999999999999999999
Q ss_pred ceeccCCC---CceeeccccCccccCcccccc
Q 043136 864 AKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
++...... ......|+..|+|||++....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 186 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYS 186 (272)
T ss_pred cccccccccccccccccCCccccCHHHhcccc
Confidence 97653221 123356889999999987643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=214.94 Aligned_cols=170 Identities=29% Similarity=0.430 Sum_probs=134.6
Q ss_pred cCCcEeeecCceEEEEEEeC-CCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...+.||+|+||.||+|.+. +++ .+++|++... .......++..|+.++++++||||+++++++.. ...+++
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i 86 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLV 86 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEE
Confidence 34578999999999999753 344 4777776322 122334567788999999999999999998754 457889
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
+||+++|+|.+++..... .+++.....++.|++.|++|+|+.+ ++||||||+||++++++.+||+|||.++..
T Consensus 87 ~e~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 87 TQLSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEeCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 999999999999975432 4678888999999999999999665 999999999999999999999999999876
Q ss_pred cCCCC---ceeeccccCccccCcccccc
Q 043136 868 QSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
..... .....|+..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~ 187 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGR 187 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCC
Confidence 43221 22345677899999986543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=7e-22 Score=216.02 Aligned_cols=171 Identities=23% Similarity=0.305 Sum_probs=139.8
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|... .++.||+|.+...........+.+.+|+++++.++||||+++++.+..++..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 44578999999999999764 57899999885443333344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+|++|.+++.... .+++.....++.|++.|++|+|+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 84 EGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999996542 3677778889999999999999665 9999999999999999999999999986421000
Q ss_pred ----------------CceeeccccCccccCccccc
Q 043136 872 ----------------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ----------------~~~~~~Gt~~y~APE~~~~~ 891 (902)
......|+..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 191 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ 191 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCC
Confidence 01124578899999998654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=220.64 Aligned_cols=175 Identities=25% Similarity=0.426 Sum_probs=139.7
Q ss_pred ccCCcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~l 786 (902)
|.+.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+. +..|+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 345578999999999999764 4789999998653312222335567899999999999999999999888 78999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC----CCCEEEeecc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG----EMEARVADFG 862 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~----~~~~kl~DFG 862 (902)
||||++ +++.+++..........++....+.++.|++.|++|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 82 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 999996 57877776544333335677888899999999999999766 999999999999999 8999999999
Q ss_pred cceeccCCCC----ceeeccccCccccCcccc
Q 043136 863 VAKLIQSDES----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~~----~~~~~Gt~~y~APE~~~~ 890 (902)
+++....... .....+|+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 189 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLG 189 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhC
Confidence 9987643221 233568899999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-22 Score=211.13 Aligned_cols=172 Identities=28% Similarity=0.477 Sum_probs=139.2
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccch--hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~l 786 (902)
|...+.||+|+||.||+|.. .+++.||+|++..... ...+..+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 34568899999999999965 4588999998754321 222345668889999999999999999998865 357889
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+|||+++++|.+++.... .+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 999999999999986532 2567777889999999999999665 99999999999999999999999999876
Q ss_pred ccC----CCCceeeccccCccccCccccc
Q 043136 867 IQS----DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~----~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
... ........|+..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGE 184 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCC
Confidence 532 1122335689999999998664
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.1e-22 Score=218.39 Aligned_cols=169 Identities=26% Similarity=0.403 Sum_probs=138.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|.+...... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 456688999999999999764 5789999988533222 1233466899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ ++|.+++..... ..++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 ~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 157 (301)
T cd07873 86 LD-KDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 157 (301)
T ss_pred cc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence 96 689888865322 3567788889999999999999665 999999999999999999999999999765322
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......+++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 158 TKTYSNEVVTLWYRPPDILLG 178 (301)
T ss_pred CCcccccceeecccCcHHHhC
Confidence 2 2234567899999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=211.29 Aligned_cols=170 Identities=26% Similarity=0.392 Sum_probs=143.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.+|+|.+...... ..+.+.+|++++++++||||+++++++.+.+..|++|||
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 445688999999999999764 5788999998543322 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ..++......++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 154 (262)
T cd06613 82 CGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT 154 (262)
T ss_pred CCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhh
Confidence 99999999887542 13677888899999999999999665 999999999999999999999999999876432
Q ss_pred C-CceeeccccCccccCccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......|+..|+|||.+.+.
T Consensus 155 ~~~~~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 155 IAKRKSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred hhccccccCCccccCchhhccc
Confidence 2 23445789999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=212.89 Aligned_cols=172 Identities=28% Similarity=0.486 Sum_probs=138.6
Q ss_pred hccCCcEeeecCceEEEEEEeCC-C---cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG-G---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+...+.||+|+||.||+|.... + ..+|+|++..... ....+.+.+|++++++++||||+++.+++...+..|+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT--EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 34556899999999999997642 3 3789998854322 2345668899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++.... ..+++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+|++|||++..
T Consensus 84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 156 (268)
T cd05063 84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRV 156 (268)
T ss_pred EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCcccee
Confidence 999999999999986532 24677888899999999999999665 99999999999999999999999999987
Q ss_pred ccCCCCc--ee--eccccCccccCccccc
Q 043136 867 IQSDESM--SV--IAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~~--~~--~~Gt~~y~APE~~~~~ 891 (902)
....... .. ...++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 185 (268)
T cd05063 157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185 (268)
T ss_pred cccccccceeccCCCcCceecCHHHhhcC
Confidence 6432211 11 1234579999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=214.66 Aligned_cols=169 Identities=26% Similarity=0.358 Sum_probs=141.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|++++++++||||+++++++......|+||||
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 445567999999999999764 5889999988533 223446688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... .+++.....++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||.+......
T Consensus 84 ~~~~~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 84 CDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred cCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999875432 4677888899999999999999766 999999999999999999999999998765332
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......|++.|+|||++..
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~ 177 (280)
T cd06611 157 LQKRDTFIGTPYWMAPEVVAC 177 (280)
T ss_pred ccccceeecchhhcCHHHHhh
Confidence 22344678999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=235.54 Aligned_cols=288 Identities=20% Similarity=0.377 Sum_probs=168.9
Q ss_pred CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc
Q 043136 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA 206 (902)
Q Consensus 127 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 206 (902)
+.+.|+++++.++. +|..+. +.|+.|+|++|+|+. +|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|+
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 45666666666663 444432 356666666666663 344332 36677777777666 3454432 356777777
Q ss_pred CCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec
Q 043136 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 207 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
+|+++ .+|..+. ++|+.|++++|+|+ .+|..+. ++|++|+|++|+|++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 77776 4555543 45777777777776 3455443 367777777777763 444332 356777777777763 4
Q ss_pred CCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCC
Q 043136 287 PVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366 (902)
Q Consensus 287 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 366 (902)
|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+++ .+|..+ .++|+.|++++|+|+. +|..+. .
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~l--p~~L~~LdLs~N~Lt~-LP~~l~--~ 388 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETL--PPTITTLDVSRNALTN-LPENLP--A 388 (754)
T ss_pred Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhh--cCCcCEEECCCCcCCC-CCHhHH--H
Confidence 44332 567777777777764 555443 56777777777775 355544 2567777777777774 343332 2
Q ss_pred ceeEEEecCCcccCCCCCCc----cCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCC-CCCcccCCCCCCc
Q 043136 367 KLLTVDVSSNSLTGPIPPTI----CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG-SIPQGFGLLPNLT 441 (902)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~----~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~ 441 (902)
.|+.|++++|+|+ .+|..+ ..++.+..+++.+|.++. ..+.+|+.| ++.+.+.| .++...+.+++++
T Consensus 389 sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~gp~i~~~~~~~~~l~ 460 (754)
T PRK15370 389 ALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQGPRVLFAMGDFSIVR 460 (754)
T ss_pred HHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccCCccccccccccccc
Confidence 5777777777776 344433 334667788888887762 234445555 44455544 3344455555665
Q ss_pred EEEccCcccCC
Q 043136 442 FMDMSRNSLSG 452 (902)
Q Consensus 442 ~L~Ls~N~l~~ 452 (902)
....-++.+.+
T Consensus 461 ~~~~l~~a~~~ 471 (754)
T PRK15370 461 VTRPLHQAVQG 471 (754)
T ss_pred ccchHHHHHhc
Confidence 54444444443
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=214.58 Aligned_cols=174 Identities=26% Similarity=0.410 Sum_probs=140.1
Q ss_pred cCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
...++||+|+||.||+|... ++..+|+|.+... .....+.+.+|++++++++|+||+++++++...+..++
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45688999999999999532 3567888887433 23445678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 787 LYEYMPNGNLDDLLHAKNKG----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
||||+++++|.+++...... ....+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 99999999999998754310 1124678888999999999999999665 9999999999999999999
Q ss_pred EEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 857 RVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 857 kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+|||+++....... .....+++.|+|||++.+..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 200 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK 200 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCC
Confidence 9999999976543221 12234567899999887654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=215.22 Aligned_cols=170 Identities=25% Similarity=0.375 Sum_probs=140.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++......++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 445678999999999999765 588999998853321 112234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++.+..++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 82 CDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred cCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 99988877764322 3678888999999999999999765 999999999999999999999999999876543
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......++..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~aPE~~~~ 174 (286)
T cd07847 154 GDDYTDYVATRWYRAPELLVG 174 (286)
T ss_pred cccccCcccccccCCHHHHhC
Confidence 3 2334568899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=211.80 Aligned_cols=168 Identities=28% Similarity=0.391 Sum_probs=138.4
Q ss_pred cEeeecCceEEEEEEeCC--C--cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPG--G--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~--~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999997633 2 36899998654432 456678899999999999999999999988 8899999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ...++...+.++.|+++||+|+|..+ ++||||||+||+++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~ 151 (257)
T cd05040 78 PLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNE 151 (257)
T ss_pred CCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccc
Confidence 99999999876432 24688889999999999999999665 9999999999999999999999999998764422
Q ss_pred C----ceeeccccCccccCcccccc
Q 043136 872 S----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .....++..|+|||++.+..
T Consensus 152 ~~~~~~~~~~~~~~y~~pE~~~~~~ 176 (257)
T cd05040 152 DHYVMEEHLKVPFAWCAPESLRTRT 176 (257)
T ss_pred cceecccCCCCCceecCHHHhcccC
Confidence 1 11245778899999886543
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.9e-22 Score=214.07 Aligned_cols=175 Identities=27% Similarity=0.339 Sum_probs=138.7
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+...+.||+|+||.||+|.+. .+..||+|.+.... .......+.+|+.++++++|+||+++++++.+.+..+
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRF 85 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcE
Confidence 455688999999999999764 35678888874322 2233456888999999999999999999999888999
Q ss_pred EEEEccCCCCHHHHHHhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEee
Q 043136 786 LLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVAD 860 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~D 860 (902)
+||||+++++|.+++...+.. ....+++..+..++.||+.|++|||+.+ ++||||||+||+++.++ .+|++|
T Consensus 86 lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 86 ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred EEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEecc
Confidence 999999999999999765422 2235788889999999999999999765 99999999999998764 599999
Q ss_pred cccceeccCCCCc---eeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
||+++........ ....++..|+|||++.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 196 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG 196 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcC
Confidence 9999876332211 112335679999998654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=214.52 Aligned_cols=171 Identities=24% Similarity=0.285 Sum_probs=140.1
Q ss_pred cCCcEeeecCceEEEEEEe----CCCcEEEEEEecccchh-hHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.||+|+||.||+|+. .+++.||+|++...... .....+.+.+|+++++++ +|++|+++++++..+...|+
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999975 36889999998543221 122345677899999999 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++.... .+++.....++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 83 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 83 ILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999987542 3566777888899999999999665 99999999999999999999999999987
Q ss_pred ccCCC--CceeeccccCccccCccccc
Q 043136 867 IQSDE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
..... ......|+..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGG 181 (290)
T ss_pred cccccccccccccCCcccCChhhccCC
Confidence 64322 22346689999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=209.88 Aligned_cols=174 Identities=25% Similarity=0.375 Sum_probs=144.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.. .+++.+|+|++..... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 44568899999999999965 4688899999854332 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~~~~ 869 (902)
+++++|.+++.... ....++..+..++.|+++|++|+|+++ ++||||||+||+++.+ +.+|++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999997643 224677888899999999999999665 9999999999999865 4689999999988765
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........|++.|+|||.+.+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~ 177 (256)
T cd08220 155 KSKAYTVVGTPCYISPELCEGKP 177 (256)
T ss_pred CccccccccCCcccCchhccCCC
Confidence 54445567899999999987654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.5e-22 Score=210.80 Aligned_cols=172 Identities=30% Similarity=0.497 Sum_probs=144.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 2 y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 2 WQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred ceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 45568899999999999965 46889999998644332 34567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ..++..+..++.|++.|++|||+.+ ++|+||||+||++++++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 99999999987532 3566778889999999999999766 999999999999999999999999998876433
Q ss_pred CC-----ceeeccccCccccCcccccc
Q 043136 871 ES-----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~-----~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. .....|++.|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~ 179 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGK 179 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCC
Confidence 22 12356889999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.1e-22 Score=213.38 Aligned_cols=165 Identities=26% Similarity=0.330 Sum_probs=131.4
Q ss_pred EeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHH---HHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 717 ILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAE---VDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~E---i~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.||+|+||.||+|.. .+++.||+|.+.++..........+..| ++.++...||+|+++++++...+..|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999966 4588999999865432211111222233 334455679999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
||+|.+++.... .+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 999998886432 4788889999999999999999665 9999999999999999999999999987654322
Q ss_pred ceeeccccCccccCcccc
Q 043136 873 MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~ 890 (902)
.....|+..|+|||++..
T Consensus 152 ~~~~~~~~~y~aPE~~~~ 169 (278)
T cd05606 152 PHASVGTHGYMAPEVLQK 169 (278)
T ss_pred CcCcCCCcCCcCcHHhcC
Confidence 234579999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=213.63 Aligned_cols=170 Identities=29% Similarity=0.435 Sum_probs=135.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+...+.||+|+||+||+|++ .+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 34568899999999999964 3444 48999875332 22345668899999999999999999999875 45789
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+|||+++|++.++++... ..+++...+.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999987532 14677888899999999999999665 99999999999999999999999999987
Q ss_pred ccCCCCce---eeccccCccccCccccc
Q 043136 867 IQSDESMS---VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~~~---~~~Gt~~y~APE~~~~~ 891 (902)
........ ...+++.|+|||+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 186 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHR 186 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccC
Confidence 75333221 12346789999998654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.7e-22 Score=216.62 Aligned_cols=171 Identities=30% Similarity=0.444 Sum_probs=141.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchh--hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKE--NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
|...+.||+|+||.||+|... +++.||+|++...... .......+..|++++++++|+||+++++++.+.+..++||
T Consensus 2 y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (298)
T cd07841 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVF 81 (298)
T ss_pred ceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEE
Confidence 345578999999999999764 6899999998644322 1223445678999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+ +|+|.+++.... ..+++..+..++.|+++||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 82 e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 82 EFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred ccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 999 899999986542 24778888999999999999999665 9999999999999999999999999998765
Q ss_pred CCC-CceeeccccCccccCcccc
Q 043136 869 SDE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
... ......+++.|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 154 SPNRKMTHQVVTRWYRAPELLFG 176 (298)
T ss_pred CCCccccccccceeeeCHHHHhC
Confidence 432 2333467889999998854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.7e-22 Score=211.77 Aligned_cols=172 Identities=25% Similarity=0.420 Sum_probs=141.2
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccch---hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHK---ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~---~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|...+.||+|+||.||+|.. .+++.||+|.+..... ......+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v 81 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLF 81 (268)
T ss_pred ccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEE
Confidence 34557899999999999965 5689999998854321 1123456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeeccccee
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKL 866 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~ 866 (902)
|||+++++|.+++.... .+++.....++.|++.|++|||+++ ++||||||+||+++.++ .+||+|||.+..
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 82 VEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 99999999999987542 3667788899999999999999765 99999999999998776 599999999887
Q ss_pred ccCCC-----CceeeccccCccccCccccc
Q 043136 867 IQSDE-----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~-----~~~~~~Gt~~y~APE~~~~~ 891 (902)
..... ......|+..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 183 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccC
Confidence 64321 12335689999999998654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-22 Score=219.36 Aligned_cols=168 Identities=26% Similarity=0.467 Sum_probs=139.7
Q ss_pred cCCcEeeecCceEEEEEEeC---CCc--EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP---GGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~---~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...+.||+|.||.||+|... .|+ .||||.-+.. ......+.|+.|+.+|+.++|||||+++|+|.+ ...|+|
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d--~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wiv 468 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD--CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIV 468 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccC--CChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEE
Confidence 34578999999999999542 233 4777875432 233457889999999999999999999999975 468999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
||.++-|.|..+++..+. .++..+...++.||+.||+|||+.. +|||||..+|||+.....||++|||++|.+
T Consensus 469 mEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred EecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhc
Confidence 999999999999987543 4777888899999999999999654 999999999999999999999999999998
Q ss_pred cCCCCceeecc--ccCccccCcccc
Q 043136 868 QSDESMSVIAG--SYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~~~~~~G--t~~y~APE~~~~ 890 (902)
.++.......| ...|||||.+.+
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINf 566 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINF 566 (974)
T ss_pred cccchhhccccccceeecCccccch
Confidence 87766655555 346999999865
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-22 Score=209.31 Aligned_cols=166 Identities=30% Similarity=0.432 Sum_probs=133.9
Q ss_pred cEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|+||.||+|.... +..+|+|.+...... ...+++.+|++++++++||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 468999999999995422 368999998644332 34567889999999999999999999876 44679999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++.... ..++..+..++.|++.|++|||..+ ++||||||+||+++.++.+||+|||.++......
T Consensus 78 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~ 149 (257)
T cd05060 78 PLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS 149 (257)
T ss_pred CCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence 9999999997543 3678888999999999999999665 9999999999999999999999999998764332
Q ss_pred Cc----eeeccccCccccCcccccc
Q 043136 872 SM----SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~~----~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ....++..|+|||.+.+..
T Consensus 150 ~~~~~~~~~~~~~~y~aPE~~~~~~ 174 (257)
T cd05060 150 DYYRATTAGRWPLKWYAPECINYGK 174 (257)
T ss_pred cccccccCccccccccCHHHhcCCC
Confidence 21 1112346799999886543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=231.25 Aligned_cols=169 Identities=21% Similarity=0.214 Sum_probs=130.0
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC------cCeeEeEEeEEecC-
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR------HRNIVRLLGCCSNR- 781 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~------h~nIv~l~~~~~~~- 781 (902)
..|.+.+.||+|+||.||+|.+ .+++.||||++..... ..+....|++++++++ |++++++++++...
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~ 204 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNET 204 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCC
Confidence 4566778999999999999966 4578899999843211 1223445666665554 45689999988764
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-------
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM------- 854 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~------- 854 (902)
...|+|||++ +++|.+++...+ .+++..+..|+.||+.||+|||++ .+||||||||+|||++.++
T Consensus 205 ~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 205 GHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred ceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccccc
Confidence 5789999998 788998886542 367788889999999999999963 2499999999999998765
Q ss_pred ---------CEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 855 ---------EARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 855 ---------~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.+||+|||.+... .......+||+.|||||++.+..
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~--~~~~~~~~gt~~Y~APE~~~~~~ 321 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE--RHSRTAIVSTRHYRSPEVVLGLG 321 (467)
T ss_pred ccccCCCCceEEECCCCccccC--ccccccccCCccccCcHHhhcCC
Confidence 4999999987643 22334578999999999997653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=212.85 Aligned_cols=170 Identities=29% Similarity=0.430 Sum_probs=136.7
Q ss_pred hccCCcEeeecCceEEEEEEeCC-C----cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG-G----EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~-~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.+...+.||+|+||.||+|.... + ..+|+|.+..... ......+.+|++++++++||||+++++++.. ...+
T Consensus 8 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 34566889999999999997532 3 2588888744322 3445668899999999999999999999987 7889
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++..... .+++.....++.|++.|++|||+.+ ++||||||+||++++++.+||+|||.++
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccc
Confidence 99999999999999875422 3678888999999999999999655 9999999999999999999999999998
Q ss_pred eccCCCCcee---eccccCccccCcccc
Q 043136 866 LIQSDESMSV---IAGSYGYIAPGTFCF 890 (902)
Q Consensus 866 ~~~~~~~~~~---~~Gt~~y~APE~~~~ 890 (902)
.......... ..++..|+|||.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhc
Confidence 7653332211 223568999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.8e-22 Score=216.20 Aligned_cols=176 Identities=29% Similarity=0.440 Sum_probs=140.9
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
.+...+.||+|+||.||+|... ++..||+|++..... ......+.+|++++++++||||+++++++...+..
T Consensus 6 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 6 NIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 3456688999999999999753 467899998854322 23446688899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhcc-----------------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCC
Q 043136 785 MLLYEYMPNGNLDDLLHAKNK-----------------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSN 847 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~N 847 (902)
++||||+++|+|.+++..... .....+++..++.++.|++.||+|+|..+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999975321 11224677888999999999999999665 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++.++.+||+|||.++....... .....++..|+|||++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 207 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN 207 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC
Confidence 9999999999999999886533221 1223356679999987654
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=214.33 Aligned_cols=169 Identities=31% Similarity=0.478 Sum_probs=140.2
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
+|...+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3556688999999999999764 688999998854433334445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+. |++.+++..... .+++..+..++.|++.|+.|||+.+ |+||||+|+||++++++.+||+|||++.....
T Consensus 96 ~~~-g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 96 YCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred hhC-CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 996 677777654322 3678888899999999999999665 99999999999999999999999999876533
Q ss_pred CCCceeeccccCccccCcccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~ 890 (902)
. ....|++.|+|||++.+
T Consensus 168 ~---~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 168 A---NSFVGTPYWMAPEVILA 185 (307)
T ss_pred C---CCccCCccccCceeeec
Confidence 2 23568899999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=210.11 Aligned_cols=172 Identities=30% Similarity=0.475 Sum_probs=139.9
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccc--hhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKH--KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~--~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~l 786 (902)
|.+.+.||+|+||.||+|.. .+++.||+|.+.... .........+.+|++++++++|+||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 44578999999999999975 458899999874321 12234456788999999999999999999998664 46889
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++.... ..++.....++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||.++.
T Consensus 84 v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 999999999999886432 2567778899999999999999666 99999999999999999999999999986
Q ss_pred ccC----CCCceeeccccCccccCccccc
Q 043136 867 IQS----DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~----~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
... ........|+..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 184 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGE 184 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCC
Confidence 532 1122345689999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=209.77 Aligned_cols=169 Identities=29% Similarity=0.425 Sum_probs=137.2
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
...||+|+||.||+|.+. ++..||+|.+.... ....+.+.+|++++++++|+||+++++++...+..++||||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 368999999999999754 57789999875432 23345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeecccceeccCCC-
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~- 871 (902)
++|.+++..... ....+...+..++.|++.|++|||+.+ |+||||||+||+++. ++.+||+|||.+.......
T Consensus 90 ~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 90 GSLSALLRSKWG--PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred CCHHHHHHHhcc--cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 999999875421 111256777789999999999999665 999999999999976 6799999999987654322
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......|++.|+|||++...
T Consensus 165 ~~~~~~~~~~~~aPE~~~~~ 184 (268)
T cd06624 165 CTETFTGTLQYMAPEVIDKG 184 (268)
T ss_pred ccccCCCCccccChhhhccc
Confidence 22335689999999998543
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=213.23 Aligned_cols=177 Identities=21% Similarity=0.305 Sum_probs=142.3
Q ss_pred HhccCCcEeeecCceEEEEEEeCC-----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-REC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~ 783 (902)
..|.+.+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 456677899999999999997655 6889999875332 23445678899999999999999999998765 467
Q ss_pred eEEEEEccCCCCHHHHHHhhccC---CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
.++++||+++|+|.+++...... ....+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998754321 1245788889999999999999999665 99999999999999999999999
Q ss_pred cccceeccCCCCc---eeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
||+++.+...... ....++..|+|||++.+.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 194 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNK 194 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcC
Confidence 9999866433221 123456789999998654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.4e-22 Score=210.31 Aligned_cols=168 Identities=27% Similarity=0.387 Sum_probs=142.9
Q ss_pred ccCCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.... ++.+|+|.+.... ..+.+.+|++++++++||||+++++++.+....|+++||
T Consensus 5 y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred chhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4556789999999999997754 7899999984321 156788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ...++.....++.|++.|+.|||+.+ ++|||++|+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (256)
T cd06612 80 CGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152 (256)
T ss_pred CCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccC
Confidence 99999999986533 24688889999999999999999665 999999999999999999999999999876543
Q ss_pred C-CceeeccccCccccCccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......|+..|+|||++.+.
T Consensus 153 ~~~~~~~~~~~~y~~PE~~~~~ 174 (256)
T cd06612 153 MAKRNTVIGTPFWMAPEVIQEI 174 (256)
T ss_pred ccccccccCCccccCHHHHhcC
Confidence 3 23345689999999998665
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.9e-22 Score=210.24 Aligned_cols=166 Identities=29% Similarity=0.417 Sum_probs=135.8
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe-cCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS-NRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~-~~~~~~lv~e~ 790 (902)
+.+.+.||+|+||.||+|.. .+..||+|.+.... ..+.+.+|+.++++++|++++++++++. ..+..++||||
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred CeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 45568899999999999976 47789999874321 2346788999999999999999999764 55678999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.++++.... ...++.....++.|++.|++|||+++ ++||||||+||++++++.+|++|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 82 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred CCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceecccc
Confidence 999999999875432 24677888899999999999999665 999999999999999999999999998865432
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ....++..|+|||++.+.
T Consensus 156 ~--~~~~~~~~y~aPE~~~~~ 174 (256)
T cd05082 156 Q--DTGKLPVKWTAPEALREK 174 (256)
T ss_pred C--CCCccceeecCHHHHccC
Confidence 2 223456789999998654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.3e-22 Score=214.32 Aligned_cols=169 Identities=26% Similarity=0.400 Sum_probs=137.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|++|.||+|... +++.||+|.+...... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 445688999999999999765 6889999998543221 1123456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ ++|.+++..... .+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++.....
T Consensus 85 ~~-~~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 85 LD-TDLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred CC-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 97 599998865432 4677888899999999999999665 999999999999999999999999998764321
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 157 SKTYSNEVVTLWYRPPDVLLG 177 (291)
T ss_pred CccccccccccccCCcHHhhc
Confidence 11223457889999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.7e-22 Score=211.47 Aligned_cols=175 Identities=25% Similarity=0.358 Sum_probs=140.6
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+...+.||+|+||.||+|+.. +.+.||+|.+..... ....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 345578999999999999753 346788998754322 224566889999999999999999999999989999
Q ss_pred EEEEccCCCCHHHHHHhhccCC----CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGE----NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
+||||+++|+|.+++....... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997654211 124788899999999999999999665 999999999999999999999999
Q ss_pred ccceeccCCC--CceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++...... ......++..|+|||.+.+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~ 193 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQED 193 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccC
Confidence 9987543221 22334567889999988654
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.4e-22 Score=210.30 Aligned_cols=167 Identities=26% Similarity=0.412 Sum_probs=131.6
Q ss_pred cEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe-cCCeeEEEEEc
Q 043136 716 KILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS-NRECTMLLYEY 790 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~-~~~~~~lv~e~ 790 (902)
+.||+|+||.||+|... ....+|+|++.... .....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999653 24579999874322 2234566788999999999999999999775 45568999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+.+|+|.+++..... ...+.....++.|++.|++|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 79 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~ 151 (262)
T cd05058 79 MKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDK 151 (262)
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCC
Confidence 999999999875322 2455667789999999999999665 999999999999999999999999999865432
Q ss_pred CC-----ceeeccccCccccCccccc
Q 043136 871 ES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....+++.|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 177 (262)
T cd05058 152 EYYSVHNHTGAKLPVKWMALESLQTQ 177 (262)
T ss_pred cceeecccccCcCCccccChhHhccC
Confidence 11 1223467789999987543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=213.55 Aligned_cols=170 Identities=28% Similarity=0.402 Sum_probs=142.9
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++......|+||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 2 YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred ceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 44567899999999999976 46889999998544321 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+ +++|.+++.... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++++|||.+......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999987543 24778888999999999999999665 999999999999999999999999999876543
Q ss_pred C--CceeeccccCccccCcccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......|+..|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYG 174 (286)
T ss_pred CCCccccccCcccccCceeeec
Confidence 3 2344578999999999854
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.4e-22 Score=214.51 Aligned_cols=171 Identities=26% Similarity=0.352 Sum_probs=140.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~ 788 (902)
|...+.||+|+||.||+|... +++.+|+|.+...... ......+.+|++++++++||||+++++++... +..|+||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~ 85 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVM 85 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEe
Confidence 344578999999999999765 5888999998543322 22234567899999999999999999998777 8899999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++ ++|.+++..... .+++.....++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++...
T Consensus 86 e~~~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 86 EYVE-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred hhcC-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 9996 599998865432 4778888999999999999999765 9999999999999999999999999998765
Q ss_pred CC-CCceeeccccCccccCccccc
Q 043136 869 SD-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .......+++.|+|||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~~ 181 (293)
T cd07843 158 SPLKPYTQLVVTLWYRAPELLLGA 181 (293)
T ss_pred CCccccccccccccccCchhhcCC
Confidence 43 233445688999999998653
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=208.30 Aligned_cols=170 Identities=30% Similarity=0.477 Sum_probs=140.3
Q ss_pred CCcEeeecCceEEEEEEeCC-----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 714 SDKILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
+.+.||+|+||.||+|.... +..||+|++...... ...+.+..|+++++.++|+||+++++++.+.+..+++|
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 45789999999999997643 488999998543322 24567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++...... ..++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||+++...
T Consensus 81 e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~ 154 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLY 154 (258)
T ss_pred eccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecc
Confidence 999999999998754321 1678889999999999999999665 9999999999999999999999999998765
Q ss_pred CCCCce--eeccccCccccCccccc
Q 043136 869 SDESMS--VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~~~~--~~~Gt~~y~APE~~~~~ 891 (902)
...... ...+++.|+|||.+.+.
T Consensus 155 ~~~~~~~~~~~~~~~y~~Pe~~~~~ 179 (258)
T smart00219 155 DDDYYKKKGGKLPIRWMAPESLKDG 179 (258)
T ss_pred cccccccccCCCcccccChHHhccC
Confidence 432221 13377899999988543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=212.79 Aligned_cols=171 Identities=27% Similarity=0.325 Sum_probs=136.9
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEe-----cCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCS-----NRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~-----~~~~~ 784 (902)
|.+.+.||+|+||.||+|.. .+++.+|+|++.... ...+.+.+|+.+++++ +||||+++++++. ..+..
T Consensus 20 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred eeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 34557899999999999966 457889999874322 1234567899999998 6999999999874 34578
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++||||+++++|.+++..... ....+++..+..++.|+++|+.|||+.+ ++|||+||+||+++.++.+|++|||++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCce
Confidence 999999999999998864322 2234677888899999999999999665 999999999999999999999999999
Q ss_pred eeccCCC-CceeeccccCccccCcccc
Q 043136 865 KLIQSDE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
+...... ......|++.|+|||++..
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIAC 198 (286)
T ss_pred eecccCCCccccccCCCcccChhhhch
Confidence 8764322 2334579999999999853
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.8e-22 Score=210.85 Aligned_cols=171 Identities=22% Similarity=0.346 Sum_probs=136.8
Q ss_pred hccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+...+.||+|+||.||+|...+ ...||+|....... ....+.+.+|+.++++++||||+++++++.+ +..|+
T Consensus 7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 7 DITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 34567899999999999996533 34688998754332 3345678899999999999999999998875 45789
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++..... .+++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+|++|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 9999999999999965321 3678888999999999999999665 99999999999999999999999999987
Q ss_pred ccCCCCc--eeeccccCccccCccccc
Q 043136 867 IQSDESM--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~~--~~~~Gt~~y~APE~~~~~ 891 (902)
....... ....+++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (270)
T cd05056 157 LEDESYYKASKGKLPIKWMAPESINFR 183 (270)
T ss_pred cccccceecCCCCccccccChhhhccC
Confidence 6443221 122345689999987644
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.1e-22 Score=213.84 Aligned_cols=172 Identities=26% Similarity=0.383 Sum_probs=141.6
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|+||.||+|... +++.||+|.+.... .......+.+|++++++++||||+++++++...+..|+||||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 34578999999999999765 68999999885332 2233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ...+++.....++.|+++|++|||+. .+|+||||||+||+++.++.+||+|||.+......
T Consensus 82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 82 DAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred CCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999988865321 22467888899999999999999963 25999999999999999999999999999765332
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......|++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~ 176 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKSG 176 (286)
T ss_pred ccccCCCccCccCcchhcCC
Confidence 22345688999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.3e-22 Score=214.66 Aligned_cols=170 Identities=28% Similarity=0.396 Sum_probs=140.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+.+.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+++++.++||||+++++++......|+||||
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 334578999999999999764 588899998753322 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++...+ .+++.....++.+++.|+.|||+. .+++||||||+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 99999999886532 367788889999999999999963 24999999999999999999999999998765322
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
. .....|+..|+|||++.+.
T Consensus 158 ~-~~~~~~~~~~~aPE~~~~~ 177 (284)
T cd06620 158 I-ADTFVGTSTYMSPERIQGG 177 (284)
T ss_pred c-cCccccCcccCCHHHHccC
Confidence 2 2345789999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=209.30 Aligned_cols=170 Identities=25% Similarity=0.354 Sum_probs=141.5
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 445567899999999999965 468899999874332 22345668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++... ..++.....++.|++.|++|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 99999999988632 3677888899999999999999665 99999999999999999999999999876643
Q ss_pred CC-CceeeccccCccccCccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ......|+..|+|||.+.+.
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~ 176 (277)
T cd06641 154 TQIKRNTFVGTPFWMAPEVIKQS 176 (277)
T ss_pred chhhhccccCCccccChhhhccC
Confidence 22 22335688999999998654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=216.90 Aligned_cols=170 Identities=26% Similarity=0.385 Sum_probs=138.4
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +|+.||+|++..... .......+.+|++++++++||||+++++++.+.+..|+|+||
T Consensus 2 y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred ceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 445578999999999999764 688999999854322 112234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ +++.+++.... ...++.....++.||++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 58888776432 23678888999999999999999766 999999999999999999999999999865432
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......+++.|+|||++.+
T Consensus 153 ~~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 153 VRCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCCcCCCccccCCcChHHHhC
Confidence 2 2233567899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=212.76 Aligned_cols=170 Identities=27% Similarity=0.371 Sum_probs=136.2
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+|++++++++|+||+++++++...+..|+||||
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEY 84 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEec
Confidence 45668899999999999965 46889999998543222 1223456899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+. +++.+.+..... ...+.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 85 MH-TDLAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred cc-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 95 678777654321 2456667789999999999999765 999999999999999999999999998764322
Q ss_pred -CCceeeccccCccccCccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......+++.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 157 SQTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred CCCCCCccccccccCCceeecC
Confidence 223345679999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=215.01 Aligned_cols=170 Identities=25% Similarity=0.350 Sum_probs=140.4
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.+ .+++.||+|.+..... ....+.+.+|++++++++||||+++++++......|+||||
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence 33446799999999999965 4578899998753322 23456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++... ..++..+..++.|+++|++|||+.+ ++|+||+|+||++++++.+|++|||+++.....
T Consensus 84 ~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 84 LGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred cCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999999988532 3567788899999999999999665 999999999999999999999999999876433
Q ss_pred C-CceeeccccCccccCcccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......|+..|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~ 177 (277)
T cd06642 155 QIKRNTFVGTPFWMAPEVIKQSA 177 (277)
T ss_pred chhhhcccCcccccCHHHhCcCC
Confidence 2 223346889999999987653
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=212.23 Aligned_cols=172 Identities=28% Similarity=0.359 Sum_probs=137.0
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.||+|+||.||++... +++.||+|++...... .....+.+|+.++.++. ||||+++++++..++..+++|||+.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~ 86 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc
Confidence 367999999999999664 5899999998543322 34556889999999996 9999999999998889999999985
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+++.++...........+++.....++.|++.|++|||+. .+++||||||+||+++.++.+||+|||+++.......
T Consensus 87 -~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 -ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred -CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4665554321111123477788889999999999999963 2499999999999999999999999999987654444
Q ss_pred ceeeccccCccccCccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~ 891 (902)
.....|++.|+|||++.+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~ 182 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPS 182 (288)
T ss_pred cccccCccCccCHHHhccc
Confidence 4445789999999998765
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=213.93 Aligned_cols=168 Identities=24% Similarity=0.415 Sum_probs=141.0
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|+++++.++||||+++++++...+..|+|+||
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 44557899999999999965 5689999998854322 2345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++... .+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~ 168 (296)
T cd06655 98 LAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE 168 (296)
T ss_pred cCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence 9999999988642 3678888999999999999999665 999999999999999999999999998865433
Q ss_pred CC-ceeeccccCccccCccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....|++.|+|||.+.+.
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~ 190 (296)
T cd06655 169 QSKRSTMVGTPYWMAPEVVTRK 190 (296)
T ss_pred cccCCCcCCCccccCcchhcCC
Confidence 22 2345789999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.8e-24 Score=207.69 Aligned_cols=168 Identities=25% Similarity=0.405 Sum_probs=135.9
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----CeeEEE
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECTMLL 787 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~~lv 787 (902)
-++.||.|+||.||.+++ ++|+.||.|++..- .......+++.+|+++++..+|.||+..++..+-. ++.|++
T Consensus 57 PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 57 PDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 358899999999999976 46999999998433 33444567788999999999999999998876543 357888
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
.|.| ..||..++-.. ..++...++.+..||++||+|||+.+ |.||||||.|.+++.+..+||+|||+|+.-
T Consensus 136 TELm-QSDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHH-HhhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence 9988 45887776532 23555666778999999999999665 999999999999999999999999999976
Q ss_pred cCCCC--ceeeccccCccccCccccc
Q 043136 868 QSDES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
+.++. ++..+-|.+|+|||.++|.
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGa 232 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGA 232 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcc
Confidence 54433 4556779999999999884
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.6e-22 Score=212.70 Aligned_cols=162 Identities=17% Similarity=0.317 Sum_probs=131.9
Q ss_pred cEeeecCceEEEEEEeCC--------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 716 KILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+.||+|+||.||+|.... ...+|+|.+... .....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999996532 234777776322 223345678899999999999999999999998899999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC--------EEEe
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME--------ARVA 859 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~--------~kl~ 859 (902)
|||+++|+|.++++..+. ..++..+..++.|++.|++|||+.+ |+||||||+||+++.++. +|++
T Consensus 78 ~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~ 150 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150 (258)
T ss_pred EecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEec
Confidence 999999999999875432 4677888899999999999999665 999999999999987765 6999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|||.+..... .....|++.|+|||++.+
T Consensus 151 d~g~~~~~~~---~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 151 DPGISITVLP---KEILLERIPWVPPECIEN 178 (258)
T ss_pred ccccccccCC---chhccccCCccCchhccC
Confidence 9999876532 233568899999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.1e-22 Score=215.59 Aligned_cols=164 Identities=25% Similarity=0.416 Sum_probs=137.7
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
..||+|+||.||++.. .+++.||+|++... .....+.+.+|+.++++++||||+++++.+...+..|+||||++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 5689999999999965 46889999988432 2234566889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-Cc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 873 (902)
+|.+++... ..++.....++.|++.|++|||+.+ |+||||||+||++++++.+||+|||++....... ..
T Consensus 105 ~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 175 (292)
T cd06658 105 ALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR 175 (292)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccC
Confidence 999987532 2567788899999999999999765 9999999999999999999999999987653222 23
Q ss_pred eeeccccCccccCccccc
Q 043136 874 SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~ 891 (902)
....|++.|+|||++.+.
T Consensus 176 ~~~~~~~~y~aPE~~~~~ 193 (292)
T cd06658 176 KSLVGTPYWMAPEVISRL 193 (292)
T ss_pred ceeecCccccCHHHHccC
Confidence 446789999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=210.27 Aligned_cols=171 Identities=24% Similarity=0.348 Sum_probs=141.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.+. +++.||+|.+..... ......+.+|++++++++||||+++++++.+....|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3444577999999999999764 588999998853322 2345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++... ..++.....++.|++.|++|+|+.+ ++|+||+|+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999988642 2566777889999999999999665 99999999999999999999999999987643
Q ss_pred CC-CceeeccccCccccCcccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......++..|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~y~apE~~~~~~ 177 (277)
T cd06640 154 TQIKRNTFVGTPFWMAPEVIQQSA 177 (277)
T ss_pred CccccccccCcccccCHhHhccCC
Confidence 32 223356888999999986643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=209.02 Aligned_cols=178 Identities=26% Similarity=0.430 Sum_probs=144.0
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTMLLYE 789 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~lv~e 789 (902)
...+.||+|+||.||+|.. .+++.||+|++..... .....+++..|++++++++||||+++++++.. ....|++||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e 81 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVME 81 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEeh
Confidence 3457899999999999965 4678899998854322 33445678899999999999999999998754 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|+++++|.+++..... ....+++...+.++.|++.|++|+|..+ +.+++|+||||+||+++.++.+|++|||++...
T Consensus 82 ~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 82 YCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999976432 2335778888999999999999999443 445999999999999999999999999999877
Q ss_pred cCCCC-ceeeccccCccccCcccccc
Q 043136 868 QSDES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
..... .....|++.|+|||++.+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~ 186 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMS 186 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCC
Confidence 54433 34467899999999986644
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=8e-22 Score=209.66 Aligned_cols=168 Identities=25% Similarity=0.442 Sum_probs=138.2
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.+.||+|+||.||+|.+.+++.+|+|++...... ...+.+|++++++++||+++++++++......++||||++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 445789999999999998777889999988533221 2457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+++|.+++..... ..++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999865321 3567788899999999999999665 99999999999999999999999999886543221
Q ss_pred --ceeeccccCccccCccccc
Q 043136 873 --MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 --~~~~~Gt~~y~APE~~~~~ 891 (902)
.....++..|+|||++.+.
T Consensus 156 ~~~~~~~~~~~~~aPe~~~~~ 176 (256)
T cd05112 156 TSSTGTKFPVKWSSPEVFSFS 176 (256)
T ss_pred cccCCCccchhhcCHhHhccC
Confidence 1122356789999998753
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-22 Score=215.08 Aligned_cols=170 Identities=27% Similarity=0.422 Sum_probs=141.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++...+..|+||||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 345688999999999999775 58899999875433222 3345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++++.++..... .+++..+..++.|+++|++|||+.+ ++|||++|+||++++++.+|++|||+++.....
T Consensus 82 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 82 VDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred CCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 99988887765321 3678889999999999999999765 999999999999999999999999999876433
Q ss_pred C-CceeeccccCccccCcccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......|+..|+|||++.+
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~ 174 (286)
T cd07846 154 GEVYTDYVATRWYRAPELLVG 174 (286)
T ss_pred ccccCcccceeeccCcHHhcc
Confidence 2 2234568899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-22 Score=216.45 Aligned_cols=165 Identities=27% Similarity=0.425 Sum_probs=138.5
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
..||+|+||.||+|... +++.||+|++..... ...+.+.+|+.++..++||||+++++++...+..|+||||++++
T Consensus 27 ~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 27 IKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 46999999999999664 688999999853322 23456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-Cc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 873 (902)
+|.+++... .+++..++.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++....... ..
T Consensus 104 ~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~ 174 (297)
T cd06659 104 ALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 174 (297)
T ss_pred CHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccccc
Confidence 999877542 3677888899999999999999665 9999999999999999999999999987654322 23
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
....|++.|+|||++.+..
T Consensus 175 ~~~~~~~~y~aPE~~~~~~ 193 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTP 193 (297)
T ss_pred cceecCccccCHHHHccCC
Confidence 4467999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=207.54 Aligned_cols=166 Identities=24% Similarity=0.319 Sum_probs=134.2
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHH-hcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il-~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.||+|+||.||+|.. .+++.||+|.+.+...........+..|..++ ...+|+|++++++++...+..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999966 45889999998543322222333445565554 445899999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
++|.+++.... ..++..+..++.|+++||.|+|+.+ ++||||+|+||+++.++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~ 150 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---N 150 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc---c
Confidence 99999987542 3667778899999999999999665 99999999999999999999999999876433 2
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
....|++.|+|||.+.+..
T Consensus 151 ~~~~~~~~y~~pe~~~~~~ 169 (260)
T cd05611 151 KKFVGTPDYLAPETILGVG 169 (260)
T ss_pred ccCCCCcCccChhhhcCCC
Confidence 3456889999999987654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=210.40 Aligned_cols=170 Identities=27% Similarity=0.338 Sum_probs=143.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||.|+||.||+|... +++.||+|.+.... .......+.+|++++++++|+||+++++++.+....|+|+||
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 344577999999999999764 58899999885432 223445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++... ..++.....++.|++.|+.|+|+.+ ++||||+|+||++++++.++++|||.++.....
T Consensus 81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 9999999998643 4677888999999999999999665 999999999999999999999999999887543
Q ss_pred -CCceeeccccCccccCcccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......|++.|+|||++.+..
T Consensus 152 ~~~~~~~~~~~~y~~PE~~~~~~ 174 (274)
T cd06609 152 MSKRNTFVGTPFWMAPEVIKQSG 174 (274)
T ss_pred ccccccccCCccccChhhhccCC
Confidence 2334467899999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=206.82 Aligned_cols=174 Identities=22% Similarity=0.310 Sum_probs=142.9
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||++.. .+++.||+|++..... .....+++.+|++++++++||||+++++++...+..|+||||
T Consensus 2 y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred ceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 44568899999999999965 4688999999853322 223455788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ...++.....++.|++.|++|+|+.+ ++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 999999998865322 23567788899999999999999665 999999999999999999999999999876432
Q ss_pred CC-ceeeccccCccccCcccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. .....|++.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~pe~~~~~~ 177 (256)
T cd08218 155 VELARTCIGTPYYLSPEICENRP 177 (256)
T ss_pred hhhhhhccCCccccCHHHhCCCC
Confidence 22 23356889999999986643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.8e-22 Score=213.24 Aligned_cols=171 Identities=27% Similarity=0.361 Sum_probs=140.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 455688999999999999765 578999998753322 223456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++.+..+.... ...++...+.++.|++.|++|||..+ ++|||+||+||++++++.+||+|||.+......
T Consensus 82 ~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 82 VERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred CCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9886666554322 13677888899999999999999665 999999999999999999999999999876543
Q ss_pred C--CceeeccccCccccCccccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......|+..|+|||++.+.
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGD 176 (288)
T ss_pred ccccccCcccccCCcCCchhcCC
Confidence 3 33446788999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=218.66 Aligned_cols=171 Identities=27% Similarity=0.343 Sum_probs=138.7
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------C
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------E 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~ 782 (902)
..|...+.||+|+||.||+|.. .+++.||+|++.+... .......+.+|++++++++||||+++++++... .
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4566678999999999999965 4689999998853322 223345577899999999999999999988643 3
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+. +++.+.+... ++......++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 5799999995 5888877532 566777889999999999999765 9999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+++............|++.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (353)
T cd07850 164 LARTAGTSFMMTPYVVTRYYRAPEVILGMG 193 (353)
T ss_pred cceeCCCCCCCCCCcccccccCHHHHhCCC
Confidence 998765544444567899999999987653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=206.51 Aligned_cols=169 Identities=31% Similarity=0.490 Sum_probs=144.2
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.+.+.||+|++|.||+|... +++.||+|++...... ...+.+.+|++++.+++|+|++++++++...+..++||||+
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 34578999999999999765 4899999998544322 44567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH-DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++++|.+++... ..++....+.++.|+++|++|+|+ .+ ++||||+|+||+++.++.++++|||.+......
T Consensus 82 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 82 DGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred CCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999998754 246778888999999999999996 55 999999999999999999999999999877543
Q ss_pred CCc-eeeccccCccccCccccc
Q 043136 871 ESM-SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~-~~~~Gt~~y~APE~~~~~ 891 (902)
... ....|+..|+|||.+...
T Consensus 154 ~~~~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 154 LDQCNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred CCcccceeecccccCHhhhCCC
Confidence 332 256789999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=208.74 Aligned_cols=176 Identities=24% Similarity=0.401 Sum_probs=142.6
Q ss_pred cCCcEeeecCceEEEEEEeCC--CcEEEEEEecccc-------hhhHHHHHHHHHHHHHHhc-CCcCeeEeEEeEEecCC
Q 043136 713 MSDKILGMGSTGTVYKAEMPG--GEIIAVKKLWGKH-------KENIRRRRGVLAEVDVLGN-VRHRNIVRLLGCCSNRE 782 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~--~~~vavK~i~~~~-------~~~~~~~~~~~~Ei~il~~-l~h~nIv~l~~~~~~~~ 782 (902)
.+.+.||+|+||.||+|.... ++.+|+|.+.... ........++.+|+.++.+ ++||||+++++++...+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 445789999999999997654 6889999875321 1223345567789998875 69999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..++||||+++++|.+++..... ....+++..++.++.|++.|+.|||+. .+++||||||+||+++.++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEeccc
Confidence 99999999999999998864322 123477788899999999999999952 249999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.+.............|+..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 188 (269)
T cd08528 160 LAKQKQPESKLTSVVGTILYSCPEIVKNE 188 (269)
T ss_pred ceeecccccccccccCcccCcChhhhcCC
Confidence 99876554444556789999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.6e-22 Score=209.88 Aligned_cols=166 Identities=29% Similarity=0.429 Sum_probs=140.5
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+|... +++.+|+|.+...........+.+.+|++++++++||||+++++.+......|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999775 4899999998655443445567788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-----
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE----- 871 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~----- 871 (902)
.+++.... .+++..++.++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99987543 3677888999999999999999665 9999999999999999999999999987653321
Q ss_pred ----CceeeccccCccccCccccc
Q 043136 872 ----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ----~~~~~~Gt~~y~APE~~~~~ 891 (902)
......++..|+|||+....
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~ 176 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQ 176 (265)
T ss_pred cccccccCcccCccccCHHHhcCC
Confidence 22335688899999988654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=208.50 Aligned_cols=170 Identities=29% Similarity=0.450 Sum_probs=139.0
Q ss_pred cCCcEeeecCceEEEEEEeC-----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTM 785 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~ 785 (902)
...+.||+|+||.||+|... +++.+|+|.+...... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 34578999999999999743 3688999998644332 345678899999999999999999999877 55789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++++|.+++..... ..++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+.
T Consensus 85 lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999975432 4778888999999999999999665 9999999999999999999999999998
Q ss_pred eccCCCCc----eeeccccCccccCccccc
Q 043136 866 LIQSDESM----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~----~~~~Gt~~y~APE~~~~~ 891 (902)
........ ....++..|+|||.+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 187 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTS 187 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccC
Confidence 76532221 112345679999988654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=211.76 Aligned_cols=167 Identities=30% Similarity=0.476 Sum_probs=139.1
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...+.||+|+||.||+|.. .+++.||+|++.............+.+|++++++++|||++++++++.+....|+||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 44557899999999999975 46889999998644333344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+. |++.+++.... ..+++..+..++.|++.|+.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~- 177 (317)
T cd06635 107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP- 177 (317)
T ss_pred CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-
Confidence 96 58877775432 24778888899999999999999766 99999999999999999999999999876432
Q ss_pred CCceeeccccCccccCccc
Q 043136 871 ESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~ 889 (902)
.....|++.|+|||++.
T Consensus 178 --~~~~~~~~~y~aPE~~~ 194 (317)
T cd06635 178 --ANSFVGTPYWMAPEVIL 194 (317)
T ss_pred --cccccCCccccChhhhh
Confidence 23456899999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=210.79 Aligned_cols=169 Identities=31% Similarity=0.430 Sum_probs=141.3
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||+|+||.||+|... +++.+|+|++..... ....+++.+|++++++++||||+++++++......++|+||++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMD 82 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecC
Confidence 3467999999999999765 588999998854432 2445678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+++|.+++.... ...+......++.|++.|++|+|+ ..+++||||||+||++++++.+||+|||.+........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 83 GGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 999999987542 246777888999999999999996 13599999999999999999999999999876643322
Q ss_pred ceeeccccCccccCccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~ 891 (902)
. ...|+..|+|||++.+.
T Consensus 157 ~-~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 157 K-TFVGTSSYMAPERIQGN 174 (265)
T ss_pred h-cccCChhccCHHHHcCC
Confidence 2 26789999999998665
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=206.53 Aligned_cols=165 Identities=29% Similarity=0.467 Sum_probs=135.1
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||.||++.. .++.||+|++.... ..+.+.+|+.++++++|||++++++++... ..++||||+
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 45678999999999999975 67889999884321 235678899999999999999999998654 479999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++..... ...++..+..++.|++.|++|+|+.+ ++||||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 81 SKGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred CCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 99999999875432 24677888899999999999999665 999999999999999999999999999765332
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+..|+|||++.+.
T Consensus 154 -~~~~~~~~~y~~pe~~~~~ 172 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHK 172 (254)
T ss_pred -CCCCCCCceecCHHHhccC
Confidence 1223345689999988654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=209.28 Aligned_cols=172 Identities=27% Similarity=0.387 Sum_probs=136.8
Q ss_pred cEeeecCceEEEEEEeCC-------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 716 KILGMGSTGTVYKAEMPG-------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
+.||+|+||.||+|+..+ ++.+|+|.+.... .......+.+|++++++++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 368999999999997542 2578999874332 1234556888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-----CEEEeec
Q 043136 789 EYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-----EARVADF 861 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-----~~kl~DF 861 (902)
||+++++|.+++...... .....++..+..++.|++.|++|+|+.+ ++|+||||+||+++.++ .+|++||
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~df 155 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDF 155 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCc
Confidence 999999999999754321 2234678888999999999999999665 99999999999999877 8999999
Q ss_pred ccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++....... .....++..|+|||++.+..
T Consensus 156 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 189 (269)
T cd05044 156 GLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK 189 (269)
T ss_pred ccccccccccccccCcccCCCccccCHHHHccCC
Confidence 99976533221 12234578899999886543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.8e-21 Score=207.57 Aligned_cols=175 Identities=25% Similarity=0.365 Sum_probs=136.9
Q ss_pred cCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------
Q 043136 713 MSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------ 782 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------ 782 (902)
.+.++||+|+||.||+|... +++.||+|++.... ......+++.+|++++++++||||+++++++....
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 2 TLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred cchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 35678999999999999643 36889999885433 22334566889999999999999999999886432
Q ss_pred eeEEEEEccCCCCHHHHHHhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
..++++||+++|++.+++..... ......++.....++.|++.|++|+|+.+ |+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 34788999999999988754322 12234677888999999999999999665 999999999999999999999999
Q ss_pred ccceeccCCCC---ceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|.++....... .....+++.|++||.+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~ 190 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADN 190 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcC
Confidence 99987643221 1223456789999987654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=210.15 Aligned_cols=169 Identities=25% Similarity=0.390 Sum_probs=140.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||++.. .+++.||+|.+.... ....+.+.+|+.++++++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 455668899999999999965 467889999874322 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++... ..++..+..++.|++.|+.|||+.+ ++|||+||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999998643 2567778899999999999999665 99999999999999999999999998876543
Q ss_pred CC-CceeeccccCccccCccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ......|++.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~y~~PE~~~~~ 190 (293)
T cd06647 168 EQSKRSTMVGTPYWMAPEVVTRK 190 (293)
T ss_pred cccccccccCChhhcCchhhccC
Confidence 22 23345689999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-24 Score=206.54 Aligned_cols=173 Identities=25% Similarity=0.454 Sum_probs=135.5
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------CCeeEE
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--------RECTML 786 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--------~~~~~l 786 (902)
.+||+|.||+||+|+.+ +++.||+|++...... ........+|++++..++|+|++.+++.|.. +..+|+
T Consensus 23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneK-eGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~yl 101 (376)
T KOG0669|consen 23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYL 101 (376)
T ss_pred HhcCCchHHHHHHHhhcCccchhHHHHHHHhccc-cCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeee
Confidence 57999999999999654 5788899887432111 1223456789999999999999999988743 345899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||++|+. ||.-++.... ..+...++.+++.++..||.|+|+. .|+|||+||+|+||+.+|.+||+|||+|+.
T Consensus 102 Vf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 102 VFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 9999965 8888886542 3477788999999999999999955 499999999999999999999999999987
Q ss_pred ccCCC-----CceeeccccCccccCcccc--cccCcee
Q 043136 867 IQSDE-----SMSVIAGSYGYIAPGTFCF--CFSVPFC 897 (902)
Q Consensus 867 ~~~~~-----~~~~~~Gt~~y~APE~~~~--~~~~p~~ 897 (902)
+.... ..+..+-|.+|.+||.+.| .++.|.+
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iD 211 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPID 211 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcch
Confidence 64222 2334556999999999977 4555543
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.4e-21 Score=209.18 Aligned_cols=168 Identities=30% Similarity=0.458 Sum_probs=138.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...+.||+|+||.||+|+. .+++.||+|++...........+.+.+|++++++++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 33456799999999999976 46889999998644333344456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+. |++.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~- 173 (313)
T cd06633 103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP- 173 (313)
T ss_pred CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence 95 68887775432 24678888899999999999999766 99999999999999999999999999865322
Q ss_pred CCceeeccccCccccCcccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~ 890 (902)
.....|+..|+|||++..
T Consensus 174 --~~~~~~~~~y~aPE~~~~ 191 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILA 191 (313)
T ss_pred --CCCccccccccChhhccc
Confidence 234578999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=204.65 Aligned_cols=173 Identities=24% Similarity=0.355 Sum_probs=143.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|... ++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+...+..|+|||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 345678999999999999754 67889999885433222 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ....++.....++.|++.|++|||+.+ ++||||||+||++++++.+|++|||++......
T Consensus 81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~ 155 (267)
T cd06610 81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADG 155 (267)
T ss_pred cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence 999999999975422 124677888899999999999999665 999999999999999999999999998776433
Q ss_pred CC-----ceeeccccCccccCccccc
Q 043136 871 ES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....|+..|+|||++...
T Consensus 156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 156 GDRTRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred ccccccccccccCChhhcChHHHccc
Confidence 22 2345689999999998665
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8e-22 Score=233.27 Aligned_cols=286 Identities=24% Similarity=0.376 Sum_probs=136.9
Q ss_pred EEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccc
Q 043136 80 ITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYS 159 (902)
Q Consensus 80 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 159 (902)
.+.|++++++++ .+|..+. ++|+.|+|++|+|+. +|..+. ++|++|+|++|+|+. +|..+
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~l------------- 239 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPATL------------- 239 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChhh-------------
Confidence 445555555555 2343332 345555555555553 333332 345555555555542 33322
Q ss_pred ccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCC
Q 043136 160 NSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP 239 (902)
Q Consensus 160 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 239 (902)
. .+|+.|+|++|.+. .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|++++|+|++ +|
T Consensus 240 -----------~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP 299 (754)
T PRK15370 240 -----------P--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LP 299 (754)
T ss_pred -----------h--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Cc
Confidence 1 23455555555544 3343332 24555555555555 3444332 345555555555553 23
Q ss_pred hhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCC
Q 043136 240 VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKG 319 (902)
Q Consensus 240 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 319 (902)
..+. ++|++|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++
T Consensus 300 ~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~ 368 (754)
T PRK15370 300 AHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PT 368 (754)
T ss_pred ccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CC
Confidence 2221 245555555555552 333221 455566666666553 444332 45666666666665 3444332 45
Q ss_pred CCEEEccCccccccCChhhhhccccceEEecCceeccccCcc----ccCCCceeEEEecCCcccCCCCCCccCCCCccEE
Q 043136 320 LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQK----LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKL 395 (902)
Q Consensus 320 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~----~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L 395 (902)
|+.|+|++|+++ .+|..+. ..|+.|++++|+|++ +|.. +...+++..|++.+|.++. ..+..|+.+
T Consensus 369 L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~~-LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L 438 (754)
T PRK15370 369 ITTLDVSRNALT-NLPENLP--AALQIMQASRNNLVR-LPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL 438 (754)
T ss_pred cCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCccc-CchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh
Confidence 666666666665 3444432 246666666666663 3332 2334566777777777652 223334444
Q ss_pred eccCCcCcc-cccccccccCCCcEEEccCCccC
Q 043136 396 ILFSNNFTY-SIPENLVNCSSLSRLRIQDNQLN 427 (902)
Q Consensus 396 ~l~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~ 427 (902)
+..+.+.| .++.....+++++....-.+.+.
T Consensus 439 -l~s~~~~gp~i~~~~~~~~~l~~~~~l~~a~~ 470 (754)
T PRK15370 439 -MSSVGYQGPRVLFAMGDFSIVRVTRPLHQAVQ 470 (754)
T ss_pred -hhcccccCCcccccccccccccccchHHHHHh
Confidence 33444443 23333444444444433334333
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=211.25 Aligned_cols=170 Identities=28% Similarity=0.444 Sum_probs=134.1
Q ss_pred cCCcEeeecCceEEEEEEeC-CCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...+.||+|+||.||+|.+. +++ .||+|.+..... ......+.+|+.++++++||||+++++++... ..+++
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v 86 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLV 86 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceee
Confidence 34578999999999999653 343 578888754322 23334578899999999999999999998754 46799
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
+||+++|++.+++..... .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 87 ~e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 87 TQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred ehhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 999999999999875422 3677788899999999999999665 999999999999999999999999999876
Q ss_pred cCCCC---ceeeccccCccccCcccccc
Q 043136 868 QSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
..... .....++..|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 187 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRK 187 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCC
Confidence 43322 12234567899999986543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=207.07 Aligned_cols=169 Identities=24% Similarity=0.386 Sum_probs=136.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec------CC
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN------RE 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~------~~ 782 (902)
.|.+.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.+++++ +||||+++++++.. ..
T Consensus 17 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 17 IFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 445568899999999999976 457889999874321 2335577899999998 69999999999853 45
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|++|||+++|+|.+++..... ...++..++.++.|++.|++|||+.+ |+|||+||+||++++++.+||+|||
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCc
Confidence 78999999999999999875432 23566777889999999999999765 9999999999999999999999999
Q ss_pred cceeccCC-CCceeeccccCccccCccc
Q 043136 863 VAKLIQSD-ESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 863 la~~~~~~-~~~~~~~Gt~~y~APE~~~ 889 (902)
+++..... .......|++.|+|||++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 167 VSAQLDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred chhhhhccccCCCcccccccccCHhhcC
Confidence 98765322 2234467999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.6e-21 Score=210.37 Aligned_cols=174 Identities=26% Similarity=0.351 Sum_probs=137.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCe-----e
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNREC-----T 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~-----~ 784 (902)
|...+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++ ||||+++++++...+. .
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 445678999999999999764 6889999987543221 122345778999999995 6999999999877655 8
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGl 863 (902)
|+||||+++ ++.+++..........+++.....++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999975 8988887554332345788889999999999999999665 999999999999998 88999999999
Q ss_pred ceeccCC-CCceeeccccCccccCcccc
Q 043136 864 AKLIQSD-ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~-~~~~~~~Gt~~y~APE~~~~ 890 (902)
++.+... .......+++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 158 GRAFSIPVKSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred ceecCCCccccCCcccccCCCChHHhhC
Confidence 9865332 22233467889999998865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=201.26 Aligned_cols=170 Identities=26% Similarity=0.452 Sum_probs=145.1
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++|++|+++++++...+..++++||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 34578999999999999765 688999999854332 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++.... ..+++..+..++.|+++|++|||..+ ++||||+|+||++++++.+||+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999987542 24678888899999999999999655 9999999999999999999999999998775544
Q ss_pred CceeeccccCccccCcccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......|+..|+|||++.+..
T Consensus 153 ~~~~~~~~~~~~~PE~~~~~~ 173 (253)
T cd05122 153 ARNTMVGTPYWMAPEVINGKP 173 (253)
T ss_pred cccceecCCcccCHHHHcCCC
Confidence 344567899999999987654
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.6e-21 Score=208.04 Aligned_cols=172 Identities=27% Similarity=0.341 Sum_probs=137.7
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC-----Cee
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~-----~~~ 784 (902)
|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ...+.+.+|+.+++++ +|||++++++++... +..
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~ 99 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQL 99 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCee
Confidence 44557899999999999976 468899999884332 1234567899999998 799999999998643 358
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+++++|.++++.... ....+++...+.++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||.+
T Consensus 100 ~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 100 WLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred EEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccc
Confidence 999999999999998865322 1224677888899999999999999665 999999999999999999999999998
Q ss_pred eeccCCC-CceeeccccCccccCccccc
Q 043136 865 KLIQSDE-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
+...... ......|+..|+|||++...
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 203 (291)
T cd06639 176 AQLTSTRLRRNTSVGTPFWMAPEVIACE 203 (291)
T ss_pred hhcccccccccCccCCccccChhhhcCC
Confidence 8754322 22345789999999998643
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=206.98 Aligned_cols=167 Identities=25% Similarity=0.400 Sum_probs=139.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC---cCeeEeEEeEEecCCeeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR---HRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~~~~~lv~ 788 (902)
...+.||+|+||.||+|.+ .+++.||+|.+..... ....+.+.+|++++++++ |||++++++++......|+||
T Consensus 4 ~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 4 QRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 3457899999999999975 5688999998754322 233456778999998886 999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++... .+++.....++.|++.|+.|||+.+ ++||||+|+||++++++.++++|||.+....
T Consensus 82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 152 (277)
T cd06917 82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLN 152 (277)
T ss_pred ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence 999999999988542 4677888899999999999999766 9999999999999999999999999998765
Q ss_pred CCC-CceeeccccCccccCcccc
Q 043136 869 SDE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
... ......|+..|+|||++.+
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 153 QNSSKRSTFVGTPYWMAPEVITE 175 (277)
T ss_pred CCccccccccCCcceeCHHHhcc
Confidence 432 2334578999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=207.99 Aligned_cols=171 Identities=29% Similarity=0.434 Sum_probs=139.6
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|++|.||+|+.. +++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 45578999999999999774 5889999998543221 22345678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+ +++.+++..... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+|++|||.++......
T Consensus 81 ~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~ 154 (284)
T cd07836 81 D-KDLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV 154 (284)
T ss_pred C-ccHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence 7 588888865432 234788889999999999999999665 9999999999999999999999999997653322
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~ 175 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGS 175 (284)
T ss_pred cccccccccccccChHHhcCC
Confidence 22335678999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-21 Score=201.35 Aligned_cols=172 Identities=26% Similarity=0.441 Sum_probs=145.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|++++++++||+++++++++.+.+..++||||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred ceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 345688999999999999664 5789999998654332 24556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ..++..+..++.|++.|+.|+|+.+ ++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 99999999987542 4678888999999999999999665 999999999999999999999999999877543
Q ss_pred CC-ceeeccccCccccCcccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. .....|+..|+|||...+..
T Consensus 153 ~~~~~~~~~~~~y~~pe~~~~~~ 175 (254)
T cd06627 153 SKDDASVVGTPYWMAPEVIEMSG 175 (254)
T ss_pred cccccccccchhhcCHhhhcCCC
Confidence 32 23457899999999886543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-22 Score=215.23 Aligned_cols=168 Identities=30% Similarity=0.479 Sum_probs=143.0
Q ss_pred CCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
...+||-|.||.||.|.++. .-.||||.+ +++....++|++|+.+|+.++|||+|+++|+|..+..+|||.|||.
T Consensus 271 MkhKLGGGQYGeVYeGvWKkyslTvAVKtL----KEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 271 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred eeeccCCCcccceeeeeeeccceeeehhhh----hhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 45789999999999997654 678999988 3444567889999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
.|+|.+++++..+. .++....+.++.||+.|++||..++ +||||+.++|+|+.++..|||+|||+++.+..+..
T Consensus 347 yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY 420 (1157)
T KOG4278|consen 347 YGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY 420 (1157)
T ss_pred CccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCce
Confidence 99999999876442 3555667789999999999999776 99999999999999999999999999999976654
Q ss_pred ceeecc---ccCccccCcccccc
Q 043136 873 MSVIAG---SYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ~~~~~G---t~~y~APE~~~~~~ 892 (902)
. ...| ...|.|||-+.+..
T Consensus 421 T-AHAGAKFPIKWTAPEsLAyNt 442 (1157)
T KOG4278|consen 421 T-AHAGAKFPIKWTAPESLAYNT 442 (1157)
T ss_pred e-cccCccCcccccCcccccccc
Confidence 3 2233 45799999987653
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-21 Score=205.65 Aligned_cols=165 Identities=25% Similarity=0.399 Sum_probs=138.5
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
-+.||+|++|.||++.. .+++.+|+|++... .....+.+.+|+.++++++||||+++++++...+..++|+||+++
T Consensus 24 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 24 FVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred ceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 46899999999999965 46889999987432 223345578899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-C
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-S 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~ 872 (902)
++|.+++... ..++..+..++.|++.|++|+|+++ ++||||||+||+++.++.+|++|||.+....... .
T Consensus 101 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~ 171 (285)
T cd06648 101 GALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171 (285)
T ss_pred CCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc
Confidence 9999988652 3567788899999999999999665 9999999999999999999999999887654322 2
Q ss_pred ceeeccccCccccCccccc
Q 043136 873 MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~ 891 (902)
.....|++.|+|||++.+.
T Consensus 172 ~~~~~~~~~y~aPE~~~~~ 190 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRL 190 (285)
T ss_pred cccccCCccccCHHHhcCC
Confidence 2345689999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.6e-21 Score=206.41 Aligned_cols=172 Identities=28% Similarity=0.393 Sum_probs=138.9
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEEEc
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLYEY 790 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 790 (902)
..+.||+|++|.||+|... +++.+|+|.+..... .....++.+|++++++++||||+++++++.+. ...|+||||
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~ 82 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEY 82 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEe
Confidence 4578999999999999764 578899998854322 23456688999999999999999999988653 468999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ....++......++.|+++|++|+|+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 83 CEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred cCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 999999998764322 2234677788899999999999999665 999999999999999999999999998765432
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ....++..|+|||.+.+..
T Consensus 159 ~~-~~~~~~~~y~~pE~~~~~~ 179 (287)
T cd06621 159 LA-GTFTGTSFYMAPERIQGKP 179 (287)
T ss_pred cc-ccccCCccccCHHHhcCCC
Confidence 22 2356788999999886543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=210.63 Aligned_cols=171 Identities=26% Similarity=0.399 Sum_probs=135.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--------
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-------- 782 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-------- 782 (902)
|...+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++...+
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 92 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKG 92 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCc
Confidence 556788999999999999764 6889999988533221 112234567999999999999999999986544
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..++||||+. +++.+++.... ..+++.+...++.|++.|++|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 93 ~~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 93 SFYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred eEEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4599999995 58888775432 24678888999999999999999665 9999999999999999999999999
Q ss_pred cceeccCCCC-----ceeeccccCccccCccccc
Q 043136 863 VAKLIQSDES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
.+........ .....++..|+|||++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 198 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGE 198 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCC
Confidence 9987643221 1234678899999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.1e-21 Score=207.05 Aligned_cols=168 Identities=29% Similarity=0.415 Sum_probs=138.6
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEEEc
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLYEY 790 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~e~ 790 (902)
+.+.||+|+||.||+|... +++.+|+|++.... ........+.+|++++++++|||++++++++... +..++||||
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 4578999999999999765 48899999986543 1223345677899999999999999999999887 889999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ +++.+++.... ..+++..+..++.|+++|++|||+.+ ++|+||||+||++++++.+||+|||.+......
T Consensus 82 ~~-~~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 82 MD-HDLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cc-ccHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 96 58888876432 24778888999999999999999765 999999999999999999999999999876543
Q ss_pred C--CceeeccccCccccCcccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......++..|+|||.+.+
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLG 175 (287)
T ss_pred CcccccccccccccCCceeeEc
Confidence 3 2233467889999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=9e-21 Score=201.42 Aligned_cols=176 Identities=24% Similarity=0.369 Sum_probs=146.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++|||++++++.+...+..++|+||
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 2 YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred ceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 345678999999999999764 588999999854322 234556688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ....+++.....++.++++|++|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999876532 1235788889999999999999999765 999999999999999999999999999876543
Q ss_pred C-CceeeccccCccccCcccccc
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......|++.|+|||.+.+..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~ 179 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQNKP 179 (258)
T ss_pred cceecceeeeecccChhHhccCC
Confidence 3 234457899999999876543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-21 Score=206.17 Aligned_cols=167 Identities=26% Similarity=0.321 Sum_probs=135.2
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecC--CeeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNR--ECTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~--~~~~lv~ 788 (902)
.+.+.||+|+||.||+|.. .+++.||+|++....... ......+|+.++.++. |+||+++++++.+. +..++||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL--EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc--hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 3457899999999999965 468899999885432221 1223457899998885 99999999999887 8899999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++ |++.+.+.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||.++...
T Consensus 80 e~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 58888876532 24788889999999999999999765 999999999999999 999999999998775
Q ss_pred CCCCceeeccccCccccCcccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.........+++.|+|||++..
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~ 172 (282)
T cd07831 151 SKPPYTEYISTRWYRAPECLLT 172 (282)
T ss_pred cCCCcCCCCCCcccCChhHhhc
Confidence 4444444568999999998643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-21 Score=205.07 Aligned_cols=173 Identities=25% Similarity=0.385 Sum_probs=140.3
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCC------
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRE------ 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~------ 782 (902)
.|...+.||+|+||.||+|... +++.+|+|++.... ...+.+.+|+++++++ +|+||+++++++....
T Consensus 7 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 7 IFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred heeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 4566789999999999999764 57889999875332 2345688999999998 6999999999986544
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+++++|.+++..... ....+++..+..++.|+++|++|||+.+ ++|+||+|+||+++.++.+|++|||
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 48999999999999999875431 1224677888899999999999999665 9999999999999999999999999
Q ss_pred cceeccCCC-CceeeccccCccccCccccc
Q 043136 863 VAKLIQSDE-SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~-~~~~~~Gt~~y~APE~~~~~ 891 (902)
.+....... ......|++.|+|||++...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (275)
T cd06608 159 VSAQLDSTLGRRNTFIGTPYWMAPEVIACD 188 (275)
T ss_pred cceecccchhhhcCccccccccCHhHhccc
Confidence 987654322 23345689999999998643
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-21 Score=208.60 Aligned_cols=171 Identities=26% Similarity=0.418 Sum_probs=138.7
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|++|.||+|+.. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 81 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeecc
Confidence 34578999999999999764 688999998853322 1223346788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
. +++.+++..... ..+++.....++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||+++......
T Consensus 82 ~-~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 82 H-QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred c-cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 5 689888865322 24678888899999999999999665 9999999999999999999999999987654322
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~ 175 (284)
T cd07860 155 RTYTHEVVTLWYRAPEILLGC 175 (284)
T ss_pred cccccccccccccCCeEEecC
Confidence 22334578899999988653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=211.30 Aligned_cols=168 Identities=19% Similarity=0.265 Sum_probs=134.3
Q ss_pred Eeeec--CceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMG--STGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G--~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+| +||+||+|++ .+++.||+|++...... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 45666 9999999976 47899999998643322 23456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC-
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES- 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~- 872 (902)
+++.+++..... ...++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+|++||+.+........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999998876432 23677788899999999999999665 99999999999999999999999986543321111
Q ss_pred c-------eeeccccCccccCccccc
Q 043136 873 M-------SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 ~-------~~~~Gt~~y~APE~~~~~ 891 (902)
. ....++..|||||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 183 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQD 183 (328)
T ss_pred ccccccccccccCccCccChhhhcCC
Confidence 0 112356679999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.9e-21 Score=207.83 Aligned_cols=164 Identities=24% Similarity=0.413 Sum_probs=137.7
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
.+||+|+||.||++.. .+++.||+|++.... ....+.+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 5689999999999966 468999999874322 234556889999999999999999999999999999999999999
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-Cc
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SM 873 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-~~ 873 (902)
+|.+++... ..++.....++.|++.|++|||+.+ ++||||||+||+++.++.++|+|||++....... ..
T Consensus 103 ~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~ 173 (292)
T cd06657 103 ALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR 173 (292)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence 999887532 2567788899999999999999665 9999999999999999999999999987664322 23
Q ss_pred eeeccccCccccCccccc
Q 043136 874 SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~ 891 (902)
....|++.|+|||++.+.
T Consensus 174 ~~~~~~~~y~~pE~~~~~ 191 (292)
T cd06657 174 KSLVGTPYWMAPELISRL 191 (292)
T ss_pred cccccCccccCHHHhcCC
Confidence 445789999999988653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.6e-21 Score=209.98 Aligned_cols=170 Identities=31% Similarity=0.406 Sum_probs=136.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~ 788 (902)
|...+.||+|+||.||+|... +++.||+|++....... .....+.+|++++++++|+||+++++++... +..++||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~ 87 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVM 87 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEE
Confidence 445678999999999999764 58999999985332211 1123356799999999999999999998754 5689999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++ ++|.+++.... ..+++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||.++...
T Consensus 88 e~~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 88 EYCE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred ecCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9995 58888886532 24778888999999999999999766 9999999999999999999999999998765
Q ss_pred CCC-CceeeccccCccccCcccc
Q 043136 869 SDE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
... ......+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 160 LPAKPMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CccCCCCcccccccccChhhhcC
Confidence 332 2233456888999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=200.31 Aligned_cols=170 Identities=31% Similarity=0.441 Sum_probs=145.2
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLYE 789 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~e 789 (902)
...+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++.+... ...++|+|
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 81 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLE 81 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEE
Confidence 44578999999999999765 6889999998544322 34567788999999999999999999999888 88999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++..++.++.|+++|++|||+.+ ++|+|++|+||+++.++.+||+|||.+.....
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 82 YVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999987543 4778888999999999999999765 99999999999999999999999999988765
Q ss_pred CCC---ceeeccccCccccCccccc
Q 043136 870 DES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
... .....++..|+|||.+.+.
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~ 178 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGE 178 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCC
Confidence 443 3456789999999998665
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=208.31 Aligned_cols=172 Identities=30% Similarity=0.415 Sum_probs=143.5
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|...+.||+|+||.||+|... +++.||+|++.+.........+.+.+|++++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 445678999999999999764 68999999885433333344566888999999998 9999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++.....++.|++.|++|||+.+ ++|+||||+||+++.++.++++|||++.....
T Consensus 83 ~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 83 YAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999987543 4788889999999999999999665 99999999999999999999999999886543
Q ss_pred CC---------------------CceeeccccCccccCccccc
Q 043136 870 DE---------------------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~---------------------~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ......|+..|+|||++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 197 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEK 197 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCC
Confidence 22 12334678999999987654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=212.49 Aligned_cols=170 Identities=26% Similarity=0.343 Sum_probs=136.3
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHH-----------HHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIR-----------RRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~-----------~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
...+.||+|+||.||+|... +++.||+|++......... ....+.+|++++++++||||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 34678999999999999754 6899999998543221100 01246789999999999999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
.+..++||||+. |++.+++.... ..+......++.|++.|++|||+.+ ++||||||+||+++.++.+|++|
T Consensus 92 ~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~d 162 (335)
T PTZ00024 92 GDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIAD 162 (335)
T ss_pred CCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECC
Confidence 999999999996 69998886432 3677788899999999999999665 99999999999999999999999
Q ss_pred cccceeccC---------------CCCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQS---------------DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~---------------~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||.++.... ........+++.|+|||++.+.
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 208 (335)
T PTZ00024 163 FGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGA 208 (335)
T ss_pred ccceeecccccccccccccccccccccccccccccCCCCChhcccC
Confidence 999976541 1112234578899999998653
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=221.84 Aligned_cols=175 Identities=30% Similarity=0.437 Sum_probs=140.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCC----cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGG----EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
..+++||+|+||+||+|-+ ..| -+||+|++.... ..+.-.+++.|+-+|.+++|||+++++++|.... ..+|
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 3468999999999999944 443 468888875433 2344567889999999999999999999998765 8899
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
++|++.|.|.++++..+. .+.....+.|..|||+|+.|||.+ ++|||||..+||||..-..+||.|||+|+..
T Consensus 776 tq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred HHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 999999999999987554 355677889999999999999954 5999999999999999999999999999988
Q ss_pred cCCCCc-eeecc--ccCccccCcccccccCcee
Q 043136 868 QSDESM-SVIAG--SYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 868 ~~~~~~-~~~~G--t~~y~APE~~~~~~~~p~~ 897 (902)
..+... ....| .+.|||=|.+.....++.+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqS 881 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQS 881 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchh
Confidence 655432 22222 4568998888766555544
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=207.01 Aligned_cols=172 Identities=24% Similarity=0.283 Sum_probs=139.7
Q ss_pred cCCcEeeecCceEEEEEEe----CCCcEEEEEEecccch-hhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
...+.||+|+||.||+|+. .+++.||||.+.+... ......+.+.+|++++.++ +||+|+++++++......|+
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3457899999999999864 3568899998853322 1223345678899999999 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++.... .+++.....++.|+++||+|||+.+ ++||||||+||+++.++.+|++|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999886432 3667778889999999999999665 99999999999999999999999999887
Q ss_pred ccCCCC--ceeeccccCccccCcccccc
Q 043136 867 IQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
...... .....|++.|+|||++.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGS 182 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCC
Confidence 543322 23356899999999986643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=204.57 Aligned_cols=169 Identities=26% Similarity=0.420 Sum_probs=141.8
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|+||.||+|... +++.||+|++..... ..+.+.+|++++++++|+||+++++++...+..|+|+||+
T Consensus 22 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 97 (286)
T cd06614 22 KNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYM 97 (286)
T ss_pred hHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEecc
Confidence 34577999999999999765 688999999854332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++++|.+++.... ..+++..+..++.|++.|++|||..+ ++|+|+||+||+++.++.+||+|||.+.......
T Consensus 98 ~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 98 DGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred CCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999998653 24778888999999999999999655 9999999999999999999999999887654322
Q ss_pred -CceeeccccCccccCcccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......|++.|+|||++.+..
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~ 192 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKD 192 (286)
T ss_pred hhhccccCCcccCCHhHhcCCC
Confidence 223456889999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.5e-21 Score=202.35 Aligned_cols=167 Identities=31% Similarity=0.388 Sum_probs=141.6
Q ss_pred eeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|+||.||+|... +++.+|+|.+...........+.+..|++++++++||||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999764 5889999998654443334556788999999999999999999999999999999999999999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-CCcee
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD-ESMSV 875 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~~~~ 875 (902)
.+++.... ..++.....++.|+++|+.|+|+.+ ++|+||||+||+++.++.++++|||.+...... .....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~ 152 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT 152 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence 99987543 3677888899999999999999665 999999999999999999999999999876443 23345
Q ss_pred eccccCccccCcccccc
Q 043136 876 IAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 876 ~~Gt~~y~APE~~~~~~ 892 (902)
..|+..|+|||.+.+..
T Consensus 153 ~~~~~~~~~Pe~~~~~~ 169 (250)
T cd05123 153 FCGTPEYLAPEVLLGKG 169 (250)
T ss_pred CcCCccccChHHhCCCC
Confidence 67899999999986643
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.3e-21 Score=203.86 Aligned_cols=175 Identities=26% Similarity=0.394 Sum_probs=144.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||++.. .+++.+|+|++..... .......+.+|++++++++|+||+++++++.+....|+||||
T Consensus 2 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred ceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 34567899999999999965 4678999999854322 233456678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... .....++...+.++.|+++|++|||+.+ ++||||+|+||++++++.+|++|||.++.....
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 999999999876432 2235678888999999999999999665 999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......|++.|+|||.+.+..
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~ 177 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRP 177 (256)
T ss_pred -CcccccCCccccCHHHHCCCC
Confidence 333456899999999986643
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8e-21 Score=206.53 Aligned_cols=171 Identities=26% Similarity=0.392 Sum_probs=135.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|++|.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 445678999999999999764 688999998854322 122335577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~ 869 (902)
++ +++.+.+.... ....++.....++.||+.||+|||+++ ++||||||+||+++. ++.+||+|||++.....
T Consensus 83 ~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 83 LD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred cc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 95 58888775432 123466777789999999999999665 999999999999985 45799999999976532
Q ss_pred CC-CceeeccccCccccCcccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
.. ......|++.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 156 PVRTFTHEVVTLWYRAPEILLG 177 (294)
T ss_pred CccccccCceeecccCHHHHhC
Confidence 21 2233467899999998865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.7e-21 Score=217.30 Aligned_cols=177 Identities=19% Similarity=0.264 Sum_probs=128.6
Q ss_pred ccCCcEeeecCceEEEEEEe-----------------CCCcEEEEEEecccchhhHH-----------HHHHHHHHHHHH
Q 043136 712 SMSDKILGMGSTGTVYKAEM-----------------PGGEIIAVKKLWGKHKENIR-----------RRRGVLAEVDVL 763 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-----------------~~~~~vavK~i~~~~~~~~~-----------~~~~~~~Ei~il 763 (902)
|...++||+|+||.||+|.. ..++.||||++......... ..+....|+.++
T Consensus 147 F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l 226 (507)
T PLN03224 147 FQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMC 226 (507)
T ss_pred ceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHH
Confidence 45678999999999999853 23567999998533211100 112234577777
Q ss_pred hcCCcCee-----EeEEeEEec--------CCeeEEEEEccCCCCHHHHHHhhccC-------------------CCccc
Q 043136 764 GNVRHRNI-----VRLLGCCSN--------RECTMLLYEYMPNGNLDDLLHAKNKG-------------------ENLVA 811 (902)
Q Consensus 764 ~~l~h~nI-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~ 811 (902)
.+++|.++ ++++++|.. ++..|+||||+++++|.++++..... .....
T Consensus 227 ~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~ 306 (507)
T PLN03224 227 AKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKR 306 (507)
T ss_pred HHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccC
Confidence 77766544 667777643 35689999999999999998753210 11234
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceee--ccccCccccCccc
Q 043136 812 DWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVI--AGSYGYIAPGTFC 889 (902)
Q Consensus 812 ~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~--~Gt~~y~APE~~~ 889 (902)
++..+..++.|+++|++|+|+.+ |+||||||+||+++.++.+||+|||+++........... .+|+.|+|||++.
T Consensus 307 ~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 307 DINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV 383 (507)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence 56778889999999999999765 999999999999999999999999999765443322222 3488999999986
Q ss_pred cc
Q 043136 890 FC 891 (902)
Q Consensus 890 ~~ 891 (902)
..
T Consensus 384 ~~ 385 (507)
T PLN03224 384 MP 385 (507)
T ss_pred CC
Confidence 53
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=208.19 Aligned_cols=179 Identities=20% Similarity=0.284 Sum_probs=126.3
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHH--------HHHHHHHHHHHhcCCcCeeEe
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRR--------RRGVLAEVDVLGNVRHRNIVR 773 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~h~nIv~ 773 (902)
|+....|.+.+.||+|+||.||+|...+ +..+|+|+..........+ ......+...+..+.|+++++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 3444567788999999999999997654 3455666532211110000 111233445566778999999
Q ss_pred EEeEEecCC----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 774 LLGCCSNRE----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 774 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
+++++.... ..++++|++ ..++.+.+.... ..++.....|+.|+++|++|+|+.+ |+||||||+||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nil 158 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIM 158 (294)
T ss_pred EEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 998765443 457888887 446766665432 1345667789999999999999665 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCC--------CceeeccccCccccCccccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDE--------SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~--------~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
++.++.+||+|||+|+.+.... ......||+.|+|||++.+...
T Consensus 159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~ 210 (294)
T PHA02882 159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV 210 (294)
T ss_pred EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC
Confidence 9999999999999998763221 1223579999999999876543
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-21 Score=206.08 Aligned_cols=169 Identities=31% Similarity=0.442 Sum_probs=140.2
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|++|.||+|... +++.||+|++...... .......+|+..+++++ ||||+++++++.+.+..|+||||
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 35678999999999999775 4788999998543321 12233457899999998 99999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+ +|++.+.+.... ...+++..+..++.|++.|++|||+++ ++|+||||+||++++++.++|+|||.++.....
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889998887543 124688889999999999999999765 999999999999999999999999999877554
Q ss_pred CCceeeccccCccccCcccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......|+..|+|||++..
T Consensus 153 ~~~~~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 153 PPYTDYVSTRWYRAPEILLR 172 (283)
T ss_pred CCcCCCCCcccccCceeeec
Confidence 44445678999999998854
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=207.80 Aligned_cols=168 Identities=29% Similarity=0.467 Sum_probs=137.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...+.||+|+||.||+|... +++.+|+|.+...........+++.+|+++++.++|+|++++++++......|+||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 334567999999999999764 5788999988543333334455678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+. |++.+++.... ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+|++|||++......
T Consensus 97 ~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 97 CL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred cC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 96 68887775432 23677888899999999999999765 999999999999999999999999998765432
Q ss_pred CCceeeccccCccccCcccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~ 890 (902)
....|++.|+|||++.+
T Consensus 169 ---~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILA 185 (308)
T ss_pred ---ccccCCccccCHHHHhh
Confidence 34568899999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.3e-20 Score=199.87 Aligned_cols=158 Identities=23% Similarity=0.312 Sum_probs=127.5
Q ss_pred eeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccCCCC
Q 043136 718 LGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGN 795 (902)
Q Consensus 718 iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 795 (902)
+|+|+||.||++.. .+++.+|+|.+...... . .|+.....+ +||||+++++++...+..|+||||+++++
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~ 95 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---A-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD 95 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---h-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence 69999999999965 46788999987433211 0 122222222 69999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccCCCCce
Q 043136 796 LDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESMS 874 (902)
Q Consensus 796 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~ 874 (902)
|.+++.... .+++.....++.|+++|++|+|+.+ ++||||||+||+++.++ .++|+|||.++..... .
T Consensus 96 L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~ 164 (267)
T PHA03390 96 LFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S 164 (267)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence 999987542 4788889999999999999999765 99999999999999998 9999999998865432 2
Q ss_pred eeccccCccccCcccccccC
Q 043136 875 VIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 875 ~~~Gt~~y~APE~~~~~~~~ 894 (902)
...|+..|+|||++.+....
T Consensus 165 ~~~~~~~y~aPE~~~~~~~~ 184 (267)
T PHA03390 165 CYDGTLDYFSPEKIKGHNYD 184 (267)
T ss_pred cCCCCCcccChhhhcCCCCC
Confidence 34689999999999765433
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.1e-21 Score=211.52 Aligned_cols=167 Identities=26% Similarity=0.374 Sum_probs=136.5
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~ 783 (902)
.|...+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|++++++++||||+++++++.... .
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred ceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 455668899999999999964 568999999985432 22334456788999999999999999999987543 4
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.++||||+ ++++.+++... .+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+|++|||+
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred EEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence 58999999 78998887532 3677888899999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++..... .....+++.|+|||++.+
T Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 165 ARQTDSE--MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred ccccccC--ccccccCCcccCHHHHhC
Confidence 9865432 234567899999999864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-21 Score=204.98 Aligned_cols=170 Identities=29% Similarity=0.406 Sum_probs=138.6
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||+|++|.||+|.. .+++.||+|++...... ....+.+.+|++++++++|||++++++++.+.+..|+||||+
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 3457899999999999965 46899999988543221 222345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+ +++.+++..... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||.++......
T Consensus 81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4 689998865432 24678889999999999999999665 9999999999999999999999999997653222
Q ss_pred -CceeeccccCccccCcccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~ 890 (902)
......+++.|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~aPE~~~~ 173 (283)
T cd07835 154 RTYTHEVVTLWYRAPEILLG 173 (283)
T ss_pred cccCccccccCCCCCceeec
Confidence 2233457889999998855
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-21 Score=203.02 Aligned_cols=173 Identities=22% Similarity=0.329 Sum_probs=141.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... ++..+|+|.+..... .....+.+.+|++++++++|+||+++++.+......|+|+||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred ceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 345678999999999999664 578899998854321 223445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 869 (902)
+++++|.+++..... ...++.....++.|+++|++|||+.+ ++|+||||+||++++++ .+|++|||.+.....
T Consensus 81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 999999999865322 24678888999999999999999766 99999999999998886 469999999887643
Q ss_pred CCC-ceeeccccCccccCccccc
Q 043136 870 DES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
... .....|++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~ape~~~~~ 177 (257)
T cd08225 155 SMELAYTCVGTPYYLSPEICQNR 177 (257)
T ss_pred CcccccccCCCccccCHHHHcCC
Confidence 322 2334689999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.7e-21 Score=211.27 Aligned_cols=168 Identities=24% Similarity=0.389 Sum_probs=134.7
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
.|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.++++++||||+++++++... ...
T Consensus 6 ~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH--QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 355678999999999999965 4689999999853221 22345577899999999999999999887543 357
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+|+||++ +++.+++... .+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 99999995 5888777532 3677788899999999999999765 999999999999999999999999999
Q ss_pred eeccCCCC----ceeeccccCccccCcccc
Q 043136 865 KLIQSDES----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~~~----~~~~~Gt~~y~APE~~~~ 890 (902)
+....... .....||+.|+|||++.+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhC
Confidence 87543221 123578999999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=204.87 Aligned_cols=170 Identities=26% Similarity=0.401 Sum_probs=137.0
Q ss_pred cCCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.+.+.||+|+||.||+|...+ ++.||||.+...... .....+.+|++++.+. .||||+++++++.+....|+||||
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 95 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMEL 95 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeec
Confidence 456889999999999997754 889999998543222 2344566788777666 499999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+ ++++.+++..... .+++..+..++.|++.|++|||+. .+|+||||+|+||++++++.+||+|||++..+...
T Consensus 96 ~-~~~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 96 M-STCLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred c-CcCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 8 4578777654322 467788889999999999999963 24999999999999999999999999999876544
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......|++.|+|||++.+.
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred CcccCCCCCccccCHhhcCCC
Confidence 444445688899999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.9e-21 Score=212.18 Aligned_cols=170 Identities=24% Similarity=0.368 Sum_probs=137.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~ 785 (902)
.|...+.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.++++++||||+++++++.. ....|
T Consensus 6 ~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred ceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 455668899999999999965 4689999999864322 12334567789999999999999999998753 34689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+. +++.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 9999995 68988876432 3678888999999999999999665 9999999999999999999999999998
Q ss_pred eccCCCC-----ceeeccccCccccCcccc
Q 043136 866 LIQSDES-----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 866 ~~~~~~~-----~~~~~Gt~~y~APE~~~~ 890 (902)
....... .....|+..|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcC
Confidence 7643221 134578999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.7e-21 Score=210.10 Aligned_cols=170 Identities=29% Similarity=0.455 Sum_probs=136.8
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC--CeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR--ECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~--~~~~ 785 (902)
..|.+.+.||+|+||.||+|... +++.+|+|++...... ......+.+|+.+++++ +||||+++++++... ...|
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 34556688999999999999764 5889999988543222 22334567899999999 999999999998653 3689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||++ ++|.+++... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++
T Consensus 86 lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 86 LVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 9999996 5998887643 3667788889999999999999665 9999999999999999999999999998
Q ss_pred eccCCC------CceeeccccCccccCcccc
Q 043136 866 LIQSDE------SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 866 ~~~~~~------~~~~~~Gt~~y~APE~~~~ 890 (902)
...... ......||+.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeec
Confidence 664322 2234568999999998854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=202.42 Aligned_cols=170 Identities=31% Similarity=0.430 Sum_probs=137.1
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEecCCe-----e
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCSNREC-----T 784 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~~~~~-----~ 784 (902)
+.+.||+|+||.||+|+.. +++.||+|++...... ......+.+|+++++++ +||||+++++++...+. .
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 4578999999999999875 4899999998643322 12234456787776655 59999999999987776 8
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
+++|||+. +++.+++..... ..+++..+..++.|+++||+|||+.+ ++|+|+||+||+++.++.+||+|||.+
T Consensus 82 ~l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 82 TLVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred EEEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 99999996 589888865322 24778889999999999999999765 999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCccccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.............++..|+|||++.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~PE~~~~~ 181 (287)
T cd07838 155 RIYSFEMALTSVVVTLWYRAPEVLLQS 181 (287)
T ss_pred eeccCCcccccccccccccChHHhccC
Confidence 887554444455688999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-20 Score=205.87 Aligned_cols=172 Identities=28% Similarity=0.384 Sum_probs=136.5
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------ 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------ 782 (902)
..|.+.+.||+|+||.||+|... +++.||+|++...... ......+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 34556789999999999999764 5889999998543211 122345678999999999999999999987654
Q ss_pred ----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 783 ----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 783 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
..++|+||+++ ++.+.+.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999975 7777765431 24678888999999999999999665 999999999999999999999
Q ss_pred eecccceeccCCC--CceeeccccCccccCcccc
Q 043136 859 ADFGVAKLIQSDE--SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 859 ~DFGla~~~~~~~--~~~~~~Gt~~y~APE~~~~ 890 (902)
+|||.+....... ......++..|+|||++.+
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcC
Confidence 9999998764332 1223456888999998864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=206.97 Aligned_cols=168 Identities=17% Similarity=0.150 Sum_probs=133.8
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGN 795 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 795 (902)
+.+|.|+++.||++.. +++.||+|++.... ......+.+.+|++++++++||||+++++++...+..+++|||+++|+
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 3345556666666544 68999999985432 223455678899999999999999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---
Q 043136 796 LDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--- 872 (902)
Q Consensus 796 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~--- 872 (902)
+.+++..... ...+......++.|+++||+|||+++ |+||||||+||+++.++.+|++|||.+........
T Consensus 86 l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (314)
T cd08216 86 CEDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159 (314)
T ss_pred HHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence 9999975432 13567778889999999999999765 99999999999999999999999998876532211
Q ss_pred -----ceeeccccCccccCccccc
Q 043136 873 -----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 873 -----~~~~~Gt~~y~APE~~~~~ 891 (902)
.....++..|+|||++...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~ 183 (314)
T cd08216 160 VVHDFPKSSVKNLPWLSPEVLQQN 183 (314)
T ss_pred ccccccccccccccccCHHHhcCC
Confidence 2334578889999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=208.26 Aligned_cols=167 Identities=25% Similarity=0.372 Sum_probs=134.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++... ..
T Consensus 18 ~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred ceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 445567899999999999965 5688999999854322 223345677899999999999999999988543 34
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|++++++ +++|.+++... .+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccc
Confidence 67888887 78998887532 3677888899999999999999766 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++.... ......|++.|+|||++.+
T Consensus 167 ~~~~~~--~~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 167 ARHTDD--EMTGYVATRWYRAPEIMLN 191 (345)
T ss_pred cccccc--cccccccCCCccCHHHHhC
Confidence 886532 2334578999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.7e-21 Score=198.11 Aligned_cols=178 Identities=23% Similarity=0.302 Sum_probs=145.9
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-c-C----eeEe
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H-R----NIVR 773 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-~----nIv~ 773 (902)
.|...|.+..+|.+-+.+|+|.||+|-.|.+ ..+..||+|++. .-.+.+++..-|+++++++. + | -+|+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik----~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIK----NVDKYREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHH----HHHHHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 4556677778888889999999999999955 347899999983 33456677888999999993 2 2 4788
Q ss_pred EEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-
Q 043136 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG- 852 (902)
Q Consensus 774 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~- 852 (902)
+.+||+..++.++|+|.+ |-++++++.... ..+++...+..|+.|++++++|||+. +++|-|+||+||++.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss 228 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSS 228 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEecc
Confidence 889999999999999998 779999997643 34678888899999999999999955 4999999999999932
Q ss_pred -------------------CCCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 853 -------------------EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 853 -------------------~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
...+||+|||.|+...+. ..+.+.|..|+|||++.|.
T Consensus 229 ~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLgL 284 (415)
T KOG0671|consen 229 EYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILGL 284 (415)
T ss_pred ceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheecc
Confidence 235999999999875443 3677899999999999774
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1e-20 Score=209.32 Aligned_cols=170 Identities=26% Similarity=0.398 Sum_probs=141.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-----eeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-----CTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-----~~~ 785 (902)
|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 456688999999999999764 489999999854322 2334566889999999999999999999987765 789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||++ ++|.+++.... .+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||.+.
T Consensus 81 lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999996 58888886432 4778888899999999999999765 9999999999999999999999999998
Q ss_pred eccCCC----CceeeccccCccccCccccc
Q 043136 866 LIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
...... ......+++.|+|||++.+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred eecccccccccccccccccCcCCceeeecc
Confidence 875443 23445689999999998765
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.4e-21 Score=209.61 Aligned_cols=166 Identities=27% Similarity=0.450 Sum_probs=137.9
Q ss_pred cEeeecCceEEEEEEeC--CC--cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMP--GG--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~--~~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.||+|.||.|++|.+. .| ..||||.+...... ....+|.+|+.+|.+++|||++++||+..+ ....||||++
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 67999999999999764 23 46899998544333 256789999999999999999999999987 6788999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
+.|+|.+.+++.. ...+.......++.|||.|++||.+++ .||||+..+|+++...-.|||+|||+.+.....+
T Consensus 193 plGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred ccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999998732 224556677789999999999999766 9999999999999998899999999999887666
Q ss_pred Cceeecc----ccCccccCcccc
Q 043136 872 SMSVIAG----SYGYIAPGTFCF 890 (902)
Q Consensus 872 ~~~~~~G----t~~y~APE~~~~ 890 (902)
.+..+.+ ...|+|||.+..
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred cceEecCCCcCcccccCHhHhcc
Confidence 5544333 456999999865
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=209.78 Aligned_cols=170 Identities=24% Similarity=0.380 Sum_probs=136.9
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
.|...+.||+|+||.||+|+. .+++.||+|++...... ......+.+|+.+++.++|+||+++++++... ...
T Consensus 6 ~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred ceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 355668899999999999965 46899999998543222 22334567899999999999999999987644 357
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+. ++|.+++.... .+++.....++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 99999995 78988886432 3677888899999999999999765 999999999999999999999999999
Q ss_pred eeccCC-CCceeeccccCccccCcccc
Q 043136 865 KLIQSD-ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~-~~~~~~~Gt~~y~APE~~~~ 890 (902)
+..... .......|+..|+|||++..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 156 RTTSEKGDFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred cccCCCcccccccccccCccChHHHhc
Confidence 876433 22334568999999998854
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=206.95 Aligned_cols=169 Identities=25% Similarity=0.330 Sum_probs=133.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-C--CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec----CCe
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-G--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN----REC 783 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~----~~~ 783 (902)
|.+.+.||+|+||.||+|+.. . +..||+|++...... ....+.+.+|+++++++ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred ceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 345678999999999999764 3 678999988532221 22345577899999999 59999999987532 245
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+++||+. ++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 788999985 68988886432 3677888899999999999999766 99999999999999999999999999
Q ss_pred ceeccCCC-----CceeeccccCccccCcccc
Q 043136 864 AKLIQSDE-----SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~-----~~~~~~Gt~~y~APE~~~~ 890 (902)
++...... ......||+.|+|||++.+
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhC
Confidence 98654321 1233578999999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=200.09 Aligned_cols=169 Identities=28% Similarity=0.398 Sum_probs=140.0
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||+|++|.||+|... +++.+|+|++...... ......+.+|++++++++|++|+++++++.+.+..++||||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC
Confidence 4578999999999999764 6888999988543322 2334567889999999999999999999999999999999996
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 871 (902)
+++.+++.... ..+++..+..++.|+++|++|||..+ |+|+||||+||+++.++.+||+|||.+.......
T Consensus 82 -~~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~ 153 (283)
T cd05118 82 -TDLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153 (283)
T ss_pred -CCHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc
Confidence 48888876542 24778888999999999999999765 9999999999999999999999999998775443
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......++..|+|||.+.+.
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~ 173 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGD 173 (283)
T ss_pred cccCccCcccccCcHHHhcC
Confidence 22335688899999998654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.8e-20 Score=203.46 Aligned_cols=168 Identities=26% Similarity=0.386 Sum_probs=135.4
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~lv 787 (902)
..|...+.||+|+||.||+|.. .+++.||+|++.+.... ....+.+.+|++++++++||||+++++++.. ....|+|
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 3456678999999999999965 47899999987543222 2234557789999999999999999999865 5678999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+ +++|.++++.. ..+......++.|+++|++|||+.+ |+||||||+||++++++.+||+|||.++..
T Consensus 89 ~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 89 TELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred eehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9998 67898887532 2456667789999999999999665 999999999999999999999999998765
Q ss_pred cCCCCceeeccccCccccCcccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.. ......+++.|+|||++.+
T Consensus 159 ~~--~~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 159 DP--QMTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred CC--CcCCCcccccccCceeeec
Confidence 32 2234567889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=205.97 Aligned_cols=166 Identities=26% Similarity=0.357 Sum_probs=132.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~ 783 (902)
.|...+.||+|+||.||+|.. .+++.||+|++...... ......+.+|++++++++||||+++++++.... .
T Consensus 16 ~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred ceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 345568999999999999975 46899999998543221 223345778999999999999999999986542 4
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+|+||+. .++.++.. ..+++..+..++.|++.|++|||..+ ++||||||+||+++.++.+|++|||+
T Consensus 95 ~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 95 FYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred EEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 689999995 47766542 13667788889999999999999665 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++.... ......|++.|+|||++.+
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILN 188 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcC
Confidence 886532 2234568899999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=201.07 Aligned_cols=169 Identities=30% Similarity=0.407 Sum_probs=139.4
Q ss_pred CCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||+|+||.||+|... +++.||+|++.... ......+.+.+|++++++++|++++++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC
Confidence 3467999999999999765 48999999986543 122234556789999999999999999999999999999999996
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 871 (902)
++|.+++.... ...++..+..++.|++.|++|||+.+ |+||||+|+||++++++.+||+|||.++......
T Consensus 82 -~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 82 -MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred -cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 59999997642 24778888999999999999999765 9999999999999999999999999998764332
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......++..|+|||++...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~ 173 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGS 173 (282)
T ss_pred ccCccccCcCcCChHHhcCC
Confidence 22334567889999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=7.3e-22 Score=216.04 Aligned_cols=163 Identities=31% Similarity=0.465 Sum_probs=139.1
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
-..+|.|+||.||+|++ .+++..|+|.++....+ .......|+-+++.++|||||.+++.+..++..|+.||||.|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d---d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgg 96 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD---DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGG 96 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCCc---cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCC
Confidence 35689999999999965 46888999988543332 344467899999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-CC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD-ES 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~-~~ 872 (902)
|+|.+..+... ++++.++..+++...+|++|+|+++ -+|||||-.||++++.|.+|++|||.+..+... ..
T Consensus 97 gslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~K 168 (829)
T KOG0576|consen 97 GSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAK 168 (829)
T ss_pred Ccccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhh
Confidence 99999876543 4777888889999999999999766 899999999999999999999999998776432 23
Q ss_pred ceeeccccCccccCcc
Q 043136 873 MSVIAGSYGYIAPGTF 888 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~ 888 (902)
...+.|||+|||||+-
T Consensus 169 rksfiGtpywmapEva 184 (829)
T KOG0576|consen 169 RKSFIGTPYWMAPEVA 184 (829)
T ss_pred hhcccCCccccchhHH
Confidence 4678999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=193.50 Aligned_cols=154 Identities=19% Similarity=0.104 Sum_probs=125.6
Q ss_pred cCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCHHHH
Q 043136 721 GSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDL 799 (902)
Q Consensus 721 G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 799 (902)
|.||.||+|++ .+++.||+|++.... ...+|...+....||||+++++++...+..|+||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999966 468899999985332 122344455556799999999999999999999999999999999
Q ss_pred HHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceeeccc
Q 043136 800 LHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGS 879 (902)
Q Consensus 800 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt 879 (902)
+.... .+++.....++.|+++|++|+|..+ |+||||||+||+++.++.++++|||.+...... .....++
T Consensus 76 l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~ 145 (237)
T cd05576 76 ISKFL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVE 145 (237)
T ss_pred HHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcC
Confidence 86543 3677888899999999999999665 999999999999999999999999988665432 2334567
Q ss_pred cCccccCcccccc
Q 043136 880 YGYIAPGTFCFCF 892 (902)
Q Consensus 880 ~~y~APE~~~~~~ 892 (902)
..|+|||++.+..
T Consensus 146 ~~y~aPE~~~~~~ 158 (237)
T cd05576 146 NMYCAPEVGGISE 158 (237)
T ss_pred ccccCCcccCCCC
Confidence 8899999986543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-20 Score=211.77 Aligned_cols=165 Identities=30% Similarity=0.455 Sum_probs=129.8
Q ss_pred CcEeeecCceE-EEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGT-VYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~-Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
++++|.|+-|+ ||+|.. .++.||||++.. .....+.+||..++.- +|||||++|+.-.++...||..|.|
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-EGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred HHHcccCCCCcEEEEEee-CCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 46689998876 699977 678999999832 2344567899999888 6999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---C--CCEEEeecccceec
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---E--MEARVADFGVAKLI 867 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~--~~~kl~DFGla~~~ 867 (902)
..+|.+++..... +.....-...+.+..|++.|+++||+.+ |||||+||+||||+. + .+++|+|||+++..
T Consensus 586 ~~sL~dlie~~~~-d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 ACSLQDLIESSGL-DVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhHHHHHhcccc-chhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 4699999987411 1111111233567899999999999655 999999999999975 3 46999999999988
Q ss_pred cCCCC----ceeeccccCccccCccccc
Q 043136 868 QSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
..+.. ..+..||-+|+|||++...
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~ 689 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLRED 689 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhcc
Confidence 65443 3456799999999999653
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.4e-20 Score=203.26 Aligned_cols=171 Identities=27% Similarity=0.398 Sum_probs=133.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--------
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-------- 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-------- 781 (902)
.|...+.||+|+||.||+|... +++.+|+|++....... .....+.+|++++++++||||+++++++...
T Consensus 9 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 3456688999999999999764 58899999885432221 1123456899999999999999999887443
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
...++||||+. +++.+.+.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 88 ~~~~lv~~~~~-~~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 88 GSVYMVTPYMD-HDLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ceEEEEEecCC-cCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 35699999995 47777665422 24788889999999999999999766 999999999999999999999999
Q ss_pred ccceeccCCCC------------ceeeccccCccccCcccc
Q 043136 862 GVAKLIQSDES------------MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 862 Gla~~~~~~~~------------~~~~~Gt~~y~APE~~~~ 890 (902)
|+++....... .....|++.|+|||++.+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 99976532211 123467889999998865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=198.32 Aligned_cols=175 Identities=24% Similarity=0.319 Sum_probs=136.1
Q ss_pred ccCCcEeeecCceEEEEEEeCC-CcEEEEEEecccch--hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHK--ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~--~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
|.+.+.||+|+||.||+|.... +..+++|.+..... ........+.+|+.++++++||||+++++++.+....++||
T Consensus 2 y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (260)
T cd08222 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIIT 81 (260)
T ss_pred ceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEE
Confidence 5567889999999999996643 44455555432111 11122344667999999999999999999999888999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++..... ....+++...+.++.|+++|++|||+.+ ++|+|+||+||++++ +.+|++|||.++...
T Consensus 82 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 82 EYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999998875322 2235788888999999999999999665 999999999999975 579999999998764
Q ss_pred CCCC-ceeeccccCccccCccccc
Q 043136 869 SDES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.... .....|++.|+|||.+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~pe~~~~~ 180 (260)
T cd08222 157 GSCDLATTFTGTPYYMSPEALKHQ 180 (260)
T ss_pred CCcccccCCCCCcCccCHHHHccC
Confidence 3322 3345689999999988654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.6e-20 Score=213.75 Aligned_cols=171 Identities=22% Similarity=0.232 Sum_probs=115.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-C----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeE------Eec
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-G----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGC------CSN 780 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~------~~~ 780 (902)
|...+.||+|+||.||+|++. + +..||+|++...... +....| . +....+.++..+... ...
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~~ 206 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNE-R-VRRACPNSCADFVYGFLEPVSSKK 206 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHH-H-HHhhchhhHHHHHHhhhccccccc
Confidence 456789999999999999764 4 689999987432211 111111 1 111112222221111 245
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccC---------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKG---------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 845 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp 845 (902)
....++||||+++++|.+++...... .........+..++.|++.||+|+|+.+ |+||||||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP 283 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKP 283 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCH
Confidence 66799999999999999998753210 0001112334578999999999999665 99999999
Q ss_pred CCEEEcC-CCCEEEeecccceeccCCC--CceeeccccCccccCcccccc
Q 043136 846 SNILLDG-EMEARVADFGVAKLIQSDE--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 846 ~NILl~~-~~~~kl~DFGla~~~~~~~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+|||++. ++.+||+|||+|+.+.... .....+||+.|||||++....
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccC
Confidence 9999986 5799999999998654322 234578999999999875443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=184.16 Aligned_cols=143 Identities=17% Similarity=0.103 Sum_probs=106.0
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHH-----------------------HHHHHHHHHHHHhcCCcCee
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIR-----------------------RRRGVLAEVDVLGNVRHRNI 771 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~-----------------------~~~~~~~Ei~il~~l~h~nI 771 (902)
.+.||+|+||.||+|...+|+.||||++......... ......+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998878999999998643211000 01233469999999987776
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEcCCCCCCEEE
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL-HHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHrDlKp~NILl 850 (902)
.....+... ..++||||++|+++....... ..++......++.|++.+++|+ |+.+ |+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 443332222 238999999887765443221 1366777889999999999999 5555 9999999999999
Q ss_pred cCCCCEEEeecccceecc
Q 043136 851 DGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~ 868 (902)
+ ++.++++|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.81 E-value=9e-20 Score=202.67 Aligned_cols=168 Identities=24% Similarity=0.397 Sum_probs=132.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------- 781 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------- 781 (902)
.+|...+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 3456678999999999999966 4688999999854432 3345677899999999999999999876543
Q ss_pred -------CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-C
Q 043136 782 -------ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-E 853 (902)
Q Consensus 782 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~ 853 (902)
...|+||||++ ++|.+++... .+++.....++.|+++|++|||+.+ |+||||||+||+++. +
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCC
Confidence 35789999996 5888877532 3567788899999999999999765 999999999999974 5
Q ss_pred CCEEEeecccceeccCCCC----ceeeccccCccccCcccc
Q 043136 854 MEARVADFGVAKLIQSDES----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 854 ~~~kl~DFGla~~~~~~~~----~~~~~Gt~~y~APE~~~~ 890 (902)
+.+|++|||.++....... .....|+..|+|||++..
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhC
Confidence 5789999999986532211 122467889999998743
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=204.07 Aligned_cols=166 Identities=25% Similarity=0.386 Sum_probs=136.1
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe------e
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC------T 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~------~ 784 (902)
|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+.++++++|||++++++++...+. .
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 95 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDV 95 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccE
Confidence 445688999999999999764 578999998754321 22334557789999999999999999988766554 8
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
++|+||+ +++|.+++... .+++..+..++.|+++|++|+|+.+ |+||||||+||++++++.+||+|||++
T Consensus 96 ~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 96 YLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred EEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccc
Confidence 9999999 67999988642 3677888899999999999999765 999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCcccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
...... .....+++.|+|||.+.+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhC
Confidence 876432 334578899999998854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-21 Score=213.76 Aligned_cols=178 Identities=21% Similarity=0.244 Sum_probs=93.5
Q ss_pred EEEcCCCCcc-cccCccccCCCCCCEEEccCCCCccc----CchhhhccCCCcEEEccCCCCCC------CCCccccccc
Q 043136 82 SLDLSRRSLS-GPIPPEIRYLTSLTHLNLSANAFDGP----LQPAILELTKLRTIDISHNSFNS------TFPPGISKLR 150 (902)
Q Consensus 82 ~L~L~~~~l~-g~~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~ 150 (902)
.|+|.++.++ +.....+..+++|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566667666 33445566667788888887777532 44455566777777777777652 1223344555
Q ss_pred ccceeccccccccCCCchhhhcccC---CcEEeccCccCcC----CCCcccCCC-CCCCEEEccCCCccCC----CCccc
Q 043136 151 FLRIFNAYSNSFTGPLPLEFVQLNS---LQQLNLGGSYFDG----EIPSDYRNL-SSLRFLDLAGNSLTGS----LPPQL 218 (902)
Q Consensus 151 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 218 (902)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|+|++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 6666666666665555555554444 6666666555542 112223333 4555555555555521 12233
Q ss_pred cCCCCCcEEEeeCcccCCC----CChhccCCCCCCEEEccCccCc
Q 043136 219 GLLTQLERIEIGYNNLQGE----VPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 219 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
..+++|++|++++|.+++. ++..+..+++|++|+|++|.++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~ 206 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT 206 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence 3444455555555554421 1222333344555555555443
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=212.49 Aligned_cols=175 Identities=29% Similarity=0.398 Sum_probs=142.3
Q ss_pred CCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 714 SDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
+.+.+|+|+||.|++|... ....||||........ .+.+.+..|+++|+.+ +|+||+.++|+|..++..
T Consensus 300 ~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 300 LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred ccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 3458999999999999532 1457999988544332 5677899999999999 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhc---------cCCC--cccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043136 785 MLLYEYMPNGNLDDLLHAKN---------KGEN--LVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE 853 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~---------~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~ 853 (902)
++|+||++.|+|.++++..+ .... ..+.....+.++.|||.|++||++.. +||||+.++|||+..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCC
Confidence 99999999999999998876 1111 23777888999999999999999655 9999999999999999
Q ss_pred CCEEEeecccceeccCCCCceee--ccc--cCccccCccccccc
Q 043136 854 MEARVADFGVAKLIQSDESMSVI--AGS--YGYIAPGTFCFCFS 893 (902)
Q Consensus 854 ~~~kl~DFGla~~~~~~~~~~~~--~Gt--~~y~APE~~~~~~~ 893 (902)
..+||+|||+|+........... .|+ ..|||||.+.+...
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f 498 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF 498 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc
Confidence 99999999999976555444322 222 34999999977433
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.5e-21 Score=211.94 Aligned_cols=250 Identities=23% Similarity=0.275 Sum_probs=149.9
Q ss_pred EEEccCCCCc-ccCchhhhccCCCcEEEccCCCCCCC----CCcccccccccceeccccccccC------CCchhhhccc
Q 043136 106 HLNLSANAFD-GPLQPAILELTKLRTIDISHNSFNST----FPPGISKLRFLRIFNAYSNSFTG------PLPLEFVQLN 174 (902)
Q Consensus 106 ~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~------~~p~~~~~l~ 174 (902)
.|+|+.+.++ ......+..+++|++|+++++.++.. ++..+...+.|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 44566777888899999999988643 45556667778888888887762 2344566677
Q ss_pred CCcEEeccCccCcCCCCcccCCCCC---CCEEEccCCCccC----CCCccccCC-CCCcEEEeeCcccCCC----CChhc
Q 043136 175 SLQQLNLGGSYFDGEIPSDYRNLSS---LRFLDLAGNSLTG----SLPPQLGLL-TQLERIEIGYNNLQGE----VPVEF 242 (902)
Q Consensus 175 ~L~~L~L~~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 242 (902)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7888888887777655555544444 7777777777762 222344455 6677777777777632 23345
Q ss_pred cCCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCcccee----cCCCCCCcCcCcEEecccCCCccccCccc
Q 043136 243 ASLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGE----IPVSYGNLQALQVLDLSDNQLSGPIPASL 314 (902)
Q Consensus 243 ~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l 314 (902)
..+.+|++|++++|.+++. ++..+..+++|++|+|++|.+++. ++..+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 5556677777777766632 223344445666666666666532 22234445566666666666654222222
Q ss_pred cc-----cCCCCEEEccCccccc----cCChhhhhccccceEEecCceec
Q 043136 315 AS-----LKGLTRLSLMNNVLFG----EIPQDIELLADLDTLLLWNNHLT 355 (902)
Q Consensus 315 ~~-----l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~ 355 (902)
.. .+.|+.|++++|.++. .+...+..+++|+.+++++|.++
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~ 291 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFG 291 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCc
Confidence 21 2456666666665541 11222333345555555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=7e-19 Score=177.44 Aligned_cols=144 Identities=17% Similarity=0.093 Sum_probs=108.5
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhh-----------------------HHHHHHHHHHHHHHhcCCcCee
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN-----------------------IRRRRGVLAEVDVLGNVRHRNI 771 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l~h~nI 771 (902)
.+.||+|+||+||+|...+|+.||||++....... ........+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987789999999986542110 0012234578999999999887
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEE
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH-DCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlKp~NILl 850 (902)
.....+... ..|+||||++|+++........ ..+......++.|++.++.++|+ .+ |+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV-----PLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc-----cCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 544443332 2489999998875543322111 24556777899999999999997 65 9999999999999
Q ss_pred cCCCCEEEeecccceeccC
Q 043136 851 DGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~ 869 (902)
+ ++.++|+|||+|+....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5e-20 Score=177.04 Aligned_cols=159 Identities=24% Similarity=0.410 Sum_probs=133.3
Q ss_pred CcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCC--eeEEEEEc
Q 043136 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRE--CTMLLYEY 790 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~--~~~lv~e~ 790 (902)
.+++|+|.|++||.|. ..+.++++||++++. ..+.+.+|+.|++.++ ||||++++++..+.. ...+|+||
T Consensus 43 vrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 43 VRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 3568999999999995 456888999998433 2345778999999996 999999999987654 46799999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 869 (902)
+.+.|...+... +....+..++.+++.||.|+|++| |+|||+||.|+++|... .++++|+|+|.++.+
T Consensus 117 v~n~Dfk~ly~t--------l~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 117 VNNTDFKQLYPT--------LTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hccccHHHHhhh--------hchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999888776543 344556678999999999999776 99999999999999764 699999999999988
Q ss_pred CCCceeeccccCccccCcccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~ 890 (902)
+......+.+..|..||.+..
T Consensus 186 ~~eYnVRVASRyfKGPELLVd 206 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVD 206 (338)
T ss_pred CceeeeeeehhhcCCchheee
Confidence 888888889999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.2e-18 Score=180.88 Aligned_cols=167 Identities=37% Similarity=0.530 Sum_probs=141.5
Q ss_pred CCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 714 SDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45789999999999997765 889999998644322 245678889999999999999999999999899999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 871 (902)
+++|.+++..... ..++.....++.+++.++.++|..+ ++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 81 GGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred CCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 9999999875432 1567788899999999999999665 9999999999999999999999999998875443
Q ss_pred -CceeeccccCccccCccc
Q 043136 872 -SMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~ 889 (902)
......++..|++||.+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~ 172 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLL 172 (225)
T ss_pred ccccceeccCCcCCHhHhc
Confidence 334567888999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.2e-19 Score=183.54 Aligned_cols=166 Identities=30% Similarity=0.363 Sum_probs=135.1
Q ss_pred CcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------CeeEEE
Q 043136 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------ECTMLL 787 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~~~lv 787 (902)
-+.+|.|+- .|..| +.-.++.||+|++... .......++..+|...+..+.|+||++++.+|.-. ..+|+|
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v 99 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLV 99 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHH
Confidence 366788887 55555 3346889999998544 22334456678899999999999999999998543 368999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||| .+++...+.- ..+-.+...|..|++.|++|+|+.+ |+|||+||+||++..++.+||.|||+|+..
T Consensus 100 ~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 100 MELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence 9999 5699888873 2566778899999999999999666 999999999999999999999999999976
Q ss_pred cCCCCceeeccccCccccCccccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..+-..+..+.|..|.|||++.|...
T Consensus 169 ~~~~~mtpyVvtRyyrapevil~~~~ 194 (369)
T KOG0665|consen 169 DTDFMMTPYVVTRYYRAPEVILGMGY 194 (369)
T ss_pred CcccccCchhheeeccCchheeccCC
Confidence 55545667889999999999998763
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.8e-21 Score=175.06 Aligned_cols=180 Identities=27% Similarity=0.485 Sum_probs=109.8
Q ss_pred CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceecc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 493 (902)
++++.|-||+|+++ .+|..+..+.+|+.|++++|+++ .+|.+++.+++|+.|+++-|++. .+|..|+++|.|++|||
T Consensus 33 s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldl 109 (264)
T KOG0617|consen 33 SNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDL 109 (264)
T ss_pred hhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhc
Confidence 33344444444444 33444444444444444444444 34444444444444444444442 34444444444444444
Q ss_pred CCCccCC-Ccc-cccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccc
Q 043136 494 SSSKLTG-KIP-DFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG 571 (902)
Q Consensus 494 s~N~l~~-~~p-~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 571 (902)
++|++.. .+| .|+.+..|..|+|++|.+. .+|.++|++++|+.|.+..|.+- .+|.+++.|++|++|.+.+|+|+
T Consensus 110 tynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~- 186 (264)
T KOG0617|consen 110 TYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT- 186 (264)
T ss_pred cccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-
Confidence 4444432 222 2344555556666666664 78899999999999999999988 68999999999999999999999
Q ss_pred cCCCCCcCCcc---ceeecccCCcccccCCC
Q 043136 572 TIPSNFENCST---LESFNVSYNLLTGPIPA 599 (902)
Q Consensus 572 ~ip~~~~~l~~---L~~l~ls~N~l~g~ip~ 599 (902)
.+|+.++++.- =+.+.+.+|++-.+|-.
T Consensus 187 vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 187 VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 78888877653 24566677777655543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.7e-19 Score=196.23 Aligned_cols=167 Identities=26% Similarity=0.309 Sum_probs=134.4
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.++..+|.|+|+.|-.+.. .+++..++|++.+.. .+..+|+.++... +||||+++.+++.+..+.|+|||+
T Consensus 325 ~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 325 EFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred ccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 3455699999999998854 568899999985442 2234577777666 699999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-cCCCCEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL-DGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl-~~~~~~kl~DFGla~~~~~ 869 (902)
+.|+-+.+.+...+. ....+..|+.+|+.|+.|||.+| |||||+||+|||+ +.+++++|+|||.++....
T Consensus 398 l~g~ell~ri~~~~~------~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE------FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ccccHHHHHHHhcch------hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999988777765432 12455579999999999999766 9999999999999 6889999999999988755
Q ss_pred CCCceeeccccCccccCcccccccCcee
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
+ ..+.+=|..|.|||+......++.+
T Consensus 469 ~--~~tp~~t~~y~APEvl~~~~yt~ac 494 (612)
T KOG0603|consen 469 S--CDTPALTLQYVAPEVLAIQEYTEAC 494 (612)
T ss_pred h--hcccchhhcccChhhhccCCCCcch
Confidence 4 3345678899999999866555543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.6e-18 Score=172.36 Aligned_cols=165 Identities=36% Similarity=0.572 Sum_probs=138.7
Q ss_pred eeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCH
Q 043136 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNL 796 (902)
Q Consensus 718 iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL 796 (902)
||+|++|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++||++.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 6899999999998754 8999999985443321 346688999999999999999999999998999999999998999
Q ss_pred HHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeecccceeccCCC-Cce
Q 043136 797 DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQSDE-SMS 874 (902)
Q Consensus 797 ~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~-~~~ 874 (902)
.+++.... ...++..+..++.+++++++++|+.+ ++|+||+|.||+++. ++.++|+|||.+....... ...
T Consensus 79 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~ 151 (215)
T cd00180 79 KDLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151 (215)
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhh
Confidence 99987542 24677888899999999999999765 999999999999999 8999999999998764432 133
Q ss_pred eeccccCccccCccccc
Q 043136 875 VIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 875 ~~~Gt~~y~APE~~~~~ 891 (902)
...+...|++||.+...
T Consensus 152 ~~~~~~~~~~pe~~~~~ 168 (215)
T cd00180 152 TIVGTPAYMAPEVLLGK 168 (215)
T ss_pred cccCCCCccChhHhccc
Confidence 45678899999998664
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.9e-18 Score=180.04 Aligned_cols=160 Identities=32% Similarity=0.511 Sum_probs=136.2
Q ss_pred CceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCHHHHH
Q 043136 722 STGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL 800 (902)
Q Consensus 722 ~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 800 (902)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|++|+++++++......+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999775 489999999864433221 567889999999999999999999999989999999999999999998
Q ss_pred HhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceeecccc
Q 043136 801 HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY 880 (902)
Q Consensus 801 ~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~ 880 (902)
..... .++...+.++.+++++++|||..+ ++|+||+|+||+++.++.++++|||.+.............|+.
T Consensus 79 ~~~~~-----~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~ 150 (244)
T smart00220 79 KKRGR-----LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTP 150 (244)
T ss_pred HhccC-----CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCc
Confidence 75432 677888899999999999999665 9999999999999999999999999998876554455667899
Q ss_pred CccccCccccc
Q 043136 881 GYIAPGTFCFC 891 (902)
Q Consensus 881 ~y~APE~~~~~ 891 (902)
.|+|||+..+.
T Consensus 151 ~~~~pE~~~~~ 161 (244)
T smart00220 151 EYMAPEVLLGK 161 (244)
T ss_pred CCCCHHHHccC
Confidence 99999988643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.2e-19 Score=173.79 Aligned_cols=163 Identities=22% Similarity=0.335 Sum_probs=126.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeE-EecCCeeEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGC-CSNRECTMLL 787 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~-~~~~~~~~lv 787 (902)
.|.+.+.+|+|.||.+-+|+++ +...+|+|.+... ....++|.+|..---.+ .|.||+.-|++ |+..+.++++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 4567789999999999999775 4677888987433 23456788888766566 59999988864 6788889999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-c-CCCCEEEeecccce
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL-D-GEMEARVADFGVAK 865 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl-~-~~~~~kl~DFGla~ 865 (902)
+||++.|||.+-+...+ +.+...++++.|++.|++|+|++. +||||||.+|||| + +..++|+||||..+
T Consensus 101 qE~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eccCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccc
Confidence 99999999998876543 344566789999999999999665 9999999999999 3 34579999999987
Q ss_pred eccCCCCceeeccccCccccCcc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTF 888 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~ 888 (902)
..... .....-+..|.|||..
T Consensus 172 k~g~t--V~~~~~~~~y~~pe~~ 192 (378)
T KOG1345|consen 172 KVGTT--VKYLEYVNNYHAPELC 192 (378)
T ss_pred ccCce--ehhhhhhcccCCcHHH
Confidence 64321 1222235568888876
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.7e-18 Score=167.98 Aligned_cols=170 Identities=22% Similarity=0.306 Sum_probs=134.4
Q ss_pred HHHHhccCCcEeeecCceEEEEE-EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCee
Q 043136 707 VLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECT 784 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~-~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~ 784 (902)
+....|...++||.|+||.+|.| ...+|+.||||.-..+.. ..++..|..+...++ ...|+.+..++.++.+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~-----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK-----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC-----CcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 33445677899999999999999 456799999998643322 234677899988886 46788888888889999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEEeec
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARVADF 861 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DF 861 (902)
.+|||.. |.+|+++..-..+ .++..+.+-++.|++.-++|+|.++ +|||||||+|+|+.- ...+.++||
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEec
Confidence 9999998 8899999875433 3667788889999999999999777 999999999999953 356999999
Q ss_pred ccceeccCCCC--------ceeeccccCccccCccc
Q 043136 862 GVAKLIQSDES--------MSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 862 Gla~~~~~~~~--------~~~~~Gt~~y~APE~~~ 889 (902)
|+|+.+.+... .....||..|++-....
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~ 194 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHL 194 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhh
Confidence 99998754222 23467999998855543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=172.15 Aligned_cols=166 Identities=21% Similarity=0.279 Sum_probs=133.9
Q ss_pred hccCCcEeeecCceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
-|.+.++||+|.||+++.|+ +-+++.||||.-..+... .++..|.+..+.+ ..+.|+..|.+.....+-.+||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A-----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA-----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc-----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 35577899999999999994 457999999986544332 3355677777777 5789999999998888899999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-----CCEEEeeccc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-----MEARVADFGV 863 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-----~~~kl~DFGl 863 (902)
|.+ |.+|+|+..-.++ .++..+..-+|.|++.-++|+|+++ +|.|||||+|+||... ..+.|+|||+
T Consensus 104 dLL-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhh-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 998 8899999876543 4778888999999999999999776 9999999999999654 3599999999
Q ss_pred ceeccCCCC--------ceeeccccCccccCccc
Q 043136 864 AKLIQSDES--------MSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 864 a~~~~~~~~--------~~~~~Gt~~y~APE~~~ 889 (902)
|+.+.+... .....||..||+=....
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHl 209 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHL 209 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccc
Confidence 998865432 24567999999954443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-20 Score=170.18 Aligned_cols=163 Identities=29% Similarity=0.538 Sum_probs=104.5
Q ss_pred ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEE
Q 043136 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203 (902)
Q Consensus 124 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 203 (902)
.+++.+.|-||+|+++ .+|+.+..|.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|
T Consensus 31 ~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl 107 (264)
T KOG0617|consen 31 NMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL 107 (264)
T ss_pred chhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence 4445555556666655 34555666666666666666665 45566666666667777666665 566677777777777
Q ss_pred EccCCCcc-CCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCcc
Q 043136 204 DLAGNSLT-GSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282 (902)
Q Consensus 204 ~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 282 (902)
||..|++. ..+|..|..++.|+.|+|+.|.+. .+|..++.+++|+.|.+..|.+- .+|..++.+++|++|.+.+|++
T Consensus 108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl 185 (264)
T KOG0617|consen 108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL 185 (264)
T ss_pred hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence 77777765 346666666666777777777766 56666677777777777766665 5666666666666666666666
Q ss_pred ceecCCCCCC
Q 043136 283 TGEIPVSYGN 292 (902)
Q Consensus 283 ~~~~p~~~~~ 292 (902)
+ .+|..+++
T Consensus 186 ~-vlppel~~ 194 (264)
T KOG0617|consen 186 T-VLPPELAN 194 (264)
T ss_pred e-ecChhhhh
Confidence 6 45544443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-18 Score=184.89 Aligned_cols=181 Identities=21% Similarity=0.264 Sum_probs=146.4
Q ss_pred CCCHHHHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC------cCeeEe
Q 043136 701 NFTADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR------HRNIVR 773 (902)
Q Consensus 701 ~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~------h~nIv~ 773 (902)
.+...|+.+.+|.+....|+|-|+.|.+|.+. .+..||||+|..... ..+.=++|++||+++. -.|+++
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 45677899999999999999999999999654 478999999965432 2344567999999995 348999
Q ss_pred EEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043136 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE 853 (902)
Q Consensus 774 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~ 853 (902)
++..|...+++|+|+|-+ .-+|.+++++.+..-.. ....+..++.|+..||..|..++ |+|.||||+||||++.
T Consensus 499 l~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL--~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 499 LFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGL--HIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNES 572 (752)
T ss_pred HHHHhhhcceeEEEehhh-hchHHHHHHHhCcccce--eehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccC
Confidence 999999999999999988 56999999987765443 44556678999999999999666 9999999999999876
Q ss_pred -CCEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 854 -MEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 854 -~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..+||||||.|..+.+.+.+. ..-+..|.|||++.|..
T Consensus 573 k~iLKLCDfGSA~~~~eneitP-YLVSRFYRaPEIiLG~~ 611 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP-YLVSRFYRAPEIILGLP 611 (752)
T ss_pred cceeeeccCccccccccccccH-HHHHHhccCcceeecCc
Confidence 568999999998876554332 33456799999997753
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.3e-17 Score=167.00 Aligned_cols=136 Identities=19% Similarity=0.290 Sum_probs=102.1
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-----CcCeeEeEEeEEecCC---eeE-
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-----RHRNIVRLLGCCSNRE---CTM- 785 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-----~h~nIv~l~~~~~~~~---~~~- 785 (902)
.+.||+|+||.||. ++.....+||++..... ...+.+.+|+++++.+ .||||++++++++++. .++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cceecCCCceEEEE--CCCCcCeEEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 47899999999996 43333347898754322 2345688999999999 5799999999998863 434
Q ss_pred EEEEc--cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEcCCCCCCEEEcC----CCCEEE
Q 043136 786 LLYEY--MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI-CYLHHDCDPVIVHRDLKPSNILLDG----EMEARV 858 (902)
Q Consensus 786 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L-~~LH~~~~~~ivHrDlKp~NILl~~----~~~~kl 858 (902)
+|+|| +.+|+|.+++.... +++. ..++.|++.++ +|||+++ ||||||||+||+++. ++.++|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEE
Confidence 78999 55799999996421 2222 24577888777 9999766 999999999999974 347999
Q ss_pred ee-ccccee
Q 043136 859 AD-FGVAKL 866 (902)
Q Consensus 859 ~D-FGla~~ 866 (902)
+| ||.+..
T Consensus 151 iDg~G~~~~ 159 (210)
T PRK10345 151 CDNIGESTF 159 (210)
T ss_pred EECCCCcce
Confidence 99 555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-17 Score=167.33 Aligned_cols=149 Identities=17% Similarity=0.130 Sum_probs=119.4
Q ss_pred HHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHH------HHHHHHHHhcCCcCeeEeEEeE
Q 043136 704 ADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRG------VLAEVDVLGNVRHRNIVRLLGC 777 (902)
Q Consensus 704 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~------~~~Ei~il~~l~h~nIv~l~~~ 777 (902)
.+++.+..|...+++|+|+||.||.++. ++..+|+|.+.+........... +.+|+..+.++.||+|+.+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3567777888899999999999999866 57789999997655444443333 6789999999999999999888
Q ss_pred EecC--------CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 778 CSNR--------ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 778 ~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
+... ...++||||++|.+|.++.. .+. ....++++++..+|..+ ++|||+||+||+
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nil 167 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFI 167 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEE
Confidence 6533 35789999999999987632 111 24568999999999666 999999999999
Q ss_pred EcCCCCEEEeecccceeccCC
Q 043136 850 LDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~ 870 (902)
++++| ++++|||..+....+
T Consensus 168 i~~~g-i~liDfg~~~~~~e~ 187 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQR 187 (232)
T ss_pred EeCCC-EEEEECCCcccccch
Confidence 99998 999999988766433
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-17 Score=162.72 Aligned_cols=155 Identities=15% Similarity=0.055 Sum_probs=113.1
Q ss_pred CCcEeeecCceEEEEEEeCCCcEEEEEEecccchh-hHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEcc
Q 043136 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
....|++|+||+||.+.. .+.+++.+.+.....- .......+.+|+++++++. |++|++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998866 6677776665322111 0111235789999999995 5889999886 3468999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC-CCCCEEEcCCCCEEEeecccceeccCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDL-KPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl-Kp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+|.+|.+.... . ...++.|++++++++|.++ |+|||| ||+||+++.++.++|+|||+|......
T Consensus 81 ~G~~L~~~~~~---------~---~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~ 145 (218)
T PRK12274 81 AGAAMYQRPPR---------G---DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR 145 (218)
T ss_pred cCccHHhhhhh---------h---hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence 99888654311 0 1246788999999999766 999999 799999999999999999999865433
Q ss_pred CCc--------------eeeccccCccccCcc
Q 043136 871 ESM--------------SVIAGSYGYIAPGTF 888 (902)
Q Consensus 871 ~~~--------------~~~~Gt~~y~APE~~ 888 (902)
... .-...++.|++|+.-
T Consensus 146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~ 177 (218)
T PRK12274 146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVER 177 (218)
T ss_pred chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence 210 012257778887754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.71 E-value=7.7e-18 Score=177.01 Aligned_cols=138 Identities=27% Similarity=0.445 Sum_probs=117.6
Q ss_pred ccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
|...++||+|.|+.||++.+. ..+.||+|.+..... ..++.+|++++..+ .+.||+++.+++..++.+.+
T Consensus 38 ~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 38 YKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 455688999999999999543 468899999854332 34478899999999 59999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~ 865 (902)
|+||++..+..++... ++...+..+++.+..||+++|+.| ||||||||+|++.+.. +.-.|+|||+|.
T Consensus 113 vlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 9999999988888764 456677788999999999999776 9999999999999765 678999999987
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.5e-17 Score=190.34 Aligned_cols=157 Identities=31% Similarity=0.515 Sum_probs=123.8
Q ss_pred hcCCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecCC--C--CCEEEEEcCCCCccccc
Q 043136 19 SANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPK--S--SQITSLDLSRRSLSGPI 94 (902)
Q Consensus 19 ~~~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~~--~--~~v~~L~L~~~~l~g~~ 94 (902)
...+.++|.+||+++|+++.++.. .+|++.+|. |.+|.|.||.|+.. . .+|+.|+|++|+++|.+
T Consensus 366 ~~~t~~~~~~aL~~~k~~~~~~~~---~~W~g~~C~--------p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~i 434 (623)
T PLN03150 366 ESKTLLEEVSALQTLKSSLGLPLR---FGWNGDPCV--------PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFI 434 (623)
T ss_pred ccccCchHHHHHHHHHHhcCCccc---CCCCCCCCC--------CcccccccceeeccCCCCceEEEEEECCCCCccccC
Confidence 456788999999999999976542 479866431 12358999999632 2 25899999999999999
Q ss_pred CccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcc-
Q 043136 95 PPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL- 173 (902)
Q Consensus 95 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l- 173 (902)
|+.++.+++|+.|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|++|+++|.+|..+..+
T Consensus 435 p~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~ 514 (623)
T PLN03150 435 PNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514 (623)
T ss_pred CHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhcc
Confidence 9999999999999999999998888888889999999998888888888888888888888888888888877777653
Q ss_pred cCCcEEeccCccC
Q 043136 174 NSLQQLNLGGSYF 186 (902)
Q Consensus 174 ~~L~~L~L~~N~l 186 (902)
.++..+++++|..
T Consensus 515 ~~~~~l~~~~N~~ 527 (623)
T PLN03150 515 LHRASFNFTDNAG 527 (623)
T ss_pred ccCceEEecCCcc
Confidence 3455666666643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9e-17 Score=176.30 Aligned_cols=176 Identities=20% Similarity=0.224 Sum_probs=134.4
Q ss_pred hccCCcEeeecCceEEEEEEeCCC--cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc----CeeEeEEeEE-ecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGG--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH----RNIVRLLGCC-SNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h----~nIv~l~~~~-~~~~~ 783 (902)
.|.+.+.||+|+||.||.|..... ..+|+|......... ...+..|+.++..+.. +++.++++.+ ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 567789999999999999976553 478888764322211 1135668888887752 6899999999 57788
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-----CCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-----MEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-----~~~kl 858 (902)
.|+||+.+ |.+|.++..... ...++..+...|+.|++.+|+++|+.| ++||||||+|+.+... ..+.+
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~l 168 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYL 168 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEE
Confidence 99999988 889999876543 234777888999999999999999666 9999999999999755 36999
Q ss_pred eecccce--eccCCC--------C-ceeeccccCccccCcccccccCce
Q 043136 859 ADFGVAK--LIQSDE--------S-MSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 859 ~DFGla~--~~~~~~--------~-~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
.|||+|+ .+.... . .....||..|+++++..+....+.
T Consensus 169 lDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~ 217 (322)
T KOG1164|consen 169 LDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR 217 (322)
T ss_pred EecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc
Confidence 9999999 431111 1 223569999999998877655443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.5e-16 Score=161.06 Aligned_cols=138 Identities=21% Similarity=0.332 Sum_probs=112.6
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccch-----hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK-----ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+.||+|++|.||+|.. .+..+++|+...... ........+.+|++++..+.|++|+....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5689999999999987 667889997643221 1122345678899999999999888777777777788999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
++|++|.+++.... . ....++.+++.++.++|..+ ++|||++|+||+++ ++.++++|||.++..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 99999999885421 1 56789999999999999665 99999999999999 789999999998764
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.5e-16 Score=163.67 Aligned_cols=145 Identities=18% Similarity=0.153 Sum_probs=107.7
Q ss_pred ccCCcEeeecCceEEEEEE--eCCCcEEEEEEecccchh-------------------h--HHHHHHHHHHHHHHhcCCc
Q 043136 712 SMSDKILGMGSTGTVYKAE--MPGGEIIAVKKLWGKHKE-------------------N--IRRRRGVLAEVDVLGNVRH 768 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~--~~~~~~vavK~i~~~~~~-------------------~--~~~~~~~~~Ei~il~~l~h 768 (902)
|.+.+.||+|+||.||+|. ..+|+.||+|++...... . ......+.+|++++.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 4567899999999999997 568999999998643210 0 0012345689999999965
Q ss_pred --CeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEcCCCC
Q 043136 769 --RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV-IVHRDLKP 845 (902)
Q Consensus 769 --~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~-ivHrDlKp 845 (902)
..+++++++ ...++||||++|+++........ .........++.|++.+++++| ..+ |+|||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp 177 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSE 177 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCCh
Confidence 334555543 23589999999888766542211 2334455689999999999999 455 99999999
Q ss_pred CCEEEcCCCCEEEeecccceeccC
Q 043136 846 SNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 846 ~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
+||+++ ++.++++|||.|.....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccCC
Confidence 999999 88999999999986544
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=184.84 Aligned_cols=138 Identities=24% Similarity=0.367 Sum_probs=109.4
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEeccc-ch----hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGK-HK----ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~-~~----~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...+.||+|+||.||+|.+.+.. +++|+...+ .. ......+++.+|++++++++|++++....++......++|
T Consensus 336 ~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 336 IPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred CccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 45689999999999999875444 444432221 11 1112345688999999999999998888777777778999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||++|++|.+++. ....++.++++++.|+|+.+ ++|||+||+||++ .++.++|+|||+++..
T Consensus 415 ~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 415 MEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999998875 23468899999999999665 9999999999999 5779999999999875
Q ss_pred c
Q 043136 868 Q 868 (902)
Q Consensus 868 ~ 868 (902)
.
T Consensus 478 ~ 478 (535)
T PRK09605 478 D 478 (535)
T ss_pred C
Confidence 3
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.1e-16 Score=168.07 Aligned_cols=140 Identities=28% Similarity=0.391 Sum_probs=115.9
Q ss_pred CHHHHHH-HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-----c---CeeE
Q 043136 703 TADDVLE-CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-----H---RNIV 772 (902)
Q Consensus 703 ~~~~~~~-~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h---~nIv 772 (902)
..+|++. .+|.+.++||-|-|++||+|.+ .+.+.||+|+++ ......+..+.||+++++++ | .+||
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvK----SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV 145 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVK----SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVV 145 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEe----hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceee
Confidence 4557777 8999999999999999999955 567889999983 34455677889999999984 2 4899
Q ss_pred eEEeEEecC----CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCE
Q 043136 773 RLLGCCSNR----ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNI 848 (902)
Q Consensus 773 ~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NI 848 (902)
++++.|... .+++||+|++ |.+|..+|...... -++...++.|++||+.||.|||..+ +|||-||||+||
T Consensus 146 ~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENv 219 (590)
T KOG1290|consen 146 QLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENV 219 (590)
T ss_pred eeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCccee
Confidence 999999753 5899999999 78999998765432 3667788899999999999999854 899999999999
Q ss_pred EEcC
Q 043136 849 LLDG 852 (902)
Q Consensus 849 Ll~~ 852 (902)
|+..
T Consensus 220 Ll~~ 223 (590)
T KOG1290|consen 220 LLCS 223 (590)
T ss_pred eeec
Confidence 9953
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=3.9e-16 Score=158.85 Aligned_cols=140 Identities=18% Similarity=0.185 Sum_probs=106.9
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhh-------------------HHHHHHHHHHHHHHhcCCcC--e
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN-------------------IRRRRGVLAEVDVLGNVRHR--N 770 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-------------------~~~~~~~~~Ei~il~~l~h~--n 770 (902)
|...+.||+|+||.||+|...+++.||||++....... ........+|+.++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 55678899999999999988889999999875322100 01122366789999888776 4
Q ss_pred eEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 771 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
+++.++. ...++||||++|+++.++... .....++.+++.++.++|+.+ |+||||||+||++
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 5555542 345899999999998765321 123467889999999999765 9999999999999
Q ss_pred cCCCCEEEeecccceeccC
Q 043136 851 DGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~ 869 (902)
++++.++|+|||++.....
T Consensus 159 ~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cCCCcEEEEECCccccCCC
Confidence 9999999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.6e-15 Score=166.89 Aligned_cols=172 Identities=32% Similarity=0.463 Sum_probs=141.8
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcC-eeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR-NIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~-nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...+.||.|+||.||++... ..+|+|.+.............+.+|+.+++.+.|+ +++++++++......++++|++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 45578999999999999775 78899998655444333567788999999999988 7999999998777789999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~ 870 (902)
.++++.+++...... ..........++.|++.+++|+|..+ ++|||+||+||+++..+ .++++|||.++.....
T Consensus 81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999776643211 24666778899999999999999766 99999999999999988 7999999999865433
Q ss_pred C-------CceeeccccCccccCccccc
Q 043136 871 E-------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~-------~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......||..|+|||.+.+.
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~ 183 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGL 183 (384)
T ss_pred CccccccccccccccccccCCHHHhcCC
Confidence 2 24567899999999999874
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=8.1e-16 Score=156.80 Aligned_cols=135 Identities=21% Similarity=0.338 Sum_probs=105.9
Q ss_pred EeeecCceEEEEEEeCCCcEEEEEEecccch-----hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 717 ILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK-----ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
.||+|+||.||+|.. ++..+++|....... ......+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 379999999999985 667899998643211 11223466788999999998876655444455566778999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
+|+++.+++.... . .++.+++++++++|..+ ++|||+||+||+++ ++.++++|||.++...
T Consensus 80 ~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEGN------D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhcH------H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 9999998875321 0 67889999999999665 99999999999999 7899999999987643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=4e-16 Score=184.68 Aligned_cols=119 Identities=34% Similarity=0.476 Sum_probs=107.1
Q ss_pred cccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeeccc
Q 043136 510 SIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVS 589 (902)
Q Consensus 510 ~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls 589 (902)
.++.|+|++|.+.|.+|.+++.+++|+.|+|++|+|+|.+|..++.+++|+.|||++|+++|.+|..+.+|++|++|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcccccCCCCCCc-CcCCCCCcccCCcccCCCCcCCCCC
Q 043136 590 YNLLTGPIPASGTI-FPNLHPSSFIGNEGLCGRVLTKPCP 628 (902)
Q Consensus 590 ~N~l~g~ip~~~~~-~~~~~~~~~~gn~~lcg~~~~~~c~ 628 (902)
+|+++|.+|..... ...+....+.||+++||.|....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 99999999976432 1122456789999999988667774
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=5.9e-15 Score=142.90 Aligned_cols=134 Identities=25% Similarity=0.261 Sum_probs=110.3
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc--CeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| ..+++++++....+..+++|||++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 3679999999999998744 7899998744322 3457789999999976 589999998888888999999998
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
++.+..+ +......++.+++++++++|.....+++|+|+||+||+++.++.++++|||.++.
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8766543 2344557889999999999976445799999999999999989999999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.7e-15 Score=147.96 Aligned_cols=140 Identities=21% Similarity=0.198 Sum_probs=97.3
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHH---------------------HHHHHHHHHhcCCcC--ee
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRR---------------------GVLAEVDVLGNVRHR--NI 771 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~---------------------~~~~Ei~il~~l~h~--nI 771 (902)
.+.||+|+||+||+|...+++.||||++............ ....|.+.+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999998878999999987543221111111 113566666665433 34
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHH-HHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEE
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDD-LLHAKNKGENLVADWVTRYKIALGVAQGICYLHH-DCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlKp~NIL 849 (902)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. . +|+|||+||+||+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEE
Confidence 555543 23589999999854321 111110 00 3455789999999999996 5 4999999999999
Q ss_pred EcCCCCEEEeecccceeccC
Q 043136 850 LDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~ 869 (902)
++ ++.++++|||.|.....
T Consensus 148 i~-~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred EE-CCcEEEEECcccccccC
Confidence 99 88999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.2e-14 Score=146.06 Aligned_cols=140 Identities=21% Similarity=0.255 Sum_probs=105.4
Q ss_pred CcEee-ecCceEEEEEEeCCCcEEEEEEecccch----------hhHHHHHHHHHHHHHHhcCCcCee--EeEEeEEecC
Q 043136 715 DKILG-MGSTGTVYKAEMPGGEIIAVKKLWGKHK----------ENIRRRRGVLAEVDVLGNVRHRNI--VRLLGCCSNR 781 (902)
Q Consensus 715 ~~~iG-~G~~g~Vy~~~~~~~~~vavK~i~~~~~----------~~~~~~~~~~~Ei~il~~l~h~nI--v~l~~~~~~~ 781 (902)
...|| .|+.|+||.++.. +..+|+|.+..... ........+.+|++++.+++|++| ++.+++...+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46788 8999999999874 67899998743211 011234567889999999988774 6777765432
Q ss_pred C----eeEEEEEccCC-CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 782 E----CTMLLYEYMPN-GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 782 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
. ..++|||+++| .+|.+++... ..+. ..+.++++++.++|..+ |+|||+||+|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCE
Confidence 2 23599999997 6998887532 1222 23578999999999666 9999999999999999999
Q ss_pred EEeecccceecc
Q 043136 857 RVADFGVAKLIQ 868 (902)
Q Consensus 857 kl~DFGla~~~~ 868 (902)
+|+|||.++...
T Consensus 182 ~LIDfg~~~~~~ 193 (239)
T PRK01723 182 WLIDFDRGELRT 193 (239)
T ss_pred EEEECCCcccCC
Confidence 999999987654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.1e-16 Score=169.61 Aligned_cols=169 Identities=28% Similarity=0.405 Sum_probs=105.4
Q ss_pred EEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccc
Q 043136 394 KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENS 473 (902)
Q Consensus 394 ~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 473 (902)
..+|+.|++. ++|..+..+..|+.+.|..|.+. .+|..++++..|++|||+.|+++ ..|..++.|+ |+.|-+++|+
T Consensus 79 ~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNk 154 (722)
T KOG0532|consen 79 FADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNK 154 (722)
T ss_pred hhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCc
Confidence 3444444444 56666666677777777777776 67777777777777777777777 5666666665 7777777777
Q ss_pred cCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCC
Q 043136 474 FQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEI 553 (902)
Q Consensus 474 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 553 (902)
+ +.+|..++.++.|..||.+.|.+...++...++.+|+.|.+..|++. .+|.+++ .-.|..||+|+|+++ .||-.|
T Consensus 155 l-~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp~El~-~LpLi~lDfScNkis-~iPv~f 230 (722)
T KOG0532|consen 155 L-TSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLPEELC-SLPLIRLDFSCNKIS-YLPVDF 230 (722)
T ss_pred c-ccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCCHHHh-CCceeeeecccCcee-ecchhh
Confidence 7 36777777667777777777776644333444555555555555553 4455555 233555555555555 455555
Q ss_pred CCCCcccEEEccCCccc
Q 043136 554 SGLPSITDVDLSHNFLT 570 (902)
Q Consensus 554 ~~l~~L~~L~Ls~N~l~ 570 (902)
..|+.|++|-|.+|.|.
T Consensus 231 r~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 231 RKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhheeeeeccCCCC
Confidence 55555555555555555
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.52 E-value=7.8e-15 Score=151.86 Aligned_cols=176 Identities=16% Similarity=0.222 Sum_probs=132.8
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-~~ 783 (902)
+......+-+|.||+||+|.+. +.+.|.+|.++.. .++-....+..|...+..+.|||+..+.+++.++ +.
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 3344567889999999999443 3456777776332 2334556788899999999999999999988654 56
Q ss_pred eEEEEEccCCCCHHHHHHhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNK---GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
.++++.++.-|+|..++...+. .........+...++.|++.|++|||.++ |||.||..+|.+||+..++|++|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence 7888999988999999974332 12234666777889999999999999665 99999999999999999999999
Q ss_pred cccceeccCCCCc---eeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
=.++|..-+.... ...-....||+||.++..
T Consensus 440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~ 473 (563)
T KOG1024|consen 440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS 473 (563)
T ss_pred chhccccCcccccccCCCCCCcccccCHHHHhhh
Confidence 9998865332211 112234579999998654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=169.83 Aligned_cols=175 Identities=23% Similarity=0.283 Sum_probs=130.7
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecc---cchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWG---KHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~---~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
...+++|.|++|.|+.+.. ...+.++.|.... ...........+..|..+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3467899999998887743 3344455554421 11111122222667888888899999988777766655555559
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|||++ ||..++.... .+....+-.++.|+..|++|+|.+| |.|||+|++|+++...|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 9999987642 2444556678999999999999766 9999999999999999999999999988764
Q ss_pred CC-----CCceeeccccCccccCcccccccCce
Q 043136 869 SD-----ESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 869 ~~-----~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
-+ ......+|+..|+|||++.+...+|-
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr 504 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPR 504 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcc
Confidence 22 22456889999999999999887764
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.3e-15 Score=166.44 Aligned_cols=169 Identities=25% Similarity=0.281 Sum_probs=132.8
Q ss_pred eeecCceEEEEEEe----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccC
Q 043136 718 LGMGSTGTVYKAEM----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 718 iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+|+|+||.|+.++. ..+..+|+|...+........ .....|..++..++ ||.+|++...++.+...+++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~-~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDR-THTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccc-cccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 69999999998742 346778888876544332211 13456788888886 9999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
||++...+.... ..++.....+...++-|++++|..+ |+|||+|++||+++.+|++|+.|||.++...+.+.
T Consensus 81 gg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 999988776433 2444555566777888999999655 99999999999999999999999999987654433
Q ss_pred ceeeccccCccccCcccccccCceee
Q 043136 873 MSVIAGSYGYIAPGTFCFCFSVPFCW 898 (902)
Q Consensus 873 ~~~~~Gt~~y~APE~~~~~~~~p~~~ 898 (902)
. |||..|||||++.|....+-.|
T Consensus 153 ~---cgt~eymApEI~~gh~~a~D~w 175 (612)
T KOG0603|consen 153 A---CGTYEYRAPEIINGHLSAADWW 175 (612)
T ss_pred c---ccchhhhhhHhhhccCCcccch
Confidence 3 9999999999999655544444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.7e-14 Score=177.74 Aligned_cols=119 Identities=13% Similarity=0.166 Sum_probs=86.5
Q ss_pred CCc-CeeEeEEeEE-------ecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043136 766 VRH-RNIVRLLGCC-------SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837 (902)
Q Consensus 766 l~h-~nIv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 837 (902)
++| +||+++++++ ...+.++.+|||+ +++|.+++.... ..+++..++.++.||++||+|||+++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 345 5777777776 2234577888987 679999996432 24788889999999999999999666
Q ss_pred eEEcCCCCCCEEEcC-------------------CCCEEEeecccceeccCCC-----------------CceeeccccC
Q 043136 838 IVHRDLKPSNILLDG-------------------EMEARVADFGVAKLIQSDE-----------------SMSVIAGSYG 881 (902)
Q Consensus 838 ivHrDlKp~NILl~~-------------------~~~~kl~DFGla~~~~~~~-----------------~~~~~~Gt~~ 881 (902)
||||||||+|||++. ++.+|++|||+++...... .....+||++
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 4456677777765421100 0112468999
Q ss_pred ccccCcccccc
Q 043136 882 YIAPGTFCFCF 892 (902)
Q Consensus 882 y~APE~~~~~~ 892 (902)
|||||++.+..
T Consensus 181 Y~APE~~~~~~ 191 (793)
T PLN00181 181 YTSPEEDNGSS 191 (793)
T ss_pred eEChhhhccCC
Confidence 99999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.2e-14 Score=165.69 Aligned_cols=167 Identities=22% Similarity=0.238 Sum_probs=124.8
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC---cCeeEeEEeEEecCCeeEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR---HRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~~~~~lv 787 (902)
.+-+++.||+|+||.||+|...+|+.||+|.-.+...-. |.--.+++.+++ -+-|..+...+...+..++|
T Consensus 699 ~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv 772 (974)
T KOG1166|consen 699 KFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLV 772 (974)
T ss_pred eEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcceee
Confidence 445678999999999999988789999999864322111 111122233333 23444455555667778899
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-------CCCEEEee
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-------EMEARVAD 860 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-------~~~~kl~D 860 (902)
+||.+.|+|.+++.. ...+++...+.++.|+++.+++||.++ |||+||||+|+++.. ..-++|+|
T Consensus 773 ~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 773 SEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 999999999999973 235777888899999999999999766 999999999999942 23589999
Q ss_pred cccceec---cCCCCceeeccccCccccCccccc
Q 043136 861 FGVAKLI---QSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~---~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||.+--+ .++......++|-.+-.+|+..|.
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence 9998654 344456778889999999988775
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.1e-15 Score=160.36 Aligned_cols=175 Identities=29% Similarity=0.511 Sum_probs=93.9
Q ss_pred ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEE
Q 043136 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203 (902)
Q Consensus 124 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 203 (902)
.++--...||+.|++. .+|..+..+-.|+.+.|+.|.+. .+|..++++..|+.|||+.|+++ ..|..+..|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3444455666666665 45555555555555555555554 34555555555555555555555 3444444443 5555
Q ss_pred EccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 204 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
-+++|+++ .+|..++.+..|..||.+.|+|. .+|..++.+.+|+.|.+..|++. .+|..+..| .|..||+|.|++.
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis 224 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS 224 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee
Confidence 55666555 45555555555555555555555 44555555555555555555555 334444432 2555555555555
Q ss_pred eecCCCCCCcCcCcEEecccCCCc
Q 043136 284 GEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 284 ~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
.+|..|.+|+.|++|-|.+|.+.
T Consensus 225 -~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 225 -YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred -ecchhhhhhhhheeeeeccCCCC
Confidence 45555555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.42 E-value=1.2e-12 Score=148.33 Aligned_cols=153 Identities=21% Similarity=0.290 Sum_probs=103.9
Q ss_pred CHHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHH-------------------------------
Q 043136 703 TADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIR------------------------------- 751 (902)
Q Consensus 703 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~------------------------------- 751 (902)
..++++... ..+.||.|++|+||+|+..+|+.||||+..+.......
T Consensus 112 ~~~~~F~~f--d~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e 189 (437)
T TIGR01982 112 PLEELFAEF--EEKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKE 189 (437)
T ss_pred CHHHHHhhC--CCcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHH
Confidence 344444332 24789999999999999999999999998643211100
Q ss_pred ------HHHHHHHHHHHHhcCC-----cCee--EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHH
Q 043136 752 ------RRRGVLAEVDVLGNVR-----HRNI--VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK 818 (902)
Q Consensus 752 ------~~~~~~~Ei~il~~l~-----h~nI--v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~ 818 (902)
..-++.+|++.+.+++ +++| ++++ .......++||||++|+++.++......+ .+ +.+
T Consensus 190 ~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~--~~~~~~~vLvmE~i~G~~L~~~~~~~~~~----~~---~~~ 260 (437)
T TIGR01982 190 FEKTLRRELDLRREAANASELGENFKNDPGVYVPEVY--WDRTSERVLTMEWIDGIPLSDIAALDEAG----LD---RKA 260 (437)
T ss_pred HHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEe--hhhcCCceEEEEeECCcccccHHHHHhcC----CC---HHH
Confidence 0012455666555552 3333 2333 22344578999999999998876532211 11 235
Q ss_pred HHHHHHH-HHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 819 IALGVAQ-GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 819 i~~qi~~-~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
++.+++. .+..+|..+ ++|+|+||.||+++.++.++++|||++..+.+
T Consensus 261 ia~~~~~~~l~ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 261 LAENLARSFLNQVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHHHHHHHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 6666665 467788655 99999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.9e-13 Score=152.43 Aligned_cols=179 Identities=35% Similarity=0.521 Sum_probs=94.2
Q ss_pred cccceeccccccccCCCchhhhccc-CCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEE
Q 043136 150 RFLRIFNAYSNSFTGPLPLEFVQLN-SLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228 (902)
Q Consensus 150 ~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 228 (902)
+.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..++++++|+.|++++|+++ .+|...+.+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44444444444444 2233333332 5555555555554 33344555555555555555555 3444444555555555
Q ss_pred eeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcc
Q 043136 229 IGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 229 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
+++|+++ .+|........|++|++++|.+. ..+..+.++.++..+.+.+|++. ..+..++.+++++.|++++|+++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence 5555555 34444444445566666666433 33445555566666666666555 224555556666666666666653
Q ss_pred ccCccccccCCCCEEEccCccccccCCh
Q 043136 309 PIPASLASLKGLTRLSLMNNVLFGEIPQ 336 (902)
Q Consensus 309 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (902)
++. +..+.+++.|++++|.+....|.
T Consensus 270 -i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 270 -ISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -ccc-ccccCccCEEeccCccccccchh
Confidence 222 56666666666666666554444
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.2e-13 Score=153.18 Aligned_cols=179 Identities=39% Similarity=0.593 Sum_probs=85.1
Q ss_pred CCCCEEEccCCCccCCCCccccCCC-CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEe
Q 043136 198 SSLRFLDLAGNSLTGSLPPQLGLLT-QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLL 276 (902)
Q Consensus 198 ~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 276 (902)
+.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.++.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 33444444444444 3333333332 4444444444444 23333444444444444444444 2333333444455555
Q ss_pred cCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecc
Q 043136 277 LFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356 (902)
Q Consensus 277 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 356 (902)
+++|+++ .+|........|++|++++|++. ..+..+.++.++..+.+.+|++. .++..++.++++++|++++|+++.
T Consensus 193 ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~~ 269 (394)
T COG4886 193 LSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269 (394)
T ss_pred ccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceeccccccccc
Confidence 5555554 33333333344555555555322 24444555555555555555543 224445555556666666666654
Q ss_pred ccCccccCCCceeEEEecCCcccCCCCC
Q 043136 357 VLPQKLGSNGKLLTVDVSSNSLTGPIPP 384 (902)
Q Consensus 357 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~ 384 (902)
..+ ++...+++.|++++|.++...|.
T Consensus 270 i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 270 ISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ccc--ccccCccCEEeccCccccccchh
Confidence 333 55566666666666666654443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.6e-12 Score=133.81 Aligned_cols=117 Identities=26% Similarity=0.354 Sum_probs=86.5
Q ss_pred CcCeeEeEEeEEec---------------------------CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHH
Q 043136 767 RHRNIVRLLGCCSN---------------------------RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI 819 (902)
Q Consensus 767 ~h~nIv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i 819 (902)
+|||||++.++|.+ ....|+||..++ .+|.+++-.+. .+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC------CchHHHHHH
Confidence 59999999877632 236799999885 58999886542 334555678
Q ss_pred HHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCCC--CEEEeecccceeccCC-------CCceeeccccCccccCcc
Q 043136 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILL--DGEM--EARVADFGVAKLIQSD-------ESMSVIAGSYGYIAPGTF 888 (902)
Q Consensus 820 ~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl--~~~~--~~kl~DFGla~~~~~~-------~~~~~~~Gt~~y~APE~~ 888 (902)
..|+++|+.|||.++ |.|||+|++|||+ |+|+ .+.|+|||++-.-+.. .......|...-||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999766 9999999999999 4444 4789999987532210 111234577789999999
Q ss_pred ccccc
Q 043136 889 CFCFS 893 (902)
Q Consensus 889 ~~~~~ 893 (902)
...+|
T Consensus 424 ta~PG 428 (598)
T KOG4158|consen 424 TAVPG 428 (598)
T ss_pred hcCCC
Confidence 76654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.2e-12 Score=144.42 Aligned_cols=155 Identities=18% Similarity=0.222 Sum_probs=95.8
Q ss_pred CHHHHHHHhccCCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhH-------------------------------
Q 043136 703 TADDVLECLSMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENI------------------------------- 750 (902)
Q Consensus 703 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~------------------------------- 750 (902)
..++++..... +.||.|++|+||+|+..+ |+.||||+..+......
T Consensus 114 ~~~~~F~~fd~--~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~ 191 (537)
T PRK04750 114 PVEEWFDDFDI--KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVA 191 (537)
T ss_pred CHHHHHHhcCh--hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHH
Confidence 44555544332 789999999999999877 99999999865421110
Q ss_pred HHHH------HHHHHHHHHhcCC----cCeeEeEEeEEe-cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHH
Q 043136 751 RRRR------GVLAEVDVLGNVR----HRNIVRLLGCCS-NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI 819 (902)
Q Consensus 751 ~~~~------~~~~Ei~il~~l~----h~nIv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i 819 (902)
...+ ++.+|+..+.+++ +...+.+-.++. .....++||||++|+.+.++-.-...+ .+. ..+
T Consensus 192 e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g----~d~---~~l 264 (537)
T PRK04750 192 EFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG----TDM---KLL 264 (537)
T ss_pred HHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC----CCH---HHH
Confidence 0111 2344555544442 333333333332 245678999999999998753211111 111 112
Q ss_pred HHHHHHH-HHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEeecccceeccC
Q 043136 820 ALGVAQG-ICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVADFGVAKLIQS 869 (902)
Q Consensus 820 ~~qi~~~-L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DFGla~~~~~ 869 (902)
+...++. +..++.. +++|+|+||.||+++.++ +++++|||++..+.+
T Consensus 265 a~~~v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 265 AERGVEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2222221 2333434 499999999999999988 999999999987643
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.6e-11 Score=127.04 Aligned_cols=169 Identities=20% Similarity=0.257 Sum_probs=107.8
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC----------cCeeEeEEeEEe----
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR----------HRNIVRLLGCCS---- 779 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~----------h~nIv~l~~~~~---- 779 (902)
.+.||.|+++.||.+++. +++.+|+|.............+++.+|.-....+. |-.++..++...
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 478999999999999775 58999999987555444455666666665554432 223333333221
Q ss_pred -----cC---Ce-----eEEEEEccCCCCHHHHHHh---hccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043136 780 -----NR---EC-----TMLLYEYMPNGNLDDLLHA---KNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDL 843 (902)
Q Consensus 780 -----~~---~~-----~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 843 (902)
.. .. .+++|+-+ .+||.+++.. .... ........+..+..|+++.++++|+.| +||+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 11 12 25678877 5699888653 2211 234556667788899999999999777 999999
Q ss_pred CCCCEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 844 KPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 844 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
||+|++++.+|.++++||+....... .......+..|.+||...-
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~~ 216 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELESC 216 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhhh
Confidence 99999999999999999998776432 1221344577999997643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.8e-11 Score=118.86 Aligned_cols=131 Identities=21% Similarity=0.157 Sum_probs=94.5
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe-eEeEEeEEecCCeeEEEEEccCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN-IVRLLGCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n-Iv~l~~~~~~~~~~~lv~e~~~~g 794 (902)
+.++.|.++.||+++.. ++.|++|....... ....+.+|+++++.+.+.. +++++.+.. ...++||||++|.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~ 76 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGS 76 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCC
Confidence 56899999999999874 77899998743321 1223467888888875443 455665543 3357999999998
Q ss_pred CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 795 NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 795 sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
++.+. . .. ...+..+++++++.||..+ ...++|+|++|.||+++ ++.++++|||.+...
T Consensus 77 ~l~~~----~-----~~----~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 77 ELLTE----D-----FS----DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred ccccc----c-----cc----CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 77542 0 00 1245678999999999764 22369999999999999 668999999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=2.2e-12 Score=132.97 Aligned_cols=241 Identities=22% Similarity=0.278 Sum_probs=134.9
Q ss_pred CEEEEEcCCCCccc----ccCccccCCCCCCEEEccC---CCCcccCch-------hhhccCCCcEEEccCCCCCCCCCc
Q 043136 79 QITSLDLSRRSLSG----PIPPEIRYLTSLTHLNLSA---NAFDGPLQP-------AILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 79 ~v~~L~L~~~~l~g----~~~~~~~~l~~L~~L~Ls~---n~l~~~~~~-------~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
.++.|+|++|.+.- .+.+.+.+.++|+..++|+ -+....+|+ ++..+++|++||||.|.|....+.
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~~ 110 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGIR 110 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccchH
Confidence 68888888888753 3556677788888888875 233333443 334566888888888887655544
Q ss_pred cc----ccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCC----CCc
Q 043136 145 GI----SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS----LPP 216 (902)
Q Consensus 145 ~l----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 216 (902)
.| .++..|++|+|.+|.+.-.--..++. .|..|. .|+ -...-+.|+.+..++|++... +..
T Consensus 111 ~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ga~~~A~ 179 (382)
T KOG1909|consen 111 GLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENGGATALAE 179 (382)
T ss_pred HHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccccHHHHHH
Confidence 43 34455666666655543111111111 111111 111 122335677777777777521 223
Q ss_pred cccCCCCCcEEEeeCcccCCC----CChhccCCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCccceecCC
Q 043136 217 QLGLLTQLERIEIGYNNLQGE----VPVEFASLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGEIPV 288 (902)
Q Consensus 217 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~ 288 (902)
.|...+.|+.+.+.+|.|... +-..|..+++|+.|||.+|-++.. +...+..+++|++|+++++.+...-..
T Consensus 180 ~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~ 259 (382)
T KOG1909|consen 180 AFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAI 259 (382)
T ss_pred HHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHH
Confidence 455566777777777776421 123466677777777777776532 224455666677777777766543322
Q ss_pred CC-----CCcCcCcEEecccCCCcc----ccCccccccCCCCEEEccCccc
Q 043136 289 SY-----GNLQALQVLDLSDNQLSG----PIPASLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 289 ~~-----~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l 330 (902)
.| ...++|++|.|.+|.|+. .+.......+.|..|+|++|.+
T Consensus 260 a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 260 AFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 22 124566666666666642 1222334455566666666665
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.2e-12 Score=146.20 Aligned_cols=169 Identities=21% Similarity=0.236 Sum_probs=127.6
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccc-hhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKH-KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~-~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
..++.+|.+.|=+|.+|+++.|. |+||++.++. ...-+..++..+|++ ...++|||++.+..+-......|+|-+|.
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv 103 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV 103 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence 44678999999999999988887 8889886554 333344444555666 55668999999999888888899999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec--cC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI--QS 869 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~--~~ 869 (902)
. -+|+|.+..+. .+...+.+-|+.|++.|+..+|..+ |+|+|||.+|||++.=.-+.++||..-+.. .+
T Consensus 104 k-hnLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 104 K-HNLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred h-hhhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 5 48999886543 3556667789999999999999666 999999999999998888999999765432 11
Q ss_pred CC--Cc----eeeccccCccccCcccccc
Q 043136 870 DE--SM----SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~--~~----~~~~Gt~~y~APE~~~~~~ 892 (902)
+. .. .+...-..|.|||.|....
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~ 203 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSAL 203 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccc
Confidence 11 11 1112234699999997654
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.13 E-value=8.9e-12 Score=131.83 Aligned_cols=200 Identities=23% Similarity=0.184 Sum_probs=112.4
Q ss_pred EEccCCCCcccCchhh----hccCCCcEEEccCCCCCCCCC-cccccccccceeccccccccCCCc--hhhhcccCCcEE
Q 043136 107 LNLSANAFDGPLQPAI----LELTKLRTIDISHNSFNSTFP-PGISKLRFLRIFNAYSNSFTGPLP--LEFVQLNSLQQL 179 (902)
Q Consensus 107 L~Ls~n~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L 179 (902)
+.+++-++.+..-+.+ .++.+|+...|.+........ .....+++++.||||.|-|....| .....|++|+.|
T Consensus 98 ~si~nK~vE~iGfDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~L 177 (505)
T KOG3207|consen 98 LSISNKQVEFIGFDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENL 177 (505)
T ss_pred hhhcCceeEEecHHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhc
Confidence 4444444443332333 356777777777776653221 245667777777777776664332 245567888888
Q ss_pred eccCccCcCCCCccc-CCCCCCCEEEccCCCccCC-CCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCcc
Q 043136 180 NLGGSYFDGEIPSDY-RNLSSLRFLDLAGNSLTGS-LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257 (902)
Q Consensus 180 ~L~~N~l~~~~p~~~-~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 257 (902)
+|+.|++........ ..++.|+.|.|+.|.|+.. +-.....+++|+.|+|.+|...+.......-+..|+.|||++|+
T Consensus 178 Nls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~ 257 (505)
T KOG3207|consen 178 NLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNN 257 (505)
T ss_pred ccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCc
Confidence 888888763332221 3456777777777777621 11223456677777777775333333344445666777777776
Q ss_pred CcccCC--ccccCCCCccEEecCCCccceecCCC------CCCcCcCcEEecccCCCc
Q 043136 258 LSGTLP--SEISNLTKLEMLLLFKNHFTGEIPVS------YGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 258 l~~~~p--~~~~~l~~L~~L~L~~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~ 307 (902)
+-. .+ ...+.++.|+.|+++.+.+...--.. ...+++|++|+++.|++.
T Consensus 258 li~-~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 258 LID-FDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR 314 (505)
T ss_pred ccc-cccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence 652 22 34455666666666666665322111 123455555555555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.9e-11 Score=140.74 Aligned_cols=137 Identities=27% Similarity=0.405 Sum_probs=95.4
Q ss_pred CcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.|.|..|+||.||.++++. .+.+|+|+- ++.. +.+- ++.....|.||
T Consensus 88 IklisngAygavylvrh~~trqrfa~kiN-kq~l--------ilRn--ilt~a~npfvv--------------------- 135 (1205)
T KOG0606|consen 88 IKLISNGAYGAVYLVRHKETRQRFAMKIN-KQNL--------ILRN--ILTFAGNPFVV--------------------- 135 (1205)
T ss_pred eEeeccCCCCceeeeeccccccchhhccc-ccch--------hhhc--cccccCCccee---------------------
Confidence 4789999999999997754 677888432 1111 1111 44444556555
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-----
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ----- 868 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~----- 868 (902)
||-.+.++.-+. .+ .+++.+++|+|+.+ |+|||+||+|.+|+.-|++|+.|||+.+..-
T Consensus 136 gDc~tllk~~g~-----lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 GDCATLLKNIGP-----LP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred chhhhhcccCCC-----Cc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 454555543211 11 12377999999655 9999999999999999999999999876431
Q ss_pred ---CC--------CCceeeccccCccccCcc-cccccCceeee
Q 043136 869 ---SD--------ESMSVIAGSYGYIAPGTF-CFCFSVPFCWV 899 (902)
Q Consensus 869 ---~~--------~~~~~~~Gt~~y~APE~~-~~~~~~p~~~~ 899 (902)
++ -.....||||.|+|||++ +.+||.|+||.
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdww 242 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWW 242 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHH
Confidence 00 012446899999999998 66899999994
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.5e-11 Score=123.64 Aligned_cols=129 Identities=28% Similarity=0.328 Sum_probs=57.9
Q ss_pred CCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEec
Q 043136 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277 (902)
Q Consensus 198 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 277 (902)
..|++||||+|.++ .+..+..-++.++.|++|+|.|... ..++.+++|+.||||+|.++ .+..+-..+-+.++|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 34444444444444 3334444444444555555544421 12444445555555555444 22223334444455555
Q ss_pred CCCccceecCCCCCCcCcCcEEecccCCCccc-cCccccccCCCCEEEccCccccc
Q 043136 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP-IPASLASLKGLTRLSLMNNVLFG 332 (902)
Q Consensus 278 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~ 332 (902)
+.|.|... ..++.+-+|..||+++|+|... --..+++++-|+.+.|.+|.+.+
T Consensus 360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 55544321 2234444555555555555321 11244555555555555555543
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.11 E-value=9.6e-10 Score=109.35 Aligned_cols=140 Identities=14% Similarity=0.060 Sum_probs=96.8
Q ss_pred cEeeecCceEEEEEEeCC-------CcEEEEEEecccch------h----h-------------HHHHHHHHHHHHHHhc
Q 043136 716 KILGMGSTGTVYKAEMPG-------GEIIAVKKLWGKHK------E----N-------------IRRRRGVLAEVDVLGN 765 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-------~~~vavK~i~~~~~------~----~-------------~~~~~~~~~Ei~il~~ 765 (902)
..||.|--+.||.|...+ +..+|||+...... . . ........+|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 47899998752110 0 0 0111223489999999
Q ss_pred CC--cCeeEeEEeEEecCCeeEEEEEccCCCCHHH-HHHhhccCCCcccCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEc
Q 043136 766 VR--HRNIVRLLGCCSNRECTMLLYEYMPNGNLDD-LLHAKNKGENLVADWVTRYKIALGVAQGICYL-HHDCDPVIVHR 841 (902)
Q Consensus 766 l~--h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L-H~~~~~~ivHr 841 (902)
+. .-.+++.+++ ...++||||+.+..+.. .++.. ..+......+..+++.++..+ |..+ +||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 84 3567777765 45789999996643321 22211 122334456778999999999 6444 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 842 DLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 842 DlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++.||+++ ++.++++|||.|.....
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 9999999997 46899999999877643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-11 Score=140.71 Aligned_cols=107 Identities=30% Similarity=0.340 Sum_probs=47.7
Q ss_pred ccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCc
Q 043136 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ 297 (902)
Q Consensus 218 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 297 (902)
+..+++|+.|++..|+|..+ ...+..+++|++|+|++|.|+... .+..++.|+.|++++|.|+.. ..+..++.|+
T Consensus 91 l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~ 165 (414)
T KOG0531|consen 91 LSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNLSGNLISDI--SGLESLKSLK 165 (414)
T ss_pred cccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhheeccCcchhc--cCCccchhhh
Confidence 33344444444444444422 111344455555555555554332 233444455555555555422 2233355555
Q ss_pred EEecccCCCccccC-ccccccCCCCEEEccCccc
Q 043136 298 VLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 298 ~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l 330 (902)
.+++++|++....+ . ...+.+++.+++.+|.+
T Consensus 166 ~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 166 LLDLSYNRIVDIENDE-LSELISLEELDLGGNSI 198 (414)
T ss_pred cccCCcchhhhhhhhh-hhhccchHHHhccCCch
Confidence 55555555543222 1 23444455555555544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.4e-11 Score=119.29 Aligned_cols=165 Identities=25% Similarity=0.409 Sum_probs=124.8
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGN 795 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gs 795 (902)
.+|.+...|+.|+|++++. .+++|++..+. ...+..++|..|.-.++-+.||||+.+++.|.......++..||+.|+
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 3578888999999998554 45567663322 233344567888888888899999999999999999999999999999
Q ss_pred HHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEe--ecccceeccCCCCc
Q 043136 796 LDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA--DFGVAKLIQSDESM 873 (902)
Q Consensus 796 L~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~--DFGla~~~~~~~~~ 873 (902)
|+.++++. .....+..+.++++.+||+|++|||+. ++-|..--+.+..+++|++.+++|. |--++. +.
T Consensus 274 lynvlhe~---t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf--qe---- 343 (448)
T KOG0195|consen 274 LYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QE---- 343 (448)
T ss_pred HHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--ec----
Confidence 99999864 345677788899999999999999987 3434455688899999999887764 322221 11
Q ss_pred eeeccccCccccCcccccc
Q 043136 874 SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~ 892 (902)
....-.|.||+||.++...
T Consensus 344 ~gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 344 VGRAYSPAWMSPEALQRKP 362 (448)
T ss_pred cccccCcccCCHHHHhcCc
Confidence 1123368899999997654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-11 Score=140.20 Aligned_cols=219 Identities=26% Similarity=0.348 Sum_probs=122.6
Q ss_pred hccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCE
Q 043136 123 LELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRF 202 (902)
Q Consensus 123 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 202 (902)
..+..++.+++..|.+.. +-..+..++.|+.|++.+|+|..... .+..+++|++|+|++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhccc-chhhhhcchheeccccccccccc--hhhccchhh
Confidence 345555555566665543 22335556666666666666654322 25556667777777777664322 345556777
Q ss_pred EEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCC-hhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCc
Q 043136 203 LDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP-VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNH 281 (902)
Q Consensus 203 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 281 (902)
|++++|.++. + ..+..++.|+.+++++|++....+ . ...+.+++.+++.+|.+... ..+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~-~-~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISD-I-SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchh-c-cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 7777777762 2 334556677777777777764433 2 45566677777777766522 233344455555666776
Q ss_pred cceecCCCCCCcC--cCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceec
Q 043136 282 FTGEIPVSYGNLQ--ALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355 (902)
Q Consensus 282 l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 355 (902)
++..-+ +..+. +|+.+++++|++. .++..+..+..+..|++.+|++... ..+.....+..+.+..|.+.
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhc
Confidence 663322 11122 2677777777765 3334555666677777777666432 12334445555555555554
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.4e-11 Score=128.64 Aligned_cols=210 Identities=21% Similarity=0.237 Sum_probs=134.7
Q ss_pred cCCCCCCEEEccCCCCcccCc-hhhhccCCCcEEEccCCCCCCCCC--cccccccccceeccccccccCCCchh-hhccc
Q 043136 99 RYLTSLTHLNLSANAFDGPLQ-PAILELTKLRTIDISHNSFNSTFP--PGISKLRFLRIFNAYSNSFTGPLPLE-FVQLN 174 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~ 174 (902)
+++.+|+...|.+..+..... .....|++++.||||+|-|....| .-...|++|+.|+|+.|++.....+. -..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 456777777777766653221 355667777777777776664322 22456777777777777766433322 22456
Q ss_pred CCcEEeccCccCcCC-CCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC-ChhccCCCCCCEEE
Q 043136 175 SLQQLNLGGSYFDGE-IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV-PVEFASLVNLKYMD 252 (902)
Q Consensus 175 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~ 252 (902)
.|+.|.|+.+.++.. +-.....+++|+.|+|..|..-+.-......+..|++|||++|++-... -...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 778888888777621 1122345678888888888533344444556777888888888876322 14567788888888
Q ss_pred ccCccCccc-CCcc-----ccCCCCccEEecCCCccceec-CCCCCCcCcCcEEecccCCCcc
Q 043136 253 ISACNLSGT-LPSE-----ISNLTKLEMLLLFKNHFTGEI-PVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 253 Ls~N~l~~~-~p~~-----~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
++.+.++.. .|+. ...+++|++|+++.|++...- -..+..+.+|+.|....|.++.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 888887743 2332 356788999999999885321 1234456778888888888863
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-09 Score=103.93 Aligned_cols=136 Identities=24% Similarity=0.349 Sum_probs=97.7
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEE-ecccc----hhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKK-LWGKH----KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~-i~~~~----~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
..+++|+-+.||.+.+.+ ..+++|. +.+.. .+..-..++..+|++++.+++--.|...+=+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997744 3355553 22221 12222345677899999988654444433344556667899999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
++|..|.+.+... ...+++.+-.-+.-||..+ |||+|+.++||++..+. +.++|||++..-.
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9998888888643 1356677788888899666 99999999999998775 9999999998643
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.04 E-value=6e-11 Score=119.28 Aligned_cols=128 Identities=24% Similarity=0.267 Sum_probs=58.6
Q ss_pred CCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEc
Q 043136 246 VNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSL 325 (902)
Q Consensus 246 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 325 (902)
..|+++|||+|.|+ .+.+...-+++++.|++|+|.|... ..+..+++|+.||||+|.++ .+..+-..+-+++.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 34555555555554 3344444445555555555555422 12444555555555555554 23333344445555555
Q ss_pred cCccccccCChhhhhccccceEEecCceecccc-CccccCCCceeEEEecCCccc
Q 043136 326 MNNVLFGEIPQDIELLADLDTLLLWNNHLTGVL-PQKLGSNGKLLTVDVSSNSLT 379 (902)
Q Consensus 326 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-~~~~~~~~~L~~L~Ls~N~l~ 379 (902)
+.|.+.. -..++.+-+|..||+++|+|.... -..+++++.|+.+.|.+|.+.
T Consensus 360 a~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~ 412 (490)
T KOG1259|consen 360 AQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLA 412 (490)
T ss_pred hhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcc
Confidence 5554421 123344445555555555554211 123444444444444444444
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.6e-11 Score=126.68 Aligned_cols=196 Identities=23% Similarity=0.307 Sum_probs=97.5
Q ss_pred cCccccCCCCCCEEEccCCCCccc----CchhhhccCCCcEEEccCCCCCC----CCCcccccccccceeccccccccCC
Q 043136 94 IPPEIRYLTSLTHLNLSANAFDGP----LQPAILELTKLRTIDISHNSFNS----TFPPGISKLRFLRIFNAYSNSFTGP 165 (902)
Q Consensus 94 ~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~ 165 (902)
+-+.+..+..+++|+||+|.|... +...+.+.++|+..++|+= ++| .+|+.+..|
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~-ftGR~~~Ei~e~L~~l---------------- 84 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDM-FTGRLKDEIPEALKML---------------- 84 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhh-hcCCcHHHHHHHHHHH----------------
Confidence 445677788899999999988643 3445667778888888763 333 333332111
Q ss_pred CchhhhcccCCcEEeccCccCcCCCCcc----cCCCCCCCEEEccCCCccCC-------------CCccccCCCCCcEEE
Q 043136 166 LPLEFVQLNSLQQLNLGGSYFDGEIPSD----YRNLSSLRFLDLAGNSLTGS-------------LPPQLGLLTQLERIE 228 (902)
Q Consensus 166 ~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~-------------~p~~~~~l~~L~~L~ 228 (902)
...+..++.|++||||.|-|.-.-+.. +.++..|++|.|.+|.+.-. ...-.+.-++|+++.
T Consensus 85 -~~aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i 163 (382)
T KOG1909|consen 85 -SKALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFI 163 (382)
T ss_pred -HHHHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEE
Confidence 112333345555555555543222221 23345555566655555410 011122335566666
Q ss_pred eeCcccCCCC----ChhccCCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCcccee----cCCCCCCcCcC
Q 043136 229 IGYNNLQGEV----PVEFASLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGE----IPVSYGNLQAL 296 (902)
Q Consensus 229 L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L 296 (902)
.++|++.... ...|...+.|+.+.++.|.|... +-..|..++.|+.|||.+|-|+.. +...+..+++|
T Consensus 164 ~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L 243 (382)
T KOG1909|consen 164 CGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHL 243 (382)
T ss_pred eeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchh
Confidence 6666664321 12344555666666666655311 112344555555555555554421 11223334444
Q ss_pred cEEecccCCCc
Q 043136 297 QVLDLSDNQLS 307 (902)
Q Consensus 297 ~~L~Ls~N~l~ 307 (902)
++|+++++.++
T Consensus 244 ~El~l~dcll~ 254 (382)
T KOG1909|consen 244 RELNLGDCLLE 254 (382)
T ss_pred eeecccccccc
Confidence 45555544443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.02 E-value=2e-10 Score=111.96 Aligned_cols=110 Identities=25% Similarity=0.286 Sum_probs=30.1
Q ss_pred ccCCCCCCEEEccCCCCcccCchhhh-ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCC
Q 043136 98 IRYLTSLTHLNLSANAFDGPLQPAIL-ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176 (902)
Q Consensus 98 ~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 176 (902)
+.+...+++|+|++|.|+.+ +.++ .+.+|+.||||+|.|+.. +.+..++.|+.|++++|+|+...+.....+++|
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L 90 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNL 90 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT-
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcC
Confidence 44455677777777777743 2344 467777777777777643 245666667777777777664332222356667
Q ss_pred cEEeccCccCcCCCC-cccCCCCCCCEEEccCCCcc
Q 043136 177 QQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 211 (902)
++|+|++|+|...-. ..+..+++|++|+|.+|.++
T Consensus 91 ~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 91 QELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp -EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 777777776653211 22344555555555555554
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.1e-10 Score=111.70 Aligned_cols=106 Identities=28% Similarity=0.428 Sum_probs=22.9
Q ss_pred CCCCCEEEccCCCccCCCCcccc-CCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccc-cCCCCccE
Q 043136 197 LSSLRFLDLAGNSLTGSLPPQLG-LLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTKLEM 274 (902)
Q Consensus 197 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 274 (902)
..++++|+|++|+|+. + +.++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+|+. ++..+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--E
T ss_pred cccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCE
Confidence 3345555555555542 2 1233 344555555555555422 1 24445555555555555552 22222 23455555
Q ss_pred EecCCCccceecC-CCCCCcCcCcEEecccCCCc
Q 043136 275 LLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 275 L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 307 (902)
|+|++|+|...-. ..+..+++|++|+|.+|.++
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 5555555542111 12333444445555544443
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.99 E-value=7.8e-10 Score=110.12 Aligned_cols=82 Identities=17% Similarity=0.174 Sum_probs=67.8
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCc
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 873 (902)
|+|.++++.++. .+++..++.|+.|++.||+|||+++ ||+||+++.++.+|+ ||.++......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 689999875432 4788999999999999999999653 999999999999999 99998764432
Q ss_pred eeeccccCccccCcccccccC
Q 043136 874 SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 874 ~~~~Gt~~y~APE~~~~~~~~ 894 (902)
..||+.|||||++.+....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~ 82 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYT 82 (176)
T ss_pred --CCCcccccChHHhcCCCCc
Confidence 2689999999999776543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.3e-09 Score=111.12 Aligned_cols=143 Identities=21% Similarity=0.241 Sum_probs=102.7
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc--CeeEeEEeEEecC---CeeEEEEEc
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVRLLGCCSNR---ECTMLLYEY 790 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--~nIv~l~~~~~~~---~~~~lv~e~ 790 (902)
+.|+.|..+.||+++..+|+.+++|........ .....+.+|+++++.+.+ ..+++++.+.... +..++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 568999999999998766788999987433221 123457789999999865 4467777776654 356899999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC------------------------------------
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC------------------------------------ 834 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------------------------------------ 834 (902)
++|.++.+.+.. ...+......++.++++++.++|+..
T Consensus 82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999877664421 02344445566667777777776420
Q ss_pred -----------------CCCeEEcCCCCCCEEEcC--CCCEEEeeccccee
Q 043136 835 -----------------DPVIVHRDLKPSNILLDG--EMEARVADFGVAKL 866 (902)
Q Consensus 835 -----------------~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~ 866 (902)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.96 E-value=9.5e-09 Score=97.54 Aligned_cols=146 Identities=21% Similarity=0.275 Sum_probs=101.4
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEec-ccc----hhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLW-GKH----KENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~-~~~----~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
...+-+|+-+.|+++.+ .|+...||.=. ++. .+..-.+++..+|++.+.++.--.|.-..=++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 46789999999999987 56666666432 221 2233345677889999998864444333333445555679999
Q ss_pred ccCC-CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEeecccce
Q 043136 790 YMPN-GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVADFGVAK 865 (902)
Q Consensus 790 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~ 865 (902)
|++| .++.+++...-..+ ..+.. ....+++|-+.+.-||..+ |||+|+..+||++.+++ .+.++|||++.
T Consensus 91 ~~~g~~~vk~~i~~~~~~~--~~d~~-~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDE--SEDEG-LAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred eccchhHHHHHHHHHccCc--ccchh-HHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 9976 37888876543321 22222 2467888999999999665 99999999999997665 36899999986
Q ss_pred ec
Q 043136 866 LI 867 (902)
Q Consensus 866 ~~ 867 (902)
.-
T Consensus 165 ~s 166 (229)
T KOG3087|consen 165 VS 166 (229)
T ss_pred cc
Confidence 43
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.1e-10 Score=136.42 Aligned_cols=170 Identities=24% Similarity=0.319 Sum_probs=130.9
Q ss_pred cCCcEeeecCceEEEEEEeC--CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP--GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e 789 (902)
...+.||+|+|+.|-.+... ....+|+|.+.... ......+....|..+-+.+. |+|++++++...+.+..++++|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 34466999999999888553 34566777664433 22333445566888888886 9999999999999999999999
Q ss_pred ccCCCCHHHHH-HhhccCCCcccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEcCCCCCCEEEcCCC-CEEEeeccccee
Q 043136 790 YMPNGNLDDLL-HAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l-~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~ 866 (902)
|.+|+++.+.+ +.... ..+......+..|+..++.|+| ..+ +.|||+||+|.+++..+ ..|++|||+|..
T Consensus 102 ~s~g~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cccccccccccccCCcc----CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 99999998887 32210 1222334467889999999999 666 99999999999999999 999999999987
Q ss_pred ccC-CCC---ceeecc-ccCccccCcccc
Q 043136 867 IQS-DES---MSVIAG-SYGYIAPGTFCF 890 (902)
Q Consensus 867 ~~~-~~~---~~~~~G-t~~y~APE~~~~ 890 (902)
+.. ... ....+| ++.|+|||...+
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccc
Confidence 754 222 344678 999999999987
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.5e-10 Score=126.37 Aligned_cols=104 Identities=25% Similarity=0.395 Sum_probs=88.0
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
.+.||.|++|+..+|.+++..++..++ .++.....++.|++.|++| ++ .+|||+||.||+...+..+||.||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~--~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF 400 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEE--RSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF 400 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccc--cchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence 468899999999999999986655443 4566778999999999999 44 999999999999999999999999
Q ss_pred ccceeccCCC-------CceeeccccCccccCccccccc
Q 043136 862 GVAKLIQSDE-------SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 862 Gla~~~~~~~-------~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
|+........ ..+..+||..||+||++.|..+
T Consensus 401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y 439 (516)
T KOG1033|consen 401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY 439 (516)
T ss_pred hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh
Confidence 9998776554 4566789999999999987544
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.6e-09 Score=131.17 Aligned_cols=148 Identities=28% Similarity=0.299 Sum_probs=96.2
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCC--CcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceec
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANA--FDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFN 156 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~--l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 156 (902)
.++...+.+|.+. .++.... .+.|++|-+..|. +.......|..++.|++||||+|.=-+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 4555555555554 2222222 2367888888775 4444444566788888888888776677888888888888888
Q ss_pred cccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCcc--CCCCccccCCCCCcEEEe
Q 043136 157 AYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLT--GSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 157 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L 229 (902)
|++..+. .+|..+.+|..|.+|++..+.-...+|.....|++|++|.+..-... ...-..+.++.+|+.+..
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~ 675 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSI 675 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhhee
Confidence 8888877 67788888888888888877665555666666788888877665422 222233344444444444
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.5e-09 Score=86.96 Aligned_cols=60 Identities=42% Similarity=0.532 Sum_probs=46.5
Q ss_pred cceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcc
Q 043136 534 KLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLL 593 (902)
Q Consensus 534 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l 593 (902)
+|+.|+|++|+|+.+.+..|.++++|++||+++|+++...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 567777777777777777777888888888888888776677778888888888887765
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.83 E-value=3.2e-09 Score=128.70 Aligned_cols=132 Identities=25% Similarity=0.291 Sum_probs=87.5
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCC--CCCCCCcccccccccceeccccccccCCCchhhhcccCC
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS--FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 176 (902)
.+....+...+-+|.+... +... ..++|++|-+..|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~~~-~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIEHI-AGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchhhc-cCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 3346667777777776532 2111 23467777777775 443344446777777777777776666777777777777
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNN 233 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 233 (902)
++|+|++..++ .+|..+++|.+|.+|++..+.-...+|.....+++|++|.+..-.
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 77777777777 667777777777777777766555556666667777777775443
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.5e-09 Score=82.90 Aligned_cols=61 Identities=36% Similarity=0.446 Sum_probs=54.8
Q ss_pred ccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcc
Q 043136 509 KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFL 569 (902)
Q Consensus 509 ~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 569 (902)
++|++|++++|+++...+..|..+++|++|++++|+++.+.|..|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3678888888888866667889999999999999999999999999999999999999986
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.2e-08 Score=96.15 Aligned_cols=130 Identities=25% Similarity=0.228 Sum_probs=82.8
Q ss_pred EEEEEEeCCCcEEEEEEecccc-----------------------hhhHHHHHHHHHHHHHHhcCCcC--eeEeEEeEEe
Q 043136 725 TVYKAEMPGGEIIAVKKLWGKH-----------------------KENIRRRRGVLAEVDVLGNVRHR--NIVRLLGCCS 779 (902)
Q Consensus 725 ~Vy~~~~~~~~~vavK~i~~~~-----------------------~~~~~~~~~~~~Ei~il~~l~h~--nIv~l~~~~~ 779 (902)
.||.|...++..+|+|+..... ...........+|.+.|.++... ++++.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899988899999999874211 01112235577899999999644 677887653
Q ss_pred cCCeeEEEEEccC--CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 780 NRECTMLLYEYMP--NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY-LHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 780 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~-LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
..++||||++ |..+..+...... ......+..+++..+.. +|.. +|||+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~~~-------~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVDLS-------PEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCGGG-------GSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHhcccc-------chhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eE
Confidence 3469999998 5555544332210 11223566677775555 4644 59999999999999987 99
Q ss_pred EEeecccceeccC
Q 043136 857 RVADFGVAKLIQS 869 (902)
Q Consensus 857 kl~DFGla~~~~~ 869 (902)
.|+|||.|.....
T Consensus 146 ~iIDf~qav~~~~ 158 (188)
T PF01163_consen 146 YIIDFGQAVDSSH 158 (188)
T ss_dssp EE--GTTEEETTS
T ss_pred EEEecCcceecCC
Confidence 9999999877543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.73 E-value=6e-09 Score=116.30 Aligned_cols=180 Identities=21% Similarity=0.200 Sum_probs=135.1
Q ss_pred HHHHHHhccCCcEeee--cCceEEEEEEe---CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEE
Q 043136 705 DDVLECLSMSDKILGM--GSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCC 778 (902)
Q Consensus 705 ~~~~~~~~~~~~~iG~--G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~ 778 (902)
.+.++......+.+|. |.+|.||.+.. .++..+|+|+-....... .....=.+|+...+++ .|++.++.+..+
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p-~~~~~k~~~~~s~~~i~~~~~~v~~~~~~ 187 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPP-LDSKRKLREFLSHHKIDSHENPVRDSPAW 187 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCc-cccccccchhhcccccCccccccccCccc
Confidence 3455566667788999 99999999965 457889999843221111 1112224577777777 499999999999
Q ss_pred ecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEcCCCCCCEEEcCC-
Q 043136 779 SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ----GICYLHHDCDPVIVHRDLKPSNILLDGE- 853 (902)
Q Consensus 779 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~----~L~~LH~~~~~~ivHrDlKp~NILl~~~- 853 (902)
+..+..|+-+|++ +.++.++.+.... ..+....+.+..+..+ |+.++|+.+ ++|-|+||+||+...+
T Consensus 188 e~~~~lfiqtE~~-~~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 188 EGSGILFIQTELC-GESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDW 259 (524)
T ss_pred ccCCcceeeeccc-cchhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheeccccc
Confidence 9999999999999 5788877765432 2444556677778888 999999666 9999999999999999
Q ss_pred CCEEEeecccceeccCCCCc------eeeccccCccccCccccccc
Q 043136 854 MEARVADFGVAKLIQSDESM------SVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 854 ~~~kl~DFGla~~~~~~~~~------~~~~Gt~~y~APE~~~~~~~ 893 (902)
...+.+|||....+.+.... ....|...|++||...+.++
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~ 305 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT 305 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc
Confidence 88999999999888655422 11247778999999987654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.73 E-value=2.9e-07 Score=97.06 Aligned_cols=145 Identities=15% Similarity=0.130 Sum_probs=99.1
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhh-HH-------HHHHHHHHHHHHhcCCc--CeeEeEEeEEec----
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN-IR-------RRRGVLAEVDVLGNVRH--RNIVRLLGCCSN---- 780 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-~~-------~~~~~~~Ei~il~~l~h--~nIv~l~~~~~~---- 780 (902)
.+.+-+.....|++++. +|+.|.||......... .+ ....+.+|.+.+.++.. -.+++.+++++.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35555555566778766 67789999774322110 00 01136788888887742 233445555543
Q ss_pred -CCeeEEEEEccCCC-CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC------
Q 043136 781 -RECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG------ 852 (902)
Q Consensus 781 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~------ 852 (902)
....++|||++++. +|.+++..... ...+......++.+++..+.-||..| |+|+|++++|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~ 179 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGRE 179 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCC
Confidence 23578999999875 79888753211 12334455688999999999999666 999999999999975
Q ss_pred -CCCEEEeeccccee
Q 043136 853 -EMEARVADFGVAKL 866 (902)
Q Consensus 853 -~~~~kl~DFGla~~ 866 (902)
+..+.++||+.++.
T Consensus 180 ~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 180 EDLKLSVIDLHRAQI 194 (268)
T ss_pred CCceEEEEECCcccc
Confidence 46899999998854
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.3e-08 Score=74.61 Aligned_cols=41 Identities=32% Similarity=0.733 Sum_probs=29.5
Q ss_pred hhhHHHHHHHHHhCCC-CCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEec
Q 043136 24 PLPLVSLLSIKASLKD-PFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCN 74 (902)
Q Consensus 24 ~~~~~aLl~~k~~~~~-~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~ 74 (902)
++|++||++||+++.+ |.+ .+.+|+... .++||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~-~l~~W~~~~---------~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSG-VLSSWNPSS---------DSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-C-CCTT--TT-----------S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCc-ccccCCCcC---------CCCCeeeccEEeC
Confidence 5799999999999996 545 899998762 1359999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.5e-08 Score=113.25 Aligned_cols=123 Identities=25% Similarity=0.481 Sum_probs=101.4
Q ss_pred HhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcC
Q 043136 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRD 842 (902)
Q Consensus 763 l~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrD 842 (902)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.|.+... ....++.....++++++.|++|+|+. +-..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeee
Confidence 35678999999999999999999999999999999999763 34588888999999999999999964 2339999
Q ss_pred CCCCCEEEcCCCCEEEeecccceeccC---CCCceeeccccCccccCccccc
Q 043136 843 LKPSNILLDGEMEARVADFGVAKLIQS---DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 843 lKp~NILl~~~~~~kl~DFGla~~~~~---~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+++.|.++|..+.+|++|||+.....+ ........-..-|.|||.+.+.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~ 126 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA 126 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence 999999999999999999999876632 1111222334568999999874
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=4.9e-07 Score=91.93 Aligned_cols=139 Identities=22% Similarity=0.214 Sum_probs=97.5
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccc---------h--------hh--HHHHHHHHHHHHHHhcCCc--Cee
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKH---------K--------EN--IRRRRGVLAEVDVLGNVRH--RNI 771 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~---------~--------~~--~~~~~~~~~Ei~il~~l~h--~nI 771 (902)
.+...||.|--+.||.|..+.|.++|||.-.... . .+ ...+....+|.++|.++.- -.|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 4568899999999999999999999999642100 0 00 1234557889999999853 377
Q ss_pred EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043136 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD 851 (902)
Q Consensus 772 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~ 851 (902)
++.+++ +...+||||++|-.|...-- +....-.+...|++-+.-.-..| |||+|+.+-||+++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 777764 45679999998866654321 11112234444555555444444 99999999999999
Q ss_pred CCCCEEEeecccceecc
Q 043136 852 GEMEARVADFGVAKLIQ 868 (902)
Q Consensus 852 ~~~~~kl~DFGla~~~~ 868 (902)
+||.+.++||--+....
T Consensus 237 ~dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 237 EDGDIVVIDWPQAVPIS 253 (304)
T ss_pred cCCCEEEEeCcccccCC
Confidence 99999999997766543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.2e-07 Score=102.58 Aligned_cols=124 Identities=15% Similarity=0.168 Sum_probs=98.0
Q ss_pred EeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCc
Q 043136 730 EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL 809 (902)
Q Consensus 730 ~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~ 809 (902)
+..++.+|.|..+..... ...+...+.++-++.++||+|+++++.++.++..|+|+|.+. -|..+++...
T Consensus 33 ~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----- 102 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----- 102 (690)
T ss_pred eeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence 345677788887744333 233445677888999999999999999999999999999984 5777776543
Q ss_pred ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 810 VADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 810 ~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
.......++||+.||.|||+ +..++|++|.-+.|+|+..|+.||++|..+....
T Consensus 103 ---~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 103 ---KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred ---HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 12333567899999999996 3469999999999999999999999999876543
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.4e-09 Score=115.93 Aligned_cols=179 Identities=26% Similarity=0.300 Sum_probs=113.0
Q ss_pred chhhhcccCCcEEeccCccCcCCCCcccCCC-CCCCEEEccCCCcc----------CCCCccccCCCCCcEEEeeCcccC
Q 043136 167 PLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL-SSLRFLDLAGNSLT----------GSLPPQLGLLTQLERIEIGYNNLQ 235 (902)
Q Consensus 167 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~----------~~~p~~~~~l~~L~~L~L~~N~l~ 235 (902)
|-.+..+.+|++|.|.+..+.. ...+..+ ..|++|-.+ |.++ |.+-.++. --.|...+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC~-~Sl~Al~~v~ascggd~~ns~~-Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLICH-NSLDALRHVFASCGGDISNSPV-WNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhhh-ccHHHHHHHHHHhccccccchh-hhhHhhhhcchhhHH
Confidence 4456667777777777776652 1111111 234444322 2222 11111111 124677778888887
Q ss_pred CCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCcccc
Q 043136 236 GEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315 (902)
Q Consensus 236 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~ 315 (902)
....++.-++.|+.|+|++|+++.. +.+..+++|++|||++|+++...--....+. |+.|.|++|.++.. ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhhh-heeeeecccHHHhh--hhHH
Confidence 5667777788888888888888754 3677888888888888888733222333344 88888888887632 3467
Q ss_pred ccCCCCEEEccCccccccCC-hhhhhccccceEEecCceec
Q 043136 316 SLKGLTRLSLMNNVLFGEIP-QDIELLADLDTLLLWNNHLT 355 (902)
Q Consensus 316 ~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 355 (902)
++.+|+.||+++|-|.+--. .-++.+..|+.|+|.+|.+-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 78888888888888764321 23566778888888888775
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=9e-07 Score=101.02 Aligned_cols=145 Identities=22% Similarity=0.264 Sum_probs=96.1
Q ss_pred CcEeeecCceEEEEEEeCCCcEEEEEEecccchhhH-------------------------------------HHHHHHH
Q 043136 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENI-------------------------------------RRRRGVL 757 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~-------------------------------------~~~~~~~ 757 (902)
.+.|+.++-|+||+|+..+|+.||||+.++.-.... ...-++.
T Consensus 130 ~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 130 PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 388999999999999999999999998764322100 0111244
Q ss_pred HHHHHHhcCC-----cCeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHH-HHHHH
Q 043136 758 AEVDVLGNVR-----HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG-ICYLH 831 (902)
Q Consensus 758 ~Ei~il~~l~-----h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~-L~~LH 831 (902)
+|+.-+.+++ .+.|.-..=|++......++|||++|-.+.+.......+ .+ +..++..++++ +..+-
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g----~d---~k~ia~~~~~~f~~q~~ 282 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG----ID---RKELAELLVRAFLRQLL 282 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC----CC---HHHHHHHHHHHHHHHHH
Confidence 5666555552 344332222344456778999999998888874332221 22 22344444443 23333
Q ss_pred hCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 832 ~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
.. +++|.|..|.||+++.+|++...|||+...+.+
T Consensus 283 ~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 283 RD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred hc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 23 499999999999999999999999999877643
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.9e-09 Score=119.14 Aligned_cols=124 Identities=32% Similarity=0.315 Sum_probs=50.4
Q ss_pred CCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCcc-ccCCCCccEEecC
Q 043136 200 LRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSE-ISNLTKLEMLLLF 278 (902)
Q Consensus 200 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~ 278 (902)
|...+.+.|.|+ .+..++.-++.|+.|+|++|+++... .+..+++|++|||++|.+. .+|.. -..+ +|+.|.|+
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhh-hheeeeec
Confidence 334444444444 33334444444444444444444221 3444444444444444444 22211 1111 24444444
Q ss_pred CCccceecCCCCCCcCcCcEEecccCCCccccC-ccccccCCCCEEEccCccc
Q 043136 279 KNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 279 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l 330 (902)
+|.++.. ..+.+|.+|+.||+++|-|.+.-- ..+..+..|+.|+|.+|.+
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl 291 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPL 291 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCcc
Confidence 4444421 123344444555555554433111 1223344445555555544
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.4e-08 Score=91.28 Aligned_cols=58 Identities=22% Similarity=0.357 Sum_probs=28.1
Q ss_pred cceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcc
Q 043136 534 KLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLL 593 (902)
Q Consensus 534 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l 593 (902)
.++.|||++|.|+ .+|.++..++.|+.|+++.|.|. ..|..+..|.+|.+|+.-+|.+
T Consensus 78 t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~ 135 (177)
T KOG4579|consen 78 TATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSPENAR 135 (177)
T ss_pred hhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCCCCcc
Confidence 4444455555554 33444555555555555555554 3444444455555555444444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=1.9e-06 Score=87.99 Aligned_cols=128 Identities=27% Similarity=0.338 Sum_probs=89.0
Q ss_pred CCcEEEEEEecccchhh----HHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecCC----eeEEEEEccCCC-CHHHHHH
Q 043136 733 GGEIIAVKKLWGKHKEN----IRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNRE----CTMLLYEYMPNG-NLDDLLH 801 (902)
Q Consensus 733 ~~~~vavK~i~~~~~~~----~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~ 801 (902)
.++.+.+|....+.... ........+|...+..+. .-.+++.+++.+... ..++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543221111 112345677888777774 334556666665432 458999999874 7998887
Q ss_pred hhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEeecccceecc
Q 043136 802 AKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVADFGVAKLIQ 868 (902)
Q Consensus 802 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~~~ 868 (902)
.... .+......++.++++.++-||..+ |+|+|+++.|||++.++ .+.++||+-++...
T Consensus 111 ~~~~-----~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 111 QWEQ-----LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred hhcc-----cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 5322 233445678999999999999766 99999999999999887 89999999877643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.8e-07 Score=104.65 Aligned_cols=143 Identities=22% Similarity=0.228 Sum_probs=110.1
Q ss_pred CcEeeecCceEEEEEEe--CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 715 DKILGMGSTGTVYKAEM--PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
...||.|.|+.|+.+.. .++..|++|.+.+..... .....-..|+-+...+ .|.++++++..|......|+--|||
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~-~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATF-ASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccch-HhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 36799999999999854 467889999875443322 2222334566666666 4999999888888878888999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeeccccee
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKL 866 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGla~~ 866 (902)
++++......-. ..++...++++..|++.++.++|++. ++|+|+||+||++..+ +..++.|||++..
T Consensus 349 ~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 349 EGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCcchhhhhHHH-----HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999887665322 23556667788999999999999554 9999999999999886 7889999999875
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.5e-06 Score=83.31 Aligned_cols=141 Identities=16% Similarity=0.058 Sum_probs=99.1
Q ss_pred eecCceEEEEEEeCCCcEEEEEEecccchhh---HHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecC----CeeEEEEE
Q 043136 719 GMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNR----ECTMLLYE 789 (902)
Q Consensus 719 G~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~----~~~~lv~e 789 (902)
|+|+-+-|++....+ +.+.+|+-....... .-.+..+.+|+..+.++. .-.+++...+.... -..++|+|
T Consensus 27 ~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 678999999987744 468889864221111 113567889999998884 22355555322221 24679999
Q ss_pred ccCC-CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC--EEEeeccccee
Q 043136 790 YMPN-GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME--ARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~ 866 (902)
-++| .||.+++..... ...+...+..+..++++.+.-||..+ +.|+|+-+.||+++.++. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 7753 588888754322 12345556689999999999999666 999999999999987677 99999987654
|
|
| >KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.4e-08 Score=102.76 Aligned_cols=140 Identities=19% Similarity=0.247 Sum_probs=73.9
Q ss_pred ccccEEecCCCCCEEEEEcCCCCcccccCccccCCC--CCCEEEccCCCCccc-Cchhhhcc-CCCcEEEccCCCCCCC-
Q 043136 67 SWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLT--SLTHLNLSANAFDGP-LQPAILEL-TKLRTIDISHNSFNST- 141 (902)
Q Consensus 67 ~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~--~L~~L~Ls~n~l~~~-~~~~~~~l-~~L~~L~Ls~N~l~~~- 141 (902)
+|+|+.-+. +--+.||+.+..|. |..++.+. ....+.+..-.+..+ ..+.+.-. +.|++||||+-.|+..
T Consensus 127 Rfyr~~~de--~lW~~lDl~~r~i~---p~~l~~l~~rgV~v~Rlar~~~~~prlae~~~~frsRlq~lDLS~s~it~st 201 (419)
T KOG2120|consen 127 RFYRLASDE--SLWQTLDLTGRNIH---PDVLGRLLSRGVIVFRLARSFMDQPRLAEHFSPFRSRLQHLDLSNSVITVST 201 (419)
T ss_pred HHhhccccc--cceeeeccCCCccC---hhHHHHHHhCCeEEEEcchhhhcCchhhhhhhhhhhhhHHhhcchhheeHHH
Confidence 677665443 35677888877665 44444442 223333332222211 11112111 3477777777666531
Q ss_pred CCcccccccccceeccccccccCCCchhhhcccCCcEEeccCc-cCcCC-CCcccCCCCCCCEEEccCCCcc
Q 043136 142 FPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGS-YFDGE-IPSDYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 142 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~ 211 (902)
.-.-+..+++|+.|.|.++++...+-..++.-.+|+.|+|+.. .|+.. ..-.+.+++.|..|+|+.+.++
T Consensus 202 l~~iLs~C~kLk~lSlEg~~LdD~I~~~iAkN~~L~~lnlsm~sG~t~n~~~ll~~scs~L~~LNlsWc~l~ 273 (419)
T KOG2120|consen 202 LHGILSQCSKLKNLSLEGLRLDDPIVNTIAKNSNLVRLNLSMCSGFTENALQLLLSSCSRLDELNLSWCFLF 273 (419)
T ss_pred HHHHHHHHHhhhhccccccccCcHHHHHHhccccceeeccccccccchhHHHHHHHhhhhHhhcCchHhhcc
Confidence 1222455666777777777776666666666677777777653 33311 1112455666666666666655
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.5e-06 Score=92.27 Aligned_cols=143 Identities=23% Similarity=0.364 Sum_probs=107.8
Q ss_pred ceEEEEEE-eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEEEEEccCC-CCH
Q 043136 723 TGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTMLLYEYMPN-GNL 796 (902)
Q Consensus 723 ~g~Vy~~~-~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~lv~e~~~~-gsL 796 (902)
-.+.|+|. ..+|..|+.|+++..+.... .....-+++++++.|+|||++.+++.. +...++||+|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35678884 45799999999843322211 112345778899999999999998863 3468899999976 588
Q ss_pred HHHHHhhcc----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 797 DDLLHAKNK----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 797 ~~~l~~~~~----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
.++...... ......++...|.++.|++.||.++|+.| ..-+-+.|.+|+++.+.+++|...|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceee
Confidence 877643221 12344667888999999999999999877 88899999999999998999998888766
Q ss_pred ccCCC
Q 043136 867 IQSDE 871 (902)
Q Consensus 867 ~~~~~ 871 (902)
...+.
T Consensus 443 l~~d~ 447 (655)
T KOG3741|consen 443 LQEDP 447 (655)
T ss_pred ecCCC
Confidence 65443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.28 E-value=7.3e-08 Score=97.56 Aligned_cols=63 Identities=25% Similarity=0.289 Sum_probs=31.2
Q ss_pred cccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCC-CcccCCCCCCCEEEccCCCc
Q 043136 148 KLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEI-PSDYRNLSSLRFLDLAGNSL 210 (902)
Q Consensus 148 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l 210 (902)
+|+.|+.|+|+.|++...|-..=..+.+|++|-|.+..+...- ...+..++.++.|++|.|++
T Consensus 95 ~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtelHmS~N~~ 158 (418)
T KOG2982|consen 95 QLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTELHMSDNSL 158 (418)
T ss_pred cCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhhhhccchh
Confidence 3444444444444443322211133456666666666655322 23345667777777777644
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=8.4e-06 Score=84.28 Aligned_cols=142 Identities=13% Similarity=0.130 Sum_probs=83.8
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcC--eeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR--NIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~--nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- -+++.+++....+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 56899999999984 24567788874322 123356789888887532 357778888777778899999988
Q ss_pred CC-HHHHHH--------------h----hccCCCcccCHHHHH-HHHHH----------HHH-HHHHHHhC-CCCCeEEc
Q 043136 794 GN-LDDLLH--------------A----KNKGENLVADWVTRY-KIALG----------VAQ-GICYLHHD-CDPVIVHR 841 (902)
Q Consensus 794 gs-L~~~l~--------------~----~~~~~~~~~~~~~~~-~i~~q----------i~~-~L~~LH~~-~~~~ivHr 841 (902)
.+ +...+. . -..-........... .+..+ +.+ ...++... ....++|+
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg 158 (226)
T TIGR02172 79 KRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG 158 (226)
T ss_pred ccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence 63 211110 0 000000000111100 00000 011 11222211 13357899
Q ss_pred CCCCCCEEEcCCCCEEEeeccccee
Q 043136 842 DLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 842 DlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
|+.|.||++++++ +.|+||+.+..
T Consensus 159 D~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 159 DFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCCCcEEEcCCC-cEEEechhcCc
Confidence 9999999999888 99999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.24 E-value=8e-07 Score=91.52 Aligned_cols=124 Identities=21% Similarity=0.320 Sum_probs=91.8
Q ss_pred HhcCCcCeeEeEEeEEecCC-----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 043136 763 LGNVRHRNIVRLLGCCSNRE-----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPV 837 (902)
Q Consensus 763 l~~l~h~nIv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ 837 (902)
+-++.|.|+|+++.|+.+.. ...++.|||+.|++.+++++.++. ...+......+|+-||..||.|||+. +++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs~-~Pp 198 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHSC-DPP 198 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhcc-CCc
Confidence 34456999999999986543 578899999999999999876543 33456677789999999999999987 789
Q ss_pred eEEcCCCCCCEEEcCCCCEEEeecccceec-----cCCCCceeeccccCccccCcc
Q 043136 838 IVHRDLKPSNILLDGEMEARVADFGVAKLI-----QSDESMSVIAGSYGYIAPGTF 888 (902)
Q Consensus 838 ivHrDlKp~NILl~~~~~~kl~DFGla~~~-----~~~~~~~~~~Gt~~y~APE~~ 888 (902)
|+|+++..+-|++..+|-+||+--.-.... ..........|-++|.|||.=
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg 254 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG 254 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC
Confidence 999999999999999998888632211100 001112223467788888864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 902 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-50 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-24 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-50 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-24 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-29 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-29 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-18 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-18 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-18 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-18 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-15 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-13 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-13 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-13 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-13 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-13 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-13 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-13 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-13 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-13 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-13 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-13 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-13 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-13 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-12 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-12 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-12 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-12 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 9e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-11 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-11 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-11 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-11 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-11 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-11 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-11 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-11 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-11 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 9e-11 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 9e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-10 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-10 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-10 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-10 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-10 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-10 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-10 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-10 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-10 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-10 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-10 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-10 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-10 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 6e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-10 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-10 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-10 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-09 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-09 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-09 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-09 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-09 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-09 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-09 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-09 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 3e-09 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-09 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-09 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-09 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 5e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 5e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 5e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 5e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 5e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 5e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 6e-09 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-09 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 7e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 7e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 8e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-09 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 8e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-09 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 8e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-09 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 9e-09 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-09 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-08 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-08 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-08 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-08 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-08 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-08 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-08 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-08 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-08 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-08 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 6e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 9e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-08 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 4e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 4e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-07 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 6e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-07 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-06 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 4e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 3v44_A | 407 | Crystal Structure Of The N-Terminal Fragment Of Zeb | 4e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 5e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 5e-06 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 5e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 6e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 6e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 7e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 8e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 8e-06 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 9e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-05 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 2e-05 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-05 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-05 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-05 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 3e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 5e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 5e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-05 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-05 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-05 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 7e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-05 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-05 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 8e-05 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-04 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-04 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-04 | ||
| 2xot_A | 361 | Crystal Structure Of Neuronal Leucine Rich Repeat P | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 2e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 3zyi_A | 452 | Netring2 In Complex With Ngl2 Length = 452 | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 4e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-04 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 5e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-04 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-04 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 6e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 7e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 8e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 8e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-04 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|2XOT|A Chain A, Crystal Structure Of Neuronal Leucine Rich Repeat Protein Amigo-1 Length = 361 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = e-176
Identities = 180/576 (31%), Positives = 280/576 (48%), Gaps = 16/576 (2%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
+ LD+S + S IP + ++L HL++S N G AI T+L+ ++IS N
Sbjct: 200 VNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQ 258
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFV-QLNSLQQLNLGGSYFDGEIPSDYRN 196
F PP L+ L+ + N FTG +P ++L L+L G++F G +P + +
Sbjct: 259 FVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGS 316
Query: 197 LSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVEFASL-VNLKYMDIS 254
S L L L+ N+ +G LP L + L+ +++ +N GE+P +L +L +D+S
Sbjct: 317 CSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLS 376
Query: 255 ACNLSGTLPSEISN--LTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPA 312
+ N SG + + L+ L L N FTG+IP + N L L LS N LSG IP+
Sbjct: 377 SNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPS 436
Query: 313 SLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVD 372
SL SL L L L N+L GEIPQ++ + L+TL+L N LTG +P L + L +
Sbjct: 437 SLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496
Query: 373 VSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432
+S+N LTG IP I + L L L +N+F+ +IP L +C SL L + N NG+IP
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Query: 433 GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN--SFQTSLPSNIWSAPNLKI 490
++ N ++G+ + N + + + N FQ +
Sbjct: 557 AMFKQSG----KIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP 612
Query: 491 LSASSSKLTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGII 549
+ +S G S+ +++ N+L+G IP +IG L +LNL N ++G I
Sbjct: 613 CNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSI 672
Query: 550 PWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHP 609
P E+ L + +DLS N L G IP + L ++S N L+GPIP F P
Sbjct: 673 PDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP-EMGQFETFPP 731
Query: 610 SSFIGNEGLCGRVLTKPCPADGLAAGDVEVRNHQQQ 645
+ F+ N GLCG L + P++ + +H
Sbjct: 732 AKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHHHHH 767
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 448 bits (1154), Expect = e-145
Identities = 164/584 (28%), Positives = 267/584 (45%), Gaps = 54/584 (9%)
Query: 29 SLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRR 88
L+S K L D N DW + C++ G+ C ++TS+DLS +
Sbjct: 16 QLISFKDVLPDK--NLLPDWSSNKNP-----------CTFDGVTCR--DDKVTSIDLSSK 60
Query: 89 SLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISK 148
L+ + ++L LT L ++ +S++ N +
Sbjct: 61 PLNVGF---------------------SAVSSSLLSLTGLESLFLSNSHINGSVSG-FKC 98
Query: 149 LRFLRIFNAYSNSFTGPLP--LEFVQLNSLQQLNLGGSYFDGEIP-SDYRNLSSLRFLDL 205
L + NS +GP+ + L+ LN+ + D S L+SL LDL
Sbjct: 99 SASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDL 158
Query: 206 AGNSLTGSLPPQL---GLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTL 262
+ NS++G+ +L+ + I N + G+V + VNL+++D+S+ N S +
Sbjct: 159 SANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGI 216
Query: 263 PSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTR 322
P + + + L+ L + N +G+ + L++L++S NQ GPIP LK L
Sbjct: 217 PF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQY 273
Query: 323 LSLMNNVLFGEIPQDIE-LLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGP 381
LSL N GEIP + L L L NH G +P GS L ++ +SSN+ +G
Sbjct: 274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGE 333
Query: 382 IPP-TICDGDRLFKLILFSNNFTYSIPENLVNCS-SLSRLRIQDNQLNGSIPQGFG--LL 437
+P T+ L L L N F+ +PE+L N S SL L + N +G I
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497
L + + N +G+IP L N +L L++S N ++PS++ S L+ L +
Sbjct: 394 NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNM 453
Query: 498 LTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGL 556
L G+IP + K++ + L N L G IP + +C L ++LS N LTG IP I L
Sbjct: 454 LEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRL 513
Query: 557 PSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
++ + LS+N +G IP+ +C +L +++ NL G IPA+
Sbjct: 514 ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAA 557
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 268 bits (688), Expect = 5e-78
Identities = 83/363 (22%), Positives = 144/363 (39%), Gaps = 30/363 (8%)
Query: 73 CNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTID 132
C + + L L +G IPP + + L L+LS N G + ++ L+KLR +
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
+ N P + ++ L N TG +P +L ++L + GEIP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 193 DYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252
L +L L L+ NS +G++P +LG L +++ N G +P
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG----K 564
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKN--HFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
I+A ++G I N + N F G L +++ G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 311 PASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLT 370
+ + + L + N+L G IP++I + L L L +N ++G +P ++G L
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 371 VDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSI 430
+D+SSN L G IP + + L+ + + +N L+G I
Sbjct: 685 LDLSSNKLDGRIPQA------------------------MSALTMLTEIDLSNNNLSGPI 720
Query: 431 PQG 433
P+
Sbjct: 721 PEM 723
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-27
Identities = 40/202 (19%), Positives = 75/202 (37%), Gaps = 37/202 (18%)
Query: 411 VNCSS--LSRLRIQDNQLN---GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLE 465
V C ++ + + LN ++ L L + +S + ++G + + L
Sbjct: 45 VTCRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLT 103
Query: 466 YLNISENSFQTSLPS--NIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNG 523
L++S NS + + ++ S LK L+ + +N L+
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLN-----------------------VSSNTLDF 140
Query: 524 SIPWDIG-HCEKLLLLNLSRNSLTGIIPWEI---SGLPSITDVDLSHNFLTGTIPSNFEN 579
G L +L+LS NS++G G + + +S N ++G +
Sbjct: 141 PGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSR 198
Query: 580 CSTLESFNVSYNLLTGPIPASG 601
C LE +VS N + IP G
Sbjct: 199 CVNLEFLDVSSNNFSTGIPFLG 220
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-18
Identities = 24/125 (19%), Positives = 49/125 (39%), Gaps = 5/125 (4%)
Query: 488 LKILSASSSKLTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
+ + S + + + + + L N+ +NGS+ L L+LSRNSL+
Sbjct: 55 IDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLS 113
Query: 547 GIIPW--EISGLPSITDVDLSHNFLTGTIP-SNFENCSTLESFNVSYNLLTGPIPASGTI 603
G + + + +++S N L S ++LE ++S N ++G +
Sbjct: 114 GPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVL 173
Query: 604 FPNLH 608
Sbjct: 174 SDGCG 178
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-104
Identities = 97/612 (15%), Positives = 192/612 (31%), Gaps = 77/612 (12%)
Query: 26 PLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDL 85
++L I +L N S + P + +++ +W + G+ N + ++T L L
Sbjct: 31 DYLALKEIWDALNGK-NWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN-SNGRVTGLSL 88
Query: 86 SRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE----LTKLRTIDISHNSFNST 141
SG +P I LT L L L ++ + + + T
Sbjct: 89 EGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKT 148
Query: 142 FPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLR 201
F + F L + + I R
Sbjct: 149 FVDYDPREDFS----------------------DLIKDCINSDPQQKSIKKSSRITLKDT 186
Query: 202 FLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGT 261
+ N++T + + LT+L + +G + E E N +Y T
Sbjct: 187 QIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKT 240
Query: 262 LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL--------SGPIPAS 313
+ NL L + ++ ++P L +Q+++++ N+ A
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 314 LASLKGLTRLSLMNNVLF-GEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVD 372
+ + + + N L + ++ + L L N L G LP GS KL +++
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLN 359
Query: 373 VSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLV--NCSSLSRLRIQDNQLNG- 428
++ N +T IP C +++ L N IP + S +S + N++
Sbjct: 360 LAYNQITE-IPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSV 417
Query: 429 ------SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT------ 476
+ N++ +++S N +S L +N+ N
Sbjct: 418 DGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSL 477
Query: 477 -SLPSNIWSAPNLKILSASSSKLTGKIPD---FIGCKSIYKIELHNNLLNGSIPWDIGHC 532
N + L + +KLT + D + I+L N + P +
Sbjct: 478 KDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535
Query: 533 EKLLLL------NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESF 586
L + N P I+ PS+T + + N + + +
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVL 592
Query: 587 NVSYNLLTGPIP 598
++ N
Sbjct: 593 DIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 3e-82
Identities = 81/501 (16%), Positives = 167/501 (33%), Gaps = 45/501 (8%)
Query: 82 SLDLSRRSLSGPIPPEI--RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFN 139
R + L ++++ ++ + K I N+
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI- 195
Query: 140 STFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSS 199
+ + +L LR F ++ F E + + + + + NL
Sbjct: 196 TFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKD 250
Query: 200 LRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNL--------QGEVPVEFASLVNLKYM 251
L +++ LP L L +++ I + N + + ++ +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 252 DISACNL-SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
I NL + + + + + KL ML N G++P ++G+ L L+L+ NQ++
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIP 369
Query: 311 PASLASLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTLLLWNNHLTGV-------LPQK 361
+ + LS +N IP + ++ + + N + V L
Sbjct: 370 ANFCGFTEQVENLSFAHN-KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFT-------YSIPENLVNCS 414
+ ++++S+N ++ G L + L N T EN N
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488
Query: 415 SLSRLRIQDNQLNGSIPQ-GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE-- 471
L+ + ++ N+L LP L +D+S NS S P N+ L+ I
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547
Query: 472 ----NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPW 527
N P I P+L L S+ + + + I +I +++ +N
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI-TPNISVLDIKDNPNISIDLS 605
Query: 528 DIGHCEKLLLLNLSRNSLTGI 548
+ + + L + I
Sbjct: 606 YVCPYIEAGMYMLFYDKTQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-67
Identities = 63/451 (13%), Positives = 151/451 (33%), Gaps = 58/451 (12%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE------------ 124
+ + T + +++ + + LT L + + F E
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240
Query: 125 -------LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFT--------GPLPLE 169
L L +++ + + P + L +++ N N +
Sbjct: 241 EDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300
Query: 170 FVQLNSLQQLNLGGSYF-DGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228
+Q + +G + + + + + L L+ N L G P G +L +
Sbjct: 301 APVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLN 359
Query: 229 IGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPS--EISNLTKLEMLLLFKNHFTG-- 284
+ YN + ++ + + L +P+ + +++ + + N
Sbjct: 360 LAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418
Query: 285 -----EIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVL-------FG 332
+ + + ++LS+NQ+S ++ L+ ++LM N+L
Sbjct: 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLK 478
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQ-KLGSNGKLLTVDVSSNSLTGPIPPTICDGDR 391
+ ++ + L ++ L N LT + + + L+ +D+S NS + P +
Sbjct: 479 DENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 392 LFKL------ILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDM 445
L N PE + C SL++L+I N + + + + PN++ +D+
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEK--ITPNISVLDI 594
Query: 446 SRNSLSGEIPRDLGNAQKLEYLNISENSFQT 476
N + + + + Q
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQD 625
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 5e-66
Identities = 59/440 (13%), Positives = 135/440 (30%), Gaps = 34/440 (7%)
Query: 193 DYRNLSSL-RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251
DY L + L+ S G + + + V S + +
Sbjct: 31 DYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK----ELDMWGAQPGVSLNSNGRVTGL 86
Query: 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTG----EIPVSYGNLQALQVLDLSDNQLS 307
+ SG +P I LT+LE+L L + P + +
Sbjct: 87 SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQ 146
Query: 308 GPIPASLASLK--GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSN 365
L + + ++ I + + + +N++T + + +
Sbjct: 147 KTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRL 205
Query: 366 GKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQ 425
KL + ++ + N L+ + + +
Sbjct: 206 TKLRQFYMGNSPFVAENICEA-----WENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260
Query: 426 LNGSIPQGFGLLPNLTFMDMSRNSL--------SGEIPRDLGNAQKLEYLNISENSFQT- 476
+P LP + ++++ N + D +K++ + I N+ +T
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 477 SLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLL 536
+ +++ L +L ++L GK+P F + + L N + G E++
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVE 380
Query: 537 LLNLSRNSLTGIIPW-EISGLPSITDVDLSHNFLTG-------TIPSNFENCSTLESFNV 588
L+ + N L I + + ++ +D S+N + + + S N+
Sbjct: 381 NLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINL 440
Query: 589 SYNLLTGPIPASGTIFPNLH 608
S N ++ + L
Sbjct: 441 SNNQISKFPKELFSTGSPLS 460
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-17
Identities = 19/183 (10%), Positives = 45/183 (24%), Gaps = 26/183 (14%)
Query: 437 LPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ----TSLPSNIWSAPNLKILS 492
+T + + SG +P +G +LE L + + + P I + + +
Sbjct: 80 NGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQ 139
Query: 493 ASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWE 552
D+ + + L+ ++ + I
Sbjct: 140 KMRMHYQKTFVDYDP---------REDFSD------------LIKDCINSDPQQKSIKKS 178
Query: 553 ISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF 612
T + N +T + + L F + + N +
Sbjct: 179 SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQ 237
Query: 613 IGN 615
Sbjct: 238 YKT 240
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 315 bits (810), Expect = 3e-96
Identities = 117/563 (20%), Positives = 198/563 (35%), Gaps = 33/563 (5%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
SQ+TSLD+ ++S P + L L LNL N T L + + NS
Sbjct: 49 SQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNS 108
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD--YR 195
K + L + N + VQL +LQ+L L + +
Sbjct: 109 IQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIF 168
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFA---SLVNLKYMD 252
SSL+ L+L+ N + P + +L + + L + + + +++ +
Sbjct: 169 ANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLS 228
Query: 253 ISACNLSGTLPSEISNL--TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
+S LS T + L T L ML L N+ S+ L L+ L N +
Sbjct: 229 LSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLF 288
Query: 311 PASLASLKGLTRLSLMNNV---------LFGEIPQDIELLADLDTLLLWNNHLTGVLPQK 361
SL L + L+L + L + L L+ L + +N + G+
Sbjct: 289 SHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM 348
Query: 362 LGSNGKLLTVDVSSNSLT-GPIPPTICDG---DRLFKLILFSNNFTYSIPENLVNCSSLS 417
L + +S++ + + L L L N + + L
Sbjct: 349 FTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLE 408
Query: 418 RLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ- 475
L + N++ + + L N+ + +S N L+ L + + +
Sbjct: 409 VLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKN 468
Query: 476 -TSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLN--------GSI 525
S PS NL IL S++ + D G + + ++L +N L G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 526 PWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLES 585
+ + L +LNL N I L + +DL N L S F N +L+S
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 586 FNVSYNLLTGPIPAS-GTIFPNL 607
N+ NL+T G F NL
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNL 611
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = 2e-93
Identities = 102/564 (18%), Positives = 202/564 (35%), Gaps = 32/564 (5%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ IT L+L+ L + LT L++ N +L L+ +++ HN
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
+ + L + SNS FV+ +L L+L +
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLL--TQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
L +L+ L L+ N + +L + + L+++E+ N ++ P F ++ L + ++
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 255 ACNLSGTLPSEIS---NLTKLEMLLLFKNHFTGEIPVSYGNLQ--ALQVLDLSDNQLSGP 309
L +L ++ T + L L + + ++ L+ L +LDLS N L+
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNN---------HLTGVLPQ 360
S A L L L N + + L ++ L L + L +
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
Query: 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV----NCSSL 416
L +++ N + G L L L ++ + N S L
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPL 383
Query: 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQ 475
L + N+++ F L +L +D+ N + E+ + + + +S N +
Sbjct: 384 HILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYL 443
Query: 476 TSLPSNIWSAPNLKILSASSSKLTG--KIPD-FIGCKSIYKIELHNNLLNGSIPWDIGHC 532
++ P+L+ L L P F +++ ++L NN + +
Sbjct: 444 QLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL 503
Query: 533 EKLLLLNLSRNSLT--------GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLE 584
EKL +L+L N+L G + + GL + ++L N F++ L+
Sbjct: 504 EKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELK 563
Query: 585 SFNVSYNLLTGPIPASGTIFPNLH 608
++ N L + +L
Sbjct: 564 IIDLGLNNLNTLPASVFNNQVSLK 587
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 5e-90
Identities = 107/564 (18%), Positives = 193/564 (34%), Gaps = 38/564 (6%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ D S L+ +P ++ T++T LNL+ N ++L ++D+ N
Sbjct: 3 TVSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
+ + P KL L++ N N + F +L +L+L + + +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVN--LKYMDIS 254
+L LDL+ N L+ + L L+ + + N +Q E N LK +++S
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYG---NLQALQVLDLSDNQLSGPIP 311
+ + P + +L L L + +++ L LS++QLS
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 312 ASLASLKG--LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP---------Q 360
+ LK LT L L N L L L+ L N++ + +
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVR 299
Query: 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
L +S SL + L L + N+ +L L
Sbjct: 300 YLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLS 359
Query: 421 IQDNQLNGSIPQGFGL----LPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT 476
+ ++ + L +++++N +S LE L++ N
Sbjct: 360 LSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQ 419
Query: 477 SLPSNIWSA-PNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNG--SIPWDIGHC 532
L W N+ + S +K + F S+ ++ L L S P
Sbjct: 420 ELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPL 479
Query: 533 EKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT--------GTIPSNFENCSTLE 584
L +L+LS N++ I + GL + +DL HN L G + S L
Sbjct: 480 RNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLH 539
Query: 585 SFNVSYNLLTGPIPASGTIFPNLH 608
N+ N +F +L
Sbjct: 540 ILNLESNGFDEIPV---EVFKDLF 560
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 253 bits (649), Expect = 2e-73
Identities = 101/506 (19%), Positives = 166/506 (32%), Gaps = 33/506 (6%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDG--PLQPAILELTKLRTIDISH 135
+ +LDLS LS L +L L LS N + I + L+ +++S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEF---VQLNSLQQLNLGGSYFDGEIPS 192
N P + L + L + + S++ L+L S +
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 193 DYRNL--SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKY 250
+ L ++L LDL+ N+L L QLE + YNN+Q L N++Y
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 251 MD---------ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDL 301
++ IS +L L LE L + N G + L L+ L L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 302 SDNQLSGPIPASLA----SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357
S++ S + + L L+L N + L L+ L L N +
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 358 LPQK-LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTY--SIPENLVNCS 414
L + + + +S N + L +L+L S P
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 415 SLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS--------GEIPRDLGNAQKLEY 466
+L+ L + +N + L L +D+ N+L+ G L L
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 467 LNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSI 525
LN+ N F LKI+ + L F S+ + L NL+
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 526 PWDIGHCEK-LLLLNLSRNSLTGIIP 550
G + L L++ N
Sbjct: 601 KKVFGPAFRNLTELDMRFNPFDCTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 6e-64
Identities = 86/420 (20%), Positives = 152/420 (36%), Gaps = 49/420 (11%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
S D + LT +P L T + + + +N L+ F L +D+ +
Sbjct: 5 SHEVADCSHLKLT-QVPD--DLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318
S P L L++L L N + ++ L L L N + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLG--SNGKLLTVDVSSN 376
L L L +N L L +L LLL NN + + ++L +N L +++SSN
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 377 SLTGPIPPTICDGDRLFKLILFSNNFTYSIPENL---VNCSSLSRLRIQDNQLNGSIPQG 433
+ P RLF L L + S+ E L + +S+ L + ++QL+ +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 434 FGLL--PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKIL 491
F L NLT +D+S N+L+ +LEY + N+ Q ++ N++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 492 SASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPW 551
+ L + ++S SL I +
Sbjct: 302 N-----------------------LKRSFTK---------------QSISLASLPKIDDF 323
Query: 552 EISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSS 611
L + +++ N + G + F L+ ++S + + + T F +L S
Sbjct: 324 SFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET-FVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-62
Identities = 92/436 (21%), Positives = 159/436 (36%), Gaps = 30/436 (6%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRY---LTSLTHLNLSANAFDGPLQPAI--LELTKLRTID 132
++ L L+ L + ++ TS+ +L+LS + L+ T L +D
Sbjct: 195 GRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLD 254
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEI-- 190
+S+N+ N + L L F N+ L +++ LNL S+ I
Sbjct: 255 LSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL 314
Query: 191 -------PSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV--PVE 241
++ L L L++ N + G L L+ + + +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 242 FASLVN--LKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY-GNLQALQV 298
F SL + L ++++ +S S L LE+L L N E+ L+ +
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE 434
Query: 299 LDLSDNQLSGPIPASLASLKGLTRLSLMNNVL--FGEIPQDIELLADLDTLLLWNNHLTG 356
+ LS N+ S A + L RL L L P + L +L L L NN++
Sbjct: 435 IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN 494
Query: 357 VLPQKLGSNGKLLTVDVSSNSLT--------GPIPPTICDGDRLFKLILFSNNFTYSIPE 408
+ L KL +D+ N+L G + L L L SN F E
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554
Query: 409 NLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA-QKLEYL 467
+ L + + N LN F +L +++ +N ++ + G A + L L
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTEL 614
Query: 468 NISENSFQTSLPSNIW 483
++ N F + S W
Sbjct: 615 DMRFNPFDCTCESIAW 630
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 1e-49
Identities = 73/360 (20%), Positives = 119/360 (33%), Gaps = 21/360 (5%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
T +S SL ++L L HLN+ N G L L+ + +S++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 137 SFNSTFPPGIS----KLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
+ + L I N N + F L L+ L+LG + E+
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTG 423
Query: 193 DY-RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG--EVPVEFASLVNLK 249
R L ++ + L+ N L+ L+R+ + L+ P F L NL
Sbjct: 424 QEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLT 483
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT--------GEIPVSYGNLQALQVLDL 301
+D+S N++ + L KLE+L L N+ G L L +L+L
Sbjct: 484 ILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNL 543
Query: 302 SDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQK 361
N L L + L N L L +L L N +T V +
Sbjct: 544 ESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKV 603
Query: 362 LGSNGKLLTV-DVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
G + LT D+ N C+ F + + + C++
Sbjct: 604 FGPAFRNLTELDMRFNPFDC-----TCESIAWFVNWINETHTNIPELSSHYLCNTPPHYH 658
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 9e-05
Identities = 14/81 (17%), Positives = 28/81 (34%), Gaps = 3/81 (3%)
Query: 75 PKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE--LTKLRTID 132
++ +DL +L+ SL LNL N ++ + L +D
Sbjct: 557 KDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELD 615
Query: 133 ISHNSFNSTFPPGISKLRFLR 153
+ N F+ T + ++
Sbjct: 616 MRFNPFDCTCESIAWFVNWIN 636
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 8e-88
Identities = 96/548 (17%), Positives = 191/548 (34%), Gaps = 33/548 (6%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNS 140
+ + IP + S +L+LS N + +L+ +D+S +
Sbjct: 10 ITYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 141 TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSL 200
L L N F L+SLQ+L + +L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 201 RFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM----DISA 255
+ L++A N + LP LT LE +++ N +Q + L + + D+S
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSGPI---P 311
++ P + +L L L N + + L L+V L +
Sbjct: 187 NPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEK 245
Query: 312 ASLASLKGLTRLSLMNNVL------FGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSN 365
++L+GL L++ L +I L ++ + L + + V N
Sbjct: 246 FDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYN 303
Query: 366 GKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQ 425
+++ + L + + V+ SL L + N
Sbjct: 304 FGWQHLELVNCKFGQ-----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNG 358
Query: 426 LN--GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIW 483
L+ G Q +L ++D+S N + + + ++LE+L+ ++ + +++
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 484 -SAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNL 540
S NL L S + F G S+ +++ N + DI L L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 541 SRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
S+ L + P + L S+ +++SHN ++ ++L+ + S N +
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 537
Query: 601 -GTIFPNL 607
+L
Sbjct: 538 LQHFPSSL 545
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 274 bits (704), Expect = 9e-82
Identities = 102/542 (18%), Positives = 178/542 (32%), Gaps = 50/542 (9%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ LDLSR + + L+ L+ L L+ N A L+ L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
S I L+ L+ N N LP F L +L+ L+L + +D R
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 197 LSSLRF----LDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP-VEFASLVNLKYM 251
L + LDL+ N + + P +L ++ + N V L L+
Sbjct: 172 LHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 252 DIS------ACNLSGTLPSEISNLTKLEML---LLFKNHFTGEIPVSYGNLQALQVLDLS 302
+ NL S + L L + L + +++ +I + L + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
+ + G L L+N ++ L L G
Sbjct: 291 SVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSE 343
Query: 363 GSNGKLLTVDVSSNSLT--GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
L +D+S N L+ G + L L L N ++ N + L L
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 402
Query: 421 IQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLP 479
Q + L F L NL ++D+S LE L ++ NSFQ +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 480 SNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLN 539
+I F +++ ++L L P L +LN
Sbjct: 463 PDI----------------------FTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 500
Query: 540 LSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENC-STLESFNVSYNLLTGPIP 598
+S N+ + + L S+ +D S N + + ++ S+L N++ N
Sbjct: 501 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 560
Query: 599 AS 600
Sbjct: 561 HQ 562
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-49
Identities = 77/412 (18%), Positives = 127/412 (30%), Gaps = 26/412 (6%)
Query: 76 KSSQITSLDLSRRSLSGPIPPE-IRYLTSLTHLNLSANAFDG---PLQPAILELTKLRTI 131
K ++ L L S + I+ L L L F + L L +
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 132 DISHNSFNS------TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY 185
I + L + F+ S + + Q L L
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQHLELVNCK 315
Query: 186 FDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ--GEVPVEFA 243
F ++L L F G + + L LE +++ N L G
Sbjct: 316 FGQFPTLKLKSLKRLTFTSNKGGNAFSEVD-----LPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 244 SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY-GNLQALQVLDLS 302
+LKY+D+S + T+ S L +LE L ++ S +L+ L LD+S
Sbjct: 371 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDIS 429
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQK 361
L L L + N DI L +L L L L + P
Sbjct: 430 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC-SSLSRLR 420
S L +++S N+ + L L N+ S + L + SSL+ L
Sbjct: 490 FNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLN 549
Query: 421 IQDNQLNGSIPQG--FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNIS 470
+ N + + + + + + P D + LNI+
Sbjct: 550 LTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-40
Identities = 68/306 (22%), Positives = 113/306 (36%), Gaps = 31/306 (10%)
Query: 75 PKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANA--FDGPLQPAILELTKLRTID 132
P + L+ S G L SL L+LS N F G + T L+ +D
Sbjct: 320 PTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLE-FVQLNSLQQLNLGGSYFDGEIP 191
+S N T L L + ++ F+ L +L L++ ++
Sbjct: 380 LSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251
+ LSSL L +AGNS + P + F L NL ++
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFLPDI-----------------------FTELRNLTFL 475
Query: 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP 311
D+S C L P+ ++L+ L++L + N+F Y L +LQVLD S N +
Sbjct: 476 DLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKK 535
Query: 312 ASLASL-KGLTRLSLMNNVLFGEIPQD--IELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368
L L L+L N ++ + D LL+ + P +
Sbjct: 536 QELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK-QGMPV 594
Query: 369 LTVDVS 374
L+++++
Sbjct: 595 LSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 33/207 (15%), Positives = 62/207 (29%), Gaps = 35/207 (16%)
Query: 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQ 462
+P C IP L + +D+S N L +
Sbjct: 4 VEVVPNITYQCME--------LNFY-KIPDN--LPFSTKNLDLSFNPLRHLGSYSFFSFP 52
Query: 463 KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522
+L+ L++S QT S +L L L N +
Sbjct: 53 ELQVLDLSRCEIQTIEDGAYQSLSHLSTLI-----------------------LTGNPIQ 89
Query: 523 GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGT-IPSNFENCS 581
L L +L + + I L ++ +++++HN + +P F N +
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 582 TLESFNVSYNLLTGPIPASGTIFPNLH 608
LE ++S N + + +
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMP 176
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 291 bits (745), Expect = 3e-85
Identities = 97/650 (14%), Positives = 207/650 (31%), Gaps = 94/650 (14%)
Query: 29 SLLSIKASLKDPFNNSFHDW--DATPAFSNPSSEQEP-VWCSWSGIKCNPKSSQITSLDL 85
+L +I +L N ++ + T N + +E +W G+ + + ++T L L
Sbjct: 273 ALKAIWEALDGK-NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD-NNGRVTGLSL 330
Query: 86 SRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN----SFNST 141
+ G +P I LT L L+ ++ + E + + +
Sbjct: 331 AGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKM 390
Query: 142 FPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD-GEIPSDYRNLSSL 200
F +L + N P++ SL+ +G I + L+ L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKL 450
Query: 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG 260
+ + A + T + Y + +++L +L +++ C
Sbjct: 451 QIIYFANSPFTYDNIAVDWEDANSD-----YAKQYENEELSWSNLKDLTDVELYNCPNMT 505
Query: 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP---------IP 311
LP + +L +L Q L+++ N+ +
Sbjct: 506 QLPDFLYDLPEL------------------------QSLNIACNRGISAAQLKADWTRLA 541
Query: 312 ASLASLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTLLLWNNHLTGVLPQKLGSNGKLL 369
+ + + N L E P L + L L +N + + + G+N KL
Sbjct: 542 DDEDTGPKIQIFYMGYNNL-EEFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLT 598
Query: 370 TVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPE--NLVNCSSLSRLRIQDNQL 426
+ + N + IP C D++ L N IP N + + + N++
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKI 656
Query: 427 NGSIPQGFGLLP-----NLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSN 481
+ N + + +S N + + + +S N TS+P N
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLM-TSIPEN 715
Query: 482 IWSA--------PNLKILSASSSKLTGKIPD---FIGCKSIYKIELHNNLLNGSIPWDIG 530
L + +KLT + D + +++ N + S P
Sbjct: 716 SLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPYLSNMDVSYNCFS-SFPTQPL 773
Query: 531 HCEKLLLLNLSR------NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLE 584
+ +L + N + P I+ PS+ + + N + + L
Sbjct: 774 NSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLY 830
Query: 585 SFNVSYN-LLTGPIPAS-GTIFPNLHPSSFIGNEGLCGRVLTKPCPADGL 632
+++ N ++ + + I ++ + + + G C A G+
Sbjct: 831 ILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG------CDALGI 874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 5e-77
Identities = 75/281 (26%), Positives = 126/281 (44%), Gaps = 7/281 (2%)
Query: 351 NNHLTGVLPQKLGSNGKLLTVDVSSNSLTG--PIPPTICDGDRLFKLILFS-NNFTYSIP 407
N GVL ++ +D+S +L PIP ++ + L L + NN IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 408 ENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYL 467
+ + L L I ++G+IP + L +D S N+LSG +P + + L +
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 468 NISENSFQTSLPSNIWSAPNL-KILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIP 526
N ++P + S L ++ S ++LTGKIP ++ ++L N+L G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214
Query: 527 WDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESF 586
G + ++L++NSL + ++ ++ +DL +N + GT+P L S
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSL 273
Query: 587 NVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPC 627
NVS+N L G IP G S++ N+ LCG L C
Sbjct: 274 NVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSPL-PAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 2e-71
Identities = 89/363 (24%), Positives = 145/363 (39%), Gaps = 68/363 (18%)
Query: 29 SLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNP--KSSQITSLDLS 86
+LL IK L +P + W T N +W G+ C+ ++ ++ +LDLS
Sbjct: 10 ALLQIKKDLGNP--TTLSSWLPTTDCCN---------RTWLGVLCDTDTQTYRVNNLDLS 58
Query: 87 RRSLSG--PIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144
+L PIP + L L L +
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGI-------------------------------- 86
Query: 145 GISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLD 204
N+ GP+P +L L L + + G IP + +L LD
Sbjct: 87 ---------------NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131
Query: 205 LAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL-KYMDISACNLSGTLP 263
+ N+L+G+LPP + L L I N + G +P + S L M IS L+G +P
Sbjct: 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP 191
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
+NL L + L +N G+ V +G+ + Q + L+ N L+ + + K L L
Sbjct: 192 PTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGL 249
Query: 324 SLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT--GP 381
L NN ++G +PQ + L L +L + N+L G +PQ G+ + ++N P
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
Query: 382 IPP 384
+P
Sbjct: 309 LPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-71
Identities = 79/291 (27%), Positives = 125/291 (42%), Gaps = 29/291 (9%)
Query: 186 FDGEIPSDYRNLSSLRFLDLAGNSLTGS--LPPQLGLLTQLERIEI-GYNNLQGEVPVEF 242
+ G + + LDL+G +L +P L L L + I G NNL G +P
Sbjct: 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
A L L Y+ I+ N+SG +P +S + L L N +G +P S +L L +
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
N++SG IP S S L + + N LTG +P
Sbjct: 158 GNRISGAIPDSYGSFSKLFTS-----------------------MTISRNRLTGKIPPTF 194
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQ 422
N L VD+S N L G K+ L N+ + + + + +L+ L ++
Sbjct: 195 A-NLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR 252
Query: 423 DNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENS 473
+N++ G++PQG L L +++S N+L GEIP GN Q+ + + N
Sbjct: 253 NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 31/159 (19%), Positives = 60/159 (37%), Gaps = 24/159 (15%)
Query: 444 DMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIP 503
D + G + ++ L++S + IP
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP----------------------KPYPIP 69
Query: 504 DFIG-CKSIYKIELHN-NLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITD 561
+ + + + N L G IP I +L L ++ +++G IP +S + ++
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 562 VDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
+D S+N L+GT+P + + L N ++G IP S
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 258 bits (662), Expect = 8e-76
Identities = 84/532 (15%), Positives = 169/532 (31%), Gaps = 15/532 (2%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ L+ S L L +LT L+L+ + +L T+ ++ N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
+S + L+ + + +L+ L LG ++
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ-GEVPVEFASLVNLKYMDISA 255
L+ LD N++ + L Q + + N + + ++
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGG 211
Query: 256 CNLSGTLPSEISN--LTKLEMLLLFKNHFTGEIPVSYGNLQA--LQVLDLSDNQLSGPIP 311
+ + N + L + P + L ++ ++L +
Sbjct: 212 TQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271
Query: 312 ASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTV 371
+ GL L L E+P + L+ L L+L N + + L +
Sbjct: 272 NTFHCFSGLQELDLTAT-HLSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330
Query: 372 DVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYS--IPENLVNCSSLSRLRIQDNQLNG 428
+ N+ + + + L +L L ++ S L N S L L + N+
Sbjct: 331 SIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSAPN 487
+ F P L +D++ L + + N L+ LN+S + S P
Sbjct: 391 LKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPA 450
Query: 488 LKILSASSSKLTGKIPD----FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543
L+ L+ + + + L L+ + + ++LS N
Sbjct: 451 LQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510
Query: 544 SLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
LT +S L I ++L+ N ++ +PS S + N+ N L
Sbjct: 511 RLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-74
Identities = 95/549 (17%), Positives = 172/549 (31%), Gaps = 19/549 (3%)
Query: 72 KCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTI 131
KC K T + L+ IP + S L S N L L +
Sbjct: 7 KCIEKEVNKT-YNCENLGLNE-IPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 132 DISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIP 191
D++ L +N +L+ L +
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251
N +L L L N ++ P+ +L+ ++ N + + +SL +
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNL 182
Query: 252 DIS-ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGN--LQALQVLDLSDNQLSG 308
++ N + + + L I N +Q+L + D
Sbjct: 183 SLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED 242
Query: 309 PIPASLASLKG--LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
PA L + ++L + F + L L L HL+ LP L
Sbjct: 243 ISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLS 301
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQ 425
L + +S+N + + L L + N + L N +L L + +
Sbjct: 302 TLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD 361
Query: 426 LNGS--IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIW 483
+ S L +L +++S N +LE L+++ + + +
Sbjct: 362 IETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPF 421
Query: 484 SA-PNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSIPWDIG---HCEKLLLL 538
LK+L+ S S L F G ++ + L N +L +L
Sbjct: 422 QNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEIL 481
Query: 539 NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIP 598
LS L+ I + L + VDLSHN LT + + + N++ N ++ +P
Sbjct: 482 VLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILP 540
Query: 599 ASGTIFPNL 607
+ I
Sbjct: 541 SLLPILSQQ 549
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-46
Identities = 73/388 (18%), Positives = 139/388 (35%), Gaps = 17/388 (4%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEIRY--LTSLTHLNLSANAFDGPLQPAILELTK--LRTI 131
S+ SL+ I ++ + SL + L + + +I
Sbjct: 200 DSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI 259
Query: 132 DISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIP 191
++ + F + L+ + + + LP V L++L++L L + F+
Sbjct: 260 NLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQ 318
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQ--GEVPVEFASLVNL 248
N SL L + GN+ L L L L +++ +++++ ++ +L +L
Sbjct: 319 ISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL 378
Query: 249 KYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLS 307
+ +++S +LE+L L + S + NL L+VL+LS + L
Sbjct: 379 QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLD 438
Query: 308 GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLD---TLLLWNNHLTGVLPQKLGS 364
L L L+L N Q L L L+L L+ + S
Sbjct: 439 ISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
Query: 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
+ VD+S N LT + L L SN+ + +P L S + ++ N
Sbjct: 499 LKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQN 557
Query: 425 QLNGSIPQGFGLLPNLTFMDMSRNSLSG 452
L+ + + L + + L
Sbjct: 558 PLDCTC----SNIYFLEWYKENMQKLED 581
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-42
Identities = 76/361 (21%), Positives = 136/361 (37%), Gaps = 45/361 (12%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
S + LDL+ LS +P + L++L L LSAN F+ Q + L + I N+
Sbjct: 278 SGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNT 336
Query: 138 FNSTFPPG-ISKLRFLRIFNAYSNSFT--GPLPLEFVQLNSLQQLNLGGSYFDGEIPSDY 194
G + L LR + + L+ L+ LQ LNL + +
Sbjct: 337 KRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396
Query: 195 RNLSSLRFLDLAGNSLTGSLPP-QLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
+ L LDLA L L L+ + + ++ L F L L+++++
Sbjct: 397 KECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNL 456
Query: 254 SACNLSGT---LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
+ + + L +LE+L+L + ++ +L+ + +DLS N+L+
Sbjct: 457 QGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSS 516
Query: 311 PASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLT 370
+L+ LKG+ L L +NH++ +LP L + T
Sbjct: 517 IEALSHLKGI-------------------------YLNLASNHISIILPSLLPILSQQRT 551
Query: 371 VDVSSNSLTGPIPPTICD-GDRLFKLILFSNNFTYSIPENLVNCSSLSRLR---IQDNQL 426
+++ N L C + F N E+ + C + LR + D L
Sbjct: 552 INLRQNPLD-------CTCSNIYFLEWYKENMQKLEDTEDTL-CENPPLLRGVRLSDVTL 603
Query: 427 N 427
+
Sbjct: 604 S 604
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 247 bits (633), Expect = 8e-72
Identities = 102/546 (18%), Positives = 193/546 (35%), Gaps = 31/546 (5%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNS 140
+ + LS +P +I +S +++LS N + ++L+ +D+S +
Sbjct: 14 ITYQCMDQKLSK-VPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 141 TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSL 200
L L N P F L SL+ L + L +L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 201 RFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM----DISA 255
+ L++A N + LP LT L +++ YN +Q + L + D+S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSG------ 308
+ + + KL L L N + I NL L V L +
Sbjct: 191 NPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 309 PIPASLASLKGLTR--LSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
P+ + L +T L F + LA++ + L + + + +
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLED--VPKHF 307
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
K ++ + L P L L L N SI V SLS L + N L
Sbjct: 308 KWQSLSIIRCQLKQ-FPTLDLP--FLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNAL 362
Query: 427 NGSIPQGFGLL--PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS 484
+ S + L +L +D+S N + + ++L++L+ ++ + + +
Sbjct: 363 SFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421
Query: 485 A-PNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLS 541
+ L L S + F+G S+ +++ N + ++ + L L+LS
Sbjct: 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481
Query: 542 RNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASG 601
+ L I L + +++SHN L S++ +L + + S+N +
Sbjct: 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 602 TIFPNL 607
+L
Sbjct: 542 HFPKSL 547
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-68
Identities = 95/537 (17%), Positives = 183/537 (34%), Gaps = 28/537 (5%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
S ++DLS L + L L+LS + A L L + ++ N
Sbjct: 31 PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGN 90
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYR 195
S P S L L A QL +L++LN+ ++ ++P+ +
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQL----ERIEIGYNNLQGEVPVEFASLVNLKYM 251
NL++L +DL+ N + L L + +++ N + F + L +
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHEL 209
Query: 252 DISACNLSGTLPSE-ISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ--------VLDLS 302
+ S + + NL L + L F E + ++ L+
Sbjct: 210 TLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
L ++ +SL + + +D+ +L + L L
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDL 327
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN--CSSLSRLR 420
L ++ ++ N + I L L L N ++S + + +SL L
Sbjct: 328 PF---LKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLD 382
Query: 421 IQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLP 479
+ N + F L L +D ++L + +KL YL+IS + +
Sbjct: 383 LSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 480 SNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLL 537
+L L + + F ++ ++L L +L L
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
LN+S N+L + + L S++ +D S N + + +L FN++ N +
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-55
Identities = 79/429 (18%), Positives = 149/429 (34%), Gaps = 30/429 (6%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
SS + +DL+ N L ++L+ +++ ++ + L +L + ++
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG-PIPASLAS 316
+ P S LT LE L+ + G L L+ L+++ N + +PA ++
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLL----LWNNHLTGVLPQKLGSNGKLLTVD 372
L L + L N + D++ L + + + N + + + KL +
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELT 210
Query: 373 VSSNSLTGPIPPTICDG------DRLFKLILFSNNFTYSIP----ENLVNCSSLSRLRIQ 422
+ N + I T RL E L + + R+
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDE-FRLT 269
Query: 423 DNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNI 482
F L N++ M ++ S+ D+ K + L+I P+
Sbjct: 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL-KQFPTL- 325
Query: 483 WSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN--GSIPWDIGHCEKLLLLNL 540
P LK L+ + +K + + S+ ++L N L+ G + L L+L
Sbjct: 326 -DLPFLKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 541 SRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP-SNFENCSTLESFNVSYNLLTGPIPA 599
S N I+ GL + +D H+ L S F + L ++SY
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD- 441
Query: 600 SGTIFPNLH 608
IF L
Sbjct: 442 --GIFLGLT 448
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-35
Identities = 60/264 (22%), Positives = 98/264 (37%), Gaps = 10/264 (3%)
Query: 69 SGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKL 128
++ PK + SL + R L P L L L L+ N + L L
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQ-FPTL--DLPFLKSLTLTMNKGSIS--FKKVALPSL 352
Query: 129 RTIDISHNSFNSTFPPGISKLRF--LRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF 186
+D+S N+ + + S L LR + N + F+ L LQ L+ S
Sbjct: 353 SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTL 411
Query: 187 DGEIPSDY-RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE-FAS 244
+L L +LD++ + LT L +++ N+ + FA+
Sbjct: 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471
Query: 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDN 304
NL ++D+S C L L +L++L + N+ Y L +L LD S N
Sbjct: 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFN 531
Query: 305 QLSGPIPASLASLKGLTRLSLMNN 328
++ K L +L NN
Sbjct: 532 RIETSKGILQHFPKSLAFFNLTNN 555
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 33/185 (17%), Positives = 71/185 (38%), Gaps = 6/185 (3%)
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPN 487
GS+ ++PN+T+ LS ++P D+ + + +++S N + + +
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 488 LKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+ L S ++ + G + + L N + P L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 547 GIIPWEISGLPSITDVDLSHNFLTG-TIPSNFENCSTLESFNVSYNLLTGPIPASGTIFP 605
+ + I L ++ ++++HNF+ +P+ F N + L ++SYN +
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 606 NLHPS 610
Sbjct: 178 ENPQV 182
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (564), Expect = 3e-65
Identities = 70/174 (40%), Positives = 102/174 (58%), Gaps = 5/174 (2%)
Query: 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+ ILG G G VYK + G ++AVK+L K + EV+++ HRN++R
Sbjct: 34 NKNILGRGGFGKVYKGRLADGTLVAVKRL--KEERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L G C +L+Y YM NG++ L + + + DW R +IALG A+G+ YLH
Sbjct: 92 LRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIALGSARGLAYLHDH 150
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--MSVIAGSYGYIAP 885
CDP I+HRD+K +NILLD E EA V DFG+AKL+ ++ + + G+ G+IAP
Sbjct: 151 CDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAP 204
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 1e-60
Identities = 62/181 (34%), Positives = 92/181 (50%), Gaps = 10/181 (5%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRR-RRGVLAEVDVLGNVR 767
+S+ +G G G VYK + + AVKKL ++ E+ V+ +
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H N+V LLG S+ + L+Y YMPNG+L D L + L W R KIA G A GI
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL--SWHMRCKIAQGAANGI 146
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---IAGSYGYIA 884
+LH + +HRD+K +NILLD A+++DFG+A+ + + I G+ Y+A
Sbjct: 147 NFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMA 203
Query: 885 P 885
P
Sbjct: 204 P 204
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 2e-56
Identities = 56/178 (31%), Positives = 89/178 (50%), Gaps = 16/178 (8%)
Query: 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRN 770
++G G G VYK + G +A+K+ +G+ E++ L RH +
Sbjct: 43 HKFLIGHGVFGKVYKGVLRDGAKVALKRR------TPESSQGIEEFETEIETLSFCRHPH 96
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+V L+G C R +L+Y+YM NGNL L+ + + W R +I +G A+G+ YL
Sbjct: 97 LVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYL 155
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---IAGSYGYIAP 885
H I+HRD+K NILLD ++ DFG++K + + + G+ GYI P
Sbjct: 156 HTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-55
Identities = 94/531 (17%), Positives = 190/531 (35%), Gaps = 32/531 (6%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNS 140
+ + IP + S +L+LS N + +L+ +D+S +
Sbjct: 10 ITYQCMELNFYK-IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 141 TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSL 200
L L N F L+SLQ+L + +L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126
Query: 201 RFLDLAGNSLT-GSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS---AC 256
+ L++A N + LP LT LE +++ N +Q + L + +++S +
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDL------SDNQLSGP 309
N + +L L L N + + L L+V L ++ L
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 310 IPASLASLKGLTRLSL---MNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
++L L LT + +I L ++ + L + + V
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW 306
Query: 367 KLLTV-DVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQ 425
+ L + + + K + F++N + + V+ SL L + N
Sbjct: 307 QHLELVNCKFGQFPTLKLKS-------LKRLTFTSNKGGNAF-SEVDLPSLEFLDLSRNG 358
Query: 426 LN--GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIW 483
L+ G Q +L ++D+S N + + + ++LE+L+ ++ + +++
Sbjct: 359 LSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 417
Query: 484 SA-PNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNL 540
+ NL L S + F G S+ +++ N + DI L L+L
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 541 SRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
S+ L + P + L S+ ++++ N L F+ ++L+ + N
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-48
Identities = 99/510 (19%), Positives = 165/510 (32%), Gaps = 53/510 (10%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ LDLSR + + L+ L+ L L+ N A L+ L+ + +
Sbjct: 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETN 111
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFT-GPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
S I L+ L+ N N LP F L +L+ L+L + +D R
Sbjct: 112 LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV 171
Query: 197 LSSLRF----LDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP-VEFASLVNLKYM 251
L + LDL+ N + + P +L ++ + N V L L+
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 252 DI------SACNLSGTLPSEISNLTKLEMLLLFKNH---FTGEIPVSYGNLQALQVLDLS 302
+ + NL S + L L + + + +I + L + L
Sbjct: 231 RLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
+ + + G L L+N + P L L L +N
Sbjct: 291 SVTIER-VK-DFSYNFGWQHLELVNCKFG-QFPTLK--LKSLKRLTFTSNKGGNAFS--E 343
Query: 363 GSNGKLLTVDVSSNSLT--GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
L +D+S N L+ G + L L L N ++ N + L L
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLD 402
Query: 421 IQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLP 479
Q + L F L NL ++D+S LE L ++ NSFQ +
Sbjct: 403 FQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 480 SNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLL 537
+I++ NL L L L + L +
Sbjct: 463 PDIFTELRNLTFLD-----------------------LSQCQLE-QLSPTAFNSLSSLQV 498
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
LN++ N L + L S+ + L N
Sbjct: 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-45
Identities = 75/417 (17%), Positives = 151/417 (36%), Gaps = 30/417 (7%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
S + LDL+ N L +L+ +++ +Q + SL +L + ++
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL-SGPIPASLAS 316
+ S L+ L+ L+ + + G+L+ L+ L+++ N + S +P ++
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLW----NNHLTGVLPQKLGSNGKLLTVD 372
L L L L +N + D+ +L + L L N + + +L +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 373 VSSNSLTGPIPPTICDG------DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQ 425
+ +N + + T G RL + ++ L +L+ +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 426 LNGS---IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA--QKLEYLNISENSFQTSLPS 480
L+ I F L N++ + ++ + N Q LE +N F T
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPT---- 321
Query: 481 NIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN--GSIPWDIGHCEKLLLL 538
+LK L+ +S+K + S+ ++L N L+ G L L
Sbjct: 322 --LKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 539 NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLT 594
+LS N + + GL + +D H+ L + F + L ++S+
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR 434
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-40
Identities = 80/444 (18%), Positives = 144/444 (32%), Gaps = 42/444 (9%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAF-DGPLQPAILELTKLRTIDISHN 136
S + L +L+ I +L +L LN++ N L LT L +D+S N
Sbjct: 100 SSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSN 159
Query: 137 SFNSTFPPGISKLRFLRIFNAY----SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
S + + L + + N N + + L +L L ++ +
Sbjct: 160 KIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 193 DY-RNLSSLRFLDLAGNSLTGS---LPPQLGLLTQLERIEIGYNNLQG------EVPVEF 242
+ L+ L L L L + I L ++ F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 243 ASLVNLKYMDISACNLSGTLP-SEISNLTKLEMLLLFKNHFTGEIPVS------------ 289
L N+ + + + S LE++ F S
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 290 ----YGNLQALQVLDLSDNQLS--GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343
+L +L+ LDLS N LS G S L L L N + + + L
Sbjct: 339 NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397
Query: 344 LDTLLLWNNHLTGVLPQKLGSN-GKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNN 401
L+ L +++L + + + L+ +D+S I +G L L + N+
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNS 456
Query: 402 FTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLG 459
F + + +L+ L + QL + F L +L ++M+ N L
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLKSVPDGIFD 515
Query: 460 NAQKLEYLNISENSFQTSLPSNIW 483
L+ + + N + S P +
Sbjct: 516 RLTSLQKIWLHTNPWDCSCPRIDY 539
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 1e-54
Identities = 97/470 (20%), Positives = 185/470 (39%), Gaps = 37/470 (7%)
Query: 128 LRTIDISH-NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF 186
L + I+ N F + L + T + L+ + L
Sbjct: 3 LGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQA--DRL 56
Query: 187 DGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246
+ L++L ++ + N LT + P L LT+L I + N + P A+L
Sbjct: 57 GIKSIDGVEYLNNLTQINFSNNQLT-DITP-LKNLTKLVDILMNNNQIADITP--LANLT 112
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
NL + + ++ + NLT L L L N + +S L +LQ L NQ+
Sbjct: 113 NLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDISALS--GLTSLQQLSFG-NQV 167
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
+ P LA+L L RL + +N + + L +L++L+ NN ++ + P LG
Sbjct: 168 TDLKP--LANLTTLERLDISSNKV--SDISVLAKLTNLESLIATNNQISDITP--LGILT 221
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
L + ++ N L T+ L L L +N + P L + L+ L++ NQ+
Sbjct: 222 NLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
+ P L LT ++++ N L P + N + L YL + N+ S + S
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDI--SPVSSLT 331
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+ L ++K++ + +I + +N ++ P + + ++ L L+ + T
Sbjct: 332 KLQRLFFYNNKVSD-VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGP 596
SI + + P+ + + ++++NL +
Sbjct: 389 NAPV-NYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYT 436
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-53
Identities = 109/498 (21%), Positives = 193/498 (38%), Gaps = 59/498 (11%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L L + +L ++ T+ S G+ L L N +N
Sbjct: 23 LAEKMKTVLGKTNVTDT--VSQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 78
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
T PL+ NL+ L + + N + L
Sbjct: 79 QLTDITPLK--------------------------NLTKLVDILMNNNQIAD--ITPLAN 110
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
LT L + + N + P +L NL +++S+ +S S +S LT L+ L N
Sbjct: 111 LTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GN 165
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL 340
T P+ NL L+ LD+S N++S LA L L L NN + P + +
Sbjct: 166 QVTDLKPL--ANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP--LGI 219
Query: 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSN 400
L +LD L L N L + L S L +D+++N ++ P + +L +L L +N
Sbjct: 220 LTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGAN 275
Query: 401 NFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN 460
+ P L ++L+ L + +NQL P L NLT++ + N++S P + +
Sbjct: 276 QISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSS 329
Query: 461 AQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNL 520
KL+ L N + S S++ + N+ LSA ++++ + I ++ L++
Sbjct: 330 LTKLQRLFFYNN--KVSDVSSLANLTNINWLSAGHNQISD-LTPLANLTRITQLGLNDQA 386
Query: 521 LNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENC 580
+ P + + + I P IS S T+ D++ N + T ++
Sbjct: 387 WT-NAPVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYTEPDITWNLPSYTNEVSYTF- 443
Query: 581 STLESFNVSYNLLTGPIP 598
S + +G +
Sbjct: 444 SQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 2e-51
Identities = 107/501 (21%), Positives = 187/501 (37%), Gaps = 59/501 (11%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ L + +++ + L +T L + L L I+ S+N
Sbjct: 24 AEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 79
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ L L +N PL L +L L L + P NL
Sbjct: 80 LTD--ITPLKNLTKLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDIDPLK--NL 133
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
++L L+L+ N+++ L LT L+++ G N + P A+L L+ +DIS+
Sbjct: 134 TNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNK 188
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
+S S ++ LT LE L+ N + P+ G L L L L+ NQL LASL
Sbjct: 189 VSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDIGT--LASL 242
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
LT L L NN + P + L L L L N ++ + P L L ++++ N
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 298
Query: 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLL 437
L P I + L L L+ NN + P + + + L RL +N+++ L
Sbjct: 299 LEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANL 352
Query: 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497
N+ ++ N +S P L N ++ L +++ ++ T+ P N + N+ I +
Sbjct: 353 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAW-TNAPVNYKA--NVSIPN----- 402
Query: 498 LTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLP 557
+ N P I +++ N +
Sbjct: 403 -----------------TVKNVTGALIAPATISDGGSYTEPDITWNLPS-YTNEVSYTFS 444
Query: 558 SITDVDLSHNFLTGTIPSNFE 578
+ +GT+ +
Sbjct: 445 QPVTIGKGTTTFSGTVTQPLK 465
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 5e-50
Identities = 80/381 (20%), Positives = 157/381 (41%), Gaps = 30/381 (7%)
Query: 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277
L + + +G N+ V L + + + + L L +
Sbjct: 20 DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINF 75
Query: 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQD 337
N T P+ NL L + +++NQ++ P LA+L LT L+L NN + P
Sbjct: 76 SNNQLTDITPLK--NLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 338 IELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLIL 397
++ L +L+ L L +N ++ + L L + N +T P + + L +L +
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDI 184
Query: 398 FSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD 457
SN + L ++L L +NQ++ P G+L NL + ++ N L
Sbjct: 185 SSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 238
Query: 458 LGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELH 517
L + L L+++ N ++L + L L +++++ I G ++ +EL+
Sbjct: 239 LASLTNLTDLDLANNQI-SNLA-PLSGLTKLTELKLGANQIS-NISPLAGLTALTNLELN 295
Query: 518 NNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNF 577
N L P I + + L L L N+++ I P +S L + + +N ++ S+
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSL 349
Query: 578 ENCSTLESFNVSYNLLTGPIP 598
N + + + +N ++ P
Sbjct: 350 ANLTNINWLSAGHNQISDLTP 370
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 54/189 (28%), Positives = 85/189 (44%), Gaps = 26/189 (13%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
L + + G G V+KA++ E +AVK + K++ + EV L ++H N
Sbjct: 26 LQLLEVK-ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY----EVYSLPGMKHEN 79
Query: 771 IVRLLGCCSNRECT----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
I++ +G L+ + G+L D L A V W IA +A+G
Sbjct: 80 ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARG 133
Query: 827 ICYLHHD-------CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVI 876
+ YLH D P I HRD+K N+LL + A +ADFG+A ++ +S
Sbjct: 134 LAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 877 AGSYGYIAP 885
G+ Y+AP
Sbjct: 194 VGTRRYMAP 202
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-49
Identities = 106/560 (18%), Positives = 203/560 (36%), Gaps = 40/560 (7%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISHN 136
+ L LS + +L L L L + + L LR +D+ +
Sbjct: 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83
Query: 137 SFNSTFPPGI-SKLRFLRIFNAYSNSFTGPL--PLEFVQLNSLQQLNLGGSYFDG-EIPS 192
P L L Y + + F L +L +L+L + +
Sbjct: 84 KI-YFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 193 DYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ--LERIEIGYNNLQGEVPVEFASLVN-LK 249
+ L+SL+ +D + N + +L L L + N+L V V++ +N +
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309
M + ++SG N +++ F N + S + + + P
Sbjct: 203 NMVLEILDVSG-------NGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 310 IPASLASLK--GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGK 367
+ A L + L L + +F + E L DL L L N + + +
Sbjct: 256 DQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDN 315
Query: 368 LLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLN 427
L +++S N L ++ + L N+ + L L ++DN L
Sbjct: 316 LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT-SLPSNIWSAP 486
+P++ + +S N L +P+ +++SEN + + + P
Sbjct: 376 -----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVP 426
Query: 487 NLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNG----SIPWDI-GHCEKLLLLN 539
+L+IL + ++ + D S+ ++ L N+L + WD+ L +L
Sbjct: 427 HLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLY 486
Query: 540 LSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPA 599
L+ N L + P S L ++ + L+ N LT ++ + LE ++S N L P P
Sbjct: 487 LNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPNP- 543
Query: 600 SGTIFPNLHPSSFIGNEGLC 619
+F +L N+ +C
Sbjct: 544 --DVFVSLSVLDITHNKFIC 561
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 168 bits (426), Expect = 5e-43
Identities = 121/582 (20%), Positives = 201/582 (34%), Gaps = 80/582 (13%)
Query: 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAF-DGPLQPAILE-LTKLRTIDIS 134
+ LDL + + P+ + L L L L D L+ L L +D+S
Sbjct: 73 PNLRILDLGSSKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLS 131
Query: 135 HNSFNS-TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL--NSLQQLNLGGSYFDGEIP 191
N S P KL L+ + SN E L +L +L + +
Sbjct: 132 KNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
Query: 192 SDYRNLS------SLRFLDLAGNSLT------------GSLPPQLGLLTQLERIEIGYNN 233
D+ L LD++GN T S L L + G++N
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251
Query: 234 LQGEVPVEFASLV--NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYG 291
++ FA L +++++D+S + L L++L L N ++
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
L LQVL+LS N L ++ L + + L N + Q + L L TL L +
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-- 409
N LT + + + +S N L T+ + LI S N ++
Sbjct: 372 NALT-----TIHFIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYF 421
Query: 410 LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL-----GNAQK 463
L+ L L + N+ + P+L + + N L +L
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 464 LEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522
L+ L ++ N SLP ++S L+ LS +S++LT L +N L
Sbjct: 482 LQVLYLNHNYL-NSLPPGVFSHLTALRGLSLNSNRLT---------------VLSHNDLP 525
Query: 523 GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP----SNFE 578
+ L +L++SRN L P L + D++HN N+
Sbjct: 526 AN----------LEILDISRNQLLAPNPDVFVSLSVL---DITHNKFICECELSTFINWL 572
Query: 579 NCSTLESFNVSYNLL-TGPIPASGTIFPNLHPSSFIGNEGLC 619
N + + ++ P SG +L E L
Sbjct: 573 NHTNVTIAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLK 614
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-41
Identities = 97/417 (23%), Positives = 158/417 (37%), Gaps = 38/417 (9%)
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDI 253
+ L++ L L+ N + L QL+ +E+G + E F +L NL+ +D+
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI--PVSYGNLQALQVLDLSDNQLSG-PI 310
+ + P L L L L+ + + + NL+AL LDLS NQ+ +
Sbjct: 81 GSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYL 140
Query: 311 PASLASLKGLTRLSLMNNVLFGEIPQDIELLA--DLDTLLLWNNHLTGVLPQKLGS---- 364
S L L + +N +F ++E L L L N L + G
Sbjct: 141 HPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNP 200
Query: 365 --NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQ 422
N L +DVS N T I FSN + S +L+ +
Sbjct: 201 FRNMVLEILDVSGNGWTVDITG------------NFSNAISKSQAFSLILAHHIMGAGFG 248
Query: 423 DNQLNGSIPQGFGLLP--NLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPS 480
+ + F L ++ +D+S + R + L+ LN++ N
Sbjct: 249 FHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADE 308
Query: 481 NIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLL 538
+ NL++L+ S + L ++ F G + I+L N + EKL L
Sbjct: 309 AFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTL 367
Query: 539 NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
+L N+LT I +PSI D+ LS N L T+P T ++S N L
Sbjct: 368 DLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKIN---LTANLIHLSENRLEN 415
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-32
Identities = 75/397 (18%), Positives = 142/397 (35%), Gaps = 48/397 (12%)
Query: 231 YNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI-PVS 289
+ NL +VP L + + +S + S L +L++L L + I +
Sbjct: 13 FCNLT-QVP---QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEA 68
Query: 290 YGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTL 347
+ NL L++LDL +++ P + L L L L L + +D L L L
Sbjct: 69 FRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRL 128
Query: 348 LLWNNHLTGV-LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD-------RLFKLILFS 399
L N + + L G L ++D SSN + +C+ + L L +
Sbjct: 129 DLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF-----LVCEHELEPLQGKTLSFFSLAA 183
Query: 400 NNFTYSIPENLVNCS------SLSRLRIQDNQ------------LNGSIPQGFGLLPNLT 441
N+ + + C L L + N ++ S L ++
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 442 FMDMSRNSLSGEIPRDLGNAQK--LEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLT 499
+++ + + +L++S + + +LK+L+ + +K+
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 500 GKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLP 557
KI D F G ++ + L NLL + K+ ++L +N + I L
Sbjct: 304 -KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLE 362
Query: 558 SITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
+ +DL N LT ++ +S N L
Sbjct: 363 KLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV 394
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-48
Identities = 107/522 (20%), Positives = 188/522 (36%), Gaps = 74/522 (14%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
I P T L ++ + + + + + PPG + R +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+ L +L L +P L L + NSLT
Sbjct: 62 VSR-----------LRDCLDRQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-E 105
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273
LP L L L P L+Y+ +S L LP E+ N + L+
Sbjct: 106 LPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLP-ELQNSSFLK 156
Query: 274 MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333
++ + N ++P +L+ + +NQL +P L +L LT + NN L +
Sbjct: 157 IIDVDNNSLK-KLPDLPPSLE---FIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSL-KK 209
Query: 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLF 393
+P +L L++++ NN L LP+ L + L T+ +N L +P L
Sbjct: 210 LP---DLPLSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT-LPDLPPS---LE 260
Query: 394 KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGE 453
L + N T +PE SL+ L + +N + + + L PNL +++ S N +
Sbjct: 261 ALNVRDNYLT-DLPELP---QSLTFLDVSENIFS-GLSE---LPPNLYYLNASSNEIR-S 311
Query: 454 IPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYK 513
+ + LE LN+S N LP+ P L+ L AS + L ++P+ ++ +
Sbjct: 312 LCDLPPS---LEELNVSNNKL-IELPALP---PRLERLIASFNHLA-EVPELPQ--NLKQ 361
Query: 514 IELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTI 573
+ + N L P E L + + +P L + + N L
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDLRMNSHLAE-----VPELPQNL---KQLHVETNPLR-EF 411
Query: 574 PSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGN 615
P E+ +E ++ + P + L F +
Sbjct: 412 PDIPES---VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 4e-48
Identities = 101/501 (20%), Positives = 179/501 (35%), Gaps = 73/501 (14%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
+P E + S T + + ++ P E ++ +
Sbjct: 26 MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQ-----------AH 74
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+ + LP L+ L + E+P ++L SL + +L+
Sbjct: 75 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS-- 127
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273
L LE + + N L+ ++P E + LK +D+ +L LP +L +
Sbjct: 128 -----DLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIA 179
Query: 274 MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333
N E+P NL L + +N L +P SL+ + NN+L E
Sbjct: 180 ---AGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-LPDLPLSLE---SIVAGNNIL--E 228
Query: 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLF 393
+++ L L T+ NN L LP S L ++V N LT +P L
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLTD-LPELPQ---SLT 280
Query: 394 KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGE 453
L + N F+ + E +L L N++ S+ L P+L +++S N L E
Sbjct: 281 FLDVSENIFS-GLSELP---PNLYYLNASSNEIR-SLC---DLPPSLEELNVSNNKLI-E 331
Query: 454 IPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYK 513
+P LE L S N +P NLK L + L + PD S+
Sbjct: 332 LPALPPR---LERLIASFNHL-AEVPELP---QNLKQLHVEYNPLR-EFPDIPE--SVED 381
Query: 514 IELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTI 573
+ ++++L +P + ++ L++ N L P + D+ ++ +
Sbjct: 382 LRMNSHL--AEVPELPQNLKQ---LHVETNPLR-EFPDIPESV---EDLRMNSERVVDPY 432
Query: 574 PSNFENCSTLESFNVSYNLLT 594
E LE ++
Sbjct: 433 EFAHETTDKLEDDVFEHHHHH 453
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-47
Identities = 98/523 (18%), Positives = 186/523 (35%), Gaps = 48/523 (9%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
++ + SLDLS ++ ++R +L L L ++ + A L L +D+S N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDGEIPSDY- 194
+S L L+ N N + + F L +LQ L +G EI
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
L+SL L++ SL L + + + + + + + L +++Y+++
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL 314
NL+ S + + + S+ L L L +++
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE----FDD 260
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
+L GL + + + E+ + +E + + L + +L L K+ + V
Sbjct: 261 CTLNGLGDFNPSESDVVSELGK-VETV-TIRRLHIPQFYLFYDLSTVYSLLEKVKRITVE 318
Query: 375 SNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLV---NCSSLSRLRIQDNQLN--G 428
++ + +P + L L L N +N SL L + N L
Sbjct: 319 NSKVFL-VPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQ 377
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNL 488
+ L NLT +D+SRN+ +P +K+ +LN+S + + I L
Sbjct: 378 KTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGI-RVVKTCIP--QTL 433
Query: 489 KILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI 548
++L S++ L L L L +SRN L +
Sbjct: 434 EVLDVSNNNLD---------------SFSLFLPR------------LQELYISRNKLKTL 466
Query: 549 IPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
S P + + +S N L F+ ++L+ + N
Sbjct: 467 PDA--SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-42
Identities = 79/473 (16%), Positives = 149/473 (31%), Gaps = 62/473 (13%)
Query: 128 LRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD 187
D SF S P G++ ++ + N T + +LQ L L S +
Sbjct: 7 SGVCDGRSRSFTS-IPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN 63
Query: 188 GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQG-EVPVEFASL 245
+ +L SL LDL+ N L+ SL G L+ L+ + + N Q V F +L
Sbjct: 64 TIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 246 VNLKYMDISACNLSGTLPSE-ISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDN 304
NL+ + I + + LT L L + S +++ + L L +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 305 QLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGS 364
+ + + L + L L + L + + + + + +
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
KLL + + + D + V ++ RL I
Sbjct: 243 LLKLLRYILELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 425 QLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLG-NAQKLEYLNISENSFQTSLPSNIW 483
L + + LL + + + + + +P + + LE+L++SEN N
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN-- 353
Query: 484 SAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543
G L L LS+N
Sbjct: 354 ------------------------------------------SACKGAWPSLQTLVLSQN 371
Query: 544 SLTGI--IPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
L + + L ++T +D+S N +P + + + N+S +
Sbjct: 372 HLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-35
Identities = 82/423 (19%), Positives = 146/423 (34%), Gaps = 35/423 (8%)
Query: 78 SQITSLDLSRRSLSG-PIPPEIRYLTSLTHLNLS-ANAFDGPLQPAILELTKLRTIDISH 135
S + L+L + LT+L L + F + LT L ++I
Sbjct: 98 SSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKA 157
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG---SYFDGEIPS 192
S + + +R + + + L + L+S++ L L + F
Sbjct: 158 LSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLP 217
Query: 193 DYRNLSSLRFLDLAGNSLT----GSLPPQLGLLTQLERIEIGYNNLQGEVPVE------- 241
S ++ L G+ LT L L + +L +E L G
Sbjct: 218 VDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVV 277
Query: 242 ----FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ 297
V ++ + I L L + S L K++ + + + +L++L+
Sbjct: 278 SELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLE 337
Query: 298 VLDLSDNQLS---GPIPASLASLKGLTRLSLMNNVL--FGEIPQDIELLADLDTLLLWNN 352
LDLS+N + A + L L L N L + + + L +L +L + N
Sbjct: 338 FLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRN 397
Query: 353 HLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN 412
+P K+ +++SS + + C L L + +NN S L
Sbjct: 398 TFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLDVSNNNLD-SFSLFL-- 450
Query: 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN 472
L L I N+L ++P L P L M +SRN L L+ + + N
Sbjct: 451 -PRLQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 473 SFQ 475
+
Sbjct: 508 PWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-31
Identities = 68/426 (15%), Positives = 141/426 (33%), Gaps = 54/426 (12%)
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+ + D S T S+P L +K +D+S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--------------------------TAAMKSLDLSF 35
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315
++ ++ L++L+L + ++ +L +L+ LDLSDN LS +
Sbjct: 36 NKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFG 95
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTL-LLWNNHLTGVLPQKLGSNGKLLTVD 372
L L L+LM N + + L +L TL + + + L ++
Sbjct: 96 PLSSLKYLNLMGN-PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELE 154
Query: 373 VSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432
+ + SL ++ + L L + + + SS+ L ++D L
Sbjct: 155 IKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFS 214
Query: 433 GFGLLPNLTFMDMSRNSLS-------GEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA 485
+ + M S E+ + L +L + + +
Sbjct: 215 PLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN---------- 264
Query: 486 PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSL 545
L + S S + ++ + +I ++ + L + EK+ + + + +
Sbjct: 265 -GLGDFNPSESDVVSELG-KVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 546 TGIIPWEISGLPSITDVDLSHNFLTGTIPSN---FENCSTLESFNVSYNLLTGPIPASGT 602
+ L S+ +DLS N + N +L++ +S N L + +G
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS-MQKTGE 381
Query: 603 IFPNLH 608
I L
Sbjct: 382 ILLTLK 387
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-23
Identities = 42/255 (16%), Positives = 83/255 (32%), Gaps = 33/255 (12%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISH 135
++ I L + + L + L + + + + L L +D+S
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSE 343
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD--GEIPSD 193
N + + N SLQ L L ++ +
Sbjct: 344 N-----------LMVEEYLKN----------SACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
L +L LD++ N+ +P ++ + + ++ V+ L+ +D+
Sbjct: 383 LLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDV 438
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPAS 313
S NL + L +L+ L + +N +P L V+ +S NQL
Sbjct: 439 SNNNLD-SFS---LFLPRLQELYISRNKLK-TLP-DASLFPVLLVMKISRNQLKSVPDGI 492
Query: 314 LASLKGLTRLSLMNN 328
L L ++ L N
Sbjct: 493 FDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 52/246 (21%), Positives = 87/246 (35%), Gaps = 6/246 (2%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS 429
D S S T IP + + L L N TY +L C++L L ++ +++N
Sbjct: 9 VCDGRSRSFTS-IPSGLTA--AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTI 65
Query: 430 IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT-SLPSNIWSAPNL 488
F L +L +D+S N LS G L+YLN+ N +QT + S + NL
Sbjct: 66 EGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNL 125
Query: 489 KILSASSSKLTGKIP--DFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
+ L + + +I DF G S+ ++E+ L + + L L +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPN 606
++ L S+ ++L L S + S
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 607 LHPSSF 612
L
Sbjct: 246 LLRYIL 251
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-19
Identities = 35/223 (15%), Positives = 73/223 (32%), Gaps = 6/223 (2%)
Query: 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDL 458
S +FT SIP L +++ L + N++ NL + + + ++
Sbjct: 14 SRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAF 70
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLT--GKIPDFIGCKSIYKIEL 516
+ LE+L++S+N + S +LK L+ + G F ++ + +
Sbjct: 71 YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 517 HNNLLNGSIP-WDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
N I D L L + SL + + I + L + +
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEI 190
Query: 576 NFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGL 618
+ S++ + L + + P + G
Sbjct: 191 FADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 6e-47
Identities = 76/395 (19%), Positives = 150/395 (37%), Gaps = 50/395 (12%)
Query: 176 LQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ 235
L + +I D +L+ L S+T + L + ++ + +
Sbjct: 2 AATLATLPAPI-NQIFPD-ADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 236 GEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQA 295
+ L NL+Y++++ ++ S +SNL KL L + N T + NL
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
L+ L L+++ +S P LA+L + L+L N ++ + + L+ L + + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVK 168
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
V P + + L ++ ++ N + L + +S
Sbjct: 169 DVTP--IANLTDLYSLSLNYNQIED--------------------------ISPLASLTS 200
Query: 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
L NQ+ P + L + + N ++ P L N +L +L I N
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL 535
+ + LK+L+ S++++ I + + L+NN L IG L
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313
Query: 536 LLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT 570
L LS+N +T I P ++ L + D ++ +
Sbjct: 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-46
Identities = 65/352 (18%), Positives = 138/352 (39%), Gaps = 24/352 (6%)
Query: 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
A L + +++ L + L++ I L L+ L+L+
Sbjct: 19 ADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA-SIQ-GIEYLTNLEYLNLN 74
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
NQ++ P L++L LT L + N + ++ L +L L L ++++ + P L
Sbjct: 75 GNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--L 128
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQ 422
+ K+ ++++ +N + + L L + + P + N + L L +
Sbjct: 129 ANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLN 185
Query: 423 DNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNI 482
NQ+ P L +L + N ++ P + N +L L I N S +
Sbjct: 186 YNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL--SPL 239
Query: 483 WSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSR 542
+ L L +++++ I + + + +N ++ + + +L L L+
Sbjct: 240 ANLSQLTWLEIGTNQIS-DINAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNN 296
Query: 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
N L I GL ++T + LS N +T P + S ++S + + ++
Sbjct: 297 NQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 9e-46
Identities = 77/395 (19%), Positives = 150/395 (37%), Gaps = 73/395 (18%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ L + S++ + L S+T L ++ I LT L ++++ N
Sbjct: 22 AEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQ 77
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+S L L +N T L+ NL
Sbjct: 78 ITD--ISPLSNLVKLTNLYIGTNKITDISALQ--------------------------NL 109
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
++LR L L ++++ L LT++ + +G N+ ++ +++ L Y+ ++
Sbjct: 110 TNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESK 166
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
+ + I+NLT L L L N P+ +L +L NQ++ P +A++
Sbjct: 167 VKD--VTPIANLTDLYSLSLNYNQIEDISPL--ASLTSLHYFTAYVNQITDITP--VANM 220
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
L L + NN + P + L+ L L + N ++ + + KL ++V SN
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQ 276
Query: 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLL 437
++ L N S L+ L + +NQL + G L
Sbjct: 277 ISD--------------------------ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGL 310
Query: 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN 472
NLT + +S+N ++ P L + K++ + +
Sbjct: 311 TNLTTLFLSQNHITDIRP--LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-40
Identities = 76/349 (21%), Positives = 134/349 (38%), Gaps = 47/349 (13%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
IT L ++ ++ I YLT+L +LNL+ N + L KL + I N
Sbjct: 44 ESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNK 99
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ L LR ++ + PL L + LNLG ++ S N+
Sbjct: 100 ITD--ISALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHN-LSDLSPLSNM 154
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+ L +L + + + + LT L + + YN ++ P ASL +L Y
Sbjct: 155 TGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQ 210
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
++ + ++N+T+L L + N T P+ NL L L++ NQ+S + L
Sbjct: 211 ITD--ITPVANMTRLNSLKIGNNKITDLSPL--ANLSQLTWLEIGTNQISDINA--VKDL 264
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
L L++ +N + + L+ L++L L NN L + +G L T+ +S N
Sbjct: 265 TKLKMLNVGSNQI--SDISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
+T P L + S + + +
Sbjct: 323 ITDIRP--------------------------LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 144 bits (367), Expect = 5e-38
Identities = 60/316 (18%), Positives = 124/316 (39%), Gaps = 22/316 (6%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
+L L ++ + L+ +T+L + + Q IE L +L+ L L
Sbjct: 20 DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV--ASIQGIEYLTNLEYLNLNG 75
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N +T + P L + KL + + +N +T + + L +L L +N + P L
Sbjct: 76 NQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISDISP--LA 129
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
N + + L + N S + L ++ ++ + + P + N L L+++
Sbjct: 130 NLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNY 186
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
N + S + S +L +A +++T I + +++ NN + P + +
Sbjct: 187 NQIEDI--SPLASLTSLHYFTAYVNQITD-ITPVANMTRLNSLKIGNNKITDLSP--LAN 241
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
+L L + N ++ I + L + +++ N ++ S N S L S ++ N
Sbjct: 242 LSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNN 297
Query: 592 LLTGPIPASGTIFPNL 607
L NL
Sbjct: 298 QLGNEDMEVIGGLTNL 313
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 26/134 (19%), Positives = 51/134 (38%), Gaps = 8/134 (5%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
+++ SL + ++ P + L+ LT L + N A+ +LTKL+ +++ N
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQ 276
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ ++ L L +N L +L L L ++ P +L
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SL 332
Query: 198 SSLRFLDLAGNSLT 211
S + D A +
Sbjct: 333 SKMDSADFANQVIK 346
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 7e-47
Identities = 62/171 (36%), Positives = 94/171 (54%), Gaps = 6/171 (3%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G GS GTV++AE G +AVK L + + R L EV ++ +RH NIV +
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKIL-MEQDFHAERVNEFLREVAIMKRLRHPNIVLFM 100
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G + ++ EY+ G+L LLH E L D R +A VA+G+ YLH+ +
Sbjct: 101 GAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQL--DERRRLSMAYDVAKGMNYLHN-RN 157
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-SMSVIAGSYGYIAP 885
P IVHR+LK N+L+D + +V DFG+++L S S AG+ ++AP
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAP 208
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 53/173 (30%), Positives = 83/173 (47%), Gaps = 15/173 (8%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
++++G G+ G V KA+ + +A+K++ ++ E+ L V H NIV+
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESERKAFIV------ELRQLSRVNHPNIVK 65
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
L G C N C L+ EY G+L ++LH L +QG+ YLH
Sbjct: 66 LYGACLNPVC--LVMEYAEGGSLYNVLHGAEPLPYY--TAAHAMSWCLQCSQGVAYLHSM 121
Query: 834 CDPVIVHRDLKPSNILLDGEME-ARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRDLKP N+LL ++ DFG A IQ+ M+ GS ++AP
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAP 172
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 53/179 (29%), Positives = 85/179 (47%), Gaps = 17/179 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+I+G+G G VY+A G+ +AVK ++ + V E + ++H NI+ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
G C L+ E+ G L+ +L K A+ +A+G+ YLH +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRI------PPDILVNWAVQIARGMNYLHDEA 125
Query: 835 DPVIVHRDLKPSNILLDGEMEAR--------VADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRDLK SNIL+ ++E + DFG+A+ MS AG+Y ++AP
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAP 183
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 2e-44
Identities = 55/180 (30%), Positives = 91/180 (50%), Gaps = 19/180 (10%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA----EVDVLGNVRHRN 770
K +G G G V+K + ++A+K L E EV ++ N+ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
IV+L G N ++ E++P G+L L +K + W + ++ L +A GI Y+
Sbjct: 85 IVKLYGLMHNPPRMVM--EFVPCGDLYHRLL--DKAHPI--KWSVKLRLMLDIALGIEYM 138
Query: 831 HHDCDPVIVHRDLKPSNILLD-----GEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ +P IVHRDL+ NI L + A+VADFG+++ QS S+S + G++ ++AP
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAP 195
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 8e-44
Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 13/177 (7%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
L+ K+ +G ++K G I VK L + R+ R E L H N
Sbjct: 12 LNFLTKL-NENHSGELWKGRW-QGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 771 IVRLLGCCSNRECT--MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
++ +LG C + L+ +MP G+L ++LH +G N V D K AL +A+G+
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMA 125
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+LH +P+I L ++++D +M AR++ V QS M + ++AP
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM----YAPAWVAP 177
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 165 bits (418), Expect = 8e-44
Identities = 63/418 (15%), Positives = 138/418 (33%), Gaps = 37/418 (8%)
Query: 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEI 229
N + + S + S ++ +++ LDL+GN L+ L T+LE + +
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS 289
N L E + SL L+ +D++ + E+ +E L N+ + VS
Sbjct: 66 SSNVLY-ETL-DLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR---VS 115
Query: 290 YGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFG-EIPQDIELLADLDTLL 348
Q + + L++N+++ + L L N + + L+ L
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 349 LWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPE 408
L N + V + KL T+D+SSN L + P + + L +N I +
Sbjct: 176 LQYNFIYDV--KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 409 NLVNCSSLSRLRIQDNQLN-GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYL 467
L +L ++ N + G++ F + +++ ++ ++
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLG 289
Query: 468 NISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPW 527
+ LP+ A L L L + +
Sbjct: 290 HYGAYCC-EDLPAPF--ADRLIALKRKEHALL---------------SGQGSETE-RLEC 330
Query: 528 DIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLES 585
+ + + ++ + +I + ++ L + + + L+
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDG 388
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 1e-43
Identities = 57/427 (13%), Positives = 131/427 (30%), Gaps = 21/427 (4%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ ++ SL + + ++ L+LS N + TKL +++S N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ L LR + +N E + S++ L+ + +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCS--RG 119
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG-EVPVEFASLVNLKYMDISAC 256
+ + LA N +T G ++++ +++ N + AS L+++++
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
+ + ++ KL+ L L N + + + + + L +N+L I +L
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
+ L L N +D + + + + Q +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 377 SLTGPIPPTICDGDRLF----KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432
P L L+ + T + N + + Q I Q
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQ 354
Query: 433 GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILS 492
++ + +L ++ +L+ Q L L++L
Sbjct: 355 VTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLR 413
Query: 493 ASSSKLT 499
A +
Sbjct: 414 AIVKRYE 420
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-39
Identities = 62/394 (15%), Positives = 127/394 (32%), Gaps = 20/394 (5%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
++ ++ L ++ +D+S N + ++ L + N SN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
L L++L+ L+L +Y E+ S+ L A N+++ +
Sbjct: 69 VLYETLD--LESLSTLRTLDLNNNYV-QELL----VGPSIETLHAANNNIS-RVSC--SR 118
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG-TLPSEISNLTKLEMLLLFK 279
+ I + N + ++ ++Y+D+ + ++ LE L L
Sbjct: 119 GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 280 NHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE 339
N ++ L+ LDLS N+L+ + S G+T +SL NN L I + +
Sbjct: 179 NFIY-DVKGQ-VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-VLIEKALR 234
Query: 340 LLADLDTLLLWNNHL-TGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKL-IL 397
+L+ L N G L N ++ TV + C L
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAY 294
Query: 398 FSNNFTYSIPENLVN--CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIP 455
+ + L+ + L Q ++ + +D + I
Sbjct: 295 CCEDLPAPFADRLIALKRKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVID 353
Query: 456 RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLK 489
+ Q L + + + + + L
Sbjct: 354 QVTLRKQAKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-38
Identities = 61/483 (12%), Positives = 138/483 (28%), Gaps = 21/483 (4%)
Query: 122 ILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNL 181
+ + ++ +S ++ + N + + L+ LNL
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 182 GGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE 241
+ D +LS+LR LDL N + +L + +E + NN+ V
Sbjct: 66 SSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR---VS 115
Query: 242 FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTG-EIPVSYGNLQALQVLD 300
+ K + ++ ++ + ++++ L L N + L+ L+
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 301 LSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQ 360
L N + + L L L +N L + + + A + + L NN L ++ +
Sbjct: 176 LQYNFIYD-VKGQ-VVFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEK 231
Query: 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
L + L D+ N + +N C+ +
Sbjct: 232 ALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH 290
Query: 421 IQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSG----EIPRDLGNAQKLEYLNISENSFQT 476
L L + + S G + + N + ++ + ++T
Sbjct: 291 YGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRT 350
Query: 477 SLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLL 536
+ L L ++ + + L + + L
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410
Query: 537 LLNLSRNSLT-GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
LL + + +I D D+ + T N +++
Sbjct: 411 LLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANA 470
Query: 596 PIP 598
+
Sbjct: 471 TLQ 473
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 9e-38
Identities = 59/397 (14%), Positives = 111/397 (27%), Gaps = 31/397 (7%)
Query: 242 FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDL 301
+ K ++ +L L S + ++ L L N + L++L+L
Sbjct: 6 KQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNL 65
Query: 302 SDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ-----------------DIELLADL 344
S N L + L SL L L L NN + E+
Sbjct: 66 SSNVLYETLD--LESLSTLRTLDLNNNYV-QELLVGPSIETLHAANNNISRVSCSRGQGK 122
Query: 345 DTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTG-PIPPTICDGDRLFKLILFSNNFT 403
+ L NN +T + G ++ +D+ N + D L L L N
Sbjct: 123 KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182
Query: 404 YSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQK 463
+ + + L L + N+L + F +T++ + N L I + L +Q
Sbjct: 183 -DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238
Query: 464 LEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG-KIPDFIGCKSIYKIELHNNLLN 522
LE+ ++ N F + + N ++ + + + + C
Sbjct: 239 LEHFDLRGNGFHCGTL-RDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
Query: 523 GSIPWDIGHCEKLLLLNLSRNSLTG----IIPWEISGLPSITDVDLSHNFLTGTIPSNFE 578
L + S G + E ++D I
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357
Query: 579 NCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGN 615
+ L + L +
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAV 394
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-34
Identities = 54/335 (16%), Positives = 123/335 (36%), Gaps = 15/335 (4%)
Query: 262 LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321
+ N + ++ + + + + ++ LDLS N LS A LA L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 322 RLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGP 381
L+L +NVL+ D+E L+ L TL L NN++ +L + T+ ++N+++
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 382 IPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG-SIPQGFGLLPNL 440
+ + G + L +N T + S + L ++ N+++ + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 441 TFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG 500
+++ N + ++ + KL+ L++S N + SA + +S ++KL
Sbjct: 172 EHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLVL 228
Query: 501 KIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSIT 560
+++ +L N + D + + +++ ++ + T
Sbjct: 229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 561 DVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
+ L+ + G
Sbjct: 288 LGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQG 322
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 103 bits (257), Expect = 4e-23
Identities = 42/205 (20%), Positives = 79/205 (38%), Gaps = 12/205 (5%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
+I E N + ++ D+ L ++ N+ +D+S N LS DL KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 465 EYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGS 524
E LN+S N + S L+ L +++ + + + SI + NN ++
Sbjct: 61 ELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-R 113
Query: 525 IPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG-TIPSNFENCSTL 583
+ G + + L+ N +T + + + +DL N + + TL
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 584 ESFNVSYNLLTGPIPASGTIFPNLH 608
E N+ YN + + +F L
Sbjct: 172 EHLNLQYNFIYD-VKG-QVVFAKLK 194
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-43
Identities = 54/321 (16%), Positives = 109/321 (33%), Gaps = 22/321 (6%)
Query: 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY 231
+ + L GS D + +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 232 NNLQGEVP--VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS 289
L+ +E A+ +++ + L P + L+ L+ + + E+P +
Sbjct: 66 RALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 290 YGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI---------EL 340
L+ L L+ N L +PAS+ASL L LS+ E+P+ + +
Sbjct: 123 MQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSN 400
L +L +L L + LP + + L ++ + ++ L+ + P I +L +L L
Sbjct: 182 LVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGC 239
Query: 401 NFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN 460
+ P + L RL ++D ++P L L +D+ +P +
Sbjct: 240 TALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299
Query: 461 AQKLEYLNISENSFQTSLPSN 481
+ + + Q L +
Sbjct: 300 LPANCIILVPPH-LQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 61/359 (16%), Positives = 111/359 (30%), Gaps = 51/359 (14%)
Query: 95 PPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRI 154
+ + +L + P + + + D + +I
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNNPQI 60
Query: 155 FNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+ LE L L + P LS L+ + + L
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273
LP + LE + + N L+ +P ASL L+ + I AC LP +++
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST---- 173
Query: 274 MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333
+ + L LQ L L + +PAS+A+L+ L L + N+ L
Sbjct: 174 -----------DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS-A 220
Query: 334 IPQDIELLADLDTL-LLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRL 392
+ I L L+ L L L PP L
Sbjct: 221 LGPAIHHLPKLEELDLRGCTALRN-------------------------YPPIFGGRAPL 255
Query: 393 FKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451
+LIL + ++P ++ + L +L ++ +P LP + + + +
Sbjct: 256 KRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 56/319 (17%), Positives = 98/319 (30%), Gaps = 37/319 (11%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDG---------------------PLQ 119
+L + P + + + +
Sbjct: 15 ENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADL 74
Query: 120 PAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQL 179
+++ FP +L L+ + LP Q L+ L
Sbjct: 75 LEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETL 132
Query: 180 NLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG---------LLTQLERIEIG 230
L + +P+ +L+ LR L + LP L L L+ + +
Sbjct: 133 TLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 231 YNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY 290
+ ++ +P A+L NLK + I LS L I +L KLE L L P +
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIF 249
Query: 291 GNLQALQVLDLSD-NQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLL 349
G L+ L L D + L +P + L L +L L V +P I L +L+
Sbjct: 250 GGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV 308
Query: 350 WNNHLTGVLPQKLGSNGKL 368
+ + + +
Sbjct: 309 PPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 6e-41
Identities = 46/267 (17%), Positives = 88/267 (32%), Gaps = 17/267 (6%)
Query: 75 PKSSQITSLDLSRRSLSGPIPPEIRYLTS--LTHLNLSANAFDGPLQPAILELTKLRTID 132
S+ + R+L + T L L + L+ L+ +
Sbjct: 53 ANSNNPQIETRTGRALKA-TADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMT 110
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG--------- 183
I P + + L N LP LN L++L++
Sbjct: 111 IDAAGLME-LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPE 168
Query: 184 SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFA 243
+ +++ L +L+ L L + SLP + L L+ ++I + L +
Sbjct: 169 PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIH 226
Query: 244 SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSD 303
L L+ +D+ C P L+ L+L +P+ L L+ LDL
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRG 286
Query: 304 NQLSGPIPASLASLKGLTRLSLMNNVL 330
+P+ +A L + + ++
Sbjct: 287 CVNLSRLPSLIAQLPANCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-40
Identities = 54/251 (21%), Positives = 95/251 (37%), Gaps = 14/251 (5%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISH 135
+L+L L P + L+ L H+ + A L + + L T+ ++
Sbjct: 79 TQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLAR 136
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLP---------LEFVQLNSLQQLNLGGSYF 186
N P I+ L LR + + LP E L +LQ L L +
Sbjct: 137 NPL-RALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGI 195
Query: 187 DGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246
+P+ NL +L+ L + + L+ +L P + L +LE +++ P F
Sbjct: 196 R-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRA 253
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
LK + + C+ TLP +I LT+LE L L +P L A ++ + +
Sbjct: 254 PLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313
Query: 307 SGPIPASLASL 317
+ +
Sbjct: 314 AQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 49/318 (15%), Positives = 94/318 (29%), Gaps = 22/318 (6%)
Query: 289 SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLL 348
+ + + L + P L+ + +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIET 62
Query: 349 LWNNHLTGVLPQKLG--SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSI 406
L L + + +++ S L P L + + + +
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-EL 119
Query: 407 PENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA----- 461
P+ + + L L + N L ++P L L + + E+P L +
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGE 178
Query: 462 ----QKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIG-CKSIYKIEL 516
L+ L + SLP++I + NLK L +S L+ + I + +++L
Sbjct: 179 HQGLVNLQSLRLEWTGI-RSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236
Query: 517 HNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN 576
+ P G L L L S +P +I L + +DL +PS
Sbjct: 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSL 296
Query: 577 FENCSTLESFNVSYNLLT 594
V +L
Sbjct: 297 IAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 31/227 (13%), Positives = 72/227 (31%), Gaps = 36/227 (15%)
Query: 405 SIPENLVNCSSLSRLRIQDN-----------------QLNGSIPQGFGLLPNLTFMDMSR 447
S + + S L Q + + + N +
Sbjct: 3 SSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIET 62
Query: 448 NSLSG--EIPRDLGNAQ--KLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIP 503
+ L +A L + P + +L+ ++ ++ L ++P
Sbjct: 63 RTGRALKATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 504 DFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSR-NSLTGI--------IPWEI 553
D + + + L N L ++P I +L L++ LT + E
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 554 SGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
GL ++ + L + ++P++ N L+S + + L+ + +
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPA 224
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 5e-13
Identities = 20/178 (11%), Positives = 46/178 (25%), Gaps = 15/178 (8%)
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPN 487
GS + ++ L Q+ + + + W N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADR-------NRWHSAWRQAN 54
Query: 488 LKILSASSSKLTG--KIPDFIGC---KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSR 542
+ D + +EL + L P L + +
Sbjct: 55 SNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDA 113
Query: 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
L +P + + + L+ N L +P++ + + L ++ +P
Sbjct: 114 AGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEP 169
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-42
Identities = 49/195 (25%), Positives = 82/195 (42%), Gaps = 32/195 (16%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
L + + I G G G VYK + +AVK +++N + + + + H N
Sbjct: 15 LKLLELI-GRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK----NIYRVPLMEHDN 68
Query: 771 IVRLLGCCSNRECT-----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
I R + +L+ EY PNG+L L +DWV+ ++A V +
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTR 122
Query: 826 GICYLHHD------CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS---------D 870
G+ YLH + P I HRDL N+L+ + ++DFG++ + D
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 871 ESMSVIAGSYGYIAP 885
+ G+ Y+AP
Sbjct: 183 NAAISEVGTIRYMAP 197
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 47/184 (25%), Positives = 78/184 (42%), Gaps = 25/184 (13%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G G G V++ GE +AVK + +++ R E+ +RH NI+ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFI 68
Query: 776 GCCSNRECT----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ L+ Y G+L D L D V+ +I L +A G+ +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLH 122
Query: 832 HD-----CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA-----GSYG 881
+ P I HRDLK NIL+ + +AD G+A + + + G+
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182
Query: 882 YIAP 885
Y+AP
Sbjct: 183 YMAP 186
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 27/193 (13%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR 767
L + + G G G K GE++ +K+L +E +R L EV V+ +
Sbjct: 10 SDLIHGEVL-GKGCFGQAIKVTHRETGEVMVMKELIRFDEET---QRTFLKEVKVMRCLE 65
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H N+++ +G + + EY+ G L ++ + W R A +A G+
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK--SMDSQY--PWSQRVSFAKDIASGM 121
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE---------------S 872
YLH I+HRDL N L+ VADFG+A+L+ ++
Sbjct: 122 AYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 873 MSVIAGSYGYIAP 885
+ G+ ++AP
Sbjct: 179 RYTVVGNPYWMAP 191
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-39
Identities = 49/185 (26%), Positives = 75/185 (40%), Gaps = 25/185 (13%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G G V+ + GE +AVK + + + R E+ +RH NI+
Sbjct: 42 VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRET----EIYQTVLMRHENILGF 96
Query: 775 LGCCSNRECT----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ + L+ +Y NG+L D L + D + K+A G+C+L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHL 150
Query: 831 H-----HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-----DESMSVIAGSY 880
H P I HRDLK NIL+ +AD G+A S D + G+
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 881 GYIAP 885
Y+ P
Sbjct: 211 RYMPP 215
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-39
Identities = 50/185 (27%), Positives = 78/185 (42%), Gaps = 25/185 (13%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G G V++ + GE +AVK + + + R E+ +RH NI+
Sbjct: 47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREA----EIYQTVMLRHENILGF 101
Query: 775 LGCCSNRECT----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ + T L+ +Y +G+L D L+ K+AL A G+ +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHL 155
Query: 831 HHD-----CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA-----GSY 880
H + P I HRDLK NIL+ +AD G+A S IA G+
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 881 GYIAP 885
Y+AP
Sbjct: 216 RYMAP 220
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 5e-38
Identities = 70/387 (18%), Positives = 137/387 (35%), Gaps = 52/387 (13%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
I ++Y +++ D + L + + +++ P +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAAL------- 64
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTG 212
++ LNL + EI + + +++ L + N++
Sbjct: 65 ----------------LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 213 SLPPQLGL-LTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNL 269
LPP + + L + + N+L +P F + L + +S NL + +
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 270 TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329
T L+ L L N T V + +L ++S N LS +LA + L +N
Sbjct: 165 TSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 330 LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
+ + + +L L L +N+LT L + L+ VD+S N L I
Sbjct: 217 I-NVVRGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK-IMYHPFVK 270
Query: 390 -DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN 448
RL +L + +N ++ +L L + N L + + L + + N
Sbjct: 271 MQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHN 328
Query: 449 SLSGEIPRDLGNAQKLEYLNISENSFQ 475
S+ + L L+ L +S N +
Sbjct: 329 SIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 67/351 (19%), Positives = 130/351 (37%), Gaps = 25/351 (7%)
Query: 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGL 320
+ S + + + L +++ ++ + A L S + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 321 TRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT 379
L+L + + EI + L + N + + P + L + + N L+
Sbjct: 72 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 380 GPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQGFGLL 437
+P I +L L + +NN I ++ +SL L++ N+L + L+
Sbjct: 131 S-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 185
Query: 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497
P+L ++S N LS L +E L+ S NS + + L IL +
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV--NVELTILKLQHNN 237
Query: 498 LTGKIPDFIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGL 556
LT + + +++L N L I + ++L L +S N L + +
Sbjct: 238 LT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 557 PSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNL 607
P++ +DLSHN L + N LE+ + +N + + S L
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTL 341
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-36
Identities = 72/409 (17%), Positives = 143/409 (34%), Gaps = 47/409 (11%)
Query: 213 SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTK 271
+ L + I E +L N K + + LP+ + + +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 70
Query: 272 LEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF 331
+E+L L ++ +Q L + N + P ++ LT L L N L
Sbjct: 71 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL- 129
Query: 332 GEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD 390
+P+ I L TL + NN+L + + L + +SSN LT + ++
Sbjct: 130 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPS- 187
Query: 391 RLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSL 450
LF + N + L ++ L N +N + + LT + + N+L
Sbjct: 188 -LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNL 238
Query: 451 SGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKS 510
+ + L N L +++S N + + F+ +
Sbjct: 239 T-DTA-WLLNYPGLVEVDLSYNEL-EKIMYHP----------------------FVKMQR 273
Query: 511 IYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT 570
+ ++ + NN L ++ L +L+LS N L + + ++ L HN +
Sbjct: 274 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
Query: 571 GTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLC 619
T+ TL++ +S+N + +F N+ + + C
Sbjct: 332 -TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQHC 375
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 30/197 (15%), Positives = 76/197 (38%), Gaps = 19/197 (9%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
+ ++S LS + ++ L+ S N+ + ++ + +L + + HN+
Sbjct: 186 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHNN 237
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ L + N + FV++ L++L + + + + +
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPI 294
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS--- 254
+L+ LDL+ N L + +LE + + +N++ ++ ++ LK + +S
Sbjct: 295 PTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHND 350
Query: 255 -ACNLSGTLPSEISNLT 270
CN L ++
Sbjct: 351 WDCNSLRALFRNVARPA 367
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 51/301 (16%), Positives = 113/301 (37%), Gaps = 16/301 (5%)
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249
I +N + + + +SL +L ++ +++ N L + A L+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309
+++S+ L ++ +L+ L L L N+ E+ +++ L ++N +S
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISR- 113
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLL 369
+ S +G + L NN + D + + L L N + V +L ++ L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 370 TV-DVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG 428
++ N + + + +L L L SN + + + ++ + +++N+L
Sbjct: 172 EHLNLQYNFIYD-VKGQVVFA-KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV- 227
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRDL-GNAQKLEYLNISENSFQTSLPSNIWSAPN 487
I + NL D+ N RD Q+++ + T + P
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 488 L 488
L
Sbjct: 288 L 288
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-34
Identities = 56/319 (17%), Positives = 108/319 (33%), Gaps = 19/319 (5%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
I + ++ ++ L ++ +D+S N + ++ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+ N SN L L++L+ L+L +Y E+ S+ L A N+++
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYV-QELL----VGPSIETLHAANNNIS-R 113
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG-TLPSEISNLTKL 272
+ + I + N + ++ ++Y+D+ + ++ L
Sbjct: 114 VSC--SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 273 EMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFG 332
E L L N ++ L+ LDLS N+L+ + S G+T +SL NN L
Sbjct: 172 EHLNLQYNFIY-DVK-GQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKL-V 227
Query: 333 EIPQDIELLADLDTLLLWNNHLT-GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDR 391
I + + +L+ L N G L N ++ TV + C
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287
Query: 392 LFKLILFSNNFTYSIPENL 410
L +P
Sbjct: 288 LGHY---GAYCCEDLPAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 53/287 (18%), Positives = 101/287 (35%), Gaps = 17/287 (5%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
+ LDLS LS ++ T L LNLS+N + L+ LRT+D+++N
Sbjct: 34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYET--LDLESLSTLRTLDLNNNY 91
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ + +A +N+ + + + + + L + D
Sbjct: 92 VQE-----LLVGPSIETLHAANNNISR---VSCSRGQGKKNIYLANNKITMLRDLDEGCR 143
Query: 198 SSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256
S +++LDL N + + LE + + YN + +V + LK +D+S+
Sbjct: 144 SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDLSSN 201
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
L+ + E + + + L N I + Q L+ DL N
Sbjct: 202 KLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF-- 257
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLG 363
R+ + ++ E + TL + + LP
Sbjct: 258 FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 52/324 (16%), Positives = 110/324 (33%), Gaps = 40/324 (12%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
N ++ ++D+ L + + S + L L N L D+ L+ L L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N L L L S L T+D+++N + + G + L +NN + + +
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS-- 117
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSG-EIPRDLGNAQKLEYLNIS 470
+ + +N++ G + ++D+ N + ++ LE+LN+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 471 ENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIG 530
N + + + ++L +N L + +
Sbjct: 178 YNFIYD-------------------------VKGQVVFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 531 HCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT-GTIPSNFENCSTLESFNVS 589
+ ++L N L +I + ++ DL N GT+ F +++
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 590 YN-LLTGPIPASGTIFPNLHPSSF 612
LTG T+ H ++
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAY 294
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 47/319 (14%), Positives = 106/319 (33%), Gaps = 19/319 (5%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
++ ++ SL + + ++ L+LS N + TKL +++S N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ L LR + +N E + S++ L+ + +
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCS--RG 119
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG-EVPVEFASLVNLKYMDISAC 256
+ + LA N +T G ++++ +++ N + AS L+++++
Sbjct: 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN 179
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
+ + ++ KL+ L L N + + + + + L +N+L I +L
Sbjct: 180 FIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRF 235
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
+ L L N + + + L + + T+
Sbjct: 236 SQNLEHFDLRGNGF-HCGTLRDFFSKNQRVQTVAKQTVKK-LTGQNEEECTVPTLGHYGA 293
Query: 377 SLTGPIPPTICDGDRLFKL 395
+P DRL L
Sbjct: 294 YCCEDLPAPF--ADRLIAL 310
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 57/311 (18%), Positives = 119/311 (38%), Gaps = 25/311 (8%)
Query: 262 LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321
+ N + ++ + + + + ++ LDLS N LS A LA L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 322 RLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGP 381
L+L +NVL E D+E L+ L TL L NN++ +L + T+ ++N+++
Sbjct: 62 LLNLSSNVL-YETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 382 IPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG-SIPQGFGLLPNL 440
+ + G + L +N T + S + L ++ N+++ + + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 441 TFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG 500
+++ N + ++ + KL+ L++S N + SA + +S ++KL
Sbjct: 172 EHLNLQYNFIY-DVKGQVVF-AKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV- 227
Query: 501 KIPD-FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSI 559
I +++ +L N HC L + + + L
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGF---------HCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
Query: 560 TDVDLSHNFLT 570
+ + + L
Sbjct: 279 NEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 42/205 (20%), Positives = 79/205 (38%), Gaps = 12/205 (5%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
+I E N + ++ D+ L ++ N+ +D+S N LS DL KL
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 465 EYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGS 524
E LN+S N + S L+ L +++ + + + SI + NN ++
Sbjct: 61 ELLNLSSNVL-YETLD-LESLSTLRTLDLNNNYVQ----ELLVGPSIETLHAANNNIS-R 113
Query: 525 IPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG-TIPSNFENCSTL 583
+ G + + L+ N +T + + + +DL N + + TL
Sbjct: 114 VSCSRG--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 584 ESFNVSYNLLTGPIPASGTIFPNLH 608
E N+ YN + + +F L
Sbjct: 172 EHLNLQYNFIYD-VKG-QVVFAKLK 194
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 39/176 (22%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+++G G G VY GE+ A++ + ++N + + EV RH N+V +
Sbjct: 39 ELIGKGRFGQVYHGRW-HGEV-AIRLI-DIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G C + ++ L ++ + L D +IA + +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVR--DAKIVL--DVNKTRQIAQEIVKGMGYLHA--- 148
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS------DESMSVIAGSYGYIAP 885
I+H+DLK N+ D + + DFG+ + ++ + + G ++AP
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 50/178 (28%), Positives = 80/178 (44%), Gaps = 15/178 (8%)
Query: 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+++ +I G GS GTVYK + G +AVK L ++ + EV VL RH N
Sbjct: 26 ITVGQRI-GSGSFGTVYKGKWHG--DVAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+ +G + ++ ++ +L LH + IA A+G+ YL
Sbjct: 82 ILLFMGYST-APQLAIVTQWCEGSSLYHHLH--ASETKF--EMKKLIDIARQTARGMDYL 136
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ---SDESMSVIAGSYGYIAP 885
H I+HRDLK +NI L + ++ DFG+A ++GS ++AP
Sbjct: 137 HA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-36
Identities = 90/505 (17%), Positives = 167/505 (33%), Gaps = 91/505 (18%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
I ++Y +++ D + L + + +++ P +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM-RKLPAAL------- 70
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTG 212
++ LNL + EI + + +++ L + N++
Sbjct: 71 ----------------LDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR- 112
Query: 213 SLPPQLGL-LTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNL 269
LPP + + L + + N+L +P F + L + +S NL + +
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 270 TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329
T L+ L L N T V + +L ++S N LS +LA + L +N
Sbjct: 171 TSLQNLQLSSNRLTH---VDLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 222
Query: 330 LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
+ + + +L L L +N+LT L + L+ VD+S N L
Sbjct: 223 I-NVVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELE---------- 267
Query: 390 DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN 448
I + V L RL I +N+L ++ +P L +D+S N
Sbjct: 268 ---------------KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHN 311
Query: 449 SLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGC 508
L + R+ +LE L + NS +L + LK L+ S +
Sbjct: 312 HLL-HVERNQPQFDRLENLYLDHNSI-VTLKLSTH--HTLKNLTLSHNDWD--------- 358
Query: 509 KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNF 568
L N+ ++ HC+ L P+ L I +
Sbjct: 359 -CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEK- 416
Query: 569 LTGTIPSNFENCSTLESFNVSYNLL 593
+ CS ++ N +L
Sbjct: 417 ----VQRAQGRCSATDTINSVQSLS 437
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 68/365 (18%), Positives = 132/365 (36%), Gaps = 25/365 (6%)
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
+Y + S + + + L +++ ++ +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTM 63
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSN 365
A L S + + L+L + + EI + L + N + + P +
Sbjct: 64 RKLPAALLDSFRQVELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNV 122
Query: 366 GKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQD 423
L + + N L+ +P I +L L + +NN I ++ +SL L++
Sbjct: 123 PLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSS 180
Query: 424 NQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIW 483
N+L + L+P+L ++S N LS L +E L+ S NS + +
Sbjct: 181 NRLT-HVD--LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGPV- 230
Query: 484 SAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSR 542
L IL + LT + + +++L N L I + ++L L +S
Sbjct: 231 -NVELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISN 287
Query: 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGT 602
N L + +P++ +DLSHN L + N LE+ + +N + + S
Sbjct: 288 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS-- 342
Query: 603 IFPNL 607
L
Sbjct: 343 THHTL 347
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 4e-34
Identities = 72/409 (17%), Positives = 143/409 (34%), Gaps = 47/409 (11%)
Query: 213 SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTK 271
+ L + I E +L N K + + LP+ + + +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQ 76
Query: 272 LEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF 331
+E+L L ++ +Q L + N + P ++ LT L L N L
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL- 135
Query: 332 GEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD 390
+P+ I L TL + NN+L + + L + +SSN LT + ++
Sbjct: 136 SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPS- 193
Query: 391 RLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSL 450
LF + N + L ++ L N +N + + LT + + N+L
Sbjct: 194 -LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVR--GPVNVELTILKLQHNNL 244
Query: 451 SGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKS 510
+ + L N L +++S N + + F+ +
Sbjct: 245 T-DTA-WLLNYPGLVEVDLSYNEL-EKIMYHP----------------------FVKMQR 279
Query: 511 IYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT 570
+ ++ + NN L ++ L +L+LS N L + + ++ L HN +
Sbjct: 280 LERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
Query: 571 GTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLC 619
T+ TL++ +S+N + +F N+ + + C
Sbjct: 338 -TLK--LSTHHTLKNLTLSHNDWDC--NSLRALFRNVARPAVDDADQHC 381
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-33
Identities = 72/440 (16%), Positives = 157/440 (35%), Gaps = 36/440 (8%)
Query: 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ + ++ +P + + LNL+ + A ++ + + N
Sbjct: 51 NNQKIVTFKNSTMRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFN 109
Query: 137 SFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-Y 194
+ PP + + L + N + F L L++ + + I D +
Sbjct: 110 AI-RYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
+ +SL+ L L+ N LT + L+ L + YN L A + ++ +D S
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL 314
+++ + + +L +L L N+ T + N L +DLS N+L +
Sbjct: 220 HNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
++ L RL + NN L + + + L L L +NHL + + +L + +
Sbjct: 275 VKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLD 332
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP--- 431
NS+ + + L L L N++ + L +++R + D + I
Sbjct: 333 HNSIV-TLKLSTH--HTLKNLTLSHNDWDCNSLRALF--RNVARPAVDDADQHCKIDYQL 387
Query: 432 -------QGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS 484
+ + ++ S+ ++ R G + +N ++
Sbjct: 388 EHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVP 447
Query: 485 APNLKILSASSSKLTGKIPD 504
+ L A ++L ++
Sbjct: 448 LQGNEQLEAEVNELRAEVQQ 467
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-36
Identities = 81/418 (19%), Positives = 149/418 (35%), Gaps = 42/418 (10%)
Query: 176 LQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ 235
L++L LD +S+T + + LT L ++ NN+
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 236 GEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQA 295
++ + NL Y+ + L+ L ++ LTKL L N T ++ VS
Sbjct: 78 T---LDLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDVS--QNPL 128
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
L L+ + N L+ ++ LT L N ++ D+ L TL N +T
Sbjct: 129 LTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
+ + N L ++ +N++T + +L L SN T I + +
Sbjct: 184 EL---DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQ 234
Query: 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
L+ N L + L LT + + L EI DL + +L Y
Sbjct: 235 LTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EI--DLTHNTQLIYFQAEGCRKI 288
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL 535
L ++ L +L ++ +T ++ D + + L+N L + D+ H KL
Sbjct: 289 KEL--DVTHNTQLYLLDCQAAGIT-EL-DLSQNPKLVYLYLNNTELT-EL--DVSHNTKL 341
Query: 536 LLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLL 593
L+ + + +P++ + + N + VS +LL
Sbjct: 342 KSLSCVNAHIQDFSS--VGKIPALNNNFEAEGQTITMPKETLTN--NSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 78/404 (19%), Positives = 141/404 (34%), Gaps = 48/404 (11%)
Query: 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG 183
+L L ++D ++S GI KL L SN+ T L+ Q +L L
Sbjct: 40 QLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITT---LDLSQNTNLTYLACDS 94
Query: 184 SYFDGEIPS-DYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEF 242
+ ++ + D L+ L +L+ N LT L + L + N L ++
Sbjct: 95 N----KLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDV 144
Query: 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
+ L +D L ++ T+L L N T E+ VS + L L+
Sbjct: 145 SHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELDVS--QNKLLNRLNCD 199
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTLLLWNNHLTGVLPQ 360
N ++ L LT L +N L +I++ L L N LT +
Sbjct: 200 TNNITKL---DLNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLTEL--- 248
Query: 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
+ + KL T+ L I T +L + ++ + + L L
Sbjct: 249 DVSTLSKLTTLHCIQTDLLE-IDLTHN--TQLIYFQAEGCRKIKEL--DVTHNTQLYLLD 303
Query: 421 IQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPS 480
Q + + P L ++ ++ L+ E+ D+ + KL+ L+ S
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL--DVSHNTKLKSLSCVNAHI-QDFSS 356
Query: 481 NIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGS 524
+ P L + + +P + I + +LL+
Sbjct: 357 -VGKIPALNNNFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 8e-32
Identities = 82/449 (18%), Positives = 154/449 (34%), Gaps = 45/449 (10%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
+ +TSLD S++ I LT LT L ++N + + T L + N
Sbjct: 42 ATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT---TLDLSQNTNLTYLACDSNK 96
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS-DYRN 196
+ ++ L L N +N T L+ Q L LN + + D +
Sbjct: 97 L-TNLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNCARN----TLTEIDVSH 146
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256
+ L LD N L + TQL ++ +N + ++ + L ++
Sbjct: 147 NTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTN 201
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
N++ L ++ +L L N T EI V+ L L D S N L+ + S +
Sbjct: 202 NIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELDVS--T 252
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
L LT L + L EI D+ L L + N +L +D +
Sbjct: 253 LSKLTTLHCIQTDL-LEI--DLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAA 307
Query: 377 SLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL 436
+T + + +L L L + T + + + + L L + + G
Sbjct: 308 GIT-ELDLSQN--PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGK 359
Query: 437 LPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSS 496
+P L + +P++ L + +S + + + +++
Sbjct: 360 IPALNNNFEAEGQTI-TMPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
Query: 497 KLTGKIPDFIGCKSIYKIELHNNLLNGSI 525
+T + Y N + G++
Sbjct: 418 TITWENLSTDNPAVTYTFTSENGAIVGTV 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-30
Identities = 67/371 (18%), Positives = 115/371 (30%), Gaps = 59/371 (15%)
Query: 224 LERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283
+Q + L L +D +++ + I LT L L+ N+ T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNIT 77
Query: 284 GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343
+ +S L L N+L+ + L LT L+ N L D+
Sbjct: 78 -TLDLS--QNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKL---TKLDVSQNPL 128
Query: 344 LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFT 403
L L N LT + + N +L +D N + +L L N T
Sbjct: 129 LTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNKIT 183
Query: 404 YSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQK 463
+ + L+RL N + + LTF+D S N L+ EI D+ +
Sbjct: 184 -ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EI--DVTPLTQ 234
Query: 464 LEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNG 523
L Y + S N T L + + L L + L
Sbjct: 235 LTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLLE----------------------- 268
Query: 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583
D+ H +L+ + +++ + +D +T + L
Sbjct: 269 ---IDLTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKL 320
Query: 584 ESFNVSYNLLT 594
++ LT
Sbjct: 321 VYLYLNNTELT 331
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 143 bits (361), Expect = 1e-35
Identities = 88/407 (21%), Positives = 139/407 (34%), Gaps = 75/407 (18%)
Query: 100 YLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYS 159
LN+ + L + + T+ I N+ S P +LR L
Sbjct: 38 LNNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTS-LPALPPELRTL---EVSG 90
Query: 160 NSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG 219
N T LP+ L L + + +P+ S L L + GN LT SLP
Sbjct: 91 NQLTS-LPVLPPGLLELSIFSNPLT----HLPA---LPSGLCKLWIFGNQLT-SLPVLPP 141
Query: 220 LLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFK 279
L+ + +S L+ +LP+ S L KL
Sbjct: 142 ---------------------------GLQELSVSDNQLA-SLPALPSELCKLWAY---N 170
Query: 280 NHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE 339
N T +P+ LQ L +SDNQL+ +P + L +L NN L +P
Sbjct: 171 NQLT-SLPMLPSGLQ---ELSVSDNQLAS-LPTLPSEL---YKLWAYNNRL-TSLP---A 218
Query: 340 LLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFS 399
L + L L++ N LT LP L + VS N LT +P L L ++
Sbjct: 219 LPSGLKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLTS-LPMLPS---GLLSLSVYR 270
Query: 400 NNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLG 459
N T +PE+L++ SS + + ++ N L+ Q + +
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 460 NAQKLEYLN---ISENSFQTSLPSNIWSA----PNLKILSASSSKLT 499
+ L + P++ W N S +L+
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLS 376
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 1e-34
Identities = 83/391 (21%), Positives = 126/391 (32%), Gaps = 91/391 (23%)
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256
+ L++ + LT +LP L + + I NNL +P L L ++S
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
L+ +LP L +L + H L L + NQL+ +P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQLTS-LPVLPPG 142
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
L LS+ +N L +P L ++L L +NN LT LP L + VS N
Sbjct: 143 L---QELSVSDNQL-ASLP---ALPSELCKLWAYNNQLT-SLPMLPSG---LQELSVSDN 191
Query: 377 SLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL 436
L S+P S L +L +N+L S+P L
Sbjct: 192 QLA-------------------------SLPTLP---SELYKLWAYNNRLT-SLP---AL 219
Query: 437 LPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSS 496
L + +S N L+ +P L+ L +S N TSLP L LS +
Sbjct: 220 PSGLKELIVSGNRLT-SLPVLPSE---LKELMVSGNRL-TSLPMLP---SGLLSLSVYRN 271
Query: 497 KLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGL 556
+LT +P + H +NL N L+ + +
Sbjct: 272 QLT------------------------RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 557 PSITDVDLSHNFLTGTIPSNFENCSTLESFN 587
S S L
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAA 338
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-32
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 43/313 (13%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
VL++ ++ L+ +P L +T L + +N L +P L +L TL + N LT
Sbjct: 42 NAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNL-TSLP---ALPPELRTLEVSGNQLT 94
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
LP +L L L KL +F N T S+P
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQLT-SLPVLPPG--- 142
Query: 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
L L + DNQL S+P L L N L+ +P L+ L++S+N
Sbjct: 143 LQELSVSDNQLA-SLPALPSELCKL---WAYNNQLT-SLPMLPSG---LQELSVSDNQL- 193
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL 535
SLP+ L L A +++LT +P + ++ + N L S+P L
Sbjct: 194 ASLPTLP---SELYKLWAYNNRLT-SLPALPS--GLKELIVSGNRLT-SLPVLPSE---L 243
Query: 536 LLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
L +S N LT +P SGL + + N LT +P + + S+ + N+ N L+
Sbjct: 244 KELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSE 298
Query: 596 PIPASGTIFPNLH 608
+ +
Sbjct: 299 RTLQALREITSAP 311
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-35
Identities = 99/477 (20%), Positives = 181/477 (37%), Gaps = 40/477 (8%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
S + T L++S+ +S +I L+ L L +S N +L +D+SHN
Sbjct: 20 SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYR 195
L+ L + N+F P+ EF ++ L+ L L ++ +
Sbjct: 80 KLVKISCHPTVNLKHLDL---SFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIA 136
Query: 196 NLSSLRFLDLAGNSLTGSLPP---QLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252
+L+ + L + G + P Q L + + V ++ NL+ +
Sbjct: 137 HLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 253 IS------ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQ---ALQVLDLSD 303
I C+ ++ +++ KL L L T + L + +S+
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 304 NQLSGPIPASLA-----SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVL 358
+L G + SLK L+ ++++V E+ ++++ + V
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 359 PQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN---LVNCS 414
L +D S+N LT C L LIL N + +
Sbjct: 317 MLCPSKISPFLHLDFSNNLLTD-TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 415 SLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENS 473
SL +L I N ++ +G +L ++MS N L+ I R L +++ L++ N
Sbjct: 375 SLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNK 432
Query: 474 FQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWD 528
+ S+P + L+ L+ +S++L +PD F S+ KI LH N PWD
Sbjct: 433 IK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN------PWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-33
Identities = 107/510 (20%), Positives = 186/510 (36%), Gaps = 57/510 (11%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNS 140
+D S+ L +P ++ T LN+S N IL L+KLR + ISHN
Sbjct: 3 FLVDRSKNGLIH-VPKDL--SQKTTILNISQNYISELWTSDILSLSKLRILIISHNRI-Q 58
Query: 141 TFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSL 200
+ F L+ L+L + +I +L
Sbjct: 59 YLDISV-----------------------FKFNQELEYLDLSHNKL-VKISCH--PTVNL 92
Query: 201 RFLDLAGNSLTGSLPPQ--LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
+ LDL+ N+ +LP G ++QL+ + + +L+ + A L K + +
Sbjct: 93 KHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY 151
Query: 259 SGTLPSE---ISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG------P 309
E N L ++ F + VS + L++ ++
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLL---LWNNHLTGVL----PQKL 362
I A L + L+ L+L N I L T+ + N L G L
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN-CSSLSRLRI 421
G++ K L++ + + G I + + F+ + T + + S L
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 422 QDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLG---NAQKLEYLNISENSFQTSL 478
+N L ++ + G L L + + N L E+ + + L+ L+IS+NS
Sbjct: 332 SNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDE 390
Query: 479 PSNIWSAP-NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLL 537
S +L L+ SS+ LT I + I ++LH+N + SIP + E L
Sbjct: 391 KKGDCSWTKSLLSLNMSSNILTDTIFRCLP-PRIKVLDLHSNKIK-SIPKQVVKLEALQE 448
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
LN++ N L + L S+ + L N
Sbjct: 449 LNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 64/414 (15%), Positives = 128/414 (30%), Gaps = 52/414 (12%)
Query: 202 FLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGT 261
+D + N L +P L + + I N + + SL L+ + IS +
Sbjct: 4 LVDRSKNGLI-HVPK--DLSQKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-Y 59
Query: 262 LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321
L + + Q L+ LDLS N+L S L
Sbjct: 60 LDISV-----------------------FKFNQELEYLDLSHNKLVK---ISCHPTVNLK 93
Query: 322 RLSLMNNVLFGEIPQDIEL--LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT 379
L L N F +P E ++ L L L HL + + V +
Sbjct: 94 HLDLSFN-AFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG 152
Query: 380 GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPN 439
P L T +++ S + ++ + + +
Sbjct: 153 EKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK--------CVLE 202
Query: 440 LTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLT 499
+ L+ + L + + NSF + +W + S S+ KL
Sbjct: 203 DNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSF-IRILQLVWH-TTVWYFSISNVKLQ 260
Query: 500 GKIP------DFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEI 553
G++ K++ ++ +++ + + + N + + +
Sbjct: 261 GQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCP 320
Query: 554 SGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNL 607
S + +D S+N LT T+ N + + LE+ + N L + + +
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQM 373
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 67.6 bits (165), Expect = 9e-12
Identities = 43/167 (25%), Positives = 66/167 (39%), Gaps = 8/167 (4%)
Query: 73 CNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFD--GPLQPAILELTKLRT 130
C K S LD S L+ + +LT L L L N + ++ L+
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQ 378
Query: 131 IDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE 189
+DIS NS + G S + L N SN T + ++ L+L +
Sbjct: 379 LDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-S 435
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQ 235
IP L +L+ L++A N L S+P LT L++I + N
Sbjct: 436 IPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 65/307 (21%), Positives = 123/307 (40%), Gaps = 12/307 (3%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+ R LDL N + + LE +E+ N + P F +L NL+ + + +
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 258 LSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
L +P + + L+ L L + +N + + +L L+ L++ DN L + +
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 317 LKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L L +L+L L IP + L L L L + ++ + +L +++S
Sbjct: 151 LNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISH 209
Query: 376 NSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG- 433
+ P G L L + N T ++P + + L L + N ++ +I
Sbjct: 210 WPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGSM 267
Query: 434 FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKIL 491
L L + + L+ + L LN+S N T+L +++ + NL+ L
Sbjct: 268 LHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETL 325
Query: 492 SASSSKL 498
S+ L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 68/332 (20%), Positives = 134/332 (40%), Gaps = 16/332 (4%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+ R + ++P G+ T+ +++G N ++ EFAS +L+ ++++
Sbjct: 11 AQDRAVLCHRKRFV-AVPE--GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENI 67
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQLSGPIPASLAS 316
+S P +NL L L L N IP+ + L L LD+S+N++ +
Sbjct: 68 VSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQD 126
Query: 317 LKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L L L + +N L I L L+ L L +LT + + L L+ + +
Sbjct: 127 LYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH 185
Query: 376 NSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG- 433
++ I RL L + + ++ N + +L+ L I L ++P
Sbjct: 186 LNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLA 243
Query: 434 FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNI-WSAPNLKILS 492
L L F+++S N +S L +L+ + + + L++L+
Sbjct: 244 VRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLN 302
Query: 493 ASSSKLTGKIPD--FIGCKSIYKIELHNNLLN 522
S ++LT + + F ++ + L +N L
Sbjct: 303 VSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-32
Identities = 85/378 (22%), Positives = 140/378 (37%), Gaps = 38/378 (10%)
Query: 58 SSEQEPVWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--- 112
S++ V C P+ ++ LDL + + E L L L+ N
Sbjct: 10 SAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS 69
Query: 113 -----AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPL 166
AF+ L LRT+ + N P G+ + L L + N L
Sbjct: 70 AVEPGAFNN--------LFNLRTLGLRSNRL-KLIPLGVFTGLSNLTKLDISENKIVILL 120
Query: 167 PLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQL 224
F L +L+ L +G + I + L+SL L L +LT S+P + L L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGL 178
Query: 225 ERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTG 284
+ + + N+ F L LK ++IS T+ L L + + T
Sbjct: 179 IVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT- 237
Query: 285 EIP-VSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLA 342
+P ++ +L L+ L+LS N +S + L L L + L+ L + L
Sbjct: 238 AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLN 296
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402
L L + N LT + S G L T+ + SN L CD L+ +F +
Sbjct: 297 YLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL-------ACDCRLLW---VFRRRW 346
Query: 403 TYSIPENLVNCSSLSRLR 420
+ C++ ++
Sbjct: 347 RLNFNRQQPTCATPEFVQ 364
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 66/307 (21%), Positives = 118/307 (38%), Gaps = 17/307 (5%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHL 354
++LDL N++ AS L L L N++ + L +L TL L +N L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVN 412
+ L +D+S N + + + L L + N+ I
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVI-LLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSG 150
Query: 413 CSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNIS 470
+SL +L ++ L SIP L L + + +++ I +L+ L IS
Sbjct: 151 LNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN-AIRDYSFKRLYRLKVLEIS 208
Query: 471 ENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWD 528
+ ++ N NL LS + LT +P + + L N ++ +I
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
Query: 529 I-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESF 586
+ +L + L L + P+ GL + +++S N LT T+ + F + LE+
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETL 325
Query: 587 NVSYNLL 593
+ N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 9e-07
Identities = 25/122 (20%), Positives = 53/122 (43%), Gaps = 7/122 (5%)
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIP--DFIGCKSIYKIELHNNLLNGSIPWDI-GHC 532
++P I ++L +++ + +F + ++EL+ N++ ++ +
Sbjct: 24 VAVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIV-SAVEPGAFNNL 79
Query: 533 EKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNL 592
L L L N L I +GL ++T +D+S N + + F++ L+S V N
Sbjct: 80 FNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDND 139
Query: 593 LT 594
L
Sbjct: 140 LV 141
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 45/183 (24%), Positives = 83/183 (45%), Gaps = 19/183 (10%)
Query: 712 SMSD----KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
SM + +G GS G + G +K++ + + + R EV VL N+
Sbjct: 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANM 80
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGV 823
+H NIV+ ++ +Y G+L ++A+ E+ + DW +I L +
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFV--QICLAL 138
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGY 882
++H D I+HRD+K NI L + ++ DFG+A+++ S + G+ Y
Sbjct: 139 K----HVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 883 IAP 885
++P
Sbjct: 192 LSP 194
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-30
Identities = 82/408 (20%), Positives = 163/408 (39%), Gaps = 46/408 (11%)
Query: 198 SSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDISA 255
+ + ++DL+ NS+ L L L+ +++ + F L +L + +
Sbjct: 30 AHVNYVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 256 CNLSGTLPSEI-SNLTKLEMLLLFKNHFTG-EIPVSY-GNLQALQVLDLSDNQLSGPIPA 312
L + + L LE+L L + + G + ++ L +L++L L DN + PA
Sbjct: 89 NQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPA 147
Query: 313 SL-ASLKGLTRLSLMNNVLFGEIPQDI---ELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368
S +++ L L N + I ++ L L + L
Sbjct: 148 SFFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQ------------- 193
Query: 369 LTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG 428
D++ L + L L N F S+ + +++ +IQ L+
Sbjct: 194 ---DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF--FDAIAGTKIQSLILSN 248
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA-PN 487
S G F D + G A ++ ++S++ +L +++S +
Sbjct: 249 SYNMGSSFGHT-NFKDPDNFTFKGL------EASGVKTCDLSKSKI-FALLKSVFSHFTD 300
Query: 488 LKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNS 544
L+ L+ + +++ KI D F G + K+ L N L GSI + + +KL +L+LS N
Sbjct: 301 LEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNH 358
Query: 545 LTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYN 591
+ + GLP++ ++ L N L ++P F+ ++L+ + N
Sbjct: 359 IRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-29
Identities = 80/483 (16%), Positives = 148/483 (30%), Gaps = 89/483 (18%)
Query: 77 SSQITSLDLSRRSLSG--PIPPEIRYL----TSLTHLNLSANAFDGPLQPAILELTKLRT 130
S + R L +P + Y+ S+ L + +F L L+
Sbjct: 9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAEL--NETSFSR--------LQDLQF 58
Query: 131 IDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF-DG 188
+ + + L L I N F F L +L+ L L
Sbjct: 59 LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118
Query: 189 EIPSDY-RNLSSLRFLDLAGNSLTGSLPPQ--LGLLTQLERIEIGYNNLQGEVPVEFASL 245
+ ++ + L+SL L L N++ + P + + +++ +N ++ + +
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIK-KIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177
Query: 246 VNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305
+ + L+ + + + + E + ++ LDLS N
Sbjct: 178 QGKHFTLL--------------RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNG 223
Query: 306 LSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE--LLADLDTLLLWNNHLTGVLPQKLG 363
+ T++ + + D D +
Sbjct: 224 FKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS-------- 275
Query: 364 SNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRI 421
+ T D+S + + + ++ L +L L N I +N + L +L +
Sbjct: 276 ---GVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNL 330
Query: 422 QDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL-GNAQKLEYLNISENSFQTSLP 479
N L GSI F L L +D+S N + + L+ L + N S+P
Sbjct: 331 SQNFL-GSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL-KSVP 387
Query: 480 SNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLN 539
I F S+ KI LH N PWD C +
Sbjct: 388 DGI----------------------FDRLTSLQKIWLHTN------PWD---CSCPRIDY 416
Query: 540 LSR 542
LSR
Sbjct: 417 LSR 419
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-21
Identities = 53/314 (16%), Positives = 101/314 (32%), Gaps = 24/314 (7%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHL 354
+ +DLS N ++ S + L+ L L + I + L+ L L L N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTG-PIPPTICDG-DRLFKLILFSNNFTYSIPENL-V 411
+ L + ++ +L G + L L+L NN P + +
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFM----------DMSRNSLSGEIPRDLGNA 461
N L + N++ + F DM+ L E +
Sbjct: 152 NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 462 QKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLL 521
+ L++S N F+ S+ + A + + + + G + N
Sbjct: 212 TSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKD--PDNFTF 269
Query: 522 NGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENC 580
G + +LS++ + ++ S + + L+ N + I N F
Sbjct: 270 KGL------EASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGL 322
Query: 581 STLESFNVSYNLLT 594
+ L N+S N L
Sbjct: 323 THLLKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 9e-08
Identities = 35/171 (20%), Positives = 63/171 (36%), Gaps = 46/171 (26%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSAN--------AFDGPLQPAILELT 126
++S + + DLS+ + + + + T L L L+ N AF G LT
Sbjct: 273 EASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEINKIDDNAFWG--------LT 323
Query: 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYF 186
L +++S N + + F L+ L+ L+L ++
Sbjct: 324 HLLKLNLSQNFL-GSIDSRM-----------------------FENLDKLEVLDLSYNHI 359
Query: 187 DGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQ 235
+ + L +L+ L L N L S+P LT L++I + N
Sbjct: 360 -RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 48/190 (25%), Positives = 83/190 (43%), Gaps = 36/190 (18%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+++G G G V+KA+ G+ +K++ + E R EV L + H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAER------EVKALAKLDHVNIVHY 69
Query: 775 LGC-------------CSNRECTMLLY---EYMPNGNLDDLLHAKNKG---ENLVADWVT 815
GC S+R T L+ E+ G L+ + + + L +
Sbjct: 70 NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF- 128
Query: 816 RYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
+I GV Y+H +++RDLKPSNI L + ++ DFG+ +++D +
Sbjct: 129 -EQITKGVD----YIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180
Query: 876 IAGSYGYIAP 885
G+ Y++P
Sbjct: 181 SKGTLRYMSP 190
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 49/180 (27%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
D +G GS TVYK + +A + K +R E ++L ++H NI
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR---FKEEAEMLKGLQHPNI 87
Query: 772 VRLLGC----CSNRECTMLLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGVAQG 826
VR ++C +L+ E M +G L L K ++ W + + +G
Sbjct: 88 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------ILKG 141
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ +LH P I+HRDLK NI + G ++ D G+A L ++ + +VI G+ ++AP
Sbjct: 142 LQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI-GTPEFMAP 199
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 49/165 (29%), Positives = 82/165 (49%), Gaps = 18/165 (10%)
Query: 716 KILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+ LG G G V GE +AVK L K + + E+++L N+ H N
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL--KPESGGNHIADLKKEIEILRNLYHEN 84
Query: 771 IVRLLGCCS--NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
IV+ G C+ L+ E++P+G+L + L KNK + + + K A+ + +G+
Sbjct: 85 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP-KNKNKINLKQQL---KYAVQICKGMD 140
Query: 829 YLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
YL VHRDL N+L++ E + ++ DFG+ K I++D+
Sbjct: 141 YLGSRQY----VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 49/184 (26%), Positives = 80/184 (43%), Gaps = 26/184 (14%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLA-EVDVLGNVRHRNIV 772
ILG G+T V++ G++ A+K + + R V E +VL + H+NIV
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF---NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 773 RLLGCCSNRECTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG----VAQ 825
+L T E+ P G+L +L + L L V
Sbjct: 71 KLFAIEEETT-TRHKVLIMEFCPCGSLYTVLEEPSNAYGL------PESEFLIVLRDVVG 123
Query: 826 GICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
G+ +L + IVHR++KP NI+ DG+ ++ DFG A+ ++ DE + G+
Sbjct: 124 GMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180
Query: 882 YIAP 885
Y+ P
Sbjct: 181 YLHP 184
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-29
Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 10/157 (6%)
Query: 716 KILGMGSTGTVYKAEMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G+ G V+ + +AVK + + L E +L H NIVRL
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRL 177
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+G C+ ++ ++ E + G+ L + +G L T ++ A G+ YL C
Sbjct: 178 IGVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVK--TLLQMVGDAAAGMEYLESKC 233
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HRDL N L+ + +++DFG+++
Sbjct: 234 ---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 47/165 (28%), Positives = 83/165 (50%), Gaps = 19/165 (11%)
Query: 715 DKILGMGSTGTVYKAE--MPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K+LG G+ GTVYK G ++ +A+K+L + + + + +L E V+ +V +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNP 77
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ RLLG C L+ + MP G L D + ++K + + +A+G+ Y
Sbjct: 78 HVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLL---NWCVQIAKGMNY 132
Query: 830 L--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
L +VHRDL N+L+ ++ DFG+AKL+ ++E
Sbjct: 133 LEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 48/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
+ L ++D LG G+ G+V + M +I +A+K L K ++ E ++
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQ 66
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+ + IVRL+G C E ML+ E G L L + E V++ ++ V+
Sbjct: 67 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVA---ELLHQVSM 121
Query: 826 GICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
G+ YL + VHRDL N+LL A+++DFG++K + +D+S
Sbjct: 122 GMKYLEEKN-----FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-29
Identities = 103/484 (21%), Positives = 182/484 (37%), Gaps = 58/484 (11%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--------AFDGPLQPAILELTKLR 129
+ +L LS+ S+S P+I +L+ L L LS N F L
Sbjct: 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFL--------FNQDLE 103
Query: 130 TIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDG 188
+D+SHN + ++ LR L + N F P+ EF L L L L + F
Sbjct: 104 YLDVSHNRLQNISCCPMASLRHLDLSF---NDFDVLPVCKEFGNLTKLTFLGLSAAKFRQ 160
Query: 189 EIPSDYRNLS-SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ---GEVPVEFAS 244
+L S LDL + G L + + + ++ +V + +
Sbjct: 161 LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNA 219
Query: 245 LVNLKYMDIS----ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQ---ALQ 297
L +L+ +I C T SE++ L + L T + V ++
Sbjct: 220 LGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVE 279
Query: 298 VLDLSDNQLSGPIP-----ASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNN 352
L++ + ++ I S +LK L + N V + A+++ +L +
Sbjct: 280 YLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSIS 339
Query: 353 HLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLV 411
+ S ++ + N T C RL LIL N + + +
Sbjct: 340 DTPFIHMVCPPSPSSFTFLNFTQNVFTD-SVFQGCSTLKRLQTLILQRNGLK-NFFKVAL 397
Query: 412 NCSSLSRLRIQDNQLNGSIPQG-----FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEY 466
++S L D LN S+ ++ +++S N L+G + R L K++
Sbjct: 398 MTKNMSSLETLDVSLN-SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKV 454
Query: 467 LNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGS 524
L++ N S+P ++ L+ L+ +S++L +PD F S+ I LH+N
Sbjct: 455 LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN----- 507
Query: 525 IPWD 528
PWD
Sbjct: 508 -PWD 510
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-27
Identities = 96/553 (17%), Positives = 207/553 (37%), Gaps = 87/553 (15%)
Query: 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAIL 123
G + + +D S R+L+ +P ++ L+LS N+ L+ +
Sbjct: 17 ALALIVGSMTPFSNELESMVDYSNRNLTH-VPKDL--PPRTKALSLSQNSISE-LRMPDI 72
Query: 124 E-LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLG 182
L++LR + +SHN + + F+ L+ L++
Sbjct: 73 SFLSELRVLRLSHNRI-RSLDFHV-----------------------FLFNQDLEYLDVS 108
Query: 183 GSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPP--QLGLLTQLERIEIGYNNLQGEVPV 240
+ I ++SLR LDL+ N LP + G LT+L + + + +
Sbjct: 109 HNRL-QNISCC--PMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQ---L 161
Query: 241 EFASLVNLKYMDISACNLSGTLPS------EISNLTKLEMLLLFKNHFTGEIPVSYGNLQ 294
+ + +L I +S + +I N T L ++ + F+ ++ +S L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALG 221
Query: 295 ALQV--LDLSDNQLSGPIPASLASLKGLTRLSLM---NNVLFGEIPQDIELL--ADLDTL 347
LQ+ + L+D + +G T L++ + + + ++ L
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 348 LLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG--DRLFKLIL--FSNNFT 403
++N +T + ++ + + + + + + ++ + S + T
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 404 YSIPENLVN-CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS--GEIPRDLGN 460
I SS + L N S+ QG L L + + RN L ++ N
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 461 AQKLEYLNISENSFQTSLPSNIWSAP-NLKILSASSSKLTGKIPDFIGCKSIYKIELHNN 519
LE L++S NS + + ++ +L+ SS+ LTG +
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR--------------- 446
Query: 520 LLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FE 578
+P K+ +L+L N + IP +++ L ++ +++++ N L ++P F+
Sbjct: 447 ----CLP------PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFD 494
Query: 579 NCSTLESFNVSYN 591
++L+ + N
Sbjct: 495 RLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 64/430 (14%), Positives = 137/430 (31%), Gaps = 62/430 (14%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+D + +LT +P L + + + + N++ + + L L+ + +S
Sbjct: 31 ELESMVDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNR 87
Query: 258 LSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL-SGPIPASLA 315
+ +L + LE L + N +S + +L+ LDLS N P+
Sbjct: 88 IR-SLDFHVFLFNQDLEYLDVSHNRLQN---ISCCPMASLRHLDLSFNDFDVLPVCKEFG 143
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
+L LT L L LD L + + HL + +D+ S
Sbjct: 144 NLTKLTFLGLSAAKF-----------RQLDLLPVAHLHL------------SCILLDLVS 180
Query: 376 NSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG------- 428
+ G ++ + ++F N +S+ N+ ++L L++ + +LN
Sbjct: 181 YHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV-NALGHLQLSNIKLNDENCQRLM 239
Query: 429 -SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQ--KLEYLNISENSFQTSLPSNIWSA 485
+ + L + + +EYLNI + + ++
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 486 PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSL 545
+ KS+ + N + S ++ + LS +
Sbjct: 300 SETAL------------------KSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341
Query: 546 TGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFP 605
I S T ++ + N T ++ L++ + N L +
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTK 400
Query: 606 NLHPSSFIGN 615
N+ +
Sbjct: 401 NMSSLETLDV 410
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 48/165 (29%), Positives = 77/165 (46%), Gaps = 14/165 (8%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVR 767
++M LG G G VY+ + +AVK L KE+ L E V+ ++
Sbjct: 13 TDITM-KHKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIK 67
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H N+V+LLG C+ ++ E+M GNL D L N+ E + +A ++ +
Sbjct: 68 HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL---YMATQISSAM 124
Query: 828 CYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL + +HRDL N L+ +VADFG+++L+ D
Sbjct: 125 EYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 49/181 (27%), Positives = 86/181 (47%), Gaps = 18/181 (9%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G GS G K G+I+ K+L ++ +++EV++L ++H NIVR
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70
Query: 775 LGCCSNRECTML--LYEYMPNGNLDDLL-HAKNKG----ENLVADWVTRYKIALGVAQGI 827
+R T L + EY G+L ++ + E V +T ++ L +
Sbjct: 71 YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT--QLTLALK--- 125
Query: 828 CYLH--HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIA 884
H D ++HRDLKP+N+ LDG+ ++ DFG+A+++ D S G+ Y++
Sbjct: 126 -ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 885 P 885
P
Sbjct: 185 P 185
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 53/174 (30%), Positives = 88/174 (50%), Gaps = 27/174 (15%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEI-IAVKKLWGKHKENI---RRRRGVLAEVDV 762
+ L++ DK LG G+ GTV K M +AVK L K + +LAE +V
Sbjct: 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL----KNEANDPALKDELLAEANV 71
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIA 820
+ + + IVR++G C E ML+ E G L+ L + K +N++ ++
Sbjct: 72 MQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNII-------ELV 123
Query: 821 LGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
V+ G+ YL + VHRDL N+LL + A+++DFG++K +++DE+
Sbjct: 124 HQVSMGMKYLEESN-----FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 57/185 (30%), Positives = 95/185 (51%), Gaps = 21/185 (11%)
Query: 705 DDVLECLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVL 763
DD E + LG G+ G V+K P G ++A K + + K IR + ++ E+ VL
Sbjct: 32 DDDFEKI----SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVL 85
Query: 764 GNVRHRNIVRLLGC-CSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIAL 821
IV G S+ E ++ + E+M G+LD +L + E ++ K+++
Sbjct: 86 HECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVLKKAGRIPEQILG------KVSI 138
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-VIAGSY 880
V +G+ YL I+HRD+KPSNIL++ E ++ DFGV+ Q +SM+ G+
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFVGTR 194
Query: 881 GYIAP 885
Y++P
Sbjct: 195 SYMSP 199
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-28
Identities = 48/179 (26%), Positives = 81/179 (45%), Gaps = 16/179 (8%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLA-EVDVLGNVRHRNIV 772
ILG G+T V++ G++ A+K + + R V E +VL + H+NIV
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVF---NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 773 RLLGCCSNRECTM--LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+L L+ E+ P G+L +L + L + V G+ +L
Sbjct: 71 KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES-EFL-IVLRDVVGGMNHL 128
Query: 831 HHDCDPVIVHRDLKPSNILL----DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ IVHR++KP NI+ DG+ ++ DFG A+ ++ DE + G+ Y+ P
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 47/175 (26%), Positives = 83/175 (47%), Gaps = 15/175 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRR---RRGVLAEVDVLGNVRHRNI 771
+LG GS VY+A + G +A+K + K+ + + + V EV + ++H +I
Sbjct: 17 NLLGKGSFAGVYRAESIHTGLEVAIKMI---DKKAMYKAGMVQRVQNEVKIHCQLKHPSI 73
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ L + L+ E NG ++ L + K ++ R+ + + G+ YLH
Sbjct: 74 LELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFMH-QIITGMLYLH 129
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
I+HRDL SN+LL M ++ADFG+A ++ + G+ YI+P
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISP 181
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 21/165 (12%)
Query: 716 KILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKEN-IRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G+V GE++AVKKL + + R E+++L +++H
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL----QHSTEEHLRDFEREIEILKSLQHD 71
Query: 770 NIVRLLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
NIV+ G C + R L+ EY+P G+L D L K+K + + + +G+
Sbjct: 72 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLL---QYTSQICKGM 127
Query: 828 CYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL +HRDL NIL++ E ++ DFG+ K++ D+
Sbjct: 128 EYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDK 168
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 51/171 (29%), Positives = 85/171 (49%), Gaps = 20/171 (11%)
Query: 709 ECLSMSDKILGMGSTGTVYKA----EMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVL 763
L K+LG G GTV+K E +I + +K + + K + + V + +
Sbjct: 13 TELRK-LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVI--EDKSGRQSFQAVTDHMLAI 69
Query: 764 GNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
G++ H +IVRLLG C L+ +Y+P G+L D + +++G + + +
Sbjct: 70 GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVR-QHRGALGPQLLL---NWGVQI 124
Query: 824 AQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
A+G+ YL H +VHR+L N+LL + +VADFGVA L+ D+
Sbjct: 125 AKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 13/158 (8%)
Query: 716 KILGMGSTGTVYKAEMPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G G VY+ + +AVK L KE+ L E V+ ++H N+V+L
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 281
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HD 833
LG C+ ++ E+M GNL D L N+ E + +A ++ + YL +
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL---YMATQISSAMEYLEKKN 338
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+HR+L N L+ +VADFG+++L+ D
Sbjct: 339 F----IHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-28
Identities = 39/165 (23%), Positives = 72/165 (43%), Gaps = 16/165 (9%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
L+ + +G G G V+ + +A+K + +E + E +V+ + H
Sbjct: 8 SELTF-VQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSH 62
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+V+L G C + L+ E+M +G L D L +G + + L V +G+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLL---GMCLDVCEGMA 118
Query: 829 YL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL ++HRDL N L+ +V+DFG+ + + D+
Sbjct: 119 YLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 6e-28
Identities = 49/164 (29%), Positives = 76/164 (46%), Gaps = 20/164 (12%)
Query: 716 KILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+ LG G G V GE++AVK L K + R G E+D+L + H +
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL--KADAGPQHRSGWKQEIDILRTLYHEH 94
Query: 771 IVRLLGCCSN--RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
I++ GCC + L+ EY+P G+L D L + G + + A + +G+
Sbjct: 95 IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMA 148
Query: 829 YLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YLH +HRDL N+LLD + ++ DFG+AK +
Sbjct: 149 YLHAQHY----IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 188
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-28
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 44/201 (21%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+LG G+ G V KA A+KK+ +H E +L+EV +L ++ H+ +VR
Sbjct: 12 AVLGQGAFGQVVKARNALDSRYYAIKKI--RHTEEKLST--ILSEVMLLASLNHQYVVRY 67
Query: 775 LGC----------CSNRECTMLLY---EYMPNGNLDDLLHAKNKG--ENLVADWVTRYKI 819
+ + L+ EY NG L DL+H++N + +I
Sbjct: 68 YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR--QI 125
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ----------- 868
++ Y+H I+HRDLKP NI +D ++ DFG+AK +
Sbjct: 126 LEALS----YIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 869 ----SDESMSVIAGSYGYIAP 885
S ++++ G+ Y+A
Sbjct: 179 NLPGSSDNLTSAIGTAMYVAT 199
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 7e-28
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 26/183 (14%)
Query: 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
+LG G+ GT+ M +AVK++ + R EV +L H N++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVI 81
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH- 831
R +R+ + E L + + K+ + + G+ +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE----PITLLQQTTSGLAHLHS 136
Query: 832 HDCDPVIVHRDLKPSNILL-----DGEMEARVADFGVAKLIQSDES----MSVIAGSYGY 882
+ IVHRDLKP NIL+ G+++A ++DFG+ K + S + G+ G+
Sbjct: 137 LN----IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 883 IAP 885
IAP
Sbjct: 193 IAP 195
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 45/185 (24%), Positives = 72/185 (38%), Gaps = 20/185 (10%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G G V++A+ A+K++ + R V+ EV L + H IVR
Sbjct: 11 QCLGRGGFGVVFEAKNKVDDCNYAIKRI--RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 775 LGC---------CSNRECTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
+ LY + NL D ++ + E + I L
Sbjct: 69 FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER--ERSVCLHIFLQ 126
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGY 882
+A+ + +LH ++HRDLKPSNI + +V DFG+ + DE +
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 883 IAPGT 887
A T
Sbjct: 184 YARHT 188
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-28
Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 21/166 (12%)
Query: 716 KILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKEN-IRRRRGVLAEVDVLGNVRHR 769
LG G+ G+V G ++AVK+L + + ++R E+ +L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQL----QHSGPDQQRDFQREIQILKALHSD 84
Query: 770 NIVRLLGCCSN--RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
IV+ G R+ L+ EY+P+G L D L +++ + + + + +G+
Sbjct: 85 FIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ-RHRARLDASRLL---LYSSQICKGM 140
Query: 828 CYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
YL C VHRDL NIL++ E ++ADFG+AKL+ D+
Sbjct: 141 EYLGSRRC----VHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 39/175 (22%), Positives = 80/175 (45%), Gaps = 16/175 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRR---GVLAEVDVLGNVRHRNI 771
+ LG G ++ + E+ A K + K + + + E+ + ++ H+++
Sbjct: 47 RFLGKGGFAKCFEISDADTKEVFAGKIV---PKSLLLKPHQREKMSMEISIHRSLAHQHV 103
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V G + + ++ E +L +L + + + RY + + G YLH
Sbjct: 104 VGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLR-QIVLGCQYLH 158
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
+ ++HRDLK N+ L+ ++E ++ DFG+A ++ D V+ G+ YIAP
Sbjct: 159 RNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 39/172 (22%), Positives = 79/172 (45%), Gaps = 10/172 (5%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G ++ + E+ A K + +R + E+ + ++ H+++V
Sbjct: 21 RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
G + + ++ E +L +L + + + RY + + G YLH +
Sbjct: 81 HGFFEDNDFVFVVLELCRRRSLLELHKRRKA----LTEPEARYYLR-QIVLGCQYLHRNR 135
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
++HRDLK N+ L+ ++E ++ DFG+A ++ D V+ G+ YIAP
Sbjct: 136 ---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 68/320 (21%), Positives = 117/320 (36%), Gaps = 36/320 (11%)
Query: 189 EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL 248
+ S + N L L+ Q +++ NL +P +
Sbjct: 28 DYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQLNRLNLS-SLPDNLPP--QI 82
Query: 249 KYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308
++I+ L +LP ++L L+ N + +P +L+ LD+ +NQL+
Sbjct: 83 TVLEITQNALI-SLPELPASLEYLD---ACDNRLS-TLPELPASLK---HLDVDNNQLTM 134
Query: 309 PIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368
+P A L+ ++ NN L +P EL L+ L + NN LT LP+ S L
Sbjct: 135 -LPELPALLE---YINADNNQL-TMLP---ELPTSLEVLSVRNNQLT-FLPELPES---L 182
Query: 369 LTVDVSSNSLTGPIPPTICDGDRL----FKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
+DVS+N L +P N T IPEN+++ + ++DN
Sbjct: 183 EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDN 240
Query: 425 QLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL-EYLNISENSFQTSLPSNIW 483
L+ I + R S + + L + + + S S IW
Sbjct: 241 PLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 484 SA----PNLKILSASSSKLT 499
A + SA +L+
Sbjct: 301 HAFEHEEHANTFSAFLDRLS 320
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-26
Identities = 65/363 (17%), Positives = 122/363 (33%), Gaps = 41/363 (11%)
Query: 94 IPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLR 153
+ E + + L L+ L + ++ ++I+ N+ + P + L +L
Sbjct: 52 LLKECL-INQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNAL-ISLPELPASLEYL- 105
Query: 154 IFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS 213
+A N + LP SL+ L++ + +P + L +++ N LT
Sbjct: 106 --DACDNRLST-LPELPA---SLKHLDVDNNQLT-MLPEL---PALLEYINADNNQLT-M 154
Query: 214 LPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273
LP L T LE + + N L +P +L+ +D+S L +LP+ E
Sbjct: 155 LPE---LPTSLEVLSVRNNQLT-FLP---ELPESLEALDVSTNLLE-SLPAVPVRNHHSE 206
Query: 274 MLLLF----KNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329
+F +N T IP + +L + L DN LS I SL+
Sbjct: 207 ETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIY 265
Query: 330 LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
+ + + + +N+ +
Sbjct: 266 F--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-------AFL 316
Query: 390 DRLFKLILFSNN--FTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSR 447
DRL + N F + L S+ + LR Q + + LT+ ++ +
Sbjct: 317 DRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRK 376
Query: 448 NSL 450
L
Sbjct: 377 TLL 379
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 61/291 (20%), Positives = 104/291 (35%), Gaps = 31/291 (10%)
Query: 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS 316
S K + +N + + L L+ LS +P +L
Sbjct: 24 GTYADYFSAWDKWEKQALPGENRNEAVSLLKEC--LINQFSELQLNRLNLSS-LPDNL-- 78
Query: 317 LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
+T L + N L +P EL A L+ L +N L+ LP+ S L DV +N
Sbjct: 79 PPQITVLEITQNAL-ISLP---ELPASLEYLDACDNRLS-TLPELPASLKHL---DVDNN 130
Query: 377 SLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL 436
LT +P L + +N T +PE +SL L +++NQL +P+ L
Sbjct: 131 QLTM-LPELPA---LLEYINADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPE---L 178
Query: 437 LPNLTFMDMSRNSLSGEIPRDLGNAQKLE----YLNISENSFQTSLPSNIWSAPNLKILS 492
+L +D+S N L +P E + EN T +P NI S +
Sbjct: 179 PESLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI-THIPENILSLDPTCTII 236
Query: 493 ASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543
+ L+ +I + + ++ + + L ++
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAW 287
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 59/308 (19%), Positives = 117/308 (37%), Gaps = 32/308 (10%)
Query: 309 PIPASLASLKGLTRLSLMNNV--LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
I + + L++ S N + + + + N +L + L +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ- 60
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
+ ++ +L+ +P + ++ L + N S+PE +SL L DN+L
Sbjct: 61 -FSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLPELP---ASLEYLDACDNRL 112
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
+ ++P+ L +L +D+ N L+ +P LEY+N N T LP
Sbjct: 113 S-TLPE---LPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQL-TMLPELP---T 160
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL----LLLNLSR 542
+L++LS +++LT +P+ S+ +++ NLL S+P +
Sbjct: 161 SLEVLSVRNNQLT-FLPELPE--SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRE 216
Query: 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGT 602
N +T I P I L + L N L+ I + + ++ + T
Sbjct: 217 NRITHI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNT 275
Query: 603 IFPNLHPS 610
+ L +
Sbjct: 276 LHRPLADA 283
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 19/165 (11%)
Query: 716 KILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+ LG G+ G+V GE++AVKKL +H R E+++L +++H N
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--QH-STEEHLRDFEREIEILKSLQHDN 103
Query: 771 IVRLLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
IV+ G C + R L+ EY+P G+L D L K+K + + + +G+
Sbjct: 104 IVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ-KHKERIDHIKLL---QYTSQICKGME 159
Query: 829 YLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
YL +HRDL NIL++ E ++ DFG+ K++ D+
Sbjct: 160 YLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 71/329 (21%), Positives = 127/329 (38%), Gaps = 39/329 (11%)
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
+L+ + S L +P ++ T L L L N T + NL+ L L L +N++
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLPPDTAL--LDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
S P + A L L RL L N L E+P+ + L L + N +T V
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQL-KELPEK--MPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 367 KLLTVDVSSNSLT-GPIPPTICDG-DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
+++ V++ +N L I G +L + + N T +IP+ L SL+ L + N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 425 QLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIW 483
++ + L NL + +S NS+S L N L L+++ N +P +
Sbjct: 203 KIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLA 260
Query: 484 SAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543
++++ ++ ++ I C Y + + ++L N
Sbjct: 261 DHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKAS----------------YSGVSLFSN 303
Query: 544 SLTGIIPWEIS-----GLPSITDVDLSHN 567
+ WEI + V L +
Sbjct: 304 PVQ---YWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 57/306 (18%), Positives = 104/306 (33%), Gaps = 44/306 (14%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNS 140
+ S L +P ++ L+L N L L T+ + +N S
Sbjct: 34 RVVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI-S 89
Query: 141 TFPPGI-SKLRFLRIFNAYSNSFTGPLPLE----------------------FVQLNSLQ 177
PG + L L N LP + F LN +
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI 148
Query: 178 QLNLGG-SYFDGEIPSDY-RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQ 235
+ LG I + + + L ++ +A ++T ++P GL L + + N +
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKIT 205
Query: 236 GEVPVE-FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQ 294
+V L NL + +S ++S ++N L L L N ++P + +
Sbjct: 206 -KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 263
Query: 295 ALQVLDLSDNQLSG------PIPASLASLKGLTRLSLMNNVL-FGEIPQDI-ELLADLDT 346
+QV+ L +N +S P + +SL +N + + EI +
Sbjct: 264 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAA 323
Query: 347 LLLWNN 352
+ L N
Sbjct: 324 VQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 56/307 (18%), Positives = 113/307 (36%), Gaps = 26/307 (8%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
LR + + L +P L +++ N + +F +L NL + + +
Sbjct: 32 HLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318
S P + L KLE L L KN E+P + LQ L + +N+++ + L
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRKSVFNGLN 145
Query: 319 GLTRLSLMNNVL-FGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
+ + L N L I + + L + + + ++T + S L + + N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPS---LTELHLDGN 202
Query: 377 SLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQGF 434
+T + G + L KL L N+ + ++ L N L L + +N+L +P G
Sbjct: 203 KITK-VDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 435 GLLPNLTFMDMSRNSLSGEIPRD-------LGNAQKLEYLNISENSFQ-TSLPSNIWSA- 485
+ + + N++S I + +++ N Q + + +
Sbjct: 260 ADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 318
Query: 486 PNLKILS 492
+
Sbjct: 319 YVRAAVQ 325
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 56/290 (19%), Positives = 115/290 (39%), Gaps = 29/290 (10%)
Query: 175 SLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNN 233
L+L + D++NL +L L L N ++ + P L +LER+ + N
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQ 111
Query: 234 LQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYG 291
L+ E+P + +L L + ++ + + + L ++ ++ L N + G
Sbjct: 112 LK-ELPEKMPKTLQEL---RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLK-SSGIENG 165
Query: 292 ---NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTL 347
++ L + ++D ++ IP L LT L L N + ++ + L +L L
Sbjct: 166 AFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKL 221
Query: 348 LLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIP 407
L N ++ V L + L + +++N L +P + D + + L +NN + +I
Sbjct: 222 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNIS-AIG 279
Query: 408 EN-------LVNCSSLSRLRIQDNQLN-GSIPQG-FGLLPNLTFMDMSRN 448
N +S S + + N + I F + + +
Sbjct: 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 62/299 (20%), Positives = 124/299 (41%), Gaps = 35/299 (11%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DR 391
++P+D+ D L L NN +T + + L T+ + +N ++ I P +
Sbjct: 45 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVK 101
Query: 392 LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSL 450
L +L L N +PE + +L LR+ +N++ + + F L + +++ N L
Sbjct: 102 LERLYLSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPL 157
Query: 451 -SGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FI 506
S I +KL Y+ I++ + T++P + P+L L +K+T K+
Sbjct: 158 KSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGLP--PSLTELHLDGNKIT-KVDAASLK 213
Query: 507 GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSH 566
G ++ K+ L N ++ + + L L+L+ N L +P ++ I V L +
Sbjct: 214 GLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 567 NFLTGTIPSN-------FENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGL 618
N ++ I SN ++ ++ N + + + PS+F
Sbjct: 273 NNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQ---------YWEIQPSTFRCVYVR 321
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 4e-20
Identities = 52/246 (21%), Positives = 102/246 (41%), Gaps = 21/246 (8%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNG 428
V S L +P + L L +N T I + N +L L + +N+++
Sbjct: 35 VVQCSDLGLEK-VPKDL--PPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKIS- 89
Query: 429 SIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA-P 486
I G F L L + +S+N L E+P + + L+ L + EN T + ++++
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEI-TKVRKSVFNGLN 145
Query: 487 NLKILSASSSKLT-GKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRN 543
+ ++ ++ L I + F G K + I + + + +IP G L L+L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGN 202
Query: 544 SLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIPASGT 602
+T + + GL ++ + LS N ++ + + N L +++ N L +P
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLVK-VPGGLA 260
Query: 603 IFPNLH 608
+
Sbjct: 261 DHKYIQ 266
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 40/233 (17%), Positives = 74/233 (31%), Gaps = 30/233 (12%)
Query: 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAF-DGPLQPAILE-LTKLRTIDIS 134
+ L + ++ + + L + + L N ++ + + KL I I+
Sbjct: 121 KTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIA 179
Query: 135 HNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD 193
+ +T P G+ L L + N T LN+L +L L +
Sbjct: 180 DTNI-TTIPQGLPPSLTELHL---DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS 235
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
N LR L L N L +P L ++ + + NN+ +F
Sbjct: 236 LANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP--------- 285
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFT-GEI-PVSYGNLQALQVLDLSDN 304
P + + LF N EI P ++ + + L +
Sbjct: 286 ---------PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 715 DKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+ LG GS G V + E P G+ + AVK L + EV+ + ++ HRN
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
++RL G ++ E P G+L D L K++G L+ + A+ VA+G+ YL
Sbjct: 83 LIRLYGVVL-TPPMKMVTELAPLGSLLDRLR-KHQGHFLLGTLS---RYAVQVAEGMGYL 137
Query: 831 --HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+HRDL N+LL ++ DFG+ + + ++
Sbjct: 138 ESKR-----FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 42/165 (25%), Positives = 75/165 (45%), Gaps = 16/165 (9%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
+ L+ K LG G G V + G +A+K + KE + E V+ N+ H
Sbjct: 24 KDLTF-LKELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSH 78
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+V+L G C+ + ++ EYM NG L + L + + + ++ V + +
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLL---EMCKDVCEAME 134
Query: 829 YL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
YL +HRDL N L++ + +V+DFG+++ + DE
Sbjct: 135 YLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 36/177 (20%), Positives = 78/177 (44%), Gaps = 16/177 (9%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G VY+A + G +A+KK+ + + R + E+D+L + H N+++
Sbjct: 38 KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLL-HAKNKG----ENLVADWVTRYKIALGVAQGICY 829
++ E G+L ++ H K + E V + ++ + +
Sbjct: 98 YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFV--QLCSALE----H 151
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM-SVIAGSYGYIAP 885
+H ++HRD+KP+N+ + ++ D G+ + S + + G+ Y++P
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 15/163 (9%)
Query: 715 DKILGMGSTGTVYKAE--MPGGEI---IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K+LG G+ GTVYK G ++ +A+K+L + + + + +L E V+ +V +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNP 77
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ RLLG C L+ + MP G L D + ++K + + +A+G+ Y
Sbjct: 78 HVCRLLGICL-TSTVQLITQLMPFGCLLDYVR-EHKDNIGSQYLL---NWCVQIAKGMNY 132
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
L +VHRDL N+L+ ++ DFG+AKL+ ++E
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 45/177 (25%), Positives = 84/177 (47%), Gaps = 19/177 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+LG G+ G VY ++ IA+K++ + + E+ + +++H+NIV+
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE---EIALHKHLKHKNIVQY 84
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK----GENLVADWVTRYKIALGVAQGICYL 830
LG S + E +P G+L LL +K E + + + + +G+ YL
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ------ILEGLKYL 138
Query: 831 HHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESMSV-IAGSYGYIAP 885
H + IVHRD+K N+L++ +++DFG +K + + G+ Y+AP
Sbjct: 139 HDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAP 192
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 43/165 (26%), Positives = 76/165 (46%), Gaps = 16/165 (9%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
E +++ K LG G G V + G +AVK + KE E + + H
Sbjct: 8 EEITL-LKELGSGQFGVVKLGKWKGQYDVAVKMI----KEGSMSEDEFFQEAQTMMKLSH 62
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+V+ G CS ++ EY+ NG L + L ++ G+ L + ++ V +G+
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLL--EMCYDVCEGMA 118
Query: 829 YL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+L H +HRDL N L+D ++ +V+DFG+ + + D+
Sbjct: 119 FLESHQ-----FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 49/164 (29%), Positives = 84/164 (51%), Gaps = 14/164 (8%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
E L + + LG G G V+ G +AVK L K+ LAE +++ ++H
Sbjct: 13 ETLKL-VERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQH 67
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+ +VRL + +E ++ EYM NG+L D L G L +A +A+G+
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLK-TPSGIKL--TINKLLDMAAQIAEGMA 123
Query: 829 YL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
++ + +HRDL+ +NIL+ + ++ADFG+A+LI+ +E
Sbjct: 124 FIEERNY----IHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 53/163 (32%), Positives = 85/163 (52%), Gaps = 17/163 (10%)
Query: 715 DKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
+KI+G G +G V +PG + A+K L + E R+RR L+E ++G H N
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPN 111
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
I+RL G + M++ EYM NG+LD L + G+ + V + GV G+ YL
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLV---GMLRGVGAGMRYL 167
Query: 831 --HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
VHRDL N+L+D + +V+DFG++++++ D
Sbjct: 168 SDLG-----YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP 205
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 18/174 (10%)
Query: 715 DKILGMGSTGTVYKAEM--PGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++++G G G VY + G+ I AVK L +I L E ++ + H N
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 771 IVRLLGCCSNREC-TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ LLG C E +++ YM +G+L + + V D + L VA+G+ +
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLI---GFGLQVAKGMKF 207
Query: 830 L--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
L VHRDL N +LD + +VADFG+A+ + E SV +
Sbjct: 208 LASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 18/164 (10%)
Query: 715 DKILGMGSTGTVYKAEM--PGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++++G G G VY + G+ I AVK L +I L E ++ + H N
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 771 IVRLLGCCSNRECT-MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ LLG C E + +++ YM +G+L + + V D + L VA+G+ Y
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLI---GFGLQVAKGMKY 143
Query: 830 L--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
L VHRDL N +LD + +VADFG+A+ + E
Sbjct: 144 LASKK-----FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 20/177 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN--IVR 773
K +G G + V++ +I A+K + + + + E+ L ++ + I+R
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH- 831
L + ++ E N +L+ L K + + V +H
Sbjct: 93 LYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYW--KNMLEAVH----TIHQ 145
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---IAGSYGYIAP 885
H IVH DLKP+N L+ + ++ DFG+A +Q D + V G+ Y+ P
Sbjct: 146 HG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 197
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 54/169 (31%), Positives = 87/169 (51%), Gaps = 18/169 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLG 764
+S+ DK++G G G V +P + I A+K L + E ++RR L E ++G
Sbjct: 45 TNISI-DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE--KQRRDFLGEASIMG 101
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
H NI+RL G + + M++ EYM NG+LD L K+ + V V + G+A
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLV---GMLRGIA 157
Query: 825 QGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
G+ YL VHRDL NIL++ + +V+DFG+ ++++ D
Sbjct: 158 SGMKYLSDMG-----YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP 201
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 7e-27
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
+ L ++D LG G+ G+V + M +I +A+K L K ++ E ++
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQ 392
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+ + IVRL+G C E ML+ E G L L + E V++ ++ V+
Sbjct: 393 LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV-GKREEIPVSNVA---ELLHQVSM 447
Query: 826 GICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
G+ YL + VHR+L N+LL A+++DFG++K + +D+S
Sbjct: 448 GMKYLEEKN-----FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 51/193 (26%), Positives = 85/193 (44%), Gaps = 31/193 (16%)
Query: 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLG-NVRHRNIV 772
S+KILG GS+GTV G +AVK++ + E+ +L + H N++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALM------EIKLLTESDDHPNVI 72
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY--KIALGVAQGICYL 830
R + + E N NL DL+ +KN + + + +A G+ +L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 831 HHDCDPVIVHRDLKPSNILLD-------------GEMEARVADFGVAKLIQSDES----- 872
H I+HRDLKP NIL+ + ++DFG+ K + S +S
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 873 MSVIAGSYGYIAP 885
++ +G+ G+ AP
Sbjct: 189 LNNPSGTSGWRAP 201
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 1e-26
Identities = 39/175 (22%), Positives = 77/175 (44%), Gaps = 26/175 (14%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G VYK + G +A+K L K K R E + ++H
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--KDKAEGPLREEFRHEAMLRARLQHP 72
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY-----------K 818
N+V LLG + + +++ Y +G+L + L ++ ++ + R
Sbjct: 73 NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132
Query: 819 IALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ +A G+ YL HH +VH+DL N+L+ ++ +++D G+ + + + +
Sbjct: 133 LVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 46/187 (24%), Positives = 75/187 (40%), Gaps = 29/187 (15%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVK----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G G V + GE +A+K +L K++E E+ ++ + H
Sbjct: 19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL------EIQIMKKLNHP 72
Query: 770 NIVRLL------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY--KIAL 821
N+V + + +L EY G+L L+ L + I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR---VADFGVAKLIQSDESMSVIAG 878
+ YLH + I+HRDLKP NI+L + + D G AK + E + G
Sbjct: 133 ALR----YLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVG 185
Query: 879 SYGYIAP 885
+ Y+AP
Sbjct: 186 TLQYLAP 192
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 20/177 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVR 773
K +G G + V++ +I A+K + + + + E+ L ++ I+R
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH- 831
L + ++ E N +L+ L K + + + + +H
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN------MLEAVHTIHQ 126
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---IAGSYGYIAP 885
H IVH DLKP+N L+ + ++ DFG+A +Q D + V G+ Y+ P
Sbjct: 127 HG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP 178
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 46/180 (25%), Positives = 79/180 (43%), Gaps = 25/180 (13%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ V + G A K KL + + + R E + ++H
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER------EARICRKLQHP 65
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGIC 828
NIVRL L+++ + G L + + A+ E + + + + + I
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIA 119
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y H IVHR+LKP N+LL + + ++ADFG+A + E+ AG+ GY++P
Sbjct: 120 YCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 20/169 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG GS G VY+ G +A+K + ++R R L E V+
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCH 88
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRY---KIALGVA 824
++VRLLG S + T+++ E M G+L L N V + ++A +A
Sbjct: 89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 825 QGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
G+ YL + VHRDL N ++ + ++ DFG+ + I +
Sbjct: 149 DGMAYLNANK-----FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 18/164 (10%)
Query: 715 DKILGMGSTGTVYKAEM---PGGEI-IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
D+++G G G VY E I A+K L +++ L E ++ + H N
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 771 IVRLLGCCSNRECT-MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ L+G E +L YM +G+L + + V D + L VA+G+ Y
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR-SPQRNPTVKDLI---SFGLQVARGMEY 139
Query: 830 L--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
L VHRDL N +LD +VADFG+A+ I E
Sbjct: 140 LAEQK-----FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 44/169 (26%), Positives = 67/169 (39%), Gaps = 20/169 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G VY+ ++ G +AVK L + + L E ++ H+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQ 93
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGI 827
NIVR +G +L E M G+L L + + +A +A G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 828 CYL--HHDCDPVIVHRDLKPSNILLDGEMEARV---ADFGVAKLIQSDE 871
YL +H +HRD+ N LL RV DFG+A+ I
Sbjct: 154 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 35/168 (20%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLG 764
E + + + +G G G V++ P + A+K K+ + R L E +
Sbjct: 15 ERIEL-GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFLQEALTMR 71
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
H +IV+L+G + ++ E G L L K +A + A ++
Sbjct: 72 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKYSLDLASLI---LYAYQLS 126
Query: 825 QGICYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ YL VHRD+ N+L+ ++ DFG+++ ++
Sbjct: 127 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 170
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 20/177 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVR 773
K +G G + V++ +I A+K + + + + E+ L ++ I+R
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH- 831
L + ++ E N +L+ L K + + + + +H
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKN------MLEAVHTIHQ 173
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV---IAGSYGYIAP 885
H IVH DLKP+N L+ + ++ DFG+A +Q D + V G+ Y+ P
Sbjct: 174 HG----IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP 225
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 39/191 (20%), Positives = 78/191 (40%), Gaps = 29/191 (15%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLA----------------- 758
+ L G + E + A+KK K + ++R
Sbjct: 37 RTLNQGKFNKIILCE-KDNKFYALKKY---EKSLLEKKRDFTKSNNDKISIKSKYDDFKN 92
Query: 759 EVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA----DWV 814
E+ ++ ++++ + G +N + ++YEYM N ++ + V
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 815 TRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS 874
+ I V Y+H++ + I HRD+KPSNIL+D +++DFG ++ D+ +
Sbjct: 153 IKCIIK-SVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE-YMVDKKIK 208
Query: 875 VIAGSYGYIAP 885
G+Y ++ P
Sbjct: 209 GSRGTYEFMPP 219
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 46/181 (25%), Positives = 80/181 (44%), Gaps = 27/181 (14%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ V + G A K KL + + + R E + ++H
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER------EARICRKLQHP 88
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGIC 828
NIVRL L+++ + G L + + A+ E + + + + + I
Sbjct: 89 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQ------ILESIA 142
Query: 829 YLH-HDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIA 884
Y H + IVHR+LKP N+LL + + ++ADFG+A + E+ AG+ GY++
Sbjct: 143 YCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLS 198
Query: 885 P 885
P
Sbjct: 199 P 199
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 39/160 (24%), Positives = 61/160 (38%), Gaps = 20/160 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G GS G V++ + G AVKK +R + E+ + IV L
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKK--------VRLEVFRVEELVACAGLSSPRIVPL 115
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHD 833
G + E + G+L L+ E+ + +G+ YLH
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-YYLGQ-----ALEGLEYLHTR 169
Query: 834 CDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDES 872
I+H D+K N+LL + A + DFG A +Q D
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 56/179 (31%), Positives = 79/179 (44%), Gaps = 18/179 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIR-RRRGVLAEVDVLGNV-R 767
+ILG G + V + P + AVK E ++ R L EVD+L V
Sbjct: 23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQG 826
H NI++L L+++ M G L D L K E I + +
Sbjct: 83 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------IMRALLEV 136
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IC LH IVHRDLKP NILLD +M ++ DFG + + E + + G+ Y+AP
Sbjct: 137 ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 55/180 (30%), Positives = 80/180 (44%), Gaps = 25/180 (13%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+LG GS G V K + + AVK K I R EV++L + H
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR------EVELLKKLDHP 81
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
NI++L + ++ E G L D+++ K E+ A I V GI
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGIT 135
Query: 829 YLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y+H IVHRDLKP NILL + + + ++ DFG++ Q + M G+ YIAP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 50/174 (28%), Positives = 75/174 (43%), Gaps = 25/174 (14%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE---IIAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
+ ++G G+ G V KA + A+K++ K + R E++VL
Sbjct: 25 NDIKF-QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGELEVLCK 81
Query: 766 V-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY------- 817
+ H NI+ LLG C +R L EY P+GNL D L E A +
Sbjct: 82 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 141
Query: 818 ----KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
A VA+G+ YL +HRDL NIL+ A++ADFG+++
Sbjct: 142 QQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-26
Identities = 43/164 (26%), Positives = 83/164 (50%), Gaps = 14/164 (8%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
E L + +K LG G G V+ A +AVK + K LAE +V+ ++H
Sbjct: 188 ESLKL-EKKLGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQH 242
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+V+L + +E ++ E+M G+L D L + + + + + +A+G+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI---DFSAQIAEGMA 298
Query: 829 YL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
++ + +HRDL+ +NIL+ + ++ADFG+A++I+ +E
Sbjct: 299 FIEQRNY----IHRDLRAANILVSASLVCKIADFGLARVIEDNE 338
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-26
Identities = 55/173 (31%), Positives = 86/173 (49%), Gaps = 23/173 (13%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEI---IAVKKLWGKHKENI--RRRRGVLAEVD 761
C++ K++G G G VYK G+ +A+K L K ++R L E
Sbjct: 44 SCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL----KAGYTEKQRVDFLGEAG 98
Query: 762 VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
++G H NI+RL G S + M++ EYM NG LD L + GE V V +
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLV---GMLR 154
Query: 822 GVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
G+A G+ YL + VHRDL NIL++ + +V+DFG++++++ D
Sbjct: 155 GIAAGMKYLANMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 48/178 (26%), Positives = 77/178 (43%), Gaps = 17/178 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVR-H 768
++G G + V + G AVK ++ R E +L V H
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
+I+ L+ + L+++ M G L D L E I + + +
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR------SIMRSLLEAV 213
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+LH + IVHRDLKP NILLD M+ R++DFG + ++ E + + G+ GY+AP
Sbjct: 214 SFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAP 268
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 8e-26
Identities = 44/169 (26%), Positives = 67/169 (39%), Gaps = 20/169 (11%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G VY+ ++ G +AVK L + + L E ++ H+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--PEVCSEQDELDFLMEALIISKFNHQ 134
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLL--HAKNKGENLVADWVTRYKIALGVAQGI 827
NIVR +G +L E M G+L L + + +A +A G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 828 CYL--HHDCDPVIVHRDLKPSNILLDGEMEARV---ADFGVAKLIQSDE 871
YL +H +HRD+ N LL RV DFG+A+ I
Sbjct: 195 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG 238
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 48/176 (27%), Positives = 84/176 (47%), Gaps = 29/176 (16%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNVRH 768
+ LG G+ G V+ AE ++AVK L K+ + R+ E ++L N++H
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQH 76
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR-----------Y 817
+IV+ G C + + ++++EYM +G+L+ L A ++ D R
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 818 KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
IA +A G+ YL H VHRDL N L+ + ++ DFG+++ + S +
Sbjct: 137 HIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD 187
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 43/176 (24%), Positives = 73/176 (41%), Gaps = 19/176 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G GS G V A + A KK+ K + E++++ ++ H NI+RL
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKI---PKYFVEDVDRFKQEIEIMKSLDHPNIIRL 71
Query: 775 LGCCSNRECTMLLYEYMPNGNL-DDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-H 832
+ L+ E G L + ++H + E+ A I V + Y H
Sbjct: 72 YETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDVLSAVAYCHKL 125
Query: 833 DCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ + HRDLKP N L + ++ DFG+A + + M G+ Y++P
Sbjct: 126 N----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 19/169 (11%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLG 764
E + + ++ILG G G VY+ GE I AVK K + + ++E ++
Sbjct: 12 EDVVL-NRILGEGFFGEVYEGVYTNHKGEKINVAVKTC--KKDCTLDNKEKFMSEAVIMK 68
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
N+ H +IV+L+G E T ++ E P G L L +NK V V +L +
Sbjct: 69 NLDHPHIVKLIGIIE-EEPTWIIMELYPYGELGHYLE-RNKNSLKVLTLV---LYSLQIC 123
Query: 825 QGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ + YL + VHRD+ NIL+ ++ DFG+++ I+ ++
Sbjct: 124 KAMAYLESIN-----CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 24/196 (12%)
Query: 698 QRLNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV 756
Q +FTA+D L+ L +G G+ G+V K P G+I+AVK++ E +++ +
Sbjct: 15 QHWDFTAED-LKDL----GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQ--L 67
Query: 757 LAEVDV-LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK------GENL 809
L ++DV + + IV+ G + E M + + D E +
Sbjct: 68 LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEI 126
Query: 810 VADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ KI L + + +L + I+HRD+KPSNILLD ++ DFG++ +
Sbjct: 127 LG------KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 870 DESMSVIAGSYGYIAP 885
+ + AG Y+AP
Sbjct: 179 SIAKTRDAGCRPYMAP 194
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 25/194 (12%)
Query: 700 LNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLA 758
+ ADD LE + LG G+ G V K +P G+I+AVK++ ++R +L
Sbjct: 2 MEVKADD-LEPI----MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKR--LLM 54
Query: 759 EVDV-LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLL-----HAKNKGENLVAD 812
++D+ + V V G + E M + +LD + E+++
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG- 112
Query: 813 WVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV-AKLIQSDE 871
KIA+ + + + +LH ++HRD+KPSN+L++ + ++ DFG+ L+
Sbjct: 113 -----KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165
Query: 872 SMSVIAGSYGYIAP 885
G Y+AP
Sbjct: 166 KDIDA-GCKPYMAP 178
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 50/181 (27%), Positives = 76/181 (41%), Gaps = 25/181 (13%)
Query: 715 DKILGMGSTGTVYKAEM-PGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRH 768
K LG G+ G V A+K + + EV VL + H
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE------EVAVLKLLDH 95
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGI 827
NI++L ++ L+ E G L D + + K E A I V G+
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV------IIKQVLSGV 149
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIA 884
YLH IVHRDLKP N+LL+ + + ++ DFG++ + ++ + M G+ YIA
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 885 P 885
P
Sbjct: 207 P 207
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 69/312 (22%), Positives = 113/312 (36%), Gaps = 42/312 (13%)
Query: 64 VWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPE-IRYLTSLTHLNLSAN-------- 112
V CS G+K PK S T LDL +S + + + L L L L N
Sbjct: 38 VQCSDLGLKAVPKEISPDTTLLDLQNNDISE-LRKDDFKGLQHLYALVLVNNKISKIHEK 96
Query: 113 AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFV 171
AF L KL+ + IS N PP + S L LRI + N F
Sbjct: 97 AFSP--------LRKLQKLYISKNHL-VEIPPNLPSSLVELRIHD---NRIRKVPKGVFS 144
Query: 172 QLNSLQQLNLGG-SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIG 230
L ++ + +GG + + L +L ++ LT +P L L + +
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLD 201
Query: 231 YNNLQGEVPVE-FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS 289
+N +Q + +E L + + + +S L L L L N + +P
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 290 YGNLQALQVLDLSDNQLSGPIPAS-------LASLKGLTRLSLMNNVL-FGEIPQDI-EL 340
+L+ LQV+ L N ++ + + +SL NN + + E+
Sbjct: 260 LPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRC 318
Query: 341 LADLDTLLLWNN 352
+ D + N
Sbjct: 319 VTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 64/334 (19%), Positives = 117/334 (35%), Gaps = 50/334 (14%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
LR + + L ++P + +++ N++ +F L +L + + +
Sbjct: 34 HLRVVQCSDLGLK-AVPK--EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318
S S L KL+ L + KNH EIP +L L + DN++ + L+
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 319 GLTRLSLMNNVL-FGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
+ + + N L L+ L + LTG+ P+ L
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI-PKDLPET------------ 194
Query: 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FG 435
L +L L N +I L+ S L RL + NQ+ I G
Sbjct: 195 --------------LNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLS 238
Query: 436 LLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS-------APNL 488
LP L + + N LS +P L + + L+ + + N+ T + N +
Sbjct: 239 FLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI-TKVGVNDFCPVGFGVKRAYY 296
Query: 489 KILSASSSKLT-GKIPD--FIGCKSIYKIELHNN 519
+S ++ + ++ F I+ N
Sbjct: 297 NGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 7e-24
Identities = 66/293 (22%), Positives = 115/293 (39%), Gaps = 36/293 (12%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DR 391
+P++I D L L NN ++ + L + + +N ++ I +
Sbjct: 47 AVPKEI--SPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRK 103
Query: 392 LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSL 450
L KL + N+ IP NL SSL LRI DN++ +P+G F L N+ ++M N L
Sbjct: 104 LQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPL 159
Query: 451 -SGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIG 507
+ + KL YL ISE T +P ++ L L +K+ I +
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKL-TGIPKDLPE--TLNELHLDHNKIQ-AIELEDLLR 215
Query: 508 CKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSH 566
+Y++ L +N + I L L+L N L+ +P + L + V L
Sbjct: 216 YSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 567 NFLTGTIPSN-------FENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSF 612
N +T + N + ++ N + + + P++F
Sbjct: 274 NNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP---------YWEVQPATF 316
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 67/361 (18%), Positives = 117/361 (32%), Gaps = 60/361 (16%)
Query: 111 ANAFDGPLQPAILELTK-----------LRTIDISHNSFNSTFPPGISK-LRFLRIFNAY 158
A G L T LR + S P IS L + N
Sbjct: 7 AETTSGIPDLDSLPPTYSAMCPFGCHCHLRVVQCSDLGL-KAVPKEISPDTTLLDLQN-- 63
Query: 159 SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ 217
N + +F L L L L + +I + L L+ L ++ N L +PP
Sbjct: 64 -NDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPLRKLQKLYISKNHLV-EIPP- 119
Query: 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL-SGTLPSEISNLTKLEMLL 276
L + L + I N ++ F+ L N+ +++ L + + KL L
Sbjct: 120 -NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLR 178
Query: 277 LFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ 336
+ + T IP + L L L N++ L L RL L +N
Sbjct: 179 ISEAKLT-GIPK--DLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN-------- 227
Query: 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLI 396
+ ++ L LP L + + +N L+ +P + D L +
Sbjct: 228 ---QIRMIENGSLSF------LPT-------LRELHLDNNKLSR-VPAGLPDLKLLQVVY 270
Query: 397 LFSNNFTYSIPEN-------LVNCSSLSRLRIQDNQL-NGSIPQG-FGLLPNLTFMDMSR 447
L +NN T + N V + + + + +N + + F + + +
Sbjct: 271 LHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329
Query: 448 N 448
Sbjct: 330 Y 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-22
Identities = 49/300 (16%), Positives = 99/300 (33%), Gaps = 53/300 (17%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVL-----------------------FG 332
+LDL +N +S L+ L L L+NN +
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT-GPIPPTICDGDR 391
EIP L + L L + +N + V + +++ N L P DG +
Sbjct: 116 EIPP--NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173
Query: 392 LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSL 450
L L + T IP++L +L+ L + N++ +I L + + N +
Sbjct: 174 LNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 451 SGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCK 509
I L L L++ N + +P+ + L+++ ++ +T K+ C
Sbjct: 230 R-MIENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCP 286
Query: 510 SIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT--GIIPWEISGLPSITDVDLSHN 567
+ ++ ++L N + + P + + +
Sbjct: 287 VGFGVKRAY----------------YNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 57/248 (22%), Positives = 97/248 (39%), Gaps = 25/248 (10%)
Query: 368 LLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQL 426
L V S L +P I L L +N+ + + ++ L L + +N++
Sbjct: 35 LRVVQCSDLGLKA-VPKEI--SPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKI 90
Query: 427 NGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA 485
+ I + F L L + +S+N L EIP +L L L I +N +P ++S
Sbjct: 91 S-KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI-RKVPKGVFSG 145
Query: 486 -PNLKILSASSSKLT-GKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLS 541
N+ + + L F G K Y + + L IP D+ E L L+L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGLKLNY-LRISEAKLT-GIPKDL--PETLNELHLD 201
Query: 542 RNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIPAS 600
N + I ++ + + L HN + I + TL ++ N L+ +PA
Sbjct: 202 HNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSR-VPAG 259
Query: 601 GTIFPNLH 608
P+L
Sbjct: 260 ---LPDLK 264
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 40/235 (17%), Positives = 80/235 (34%), Gaps = 33/235 (14%)
Query: 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAF-DGPLQPAILELTKLRTIDISH 135
S + L + + +P + L ++ + + N + +P + KL + IS
Sbjct: 123 SSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISE 181
Query: 136 NSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD- 193
+ P + L L + N + ++ + L +L LG + I +
Sbjct: 182 AKL-TGIPKDLPETLNELHL---DHNKIQAIELEDLLRYSKLYRLGLGHNQIR-MIENGS 236
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMD 252
L +LR L L N L+ +P L L L+ + + NN+ +V V F +
Sbjct: 237 LSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFG---- 290
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFT-GEI-PVSYGNLQALQVLDLSDNQ 305
+ LF N E+ P ++ + + + +
Sbjct: 291 --------------VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 46/194 (23%), Positives = 76/194 (39%), Gaps = 28/194 (14%)
Query: 705 DDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLA 758
++ ++ K LG G V + G+ A K + + I
Sbjct: 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH------ 77
Query: 759 EVDVLGNVRHR-NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWV 814
E+ VL + ++ L N +L+ EY G + L + EN V +
Sbjct: 78 EIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLI 137
Query: 815 TRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDE 871
+ + +G+ YLH + IVH DLKP NILL ++ DFG+++ I
Sbjct: 138 KQ------ILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC 188
Query: 872 SMSVIAGSYGYIAP 885
+ I G+ Y+AP
Sbjct: 189 ELREIMGTPEYLAP 202
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 51/175 (29%), Positives = 78/175 (44%), Gaps = 18/175 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
+ LG G G VY A E I+A+K L K + + EV++ ++RH NI
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVL---FKAQLEKAGVEHQLRREVEIQSHLRHPNI 71
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+RL G + L+ EY P G + L +K + T I +A + Y H
Sbjct: 72 LRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITE-LANALSYCH 126
Query: 832 -HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRD+KP N+LL E ++ADFG + S + G+ Y+ P
Sbjct: 127 SKR----VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-LCGTLDYLPP 176
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 28/175 (16%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNVRH 768
LG G+ G V+ AE ++AVK L KE + R+ E ++L ++H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL----KEASESARQDFQREAELLTMLQH 102
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK---------- 818
++IVR G C+ ++++EYM +G+L+ L + L+A
Sbjct: 103 QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162
Query: 819 IALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+A VA G+ YL H VHRDL N L+ + ++ DFG+++ I S +
Sbjct: 163 VASQVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD 212
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 49/156 (31%), Positives = 74/156 (47%), Gaps = 11/156 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
LG G G V+ G +A+K L K L E V+ +RH +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 245
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
S E ++ EYM G+L D L G+ L + +A +A G+ Y+
Sbjct: 246 AVVS-EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLVD--MAAQIASGMAYVERMN- 300
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
VHRDL+ +NIL+ + +VADFG+A+LI+ +E
Sbjct: 301 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 54/180 (30%), Positives = 79/180 (43%), Gaps = 25/180 (13%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+LG GS G V K + + AVK K I R EV++L + H
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR------EVELLKKLDHP 81
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGIC 828
NI++L + ++ E G L D + + + E+ A I V GI
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGIT 135
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y+H IVHRDLKP NILL+ + + ++ DFG++ Q + M G+ YIAP
Sbjct: 136 YMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-25
Identities = 45/180 (25%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ G V A E + +A++ K V E+++L + H
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGIC 828
I+++ + ++L E M G L D + + E + +
Sbjct: 201 CIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCK------LYFYQMLLAVQ 253
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIAP 885
YLH + I+HRDLKP N+LL + E ++ DFG +K++ M + G+ Y+AP
Sbjct: 254 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 35/168 (20%), Positives = 67/168 (39%), Gaps = 17/168 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEII--AVKKLWGKHKENIRRRRGVLAEVDVLG 764
E + + + +G G G V++ P + A+K K+ + R L E +
Sbjct: 390 ERIEL-GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVREKFLQEALTMR 446
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
H +IV+L+G + ++ E G L L K +A + A ++
Sbjct: 447 QFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQ-VRKFSLDLASLI---LYAYQLS 501
Query: 825 QGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ YL VHRD+ N+L+ ++ DFG+++ ++
Sbjct: 502 TALAYLESKRF----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 50/179 (27%), Positives = 72/179 (40%), Gaps = 18/179 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G V K E G A K K + R + EV +L V H N+
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYL 830
+ L NR +L+ E + G L D L K E ++ + + G+ YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGVNYL 131
Query: 831 HHDCDPVIVHRDLKPSNILL----DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H I H DLKP NI+L ++ DFG+A I+ I G+ ++AP
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-25
Identities = 63/300 (21%), Positives = 114/300 (38%), Gaps = 24/300 (8%)
Query: 127 KLRTIDISHNSFNSTFPPGISK-LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY 185
+ + + P GIS R L + N F L L+ L L ++
Sbjct: 44 QFSKVICVRKNL-REVPDGISTNTRLLNLHE---NQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 186 FDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-F 242
I + L++L L+L N LT ++P L++L+ + + N ++ +P F
Sbjct: 100 I-RTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 243 ASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDL 301
+ +L+ +D+ + L+ L L L + EIP + L L LDL
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDL 214
Query: 302 SDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQD-IELLADLDTLLLWNNHLTGVLPQ 360
S N LS P S L L +L ++ + + I ++ + L L + L +N+LT +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420
L + + N C+ + L + + S C++ L+
Sbjct: 274 LFTPLHHLERIHLHHNPWN-------CNC-DILWLSWWIKDMAPSNTACCARCNTPPNLK 325
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 8e-25
Identities = 65/256 (25%), Positives = 108/256 (42%), Gaps = 12/256 (4%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
S+Q + + R++L +P I T+ LNL N + L L + +S N
Sbjct: 42 SNQFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN 98
Query: 137 SFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-Y 194
T G + L L + N T FV L+ L++L L + + IPS +
Sbjct: 99 HI-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 195 RNLSSLRFLDLAG-NSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252
+ SLR LDL L+ + L+ L + + NL+ E+P L+ L +D
Sbjct: 157 NRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELD 213
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPA 312
+S +LS P L L+ L + ++ ++ NLQ+L ++L+ N L+
Sbjct: 214 LSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHD 273
Query: 313 SLASLKGLTRLSLMNN 328
L L R+ L +N
Sbjct: 274 LFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 4e-21
Identities = 60/237 (25%), Positives = 98/237 (41%), Gaps = 17/237 (7%)
Query: 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQD 423
+ + V +L +P I L L N I N + L L++
Sbjct: 42 SNQFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSR 97
Query: 424 NQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSN 481
N + +I G F L NL +++ N L+ IP KL+ L + N S+PS
Sbjct: 98 NHIR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPI-ESIPSY 154
Query: 482 IWSA-PNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLL 538
++ P+L+ L K I + F G ++ + L L IP ++ KL L
Sbjct: 155 AFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL 212
Query: 539 NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLT 594
+LS N L+ I P GL + + + + + I N F+N +L N+++N LT
Sbjct: 213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 61/261 (23%), Positives = 105/261 (40%), Gaps = 23/261 (8%)
Query: 58 SSEQEPVWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--- 112
S++ V C ++ P S+ L+L + ++L L L LS N
Sbjct: 42 SNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 113 -----AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPL 166
AF+G L L T+++ N +T P G L L+ +N
Sbjct: 102 TIEIGAFNG--------LANLNTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIP 152
Query: 167 PLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE 225
F ++ SL++L+LG I + LS+LR+L+LA +L P L L +L+
Sbjct: 153 SYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLD 210
Query: 226 RIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGE 285
+++ N+L P F L++L+ + + + + NL L + L N+ T
Sbjct: 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL 270
Query: 286 IPVSYGNLQALQVLDLSDNQL 306
+ L L+ + L N
Sbjct: 271 PHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 3e-19
Identities = 55/256 (21%), Positives = 105/256 (41%), Gaps = 17/256 (6%)
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNN 401
++ +L V P + +N +LL ++ N + I L L L N+
Sbjct: 44 QFSKVICVRKNLREV-PDGISTNTRLL--NLHENQIQI-IKVNSFKHLRHLEILQLSRNH 99
Query: 402 FTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL- 458
+I ++L+ L + DN+L +IP G F L L + + N + IP
Sbjct: 100 IR-TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAF 156
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELH 517
L L++ E + + + NL+ L+ + L +IP+ + +++L
Sbjct: 157 NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLS 215
Query: 518 NNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN 576
N L+ +I L L + ++ + I L S+ +++L+HN LT +P +
Sbjct: 216 GNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHD 273
Query: 577 -FENCSTLESFNVSYN 591
F LE ++ +N
Sbjct: 274 LFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 88.3 bits (219), Expect = 2e-18
Identities = 61/241 (25%), Positives = 99/241 (41%), Gaps = 15/241 (6%)
Query: 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGL 320
+P IS T +L L +N S+ +L+ L++L LS N + + L L
Sbjct: 57 EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114
Query: 321 TRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS-NSL 378
L L +N L IP L+ L L L NN + + L +D+ L
Sbjct: 115 NTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 379 TGPIPPTICDG-DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGL 436
+ I +G L L L N IP L L L + N L+ +I G F
Sbjct: 174 SY-ISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLS-AIRPGSFQG 229
Query: 437 LPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSAS 494
L +L + M ++ + I R+ N Q L +N++ N+ T LP ++++ +L+ +
Sbjct: 230 LMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNL-TLLPHDLFTPLHHLERIHLH 287
Query: 495 S 495
Sbjct: 288 H 288
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 45/174 (25%), Positives = 65/174 (37%), Gaps = 15/174 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVR 773
LG GS G V+K G + AVK+ + R LAEV V +H VR
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLH 831
L L E +L A E V ++ + +LH
Sbjct: 122 LEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRD------TLLALAHLH 174
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+VH D+KP+NI L ++ DFG+ + + + V G Y+AP
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 69/302 (22%), Positives = 110/302 (36%), Gaps = 55/302 (18%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISHNSFN 139
T + + + L+ +P I +S T L L +N L + + LT+L + +S N
Sbjct: 10 TEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGL- 64
Query: 140 STFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSS 199
SF G SL+ L+L + + S++ L
Sbjct: 65 ---------------------SFKGCCSQSDFGTTSLKYLDLSFNGV-ITMSSNFLGLEQ 102
Query: 200 LRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259
L LD ++L + F SL NL Y+DIS +
Sbjct: 103 LEHLDFQHSNLKQMSEFSV-----------------------FLSLRNLIYLDISHTHTR 139
Query: 260 GTLPSEI-SNLTKLEMLLLFKNHFTGEI-PVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
+ I + L+ LE+L + N F P + L+ L LDLS QL P + SL
Sbjct: 140 -VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL 198
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGS-NGKLLTVDVSSN 376
L L++ +N F + L L L NH+ Q+L L ++++ N
Sbjct: 199 SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQN 258
Query: 377 SL 378
Sbjct: 259 DF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 56/265 (21%), Positives = 93/265 (35%), Gaps = 33/265 (12%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT-GPIPPTICDG-D 390
+P I + L L +N L + +L + +SSN L+ G
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 391 RLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNS 449
L L L N ++ N + L L Q + L F L NL ++D+S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 450 LSGEIPRD-LGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIG 507
LE L ++ NSFQ + +I++ NL L S +L
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-------- 188
Query: 508 CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
+L N L +LN+S N+ + + L S+ +D S N
Sbjct: 189 -------QLSPTAFNSL--------SSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 568 FLTGTIPSNFEN-CSTLESFNVSYN 591
+ + ++ S+L N++ N
Sbjct: 234 HIMTSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 46/232 (19%), Positives = 98/232 (42%), Gaps = 13/232 (5%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLN-- 427
+ +S LT +P I +L L SN + L++L + N L+
Sbjct: 11 EIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA-P 486
G Q +L ++D+S N + + + ++LE+L+ ++ + +++ +
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 487 NLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRN 543
NL L S + + F G S+ +++ N + DI L L+LS+
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQC 185
Query: 544 SLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLT 594
L + P + L S+ +++SHN ++ + ++ ++L+ + S N +
Sbjct: 186 QLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 58/261 (22%), Positives = 98/261 (37%), Gaps = 15/261 (5%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
S + LT S+P G+ + R+E+ N LQ F L L + +S+ L
Sbjct: 8 SGTEIRCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64
Query: 259 S--GTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL-A 315
S G T L+ L L N + ++ L+ L+ LD + L S+
Sbjct: 65 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 123
Query: 316 SLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLL-WNNHLTGVLPQKLGSNGKLLTVDV 373
SL+ L L + + I L+ L+ L + N+ LP L +D+
Sbjct: 124 SLRNLIYLDISHTHT-RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 374 SSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ 432
S L + PT + L L + NNF +SL L N + + +
Sbjct: 183 SQCQLEQ-LSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKK 240
Query: 433 G--FGLLPNLTFMDMSRNSLS 451
+L F+++++N +
Sbjct: 241 QELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 60/259 (23%), Positives = 98/259 (37%), Gaps = 34/259 (13%)
Query: 77 SSQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISH 135
S T L+L L +P + LT LT L+LS+N L
Sbjct: 27 PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSN--------------GLSFKGCCS 71
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-- 193
S L+ + N + F+ L L+ L+ S ++
Sbjct: 72 QSD--------FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSV 121
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYM 251
+ +L +L +LD++ L+ LE +++ N+ Q + F L NL ++
Sbjct: 122 FLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFL 180
Query: 252 DISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
D+S C L L ++L+ L++L + N+F Y L +LQVLD S N +
Sbjct: 181 DLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 239
Query: 311 PASLASL-KGLTRLSLMNN 328
L L L+L N
Sbjct: 240 KQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 52/237 (21%), Positives = 89/237 (37%), Gaps = 34/237 (14%)
Query: 78 SQITSLDLSRRSLS--GPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISH 135
+Q+T L LS LS G TSL +L+LS N + L L +L +D H
Sbjct: 52 TQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH 110
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-Y 194
++ + F+ L +L L++ ++ + +
Sbjct: 111 SNLKQMSEFSV-----------------------FLSLRNLIYLDISHTHTR-VAFNGIF 146
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMD 252
LSSL L +AGNS + P L L +++ L+ ++ F SL +L+ ++
Sbjct: 147 NGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLN 205
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS--YGNLQALQVLDLSDNQLS 307
+S N L L++L NH +L L+L+ N +
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 39/165 (23%), Positives = 66/165 (40%), Gaps = 7/165 (4%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDI 133
Q+ LD +L + L +L +L++S I L+ L + +
Sbjct: 99 GLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKM 157
Query: 134 SHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
+ NSF F P I ++LR L + P F L+SLQ LN+ + F
Sbjct: 158 AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTF 217
Query: 193 DYRNLSSLRFLDLAGNSLTGSLPPQL--GLLTQLERIEIGYNNLQ 235
Y+ L+SL+ LD + N + + Q + L + + N+
Sbjct: 218 PYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 715 DKILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKEN--IRRRRGVLAEVDVLGNV 766
K LG G+ G V +A G +AVK L K + +++E+ ++ ++
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----KSTAHADEKEALMSELKIMSHL 106
Query: 767 -RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR--------- 816
+H NIV LLG C++ +++ EY G+L + L K++ +
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 817 YKIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ VAQG+ +L + +HRD+ N+LL A++ DFG+A+ I +D
Sbjct: 167 LHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-25
Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++LG GS G V + G+ AVK + + + + +L EV +L + H NI++L
Sbjct: 32 RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHD 833
++ L+ E G L D + ++ + E A I V GI Y+H +
Sbjct: 92 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR------IIRQVLSGITYMHKN 145
Query: 834 CDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IVHRDLKP N+LL+ + + R+ DFG++ ++ + M G+ YIAP
Sbjct: 146 K---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 20/180 (11%)
Query: 715 DKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+ LG G+ G V+ E G +K + K + + + + AE++VL ++ H NI++
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTI-NKDRSQVPMEQ-IEAEIEVLKSLDHPNIIK 84
Query: 774 LLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNKGENL---VADWVTRYKIALGVAQGICY 829
+ + ++ E G L + ++ A+ +G+ L + + ++ +A Y
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK-QMMNALA----Y 139
Query: 830 LH-HDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H +VH+DLKP NIL ++ DFG+A+L +SDE + AG+ Y+AP
Sbjct: 140 FHSQH----VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 29/179 (16%)
Query: 715 DKILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-R 767
K LG G+ G V +A G +AVK L K ++ R +++E+ VL +
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGN 85
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK--------- 818
H NIV LLG C+ T+++ EY G+L + L K +
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 819 ----IALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ VA+G+ +L + +HRDL NILL ++ DFG+A+ I++D
Sbjct: 146 DLLSFSYQVAKGMAFLASKN-----CIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRH 768
K LG G+ G V A E + +A+K K V E+++L + H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGI 827
I+++ + ++L E M G L D + + E + Y++ L V
Sbjct: 75 PCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYF--YQMLLAVQ--- 128
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIA 884
YLH + I+HRDLKP N+LL + E ++ DFG +K++ M + G+ Y+A
Sbjct: 129 -YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 885 P 885
P
Sbjct: 185 P 185
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 66/351 (18%), Positives = 127/351 (36%), Gaps = 52/351 (14%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISHN 136
+ S SL+ IP + ++ L+LS N + + L+ L+ + ++ N
Sbjct: 31 DRNGICKGSSGSLNS-IPSGL--TEAVKSLDLSNNRITY-ISNSDLQRCVNLQALVLTSN 86
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YR 195
+T F L SL+ L+L +Y + S ++
Sbjct: 87 GI-NTIEEDS-----------------------FSSLGSLEHLDLSYNYL-SNLSSSWFK 121
Query: 196 NLSSLRFLDLAGNSLTGSLPPQ--LGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMD 252
LSSL FL+L GN +L LT+L+ + +G + ++ + FA L L+ ++
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP--- 309
I A +L P + ++ + L+L + + +++ L+L D L
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 310 -----IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGS 364
SL + + + LF ++ + + ++ L L N L V
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDR 299
Query: 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
L + + +N C R+ L + N + + CS
Sbjct: 300 LTSLQKIWLHTNPWD-------CSCPRIDYLSRWLNKNSQKEQGSAK-CSG 342
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 66/347 (19%), Positives = 129/347 (37%), Gaps = 52/347 (14%)
Query: 109 LSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPL 168
+ + + + A L + S S NS P G+++ ++ + +N T
Sbjct: 14 IISLSKEESSNQASLSCDRNGICKGSSGSLNS-IPSGLTE--AVKSLDLSNNRITYISNS 70
Query: 169 EFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERI 227
+ + +LQ L L + + I D + +L SL LDL+ N L+ +L
Sbjct: 71 DLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLS-NLSSSW--------- 119
Query: 228 EIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEI 286
F L +L ++++ + + S+LTKL++L + +I
Sbjct: 120 --------------FKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165
Query: 287 PV-SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADL 344
+ L L+ L++ + L P SL S++ ++ L L + + ++ + +
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH-ILLLEIFVDVTSSV 224
Query: 345 DTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTY 404
+ L L + L +L + +NSL + + +
Sbjct: 225 ECLELRDTDLDTFHFSELSTG--------ETNSLIKKF--------TFRNVKITDESLF- 267
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSL 450
+ + L S L L NQL S+P G F L +L + + N
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 2e-21
Identities = 49/278 (17%), Positives = 94/278 (33%), Gaps = 26/278 (9%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHL 354
++ LDLS+N+++ + L L L L +N + I +D L L+ L L N+L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYL 112
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD--RLFKLILFSNNFTYSIPEN-LV 411
+ + L +++ N + T +L L + + + I
Sbjct: 113 SNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 412 NCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL-GNAQKLEYLNI 469
+ L L I + L S + N++ + + + +E L +
Sbjct: 172 GLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLEL 229
Query: 470 SENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDI 529
+ T S + TG+ I + +++ + L + +
Sbjct: 230 RDTDLDTFHFSEL---------------STGETNSLIKKFTFRNVKITDESLF-QVMKLL 273
Query: 530 GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
LL L SRN L + L S+ + L N
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 4e-18
Identities = 46/278 (16%), Positives = 98/278 (35%), Gaps = 26/278 (9%)
Query: 331 FGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG- 389
IP + + +L L NN +T + L L + ++SN + I
Sbjct: 43 LNSIPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSL 99
Query: 390 DRLFKLILFSNNFTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQG--FGLLPNLTFMDMS 446
L L L N + ++ + SSL+ L + N ++ + F L L + +
Sbjct: 100 GSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVG 157
Query: 447 RNSLSGEIP-RDLGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPD 504
+I +D LE L I + S + N+ L + + +
Sbjct: 158 NMDTFTKIQRKDFAGLTFLEELEIDASDL-QSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215
Query: 505 --FIGCKSIYKIELHNNLLNG----SIPWDI----GHCEKLLLLNLSRNSLTGIIPWEIS 554
S+ +EL + L+ + + ++ SL ++ ++
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMK-LLN 274
Query: 555 GLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYN 591
+ + +++ S N L ++P F+ ++L+ + N
Sbjct: 275 QISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 5e-14
Identities = 37/238 (15%), Positives = 79/238 (33%), Gaps = 16/238 (6%)
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
+ + S S DR S + SIP L ++ L + +N++
Sbjct: 8 VWVLGVIISLSKEESSNQASLSCDRNGICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRI 64
Query: 427 NGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL-GNAQKLEYLNISENSFQTSLPSNI-W 483
I NL + ++ N ++ I D + LE+L++S N ++L S+
Sbjct: 65 T-YISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYL-SNLSSSWFK 121
Query: 484 SAPNLKILSASSSKLTGKIPD---FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLN 539
+L L+ + + + F + + + N I L L
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 540 LSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGP 596
+ + L P + + +++ + L + + S++E + L
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 51/179 (28%), Positives = 72/179 (40%), Gaps = 18/179 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G V K E G A K K + R + EV +L V H NI
Sbjct: 18 EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYL 830
+ L NR +L+ E + G L D L K E ++ + + G+ YL
Sbjct: 78 ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ------ILDGVNYL 131
Query: 831 HHDCDPVIVHRDLKPSNILL----DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H I H DLKP NI+L ++ DFG+A I+ I G+ ++AP
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
LG G G V+ G +A+K L K L E V+ +RH +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLY 328
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL-VADWVTRYKIALGVAQGICYLH-HD 833
S E ++ EYM G+L D L G+ L + V +A +A G+ Y+ +
Sbjct: 329 AVVS-EEPIYIVTEYMSKGSLLDFLK-GETGKYLRLPQLV---DMAAQIASGMAYVERMN 383
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
VHRDL+ +NIL+ + +VADFG+A+LI+ +E
Sbjct: 384 Y----VHRDLRAANILVGENLVCKVADFGLARLIEDNE 417
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 18/179 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G V K + G+ A K K R + EV++L +RH NI
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYL 830
+ L N+ +L+ E + G L D L K E+ + + G+ YL
Sbjct: 71 ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ-FLKQ-----ILDGVHYL 124
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEA----RVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H I H DLKP NI+L + ++ DFG+A I++ I G+ ++AP
Sbjct: 125 H---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 49/178 (27%), Positives = 80/178 (44%), Gaps = 25/178 (14%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE----IIAVKKLWGKHKENI---RRRRGVLAEVD 761
L + KILG G G+V + + + +AVK + K + R L+E
Sbjct: 34 NLLIL-GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM----KLDNSSQREIEEFLSEAA 88
Query: 762 VLGNVRHRNIVRLLGCCSNRE-----CTMLLYEYMPNGNLDD-LLHAKNKGENLVADWVT 815
+ + H N++RLLG C M++ +M G+L LL+++ + T
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 816 RYKIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
K + +A G+ YL + +HRDL N +L +M VADFG++K I S +
Sbjct: 149 LLKFMVDIALGMEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 44/185 (23%), Positives = 67/185 (36%), Gaps = 22/185 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G V E + G A+K++ + R E D+ H NI+RL
Sbjct: 35 QKLGEGGFSYVDLVEGLHDGHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 775 LGCCSNRECTM----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ C LL + G L + + N + + + LG+ +G+ +
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAI 150
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA----------GSY 880
H HRDLKP+NILL E + + D G S A +
Sbjct: 151 H---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 881 GYIAP 885
Y AP
Sbjct: 208 SYRAP 212
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 45/179 (25%), Positives = 79/179 (44%), Gaps = 26/179 (14%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE----IIAVKKLWGKHKENI---RRRRGVLAEVD 761
+ ++ ++LG G G+V +A++ + +AVK L K +I L E
Sbjct: 23 QQFTL-GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML----KADIIASSDIEEFLREAA 77
Query: 762 VLGNVRHRNIVRLLGCCSNRECT------MLLYEYMPNGNLDDLLHAKNKGENLVA-DWV 814
+ H ++ +L+G M++ +M +G+L L A GEN
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 815 TRYKIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
T + + +A G+ YL + +HRDL N +L +M VADFG+++ I S +
Sbjct: 138 TLVRFMVDIACGMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD 191
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 20/176 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++LG G+ V+ + G++ A+K + K R + E+ VL ++H NIV L
Sbjct: 15 EVLGSGAFSEVFLVKQRLTGKLFALKCI---KKSPAFRDSSLENEIAVLKKIKHENIVTL 71
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH-H 832
+ L+ + + G L D + + E + + V + YLH +
Sbjct: 72 EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVLSAVKYLHEN 125
Query: 833 DCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IVHRDLKP N+L + + + DFG++K+ Q + MS G+ GY+AP
Sbjct: 126 G----IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-NGIMSTACGTPGYVAP 176
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 37/178 (20%), Positives = 82/178 (46%), Gaps = 24/178 (13%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+ LG G G V++ E + K K+ G + +++ E+ +L RHRNI+
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK------EISILNIARHRNIL 64
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYL 830
L + E ++++E++ ++ + ++ E + +V + V + + +L
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ------VCEALQFL 118
Query: 831 H-HDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
H H+ I H D++P NI+ + + +FG A+ ++ ++ ++ + Y AP
Sbjct: 119 HSHN----IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 20/192 (10%)
Query: 698 QRLNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV 756
QR +D LE L +G G+ G V+K G +IAVK++ + +R +
Sbjct: 18 QRYQAEIND-LENL----GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKR--I 70
Query: 757 LAEVDVLGN-VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADW 813
L ++DV+ IV+ G + E M + L E ++
Sbjct: 71 LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILG-- 127
Query: 814 VTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
K+ + + + + YL ++HRD+KPSNILLD + ++ DFG++ + D++
Sbjct: 128 ----KMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK 181
Query: 874 SVIAGSYGYIAP 885
AG Y+AP
Sbjct: 182 DRSAGCAAYMAP 193
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 49/183 (26%), Positives = 79/183 (43%), Gaps = 34/183 (18%)
Query: 716 KILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ +G G+ G V++A PG ++AVK L K + + + E ++ +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--KEEASADMQADFQREAALMAEFDNP 110
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY------------ 817
NIV+LLG C+ + LL+EYM G+L++ L + +
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170
Query: 818 -------KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868
IA VA G+ YL VHRDL N L+ M ++ADFG+++ I
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNIY 225
Query: 869 SDE 871
S +
Sbjct: 226 SAD 228
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 16/174 (9%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDVLGNVRHRNI 771
+ LG G G VY A E I+A+K L K + + E+++ ++RH NI
Sbjct: 20 RPLGKGKFGNVYLAREKQNKFIMALKVL---FKSQLEKEGVEHQLRREIEIQSHLRHPNI 76
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+R+ +R+ L+ E+ P G L L + + + + +A + Y H
Sbjct: 77 LRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR----FDEQRSATFMEE-LADALHYCH 131
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
++HRD+KP N+L+ + E ++ADFG + S + + G+ Y+ P
Sbjct: 132 ERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPP 181
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-24
Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 24/185 (12%)
Query: 716 KILGMGSTGTVYKAEM-PGGEIIAVK----------KLWGKHKENIRRRRGVLAEVDVLG 764
+ LG G+ G V + G A+K + +K + + E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 765 NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGV 823
++ H NI++L +++ L+ E+ G L + + ++K E A+ I +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN------IMKQI 155
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSY 880
GICYLH IVHRD+KP NILL + + ++ DFG++ D + G+
Sbjct: 156 LSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA 212
Query: 881 GYIAP 885
YIAP
Sbjct: 213 YYIAP 217
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 5e-24
Identities = 46/159 (28%), Positives = 79/159 (49%), Gaps = 16/159 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
+ L + + +G G G V + G ++ AVK + K + + LAE V+ +RH
Sbjct: 21 KELKL-LQTIGKGEFGDVMLGDYRGNKV-AVKCI----KNDATAQA-FLAEASVMTQLRH 73
Query: 769 RNIVRLLGCCSNRE-CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
N+V+LLG + ++ EYM G+L D L ++ + + K +L V + +
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL---KFSLDVCEAM 130
Query: 828 CYL-HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
YL ++ VHRDL N+L+ + A+V+DFG+ K
Sbjct: 131 EYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 33/181 (18%), Positives = 72/181 (39%), Gaps = 31/181 (17%)
Query: 709 ECLSMSDKILGMGSTGTVYKAE--MPGGEI------IAVKKLWGKHKENIRRRRGVLAEV 760
E L ++ LG G+ ++K G + +K L K +
Sbjct: 8 EDLIF-NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAA 63
Query: 761 DVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIA 820
++ + H+++V G C + +L+ E++ G+LD L K + W ++A
Sbjct: 64 SMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKL--EVA 119
Query: 821 LGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEAR--------VADFGVAKLIQSD 870
+A + +L + ++H ++ NILL E + + ++D G++ +
Sbjct: 120 KQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174
Query: 871 E 871
+
Sbjct: 175 D 175
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 6e-24
Identities = 41/179 (22%), Positives = 82/179 (45%), Gaps = 25/179 (13%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G+ G V++ E G + K + K ++ E+ ++ + H +
Sbjct: 57 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN------EISIMNQLHHPKL 110
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICY 829
+ L ++ +L+ E++ G L D + A++ E V +++ + +G+ +
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ------ACEGLKH 164
Query: 830 LH-HDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
+H H IVH D+KP NI+ + + + V DFG+A + DE + V + + AP
Sbjct: 165 MHEHS----IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 49/186 (26%), Positives = 76/186 (40%), Gaps = 38/186 (20%)
Query: 715 DKILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKEN--IRRRRGVLAEVDVLGNV 766
K LG G G V KA + +AVK L KEN R +L+E +VL V
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML----KENASPSELRDLLSEFNVLKQV 83
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY--------- 817
H ++++L G CS +L+ EY G+L L K
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 818 ----------KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
A ++QG+ YL +VHRDL NIL+ + +++DFG+++
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSR 198
Query: 866 LIQSDE 871
+ ++
Sbjct: 199 DVYEED 204
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-24
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G G G V + G +AVK + K + + LAE V+ +RH N+V+LL
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQA-FLAEASVMTQLRHSNLVQLL 252
Query: 776 GCCSNRE-CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL-HHD 833
G + ++ EYM G+L D L ++ + + K +L V + + YL ++
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL---KFSLDVCEAMEYLEGNN 309
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
VHRDL N+L+ + A+V+DFG+ K
Sbjct: 310 F----VHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 45/176 (25%), Positives = 83/176 (47%), Gaps = 19/176 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ILG G G V+K E G +A K + ++ + V E+ V+ + H N+++L
Sbjct: 95 EILGGGRFGQVHKCEETATGLKLAAKII---KTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLH- 831
++ +L+ EY+ G L D + ++ E ++ + + +GI ++H
Sbjct: 152 YDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ------ICEGIRHMHQ 205
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+H DLKP NIL ++ DFG+A+ + E + V G+ ++AP
Sbjct: 206 MY----ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 51/184 (27%), Positives = 79/184 (42%), Gaps = 34/184 (18%)
Query: 715 DKILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-R 767
K+LG G+ G V A G +AVK L K K + R +++E+ ++ +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--KEKADSSEREALMSELKMMTQLGS 107
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK--------- 818
H NIV LLG C+ L++EY G+L + L +K + + K
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167
Query: 819 ---------IALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
A VA+G+ +L VHRDL N+L+ ++ DFG+A+ I
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGLARDI 222
Query: 868 QSDE 871
SD
Sbjct: 223 MSDS 226
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 49/180 (27%), Positives = 74/180 (41%), Gaps = 20/180 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G V K E G A K K K R + EV +L ++H N+
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYL 830
+ L N+ +L+ E + G L D L K E +++ + + G+ YL
Sbjct: 77 ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ------ILNGVYYL 130
Query: 831 H-HDCDPVIVHRDLKPSNILL----DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H I H DLKP NI+L + ++ DFG+A I I G+ ++AP
Sbjct: 131 HSLQ----IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-23
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG G+ G V++ E G A K KE +R+ E+ + +RH +
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK------EIQTMSVLRHPTL 216
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNK-GENLVADWVTRYKIALGVAQGICY 829
V L + +++YE+M G L + + NK E+ +++ + V +G+C+
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ------VCKGLCH 270
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
+H + VH DLKP NI+ + + DFG+ + +S+ V G+ + AP
Sbjct: 271 MH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 41/177 (23%), Positives = 85/177 (48%), Gaps = 18/177 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G+ V + ++ G+ A + K + R + + E + ++H NIVRL
Sbjct: 17 EELGKGAFSVVRRCVKVLAGQEYAAMII-NTKKLSARDHQKLEREARICRLLKHPNIVRL 75
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH-H 832
S L+++ + G L + + A+ E + + + + + + + H
Sbjct: 76 HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ------ILEAVLHCHQM 129
Query: 833 DCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSD-ESMSVIAGSYGYIAP 885
+VHR+LKP N+LL +++ ++ADFG+A ++ + ++ AG+ GY++P
Sbjct: 130 G----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSP 182
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-23
Identities = 74/280 (26%), Positives = 119/280 (42%), Gaps = 36/280 (12%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
S+Q + + +RR LS +P I ++ +LNL N L L + + N
Sbjct: 53 SNQFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YR 195
I ++ +F G L SL L L ++ IPS +
Sbjct: 110 --------SIRQIE--------VGAFNG--------LASLNTLELFDNWLT-VIPSGAFE 144
Query: 196 NLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDI 253
LS LR L L N + S+P + L R+++G + F L NLKY+++
Sbjct: 145 YLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPAS 313
CN+ +P+ ++ L LE L + NHF P S+ L +L+ L + ++Q+S +
Sbjct: 204 GMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNA 261
Query: 314 LASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNN 352
L L L+L +N L +P D+ L L L L +N
Sbjct: 262 FDGLASLVELNLAHNNL-SSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 12/257 (4%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+ + L+ +P G+ + + + NN+Q F L +L+ + + +
Sbjct: 54 NQFSKVVCTRRGLS-EVPQ--GIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 258 LSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQLSGPIPASLA 315
+ + + L L L LF N T IP ++ L L+ L L +N + +
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFN 168
Query: 316 SLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
+ L RL L I + E L +L L L ++ + L L +++S
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMS 226
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG- 433
N P + L KL + ++ + +SL L + N L+ S+P
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 434 FGLLPNLTFMDMSRNSL 450
F L L + + N
Sbjct: 286 FTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-22
Identities = 54/282 (19%), Positives = 105/282 (37%), Gaps = 40/282 (14%)
Query: 127 KLRTIDISHNSFNSTFPPGISK-LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY 185
+ + + S P GI R+L + N+ F L+ L+ L LG +
Sbjct: 55 QFSKVVCTRRGL-SEVPQGIPSNTRYLNLME---NNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 186 FDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-F 242
+I + L+SL L+L N LT +P L++L + + N ++ +P F
Sbjct: 111 I-RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
Query: 243 ASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDL 301
+ +L +D+ + L L+ L L + ++P + L L+ L++
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEM 225
Query: 302 SDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQK 361
S N P S L L +L + N+ ++ +
Sbjct: 226 SGNHFPEIRPGSFHGLSSLKKLWV------------------------MNSQVSLIERNA 261
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNF 402
L+ ++++ N+L+ +P + L +L L N +
Sbjct: 262 FDGLASLVELNLAHNNLSS-LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 5e-21
Identities = 52/236 (22%), Positives = 95/236 (40%), Gaps = 15/236 (6%)
Query: 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
+ + V + L+ +P I L L NN + + L L++ N
Sbjct: 53 SNQFSKVVCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRN 109
Query: 425 QLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSNI 482
+ I G F L +L +++ N L+ IP KL L + N S+PS
Sbjct: 110 SIR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPI-ESIPSYA 166
Query: 483 WSA-PNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLN 539
++ P+L L K I + F G ++ + L + +P ++ L L
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELE 224
Query: 540 LSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLT 594
+S N I P GL S+ + + ++ ++ I N F+ ++L N+++N L+
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 5e-20
Identities = 54/256 (21%), Positives = 98/256 (38%), Gaps = 17/256 (6%)
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNN 401
++ L+ V PQ + SN + L ++ N++ I L L L N+
Sbjct: 55 QFSKVVCTRRGLSEV-PQGIPSNTRYL--NLMENNIQM-IQADTFRHLHHLEVLQLGRNS 110
Query: 402 FTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-L 458
I +SL+ L + DN L IP G F L L + + N + IP
Sbjct: 111 IR-QIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAF 167
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELH 517
L L++ E + + NLK L+ + +P+ + ++E+
Sbjct: 168 NRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMS 226
Query: 518 NNLLNGSIPWD-IGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN 576
N I L L + + ++ I GL S+ +++L+HN L+ ++P +
Sbjct: 227 GNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHD 284
Query: 577 -FENCSTLESFNVSYN 591
F L ++ +N
Sbjct: 285 LFTPLRYLVELHLHHN 300
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 22/182 (12%)
Query: 711 LSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H 768
L + DK LG GS K + AVK + + + N ++ E+ L H
Sbjct: 12 LDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK------EITALKLCEGH 65
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNL-DDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
NIV+L ++ T L+ E + G L + + K+ E + I + +
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLVSAV 119
Query: 828 CYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSD-ESMSVIAGSYGYI 883
++H +VHRDLKP N+L + +E ++ DFG A+L D + + + Y
Sbjct: 120 SHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 884 AP 885
AP
Sbjct: 177 AP 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-23
Identities = 39/188 (20%), Positives = 77/188 (40%), Gaps = 33/188 (17%)
Query: 716 KILGMGSTGTVYKA-EMPGGE-----IIAVKKLWGKH---KENIRRRRGVLAEVDVLGNV 766
+++G G V + G+ I+ V K E+++R E + +
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKR------EASICHML 83
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENL----VADWVTRYKIALG 822
+H +IV LL S+ +++E+M +L + + + VA R
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQ----- 138
Query: 823 VAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSD-ESMSVIA 877
+ + + Y H ++ I+HRD+KP +LL + + ++ FGVA +
Sbjct: 139 ILEALRYCHDNN----IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194
Query: 878 GSYGYIAP 885
G+ ++AP
Sbjct: 195 GTPHFMAP 202
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 29/179 (16%)
Query: 715 DKILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
K LG G+ G V AE G + +AVK L K + +++E++++ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMI 97
Query: 767 -RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR--------- 816
+H+NI+ LLG C+ ++ EY GNL + L A+ + + R
Sbjct: 98 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 817 --YKIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+A+G+ YL +HRDL N+L+ ++ADFG+A+ I + +
Sbjct: 158 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 46/179 (25%), Positives = 79/179 (44%), Gaps = 29/179 (16%)
Query: 715 DKILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
K LG G G V AE G + +AVK L K + +++E++++ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--KDDATEKDLSDLVSEMEMMKMI 143
Query: 767 -RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY-------- 817
+H+NI+ LLG C+ ++ EY GNL + L A+ + + R
Sbjct: 144 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 818 ---KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+A+G+ YL +HRDL N+L+ ++ADFG+A+ I + +
Sbjct: 204 DLVSCTYQLARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 8e-23
Identities = 39/163 (23%), Positives = 81/163 (49%), Gaps = 14/163 (8%)
Query: 703 TADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVD 761
+ D + + +KI G G++GTVY A ++ G+ +A++++ + + ++ ++ E+
Sbjct: 14 SVGDPKKKYTRFEKI-GQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEIL 69
Query: 762 VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
V+ ++ NIV L + ++ EY+ G+L D++ E +A +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCR 123
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
Q + +LH + ++HRD+K NILL + ++ DFG
Sbjct: 124 ECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 52/176 (29%), Positives = 81/176 (46%), Gaps = 21/176 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G+T VY+ + + A+K L + I R E+ VL + H NI++L
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT-----EIGVLLRLSHPNIIKL 113
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLH-H 832
L+ E + G L D + K E AD V + + + + YLH +
Sbjct: 114 KEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ------ILEAVAYLHEN 167
Query: 833 DCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IVHRDLKP N+L + ++ADFG++K+++ M + G+ GY AP
Sbjct: 168 G----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 48/178 (26%), Positives = 76/178 (42%), Gaps = 28/178 (15%)
Query: 715 DKILGMGSTGTVYKAEMPGGE------IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-R 767
K LG G+ G V +A+ G + +AVK L K R +++E+ +L ++
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGH 89
Query: 768 HRNIVRLLGCCSNREC-TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY--------- 817
H N+V LLG C+ M++ E+ GNL L +K
Sbjct: 90 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 818 --KIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ VA+G+ +L +HRDL NILL + ++ DFG+A+ I D
Sbjct: 150 LICYSFQVAKGMEFLASRK-----CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 9e-23
Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 24/178 (13%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLG-NVRHRNIVR 773
+ +G+GS + AVK + K K + E+++L +H NI+
Sbjct: 28 EDIGVGSYSVCKRCIHKATNMEFAVKII-DKSKRDPTE------EIEILLRYGQHPNIIT 80
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHH 832
L + + ++ E M G L D + + E + + + + + YLH
Sbjct: 81 LKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASA------VLFTITKTVEYLH- 133
Query: 833 DCDPVIVHRDLKPSNILLDGEMEA----RVADFGVAKLIQSDES-MSVIAGSYGYIAP 885
+VHRDLKPSNIL E R+ DFG AK ++++ + + ++AP
Sbjct: 134 AQG--VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 52/183 (28%), Positives = 87/183 (47%), Gaps = 17/183 (9%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
++ + ++LG G G V ++ G++ A KKL K+ I++R+G L E +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQI 237
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L V R +V L ++ L+ M G+L H + G+ + + A
Sbjct: 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAA-E 294
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGY 882
+ G+ LH IV+RDLKP NILLD R++D G+A + +++ G+ GY
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGY 351
Query: 883 IAP 885
+AP
Sbjct: 352 MAP 354
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 1e-22
Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 30/185 (16%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE--------IIAVKKLWGKHKENIRRRRGVLAEV 760
+ L + K LG G+ G V AE G + +AVK L K + +++E+
Sbjct: 69 DRLVL-GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--KSDATEKDLSDLISEM 125
Query: 761 DVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR--- 816
+++ + +H+NI+ LLG C+ ++ EY GNL + L A+ + +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 817 --------YKIALGVAQGICYL--HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866
A VA+G+ YL +HRDL N+L+ + ++ADFG+A+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKK-----CIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 867 IQSDE 871
I +
Sbjct: 241 IHHID 245
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 46/163 (28%), Positives = 74/163 (45%), Gaps = 14/163 (8%)
Query: 703 TADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVD 761
D L KI G GSTG V A E G +AVK + + ++ RR + EV
Sbjct: 39 DQGDPRLLLDSYVKI-GEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVV 94
Query: 762 VLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
++ + +H N+V + E +L E++ G L D++ E +A +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA------TVCE 148
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
V Q + YLH ++HRD+K +ILL + +++DFG
Sbjct: 149 AVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 48/176 (27%), Positives = 74/176 (42%), Gaps = 20/176 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K +G G+ V A + G +A+K +L + + R EV ++ + H
Sbjct: 21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR------EVRIMKILNHP 74
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIV+L + L+ EY G + D L A + + A R + + Y
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA----R-SKFRQIVSAVQY 129
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H IVHRDLK N+LLD +M ++ADFG + + G+ Y AP
Sbjct: 130 CHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAP 182
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 15/150 (10%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
LG G+ G VYKA G + A K + K +E + + E+++L H IV+LLG
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED---YIVEIEILATCDHPYIVKLLG 83
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDC 834
+ ++ E+ P G +D ++ ++G E + + + + + +LH
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ------VVCRQMLEALNFLHSKR 137
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVA 864
I+HRDLK N+L+ E + R+ADFGV+
Sbjct: 138 ---IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 98.2 bits (244), Expect = 6e-22
Identities = 31/200 (15%), Positives = 63/200 (31%), Gaps = 37/200 (18%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKL-------------------------WGKHKEN 749
+LG +A + GE V K+++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 750 IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM-PNGNLDDL---LHAKNK 805
+ + D++ + + + ++R+ + + Y NL L + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 806 GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+ + L V + + LHH +VH L+P +I+LD + F
Sbjct: 199 THKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 866 LIQSDESMSVIAGSYGYIAP 885
D + V + S G+ P
Sbjct: 255 ---RDGARVVSSVSRGFEPP 271
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 9e-22
Identities = 42/202 (20%), Positives = 79/202 (39%), Gaps = 45/202 (22%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVR 773
+ +G G G+V+K + G I A+K+ K + L EV + +H ++VR
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRS-KKPLAGSVDEQNALREVYAHAVLGQHSHVVR 75
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG-----ENLVADWVTRYKIALGVAQGIC 828
+ + ++ EY G+L D + + E + D + L V +G+
Sbjct: 76 YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL------LQVGRGLR 129
Query: 829 YLHHDCDPVIVHRDLKPSNILLD-------------------GEMEARVADFGVAKLIQS 869
Y+H +VH D+KPSNI + ++ ++ D G I S
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 870 DES-------MS--VIAGSYGY 882
+ ++ V+ +Y +
Sbjct: 187 PQVEEGDSRFLANEVLQENYTH 208
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-22
Identities = 45/218 (20%), Positives = 73/218 (33%), Gaps = 54/218 (24%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+G GS G V A E I A+K K+ + +++ R + EV ++ + H
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVER---IKTEVRLMKKLHHP 88
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG------- 822
NI RL + + L+ E G+L D L+
Sbjct: 89 NIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEE 148
Query: 823 ----------------------------VAQGICYLHHDCDPVIVHRDLKPSNILLDGEM 854
+ + YLH + I HRD+KP N L
Sbjct: 149 AINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNK 205
Query: 855 EARV--ADFGVAKLIQSDES-----MSVIAGSYGYIAP 885
+ DFG++K + M+ AG+ ++AP
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP 243
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 97.0 bits (241), Expect = 1e-21
Identities = 30/191 (15%), Positives = 57/191 (29%), Gaps = 26/191 (13%)
Query: 715 DKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH 768
+LG G+ VY+A + +K N ++ L
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQ---KPANPWEFYIGTQLMERLKPSMQ 126
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
++ + ++L+ E G L + ++ V A+ + I
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEA-----------RVADFGVA---KLIQSDESMS 874
+H D I+H D+KP N +L + D G + KL +
Sbjct: 187 QVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 875 VIAGSYGYIAP 885
+ G+
Sbjct: 244 AKCETSGFQCV 254
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 20/152 (13%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+G GS G V+K + +++A+K + E+I++ E+ VL +
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ------EITVLSQCDSPYVT 83
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
+ G ++ EY+ G+ DLL E +A I + +G+ YLH
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA------TILREILKGLDYLHS 137
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ +HRD+K +N+LL E ++ADFGVA
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFGVA 166
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 96.7 bits (240), Expect = 2e-21
Identities = 17/200 (8%), Positives = 39/200 (19%), Gaps = 35/200 (17%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+ L +G V+ ++ E A+K + + + + +
Sbjct: 67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEE 126
Query: 774 LLGCC--------------------------SNRECTMLLYEYMP--NGNLDDLLHAKNK 805
+LL L L
Sbjct: 127 ARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV 186
Query: 806 GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+ + + L +VH P N+ + + + D
Sbjct: 187 FRGDEGILALHI-LTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 866 LIQSDESMSVIAGSYGYIAP 885
+ + Y
Sbjct: 243 --KVGTRGPASSVPVTYAPR 260
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 30/189 (15%)
Query: 713 MSDKILGMGSTGTVYKA-EMPGGEIIAVK---KLWGKHKENIRRRRGVLAEVDVLGNVR- 767
+ + +LG G+ V + + AVK K G + + R EV++L +
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR------EVEMLYQCQG 69
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
HRN++ L+ + L++E M G++ +H + L A V + VA +
Sbjct: 70 HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD-----VASAL 124
Query: 828 CYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQ--------SDESMSVI 876
+LH + I HRDLKP NIL + ++ DF + I+ S +
Sbjct: 125 DFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 877 AGSYGYIAP 885
GS Y+AP
Sbjct: 182 CGSAEYMAP 190
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 44/181 (24%), Positives = 75/181 (41%), Gaps = 23/181 (12%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVR 773
++L G VY+A+ + G A+K+L +E R ++ EV + + H NIV+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRA---IIQEVCFMKKLSGHPNIVQ 90
Query: 774 LLGCCSNRECT--------MLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALG 822
S + +LL E ++ L +++G + V KI
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTV------LKIFYQ 144
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGY 882
+ + ++H P I+HRDLK N+LL + ++ DFG A I S A
Sbjct: 145 TCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 883 I 883
+
Sbjct: 204 V 204
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 40/214 (18%), Positives = 81/214 (37%), Gaps = 13/214 (6%)
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDM 445
C + ++P + ++ R+ + N+++ +P F NLT + +
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWL 63
Query: 446 SRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPD 504
N L+ LE L++S+N+ S+ + L L L ++
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 505 --FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITD 561
F G ++ + L +N L ++P D L L L N ++ + GL S+
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 562 VDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLT 594
+ L N + + + F + L + + N L+
Sbjct: 182 LLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 8e-21
Identities = 51/220 (23%), Positives = 85/220 (38%), Gaps = 11/220 (5%)
Query: 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGL 320
+P I + + L N + S+ + L +L L N L+ A+ L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 321 TRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT 379
+L L +N + L L TL L L + P L + + N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 380 GPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FGL 436
+P L L L N + S+PE SL RL + N++ + F
Sbjct: 143 A-LPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
Query: 437 LPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQ 475
L L + + N+LS +P + L + L+YL +++N +
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 53/234 (22%), Positives = 85/234 (36%), Gaps = 10/234 (4%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
L ++P G+ +RI + N + F + NL + + +
Sbjct: 11 EPKVTTSCPQQGLQ-AVPV--GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLSGPIPASLAS 316
L+ + + L LE L L N + + + L L L L L P
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 317 LKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L L L L +N L +P D L +L L L N ++ V + L + +
Sbjct: 128 LAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 376 NSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLN 427
N + + P RL L LF+NN + ++P L +L LR+ DN
Sbjct: 187 NRVAH-VHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 45/235 (19%), Positives = 84/235 (35%), Gaps = 15/235 (6%)
Query: 364 SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQD 423
N +T L +P I ++ L N ++ + C +L+ L +
Sbjct: 9 YNEPKVTTSCPQQGLQA-VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 424 NQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISENSFQTSLPSN 481
N L I F L L +D+S N+ + +L L++ L
Sbjct: 66 NVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPG 123
Query: 482 IWSA-PNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLL 537
++ L+ L + L +PD F ++ + LH N ++ S+P L
Sbjct: 124 LFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR 181
Query: 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYN 591
L L +N + + P L + + L N L+ +P+ L+ ++ N
Sbjct: 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 60/231 (25%), Positives = 91/231 (39%), Gaps = 25/231 (10%)
Query: 64 VWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--------A 113
C G++ P + + L +S R +LT L L +N A
Sbjct: 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 114 FDGPLQPAILELTKLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQ 172
F G L L +D+S N+ + P L L + P F
Sbjct: 76 FTG--------LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRG 127
Query: 173 LNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIG 230
L +LQ L L + +P D +R+L +L L L GN ++ S+P + L L+R+ +
Sbjct: 128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLH 185
Query: 231 YNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKN 280
N + P F L L + + A NLS LP+E + L L+ L L N
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 5e-21
Identities = 42/180 (23%), Positives = 72/180 (40%), Gaps = 21/180 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
LG G+ G V+ A + + VK K+ + V E+ +L V H
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGN-LDDLLHAKNKGENLVADWVTRYK---IALGVAQ 825
NI+++L N+ L+ E +G L + + + +A Y + V
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLA----SYIFRQLVSAVG- 144
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
YL I+HRD+K NI++ + ++ DFG A ++ + G+ Y AP
Sbjct: 145 ---YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAP 198
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 30/190 (15%)
Query: 711 LSMSD----KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
D KILG GS TV A E+ A+K L K +I + V E DV
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDV 83
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKI 819
+ + H V+L + E Y NG L L + + G E TR+
Sbjct: 84 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIGSFDET-----CTRFYT 136
Query: 820 ALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV--- 875
A + + YLH I+HRDLKP NILL+ +M ++ DFG AK++ + +
Sbjct: 137 A-EIVSALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 876 IAGSYGYIAP 885
G+ Y++P
Sbjct: 192 FVGTAQYVSP 201
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 53/207 (25%), Positives = 79/207 (38%), Gaps = 9/207 (4%)
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
++S ++ +LT +LPP L + + N L L +++
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPP--DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL 314
L+ L + L L L L N +P+ L AL VLD+S N+L+ +L
Sbjct: 64 RAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDV 373
L L L L N L +P + L+ L L NN+LT + L L T+ +
Sbjct: 121 RGLGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 374 SSNSLTGPIPPTICDGDRLFKLILFSN 400
NSL IP L L N
Sbjct: 180 QENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 54/254 (21%), Positives = 89/254 (35%), Gaps = 59/254 (23%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ ++ +R+L+ +PP++ T L+LS N ++ T+L +++
Sbjct: 9 VASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRN 196
+L L++ L L L+L + +P +
Sbjct: 66 -----------ELTKLQVDG---------------TLPVLGTLDLSHNQLQ-SLPLLGQT 98
Query: 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256
L +L LD++ N LT SLP L L+ + +
Sbjct: 99 LPALTVLDVSFNRLT-SLPLGA-----------------------LRGLGELQELYLKGN 134
Query: 257 NLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLSGPIPASL 314
L TLP + + KLE L L N+ T E+P L+ L L L +N L IP
Sbjct: 135 ELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGF 191
Query: 315 ASLKGLTRLSLMNN 328
L L N
Sbjct: 192 FGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 52/205 (25%), Positives = 77/205 (37%), Gaps = 16/205 (7%)
Query: 368 LLTVDVSSNSLTGPIPPTI-CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
L V+ +LT +PP + D L L N L+ + L++L + +L
Sbjct: 12 HLEVNCDKRNLTA-LPPDLPKDTTILH---LSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNI-WSA 485
+ G LP L +D+S N L +P L L++S N SLP
Sbjct: 68 T-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGL 123
Query: 486 PNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSR 542
L+ L ++L +P + K+ L NN L +P + E L L L
Sbjct: 124 GELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQE 181
Query: 543 NSLTGIIPWEISGLPSITDVDLSHN 567
NSL IP G + L N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 6e-11
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDL 458
N T ++P +L + L + +N L LT +++ R L+ ++ D
Sbjct: 19 KRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD- 73
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIEL 516
G L L++S N SLP + P L +L S ++LT +P G + ++ L
Sbjct: 74 GTLPVLGTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYL 131
Query: 517 HNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
N L ++P + KL L+L+ N+LT + ++GL ++ + L N L TIP
Sbjct: 132 KGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPK 189
Query: 576 NFENCSTLESFNVSYN 591
F L + N
Sbjct: 190 GFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 39/176 (22%), Positives = 76/176 (43%), Gaps = 16/176 (9%)
Query: 437 LPNLTFMDMSRNSLS---GEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493
+ + ++ + +L+ ++P+D L++SEN T + + L L+
Sbjct: 9 VASHLEVNCDKRNLTALPPDLPKDT------TILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 494 SSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEI 553
++LT K+ + ++L +N L S+P L +L++S N LT + +
Sbjct: 63 DRAELT-KLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 554 SGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIPASGTIFPNLH 608
GL + ++ L N L T+P LE +++ N LT +PA + L
Sbjct: 121 RGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTE-LPAG--LLNGLE 172
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 2e-20
Identities = 48/184 (26%), Positives = 86/184 (46%), Gaps = 16/184 (8%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
+ ++LG G G V+ +M G++ A KKL +K+ +++R+G + E +
Sbjct: 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKL---NKKRLKKRKGYQGAMVEKKI 238
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L V R IV L + L+ M G++ ++ ++ + + A
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-Q 297
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK-LIQSDESMSVIAGSYG 881
+ G+ +LH I++RDLKP N+LLD + R++D G+A L AG+ G
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPG 354
Query: 882 YIAP 885
++AP
Sbjct: 355 FMAP 358
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-20
Identities = 51/157 (32%), Positives = 80/157 (50%), Gaps = 18/157 (11%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHR 769
D + G G TVYKA + +I+A+KK+ K + G+ L E+ +L + H
Sbjct: 16 DFL-GEGQFATVYKARDKNTNQIVAIKKI--KLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDL-LHAKNKGENLVADWVTRYKIALGVAQGIC 828
NI+ LL ++ L++++M DL + K+ L + Y + QG+
Sbjct: 73 NIIGLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMT--LQGLE 126
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
YLH I+HRDLKP+N+LLD ++ADFG+AK
Sbjct: 127 YLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 37/155 (23%), Positives = 68/155 (43%), Gaps = 17/155 (10%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKL----WGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+G G+T V A P E +A+K++ + + + E+ + H NIV
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK------EIQAMSQCHHPNIV 76
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL---GVAQGICY 829
++ L+ + + G++ D++ + + IA V +G+ Y
Sbjct: 77 SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
LH + +HRD+K NILL + ++ADFGV+
Sbjct: 137 LHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 47/177 (26%), Positives = 86/177 (48%), Gaps = 18/177 (10%)
Query: 691 PWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKEN 749
P + + E + +K+ G GS G+VYKA G+I+A+K++ + +
Sbjct: 11 PRRQLKKLDEDSLTKQPEEVFDVLEKL-GEGSYGSVYKAIHKETGQIVAIKQV--PVESD 67
Query: 750 IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--E 807
++ ++ E+ ++ ++V+ G ++ EY G++ D++ +NK E
Sbjct: 68 LQE---IIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTE 124
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ +A I +G+ YLH +HRD+K NILL+ E A++ADFGVA
Sbjct: 125 DEIA------TILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 24/177 (13%)
Query: 696 AFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIR---R 752
+ R N ++E +K+ G G+ G VYKA+ G I+A+K+ IR
Sbjct: 8 SSGRENLYFQGLMEKYQKLEKV-GEGTYGVVYKAKDSQGRIVALKR--------IRLDAE 58
Query: 753 RRGV----LAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGEN 808
G+ + E+ +L + H NIV L+ + C L++E+M +L +L
Sbjct: 59 DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTG 115
Query: 809 LVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
L + Y L +G+ + H I+HRDLKP N+L++ + ++ADFG+A+
Sbjct: 116 LQDSQIKIYLYQL--LRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 29/183 (15%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
++LG+G G V + E A+K ++ EV++ + +IV
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPKARREVELHWRASQCPHIV 118
Query: 773 RLLG----CCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQ 825
R++ + R+C +++ E + G L + + E ++ I + +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------IMKSIGE 172
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGY 882
I YLH I HRD+KP N+L + ++ DFG AK S S++ + Y
Sbjct: 173 AIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY 229
Query: 883 IAP 885
+AP
Sbjct: 230 VAP 232
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 3e-20
Identities = 52/174 (29%), Positives = 83/174 (47%), Gaps = 15/174 (8%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRR---GVLAEVDVLGNVRHRNI 771
LG+G+ G V E G +AVK L +++ IR + E+ L RH +I
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKIL---NRQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
++L S ++ EY+ G L D + + E + A + + ++ + Y H
Sbjct: 74 IKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AVDYCH 128
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+VHRDLKP N+LLD M A++ADFG++ ++ E + GS Y AP
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 4e-20
Identities = 53/303 (17%), Positives = 106/303 (34%), Gaps = 25/303 (8%)
Query: 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSF 138
+ + +++ + L +T L+ + L L +++ N
Sbjct: 20 NAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQI 75
Query: 139 NSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLS 198
+ L + N + L S++ L+L + P LS
Sbjct: 76 TD--LAPLKNLTKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITDVTPLA--GLS 129
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
+L+ L L N +T ++ P L LT L+ + IG + P A+L L + +
Sbjct: 130 NLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185
Query: 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318
S S +++L L + L N + P++ N L ++ L++ ++ +L
Sbjct: 186 SDI--SPLASLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTNQTITNQPVFYNNNL- 240
Query: 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSL 378
++ NV+ G I D + +LT L + + V+ +
Sbjct: 241 ------VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNT 294
Query: 379 TGP 381
T P
Sbjct: 295 TVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 54/305 (17%), Positives = 111/305 (36%), Gaps = 43/305 (14%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
L + + ++ + A L G+T LS + + ++ L +L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELKD 72
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N +T + P L + K+ +++S N L +
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK--------------------------NVSAIA 104
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
S+ L + Q+ P L NL + + N ++ I L L+YL+I
Sbjct: 105 GLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGN 160
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
+ L + + + L L A +K++ I ++ ++ L NN ++ P + +
Sbjct: 161 AQV-SDL-TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
L ++ L+ ++T + + L V P+ + T S N+++N
Sbjct: 216 TSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKG--PSGAPIAPATISDNGTYASPNLTWN 273
Query: 592 LLTGP 596
L +
Sbjct: 274 LTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 56/288 (19%), Positives = 105/288 (36%), Gaps = 25/288 (8%)
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
L + K++ T + + +L + L ++ I + L L L
Sbjct: 13 FPDPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEG-VQYLNNLIGL 68
Query: 324 SLMNNVLFGEIPQDIELLAD---LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTG 380
L +N + D+ L + + L L N L V + + T+D++S +T
Sbjct: 69 ELKDNQI-----TDLAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD 121
Query: 381 PIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNL 440
P + L L L N T +I L ++L L I + Q++ + L L
Sbjct: 122 VTP--LAGLSNLQVLYLDLNQIT-NI-SPLAGLTNLQYLSIGNAQVS-DLT-PLANLSKL 175
Query: 441 TFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG 500
T + N +S +I L + L +++ N + + S + + NL I++ ++ +T
Sbjct: 176 TTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQI-SDV-SPLANTSNLFIVTLTNQTIT- 230
Query: 501 KIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI 548
P F + + P I NL+ N + I
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 52/252 (20%), Positives = 92/252 (36%), Gaps = 42/252 (16%)
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
L +I G +N+ V A L + + ++ + L L L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL 340
T P+ NL + L+LS N L +A L+ + L L + + ++ +
Sbjct: 74 QITDLAPLK--NLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQI-TDVT-PLAG 127
Query: 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSN 400
L++L L L N +T + P L L + + + ++
Sbjct: 128 LSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS--------------------- 164
Query: 401 NFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN 460
+ L N S L+ L+ DN+++ I LPNL + + N +S P L N
Sbjct: 165 ----DL-TPLANLSKLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVSP--LAN 215
Query: 461 AQKLEYLNISEN 472
L + ++
Sbjct: 216 TSNLFIVTLTNQ 227
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 6e-17
Identities = 53/233 (22%), Positives = 95/233 (40%), Gaps = 16/233 (6%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
IT+L ++ I ++YL +L L L N + LTK+ +++S N
Sbjct: 41 DGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKDNQITDL--APLKNLTKITELELSGNP 96
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ I+ L+ ++ + S T PL L++LQ L L + I S L
Sbjct: 97 LKNVSA--IAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NI-SPLAGL 150
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
++L++L + ++ L P L L++L ++ N + P ASL NL + +
Sbjct: 151 TNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQ 206
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
+S S ++N + L ++ L T + NL V+ P
Sbjct: 207 ISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAPA 257
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 92.8 bits (230), Expect = 4e-20
Identities = 29/205 (14%), Positives = 58/205 (28%), Gaps = 42/205 (20%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKL-------------------------WGKHKEN 749
+LG +A GE V K+++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 750 IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP--NGNLDDL---LHAKN 804
+ + D++ + + + ++R+ + + P NL L + +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRL-DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHS 202
Query: 805 KGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ + L V + + LHH +VH L+P +I+LD + F
Sbjct: 203 STHKSLVHHARLQ-LTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 865 KLIQSDESMSVIAGS-YG---YIAP 885
S G + A
Sbjct: 259 VRD--GASAVSPIGRGFAPPETTAE 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 4e-20
Identities = 35/152 (23%), Positives = 57/152 (37%), Gaps = 18/152 (11%)
Query: 719 GMGSTGTVYKA-EMPGGEIIAVKK--LWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
G TV A P GE + V++ L E + + E+ V H NIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTF---LQGELHVSKLFNHPNIVPYR 92
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQGICYLHH 832
++ +M G+ DL+ E +A I GV + + Y+HH
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIA------YILQGVLKALDYIHH 146
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
VHR +K S+IL+ + + ++
Sbjct: 147 MG---YVHRSVKASHILISVDGKVYLSGLRSN 175
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 6e-20
Identities = 56/266 (21%), Positives = 89/266 (33%), Gaps = 38/266 (14%)
Query: 76 KSSQITSLDLSRRSLSGPIPPEIRYL---TSLTHLNLSANAFDGPLQPAILELT--KLRT 130
KS + L + + I + + L L L G P +LE T L
Sbjct: 66 KSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNI 125
Query: 131 IDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEI 190
+++ + S+ T +++L+ L+ L++ ++
Sbjct: 126 LNLRNVSWA-TRDAWLAELQQWL-------------------KPGLKVLSIAQAHSLNFS 165
Query: 191 PSDYRNLSSLRFLDLAGNSLTGSL-------PPQLGLLTQLERIEIGYNNLQGEVPVEFA 243
R +L LDL+ N G P + L L G G A
Sbjct: 166 CEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAA 225
Query: 244 SLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
+ V L+ +D+S +L + ++L L L V G L VLDLS
Sbjct: 226 ARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ---VPKGLPAKLSVLDLS 282
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNN 328
N+L P S L + LSL N
Sbjct: 283 YNRLDR-NP-SPDELPQVGNLSLKGN 306
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 55/309 (17%), Positives = 94/309 (30%), Gaps = 39/309 (12%)
Query: 206 AGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP-VEFASLVNLKYMDISACNLSGTLPS 264
A N L + G LE + + + ++LK + + A + +
Sbjct: 27 AFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILF 86
Query: 265 EIS---NLTKLEMLLLFKNHFTGEIPVSYGNLQ--ALQVLDLSDNQLSGPIPASLASLKG 319
++ L+ L L TG P L +L+L + + A LA L+
Sbjct: 87 GALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQ 145
Query: 320 LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLT 379
L L L + H +++ L T+D+S N
Sbjct: 146 W-------------------LKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPEL 186
Query: 380 G--PIPPTICDG--DRLFKLILFSNNFT---YSIPENLVNCSSLSRLRIQDNQLNGSIP- 431
G + +C L L L + L L + N L +
Sbjct: 187 GERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246
Query: 432 QGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKIL 491
L +++S L ++P+ L KL L++S N PS P + L
Sbjct: 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRL-DRNPS-PDELPQVGNL 301
Query: 492 SASSSKLTG 500
S +
Sbjct: 302 SLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 60/324 (18%), Positives = 106/324 (32%), Gaps = 65/324 (20%)
Query: 142 FPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD---YRNLS 198
+ G S L+ + ++ + ++ SL++L + + I +S
Sbjct: 39 YGGGRSLEYLLKRVDTEADLGQ---FTDIIKSLSLKRLTVRAARIPSRILFGALRVLGIS 95
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
L+ L L +TG+ PP L T +L +++ +
Sbjct: 96 GLQELTLENLEVTGTAPPPLLEATGP----------------------DLNILNLRNVSW 133
Query: 259 SGTLPSEISNL-----TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPAS 313
+ + ++ L L++L + + H AL LDLSDN G
Sbjct: 134 AT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 314 LA----SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLL 369
A L L+L N + +GV + +L
Sbjct: 193 SALCPLKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQ 231
Query: 370 TVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG 428
+D+S NSL CD +L L L +P+ L + LS L + N+L+
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD- 287
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSG 452
P LP + + + N
Sbjct: 288 RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-19
Identities = 54/355 (15%), Positives = 104/355 (29%), Gaps = 70/355 (19%)
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL 314
+CN S P + F ++ + G +L D + +
Sbjct: 14 SCNFSDPKP---------DWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDI 64
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
L RL++ + I ++ L + +
Sbjct: 65 IKSLSLKRLTVRAARIPSRILFGA---------------------LRVLGISGLQELTLE 103
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN------CSSLSRLRIQDNQLNG 428
+ +TG PP + + IL N +++ + + L L I
Sbjct: 104 NLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLN 163
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRD----LGNAQKLEYLNISENSFQT---SLPSN 481
+ + P L+ +D+S N GE L+ L + +T +
Sbjct: 164 FSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223
Query: 482 IWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLS 541
+ L+ L S HN+L + + +L LNLS
Sbjct: 224 AAARVQLQGLDLS----------------------HNSLRDAAGAPSCDWPSQLNSLNLS 261
Query: 542 RNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGP 596
L +P + ++ +DLS+N L PS + + + ++ N
Sbjct: 262 FTGLKQ-VPKGLP--AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 1e-18
Identities = 43/245 (17%), Positives = 69/245 (28%), Gaps = 41/245 (16%)
Query: 78 SQITSLDLSRRSLSGPIPPEI--RYLTSLTHLNLSANAFDGPLQPA----ILELTKLRTI 131
S + L L ++G PP + L LNL ++ L+ +
Sbjct: 95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVL 154
Query: 132 DISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLE----FVQLNSLQQLNL---GGS 184
I+ + + L + N G L ++ +LQ L L G
Sbjct: 155 SIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGME 214
Query: 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFAS 244
G + L+ LDL+ NSL +
Sbjct: 215 TPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS-----------------------CDW 251
Query: 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDN 304
L +++S L +P + KL +L L N P L + L L N
Sbjct: 252 PSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSP-DELPQVGNLSLKGN 306
Query: 305 QLSGP 309
Sbjct: 307 PFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 37/213 (17%), Positives = 67/213 (31%), Gaps = 39/213 (18%)
Query: 409 NLVNCSSLSRLRIQDNQLNGSIPQG---FGLLPNLTFMDMSRNSLSGEIPRDLGNAQ--K 463
+++ SL RL ++ ++ I G + L + + ++G P L A
Sbjct: 63 DIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPD 122
Query: 464 LEYLNISENSFQTSLPS----NIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNN 519
L LN+ S+ T W P LK+LS +
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLS-----------------------IAQA 159
Query: 520 LLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEIS----GLPSITDVDLSHNFLT---GT 572
+ L L+LS N G + P++ + L + + G
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 573 IPSNFENCSTLESFNVSYNLLTGPIPASGTIFP 605
+ L+ ++S+N L A +P
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWP 252
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 5e-12
Identities = 28/171 (16%), Positives = 57/171 (33%), Gaps = 13/171 (7%)
Query: 74 NPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAF--DGPLQPAILE--LTKLR 129
+ L +++ ++R +L+ L+LS N + L A+ L+
Sbjct: 145 QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQ 204
Query: 130 TIDISHNSFNS---TFPPGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSY 185
+ + + + + L+ + NS + L LNL +
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTG 264
Query: 186 FDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG 236
++P + L LDL+ N L + P L Q+ + + N
Sbjct: 265 LK-QVPKGL--PAKLSVLDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 24/154 (15%), Positives = 51/154 (33%), Gaps = 7/154 (4%)
Query: 464 LEYLNISENSFQTSLPSNIWSAPNLKILSAS-SSKLTGKIPDFIGCKSIYKIELHNNLLN 522
L+ ++ + Q + S L + +A S++ +G + ++ L N +
Sbjct: 49 LKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVT 108
Query: 523 GSIPWDIG--HCEKLLLLNLSRNSLTGIIPW----EISGLPSITDVDLSHNFLTGTIPSN 576
G+ P + L +LNL S W + P + + ++
Sbjct: 109 GTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQ 168
Query: 577 FENCSTLESFNVSYNLLTGPIPASGTIFPNLHPS 610
L + ++S N G + P P+
Sbjct: 169 VRVFPALSTLDLSDNPELGERGLISALCPLKFPT 202
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 6e-20
Identities = 49/153 (32%), Positives = 81/153 (52%), Gaps = 19/153 (12%)
Query: 718 LGMGSTGTVYKAEMPGGEIIAVKKL-WGKHKENIRRRRGV----LAEVDVLGNVRHRNIV 772
+G G+ G VYKA+ GE A+KK+ K E G+ + E+ +L ++H NIV
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDE------GIPSTTIREISILKELKHSNIV 63
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
+L ++ +L++E++ +L LL G L + + + L GI Y H
Sbjct: 64 KLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG--LESVTAKSFLLQL--LNGIAYCHD 118
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
++HRDLKP N+L++ E E ++ADFG+A+
Sbjct: 119 RR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 19/154 (12%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKL-WGKHKENIRRRRGV----LAEVDVLGNVRHRNI 771
+G G+ G VYKA GE++A+KK+ E GV + E+ +L + H NI
Sbjct: 11 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE------GVPSTAIREISLLKELNHPNI 64
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+LL L++E++ +L + A + + Y L QG+ + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTG-IPLPLIKSYLFQL--LQGLAFCH 120
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 121 SHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 89.1 bits (222), Expect = 1e-19
Identities = 44/156 (28%), Positives = 79/156 (50%), Gaps = 24/156 (15%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIR---RRRGV----LAEVDVLGNVRHR 769
+G G+ GTV+KA EI+A+K+ +R GV L E+ +L ++H+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKR--------VRLDDDDEGVPSSALREICLLKELKHK 61
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIVRL + + L++E+ +L + +L + V + L +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF--DSCNGDLDPEIVKSFLFQL--LKGLGF 116
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
H ++HRDLKP N+L++ E ++A+FG+A+
Sbjct: 117 CHSRN---VLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-19
Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 11/149 (7%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
+G GS G VY A ++ E++A+KK+ K++ + + ++ EV L +RH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHDCD 835
C L+ EY D L K E +A + G QG+ YLH
Sbjct: 122 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA------AVTHGALQGLAYLHSHN- 174
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVA 864
++HRD+K NILL ++ DFG A
Sbjct: 175 --MIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 44/154 (28%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRNIV 772
LG G+ TVYK G +A+K++ +E G + E+ ++ ++H NIV
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEE------GTPSTAIREISLMKELKHENIV 66
Query: 773 RLLGCCSNRECTMLLYEYMPN--GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
RL L++E+M N D N L + V ++ L QG+ +
Sbjct: 67 RLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL--LQGLAFC 124
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
H + I+HRDLKP N+L++ + ++ DFG+A
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 52/178 (29%), Positives = 82/178 (46%), Gaps = 23/178 (12%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHK-------ENIRRRRGVLAEVDVLGNVR 767
LG+G+ G V + G +AVK L + K IRR E+ L R
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKIL-NRQKIRSLDVVGKIRR------EIQNLKLFR 74
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H +I++L S ++ EY+ G L D + + + + + + ++ G+
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GV 129
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y H +VHRDLKP N+LLD M A++ADFG++ ++ E + GS Y AP
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 184
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-19
Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 28/167 (16%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVK--KLWGKHKENIRRRRGVLAEVDVLGNV-RHRNI 771
+++G G+ G VYK + G++ A+K + G +E I++ E+++L HRNI
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ------EINMLKKYSHHRNI 83
Query: 772 VRLLGCCSNRECTM------LLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALG 822
G + L+ E+ G++ DL+ E +A ++ R
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA-YICR-----E 137
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ +G+ +LH ++HRD+K N+LL E ++ DFGV+ +
Sbjct: 138 ILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 43/158 (27%), Positives = 74/158 (46%), Gaps = 16/158 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKL-WGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+G GS G V+K G+I+A+KK + I++ L E+ +L ++H N+V
Sbjct: 9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI--ALREIRMLKQLKHPNLVN 66
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLH 831
LL + L++EY + + L +G E+LV ++ Q + + H
Sbjct: 67 LLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSIT--WQTL----QAVNFCH 119
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+HRD+KP NIL+ ++ DFG A+L+
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 3e-19
Identities = 43/187 (22%), Positives = 81/187 (43%), Gaps = 27/187 (14%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
++ + +G GS G V + ++ A+K + +K+ R V E+ +
Sbjct: 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYM---NKQKCVERNEVRNVFKELQI 68
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKI 819
+ + H +V L + E ++ + + G+L H + E V ++ +
Sbjct: 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHLQQNVHFKEETVKLFICELVM 126
Query: 820 ALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAG 878
AL YL I+HRD+KP NILLD + DF +A ++ + ++ +AG
Sbjct: 127 ALD------YLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG 176
Query: 879 SYGYIAP 885
+ Y+AP
Sbjct: 177 TKPYMAP 183
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 4e-19
Identities = 45/201 (22%), Positives = 75/201 (37%), Gaps = 30/201 (14%)
Query: 697 FQRLNFTADDVLECLSMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRG 755
FQ V + +S ++LG+G G V + G+ A+K +
Sbjct: 16 FQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKL--------LYDSPK 67
Query: 756 VLAEVDVLGNV-RHRNIVRLLGCC----SNRECTMLLYEYMPNGNLDDLLHAKNKG---E 807
EVD +IV +L + C +++ E M G L + + E
Sbjct: 68 ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE 127
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVA 864
A+ I + I +LH I HRD+KP N+L + + ++ DFG A
Sbjct: 128 REAAE------IMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
Query: 865 KLIQSDESMSVIAGSYGYIAP 885
K ++ + Y+AP
Sbjct: 179 KETT-QNALQTPCYTPYYVAP 198
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 4e-19
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G V A E +AVK + ENI++ E+ + + H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKK------EICINKMLNHE 65
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK---IALGVAQG 826
N+V+ G L EY G L D + + + + + GV
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVV-- 119
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA---GSYGYI 883
YLH I HRD+KP N+LLD +++DFG+A + + + ++ G+ Y+
Sbjct: 120 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 884 AP 885
AP
Sbjct: 175 AP 176
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 45/153 (29%), Positives = 78/153 (50%), Gaps = 19/153 (12%)
Query: 718 LGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV----LAEVDVLGNVRHRNIV 772
LG G+ TVYK + ++A+K++ +H+E G + EV +L +++H NIV
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEE------GAPCTAIREVSLLKDLKHANIV 63
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
L + L++EY+ +L L + G + V + L +G+ Y H
Sbjct: 64 TLHDIIHTEKSLTLVFEYLDK-DLKQYL--DDCGNIINMHNVKLFLFQL--LRGLAYCHR 118
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
++HRDLKP N+L++ E ++ADFG+A+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 49/179 (27%), Positives = 71/179 (39%), Gaps = 27/179 (15%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHK---ENIRRRRGVLAEVDVLGNVRHRNI 771
K +G G+ G E++AVK + + EN++R E+ ++RH NI
Sbjct: 26 KDIGSGNFGVARLMRDKLTKELVAVKYI-ERGAAIDENVQR------EIINHRSLRHPNI 78
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK---IALGVAQGIC 828
VR ++ EY G L + + + A R+ + GV+
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA----RFFFQQLLSGVS---- 130
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEAR--VADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y H I HRDLK N LLDG R + DFG +K G+ YIAP
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 186
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 6e-19
Identities = 45/162 (27%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRR---GV----LAEVDVLGNVR 767
++G GS G V K G I+A+KK V + E+ +L +R
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKK--------FLESDDDKMVKKIAMREIKLLKQLR 82
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H N+V LL C ++ L++E++ + + D L G L V +Y + GI
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG--LDYQVVQKYLFQI--INGI 137
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869
+ H I+HRD+KP NIL+ ++ DFG A+ + +
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 7e-19
Identities = 46/170 (27%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K++G GS G VY+A GE++A+KK+ + R E+ ++ + H NIVRL
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCNIVRL 112
Query: 775 LGC-CSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTR---YKIALGVAQ 825
S+ E L+ +Y+P + + ++ + + + Y++ +A
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA- 170
Query: 826 GICYLH-HDCDPVIVHRDLKPSNILLDGEMEA-RVADFGVAKLIQSDESM 873
Y+H I HRD+KP N+LLD + ++ DFG AK + E
Sbjct: 171 ---YIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN 213
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 47/182 (25%), Positives = 76/182 (41%), Gaps = 30/182 (16%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK-----KLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG G+ G V A E +AVK + ENI++ E+ + + H
Sbjct: 13 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKK------EICINKMLNHE 65
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK---IALGVAQG 826
N+V+ G L EY G L D + + + + + GV
Sbjct: 66 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQLMAGVV-- 119
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA---GSYGYI 883
YLH I HRD+KP N+LLD +++DFG+A + + + ++ G+ Y+
Sbjct: 120 --YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 884 AP 885
AP
Sbjct: 175 AP 176
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-18
Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 23/186 (12%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L+M+D +I+G G G VY G++ A+K L K+ I+ ++G L E +
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIM 242
Query: 763 LGNV---RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI 819
L V IV + + + + M G+L H G ++ R+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHLSQHGV--FSEADMRFYA 298
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGS 879
A + G+ ++H+ +V+RDLKP+NILLD R++D G+A + + G+
Sbjct: 299 A-EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA-SVGT 353
Query: 880 YGYIAP 885
+GY+AP
Sbjct: 354 HGYMAP 359
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 1e-18
Identities = 53/186 (28%), Positives = 85/186 (45%), Gaps = 22/186 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L D K++G G+ G V ++ ++ A+K L +K + +R E DV
Sbjct: 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKIL---NKWEMLKRAETACFREERDV 127
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L N + I L + L+ +Y G DLL +K E+ + + + R+ +A
Sbjct: 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGG---DLLTLLSKFEDRLPEEMARFYLA-E 183
Query: 823 VAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGS 879
+ I +H VHRD+KP NIL+D R+ADFG + D ++ SV G+
Sbjct: 184 MVIAIDSVHQLH----YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGT 239
Query: 880 YGYIAP 885
YI+P
Sbjct: 240 PDYISP 245
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 50/204 (24%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA---------------- 758
+G GS G V A A+K L K+ + R+ G
Sbjct: 19 DEIGKGSYGVVKLAYNENDNTYYAMKVL---SKKKLIRQAGFPRRPPPRGTRPAPGGCIQ 75
Query: 759 ----------EVDVLGNVRHRNIVRL---LGCCSNRECTMLLYEYMPNGNLDDLLHAKNK 805
E+ +L + H N+V+L L + M+ E + G + ++ K
Sbjct: 76 PRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVF-ELVNQGPVMEVPTLKPL 134
Query: 806 GENLVADWVTRYK---IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862
E+ R+ + G+ YLH+ I+HRD+KPSN+L+ + ++ADFG
Sbjct: 135 SED-----QARFYFQDLIKGIE----YLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 863 VAKLIQSDESM-SVIAGSYGYIAP 885
V+ + +++ S G+ ++AP
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAP 206
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 51/203 (25%), Positives = 84/203 (41%), Gaps = 36/203 (17%)
Query: 687 REIGPWKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGK 745
R IGP+ + + LG GS G V A + +A+K +
Sbjct: 6 RHIGPYII--------------------RETLGEGSFGKVKLATHYKTQQKVALKFI--- 42
Query: 746 HKENIRRRR---GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA 802
++ +++ V E+ L +RH +I++L + +++ EY G L D +
Sbjct: 43 SRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVE 101
Query: 803 KNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862
K + + I I Y H IVHRDLKP N+LLD + ++ADFG
Sbjct: 102 KKRMTEDEGRRFFQQIIC-----AIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFG 153
Query: 863 VAKLIQSDESMSVIAGSYGYIAP 885
++ ++ + GS Y AP
Sbjct: 154 LSNIMTDGNFLKTSCGSPNYAAP 176
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 49/189 (25%), Positives = 81/189 (42%), Gaps = 38/189 (20%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA----EVDVLGNVRHRN 770
+LG GS G V + AVK L K+ +RR A E+ +L +RH+N
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKIL---KKKKLRRIPNGEANVKKEIQLLRRLRHKN 67
Query: 771 IVRL---LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ-- 825
+++L L ++ M++ EY G + ++L D V + + A
Sbjct: 68 VIQLVDVLYNEEKQKMYMVM-EYCVCG-MQEML-----------DSVPEKRFPVCQAHGY 114
Query: 826 ------GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS---DESMSVI 876
G+ YLH IVH+D+KP N+LL +++ GVA+ + D++
Sbjct: 115 FCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 877 AGSYGYIAP 885
GS + P
Sbjct: 172 QGSPAFQPP 180
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 19/184 (10%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
++M++ K+LG G+ G V + G A+K L KE I + V L E V
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHTLTENRV 201
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L N RH + L + + EY G L H E + ++ R+ A
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR--ERVFSEDRARFYGA-E 256
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSYG 881
+ + YLH + + +V+RDLK N++LD + ++ DFG+ K I+ +M G+
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 882 YIAP 885
Y+AP
Sbjct: 315 YLAP 318
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 46/263 (17%), Positives = 84/263 (31%), Gaps = 49/263 (18%)
Query: 78 SQITSLDLSRRSLSG--PIPPEIRYLTSLTHLNLS---ANAFDGPLQPAILELTKLRTID 132
Q ++ + + +PP + L L +L ++AF L + I
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPPSTQTL-KLIETHLRTIPSHAFSN--------LPNISRIY 61
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
+S + F L+ + + + + I
Sbjct: 62 VSIDVTLQQLESHS-----------------------FYNLSKVTHIEIRNTRNLTYIDP 98
Query: 193 D-YRNLSSLRFLDLAGNSLTGSLPPQ--LGLLTQLERIEIGYNNLQGEVPVE-FASLVN- 247
D + L L+FL + L P + +EI N +PV F L N
Sbjct: 99 DALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE 157
Query: 248 LKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS--YGNLQALQVLDLSDNQ 305
+ + + ++ N TKL+ + L KN + I G +LD+S
Sbjct: 158 TLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTS 216
Query: 306 LSGPIPASLASLKGLTRLSLMNN 328
++ +P+ L+ L L N
Sbjct: 217 VTA-LPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 7e-17
Identities = 46/232 (19%), Positives = 96/232 (41%), Gaps = 18/232 (7%)
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQ 305
+ ++ ++ +PS + L+ L + H IP ++ NL + + +S +
Sbjct: 12 QEEDFRVTCKDIQ-RIPSLPPSTQTLK---LIETHLR-TIPSHAFSNLPNISRIYVSIDV 66
Query: 306 LSGPIPA-SLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQ--K 361
+ + S +L +T + + N I D + L L L ++N L + P K
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDG--DRLFKLILFSNNFTYSIPENLVNCSSLSRL 419
+ S ++++ N IP G + L L++N FT S+ N + L +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 420 RIQDNQLNGSIPQG--FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLN 468
+ N+ I + G+ + +D+S+ S++ +P L + ++L N
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 41/234 (17%), Positives = 78/234 (33%), Gaps = 15/234 (6%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
+ + +P L + +++ +L+ F++L N+ + +S
Sbjct: 11 HQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 258 LSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLSG-PIPASL 314
L S NL+K+ + + I L L+ L + + L P +
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKV 126
Query: 315 ASLKGLTRLSLMNNVLFGEIPQDI--ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVD 372
S L + +N IP + L + TL L+NN T + + KL V
Sbjct: 127 YSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVY 185
Query: 373 VSSNSLTGPIPPTICDG--DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDN 424
++ N I G L + + T ++P L L ++
Sbjct: 186 LNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 45/260 (17%), Positives = 90/260 (34%), Gaps = 42/260 (16%)
Query: 343 DLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNN 401
+ + + + P S T+ + L IP + ++ + +
Sbjct: 12 QEEDFRVTCKDIQRI-PSLPPS---TQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDV 66
Query: 402 FTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-- 457
+ + N S ++ + I++ + I LP L F+ + L P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 458 LGNAQKLEYLNISENSFQTSLPSNIWS--APNLKILSASSSKLTGKIPDFIGCKSIYKIE 515
+ + L I++N + TS+P N + L ++ T
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT---------------S 170
Query: 516 LHNNLLNGSIPWDIGHCEKLLLLNLSRN-SLTGIIPWEISGLPS-ITDVDLSHNFLTGTI 573
+ NG+ KL + L++N LT I G+ S + +D+S +T +
Sbjct: 171 VQGYAFNGT---------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-AL 220
Query: 574 PSN-FENCSTLESFNVSYNL 592
PS E+ L + N ++ L
Sbjct: 221 PSKGLEHLKELIARN-TWTL 239
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 8e-05
Identities = 30/198 (15%), Positives = 53/198 (26%), Gaps = 56/198 (28%)
Query: 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLNISE 471
C R+ + IP L P+ + + L IP N + + +S
Sbjct: 10 CHQEEDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
+ L S+ F + IE+ N
Sbjct: 65 DVTLQQLESHS----------------------FYNLSKVTHIEIRNT------------ 90
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP--SNFENCSTLESFNVS 589
+LT I P + LP + + + + L P + + ++
Sbjct: 91 -----------RNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEIT 138
Query: 590 YNLLTGPIPASGTIFPNL 607
N IP + F L
Sbjct: 139 DNPYMTSIPVN--AFQGL 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-18
Identities = 32/185 (17%), Positives = 74/185 (40%), Gaps = 10/185 (5%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
+ + L ++ + A ++ L I +++ + GI ++ +
Sbjct: 22 FKAYLNGLLGQSS-TANITEA--QMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
T P+ L++L++L + G + + L+SL LD++ ++ S+ ++
Sbjct: 77 HATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
L ++ I++ YN ++ +L LK ++I + I + KL L F
Sbjct: 135 LPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQ 191
Query: 281 HFTGE 285
G+
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 33/185 (17%), Positives = 70/185 (37%), Gaps = 10/185 (5%)
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+ L +S + L I + N+ +E+ N+K + I+
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDLTGIEY--AHNIKDLTINN 75
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315
+ + + IS L+ LE L + T + + L +L +LD+S + I +
Sbjct: 76 IHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
+L + + L N +I ++ L +L +L + + + + KL + S
Sbjct: 134 TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
Query: 376 NSLTG 380
++ G
Sbjct: 191 QTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 31/163 (19%), Positives = 66/163 (40%), Gaps = 14/163 (8%)
Query: 437 LPNLTFMDMSRN---SLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493
+ +LT++ ++ L+G + A ++ L I+ T+ + I NL+ L
Sbjct: 43 MNSLTYITLANINVTDLTG-----IEYAHNIKDLTINNIHA-TNY-NPISGLSNLERLRI 95
Query: 494 SSSKLTG-KIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWE 552
+T KIP+ G S+ +++ ++ + SI I K+ ++LS N I
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-P 154
Query: 553 ISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595
+ LP + +++ + + E+ L + G
Sbjct: 155 LKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 1e-12
Identities = 29/174 (16%), Positives = 60/174 (34%), Gaps = 8/174 (4%)
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGF 434
S T I T + L + L + N T + + ++ L I + P
Sbjct: 31 GQSSTANI--TEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNP--I 84
Query: 435 GLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSAS 494
L NL + + ++ + +L L L+IS ++ S+ + I + P + + S
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 495 SSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI 548
+ I + + + + ++ I KL L ++ G
Sbjct: 145 YNGAITDIMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 27/136 (19%), Positives = 59/136 (43%), Gaps = 4/136 (2%)
Query: 459 GNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHN 518
L Y+ ++ + T L + I A N+K L+ ++ T G ++ ++ +
Sbjct: 41 AQMNSLTYITLANINV-TDL-TGIEYAHNIKDLTINNIHAT-NYNPISGLSNLERLRIMG 97
Query: 519 NLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFE 578
+ ++ L LL++S ++ I +I+ LP + +DLS+N I +
Sbjct: 98 KDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLK 156
Query: 579 NCSTLESFNVSYNLLT 594
L+S N+ ++ +
Sbjct: 157 TLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 23/130 (17%), Positives = 52/130 (40%), Gaps = 6/130 (4%)
Query: 462 QKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLL 521
+ + ++S + + +L ++ ++ +T + +I + ++N
Sbjct: 23 KAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DLTGIEYAHNIKDLTINNIHA 78
Query: 522 NGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCS 581
P I L L + +T +SGL S+T +D+SH+ +I +
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 582 TLESFNVSYN 591
+ S ++SYN
Sbjct: 137 KVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 27/106 (25%), Positives = 46/106 (43%), Gaps = 3/106 (2%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
S + L + + ++ P + LTSLT L++S +A D + I L K+ +ID+S+N
Sbjct: 88 SNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNG 147
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG 183
+ P + L L+ N + +E L QL
Sbjct: 148 AITDIMP-LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 24/160 (15%), Positives = 52/160 (32%), Gaps = 29/160 (18%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS 137
I L ++ + P I L++L L + P + LT L +DISH++
Sbjct: 66 HNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA 123
Query: 138 FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197
+ + I+ L + + N + + L L
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNG----------AITDIMPLK---------------TL 158
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGE 237
L+ L++ + + + +L ++ + G+
Sbjct: 159 PELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGGK 196
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 54/187 (28%), Positives = 86/187 (45%), Gaps = 24/187 (12%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L D K++G G+ V +M G++ A+K + +K ++ +R V E DV
Sbjct: 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIM---NKWDMLKRGEVSCFREERDV 114
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L N R I +L + L+ EY G+L L GE + A+ Y
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEMARFY----- 167
Query: 823 VAQGICYLH--HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAG 878
+A+ + + H VHRD+KP NILLD R+ADFG +++D ++ V G
Sbjct: 168 LAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG 225
Query: 879 SYGYIAP 885
+ Y++P
Sbjct: 226 TPDYLSP 232
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-18
Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 28/173 (16%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++ G G+ GTV E G +A+KK+ ++ R R L + L + H NIV+L
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVI----QDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 775 LGC-CSNRECTM------LLYEYMPNGNLDDL----LHAKNKGENLVADWV--TRYKIAL 821
+ E ++ EY+P D L + + + +++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESM 873
+ LH V HRD+KP N+L++ ++ DFG AK + E
Sbjct: 141 SIG----CLHLPSVNVC-HRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 6e-18
Identities = 45/183 (24%), Positives = 74/183 (40%), Gaps = 27/183 (14%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVK-------KLWGKHKENIRRRRGVLAEVDVLGNVR 767
+LG G G+VY + +A+K WG+ R EV +L V
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM----EVVLLKKVS 104
Query: 768 HR--NIVRLLGCCSNRECTMLLYEY-MPNGNLDDLLHAKNK-GENLVADWVTRYKIALGV 823
++RLL + +L+ E P +L D + + E L R V
Sbjct: 105 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL-----AR-SFFWQV 158
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYGY 882
+ + + H+ ++HRD+K NIL+D E ++ DFG L++ D + G+ Y
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVY 214
Query: 883 IAP 885
P
Sbjct: 215 SPP 217
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 7e-18
Identities = 48/286 (16%), Positives = 90/286 (31%), Gaps = 55/286 (19%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--------AFDGPLQPAILELTKLRTID 132
++ IP ++ + L AF G L I+
Sbjct: 12 RVFLCQESKVTE-IPSDL--PRNAIELRFVLTKLRVIQKGAFSG--------FGDLEKIE 60
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS 192
IS N + F L L ++ + + I
Sbjct: 61 ISQNDVLEVIEADV-----------------------FSNLPKLHEIRIEKANNLLYINP 97
Query: 193 DY-RNLSSLRFLDLAGNSLTGSLPPQLGL-LTQLERIEIGYNNLQGEVPVE-FASL-VNL 248
+ +NL +L++L ++ + LP + Q ++I N + F L
Sbjct: 98 EAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFES 156
Query: 249 KYMDISACNLSGTLPSEISNLTKL-EMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQL 306
+ ++ + + + N T+L E+ L N+ E+P + +LD+S ++
Sbjct: 157 VILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRI 214
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNN 352
L +LK L S N ++P +E L L L
Sbjct: 215 HSLPSYGLENLKKLRARSTYNL---KKLP-TLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 44/232 (18%), Positives = 78/232 (33%), Gaps = 15/232 (6%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWN-NH 353
L +L + + L ++ + N + I D+ L L + + N+
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 354 LTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LV 411
L + P+ + L + +S+ + +P + L + N ++I N V
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 412 NCSSLSR-LRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLN 468
S S L + N + I F N+L E+P D A L+
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 469 ISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNN 519
IS SLPS L+ S + K K+P ++ + L
Sbjct: 209 ISRTRI-HSLPSYGLENLKKLRARSTYNLK---KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 39/244 (15%), Positives = 90/244 (36%), Gaps = 17/244 (6%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DR 391
EIP D+ + L L + G L +++S N + I + +
Sbjct: 23 EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80
Query: 392 LFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNS 449
L ++ + N I N +L L I + + +P +D+ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 450 LSGEIPRDL--GNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--F 505
I R+ G + + L +++N + ++ ++ L L+ S + ++P+ F
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDNNNLEELPNDVF 198
Query: 506 IGCKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDL 564
G +++ ++ S+P + +KL + +L + + L ++ + L
Sbjct: 199 HGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPT--LEKLVALMEASL 253
Query: 565 SHNF 568
++
Sbjct: 254 TYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 5e-15
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 17/218 (7%)
Query: 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRD 457
+ T IP +L + LR +L I +G F +L +++S+N + I D
Sbjct: 18 ESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 458 -LGNAQKLEYLNISENSFQTSLPSNI-WSAPNLKILSASSSKLTGKIPD--FIGCKSIYK 513
N KL + I + + + + PNL+ L S++ + +PD I
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 514 IELHNNLLNGSIPWDI--GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG 571
+++ +N+ +I + G + ++L L++N + I +G +N L
Sbjct: 133 LDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE- 191
Query: 572 TIPSN-FENCSTLESFNVSYNLLTGPIPASGTIFPNLH 608
+P++ F S ++S + +P+ G NL
Sbjct: 192 ELPNDVFHGASGPVILDISRTRIH-SLPSYG--LENLK 226
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.0 bits (187), Expect = 7e-15
Identities = 45/247 (18%), Positives = 78/247 (31%), Gaps = 18/247 (7%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNG 428
+ +T IP + +L I + L ++ I N +
Sbjct: 13 VFLCQESKVTE-IPSDLPRN--AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 429 SIPQG-FGLLPNLTFMDMSR-NSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
I F LP L + + + N+L P N L+YL IS + + +
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 128
Query: 487 NLKILSASSSKLTGKIPD--FIGCKS-IYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSR 542
+L + I F+G + L+ N + I + L
Sbjct: 129 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187
Query: 543 NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIPASG 601
N+L + G +D+S + ++PS EN L + + +YNL P
Sbjct: 188 NNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARS-TYNLKKLPTLEK- 244
Query: 602 TIFPNLH 608
L
Sbjct: 245 --LVALM 249
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 41/194 (21%), Positives = 75/194 (38%), Gaps = 12/194 (6%)
Query: 191 PSDYRNLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQGEVPVE-FASLVNL 248
+ + L+ LDL+ + ++ L+ L + + N +Q + + F+ L +L
Sbjct: 45 SYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSL 102
Query: 249 KYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTG-EIPVSYGNLQALQVLDLSDNQL 306
+ + NL+ +L + +L L+ L + N ++P + NL L+ LDLS N++
Sbjct: 103 QKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Query: 307 SGPIPASLASLKGLT----RLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
L L + L L N + I L L L N L V
Sbjct: 162 QSIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDGIF 220
Query: 363 GSNGKLLTVDVSSN 376
L + + +N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 51/239 (21%), Positives = 82/239 (34%), Gaps = 29/239 (12%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DR 391
+IP ++ L L N L + S +L +D+S + I
Sbjct: 21 KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH 77
Query: 392 LFKLILFSNNFTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNS 449
L LIL N S+ SSL +L + L S+ G L L ++++ N
Sbjct: 78 LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNL 135
Query: 450 L-SGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGC 508
+ S ++P N LE+L++S N S+ L + + L
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKI-QSIYCTDLR--VLHQMPLLNLSL---------- 182
Query: 509 KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
+L N +N I +L L L N L + L S+ + L N
Sbjct: 183 ------DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 52/261 (19%), Positives = 84/261 (32%), Gaps = 68/261 (26%)
Query: 80 ITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSF 138
+LDLS L + L L+LS +++TI
Sbjct: 30 TKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRC--------------EIQTI------- 67
Query: 139 NSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG---SYFDGEIPSDYR 195
G + L+ L L L G S
Sbjct: 68 ----EDGA-----------------------YQSLSHLSTLILTGNPIQSLALGAFS--- 97
Query: 196 NLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQGEVPVE--FASLVNLKYMD 252
LSSL+ L +L SL G L L+ + + +N +Q + F++L NL+++D
Sbjct: 98 GLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTNLEHLD 155
Query: 253 ISACNLSGTLPSEI-SNLTKLEM----LLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307
+S+ + ++ L ++ + L L N I L+ L L NQL
Sbjct: 156 LSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
Query: 308 GPIPASLASLKGLTRLSLMNN 328
L L ++ L N
Sbjct: 214 SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 47/255 (18%), Positives = 79/255 (30%), Gaps = 49/255 (19%)
Query: 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
+ +P L + +++ +N L+ F S L+ +D+S C + T+
Sbjct: 16 ELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA 71
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
+ L L L L+ N + + + L L +L +
Sbjct: 72 ---------------YQS--------LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 327 NNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNG------KLLTVDVSSNSLT 379
L + L L L + +N + L +D+SSN +
Sbjct: 109 ETNLA-SLENFPIGHLKTLKELNVAHNLIQ-----SFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 380 GPIPPTICDG-----DRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG- 433
I T L L N I L L + NQL S+P G
Sbjct: 163 S-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI 219
Query: 434 FGLLPNLTFMDMSRN 448
F L +L + + N
Sbjct: 220 FDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 39/194 (20%), Positives = 73/194 (37%), Gaps = 21/194 (10%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
+P C L+ IP L + +D+S N L + +L
Sbjct: 6 VVPNITYQCMELN--------FY-KIPDN--LPFSTKNLDLSFNPLRHLGSYSFFSFPEL 54
Query: 465 EYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLL 521
+ L++S Q ++ + + +L L + + + + F G S+ K+ L
Sbjct: 55 QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 522 NGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEI-SGLPSITDVDLSHNFLTGTIPSN-FE 578
S+ GH + L LN++ N + E S L ++ +DLS N + +I
Sbjct: 113 A-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLR 170
Query: 579 NCSTLESFNVSYNL 592
+ N+S +L
Sbjct: 171 VLHQMPLLNLSLDL 184
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 29/185 (15%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKL-------WGKHKENIRRRRGVLAEVDVLGNVR 767
+LG G GTV+ + +A+K + W +++ EV +L V
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL----EVALLWKVG 92
Query: 768 ----HRNIVRLLGCCSNRECTMLLYEY-MPNGNLDDLLHAKNK-GENLVADWVTRYKIAL 821
H ++RLL +E ML+ E +P +L D + K GE +R
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP-----SR-CFFG 146
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESMSVIAGSY 880
V I + H +VHRD+K NIL+D A++ DFG L+ DE + G+
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH-DEPYTDFDGTR 202
Query: 881 GYIAP 885
Y P
Sbjct: 203 VYSPP 207
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 46/238 (19%), Positives = 92/238 (38%), Gaps = 20/238 (8%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFD--GPLQPAILELTKLRTIDISH 135
++ +L ++S++ + L S+ + + + +Q L + + ++
Sbjct: 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ----YLPNVTKLFLNG 74
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYR 195
N P ++ L+ L N L+ L L+ L+L + +I +
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGIS-DI-NGLV 128
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+L L L L N +T + L LT+L+ + + N + VP A L L+ + +S
Sbjct: 129 HLPQLESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 184
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPAS 313
++S ++ L L++L LF + NL + +D L P S
Sbjct: 185 NHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 240
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.8 bits (209), Expect = 5e-17
Identities = 49/232 (21%), Positives = 93/232 (40%), Gaps = 16/232 (6%)
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+ +L S+T ++ L +++I ++++ ++ L N+ + ++
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 74
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315
L+ ++NL L L L +N + +L+ L+ L L N +S I L
Sbjct: 75 NKLTDI--KPLTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEHNGISD-ING-LV 128
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L L L L NN + + L LDTL L +N ++ ++P L KL + +S
Sbjct: 129 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 184
Query: 376 NSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLN 427
N ++ + + L L LFS + N + ++ D L
Sbjct: 185 NHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 234
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 5e-16
Identities = 46/283 (16%), Positives = 99/283 (34%), Gaps = 20/283 (7%)
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
+ L K T + + L ++ + +++ + + + L +T+L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS-VQG-IQYLPNVTKL 70
Query: 324 SLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIP 383
L N L +I + + L +L L L N + + L KL ++ + N ++ I
Sbjct: 71 FLNGNKL-TDI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGISD-IN 125
Query: 384 PTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFM 443
+ +L L L +N T L + L L ++DNQ++ I L L +
Sbjct: 126 G-LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 180
Query: 444 DMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIP 503
+S+N +S ++ L + L+ L + ++ NL + + + G +
Sbjct: 181 YLSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQ---SNLVVPN-TVKNTDGSLV 234
Query: 504 DFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
E N + + + + +
Sbjct: 235 TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKAR 277
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 1e-17
Identities = 42/175 (24%), Positives = 68/175 (38%), Gaps = 23/175 (13%)
Query: 718 LGMGSTGTVYKAE--MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ G G +Y A G + +K L + +AE L V H +IV++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM--AMAERQFLAEVVHPSIVQIF 145
Query: 776 --GCCSNRECTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
++R + Y EY+ +L G+ L L + + YL
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIA--YLLEILPALSYL 198
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H +V+ DLKP NI+L E + ++ D G I S + G+ G+ AP
Sbjct: 199 HSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAP 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 46/183 (25%), Positives = 76/183 (41%), Gaps = 21/183 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
+ K LG GS G V + G A+K L K+ + + + + L E +
Sbjct: 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL---DKQKVVKLKQIEHTLNEKRI 94
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L V +V+L + ++ EY+ G + L + A R+ A
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA----RFYAA-Q 149
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGY 882
+ YLH D +++RDLKP N+L+D + +V DFG AK + + G+
Sbjct: 150 IVLTFEYLH-SLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEA 204
Query: 883 IAP 885
+AP
Sbjct: 205 LAP 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 45/159 (28%), Positives = 73/159 (45%), Gaps = 26/159 (16%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKL-WGKHKENIRRRRGV----LAEVDVLGNVRHRNI 771
LG G+ G VYKA + E +A+K++ +E GV + EV +L ++HRNI
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEE------GVPGTAIREVSLLKELQHRNI 95
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ L + L++EY N DL +K ++ + + L G+ + H
Sbjct: 96 IELKSVIHHNHRLHLIFEYAEN----DLKKYMDKNPDVSMRVIKSFLYQL--INGVNFCH 149
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEAR-----VADFGVAK 865
+HRDLKP N+LL + + DFG+A+
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 44/186 (23%), Positives = 78/186 (41%), Gaps = 24/186 (12%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
+ D K++G G+ G V ++ A+K L K + +R E D+
Sbjct: 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLL---SKFEMIKRSDSAFFWEERDI 122
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
+ +V+L + ++ EYMP G DL++ + + V + R+ A
Sbjct: 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG---DLVNLMSNYD--VPEKWARFYTA-E 176
Query: 823 VAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGS 879
V + +H +HRD+KP N+LLD ++ADFG + + + G+
Sbjct: 177 VVLALDAIHSMG----FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 232
Query: 880 YGYIAP 885
YI+P
Sbjct: 233 PDYISP 238
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 43/166 (25%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 718 LGMGSTGTVYKA---EMPGGEIIAVKKL--WGKHKENIRRRRGVLAEVDVLGNVRHRNIV 772
+G G+ G VYKA + + A+K++ G R E+ +L ++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNVI 81
Query: 773 RLLGCCSNR--ECTMLLYEYMPN---GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
L + LL++Y + + +K + + + + GI
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEAR----VADFGVAKLIQS 869
YLH + ++HRDLKP+NIL+ GE R +AD G A+L S
Sbjct: 142 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 3e-17
Identities = 52/255 (20%), Positives = 101/255 (39%), Gaps = 18/255 (7%)
Query: 125 LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGS 184
+ ++ S ++L + A ++ ++ L ++ +L L G+
Sbjct: 23 FAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGN 78
Query: 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFAS 244
+I NL +L +L L N + L L L +L+ + + +N + ++
Sbjct: 79 KLT-DI-KPLANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVH 132
Query: 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDN 304
L L+ + + ++ + +S LTKL+ L L N + +P++ L LQ L LS N
Sbjct: 133 LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLYLSKN 188
Query: 305 QLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGS 364
+S LA LK L L L + + L +T + N + V P+ +
Sbjct: 189 HISDLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNT--VKNTDGSLVTPEIISD 244
Query: 365 NGKLLTVDVSSNSLT 379
+G +V +
Sbjct: 245 DGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 48/278 (17%), Positives = 99/278 (35%), Gaps = 47/278 (16%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFD--GPLQPAILELTKLRTIDISH 135
++ +L ++S++ + L S+ + + + +Q L + + ++
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ----YLPNVTKLFLNG 77
Query: 136 NSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYR 195
N P ++ L+ L N ++ L L
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDEN-----------KVKDLSSLK--------------- 109
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+L L+ L L N ++ + L L QLE + +G N + + L L + +
Sbjct: 110 DLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315
+S ++ LTKL+ L L KNH + ++ L+ L VL+L + +
Sbjct: 166 NQISDI--VPLAGLTKLQNLYLSKNHISDLRALA--GLKNLDVLELFSQECLNKPINHQS 221
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIELLADLDTL-LLWNN 352
+L + + L P+ I D + + W+
Sbjct: 222 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 257
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 39/234 (16%), Positives = 101/234 (43%), Gaps = 15/234 (6%)
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
+ + ++ S+T + + + + ++I +++ S+ + + ++++L + N+L
Sbjct: 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFLNGNKL 80
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
I L NL ++ + N + ++ L + +KL+ L++ N + + + + P
Sbjct: 81 T-DIK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGI-SDI-NGLVHLP 134
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+ L ++K+T I + + L +N ++ I + KL L LS+N ++
Sbjct: 135 QLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 191
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600
+ ++GL ++ ++L ++ N + + L P S
Sbjct: 192 DLRA--LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIIS 243
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 8e-14
Identities = 47/255 (18%), Positives = 90/255 (35%), Gaps = 17/255 (6%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
+L ++ + L + ++ N+ + + Q I+ L ++ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-QGIQYLPNVTKLFLNG 77
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N LT + P L + L + + N + + + D +L L L N + I LV
Sbjct: 78 NKLTDIKP--LANLKNLGWLFLDENKVKD-LSS-LKDLKKLKSLSLEHNGIS-DI-NGLV 131
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
+ L L + +N++ + L L + + N +S +I L KL+ L +S+
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNLYLSK 187
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
N S + NL +L S + P + + N + P I
Sbjct: 188 N--HISDLRALAGLKNLDVLELFSQECL-NKPINHQSNLVVPNTVKNTDGSLVTPEIISD 244
Query: 532 CEKLLLLNLSRNSLT 546
N+ +
Sbjct: 245 DGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 48/231 (20%), Positives = 92/231 (39%), Gaps = 16/231 (6%)
Query: 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255
+ +L S+T ++ L +++I ++++ ++ L N+ + ++
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLA 315
L+ ++NL L L L +N + +L+ L+ L L N +S L
Sbjct: 78 NKLTDI--KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHNGISDING--LV 131
Query: 316 SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L L L L NN + + L LDTL L +N ++ ++P L KL + +S
Sbjct: 132 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 376 NSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
N ++ + + L L LFS + N + ++ D L
Sbjct: 188 NHISD-LRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 3e-17
Identities = 58/184 (31%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 711 LSMSD----KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
S+ D + LG GS G V+ G A+K L KE + R + V E +
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL---KKEIVVRLKQVEHTNDERLM 59
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L V H I+R+ G + + ++ +Y+ G L LL + N VA ++ A
Sbjct: 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA----KFYAA-E 114
Query: 823 VAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
V + YLH D I++RDLKP NILLD ++ DFG AK + + + G+
Sbjct: 115 VCLALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPD 168
Query: 882 YIAP 885
YIAP
Sbjct: 169 YIAP 172
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 50/185 (27%), Positives = 77/185 (41%), Gaps = 22/185 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
++M+D K+LG G+ G V G A+K L KE I + V + E V
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKIL---RKEVIIAKDEVAHTVTESRV 58
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
L N RH + L + + EY G L H + + Y
Sbjct: 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERV-FTEERARFY--GAE 113
Query: 823 VAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSY 880
+ + YLH D +V+RD+K N++LD + ++ DFG+ K I +M G+
Sbjct: 114 IVSALEYLHSRD----VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 169
Query: 881 GYIAP 885
Y+AP
Sbjct: 170 EYLAP 174
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 9e-17
Identities = 42/169 (24%), Positives = 77/169 (45%), Gaps = 27/169 (15%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K++G GS G V++A++ + +A+KK+ + R E+ ++ V+H N+V L
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPNVVDLK 98
Query: 776 GC------CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR---YKIALGVAQG 826
+ L+ EY+P + K + + + + Y++ +A
Sbjct: 99 AFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA-- 155
Query: 827 ICYLH-HDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQSDESM 873
Y+H I HRD+KP N+LLD ++ DFG AK++ + E
Sbjct: 156 --YIHSIG----ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN 198
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-16
Identities = 80/466 (17%), Positives = 144/466 (30%), Gaps = 80/466 (17%)
Query: 77 SSQITSLDLSRRSLSGP-IPPEIRYLTSLTHLNLSANAFD----GPLQPAILELTKLRTI 131
S I SLD+ LS + L + L + A+ L +
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 61
Query: 132 DISHNSFNSTFPPGISKL--------RFLRIFNAYSNSFT----GPLPLEFVQLNSLQQL 179
++ N G+ + ++ + + T G L L +LQ+L
Sbjct: 62 NLRSNELG---DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 180 NLGGSYFDGE-----IPSDYRNLSSLRFLDLAGNSLT----GSLPPQLGLLTQLERIEIG 230
+L + L L L SL+ L L + + +
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 231 YNNLQGEVPVEFA-----SLVNLKYMDISACNLS----GTLPSEISNLTKLEMLLLFKNH 281
N++ S L+ + + +C ++ L +++ L L L N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNK 238
Query: 282 FTGE-----IPVSYGNLQALQVLDLSDNQLSGP----IPASLASLKGLTRLSLMNNVLFG 332
P L+ L + + ++ + L + + L LSL N L
Sbjct: 239 LGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD 298
Query: 333 EIPQDI-ELLAD----LDTLLLWNNHLTGV----LPQKLGSNGKLLTVDVSSNSLTGPIP 383
E + + E L + L++L + + T L N LL + +S+N L
Sbjct: 299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358
Query: 384 PTICDG-----DRLFKLILFSNNFTY----SIPENLVNCSSLSRLRIQDNQLNGSIPQGF 434
+C G L L L + + S+ L+ SL L + +N L G
Sbjct: 359 RELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGI 415
Query: 435 GLL--------PNLTFMDMSRNSLSGEIPRDLGNAQK----LEYLN 468
L L + + S E+ L +K L ++
Sbjct: 416 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 461
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 8e-13
Identities = 66/377 (17%), Positives = 115/377 (30%), Gaps = 74/377 (19%)
Query: 267 SNLTKLEMLLLFKNHFTGE-IPVSYGNLQALQVLDLSDNQLS----GPIPASLASLKGLT 321
++ L+ + + LQ QV+ L D L+ I ++L L
Sbjct: 3 LDIQSLD---IQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALA 59
Query: 322 RLSLMNNVLFGEIPQDIELLAD--------LDTLLLWNNHLT----GVLPQKLGSNGKLL 369
L+L +N L + + + L L N LT GVL L + L
Sbjct: 60 ELNLRSNEL---GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQ 116
Query: 370 TVDVSSNSLTGPIPPTICDGDR-----LFKLILFSNNFTY----SIPENLVNCSSLSRLR 420
+ +S N L +C+G L KL L + + + L L
Sbjct: 117 ELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELT 176
Query: 421 IQDNQLNGS----IPQGFGLLP-NLTFMDMSRNSLSGEIPRDLGNA----QKLEYLNISE 471
+ +N +N + + QG P L + + ++ + RDL L L +
Sbjct: 177 VSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS 236
Query: 472 NSFQTSLPSNIWSA-----PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIP 526
N + + L+ L +T K GC + ++
Sbjct: 237 NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK-----GCGDLCRV------------ 279
Query: 527 WDIGHCEKLLLLNLSRNSLT-----GIIPWEISGLPSITDVDLSHNFLTGT----IPSNF 577
+ E L L+L+ N L + + + + + T S
Sbjct: 280 --LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVL 337
Query: 578 ENCSTLESFNVSYNLLT 594
L +S N L
Sbjct: 338 AQNRFLLELQISNNRLE 354
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-12
Identities = 72/426 (16%), Positives = 126/426 (29%), Gaps = 93/426 (21%)
Query: 173 LNSLQQLNLGGSYFDGE----IPSDYRNLSSLRFLDLAGNSLTGS----LPPQLGLL-TQ 223
L Q + L I S R +L L+L N L + L +
Sbjct: 27 LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86
Query: 224 LERIEIGYNNLQGEVPVEFASLV----NLKYMDISACNLSGTLPSEISNLTKLEMLLLFK 279
++++ + L G +S + L+ + +S L + L L LL
Sbjct: 87 IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD------AGLQLLCEGLLDP 140
Query: 280 NHFTGEIPVSYGNLQALQVLDLSDNQLS----GPIPASLASLKGLTRLSLMNNVLFGEIP 335
L+ L L LS P+ + L + L++ NN +
Sbjct: 141 Q-------------CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI---NE 184
Query: 336 QDIELLAD--------LDTLLLWNNHLT----GVLPQKLGSNGKLLTVDVSSNSLTGPIP 383
+ +L L+ L L + +T L + S L + + SN L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 384 PTICDG-----DRLFKLILFSNNFTY----SIPENLVNCSSLSRLRIQDNQLNGSIPQGF 434
+C G RL L ++ T + L SL L + N+L +
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 304
Query: 435 GLL-----PNLTFMDMSRNSLSGEIPRDLGNA----QKLEYLNISENSFQTSLPSNIWSA 485
L + + S + + + L L IS N + + +
Sbjct: 305 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQG 364
Query: 486 -----PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNL 540
L++L + ++ C S+ + L L+L
Sbjct: 365 LGQPGSVLRVLWLADCDVSDS-----SCSSLAAT--------------LLANHSLRELDL 405
Query: 541 SRNSLT 546
S N L
Sbjct: 406 SNNCLG 411
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 39/180 (21%), Positives = 69/180 (38%), Gaps = 39/180 (21%)
Query: 715 DKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
++LG+G G V + E A+K ++ EV++ + +IV
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKM--------LQDCPKARREVELHWRASQCPHIV 74
Query: 773 RLLGCC----SNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYKIALGVAQ 825
R++ + R+C +++ E + G L + + E ++ I + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------IMKSIGE 128
Query: 826 GICYLH-HDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYG 881
I YLH + I HRD+KP N+L ++ DFG AK E Y
Sbjct: 129 AIQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-----E---TTGEKYD 176
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-16
Identities = 47/186 (25%), Positives = 81/186 (43%), Gaps = 36/186 (19%)
Query: 710 CLSMSD----KILGMGSTGTVYKA--EMPGGEIIAVKKLWGKHKENIR---RRRGV---- 756
C + +G G+ G V+KA GG +A+K+ +R G+
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--------VRVQTGEEGMPLST 58
Query: 757 LAEVDVL---GNVRHRNIVRLLGCCSNRECT-----MLLYEYMPNGNLDDLLHAKNKGEN 808
+ EV VL H N+VRL C+ L++E++ +L L K
Sbjct: 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPG 116
Query: 809 LVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868
+ + + L +G+ +LH +VHRDLKP NIL+ + ++ADFG+A++
Sbjct: 117 VPTETIKDMMFQL--LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 869 SDESMS 874
+++
Sbjct: 172 FQMALT 177
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 43/184 (23%), Positives = 71/184 (38%), Gaps = 31/184 (16%)
Query: 715 DKILGMGSTGTVYKAEMPG-GEIIAVKKL---WGKHKENIRR-RRGVLAEVDVLGNVRHR 769
+++G G G VY+AE I+A+K + R +R E G ++
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQR----EARTAGRLQEP 94
Query: 770 NIVRL--LGCCSNRECTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVA 824
++V + G E LY + +L +L + L I +
Sbjct: 95 HVVPIHDFG-----EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVA--IVRQIG 144
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM---SVIAGSYG 881
+ H HRD+KP NIL+ + A + DFG+A +DE + G+
Sbjct: 145 SALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLY 200
Query: 882 YIAP 885
Y+AP
Sbjct: 201 YMAP 204
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 8e-16
Identities = 49/187 (26%), Positives = 85/187 (45%), Gaps = 36/187 (19%)
Query: 710 CLSMSD--KI--LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKEN---------IRRRRG 755
++ S + +G+G+ GTVYKA + G +A+K + + +R
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR---- 60
Query: 756 VLAEVDVL---GNVRHRNIVRLLGCCSNRECT-----MLLYEYMPNGNLDDLLHAKNKGE 807
EV +L H N+VRL+ C+ L++E++ +L L K
Sbjct: 61 ---EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD-KAPPP 115
Query: 808 NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867
L A+ + +G+ +LH +C IVHRDLKP NIL+ ++ADFG+A++
Sbjct: 116 GLPAETIKDLMRQF--LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 868 QSDESMS 874
+++
Sbjct: 171 SYQMALT 177
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 11/206 (5%)
Query: 127 KLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY 185
++D S + P I + + L + SN + F +L L+ L L +
Sbjct: 17 NKNSVDCSSKKLTA-IPSNIPADTKKLDL---QSNKLSSLPSKAFHRLTKLRLLYLNDNK 72
Query: 186 FDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQGEVPVEFA 243
+P+ ++ L +L L + N L +LP + L L + + N L+ P F
Sbjct: 73 LQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFD 130
Query: 244 SLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
SL L Y+ + L +LP + LT L+ L L+ N ++ L L+ L L
Sbjct: 131 SLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLD 189
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNN 328
+NQL + SL+ L L L N
Sbjct: 190 NNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 55/242 (22%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSAN--------AFDGPLQPAILELTKL 128
++ S+D S + L+ IP I L+L +N AF LTKL
Sbjct: 15 NNNKNSVDCSSKKLTA-IPSNI--PADTKKLDLQSNKLSSLPSKAFHR--------LTKL 63
Query: 129 RTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG 188
R + ++ N T P GI F +L +L+ L + +
Sbjct: 64 RLLYLNDNKL-QTLPAGI-----------------------FKELKNLETLWVTDNKLQ- 98
Query: 189 EIPSD-YRNLSSLRFLDLAGNSLTGSLPPQLGL---LTQLERIEIGYNNLQGEVPVE-FA 243
+P + L +L L L N L SLPP + LT+L + +GYN LQ +P F
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPP--RVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 244 SLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
L +LK + + L +P LT+L+ L L N ++ +L+ L++L L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 303 DN 304
+N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 55/184 (29%), Positives = 81/184 (44%), Gaps = 12/184 (6%)
Query: 175 SLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNN 233
++L+L + + L+ LR L L N L +LP + L LE + + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 234 LQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPV-SY 290
LQ +P+ F LVNL + + L +LP + +LTKL L L N +P +
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 291 GNLQALQVLDLSDNQLSGPIPASL-ASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLL 348
L +L+ L L +NQL +P L L L L NN L +P+ + L L L
Sbjct: 154 DKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQL-KRVPEGAFDSLEKLKMLQ 211
Query: 349 LWNN 352
L N
Sbjct: 212 LQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 5e-13
Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 22/195 (11%)
Query: 286 IPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADL 344
IP + LDL N+LS + L L L L +N L +P I + L +L
Sbjct: 35 IPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNL 87
Query: 345 DTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFT 403
+TL + +N L + L + + N L +PP + D +L L L N
Sbjct: 88 ETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ 146
Query: 404 YSIPEN----LVNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDL 458
S+P+ L + L LR+ +NQL +P+G F L L + + N L +P
Sbjct: 147 -SLPKGVFDKLTS---LKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA 200
Query: 459 -GNAQKLEYLNISEN 472
+ +KL+ L + EN
Sbjct: 201 FDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 52/235 (22%), Positives = 81/235 (34%), Gaps = 42/235 (17%)
Query: 365 NGKLLTVDVSSNSLT---GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRI 421
N +VD SS LT IP KL L SN + + + L L +
Sbjct: 15 NNNKNSVDCSSKKLTAIPSNIPAD------TKKLDLQSNKLSSLPSKAFHRLTKLRLLYL 68
Query: 422 QDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPS 480
DN+L ++P G F L NL + ++ N L +LP
Sbjct: 69 NDNKLQ-TLPAGIFKELKNLETLWVTDNKL-------------------------QALPI 102
Query: 481 NIWSAP-NLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDI-GHCEKLL 536
++ NL L ++L +P F + + L N L S+P + L
Sbjct: 103 GVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLK 160
Query: 537 LLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
L L N L + L + + L +N L F++ L+ + N
Sbjct: 161 ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 46/173 (26%), Positives = 82/173 (47%), Gaps = 32/173 (18%)
Query: 710 CLSMS--DKI--LGMGSTGTVYKA-EMPGGEIIAVKKL-WGKHKENIRRRRGV----LAE 759
C +S +K+ +G G+ G V+KA G+ +A+KK+ KE G L E
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALRE 66
Query: 760 VDVLGNVRHRNIVRLLGCC--------SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA 811
+ +L ++H N+V L+ C + L++++ + +L LL N
Sbjct: 67 IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS--NVLVKFTL 123
Query: 812 DWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864
+ R L G+ Y+H + I+HRD+K +N+L+ + ++ADFG+A
Sbjct: 124 SEIKRVMQML--LNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 171
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 44/241 (18%), Positives = 76/241 (31%), Gaps = 78/241 (32%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLW----GKHKENIRRRRGVLAEVDVLGNVRHRN 770
+ +G G G V++A+ A+K++ +E + R LA+++ G VR+ N
Sbjct: 12 QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71
Query: 771 IVRLLGCCSN------------------------------------------------RE 782
Sbjct: 72 AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131
Query: 783 CTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRY--KIALGVAQGICYLHHDCDPV 837
+ LY + NL D ++ + E+ +IA V +LH
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE----FLHSKG--- 184
Query: 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIA-------------GSYGYIA 884
++HRDLKPSNI + +V DFG+ + DE + G+ Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 885 P 885
P
Sbjct: 245 P 245
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 21/179 (11%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKL---WGKHKENIRR-RRGVLAEVDVLGNVRHR 769
LG G TVY AE +A+K + + +E ++R R EV + H+
Sbjct: 16 VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFER----EVHNSSQLSHQ 71
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
NIV ++ +C L+ EY+ L + + + L D + GI +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAIN--FTNQILDGIKH 126
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAP 885
H IVHRD+KP NIL+D ++ DFG+AK + S+ S+ + + G+ Y +P
Sbjct: 127 AHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSP 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 39/174 (22%), Positives = 70/174 (40%), Gaps = 27/174 (15%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRR--------RGVLAEVDVLGNVR 767
+ + GS G V G +A+K+++ + + VL E+ +L +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 768 HRNIVRLLGCCSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
H NI+ L + E L+ E M +L ++H + ++ I
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQR-------IVISPQHIQYF 139
Query: 823 VAQ---GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
+ G+ LH + +VHRDL P NILL + + DF +A+ +D +
Sbjct: 140 MYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 3e-14
Identities = 51/190 (26%), Positives = 83/190 (43%), Gaps = 30/190 (15%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGV--LAEV 760
S K+LG GS G V+ + ++ A+K L K ++ R V E
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMER 77
Query: 761 DVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRY 817
D+L V H IV+L L+ +++ G+L + E ++
Sbjct: 78 DILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEE-----DVKF 130
Query: 818 KIALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSV 875
+A +A + +LH I++RDLKP NILLD E ++ DFG++K I ++
Sbjct: 131 YLA-ELALALDHLHSLG----IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
Query: 876 IAGSYGYIAP 885
G+ Y+AP
Sbjct: 186 FCGTVEYMAP 195
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 74.7 bits (183), Expect = 7e-14
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
+ ++D +LG GS G V +E G E+ AVK L K+ + + V + E V
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRV 394
Query: 763 LGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
L + + +L C + + EY+ G+L + H + G Y A
Sbjct: 395 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGR-FKEPHAVFY--AA 449
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSY 880
+A G+ +L I++RDLK N++LD E ++ADFG+ K I + G+
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 506
Query: 881 GYIAP 885
YIAP
Sbjct: 507 DYIAP 511
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 42/208 (20%), Positives = 76/208 (36%), Gaps = 56/208 (26%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K LG GS G V + ++ G+ A+KK+ R + E+D++ + H NI++L
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKV-----LQDPRYK--NRELDIMKVLDHVNIIKL 65
Query: 775 LGC---CSNRECTMLLYEYMPNGNLDDLLHAKNKGE------------NLVADWV--TRY 817
+ + E N N + N++ ++V T +
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH 125
Query: 818 KIALGVAQ-------------------GICYLH-HDCDPVIVHRDLKPSNILLDGEM-EA 856
K+ + + ++H I HRD+KP N+L++ +
Sbjct: 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG----ICHRDIKPQNLLVNSKDNTL 181
Query: 857 RVADFGVAKLIQSDESMSVIAGSYGYIA 884
++ DFG AK + E YI
Sbjct: 182 KLCDFGSAKKLIPSEPSV------AYIC 203
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 32/192 (16%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRG----VLA 758
+ ++LG G G V++ G+I A+K L K I R A
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL---KKAMIVRNAKDTAHTKA 70
Query: 759 EVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVT 815
E ++L V+H IV L+ L+ EY+ G L + + +G E+
Sbjct: 71 ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFMED-----TA 123
Query: 816 RYKIALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESM 873
+ +A ++ + +LH I++RDLKP NI+L+ + ++ DFG+ K I
Sbjct: 124 CFYLA-EISMALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT 178
Query: 874 SVIAGSYGYIAP 885
G+ Y+AP
Sbjct: 179 HTFCGTIEYMAP 190
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 1e-13
Identities = 32/143 (22%), Positives = 62/143 (43%), Gaps = 14/143 (9%)
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVE-FASLVN 247
+P + L N++ +PP +L RI++ N + E+ + F L +
Sbjct: 30 LPETITEI------RLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 248 LKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQ 305
L + + ++ LP + L L++LLL N + V ++ +L L +L L DN+
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 306 LSGPIPASLASLKGLTRLSLMNN 328
L + + L+ + + L N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 9e-10
Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 9/149 (6%)
Query: 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
G LT +P L + I + N ++ P F+ L+ +D+S +S L +
Sbjct: 20 GKGLT-EIPT--NLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA 75
Query: 267 -SNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLS 324
L L L+L+ N T E+P S + L +LQ+L L+ N+++ + L L LS
Sbjct: 76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLS 134
Query: 325 LMNNVLFGEIPQDI-ELLADLDTLLLWNN 352
L +N L I + L + T+ L N
Sbjct: 135 LYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 33/145 (22%), Positives = 64/145 (44%), Gaps = 8/145 (5%)
Query: 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DR 391
EIP ++ + + L N + + P KL +D+S+N ++ + P G
Sbjct: 25 EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS 81
Query: 392 LFKLILFSNNFTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNS 449
L L+L+ N T +P++L SL L + N++N + F L NL + + N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 450 LSGEIPRDLGNAQKLEYLNISENSF 474
L + ++ +++++N F
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 7e-07
Identities = 40/177 (22%), Positives = 65/177 (36%), Gaps = 44/177 (24%)
Query: 408 ENLVNCSSLS-------------RLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGE 453
N+V+C +R++ N + IP G F L +D+S N +S E
Sbjct: 13 NNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-E 70
Query: 454 IPRDL-GNAQKLEYLNISENSFQTSLPSNIW-SAPNLKILSASSSKLTGKIPDFIGCKSI 511
+ D + L L + N T LP +++ +L++L
Sbjct: 71 LAPDAFQGLRSLNSLVLYGNKI-TELPKSLFEGLFSLQLLL------------------- 110
Query: 512 YKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
L+ N +N + D L LL+L N L I S L +I + L+ N
Sbjct: 111 ----LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 33/142 (23%), Positives = 56/142 (39%), Gaps = 6/142 (4%)
Query: 263 PSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTR 322
P+ + + L +N P ++ + L+ +DLS+NQ+S P + L+ L
Sbjct: 27 PTNLPETI--TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84
Query: 323 LSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGP 381
L L N + E+P+ + E L L LLL N + + L + + N L
Sbjct: 85 LVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQT- 142
Query: 382 IPPTICDG-DRLFKLILFSNNF 402
I + + L N F
Sbjct: 143 IAKGTFSPLRAIQTMHLAQNPF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 34/184 (18%), Positives = 53/184 (28%), Gaps = 68/184 (36%)
Query: 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSAN--------AFDGPLQPAILELTKL 128
IT + L + ++ IPP L ++LS N AF G L L
Sbjct: 32 ETITEIRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQISELAPDAFQG--------LRSL 82
Query: 129 RTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG 188
++ + N + P + F+G
Sbjct: 83 NSLVLYGNKI-TELPKSL---------------------------------------FEG 102
Query: 189 EIPSDYRNLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQGEVPVEFASLVN 247
L SL+ L L N + L L L + + N LQ F+ L
Sbjct: 103 --------LFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 248 LKYM 251
++ M
Sbjct: 154 IQTM 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 48/187 (25%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L + D +++G GS V + I A+K + KE + + E V
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVV---KKELVNDDEDIDWVQTEKHV 62
Query: 763 LGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK--I 819
H +V L C + EY+ G+L + H + + + L + Y I
Sbjct: 63 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-LPEEHARFYSAEI 119
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAG 878
+L + YLH + I++RDLK N+LLD E ++ D+G+ K ++ ++ S G
Sbjct: 120 SLALN----YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 172
Query: 879 SYGYIAP 885
+ YIAP
Sbjct: 173 TPNYIAP 179
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 38/164 (23%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++G GS G V +A + ++A+KK+ ++ I +R +L E+ +L + H ++V++
Sbjct: 59 HLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-ILREIAILNRLNHDHVVKV 117
Query: 775 LGCCSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
L ++ ++ E + D L + + + + G+ Y
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIADS----DFKKLFRTPVYLTELHI-KT-LLYNLLVGVKY 171
Query: 830 LH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+H I+HRDLKP+N L++ + +V DFG+A+ + E+
Sbjct: 172 VHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 52/188 (27%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L + D K+LG GS G V+ AE + A+K L K+ + V + E V
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKAL---KKDVVLMDDDVECTMVEKRV 70
Query: 763 LG-NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYK 818
L H + + +E + EY+ G+L + H ++ + +
Sbjct: 71 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLS-----RATFY 123
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIA 877
A + G+ +LH IV+RDLK NILLD + ++ADFG+ K + D +
Sbjct: 124 AA-EIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC 179
Query: 878 GSYGYIAP 885
G+ YIAP
Sbjct: 180 GTPDYIAP 187
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 42/184 (22%), Positives = 75/184 (40%), Gaps = 25/184 (13%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKEN---IRR-RRGVLAEVDVLGNVRHR 769
+ILG G V+ A + +AVK L + R RR E + H
Sbjct: 17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR----EAQNAAALNHP 72
Query: 770 NIVRLL--GCCSNRECTM--LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
IV + G + ++ EY+ L D++H + + + Q
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIE--VIADACQ 127
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM----SVIAGSYG 881
+ + H + I+HRD+KP+NI++ +V DFG+A+ I + + + G+
Sbjct: 128 ALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184
Query: 882 YIAP 885
Y++P
Sbjct: 185 YLSP 188
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 29/170 (17%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWG--KHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K +G G+ G V A + +A+KKL +++ + +R E+ ++ V H+NI+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR---AYRELVLMKCVNHKNII 87
Query: 773 RLL------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ- 825
LL + ++ E M NL ++ + + +++ + Q
Sbjct: 88 GLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQME----------LDHERMSYLLYQM 136
Query: 826 --GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
GI +LH I+HRDLKPSNI++ + ++ DFG+A+ + M
Sbjct: 137 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 183
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 21/185 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L + + ++LG GS G V A + G++ AVK L K+ I + V + E +
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVL---KKDVILQDDDVECTMTEKRI 76
Query: 763 LGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
L H + +L C + + E++ G+L + H + Y A
Sbjct: 77 LSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRR-FDEARARFY--AA 131
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSY 880
+ + +LH D I++RDLK N+LLD E ++ADFG+ K I + + + G+
Sbjct: 132 EIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTP 188
Query: 881 GYIAP 885
YIAP
Sbjct: 189 DYIAP 193
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 3e-13
Identities = 47/187 (25%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
L + D +++G GS V + I A++ + KE + + E V
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVV---KKELVNDDEDIDWVQTEKHV 105
Query: 763 LGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK--I 819
H +V L C + EY+ G+L + H + + + L + Y I
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRK-LPEEHARFYSAEI 162
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAG 878
+L + YLH + I++RDLK N+LLD E ++ D+G+ K ++ ++ S G
Sbjct: 163 SLALN----YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCG 215
Query: 879 SYGYIAP 885
+ YIAP
Sbjct: 216 TPNYIAP 222
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 4e-13
Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWG--KHKENIRRRRGVLAEVDVLGNVRHRNIV 772
K +G G+ G V A + +A+KKL +++ + +R E+ ++ V H+NI+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR---AYRELVLMKCVNHKNII 124
Query: 773 RLL------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVT--RYKIALGVA 824
LL + L+ E M NL ++ L + ++ Y++ G+
Sbjct: 125 SLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIK 178
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
+LH I+HRDLKPSNI++ + ++ DFG+A+ + M
Sbjct: 179 ----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 220
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 52/185 (28%), Positives = 83/185 (44%), Gaps = 21/185 (11%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
+ ++D +LG GS G V +E G E+ AVK L K+ + + V + E V
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKIL---KKDVVIQDDDVECTMVEKRV 73
Query: 763 LGNV-RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIAL 821
L + + +L C + + EY+ G+L + H + G Y A
Sbjct: 74 LALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGR-FKEPHAVFY--AA 128
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVIAGSY 880
+A G+ +L I++RDLK N++LD E ++ADFG+ K I + G+
Sbjct: 129 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTP 185
Query: 881 GYIAP 885
YIAP
Sbjct: 186 DYIAP 190
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-13
Identities = 56/189 (29%), Positives = 86/189 (45%), Gaps = 29/189 (15%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGV---LAEVDV 762
SD K++G GS G V A AVK L K+ I +++ ++E +V
Sbjct: 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVL---QKKAILKKKEEKHIMSERNV 91
Query: 763 LG-NVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWVTRYK 818
L NV+H +V L + + +Y+ G L H + + E R+
Sbjct: 92 LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEP-----RARFY 144
Query: 819 IALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL-IQSDESMSVI 876
A +A + YLH + IV+RDLKP NILLD + + DFG+ K I+ + + S
Sbjct: 145 AA-EIASALGYLHSLN----IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF 199
Query: 877 AGSYGYIAP 885
G+ Y+AP
Sbjct: 200 CGTPEYLAP 208
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 17/148 (11%), Positives = 44/148 (29%), Gaps = 11/148 (7%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG 776
G ++A +A+ + + + L+ L + + R+L
Sbjct: 39 HGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD 98
Query: 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDP 836
R +++ E++ G+L ++ + R +A H
Sbjct: 99 VVHTRAGGLVVAEWIRGGSLQEVAD-----TSPSPVGAIR--AMQSLAAAADAAHRAG-- 149
Query: 837 VIVHRDLKPSNILLDGEMEARVADFGVA 864
+ PS + + + + +A
Sbjct: 150 -VALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 9e-13
Identities = 53/320 (16%), Positives = 98/320 (30%), Gaps = 59/320 (18%)
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
+L ++ T + + +L K+ S + L +LS +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDS-ATDEQLFRCELSVEKS 361
Query: 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366
+ + + L S K L L N I + L L + + +
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTL--------- 411
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
D R L + F + + + L + L
Sbjct: 412 ------------------KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL 453
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
++ L +T +D+S N L +P L + LE L S+N+ ++ + + P
Sbjct: 454 --TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL-ENVD-GVANLP 508
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
L+ L +N L + + C +L+LLNL NSL
Sbjct: 509 RLQELLLC----------------------NNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
Query: 547 GIIPWE---ISGLPSITDVD 563
+ LPS++ +
Sbjct: 547 QEEGIQERLAEMLPSVSSIL 566
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.4 bits (169), Expect = 3e-12
Identities = 57/358 (15%), Positives = 104/358 (29%), Gaps = 52/358 (14%)
Query: 10 FFLHLLVVFSANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWS 69
+F H ++ A + +S + + + + ++ P+ W
Sbjct: 229 WFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWR 288
Query: 70 GIKCNPKSSQITSLDLSRRSLSGPIP-----PEIRYLTSLTHLNLSANAFDGPLQPAILE 124
+ S + DL SL+ +P S L + +
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPEC-WCRDSAT 347
Query: 125 LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGS 184
+L ++S E LQ+L
Sbjct: 348 DEQLFRCELSVEKSTVL-------------------------QSELESCKELQELEPENK 382
Query: 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY-----NNLQGEVP 239
+ I R L L + + L ++ + Y + E
Sbjct: 383 WCLLTIILLMRALDPLLYEKETLQYFST--------LKAVDPMRAAYLDDLRSKFLLENS 434
Query: 240 VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVL 299
V +++ + ++ +L T+ + L + L L N +P + L+ L+VL
Sbjct: 435 VLKMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVL 491
Query: 300 DLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL--LADLDTLLLWNNHLT 355
SDN L + +A+L L L L NN L + L L L L N L
Sbjct: 492 QASDNALEN-VD-GVANLPRLQELLLCNNRL-QQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.8 bits (144), Expect = 3e-09
Identities = 29/228 (12%), Positives = 60/228 (26%), Gaps = 9/228 (3%)
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
L ++ D + +L + + L R + +
Sbjct: 303 DLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDR-PECWCRDSATDEQLFRCELSVEKS 361
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
+ L ++ I + L Y + F T +
Sbjct: 362 T-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPM--R 418
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
+ S L + + + L + L + + + L+LS N L
Sbjct: 419 AAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR 476
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
+ P ++ L + + S N L + N L+ + N L
Sbjct: 477 AL-PPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 44/165 (26%), Positives = 78/165 (47%), Gaps = 25/165 (15%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ G+V A + GE +A+KKL + I +R E+ +L +++H N++ L
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-AYRELLLLKHMQHENVIGL 88
Query: 775 L------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ--- 825
L N L+ +M +L ++ K + KI V Q
Sbjct: 89 LDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLK----------FSEEKIQYLVYQMLK 137
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
G+ Y+H +VHRDLKP N+ ++ + E ++ DFG+A+ ++
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-12
Identities = 41/164 (25%), Positives = 76/164 (46%), Gaps = 24/164 (14%)
Query: 718 LGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLL 775
LG G V++A + E + VK L K+ I+R E+ +L N+R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR------EIKILENLRGGPNIITLA 97
Query: 776 GCCSNRE--CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-H 832
+ L++E++ N + L + D+ R+ + + + + Y H
Sbjct: 98 DIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYM-YEILKALDYCHSM 149
Query: 833 DCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSV 875
I+HRD+KP N+++D E + R+ D+G+A+ + +V
Sbjct: 150 G----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 189
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 39/173 (22%), Positives = 79/173 (45%), Gaps = 29/173 (16%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K LG G G V+ A + + +A+KK+ ++++ L E+ ++ + H NIV++
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH---ALREIKIIRRLDHDNIVKV 73
Query: 775 L--------------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIA 820
G + ++ EYM + L + L+ + R
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHA-RL-FM 126
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDES 872
+ +G+ Y+H ++HRDLKP+N+ ++ E + ++ DFG+A+++ S
Sbjct: 127 YQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 3e-12
Identities = 42/162 (25%), Positives = 79/162 (48%), Gaps = 18/162 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G+ G V A + G +A+KKL+ + + +R E+ +L ++RH N++ L
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMRHENVIGL 89
Query: 775 L------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L + L+ +M L K E L D + ++ + + +G+
Sbjct: 90 LDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRI-QF-LVYQMLKGLR 142
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
Y+H I+HRDLKP N+ ++ + E ++ DFG+A+ S+
Sbjct: 143 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 62/328 (18%), Positives = 108/328 (32%), Gaps = 69/328 (21%)
Query: 199 SLRFLDLAGNSLTG----SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
S+ L +++T S+ L ++ I + N + +
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG----------------TEA 48
Query: 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNL-------QALQVLDLSDNQLS 307
A LS + + +L E +F EIP + L L + LSDN
Sbjct: 49 ARWLSENI-ASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG 107
Query: 308 G----PIPASLASLKGLTRLSLMNNVL-------------FGEIPQDIELLADLDTLLLW 350
P+ L+ L L L NN L + + + L +++
Sbjct: 108 PTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167
Query: 351 NNHLT--GV--LPQKLGSNGKLLTVDVSSNSLTGP-IPPTICDG----DRLFKLILFSNN 401
N L + + S+ L TV + N + I + +G L L L N
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227
Query: 402 FT----YSIPENLVNCSSLSRLRIQDNQLNG----SIPQGFGLLPN--LTFMDMSRNSLS 451
FT ++ L + +L L + D L+ ++ F L N L + + N +
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 452 GEIPRDLGNAQK-----LEYLNISENSF 474
+ R L L +L ++ N F
Sbjct: 288 LDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-09
Identities = 58/369 (15%), Positives = 114/369 (30%), Gaps = 93/369 (25%)
Query: 266 ISNLTKLEMLLLFKNHFTGE----IPVSYGNLQALQVLDLSDNQLSGP----IPASLASL 317
++ + +E L + T E + +++ + LS N + + ++AS
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 318 KGLTRLSLMNNV---LFGEIPQDIELLAD-------LDTLLLWNNHLT--GVLP--QKLG 363
K L + + EIP+ + LL L T+ L +N P L
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLS 119
Query: 364 SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQD 423
+ L + + +N L L ++ + N L +
Sbjct: 120 KHTPLEHLYLHNNGLG-------PQAGAKIARALQEL----AVNKKAKNAPPLRSIICGR 168
Query: 424 NQLNG----SIPQGFGLLPNLTFMDMSRNSLSGE-----IPRDLGNAQKLEYLNISENSF 474
N+L + F L + M +N + E + L Q+L+ L++ +N+F
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 475 QT--------SLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYK-IELHNNLLNGSI 525
+L S PNL+ L + L+ + G ++ N+
Sbjct: 229 THLGSSALAIALKSW----PNLRELGLNDCLLSAR-----GAAAVVDAFSKLENI----- 274
Query: 526 PWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLES 585
L L L N + + ++ V + E L
Sbjct: 275 --------GLQTLRLQYNEIEL------DAVRTLKTV-ID------------EKMPDLLF 307
Query: 586 FNVSYNLLT 594
++ N +
Sbjct: 308 LELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 55/346 (15%), Positives = 96/346 (27%), Gaps = 81/346 (23%)
Query: 80 ITSLDLSRRSLSG----PIPPEIRYLTSLTHLNLSANAFDGP-----LQPAILELTKLRT 130
I L +++ + + S+ + LS N G L I L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTI-GTEAARWLSENIASKKDLEI 64
Query: 131 IDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE- 189
+ S LR L A ++ L + L + F
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLL--LQA------------LLKCPKLHTVRLSDNAFGPTA 110
Query: 190 ---IPSDYRNLSSLRFLDLAGNSLT-------------GSLPPQLGLLTQLERIEIGYNN 233
+ + L L L N L ++ + L I G N
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 170
Query: 234 LQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGE-----IPV 288
L+ + S + T + L + + +N E +
Sbjct: 171 LE----------------NGSMKEWAKTF----QSHRLLHTVKMVQNGIRPEGIEHLLLE 210
Query: 289 SYGNLQALQVLDLSDNQLSGP----IPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLAD 343
Q L+VLDL DN + + +L S L L L + +L + + +
Sbjct: 211 GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSK 270
Query: 344 -----LDTLLLWNNHLTG----VLPQKLGSNGKLLT-VDVSSNSLT 379
L TL L N + L + L ++++ N +
Sbjct: 271 LENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 49/312 (15%), Positives = 80/312 (25%), Gaps = 66/312 (21%)
Query: 76 KSSQITSLDLSRRSLSGP---IPPEIRYL-------TSLTHLNLSANAF--DG--PLQPA 121
+ + S IP +R L L + LS NAF PL
Sbjct: 58 SKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 117
Query: 122 ILELTKLRTIDISHNSF-------------NSTFPPGISKLRFLRIFNAYSNSFTGP--- 165
+ + T L + + +N LR N
Sbjct: 118 LSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMK 177
Query: 166 -LPLEFVQLNSLQQLNLGGSYFDGE-----IPSDYRNLSSLRFLDLAGNSLTG----SLP 215
F L + + + E + L+ LDL N+ T +L
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 237
Query: 216 PQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEML 275
L L + + L A + S++ N L+ L
Sbjct: 238 IALKSWPNLRELGLNDCLLS----------------ARGAAAVVDAF-SKLEN-IGLQTL 279
Query: 276 LLFKNHFTGE-----IPVSYGNLQALQVLDLSDNQLS--GPIPASLAS-LKGLTRLSLMN 327
L N + V + L L+L+ N+ S + + R L
Sbjct: 280 RLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339
Query: 328 NVLFGEIPQDIE 339
E+ + E
Sbjct: 340 LDDMEELTDEEE 351
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 4e-12
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 22/181 (12%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
++G GS G VY A + + +A+KK+ ++ I +R +L E+ +L ++ I+RL
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-ILREITILNRLKSDYIIRL 90
Query: 775 LGCC--SNRECTMLLY---EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ---G 826
+ LY E + +L L +T I + G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIF--------LTEEHIKTILYNLLLG 141
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPG 886
++H + I+HRDLKP+N LL+ + +V DFG+A+ I S++ +++ PG
Sbjct: 142 ENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 887 T 887
Sbjct: 199 P 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 8e-12
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 19/175 (10%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQG--FGLLPNLTFMDMSRNSLSGEIPRD-LGNA 461
++P++L S + L + N L + L NL + +S N L+ I +
Sbjct: 32 NVPQSLP--SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPV 87
Query: 462 QKLEYLNISENSFQTSLPSNI-WSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHN 518
L YL++S N +L + L++L ++ + + F + K+ L
Sbjct: 88 PNLRYLDLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQ 145
Query: 519 NLLNGSIPWDI----GHCEKLLLLNLSRNSLTGIIPWEISGLPSIT--DVDLSHN 567
N ++ P ++ KL+LL+LS N L + ++ LP+ + L +N
Sbjct: 146 NQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 46/188 (24%), Positives = 71/188 (37%), Gaps = 30/188 (15%)
Query: 246 VNLKYMDISACNLSGTLPSEI--SNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLS 302
+D+S NLS L +E + LT L LLL NH I ++ + L+ LDLS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQK 361
N L + L+ L L L NN + + ++ E +A L L L N ++ +
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSR--L 419
+ KL +L L L SN +L + + L
Sbjct: 156 IKDGNKL---------------------PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 420 RIQDNQLN 427
+ +N L
Sbjct: 195 YLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 46/171 (26%), Positives = 65/171 (38%), Gaps = 24/171 (14%)
Query: 77 SSQITSLDLSRRSLSGPIPPEI--RYLTSLTHLNLSAN--------AFDGPLQPAILELT 126
S LDLS +LS + E LT+L L LS N AF +
Sbjct: 38 PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVP--------VP 88
Query: 127 KLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG-- 183
LR +D+S N ++ + S L+ L + Y+N F + LQ+L L
Sbjct: 89 NLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQ 147
Query: 184 -SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNN 233
S F E+ D L L LDL+ N L L L + + +N
Sbjct: 148 ISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 8e-09
Identities = 39/189 (20%), Positives = 62/189 (32%), Gaps = 36/189 (19%)
Query: 296 LQVLDLSDNQLSG-PIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNH 353
+LDLS N LS + L L L L +N L I + + +L L L +NH
Sbjct: 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSNH 99
Query: 354 LTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVN 412
L + L + + +N + + N +
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-------------------------VVDRNAFED 134
Query: 413 CSSLSRLRIQDNQLNGSIPQG----FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL--EY 466
+ L +L + NQ++ P LP L +D+S N L DL
Sbjct: 135 MAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
Query: 467 LNISENSFQ 475
L + N +
Sbjct: 194 LYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 37/211 (17%), Positives = 71/211 (33%), Gaps = 46/211 (21%)
Query: 409 NLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD--LGNAQKLEY 466
N+++CS +L ++PQ L +D+S N+LS + + L
Sbjct: 21 NILSCSKQ-QLP--------NVPQS--LPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHS 68
Query: 467 LNISENSFQTSLPSNIWS-APNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSI 525
L +S N + S + PNL+ L +L +N L+ ++
Sbjct: 69 LLLSHNHLNF-ISSEAFVPVPNLRYL-----------------------DLSSNHLH-TL 103
Query: 526 PWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP----SNFENC 580
+ + L +L L N + + + + + LS N ++ P +
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKL 162
Query: 581 STLESFNVSYNLLTGPIPASGTIFPNLHPSS 611
L ++S N L P +
Sbjct: 163 PKLMLLDLSSNKLKKLPLTDLQKLPAWVKNG 193
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 26/149 (17%), Positives = 56/149 (37%), Gaps = 23/149 (15%)
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIP---DFIGCKSIYKIELHNNLLNGSIPWDI-GH 531
++P ++ +L S + L+ ++ +++ + L +N LN I +
Sbjct: 31 PNVPQSL--PSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVP 86
Query: 532 CEKLLLLNLSRNSLTGIIPWEI-SGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVS 589
L L+LS N L + + S L ++ + L +N + + N FE+ + L+ +S
Sbjct: 87 VPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLS 144
Query: 590 YNLLTGPIPASGTIFPNLHPSSFIGNEGL 618
N ++ L
Sbjct: 145 QNQIS-----------RFPVELIKDGNKL 162
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ G+V A + G +AVKKL + I +R E+ +L +++H N++ L
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGL 93
Query: 775 L------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L L+ M L+ K + L D V ++ + + +G+
Sbjct: 94 LDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHV-QF-LIYQILRGLK 146
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
Y+H I+HRDLKPSN+ ++ + E ++ DFG+A+ +
Sbjct: 147 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 6/155 (3%)
Query: 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQ 235
++L+L + + +R L+ L +L+L N L +L + LT+L + + N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 236 GEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVS-YGNL 293
F L L + + N +LPS + LTKL+ L L N IP + L
Sbjct: 97 SLPLGVFDHLTQLDKLYLG-GNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 294 QALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328
LQ L LS NQL + L L ++L N
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 55/212 (25%), Positives = 79/212 (37%), Gaps = 39/212 (18%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136
+ +D +SL +P I L+L + LTKL +++ +N
Sbjct: 13 NEGKKEVDCQGKSLDS-VPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYN 69
Query: 137 SFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL--NSLQQLNLGGSYFDGEIPSDY 194
T G+ F L + L N L L LG FD
Sbjct: 70 QL-QTLSAGV---------------FDDLTELGTLGLANNQLASLPLG--VFDH------ 105
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGL---LTQLERIEIGYNNLQGEVPVE-FASLVNLKY 250
L+ L L L GN L SLP G+ LT+L+ + + N LQ +P F L NL+
Sbjct: 106 --LTQLDKLYLGGNQLK-SLPS--GVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQT 159
Query: 251 MDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282
+ +S L L KL+ + LF N F
Sbjct: 160 LSLSTNQLQSVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 46/159 (28%), Positives = 67/159 (42%), Gaps = 14/159 (8%)
Query: 297 QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLT 355
+ LDL L+ A+ L LT L+L N L + + + L +L TL L NN L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPE----NL 410
+ +L + + N L +P + D +L +L L +N SIP L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 411 VNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRN 448
N L L + NQL S+P G F L L + + N
Sbjct: 155 TN---LQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 43/153 (28%), Positives = 65/153 (42%), Gaps = 10/153 (6%)
Query: 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPP 216
S F L L LNL + + + + +L+ L L LA N L SLP
Sbjct: 43 QSTGLATLSDATFRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPL 100
Query: 217 QLGL---LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLTKL 272
G+ LTQL+++ +G N L+ F L LK + ++ N ++P+ LT L
Sbjct: 101 --GVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLN-TNQLQSIPAGAFDKLTNL 157
Query: 273 EMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305
+ L L N ++ L LQ + L NQ
Sbjct: 158 QTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 41/177 (23%), Positives = 65/177 (36%), Gaps = 26/177 (14%)
Query: 411 VNCSSLS-------------RLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN---SLSGEI 454
V+C S +L +Q L F L LT++++ N +LS +
Sbjct: 19 VDCQGKSLDSVPSGIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGV 78
Query: 455 PRDLGNAQKLEYLNISENSFQTSLPSNIW-SAPNLKILSASSSKLTGKIPD--FIGCKSI 511
DL L L ++ N SLP ++ L L ++L +P F +
Sbjct: 79 FDDLTE---LGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKL 133
Query: 512 YKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
++ L+ N L SIP L L+LS N L + L + + L N
Sbjct: 134 KELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-11
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 24/166 (14%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ G V A + +A+KK+ E+ + L E+ +L RH NI+ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKI--SPFEHQTYCQRTLREIKILLRFRHENIIGI 90
Query: 775 LGCCSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ---G 826
++ + M + L+ K ++L + I + Q G
Sbjct: 91 NDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHL-----SNDHICYFLYQILRG 140
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ Y+H ++HRDLKPSN+LL+ + ++ DFG+A++ D
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 38/231 (16%), Positives = 75/231 (32%), Gaps = 48/231 (20%)
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
L L K T + L +Q + ++ + + L L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLAG--MQFFTNLKEL 68
Query: 324 SLMNNVLFGEIPQDIELLAD---LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTG 380
L +N + D+ L D L+ L + N L + + L + + +N L
Sbjct: 69 HLSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELRD 120
Query: 381 PIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNL 440
++L++ +L L I++N+L SI G L L
Sbjct: 121 --------------------------TDSLIHLKNLEILSIRNNKLK-SIV-MLGFLSKL 152
Query: 441 TFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKIL 491
+D+ N ++ L +K+ +++++ + P L I
Sbjct: 153 EVLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKCVN---EPVKYQPELYIT 198
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 37/215 (17%), Positives = 72/215 (33%), Gaps = 19/215 (8%)
Query: 98 IRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157
L + NL + + EL+ ++ + +++ S G+ L+ +
Sbjct: 15 DPGLANAVKQNLGKQSVTDL--VSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLS--SLRFLDLAGNSLTGSLP 215
N + PL+ L L++L++ + + + L L L N L
Sbjct: 71 SHNQISDLSPLK--DLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR-DTD 122
Query: 216 PQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEML 275
L L LE + I N L+ V L L+ +D+ ++ ++ L K+ +
Sbjct: 123 S-LIHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHGNEITN--TGGLTRLKKVNWI 177
Query: 276 LLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI 310
L E L + D + P
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 44/223 (19%), Positives = 73/223 (32%), Gaps = 45/223 (20%)
Query: 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277
L + +G ++ V + L ++ + N+ + + T L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP-------------------ASLASLK 318
N + P+ +L L+ L ++ N+L SL LK
Sbjct: 71 SHNQISDLSPLK--DLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDSLIHLK 128
Query: 319 GLTRLSLMNNVLFGEIPQDIELLADLD---TLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
L LS+ NN L + I +L L L L N +T L K+ +D++
Sbjct: 129 NLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTG 181
Query: 376 NSLTGP---------IPPTICDGD-RLFKLILFSNNFTYSIPE 408
I T+ D D R SN +Y
Sbjct: 182 QKCVNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGC 224
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 44/274 (16%), Positives = 96/274 (35%), Gaps = 29/274 (10%)
Query: 338 IELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKL-- 395
LA+ L +T ++ QK S + + ++++ ++ L
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVSQKELSG--VQNFNGDNSNIQ-----SLAGMQFFTNLKE 67
Query: 396 ILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIP 455
+ S+N + L + + L L + N+L ++ L+ + + N L
Sbjct: 68 LHLSHNQISDL-SPLKDLTKLEELSVNRNRLK-NLNGIPSA--CLSRLFLDNNELRD--T 121
Query: 456 RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIE 515
L + + LE L+I N S+ + L++L +++T K + I+
Sbjct: 122 DSLIHLKNLEILSIRNNKL-KSI-VMLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWID 178
Query: 516 LHNNLLNGSIPWDIGHCEKLLLLNLSRN-SLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574
L + + + +L + N ++ I P+ IS S D + T
Sbjct: 179 LTGQKC---VNEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWELPVYTDE 235
Query: 575 SNFENCSTLESFNVSYNLLTGPIPASGTIFPNLH 608
+++ F+ N+ GT+ +
Sbjct: 236 VSYK-------FSEYINVGETEAIFDGTVTQPIK 262
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 10/79 (12%), Positives = 33/79 (41%), Gaps = 6/79 (7%)
Query: 516 LHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
+N P + NL + S+T ++ L + + + ++ + ++ +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 576 NFENCSTLESFNVSYNLLT 594
+ + L+ ++S+N ++
Sbjct: 58 GMQFFTNLKELHLSHNQIS 76
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 34/194 (17%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRG----VLA 758
+ + + K+LG G+ G V+ G++ A+K L K I ++
Sbjct: 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVL---KKATIVQKAKTTEHTRT 107
Query: 759 EVDVLGNVRHRN-IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG---ENLVADWV 814
E VL ++R +V L L+ +Y+ G L H + E+
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTEH-----E 160
Query: 815 TRYKIALGVAQGICYLH-HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
+ + + + +LH I++RD+K NILLD + DFG++K +DE+
Sbjct: 161 VQIYVG-EIVLALEHLHKLG----IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215
Query: 874 --SVIAGSYGYIAP 885
G+ Y+AP
Sbjct: 216 RAYDFCGTIEYMAP 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 44/167 (26%), Positives = 73/167 (43%), Gaps = 26/167 (15%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWG-KHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
+LG G+ G V A P GEI+A+KK+ R L E+ +L + +H NI+
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR---TLREIKILKHFKHENIIT 73
Query: 774 LLGCCSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ--- 825
+ ++ E M LH + L + I + Q
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQML-----SDDHIQYFIYQTLR 123
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
+ LH + ++HRDLKPSN+L++ + +V DFG+A++I +
Sbjct: 124 AVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 7e-11
Identities = 41/193 (21%), Positives = 68/193 (35%), Gaps = 23/193 (11%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDV 762
+ L + K LG G+ G V +A+ G +AVK L K R +++E+ +
Sbjct: 22 DRLKL-GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKI 78
Query: 763 LGNV-RHRNIVRLLGCCSNREC-TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIA 820
L ++ H N+V LLG C+ M++ E+ GNL L +K
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKT-------- 130
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY 880
+G + + DLK + + + F K + E Y
Sbjct: 131 ----KGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY 186
Query: 881 GYIAPGTFCFCFS 893
C+S
Sbjct: 187 KDFLTLEHLICYS 199
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 18/54 (33%), Positives = 28/54 (51%), Gaps = 3/54 (5%)
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871
+ VA+G+ +L +HRDL NILL + ++ DFG+A+ I D
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 51/163 (31%), Positives = 84/163 (51%), Gaps = 19/163 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWG--KHKENIRRRRGVLAEVDVLGNVR-HRNI 771
K LG G+ G V+K+ + GE++AVKK++ ++ + +R E+ +L + H NI
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR---TFREIMILTELSGHENI 71
Query: 772 VRLLGCC--SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
V LL N L+++YM + LHA + L +Y + + + I Y
Sbjct: 72 VNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHK-QY-VVYQLIKVIKY 124
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872
LH ++HRD+KPSNILL+ E +VADFG+++ +
Sbjct: 125 LH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-10
Identities = 42/141 (29%), Positives = 58/141 (41%), Gaps = 11/141 (7%)
Query: 190 IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE-FASLVNL 248
IP++ + L L N +T P L L+ + +G N L +PV F SL L
Sbjct: 38 IPTNAQIL------YLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 249 KYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307
+D+ L+ LPS + L L+ L + N T E+P L L L L NQL
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
Query: 308 GPIPASLASLKGLTRLSLMNN 328
+ L LT L N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 45/147 (30%), Positives = 62/147 (42%), Gaps = 29/147 (19%)
Query: 297 QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLT 355
Q+L L DNQ++ P SL L L L +N L G +P + + L L L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
VLP + + L L +L + N T +P + +
Sbjct: 102 -VLPSAV------------FDRLV-----------HLKELFMCCNKLT-ELPRGIERLTH 136
Query: 416 LSRLRIQDNQLNGSIPQG-FGLLPNLT 441
L+ L + NQL SIP G F L +LT
Sbjct: 137 LTHLALDQNQLK-SIPHGAFDRLSSLT 162
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 35/162 (21%), Positives = 49/162 (30%), Gaps = 50/162 (30%)
Query: 411 VNCSSLS-------------RLRIQDNQLNGSIPQGFGLLPNLTFMDMSRN---SLSGEI 454
V+C S L + DNQ+ P F L NL + + N +L +
Sbjct: 24 VDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGV 83
Query: 455 PRDLGNAQ---------------------KLEYLNISENSFQTSLPSNIWSAPNLKILSA 493
L L+ L + N LP I +L L+
Sbjct: 84 FDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLAL 142
Query: 494 SSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCE 533
++L IP F S+ L N PWD CE
Sbjct: 143 DQNQLK-SIPHGAFDRLSSLTHAYLFGN------PWD---CE 174
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 40/204 (19%), Positives = 57/204 (27%), Gaps = 67/204 (32%)
Query: 58 SSEQEPVWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFD 115
S V C P + L L ++ P L +L L L +N
Sbjct: 18 SCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN--- 74
Query: 116 GPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNS 175
+L L P G+ F L
Sbjct: 75 --------QLGAL--------------PVGV-----------------------FDSLTQ 89
Query: 176 LQQLNLGGS--------YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERI 227
L L+LG + FD L L+ L + N LT LP + LT L +
Sbjct: 90 LTVLDLGTNQLTVLPSAVFD--------RLVHLKELFMCCNKLT-ELPRGIERLTHLTHL 140
Query: 228 EIGYNNLQGEVPVEFASLVNLKYM 251
+ N L+ F L +L +
Sbjct: 141 ALDQNQLKSIPHGAFDRLSSLTHA 164
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 8/166 (4%)
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
L+S+ + + + S+ + L + + +G N L ++ L NL Y+ +
Sbjct: 37 QNELNSIDQIIANNSDIK-SVQG-IQYLPNVRYLALGGNKLH-DISA-LKELTNLTYLIL 92
Query: 254 SACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPA 312
+ L +LP+ + LT L+ L+L +N + L L L+L+ NQL
Sbjct: 93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKG 151
Query: 313 SLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGV 357
L LT L L N L +P+ + + L L L L+ N L V
Sbjct: 152 VFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQLKSV 196
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 53/240 (22%)
Query: 55 SNPSSEQEPVWCSWSGIKCNPKSSQITSLD-LSRRSLSGPIPPEIRYLTSLTHLNLSAN- 112
+ +E + +++ S+D + + I+YL ++ +L L N
Sbjct: 15 DDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNK 74
Query: 113 -----AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLP 167
A LT L + ++ N + P G+ F
Sbjct: 75 LHDISALKE--------LTNLTYLILTGNQL-QSLPNGV---------------FDKLTN 110
Query: 168 LEFVQL--NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL---LT 222
L+ + L N LQ L G FD L++L +L+LA N L SLP G+ LT
Sbjct: 111 LKELVLVENQLQSLPDG--VFD--------KLTNLTYLNLAHNQLQ-SLPK--GVFDKLT 157
Query: 223 QLERIEIGYNNLQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKN 280
L +++ YN LQ +P F L LK + + L ++P + LT L+ + L N
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 53/222 (23%), Positives = 81/222 (36%), Gaps = 70/222 (31%)
Query: 52 PAFSNPSSEQEPVWCSWSGIKCNP---KSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLN 108
N + + + + S IK + L L L ++ LT+LT+L
Sbjct: 35 VTQ-NELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLI 91
Query: 109 LSAN--------AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L+ N FD LT L+ + + N + P G+
Sbjct: 92 LTGNQLQSLPNGVFDK--------LTNLKELVLVENQL-QSLPDGV-------------- 128
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGS--------YFDGEIPSDYRNLSSLRFLDLAGNSLTG 212
F +L +L LNL + FD L++L LDL+ N L
Sbjct: 129 ---------FDKLTNLTYLNLAHNQLQSLPKGVFD--------KLTNLTELDLSYNQLQ- 170
Query: 213 SLPPQLGL---LTQLERIEIGYNNLQGEVPVE-FASLVNLKY 250
SLP G+ LTQL+ + + N L+ VP F L +L+Y
Sbjct: 171 SLPE--GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQY 209
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 59.5 bits (143), Expect = 5e-09
Identities = 85/573 (14%), Positives = 159/573 (27%), Gaps = 204/573 (35%)
Query: 117 PLQPAILELTKLRTIDISHNSFNSTFPPG-ISKLRFLRIFNAYSNSFTGPLPLEFVQL-N 174
QP+++ + D +N N F +S+L+ +++L
Sbjct: 102 QRQPSMMTRMYIEQRDRLYND-NQVFAKYNVSRLQ------------------PYLKLRQ 142
Query: 175 SLQQLN---------LGGSYFDG------EIPSDYRNLSSLRF----LDLAGNSLTGSLP 215
+L +L + GS G ++ Y+ + F L+L N +
Sbjct: 143 ALLELRPAKNVLIDGVLGS---GKTWVALDVCLSYKVQCKMDFKIFWLNL-KNCNSPET- 197
Query: 216 PQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNL-TKLEM 274
+L L L L + S + S + I ++ +L
Sbjct: 198 ----VLEML-------QKL----------LYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236
Query: 275 LLLFKNHFTGEIPVSYGNLQALQVLD-LSDNQLSGPIPASLASLKGL--TRLSLMNNVLF 331
LL K + L VL + + + A S K L TR + + L
Sbjct: 237 LLKSKPY-----------ENCLLVLLNVQNAKA---WNAFNLSCKILLTTRFKQVTDFLS 282
Query: 332 GEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD- 390
I L TL + K L +P + +
Sbjct: 283 AATTTHISLDHHSMTL---------TPDEVKSLLLKYLDCRPQD------LPREVLTTNP 327
Query: 391 RLFKLI--LFSNNFTYSIPENL--VNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
R +I + + +N VNC L+ + ++ S
Sbjct: 328 RRLSIIAESIRDGL--ATWDNWKHVNCDKLTTI-----------------------IESS 362
Query: 447 RNSLSGEIPRDLGNAQKLEYLNISENSFQ--TSLPSN----IWSAP-------------N 487
N L R + + L++ F +P+ IW
Sbjct: 363 LNVLEPAEYRKM-----FDRLSV----FPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHK 413
Query: 488 LKILSASSSKLTGKIPDF---IGCKSIYKIELHNNLLN-------------GSIPWD--- 528
++ + T IP + K + LH ++++ D
Sbjct: 414 YSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYF 473
Query: 529 ---IGH----CE--------KLLLLNLS------RNSLTGIIPWEISG--LPSITDVDLS 565
IGH E +++ L+ R+ T W SG L ++ +
Sbjct: 474 YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST---AWNASGSILNTLQQLKFY 530
Query: 566 HNFLTGTIPSNFENCSTLESF--NVSYNLLTGP 596
++ P + + F + NL+
Sbjct: 531 KPYICDNDPKYERLVNAILDFLPKIEENLICSK 563
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 5e-08
Identities = 76/419 (18%), Positives = 135/419 (32%), Gaps = 99/419 (23%)
Query: 62 EPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLS-------ANAF 114
+P W S S N K + RR L Y L L L NAF
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----PYENCL--LVLLNVQNAKAWNAF 262
Query: 115 DGPLQPAILELTK----------LRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTG 164
+ L IL T+ T IS + + T P + Y +
Sbjct: 263 N--LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEV----KSLLLKYLDCRPQ 316
Query: 165 PLPLEFVQLNSLQQLNL-GGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPP------ 216
LP E + N + L++ S DG D +++++ + + +SL L P
Sbjct: 317 DLPREVLTTNPRR-LSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-VLEPAEYRKM 374
Query: 217 --QLGLL-------TQLERIEIGYNNLQGEVPVEFAS-LVNLKYMDISACNLSGTLPS-- 264
+L + T L + + + ++ + + L ++ + ++PS
Sbjct: 375 FDRLSVFPPSAHIPTIL--LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIY 432
Query: 265 -----EISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLAS-LK 318
++ N L ++ +H Y + DL L + + LK
Sbjct: 433 LELKVKLENEYALHRSIV--DH--------YNIPKTFDSDDLIPPYLDQYFYSHIGHHLK 482
Query: 319 GLT---RLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375
+ R++L V D + L QK+ + S
Sbjct: 483 NIEHPERMTLFRMVFL-----------DFR----F-------LEQKIRHDSTAWNASGSI 520
Query: 376 NSLTGPIP---PTICDGDRLFKLILFS-NNFTYSIPENLVNCSSLSRLRIQDNQLNGSI 430
+ + P ICD D ++ ++ + +F I ENL+ LRI + +I
Sbjct: 521 LNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 6e-06
Identities = 58/376 (15%), Positives = 114/376 (30%), Gaps = 112/376 (29%)
Query: 552 EISGLPSITDVDLSHNFLTGTIPSNFENCSTLESF-----NVSYNLLTGPIPASGTIFPN 606
I D L T+ S E ++ F ++Y L PI + P+
Sbjct: 53 HIIMSK---DAVSGTLRLFWTLLSKQEE--MVQKFVEEVLRINYKFLMSPI-KTEQRQPS 106
Query: 607 LHPSSFIGN-EGLC--GRVLTKPCPADGLAAGDV-------EVRNHQQQPKKTAGAIVWI 656
+ +I + L +V K +V ++R + + ++
Sbjct: 107 MMTRMYIEQRDRLYNDNQVFAK---------YNVSRLQPYLKLRQALLELRPAKNVLIDG 157
Query: 657 MAAAFGIGLFVLVAGTRCFRANYSRGFSNDREIGPWKLTAFQRLNF----TADDVLECL- 711
+ G G + C +Y D +I W LN + + VLE L
Sbjct: 158 VL---GSGKTWVALDV-C--LSYKVQCKMDFKIF-W-------LNLKNCNSPETVLEMLQ 203
Query: 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRR-------RRGVLAEVDVLG 764
+ +I + + I ++ + + +RR +L VL
Sbjct: 204 KLLYQIDPN------WTSRSDHSSNIKLRIHSIQAE--LRRLLKSKPYENCLL----VLL 251
Query: 765 NVRHRNIVRLLGCCSNRECTMLL---------------YEYMPNGNLDDLLHAKNKGENL 809
NV++ N C +LL ++ + L ++ ++L
Sbjct: 252 NVQNAKAWNAF----NLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLT-PDEVKSL 306
Query: 810 VADWV-TRYK----------------IALGVAQGIC----YLHHDCDPVIVHRDLKPS-N 847
+ ++ R + IA + G+ + H +CD + ++ S N
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLN 364
Query: 848 ILLDGEMEARVADFGV 863
+L E V
Sbjct: 365 VLEPAEYRKMFDRLSV 380
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 2e-04
Identities = 46/250 (18%), Positives = 81/250 (32%), Gaps = 68/250 (27%)
Query: 15 LVVFSANT-LPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPV---WCSWSG 70
L VF + +P L+SL+ W S+ V +S
Sbjct: 378 LSVFPPSAHIPTILLSLI----------------WFDVI-----KSDVMVVVNKLHKYSL 416
Query: 71 IKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSL-----THLNLSANAFDGPLQPAILE- 124
++ PK S I+ + ++ +L H N+ L P L+
Sbjct: 417 VEKQPKESTISIPSIYLELK-----VKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQ 471
Query: 125 ---------LTKLRTIDISHNSFNSTFPPGISKLRFLR---IFNAYSNSFTGPLPLEFVQ 172
L + + F F RFL ++ + + +G +
Sbjct: 472 YFYSHIGHHLKNIEHPE-RMTLFRMVF----LDFRFLEQKIRHDSTAWNASGSI------ 520
Query: 173 LNSLQQLNLGGSYFDGEIPSDYRNLSSL-RFLDLAGNSLTGSLPP-----QLGLLTQLER 226
LN+LQQL Y P R ++++ FL +L S ++ L+ + E
Sbjct: 521 LNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICS--KYTDLLRIALMAEDEA 578
Query: 227 I-EIGYNNLQ 235
I E + +Q
Sbjct: 579 IFEEAHKQVQ 588
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 42/194 (21%), Positives = 78/194 (40%), Gaps = 38/194 (19%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR------- 767
+ LG G TV+ A+ M +A+K + + + E+ +L V
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 768 ----HRNIVRLL------GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRY 817
+I++LL G +++E + NL L+ K + + +V
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVV--MVFEVL-GENLLALIK-KYEHRGIPLIYV--K 134
Query: 818 KIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA------RVADFGVAKLIQSDE 871
+I+ + G+ Y+H C I+H D+KP N+L++ ++AD G A DE
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDE 190
Query: 872 SMSVIAGSYGYIAP 885
+ + Y +P
Sbjct: 191 HYTNSIQTREYRSP 204
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 35/136 (25%), Positives = 47/136 (34%), Gaps = 28/136 (20%)
Query: 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253
Y N R LDL G ++ IE NL A+L +D
Sbjct: 15 YTNAVRDRELDLRGY--------------KIPVIE----NLG-------ATLDQFDAIDF 49
Query: 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP-IPA 312
S + L +L+ LL+ N L L L L++N L
Sbjct: 50 SDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLD 107
Query: 313 SLASLKGLTRLSLMNN 328
LASLK LT L ++ N
Sbjct: 108 PLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 9e-06
Identities = 10/100 (10%), Positives = 35/100 (35%), Gaps = 3/100 (3%)
Query: 495 SSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEIS 554
+++L + + +++L + I ++ ++ S N + + +
Sbjct: 5 TAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP-- 61
Query: 555 GLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
L + + +++N + + L ++ N L
Sbjct: 62 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 7e-04
Identities = 23/112 (20%), Positives = 35/112 (31%), Gaps = 4/112 (3%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L+L ++ L + ID S N G LR L+ +N
Sbjct: 18 AVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNN 74
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDY-RNLSSLRFLDLAGNSLT 211
L L +L L + D +L SL +L + N +T
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 126
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 2e-08
Identities = 21/185 (11%), Positives = 48/185 (25%), Gaps = 39/185 (21%)
Query: 718 LGMGSTGTVYKAEMPGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVL---------G 764
+G G G V++ IIA++ + + + +L E+ +
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 765 NVRHRNIVRLLGCCSNR----ECTMLLYEYMPNGN--------------------LDDLL 800
R + L + + +++ + +
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 801 HAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860
+ ++ T I + + HRDL N+LL ++
Sbjct: 148 IDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHY 205
Query: 861 FGVAK 865
K
Sbjct: 206 TLNGK 210
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 49/179 (27%), Positives = 74/179 (41%), Gaps = 20/179 (11%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR----- 769
++G GS G V KA E +A+K + K EV +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII----KNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 770 -NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
IV L R L++E + + NL DLL +N V+ +TR K A + +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLL--RNTNFRGVSLNLTR-KFAQQMCTALL 171
Query: 829 YLHHDCDPVIVHRDLKPSNILL--DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+L + I+H DLKP NILL ++ DFG + Q + + S Y +P
Sbjct: 172 FLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSP 227
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 30/135 (22%), Positives = 55/135 (40%), Gaps = 7/135 (5%)
Query: 297 QVLDLSDNQLSG-PIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHL 354
L L++N+ + L L +++ NN + +I + E + ++ +LL +N L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI-TDIEEGAFEGASGVNEILLTSNRL 93
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPEN-LVN 412
V + L T+ + SN +T + G + L L+ N T ++
Sbjct: 94 ENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDT 151
Query: 413 CSSLSRLRIQDNQLN 427
SLS L + N N
Sbjct: 152 LHSLSTLNLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 24/112 (21%), Positives = 47/112 (41%), Gaps = 4/112 (3%)
Query: 267 SNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSL 325
L +L + N T +I ++ + + L+ N+L L+ L L L
Sbjct: 54 KKLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLML 112
Query: 326 MNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSN 376
+N + + D L+ + L L++N +T V P + L T+++ +N
Sbjct: 113 RSNRI-TCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 8e-07
Identities = 38/206 (18%), Positives = 68/206 (33%), Gaps = 58/206 (28%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAIL-ELTKLRTIDISHNSFN 139
T++D S + L+ IP I L L+ N F I +L +LR I+ S+N
Sbjct: 14 TTVDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKI- 69
Query: 140 STFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSS 199
+ G F+G S
Sbjct: 70 TDIEEGA---------------------------------------FEG--------ASG 82
Query: 200 LRFLDLAGNSLTGSLPPQL-GLLTQLERIEIGYNNLQGEVPVE-FASLVNLKYMDISACN 257
+ + L N L ++ ++ L L+ + + N + V + F L +++ + +
Sbjct: 83 VNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQ 140
Query: 258 LSGTLPSEI-SNLTKLEMLLLFKNHF 282
++ T+ L L L L N F
Sbjct: 141 IT-TVAPGAFDTLHSLSTLNLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 32/174 (18%), Positives = 62/174 (35%), Gaps = 43/174 (24%)
Query: 411 VNCSSLS-------------RLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPR 456
V+CS+ LR+ +N+ G F LP L ++ S N ++ +I
Sbjct: 16 VDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEE 74
Query: 457 D-LGNAQKLEYLNISENSFQTSLPSNI-WSAPNLKILSASSSKLTGKIPDFIGCKSIYKI 514
A + + ++ N + ++ + +LK L
Sbjct: 75 GAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLM---------------------- 111
Query: 515 ELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
L +N + + D + LL+L N +T + P L S++ ++L N
Sbjct: 112 -LRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/188 (18%), Positives = 59/188 (31%), Gaps = 55/188 (29%)
Query: 66 CSWSGIKCNPKS---------SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSAN--- 112
C + + C+ + L L+ + I + L L +N S N
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 113 -----AFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLP 167
AF+G + + I ++ N +
Sbjct: 71 DIEEGAFEG--------ASGVNEILLTSNRL-ENVQHKM--------------------- 100
Query: 168 LEFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLE 225
F L SL+ L L + + +D + LSS+R L L N +T ++ P L L
Sbjct: 101 --FKGLESLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLS 156
Query: 226 RIEIGYNN 233
+ + N
Sbjct: 157 TLNL-LAN 163
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 6e-08
Identities = 27/100 (27%), Positives = 42/100 (42%), Gaps = 3/100 (3%)
Query: 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS 289
+ G++ A VNL+++ + L S + L KL+ L L +N G + +
Sbjct: 33 NCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDML 90
Query: 290 YGNLQALQVLDLSDNQLSGP-IPASLASLKGLTRLSLMNN 328
L L L+LS N+L L L+ L L L N
Sbjct: 91 AEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 25/137 (18%), Positives = 44/137 (32%), Gaps = 28/137 (20%)
Query: 173 LNSLQQLNLGGSYFD-GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY 231
++++L L + G+I +L FL L L +
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--------------SVSN-- 66
Query: 232 NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY- 290
L LK +++S + G L L L L L N +
Sbjct: 67 ----------LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL 116
Query: 291 GNLQALQVLDLSDNQLS 307
L+ L+ LDL + +++
Sbjct: 117 KKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 21/83 (25%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 513 KIELHNNLLN-GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG 571
++ L N N G I L L+L L + + LP + ++LS N + G
Sbjct: 28 ELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENRIFG 85
Query: 572 TIPSNFENCSTLESFNVSYNLLT 594
+ E L N+S N L
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 8e-05
Identities = 35/139 (25%), Positives = 49/139 (35%), Gaps = 7/139 (5%)
Query: 316 SLKGLTRLSLMNNVL-FGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVS 374
+ + L L N G+I +L+ L L N L V L KL +++S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 375 SNSLTGPIPPTICDGDRLFKLILFSNNFT-YSIPENLVNCSSLSRLRIQDN---QLNGSI 430
N + G + L L L N S E L L L + + LN
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR 139
Query: 431 PQGFGLLPNLTFMDMSRNS 449
F LLP LT++D
Sbjct: 140 ESVFKLLPQLTYLDGYDRE 158
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 4/114 (3%)
Query: 268 NLTKLEMLLLFKNHFT-GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
+ L+L G+I L+ L L + L ++L L L +L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI--SVSNLPKLPKLKKLELS 79
Query: 327 NNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP-QKLGSNGKLLTVDVSSNSLT 379
N +FG + E L +L L L N L + + L L ++D+ + +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 20/91 (21%), Positives = 33/91 (36%), Gaps = 7/91 (7%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
I +L L + + L S+ LP L +++S N + G + L
Sbjct: 40 KIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNL 97
Query: 465 EYLNISENSFQTSLPSNIW---SAPNLKILS 492
+LN+S N + S + LK L
Sbjct: 98 THLNLSGNKLKD--ISTLEPLKKLECLKSLD 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-08
Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 3/87 (3%)
Query: 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
L+++ L+ + + L KL+ L L N +G + V L L+LS
Sbjct: 39 DEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLS 96
Query: 303 DNQLSGP-IPASLASLKGLTRLSLMNN 328
N++ L L+ L L L N
Sbjct: 97 GNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 21/88 (23%), Positives = 37/88 (42%), Gaps = 3/88 (3%)
Query: 508 CKSIYKIELHNNLLN-GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSH 566
+ ++ L N+ N G + E+L L+ LT I + L + ++LS
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIAN--LPKLNKLKKLELSD 73
Query: 567 NFLTGTIPSNFENCSTLESFNVSYNLLT 594
N ++G + E C L N+S N +
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIK 101
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 3/89 (3%)
Query: 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
+ L L + L SI L L +++S N +SG + L
Sbjct: 33 KLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNL 90
Query: 465 EYLNISENSFQT-SLPSNIWSAPNLKILS 492
+LN+S N + S + NLK L
Sbjct: 91 THLNLSGNKIKDLSTIEPLKKLENLKSLD 119
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR---- 769
K++G GS G V KA + +A+K + + R R E+ +L ++R +
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMV----RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 770 --NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGVAQG 826
N++ +L + R + +E + + NL +L+ K +G +L R K A + Q
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPL---VR-KFAHSILQC 212
Query: 827 ICYLHHDCDPVIVHRDLKPSNILL--DGEMEARVADFGVA 864
+ LH I+H DLKP NILL G +V DFG +
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 1e-07
Identities = 28/171 (16%), Positives = 60/171 (35%), Gaps = 19/171 (11%)
Query: 173 LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG--LLTQLERIEI- 229
L+++ LN + + +L+ L++ L S+ + L LE++ +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 230 -GYNNLQGEVPVEF-------ASLVNLKYMDISACNLSGTLPSEISN---LTKLEMLLLF 278
G + + + NLK++ I + L +LE + +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 279 KNHFTGE----IPVSYGNLQALQVLDLSDNQLSGPIPASLA-SLKGLTRLS 324
T E + ++ L+ +++ N LS + L SL +S
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 5e-04
Identities = 30/179 (16%), Positives = 54/179 (30%), Gaps = 26/179 (14%)
Query: 439 NLTFMDMSRNSLS----GEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSAS 494
+D +S ++ L L L I +L PNLK L
Sbjct: 145 FWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGT---NNLSIGKKPRPNLKSLEII 201
Query: 495 SSKLTGKIPDFIG---CKSIYKIELH---NNLLNGSIPWDI------GHCEKLLLLNLSR 542
S L + + I ++ K+ L+ + L L +
Sbjct: 202 SGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVD 261
Query: 543 NSLTGIIPWEISG---LPSITDVDLSHNFLTGT----IPSNFENCSTLESFNVSYNLLT 594
++ LP + +D+S LT + + + L+ N+ YN L+
Sbjct: 262 AEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 8e-04
Identities = 31/189 (16%), Positives = 70/189 (37%), Gaps = 25/189 (13%)
Query: 293 LQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI--ELLADLDTLLLW 350
L A+ +L+ + + + L L +++ L + +DI L +L+ L+L+
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 351 NNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENL 410
+ G ++V + P L L + + E
Sbjct: 228 VG---------VEDYGFDGDMNVFRPLFSKDRFP------NLKWLGIVDAEEQNVVVEMF 272
Query: 411 VNCSSLSRLRIQD---NQLNGS----IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQK 463
+ L +L D L + + +L F++M N LS E+ ++L +
Sbjct: 273 LESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLP 332
Query: 464 LEYLNISEN 472
++ +++S++
Sbjct: 333 MK-IDVSDS 340
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 57/515 (11%), Positives = 154/515 (29%), Gaps = 56/515 (10%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYS 159
+ + ++ K+R++++ + F + + +
Sbjct: 40 IERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADF--NLVPDGWGGYVYPWI 97
Query: 160 NSFTGPLPLEFVQLNSLQQLNLGGSYF-DGEIPSDYRNLSSLRFLDLAGNSL--TGSLPP 216
+ + L+++ L D + ++ + + L L+ T L
Sbjct: 98 EAMSSSYT-------WLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAA 150
Query: 217 QLGLLTQLERIEIGYNNLQGEVPVEFASLV----NLKYMDISACNLSGT---LPSEISNL 269
L+ +++ +++ + +L ++IS + L ++
Sbjct: 151 IAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRC 210
Query: 270 TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS------DNQLSGPIPASLASLKGLTRL 323
L+ L L + ++ L+ L + + +L+ K L L
Sbjct: 211 PNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCL 270
Query: 324 SLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIP 383
S + + +P + + L TL L + KL L + +
Sbjct: 271 SGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGL 330
Query: 384 PTICDGDR-LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTF 442
+ + L +L +F + P + L + P L
Sbjct: 331 EVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV--------------SMGCPKLES 376
Query: 443 MDMSRNSLSGEIPRDLG-NAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGK 501
+ ++ + N + + + L+ L +
Sbjct: 377 VLYFCRQMTNAALITIARNRPNMTRFRLC------IIEPKAPDYLTLEPLDIGFGAIVE- 429
Query: 502 IPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI-IPWEISGLPSIT 560
CK + ++ L L + + + +K+ +L+++ + + + +SG S+
Sbjct: 430 -----HCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLR 484
Query: 561 DVDLSH-NFLTGTIPSNFENCSTLESFNVSYNLLT 594
+++ F + +N T+ S +S ++
Sbjct: 485 KLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 59/410 (14%), Positives = 130/410 (31%), Gaps = 48/410 (11%)
Query: 78 SQITSLDLSRRSLSGPIPPEIRYL----TSLTHLNLSANAF---DGPLQPAILELTKLRT 130
+ LDL + + + TSL LN+S A L+ + L++
Sbjct: 156 RNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 131 IDISHNSFNSTFPPGISKLRFLRIFNAYS------NSFTGPLPLEFVQLNSLQQLNLGGS 184
+ ++ + + L L + L+ L+
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFA 243
+P+ Y S L L+L+ ++ L L +L+R+ + + V +
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAS 335
Query: 244 SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSD 303
+ +L+ + + + LT+ ++ + L+ +
Sbjct: 336 TCKDLRELRVFPSE--PFVMEPNVALTEQGLVSVSM------------GCPKLESVLYFC 381
Query: 304 NQLSGPIPASLA-SLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKL 362
Q++ ++A + +TR L + + + +
Sbjct: 382 RQMTNAALITIARNRPNMTRFRLC--------------IIEPKAPDYLTLEPLDIGFGAI 427
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSN-NFT-YSIPENLVNCSSLSRLR 420
+ K L S LT + I + +++ + + + L C SL +L
Sbjct: 428 VEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLE 487
Query: 421 IQD-NQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNI 469
I+D + ++ L + + MS S+S + L QK+ LN+
Sbjct: 488 IRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLL--GQKMPKLNV 535
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 61/459 (13%), Positives = 141/459 (30%), Gaps = 60/459 (13%)
Query: 171 VQLNSLQQLNLGGSY--FDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228
++ +++ +G Y + + + S+ + +P G
Sbjct: 40 IERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEA 99
Query: 229 IGYNNLQGEVPVEFASLVNLKYMDISACNLS-GTLPSEISNLTKLEMLLLFK-NHFTGE- 285
+ +S L+ + + ++ L + ++L+L F+ +
Sbjct: 100 M------------SSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDG 147
Query: 286 IPVSYGNLQALQVLDLSDNQLSGPIPASLASL----KGLTRLSLMNNVLFGEI-PQDIEL 340
+ + L+ LDL ++ + L+ L L++ L E+ +E
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISC--LASEVSFSALER 205
Query: 341 LAD----LDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLI 396
L L +L L L L +L + + D L
Sbjct: 206 LVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTA-------EVRPDVYSGLS 258
Query: 397 LFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGE-IP 455
L C L L + + +P + + LT +++S ++ +
Sbjct: 259 -----------VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLV 307
Query: 456 RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILS-ASSSKLTGKIPDFIGCKSIYKI 514
+ L KL+ L + + L + +L+ L S + + + + +
Sbjct: 308 KLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV 367
Query: 515 ELHNNLLNGSIPWDIGHCEK-----LLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFL 569
+ L S+ + C + L+ + +R ++T + + L+ L
Sbjct: 368 SMGCPKLE-SV---LYFCRQMTNAALITIARNRPNMTRF---RLCIIEPKAPDYLTLEPL 420
Query: 570 TGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLH 608
+ E+C L ++S L GT +
Sbjct: 421 DIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKME 459
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 4e-07
Identities = 26/137 (18%), Positives = 54/137 (39%), Gaps = 25/137 (18%)
Query: 408 ENLVNCSSLS-------------RLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEI 454
+ +V CS+ L + NQ +P+ +LT +D+S N +S
Sbjct: 12 DTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLS 70
Query: 455 PRDLGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPD--FIGCKSI 511
+ N +L L +S N + +P + +L++LS + ++ +P+ F ++
Sbjct: 71 NQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSAL 128
Query: 512 YKIELHNNLLNGSIPWD 528
+ + N P
Sbjct: 129 SHLAIGAN------PLY 139
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 27/109 (24%), Positives = 52/109 (47%), Gaps = 11/109 (10%)
Query: 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL---LTQLERIEIGYNN 233
+L L G+ F +P + N L +DL+ N ++ +L +TQL + + YN
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLLTLILSYNR 89
Query: 234 LQGEVPVE-FASLVNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKN 280
L+ +P F L +L+ + + ++S +P ++L+ L L + N
Sbjct: 90 LR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 32/116 (27%), Positives = 46/116 (39%), Gaps = 16/116 (13%)
Query: 254 SACNLSGT-----------LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302
+ C T LP I L L N FT +P N + L ++DLS
Sbjct: 6 TECTCLDTVVRCSNKGLKVLPKGIPRDV--TELYLDGNQFT-LVPKELSNYKHLTLIDLS 62
Query: 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGV 357
+N++S S +++ L L L N L IP + L L L L N ++ V
Sbjct: 63 NNRISTLSNQSFSNMTQLLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDISVV 117
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 29/135 (21%), Positives = 57/135 (42%), Gaps = 25/135 (18%)
Query: 411 VNCSSLS-------------RLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPR 456
V+C+ L + DN+L G FG LP+L +++ RN L+G P
Sbjct: 13 VDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPN 72
Query: 457 DLGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPD--FIGCKSIYK 513
A ++ L + EN + + + ++ LK L+ ++++ + F S+
Sbjct: 73 AFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTS 130
Query: 514 IELHNNLLNGSIPWD 528
+ L +N P++
Sbjct: 131 LNLASN------PFN 139
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 29/123 (23%), Positives = 50/123 (40%), Gaps = 8/123 (6%)
Query: 209 SLTGSLPPQLGLLTQLERIEIGYNNLQGEVPV-EFASLVNLKYMDISACNLSGTLPSEI- 266
L +P + + + N L F L +L +++ L+ +
Sbjct: 19 GLK-EIPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAF 74
Query: 267 SNLTKLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSL 325
+ ++ L L +N EI + L L+ L+L DNQ+S +P S L LT L+L
Sbjct: 75 EGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 326 MNN 328
+N
Sbjct: 134 ASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 17/115 (14%)
Query: 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL---LTQLERIE 228
N L +++ G F L L L+L N LT + P + ++ ++
Sbjct: 37 NDNELGRISSDGL-FGR--------LPHLVKLELKRNQLT-GIEP--NAFEGASHIQELQ 84
Query: 229 IGYNNLQGEVPVE-FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHF 282
+G N ++ E+ + F L LK +++ +S +P +L L L L N F
Sbjct: 85 LGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPF 138
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 40/184 (21%), Positives = 77/184 (41%), Gaps = 22/184 (11%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA-EVDVLGNVRH-RNI 771
+ +G GS G +Y + GE +A+K E ++ + L E + ++ I
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKL------ECVKTKHPQLHIESKIYKMMQGGVGI 67
Query: 772 VRLLGCCSNRECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ C + + +++ E + G +L+DL + ++ +L T +A + I Y+
Sbjct: 68 PTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLK----TVLLLADQMISRIEYI 121
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEA---RVADFGVAKLIQSDESMSVIAGSYGYIAPGT 887
H +HRD+KP N L+ + + DFG+AK + + I GT
Sbjct: 122 HSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 888 FCFC 891
+
Sbjct: 179 ARYA 182
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 9e-07
Identities = 35/194 (18%), Positives = 70/194 (36%), Gaps = 39/194 (20%)
Query: 168 LEFVQLNSLQQLNLGGSYFD-GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLER 226
+ V +++ L G ++ + L + + L L+ N +E+
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTN--------------NIEK 62
Query: 227 IEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNL----TKLEMLLLFKNHF 282
I +L G + NL+ + + + +I NL LE L + N
Sbjct: 63 IS----SLSG--------MENLRILSLGRNLIK-----KIENLDAVADTLEELWISYNQI 105
Query: 283 TGEIPVSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFGEIPQDIELL 341
+ L L+VL +S+N+++ LA+L L L L N L+ + ++
Sbjct: 106 ASLSGIE--KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATS 163
Query: 342 ADLDTLLLWNNHLT 355
++ +L
Sbjct: 164 EYRIEVVKRLPNLK 177
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 7e-06
Identities = 23/156 (14%), Positives = 54/156 (34%), Gaps = 34/156 (21%)
Query: 445 MSRNSLSGEIPRDLGNAQKLEYLNISENSFQ------TSLPSNIWSAPNLKILSASSSKL 498
M++ + + R + + + + + + + K L+ S++
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNN- 59
Query: 499 TGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPS 558
I KI + E L +L+L RN + I + + +
Sbjct: 60 ------------IEKIS------------SLSGMENLRILSLGRNLIKKIENLD-AVADT 94
Query: 559 ITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
+ ++ +S+N + ++ S E L +S N +T
Sbjct: 95 LEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 17/108 (15%), Positives = 36/108 (33%), Gaps = 5/108 (4%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN-LVNCSSLSRLRIQDNQLNG 428
+ + + + + L +L + + + L L L I + L
Sbjct: 12 GLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR- 69
Query: 429 SIPQG-FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
+ F P L+ +++S N+L + L+ L +S N
Sbjct: 70 FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 4e-06
Identities = 21/95 (22%), Positives = 37/95 (38%), Gaps = 2/95 (2%)
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIP-QDIELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368
L + LT L + N + +D+ L +L L + + L V P +L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 369 LTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFT 403
+++S N+L + G L +L+L N
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 7e-06
Identities = 26/118 (22%), Positives = 40/118 (33%), Gaps = 7/118 (5%)
Query: 72 KCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQP-AILELTKLRT 130
C P S + L +R + +LT L + L+ + L +LR
Sbjct: 4 ACCPHGS--SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN 60
Query: 131 IDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD 187
+ I + P L N N+ L + VQ SLQ+L L G+
Sbjct: 61 LTIVKSGL-RFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.8 bits (113), Expect = 9e-06
Identities = 18/96 (18%), Positives = 29/96 (30%), Gaps = 2/96 (2%)
Query: 261 TLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSGPIPASLASLKG 319
+ L L + + L L+ L + + L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 320 LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
L+RL+L N L + L L+L N L
Sbjct: 82 LSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 21/111 (18%), Positives = 36/111 (32%), Gaps = 2/111 (1%)
Query: 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPR-DLGNAQKLEYLNISE 471
S LR + NLT + + + DL +L L I +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522
+ + P P L L+ S + L + S+ ++ L N L+
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 5e-04
Identities = 19/128 (14%), Positives = 33/128 (25%), Gaps = 28/128 (21%)
Query: 109 LSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPL 168
A D + L + I +
Sbjct: 16 TRDGALDSL--HHLPGAENLTELYIENQQHLQHLELRD---------------------- 51
Query: 169 EFVQLNSLQQLNLGGSYFDGEIPSD-YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERI 227
L L+ L + S + D + L L+L+ N+L SL + L+ +
Sbjct: 52 -LRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQEL 108
Query: 228 EIGYNNLQ 235
+ N L
Sbjct: 109 VLSGNPLH 116
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/328 (13%), Positives = 95/328 (28%), Gaps = 71/328 (21%)
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLG-----LLTQLERIEIGYNNLQGEVPVEFASLVNLK 249
+ LDL+ N+L +L + + + N+L
Sbjct: 19 SIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLG-------------- 64
Query: 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGE-----IPVSYGNLQALQVLDLSDN 304
++ L L + +N+T L L N + + + + VLDL N
Sbjct: 65 --FKNSDELVQILAAIPANVTSLN---LSGNFLSYKSSDELVKTLAAIPFTITVLDLGWN 119
Query: 305 QLSGPIPASLASL-----KGLTRLSLMNNVLFGEIPQDIELLAD--------LDTLLLWN 351
S + +T L+L N L G + + L +++L L
Sbjct: 120 DFSSKSSSEFKQAFSNLPASITSLNLRGNDL-GI--KSSDELIQILAAIPANVNSLNLRG 176
Query: 352 NHLTGVLPQKLGS-----NGKLLTVDVSSNSLTGPIPPTICDG-----DRLFKLILFSNN 401
N+L +L + ++D+S+N L + + + L L N
Sbjct: 177 NNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNC 236
Query: 402 FTYS----IPENLVNCSSLSRLRIQDNQLNGSIPQGFGLL-------PNLTFMDMSRNSL 450
+ + L + + + + + L + +D + +
Sbjct: 237 LHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
Query: 451 SGEIPRDLGNA-----QKLEYLNISENS 473
+ N K + ++
Sbjct: 297 HPSHSIPISNLIRELSGKADVPSLLNQC 324
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 43/296 (14%), Positives = 101/296 (34%), Gaps = 61/296 (20%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASL-----KGLTRLSLMNNVLFGEIPQDIELLADLDT 346
+ LDLS N L L +T L+L N L ++ + L +
Sbjct: 20 IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL---GFKNSDELVQI-- 74
Query: 347 LLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-----DRLFKLILFSNN 401
L ++T ++++S N L+ + + L L N+
Sbjct: 75 LAAIPANVT--------------SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWND 120
Query: 402 FTYS----IPENLVNC-SSLSRLRIQDNQLNG----SIPQGFGLLP-NLTFMDMSRNSLS 451
F+ + N +S++ L ++ N L + Q +P N+ +++ N+L+
Sbjct: 121 FSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
Query: 452 GEIPRDLGNA-----QKLEYLNISENSFQTSLPSNIWSA-----PNLKILSASSSKLTGK 501
+ +L + L++S N + + ++ L+ + L G
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGP 240
Query: 502 IPDFIG-----CKSIYKIELHNNLLNGSIPWD-------IGHCEKLLLLNLSRNSL 545
+ + K + + L +++ + +K++L++ + +
Sbjct: 241 SLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 56/387 (14%), Positives = 121/387 (31%), Gaps = 92/387 (23%)
Query: 102 TSLTHLNLSANAFDGPLQPAILEL-----TKLRTIDISHNSFNSTFPPGISKL-RFLRIF 155
+T L+LS N +++ + ++++S NS +L + L
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFK---NSDELVQILAAI 78
Query: 156 NAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE-----IPSDYRNLSSLRFLDLAGNSL 210
A ++ LNL G++ + + + ++ LDL N
Sbjct: 79 PA-----------------NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDF 121
Query: 211 TGSLPPQLGLL-----TQLERIEIGYNNLQGEVPVEFASL-----VNLKYMDISACN--- 257
+ + + + + N+L + E + N+ +++ N
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181
Query: 258 -----LSGTLPSEISNLTKLEMLLLFKNHFTGE-----IPVSYGNLQALQVLDLSDNQLS 307
L+ L S +++T L+ L N + + + L+L N L
Sbjct: 182 KNCAELAKFLASIPASVTSLD---LSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLH 238
Query: 308 GP----IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLG 363
GP + SLK L + L +++ + + L
Sbjct: 239 GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAA-----------------FP 281
Query: 364 SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQD 423
+ K++ VD + + I + + + +P +L+N + + Q
Sbjct: 282 NIQKIILVDKNGKEIHPSHSIPISNL-------IRELSGKADVP-SLLNQCLIFAQKHQT 333
Query: 424 NQLNGSIPQGFGLLPNLTFMDMSRNSL 450
N + +IP L + L
Sbjct: 334 NIEDLNIPD------ELRESIQTCKPL 354
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 35/127 (27%), Positives = 52/127 (40%), Gaps = 7/127 (5%)
Query: 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLP 263
LT S+P G+ + R+E+ N LQ F L L + +S + +LP
Sbjct: 13 RCNSKGLT-SVPT--GIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLP 68
Query: 264 SEI-SNLTKLEMLLLFKNHFTGEIPVS-YGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321
+ LTKL +L L +N +P + L L+ L L NQL L L
Sbjct: 69 DGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQ 127
Query: 322 RLSLMNN 328
++ L N
Sbjct: 128 KIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 40/135 (29%), Positives = 60/135 (44%), Gaps = 26/135 (19%)
Query: 411 VNCSSLS-------------RLRIQDNQLNGSIPQG-FGLLPNLTFMDMSRNSLSGEIPR 456
+ C+S RL ++ N+L S+P G F L LT + +S+N +
Sbjct: 12 IRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70
Query: 457 DLGNAQKLEYLNISENSFQTSLPSNIW-SAPNLKILSASSSKLTGKIPD--FIGCKSIYK 513
KL L + EN Q SLP+ ++ LK L+ +++L +PD F S+ K
Sbjct: 71 VFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQK 128
Query: 514 IELHNNLLNGSIPWD 528
I LH N PWD
Sbjct: 129 IWLHTN------PWD 137
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 38/184 (20%), Positives = 75/184 (40%), Gaps = 22/184 (11%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA-EVDVLGNVR-HRNI 771
+ +G GS G +Y + E +A+K EN++ + L E + ++ I
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKL------ENVKTKHPQLLYESKIYRILQGGTGI 65
Query: 772 VRLLGCCSNRECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ + +L+ + + G +L+DL + ++ +L T +A + + ++
Sbjct: 66 PNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLK----TVLMLADQMINRVEFV 119
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEAR---VADFGVAKLIQSDESMSVIAGSYGYIAPGT 887
H +HRD+KP N L+ A + DFG+AK + + I GT
Sbjct: 120 H---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 888 FCFC 891
+
Sbjct: 177 ARYA 180
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 34/186 (18%), Positives = 68/186 (36%), Gaps = 24/186 (12%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLA-EVDVLGNVRH-RNI 771
+ +G GS G +++ + + +A+K E R L E + I
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQVAIKF------EPRRSDAPQLRDEYRTYKLLAGCTGI 68
Query: 772 VRLLGCCSNRECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ +L+ + + G +L+DLL + ++ T A + + +
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVK----TVAMAAKQMLARVQSI 122
Query: 831 HHDCDPVIVHRDLKPSNILL---DGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
H +V+RD+KP N L+ + + + DFG+ K + + I
Sbjct: 123 HEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 886 GTFCFC 891
GT +
Sbjct: 180 GTARYM 185
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 8e-06
Identities = 76/526 (14%), Positives = 150/526 (28%), Gaps = 97/526 (18%)
Query: 98 IRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157
R +L L L G + A+ L + + +L+ + F
Sbjct: 69 SRRFPNLRSLKLK-----GKPRAAMFNLIPENWGGYVTPWV-TEISNNLRQLKSVH-FRR 121
Query: 158 YSNSFTGPLPLEFVQLNSLQQLNLGG--SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLP 215
S L + + L+ L L + + S + ++ L + +S +
Sbjct: 122 MIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDG 181
Query: 216 PQLGLL----TQLERIEIGYNNLQGEVPVEFASLV----NLKYMDISACNLSGTLPSEIS 267
L L T LE + P + ++ +L + + + L
Sbjct: 182 KWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEIL-ELVGFFK 240
Query: 268 NLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP--IPASLASLKGLTRLSL 325
LE + +P Y NL + L GP +P + +L L
Sbjct: 241 AAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDL 300
Query: 326 MNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPT 385
+ +L T + L ++ +
Sbjct: 301 LYALL-----------------------ETEDHCTLIQKCPNLEVLETRN---------- 327
Query: 386 ICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDM 445
GDR +++ C L RLRI+ + GL+ + +
Sbjct: 328 -VIGDRGLEVLAQ-------------YCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373
Query: 446 SRNSLSGEIPRDLGNAQKLEYLNISENSF-QTSLPSNIWSAPNLKILS----ASSSKLTG 500
++ Q+LEY+ + + SL S NL ++T
Sbjct: 374 AQG------------CQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITD 421
Query: 501 KIPD------FIGCKSIYKIELHNN--LLNGSIPWDIG-HCEKLLLLNLSRNSLT--GII 549
D IGCK + + + L IG + + + L + G++
Sbjct: 422 LPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLM 481
Query: 550 PWEISGLPSITDVDLSHNFLT-GTIPSNFENCSTLESFNVSYNLLT 594
+ G P++ +++ + I + +L V +
Sbjct: 482 EF-SRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 30/282 (10%), Positives = 77/282 (27%), Gaps = 30/282 (10%)
Query: 75 PKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDIS 134
+ S+ + + + + +L + D + + L R +
Sbjct: 217 RNCRSLVSVKVGDFEILELVGF-FKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 135 HNSF--NSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQ-LNSLQQLNLGGSYFDGEIP 191
S+ + P +R + +Q +L+ L D +
Sbjct: 276 GLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQLGLLT------------QLERIEIGYNNLQGEVP 239
+ L+ L + + + + GL++ +LE + + +++ E
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 240 VEFAS----LVNLKYMDISACNLSGTLPSE------ISNLTKLEMLLLFKN--HFTGEIP 287
+ L + + + + LP + + KL + T
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455
Query: 288 VSYG-NLQALQVLDLSDNQLSGP-IPASLASLKGLTRLSLMN 327
G ++ + L S + L +L +
Sbjct: 456 SYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 38/209 (18%), Positives = 75/209 (35%), Gaps = 11/209 (5%)
Query: 76 KSSQITSLDLSRRSLS-GPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDIS 134
++ +DLS + + + + L +L+L P+ + + + L +++S
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 135 HNSF--NSTFPPGISKLRFLRIFN-AYSNSFTGPLPLEFVQLN--SLQQLNLGGSYF--- 186
S +S L N ++ FT V ++ QLNL G
Sbjct: 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 210
Query: 187 DGEIPSDYRNLSSLRFLDLAG-NSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFAS 244
++ + R +L LDL+ L + L L+ + + ++ E +E
Sbjct: 211 KSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 270
Query: 245 LVNLKYMDISACNLSGTLPSEISNLTKLE 273
+ LK + + GTL L L+
Sbjct: 271 IPTLKTLQVFGIVPDGTLQLLKEALPHLQ 299
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 45/228 (19%), Positives = 78/228 (34%), Gaps = 16/228 (7%)
Query: 391 RLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSL 450
R + + + P + + LS I+ + L+G + Q L + + L
Sbjct: 76 RCPRSFMDQPLAEHFSPFRVQHMD-LSNSVIEVSTLHGILSQ----CSKLQNLSLEGLRL 130
Query: 451 SGEIPRDLGNAQKLEYLNISENSFQT--SLPSNIWSAPNLKILSASS-SKLTGKIPDFI- 506
S I L L LN+S S + +L + + S L L+ S T K
Sbjct: 131 SDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190
Query: 507 --GCKSIYKIEL---HNNLLNGSIPWDIGHCEKLLLLNLSR-NSLTGIIPWEISGLPSIT 560
++I ++ L NL + + C L+ L+LS L E L +
Sbjct: 191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 250
Query: 561 DVDLSH-NFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNL 607
+ LS + TL++ V + G + P+L
Sbjct: 251 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALPHL 298
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 30/152 (19%), Positives = 54/152 (35%), Gaps = 37/152 (24%)
Query: 716 KILGMGSTGTVYKA--EMPGGEIIAVKKLWGKHKENIRR-RRGVLAEVDVLGNVRHR--- 769
LG G+ G V + G +A+K + N+ + R E++VL ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKII-----RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 770 ---NIVRLLGCCSNRE--C------TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK 818
V + + C +E++ N + L R
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--------FQPYPLPH---VR-H 127
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850
+A + + +LH + + H DLKP NIL
Sbjct: 128 MAYQLCHALRFLH-ENQ--LTHTDLKPENILF 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 31/159 (19%), Positives = 62/159 (38%), Gaps = 22/159 (13%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIV 772
K +G G+ G + + + E +A+K K + E + I
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL-----EYRFYKQLGSGDGIP 68
Query: 773 RLLGCCSNRECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
++ + ++ E + G +L+DL ++ +L T IA+ + + Y+H
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLK----TVLMIAIQLISRMEYVH 122
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEAR-----VADFGVAK 865
+++RD+KP N L+ + DF +AK
Sbjct: 123 SKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 42/149 (28%), Positives = 66/149 (44%), Gaps = 29/149 (19%)
Query: 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR--------H 768
LG G TV+ + + G + +A+K + K L E+ +L +VR
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV----KSAEHYTETALDEIRLLKSVRNSDPNDPNR 100
Query: 769 RNIVRLL------GCCSNRECTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIAL 821
+V+LL G C +++E + G +L + K+ + L V + I
Sbjct: 101 EMVVQLLDDFKISGVNGTHIC--MVFEVL--GHHLLKWII-KSNYQGLPLPCVKK--IIQ 153
Query: 822 GVAQGICYLHHDCDPVIVHRDLKPSNILL 850
V QG+ YLH C I+H D+KP NILL
Sbjct: 154 QVLQGLDYLHTKCR--IIHTDIKPENILL 180
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 21/144 (14%)
Query: 716 KILGMGSTGTVYKA--EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR---- 769
LG G+ G V + GG +AVK + K R +E+ VL ++
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVKIV----KNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 770 --NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHA-KNKGENLVADWVTRYKIALGVAQG 826
V++L + +++E + + D + L R K+A + +
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDH---IR-KMAYQICKS 130
Query: 827 ICYLHHDCDPVIVHRDLKPSNILL 850
+ +LH + H DLKP NIL
Sbjct: 131 VNFLH-SNK--LTHTDLKPENILF 151
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 32/144 (22%), Positives = 62/144 (43%), Gaps = 23/144 (15%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR----- 769
+ +G G+ G V + + + AVK + + + R E D+L +++
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVKVV----RNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 770 NIVRLLGCCSNRE--CTMLLYEYMPNGNLDDLLHAKN-KGENLVADWVTRYKIALGVAQG 826
NIV+ G + C L++E + +L +++ N G ++ + + + +
Sbjct: 97 NIVKYHGKFMYYDHMC--LIFEPL-GPSLYEIITRNNYNGFHIED---IK-LYCIEILKA 149
Query: 827 ICYLHHDCDPVIVHRDLKPSNILL 850
+ YL + H DLKP NILL
Sbjct: 150 LNYLR-KMS--LTHTDLKPENILL 170
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 28/174 (16%), Positives = 62/174 (35%), Gaps = 36/174 (20%)
Query: 716 KILGMGSTGTVYKAE---------MPGGEIIAVK----KLWGKHKENIRRRRGVLAEVDV 762
+ G +Y+A P + ++K +++N +R +V+
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 763 ---LGNVRHRNIVRLLGCCSNRECTMLLYEYM------PNGNLDDLLHAKNKGENLVADW 813
L + I +G +++ Y ++ + L L K
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQD----KYRFLVLPSLGRS--LQSALDVSPKHVLSER-- 159
Query: 814 VTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAK 865
+ ++A + + +LH + VH ++ NI +D E +++V A +G A
Sbjct: 160 -SVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 43/303 (14%), Positives = 85/303 (28%), Gaps = 72/303 (23%)
Query: 232 NNLQGEVPVEFASLVN--LKYMDISACNLSGTLPSEI-----SNLTKLEMLLLFKNHFTG 284
Q + F++ V L+ ++++ ++ + + S L+ + L
Sbjct: 59 YEFQNQ---RFSAEVLSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDP 115
Query: 285 E-----IPVSYGNLQALQVLDLSDNQLSGPIPASLAS-LKG----LTRLSLMNNVLFGEI 334
+PV + L L N L L L +T L L NN L
Sbjct: 116 AGLRTLLPV----FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPL---- 167
Query: 335 PQDI--ELLAD-------LDTLLLWNNHLT--GV--LPQKLGSNGKLLTVDVSSNSLTGP 381
+L + + L L + L G+ L +L N +L ++V+ N
Sbjct: 168 -TAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDT 226
Query: 382 IPPTICDG----DRLFKLILFSNNFTYS----IPENLVNCSSLSRLRIQDNQLNGSIPQG 433
+ L L L+ N + + + +R+ + +
Sbjct: 227 AALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVSEYW 286
Query: 434 FGLL------------------PNLTFMDMSRNSLSGEIPRDLGNA----QKLEYLNISE 471
+L L D+ + + P ++ L
Sbjct: 287 SVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQL 346
Query: 472 NSF 474
S
Sbjct: 347 GSS 349
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 30/172 (17%), Positives = 63/172 (36%), Gaps = 32/172 (18%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWG---KHKEN-----------IRRRRGVLAEVD 761
+G G G +Y A+M E + + +N + + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 762 VLGNVRHRNIVRLLGCCSNRECTMLLYEYM------PNGNLDDLLHAKNKGENLVADWVT 815
+++ + + G + + Y +M + L + A K + T
Sbjct: 101 RTRKLKYLGVPKYWGSGLH-DKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSRK----T 153
Query: 816 RYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAK 865
+++L + + Y+H VH D+K SN+LL+ + +V D+G+A
Sbjct: 154 VLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 42/152 (27%), Positives = 54/152 (35%), Gaps = 38/152 (25%)
Query: 297 QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLT 355
LDL N L L LT+L L N L +P + L L L L N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG-DRLFKLILFSNNFTYSIPE----NL 410
SL P + D +L +L L +N S+P+ L
Sbjct: 90 ---------------------SL----PNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL 123
Query: 411 VNCSSLSRLRIQDNQLNGSIPQG-FGLLPNLT 441
L LR+ NQL S+P G F L +L
Sbjct: 124 TQ---LKDLRLYQNQLK-SVPDGVFDRLTSLQ 151
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 42/148 (28%), Positives = 54/148 (36%), Gaps = 22/148 (14%)
Query: 263 PSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTR 322
P+ I T L L N + L +L L L N+L L LT
Sbjct: 23 PTGIPAQT--TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTY 80
Query: 323 LSLMNNVLFGEIPQDI-ELLADLDTLLLWNNHLTGVLPQ----KLGSNGKLLTVDVSSNS 377
L+L N L +P + + L L L L N L LP KL +L + + N
Sbjct: 81 LNLSTNQL-QSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKL---TQLKDLRLYQNQ 135
Query: 378 LTGPIPPTICDG--DRLFKL---ILFSN 400
L +P DG DRL L L N
Sbjct: 136 LKS-VP----DGVFDRLTSLQYIWLHDN 158
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.98 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.98 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.98 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.97 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.97 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.97 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.97 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.97 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.97 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.96 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.96 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.95 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.95 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.95 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.95 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.95 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.95 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.95 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.95 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.95 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.95 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.95 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.95 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.95 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.95 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.95 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.95 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.95 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.95 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.95 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.95 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.94 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.94 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.94 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.94 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.94 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.94 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.94 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.94 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.94 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.94 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.94 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.94 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.94 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.94 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.94 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.94 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.94 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.94 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.94 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.94 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.94 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.94 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.94 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.94 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.93 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.93 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.93 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.93 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.93 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.93 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.93 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.93 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.93 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.93 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.93 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.93 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.93 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.93 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.93 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.93 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.93 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.93 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.93 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.93 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.93 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.93 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.93 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.93 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.93 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.93 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.93 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.93 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.93 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.93 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.93 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.93 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.93 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.93 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.93 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.93 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.93 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.93 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.93 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.93 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.93 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.93 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.93 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.92 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.92 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.92 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.92 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.92 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.92 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.92 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.92 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.92 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.92 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.92 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.92 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.92 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.92 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.92 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.92 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.92 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.92 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.92 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.92 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.92 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.92 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.92 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.92 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.92 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.92 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.92 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.92 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.92 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.92 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.92 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.92 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.92 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.91 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.91 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.91 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.91 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.91 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.91 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.91 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.91 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.91 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.91 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.91 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.91 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.91 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.91 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.91 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.91 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.91 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.91 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.91 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.91 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.9 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.9 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.9 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.9 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.9 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.9 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.9 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.9 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.9 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.9 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.9 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.9 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.9 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.9 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.9 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.9 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.9 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.9 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.89 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.89 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.89 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.89 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.89 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.89 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.89 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.89 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.88 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.86 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.85 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.84 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.83 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.82 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.81 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.81 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.8 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.8 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.8 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.77 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.76 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.73 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.73 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.65 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.64 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.62 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.57 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.55 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.54 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.53 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.44 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.43 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.35 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.34 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.33 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.29 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.26 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.25 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 99.01 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.97 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.96 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.96 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.91 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.88 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.56 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.44 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.41 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.41 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.32 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.27 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.22 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.17 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.06 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.73 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.72 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.52 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.47 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.38 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.18 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.15 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.02 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.76 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.61 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.57 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.5 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.45 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.21 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.12 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.38 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.13 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.4 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-90 Score=845.36 Aligned_cols=598 Identities=31% Similarity=0.512 Sum_probs=482.9
Q ss_pred HhhcCCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecCCCCCEEEEEcCCCCcccc---
Q 043136 17 VFSANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGP--- 93 (902)
Q Consensus 17 ~~~~~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~--- 93 (902)
.+++.+.++|++||++||+++.||. .+++|+.+ + +||+|.||+|+ +++|+.|+|++++++|.
T Consensus 4 ~~~~~~~~~~~~all~~k~~~~~~~--~l~~W~~~------~-----~~C~w~gv~C~--~~~v~~L~L~~~~l~g~~~~ 68 (768)
T 3rgz_A 4 ASPSQSLYREIHQLISFKDVLPDKN--LLPDWSSN------K-----NPCTFDGVTCR--DDKVTSIDLSSKPLNVGFSA 68 (768)
T ss_dssp ----CCHHHHHHHHHHHHTTCSCTT--SSTTCCTT------S-----CGGGSTTEEEE--TTEEEEEECTTSCCCEEHHH
T ss_pred CccccCCHHHHHHHHHHHhhCCCcc--cccCCCCC------C-----CCcCCcceEEC--CCcEEEEECCCCCcCCccCc
Confidence 3445567889999999999999876 69999744 3 39999999999 57999999999999987
Q ss_pred cC-----------------------ccccCCCCCCEEEccCCCCcccCch--hhhccCCCcEEEccCCCCCCCCCccc-c
Q 043136 94 IP-----------------------PEIRYLTSLTHLNLSANAFDGPLQP--AILELTKLRTIDISHNSFNSTFPPGI-S 147 (902)
Q Consensus 94 ~~-----------------------~~~~~l~~L~~L~Ls~n~l~~~~~~--~~~~l~~L~~L~Ls~N~l~~~~p~~l-~ 147 (902)
+| +.|+.+++|++|+|++|.++|.+|. .++++++|++|+|++|.+++.+|..+ .
T Consensus 69 l~~~l~~L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~ 148 (768)
T 3rgz_A 69 VSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGL 148 (768)
T ss_dssp HHHHTTTCTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCC
T ss_pred cChhHhccCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhc
Confidence 44 5788889999999999999999988 89999999999999999998888775 6
Q ss_pred cccccceeccccccccCCCchh---h----------------------hcccCCcEEeccCccCcCCCCcccCCCCCCCE
Q 043136 148 KLRFLRIFNAYSNSFTGPLPLE---F----------------------VQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRF 202 (902)
Q Consensus 148 ~l~~L~~L~L~~N~l~~~~p~~---~----------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 202 (902)
++++|++|+|++|++++..|.. + ..+++|++|+|++|++++.+|. ++++++|++
T Consensus 149 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~ 227 (768)
T 3rgz_A 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227 (768)
T ss_dssp CCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCE
T ss_pred cCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCE
Confidence 7777777777777776665544 2 4566777777777888777776 788888888
Q ss_pred EEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCC-CCccEEecCCCc
Q 043136 203 LDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNL-TKLEMLLLFKNH 281 (902)
Q Consensus 203 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~L~~N~ 281 (902)
|+|++|++++.+|..++.+++|++|++++|++++.+|.. .+++|++|+|++|++++.+|..+..+ ++|++|+|++|+
T Consensus 228 L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~ 305 (768)
T 3rgz_A 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNH 305 (768)
T ss_dssp EECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSE
T ss_pred EECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCc
Confidence 888888888777777777777777777777776555443 44555555555555555555444443 455555555555
Q ss_pred cceecCCCCCCcCcCcEEecccCCCc-------------------------cccCccccccC-CCCEEEccCccccccCC
Q 043136 282 FTGEIPVSYGNLQALQVLDLSDNQLS-------------------------GPIPASLASLK-GLTRLSLMNNVLFGEIP 335 (902)
Q Consensus 282 l~~~~p~~~~~l~~L~~L~Ls~N~l~-------------------------~~~p~~l~~l~-~L~~L~L~~N~l~~~~p 335 (902)
+++.+|..|+++++|++|+|++|+++ +.+|..+..++ +|++|++++|.+++.+|
T Consensus 306 l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~ 385 (768)
T 3rgz_A 306 FYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385 (768)
T ss_dssp EEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECC
T ss_pred CCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcC
Confidence 55444544555555555555555544 44444444444 45555555555544444
Q ss_pred hhhhh--ccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccccc
Q 043136 336 QDIEL--LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC 413 (902)
Q Consensus 336 ~~~~~--l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l 413 (902)
..+.. +++|++|++++|++++.+|..+..+++|+.|++++|++++.+|..++.+++|++|++++|++++.+|..+..+
T Consensus 386 ~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l 465 (768)
T 3rgz_A 386 PNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465 (768)
T ss_dssp TTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGC
T ss_pred hhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCC
Confidence 44443 5567777777777777888888889999999999999999999999999999999999999999999999999
Q ss_pred CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceecc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 493 (902)
++|++|++++|+++|.+|.+++.+++|++|+|++|++++.+|.+++++++|++|+|++|++++.+|..++.+++|+.|++
T Consensus 466 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 545 (768)
T 3rgz_A 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDL 545 (768)
T ss_dssp TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEEC
T ss_pred CCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEEC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCCcccccc------------------------------------------------------------------
Q 043136 494 SSSKLTGKIPDFIG------------------------------------------------------------------ 507 (902)
Q Consensus 494 s~N~l~~~~p~~~~------------------------------------------------------------------ 507 (902)
++|+++|.+|..+.
T Consensus 546 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~ 625 (768)
T 3rgz_A 546 NTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625 (768)
T ss_dssp CSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECC
T ss_pred CCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCc
Confidence 99999988875321
Q ss_pred -----cccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCcc
Q 043136 508 -----CKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCST 582 (902)
Q Consensus 508 -----~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 582 (902)
+.+|+.|||++|+++|.+|.+++.+++|+.|+|++|+++|.+|..|+++++|++||||+|+++|.||..|.++++
T Consensus 626 ~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~ 705 (768)
T 3rgz_A 626 PTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTM 705 (768)
T ss_dssp CSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCC
T ss_pred hhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence 356889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCcccccCCCCCCcCcCCCCCcccCCcccCCCCcCCCCCCCCCCC
Q 043136 583 LESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPADGLAA 634 (902)
Q Consensus 583 L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~gn~~lcg~~~~~~c~~~~~~~ 634 (902)
|++||||+|+|+|+||+.+++.++ ++.+|.||++|||.|+. +|+...++.
T Consensus 706 L~~L~ls~N~l~g~iP~~~~~~~~-~~~~~~gN~~Lcg~~l~-~C~~~~~~~ 755 (768)
T 3rgz_A 706 LTEIDLSNNNLSGPIPEMGQFETF-PPAKFLNNPGLCGYPLP-RCDPSNADG 755 (768)
T ss_dssp CSEEECCSSEEEEECCSSSSGGGS-CGGGGCSCTEEESTTSC-CCCSCC---
T ss_pred CCEEECcCCcccccCCCchhhccC-CHHHhcCCchhcCCCCc-CCCCCccCC
Confidence 999999999999999999998875 89999999999999976 898655443
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-70 Score=671.60 Aligned_cols=515 Identities=34% Similarity=0.510 Sum_probs=463.2
Q ss_pred CCEEEEEcCCCCcccccCccc-cCCCCCCEEEccCCCCcccCchh---h----------------------hccCCCcEE
Q 043136 78 SQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDGPLQPA---I----------------------LELTKLRTI 131 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~-~~l~~L~~L~Ls~n~l~~~~~~~---~----------------------~~l~~L~~L 131 (902)
.+++.|+|++|.+++.+|..+ .++++|++|+|++|++++..|.. + ..+++|++|
T Consensus 126 ~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L 205 (768)
T 3rgz_A 126 SGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL 205 (768)
T ss_dssp TTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEE
T ss_pred CCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEE
Confidence 368888888888888777765 77777777777777777766554 3 456677777
Q ss_pred EccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCcc
Q 043136 132 DISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 132 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 211 (902)
+|++|++++.+|. ++++++|++|++++|++++.+|..|+.+++|++|+|++|++++.+|.. .+++|++|+|++|+++
T Consensus 206 ~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~ 282 (768)
T 3rgz_A 206 DVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFT 282 (768)
T ss_dssp ECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEE
T ss_pred ECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccC
Confidence 7777777776666 888888888888888888888888888888888888888888777765 7888888888888888
Q ss_pred CCCCccccCC-CCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCcc-ccCCCCccEEecCCCccceecCCC
Q 043136 212 GSLPPQLGLL-TQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSE-ISNLTKLEMLLLFKNHFTGEIPVS 289 (902)
Q Consensus 212 ~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~ 289 (902)
+.+|..+... ++|++|++++|++++.+|..|+.+++|++|+|++|+++|.+|.. +.++++|++|+|++|++++.+|..
T Consensus 283 ~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 362 (768)
T 3rgz_A 283 GEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362 (768)
T ss_dssp ESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT
T ss_pred CccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH
Confidence 8889888775 99999999999999999999999999999999999999888866 899999999999999999999999
Q ss_pred CCCcC-cCcEEecccCCCccccCccccc--cCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCC
Q 043136 290 YGNLQ-ALQVLDLSDNQLSGPIPASLAS--LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNG 366 (902)
Q Consensus 290 ~~~l~-~L~~L~Ls~N~l~~~~p~~l~~--l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~ 366 (902)
+.+++ +|++|+|++|++++.+|..+.. +++|++|++++|.+++.+|..+..+++|++|++++|++++.+|..+..++
T Consensus 363 l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 442 (768)
T 3rgz_A 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442 (768)
T ss_dssp HHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCT
T ss_pred HHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCC
Confidence 99887 9999999999999999998887 88999999999999999999999999999999999999999999999999
Q ss_pred ceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEcc
Q 043136 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446 (902)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 446 (902)
+|+.|++++|++++.+|..+..+++|++|++++|++++.+|..+.++++|++|+|++|++++.+|.+|+.+++|++|+|+
T Consensus 443 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 522 (768)
T 3rgz_A 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLS 522 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECC
T ss_pred CCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCcCcccCcCceecccccccCCCcChhhhc------------------------------------------
Q 043136 447 RNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS------------------------------------------ 484 (902)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------------------------------------------ 484 (902)
+|+++|.+|..++++++|++|+|++|+++|.+|.+++.
T Consensus 523 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 602 (768)
T 3rgz_A 523 NNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602 (768)
T ss_dssp SSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGG
T ss_pred CCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccch
Confidence 99999999999999999999999999999888876543
Q ss_pred ----------------------------ccccceeccCCCccCCCcccccc-cccccEEeccCccccccCCccccccccc
Q 043136 485 ----------------------------APNLKILSASSSKLTGKIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKL 535 (902)
Q Consensus 485 ----------------------------l~~L~~L~ls~N~l~~~~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~l~~L 535 (902)
+++|+.|||++|+++|.+|..++ +++|+.|+|++|+++|.||.+++.+++|
T Consensus 603 ~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L 682 (768)
T 3rgz_A 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682 (768)
T ss_dssp GGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTC
T ss_pred hhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCC
Confidence 46789999999999999998777 9999999999999999999999999999
Q ss_pred eEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCc-cccc
Q 043136 536 LLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNL-LTGP 596 (902)
Q Consensus 536 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~-l~g~ 596 (902)
+.||||+|+++|.+|..++++++|++||||+|+|+|.||.. ..+..+....+.+|+ |+|.
T Consensus 683 ~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~-~~~~~~~~~~~~gN~~Lcg~ 743 (768)
T 3rgz_A 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM-GQFETFPPAKFLNNPGLCGY 743 (768)
T ss_dssp CEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSS-SSGGGSCGGGGCSCTEEEST
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCc-hhhccCCHHHhcCCchhcCC
Confidence 99999999999999999999999999999999999999974 455666667777885 7874
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-64 Score=608.82 Aligned_cols=543 Identities=21% Similarity=0.205 Sum_probs=484.2
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecc
Q 043136 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 157 (902)
.+++.|+|++|++++..+..|+++++|++|+|++|.+++..|.+|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 58999999999999888889999999999999999999999999999999999999999999876678999999999999
Q ss_pred ccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCcccc--CCCCCcEEEeeCcccC
Q 043136 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG--LLTQLERIEIGYNNLQ 235 (902)
Q Consensus 158 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~ 235 (902)
++|++++..|..|+++++|++|+|++|.+++..|..++++++|++|+|++|++++..+..+. .+++|++|++++|+++
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 99999998889999999999999999999999999999999999999999999987777665 5689999999999999
Q ss_pred CCCChhccCC---------------------------CCCCEEEccCccCcccCCccccCCCC--ccEEecCCCccceec
Q 043136 236 GEVPVEFASL---------------------------VNLKYMDISACNLSGTLPSEISNLTK--LEMLLLFKNHFTGEI 286 (902)
Q Consensus 236 ~~~p~~~~~l---------------------------~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l~~~~ 286 (902)
+..|..|..+ ++|++|++++|.+++..|..|.+++. |++|+|++|++++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 9888877654 56788888999999888988988865 999999999999988
Q ss_pred CCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccc-----cCCh----hhhhccccceEEecCceeccc
Q 043136 287 PVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFG-----EIPQ----DIELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 287 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~-----~~p~----~~~~l~~L~~L~L~~N~l~~~ 357 (902)
|..|+.+++|++|+|++|++++..|..|..+++|++|++++|...+ .+|. .|..+++|++|++++|++++.
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~ 344 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGI 344 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCC
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCC
Confidence 8999999999999999999999999999999999999999886654 2333 678899999999999999999
Q ss_pred cCccccCCCceeEEEecCCcccCCC--CCCccC--CCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCC-c
Q 043136 358 LPQKLGSNGKLLTVDVSSNSLTGPI--PPTICD--GDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP-Q 432 (902)
Q Consensus 358 ~~~~~~~~~~L~~L~Ls~N~l~~~~--p~~~~~--~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~ 432 (902)
.+..|..+++|++|++++|.+++.. +..+.. ..+|+.|++++|++++..|..+..+++|+.|+|++|++++.+| .
T Consensus 345 ~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 424 (680)
T 1ziw_A 345 KSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424 (680)
T ss_dssp CTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCEEECCSG
T ss_pred ChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCCCEEeCCCCcCccccCcc
Confidence 9999999999999999999865432 223332 2589999999999999999999999999999999999998766 6
Q ss_pred ccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccC--CCcChhhhcccccceeccCCCccCCCccccc-ccc
Q 043136 433 GFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ--TSLPSNIWSAPNLKILSASSSKLTGKIPDFI-GCK 509 (902)
Q Consensus 433 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~ 509 (902)
.|..+++|++|++++|++.+..+..|..+++|+.|++++|.++ +.+|..+..+++|+.|++++|++++..|..+ +++
T Consensus 425 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~ 504 (680)
T 1ziw_A 425 EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLE 504 (680)
T ss_dssp GGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred cccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhcccc
Confidence 8999999999999999999999999999999999999999987 6789999999999999999999998877754 599
Q ss_pred cccEEeccCccccccC--------CccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCc
Q 043136 510 SIYKIELHNNLLNGSI--------PWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCS 581 (902)
Q Consensus 510 ~l~~l~Ls~N~l~g~i--------p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~ 581 (902)
+|+.|+|++|++++.. +..++.+++|+.|+|++|+++.+.+..|+++++|+.|||++|+|++..|..|.+++
T Consensus 505 ~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~ 584 (680)
T 1ziw_A 505 KLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQV 584 (680)
T ss_dssp TCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCT
T ss_pred ccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCC
Confidence 9999999999998642 23478999999999999999976667899999999999999999977777889999
Q ss_pred cceeecccCCcccccCCCCCC-cCcCCCCCcccCCcccCC
Q 043136 582 TLESFNVSYNLLTGPIPASGT-IFPNLHPSSFIGNEGLCG 620 (902)
Q Consensus 582 ~L~~l~ls~N~l~g~ip~~~~-~~~~~~~~~~~gn~~lcg 620 (902)
+|+.|+|++|+|++.+|.... ..+.+......||+..|.
T Consensus 585 ~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 585 SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp TCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBC
T ss_pred CCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccC
Confidence 999999999999998775432 234456677889988885
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-61 Score=579.82 Aligned_cols=493 Identities=17% Similarity=0.164 Sum_probs=348.0
Q ss_pred CCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEecc
Q 043136 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLG 182 (902)
Q Consensus 103 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 182 (902)
++++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|+
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 44555555555555445555555555555555555555445555555555555555555555555555555555555555
Q ss_pred CccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCC--EEEccCccCcc
Q 043136 183 GSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK--YMDISACNLSG 260 (902)
Q Consensus 183 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~Ls~N~l~~ 260 (902)
+|++++..|..|+++++|++|+|++|++++..++.+..+++|++|++++|++++..|..|+.+++|+ .|++++|.+++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~~ 193 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG 193 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCCE
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccCc
Confidence 5555544444455555555555555555542222233355555555555555544444555555555 45555555554
Q ss_pred cCCccccCCCCccEEecCCCc---------------------cc-----eecCCCCCCcC--cCcEEecccCCCccccCc
Q 043136 261 TLPSEISNLTKLEMLLLFKNH---------------------FT-----GEIPVSYGNLQ--ALQVLDLSDNQLSGPIPA 312 (902)
Q Consensus 261 ~~p~~~~~l~~L~~L~L~~N~---------------------l~-----~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p~ 312 (902)
..|..+.. .+|++|++++|. +. ...+..+..+. +|+.|++++|.+++..+.
T Consensus 194 ~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~ 272 (606)
T 3t6q_A 194 IEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSN 272 (606)
T ss_dssp ECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTT
T ss_pred cChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHH
Confidence 44433322 345555554443 11 11112223332 688888999988887777
Q ss_pred cccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCC-ccCCCC
Q 043136 313 SLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPT-ICDGDR 391 (902)
Q Consensus 313 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~-~~~~~~ 391 (902)
.|..+++|++|++++|.++ .+|..+..+++|++|++++|++++..|..+..+++|+.|++++|.+.+.+|.. +..+++
T Consensus 273 ~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~ 351 (606)
T 3t6q_A 273 TFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLEN 351 (606)
T ss_dssp TTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTT
T ss_pred HhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCc
Confidence 8888888999999988886 67778888888999999999888888888888888999999999888777654 788888
Q ss_pred ccEEeccCCcCcccc--cccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCc-CcccCcCceec
Q 043136 392 LFKLILFSNNFTYSI--PENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQKLEYLN 468 (902)
Q Consensus 392 L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~ 468 (902)
|++|++++|++.+.. |..+..+++|++|++++|++++..|..|..+++|++|++++|++++..|.. +..+++|++|+
T Consensus 352 L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ 431 (606)
T 3t6q_A 352 LRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431 (606)
T ss_dssp CCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEE
T ss_pred CCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEE
Confidence 889999988888766 777888889999999999888888888888899999999999988776544 88888999999
Q ss_pred ccccccCCCcChhhhcccccceeccCCCccCCC-cc--c-ccccccccEEeccCccccccCCccccccccceEEEeeCCc
Q 043136 469 ISENSFQTSLPSNIWSAPNLKILSASSSKLTGK-IP--D-FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNS 544 (902)
Q Consensus 469 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p--~-~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~ 544 (902)
+++|.+++..|..+..+++|+.|++++|++++. +| . +..+++|+.|++++|++++.+|..++.+++|+.|+|++|+
T Consensus 432 l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 511 (606)
T 3t6q_A 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNR 511 (606)
T ss_dssp CTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSC
T ss_pred CCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCc
Confidence 999998888888888888999999999988763 22 2 3347888889999998888888888888899999999999
Q ss_pred ceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCC
Q 043136 545 LTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIP 598 (902)
Q Consensus 545 l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip 598 (902)
+++.+|..+.+++.| .|||++|++++.+|..|..+++|+.|++++|++.+..+
T Consensus 512 l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 512 LTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred cCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 988888888888888 89999999988888888888888999999998887555
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-60 Score=572.79 Aligned_cols=531 Identities=20% Similarity=0.213 Sum_probs=461.7
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNS 161 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 161 (902)
.+|+++++++ .+|..+. +++++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 8 ~~~cs~~~L~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 84 (680)
T 1ziw_A 8 VADCSHLKLT-QVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84 (680)
T ss_dssp EEECCSSCCS-SCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSC
T ss_pred eeECCCCCcc-ccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCc
Confidence 3566667776 5776664 799999999999999888899999999999999999999999999999999999999999
Q ss_pred ccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChh
Q 043136 162 FTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE 241 (902)
Q Consensus 162 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 241 (902)
+++..+..|+++++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..++.+++|++|++++|++++..+..
T Consensus 85 l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 164 (680)
T 1ziw_A 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEE 164 (680)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHH
T ss_pred cCccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHH
Confidence 99877778999999999999999999888889999999999999999999999999999999999999999999888877
Q ss_pred cc--CCCCCCEEEccCccCcccCCccccCC---------------------------CCccEEecCCCccceecCCCCCC
Q 043136 242 FA--SLVNLKYMDISACNLSGTLPSEISNL---------------------------TKLEMLLLFKNHFTGEIPVSYGN 292 (902)
Q Consensus 242 ~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l---------------------------~~L~~L~L~~N~l~~~~p~~~~~ 292 (902)
+. .+++|++|++++|++++..|..|..+ ++|++|++++|++++..|..|.+
T Consensus 165 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~ 244 (680)
T 1ziw_A 165 LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG 244 (680)
T ss_dssp HGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGG
T ss_pred hhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhc
Confidence 65 56899999999999998888777654 56788888899999888989988
Q ss_pred cCc--CcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecc-----ccC----cc
Q 043136 293 LQA--LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG-----VLP----QK 361 (902)
Q Consensus 293 l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~~----~~ 361 (902)
++. |++|+|++|++++..|..|..+++|++|++++|.+.+..|..|..+++|+.|++++|...+ .+| ..
T Consensus 245 l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~ 324 (680)
T 1ziw_A 245 LKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFS 324 (680)
T ss_dssp GGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTT
T ss_pred cCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhh
Confidence 865 9999999999998888999999999999999999999999999999999999999876553 223 36
Q ss_pred ccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccc--ccccccc--CCCcEEEccCCccCCCCCcccCCC
Q 043136 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSI--PENLVNC--SSLSRLRIQDNQLNGSIPQGFGLL 437 (902)
Q Consensus 362 ~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~--p~~l~~l--~~L~~L~Ls~N~l~~~~p~~~~~l 437 (902)
|..+++|+.|++++|++++..|..+..+++|++|++++|.+.... +..+..+ ++|+.|++++|++++..|..|..+
T Consensus 325 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 404 (680)
T 1ziw_A 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404 (680)
T ss_dssp TTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTC
T ss_pred cccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCC
Confidence 788999999999999999998999999999999999999865432 2234433 589999999999999999999999
Q ss_pred CCCcEEEccCcccCCCCC-CcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccC--CCcccccc-cccccE
Q 043136 438 PNLTFMDMSRNSLSGEIP-RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLT--GKIPDFIG-CKSIYK 513 (902)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~--~~~p~~~~-~~~l~~ 513 (902)
++|++|+|++|++++.+| ..|.++++|++|++++|++.+..+..+..+++|+.|++++|.++ +.+|..++ +++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 999999999999998776 68899999999999999999888999999999999999999987 45676554 899999
Q ss_pred EeccCccccccCCccccccccceEEEeeCCcceecCC--------CCCCCCCcccEEEccCCcccccCCCCCcCCcccee
Q 043136 514 IELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIP--------WEISGLPSITDVDLSHNFLTGTIPSNFENCSTLES 585 (902)
Q Consensus 514 l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p--------~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~ 585 (902)
|+|++|++++..|..++.+++|++|+|++|++++..+ ..++++++|++|+|++|+++...+..|.++++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 9999999998878889999999999999999997632 34789999999999999999544457999999999
Q ss_pred ecccCCcccccCCCCCCcCcCCCCCcccCC
Q 043136 586 FNVSYNLLTGPIPASGTIFPNLHPSSFIGN 615 (902)
Q Consensus 586 l~ls~N~l~g~ip~~~~~~~~~~~~~~~gn 615 (902)
|+|++|+|++..|......+.+......+|
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N 594 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCC
Confidence 999999999655543232333344444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-62 Score=585.77 Aligned_cols=499 Identities=21% Similarity=0.280 Sum_probs=325.4
Q ss_pred ChhhHHHHHHHHHhCCCCCCC-------CcCCCCCCCCCCCCCCCCCCCCCcc---ccEEecCCCCCEEEEEcCCCCccc
Q 043136 23 LPLPLVSLLSIKASLKDPFNN-------SFHDWDATPAFSNPSSEQEPVWCSW---SGIKCNPKSSQITSLDLSRRSLSG 92 (902)
Q Consensus 23 ~~~~~~aLl~~k~~~~~~~~~-------~l~~W~~~~~~~~~~~~~~~~~C~w---~Gv~c~~~~~~v~~L~L~~~~l~g 92 (902)
...|++||.+||+++.++... ...+|+.+ ++||.| .||+|+.. +||+.|+|++++++|
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-----------~~~c~w~~~~GV~C~~~-~~V~~L~L~~~~l~g 95 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-----------KELDMWGAQPGVSLNSN-GRVTGLSLEGFGASG 95 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-----------SCGGGTTCCTTEEECTT-CCEEEEECTTSCCEE
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-----------CCcccccCCCCeEEcCC-CCEEEEEecCcccCC
Confidence 456999999999998765331 12367644 249999 99999876 699999999999999
Q ss_pred ccCccccCCCCCCEEEccCCCC------cc------cCchhhhccCCCcEEEccCCCCCCCCCccccc-ccccceecccc
Q 043136 93 PIPPEIRYLTSLTHLNLSANAF------DG------PLQPAILELTKLRTIDISHNSFNSTFPPGISK-LRFLRIFNAYS 159 (902)
Q Consensus 93 ~~~~~~~~l~~L~~L~Ls~n~l------~~------~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~~ 159 (902)
.+|+++++|++|++|+|++|.+ .| .+|... +.+|+ +++++|.+.+.+|..++. +..+..+++..
T Consensus 96 ~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~ 172 (636)
T 4eco_A 96 RVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPREDFSDLIKDCINSDPQQ 172 (636)
T ss_dssp EECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGGSCHHHHHHHHHCTTS
T ss_pred cCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhhHHHHHHHHhhcCccc
Confidence 9999999999999999999976 33 344444 56677 888888888877777663 23444444443
Q ss_pred ccccCCCchhhhcccCCcEEecc--CccCcCCCCcccCCCCCCCEEEccCCCccCC-----------------CCcccc-
Q 043136 160 NSFTGPLPLEFVQLNSLQQLNLG--GSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS-----------------LPPQLG- 219 (902)
Q Consensus 160 N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-----------------~p~~~~- 219 (902)
..+.. .....++.+.+. +|+++| +|..|+++++|++|+|++|++++. +|..++
T Consensus 173 ~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~ 245 (636)
T 4eco_A 173 KSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245 (636)
T ss_dssp CCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred ccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhh
Confidence 32221 111223333333 466666 666677777777777777777664 677766
Q ss_pred -CCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCcc-Ccc-cCCccccCC------CCccEEecCCCccceecCC--
Q 043136 220 -LLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN-LSG-TLPSEISNL------TKLEMLLLFKNHFTGEIPV-- 288 (902)
Q Consensus 220 -~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~-- 288 (902)
++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++++ ++|++|+|++|+++ .+|.
T Consensus 246 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~ 324 (636)
T 4eco_A 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVET 324 (636)
T ss_dssp GGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHH
T ss_pred cccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchh
Confidence 77777777777777777777777777777777777776 776 667666665 67777777777777 6666
Q ss_pred CCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccc-cceEEecCceeccccCccccCCC-
Q 043136 289 SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD-LDTLLLWNNHLTGVLPQKLGSNG- 366 (902)
Q Consensus 289 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~~~~~- 366 (902)
.++++++|++|+|++|+++|.+| .+..+++|++|++++|+++ .+|..+..+++ |++|++++|+++ .+|..+....
T Consensus 325 ~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l 401 (636)
T 4eco_A 325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSV 401 (636)
T ss_dssp HHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCS
T ss_pred hhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhccc
Confidence 67777777777777777776666 6677777777777777766 66666666766 777777777776 5566655544
Q ss_pred -ceeEEEecCCcccCCCCCCcc-------CCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCC-C
Q 043136 367 -KLLTVDVSSNSLTGPIPPTIC-------DGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL-L 437 (902)
Q Consensus 367 -~L~~L~Ls~N~l~~~~p~~~~-------~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l 437 (902)
+|+.|++++|++++.+|..+. .+.+|++|++++|+++...+..+..+++|+.|+|++|+++ .+|..+.. .
T Consensus 402 ~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~ 480 (636)
T 4eco_A 402 SVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDE 480 (636)
T ss_dssp SCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEET
T ss_pred CccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccc
Confidence 677777777777777776666 5555666666666665322222344566666666666666 34433221 1
Q ss_pred -------CCCcEEEccCcccCCCCCCcCc--ccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCccccccc
Q 043136 438 -------PNLTFMDMSRNSLSGEIPRDLG--NAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGC 508 (902)
Q Consensus 438 -------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 508 (902)
++|++|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|++++|+
T Consensus 481 ~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~----------- 547 (636)
T 4eco_A 481 NENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR----------- 547 (636)
T ss_dssp TEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCB-----------
T ss_pred cccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCc-----------
Confidence 15566666666655 4555554 55556666666665554 55555555555555555554
Q ss_pred ccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCccc
Q 043136 509 KSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT 570 (902)
Q Consensus 509 ~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~ 570 (902)
++++|++.+.+|..++.+++|+.|+|++|+| +.+|..+. ++|+.|||++|++.
T Consensus 548 ------~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~ 600 (636)
T 4eco_A 548 ------DAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNI 600 (636)
T ss_dssp ------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTC
T ss_pred ------ccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCc
Confidence 2355666666666666666666666666666 45555544 55666666666554
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-60 Score=585.43 Aligned_cols=544 Identities=20% Similarity=0.206 Sum_probs=454.8
Q ss_pred CccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccC-chhhhccCCCcEEEccCCCCCCCCCc
Q 043136 66 CSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPL-QPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 66 C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
|+|..|-+ .+.+++.|||++|.+++..|..|+++++|++|+|++|.+.+.+ |.+|.++++|++|+|++|.+++..|.
T Consensus 14 ~~L~~vP~--lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~ 91 (844)
T 3j0a_A 14 CNLTQVPQ--VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91 (844)
T ss_dssp CCSSCCCS--SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred CCCCCCCC--CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence 56777776 4458999999999999988999999999999999999766655 77899999999999999999999999
Q ss_pred ccccccccceeccccccccCCCchh--hhcccCCcEEeccCccCcCCCC-cccCCCCCCCEEEccCCCccCCCCccccCC
Q 043136 145 GISKLRFLRIFNAYSNSFTGPLPLE--FVQLNSLQQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGNSLTGSLPPQLGLL 221 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 221 (902)
.|+++++|++|+|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+..+
T Consensus 92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l 171 (844)
T 3j0a_A 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL 171 (844)
T ss_dssp SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHH
T ss_pred HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccc
Confidence 9999999999999999999877765 9999999999999999987765 578999999999999999999899999888
Q ss_pred --CCCcEEEeeCcccCCCCChhccCCCC------CCEEEccCccCcccCCccccCC---CCccEEecCCC---------c
Q 043136 222 --TQLERIEIGYNNLQGEVPVEFASLVN------LKYMDISACNLSGTLPSEISNL---TKLEMLLLFKN---------H 281 (902)
Q Consensus 222 --~~L~~L~L~~N~l~~~~p~~~~~l~~------L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N---------~ 281 (902)
++|+.|+++.|.+.+..|..++.+.+ |++|++++|.+++..|..+... ++++.|.++.+ .
T Consensus 172 ~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~ 251 (844)
T 3j0a_A 172 QGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251 (844)
T ss_dssp HHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSS
T ss_pred cCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccc
Confidence 89999999999999988887777665 9999999999998888776643 67888887743 3
Q ss_pred cceecCCCCCCc--CcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccC
Q 043136 282 FTGEIPVSYGNL--QALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP 359 (902)
Q Consensus 282 l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 359 (902)
+.+..+..|..+ ++|+.|+|++|.+++..|..|..+++|+.|+|++|.+.+..|..|..+++|++|+|++|++++..|
T Consensus 252 l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 331 (844)
T 3j0a_A 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYS 331 (844)
T ss_dssp STTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCS
T ss_pred cCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCH
Confidence 333444455554 689999999999998888999999999999999999998888899999999999999999998889
Q ss_pred ccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCC
Q 043136 360 QKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPN 439 (902)
Q Consensus 360 ~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 439 (902)
..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+++. ..+++|+.|++++|+++ .+|.. ..+
T Consensus 332 ~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i-----~~~~~L~~L~l~~N~l~-~l~~~---~~~ 402 (844)
T 3j0a_A 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI-----HFIPSIPDIFLSGNKLV-TLPKI---NLT 402 (844)
T ss_dssp CSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCC-----SSCCSCSEEEEESCCCC-CCCCC---CTT
T ss_pred HHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcc-----cCCCCcchhccCCCCcc-ccccc---ccc
Confidence 9999999999999999999988888899999999999999998842 23788999999999998 55654 567
Q ss_pred CcEEEccCcccCCCC-CCcCcccCcCceecccccccCCCcCh-hhhcccccceeccCCCccCCC-----cccc-cccccc
Q 043136 440 LTFMDMSRNSLSGEI-PRDLGNAQKLEYLNISENSFQTSLPS-NIWSAPNLKILSASSSKLTGK-----IPDF-IGCKSI 511 (902)
Q Consensus 440 L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~-----~p~~-~~~~~l 511 (902)
++.|++++|++++.. +..+.++++|++|+|++|++++..+. .+..+++|+.|++++|++++. .+.. .++++|
T Consensus 403 l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L 482 (844)
T 3j0a_A 403 ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHL 482 (844)
T ss_dssp CCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCE
T ss_pred cceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccc
Confidence 899999999998642 22356889999999999999865443 455678999999999998743 3333 348899
Q ss_pred cEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCC
Q 043136 512 YKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591 (902)
Q Consensus 512 ~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N 591 (902)
+.|+|++|++++.+|..++.+++|+.|+|++|+|++.+|..+. ++|+.|||++|+|++.+|..|. +|+.+++++|
T Consensus 483 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~N 557 (844)
T 3j0a_A 483 QVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHN 557 (844)
T ss_dssp ECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEE
T ss_pred cEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCC
Confidence 9999999999988888899999999999999999988887776 8899999999999999888765 6788999999
Q ss_pred cccccCCCCCCcCcCCCCCcccCCcccCCCCcCCCCCCC
Q 043136 592 LLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPCPAD 630 (902)
Q Consensus 592 ~l~g~ip~~~~~~~~~~~~~~~gn~~lcg~~~~~~c~~~ 630 (902)
++.+..+.. .+ ......+|..+||.+....|..+
T Consensus 558 p~~C~c~~~----~f-~~~~~~~~~~~~~~~~~~~C~~p 591 (844)
T 3j0a_A 558 KFICECELS----TF-INWLNHTNVTIAGPPADIYCVYP 591 (844)
T ss_dssp CCCCSSSCC----SH-HHHHHHTTTTTCCCGGGCCCSSC
T ss_pred CcccccccH----HH-HHHHHhcCcccccccccCccCCc
Confidence 998766532 11 11223456677887777778643
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-60 Score=578.40 Aligned_cols=525 Identities=20% Similarity=0.266 Sum_probs=341.7
Q ss_pred cCCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCcc------------ccEEecCCCCCEEEEEcCC
Q 043136 20 ANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSW------------SGIKCNPKSSQITSLDLSR 87 (902)
Q Consensus 20 ~~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w------------~Gv~c~~~~~~v~~L~L~~ 87 (902)
+++..+|++||++||+++.+| +|+.+..+. ...|++|+| .||+|+. .+||+.|+|++
T Consensus 264 ~~~~~~d~~ALl~~k~~l~~~------~W~~~~~~~----~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~ 332 (876)
T 4ecn_A 264 TAEYIKDYKALKAIWEALDGK------NWRYYSGTI----NNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAG 332 (876)
T ss_dssp CCHHHHHHHHHHHHHHHTTGG------GCCCCCSSC----SSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTT
T ss_pred cccchHHHHHHHHHHHHcCCC------CCCcCCCcc----cccCCccccccccccccccCcCceEecC-CCCEEEEECcc
Confidence 345678999999999999765 687652000 012334999 9999987 46999999999
Q ss_pred CCcccccCccccCCCCCCEEEc-cCCCCcccCchhhhcc----C-----CCcEE------E-ccCCCCCCC---------
Q 043136 88 RSLSGPIPPEIRYLTSLTHLNL-SANAFDGPLQPAILEL----T-----KLRTI------D-ISHNSFNST--------- 141 (902)
Q Consensus 88 ~~l~g~~~~~~~~l~~L~~L~L-s~n~l~~~~~~~~~~l----~-----~L~~L------~-Ls~N~l~~~--------- 141 (902)
++++|.+|++|++|++|++|+| ++|.++|..|...... + .++.. + .....+.+.
T Consensus 333 ~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~ 412 (876)
T 4ecn_A 333 FGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNP 412 (876)
T ss_dssp TCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCT
T ss_pred CCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCc
Confidence 9999999999999999999999 8999988744321111 0 00000 0 000001100
Q ss_pred --CCcccccccccceecccc--ccccCCCchhhhcccCCcEEeccCccCcCC-CCcccCCCCCCCEEEccCCCccCCCCc
Q 043136 142 --FPPGISKLRFLRIFNAYS--NSFTGPLPLEFVQLNSLQQLNLGGSYFDGE-IPSDYRNLSSLRFLDLAGNSLTGSLPP 216 (902)
Q Consensus 142 --~p~~l~~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~ 216 (902)
.+........++.+.+.. |++++ +|..|+++++|++|+|++|++++. +|..+.. ++.|.++|.+|.
T Consensus 413 ~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~--------~s~n~~~g~iP~ 483 (876)
T 4ecn_A 413 EMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWED--------ANSDYAKQYENE 483 (876)
T ss_dssp TSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC--------TTSHHHHHHTTS
T ss_pred cccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCcccccccc--------cccccccccCCh
Confidence 111112223344444443 66666 666677777777777777776651 1111110 111333334666
Q ss_pred ccc--CCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCcc-Ccc-cCCccccCCC-------CccEEecCCCcccee
Q 043136 217 QLG--LLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN-LSG-TLPSEISNLT-------KLEMLLLFKNHFTGE 285 (902)
Q Consensus 217 ~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~ 285 (902)
.++ .+++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .
T Consensus 484 ~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ 562 (876)
T 4ecn_A 484 ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-E 562 (876)
T ss_dssp CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-B
T ss_pred hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-c
Confidence 655 66666666666666666666666666666666666666 666 5665555444 6777777777776 5
Q ss_pred cCC--CCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccc-cceEEecCceeccccCccc
Q 043136 286 IPV--SYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD-LDTLLLWNNHLTGVLPQKL 362 (902)
Q Consensus 286 ~p~--~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~~~~~ 362 (902)
+|. .++++++|+.|+|++|+++ .+| .|..+++|+.|+|++|++. .+|..+..+++ |+.|+|++|+++ .+|..+
T Consensus 563 ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~ 638 (876)
T 4ecn_A 563 FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIF 638 (876)
T ss_dssp CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCC
T ss_pred cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhh
Confidence 666 6666777777777777776 556 6666777777777777766 66666666666 777777777776 556666
Q ss_pred cCCCc--eeEEEecCCcccCCCCCCcc-----CCCCccEEeccCCcCcccccccc-cccCCCcEEEccCCccCCCCCccc
Q 043136 363 GSNGK--LLTVDVSSNSLTGPIPPTIC-----DGDRLFKLILFSNNFTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQGF 434 (902)
Q Consensus 363 ~~~~~--L~~L~Ls~N~l~~~~p~~~~-----~~~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~ 434 (902)
..... |+.|++++|+++|.+|...+ .+.+|+.|++++|+++ .+|..+ ..+++|+.|+|++|+|+ .+|..+
T Consensus 639 ~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 716 (876)
T 4ecn_A 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENS 716 (876)
T ss_dssp CTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTS
T ss_pred hccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHH
Confidence 55543 77888888888776553321 2336677777777777 444443 46777777777777777 555544
Q ss_pred CCC--------CCCcEEEccCcccCCCCCCcCc--ccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCccc
Q 043136 435 GLL--------PNLTFMDMSRNSLSGEIPRDLG--NAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD 504 (902)
Q Consensus 435 ~~l--------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 504 (902)
... ++|+.|+|++|+++ .+|..+. .+++|+.|+|++|++++ +|..+..+++|+.|+|++|+
T Consensus 717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~------- 787 (876)
T 4ecn_A 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQR------- 787 (876)
T ss_dssp SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCB-------
T ss_pred hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCC-------
Confidence 332 26777777777777 5666665 67777777777777765 67777777777777777765
Q ss_pred ccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccce
Q 043136 505 FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLE 584 (902)
Q Consensus 505 ~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 584 (902)
++++|++.+.+|..++.+++|+.|+|++|+| +.+|..+. ++|+.|||++|++....+..+.....+.
T Consensus 788 ----------~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~ 854 (876)
T 4ecn_A 788 ----------DAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAG 854 (876)
T ss_dssp ----------CTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTT
T ss_pred ----------CcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccch
Confidence 4566777788888888888888888888888 57777665 5788888888887766666665555566
Q ss_pred eecccCCcc
Q 043136 585 SFNVSYNLL 593 (902)
Q Consensus 585 ~l~ls~N~l 593 (902)
.+.|++|++
T Consensus 855 ~~~L~~n~~ 863 (876)
T 4ecn_A 855 MYVLLYDKT 863 (876)
T ss_dssp CCEEECCTT
T ss_pred heeecCCCc
Confidence 666666654
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-60 Score=564.58 Aligned_cols=494 Identities=20% Similarity=0.196 Sum_probs=451.4
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecc
Q 043136 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 157 (902)
..++.|+|++|.+++..|..|+.+++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus 33 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 112 (606)
T 3t6q_A 33 NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFF 112 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEEC
T ss_pred CcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeec
Confidence 57999999999999988999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc--EEEeeCcccC
Q 043136 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE--RIEIGYNNLQ 235 (902)
Q Consensus 158 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~--~L~L~~N~l~ 235 (902)
++|++++..|..|+++++|++|+|++|++++..++.+..+++|++|+|++|++++..|..|+.+++|+ +|++++|+++
T Consensus 113 ~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 113 IQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred cccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999998888999999999999999999986555566699999999999999988888999999999 9999999999
Q ss_pred CCCChhccCCCCCCEEEccCccCc--------------------------ccCCccccCCC--CccEEecCCCccceecC
Q 043136 236 GEVPVEFASLVNLKYMDISACNLS--------------------------GTLPSEISNLT--KLEMLLLFKNHFTGEIP 287 (902)
Q Consensus 236 ~~~p~~~~~l~~L~~L~Ls~N~l~--------------------------~~~p~~~~~l~--~L~~L~L~~N~l~~~~p 287 (902)
+..|..|.. .+|++|++++|... ...+..+..+. +|++|++++|++++..+
T Consensus 193 ~~~~~~~~~-~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~ 271 (606)
T 3t6q_A 193 GIEPGAFDS-AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISS 271 (606)
T ss_dssp EECTTTTTT-CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCT
T ss_pred ccChhHhhh-ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCH
Confidence 888877665 68999999987511 11122333333 79999999999998888
Q ss_pred CCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCc-cccCCC
Q 043136 288 VSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQ-KLGSNG 366 (902)
Q Consensus 288 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~-~~~~~~ 366 (902)
..|+.+++|++|++++|+++ .+|..+..+++|++|++++|.+.+..|..+..+++|++|++++|.+.+.+|. .+..++
T Consensus 272 ~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~ 350 (606)
T 3t6q_A 272 NTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLE 350 (606)
T ss_dssp TTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCT
T ss_pred HHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccC
Confidence 88999999999999999998 7888999999999999999999988898999999999999999999876655 589999
Q ss_pred ceeEEEecCCcccCCC--CCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCc-ccCCCCCCcEE
Q 043136 367 KLLTVDVSSNSLTGPI--PPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQ-GFGLLPNLTFM 443 (902)
Q Consensus 367 ~L~~L~Ls~N~l~~~~--p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L 443 (902)
+|+.|++++|++++.. |..+..+++|++|++++|++.+..|..+..+++|+.|++++|++++..|. .|..+++|++|
T Consensus 351 ~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L 430 (606)
T 3t6q_A 351 NLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430 (606)
T ss_dssp TCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEE
T ss_pred cCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEE
Confidence 9999999999999876 88899999999999999999999999999999999999999999987665 49999999999
Q ss_pred EccCcccCCCCCCcCcccCcCceecccccccCCC---cChhhhcccccceeccCCCccCCCcccccc-cccccEEeccCc
Q 043136 444 DMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTS---LPSNIWSAPNLKILSASSSKLTGKIPDFIG-CKSIYKIELHNN 519 (902)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~~~l~~l~Ls~N 519 (902)
++++|.+++..|..+..+++|++|++++|++.+. .+..+..+++|+.|++++|++++.+|..++ +++|+.|+|++|
T Consensus 431 ~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 510 (606)
T 3t6q_A 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHN 510 (606)
T ss_dssp ECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred ECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCC
Confidence 9999999999999999999999999999999863 346799999999999999999998887655 999999999999
Q ss_pred cccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCC
Q 043136 520 LLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574 (902)
Q Consensus 520 ~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 574 (902)
++++.+|..+..++.| .|+|++|++++.+|..++.+++|+.|+|++|.+++..+
T Consensus 511 ~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 511 RLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred ccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 9999999999999999 99999999999999999999999999999999997544
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=563.97 Aligned_cols=510 Identities=20% Similarity=0.212 Sum_probs=338.6
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecc
Q 043136 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 157 (902)
.+++.|+|++|.+++..+..|+++++|++|+|++|++++..|.+|.++++|++|+|++|++++..|..|+++++|++|++
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 35666677766666666666666667777777766666666666666667777777766666666666666666777777
Q ss_pred ccccccCCCchhhhcccCCcEEeccCccCcC-CCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc----EEEeeCc
Q 043136 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE----RIEIGYN 232 (902)
Q Consensus 158 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~L~~N 232 (902)
++|.+++..|..|+++++|++|+|++|++++ .+|..|+++++|++|+|++|++++..|..|+.+++|+ +|++++|
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n 191 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTC
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCC
Confidence 7666666666666666667777776666664 4566666666677777776666666666666555544 5666666
Q ss_pred ccCCCCChhccCCCCCCEEEccCccCc-ccCCccccCCCCccEEecCCCcccee------cCCCCCCcC--cCcEEec-c
Q 043136 233 NLQGEVPVEFASLVNLKYMDISACNLS-GTLPSEISNLTKLEMLLLFKNHFTGE------IPVSYGNLQ--ALQVLDL-S 302 (902)
Q Consensus 233 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~------~p~~~~~l~--~L~~L~L-s 302 (902)
++++..+..+... +|++|++++|.++ +.+|..+.++++|+.+++..+.+.+. .+..+..+. .++.+++ .
T Consensus 192 ~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 270 (606)
T 3vq2_A 192 PIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270 (606)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECC
T ss_pred CcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccc
Confidence 6665555444443 6666666666665 34455666666666666654443321 011111111 3455555 6
Q ss_pred cCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCC
Q 043136 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPI 382 (902)
Q Consensus 303 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 382 (902)
.|.+++.+|. +..+++|+.|++++|.+. .+| .+..+++|+.|++++|++ +.+| .+ .+++|+.|++++|+..+.+
T Consensus 271 ~~~~~~~~~~-~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~ 344 (606)
T 3vq2_A 271 TNDFSDDIVK-FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF 344 (606)
T ss_dssp CTTCCGGGGS-CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC
T ss_pred cccccccccc-cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch
Confidence 6667666666 777777777777777774 344 666677777777777777 4555 33 6777777777777554433
Q ss_pred CCCccCCCCccEEeccCCcCccc--ccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCC-CcCc
Q 043136 383 PPTICDGDRLFKLILFSNNFTYS--IPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIP-RDLG 459 (902)
Q Consensus 383 p~~~~~~~~L~~L~l~~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~ 459 (902)
.+..+++|++|++++|++++. +|..+..+++|++|++++|.+++ +|..|..+++|+.|++++|++++..| ..+.
T Consensus 345 --~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~ 421 (606)
T 3vq2_A 345 --KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFL 421 (606)
T ss_dssp --CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTT
T ss_pred --hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhh
Confidence 455667777777777777655 36667777777777777777764 55677777777777777777776666 5677
Q ss_pred ccCcCceecccccccCCCcChhhhcccccceeccCCCccCCC-cccccc-cccccEEeccCccccccCCccccccccceE
Q 043136 460 NAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGK-IPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLL 537 (902)
Q Consensus 460 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~ 537 (902)
++++|++|++++|++.+.+|..+..+++|++|++++|++++. +|..++ +++|+.|+|++|++++.+|..++.+++|+.
T Consensus 422 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~ 501 (606)
T 3vq2_A 422 SLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501 (606)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCE
Confidence 777777777777777777777777777777777777777763 455443 677777777777777777777777777777
Q ss_pred EEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCc-cceeecccCCcccccCC
Q 043136 538 LNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCS-TLESFNVSYNLLTGPIP 598 (902)
Q Consensus 538 L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~-~L~~l~ls~N~l~g~ip 598 (902)
|+|++|++++.+|..++++++|++|||++|+++ .+|..+..++ +|++|++++|++.+..|
T Consensus 502 L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp EECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred EECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 777777777777777777777777777777777 5666677665 47777777777766544
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-58 Score=566.43 Aligned_cols=523 Identities=22% Similarity=0.242 Sum_probs=461.8
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCC-Ccccccccccceeccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTF-PPGISKLRFLRIFNAYSN 160 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N 160 (902)
..|.++++++ .+|. ..++|++|||++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|
T Consensus 8 ~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N 83 (844)
T 3j0a_A 8 IAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSS 83 (844)
T ss_dssp EEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTC
T ss_pred EEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCC
Confidence 3455677777 4565 5689999999999999999999999999999999999777766 778999999999999999
Q ss_pred cccCCCchhhhcccCCcEEeccCccCcCCCCcc--cCCCCCCCEEEccCCCccCCCC-ccccCCCCCcEEEeeCcccCCC
Q 043136 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD--YRNLSSLRFLDLAGNSLTGSLP-PQLGLLTQLERIEIGYNNLQGE 237 (902)
Q Consensus 161 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~ 237 (902)
++++..|..|+++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++.
T Consensus 84 ~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~ 163 (844)
T 3j0a_A 84 KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLV 163 (844)
T ss_dssp CCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCC
T ss_pred cCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCee
Confidence 999999999999999999999999999877765 9999999999999999997755 5799999999999999999999
Q ss_pred CChhccCC--CCCCEEEccCccCcccCCccccCCCC------ccEEecCCCccceecCCCCCCc---CcCcEEeccc---
Q 043136 238 VPVEFASL--VNLKYMDISACNLSGTLPSEISNLTK------LEMLLLFKNHFTGEIPVSYGNL---QALQVLDLSD--- 303 (902)
Q Consensus 238 ~p~~~~~l--~~L~~L~Ls~N~l~~~~p~~~~~l~~------L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~--- 303 (902)
.|..|..+ ++|++|+|++|.+.+..|..+..+++ |++|++++|.+++..+..+... ++++.|.++.
T Consensus 164 ~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~ 243 (844)
T 3j0a_A 164 CEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243 (844)
T ss_dssp CSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCC
T ss_pred CHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccc
Confidence 99999888 89999999999999988887777766 9999999999998888776543 6788888873
Q ss_pred ------CCCccccCcccccc--CCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecC
Q 043136 304 ------NQLSGPIPASLASL--KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375 (902)
Q Consensus 304 ------N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~ 375 (902)
|.+.+..+..|..+ ++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..|..|..+++|+.|++++
T Consensus 244 ~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~ 323 (844)
T 3j0a_A 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323 (844)
T ss_dssp BCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEES
T ss_pred cccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCC
Confidence 44444555566665 7899999999999999999999999999999999999999999999999999999999
Q ss_pred CcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCC
Q 043136 376 NSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIP 455 (902)
Q Consensus 376 N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 455 (902)
|++++..|..+..+++|+.|++++|++.+..+..|.++++|+.|+|++|.+++ ++ .+++|+.|++++|+++ .+|
T Consensus 324 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~----~~~~L~~L~l~~N~l~-~l~ 397 (844)
T 3j0a_A 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IH----FIPSIPDIFLSGNKLV-TLP 397 (844)
T ss_dssp CCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CS----SCCSCSEEEEESCCCC-CCC
T ss_pred CCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-cc----CCCCcchhccCCCCcc-ccc
Confidence 99999999999999999999999999998888899999999999999999984 33 3899999999999999 556
Q ss_pred CcCcccCcCceecccccccCCCc-ChhhhcccccceeccCCCccCCCccc--ccccccccEEeccCcccc-----ccCCc
Q 043136 456 RDLGNAQKLEYLNISENSFQTSL-PSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLN-----GSIPW 527 (902)
Q Consensus 456 ~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~l~~l~Ls~N~l~-----g~ip~ 527 (902)
.. ..+++.|++++|++++.. +..+..+++|+.|++++|++++..+. ...+++|+.|+|++|.++ +..|.
T Consensus 398 ~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~ 474 (844)
T 3j0a_A 398 KI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474 (844)
T ss_dssp CC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred cc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence 54 467999999999998643 33466899999999999999986654 334889999999999997 55567
Q ss_pred cccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCCCCCcCcCC
Q 043136 528 DIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNL 607 (902)
Q Consensus 528 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~~~~~~~ 607 (902)
.+..+++|+.|+|++|+|++.+|..|+++++|+.|||++|+|++..|..+. ++|+.|+|++|+|+|.+|.... .+
T Consensus 475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L 549 (844)
T 3j0a_A 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SL 549 (844)
T ss_dssp CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SC
T ss_pred hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---Cc
Confidence 789999999999999999999999999999999999999999987777776 8999999999999999997633 34
Q ss_pred CCCcccCCcccCCCC
Q 043136 608 HPSSFIGNEGLCGRV 622 (902)
Q Consensus 608 ~~~~~~gn~~lcg~~ 622 (902)
....+.||+..|..+
T Consensus 550 ~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 550 SVLDITHNKFICECE 564 (844)
T ss_dssp CEEEEEEECCCCSSS
T ss_pred CEEEecCCCcccccc
Confidence 667789999998654
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-58 Score=548.96 Aligned_cols=527 Identities=20% Similarity=0.197 Sum_probs=464.3
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNS 161 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 161 (902)
.++.++++++ .+|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+
T Consensus 15 ~~~c~~~~l~-~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~ 91 (606)
T 3vq2_A 15 TYQCMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91 (606)
T ss_dssp EEECTTSCCS-SCCTTSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred ceEccCCCcc-cCCCCCC--CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCc
Confidence 4677788887 5676654 899999999999999999999999999999999999999889999999999999999999
Q ss_pred ccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccC-CCCccccCCCCCcEEEeeCcccCCCCCh
Q 043136 162 FTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPV 240 (902)
Q Consensus 162 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 240 (902)
+++..|..|+++++|++|+|++|++++..+..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++++..|.
T Consensus 92 l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~ 171 (606)
T 3vq2_A 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVN 171 (606)
T ss_dssp CCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTT
T ss_pred ccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChh
Confidence 999999999999999999999999998888899999999999999999986 5799999999999999999999998888
Q ss_pred hccCCCCCC----EEEccCccCcccCCccccCCCCccEEecCCCccc-eecCCCCCCcCcCcEEecccCCCcc------c
Q 043136 241 EFASLVNLK----YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT-GEIPVSYGNLQALQVLDLSDNQLSG------P 309 (902)
Q Consensus 241 ~~~~l~~L~----~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~------~ 309 (902)
.|+.+++|+ +|++++|.+++..+..+... +|++|++++|.+. +..|..+.+++.|+.+++..+.+.+ .
T Consensus 172 ~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~ 250 (606)
T 3vq2_A 172 DLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250 (606)
T ss_dssp TTHHHHHCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCC
T ss_pred hhhhhhccccccceeeccCCCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCCccccc
Confidence 888877665 89999999997766666555 8999999999987 4667788899999999997766542 1
Q ss_pred cCccccccC--CCCEEEc-cCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCc
Q 043136 310 IPASLASLK--GLTRLSL-MNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386 (902)
Q Consensus 310 ~p~~l~~l~--~L~~L~L-~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~ 386 (902)
.+..+..+. .++.+++ ..|.+.+.+|. +..+++|+.|++++|.++. +| .+..+++|+.|++++|++ +.+| .+
T Consensus 251 ~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~ 325 (606)
T 3vq2_A 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL 325 (606)
T ss_dssp CGGGGTTGGGSEEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC
T ss_pred ChHHhhhhhhccHhheeccccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC
Confidence 122222222 4667777 78888888887 9999999999999999975 45 888999999999999999 6888 44
Q ss_pred cCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCC--CCcccCCCCCCcEEEccCcccCCCCCCcCcccCcC
Q 043136 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS--IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464 (902)
Q Consensus 387 ~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 464 (902)
.+++|+.|++++|+..+.+ .+..+++|++|++++|++++. +|..+..+++|++|++++|.+++ +|..+..+++|
T Consensus 326 -~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L 401 (606)
T 3vq2_A 326 -DLPFLKSLTLTMNKGSISF--KKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEEL 401 (606)
T ss_dssp -CCSSCCEEEEESCSSCEEC--CCCCCTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTC
T ss_pred -CCCccceeeccCCcCccch--hhccCCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCC
Confidence 8999999999999766544 677899999999999999976 48899999999999999999985 67899999999
Q ss_pred ceecccccccCCCcC-hhhhcccccceeccCCCccCCCcccccc-cccccEEeccCccccc-cCCccccccccceEEEee
Q 043136 465 EYLNISENSFQTSLP-SNIWSAPNLKILSASSSKLTGKIPDFIG-CKSIYKIELHNNLLNG-SIPWDIGHCEKLLLLNLS 541 (902)
Q Consensus 465 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~~~l~~l~Ls~N~l~g-~ip~~~~~l~~L~~L~Ls 541 (902)
+.|++++|++.+..| ..+..+++|+.|++++|++++.+|..++ +++|+.|++++|.+++ .+|..++.+++|+.|+|+
T Consensus 402 ~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls 481 (606)
T 3vq2_A 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLS 481 (606)
T ss_dssp CEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECT
T ss_pred CeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECC
Confidence 999999999998888 7899999999999999999998887665 9999999999999998 489999999999999999
Q ss_pred CCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCCCCCcCc-CCCCCcccCCcccCC
Q 043136 542 RNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFP-NLHPSSFIGNEGLCG 620 (902)
Q Consensus 542 ~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~~~~~-~~~~~~~~gn~~lcg 620 (902)
+|++++.+|..++++++|++|+|++|++++.+|..|.++++|++|++++|+++ .+|......+ .+......||+..|.
T Consensus 482 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 482 KCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp TSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred CCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccC
Confidence 99999999999999999999999999999999999999999999999999999 5776533322 345567789988885
Q ss_pred CC
Q 043136 621 RV 622 (902)
Q Consensus 621 ~~ 622 (902)
.+
T Consensus 561 c~ 562 (606)
T 3vq2_A 561 CE 562 (606)
T ss_dssp ST
T ss_pred Cc
Confidence 44
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-55 Score=517.33 Aligned_cols=493 Identities=19% Similarity=0.213 Sum_probs=366.5
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
.|.|.|| |+. ++++++ .+|+.+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|.
T Consensus 3 ~C~~~~~-c~~----------~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~ 68 (549)
T 2z81_A 3 SCDASGV-CDG----------RSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGD 68 (549)
T ss_dssp EECTTSE-EEC----------TTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTT
T ss_pred cCCCCce-EEC----------CCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChh
Confidence 5999999 854 455666 5677654 7999999999999999899999999999999999999998889
Q ss_pred ccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcC-CCCcccCCCCCCCEEEccCCCccCCCC-ccccCCC
Q 043136 145 GISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYRNLSSLRFLDLAGNSLTGSLP-PQLGLLT 222 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~ 222 (902)
.|+++++|++|+|++|++++..|..|+++++|++|+|++|++++ .+|..|+++++|++|++++|++.+.+| ..|..++
T Consensus 69 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~ 148 (549)
T 2z81_A 69 AFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148 (549)
T ss_dssp TTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCC
T ss_pred hccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhccc
Confidence 99999999999999999999888889999999999999999986 467788999999999999998544554 6789999
Q ss_pred CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec--C-CCCCCcCcCcEE
Q 043136 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI--P-VSYGNLQALQVL 299 (902)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p-~~~~~l~~L~~L 299 (902)
+|++|++++|++++..|..+..+++|++|+++.|.+....+..+..+++|++|++++|++++.. | .....+++|+.|
T Consensus 149 ~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L 228 (549)
T 2z81_A 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKL 228 (549)
T ss_dssp EEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEE
T ss_pred ccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccce
Confidence 9999999999999888999999999999999999887433333456888888888888888642 2 123346777888
Q ss_pred ecccCCCccccCc----cccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecC
Q 043136 300 DLSDNQLSGPIPA----SLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS 375 (902)
Q Consensus 300 ~Ls~N~l~~~~p~----~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~ 375 (902)
++++|.+++..+. .+..+++|+.|++++|.+.+...-.. .....+..+.+|+.|++++
T Consensus 229 ~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~------------------~~~~~~~~l~~L~~L~l~~ 290 (549)
T 2z81_A 229 AFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP------------------SESDVVSELGKVETVTIRR 290 (549)
T ss_dssp EEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCC------------------CTTTCCCCCTTCCEEEEES
T ss_pred eccccccchhHHHHHHHHhhhhccccccccccccccccccccc------------------cchhhhhhhcccccccccc
Confidence 8888777654433 33455666777777666654211000 0011223334444455544
Q ss_pred CcccCC-----CCCCccCCCCccEEeccCCcCcccccccc-cccCCCcEEEccCCccCCCCCc---ccCCCCCCcEEEcc
Q 043136 376 NSLTGP-----IPPTICDGDRLFKLILFSNNFTYSIPENL-VNCSSLSRLRIQDNQLNGSIPQ---GFGLLPNLTFMDMS 446 (902)
Q Consensus 376 N~l~~~-----~p~~~~~~~~L~~L~l~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~Ls 446 (902)
+.+... ++..+....+|+.|++++|++. .+|..+ ..+++|++|++++|++++.+|. .++.+++|++|+|+
T Consensus 291 ~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls 369 (549)
T 2z81_A 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLS 369 (549)
T ss_dssp CBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECT
T ss_pred cccchhhhcccchhhhhhcccceEEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEcc
Confidence 443321 1111122345666666666665 455554 4677777777777777765542 36677777777777
Q ss_pred CcccCCCCC--CcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCcccccc
Q 043136 447 RNSLSGEIP--RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGS 524 (902)
Q Consensus 447 ~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ 524 (902)
+|++++..+ ..+..+++|++|+|++|+++ .+|..+..+++|++|++++|++++. |..+ .++|+.|||++|++++.
T Consensus 370 ~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~-~~~L~~L~Ls~N~l~~~ 446 (549)
T 2z81_A 370 QNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVV-KTCI-PQTLEVLDVSNNNLDSF 446 (549)
T ss_dssp TSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSCC-CTTS-CTTCSEEECCSSCCSCC
T ss_pred CCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcccc-cchh-cCCceEEECCCCChhhh
Confidence 777775432 44677777777788877776 5677777777788888888877642 2222 25788888888888864
Q ss_pred CCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCC
Q 043136 525 IPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPA 599 (902)
Q Consensus 525 ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~ 599 (902)
+ +.+++|+.|+|++|+|+ .+|. .+.+++|++|||++|++++.+|..|.++++|+.|++++|++++..|.
T Consensus 447 ~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 515 (549)
T 2z81_A 447 S----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 515 (549)
T ss_dssp C----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred c----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence 3 57889999999999998 5665 56789999999999999988888899999999999999999988874
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-54 Score=513.81 Aligned_cols=491 Identities=19% Similarity=0.185 Sum_probs=361.8
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEec
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNL 181 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 181 (902)
+++++|+|++|++++..+.+|.++++|++|+|++|++++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 45667777777776666666677777777777777766666666667777777777777766666666777777777777
Q ss_pred cCccCcCCCCcccCCCCCCCEEEccCCCccC-CCCccccCCCCCcEEEeeCcccCCCCChhccCCCCC----CEEEccCc
Q 043136 182 GGSYFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL----KYMDISAC 256 (902)
Q Consensus 182 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N 256 (902)
++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..|+.+++| +.|++++|
T Consensus 108 ~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n 187 (570)
T 2z63_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187 (570)
T ss_dssp TTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred cccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCC
Confidence 7777665555456677777777777777665 356667777777777777777766666666666666 66777777
Q ss_pred cCcccCCccccCCCCccEEecCCCccce-ecCCCCCCcCcCcEEecccCCC------ccccCccccccCC--CCEEEccC
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTG-EIPVSYGNLQALQVLDLSDNQL------SGPIPASLASLKG--LTRLSLMN 327 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l------~~~~p~~l~~l~~--L~~L~L~~ 327 (902)
.+++..|..+..+ +|++|++++|.... .++..+..++.++.+.+.-+.+ .......+..+.+ ++.+++++
T Consensus 188 ~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~ 266 (570)
T 2z63_A 188 PMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266 (570)
T ss_dssp CCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE
T ss_pred CceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc
Confidence 7776666655544 57777776664321 2233344455555544433222 1122223333332 46667777
Q ss_pred c-cccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccc
Q 043136 328 N-VLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSI 406 (902)
Q Consensus 328 N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~ 406 (902)
| .+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|+++ .+|. ..+++|+.|++.+|.+.+..
T Consensus 267 ~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSCCEEEEESCBSCCBC
T ss_pred chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--ccccccCEEeCcCCcccccc
Confidence 6 667777777888888888888888887 466667777 8888888888887 4554 45677888888888877666
Q ss_pred cccccccCCCcEEEccCCccCCCC--CcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcC-hhhh
Q 043136 407 PENLVNCSSLSRLRIQDNQLNGSI--PQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLP-SNIW 483 (902)
Q Consensus 407 p~~l~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~ 483 (902)
+. ..+++|++|++++|++++.. |..+..+++|++|++++|++++..+. +..+++|+.|++++|.+.+..| ..+.
T Consensus 342 ~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~ 418 (570)
T 2z63_A 342 SE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFL 418 (570)
T ss_dssp CC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTT
T ss_pred cc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhh
Confidence 55 67788888888888887544 67788888888888888888865444 8888888888888888877665 5678
Q ss_pred cccccceeccCCCccCCCcccccc-cccccEEeccCcccc-ccCCccccccccceEEEeeCCcceecCCCCCCCCCcccE
Q 043136 484 SAPNLKILSASSSKLTGKIPDFIG-CKSIYKIELHNNLLN-GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITD 561 (902)
Q Consensus 484 ~l~~L~~L~ls~N~l~~~~p~~~~-~~~l~~l~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~ 561 (902)
.+++|++|++++|++++.+|..++ +++|+.|+|++|.++ +.+|..++.+++|+.|+|++|++++.+|..++.+++|+.
T Consensus 419 ~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 498 (570)
T 2z63_A 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 498 (570)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCE
Confidence 888888888888888887776554 889999999999987 689999999999999999999999999999999999999
Q ss_pred EEccCCcccccCCCCCcCCccceeecccCCcccccCCCCC
Q 043136 562 VDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASG 601 (902)
Q Consensus 562 L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~ 601 (902)
|+|++|++++.+|..|.++++|+.|++++|+++|.+|...
T Consensus 499 L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~ 538 (570)
T 2z63_A 499 LNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 538 (570)
T ss_dssp EECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred EeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence 9999999999888899999999999999999999988753
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=507.14 Aligned_cols=501 Identities=19% Similarity=0.195 Sum_probs=440.1
Q ss_pred CccccEEecCC--CCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 66 CSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 66 C~w~Gv~c~~~--~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
|++.|.+-.+. +.+++.|+|++|.+++..+.+|+.+++|++|+|++|++++..+.+|.++++|++|+|++|++++..|
T Consensus 14 c~~~~l~~ip~~l~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (570)
T 2z63_A 14 CMELNFYKIPDNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLAL 93 (570)
T ss_dssp CCSSCCSSCCSSSCSSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECT
T ss_pred eCCCCccccCCCccccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCH
Confidence 44444433332 3579999999999999888899999999999999999999888999999999999999999999888
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcC-CCCcccCCCCCCCEEEccCCCccCCCCccccCCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLT 222 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 222 (902)
..|+.+++|++|++++|++++..+..|+++++|++|+|++|.+++ .+|..|+++++|++|++++|++++..|..++.++
T Consensus 94 ~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 173 (570)
T 2z63_A 94 GAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173 (570)
T ss_dssp TTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHH
T ss_pred hhhcCccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchh
Confidence 999999999999999999998877789999999999999999987 4799999999999999999999988888899999
Q ss_pred CC----cEEEeeCcccCCCCChhccCCCCCCEEEccCccCcc-cCCccccCCCCccEEecCCCcc------ceecCCCCC
Q 043136 223 QL----ERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG-TLPSEISNLTKLEMLLLFKNHF------TGEIPVSYG 291 (902)
Q Consensus 223 ~L----~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l------~~~~p~~~~ 291 (902)
+| ++|++++|.+++..|..|... +|++|++++|.... .++..+..+++++.+.+..+.+ .......+.
T Consensus 174 ~L~~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~ 252 (570)
T 2z63_A 174 QMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252 (570)
T ss_dssp TCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTG
T ss_pred ccchhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhc
Confidence 98 899999999999888888776 89999999986542 3456677888888777654433 222233344
Q ss_pred CcC--cCcEEecccC-CCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCce
Q 043136 292 NLQ--ALQVLDLSDN-QLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368 (902)
Q Consensus 292 ~l~--~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L 368 (902)
.++ .++.+++++| .+.+.+|..+..+++|+.|++++|.+. .+|..+..+ +|+.|++++|.++ .+|. ..+++|
T Consensus 253 ~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~--~~l~~L 327 (570)
T 2z63_A 253 GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPT--LKLKSL 327 (570)
T ss_dssp GGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCB--CBCSSC
T ss_pred cccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCc--cccccc
Confidence 443 3578888888 788889999999999999999999997 588888888 9999999999998 4444 467899
Q ss_pred eEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccc--cccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEcc
Q 043136 369 LTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSI--PENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446 (902)
Q Consensus 369 ~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 446 (902)
+.|++++|.+.+..+. ..+++|++|++++|++++.. |..+.++++|++|++++|++++..+ .+..+++|+.|+++
T Consensus 328 ~~L~l~~n~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~ 404 (570)
T 2z63_A 328 KRLTFTSNKGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQ 404 (570)
T ss_dssp CEEEEESCBSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECT
T ss_pred CEEeCcCCcccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccc-cccccCCCCEEEcc
Confidence 9999999999887766 77899999999999998764 7889999999999999999996544 49999999999999
Q ss_pred CcccCCCCC-CcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccC-CCcccccc-cccccEEeccCccccc
Q 043136 447 RNSLSGEIP-RDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLT-GKIPDFIG-CKSIYKIELHNNLLNG 523 (902)
Q Consensus 447 ~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~-~~~l~~l~Ls~N~l~g 523 (902)
+|++++..| ..+.++++|++|++++|.+.+..|..+..+++|+.|++++|+++ +.+|..++ +++|+.|+|++|++++
T Consensus 405 ~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~ 484 (570)
T 2z63_A 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQ 484 (570)
T ss_dssp TSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCE
T ss_pred CCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCcccc
Confidence 999998776 57899999999999999999999999999999999999999998 56777655 9999999999999999
Q ss_pred cCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCC
Q 043136 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575 (902)
Q Consensus 524 ~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 575 (902)
..|..++.+++|+.|+|++|++++.+|..++.+++|+.|++++|.+++..|.
T Consensus 485 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 485 LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred CChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 9999999999999999999999999999999999999999999999988774
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-54 Score=515.53 Aligned_cols=457 Identities=18% Similarity=0.221 Sum_probs=307.6
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCC------CC------CCCcccccccccceeccccccccCCCchh
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSF------NS------TFPPGISKLRFLRIFNAYSNSFTGPLPLE 169 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l------~~------~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 169 (902)
.+++.|+|++|.++|.+|++|++|++|++|+|++|.+ .+ .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 4788999999999999999999999999999999977 23 334333 56677 888888888887776
Q ss_pred hhc-ccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc--CCCccCCCCccccCCCCCcEEEeeCcccCCC---------
Q 043136 170 FVQ-LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA--GNSLTGSLPPQLGLLTQLERIEIGYNNLQGE--------- 237 (902)
Q Consensus 170 ~~~-l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--------- 237 (902)
+.. +..+..+++....+.. .....++.+.+. .|++++ +|..|+++++|++|+|++|+++|.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~------~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~ 230 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKK------SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENE 230 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCC------CCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred HHHHHHHHhhcCcccccccc------ccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccccccccccc
Confidence 663 3345555555443331 112233333333 578887 788888888888888888888875
Q ss_pred --------CChhcc--CCCCCCEEEccCccCcccCCccccCCCCccEEecCCCc-cce-ecCCCCCCc------CcCcEE
Q 043136 238 --------VPVEFA--SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNH-FTG-EIPVSYGNL------QALQVL 299 (902)
Q Consensus 238 --------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~-~~p~~~~~l------~~L~~L 299 (902)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++.+ ++|++|
T Consensus 231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L 310 (636)
T 4eco_A 231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310 (636)
T ss_dssp TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence 677766 77777777777777777777777777777777777776 776 666666655 677777
Q ss_pred ecccCCCccccCc--cccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCc-eeEEEecCC
Q 043136 300 DLSDNQLSGPIPA--SLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGK-LLTVDVSSN 376 (902)
Q Consensus 300 ~Ls~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~-L~~L~Ls~N 376 (902)
+|++|+++ .+|. .+..+++|++|++++|++.|.+| .+..+++|++|++++|+++ .+|..+..+++ |+.|++++|
T Consensus 311 ~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N 387 (636)
T 4eco_A 311 YIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHN 387 (636)
T ss_dssp ECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSS
T ss_pred ECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCC
Confidence 77777776 5666 67777777777777777776677 6666777777777777776 55666666666 667777666
Q ss_pred cccCCCCCCccCCC--CccEEeccCCcCccccccccc-------ccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccC
Q 043136 377 SLTGPIPPTICDGD--RLFKLILFSNNFTYSIPENLV-------NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSR 447 (902)
Q Consensus 377 ~l~~~~p~~~~~~~--~L~~L~l~~N~l~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 447 (902)
+++ .+|..+.... +|+.|++++|++++.+|..+. .+++|+.|+|++|++++..+..+..+++|++|+|++
T Consensus 388 ~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~ 466 (636)
T 4eco_A 388 KLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466 (636)
T ss_dssp CCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCS
T ss_pred cCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCC
Confidence 666 5555554433 455555555555555555444 444455555555555422222233345555555555
Q ss_pred cccCCCCCCcCcc-cCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccc-c--ccccccEEeccCccccc
Q 043136 448 NSLSGEIPRDLGN-AQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDF-I--GCKSIYKIELHNNLLNG 523 (902)
Q Consensus 448 N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~-~--~~~~l~~l~Ls~N~l~g 523 (902)
|+++ .+|..+.. .. ..+.++++|+.|++++|+++ .+|.. . .+++|+.|+|++|++++
T Consensus 467 N~l~-~i~~~~~~~~~-----------------~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~ 527 (636)
T 4eco_A 467 NMLT-EIPKNSLKDEN-----------------ENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK 527 (636)
T ss_dssp SCCS-BCCSSSSEETT-----------------EECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS
T ss_pred CCCC-CcCHHHhcccc-----------------ccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC
Confidence 5554 23322211 11 00011125556666666655 33332 2 45666666666777765
Q ss_pred cCCccccccccceEEEe------eCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccc
Q 043136 524 SIPWDIGHCEKLLLLNL------SRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595 (902)
Q Consensus 524 ~ip~~~~~l~~L~~L~L------s~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g 595 (902)
+|..++.+++|+.|+| ++|++.+.+|..++++++|++|||++|++ +.+|..+. ++|+.|+|++|++..
T Consensus 528 -ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 528 -FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNIS 601 (636)
T ss_dssp -CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCE
T ss_pred -cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCcc
Confidence 7777777777888877 67889999999999999999999999999 68998876 799999999998864
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=486.17 Aligned_cols=452 Identities=18% Similarity=0.219 Sum_probs=300.5
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNS 161 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 161 (902)
.||+++|+++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|+
T Consensus 4 ~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~ 80 (520)
T 2z7x_B 4 LVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80 (520)
T ss_dssp EEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSC
T ss_pred eEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCc
Confidence 5666777666 4555554 666666666666666666666666666666666666665555555555555555555555
Q ss_pred ccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccC-CCCccccCCCCCcEEEeeCcccCCCCCh
Q 043136 162 FTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPV 240 (902)
Q Consensus 162 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 240 (902)
++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|++++|+|++ .
T Consensus 81 l~-------------------------~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~ 130 (520)
T 2z7x_B 81 LV-------------------------KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---S 130 (520)
T ss_dssp CC-------------------------EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---G
T ss_pred ee-------------------------ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---h
Confidence 44 23333 45555555555555554 244555555555555555555553 2
Q ss_pred hccCCCCC--CEEEccCccC--cccCCccccCCC-CccEEecCCCccceecCC-CCCCcCcCcEEecccCC-------Cc
Q 043136 241 EFASLVNL--KYMDISACNL--SGTLPSEISNLT-KLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQ-------LS 307 (902)
Q Consensus 241 ~~~~l~~L--~~L~Ls~N~l--~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~-------l~ 307 (902)
.|..+++| ++|++++|.+ .+..|..+..+. +...+++++|++.+.++. .+.++++|+.|++++|. +.
T Consensus 131 ~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 210 (520)
T 2z7x_B 131 SVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFL 210 (520)
T ss_dssp GGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHH
T ss_pred hccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceee
Confidence 34444445 6666666665 555555555544 233456666666654443 46677778888888876 66
Q ss_pred cccCccccccCCCCEEEccCccccccCChhhh---hccccceEEecCceeccccCccc-----cCCCceeEEEecCCccc
Q 043136 308 GPIPASLASLKGLTRLSLMNNVLFGEIPQDIE---LLADLDTLLLWNNHLTGVLPQKL-----GSNGKLLTVDVSSNSLT 379 (902)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~L~~L~Ls~N~l~ 379 (902)
+.+| .+..+++|+.|++++|.+.+..+..+. ..++|++|++++|+++|.+|..+ ..+++|+.+++++|.+
T Consensus 211 ~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~- 288 (520)
T 2z7x_B 211 SILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF- 288 (520)
T ss_dssp HHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-
T ss_pred cchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-
Confidence 6665 677788888888888777654433321 13467777777777777777666 6666666666666665
Q ss_pred CCCCCCccCCCCccEEeccCCcCccccccccccc---CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCC
Q 043136 380 GPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC---SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPR 456 (902)
Q Consensus 380 ~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 456 (902)
.+|. ..+..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|.
T Consensus 289 -~~p~-----------------------~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~ 342 (520)
T 2z7x_B 289 -GFPQ-----------------------SYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFE 342 (520)
T ss_dssp -CSCT-----------------------HHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTT
T ss_pred -ecch-----------------------hhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhh
Confidence 2331 223222 45777777777765321 125677788888888888777777
Q ss_pred cCcccCcCceecccccccCC--CcChhhhcccccceeccCCCccCCCccc--ccccccccEEeccCccccccCCcccccc
Q 043136 457 DLGNAQKLEYLNISENSFQT--SLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHC 532 (902)
Q Consensus 457 ~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~l~~l~Ls~N~l~g~ip~~~~~l 532 (902)
.++++++|++|+|++|++++ .+|..+..+++|++|++++|++++.+|. +.++++|+.|++++|++++.+|..+.
T Consensus 343 ~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~-- 420 (520)
T 2z7x_B 343 NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP-- 420 (520)
T ss_dssp TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--
T ss_pred hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--
Confidence 77778888888888888775 4567777888888888888888875554 34478888888888888888887765
Q ss_pred ccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCC-CcCCccceeecccCCcccccCC
Q 043136 533 EKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIP 598 (902)
Q Consensus 533 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~l~ls~N~l~g~ip 598 (902)
++|+.|+|++|+++ .+|..+..+++|++|||++|+++ .+|.. |..+++|++|++++|++++..+
T Consensus 421 ~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 421 PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 78899999999998 67777779999999999999998 56665 8889999999999999987655
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=484.82 Aligned_cols=455 Identities=19% Similarity=0.216 Sum_probs=369.8
Q ss_pred cEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCC
Q 043136 129 RTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGN 208 (902)
Q Consensus 129 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 208 (902)
++||+++|.++ .+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46777777777 3666555 77888888888888888889999999999999999999888999999999999999999
Q ss_pred CccCCCCccccCCCCCcEEEeeCcccCC-CCChhccCCCCCCEEEccCccCcccCCccccCCCCc--cEEecCCCcc--c
Q 043136 209 SLTGSLPPQLGLLTQLERIEIGYNNLQG-EVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKL--EMLLLFKNHF--T 283 (902)
Q Consensus 209 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L--~~L~L~~N~l--~ 283 (902)
+++ .+|.. .+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++ ..+..+++| ++|++++|++ .
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~ 153 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGE 153 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTS
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeeccccccc
Confidence 999 56666 89999999999999997 478999999999999999999986 457777888 9999999999 7
Q ss_pred eecCCCCCCcC-cCcEEecccCCCccccCc-cccccCCCCEEEccCcc-------ccccCChhhhhccccceEEecCcee
Q 043136 284 GEIPVSYGNLQ-ALQVLDLSDNQLSGPIPA-SLASLKGLTRLSLMNNV-------LFGEIPQDIELLADLDTLLLWNNHL 354 (902)
Q Consensus 284 ~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~N~-------l~~~~p~~~~~l~~L~~L~L~~N~l 354 (902)
+..|..+..+. ....+++++|++.+.++. .+..+++|+.|++++|. +.+.+| .+..+++|+.|++++|.+
T Consensus 154 ~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l 232 (520)
T 2z7x_B 154 KEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIET 232 (520)
T ss_dssp SCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEE
T ss_pred ccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccccc
Confidence 78888887765 455678888988776554 67788899999999887 666665 677888888888888888
Q ss_pred ccccCcccc---CCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCC
Q 043136 355 TGVLPQKLG---SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP 431 (902)
Q Consensus 355 ~~~~~~~~~---~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 431 (902)
++..+..+. ..++|+.|++++|+++|.+|..+.... ...+++|+.+++++|.+ .+|
T Consensus 233 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~-------------------~~~l~~L~~l~l~~n~~--~~p 291 (520)
T 2z7x_B 233 TWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS-------------------GTSLKALSIHQVVSDVF--GFP 291 (520)
T ss_dssp EHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCC-------------------SCCCCEEEEEEEEECCC--CSC
T ss_pred CHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcc-------------------cccCceeEeccccccce--ecc
Confidence 764332221 134666666666666665555442210 16788899999999999 466
Q ss_pred -cccCCC---CCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCC--Ccccc
Q 043136 432 -QGFGLL---PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG--KIPDF 505 (902)
Q Consensus 432 -~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~ 505 (902)
.++..+ .+|+.|++++|.+.+.. .+..+++|++|++++|++++.+|.++..+++|+.|++++|++++ .+|..
T Consensus 292 ~~~~~~~~~~~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~ 369 (520)
T 2z7x_B 292 QSYIYEIFSNMNIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEM 369 (520)
T ss_dssp THHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHH
T ss_pred hhhhhcccccCceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHH
Confidence 555555 78999999999987532 23688999999999999999999999999999999999999997 45554
Q ss_pred c-ccccccEEeccCccccccCCcc-ccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccc
Q 043136 506 I-GCKSIYKIELHNNLLNGSIPWD-IGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583 (902)
Q Consensus 506 ~-~~~~l~~l~Ls~N~l~g~ip~~-~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L 583 (902)
+ .+++|+.|+|++|.+++.+|.. +..+++|+.|+|++|++++.+|..+. ++|+.|||++|+++ .+|..+..+++|
T Consensus 370 ~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L 446 (520)
T 2z7x_B 370 TTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEAL 446 (520)
T ss_dssp HTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTC
T ss_pred HhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCC
Confidence 4 4899999999999999878875 88899999999999999999888775 79999999999999 899988899999
Q ss_pred eeecccCCcccccCCCC-CCcCcCCCCCcccCCcccCC
Q 043136 584 ESFNVSYNLLTGPIPAS-GTIFPNLHPSSFIGNEGLCG 620 (902)
Q Consensus 584 ~~l~ls~N~l~g~ip~~-~~~~~~~~~~~~~gn~~lcg 620 (902)
++|++++|+++ .+|.. ....+.+......+|+--|.
T Consensus 447 ~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~ 483 (520)
T 2z7x_B 447 QELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCS 483 (520)
T ss_dssp CEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCccc
Confidence 99999999999 46764 33334455666788887774
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=487.03 Aligned_cols=475 Identities=20% Similarity=0.224 Sum_probs=369.3
Q ss_pred CccccEEecCC--CCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 66 CSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 66 C~w~Gv~c~~~--~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
|++.+++.-+. ..+++.|+|++|++++..|..|+.+++|++|+|++|++++..|.+|+++++|++|+|++|++++..|
T Consensus 12 ~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 91 (549)
T 2z81_A 12 GRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSS 91 (549)
T ss_dssp CTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCH
T ss_pred CCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCH
Confidence 56667766554 3589999999999999989999999999999999999999999999999999999999999999888
Q ss_pred cccccccccceeccccccccC-CCchhhhcccCCcEEeccCccCcCCCC-cccCCCCCCCEEEccCCCccCCCCccccCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTG-PLPLEFVQLNSLQQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGNSLTGSLPPQLGLL 221 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 221 (902)
..|+++++|++|++++|.+++ ..|..|+++++|++|+|++|.+.+.+| ..|.++++|++|++++|++++.+|..++.+
T Consensus 92 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 171 (549)
T 2z81_A 92 SWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSI 171 (549)
T ss_dssp HHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTC
T ss_pred HHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhcc
Confidence 889999999999999999997 467899999999999999999555555 689999999999999999999999999999
Q ss_pred CCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccC--C-ccccCCCCccEEecCCCccceecC----CCCCCcC
Q 043136 222 TQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTL--P-SEISNLTKLEMLLLFKNHFTGEIP----VSYGNLQ 294 (902)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~--p-~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~ 294 (902)
++|++|+++.|.+....+..+..+++|++|++++|++++.. | .....+++|+.|++++|.+++..+ ..+..++
T Consensus 172 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~ 251 (549)
T 2z81_A 172 RDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251 (549)
T ss_dssp SEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCT
T ss_pred ccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhc
Confidence 99999999999997443344567999999999999999752 2 233567899999999999987544 3456788
Q ss_pred cCcEEecccCCCcccc------CccccccCCCCEEEccCcccccc-----CChhhhhccccceEEecCceeccccCcccc
Q 043136 295 ALQVLDLSDNQLSGPI------PASLASLKGLTRLSLMNNVLFGE-----IPQDIELLADLDTLLLWNNHLTGVLPQKLG 363 (902)
Q Consensus 295 ~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 363 (902)
+|+.|++++|.+.+.. ...+..+.+|+.|++.++.+... ++..+....+|+.|++++|+++
T Consensus 252 ~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~-------- 323 (549)
T 2z81_A 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-------- 323 (549)
T ss_dssp TCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCC--------
T ss_pred cccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccc--------
Confidence 9999999999987632 12345667778888877765421 1222233344555555555554
Q ss_pred CCCceeEEEecCCcccCCCCCCc-cCCCCccEEeccCCcCccccc---ccccccCCCcEEEccCCccCCCCC--cccCCC
Q 043136 364 SNGKLLTVDVSSNSLTGPIPPTI-CDGDRLFKLILFSNNFTYSIP---ENLVNCSSLSRLRIQDNQLNGSIP--QGFGLL 437 (902)
Q Consensus 364 ~~~~L~~L~Ls~N~l~~~~p~~~-~~~~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~L~Ls~N~l~~~~p--~~~~~l 437 (902)
.+|..+ ..+++|++|++++|++++.+| ..+..+++|+.|+|++|++++..+ ..+..+
T Consensus 324 -----------------~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l 386 (549)
T 2z81_A 324 -----------------LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTL 386 (549)
T ss_dssp -----------------CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGC
T ss_pred -----------------cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcC
Confidence 333333 234445555555555554443 235566777777777777764322 346677
Q ss_pred CCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEecc
Q 043136 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELH 517 (902)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls 517 (902)
++|++|||++|+++ .+|..+..+++|++|++++|++++ +|..+ .++|++|++++|++++.+ .++++|++|+|+
T Consensus 387 ~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~--~~~L~~L~Ls~N~l~~~~---~~l~~L~~L~Ls 459 (549)
T 2z81_A 387 KNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSNNNLDSFS---LFLPRLQELYIS 459 (549)
T ss_dssp TTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCSC-CCTTS--CTTCSEEECCSSCCSCCC---CCCTTCCEEECC
T ss_pred CCCCEEECCCCCCc-cCChhhcccccccEEECCCCCccc-ccchh--cCCceEEECCCCChhhhc---ccCChhcEEECC
Confidence 77777777777777 567777777777777777777753 44433 257888888888887653 247788999999
Q ss_pred CccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCC
Q 043136 518 NNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574 (902)
Q Consensus 518 ~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 574 (902)
+|+++ .+|. .+.+++|+.|+|++|+|++.+|..++.+++|+.|||++|.+++..|
T Consensus 460 ~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 514 (549)
T 2z81_A 460 RNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 514 (549)
T ss_dssp SSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCCHH
T ss_pred CCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCCCc
Confidence 99997 7776 5789999999999999999999999999999999999999987665
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=477.00 Aligned_cols=483 Identities=19% Similarity=0.190 Sum_probs=267.4
Q ss_pred CCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEecc
Q 043136 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLG 182 (902)
Q Consensus 103 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 182 (902)
++++|||++|+|++..+.+|.++++|++|||++|+|++..|..|+++++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 45555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CccCcCCCCcccCCCCCCCEEEccCCCccC-CCCccccCCCCCcEEEeeCcccCCCCChhccCCCCC----CEEEccCcc
Q 043136 183 GSYFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL----KYMDISACN 257 (902)
Q Consensus 183 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~Ls~N~ 257 (902)
+|++++..+..|+++++|++|+|++|++++ .+|..++.+++|++|++++|+|++..|..|..+.++ ..++++.|.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 555555444555555555555555555543 234555555555555555555555555555443332 245555555
Q ss_pred CcccCCccccCCCCccEEecCCCccce-------------------------------ecCCCCCCcCcCcEEecccCCC
Q 043136 258 LSGTLPSEISNLTKLEMLLLFKNHFTG-------------------------------EIPVSYGNLQALQVLDLSDNQL 306 (902)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~L~~N~l~~-------------------------------~~p~~~~~l~~L~~L~Ls~N~l 306 (902)
++...+..+ ....++.+++.+|.... .....+..+..+..+++..+..
T Consensus 213 l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~ 291 (635)
T 4g8a_A 213 MNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 291 (635)
T ss_dssp CCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECC
T ss_pred ccccCcccc-cchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhh
Confidence 554333322 22334445555543321 1122233333344444433322
Q ss_pred c---cccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCC
Q 043136 307 S---GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIP 383 (902)
Q Consensus 307 ~---~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p 383 (902)
. ..++..+..+.+++.+++.+|.+... ..+.....|+.|++.+|.+.+..+. .+..|+.++++.|.+...
T Consensus 292 ~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~-- 364 (635)
T 4g8a_A 292 DYYLDGIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNA-- 364 (635)
T ss_dssp CSCEEECTTTTGGGTTCSEEEEESCEEEEC--GGGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCB--
T ss_pred cccccchhhhhhhhcccccccccccccccc--cccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCC--
Confidence 1 12233444555666666666655432 2244455566666666666544332 234555666666655432
Q ss_pred CCccCCCCccEEeccCCcCcc--cccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCC-CcCcc
Q 043136 384 PTICDGDRLFKLILFSNNFTY--SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIP-RDLGN 460 (902)
Q Consensus 384 ~~~~~~~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 460 (902)
....++++|+.++++.|.+.. ..+..+..+.+|+.|+++.|.+.+ ++..+..+++|+.+++++|+.....+ ..|..
T Consensus 365 ~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~ 443 (635)
T 4g8a_A 365 FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS 443 (635)
T ss_dssp CCCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTT
T ss_pred cccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhcccccccccccccc
Confidence 223355666666666666543 334445555666666666666653 44456666666666666665554433 34556
Q ss_pred cCcCceecccccccCCCcChhhhcccccceeccCCCccCC-Ccccccc-cccccEEeccCccccccCCccccccccceEE
Q 043136 461 AQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTG-KIPDFIG-CKSIYKIELHNNLLNGSIPWDIGHCEKLLLL 538 (902)
Q Consensus 461 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L 538 (902)
+++++.++++.|.+.+..|..+..++.|+.|++++|++.. .+|+.+. +++|+.|||++|+|++.+|..|+.+++|++|
T Consensus 444 l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L 523 (635)
T 4g8a_A 444 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL 523 (635)
T ss_dssp CTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred ccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence 6666666666666666666666666666666666665332 3344333 5666666666666666666666666666666
Q ss_pred EeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCC-ccceeecccCCccc
Q 043136 539 NLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENC-STLESFNVSYNLLT 594 (902)
Q Consensus 539 ~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l-~~L~~l~ls~N~l~ 594 (902)
+|++|+|++++|..|+++++|++|||++|+|++.+|..|..+ ++|++|+|++|++.
T Consensus 524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~ 580 (635)
T 4g8a_A 524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 580 (635)
T ss_dssp ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBC
T ss_pred ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCc
Confidence 666666666666666666666666666666666666666665 45666666666664
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=490.45 Aligned_cols=371 Identities=19% Similarity=0.238 Sum_probs=256.3
Q ss_pred CCccCCCCccccCCCCCcEEEeeCcccCCC-CChhccCCCCCCEEEccCccCcccCCcccc--CCCCccEEecCCCccce
Q 043136 208 NSLTGSLPPQLGLLTQLERIEIGYNNLQGE-VPVEFASLVNLKYMDISACNLSGTLPSEIS--NLTKLEMLLLFKNHFTG 284 (902)
Q Consensus 208 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~ 284 (902)
|++++ +|..|+++++|++|+|++|+|++. +|..+. .++.|.++|.+|..++ ++++|++|+|++|++.+
T Consensus 435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~--------~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~ 505 (876)
T 4ecn_A 435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWE--------DANSDYAKQYENEELSWSNLKDLTDVELYNCPNMT 505 (876)
T ss_dssp CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCS--------CTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCC
T ss_pred Ccccc-hhHHHhcCCCCCEEECcCCcCCCCccccccc--------ccccccccccCChhhhhccCCCCCEEECcCCCCCc
Confidence 55555 566666666666666666666551 111100 0111222234666655 66666666666666666
Q ss_pred ecCCCCCCcCcCcEEecccCC-Ccc-ccCccccccC-------CCCEEEccCccccccCCh--hhhhccccceEEecCce
Q 043136 285 EIPVSYGNLQALQVLDLSDNQ-LSG-PIPASLASLK-------GLTRLSLMNNVLFGEIPQ--DIELLADLDTLLLWNNH 353 (902)
Q Consensus 285 ~~p~~~~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~ 353 (902)
.+|..|+++++|++|+|++|+ ++| .+|..+..++ +|+.|+|++|.++ .+|. .+..+++|+.|+|++|+
T Consensus 506 ~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~ 584 (876)
T 4ecn_A 506 QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNK 584 (876)
T ss_dssp SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSC
T ss_pred cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCC
Confidence 666666666666666666666 666 5666555544 6777777777766 5666 66677777777777777
Q ss_pred eccccCccccCCCceeEEEecCCcccCCCCCCccCCCC-ccEEeccCCcCcccccccccccCC--CcEEEccCCccCCCC
Q 043136 354 LTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDR-LFKLILFSNNFTYSIPENLVNCSS--LSRLRIQDNQLNGSI 430 (902)
Q Consensus 354 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~-L~~L~l~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~ 430 (902)
++ .+| .|+.+++|+.|++++|+++ .+|..++.+++ |+.|++++|+++ .+|..+..++. |+.|+|++|+++|.+
T Consensus 585 l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~i 660 (876)
T 4ecn_A 585 VR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEG 660 (876)
T ss_dssp CC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTS
T ss_pred cc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCcc
Confidence 76 555 6667777777777777777 66666777766 777777777776 66666665543 777777777777665
Q ss_pred Cccc---C--CCCCCcEEEccCcccCCCCCCcC-cccCcCceecccccccCCCcChhhhcc--------cccceeccCCC
Q 043136 431 PQGF---G--LLPNLTFMDMSRNSLSGEIPRDL-GNAQKLEYLNISENSFQTSLPSNIWSA--------PNLKILSASSS 496 (902)
Q Consensus 431 p~~~---~--~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~~l--------~~L~~L~ls~N 496 (902)
|... + .+++|+.|+|++|+++ .+|..+ ..+++|+.|+|++|+++ .+|..+... ++|+.|+|++|
T Consensus 661 p~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N 738 (876)
T 4ecn_A 661 RNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFN 738 (876)
T ss_dssp SSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSS
T ss_pred ccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhccccccccccCCccEEECCCC
Confidence 5322 2 2347777777777777 445443 46777777777777776 555554432 37888888888
Q ss_pred ccCCCccccc---ccccccEEeccCccccccCCccccccccceEEEeeC------CcceecCCCCCCCCCcccEEEccCC
Q 043136 497 KLTGKIPDFI---GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSR------NSLTGIIPWEISGLPSITDVDLSHN 567 (902)
Q Consensus 497 ~l~~~~p~~~---~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~------N~l~g~~p~~~~~l~~L~~L~Ls~N 567 (902)
+++ .+|..+ .+++|+.|+|++|++++ +|..++.+++|+.|+|++ |++.+.+|..|+++++|+.|+|++|
T Consensus 739 ~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N 816 (876)
T 4ecn_A 739 KLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSN 816 (876)
T ss_dssp CCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSS
T ss_pred CCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCC
Confidence 887 455433 47888888888888886 788888888888888876 8899999999999999999999999
Q ss_pred cccccCCCCCcCCccceeecccCCcccccCCC
Q 043136 568 FLTGTIPSNFENCSTLESFNVSYNLLTGPIPA 599 (902)
Q Consensus 568 ~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~ 599 (902)
++ +.+|..+. ++|+.|+|++|++...-+.
T Consensus 817 ~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~ 845 (876)
T 4ecn_A 817 DI-RKVDEKLT--PQLYILDIADNPNISIDVT 845 (876)
T ss_dssp CC-CBCCSCCC--SSSCEEECCSCTTCEEECG
T ss_pred CC-CccCHhhc--CCCCEEECCCCCCCccChH
Confidence 99 79999876 5999999999999765443
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=458.54 Aligned_cols=458 Identities=17% Similarity=0.212 Sum_probs=334.8
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEec
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNL 181 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 181 (902)
...+++++++|++++ +|..+. ++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 ~~~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 31 ELESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp --CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 345899999999986 666554 78999999999999888888899999999999999998888888888999999999
Q ss_pred cCccCcCCCCcccCCCCCCCEEEccCCCccC-CCCccccCCCCCcEEEeeCcccCCCCChhccCCCCC--CEEEccCccC
Q 043136 182 GGSYFDGEIPSDYRNLSSLRFLDLAGNSLTG-SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL--KYMDISACNL 258 (902)
Q Consensus 182 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~Ls~N~l 258 (902)
++|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|++++. .+..+++| ++|++++|.+
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l 181 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSY 181 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSC
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccc
Confidence 999888 56655 78889999999998886 3467888888888888888888763 34444555 8888888888
Q ss_pred --cccCCccccCCC--CccEEecCCCccceecCC-CCCCcCcCcEEecccCCC-----ccccCccccccCCCCEEEccCc
Q 043136 259 --SGTLPSEISNLT--KLEMLLLFKNHFTGEIPV-SYGNLQALQVLDLSDNQL-----SGPIPASLASLKGLTRLSLMNN 328 (902)
Q Consensus 259 --~~~~p~~~~~l~--~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l-----~~~~p~~l~~l~~L~~L~L~~N 328 (902)
++..|..+..+. .| .++++.|.+.+.++. .+..+++|+.|++++|+. .+. ...+..+++|+.|+++++
T Consensus 182 ~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~-~~~l~~l~~L~~L~L~~~ 259 (562)
T 3a79_B 182 HIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF-LSELTRGPTLLNVTLQHI 259 (562)
T ss_dssp CCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH-HHHHHSCSSCEEEEEEEE
T ss_pred cccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccccchHHHH-HHHHhccCcceEEEecCC
Confidence 777777777654 33 557777777765543 355677777777777752 211 223555666666666665
Q ss_pred cccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCc-----cCCCCccEEeccCCcCc
Q 043136 329 VLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI-----CDGDRLFKLILFSNNFT 403 (902)
Q Consensus 329 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~-----~~~~~L~~L~l~~N~l~ 403 (902)
.+.+.....+ .+ .+ ...+|++|++++|+++|.+|..+ ..+..|..+++..|.+
T Consensus 260 ~l~~~~~~~~-------------------~~-~~-~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~- 317 (562)
T 3a79_B 260 ETTWKCSVKL-------------------FQ-FF-WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF- 317 (562)
T ss_dssp EECHHHHHHH-------------------HH-HH-TTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC-
T ss_pred cCcHHHHHHH-------------------HH-hh-hcccccEEEEeccEeeccccchhhhcccccchheehhhccccee-
Confidence 5543211111 00 11 11244455555555554444444 3444444444444444
Q ss_pred cccc-ccccc---cCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCC--C
Q 043136 404 YSIP-ENLVN---CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT--S 477 (902)
Q Consensus 404 ~~~p-~~l~~---l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~ 477 (902)
.+| ..+.. ..+|+.|++++|.+.... ....+++|++|++++|++++.+|..++++++|++|+|++|++++ .
T Consensus 318 -~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 394 (562)
T 3a79_B 318 -LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK 394 (562)
T ss_dssp -SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH
T ss_pred -ecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCccc
Confidence 233 22222 256888888888876321 12678888888888888888888888888888889998888876 3
Q ss_pred cChhhhcccccceeccCCCccCCCccc--ccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCC
Q 043136 478 LPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISG 555 (902)
Q Consensus 478 ~p~~~~~l~~L~~L~ls~N~l~~~~p~--~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 555 (902)
+|..+..+++|+.|++++|++++.+|. +.++++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..
T Consensus 395 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~ 471 (562)
T 3a79_B 395 VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTH 471 (562)
T ss_dssp HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTS
T ss_pred chhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcC
Confidence 456788888999999999998885654 34488999999999999888887765 78999999999999 67777779
Q ss_pred CCcccEEEccCCcccccCCCC-CcCCccceeecccCCcccccCCC
Q 043136 556 LPSITDVDLSHNFLTGTIPSN-FENCSTLESFNVSYNLLTGPIPA 599 (902)
Q Consensus 556 l~~L~~L~Ls~N~l~g~ip~~-~~~l~~L~~l~ls~N~l~g~ip~ 599 (902)
+++|++|||++|+|+ .+|.. |..+++|++|++++|++.+..|.
T Consensus 472 l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~ 515 (562)
T 3a79_B 472 LQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPG 515 (562)
T ss_dssp SCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHH
T ss_pred CCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcch
Confidence 999999999999999 56665 99999999999999999987764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-48 Score=458.23 Aligned_cols=458 Identities=21% Similarity=0.219 Sum_probs=345.3
Q ss_pred EEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccc
Q 043136 80 ITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYS 159 (902)
Q Consensus 80 v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 159 (902)
.+.+|++++++++ +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+++++|++|+|++
T Consensus 33 ~~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 109 (562)
T 3a79_B 33 ESMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSH 109 (562)
T ss_dssp CCEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTT
T ss_pred CcEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCC
Confidence 3789999999995 787664 8999999999999998889999999999999999999999999999999999999999
Q ss_pred ccccCCCchhhhcccCCcEEeccCccCcC-CCCcccCCCCCCCEEEccCCCccCCCCccccCCCCC--cEEEeeCccc--
Q 043136 160 NSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQL--ERIEIGYNNL-- 234 (902)
Q Consensus 160 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L--~~L~L~~N~l-- 234 (902)
|+++ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .+..+++| ++|++++|++
T Consensus 110 N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~ 183 (562)
T 3a79_B 110 NRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHI 183 (562)
T ss_dssp SCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCC
T ss_pred CcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccc
Confidence 9999 45655 89999999999999997 4578999999999999999999863 45666666 9999999999
Q ss_pred CCCCChhccCCC-CCCEEEccCccCcccCCc-cccCCCCccEEecCCCc-----cceecCCCCCCcCcCcEEecccCCCc
Q 043136 235 QGEVPVEFASLV-NLKYMDISACNLSGTLPS-EISNLTKLEMLLLFKNH-----FTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 235 ~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~-----l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++..|..|..+. ..-.+++++|.+.+.++. .+.++++|+.|++++|+ +.+.+ ..+..+++|+.|+++++.++
T Consensus 184 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~-~~l~~l~~L~~L~L~~~~l~ 262 (562)
T 3a79_B 184 KGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFL-SELTRGPTLLNVTLQHIETT 262 (562)
T ss_dssp CSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHH-HHHHSCSSCEEEEEEEEEEC
T ss_pred cccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHH-HHHhccCcceEEEecCCcCc
Confidence 889999988765 222678999999887664 56789999999999995 33222 34677889999999888776
Q ss_pred cccCcc---ccccCCCCEEEccCccccccCChhh-----hhccccceEEecCceeccccC-ccccCCCceeEEEecCCcc
Q 043136 308 GPIPAS---LASLKGLTRLSLMNNVLFGEIPQDI-----ELLADLDTLLLWNNHLTGVLP-QKLGSNGKLLTVDVSSNSL 378 (902)
Q Consensus 308 ~~~p~~---l~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l 378 (902)
+..... ....++|++|++++|.++|.+|..+ ..++.|+.++++.|.+ .+| ..+..+
T Consensus 263 ~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~~~~~------------- 327 (562)
T 3a79_B 263 WKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVF--LFSKEALYSV------------- 327 (562)
T ss_dssp HHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCC--SSCHHHHHHH-------------
T ss_pred HHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhccccee--ecChhhhhhh-------------
Confidence 422111 1112366666666666666666554 4444444444444444 122 111111
Q ss_pred cCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCC--CCCC
Q 043136 379 TGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSG--EIPR 456 (902)
Q Consensus 379 ~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~ 456 (902)
....+++.|++++|.+.... ....+++|++|++++|++++.+|..++.+++|++|+|++|++++ .+|.
T Consensus 328 --------~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 397 (562)
T 3a79_B 328 --------FAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVAL 397 (562)
T ss_dssp --------HHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHH
T ss_pred --------hccCcceEEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchh
Confidence 00123444444444443211 11456677777777777777777777777777777777777775 2345
Q ss_pred cCcccCcCceecccccccCCCcCh-hhhcccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccc
Q 043136 457 DLGNAQKLEYLNISENSFQTSLPS-NIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL 535 (902)
Q Consensus 457 ~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L 535 (902)
.+.++++|++|++++|++++.+|. .+..+++|+.|++++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|
T Consensus 398 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~-~~L~~L~L~~N~l~-~ip~~~~~l~~L 475 (562)
T 3a79_B 398 MTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP-PKVKVLDLHNNRIM-SIPKDVTHLQAL 475 (562)
T ss_dssp TTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC-TTCSEEECCSSCCC-CCCTTTTSSCCC
T ss_pred hhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc-CcCCEEECCCCcCc-ccChhhcCCCCC
Confidence 677777777777777777764444 466777888888888888776665544 68899999999997 789888899999
Q ss_pred eEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCC
Q 043136 536 LLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574 (902)
Q Consensus 536 ~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 574 (902)
+.|+|++|+|+++.+..++.+++|+.|+|++|.+++..|
T Consensus 476 ~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 514 (562)
T 3a79_B 476 QELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 514 (562)
T ss_dssp SEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBCCCHH
T ss_pred CEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcCCCcc
Confidence 999999999996544459999999999999999997654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=458.48 Aligned_cols=485 Identities=20% Similarity=0.183 Sum_probs=408.6
Q ss_pred CCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecc
Q 043136 78 SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNA 157 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 157 (902)
..++.|||++|+|++..+.+|.++++|++|||++|+|+++.+.+|.+|++|++|+|++|+|++..+..|+++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999888889999999999999999999988999999999999999999999888888999999999999
Q ss_pred ccccccCCCchhhhcccCCcEEeccCccCcC-CCCcccCCCCCCCEEEccCCCccCCCCccccCCCCC----cEEEeeCc
Q 043136 158 YSNSFTGPLPLEFVQLNSLQQLNLGGSYFDG-EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQL----ERIEIGYN 232 (902)
Q Consensus 158 ~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L----~~L~L~~N 232 (902)
++|++++..+..|+++++|++|+|++|++++ .+|..++++++|++|+|++|++++..|..|..+.++ ..++++.|
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n 211 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 211 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTC
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccC
Confidence 9999999888899999999999999999976 467888999999999999999998888888776654 47889999
Q ss_pred ccCCCCChhccCCCCCCEEEccCccCcccC-Cccc------------------------------cCCCCccEEecCCCc
Q 043136 233 NLQGEVPVEFASLVNLKYMDISACNLSGTL-PSEI------------------------------SNLTKLEMLLLFKNH 281 (902)
Q Consensus 233 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~------------------------------~~l~~L~~L~L~~N~ 281 (902)
.++...+..+. ...++.+++++|..+..+ +..+ ..+..+...++..+.
T Consensus 212 ~l~~i~~~~~~-~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~ 290 (635)
T 4g8a_A 212 PMNFIQPGAFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 290 (635)
T ss_dssp CCCEECTTTTT-TCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEEC
T ss_pred cccccCccccc-chhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhh
Confidence 99866555544 345677888777554211 1222 223333344433332
Q ss_pred c---ceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecccc
Q 043136 282 F---TGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVL 358 (902)
Q Consensus 282 l---~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 358 (902)
. ....+..+..+.+++.+++.+|.+.... .+.....|+.|++++|.+.+..+. .+..|+.+++.+|.+....
T Consensus 291 ~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~~---~l~~L~~l~l~~n~~~~~~ 365 (635)
T 4g8a_A 291 LDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPTL---KLKSLKRLTFTSNKGGNAF 365 (635)
T ss_dssp CCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCCC---BCTTCCEEEEESCCSCCBC
T ss_pred hcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCcc---cchhhhhcccccccCCCCc
Confidence 2 2234455677889999999999987543 356678899999999998765443 4678899999999887543
Q ss_pred CccccCCCceeEEEecCCcccC--CCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCC-cccC
Q 043136 359 PQKLGSNGKLLTVDVSSNSLTG--PIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP-QGFG 435 (902)
Q Consensus 359 ~~~~~~~~~L~~L~Ls~N~l~~--~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~ 435 (902)
....+++|+.+++++|.+.. ..+..+....+++++++..|.... ++..+..+++|+.++++.|+.....+ ..|.
T Consensus 366 --~~~~l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~ 442 (635)
T 4g8a_A 366 --SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 442 (635)
T ss_dssp --CCCBCTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTT
T ss_pred --ccccccccccchhhccccccccccccchhhhhhhhhhhcccccccc-ccccccccccccchhhhhccccccccccccc
Confidence 34578899999999999863 456667788899999999998874 56678889999999999998876554 5688
Q ss_pred CCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccC-CCcChhhhcccccceeccCCCccCCCcccccc-cccccE
Q 043136 436 LLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ-TSLPSNIWSAPNLKILSASSSKLTGKIPDFIG-CKSIYK 513 (902)
Q Consensus 436 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~-~~~l~~ 513 (902)
.+++++.++++.|.+++..|..+..++.|+.|+|++|++. +.+|..+..+++|++|+|++|++++.+|..++ +++|++
T Consensus 443 ~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~ 522 (635)
T 4g8a_A 443 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQV 522 (635)
T ss_dssp TCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred cccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCE
Confidence 9999999999999999999999999999999999999854 56788999999999999999999998887654 999999
Q ss_pred EeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCC-CcccEEEccCCcccc
Q 043136 514 IELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGL-PSITDVDLSHNFLTG 571 (902)
Q Consensus 514 l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l-~~L~~L~Ls~N~l~g 571 (902)
|+|++|+|++..|..++.+++|+.|||++|+|++.+|..+..+ ++|+.|+|++|.++.
T Consensus 523 L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C 581 (635)
T 4g8a_A 523 LNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 581 (635)
T ss_dssp EECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCC
T ss_pred EECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcc
Confidence 9999999999999999999999999999999999999999998 689999999999985
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=428.96 Aligned_cols=423 Identities=24% Similarity=0.290 Sum_probs=230.2
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
...++|++|++++|.+ |.+|.+|+++++|++|++++|.++|.+|..++++++|+.+++..+.. .++++
T Consensus 8 ~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~ 75 (454)
T 1jl5_A 8 VSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHE 75 (454)
T ss_dssp ---------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSE
T ss_pred cccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCE
Confidence 3467888888888888 78888888888888888888888888888888888887777766542 46788
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
|++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++. |.. .++|++|++++|++
T Consensus 76 L~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l 143 (454)
T 1jl5_A 76 LELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQL 143 (454)
T ss_dssp EECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCC
T ss_pred EEecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCC
Confidence 8888888875 3432 3678888888888886 6643 36788888888888753 221 15788888888888
Q ss_pred cccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhh
Q 043136 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI 338 (902)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 338 (902)
++ +| .|.++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .+..+++|++|++++|++++ +|..
T Consensus 144 ~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~- 213 (454)
T 1jl5_A 144 EK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDL- 213 (454)
T ss_dssp SS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCC-
T ss_pred CC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCC-
Confidence 75 66 47888888888888888875 45433 478888888888876 45 57778888888888888765 3432
Q ss_pred hhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcE
Q 043136 339 ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSR 418 (902)
Q Consensus 339 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 418 (902)
.++|++|++++|+++ .+| .++.+++|+.|++++|++++ +|.. ..+|+.|++++|++++ +|.. +++|+.
T Consensus 214 --~~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~ 281 (454)
T 1jl5_A 214 --PLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTF 281 (454)
T ss_dssp --CTTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCE
T ss_pred --cCcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCE
Confidence 246777777777777 445 36777777777777777775 3332 2556666666666664 4432 256666
Q ss_pred EEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCcc
Q 043136 419 LRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKL 498 (902)
Q Consensus 419 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 498 (902)
|++++|++++ +|.. .++|++|++++|++++ ++.. .++|++|++++|++++ +|.. +++|+.|++++|++
T Consensus 282 L~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l 349 (454)
T 1jl5_A 282 LDVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LCDL---PPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHL 349 (454)
T ss_dssp EECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-ECCC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCC
T ss_pred EECcCCccCc-ccCc---CCcCCEEECcCCcCCc-ccCC---cCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcc
Confidence 7777766664 2211 2466666666666664 2211 1356666666666654 4443 35566666666666
Q ss_pred CCCcccccccccccEEeccCccccc--cCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccc--cCC
Q 043136 499 TGKIPDFIGCKSIYKIELHNNLLNG--SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG--TIP 574 (902)
Q Consensus 499 ~~~~p~~~~~~~l~~l~Ls~N~l~g--~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g--~ip 574 (902)
++ +|. .+++|+.|++++|++++ .+|.+++. |+.|++.|.+|.. +++|+.||+++|+++| .+|
T Consensus 350 ~~-lp~--~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 350 AE-VPE--LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp SC-CCC--CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred cc-ccc--hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 53 333 34566666666666665 55554432 2345555555542 3566666666666665 455
Q ss_pred CCCcCCccceeecccCCcccccCCC
Q 043136 575 SNFENCSTLESFNVSYNLLTGPIPA 599 (902)
Q Consensus 575 ~~~~~l~~L~~l~ls~N~l~g~ip~ 599 (902)
.+ |+.|.+.+|.+.+++|.
T Consensus 416 ~s------l~~L~~~~~~~~~~~~~ 434 (454)
T 1jl5_A 416 ES------VEDLRMNSERVVDPYEF 434 (454)
T ss_dssp -------------------------
T ss_pred hh------HhheeCcCcccCCcccc
Confidence 43 34445566666665554
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=405.83 Aligned_cols=294 Identities=29% Similarity=0.498 Sum_probs=216.3
Q ss_pred cCCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCc--cccEEecCCC--CCEEEEEcCCCCccc--c
Q 043136 20 ANTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCS--WSGIKCNPKS--SQITSLDLSRRSLSG--P 93 (902)
Q Consensus 20 ~~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~--w~Gv~c~~~~--~~v~~L~L~~~~l~g--~ 93 (902)
+.|.++|++||++||+++.+|. .+++|+.+ ++ ||. |.||+|+..+ ++|+.|+|++++++| .
T Consensus 1 ~~c~~~~~~aL~~~k~~~~~~~--~l~~W~~~------~~-----~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~ 67 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLGNPT--TLSSWLPT------TD-----CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP 67 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTTCCG--GGTTCCTT------SC-----TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEE
T ss_pred CCCCHHHHHHHHHHHHhcCCcc--cccCCCCC------CC-----CCcCCCcceEeCCCCCCceEEEEECCCCCccCCcc
Confidence 3699999999999999998775 58999754 23 888 9999998765 799999999999999 8
Q ss_pred cCccccCCCCCCEEEccC-CCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhc
Q 043136 94 IPPEIRYLTSLTHLNLSA-NAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQ 172 (902)
Q Consensus 94 ~~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 172 (902)
+|+.|+.+++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|+++++|++|+|++|.+++.+|..|..
T Consensus 68 ~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 147 (313)
T 1ogq_A 68 IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147 (313)
T ss_dssp CCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGG
T ss_pred cChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhc
Confidence 999999999999999995 9999889989999999999999999888888888888888888888888887777777777
Q ss_pred ccCCcEEeccCccCcCCCCcccCCCC-CCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEE
Q 043136 173 LNSLQQLNLGGSYFDGEIPSDYRNLS-SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251 (902)
Q Consensus 173 l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 251 (902)
+++|++|+|++|++++.+|..+.+++ +|++|+|++|++++.+|..+..++ |++|++++|++++..|..|..+++|++|
T Consensus 148 l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 226 (313)
T 1ogq_A 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKI 226 (313)
T ss_dssp CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEE
T ss_pred CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEE
Confidence 77777777777777777777777776 677777777777766666666665 6666666666666666666666666666
Q ss_pred EccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcc
Q 043136 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329 (902)
Q Consensus 252 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (902)
+|++|++++.+|. +..+++|++|+|++|++++.+|..+..+++|++|+|++|+++|.+|.. ..+++|+.|++++|.
T Consensus 227 ~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 227 HLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp ECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 6666666644443 445555555555555555555555555555555555555555554443 444445555555544
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=419.51 Aligned_cols=406 Identities=24% Similarity=0.286 Sum_probs=279.5
Q ss_pred ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEE
Q 043136 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203 (902)
Q Consensus 124 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 203 (902)
+.+.|++|++++|.+ |.+|..++++++|++|++++|+++|.+|..++++++|+.+++..+.. .++++|
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~-----------~~l~~L 76 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLD-----------RQAHEL 76 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHH-----------HTCSEE
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhc-----------cCCCEE
Confidence 568999999999999 78999999999999999999999999999999999999888887643 578999
Q ss_pred EccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 204 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
++++|.+++ +|.. .++|++|++++|++++ +|.. +++|++|++++|++++ +|.. .++|++|++++|+++
T Consensus 77 ~l~~~~l~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~ 144 (454)
T 1jl5_A 77 ELNNLGLSS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLE 144 (454)
T ss_dssp ECTTSCCSC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCS
T ss_pred EecCCcccc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCC
Confidence 999999996 5542 3789999999999997 6643 4789999999999985 3322 268999999999999
Q ss_pred eecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCcccc
Q 043136 284 GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLG 363 (902)
Q Consensus 284 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 363 (902)
+ +| .++++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++.+++|++|++++|++++ +|...
T Consensus 145 ~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~- 214 (454)
T 1jl5_A 145 K-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP- 214 (454)
T ss_dssp S-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC-
T ss_pred C-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc-
Confidence 6 67 59999999999999999986 56543 589999999999987 56 58899999999999999986 34332
Q ss_pred CCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEE
Q 043136 364 SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFM 443 (902)
Q Consensus 364 ~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 443 (902)
.+|+.|++++|+++ .+| .++.+++|++|++++|++++ +|.. +++|+.|++++|++++ +|.. +++|++|
T Consensus 215 --~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~-l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L 282 (454)
T 1jl5_A 215 --LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFL 282 (454)
T ss_dssp --TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred --CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCc-cccc---ccccCEEECCCCcccc-cCcc---cCcCCEE
Confidence 58899999999998 566 48888899999999998885 4543 3788999999999885 5653 4788999
Q ss_pred EccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcc-cccceeccCCCccCCCcccccccccccEEeccCcccc
Q 043136 444 DMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA-PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN 522 (902)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~ 522 (902)
++++|++++ +|.. .++|++|++++|++++ ++ .+ ++|+.|++++|++++ +|.. +++|+.|++++|+++
T Consensus 283 ~ls~N~l~~-l~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~--~~~L~~L~L~~N~l~ 350 (454)
T 1jl5_A 283 DVSENIFSG-LSEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL--PPRLERLIASFNHLA 350 (454)
T ss_dssp ECCSSCCSE-ESCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC--CTTCCEEECCSSCCS
T ss_pred ECcCCccCc-ccCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc--CCcCCEEECCCCccc
Confidence 999999886 2321 2578888999998875 33 23 478888888888886 5543 478888888888887
Q ss_pred ccCCccccccccceEEEeeCCccee--cCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccc--cCC
Q 043136 523 GSIPWDIGHCEKLLLLNLSRNSLTG--IIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG--PIP 598 (902)
Q Consensus 523 g~ip~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g--~ip 598 (902)
.+|. .+++|+.|+|++|++++ .+|.+++. |+.|.+.|.+|.. +++|++|++++|+++| .||
T Consensus 351 -~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~--------L~~n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP 415 (454)
T 1jl5_A 351 -EVPE---LPQNLKQLHVEYNPLREFPDIPESVED--------LRMNSHLAEVPEL---PQNLKQLHVETNPLREFPDIP 415 (454)
T ss_dssp -CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCE--------EECCC--------------------------------
T ss_pred -cccc---hhhhccEEECCCCCCCcCCCChHHHHh--------hhhcccccccccc---cCcCCEEECCCCcCCccccch
Confidence 5666 46788888888888887 56665542 3457788888864 4789999999999998 888
Q ss_pred CCCC
Q 043136 599 ASGT 602 (902)
Q Consensus 599 ~~~~ 602 (902)
.+.+
T Consensus 416 ~sl~ 419 (454)
T 1jl5_A 416 ESVE 419 (454)
T ss_dssp ----
T ss_pred hhHh
Confidence 7643
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=412.52 Aligned_cols=364 Identities=18% Similarity=0.183 Sum_probs=285.8
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCC-CcccccccccceeccccccccCCCchhhhcccCCcEEe
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTF-PPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 180 (902)
++|++|+|++|.+++..|..|.++++|++|+|++|.+.+.+ |..|+++++|++|+|++|++++..|..|+++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 67888888888888777778888888888888888877555 45578888888888888888877788888888888888
Q ss_pred ccCccCcCCCCcc--cCCCCCCCEEEccCCCccCCCCcc-ccCCCCCcEEEeeCcccCCCCChhccCC--CCCCEEEccC
Q 043136 181 LGGSYFDGEIPSD--YRNLSSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQGEVPVEFASL--VNLKYMDISA 255 (902)
Q Consensus 181 L~~N~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L~~L~Ls~ 255 (902)
|++|++++.+|.. |.++++|++|+|++|++++..|.. +..+++|++|++++|++++..|..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 8888887755544 778888888888888888776765 7788888888888888888777777665 6788888888
Q ss_pred ccCcccCCcc--------ccCCCCccEEecCCCccceecCCCCCCc---CcCcEEecccCCCccccCccccccCCCCEEE
Q 043136 256 CNLSGTLPSE--------ISNLTKLEMLLLFKNHFTGEIPVSYGNL---QALQVLDLSDNQLSGPIPASLASLKGLTRLS 324 (902)
Q Consensus 256 N~l~~~~p~~--------~~~l~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 324 (902)
|.+.+..+.. +..+++|++|++++|++++..|..+... ++|+.|++++|.+.+..
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~-------------- 255 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSS-------------- 255 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCC--------------
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccc--------------
Confidence 8887654433 3356788888888888887777666543 78888888888765431
Q ss_pred ccCccccccCChhhhhc--cccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcC
Q 043136 325 LMNNVLFGEIPQDIELL--ADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNF 402 (902)
Q Consensus 325 L~~N~l~~~~p~~~~~l--~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l 402 (902)
+..+.+.+..+..+..+ ++|+.|++++|++++..|..+..+++|+.|++++|++++..|..+..+++|++|++++|++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 335 (455)
T 3v47_A 256 FGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL 335 (455)
T ss_dssp TTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred cchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCcc
Confidence 11222222233333333 5778888888888877788888888888888888888887788888888888888888888
Q ss_pred cccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcC
Q 043136 403 TYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLP 479 (902)
Q Consensus 403 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 479 (902)
++..|..+.++++|++|+|++|++++..|.+|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|
T Consensus 336 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 412 (455)
T 3v47_A 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 412 (455)
T ss_dssp CEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence 87888888999999999999999998889999999999999999999998777788999999999999999998877
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=408.30 Aligned_cols=385 Identities=17% Similarity=0.207 Sum_probs=241.0
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC-ChhccCCCCCCEEEccC
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV-PVEFASLVNLKYMDISA 255 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 255 (902)
+.++.+++.++ .+|. + .++|++|+|++|++++..|..|+.+++|++|++++|.+.+.+ |..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 34555555555 3443 2 145666666666666555566666666666666666655333 34455566666666666
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCC--CCCcCcCcEEecccCCCccccCcc-ccccCCCCEEEccCccccc
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVS--YGNLQALQVLDLSDNQLSGPIPAS-LASLKGLTRLSLMNNVLFG 332 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~--~~~l~~L~~L~Ls~N~l~~~~p~~-l~~l~~L~~L~L~~N~l~~ 332 (902)
|++++..|..|.++++|++|+|++|++++..|.. +..+++|++|+|++|++++..|.. +..+++|++|++++|.+.+
T Consensus 89 n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~ 168 (455)
T 3v47_A 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKS 168 (455)
T ss_dssp CTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSC
T ss_pred CccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccc
Confidence 6665555555555666666666666555433322 555555555555555555544443 4555555555555555555
Q ss_pred cCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCC--------ccCCCCccEEeccCCcCcc
Q 043136 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPT--------ICDGDRLFKLILFSNNFTY 404 (902)
Q Consensus 333 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~--------~~~~~~L~~L~l~~N~l~~ 404 (902)
..|..+..+. ..+|+.|++++|.+.+..+.. +..+++|+.|++++|++++
T Consensus 169 ~~~~~l~~l~----------------------~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~ 226 (455)
T 3v47_A 169 ICEEDLLNFQ----------------------GKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226 (455)
T ss_dssp CCTTTSGGGT----------------------TCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCH
T ss_pred cChhhhhccc----------------------cccccccccccCcccccchhhccccccccccccceeeeEecCCCcccc
Confidence 5554444331 034555555555554433322 2234456666666666665
Q ss_pred ccccccccc---CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCccc--CcCceecccccccCCCcC
Q 043136 405 SIPENLVNC---SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA--QKLEYLNISENSFQTSLP 479 (902)
Q Consensus 405 ~~p~~l~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l--~~L~~L~Ls~N~l~~~~p 479 (902)
..|..+... ++|+.|++++|.+.+... ..+.+.+..+..+..+ ++|+.|++++|++.+.+|
T Consensus 227 ~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 292 (455)
T 3v47_A 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSF--------------GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLK 292 (455)
T ss_dssp HHHHHHHHHTTTCCEEEEECTTCTTTSCCT--------------TCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECT
T ss_pred cchhhhhccccccceeeEeecccccccccc--------------chhhhccCcccccccccccCceEEEecCccccccch
Confidence 565555443 567777777766553211 1122222222233322 456666666666666666
Q ss_pred hhhhcccccceeccCCCccCCCccccc-ccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCc
Q 043136 480 SNIWSAPNLKILSASSSKLTGKIPDFI-GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPS 558 (902)
Q Consensus 480 ~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 558 (902)
..+..+++|+.|++++|++++..|..+ ++++|++|+|++|.+++..|..++.+++|+.|+|++|++++.+|..++++++
T Consensus 293 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 372 (455)
T 3v47_A 293 SVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPN 372 (455)
T ss_dssp TTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTT
T ss_pred hhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcccccc
Confidence 666666666666666666666555443 3677777777777787777888899999999999999999999999999999
Q ss_pred ccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCCCC
Q 043136 559 ITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASG 601 (902)
Q Consensus 559 L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~ 601 (902)
|++|||++|++++..+..|..+++|++|++++|++++.+|...
T Consensus 373 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 415 (455)
T 3v47_A 373 LKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID 415 (455)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred ccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcch
Confidence 9999999999998777788999999999999999999999654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=397.07 Aligned_cols=235 Identities=23% Similarity=0.202 Sum_probs=158.4
Q ss_pred cccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchh
Q 043136 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLE 169 (902)
Q Consensus 90 l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 169 (902)
..+..+..++++++|++|+|++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|++++|++++. |
T Consensus 30 ~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~-- 101 (457)
T 3bz5_A 30 MQATDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D-- 101 (457)
T ss_dssp CCTTSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--
T ss_pred cCcccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--
Confidence 3445556778888888888888888864 4 678888888888888888774 3 77777777777777777764 3
Q ss_pred hhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCC
Q 043136 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249 (902)
Q Consensus 170 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 249 (902)
++++++|++|+|++|++++. | ++++++|++|++++|++++. + ++.+++|++|++++|+..+.+ .+..+++|+
T Consensus 102 ~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 173 (457)
T 3bz5_A 102 VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLT 173 (457)
T ss_dssp CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCC
T ss_pred cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCC
Confidence 67777777777777777753 3 67777777777777777753 2 666777777777777544444 366667777
Q ss_pred EEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcc
Q 043136 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329 (902)
Q Consensus 250 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (902)
+|++++|++++ +| +..+++|++|++++|++++. .++.+++|++|++++|++++ +| +..+++|++|++++|+
T Consensus 174 ~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 174 TLDCSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNP 244 (457)
T ss_dssp EEECCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSC
T ss_pred EEECCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCc
Confidence 77777777765 33 56666677777777766653 36666666666666666665 34 5566666666666666
Q ss_pred ccccCChhhhhccccceEEecCc
Q 043136 330 LFGEIPQDIELLADLDTLLLWNN 352 (902)
Q Consensus 330 l~~~~p~~~~~l~~L~~L~L~~N 352 (902)
+++.. ++.+++|+.|++++|
T Consensus 245 l~~~~---~~~l~~L~~L~l~~n 264 (457)
T 3bz5_A 245 LTELD---VSTLSKLTTLHCIQT 264 (457)
T ss_dssp CSCCC---CTTCTTCCEEECTTC
T ss_pred CCCcC---HHHCCCCCEEeccCC
Confidence 65532 233445555555444
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=396.86 Aligned_cols=361 Identities=21% Similarity=0.190 Sum_probs=222.8
Q ss_pred CCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccC
Q 043136 165 PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFAS 244 (902)
Q Consensus 165 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 244 (902)
..+..++++++|++|+|++|.+++. | .++.+++|++|+|++|++++. | ++.+++|++|++++|+|++. | ++.
T Consensus 33 ~~~~~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~ 104 (457)
T 3bz5_A 33 TDTISEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTP 104 (457)
T ss_dssp TSEEEHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTT
T ss_pred ccccChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCC
Confidence 3333444444444444444444432 2 344444555555555554432 2 44444555555555554432 2 444
Q ss_pred CCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEE
Q 043136 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLS 324 (902)
Q Consensus 245 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 324 (902)
+++|++|++++|++++ +| +.++++|++|++++|++++. .++.+++|++|++++|+..+.+ .+..+++|++|+
T Consensus 105 l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ 176 (457)
T 3bz5_A 105 LTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLD 176 (457)
T ss_dssp CTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEE
T ss_pred CCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc--ccccCCcCCEEE
Confidence 5555555555555543 22 44455555555555555442 1444555555555555333333 244455555555
Q ss_pred ccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcc
Q 043136 325 LMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTY 404 (902)
Q Consensus 325 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~ 404 (902)
+++|++++ +| +..+++|+.|++++|++++. .+..+++|+.|++++|++++ +| +..+++|+.|++++|++++
T Consensus 177 ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~ 247 (457)
T 3bz5_A 177 CSFNKITE-LD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTE 247 (457)
T ss_dssp CCSSCCCC-CC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC
T ss_pred CCCCccce-ec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCC
Confidence 55555544 22 44455555555555555543 24555666666666666665 33 5555666666666666665
Q ss_pred cccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhc
Q 043136 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS 484 (902)
Q Consensus 405 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 484 (902)
.. +..+++|+.|++++|+ |+.|++++|.+.+.+| ++.+++|+.|++++|.+.+.+|. .
T Consensus 248 ~~---~~~l~~L~~L~l~~n~--------------L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~---~ 305 (457)
T 3bz5_A 248 LD---VSTLSKLTTLHCIQTD--------------LLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDC---Q 305 (457)
T ss_dssp CC---CTTCTTCCEEECTTCC--------------CSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEEC---T
T ss_pred cC---HHHCCCCCEEeccCCC--------------CCEEECCCCccCCccc--ccccccCCEEECCCCcccceecc---C
Confidence 42 3455677777777653 4567788888777776 46778888888888888777774 4
Q ss_pred ccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEc
Q 043136 485 APNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDL 564 (902)
Q Consensus 485 l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 564 (902)
.++|+.|++++| ++|+.|+|++|+|++ +| ++.+++|+.|+|++|+|+| ++.|+.|++
T Consensus 306 ~~~L~~L~l~~~------------~~L~~L~L~~N~l~~-l~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l 362 (457)
T 3bz5_A 306 AAGITELDLSQN------------PKLVYLYLNNTELTE-LD--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPA 362 (457)
T ss_dssp TCCCSCCCCTTC------------TTCCEEECTTCCCSC-CC--CTTCTTCSEEECCSSCCCB--------CTTGGGSSG
T ss_pred CCcceEechhhc------------ccCCEEECCCCcccc-cc--cccCCcCcEEECCCCCCCC--------ccccccccc
Confidence 466777777765 578899999999998 43 8999999999999999997 357788899
Q ss_pred cCCcccccCCCCCcCCccceeecccCCcccccCCCC
Q 043136 565 SHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPAS 600 (902)
Q Consensus 565 s~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~ 600 (902)
++|.++|. .++..|+.+++++|+|+|.||..
T Consensus 363 ~~n~l~g~-----~~~~~l~~l~l~~N~l~g~ip~~ 393 (457)
T 3bz5_A 363 LNNNFEAE-----GQTITMPKETLTNNSLTIAVSPD 393 (457)
T ss_dssp GGTSEEEE-----EEEEECCCBCCBTTBEEEECCTT
T ss_pred cCCcEEec-----ceeeecCccccccCcEEEEcChh
Confidence 99999987 46778999999999999999975
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=376.66 Aligned_cols=344 Identities=25% Similarity=0.369 Sum_probs=157.4
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEc
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 253 (902)
++|+.|+++++.+.. +|. +..+++|++|+|++|.+++. |. +..+++|++|++++|++++..+ +..+++|++|++
T Consensus 46 ~~l~~L~l~~~~i~~-l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L 119 (466)
T 1o6v_A 46 DQVTTLQADRLGIKS-IDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119 (466)
T ss_dssp HTCCEEECCSSCCCC-CTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEEC
T ss_pred ccccEEecCCCCCcc-Ccc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh--hcCCCCCCEEEC
Confidence 344444444444432 221 34444444444444444432 22 4444444444444444443322 444444444444
Q ss_pred cCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccccc
Q 043136 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 254 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
++|.+++..+ +.++++|++|++++|++++. + .++.+++|++|+++ |.+.+..+ +..+++|++|++++|.+.+.
T Consensus 120 ~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 120 FNNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp CSSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCcCCCC
Confidence 4444443221 44444444444444444432 1 24444455555553 23332211 44455555555555554332
Q ss_pred CChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccccc
Q 043136 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC 413 (902)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l 413 (902)
..+..+++|++|++++|++++..| ++.+++|+.|++++|++++. +.+..+++|+.|++++|++.+..| +..+
T Consensus 193 --~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l 264 (466)
T 1o6v_A 193 --SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGL 264 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred --hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcC
Confidence 124444555555555555544433 34445555555555555431 123333333333333333333222 4444
Q ss_pred CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceecc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSA 493 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 493 (902)
++|+.|++++|++++..+ +..+++|+.|+|++|++++..| +..+++|+.|+|++|++++..| +..++
T Consensus 265 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~------- 331 (466)
T 1o6v_A 265 TKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT------- 331 (466)
T ss_dssp TTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCT-------
T ss_pred CCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCc-------
Confidence 455555555555543222 4445555555555555544322 4444445555555554444333 33444
Q ss_pred CCCccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccc
Q 043136 494 SSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG 571 (902)
Q Consensus 494 s~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g 571 (902)
+|+.|++++|.+++. ..++.+++|+.|+|++|++++.+| +..+++|+.|++++|.+++
T Consensus 332 ----------------~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 332 ----------------KLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp ----------------TCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEEC
T ss_pred ----------------cCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccC
Confidence 444444444444432 245555555666666666655554 5555666666666666554
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=376.56 Aligned_cols=342 Identities=27% Similarity=0.383 Sum_probs=187.3
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccc
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAY 158 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 158 (902)
+++.|++++++++. +| .+..+++|++|+|++|.+++..+ +..+++|++|++++|.+++..+ ++++++|++|+++
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~ 120 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 120 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECC
Confidence 56666666666653 33 36666667777777666665433 6666666666666666665443 6666666666666
Q ss_pred cccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC
Q 043136 159 SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV 238 (902)
Q Consensus 159 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 238 (902)
+|.+++..+ +..+++|++|++++|.+++. + .+.++++|++|+++ |.+.+.. .+..+++|++|++++|++++.
T Consensus 121 ~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~l~~~- 192 (466)
T 1o6v_A 121 NNQITDIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNKVSDI- 192 (466)
T ss_dssp SSCCCCCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSCCCCC-
T ss_pred CCCCCCChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCch--hhccCCCCCEEECcCCcCCCC-
Confidence 666665433 66666666666666666542 2 35666666666664 3344221 255666666666666666543
Q ss_pred ChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccC
Q 043136 239 PVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318 (902)
Q Consensus 239 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 318 (902)
..+..+++|++|++++|.+++..| ++.+++|++|++++|++++. ..+..+++|++|++++|.+++..+ +..++
T Consensus 193 -~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~ 265 (466)
T 1o6v_A 193 -SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLT 265 (466)
T ss_dssp -GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred -hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCC
Confidence 235556666666666666654433 45556666666666665532 235555566666666666554433 55555
Q ss_pred CCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEecc
Q 043136 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILF 398 (902)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~ 398 (902)
+|++|++++|.+.+..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|++++..| +..+++|+.|+++
T Consensus 266 ~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~ 339 (466)
T 1o6v_A 266 KLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFY 339 (466)
T ss_dssp TCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGG--GGGCTTCCEEECC
T ss_pred CCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCCchh--hccCccCCEeECC
Confidence 56666666665554332 4555555555555555554433 4455555555555555554333 3344444444444
Q ss_pred CCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccC
Q 043136 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451 (902)
Q Consensus 399 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 451 (902)
+|++++. ..+.++++|+.|++++|++++..| +..+++|+.|++++|+++
T Consensus 340 ~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 340 NNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp SSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred CCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 4444432 234444444444444444444333 444444444444444444
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=372.35 Aligned_cols=346 Identities=19% Similarity=0.167 Sum_probs=235.2
Q ss_pred CEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCc
Q 043136 249 KYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328 (902)
Q Consensus 249 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 328 (902)
+.++.++++++ .+|..+. +++++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 56777777777 4555443 46777888888777777777777777777777777777777777777777777777777
Q ss_pred cccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccc
Q 043136 329 VLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPE 408 (902)
Q Consensus 329 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~ 408 (902)
++.+..+..|..+++|++|+|++|++++..+..|..+++|+.|++++|++++..|.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~------------------------ 146 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR------------------------ 146 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT------------------------
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh------------------------
Confidence 77655555566666677777776666666666666666666666666666554444
Q ss_pred cccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhccccc
Q 043136 409 NLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNL 488 (902)
Q Consensus 409 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 488 (902)
.|.++++|+.|+|++|++++..+..|..+++|+.|+|++|++.+..+..|..+++|++|++++|.+.+.+|..+....+|
T Consensus 147 ~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L 226 (477)
T 2id5_A 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226 (477)
T ss_dssp SSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCC
T ss_pred hccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccc
Confidence 44455555555555555554444455555556666666665555555555556666666666655555555555555566
Q ss_pred ceeccCCCccCCCcccc-cccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCC
Q 043136 489 KILSASSSKLTGKIPDF-IGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567 (902)
Q Consensus 489 ~~L~ls~N~l~~~~p~~-~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N 567 (902)
+.|++++|++++..+.. ..+++|+.|+|++|.+++..+..+..+++|+.|+|++|++++..|..|.++++|+.|||++|
T Consensus 227 ~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 306 (477)
T 2id5_A 227 TSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGN 306 (477)
T ss_dssp SEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSS
T ss_pred cEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCC
Confidence 66666666665433222 23666777777777777677777888889999999999999988999999999999999999
Q ss_pred cccccCCCCCcCCccceeecccCCcccccCCCCCCcCcCCCCCcccCCcccCCCC
Q 043136 568 FLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLCGRV 622 (902)
Q Consensus 568 ~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~gn~~lcg~~ 622 (902)
+|++..+..|..+++|+.|+|++|++.+..+.... ........+.++...|..|
T Consensus 307 ~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~~~-~~~~~~~~~~~~~~~C~~p 360 (477)
T 2id5_A 307 QLTTLEESVFHSVGNLETLILDSNPLACDCRLLWV-FRRRWRLNFNRQQPTCATP 360 (477)
T ss_dssp CCSCCCGGGBSCGGGCCEEECCSSCEECSGGGHHH-HTTTTSSCCTTCCCBEEES
T ss_pred cCceeCHhHcCCCcccCEEEccCCCccCccchHhH-HhhhhccccCccCceeCCc
Confidence 99977777788899999999999998765432111 1112335567777788765
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=366.44 Aligned_cols=321 Identities=20% Similarity=0.191 Sum_probs=235.5
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+.++.+++.++ .+|..+. +++++|+|++|++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 34555555555 3444432 46667777777776666666677777777777777777666667777777777777777
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCCh
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ 336 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (902)
++++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++..+..|..+++|+.|+|++|.+++..+.
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 170 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTE 170 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChh
Confidence 77755555666777777777777777766667777777777777777777776677777777777777777777766556
Q ss_pred hhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCC
Q 043136 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSL 416 (902)
Q Consensus 337 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L 416 (902)
.+..+++|+.|+|++|.+++..+..|..+++|+.|++++|.+.+.+|.......+|+.|++++|+++...+..+..+++|
T Consensus 171 ~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L 250 (477)
T 2id5_A 171 ALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYL 250 (477)
T ss_dssp HHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTC
T ss_pred HhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCcccc
Confidence 67777777777777777777777777788888888888887777777777666677777777777775555667778888
Q ss_pred cEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCC
Q 043136 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSS 496 (902)
Q Consensus 417 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N 496 (902)
+.|+|++|++++..+..|..+++|+.|+|++|++++..|..|.++++|++|+|++|++++..+..|..+++|+.|++++|
T Consensus 251 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N 330 (477)
T 2id5_A 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSN 330 (477)
T ss_dssp CEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSS
T ss_pred CeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCC
Confidence 88888888888777777888888888888888888777888888888888888888887766667777778888888887
Q ss_pred ccCC
Q 043136 497 KLTG 500 (902)
Q Consensus 497 ~l~~ 500 (902)
+++.
T Consensus 331 ~l~c 334 (477)
T 2id5_A 331 PLAC 334 (477)
T ss_dssp CEEC
T ss_pred CccC
Confidence 7764
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=350.89 Aligned_cols=311 Identities=16% Similarity=0.116 Sum_probs=193.9
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
..++++++|++++|.++...+..|..+++|++|+|++|.+++..+..|+.+++|++|+|++|.+++..|..|+++++|++
T Consensus 42 ~~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~ 121 (390)
T 3o6n_A 42 ITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTV 121 (390)
T ss_dssp GGGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred cccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCE
Confidence 45688999999999998776667889999999999999998877778888888888888888888877777888888888
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
|+|++|+++...+..|.++++|++|+|++|++++..|..|..+++|++|++++|++++. .+..+++|++|++++|.+
T Consensus 122 L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l 198 (390)
T 3o6n_A 122 LVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198 (390)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCC
T ss_pred EECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccc
Confidence 88888888755445567778888888888887776666777777777777777777754 245566677777777766
Q ss_pred cccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhh
Q 043136 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI 338 (902)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 338 (902)
++. ...++|++|++++|++... |.. ..++|+.|++++|++++. ..+..+++|++|++++|.+.+
T Consensus 199 ~~~-----~~~~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~------ 262 (390)
T 3o6n_A 199 STL-----AIPIAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEK------ 262 (390)
T ss_dssp SEE-----ECCSSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCE------
T ss_pred ccc-----CCCCcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCC------
Confidence 632 2334566666666666543 221 134555566666655532 344445555555555555544
Q ss_pred hhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcE
Q 043136 339 ELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSR 418 (902)
Q Consensus 339 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~ 418 (902)
..|..|..+++|+.|++++|++++ +|..+..+++|+.|++++|++. .+|..+..+++|+.
T Consensus 263 ------------------~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~ 322 (390)
T 3o6n_A 263 ------------------IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLEN 322 (390)
T ss_dssp ------------------EESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSE
T ss_pred ------------------cChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCE
Confidence 444445555555555555555542 1222222233333333333333 23333444455555
Q ss_pred EEccCCccCCCCCcccCCCCCCcEEEccCcccC
Q 043136 419 LRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451 (902)
Q Consensus 419 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 451 (902)
|++++|+|++. | +..+++|+.|++++|.++
T Consensus 323 L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~ 352 (390)
T 3o6n_A 323 LYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWD 352 (390)
T ss_dssp EECCSSCCCCC-C--CCTTCCCSEEECCSSCEE
T ss_pred EECCCCcccee-C--chhhccCCEEEcCCCCcc
Confidence 55555555422 2 334444444444444444
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=364.24 Aligned_cols=311 Identities=15% Similarity=0.120 Sum_probs=198.6
Q ss_pred CCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEE
Q 043136 100 YLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQL 179 (902)
Q Consensus 100 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 179 (902)
.+++++.|++++|.++...+..|..+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|++|
T Consensus 49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 128 (597)
T 3oja_B 49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128 (597)
T ss_dssp GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEE
Confidence 46788999999999888777778889999999999998888777788888888888888888887777777777777777
Q ss_pred eccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCc
Q 043136 180 NLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 180 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
+|++|.+++..+..|+++++|++|+|++|.+++..|..|+.+++|++|++++|.+++.. +..+++|++|++++|.++
T Consensus 129 ~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~ 205 (597)
T 3oja_B 129 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLS 205 (597)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCS
T ss_pred EeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccc
Confidence 77777777555555677777777777777777666666777777777777777776542 344566666666666665
Q ss_pred ccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhh
Q 043136 260 GTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE 339 (902)
Q Consensus 260 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 339 (902)
+ +...++|++|++++|.++...+.. .++|+.|+|++|.+++ +..+.
T Consensus 206 ~-----l~~~~~L~~L~ls~n~l~~~~~~~---~~~L~~L~L~~n~l~~--------------------------~~~l~ 251 (597)
T 3oja_B 206 T-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLTD--------------------------TAWLL 251 (597)
T ss_dssp E-----EECCTTCSEEECCSSCCCEEECSC---CSCCCEEECCSSCCCC--------------------------CGGGG
T ss_pred c-----ccCCchhheeeccCCccccccccc---CCCCCEEECCCCCCCC--------------------------Chhhc
Confidence 3 223345566666666555332221 1345555555555543 23444
Q ss_pred hccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEE
Q 043136 340 LLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRL 419 (902)
Q Consensus 340 ~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L 419 (902)
.+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ +|.. +..+++|+.|
T Consensus 252 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~------------------------~~~l~~L~~L 306 (597)
T 3oja_B 252 NYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLY------------------------GQPIPTLKVL 306 (597)
T ss_dssp GCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECS------------------------SSCCTTCCEE
T ss_pred cCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcc------------------------cccCCCCcEE
Confidence 55555555555555555555555556666666666665553 1222 2334455555
Q ss_pred EccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCC
Q 043136 420 RIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT 476 (902)
Q Consensus 420 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 476 (902)
+|++|.++ .+|..++.+++|++|+|++|++++. | +..+++|+.|+|++|.+.+
T Consensus 307 ~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~ 359 (597)
T 3oja_B 307 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDC 359 (597)
T ss_dssp ECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEH
T ss_pred ECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCC
Confidence 55555555 3455555555566666666655533 2 4455666666666666653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-37 Score=363.58 Aligned_cols=335 Identities=18% Similarity=0.177 Sum_probs=200.0
Q ss_pred CCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEe
Q 043136 197 LSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLL 276 (902)
Q Consensus 197 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 276 (902)
+++++.|++++|.++...+..|..+++|++|+|++|.|++..|..|..+++|++|+|++|.+++..|..|+++++|++|+
T Consensus 50 l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 129 (597)
T 3oja_B 50 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV 129 (597)
T ss_dssp GCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence 56788899999888865555677888888888888888877777888888888888888888877777778888888888
Q ss_pred cCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecc
Q 043136 277 LFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356 (902)
Q Consensus 277 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 356 (902)
|++|.+++..+..|+++++|++|+|++|.+++..|..|..+++|++|+|++|.+++.. +..+++|+.|++++|.+++
T Consensus 130 L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~ 206 (597)
T 3oja_B 130 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLST 206 (597)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSE
T ss_pred eeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCcccc
Confidence 8888888655555677888888888888887777777777777777777777776532 3344555555555554442
Q ss_pred ccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCC
Q 043136 357 VLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL 436 (902)
Q Consensus 357 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 436 (902)
. .... +|+.|++++|.++.. |..+
T Consensus 207 l-----~~~~------------------------------------------------~L~~L~ls~n~l~~~-~~~~-- 230 (597)
T 3oja_B 207 L-----AIPI------------------------------------------------AVEELDASHNSINVV-RGPV-- 230 (597)
T ss_dssp E-----ECCT------------------------------------------------TCSEEECCSSCCCEE-ECSC--
T ss_pred c-----cCCc------------------------------------------------hhheeeccCCccccc-cccc--
Confidence 1 1112 233344444433321 1111
Q ss_pred CCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEec
Q 043136 437 LPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIEL 516 (902)
Q Consensus 437 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~L 516 (902)
.++|+.|+|++|.+++ +..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|++++
T Consensus 231 ~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~---------------- 292 (597)
T 3oja_B 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA---------------- 292 (597)
T ss_dssp CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE----------------
T ss_pred CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC----------------
Confidence 1344444444444443 2334444555555555555544445555555555555544444443
Q ss_pred cCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCccccc
Q 043136 517 HNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGP 596 (902)
Q Consensus 517 s~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ 596 (902)
+|..++.+++|+.|+|++|.++ .+|..++.+++|+.|+|++|.+++. | +..+++|+.|++++|++++.
T Consensus 293 --------l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 293 --------LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp --------EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHH
T ss_pred --------CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCCh
Confidence 1222233344444444444444 2333444455555555555555432 2 44455566666666666554
Q ss_pred CCCCCCcCcCCCCCcccCCcccCCCC
Q 043136 597 IPASGTIFPNLHPSSFIGNEGLCGRV 622 (902)
Q Consensus 597 ip~~~~~~~~~~~~~~~gn~~lcg~~ 622 (902)
.+. .+...+....+.+++..|+.+
T Consensus 361 ~~~--~~~~~~~~~~~~~~~~~C~~~ 384 (597)
T 3oja_B 361 SLR--ALFRNVARPAVDDADQHCKID 384 (597)
T ss_dssp HHH--HHTTTCCTTTBCCCCCCCCTT
T ss_pred hHH--HHHHHHhhhccccccccCCcc
Confidence 321 122223556678888889864
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=343.02 Aligned_cols=157 Identities=18% Similarity=0.202 Sum_probs=117.8
Q ss_pred CCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEE
Q 043136 196 NLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEML 275 (902)
Q Consensus 196 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 275 (902)
.++++++|++++|.++...+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..|..|.++++|++|
T Consensus 43 ~l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 122 (390)
T 3o6n_A 43 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 122 (390)
T ss_dssp GGCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred ccCCceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence 35788899999988885444457788888888888888887777788888888888888888887777778888888888
Q ss_pred ecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceec
Q 043136 276 LLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355 (902)
Q Consensus 276 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 355 (902)
+|++|+++...+..|+++++|++|+|++|++++..|..+..+++|++|++++|.+++. .+..+++|+.|++++|.++
T Consensus 123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~ 199 (390)
T 3o6n_A 123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS 199 (390)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCS
T ss_pred ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc---ccccccccceeeccccccc
Confidence 8888888854444567788888888888888777777777777888888877777643 1344455555555555544
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.67 Aligned_cols=259 Identities=27% Similarity=0.427 Sum_probs=206.9
Q ss_pred CceeEEEecCCcccC--CCCCCccCCCCccEEeccC-CcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcE
Q 043136 366 GKLLTVDVSSNSLTG--PIPPTICDGDRLFKLILFS-NNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTF 442 (902)
Q Consensus 366 ~~L~~L~Ls~N~l~~--~~p~~~~~~~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 442 (902)
.+++.|++++|++++ .+|..+..+++|++|++++ |++.+.+|..|.++++|++|+|++|++++.+|..|+.+++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 356666666666666 5666666666666666663 6666667777777777777777777777777777777777777
Q ss_pred EEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhccc-ccceeccCCCccCCCcccccccccccEEeccCccc
Q 043136 443 MDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP-NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLL 521 (902)
Q Consensus 443 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l 521 (902)
|+|++|++++.+|..|..+++|++|+|++|++++.+|..+..++ +|+.|++++|++++.+|..++...|+.|+|++|.+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l 209 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcc
Confidence 77777777777777777777777777777777777777777776 77788888887777777666533488888888888
Q ss_pred cccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCCCC
Q 043136 522 NGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASG 601 (902)
Q Consensus 522 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~ 601 (902)
++.+|..++.+++|+.|+|++|++++.+|. +..+++|++|||++|+++|.+|..|.++++|++|+|++|+++|.+|...
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~ 288 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCc
Confidence 888999999999999999999999988776 8889999999999999999999999999999999999999999999985
Q ss_pred CcCcCCCCCcccCCcccCCCCcCCCC
Q 043136 602 TIFPNLHPSSFIGNEGLCGRVLTKPC 627 (902)
Q Consensus 602 ~~~~~~~~~~~~gn~~lcg~~~~~~c 627 (902)
.+. .+....+.||+++||.|+. +|
T Consensus 289 ~l~-~L~~l~l~~N~~lc~~p~~-~C 312 (313)
T 1ogq_A 289 NLQ-RFDVSAYANNKCLCGSPLP-AC 312 (313)
T ss_dssp TGG-GSCGGGTCSSSEEESTTSS-CC
T ss_pred ccc-ccChHHhcCCCCccCCCCC-CC
Confidence 544 4588889999999999854 57
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.07 Aligned_cols=284 Identities=19% Similarity=0.263 Sum_probs=206.3
Q ss_pred cCCChhhHHHHHHHHHhCC-CCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecC--------CCCCEEEEEcCCCCc
Q 043136 20 ANTLPLPLVSLLSIKASLK-DPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNP--------KSSQITSLDLSRRSL 90 (902)
Q Consensus 20 ~~~~~~~~~aLl~~k~~~~-~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~--------~~~~v~~L~L~~~~l 90 (902)
..+..+|++||++||+++. ++.+ .+.+|..... ..+++|.|.|+.|.. ...+|+.|+|++|++
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~-~~~~w~~~~~-------~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l 93 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNR-WHSAWRQANS-------NNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL 93 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTT-HHHHHHHHTT-------TCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCC
T ss_pred cccCchHHHHHHHHHHhccCCchh-hhhhhccccc-------ccccccccCCcchhhhHHHHhcccccceeEEEccCCCc
Confidence 3467889999999999985 4544 6788952210 023489999999952 234777777777777
Q ss_pred ccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhh
Q 043136 91 SGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEF 170 (902)
Q Consensus 91 ~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 170 (902)
+ .+|+.++.+++|++|+|++|.++ .+|..++.+++|++|+|++|.++ .+|..++++++|++|++++|++.+.+|..+
T Consensus 94 ~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~ 170 (328)
T 4fcg_A 94 P-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPL 170 (328)
T ss_dssp S-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCS
T ss_pred h-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhH
Confidence 7 66777777777777777777777 66667777777777777777776 556666666666666666666666666544
Q ss_pred hcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCE
Q 043136 171 VQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKY 250 (902)
Q Consensus 171 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 250 (902)
... .++..|.++++|++|+|++|+++ .+|..++.+++|++|+|++|++++ +|..+..+++|++
T Consensus 171 ~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~~l~~L~~ 233 (328)
T 4fcg_A 171 AST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEE 233 (328)
T ss_dssp EEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGGGCTTCCE
T ss_pred hhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-CchhhccCCCCCE
Confidence 331 11123445777888888888777 677777778888888888888874 5556777888888
Q ss_pred EEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccc
Q 043136 251 MDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 251 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 330 (902)
|+|++|++.+.+|..+.++++|++|+|++|++.+.+|..++++++|++|+|++|++.+.+|..+.++++|+.+++..|.+
T Consensus 234 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~ 313 (328)
T 4fcg_A 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQ 313 (328)
T ss_dssp EECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGS
T ss_pred EECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHH
Confidence 88888888878888888888888888888888878888888888888888888888888888888888888888877665
Q ss_pred c
Q 043136 331 F 331 (902)
Q Consensus 331 ~ 331 (902)
.
T Consensus 314 ~ 314 (328)
T 4fcg_A 314 A 314 (328)
T ss_dssp C
T ss_pred H
Confidence 4
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.88 Aligned_cols=174 Identities=28% Similarity=0.351 Sum_probs=151.0
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|++ .+++.||||++.+.........+.+.+|++++++++|||||++++++++++..|+||||
T Consensus 34 y~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy 113 (311)
T 4aw0_A 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 113 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEec
Confidence 56678999999999999976 56899999999654333333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
|+||+|.+++...+ .+++.....++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.+...
T Consensus 114 ~~gG~L~~~i~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 114 AKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999998654 3778888899999999999999776 999999999999999999999999999987533
Q ss_pred ---CCceeeccccCccccCccccccc
Q 043136 871 ---ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 ---~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+.+||+.|||||++.+..+
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y 211 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSA 211 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCB
T ss_pred CCcccccCcccCcccCCHHHHcCCCC
Confidence 23456899999999999987544
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=319.75 Aligned_cols=307 Identities=26% Similarity=0.362 Sum_probs=136.6
Q ss_pred hhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCC
Q 043136 121 AILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSL 200 (902)
Q Consensus 121 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 200 (902)
.+..+++|++|++++|.+... | .+..+++|++|++++|++++..+ +..+++|++|+|++|.++. +| .+.++++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTC
T ss_pred cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcC
Confidence 355677777777777777542 2 25556666666666665554332 5555555555555555553 22 35555555
Q ss_pred CEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCC
Q 043136 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280 (902)
Q Consensus 201 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 280 (902)
++|+|++|++++ ++. +..+++|++|++++|.....++ .+..+++|++|++++|.+++..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~-~~~-~~~l~~L~~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISD-ISP-LANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCC-CGG-GTTCTTCCEEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccC-chh-hccCCceeEEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 555555555553 222 4445555555555553332222 24444444444444444443222 344444444444444
Q ss_pred ccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCc
Q 043136 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQ 360 (902)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 360 (902)
.+.+.. + +..+++|+.|++++|.+.+..+ +..+++|++|++++|++++..+
T Consensus 188 ~l~~~~------------------------~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~- 238 (347)
T 4fmz_A 188 QIEDIS------------------------P--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238 (347)
T ss_dssp CCCCCG------------------------G--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-
T ss_pred cccccc------------------------c--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc-
Confidence 443221 1 3334444444444444432222 3334444444444444443222
Q ss_pred cccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCC
Q 043136 361 KLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNL 440 (902)
Q Consensus 361 ~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 440 (902)
+..+++|+.|++++|++++. +.+..+++|++|++++|++++. +.+..+++|+.|++++|++++..|..|+.+++|
T Consensus 239 -~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp -GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred -hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 34444444444444444421 1222222333333333333221 123334444444444444444444444444444
Q ss_pred cEEEccCcccCCCCCCcCcccCcCceeccccccc
Q 043136 441 TFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSF 474 (902)
Q Consensus 441 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 474 (902)
++|+|++|++++..| +..+++|++|++++|.|
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC--
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhcc
Confidence 444444444443333 33444444444444443
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.44 Aligned_cols=308 Identities=22% Similarity=0.312 Sum_probs=247.1
Q ss_pred cccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCC
Q 043136 97 EIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176 (902)
Q Consensus 97 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 176 (902)
.+..+++|++|++++|.+... + .+..+++|++|++++|++++..+ +..+++|++|++++|.++.. ..|..+++|
T Consensus 39 ~~~~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L 112 (347)
T 4fmz_A 39 TQEELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNL 112 (347)
T ss_dssp CHHHHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTC
T ss_pred cchhcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcC
Confidence 456889999999999999864 3 48999999999999999987544 99999999999999999874 369999999
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
++|+|++|.+++..+ +..+++|++|++++|.....+ ..+..+++|++|++++|.+.+..+ +..+++|++|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCC
Confidence 999999999986543 899999999999999766444 459999999999999999986654 889999999999999
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCCh
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ 336 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (902)
.+++..+ +..+++|++|++++|.+++..+ +..+++|++|++++|++++..+ +..+++|++|++++|.+++. +
T Consensus 188 ~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~ 259 (347)
T 4fmz_A 188 QIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--N 259 (347)
T ss_dssp CCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--G
T ss_pred ccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--h
Confidence 9986543 8899999999999999986544 7888999999999999986544 77888888888888887653 3
Q ss_pred hhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCC
Q 043136 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSL 416 (902)
Q Consensus 337 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L 416 (902)
.+..+++|++|++++|++++. +.+..+++|+.|++++|++++..|..+..+++|
T Consensus 260 ~~~~l~~L~~L~l~~n~l~~~--------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L 313 (347)
T 4fmz_A 260 AVKDLTKLKMLNVGSNQISDI--------------------------SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNL 313 (347)
T ss_dssp GGTTCTTCCEEECCSSCCCCC--------------------------GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTC
T ss_pred hHhcCCCcCEEEccCCccCCC--------------------------hhhcCCCCCCEEECcCCcCCCcChhHhhccccC
Confidence 455556666666666655542 234445555666666666666677777888888
Q ss_pred cEEEccCCccCCCCCcccCCCCCCcEEEccCcccC
Q 043136 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451 (902)
Q Consensus 417 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 451 (902)
++|++++|++++..| +..+++|++|++++|.|+
T Consensus 314 ~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 314 TTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp SEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred CEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 888888888886655 778888888888888875
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=326.57 Aligned_cols=177 Identities=21% Similarity=0.285 Sum_probs=145.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||+||+|++ .+++.||||++.+... .....+.+.+|++++++++|||||++++++++++..|+|||
T Consensus 25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356678999999999999976 4689999999965432 33456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||+||+|.+++...+. ..+++.....|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG---VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 9999999999975432 24677888899999999999999776 99999999999999999999999999987654
Q ss_pred CC-CceeeccccCccccCcccccccC
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.. ...+.+||+.|||||++.+..+.
T Consensus 178 ~~~~~~~~~GT~~YmAPE~l~~~~y~ 203 (350)
T 4b9d_A 178 TVELARACIGTPYYLSPEICENKPYN 203 (350)
T ss_dssp HHHHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred CcccccccCCCccccCHHHHCCCCCC
Confidence 32 23457899999999999876443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=314.84 Aligned_cols=174 Identities=26% Similarity=0.376 Sum_probs=135.3
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||+||+|+. .+++.||||++.+.........+.+.+|++++++++|||||++++++++++..|+|||
T Consensus 14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 93 (275)
T 3hyh_A 14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE 93 (275)
T ss_dssp CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence 466778999999999999976 4689999999965544444445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+ +|+|.+++..++ .+++.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 94 y~-~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 94 YA-GNELFDYIVQRD-----KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp CC-CEEHHHHHHHSC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred CC-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 99 789999987643 3778888999999999999999776 99999999999999999999999999998776
Q ss_pred CCCceeeccccCccccCccccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.....+.+||+.|||||++.+...
T Consensus 165 ~~~~~~~~GT~~Y~APE~~~~~~y 188 (275)
T 3hyh_A 165 GNFLKTSCGSPNYAAPEVISGKLY 188 (275)
T ss_dssp ----------CTTSCHHHHSSSSC
T ss_pred CCccCCeeECcccCChhhhcCCCC
Confidence 666677899999999999987643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.19 Aligned_cols=173 Identities=27% Similarity=0.405 Sum_probs=145.7
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~lv 787 (902)
.+++.||+|+||+||+|.+ .+++.||+|++..... .....+.+.+|++++++++|||||+++++|++ ++..|+|
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4567899999999999976 4688999999865432 33456779999999999999999999999865 3568999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeeccccee
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKL 866 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~ 866 (902)
||||+||+|.++++... .+++..+..|+.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+.
T Consensus 108 mEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999997653 4778888899999999999999652 45999999999999974 79999999999985
Q ss_pred ccCCCCceeeccccCccccCccccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
. ......+.+||+.|||||++.+.+.
T Consensus 182 ~-~~~~~~~~~GTp~YmAPE~~~~~y~ 207 (290)
T 3fpq_A 182 K-RASFAKAVIGTPEFMAPEMYEEKYD 207 (290)
T ss_dssp C-CTTSBEESCSSCCCCCGGGGGTCCC
T ss_pred C-CCCccCCcccCccccCHHHcCCCCC
Confidence 4 3344567899999999999987544
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=323.26 Aligned_cols=170 Identities=24% Similarity=0.380 Sum_probs=147.4
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||+||+|++. +|+.||||++...... ..+.+.+|++++++++|||||+++++|.+++..|+||||
T Consensus 76 y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 76 LDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred cEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 445578999999999999764 6999999999543322 234578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
|+||+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 153 ~~gg~L~~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 153 LEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp CTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred CCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 9999999998653 3678888999999999999999776 999999999999999999999999999987543
Q ss_pred -CCceeeccccCccccCccccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+.+||+.|||||++.+..+
T Consensus 224 ~~~~~~~~GTp~YmAPEvl~~~~y 247 (346)
T 4fih_A 224 VPRRKSLVGTPYWMAPELISRLPY 247 (346)
T ss_dssp SCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred CCcccccccCcCcCCHHHHCCCCC
Confidence 34567899999999999976543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.79 Aligned_cols=177 Identities=25% Similarity=0.436 Sum_probs=146.8
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+.+.+.||+|+||+||+|++. +++.||||++... .....+++.+|++++++++|||||+++++|.+.+..|
T Consensus 15 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 15 IVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp EEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred eEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 346689999999999999763 4778999998543 2345677999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhc--------cCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEE
Q 043136 786 LLYEYMPNGNLDDLLHAKN--------KGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~k 857 (902)
+|||||++|+|.++++..+ ......++|..+..|+.|||+||+|||+++ ||||||||+|||++.++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEE
Confidence 9999999999999997643 123346899999999999999999999766 99999999999999999999
Q ss_pred EeecccceeccCCCCc---eeeccccCccccCcccccccC
Q 043136 858 VADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 858 l~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~~~~ 894 (902)
|+|||+|+........ ...+||+.|||||++.+....
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 208 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT 208 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC
Confidence 9999999876443322 235699999999999765443
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.36 Aligned_cols=173 Identities=29% Similarity=0.420 Sum_probs=141.5
Q ss_pred CCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 714 SDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.+.||+|+||+||+|++.+ .||||++.... ......+.|.+|++++++++|||||++++++.+ +..|+|||||++
T Consensus 40 l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~g 115 (307)
T 3omv_A 40 LSTRIGSGSFGTVYKGKWHG--DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEG 115 (307)
T ss_dssp EEEECCCCSSSEEEEEESSS--EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSS
T ss_pred EeeEEeeCCCcEEEEEEECC--cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCC
Confidence 45789999999999998643 59999985433 234556789999999999999999999998864 568999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC---
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD--- 870 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~--- 870 (902)
|+|.++++... ..+++..+..|+.|||+||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 116 GsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 116 SSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred CCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999997543 24789999999999999999999766 999999999999999999999999999876432
Q ss_pred CCceeeccccCccccCcccccccCcee
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
......+||+.|||||++.+....||+
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~ 215 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFS 215 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCC
T ss_pred eeecccccCCCccCHHHhhccCCCCCC
Confidence 233557899999999999776544544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-35 Score=325.79 Aligned_cols=172 Identities=24% Similarity=0.372 Sum_probs=148.7
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|++ .+|+.||||++...... ..+.+.+|+++|++++|||||+++++|.+.+.+|+|||
T Consensus 152 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 152 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 355668899999999999976 46899999999644322 23457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||+||+|.++++.. .+++..+..|+.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+..
T Consensus 229 y~~gG~L~~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 229 FLEGGALTDIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CCTTEEHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 99999999998643 2678888999999999999999776 99999999999999999999999999998754
Q ss_pred C-CCceeeccccCccccCcccccccC
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
. ....+.+||+.|||||++.+..+.
T Consensus 300 ~~~~~~~~~GTp~YmAPEvl~~~~y~ 325 (423)
T 4fie_A 300 EVPRRKSLVGTPYWMAPELISRLPYG 325 (423)
T ss_dssp SCCCBCCCEECTTTCCHHHHTTCCBC
T ss_pred CCccccccccCcCcCCHHHHCCCCCC
Confidence 3 345678999999999999875443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-35 Score=317.74 Aligned_cols=176 Identities=26% Similarity=0.398 Sum_probs=141.5
Q ss_pred cCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.||+|+||+||+|++. +++.||||++... .....++|.+|++++++++|||||+++++|.+.+..|+
T Consensus 44 ~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp EEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred EEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 34578999999999999764 4788999999543 33456779999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 787 LYEYMPNGNLDDLLHAKNKG----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
|||||++|+|.++++..... ...+++|.+++.|+.|||+||+|||+++ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 99999999999999764321 1235889999999999999999999766 9999999999999999999
Q ss_pred EEeecccceeccCCCC---ceeeccccCccccCcccccccC
Q 043136 857 RVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 857 kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
||+|||+|+....... ....+||+.|||||++.+....
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~ 238 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCC
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCC
Confidence 9999999987643322 2446799999999999876443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.61 Aligned_cols=167 Identities=25% Similarity=0.261 Sum_probs=140.9
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...++||+|+||+||+|++ .+|+.||||++..... ..+|++++++++|||||++++++.+.+..|+||||
T Consensus 60 ~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred eEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 34557899999999999976 4689999999854321 24699999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 869 (902)
|+||+|.++++..+ .+++.....++.||+.||+|||+++ ||||||||+|||++.+| ++||+|||+|+.+..
T Consensus 132 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG-----CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred cCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 99999999997654 3788889999999999999999665 99999999999999998 699999999998754
Q ss_pred CCC------ceeeccccCccccCcccccccC
Q 043136 870 DES------MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~~------~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+.. ....+||+.|||||++.+..+.
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 234 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCC
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCC
Confidence 322 2336899999999999876443
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.65 Aligned_cols=176 Identities=20% Similarity=0.332 Sum_probs=146.5
Q ss_pred cCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.+.+.||+|+||+||+|++. +++.||||++..... ....++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 29 ~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~--~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 29 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC--C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC--hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 45578999999999999752 467899999864332 2335678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 787 LYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
|||||++|+|.+++..+... ....+++..+..|+.|||+||+|||+++ ||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 99999999999999764321 1235889999999999999999999776 999999999999999999
Q ss_pred EEEeecccceeccCCC---CceeeccccCccccCccccccc
Q 043136 856 ARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+||+|||+|+...... .....+||+.|||||++.+...
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~ 224 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF 224 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC
Confidence 9999999998764322 2345689999999999976543
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.78 Aligned_cols=288 Identities=20% Similarity=0.276 Sum_probs=164.0
Q ss_pred CCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecC
Q 043136 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLF 278 (902)
Q Consensus 199 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 278 (902)
+++.+++++|.++ .+|..+. ++|++|++++|++++..|..|.++++|++|+|++|++++..|..|.++++|++|+|+
T Consensus 34 ~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 110 (332)
T 2ft3_A 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYIS 110 (332)
T ss_dssp ETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECC
T ss_pred cCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECC
Confidence 3444444444444 3343332 344555555555544444445555555555555555554444555555555555555
Q ss_pred CCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc--ccCChhhhhccccceEEecCceecc
Q 043136 279 KNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF--GEIPQDIELLADLDTLLLWNNHLTG 356 (902)
Q Consensus 279 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~ 356 (902)
+|+++ .+|..+. ++|++|++++|++++..+..|..+++|+.|++++|.+. +..|..+..+ +|+.|++++|++++
T Consensus 111 ~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~ 186 (332)
T 2ft3_A 111 KNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG 186 (332)
T ss_dssp SSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS
T ss_pred CCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc
Confidence 55554 3333332 45555555555555444444555555555555555553 2444444444 55555555555554
Q ss_pred ccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCC
Q 043136 357 VLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL 436 (902)
Q Consensus 357 ~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 436 (902)
+|..+. ++|+.|++++|++++..+..+..+++|+.|++++|++++..|..+..+++|++|+|++|+++ .+|.++..
T Consensus 187 -l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~ 262 (332)
T 2ft3_A 187 -IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262 (332)
T ss_dssp -CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGG
T ss_pred -cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhc
Confidence 232222 45666666666666666666666666666666666666666666777777777777777777 66777777
Q ss_pred CCCCcEEEccCcccCCCCCCcCccc------CcCceecccccccC--CCcChhhhcccccceeccCCCc
Q 043136 437 LPNLTFMDMSRNSLSGEIPRDLGNA------QKLEYLNISENSFQ--TSLPSNIWSAPNLKILSASSSK 497 (902)
Q Consensus 437 l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~ls~N~ 497 (902)
+++|++|++++|++++..+..|... ..|+.|++++|.+. +..|..+..+++|+.+++++|+
T Consensus 263 l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 263 LKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 7777777777777776655555543 45677777777765 4556666667777777766663
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=309.11 Aligned_cols=176 Identities=24% Similarity=0.342 Sum_probs=136.1
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--------
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-------- 782 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-------- 782 (902)
|...+.||+|+||+||+|++ .+++.||||++.... .....+.+.+|++++++++|||||+++++|.+.+
T Consensus 7 y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp EEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred CEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45568999999999999976 468999999985433 2344567899999999999999999999986543
Q ss_pred ----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 783 ----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 783 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
+.|+|||||++|+|.+++..+... ...++.....|+.||++||+|||+++ ||||||||+|||++.++.+||
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl 159 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTI--EERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKV 159 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSG--GGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCC--ChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEE
Confidence 479999999999999999765322 23455667789999999999999776 999999999999999999999
Q ss_pred eecccceeccCCCC-------------ceeeccccCccccCcccccccC
Q 043136 859 ADFGVAKLIQSDES-------------MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 859 ~DFGla~~~~~~~~-------------~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+|||+|+....... ..+.+||+.|||||++.+..+.
T Consensus 160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 208 (299)
T 4g31_A 160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS 208 (299)
T ss_dssp CCCCCC--------------------------CCCTTSCHHHHTTCCCC
T ss_pred ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC
Confidence 99999987754321 2346899999999999876443
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-33 Score=308.74 Aligned_cols=287 Identities=18% Similarity=0.237 Sum_probs=162.1
Q ss_pred CcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC
Q 043136 176 LQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255 (902)
Q Consensus 176 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 255 (902)
|+.++++++.++ .+|..+. ++|++|+|++|++++..|..|..+++|++|++++|++++..|..|.++++|++|+|++
T Consensus 35 l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 111 (332)
T 2ft3_A 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISK 111 (332)
T ss_dssp TTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCS
T ss_pred CCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCC
Confidence 444444444443 3333332 3444555555554444444445555555555555555444444455555555555555
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc--cccCccccccCCCCEEEccCcccccc
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS--GPIPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++ +..|..+..+ +|++|++++|.+++
T Consensus 112 n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~- 186 (332)
T 2ft3_A 112 NHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG- 186 (332)
T ss_dssp SCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-
T ss_pred CcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-
Confidence 5554 2333222 44555555555555433334455555555555555553 2344444444 55555555555543
Q ss_pred CChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccccc
Q 043136 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC 413 (902)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l 413 (902)
+|..+. ++|++|++++|++++..+..+..+++|+.|++++|++++..+..+..+++|+.|++++|+++ .+|..+..+
T Consensus 187 l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l 263 (332)
T 2ft3_A 187 IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDL 263 (332)
T ss_dssp CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGC
T ss_pred cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcC
Confidence 333222 45555666666666555555666666666666666666655556666666666666666666 566777778
Q ss_pred CCCcEEEccCCccCCCCCcccCC------CCCCcEEEccCcccC--CCCCCcCcccCcCceecccccc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGL------LPNLTFMDMSRNSLS--GEIPRDLGNAQKLEYLNISENS 473 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~Ls~N~ 473 (902)
++|+.|++++|+|++..+..|.. .++|+.|++++|.+. +..|..|..+++|+.+++++|+
T Consensus 264 ~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 264 KLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 88888888888888666666654 367888888888887 6677788888889988888874
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=357.93 Aligned_cols=255 Identities=19% Similarity=0.202 Sum_probs=141.2
Q ss_pred CEEEEEcCCCCcccccCcc-ccCCCCCCEEEccCCCCcc----cCchhhhccCCCcEEEccCCCCCCCCCccc-cccc--
Q 043136 79 QITSLDLSRRSLSGPIPPE-IRYLTSLTHLNLSANAFDG----PLQPAILELTKLRTIDISHNSFNSTFPPGI-SKLR-- 150 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~-~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~-- 150 (902)
+++.|||++++++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|.++...+..+ ..++
T Consensus 4 ~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~ 83 (461)
T 1z7x_W 4 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 83 (461)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred cceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhC
Confidence 5677777777776543332 6667777777777777764 245556667777777777777765433332 2233
Q ss_pred --ccceeccccccccC----CCchhhhcccCCcEEeccCccCcCCCCccc-----CCCCCCCEEEccCCCccCC----CC
Q 043136 151 --FLRIFNAYSNSFTG----PLPLEFVQLNSLQQLNLGGSYFDGEIPSDY-----RNLSSLRFLDLAGNSLTGS----LP 215 (902)
Q Consensus 151 --~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~~----~p 215 (902)
+|++|+|++|+++. .+|..+..+++|++|+|++|.+++..+..+ ...++|++|+|++|++++. ++
T Consensus 84 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~ 163 (461)
T 1z7x_W 84 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 163 (461)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHH
Confidence 46666666666663 346666666666666666666653322222 2244566666666666642 23
Q ss_pred ccccCCCCCcEEEeeCcccCCCCChhcc-----CCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCccceec
Q 043136 216 PQLGLLTQLERIEIGYNNLQGEVPVEFA-----SLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 216 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
..+..+++|++|++++|.++...+..+. ..++|++|+|++|.+++. ++..+..+++|++|+|++|++++..
T Consensus 164 ~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~ 243 (461)
T 1z7x_W 164 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 243 (461)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHH
Confidence 4444556666666666665543333332 244566666666665542 3444555555666666666554321
Q ss_pred -----CCCCCCcCcCcEEecccCCCccc----cCccccccCCCCEEEccCcccccc
Q 043136 287 -----PVSYGNLQALQVLDLSDNQLSGP----IPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 287 -----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
+..+..+++|++|+|++|++++. ++..+..+++|++|++++|.+.+.
T Consensus 244 ~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~ 299 (461)
T 1z7x_W 244 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE 299 (461)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHH
T ss_pred HHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchH
Confidence 11122345555555555555432 344444455555555555555433
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-33 Score=303.83 Aligned_cols=295 Identities=19% Similarity=0.230 Sum_probs=167.9
Q ss_pred CCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEecc
Q 043136 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLG 182 (902)
Q Consensus 103 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 182 (902)
+++.++++++.++. +|..+. ++|++|+|++|++++..+..|+++ ++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~~-lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l------------------------~~L~~L~L~ 84 (330)
T 1xku_A 32 HLRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNL------------------------KNLHTLILI 84 (330)
T ss_dssp ETTEEECTTSCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTC------------------------TTCCEEECC
T ss_pred CCeEEEecCCCccc-cCccCC--CCCeEEECCCCcCCEeChhhhccC------------------------CCCCEEECC
Confidence 45666666666653 333332 455555555555554444444444 444555555
Q ss_pred CccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcc--
Q 043136 183 GSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG-- 260 (902)
Q Consensus 183 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-- 260 (902)
+|++++..|..|.++++|++|+|++|+++ .+|..+. ++|++|++++|++++..+..|.++++|++|++++|.++.
T Consensus 85 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 85 NNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 55554444455555555555555555555 3343332 455556666666555555556666666666666666542
Q ss_pred cCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhh
Q 043136 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL 340 (902)
Q Consensus 261 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 340 (902)
..+..+.++++|++|++++|+++. +|..+. ++|++|++++|++++..|..|..+++|++|++++|.+++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 445556666666666666666653 343332 56666666666666655666666666666666666666655556666
Q ss_pred ccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEE
Q 043136 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLR 420 (902)
Q Consensus 341 l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 420 (902)
+++|++|+|++|+++ .+|..+..+++|++|++++|++++..+..++... .......|+.|+
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~ 299 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVS 299 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEE
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceE
Confidence 666666666666666 4555566666666666666666654444443221 011235677778
Q ss_pred ccCCccCC--CCCcccCCCCCCcEEEccCcc
Q 043136 421 IQDNQLNG--SIPQGFGLLPNLTFMDMSRNS 449 (902)
Q Consensus 421 Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~ 449 (902)
+++|.+.. ..|..|..+.+|+.++|++|+
T Consensus 300 l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 300 LFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp CCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred eecCcccccccCccccccccceeEEEecccC
Confidence 88887752 556778888888888888875
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-33 Score=304.25 Aligned_cols=288 Identities=20% Similarity=0.247 Sum_probs=152.0
Q ss_pred CCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEcc
Q 043136 175 SLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254 (902)
Q Consensus 175 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 254 (902)
+|+.++++++.++ .+|..+. ++|++|+|++|++++..+..|+.+++|++|+|++|++++..|..|..+++|++|+|+
T Consensus 32 ~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls 108 (330)
T 1xku_A 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 108 (330)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECC
Confidence 4555666655555 3444332 355555555555554444455555555555555555555445555555555555555
Q ss_pred CccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc--c
Q 043136 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF--G 332 (902)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~ 332 (902)
+|+++ .+|..+. ++ |++|++++|++++..+..|..+++|++|++++|.+. +
T Consensus 109 ~n~l~-~l~~~~~--~~------------------------L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 161 (330)
T 1xku_A 109 KNQLK-ELPEKMP--KT------------------------LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161 (330)
T ss_dssp SSCCS-BCCSSCC--TT------------------------CCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG
T ss_pred CCcCC-ccChhhc--cc------------------------ccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccC
Confidence 55554 2333222 34 444444444444444444444444444444444442 1
Q ss_pred cCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccc
Q 043136 333 EIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN 412 (902)
Q Consensus 333 ~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~ 412 (902)
..+..+..+++|++|++++|+++. +|..+. ++|+.|++++|++++..|..+..+++|+.|++++|++++..+..+..
T Consensus 162 ~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 238 (330)
T 1xku_A 162 IENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 238 (330)
T ss_dssp BCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGG
T ss_pred cChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccC
Confidence 334444444555555555555443 222221 45555555555555555555555555555555555555555556666
Q ss_pred cCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCccc------CcCceecccccccCC--CcChhhhc
Q 043136 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA------QKLEYLNISENSFQT--SLPSNIWS 484 (902)
Q Consensus 413 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~--~~p~~~~~ 484 (902)
+++|++|+|++|+++ .+|.++..+++|++|+|++|++++..+..|... ..|+.|++++|.+.. ..|..+..
T Consensus 239 l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~ 317 (330)
T 1xku_A 239 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRC 317 (330)
T ss_dssp STTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTT
T ss_pred CCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCcccccc
Confidence 666777777777776 566666677777777777777766555555432 456666666666542 34455555
Q ss_pred ccccceeccCCC
Q 043136 485 APNLKILSASSS 496 (902)
Q Consensus 485 l~~L~~L~ls~N 496 (902)
+.+++.+++++|
T Consensus 318 ~~~l~~l~L~~N 329 (330)
T 1xku_A 318 VYVRAAVQLGNY 329 (330)
T ss_dssp CCCGGGEEC---
T ss_pred ccceeEEEeccc
Confidence 555555555555
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-35 Score=314.70 Aligned_cols=174 Identities=27% Similarity=0.287 Sum_probs=141.2
Q ss_pred ccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|.+.+.||+|+||+||+|+.. +++.||||++.+..... .....+.+|++++++++|||||++++++++++..|+|
T Consensus 26 Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 104 (304)
T 3ubd_A 26 FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLI 104 (304)
T ss_dssp EEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEETTEEEEE
T ss_pred cEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 556789999999999999752 47899999986433211 1223477899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
||||+||+|.+++...+ .+++.....++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+..
T Consensus 105 mEy~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 105 LDFLRGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp ECCCTTCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEcCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 99999999999997654 3778888899999999999999776 999999999999999999999999999875
Q ss_pred cC-CCCceeeccccCccccCcccccccC
Q 043136 868 QS-DESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 868 ~~-~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.. .....+.+||+.|||||++.+..+.
T Consensus 177 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~ 204 (304)
T 3ubd_A 177 IDHEKKAYSFCGTVEYMAPEVVNRRGHT 204 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred cCCCccccccccCcccCCHHHhccCCCC
Confidence 43 3344568999999999999876544
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=354.57 Aligned_cols=374 Identities=18% Similarity=0.182 Sum_probs=225.9
Q ss_pred CCCCEEEccCCCccCCCCcc-ccCCCCCcEEEeeCcccCC----CCChhccCCCCCCEEEccCccCcccCCccc-cCCC-
Q 043136 198 SSLRFLDLAGNSLTGSLPPQ-LGLLTQLERIEIGYNNLQG----EVPVEFASLVNLKYMDISACNLSGTLPSEI-SNLT- 270 (902)
Q Consensus 198 ~~L~~L~L~~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~- 270 (902)
++|++|+|++|+++...... +..+++|++|++++|+++. .++..+..+++|++|+|++|.+++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56788888888887443332 6778888888888888874 345667778888888888888875444333 2344
Q ss_pred ---CccEEecCCCccce----ecCCCCCCcCcCcEEecccCCCccccCccccc-----cCCCCEEEccCccccccC----
Q 043136 271 ---KLEMLLLFKNHFTG----EIPVSYGNLQALQVLDLSDNQLSGPIPASLAS-----LKGLTRLSLMNNVLFGEI---- 334 (902)
Q Consensus 271 ---~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~---- 334 (902)
+|++|+|++|+++. .++..+..+++|++|+|++|.+++..+..+.. .++|++|++++|.+++..
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 58888888888773 45667777888888888888876544443332 456888888888776643
Q ss_pred ChhhhhccccceEEecCceeccccCccccC-----CCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccc
Q 043136 335 PQDIELLADLDTLLLWNNHLTGVLPQKLGS-----NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN 409 (902)
Q Consensus 335 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~ 409 (902)
+..+..+++|++|++++|.+++..+..+.. .++|+.|++++|++++... ..++..
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~--------------------~~l~~~ 222 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC--------------------RDLCGI 222 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHH--------------------HHHHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHH--------------------HHHHHH
Confidence 444556677777777777776544433322 3456666666666553200 013444
Q ss_pred ccccCCCcEEEccCCccCCCC-----CcccCCCCCCcEEEccCcccCCC----CCCcCcccCcCceecccccccCCCcCh
Q 043136 410 LVNCSSLSRLRIQDNQLNGSI-----PQGFGLLPNLTFMDMSRNSLSGE----IPRDLGNAQKLEYLNISENSFQTSLPS 480 (902)
Q Consensus 410 l~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 480 (902)
+..+++|++|++++|++++.. +..+..+++|++|+|++|++++. ++..+..+++|++|+|++|.+.+..+.
T Consensus 223 l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~ 302 (461)
T 1z7x_W 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 302 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHH
T ss_pred HHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHH
Confidence 555556666666666554321 22233455666666666666543 444555566666666666665443333
Q ss_pred hhhcc-----cccceeccCCCccCCC----cccccc-cccccEEeccCccccccCCccccc-----cccceEEEeeCCcc
Q 043136 481 NIWSA-----PNLKILSASSSKLTGK----IPDFIG-CKSIYKIELHNNLLNGSIPWDIGH-----CEKLLLLNLSRNSL 545 (902)
Q Consensus 481 ~~~~l-----~~L~~L~ls~N~l~~~----~p~~~~-~~~l~~l~Ls~N~l~g~ip~~~~~-----l~~L~~L~Ls~N~l 545 (902)
.+... ++|+.|++++|++++. ++..+. +++|+.|+|++|.+++..+..+.. .++|+.|+|++|++
T Consensus 303 ~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i 382 (461)
T 1z7x_W 303 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDV 382 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCC
Confidence 33322 4566666666665543 222222 456666666666665544444432 45677777777777
Q ss_pred ee----cCCCCCCCCCcccEEEccCCccccc--------CCCCCcCCccceeecccCC
Q 043136 546 TG----IIPWEISGLPSITDVDLSHNFLTGT--------IPSNFENCSTLESFNVSYN 591 (902)
Q Consensus 546 ~g----~~p~~~~~l~~L~~L~Ls~N~l~g~--------ip~~~~~l~~L~~l~ls~N 591 (902)
++ .+|..+..+++|++|||++|++++. +|.....++.|..++++.|
T Consensus 383 ~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~~~~~~l~~~l~~~~~~L~~L~~~~~~~~ 440 (461)
T 1z7x_W 383 SDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440 (461)
T ss_dssp CHHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred ChhhHHHHHHHHHhCCCccEEECCCCCCCHHHHHHHHHHhccCCcchhheeecccccC
Confidence 75 5666666777777777777777654 4444444444444444433
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=303.93 Aligned_cols=169 Identities=28% Similarity=0.376 Sum_probs=137.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC----eeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE----CTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~----~~~lv 787 (902)
+..++.||+|+||+||+|++ +|+.||||++..... ......+|+..+.+++|||||++++++.+.+ ..|+|
T Consensus 5 i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 45678999999999999987 689999999854322 1222345677778899999999999997653 57999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-----CDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
||||++|+|.++++.. .+++..+.+++.|+++||+|||++ +.++||||||||+|||++.++++||+|||
T Consensus 80 ~Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred ecCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999753 378889999999999999999975 23469999999999999999999999999
Q ss_pred cceeccCCCC-----ceeeccccCccccCccccc
Q 043136 863 VAKLIQSDES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
+|+....... ....+||+.|||||++.+.
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~ 187 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhccc
Confidence 9998754332 2346899999999999764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=304.03 Aligned_cols=283 Identities=20% Similarity=0.216 Sum_probs=208.8
Q ss_pred CCCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 64 ~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
.+|.|.|+ |+ +++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|
T Consensus 28 ~~C~~~~~-c~----------~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 93 (353)
T 2z80_A 28 LSCDRNGI-CK----------GSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93 (353)
T ss_dssp CEECTTSE-EE----------CCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECT
T ss_pred CCCCCCeE-ee----------CCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCH
Confidence 37999988 75 3556666 5676554 589999999999998877799999999999999999998888
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCC-cccCCCCCCCEEEccCC-CccCCCCccccCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGN-SLTGSLPPQLGLL 221 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l 221 (902)
..|+++++|++|++++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .+++..|..|+.+
T Consensus 94 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l 173 (353)
T 2z80_A 94 DSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173 (353)
T ss_dssp TTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTC
T ss_pred hhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCC
Confidence 889999999999999999998777779999999999999999985444 47889999999999998 4776667788889
Q ss_pred CCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCC---CcCcCcE
Q 043136 222 TQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYG---NLQALQV 298 (902)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~ 298 (902)
++|++|++++|++++..|..|..+++|++|++++|+++...+..+..+++|++|++++|++++..+..+. ....++.
T Consensus 174 ~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~ 253 (353)
T 2z80_A 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKK 253 (353)
T ss_dssp CEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCE
T ss_pred CCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhc
Confidence 9999999999999888888898899999999999988744444455678888888888888865544332 2344555
Q ss_pred EecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcc
Q 043136 299 LDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSL 378 (902)
Q Consensus 299 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l 378 (902)
++|++|.+++. .+. .+|+.+..+++|+.|++++|+++...+..|..+++|+.|++++|.+
T Consensus 254 l~L~~~~l~~~-------------------~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~ 313 (353)
T 2z80_A 254 FTFRNVKITDE-------------------SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPW 313 (353)
T ss_dssp EEEESCBCCHH-------------------HHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred cccccccccCc-------------------chh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCc
Confidence 55555555431 000 2344444445555555555555533333345555555555555555
Q ss_pred cC
Q 043136 379 TG 380 (902)
Q Consensus 379 ~~ 380 (902)
++
T Consensus 314 ~~ 315 (353)
T 2z80_A 314 DC 315 (353)
T ss_dssp CC
T ss_pred cC
Confidence 43
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.2e-35 Score=349.66 Aligned_cols=430 Identities=15% Similarity=0.099 Sum_probs=284.9
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCC---cccCchh------------hhccCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAF---DGPLQPA------------ILELTKLR 129 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l---~~~~~~~------------~~~l~~L~ 129 (902)
|++|.++.+... ..+.+.+ ......+..+..+++|++|+|+++.. .+.+|.. +..+++|+
T Consensus 41 ck~W~~~~~~~~----~~l~~~~-~~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~ 115 (592)
T 3ogk_B 41 CRRWFKIDSETR----EHVTMAL-CYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLK 115 (592)
T ss_dssp CHHHHHHHHHHC----CEEEESC-GGGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred hHHHHHhhhccc----cEEEEee-ccccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCC
Confidence 558999854322 2233332 23333445667888899999977432 1222222 22788999
Q ss_pred EEEccCCCCCCCCCcccccc--cccceecccccc-ccC-CCchhhhcccCCcEEeccCccCcCC----CCcccCCCCCCC
Q 043136 130 TIDISHNSFNSTFPPGISKL--RFLRIFNAYSNS-FTG-PLPLEFVQLNSLQQLNLGGSYFDGE----IPSDYRNLSSLR 201 (902)
Q Consensus 130 ~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~ 201 (902)
+|+|++|.+++..+..+..+ ++|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+.++++|+
T Consensus 116 ~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~ 195 (592)
T 3ogk_B 116 SVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLE 195 (592)
T ss_dssp EEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCC
T ss_pred eEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCcc
Confidence 99999998887766666664 448999998876 221 1233345788899999998888765 333456778888
Q ss_pred EEEccCCCccC----CCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCc---ccCCccccCCCCccE
Q 043136 202 FLDLAGNSLTG----SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS---GTLPSEISNLTKLEM 274 (902)
Q Consensus 202 ~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~---~~~p~~~~~l~~L~~ 274 (902)
+|+|++|.+++ .++..+..+++|++|++++|.+.+ +|..+..+++|++|+++.+... +..+..+..+++|+.
T Consensus 196 ~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~ 274 (592)
T 3ogk_B 196 VLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCR 274 (592)
T ss_dssp EEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCE
T ss_pred EEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccc
Confidence 99998888873 334445678888888888888885 6677888888888888764332 233456677788888
Q ss_pred EecCCCccceecCCCCCCcCcCcEEecccCCCccccC-ccccccCCCCEEEccCccccccCChhhhhccccceEEec---
Q 043136 275 LLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLW--- 350 (902)
Q Consensus 275 L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~--- 350 (902)
|+++++... .+|..+..+++|++|+|++|.+++... ..+..+++|+.|+++++...+.++..+..+++|++|+++
T Consensus 275 L~l~~~~~~-~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~ 353 (592)
T 3ogk_B 275 LGLSYMGPN-EMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGA 353 (592)
T ss_dssp EEETTCCTT-TGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCC
T ss_pred cCccccchh-HHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCc
Confidence 888876433 566677778888888888888765443 345778888888888333223333444667788888888
Q ss_pred --------CceeccccC-ccccCCCceeEEEecCCcccCCCCCCccC-CCCccEEecc----CCcCccc-----cccccc
Q 043136 351 --------NNHLTGVLP-QKLGSNGKLLTVDVSSNSLTGPIPPTICD-GDRLFKLILF----SNNFTYS-----IPENLV 411 (902)
Q Consensus 351 --------~N~l~~~~~-~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~-~~~L~~L~l~----~N~l~~~-----~p~~l~ 411 (902)
.|.+++... .....+++|+.|+++.|++++..+..+.. +++|+.|+++ .|++++. ++..+.
T Consensus 354 ~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~ 433 (592)
T 3ogk_B 354 DEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLI 433 (592)
T ss_dssp CSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHH
T ss_pred cccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHH
Confidence 356664322 22345677888888778777665555544 6677777775 5666653 444466
Q ss_pred ccCCCcEEEccCC--ccCCCCCcccC-CCCCCcEEEccCcccCC-CCCCcCcccCcCceecccccccCCC-cChhhhccc
Q 043136 412 NCSSLSRLRIQDN--QLNGSIPQGFG-LLPNLTFMDMSRNSLSG-EIPRDLGNAQKLEYLNISENSFQTS-LPSNIWSAP 486 (902)
Q Consensus 412 ~l~~L~~L~Ls~N--~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~ 486 (902)
++++|+.|+++.+ .+++..+..++ .+++|++|+|++|++++ .++..+..+++|++|+|++|.+++. ++..+..++
T Consensus 434 ~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~ 513 (592)
T 3ogk_B 434 GCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLP 513 (592)
T ss_dssp HCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCS
T ss_pred hCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcC
Confidence 6777888887643 35554444443 36778888888877765 3444556677788888888777533 344455677
Q ss_pred ccceeccCCCccCCC
Q 043136 487 NLKILSASSSKLTGK 501 (902)
Q Consensus 487 ~L~~L~ls~N~l~~~ 501 (902)
+|+.|++++|++++.
T Consensus 514 ~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 514 SLRYLWVQGYRASMT 528 (592)
T ss_dssp SCCEEEEESCBCCTT
T ss_pred ccCeeECcCCcCCHH
Confidence 777777777777654
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.4e-32 Score=295.26 Aligned_cols=284 Identities=24% Similarity=0.342 Sum_probs=220.4
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCC--C
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNST--F 142 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~ 142 (902)
.|.|.+|.|+.. +++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++.. .
T Consensus 6 ~C~~~~l~c~~~------------~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~ 70 (306)
T 2z66_A 6 SCSGTEIRCNSK------------GLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCC 70 (306)
T ss_dssp EEETTEEECCSS------------CCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEE
T ss_pred eeCCCEEEcCCC------------Ccc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCc
Confidence 589999988644 233 3454433 6888999999998866556678889999999999988743 3
Q ss_pred CcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCC-cccCCCCCCCEEEccCCCccCCCCccccCC
Q 043136 143 PPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGNSLTGSLPPQLGLL 221 (902)
Q Consensus 143 p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 221 (902)
|..+..+++|++|++++|.+++ +|..+..+++|++|+|++|++++..+ ..+.++++|++|++++|.+++..|..+..+
T Consensus 71 ~~~~~~~~~L~~L~Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l 149 (306)
T 2z66_A 71 SQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 149 (306)
T ss_dssp EHHHHSCSCCCEEECCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTC
T ss_pred ccccccccccCEEECCCCcccc-ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccC
Confidence 5666778888888888888874 56668888888888888888886655 578888888888888888888888888888
Q ss_pred CCCcEEEeeCcccCC-CCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEe
Q 043136 222 TQLERIEIGYNNLQG-EVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLD 300 (902)
Q Consensus 222 ~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 300 (902)
++|++|++++|.+++ ..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+++|++|+
T Consensus 150 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 229 (306)
T 2z66_A 150 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLD 229 (306)
T ss_dssp TTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEE
T ss_pred cCCCEEECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeE
Confidence 888888888888876 5778888888888888888888887788888888888888888888877666788888888888
Q ss_pred cccCCCccccCccccccC-CCCEEEccCccccccCCh--hhhhccccceEEecCceeccccCccccC
Q 043136 301 LSDNQLSGPIPASLASLK-GLTRLSLMNNVLFGEIPQ--DIELLADLDTLLLWNNHLTGVLPQKLGS 364 (902)
Q Consensus 301 Ls~N~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 364 (902)
|++|++++..|..+..++ +|++|+|++|.+.+..+. ....+...+.+....+.+....|..+.+
T Consensus 230 L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~~~g 296 (306)
T 2z66_A 230 YSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQG 296 (306)
T ss_dssp CTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGGGTT
T ss_pred CCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchhhCC
Confidence 888888888888888874 888888888888765331 1233445555566666676666666544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=4.7e-33 Score=305.55 Aligned_cols=180 Identities=28% Similarity=0.363 Sum_probs=147.4
Q ss_pred HHhccCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc-CeeEeEEeEEecC
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIVRLLGCCSNR 781 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-~nIv~l~~~~~~~ 781 (902)
...+.+.+.||+|+||+||+|++.. ++.||||++..... ....+++.+|++++.+++| ||||+++++|.+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 3456677899999999999997532 46899999854332 3445678999999999965 8999999999664
Q ss_pred -CeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 782 -ECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 782 -~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
+..|+|||||++|+|.++++..+.. ....+++..+..++.|||+||+|||+++ ||||||||+|||
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NIL 217 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 217 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCcccee
Confidence 5789999999999999999764321 1235788999999999999999999776 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+++++.+||+|||+|+.+..+.. ....+||+.|||||++.+...
T Consensus 218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 99999999999999997754433 234679999999999976543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-34 Score=340.15 Aligned_cols=428 Identities=14% Similarity=0.089 Sum_probs=255.3
Q ss_pred CcccCchhhhccCCCcEEEccCCCC---CCCCCcccc------------cccccceeccccccccCCCchhhhcc--cCC
Q 043136 114 FDGPLQPAILELTKLRTIDISHNSF---NSTFPPGIS------------KLRFLRIFNAYSNSFTGPLPLEFVQL--NSL 176 (902)
Q Consensus 114 l~~~~~~~~~~l~~L~~L~Ls~N~l---~~~~p~~l~------------~l~~L~~L~L~~N~l~~~~p~~~~~l--~~L 176 (902)
+....+..+..+++|++|+|+++.. .+.+|..++ .+++|++|+|++|.+++..+..+... .+|
T Consensus 61 ~~~~~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L 140 (592)
T 3ogk_B 61 YTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDL 140 (592)
T ss_dssp GGSCHHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGC
T ss_pred cccChHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccC
Confidence 3344455677899999999988632 134444333 67888888888888877777777664 448
Q ss_pred cEEeccCcc-CcC-CCCcccCCCCCCCEEEccCCCccCC----CCccccCCCCCcEEEeeCcccCC----CCChhccCCC
Q 043136 177 QQLNLGGSY-FDG-EIPSDYRNLSSLRFLDLAGNSLTGS----LPPQLGLLTQLERIEIGYNNLQG----EVPVEFASLV 246 (902)
Q Consensus 177 ~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~----~~p~~~~~l~ 246 (902)
++|+|++|. ++. .++....++++|++|+|++|.+++. ++..+..+++|++|++++|.+++ .++..+.+++
T Consensus 141 ~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~ 220 (592)
T 3ogk_B 141 ETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCR 220 (592)
T ss_dssp CEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCT
T ss_pred cEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCC
Confidence 888888776 211 1222234678888888888887755 33345567888888888888873 3344456778
Q ss_pred CCCEEEccCccCcccCCccccCCCCccEEecCCCccc---eecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEE
Q 043136 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT---GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323 (902)
Q Consensus 247 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 323 (902)
+|++|+|++|.+.+ +|..+.++++|++|+++..... +..+..+..+++|+.|+++++.. +.+|..+..+++|++|
T Consensus 221 ~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~-~~l~~~~~~~~~L~~L 298 (592)
T 3ogk_B 221 SLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGP-NEMPILFPFAAQIRKL 298 (592)
T ss_dssp TCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCT-TTGGGGGGGGGGCCEE
T ss_pred CCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccch-hHHHHHHhhcCCCcEE
Confidence 88888888888775 5677778888888888753322 23334566677778887777543 3566677777777777
Q ss_pred EccCccccccCC-hhhhhccccceEEecCceeccccCccccCCCceeEEEecC-----------CcccCCCCCCccCCCC
Q 043136 324 SLMNNVLFGEIP-QDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSS-----------NSLTGPIPPTICDGDR 391 (902)
Q Consensus 324 ~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~-----------N~l~~~~p~~~~~~~~ 391 (902)
+|++|.+++... ..+..+++|+.|+++++...+.++..+..+++|+.|++++ |.+++.
T Consensus 299 ~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~---------- 368 (592)
T 3ogk_B 299 DLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQR---------- 368 (592)
T ss_dssp EETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHH----------
T ss_pred ecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHH----------
Confidence 777777654433 2345667777777773322223333334556666666662 333211
Q ss_pred ccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCC-CCCCcEEEcc----CcccCCC-----CCCcCccc
Q 043136 392 LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGL-LPNLTFMDMS----RNSLSGE-----IPRDLGNA 461 (902)
Q Consensus 392 L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l 461 (902)
.++.....+++|++|+++.|++++..+..++. +++|+.|+|+ .|++++. ++..+.++
T Consensus 369 -------------~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~ 435 (592)
T 3ogk_B 369 -------------GLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGC 435 (592)
T ss_dssp -------------HHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHC
T ss_pred -------------HHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhC
Confidence 11222334666667777666666555555544 6666777664 5555542 22334556
Q ss_pred CcCceeccccc--ccCCCcChhhhc-ccccceeccCCCccCC-Cccccc-ccccccEEeccCcccccc-CCccccccccc
Q 043136 462 QKLEYLNISEN--SFQTSLPSNIWS-APNLKILSASSSKLTG-KIPDFI-GCKSIYKIELHNNLLNGS-IPWDIGHCEKL 535 (902)
Q Consensus 462 ~~L~~L~Ls~N--~l~~~~p~~~~~-l~~L~~L~ls~N~l~~-~~p~~~-~~~~l~~l~Ls~N~l~g~-ip~~~~~l~~L 535 (902)
++|+.|+|+.| .+++..+..+.. +++|+.|++++|++++ .++.+. ++++|++|+|++|.+++. ++..+..+++|
T Consensus 436 ~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L 515 (592)
T 3ogk_B 436 KKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSL 515 (592)
T ss_dssp TTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSC
T ss_pred CCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCcc
Confidence 66666666532 244444444433 5666666666666554 222222 255566666666665433 23333455666
Q ss_pred eEEEeeCCcceecCCCCC-CCCCcccEEEccC
Q 043136 536 LLLNLSRNSLTGIIPWEI-SGLPSITDVDLSH 566 (902)
Q Consensus 536 ~~L~Ls~N~l~g~~p~~~-~~l~~L~~L~Ls~ 566 (902)
++|+|++|++++.--..+ ..++.+....+..
T Consensus 516 ~~L~ls~n~it~~~~~~l~~~~p~l~~~~~~~ 547 (592)
T 3ogk_B 516 RYLWVQGYRASMTGQDLMQMARPYWNIELIPS 547 (592)
T ss_dssp CEEEEESCBCCTTCTTGGGGCCTTEEEEEECC
T ss_pred CeeECcCCcCCHHHHHHHHHhCCCcEEEEecC
Confidence 666666666554322222 2345444444443
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=316.29 Aligned_cols=170 Identities=24% Similarity=0.287 Sum_probs=142.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhh---HHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|.+.++||+|+||+||+|+.. +|+.||||++.+..... .........++++++.++|||||+++++|++.+..|+|
T Consensus 191 f~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylV 270 (689)
T 3v5w_A 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 270 (689)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred eEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEE
Confidence 445689999999999999764 68999999996433221 11122223456778888999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
||||+||+|.+++...+ .+++.....++.||+.||+|||+++ ||||||||+|||++.+|++||+|||+|+.+
T Consensus 271 mEy~~GGdL~~~l~~~~-----~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 271 LDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp ECCCCSCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999998654 3778888899999999999999666 999999999999999999999999999987
Q ss_pred cCCCCceeeccccCccccCcccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.... ..+.+||+.|||||++..
T Consensus 343 ~~~~-~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 343 SKKK-PHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp SSCC-CCSCCSCGGGCCHHHHST
T ss_pred CCCC-CCCccCCcCccCHHHHhC
Confidence 5443 456799999999999964
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=299.59 Aligned_cols=171 Identities=23% Similarity=0.367 Sum_probs=143.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec------CCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN------REC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~------~~~ 783 (902)
.|.+.+.||+|+||+||+|++ .+|+.||||++.+... .....+.+.+|+++|++++|||||++++++.. .+.
T Consensus 55 ~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 55 EYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 355668999999999999976 4699999999964432 33445678899999999999999999998754 357
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~-----~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ-----PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEeCCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 899999995 78999986543 4788889999999999999999776 99999999999999999999999999
Q ss_pred ceeccC-----CCCceeeccccCccccCccccc
Q 043136 864 AKLIQS-----DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~-----~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+.+.. .....+.+||+.|||||++.+.
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTC
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCC
Confidence 987632 2234567999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-31 Score=292.99 Aligned_cols=166 Identities=24% Similarity=0.378 Sum_probs=138.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
..|.+.+.||+|+||+||+|+.+ +++.||+|++.+... ..++.+|+++++.+ +|||||++++++.+.++.
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 35677899999999999999653 478899999854332 23467899999988 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGl 863 (902)
|+||||++||+|.++++ .+++.....++.|++.||+|||+++ ||||||||+|||++.+ +.+||+|||+
T Consensus 96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGl 164 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGL 164 (361)
T ss_dssp EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence 99999999999999984 2567788899999999999999776 9999999999999877 7999999999
Q ss_pred ceeccCCC-----------------------------CceeeccccCccccCccccc
Q 043136 864 AKLIQSDE-----------------------------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~-----------------------------~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+...+.. ...+.+||+.|||||++.+.
T Consensus 165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 98653221 12345899999999999764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=289.16 Aligned_cols=281 Identities=19% Similarity=0.250 Sum_probs=142.3
Q ss_pred cccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEe
Q 043136 150 RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 150 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 229 (902)
+.....++++|.++. +|..+. ++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|+.+++|++|++
T Consensus 31 ~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (353)
T 2z80_A 31 DRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDL 107 (353)
T ss_dssp CTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEEC
Confidence 333445555555553 333332 25555555555555444445555555555555555555544555555555555555
Q ss_pred eCcccCCCCChhccCCCCCCEEEccCccCcccCC-ccccCCCCccEEecCCC-ccceecCCCCCCcCcCcEEecccCCCc
Q 043136 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLP-SEISNLTKLEMLLLFKN-HFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++|++++..+..|.++++|++|+|++|++++..+ ..|.++++|++|++++| .+.+..+..|.++++|++|++++|+++
T Consensus 108 s~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~ 187 (353)
T 2z80_A 108 SYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ 187 (353)
T ss_dssp CSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCC
T ss_pred CCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcC
Confidence 5555554444445555555555555555553222 24555555555555555 344444445555555555555555555
Q ss_pred cccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCcc
Q 043136 308 GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTIC 387 (902)
Q Consensus 308 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~ 387 (902)
+..|..+..+++|++|++++|.+ +...+..+..+++|+.|++++|++++..+..+.
T Consensus 188 ~~~~~~l~~l~~L~~L~l~~n~l------------------------~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~ 243 (353)
T 2z80_A 188 SYEPKSLKSIQNVSHLILHMKQH------------------------ILLLEIFVDVTSSVECLELRDTDLDTFHFSELS 243 (353)
T ss_dssp EECTTTTTTCSEEEEEEEECSCS------------------------TTHHHHHHHHTTTEEEEEEESCBCTTCCCC---
T ss_pred ccCHHHHhccccCCeecCCCCcc------------------------ccchhhhhhhcccccEEECCCCccccccccccc
Confidence 54455555555555555555554 332222233344555555555555443222211
Q ss_pred CCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCC----CCCcccCCCCCCcEEEccCcccCCCCCCc-CcccC
Q 043136 388 DGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG----SIPQGFGLLPNLTFMDMSRNSLSGEIPRD-LGNAQ 462 (902)
Q Consensus 388 ~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~ 462 (902)
. ....+.++.++|++|.+++ .+|.++..+++|++|||++|+++. +|.. |.+++
T Consensus 244 ~---------------------~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~-i~~~~~~~l~ 301 (353)
T 2z80_A 244 T---------------------GETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301 (353)
T ss_dssp ------------------------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCC-CCTTTTTTCT
T ss_pred c---------------------ccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCc-cCHHHHhcCC
Confidence 1 0112334444555554443 345556666666666666666663 3333 46666
Q ss_pred cCceecccccccCCCcC
Q 043136 463 KLEYLNISENSFQTSLP 479 (902)
Q Consensus 463 ~L~~L~Ls~N~l~~~~p 479 (902)
+|++|+|++|.+.+..|
T Consensus 302 ~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 302 SLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp TCCEEECCSSCBCCCHH
T ss_pred CCCEEEeeCCCccCcCC
Confidence 66666666666665443
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-30 Score=281.16 Aligned_cols=288 Identities=19% Similarity=0.261 Sum_probs=217.2
Q ss_pred HHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecCCCCCEEEEEcCCCCcccc----cCccc--cCCCCCCEE
Q 043136 34 KASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGP----IPPEI--RYLTSLTHL 107 (902)
Q Consensus 34 k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~----~~~~~--~~l~~L~~L 107 (902)
|.++.++.. ++..|+..- ..++|.|.++.|...... -.-+...|. ++..+ ...+++++|
T Consensus 22 ~~~~~~~~~-aLl~~k~~~---------~~~~~~~~~~w~~~~~~~-----~~~~~~~g~~~~~~~~~l~~~~~~~l~~L 86 (328)
T 4fcg_A 22 STALRPYHD-VLSQWQRHY---------NADRNRWHSAWRQANSNN-----PQIETRTGRALKATADLLEDATQPGRVAL 86 (328)
T ss_dssp -CCCCCHHH-HHHHHHHHH---------HHCCTTHHHHHHHHTTTC-----TTSCCSHHHHHHHHHHHHHHHTSTTCCEE
T ss_pred cccCchHHH-HHHHHHHhc---------cCCchhhhhhhccccccc-----ccccccCCcchhhhHHHHhcccccceeEE
Confidence 334444444 677887531 013799999988433210 011122221 11111 234677777
Q ss_pred EccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCc
Q 043136 108 NLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD 187 (902)
Q Consensus 108 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 187 (902)
+|++|.++ .+|..++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+|..|+++++|++|+|++|.+.
T Consensus 87 ~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~ 163 (328)
T 4fcg_A 87 ELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163 (328)
T ss_dssp EEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTC
T ss_pred EccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCc
Confidence 77777777 56666777777777777777777 66666777777777777777666 55666666666666666666666
Q ss_pred CCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCcccc
Q 043136 188 GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEIS 267 (902)
Q Consensus 188 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 267 (902)
+.+|..+... .++..|..+++|++|++++|+|+ .+|..+..+++|++|+|++|++++ +|..+.
T Consensus 164 ~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~ 226 (328)
T 4fcg_A 164 TELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH 226 (328)
T ss_dssp CCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG
T ss_pred cccChhHhhc---------------cchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhc
Confidence 6666544321 12234567999999999999999 789999999999999999999995 666899
Q ss_pred CCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceE
Q 043136 268 NLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTL 347 (902)
Q Consensus 268 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 347 (902)
.+++|++|+|++|++.+.+|..++.+++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.+|..++.+++|+.+
T Consensus 227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l 306 (328)
T 4fcg_A 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCII 306 (328)
T ss_dssp GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEE
T ss_pred cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EecCceecc
Q 043136 348 LLWNNHLTG 356 (902)
Q Consensus 348 ~L~~N~l~~ 356 (902)
++..|.+..
T Consensus 307 ~l~~~~~~~ 315 (328)
T 4fcg_A 307 LVPPHLQAQ 315 (328)
T ss_dssp ECCGGGSCC
T ss_pred eCCHHHHHH
Confidence 999887653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-30 Score=280.56 Aligned_cols=248 Identities=22% Similarity=0.244 Sum_probs=124.3
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCC--CChhccCCCCCCEEEcc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGE--VPVEFASLVNLKYMDIS 254 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~p~~~~~l~~L~~L~Ls 254 (902)
+.++.+++.++ .+|..+. ++|++|+|++|+++...+..|..+++|++|+|++|+++.. .|..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 45666666665 3444332 4566666666666633333455666666666666665522 24445555555555555
Q ss_pred CccCcccCCccccCCCCccEEecCCCccceecC-CCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccccc
Q 043136 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
+|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|.+++..+..+..+++|++|++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l-------- 157 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKM-------- 157 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEEC--------
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEEC--------
Confidence 55555 234445555555555555555553332 34444555555555555544444444444444444444
Q ss_pred CChhhhhccccceEEecCceecc-ccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccc
Q 043136 334 IPQDIELLADLDTLLLWNNHLTG-VLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN 412 (902)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~ 412 (902)
++|.+++ ..|..+..+++|+.|++++|++++..|..+..+++|+.|++++|++++..+..+..
T Consensus 158 ----------------~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 221 (306)
T 2z66_A 158 ----------------AGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 221 (306)
T ss_dssp ----------------TTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTT
T ss_pred ----------------CCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccC
Confidence 4444443 34444445555555555555554443444433333444444444443333334444
Q ss_pred cCCCcEEEccCCccCCCCCcccCCCC-CCcEEEccCcccCC
Q 043136 413 CSSLSRLRIQDNQLNGSIPQGFGLLP-NLTFMDMSRNSLSG 452 (902)
Q Consensus 413 l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 452 (902)
+++|+.|+|++|++++..|..+..++ +|++|+|++|.+++
T Consensus 222 l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~ 262 (306)
T 2z66_A 222 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262 (306)
T ss_dssp CTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEEC
T ss_pred cccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeec
Confidence 55555555555555555555555553 55555555555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=291.02 Aligned_cols=250 Identities=19% Similarity=0.160 Sum_probs=183.4
Q ss_pred hhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccc-cCCCchhhh-------cccCCcEEeccCccCcCCCCc
Q 043136 121 AILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF-TGPLPLEFV-------QLNSLQQLNLGGSYFDGEIPS 192 (902)
Q Consensus 121 ~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l-~~~~p~~~~-------~l~~L~~L~L~~N~l~~~~p~ 192 (902)
.++..++|++|++++|.+ .+|..+... |+.|+|++|++ .+.+|..+. ++++|++|+|++|++++.+|.
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 113 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHH
Confidence 355667778888888887 566665544 78888888887 455666665 688888888888888888888
Q ss_pred cc--CCCCCCCEEEccCCCccCCCCccccCC-----CCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCccc--CC
Q 043136 193 DY--RNLSSLRFLDLAGNSLTGSLPPQLGLL-----TQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGT--LP 263 (902)
Q Consensus 193 ~~--~~l~~L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p 263 (902)
.+ ..+++|++|+|++|++++. |..++.+ ++|++|++++|+|++..|..|+.+++|++|+|++|++.+. .|
T Consensus 114 ~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 192 (312)
T 1wwl_A 114 PLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192 (312)
T ss_dssp CSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHH
T ss_pred HHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHH
Confidence 76 8888888888888888876 7777776 8888888888888887778888888888888888887765 23
Q ss_pred ccc--cCCCCccEEecCCCcccee--cC-CCCCCcCcCcEEecccCCCccccC-ccccccCCCCEEEccCccccccCChh
Q 043136 264 SEI--SNLTKLEMLLLFKNHFTGE--IP-VSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFGEIPQD 337 (902)
Q Consensus 264 ~~~--~~l~~L~~L~L~~N~l~~~--~p-~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~ 337 (902)
..+ .++++|++|+|++|++++. ++ ..+.++++|++|+|++|++++.+| ..+..+++|++|+|++|+++ .+|..
T Consensus 193 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~ 271 (312)
T 1wwl_A 193 SALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271 (312)
T ss_dssp HHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSS
T ss_pred HHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhh
Confidence 333 6778888888888887731 12 234566778888888888877664 44556777777777777776 56655
Q ss_pred hhhccccceEEecCceeccccCccccCCCceeEEEecCCcccC
Q 043136 338 IELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTG 380 (902)
Q Consensus 338 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~ 380 (902)
+. ++|++|+|++|+|++. |. +..+++|+.|++++|++++
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 54 6677777777777665 44 6666777777777776664
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=305.96 Aligned_cols=173 Identities=24% Similarity=0.360 Sum_probs=151.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||+||+|.. .+|+.||+|++.... ....+.+.+|+++|+.++|||||++++++.+.+..|+|||
T Consensus 158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 466778999999999999976 468999999985443 2345668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE--MEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~--~~~kl~DFGla~~~ 867 (902)
||+||+|.+++.... ..+++.....++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.+
T Consensus 235 ~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 235 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp CCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred ecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 999999999986432 24778888999999999999999776 9999999999999854 89999999999998
Q ss_pred cCCCCceeeccccCccccCccccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.........+||+.|||||++.+..+
T Consensus 308 ~~~~~~~~~~GT~~y~APEv~~~~~y 333 (573)
T 3uto_A 308 DPKQSVKVTTGTAEFAAPEVAEGKPV 333 (573)
T ss_dssp CTTSEEEEECSSGGGCCHHHHTTCCB
T ss_pred cCCCceeeeEECccccCHHHhCCCCC
Confidence 77777788899999999999987543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-30 Score=278.51 Aligned_cols=255 Identities=23% Similarity=0.263 Sum_probs=153.3
Q ss_pred EEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccc
Q 043136 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160 (902)
Q Consensus 81 ~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 160 (902)
+.++.++++++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|+.+++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 56777777777 355433 468888888888888777777788888888888888777666666666666666666666
Q ss_pred c-ccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCC
Q 043136 161 S-FTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP 239 (902)
Q Consensus 161 ~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 239 (902)
. ++...|..|..+++|++|+|++|.+++..|..|.++++|++|+|+ +|++++..+
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~------------------------~n~l~~~~~ 146 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQ------------------------DNALQALPD 146 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC------------------------SSCCCCCCT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECC------------------------CCcccccCH
Confidence 5 544445555555555555555555554444444444445555544 444444444
Q ss_pred hhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCC
Q 043136 240 VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKG 319 (902)
Q Consensus 240 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 319 (902)
..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|++++..+..+..+++
T Consensus 147 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~ 226 (285)
T 1ozn_A 147 DTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTT
T ss_pred hHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcc
Confidence 44555555555555555555444445555566666666666666555666666666666666666666555555666666
Q ss_pred CCEEEccCccccccCChhhhhccccceEEecCceeccccCcccc
Q 043136 320 LTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLG 363 (902)
Q Consensus 320 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 363 (902)
|++|++++|.+....+.. .....++.+..+.+.+....|..+.
T Consensus 227 L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~ 269 (285)
T 1ozn_A 227 LQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLA 269 (285)
T ss_dssp CCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGT
T ss_pred cCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhC
Confidence 666666666665433321 1223344455566666666666554
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=292.26 Aligned_cols=244 Identities=22% Similarity=0.268 Sum_probs=157.8
Q ss_pred EEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccc
Q 043136 83 LDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF 162 (902)
Q Consensus 83 L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 162 (902)
++.++.+++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..|..|.++++|++|+|++|++
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 444555555 4555443 5778888888888877777788888888888888887777667777777777777777777
Q ss_pred cCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccC-CCccCCCCccccCCCCCcEEEeeCcccCCCCChh
Q 043136 163 TGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAG-NSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE 241 (902)
Q Consensus 163 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 241 (902)
++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++ |.++...+..|..+++|++|+|++|++++. | .
T Consensus 136 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~ 213 (452)
T 3zyi_A 136 TVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-N 213 (452)
T ss_dssp SBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-C
T ss_pred CccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-c
Confidence 766666677777777777777777655555666777777777766 334333333466666666666666666643 2 3
Q ss_pred ccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCC
Q 043136 242 FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321 (902)
Q Consensus 242 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 321 (902)
+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus 214 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~ 293 (452)
T 3zyi_A 214 LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLV 293 (452)
T ss_dssp CTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCC
T ss_pred ccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCC
Confidence 55566666666666666665566666666666666666666655555566666666666666666655555555555555
Q ss_pred EEEccCcccc
Q 043136 322 RLSLMNNVLF 331 (902)
Q Consensus 322 ~L~L~~N~l~ 331 (902)
.|+|++|.+.
T Consensus 294 ~L~L~~Np~~ 303 (452)
T 3zyi_A 294 ELHLHHNPWN 303 (452)
T ss_dssp EEECCSSCEE
T ss_pred EEEccCCCcC
Confidence 5555555543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-32 Score=294.89 Aligned_cols=249 Identities=18% Similarity=0.183 Sum_probs=118.0
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCCC-cccCchhhh-------ccCCCcEEEccCCCCCCCCCccc--cc
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAF-DGPLQPAIL-------ELTKLRTIDISHNSFNSTFPPGI--SK 148 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l-~~~~~~~~~-------~l~~L~~L~Ls~N~l~~~~p~~l--~~ 148 (902)
+++.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+ +.
T Consensus 44 ~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~ 119 (312)
T 1wwl_A 44 SLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119 (312)
T ss_dssp ECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCC
T ss_pred CceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhc
Confidence 344445555555 344433332 45555555555 233444333 45555555555555555455443 44
Q ss_pred ccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEE
Q 043136 149 LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228 (902)
Q Consensus 149 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 228 (902)
+++|++|+|++|++++. |..++.+. ...+++|++|+|++|++++..|..|+.+++|++|+
T Consensus 120 l~~L~~L~Ls~N~l~~~-~~~~~~l~-------------------~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 179 (312)
T 1wwl_A 120 GPDLNILNLRNVSWATR-DAWLAELQ-------------------QWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLD 179 (312)
T ss_dssp SCCCSEEEEESCBCSSS-SSHHHHHH-------------------TTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEE
T ss_pred CCCccEEEccCCCCcch-hHHHHHHH-------------------HhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEE
Confidence 55555555555555544 44444440 00004444444444444444444444444555555
Q ss_pred eeCcccCCC--CChhc--cCCCCCCEEEccCccCcc---cCCccccCCCCccEEecCCCccceecC-CCCCCcCcCcEEe
Q 043136 229 IGYNNLQGE--VPVEF--ASLVNLKYMDISACNLSG---TLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLD 300 (902)
Q Consensus 229 L~~N~l~~~--~p~~~--~~l~~L~~L~Ls~N~l~~---~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~ 300 (902)
+++|++.+. .|..+ ..+++|++|+|++|++++ .....+.++++|++|+|++|++++..| ..+..+++|++|+
T Consensus 180 Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~ 259 (312)
T 1wwl_A 180 LSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLN 259 (312)
T ss_dssp CCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEE
T ss_pred CCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEE
Confidence 555444432 12222 445555555555555542 111223344555555555555554443 2334455555555
Q ss_pred cccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecc
Q 043136 301 LSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356 (902)
Q Consensus 301 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 356 (902)
|++|+|+ .+|..+. ++|++|+|++|++++. |. +..+++|++|++++|++++
T Consensus 260 Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 260 LSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp CTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred CCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 5555555 4444443 4555555555555543 33 5555555566666655543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-29 Score=272.86 Aligned_cols=237 Identities=21% Similarity=0.204 Sum_probs=193.4
Q ss_pred ccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCC-ccCCCCccccCCCCCcEEEe
Q 043136 151 FLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNS-LTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 151 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L 229 (902)
+|++|++++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|++|++
T Consensus 33 ~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l 112 (285)
T 1ozn_A 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (285)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEEC
Confidence 44444555555554455566666777777777777776667777778888888888886 77666778888888888888
Q ss_pred eCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccc
Q 043136 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 309 (902)
++|++++..|..|..+++|++|++++|++++..+..|.++++|++|+|++|++++..+..+..+++|++|+|++|++++.
T Consensus 113 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 192 (285)
T 1ozn_A 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (285)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECCCCccccc
Confidence 88888888888899999999999999999987778899999999999999999987777899999999999999999999
Q ss_pred cCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccC
Q 043136 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388 (902)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 388 (902)
.|..|..+++|+.|++++|.+++..+..+..+++|+.|++++|.+....+.. .....++.+..+.+.+....|..+..
T Consensus 193 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~-~~~~~l~~~~~~~~~~~c~~p~~l~g 270 (285)
T 1ozn_A 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR-PLWAWLQKFRGSSSEVPCSLPQRLAG 270 (285)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH-HHHHHHHHCCSEECCCBEEESGGGTT
T ss_pred CHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcH-HHHHHHHhcccccCccccCCchHhCC
Confidence 9999999999999999999999877778999999999999999998644322 12234555667788888888876543
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-29 Score=286.42 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=143.4
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNS 161 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 161 (902)
.++.++++++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|+
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 3444555565 5666554 678888888888888777788888888888888888877666666666666666666666
Q ss_pred ccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCC-CccCCCCccccCCCCCcEEEeeCcccCCCCCh
Q 043136 162 FTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGN-SLTGSLPPQLGLLTQLERIEIGYNNLQGEVPV 240 (902)
Q Consensus 162 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 240 (902)
+++..+..|..+++|++|+|++|+++...+..|.++++|++|+|++| .++...+..|..+++|++|+|++|+++. +|
T Consensus 124 l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~- 201 (440)
T 3zyj_A 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP- 201 (440)
T ss_dssp CSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS-CC-
T ss_pred CCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc-cc-
Confidence 66555556666666666666666666555555666666666666653 3332223345555555555555555552 23
Q ss_pred hccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCC
Q 043136 241 EFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGL 320 (902)
Q Consensus 241 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 320 (902)
.+..+++|++|+|++|++++..|..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 24445555555555555554445555555555555555555554444445555555555555555544444444444444
Q ss_pred CEEEccCccc
Q 043136 321 TRLSLMNNVL 330 (902)
Q Consensus 321 ~~L~L~~N~l 330 (902)
+.|+|++|.+
T Consensus 282 ~~L~L~~Np~ 291 (440)
T 3zyj_A 282 ERIHLHHNPW 291 (440)
T ss_dssp CEEECCSSCE
T ss_pred CEEEcCCCCc
Confidence 4444444444
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=282.88 Aligned_cols=269 Identities=18% Similarity=0.167 Sum_probs=217.7
Q ss_pred CEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccc
Q 043136 79 QITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAY 158 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 158 (902)
+.+.++++.+.+...+...+..+++|++|+|++|++++..|..|..+++|++|+|++|.+++..+ ++.+++|++|+++
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 56777888888876666677788899999999999999888899999999999999999987655 8899999999999
Q ss_pred cccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCC
Q 043136 159 SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEV 238 (902)
Q Consensus 159 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 238 (902)
+|++++.. ..++|++|++++|++++..+.. +++|++|+|++|++++..|..++.+++|++|++++|++++..
T Consensus 89 ~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQELL-----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEEE-----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCcccccc-----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 99988543 3478999999999988665543 577899999999998877778888889999999999988877
Q ss_pred Chhcc-CCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCcccccc
Q 043136 239 PVEFA-SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317 (902)
Q Consensus 239 p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l 317 (902)
+..+. .+++|++|+|++|.+++. | ....+++|++|+|++|++++. |..+..+++|++|+|++|+++ .+|..+..+
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 77764 688899999999988865 3 233588888888888888854 445888888888888888888 467778888
Q ss_pred CCCCEEEccCcccc-ccCChhhhhccccceEEec-CceeccccCcc
Q 043136 318 KGLTRLSLMNNVLF-GEIPQDIELLADLDTLLLW-NNHLTGVLPQK 361 (902)
Q Consensus 318 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~-~N~l~~~~~~~ 361 (902)
++|+.|++++|.+. +.+|..+..+++|+.++++ .+.+++..|..
T Consensus 237 ~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 237 QNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp TTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred CCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 88888888888887 6777778888888888887 44566554443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=282.50 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=165.0
Q ss_pred CCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccC
Q 043136 104 LTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGG 183 (902)
Q Consensus 104 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 183 (902)
.+.++.+++.++. +|..+. +++++|+|++|++++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++
T Consensus 45 ~~~v~c~~~~l~~-iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~ 121 (440)
T 3zyj_A 45 FSKVICVRKNLRE-VPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121 (440)
T ss_dssp SCEEECCSCCCSS-CCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCS
T ss_pred CCEEEeCCCCcCc-CCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCC
Confidence 4578888888874 555443 6788899999998887778888888888888888888877777888888888888888
Q ss_pred ccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCc-ccCCCCChhccCCCCCCEEEccCccCcccC
Q 043136 184 SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN-NLQGEVPVEFASLVNLKYMDISACNLSGTL 262 (902)
Q Consensus 184 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 262 (902)
|++++..+..|.++++|++|+|++|+++...+..|..+++|++|++++| .++...+..|.++++|++|+|++|+++ .+
T Consensus 122 n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~ 200 (440)
T 3zyj_A 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EI 200 (440)
T ss_dssp SCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SC
T ss_pred CcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-cc
Confidence 8887666667777888888888888877666667777777777777763 344344446677777777777777776 33
Q ss_pred CccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhcc
Q 043136 263 PSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLA 342 (902)
Q Consensus 263 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 342 (902)
| .+..+++|++|+|++|++++..|..|.++++|+.|+|++|++++..+..|..+++|++|+|++|++++..+..|..++
T Consensus 201 ~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 279 (440)
T 3zyj_A 201 P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLH 279 (440)
T ss_dssp C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCT
T ss_pred c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhcccc
Confidence 4 355666666666666666665566666666666666666666655555555555555555555555544333333333
Q ss_pred ccceEEecCce
Q 043136 343 DLDTLLLWNNH 353 (902)
Q Consensus 343 ~L~~L~L~~N~ 353 (902)
+|+.|+|++|.
T Consensus 280 ~L~~L~L~~Np 290 (440)
T 3zyj_A 280 HLERIHLHHNP 290 (440)
T ss_dssp TCCEEECCSSC
T ss_pred CCCEEEcCCCC
Confidence 33333333333
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=284.55 Aligned_cols=266 Identities=18% Similarity=0.178 Sum_probs=176.0
Q ss_pred EEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCc
Q 043136 298 VLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377 (902)
Q Consensus 298 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~ 377 (902)
.++++.+.+...+...+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..+ +..+++|++|++++|+
T Consensus 14 i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~ 91 (317)
T 3o53_A 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNY 91 (317)
T ss_dssp EESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSE
T ss_pred EeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCc
Confidence 33444444433333333344445555555555544444444455555555555555544333 4445555555555555
Q ss_pred ccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCc
Q 043136 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD 457 (902)
Q Consensus 378 l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 457 (902)
+++.. ..++|++|++++|++++..+. .+++|++|++++|++++..|..
T Consensus 92 l~~l~-----------------------------~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~ 139 (317)
T 3o53_A 92 VQELL-----------------------------VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLD 139 (317)
T ss_dssp EEEEE-----------------------------ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBC
T ss_pred ccccc-----------------------------CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchh
Confidence 44211 124566666666666544332 2456667777777776666666
Q ss_pred CcccCcCceecccccccCCCcChhhh-cccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccce
Q 043136 458 LGNAQKLEYLNISENSFQTSLPSNIW-SAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLL 536 (902)
Q Consensus 458 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~ 536 (902)
+..+++|++|+|++|++++..|..+. .+++|++|++++|++++. |....+++|+.|+|++|++++ +|..+..+++|+
T Consensus 140 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~ 217 (317)
T 3o53_A 140 EGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217 (317)
T ss_dssp TGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCS
T ss_pred hhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-ccccccccCCEEECCCCcCCc-chhhhcccCccc
Confidence 66677777777777777666565553 567777777777777654 444457888899999999974 566699999999
Q ss_pred EEEeeCCcceecCCCCCCCCCcccEEEccCCccc-ccCCCCCcCCccceeeccc-CCcccccCCCC
Q 043136 537 LLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLT-GTIPSNFENCSTLESFNVS-YNLLTGPIPAS 600 (902)
Q Consensus 537 ~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~l~ls-~N~l~g~ip~~ 600 (902)
.|+|++|+|++ +|..+..+++|+.|+|++|.++ +.+|..+..++.|+.++++ .+.++|..|..
T Consensus 218 ~L~L~~N~l~~-l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 218 WISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp EEECTTSCCCE-ECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred EEECcCCcccc-hhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 99999999995 6788999999999999999999 8889999999999999999 66788877764
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=284.06 Aligned_cols=228 Identities=18% Similarity=0.143 Sum_probs=173.5
Q ss_pred ceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEcc
Q 043136 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446 (902)
Q Consensus 367 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 446 (902)
+++.|+|++|++++..|..|..+++|++|++++|++++..|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 44555555555555555555555555555555555555556666777777777777777776666667777777777777
Q ss_pred CcccCCCCCCcCcccCcCceeccccc-ccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCccccccC
Q 043136 447 RNSLSGEIPRDLGNAQKLEYLNISEN-SFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSI 525 (902)
Q Consensus 447 ~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~i 525 (902)
+|++++..+..|.++++|++|+|++| .+....+..+..+++|++|++++|++++ +|.+..+.+|+.|+|++|.+++..
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~ 234 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MPNLTPLVGLEELEMSGNHFPEIR 234 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CCCCTTCTTCCEEECTTSCCSEEC
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cccccccccccEEECcCCcCcccC
Confidence 77777666667777777777777774 4433333457777888888888888875 466666888999999999999888
Q ss_pred CccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccc
Q 043136 526 PWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTG 595 (902)
Q Consensus 526 p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g 595 (902)
|..|..+++|+.|+|++|++++..|..|.++++|+.|||++|+|++..+..|..+++|+.|+|++|++..
T Consensus 235 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp GGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred cccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCC
Confidence 9999999999999999999999999999999999999999999998777888999999999999998753
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=293.93 Aligned_cols=292 Identities=24% Similarity=0.318 Sum_probs=172.5
Q ss_pred CcCCCCCCCCCCCCCCCCCCCCCccccEEe------cCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCccc
Q 043136 44 SFHDWDATPAFSNPSSEQEPVWCSWSGIKC------NPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGP 117 (902)
Q Consensus 44 ~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c------~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~ 117 (902)
.+++|... . +||.|.|..| ......++.|++++++++ .+|..+. ++|++|+|++|.|+.
T Consensus 11 ~w~~W~~~------~-----~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~- 75 (622)
T 3g06_A 11 VWSAWRRA------A-----PAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS- 75 (622)
T ss_dssp HHHHHHHT------C-----CGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSC-
T ss_pred HHHHHHhc------C-----CcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCC-
Confidence 55677654 2 3899976532 111235788999999888 6777665 788888888888884
Q ss_pred CchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCC
Q 043136 118 LQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNL 197 (902)
Q Consensus 118 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 197 (902)
+|. .+++|++|+|++|+|++ +|. .+++|++|+|++|.+++..+ .+++|+.|+|++|++++ +|.. +
T Consensus 76 lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~~-lp~~---l 140 (622)
T 3g06_A 76 LPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTHLPA----LPSGLCKLWIFGNQLTS-LPVL---P 140 (622)
T ss_dssp CCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCCCCCC----CCTTCCEEECCSSCCSC-CCCC---C
T ss_pred CCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCCCCC----CCCCcCEEECCCCCCCc-CCCC---C
Confidence 444 56788888888888874 444 55667777777776665322 44566666666666653 3332 3
Q ss_pred CCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEec
Q 043136 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277 (902)
Q Consensus 198 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 277 (902)
++|++|+|++|++++ +|. .+++|+.|++++|+|++ +| ..+++|++|+|++|++++ +|.. +++|+.|++
T Consensus 141 ~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L 208 (622)
T 3g06_A 141 PGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWA 208 (622)
T ss_dssp TTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEEC
T ss_pred CCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEEC
Confidence 556666666666653 332 22445555555555553 33 234455555555555553 2221 244555555
Q ss_pred CCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccc
Q 043136 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 278 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 357 (902)
++|.++ .+| .. +++|+.|+|++|.+++ +| ..+++|+.|+|++|+|++
T Consensus 209 ~~N~l~-~l~------------------------~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~- 255 (622)
T 3g06_A 209 YNNRLT-SLP------------------------AL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTS- 255 (622)
T ss_dssp CSSCCS-SCC------------------------CC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-
T ss_pred cCCccc-ccC------------------------CC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCc-
Confidence 555544 222 21 2445555555555443 33 233455555555555553
Q ss_pred cCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccC
Q 043136 358 LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCS 414 (902)
Q Consensus 358 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~ 414 (902)
+|. .+++|+.|+|++|+|+ .+|..+..+++|+.|++++|.+++..|..+..++
T Consensus 256 lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~ 308 (622)
T 3g06_A 256 LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 308 (622)
T ss_dssp CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence 222 3456677777777776 5666777777777777777777777777766554
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-29 Score=277.68 Aligned_cols=178 Identities=22% Similarity=0.338 Sum_probs=152.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e 95 (384)
T 4fr4_A 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVD 95 (384)
T ss_dssp GEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEe
Confidence 3556789999999999999764 588999999854432223334668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++||+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+....
T Consensus 96 ~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 96 LLLGGDLRYHLQQNV-----HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCTTEEHHHHHHTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 999999999997542 3778888999999999999999776 99999999999999999999999999998876
Q ss_pred CCCceeeccccCccccCcccccccCce
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
.......+||+.|+|||++.+..+.++
T Consensus 168 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~ 194 (384)
T 4fr4_A 168 ETQITTMAGTKPYMAPEMFSSRKGAGY 194 (384)
T ss_dssp TCCBCCCCSCGGGCCGGGTCCCSSCCB
T ss_pred CCceeccCCCccccCCeeeccCCCCCC
Confidence 666777899999999999976443333
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=258.48 Aligned_cols=216 Identities=24% Similarity=0.311 Sum_probs=133.9
Q ss_pred CCCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 64 ~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
++|.|.|+.|.... .++.+++++++++. +|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.++...+
T Consensus 3 ~~C~~~~~~C~c~~-~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 3 ALCKKDGGVCSCNN-NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCBGGGTCSBEEET-TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred ccCCCCCCCCEeCC-CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 48999999987543 56789999999884 666554 678888888888887766677788888888888887775544
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ 223 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 223 (902)
..|..+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|+++
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~------------ 146 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ------------ 146 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC------------
T ss_pred hhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCC------------
Confidence 44566666666666666665555555555555555555555555444444455555555555555554
Q ss_pred CcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEeccc
Q 043136 224 LERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSD 303 (902)
Q Consensus 224 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 303 (902)
+..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+.|+|++
T Consensus 147 ------------~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 214 (270)
T 2o6q_A 147 ------------SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQE 214 (270)
T ss_dssp ------------CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred ------------ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecC
Confidence 44344445555555555555555544444455555555555555555544444455566666666666
Q ss_pred CCCc
Q 043136 304 NQLS 307 (902)
Q Consensus 304 N~l~ 307 (902)
|.+.
T Consensus 215 N~~~ 218 (270)
T 2o6q_A 215 NPWD 218 (270)
T ss_dssp SCBC
T ss_pred CCee
Confidence 6654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=269.88 Aligned_cols=173 Identities=27% Similarity=0.345 Sum_probs=151.3
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|++ .+++.||||++..... .....+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 17 y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 95 (328)
T 3fe3_A 17 YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEY 95 (328)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEEC
Confidence 55668999999999999976 5799999999854432 334556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++...+ .+++.....++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 96 ~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 96 ASGGEVFDYLVAHG-----RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999997653 3677888899999999999999776 999999999999999999999999999887666
Q ss_pred CCceeeccccCccccCccccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
......+||+.|+|||++.+...
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~~~~ 190 (328)
T 3fe3_A 168 GKLDAFCGAPPYAAPELFQGKKY 190 (328)
T ss_dssp CGGGTTSSSGGGCCHHHHHTCCC
T ss_pred CccccccCCcceeCcccccCCCc
Confidence 66667789999999999976543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=268.46 Aligned_cols=173 Identities=24% Similarity=0.258 Sum_probs=147.4
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~ 86 (337)
T 1o6l_A 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeC
Confidence 455689999999999999764 6899999998543322223345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-C
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ-S 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~-~ 869 (902)
++||+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.+|.+||+|||+|+... .
T Consensus 87 ~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 87 ANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999987643 3677888899999999999999776 9999999999999999999999999998643 3
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......+||+.|+|||++.+..
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~ 181 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDND 181 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSC
T ss_pred CCcccccccChhhCChhhhcCCC
Confidence 34456678999999999997653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=279.06 Aligned_cols=268 Identities=31% Similarity=0.409 Sum_probs=147.2
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEc
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 253 (902)
.+++.|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|+|++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 34666777776666 5555444 56777777777766 3444 45667777777777663 333 5566777777
Q ss_pred cCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccccc
Q 043136 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE 333 (902)
Q Consensus 254 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 333 (902)
++|++++ +|. .+++|++|++++|++++ +|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+++
T Consensus 109 s~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~- 175 (622)
T 3g06_A 109 FSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS- 175 (622)
T ss_dssp CSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-
T ss_pred cCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-
Confidence 7776664 333 45666667777776663 3432 3566677777776664 332 23456666666666654
Q ss_pred CChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccccc
Q 043136 334 IPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNC 413 (902)
Q Consensus 334 ~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l 413 (902)
+| ..+++|+.|++++|+|++. |.. .++|+.|++++|+++. +|.. .++|+.|++++|++++ +| ..+
T Consensus 176 l~---~~~~~L~~L~Ls~N~l~~l-~~~---~~~L~~L~L~~N~l~~-l~~~---~~~L~~L~Ls~N~L~~-lp---~~l 240 (622)
T 3g06_A 176 LP---MLPSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LP---VLP 240 (622)
T ss_dssp CC---CCCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CC---CCC
T ss_pred Cc---ccCCCCcEEECCCCCCCCC-CCc---cchhhEEECcCCcccc-cCCC---CCCCCEEEccCCccCc-CC---CCC
Confidence 33 2345566666666666542 221 2456666666666652 2221 1344444444444443 33 223
Q ss_pred CCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcc
Q 043136 414 SSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSA 485 (902)
Q Consensus 414 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 485 (902)
++|+.|+|++|+|+ .+|. .+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|.+++.+|..+..+
T Consensus 241 ~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L 307 (622)
T 3g06_A 241 SELKELMVSGNRLT-SLPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307 (622)
T ss_dssp TTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHHHHHHH
T ss_pred CcCcEEECCCCCCC-cCCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHHHHHhc
Confidence 45555555555555 2333 3455555555555555 445555555555555555555555544444433
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=270.90 Aligned_cols=174 Identities=25% Similarity=0.324 Sum_probs=143.3
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+++++.+ +||||+++++++.+.+..|+||
T Consensus 24 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~ 103 (353)
T 3txo_A 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVM 103 (353)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred heEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEE
Confidence 4556789999999999999764 5899999998654333334456678899999988 7999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++||+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 104 EFVNGGDLMFHIQKSR-----RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence 9999999999997653 3778888999999999999999776 9999999999999999999999999998643
Q ss_pred -CCCCceeeccccCccccCcccccc
Q 043136 869 -SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 -~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|||||++.+..
T Consensus 176 ~~~~~~~~~~gt~~y~aPE~~~~~~ 200 (353)
T 3txo_A 176 CNGVTTATFCGTPDYIAPEILQEML 200 (353)
T ss_dssp C---------CCGGGCCHHHHHHHH
T ss_pred cCCccccccCCCcCeEChhhcCCCC
Confidence 333455678999999999987653
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=285.55 Aligned_cols=238 Identities=18% Similarity=0.158 Sum_probs=178.9
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
..+++|++|+|++|.+++..|..|..+++|++|+|++|.+++..| ++.+++|++|+|++|.|++..+ .++|++
T Consensus 31 ~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~~ 103 (487)
T 3oja_A 31 QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV-----GPSIET 103 (487)
T ss_dssp TTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCCE
T ss_pred ccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC-----CCCcCE
Confidence 344488899999988888888888888888999998888887665 8888888888888888876443 377888
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhcc-CCCCCCEEEccCcc
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFA-SLVNLKYMDISACN 257 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~ 257 (902)
|+|++|.+++..+.. +++|++|+|++|.+++..|..++.+++|++|+|++|.|++.+|..+. .+++|++|+|++|.
T Consensus 104 L~L~~N~l~~~~~~~---l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~ 180 (487)
T 3oja_A 104 LHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180 (487)
T ss_dssp EECCSSCCCCEEECC---CSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSC
T ss_pred EECcCCcCCCCCccc---cCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCc
Confidence 888888887665543 46788888888888877777778888888888888888877777765 67788888888888
Q ss_pred CcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc-ccCCh
Q 043136 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF-GEIPQ 336 (902)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~-~~~p~ 336 (902)
+++..+ +..+++|++|+|++|+|++.. ..+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|.+. +.+|.
T Consensus 181 l~~~~~--~~~l~~L~~L~Ls~N~l~~~~-~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~ 256 (487)
T 3oja_A 181 IYDVKG--QVVFAKLKTLDLSSNKLAFMG-PEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRD 256 (487)
T ss_dssp CCEEEC--CCCCTTCCEEECCSSCCCEEC-GGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHH
T ss_pred cccccc--cccCCCCCEEECCCCCCCCCC-HhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHH
Confidence 876532 335777888888888877543 347777778888888888774 5666777777777777777776 55566
Q ss_pred hhhhccccceEEec
Q 043136 337 DIELLADLDTLLLW 350 (902)
Q Consensus 337 ~~~~l~~L~~L~L~ 350 (902)
.+..++.|+.++++
T Consensus 257 ~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 257 FFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHTTCHHHHHHHHH
T ss_pred HHHhCCCCcEEecc
Confidence 66666666666654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=273.41 Aligned_cols=173 Identities=23% Similarity=0.284 Sum_probs=146.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|...++||+|+||+||+|+.. +++.||+|++.+.........+.+.+|..++.++ +||||+++++++.+.+..|+|||
T Consensus 54 y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E 133 (396)
T 4dc2_A 54 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 133 (396)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEE
Confidence 456689999999999999765 5789999999655444444455678899999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec-c
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-Q 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~-~ 868 (902)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.. .
T Consensus 134 ~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 134 YVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999987653 3778888999999999999999776 999999999999999999999999999863 3
Q ss_pred CCCCceeeccccCccccCcccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|||||++.+..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~ 229 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGED 229 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCC
T ss_pred CCCccccccCCcccCCchhhcCCC
Confidence 444566789999999999997753
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.5e-29 Score=285.99 Aligned_cols=234 Identities=18% Similarity=0.174 Sum_probs=172.0
Q ss_pred CCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEecc
Q 043136 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILF 398 (902)
Q Consensus 319 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~ 398 (902)
+|+.|+|++|.+++..|..|..+++|++|+|++|.+++..| +..+++|+.|+|++|.|+
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~------------------- 93 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ------------------- 93 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEE-------------------
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCC-------------------
Confidence 55666666666555555555555555555555555554443 445555555555555444
Q ss_pred CCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCc
Q 043136 399 SNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSL 478 (902)
Q Consensus 399 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 478 (902)
+.. ..++|+.|++++|.|++..+. .+++|+.|+|++|++++..|..++++++|++|+|++|.+++.+
T Consensus 94 -----~l~-----~~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (487)
T 3oja_A 94 -----ELL-----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (487)
T ss_dssp -----EEE-----ECTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEE
T ss_pred -----CCC-----CCCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcC
Confidence 222 126788888888888765543 3577888888888888887888888888888888888888877
Q ss_pred Chhhh-cccccceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCC
Q 043136 479 PSNIW-SAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLP 557 (902)
Q Consensus 479 p~~~~-~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~ 557 (902)
|..+. .+++|+.|+|++|.+++. |....+++|+.|+|++|.+++ +|+.++.+++|+.|+|++|.|++ +|..++.++
T Consensus 161 ~~~l~~~l~~L~~L~Ls~N~l~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~ 237 (487)
T 3oja_A 161 FAELAASSDTLEHLNLQYNFIYDV-KGQVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQ 237 (487)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-ECCCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCT
T ss_pred hHHHhhhCCcccEEecCCCccccc-cccccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCC
Confidence 87776 688888888888888865 444457888899999999886 55568889999999999999996 677788899
Q ss_pred cccEEEccCCccc-ccCCCCCcCCccceeeccc
Q 043136 558 SITDVDLSHNFLT-GTIPSNFENCSTLESFNVS 589 (902)
Q Consensus 558 ~L~~L~Ls~N~l~-g~ip~~~~~l~~L~~l~ls 589 (902)
+|+.|+|++|.++ +.+|..+..++.|+.++++
T Consensus 238 ~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 238 NLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp TCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred CCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 9999999999998 7778888888888888876
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-31 Score=316.94 Aligned_cols=448 Identities=15% Similarity=0.121 Sum_probs=258.3
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcc---cC------------chhhhccCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDG---PL------------QPAILELTKLR 129 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~---~~------------~~~~~~l~~L~ 129 (902)
|++|.++... ..+.+++.+..-. ..+..+..+++|++|+|+++.... .. +..+..+++|+
T Consensus 34 ck~W~~~~~~----~~~~l~~~~~~~~-~~~~~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~ 108 (594)
T 2p1m_B 34 CKSWYEIERW----CRRKVFIGNCYAV-SPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLE 108 (594)
T ss_dssp CHHHHHHHHH----HCCEEEESSTTSS-CHHHHHHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCC
T ss_pred HHHHHHhhhh----hceEEeecccccc-CHHHHHhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCC
Confidence 5689988221 3345666543322 122356778899999999875321 11 12234688999
Q ss_pred EEEccCCCCCCCCCcccc-cccccceeccccc-cccCC-CchhhhcccCCcEEeccCccCcCCCCccc----CCCCCCCE
Q 043136 130 TIDISHNSFNSTFPPGIS-KLRFLRIFNAYSN-SFTGP-LPLEFVQLNSLQQLNLGGSYFDGEIPSDY----RNLSSLRF 202 (902)
Q Consensus 130 ~L~Ls~N~l~~~~p~~l~-~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~ 202 (902)
+|+|++|.+++..+..+. .+++|++|+|++| .++.. ++..+.++++|++|+|++|.+++..+..+ ..+++|++
T Consensus 109 ~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~ 188 (594)
T 2p1m_B 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVS 188 (594)
T ss_dssp EEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCE
T ss_pred eEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcE
Confidence 999999988877666665 6888999999888 45432 44555678889999998888776554443 35668888
Q ss_pred EEccCCC--ccC-CCCccccCCCCCcEEEeeCc-ccCCCCChhccCCCCCCEEEccCc-------cCcccCCccccCCCC
Q 043136 203 LDLAGNS--LTG-SLPPQLGLLTQLERIEIGYN-NLQGEVPVEFASLVNLKYMDISAC-------NLSGTLPSEISNLTK 271 (902)
Q Consensus 203 L~L~~N~--l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N-------~l~~~~p~~~~~l~~ 271 (902)
|+|++|. ++. .++..+..+++|++|++++| .+.+ +|..+..+++|++|+++.+ .+.+ ++..+.++++
T Consensus 189 L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~ 266 (594)
T 2p1m_B 189 LNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKE 266 (594)
T ss_dssp EECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTT
T ss_pred EEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCC
Confidence 8888886 211 01112234578888888877 4443 6677777888888875443 3333 3335667777
Q ss_pred ccEE-ecCCCccceecCCCCCCcCcCcEEecccCCCccccC-ccccccCCCCEEEccCcccccc-CChhhhhccccceEE
Q 043136 272 LEML-LLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFGE-IPQDIELLADLDTLL 348 (902)
Q Consensus 272 L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 348 (902)
|+.| .+.+... +.++..+..+++|++|+|++|.+++... ..+..+++|+.|++++| +... ++.....+++|+.|+
T Consensus 267 L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~ 344 (594)
T 2p1m_B 267 LRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELR 344 (594)
T ss_dssp CCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEE
T ss_pred cccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEE
Confidence 7777 3333322 2334444456677777777777654322 22446667777777766 3321 111223456666666
Q ss_pred ecC---------ceeccccCcccc-CCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccc-ccCCCc
Q 043136 349 LWN---------NHLTGVLPQKLG-SNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV-NCSSLS 417 (902)
Q Consensus 349 L~~---------N~l~~~~~~~~~-~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~-~l~~L~ 417 (902)
+++ +.+++.....+. .+++ |+.|.+..|++++..+..+. .+++|+
T Consensus 345 L~~~~~~g~~~~~~l~~~~l~~l~~~~~~------------------------L~~L~~~~~~l~~~~~~~l~~~~~~L~ 400 (594)
T 2p1m_B 345 VFPSEPFVMEPNVALTEQGLVSVSMGCPK------------------------LESVLYFCRQMTNAALITIARNRPNMT 400 (594)
T ss_dssp EECSCTTCSSCSSCCCHHHHHHHHHHCTT------------------------CCEEEEEESCCCHHHHHHHHHHCTTCC
T ss_pred EecCcccccccCCCCCHHHHHHHHHhchh------------------------HHHHHHhcCCcCHHHHHHHHhhCCCcc
Confidence 632 333322222221 2344 44444444444444333333 356666
Q ss_pred EEEcc--C----CccCCC-----CCcccCCCCCCcEEEccCcccCCCCCCcCcc-cCcCceecccccccCCCcChhh-hc
Q 043136 418 RLRIQ--D----NQLNGS-----IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN-AQKLEYLNISENSFQTSLPSNI-WS 484 (902)
Q Consensus 418 ~L~Ls--~----N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~ 484 (902)
.|+++ + |.+++. ++..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..+..+ ..
T Consensus 401 ~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~ 479 (594)
T 2p1m_B 401 RFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSG 479 (594)
T ss_dssp EEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHH
T ss_pred eeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhc
Confidence 66666 3 444421 112244566677777755 555444444443 6667777777776654444333 45
Q ss_pred ccccceeccCCCccCCCccc-ccc-cccccEEeccCccccccCCccc-cccccceEEEeeCCcce
Q 043136 485 APNLKILSASSSKLTGKIPD-FIG-CKSIYKIELHNNLLNGSIPWDI-GHCEKLLLLNLSRNSLT 546 (902)
Q Consensus 485 l~~L~~L~ls~N~l~~~~p~-~~~-~~~l~~l~Ls~N~l~g~ip~~~-~~l~~L~~L~Ls~N~l~ 546 (902)
+++|+.|++++|++++.... ... +++|+.|++++|.++..-...+ ..+++|+...+..+.-.
T Consensus 480 ~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~~~~~~ 544 (594)
T 2p1m_B 480 CDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAP 544 (594)
T ss_dssp CTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEECSSSCG
T ss_pred CCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEecCCCcc
Confidence 67777777777776433222 222 6677777777777643322333 34667777777666543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=277.86 Aligned_cols=172 Identities=26% Similarity=0.261 Sum_probs=144.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...++||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+.++..++||||+++++++.+.+..|+|||
T Consensus 75 ~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~E 154 (437)
T 4aw2_A 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154 (437)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred heEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEe
Confidence 3556789999999999999775 478999999854322222223347789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 155 y~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 227 (437)
T 4aw2_A 155 YYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 227 (437)
T ss_dssp CCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence 999999999997632 24778888899999999999999776 99999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccCccc
Q 043136 870 DESM--SVIAGSYGYIAPGTFC 889 (902)
Q Consensus 870 ~~~~--~~~~Gt~~y~APE~~~ 889 (902)
.... ...+||+.|||||++.
T Consensus 228 ~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 228 DGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TSCEECCSCCSCGGGCCHHHHH
T ss_pred CCCcccccccCCcCeeChHHHh
Confidence 4332 3368999999999996
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-28 Score=265.30 Aligned_cols=172 Identities=23% Similarity=0.289 Sum_probs=148.6
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.+++++ +||||+++++++.+.+..|+|||
T Consensus 11 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e 90 (345)
T 3a8x_A 11 FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIE 90 (345)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEe
Confidence 455689999999999999764 5889999999765444445566788999999887 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ- 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~- 868 (902)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++++||+|||+|+...
T Consensus 91 ~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 91 YVNGGDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 999999999997643 3678888899999999999999776 9999999999999999999999999998643
Q ss_pred CCCCceeeccccCccccCccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
........+||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~gt~~y~aPE~~~~~ 185 (345)
T 3a8x_A 163 PGDTTSTFCGTPNYIAPEILRGE 185 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTC
T ss_pred CCCcccccCCCccccCccccCCC
Confidence 33445667899999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-28 Score=265.82 Aligned_cols=173 Identities=27% Similarity=0.364 Sum_probs=148.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.+ .+++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 10 ~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E 89 (336)
T 3h4j_B 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE 89 (336)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEE
Confidence 356678999999999999976 5789999999854322222223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+ +|++.+++...+ .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~~-~g~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 90 YA-GGELFDYIVEKK-----RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp CC-CEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred CC-CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 99 789999887653 3778888999999999999999776 99999999999999999999999999988766
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......+||+.|+|||++.+..
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~ 183 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKL 183 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSG
T ss_pred CcccccccCCcCcCCHHHHcCCC
Confidence 66667788999999999997654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=260.82 Aligned_cols=173 Identities=27% Similarity=0.462 Sum_probs=146.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 12 ~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 456689999999999999764 5899999988543 334566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS----QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp CTTCBHHHHHHHCCT----TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999976322 4788899999999999999999776 999999999999999999999999999876432
Q ss_pred CCc---------------eeeccccCccccCcccccccC
Q 043136 871 ESM---------------SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~~~---------------~~~~Gt~~y~APE~~~~~~~~ 894 (902)
... ...+||+.|+|||++.+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 200 (310)
T 3s95_A 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD 200 (310)
T ss_dssp ------------------CCCCSCGGGCCHHHHTTCCCC
T ss_pred cccccccccccccccccccccCCCcceeCHHHhcCCCCC
Confidence 221 146799999999999775433
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=267.47 Aligned_cols=175 Identities=27% Similarity=0.342 Sum_probs=149.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhH---HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENI---RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..|.+.+.||+|+||.||+|... +++.||+|++.+...... ...+.+.+|++++++++||||+++++++.+.+..|
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 35667789999999999999764 689999999865432211 12456889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEeec
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVADF 861 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DF 861 (902)
+||||++||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++ .+||+||
T Consensus 92 lv~e~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEECCCSCBHHHHHTTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 9999999999999986532 4788889999999999999999776 99999999999998877 7999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++...........+||+.|+|||++.+..
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTTCC
T ss_pred CCceEcCCCCccccCCCCccEECchHHcCCC
Confidence 9999887666666778999999999997643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=274.98 Aligned_cols=172 Identities=22% Similarity=0.262 Sum_probs=144.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...++||+|+||+||+|+.. +++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 71 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~ 150 (410)
T 3v8s_A 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 150 (410)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 456689999999999999765 5889999998543222112233477899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++||+|.++++.. .+++.....++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 151 ~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 151 MPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp CTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999998653 2677788899999999999999776 999999999999999999999999999877544
Q ss_pred CC--ceeeccccCccccCcccccc
Q 043136 871 ES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ..+.+||+.|||||++.+..
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~ 245 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQG 245 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTT
T ss_pred CcccccCCcCCccccCHHHhhccC
Confidence 32 23578999999999997654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=8.6e-28 Score=262.29 Aligned_cols=171 Identities=28% Similarity=0.350 Sum_probs=146.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 8 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~ 87 (318)
T 1fot_A 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 87 (318)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeC
Confidence 456689999999999999764 6899999998543322223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+||+++.+|.+||+|||+++....
T Consensus 88 ~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~- 158 (318)
T 1fot_A 88 IEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD- 158 (318)
T ss_dssp CCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence 99999999997643 3677888899999999999999665 99999999999999999999999999987643
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+||+.|+|||++.+..
T Consensus 159 -~~~~~~gt~~y~aPE~~~~~~ 179 (318)
T 1fot_A 159 -VTYTLCGTPDYIAPEVVSTKP 179 (318)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCC
T ss_pred -ccccccCCccccCHhHhcCCC
Confidence 234568999999999997653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=260.27 Aligned_cols=181 Identities=24% Similarity=0.282 Sum_probs=147.3
Q ss_pred HHHHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC
Q 043136 704 ADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR 781 (902)
Q Consensus 704 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~ 781 (902)
.++++...|...++||+|+||+||+|++. +++.||||++....... .......+|+..+.++ +||||+++++++.+.
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~ 129 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG 129 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC
Confidence 34566778888899999999999999775 68999999985543332 3334455666666555 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
+..|+||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DF 201 (311)
T 3p1a_A 130 GILYLQTELC-GPSLQQHCEAWGA----SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDF 201 (311)
T ss_dssp TEEEEEEECC-CCBHHHHHHHHCS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCC
T ss_pred CEEEEEEecc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccc
Confidence 9999999999 7799998876532 4788999999999999999999776 999999999999999999999999
Q ss_pred ccceeccCCCCceeeccccCccccCccccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
|+++............||+.|+|||++.+.++
T Consensus 202 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 233 (311)
T 3p1a_A 202 GLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233 (311)
T ss_dssp TTCEECC------CCCCCGGGCCGGGGGTCCS
T ss_pred eeeeecccCCCCcccCCCccccCHhHhcCCCC
Confidence 99988766555566779999999999987543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-28 Score=274.06 Aligned_cols=173 Identities=27% Similarity=0.268 Sum_probs=146.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||+||+|+.. +++.||+|++.+.........+.+.+|++++..++||||+++++++.+.+..|+|||
T Consensus 62 ~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE 141 (412)
T 2vd5_A 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVME 141 (412)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEEC
T ss_pred hEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEc
Confidence 3456689999999999999774 689999999854332222233457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++||+|.+++...+. .+++..+..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+....
T Consensus 142 ~~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~ 214 (412)
T 2vd5_A 142 YYVGGDLLTLLSKFGE----RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA 214 (412)
T ss_dssp CCCSCBHHHHHHHHSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred CCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence 9999999999976432 4677888899999999999999776 99999999999999999999999999988755
Q ss_pred CCCc--eeeccccCccccCcccc
Q 043136 870 DESM--SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~--~~~~Gt~~y~APE~~~~ 890 (902)
.... ...+||+.|||||++..
T Consensus 215 ~~~~~~~~~~Gt~~Y~APE~l~~ 237 (412)
T 2vd5_A 215 DGTVRSLVAVGTPDYLSPEILQA 237 (412)
T ss_dssp TSCEECSSCCSCGGGCCHHHHHH
T ss_pred CCccccceeccccCcCCHHHHhh
Confidence 4332 34689999999999973
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=258.64 Aligned_cols=176 Identities=26% Similarity=0.345 Sum_probs=146.8
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||.||+|++ .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 4566778999999999999976 468899999986555555566778899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 91 e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG-----PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp ECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999997653 3778889999999999999999776 9999999999999999999999999998764
Q ss_pred CCC--CceeeccccCccccCccccccc
Q 043136 869 SDE--SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 869 ~~~--~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
... .....+||+.|+|||++.+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~ 189 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKGEAT 189 (294)
T ss_dssp ------------CCSSCCHHHHHTCCC
T ss_pred cccccccCccccCccccCHhHhcCCCC
Confidence 332 2344679999999999977544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=265.60 Aligned_cols=174 Identities=25% Similarity=0.287 Sum_probs=147.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|.+++..+ +||+|+++++++.+.+..|+||
T Consensus 21 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~ 100 (353)
T 2i0e_A 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 100 (353)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEE
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEE
Confidence 3456689999999999999775 4789999998644322223345678899999988 7999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++||+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.+|.+||+|||+|+...
T Consensus 101 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 101 EYVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred eCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999997643 3678888899999999999999776 9999999999999999999999999998643
Q ss_pred -CCCCceeeccccCccccCcccccc
Q 043136 869 -SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 -~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|+|||++.+..
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (353)
T 2i0e_A 173 WDGVTTKTFCGTPDYIAPEIIAYQP 197 (353)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred cCCcccccccCCccccChhhhcCCC
Confidence 333456678999999999997643
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=278.61 Aligned_cols=174 Identities=27% Similarity=0.348 Sum_probs=150.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++.+...........+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 186 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy 265 (576)
T 2acx_A 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 265 (576)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEc
Confidence 455689999999999999764 6899999998544322223345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++||+|.+++..... ..+++..+..++.||+.||+|||+++ ||||||||+||+++.+|.+||+|||+|+.....
T Consensus 266 ~~gg~L~~~l~~~~~---~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 266 MNGGDLKFHIYHMGQ---AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp CCSCBHHHHHHSSSS---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 999999999875432 23778888999999999999999776 999999999999999999999999999988766
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+||+.|+|||++.+.
T Consensus 340 ~~~~~~~GT~~Y~APEvl~~~ 360 (576)
T 2acx_A 340 QTIKGRVGTVGYMAPEVVKNE 360 (576)
T ss_dssp CCEECCCSCGGGCCHHHHTTC
T ss_pred ccccccCCCccccCHHHHcCC
Confidence 666677999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=265.53 Aligned_cols=174 Identities=28% Similarity=0.341 Sum_probs=146.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|.+++..+ +||||+++++++.+.+..|+||
T Consensus 18 ~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~ 97 (345)
T 1xjd_A 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM 97 (345)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred HeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEE
Confidence 3556789999999999999774 5899999998543322222345577899999876 8999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++||+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+|+...
T Consensus 98 E~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 98 EYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 169 (345)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence 9999999999997643 3677888899999999999999776 9999999999999999999999999998653
Q ss_pred -CCCCceeeccccCccccCcccccc
Q 043136 869 -SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 -~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|+|||++.+..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (345)
T 1xjd_A 170 LGDAKTNTFCGTPDYIAPEILLGQK 194 (345)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHTTCC
T ss_pred cCCCcccCCCCCcccCChhhhcCCC
Confidence 233456678999999999997753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=264.20 Aligned_cols=171 Identities=25% Similarity=0.259 Sum_probs=147.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|+++++.++||||+++++++.+.+..|+||||
T Consensus 43 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 122 (350)
T 1rdq_E 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 455689999999999999764 6899999998544332223456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 123 ~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 123 VAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 99999999997653 3677888899999999999999776 999999999999999999999999999876433
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
....+||+.|+|||++.+..
T Consensus 195 --~~~~~gt~~y~aPE~~~~~~ 214 (350)
T 1rdq_E 195 --TWTLCGTPEALAPEIILSKG 214 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCC
T ss_pred --cccccCCccccCHHHhcCCC
Confidence 34568999999999997653
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-27 Score=260.78 Aligned_cols=171 Identities=20% Similarity=0.291 Sum_probs=148.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|... +++.||+|.+.... ...+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 6 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 4566789999999999999764 58899999985332 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--CCCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--EMEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~ 867 (902)
|+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++. ++.+||+|||+++..
T Consensus 82 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~ 154 (321)
T 1tki_A 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred eCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence 999999999986432 24778889999999999999999776 999999999999987 789999999999988
Q ss_pred cCCCCceeeccccCccccCcccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..........||+.|+|||++.+..
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~ 179 (321)
T 1tki_A 155 KPGDNFRLLFTAPEYYAPEVHQHDV 179 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCE
T ss_pred CCCCccccccCChhhcCcHHhcCCC
Confidence 7666667788999999999997754
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=257.19 Aligned_cols=171 Identities=23% Similarity=0.376 Sum_probs=146.9
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.+ .+++.||+|++...... ..+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 21 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp TBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 466778999999999999975 56899999998543322 23557889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (297)
T 3fxz_A 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (297)
T ss_dssp CCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999998753 3677888999999999999999776 99999999999999999999999999987754
Q ss_pred CC-CceeeccccCccccCccccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.. .....+||+.|+|||++.+...
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~ 193 (297)
T 3fxz_A 169 EQSKRSTMVGTPYWMAPEVVTRKAY 193 (297)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHCSCB
T ss_pred cccccCCccCCcCccChhhhcCCCC
Confidence 33 3445689999999999976543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=263.99 Aligned_cols=177 Identities=25% Similarity=0.337 Sum_probs=151.4
Q ss_pred HHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.+...|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence 34456778899999999999999764 689999999864432 3345567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEEEeecc
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEARVADFG 862 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFG 862 (902)
+||||+++|+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+||+++.+ +.+||+|||
T Consensus 105 lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG 176 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176 (362)
T ss_dssp EEECCCCSCBHHHHHTTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecC
Confidence 9999999999999886532 4678889999999999999999776 9999999999999765 459999999
Q ss_pred cceeccCCCCceeeccccCccccCcccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+++...........+||+.|+|||++.+..
T Consensus 177 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 206 (362)
T 2bdw_A 177 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP 206 (362)
T ss_dssp TCBCCTTCCSCCCSCSCTTTCCHHHHTTCC
T ss_pred cceEecCCcccccCCCCccccCHHHHccCC
Confidence 998877665556678999999999997753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=263.65 Aligned_cols=182 Identities=20% Similarity=0.252 Sum_probs=149.3
Q ss_pred HHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhh--HHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKEN--IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
+++..|.+.+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|++++++++||||+++++++.+.+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 100 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM 100 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3456788889999999999999976 468999999985322111 0124568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC---EEEee
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME---ARVAD 860 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~---~kl~D 860 (902)
.|+||||+++|+|.+.+..... ....+++..+..++.||++||+|||+++ |+||||||+||+++.++. +||+|
T Consensus 101 ~~lv~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~D 176 (351)
T 3c0i_A 101 LYMVFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGG 176 (351)
T ss_dssp EEEEEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECC
T ss_pred EEEEEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEec
Confidence 9999999999999988865432 2234678888899999999999999776 999999999999986654 99999
Q ss_pred cccceeccCCCC-ceeeccccCccccCcccccc
Q 043136 861 FGVAKLIQSDES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 861 FGla~~~~~~~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+++....... ....+||+.|+|||++.+..
T Consensus 177 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 209 (351)
T 3c0i_A 177 FGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP 209 (351)
T ss_dssp CTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC
T ss_pred CcceeEecCCCeeecCCcCCcCccCHHHHcCCC
Confidence 999988754432 34568999999999997653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-27 Score=260.26 Aligned_cols=176 Identities=26% Similarity=0.354 Sum_probs=150.3
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhH---HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENI---RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
...|...+.||+|+||.||+|... +++.||+|++........ ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 456778899999999999999764 589999999865432211 1245688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEee
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVAD 860 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~D 860 (902)
|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 99999999999999986432 4778889999999999999999776 99999999999999887 799999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+++...........+||+.|+|||++.+..
T Consensus 162 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (326)
T 2y0a_A 162 FGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 193 (326)
T ss_dssp CTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC
T ss_pred CCCCeECCCCCccccccCCcCcCCceeecCCC
Confidence 99999876555556678999999999997653
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=266.32 Aligned_cols=173 Identities=29% Similarity=0.319 Sum_probs=137.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHH-HhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDV-LGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~i-l~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|.+.+.||+|+||.||+|+.. +++.||+|++.+.........+.+.+|..+ ++.++||||+++++++.+.+..|+|||
T Consensus 40 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E 119 (373)
T 2r5t_A 40 FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLD 119 (373)
T ss_dssp EEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEe
Confidence 456689999999999999765 588999999966544334445567778877 467899999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ- 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~- 868 (902)
|++||+|.+++...+ .+++.....++.||+.||+|||+++ |+||||||+||+++.+|++||+|||+++...
T Consensus 120 ~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 120 YINGGELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIE 191 (373)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence 999999999997643 3667778889999999999999776 9999999999999999999999999998643
Q ss_pred CCCCceeeccccCccccCcccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|+|||++.+..
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~ 215 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQP 215 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCC
T ss_pred CCCccccccCCccccCHHHhCCCC
Confidence 333456678999999999997653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-27 Score=266.56 Aligned_cols=173 Identities=15% Similarity=0.183 Sum_probs=143.9
Q ss_pred hccCCcEeeecCceEEEEEE------eCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC---cCeeEeEEeEEecC
Q 043136 711 LSMSDKILGMGSTGTVYKAE------MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR---HRNIVRLLGCCSNR 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~------~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~ 781 (902)
.|...+.||+|+||.||+|. ..+++.||+|++.... ..++.+|++++++++ |+||+++++++...
T Consensus 66 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp EEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 45667899999999999993 4568899999985432 224566777777776 99999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---------
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--------- 852 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--------- 852 (902)
+..|+||||+++|+|.+++...+......+++..++.|+.||++||+|||+++ ||||||||+|||++.
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC----
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccc
Confidence 99999999999999999998755444456889999999999999999999665 999999999999998
Q ss_pred --CCCEEEeecccceeccC---CCCceeeccccCccccCcccccc
Q 043136 853 --EMEARVADFGVAKLIQS---DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 853 --~~~~kl~DFGla~~~~~---~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.+||+|||+|+.+.. .......+||+.|||||++.+..
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 261 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP 261 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC
Confidence 89999999999986542 22334567999999999998764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.4e-27 Score=258.61 Aligned_cols=176 Identities=23% Similarity=0.328 Sum_probs=143.0
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-------
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------- 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------- 782 (902)
.|...+.||+|+||.||+|++. +++.||||++..... ....+.+.+|++++++++||||+++++++.+..
T Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST--TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 4667789999999999999775 789999999864332 234567889999999999999999999885433
Q ss_pred --------------------------------------------------eeEEEEEccCCCCHHHHHHhhccCCCcccC
Q 043136 783 --------------------------------------------------CTMLLYEYMPNGNLDDLLHAKNKGENLVAD 812 (902)
Q Consensus 783 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~ 812 (902)
..++||||+++|+|.+++..... ....+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~ 162 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE 162 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence 37999999999999999986543 22345
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-------------Cceeeccc
Q 043136 813 WVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-------------SMSVIAGS 879 (902)
Q Consensus 813 ~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~-------------~~~~~~Gt 879 (902)
+..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++...... .....+||
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred hHHHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 6677899999999999999776 9999999999999999999999999998875432 12335799
Q ss_pred cCccccCccccccc
Q 043136 880 YGYIAPGTFCFCFS 893 (902)
Q Consensus 880 ~~y~APE~~~~~~~ 893 (902)
+.|+|||++.+...
T Consensus 240 ~~y~aPE~~~~~~~ 253 (332)
T 3qd2_B 240 KLYMSPEQIHGNNY 253 (332)
T ss_dssp GGGSCHHHHHCCCC
T ss_pred cCccChHHhcCCCC
Confidence 99999999976543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-27 Score=273.44 Aligned_cols=174 Identities=28% Similarity=0.439 Sum_probs=150.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|++. +++.||||++...........+.+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 17 ~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E 96 (476)
T 2y94_A 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVME 96 (476)
T ss_dssp TEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 3556789999999999999765 789999999854332222234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 97 ~~~gg~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 97 YVSGGELFDYICKNG-----RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp CCSSEEHHHHTTSSS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999986432 3778888999999999999999665 99999999999999999999999999998776
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......+||+.|+|||++.+..
T Consensus 169 ~~~~~~~~gt~~y~aPE~~~~~~ 191 (476)
T 2y94_A 169 GEFLRTSCGSPNYAAPEVISGRL 191 (476)
T ss_dssp TCCBCCCCSCSTTCCHHHHTTCC
T ss_pred cccccccCCCcCeEChhhccCCC
Confidence 66666788999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.5e-27 Score=257.35 Aligned_cols=182 Identities=26% Similarity=0.354 Sum_probs=151.4
Q ss_pred cCCCHHHHHHHh------------ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC
Q 043136 700 LNFTADDVLECL------------SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766 (902)
Q Consensus 700 ~~~~~~~~~~~~------------~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l 766 (902)
..++.+++.++. +...+.||+|+||.||+|+.. +++.||||++...... ..+.+.+|+.+++++
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l 99 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDY 99 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTC
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhC
Confidence 346666666554 334568999999999999875 6999999998543322 245578999999999
Q ss_pred CcCeeEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043136 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846 (902)
Q Consensus 767 ~h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~ 846 (902)
+||||+++++++...+..|+||||+++|+|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+
T Consensus 100 ~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~ 170 (321)
T 2c30_A 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSD 170 (321)
T ss_dssp CCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGG
T ss_pred CCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHH
Confidence 9999999999999999999999999999999988642 3778899999999999999999766 999999999
Q ss_pred CEEEcCCCCEEEeecccceeccCCC-CceeeccccCccccCccccccc
Q 043136 847 NILLDGEMEARVADFGVAKLIQSDE-SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 847 NILl~~~~~~kl~DFGla~~~~~~~-~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
||+++.++.+||+|||+++...... .....+||+.|+|||++.+...
T Consensus 171 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 218 (321)
T 2c30_A 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY 218 (321)
T ss_dssp GEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred HEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCC
Confidence 9999999999999999998775432 3455689999999999976543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=267.44 Aligned_cols=176 Identities=23% Similarity=0.290 Sum_probs=148.1
Q ss_pred HHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+...|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..|+
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 345677789999999999999965 5689999999865433 33455678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCCEEEeeccc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD---GEMEARVADFGV 863 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGl 863 (902)
||||+++|+|.+.+.... .+++.....++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~~~-----~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE-----YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 999999999999987643 3778888999999999999999776 99999999999998 467899999999
Q ss_pred ceeccCCCC-ceeeccccCccccCcccccc
Q 043136 864 AKLIQSDES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+....... ....+||+.|+|||++.+..
T Consensus 160 a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 189 (444)
T 3soa_A 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDP 189 (444)
T ss_dssp CBCCCTTCCBCCCSCSCGGGCCHHHHTTCC
T ss_pred eEEecCCCceeecccCCcccCCHHHhcCCC
Confidence 987754332 34578999999999997753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.8e-27 Score=264.18 Aligned_cols=177 Identities=25% Similarity=0.377 Sum_probs=146.8
Q ss_pred hccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~ 781 (902)
.|.+.+.||+|+||.||+|++. ++..||||++.... .....+.+.+|+++++++ +||||+++++++.+.
T Consensus 82 ~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 82 KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 4566789999999999999752 35679999985442 334566789999999999 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
+..|+||||+++|+|.+++...... ....+++..++.++.||++||+|||+++ |+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 9999999999999999999865421 1234788889999999999999999776 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 851 DGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+.++.+||+|||+|+....... .....||+.|+|||++.+..
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 281 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV 281 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC
Confidence 9999999999999987654322 23345788999999987654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.94 E-value=4.2e-27 Score=272.95 Aligned_cols=176 Identities=26% Similarity=0.384 Sum_probs=148.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...++||+|+||.||+|+.. +++.||+|++.+.........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 187 f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~ 266 (543)
T 3c4z_A 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTI 266 (543)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 344578999999999999774 6899999998544332223345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++||+|.+++..... ....+++.....++.||+.||+|||+++ |+||||||+||+++.+|.+||+|||+++.+...
T Consensus 267 ~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~ 342 (543)
T 3c4z_A 267 MNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAG 342 (543)
T ss_dssp CTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCC
Confidence 999999999875432 2335788888899999999999999776 999999999999999999999999999987554
Q ss_pred CC-ceeeccccCccccCccccc
Q 043136 871 ES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ....+||+.|||||++.+.
T Consensus 343 ~~~~~~~~GT~~Y~APE~l~~~ 364 (543)
T 3c4z_A 343 QTKTKGYAGTPGFMAPELLLGE 364 (543)
T ss_dssp CCCBCCCCSCTTTSCHHHHTTC
T ss_pred CcccccccCCccccChhhhcCC
Confidence 33 3446899999999999775
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.7e-27 Score=257.93 Aligned_cols=174 Identities=26% Similarity=0.328 Sum_probs=136.7
Q ss_pred hccCCcEeeecCceEEEEEEe----CCCcEEEEEEecccchh-hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.|...+.||+|+||.||+|+. .+++.||+|++.+.... .......+.+|++++++++||||+++++++.+.+..|
T Consensus 18 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 97 (327)
T 3a62_A 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLY 97 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEE
T ss_pred HeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEE
Confidence 466778999999999999976 47899999998654321 2233456778999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 98 lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 98 LILEYLSGGELFMQLEREG-----IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEeCCCCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 9999999999999997643 3667788899999999999999776 9999999999999999999999999998
Q ss_pred eccC-CCCceeeccccCccccCcccccc
Q 043136 866 LIQS-DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~-~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.... .......+||+.|+|||++.+..
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 197 (327)
T 3a62_A 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG 197 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSC
T ss_pred ccccCCccccccCCCcCccCHhhCcCCC
Confidence 6532 22334567999999999987653
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=255.25 Aligned_cols=171 Identities=26% Similarity=0.404 Sum_probs=142.1
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|...+.||+|+||.||+|++.+++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 100 (311)
T 3niz_A 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEF 100 (311)
T ss_dssp EEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEEC
T ss_pred hhHhhhhccCCCCeEEEEEEECCCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcC
Confidence 456678999999999999998889999999985432 2223346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ |++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 101 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 101 ME-KDLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp CS-EEHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred CC-CCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 97 58888886543 23677888999999999999999776 999999999999999999999999999876533
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
.......||+.|+|||++.+
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 173 VRSYTHEVVTLWYRAPDVLMG 193 (311)
T ss_dssp CC---CCCCCCTTCCHHHHTT
T ss_pred cccccCCcccCCcCCHHHhcC
Confidence 23345679999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.94 E-value=7.7e-27 Score=261.46 Aligned_cols=172 Identities=21% Similarity=0.316 Sum_probs=147.9
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 52 ~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 4666789999999999999764 688999999854332 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--CCCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--EMEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~ 867 (902)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+|+..
T Consensus 129 ~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~ 201 (387)
T 1kob_A 129 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 201 (387)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceec
Confidence 999999999886432 24788889999999999999999776 999999999999974 478999999999988
Q ss_pred cCCCCceeeccccCccccCcccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.........+||+.|+|||++.+..
T Consensus 202 ~~~~~~~~~~gt~~y~aPE~~~~~~ 226 (387)
T 1kob_A 202 NPDEIVKVTTATAEFAAPEIVDREP 226 (387)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCC
T ss_pred CCCcceeeeccCCCccCchhccCCC
Confidence 7666666778999999999997653
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=245.71 Aligned_cols=217 Identities=22% Similarity=0.232 Sum_probs=133.0
Q ss_pred ccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhc
Q 043136 93 PIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQ 172 (902)
Q Consensus 93 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~ 172 (902)
.+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|.+++..+..|.+
T Consensus 21 ~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 98 (276)
T 2z62_A 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98 (276)
T ss_dssp SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTT
T ss_pred ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcC
Confidence 3555443 57888888888888777777888888888888888877665556666666666666666666555555555
Q ss_pred ccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEE
Q 043136 173 LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252 (902)
Q Consensus 173 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 252 (902)
+++|++|++++|.+.+..+..++++++|++|+|++|++++. .+|..|..+++|++|+
T Consensus 99 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~l~~~~~~l~~L~~L~ 155 (276)
T 2z62_A 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-----------------------KLPEYFSNLTNLEHLD 155 (276)
T ss_dssp CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCC-----------------------CCCGGGGGCTTCCEEE
T ss_pred CccccEEECCCCCccccCchhcccCCCCCEEECcCCcccee-----------------------cCchhhccCCCCCEEE
Confidence 55555555555555544444455555555555555555432 1344555555555555
Q ss_pred ccCccCcccCCccccCCCCcc----EEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCc
Q 043136 253 ISACNLSGTLPSEISNLTKLE----MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328 (902)
Q Consensus 253 Ls~N~l~~~~p~~~~~l~~L~----~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 328 (902)
|++|++++..+..+..+++|+ +|++++|++++..+..+.. .+|++|+|++|++++..+..|..+++|+.|++++|
T Consensus 156 Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 156 LSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp CCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred CCCCCCCcCCHHHhhhhhhccccceeeecCCCcccccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 555555544444454444444 5666666666544444433 36777777777776655556666777777777777
Q ss_pred cccccCC
Q 043136 329 VLFGEIP 335 (902)
Q Consensus 329 ~l~~~~p 335 (902)
.+.+..|
T Consensus 235 ~~~c~c~ 241 (276)
T 2z62_A 235 PWDCSCP 241 (276)
T ss_dssp CBCCCTT
T ss_pred cccccCC
Confidence 7765543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-27 Score=256.94 Aligned_cols=174 Identities=29% Similarity=0.483 Sum_probs=143.1
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..|.+.+.||+|+||.||+|.+. .+..||||++.... .....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 45667789999999999999774 35569999985432 2345567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG----QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccc
Confidence 99999999999999965422 4778889999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC----ceeeccccCccccCcccccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....||+.|+|||++.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 230 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCE
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCC
Confidence 7754322 12234678899999987543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-27 Score=257.84 Aligned_cols=175 Identities=22% Similarity=0.295 Sum_probs=141.1
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe----e
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC----T 784 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~----~ 784 (902)
..|.+.+.||+|+||.||+|++ .+++.||||++.............+.+|++++++++||||+++++++..... .
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 4566778999999999999976 5789999999976554555566778999999999999999999999876543 4
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred EEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999997643 3678888999999999999999776 999999999999999999999999999
Q ss_pred eeccCCC----CceeeccccCccccCcccccc
Q 043136 865 KLIQSDE----SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 865 ~~~~~~~----~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+.+.... .....+||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195 (311)
T ss_dssp ------------------CCTTCCHHHHHTCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCC
Confidence 8764332 223457999999999997654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4e-27 Score=256.21 Aligned_cols=179 Identities=34% Similarity=0.463 Sum_probs=139.6
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|.+.+.||+|+||.||+|+. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 38 ~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 115 (309)
T 3p86_A 38 DLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEY 115 (309)
T ss_dssp GEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEEC
T ss_pred HceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEec
Confidence 456678999999999999987 678899999865432 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 116 ~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~ 192 (309)
T 3p86_A 116 LSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST 192 (309)
T ss_dssp CTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred CCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence 999999999975431 123778888999999999999999542 23999999999999999999999999999865433
Q ss_pred C-CceeeccccCccccCcccccccC
Q 043136 871 E-SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~-~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
. ......||+.|+|||++.+....
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~ 217 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSN 217 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCC
T ss_pred ccccccCCCCccccChhhhcCCCCC
Confidence 2 23456899999999999776443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.2e-26 Score=248.38 Aligned_cols=174 Identities=24% Similarity=0.308 Sum_probs=150.5
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...|...+.||+|+||.||+|... ++..||+|++...... ..+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 456778899999999999999764 4778999998543322 245678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVA 864 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla 864 (902)
|||+++++|.+++.... .+++..+..++.|++.|++|||+++ |+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVHKR-----VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 99999999999887643 3678889999999999999999776 9999999999999 78899999999999
Q ss_pred eeccCCCCceeeccccCccccCccccccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+............||+.|+|||++.+.++
T Consensus 157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 185 (277)
T 3f3z_A 157 ARFKPGKMMRTKVGTPYYVSPQVLEGLYG 185 (277)
T ss_dssp EECCTTSCBCCCCSCTTTCCHHHHTTCBC
T ss_pred eeccCccchhccCCCCCccChHHhcccCC
Confidence 98776666667789999999999876533
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-27 Score=260.89 Aligned_cols=184 Identities=38% Similarity=0.659 Sum_probs=150.9
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
++....|...+.||+|+||.||+|+..+++.||||++...... .....+.+|++++++++||||+++++++.+.+..+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred HHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence 3334456778999999999999998888999999998543221 12235789999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++..... ....+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||+++
T Consensus 104 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 104 LVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 99999999999999976543 33457889999999999999999998733359999999999999999999999999998
Q ss_pred eccCCCC--ceeeccccCccccCcccccc
Q 043136 866 LIQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....||+.|+|||++.+..
T Consensus 183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 211 (326)
T 3uim_A 183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK 211 (326)
T ss_dssp ECCSSSSCEECCCCSCGGGCCHHHHHHSE
T ss_pred ccCcccccccccccCCcCccCHHHhccCC
Confidence 7653322 33456999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=271.53 Aligned_cols=174 Identities=25% Similarity=0.258 Sum_probs=137.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+. .+++.||||++.+...........+.+|+++++.++||||+++++++.+.+..|+|||
T Consensus 149 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 228 (446)
T 4ejn_A 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 228 (446)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEEC
T ss_pred HcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEe
Confidence 356678999999999999976 4689999999864433333445667889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH-DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|+++|+|.+++.... .+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 229 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 229 YANGGELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp CCSSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred eCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999987643 36788889999999999999997 55 9999999999999999999999999998643
Q ss_pred -CCCCceeeccccCccccCcccccc
Q 043136 869 -SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 -~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|||||++.+..
T Consensus 301 ~~~~~~~~~~gt~~y~aPE~~~~~~ 325 (446)
T 4ejn_A 301 KDGATMKTFCGTPEYLAPEVLEDND 325 (446)
T ss_dssp C-----CCSSSCGGGCCHHHHHTSC
T ss_pred CCCcccccccCCccccCHhhcCCCC
Confidence 233345678999999999997653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=259.83 Aligned_cols=168 Identities=27% Similarity=0.432 Sum_probs=140.3
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..|+||||+++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~ 170 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCC
Confidence 46799999999999976 4689999999864432 3456788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE--cCCCCEEEeecccceeccCCC
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL--DGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl--~~~~~~kl~DFGla~~~~~~~ 871 (902)
|+|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++......
T Consensus 171 ~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 171 GELFDRIIDES----YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp CEEHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 99999886543 24778888999999999999999776 9999999999999 567899999999999887666
Q ss_pred CceeeccccCccccCcccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+||+.|+|||++.+..
T Consensus 244 ~~~~~~gt~~y~aPE~~~~~~ 264 (373)
T 2x4f_A 244 KLKVNFGTPEFLAPEVVNYDF 264 (373)
T ss_dssp BCCCCCSSCTTCCHHHHTTCB
T ss_pred ccccccCCCcEeChhhccCCC
Confidence 566678999999999987654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.3e-27 Score=255.41 Aligned_cols=174 Identities=33% Similarity=0.582 Sum_probs=147.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|...+.||+|+||.||+|++.+++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 41 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 117 (321)
T 2qkw_B 41 FDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117 (321)
T ss_dssp CSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS---SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECC
T ss_pred cCccceeecCCCeeEEEEEECCCCEEEEEEecccCh---HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcC
Confidence 456688999999999999988899999999864432 23456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD- 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~- 870 (902)
++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 118 ~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 193 (321)
T 2qkw_B 118 ENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELD 193 (321)
T ss_dssp TTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred CCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999998865432 2335788999999999999999999766 999999999999999999999999999875422
Q ss_pred --CCceeeccccCccccCcccccc
Q 043136 871 --ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 --~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......||+.|+|||++.+..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~ 217 (321)
T 2qkw_B 194 QTHLSTVVKGTLGYIDPEYFIKGR 217 (321)
T ss_dssp CCCCBCCCEEETTTCCHHHHHHCB
T ss_pred ccccccccCCCccccCHHHhcCCC
Confidence 1233456999999999986543
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.9e-29 Score=299.18 Aligned_cols=392 Identities=15% Similarity=0.122 Sum_probs=261.7
Q ss_pred CCEEEEEcCCCCcccc---cC------------ccccCCCCCCEEEccCCCCcccCchhhh-ccCCCcEEEccCC-CCCC
Q 043136 78 SQITSLDLSRRSLSGP---IP------------PEIRYLTSLTHLNLSANAFDGPLQPAIL-ELTKLRTIDISHN-SFNS 140 (902)
Q Consensus 78 ~~v~~L~L~~~~l~g~---~~------------~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N-~l~~ 140 (902)
.+++.|+|+++..... .| .....+++|++|+|++|.+++..+..+. .+++|++|+|++| .++.
T Consensus 66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 145 (594)
T 2p1m_B 66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145 (594)
T ss_dssp TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence 3688999988653221 11 2235688999999999999988777776 7999999999999 5554
Q ss_pred C-CCcccccccccceeccccccccCCCchhhh----cccCCcEEeccCcc--CcCC-CCcccCCCCCCCEEEccCC-Ccc
Q 043136 141 T-FPPGISKLRFLRIFNAYSNSFTGPLPLEFV----QLNSLQQLNLGGSY--FDGE-IPSDYRNLSSLRFLDLAGN-SLT 211 (902)
Q Consensus 141 ~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~----~l~~L~~L~L~~N~--l~~~-~p~~~~~l~~L~~L~L~~N-~l~ 211 (902)
. ++..+.++++|++|+|++|.+++..+..+. .+++|++|+|++|. ++.. ++..+.++++|++|+|++| .++
T Consensus 146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~ 225 (594)
T 2p1m_B 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLE 225 (594)
T ss_dssp HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHH
T ss_pred HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHH
Confidence 3 444456899999999999999887666555 56699999999987 2211 1122345799999999999 555
Q ss_pred CCCCccccCCCCCcEEEee-------CcccCCCCChhccCCCCCCEE-EccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 212 GSLPPQLGLLTQLERIEIG-------YNNLQGEVPVEFASLVNLKYM-DISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 212 ~~~p~~~~~l~~L~~L~L~-------~N~l~~~~p~~~~~l~~L~~L-~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
+ +|..+..+++|++|+++ .|.+.+ ++..+.++++|+.| .+.+... +.++..+..+++|++|+|++|.++
T Consensus 226 ~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~~L~~L~L~~~~l~ 302 (594)
T 2p1m_B 226 K-LATLLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCKELRCLSGFWDAVP-AYLPAVYSVCSRLTTLNLSYATVQ 302 (594)
T ss_dssp H-HHHHHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCTTCCEEECCBTCCG-GGGGGGHHHHTTCCEEECTTCCCC
T ss_pred H-HHHHHhcCCcceEcccccccCccchhhHHH-HHHHHhcCCCcccccCCcccch-hhHHHHHHhhCCCCEEEccCCCCC
Confidence 4 78888899999999954 445554 44578999999999 4544433 345666668899999999999987
Q ss_pred eecCC-CCCCcCcCcEEecccCCCccc-cCccccccCCCCEEEcc---------CccccccCChhhh-hccccceEEecC
Q 043136 284 GEIPV-SYGNLQALQVLDLSDNQLSGP-IPASLASLKGLTRLSLM---------NNVLFGEIPQDIE-LLADLDTLLLWN 351 (902)
Q Consensus 284 ~~~p~-~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~---------~N~l~~~~p~~~~-~l~~L~~L~L~~ 351 (902)
+.... .+..+++|++|++++| ++.. ++.....+++|++|+++ .+.+++.....+. .+++|+.|.++.
T Consensus 303 ~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~ 381 (594)
T 2p1m_B 303 SYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFC 381 (594)
T ss_dssp HHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEE
T ss_pred HHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhc
Confidence 54322 3567899999999998 5432 33334468999999993 4566554444443 488999999999
Q ss_pred ceeccccCcccc-CCCceeEEEec--C----CcccCCCC-----CCccCCCCccEEeccCCcCcccccccccc-cCCCcE
Q 043136 352 NHLTGVLPQKLG-SNGKLLTVDVS--S----NSLTGPIP-----PTICDGDRLFKLILFSNNFTYSIPENLVN-CSSLSR 418 (902)
Q Consensus 352 N~l~~~~~~~~~-~~~~L~~L~Ls--~----N~l~~~~p-----~~~~~~~~L~~L~l~~N~l~~~~p~~l~~-l~~L~~ 418 (902)
|++++.....+. .+++|+.|+++ + |++++... ..+..+++|+.|++++ ++++..+..+.. +++|+.
T Consensus 382 ~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~ 460 (594)
T 2p1m_B 382 RQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEM 460 (594)
T ss_dssp SCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCE
T ss_pred CCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccE
Confidence 999877666665 57899999999 3 44542111 1133344555555544 444433333333 455555
Q ss_pred EEccCCccCCCCCccc-CCCCCCcEEEccCcccCCCCCC-cCcccCcCceeccccccc
Q 043136 419 LRIQDNQLNGSIPQGF-GLLPNLTFMDMSRNSLSGEIPR-DLGNAQKLEYLNISENSF 474 (902)
Q Consensus 419 L~Ls~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l 474 (902)
|+|++|.+++..+..+ ..+++|+.|+|++|.+++..+. .+..+++|++|++++|++
T Consensus 461 L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~ 518 (594)
T 2p1m_B 461 LSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV 518 (594)
T ss_dssp EEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred eeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence 5555555543333222 3355555555555555332222 223345555555555554
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=254.89 Aligned_cols=170 Identities=31% Similarity=0.458 Sum_probs=140.3
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC----eeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE----CTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~----~~~l 786 (902)
.|...+.||+|+||.||+|+.. ++.||||++.... .......+|+.++++++||||+++++++.... ..|+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 25 PLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp EEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hchhhheecccCceEEEEEEEC-CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 3456689999999999999874 7899999985332 22344566999999999999999999997743 4699
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-------CCCCeEEcCCCCCCEEEcCCCCEEEe
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-------CDPVIVHRDLKPSNILLDGEMEARVA 859 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------~~~~ivHrDlKp~NILl~~~~~~kl~ 859 (902)
||||+++|+|.++++.. .+++..++.++.|+++||+|||+. +..+|+||||||+||+++.++.+||+
T Consensus 100 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred EEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence 99999999999999653 378889999999999999999965 01159999999999999999999999
Q ss_pred ecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 860 DFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 860 DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|||+|+....... ....+||+.|+|||++.+.
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 208 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGA 208 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTC
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccc
Confidence 9999987654332 2335799999999999764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=257.14 Aligned_cols=170 Identities=30% Similarity=0.473 Sum_probs=145.8
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|...+.||+|+||.||+|+. .+++.||||++...........+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3466678899999999999976 578999999986554444455677899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+. |++.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 134 e~~~-g~l~~~l~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp ECCS-EEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred ecCC-CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 9996 688888865432 4778889999999999999999776 9999999999999999999999999998764
Q ss_pred CCCCceeeccccCccccCcccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.. ...+||+.|+|||++.+
T Consensus 206 ~~---~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 206 PA---NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp SB---CCCCSCGGGCCHHHHHT
T ss_pred CC---CcccCCcceeCHhhhcc
Confidence 32 34679999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-28 Score=266.85 Aligned_cols=169 Identities=14% Similarity=0.145 Sum_probs=135.0
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchh-----hHHHHHHHHHHHHHHhcCC---------cCeeEeEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKE-----NIRRRRGVLAEVDVLGNVR---------HRNIVRLL 775 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~---------h~nIv~l~ 775 (902)
..|...+.||+|+||+||+|++ +++.||||++...... .....+.+.+|++++++++ ||||+++.
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~ 98 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN 98 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred ccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence 4566789999999999999987 7899999999654321 1122345677888877775 77777776
Q ss_pred eEEe-----------------c-------------CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHH
Q 043136 776 GCCS-----------------N-------------RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825 (902)
Q Consensus 776 ~~~~-----------------~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~ 825 (902)
+++. + .+..|+||||+++|++.+.+.. ..+++..+..++.||+.
T Consensus 99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence 6542 2 6789999999999976666533 13678889999999999
Q ss_pred HHHHHH-hCCCCCeEEcCCCCCCEEEcCCC--------------------CEEEeecccceeccCCCCceeeccccCccc
Q 043136 826 GICYLH-HDCDPVIVHRDLKPSNILLDGEM--------------------EARVADFGVAKLIQSDESMSVIAGSYGYIA 884 (902)
Q Consensus 826 ~L~~LH-~~~~~~ivHrDlKp~NILl~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~Gt~~y~A 884 (902)
||+||| +++ ||||||||+|||++.++ .+||+|||+|+..... ..+||+.|||
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~a 245 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTC
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccC
Confidence 999999 777 99999999999999887 8999999999976543 4589999999
Q ss_pred cCcccccc
Q 043136 885 PGTFCFCF 892 (902)
Q Consensus 885 PE~~~~~~ 892 (902)
||++.+..
T Consensus 246 PE~~~g~~ 253 (336)
T 2vuw_A 246 EDLFTGDG 253 (336)
T ss_dssp SGGGCCCS
T ss_pred hhhhcCCC
Confidence 99998764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.6e-26 Score=252.89 Aligned_cols=173 Identities=27% Similarity=0.450 Sum_probs=146.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--eeEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--CTML 786 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--~~~l 786 (902)
..|.+.+.||+|+||.||+|+.. +++.||||++...... ...+.+.+|++++++++||||+++++++.... ..|+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 34667789999999999999765 4899999998643322 22455778999999999999999999998655 7899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCCEEEeecc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVADFG 862 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFG 862 (902)
||||+++|+|.+++...... ..+++..++.++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 99999999999999865432 23788889999999999999999776 9999999999999 778889999999
Q ss_pred cceeccCCCCceeeccccCccccCccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
+|+...........+||+.|+|||++.
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 162 AARELEDDEQFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred CceecCCCCceeecccCCCccCHHHhh
Confidence 999887666666778999999999986
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=242.74 Aligned_cols=207 Identities=24% Similarity=0.227 Sum_probs=166.9
Q ss_pred cceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeC
Q 043136 152 LRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY 231 (902)
Q Consensus 152 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 231 (902)
|++|++++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++
T Consensus 30 l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~ 109 (276)
T 2z62_A 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE 109 (276)
T ss_dssp CCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTT
T ss_pred ccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCC
Confidence 44444444444444444566666667777777777666666777778888888888888777777788888888888888
Q ss_pred cccCCCCChhccCCCCCCEEEccCccCccc-CCccccCCCCccEEecCCCccceecCCCCCCcCcCc----EEecccCCC
Q 043136 232 NNLQGEVPVEFASLVNLKYMDISACNLSGT-LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ----VLDLSDNQL 306 (902)
Q Consensus 232 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~----~L~Ls~N~l 306 (902)
|++++..+..+..+++|++|++++|++++. +|..|.++++|++|+|++|++++..+..+..+++|+ .|++++|++
T Consensus 110 n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l 189 (276)
T 2z62_A 110 TNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189 (276)
T ss_dssp SCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCC
T ss_pred CCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcc
Confidence 888877777899999999999999999874 689999999999999999999988888888887777 899999999
Q ss_pred ccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccC
Q 043136 307 SGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP 359 (902)
Q Consensus 307 ~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~ 359 (902)
++..+..+.. .+|++|++++|++++..+..+..+++|+.|++++|.+++..+
T Consensus 190 ~~~~~~~~~~-~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 190 NFIQPGAFKE-IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CEECTTSSCS-CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred cccCccccCC-CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 9766665554 589999999999998777778999999999999999986543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-27 Score=256.45 Aligned_cols=171 Identities=26% Similarity=0.340 Sum_probs=142.8
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 8 ~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3556789999999999999765 7899999998543322 234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 157 (323)
T 3tki_A 86 YCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (323)
T ss_dssp CCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence 999999999886432 3778889999999999999999776 99999999999999999999999999987643
Q ss_pred CC---CceeeccccCccccCccccc
Q 043136 870 DE---SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~---~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....+||+.|+|||++.+.
T Consensus 158 ~~~~~~~~~~~gt~~y~aPE~~~~~ 182 (323)
T 3tki_A 158 NNRERLLNKMCGTLPYVAPELLKRR 182 (323)
T ss_dssp TTEECCBCSCCSCGGGSCHHHHHCS
T ss_pred CCcccccCCCccCcCccCcHHhccC
Confidence 22 23456899999999999764
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5e-27 Score=272.36 Aligned_cols=179 Identities=28% Similarity=0.429 Sum_probs=153.6
Q ss_pred HHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
++...|...+.||+|+||.||+|+.. +++.||||++.+.........+.+.+|++++++++||||+++++++.+.+..|
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 44567888899999999999999765 68999999986543322234566889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecc
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFG 862 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFG 862 (902)
+||||+.+|+|.+.+.... .+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||
T Consensus 103 lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 174 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIISRK-----RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFG 174 (484)
T ss_dssp EEECCCCSCBHHHHHHTCS-----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred EEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence 9999999999999887543 3778888999999999999999776 9999999999999 567899999999
Q ss_pred cceeccCCCCceeeccccCccccCccccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+|+.+.........+||+.|+|||++.+.+.
T Consensus 175 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (484)
T 3nyv_A 175 LSTHFEASKKMKDKIGTAYYIAPEVLHGTYD 205 (484)
T ss_dssp HHHHBCCCCSHHHHTTGGGTCCHHHHHTCCC
T ss_pred eeEEcccccccccCCCCccccCceeecCCCC
Confidence 9988776666667789999999999977543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=250.73 Aligned_cols=176 Identities=25% Similarity=0.367 Sum_probs=142.0
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||.||+|+. .+++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 4577789999999999999976 46889999998544322 23456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccce
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAK 865 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~ 865 (902)
||+++|+|.+++..... ....+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++
T Consensus 100 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 99999999999865432 1224778889999999999999999776 9999999999999 456789999999998
Q ss_pred eccCCCCceeeccccCccccCccccc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
............||+.|+|||++.+.
T Consensus 176 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 201 (285)
T 3is5_A 176 LFKSDEHSTNAAGTALYMAPEVFKRD 201 (285)
T ss_dssp C----------CTTGGGCCHHHHTTC
T ss_pred ecCCcccCcCcccccCcCChHHhccC
Confidence 87665556667899999999998654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-27 Score=260.89 Aligned_cols=170 Identities=25% Similarity=0.252 Sum_probs=135.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 21 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4667789999999999999775 6899999998543322 2446789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC--EEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME--ARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~~ 867 (902)
|+++|+|.+++...+ .+++..+..++.|++.||+|||+++ |+||||||+||+++.++. +||+|||+|+..
T Consensus 97 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 97 YASGGELYERICNAG-----RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred eCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999987643 3778888999999999999999776 999999999999987765 999999999865
Q ss_pred cCCCCceeeccccCccccCcccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.........+||+.|+|||++.+..
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (361)
T 3uc3_A 169 VLHSQPKSTVGTPAYIAPEVLLRQE 193 (361)
T ss_dssp ------------CTTSCHHHHHCSS
T ss_pred cccCCCCCCcCCCCcCChhhhcCCC
Confidence 5444455678999999999986643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=249.66 Aligned_cols=171 Identities=24% Similarity=0.374 Sum_probs=145.4
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
..|...+.||+|+||.||+|+..++..||+|++...... .+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 345667899999999999999888889999998543322 2457889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++..... .+++..++.++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||.++....
T Consensus 84 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGK----GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecch
Confidence 9999999999976532 4778889999999999999999776 99999999999999999999999999987654
Q ss_pred CCCc--eeeccccCccccCccccc
Q 043136 870 DESM--SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~~--~~~~Gt~~y~APE~~~~~ 891 (902)
.... ....||+.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~ 180 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYF 180 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHS
T ss_pred hhhhcccCCCcCcccCCHHHHhcc
Confidence 3322 224467789999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=252.67 Aligned_cols=173 Identities=24% Similarity=0.339 Sum_probs=139.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhh-----------------------HHHHHHHHHHHHHHhcC
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKEN-----------------------IRRRRGVLAEVDVLGNV 766 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~-----------------------~~~~~~~~~Ei~il~~l 766 (902)
.|...+.||+|+||.||+|+. .+++.||||++....... ....+.+.+|+++++++
T Consensus 14 ~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 93 (298)
T 2zv2_A 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKL 93 (298)
T ss_dssp TEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTC
T ss_pred ceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhC
Confidence 355678999999999999976 468899999986443211 11235688999999999
Q ss_pred CcCeeEeEEeEEec--CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043136 767 RHRNIVRLLGCCSN--RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLK 844 (902)
Q Consensus 767 ~h~nIv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlK 844 (902)
+||||+++++++.+ .+..|+||||+++++|.+++.. ..+++..+..++.|+++||+|||+++ |+|||||
T Consensus 94 ~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 94 DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 99999999999986 5688999999999999875432 24788889999999999999999776 9999999
Q ss_pred CCCEEEcCCCCEEEeecccceeccCCCC-ceeeccccCccccCcccccc
Q 043136 845 PSNILLDGEMEARVADFGVAKLIQSDES-MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 845 p~NILl~~~~~~kl~DFGla~~~~~~~~-~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+||+++.++.+||+|||+++....... .....||+.|+|||++.+..
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 213 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETR 213 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTC
T ss_pred HHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCC
Confidence 9999999999999999999987754332 34567999999999997654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.9e-27 Score=251.85 Aligned_cols=171 Identities=29% Similarity=0.431 Sum_probs=140.1
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|...+.||+|+||.||+|+..+++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..|+||||+
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (288)
T 1ob3_A 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred chhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccc-cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEec
Confidence 4566899999999999998888999999998644322 222355778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC-
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD- 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~- 870 (902)
++ +|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 83 DQ-DLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp SE-EHHHHHHTSTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred CC-CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 65 99998875322 3677888899999999999999776 999999999999999999999999999876432
Q ss_pred CCceeeccccCccccCccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......||+.|+|||++.+.
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~ 175 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGS 175 (288)
T ss_dssp -------CCCTTCCHHHHTTC
T ss_pred cccccccccccccCchheeCC
Confidence 223456799999999998653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=252.01 Aligned_cols=176 Identities=27% Similarity=0.352 Sum_probs=150.6
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhH---HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENI---RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
...|.+.+.||+|+||.||+|+.. +++.||+|++........ ...+.+.+|++++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 456778899999999999999764 689999999865432211 1245688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEee
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVAD 860 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~D 860 (902)
|+||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQKE-----SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEECCCCSCBHHHHHHTCS-----CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEcc
Confidence 99999999999999997532 4778889999999999999999776 99999999999999888 799999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+++............||+.|+|||++.+..
T Consensus 163 fg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (321)
T 2a2a_A 163 FGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP 194 (321)
T ss_dssp CTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC
T ss_pred CccceecCccccccccCCCCCccCcccccCCC
Confidence 99999876665556678999999999997654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.2e-26 Score=245.74 Aligned_cols=174 Identities=22% Similarity=0.350 Sum_probs=149.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 95 (294)
T 2rku_A 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 95 (294)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEe
Confidence 4566789999999999999775 578899999865544444566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++..+..++.|+++|++|||+++ |+||||||+||+++.++.+||+|||.++....
T Consensus 96 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 96 LCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp CCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999887543 3678889999999999999999776 99999999999999999999999999987653
Q ss_pred C-CCceeeccccCccccCcccccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .......||+.|+|||++.+..
T Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~ 191 (294)
T 2rku_A 168 DGERKKVLCGTPNYIAPEVLSKKG 191 (294)
T ss_dssp TTCCBCCCCSCCSSCCHHHHTTSC
T ss_pred CccccccccCCCCcCCcchhccCC
Confidence 2 3344567999999999987653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=259.83 Aligned_cols=174 Identities=28% Similarity=0.456 Sum_probs=135.6
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..+...+.||+|+||.||+|+.. ++..||||++.... .....+.+.+|++++++++||||+++++++.+.+..|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 34567799999999999999764 57789999985432 3345667899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.++++... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 9999999999999997542 24778889999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC----ceeeccccCccccCcccccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....+|+.|+|||++.+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226 (373)
T ss_dssp ------------------CTTSCHHHHHHCC
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCC
Confidence 7654321 12234577899999987643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-26 Score=251.34 Aligned_cols=174 Identities=22% Similarity=0.350 Sum_probs=149.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|++. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 42 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 121 (335)
T 2owb_A 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLE 121 (335)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEe
Confidence 3556689999999999999765 578999999865544444566778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 122 ~~~~~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 122 LCRRRSLLELHKRRK-----ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp CCTTCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred cCCCCCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999887543 3678889999999999999999776 99999999999999999999999999987653
Q ss_pred C-CCceeeccccCccccCcccccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .......||+.|+|||++.+..
T Consensus 194 ~~~~~~~~~gt~~y~aPE~~~~~~ 217 (335)
T 2owb_A 194 DGERKKVLCGTPNYIAPEVLSKKG 217 (335)
T ss_dssp TTCCBCCCCSCCSSCCHHHHHTSC
T ss_pred CcccccccCCCccccCHHHhccCC
Confidence 2 3345567999999999987653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.4e-27 Score=257.12 Aligned_cols=176 Identities=23% Similarity=0.284 Sum_probs=149.6
Q ss_pred HHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhH-----HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENI-----RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE 782 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~-----~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~ 782 (902)
...|...+.||+|+||.||+|.+ .+++.||||++........ ...+.+.+|++++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 35677789999999999999975 5688999999864422110 12234667999999999999999999999999
Q ss_pred eeEEEEEccCCC-CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 783 CTMLLYEYMPNG-NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 783 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP-----RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 999999999776 9999987543 3778888999999999999999776 999999999999999999999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++...........+||+.|+|||++.+..
T Consensus 175 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 205 (335)
T 3dls_A 175 GSAAYLERGKLFYTFCGTIEYCAPEVLMGNP 205 (335)
T ss_dssp TTCEECCTTCCBCEECSCGGGCCHHHHTTCC
T ss_pred ccceECCCCCceeccCCCccccChhhhcCCC
Confidence 9999887766667788999999999997654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=247.35 Aligned_cols=186 Identities=34% Similarity=0.523 Sum_probs=154.9
Q ss_pred cCCCHHHHHHHhccCC--------cEeeecCceEEEEEEeCCCcEEEEEEecccch-hhHHHHHHHHHHHHHHhcCCcCe
Q 043136 700 LNFTADDVLECLSMSD--------KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNVRHRN 770 (902)
Q Consensus 700 ~~~~~~~~~~~~~~~~--------~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l~h~n 770 (902)
..|+.+++.+....++ +.||+|+||.||+|.. +++.||+|++..... ......+.+.+|++++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 4578888887765443 6799999999999987 678999999864322 12234567889999999999999
Q ss_pred eEeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 771 Iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
|+++++++.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+||++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999975433 235788899999999999999999776 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 851 DGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
+.++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~ 210 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE 210 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC
Confidence 9999999999999987654322 2335799999999998764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=257.79 Aligned_cols=174 Identities=19% Similarity=0.167 Sum_probs=146.9
Q ss_pred hccCCcEeeec--CceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 711 LSMSDKILGMG--STGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 711 ~~~~~~~iG~G--~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
.|.+.+.||+| +||.||+|+.. +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 26 ~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 45667899999 99999999775 689999999864432 234567788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.++.+||+|||.+...
T Consensus 105 ~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999976432 23778888999999999999999776 999999999999999999999999998765
Q ss_pred cCCC--------CceeeccccCccccCccccc
Q 043136 868 QSDE--------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~--------~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... .....+||+.|+|||++.+.
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTT
T ss_pred ccccccccccccccccccccccccCHHHHhcc
Confidence 3221 12234799999999999873
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=267.34 Aligned_cols=176 Identities=28% Similarity=0.369 Sum_probs=145.2
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...|...+.||+|+||.||+|+.. +++.||+|++.+.... ......+.+|+++++.++||||+++++++.+.+..|+|
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 445777889999999999999764 6889999998643221 12245678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEEEeecccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEARVADFGVA 864 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DFGla 864 (902)
|||+++|+|.+.+.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.. +.+||+|||+|
T Consensus 115 ~e~~~~g~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 99999999999887653 3677888899999999999999776 9999999999999764 55999999999
Q ss_pred eeccCCCCceeeccccCccccCccccccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+...........+||+.|+|||++.+.+.
T Consensus 187 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~ 215 (494)
T 3lij_A 187 AVFENQKKMKERLGTAYYIAPEVLRKKYD 215 (494)
T ss_dssp EECBTTBCBCCCCSCTTTCCHHHHTTCBC
T ss_pred eECCCCccccccCCCcCeeCHHHHcccCC
Confidence 98876666667789999999999876543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-27 Score=248.52 Aligned_cols=171 Identities=25% Similarity=0.435 Sum_probs=144.6
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|...+.||+|+||.||+|.+.+++.||+|++...... .+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 11 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 35566899999999999999888899999998644322 24578999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... .+++..++.++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 87 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 87 MEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp CTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHHhcCc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccc
Confidence 999999999975432 4778888999999999999999776 999999999999999999999999999865432
Q ss_pred C--CceeeccccCccccCcccccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~ 183 (269)
T 4hcu_A 160 QYTSSTGTKFPVKWASPEVFSFSR 183 (269)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCC
T ss_pred ccccccCcccccccCCHHHhcCCC
Confidence 1 123345788899999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=248.43 Aligned_cols=171 Identities=25% Similarity=0.370 Sum_probs=142.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|++. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 82 (292)
T 3o0g_A 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEec
Confidence 556689999999999999764 689999999864432 223445678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++ ++.+.+.... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 83 CDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 965 6666665432 24778889999999999999999776 999999999999999999999999999876533
Q ss_pred -CCceeeccccCccccCccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.......||+.|+|||++.+.
T Consensus 155 ~~~~~~~~~t~~y~aPE~~~~~ 176 (292)
T 3o0g_A 155 VRCYSAEVVTLWYRPPDVLFGA 176 (292)
T ss_dssp CSCCCSCCSCGGGCCHHHHTTC
T ss_pred cccccCCccccCCcChHHHcCC
Confidence 233456899999999998664
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=268.95 Aligned_cols=176 Identities=28% Similarity=0.383 Sum_probs=147.4
Q ss_pred HHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+...|.+.+.||+|+||.||+|... +++.||||++.+.... ......+.+|++++++++||||+++++++.+....|+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEE
Confidence 3456778899999999999999764 6899999998533211 1234568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCCEEEeeccc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD---GEMEARVADFGV 863 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGl 863 (902)
||||+++|+|.+.+.... .+++..+..++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 99 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 170 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGL 170 (486)
T ss_dssp EECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred EEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCc
Confidence 999999999999887653 3678888999999999999999776 99999999999995 456799999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+...........+||+.|+|||++.+.+
T Consensus 171 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 199 (486)
T 3mwu_A 171 STCFQQNTKMKDRIGTAYYIAPEVLRGTY 199 (486)
T ss_dssp TTTBCCC----CCTTGGGGCCGGGGGSCC
T ss_pred CeECCCCCccCCCcCCCCCCCHHHhCCCC
Confidence 98876666666778999999999998753
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=246.72 Aligned_cols=174 Identities=27% Similarity=0.377 Sum_probs=129.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||.||+|+. .+++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+||||
T Consensus 13 y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 92 (278)
T 3cok_A 13 FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEM 92 (278)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEec
Confidence 55668999999999999976 57899999998543222222246688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.++.....
T Consensus 93 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 93 CHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp CTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred CCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999987532 24778889999999999999999776 999999999999999999999999999876432
Q ss_pred -CCceeeccccCccccCcccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.......||+.|+|||++.+..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~ 188 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSA 188 (278)
T ss_dssp -----------------------
T ss_pred CCcceeccCCCCcCCcchhcCCC
Confidence 2234567999999999987653
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=276.50 Aligned_cols=173 Identities=25% Similarity=0.296 Sum_probs=146.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|.+.+.||+|+||.||+|+.. +++.||||++.+.........+.+..|.+++..+ +||+|+++++++++.+..|+|||
T Consensus 343 f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E 422 (674)
T 3pfq_A 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVME 422 (674)
T ss_dssp EEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEE
T ss_pred eEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEe
Confidence 455689999999999999764 5889999998643322223345677899999988 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc-
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ- 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~- 868 (902)
|+++|+|.+++...+ .+++..+..++.||+.||+|||+.+ ||||||||+|||++.++++||+|||+|+...
T Consensus 423 ~~~gg~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 423 YVNGGDLMYHIQQVG-----RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred CcCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 999999999998653 3778888999999999999999776 9999999999999999999999999998643
Q ss_pred CCCCceeeccccCccccCcccccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........+||+.|||||++.+..
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~~~ 518 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAYQP 518 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTCCC
T ss_pred CCcccccccCCCcccCHhhhcCCC
Confidence 344456688999999999997643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=252.84 Aligned_cols=176 Identities=27% Similarity=0.428 Sum_probs=151.5
Q ss_pred HHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccc-----hhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKH-----KENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN 780 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~-----~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~ 780 (902)
+...|...+.||+|+||.||+|.+. +|+.||||++.... .......+.+.+|+++++++ +||||+++++++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 3355777899999999999999875 69999999985432 12223356688999999998 79999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
....|+||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred CCEEEEEEEeCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999997543 3778888999999999999999776 99999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||++..+.........+||+.|+|||++.+.
T Consensus 244 fG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 274 (365)
T 2y7j_A 244 FGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274 (365)
T ss_dssp CTTCEECCTTCCBCCCCSCGGGCCHHHHHHT
T ss_pred cCcccccCCCcccccCCCCCCccChhhcccc
Confidence 9999988766666678899999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=256.05 Aligned_cols=169 Identities=28% Similarity=0.423 Sum_probs=129.0
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 54 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4566789999999999999775 57899999985332 23557789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEEeeccccee
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla~~ 866 (902)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.
T Consensus 129 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG-----YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCSCBHHHHHTTCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred eCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 999999999986532 3678889999999999999999776 999999999999975 88999999999987
Q ss_pred ccCCCCceeeccccCccccCcccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..........+||+.|+|||++.+..
T Consensus 201 ~~~~~~~~~~~gt~~y~aPE~~~~~~ 226 (349)
T 2w4o_A 201 VEHQVLMKTVCGTPGYCAPEILRGCA 226 (349)
T ss_dssp ------------CGGGSCHHHHTTCC
T ss_pred cCcccccccccCCCCccCHHHhcCCC
Confidence 76555556678999999999997754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.3e-26 Score=243.65 Aligned_cols=173 Identities=25% Similarity=0.352 Sum_probs=148.8
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 4566789999999999999764 588999999854432 33455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC---EEEeeccccee
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME---ARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFGla~~ 866 (902)
|+++++|.+.+.... .+++..+..++.|++.|++|||+.+ |+||||||+||+++.++. +||+|||.+..
T Consensus 86 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 86 LVTGGELFEDIVARE-----FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred cCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 999999999887653 3678888999999999999999776 999999999999986655 99999999988
Q ss_pred ccCCCCceeeccccCccccCcccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
...........||+.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 183 (284)
T 3kk8_A 158 VNDSEAWHGFAGTPGYLSPEVLKKDP 183 (284)
T ss_dssp CCSSCBCCCSCSCGGGCCHHHHTTCC
T ss_pred cccCccccCCCCCcCCcCchhhcCCC
Confidence 77666556678999999999997654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-27 Score=253.21 Aligned_cols=174 Identities=28% Similarity=0.445 Sum_probs=140.8
Q ss_pred HHhccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-- 781 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-- 781 (902)
...|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHH
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 34566778999999999999973 368899999985432 34456788999999999999999999998653
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
...++||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Df 158 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDF 158 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG----GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCC
T ss_pred CceEEEEEeCCCCCHHHHHHhccc----ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccC
Confidence 568999999999999999976432 4778889999999999999999776 999999999999999999999999
Q ss_pred ccceeccCCCC----ceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++....... .....||+.|+|||++.+..
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (295)
T 3ugc_A 159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK 193 (295)
T ss_dssp CSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred cccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence 99987644322 22345778899999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-26 Score=260.05 Aligned_cols=171 Identities=22% Similarity=0.391 Sum_probs=143.0
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...+.||+|+||.||+|++. +++.||||++.... .....+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 116 ~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 193 (377)
T 3cbl_A 116 LVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL 193 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEc
Confidence 455689999999999999875 68999999985432 233456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.++++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 194 ~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 194 VQGGDFLTFLRTEGA----RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp CTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 999999999976432 4678888999999999999999776 999999999999999999999999999865432
Q ss_pred CCc---eeeccccCccccCccccc
Q 043136 871 ESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
... ....+++.|+|||++.+.
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~ 290 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYG 290 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHC
T ss_pred ceeecCCCCCCCcCcCCHhHhccC
Confidence 111 122357789999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=266.82 Aligned_cols=176 Identities=26% Similarity=0.431 Sum_probs=146.7
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhH----------HHHHHHHHHHHHHhcCCcCeeEeEEeEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENI----------RRRRGVLAEVDVLGNVRHRNIVRLLGCC 778 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~----------~~~~~~~~Ei~il~~l~h~nIv~l~~~~ 778 (902)
..|.+.+.||+|+||.||+|+.. +++.||+|++.+...... ...+.+.+|++++++++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34666789999999999999764 578999999864332211 2246688999999999999999999999
Q ss_pred ecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---C
Q 043136 779 SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---E 855 (902)
Q Consensus 779 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~ 855 (902)
.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRH-----KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999987653 3778889999999999999999776 99999999999998776 6
Q ss_pred EEEeecccceeccCCCCceeeccccCccccCccccccc
Q 043136 856 ARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+||+|||+|+...........+||+.|+|||++.+.+.
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 225 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYN 225 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCC
Confidence 99999999998876666667789999999999876543
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=244.42 Aligned_cols=174 Identities=28% Similarity=0.430 Sum_probs=139.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|++. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 12 ~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 91 (276)
T 2h6d_A 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVME 91 (276)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4566789999999999999775 689999999854332222334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 92 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 92 YVSGGELFDYICKHG-----RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp CCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred ccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999997653 3677888999999999999999776 99999999999999999999999999988765
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
........||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~ 186 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRL 186 (276)
T ss_dssp -------------CCTGGGTTSC
T ss_pred CcceecccCCccccCHHHHcCCC
Confidence 55555678999999999997653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=244.52 Aligned_cols=177 Identities=27% Similarity=0.375 Sum_probs=145.7
Q ss_pred HHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhH---HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENI---RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
+...|...+.||+|+||.||+|+.. +++.||+|++........ ...+.+.+|++++++++||||+++++++.+.+.
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3456778899999999999999775 689999999864432211 124568899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEe
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVA 859 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~ 859 (902)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKE-----SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEE
Confidence 999999999999999997543 3678889999999999999999776 99999999999998877 89999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|||.++............||+.|+|||++.+..
T Consensus 155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 187 (283)
T 3bhy_A 155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP 187 (283)
T ss_dssp CCTTCEECC--------CCCGGGCCHHHHTTCC
T ss_pred ecccceeccCCCcccccCCCcCccCcceecCCC
Confidence 999998876555555678999999999987653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-26 Score=266.10 Aligned_cols=169 Identities=23% Similarity=0.382 Sum_probs=129.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-----CCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-----RECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-----~~~~ 784 (902)
.|.+.+.||+|+||.||+|.+. +++.||||++.... ......+.+.+|++++++++||||+++++++.. ....
T Consensus 54 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 4667789999999999999654 68999999985432 234455678899999999999999999999843 3578
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+ +|+|.+++.... .+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTPV-----YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEECCC-SEEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecc-ccchhhhcccCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 9999998 579999986532 4778889999999999999999776 999999999999999999999999999
Q ss_pred eeccCCC----------------------------CceeeccccCccccCccc
Q 043136 865 KLIQSDE----------------------------SMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 865 ~~~~~~~----------------------------~~~~~~Gt~~y~APE~~~ 889 (902)
+...... .....+||++|||||++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 8764221 234467899999999863
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=259.74 Aligned_cols=168 Identities=26% Similarity=0.365 Sum_probs=130.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhc-CCcCeeEeEEeEEec----CCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN-VRHRNIVRLLGCCSN----RECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~-l~h~nIv~l~~~~~~----~~~~ 784 (902)
++...+.||+|+||.||+|.+. +++.||||++... ..+.+|++++.+ .+||||+++++++.. ....
T Consensus 63 y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3334478999999999999764 6889999998421 234568887744 589999999999865 5678
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEEeec
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARVADF 861 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DF 861 (902)
|+||||+++|+|.+++.... ...+++..+..|+.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred EEEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEec
Confidence 99999999999999997542 224788899999999999999999776 999999999999987 789999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++...........+||+.|+|||++.+..
T Consensus 209 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 239 (400)
T 1nxk_A 209 GFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239 (400)
T ss_dssp TTCEECC-----------CTTCCGGGSCCCC
T ss_pred ccccccCCCCccccCCCCCCccCHhhcCCCC
Confidence 9999876555556788999999999996643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3e-26 Score=250.47 Aligned_cols=175 Identities=25% Similarity=0.381 Sum_probs=134.5
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|... +++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp -------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 3456688999999999999764 5899999998543321 223457789999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 790 YMPNGNLDDLLHAKNKG-ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|++ |+|.+++...... ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 6999998765432 2234778888899999999999999776 9999999999999999999999999998765
Q ss_pred CC-CCceeeccccCccccCccccc
Q 043136 869 SD-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.. ......+||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~t~~y~aPE~~~~~ 183 (317)
T 2pmi_A 160 IPVNTFSSEVVTLWYRAPDVLMGS 183 (317)
T ss_dssp SCCCCCCCCCSCCTTCCHHHHTTC
T ss_pred CCcccCCCCcccccccCchHhhCC
Confidence 33 233456899999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=265.19 Aligned_cols=175 Identities=25% Similarity=0.359 Sum_probs=135.0
Q ss_pred HHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh-----hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE-----NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
.....|...+.||+|+||.||+|.. .+++.||||++.+.... .......+.+|++++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4455677889999999999999966 45899999998654321 11223357889999999999999999999864
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEAR 857 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~k 857 (902)
+..|+||||+++|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+||+++.+ +.+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEE
T ss_pred -CceEEEEEcCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEE
Confidence 45799999999999988876432 4778889999999999999999776 9999999999999654 4599
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccc
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+|||+|+...........+||+.|+|||++.+
T Consensus 283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp ECCSSTTTSCC-----------CTTCCTTTTC-
T ss_pred EeecccceecCCCccccccCCCCCccCceeeec
Confidence 999999998766555667889999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=257.54 Aligned_cols=178 Identities=26% Similarity=0.369 Sum_probs=147.6
Q ss_pred HhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~ 780 (902)
..+.+.+.||+|+||.||+|+.. .+..||||++.... .....+.+.+|+++++++ +||||+++++++..
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 35567789999999999999752 24679999985442 334556788999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
.+..++||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 99999999999999999999865421 1235788999999999999999999776 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCC---CceeeccccCccccCcccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.++.+||+|||+|+...... ......||+.|+|||++.+..
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 269 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC
Confidence 9999999999999998764332 223356788999999987654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=250.41 Aligned_cols=164 Identities=27% Similarity=0.345 Sum_probs=123.1
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
++.||+|+||.||+|.+. +++.||||++.+. ....+.+|+++++.+. ||||+++++++.+....|+||||++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~ 89 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccC
Confidence 478999999999999764 6899999998432 1234668999999996 9999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEeecccceeccC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVADFGVAKLIQS 869 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~DFGla~~~~~ 869 (902)
+|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+++....
T Consensus 90 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 161 (325)
T 3kn6_A 90 GGELFERIKKKK-----HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161 (325)
T ss_dssp SCBHHHHHHHCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCC
Confidence 999999997643 4788889999999999999999776 99999999999998766 799999999987643
Q ss_pred C-CCceeeccccCccccCcccccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......+||+.|+|||++.+..
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~~~~ 185 (325)
T 3kn6_A 162 DNQPLKTPCFTLHYAAPELLNQNG 185 (325)
T ss_dssp ----------------------CC
T ss_pred CCCcccccCCCcCccCHHHhcCCC
Confidence 3 2345578999999999997654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=255.14 Aligned_cols=182 Identities=22% Similarity=0.287 Sum_probs=151.2
Q ss_pred ccCCCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-----cCeeE
Q 043136 699 RLNFTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-----HRNIV 772 (902)
Q Consensus 699 ~~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----h~nIv 772 (902)
...+...+++...|.+.+.||+|+||.||+|++ .+++.||||++... ....+.+..|++++++++ ||||+
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345566666677888889999999999999976 46889999998532 233445677999998886 99999
Q ss_pred eEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC
Q 043136 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG 852 (902)
Q Consensus 773 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~ 852 (902)
++++++...+..|+||||+ +++|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||+++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~ 172 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDD 172 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESC
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcc
Confidence 9999999999999999999 9999999976532 23677888999999999999999776 999999999999975
Q ss_pred -------------------------CCCEEEeecccceeccCCCCceeeccccCccccCccccccc
Q 043136 853 -------------------------EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 853 -------------------------~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
++.+||+|||+|+..... ....+||+.|+|||++.+...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~ 236 (360)
T 3llt_A 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGW 236 (360)
T ss_dssp TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCC
T ss_pred ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCC
Confidence 789999999999875432 345689999999999977543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=260.78 Aligned_cols=169 Identities=25% Similarity=0.379 Sum_probs=139.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
.|.+.+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|++++++++||||+++++++... ...
T Consensus 27 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 466778999999999999976 458899999986432 3344566788999999999999999999998765 578
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||++ |+|.+++.... .+++..+..++.||++||+|||+++ |+||||||+||+++.++.+||+|||+|
T Consensus 106 ~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 106 YIVLEIAD-SDLKKLFKTPI-----FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEECCS-EEHHHHHHSSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecCC-cCHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 99999995 69999987532 4788889999999999999999776 999999999999999999999999999
Q ss_pred eeccCCC-----------------------CceeeccccCccccCccc
Q 043136 865 KLIQSDE-----------------------SMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 865 ~~~~~~~-----------------------~~~~~~Gt~~y~APE~~~ 889 (902)
+...... .....+||++|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~ 224 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELIL 224 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHh
Confidence 9764332 135678999999999863
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-26 Score=263.88 Aligned_cols=170 Identities=27% Similarity=0.317 Sum_probs=136.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.+ .+++.||||++.... ......+++.+|+++++.++||||+++++++... ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 456678999999999999965 468999999986442 2344566788999999999999999999999654 35
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 142 ~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 142 VYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred EEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 7999999965 56666642 2677888899999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+...........+||+.|+|||++.+..
T Consensus 211 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 239 (464)
T 3ttj_A 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMG 239 (464)
T ss_dssp C-----CCCC----CCCTTCCHHHHTTCC
T ss_pred eeecCCCcccCCCcccccccCHHHHcCCC
Confidence 99876665667789999999999997753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=254.83 Aligned_cols=177 Identities=28% Similarity=0.411 Sum_probs=145.3
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..
T Consensus 48 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 4556789999999999999764 34889999986443 234456789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC-------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKG-------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 845 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp 845 (902)
|+||||+++|+|.+++...... ....+++..++.++.||++||+|||+++ |+||||||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp 202 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLAT 202 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCc
Confidence 9999999999999999764311 1145788899999999999999999776 99999999
Q ss_pred CCEEEcCCCCEEEeecccceeccCCC---CceeeccccCccccCcccccc
Q 043136 846 SNILLDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 846 ~NILl~~~~~~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+||+++.++.+||+|||+++...... ......||+.|+|||++.+..
T Consensus 203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 252 (343)
T 1luf_A 203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 252 (343)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC
Confidence 99999999999999999998764322 223456899999999986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=243.95 Aligned_cols=173 Identities=28% Similarity=0.404 Sum_probs=142.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 11 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (279)
T 3fdn_A 11 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 90 (279)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEec
Confidence 556689999999999999664 5779999998544333333356688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++..+..++.|++.|++|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 91 ~~~~~l~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 91 APLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred CCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999987653 3677888999999999999999665 999999999999999999999999998665432
Q ss_pred CCceeeccccCccccCccccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
......||+.|+|||++.+...
T Consensus 163 -~~~~~~~~~~y~aPE~~~~~~~ 184 (279)
T 3fdn_A 163 -RRTDLCGTLDYLPPEMIEGRMH 184 (279)
T ss_dssp ------CCCCTTCCHHHHTTCCC
T ss_pred -cccccCCCCCccCHhHhccCCC
Confidence 2345679999999999876543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-26 Score=247.46 Aligned_cols=167 Identities=27% Similarity=0.405 Sum_probs=136.1
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhc--CCcCeeEeEEeEEec----CCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN--VRHRNIVRLLGCCSN----REC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~h~nIv~l~~~~~~----~~~ 783 (902)
..|...+.||+|+||.||+|+. +++.||||++.... ...+.+|.+++.. ++||||+++++++.. ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 4566778999999999999987 78999999985332 1233445555554 799999999998654 346
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH--------HDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
.|+||||+++|+|.++++.. .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~ 151 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQ 151 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSC
T ss_pred eEEehhhccCCCHHHHHhhc------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCC
Confidence 89999999999999999532 4788889999999999999999 555 999999999999999999
Q ss_pred EEEeecccceeccCCCCc-----eeeccccCccccCcccccc
Q 043136 856 ARVADFGVAKLIQSDESM-----SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~~-----~~~~Gt~~y~APE~~~~~~ 892 (902)
+||+|||+|+........ ...+||+.|+|||++.+..
T Consensus 152 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 193 (301)
T 3q4u_A 152 CCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193 (301)
T ss_dssp EEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCC
T ss_pred EEEeeCCCeeecccccccccccccccccccceeChhhhcCcC
Confidence 999999999876544332 2347999999999997753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=249.53 Aligned_cols=177 Identities=28% Similarity=0.387 Sum_probs=146.8
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..|...+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3456778999999999999975 245789999986433 23455678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC-------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG-------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLK 844 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlK 844 (902)
.++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+++ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 99999999999999999865321 1234788889999999999999999776 9999999
Q ss_pred CCCEEEcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 845 PSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 845 p~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
|+||+++.++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 227 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDH 227 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCC
Confidence 9999999999999999999987654332 2334578899999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=253.28 Aligned_cols=179 Identities=26% Similarity=0.328 Sum_probs=142.6
Q ss_pred HHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh--hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE--NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
...|...+.||+|+||.||+|.. .+++.||+|++...... .....+.+.+|++++++++||||+++++++.+.+..+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 45677889999999999999976 46889999998543211 2234567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccC-----------------------------------CCcccCHHHHHHHHHHHHHHHHHH
Q 043136 786 LLYEYMPNGNLDDLLHAKNKG-----------------------------------ENLVADWVTRYKIALGVAQGICYL 830 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~-----------------------------------~~~~~~~~~~~~i~~qi~~~L~~L 830 (902)
+||||+++|+|.+++...... .....++..++.++.|+++||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998532111 012235667788999999999999
Q ss_pred HhCCCCCeEEcCCCCCCEEEcCCC--CEEEeecccceeccCCC-----CceeeccccCccccCcccc
Q 043136 831 HHDCDPVIVHRDLKPSNILLDGEM--EARVADFGVAKLIQSDE-----SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 831 H~~~~~~ivHrDlKp~NILl~~~~--~~kl~DFGla~~~~~~~-----~~~~~~Gt~~y~APE~~~~ 890 (902)
|+.+ |+||||||+||+++.++ .+||+|||+++.+.... ......||+.|+|||++.+
T Consensus 185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9776 99999999999998776 89999999998764321 1345679999999999965
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=246.22 Aligned_cols=174 Identities=21% Similarity=0.278 Sum_probs=141.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 35 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 2h34_A 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMR 114 (309)
T ss_dssp CEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEE
Confidence 3566789999999999999764 688999999865544445556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 115 ~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 115 LINGVDLAAMLRRQG-----PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp CCCCEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred ecCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999997643 3678888999999999999999776 99999999999999999999999999987644
Q ss_pred CC--CceeeccccCccccCcccccc
Q 043136 870 DE--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......||+.|+|||++.+..
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~ 211 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESH 211 (309)
T ss_dssp ----------CCGGGCCGGGTCC--
T ss_pred cccccccccCCCcCccCHHHHcCCC
Confidence 32 223467999999999997653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=243.71 Aligned_cols=176 Identities=24% Similarity=0.443 Sum_probs=149.1
Q ss_pred HHHHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--
Q 043136 704 ADDVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-- 780 (902)
Q Consensus 704 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-- 780 (902)
.++.+...|...+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 77 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFD 77 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEE
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccc
Confidence 34556667888899999999999999775 68999999985433 235679999999999999999998854
Q ss_pred --------------CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043136 781 --------------RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846 (902)
Q Consensus 781 --------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~ 846 (902)
....|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 78 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~ 151 (284)
T 2a19_B 78 YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPS 151 (284)
T ss_dssp EC---------CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGG
T ss_pred cCcccccccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHH
Confidence 3458999999999999999976432 24778888999999999999999776 999999999
Q ss_pred CEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 847 NILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 847 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+++.++.+||+|||+++............||+.|+|||++.+..
T Consensus 152 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 197 (284)
T 2a19_B 152 NIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD 197 (284)
T ss_dssp GEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC
T ss_pred HEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCC
Confidence 9999999999999999999876655555678999999999987653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.6e-26 Score=256.15 Aligned_cols=177 Identities=24% Similarity=0.330 Sum_probs=145.0
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
.|.+.+.||+|+||.||+|+.. +++.||||++.... .......+.+|+.++++++||||+++++++.+....
T Consensus 72 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 72 NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 4556789999999999999743 46789999985332 234455688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC---CEEEe
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM---EARVA 859 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~---~~kl~ 859 (902)
|+||||+++|+|.+++...+.. ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 9999999999999999875432 2235788899999999999999999776 99999999999999555 59999
Q ss_pred ecccceeccCC---CCceeeccccCccccCcccccc
Q 043136 860 DFGVAKLIQSD---ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 860 DFGla~~~~~~---~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|||+|+..... .......||+.|+|||++.+..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~ 262 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI 262 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCC
Confidence 99999865321 2234457899999999986543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=241.32 Aligned_cols=188 Identities=24% Similarity=0.244 Sum_probs=98.9
Q ss_pred cccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc
Q 043136 146 ISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE 225 (902)
Q Consensus 146 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 225 (902)
++.+++|++|++++|.+++. ..+..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..|+.+++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 33444444444444444431 2344455555555555555544444455555555555555555544444455555555
Q ss_pred EEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCC
Q 043136 226 RIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305 (902)
Q Consensus 226 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 305 (902)
+|++++|++++..+..|..+++|++|++++|++++..+..|.++++|++|+|++|++++..|..+..+++|++|+|++|.
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 55555555555444445555555555555555555444445555555555555555555555555555566666666665
Q ss_pred CccccCccccccCCCCEEEccCccccccCChhhhhcc
Q 043136 306 LSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLA 342 (902)
Q Consensus 306 l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 342 (902)
+.+. +++|++|+++.|.++|.+|..++.+.
T Consensus 217 ~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 217 WDCT-------CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp BCCC-------TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred cccc-------CcHHHHHHHHHHhCCCcccCcccccC
Confidence 5432 33455566666666666665555443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.5e-26 Score=256.48 Aligned_cols=172 Identities=30% Similarity=0.459 Sum_probs=133.2
Q ss_pred HHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCC--e
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRE--C 783 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~--~ 783 (902)
.-..|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 345677788999999999999975 468999999985432 23344566789999999997 999999999997544 6
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~ 155 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGL 155 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcc
Confidence 899999996 6999988753 3677888899999999999999776 99999999999999999999999999
Q ss_pred ceeccC----------------------CCCceeeccccCccccCcccc
Q 043136 864 AKLIQS----------------------DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~----------------------~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+.+.. .......+||++|+|||++.+
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 987532 112244689999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=250.79 Aligned_cols=188 Identities=25% Similarity=0.359 Sum_probs=150.7
Q ss_pred ccCCCHHHHHHHhccCC-cEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEE
Q 043136 699 RLNFTADDVLECLSMSD-KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLL 775 (902)
Q Consensus 699 ~~~~~~~~~~~~~~~~~-~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~ 775 (902)
...|...+.+...|.+. +.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++++ .||||++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 34566667777777766 89999999999999764 58999999986543221 2345678899999999 579999999
Q ss_pred eEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---
Q 043136 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--- 852 (902)
Q Consensus 776 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--- 852 (902)
+++.+.+..|+||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||+||+++.
T Consensus 96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~ 169 (327)
T 3lm5_A 96 EVYENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169 (327)
T ss_dssp EEEECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTT
T ss_pred EEEEeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCC
Confidence 99999999999999999999999885432 224788889999999999999999776 999999999999987
Q ss_pred CCCEEEeecccceeccCCCCceeeccccCccccCccccccc
Q 043136 853 EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 853 ~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
++.+||+|||+++...........+||+.|+|||++.+...
T Consensus 170 ~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 210 (327)
T 3lm5_A 170 LGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI 210 (327)
T ss_dssp BCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCC
T ss_pred CCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCC
Confidence 78999999999998766555566789999999999976543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=4.1e-26 Score=257.40 Aligned_cols=174 Identities=27% Similarity=0.441 Sum_probs=146.2
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--eeEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--CTML 786 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--~~~l 786 (902)
..|.+.+.||+|+||.||+|++. +++.||||++...... ...+.+.+|++++++++||||+++++++...+ ..|+
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 35667789999999999999765 4899999998643322 22455778999999999999999999998755 7799
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCCEEEeecc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVADFG 862 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl----~~~~~~kl~DFG 862 (902)
||||+++|+|.+++...... ..+++..++.++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 99999999999999765432 23788889999999999999999776 9999999999999 777889999999
Q ss_pred cceeccCCCCceeeccccCccccCcccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
+|+...........+||+.|+|||++.+
T Consensus 162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 162 AARELEDDEQFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp GCEECCCGGGSSCSSSCCTTCCHHHHHH
T ss_pred CceEccCCCccccccCCccccCHHHhhc
Confidence 9998766555556789999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.3e-26 Score=246.65 Aligned_cols=171 Identities=25% Similarity=0.361 Sum_probs=139.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|++. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 3556789999999999999774 58999999985543 233445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++++++.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++....
T Consensus 83 ~~~~~~l~~~~~~~~-----~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRYQR-----GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHTSS-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 999999988876432 3678888999999999999999776 99999999999999999999999999987653
Q ss_pred C-CCceeeccccCccccCcccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~ 890 (902)
. ......+||+.|+|||++.+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 155 PSDYYDDEVATRWYRSPELLVG 176 (311)
T ss_dssp -----------GGGCCHHHHHT
T ss_pred cccccCCCcCCccccChHHHhc
Confidence 3 23355689999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-26 Score=247.73 Aligned_cols=173 Identities=27% Similarity=0.436 Sum_probs=142.4
Q ss_pred HhccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--C
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--E 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~ 782 (902)
..|...+.||+|+||.||+|++ .+++.||+|++..... ....+.+.+|++++++++||||+++++++... .
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 98 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 98 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccccc--chhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence 3466778999999999999973 4689999999854332 22345688999999999999999999999876 6
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..++||||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||
T Consensus 99 ~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 99 GIKLIMEFLPSGSLKEYLPKNKN----KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp CEEEEEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCT
T ss_pred eEEEEEEeCCCCcHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccc
Confidence 68999999999999999965432 3778889999999999999999776 9999999999999999999999999
Q ss_pred cceeccCCCC----ceeeccccCccccCccccc
Q 043136 863 VAKLIQSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
+++....... .....||+.|+|||++.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 204 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCC
Confidence 9988754432 2335688889999998654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=247.68 Aligned_cols=171 Identities=24% Similarity=0.349 Sum_probs=142.0
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|...+.||+|+||.||+|++.++..||+|++...... .+++.+|++++++++||||+++++++.+.+..|+||||
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 25 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 45567899999999999999988889999998644322 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 101 ~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 101 MANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CTTCBHHHHHHCGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred cCCCcHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 999999999976432 3778889999999999999999776 999999999999999999999999999865432
Q ss_pred C--CceeeccccCccccCcccccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~ 197 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSK 197 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCC
T ss_pred ccccccCCccCcccCCHHHhccCC
Confidence 1 122345778899999987543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=248.05 Aligned_cols=178 Identities=27% Similarity=0.424 Sum_probs=141.5
Q ss_pred HHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhc--CCcCeeEeEEeEEecC
Q 043136 704 ADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN--VRHRNIVRLLGCCSNR 781 (902)
Q Consensus 704 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~h~nIv~l~~~~~~~ 781 (902)
..+.....|...+.||+|+||.||+|+.. ++.||||++..... ....+|.+++.. ++||||+++++++...
T Consensus 31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~------~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH------HHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc------chhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 34455667888899999999999999874 89999999843221 223445555555 4899999999999876
Q ss_pred ----CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEcCCCCCCEEEcC
Q 043136 782 ----ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC-----DPVIVHRDLKPSNILLDG 852 (902)
Q Consensus 782 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~-----~~~ivHrDlKp~NILl~~ 852 (902)
...|+||||+++|+|.++++.. .+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKK 177 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECT
T ss_pred CCCCCceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECC
Confidence 6889999999999999999653 3778889999999999999999660 115999999999999999
Q ss_pred CCCEEEeecccceeccCCCCc-----eeeccccCccccCcccccccC
Q 043136 853 EMEARVADFGVAKLIQSDESM-----SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 853 ~~~~kl~DFGla~~~~~~~~~-----~~~~Gt~~y~APE~~~~~~~~ 894 (902)
++.+||+|||+|+.+...... ...+||+.|+|||++.+....
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 224 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNR 224 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCT
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCC
Confidence 999999999999876433221 245799999999999776443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-25 Score=240.92 Aligned_cols=175 Identities=23% Similarity=0.324 Sum_probs=145.3
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
...|...+.||+|+||.||+|... +++.||+|++....... .....+.+|+..+.++ +||||+++++++.+.+..++
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 345677889999999999999775 68999999986543322 3345678899999998 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-------------
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE------------- 853 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~------------- 853 (902)
||||+++|+|.+++...... ...+++..++.++.|+++||+|||+++ |+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999765321 124678889999999999999999776 9999999999999844
Q ss_pred ------CCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 854 ------MEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 854 ------~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
..+||+|||.++...... ...||+.|+|||++.+.
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQEN 205 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTC
T ss_pred cccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCC
Confidence 479999999998765432 34699999999999765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=256.17 Aligned_cols=178 Identities=28% Similarity=0.365 Sum_probs=144.5
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~ 782 (902)
..|...+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|++++.++ +||||+++++++.+.+
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~ 99 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 99 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCC
Confidence 4566778999999999999963 346899999985432 234456789999999999 7999999999998755
Q ss_pred -eeEEEEEccCCCCHHHHHHhhccCC------------------------------------------------------
Q 043136 783 -CTMLLYEYMPNGNLDDLLHAKNKGE------------------------------------------------------ 807 (902)
Q Consensus 783 -~~~lv~e~~~~gsL~~~l~~~~~~~------------------------------------------------------ 807 (902)
..++||||+++|+|.++++......
T Consensus 100 ~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (359)
T 3vhe_A 100 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179 (359)
T ss_dssp SCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------------
T ss_pred CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhc
Confidence 4899999999999999997653210
Q ss_pred -------CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC---ceeec
Q 043136 808 -------NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIA 877 (902)
Q Consensus 808 -------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~---~~~~~ 877 (902)
...+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++....... .....
T Consensus 180 ~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 180 EAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp ----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred ccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 112788889999999999999999776 99999999999999999999999999987643332 23457
Q ss_pred cccCccccCcccccc
Q 043136 878 GSYGYIAPGTFCFCF 892 (902)
Q Consensus 878 Gt~~y~APE~~~~~~ 892 (902)
||+.|+|||++.+..
T Consensus 257 ~t~~y~aPE~~~~~~ 271 (359)
T 3vhe_A 257 LPLKWMAPETIFDRV 271 (359)
T ss_dssp ECGGGCCHHHHHHCC
T ss_pred CCceeEChhhhcCCC
Confidence 899999999986543
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=240.08 Aligned_cols=187 Identities=27% Similarity=0.318 Sum_probs=90.7
Q ss_pred hhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCC
Q 043136 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249 (902)
Q Consensus 170 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 249 (902)
+..+++|++|+|++|.+++. +.+.++++|++|+|++|++++..+..|+.+++|++|++++|++++..+..|..+++|+
T Consensus 59 l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 136 (272)
T 3rfs_A 59 IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLT 136 (272)
T ss_dssp GGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCC
T ss_pred cccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCC
Confidence 44445555555555554431 2344455555555555555544444445555555555555555544444445555555
Q ss_pred EEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcc
Q 043136 250 YMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329 (902)
Q Consensus 250 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (902)
+|+|++|++++..+..|.++++|++|++++|++++..+..++.+++|++|+|++|++++..|..+..+++|++|++++|.
T Consensus 137 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (272)
T 3rfs_A 137 YLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNP 216 (272)
T ss_dssp EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCC
Confidence 55555555554444444455555555555555554444444445555555555555554444444455555555555554
Q ss_pred ccccCChhhhhccccceEEecCceeccccCccccCC
Q 043136 330 LFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSN 365 (902)
Q Consensus 330 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 365 (902)
+.+..| +|+.++++.|+++|.+|..++.+
T Consensus 217 ~~~~~~-------~l~~l~~~~n~~~g~ip~~~~~~ 245 (272)
T 3rfs_A 217 WDCTCP-------GIRYLSEWINKHSGVVRNSAGSV 245 (272)
T ss_dssp BCCCTT-------TTHHHHHHHHHTGGGBBCTTSCB
T ss_pred ccccCc-------HHHHHHHHHHhCCCcccCccccc
Confidence 443322 34444445555555555444433
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-26 Score=270.46 Aligned_cols=166 Identities=21% Similarity=0.215 Sum_probs=125.9
Q ss_pred eeecCceEEEEEE-eCCCcEEEEEEecccc-------hhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 718 LGMGSTGTVYKAE-MPGGEIIAVKKLWGKH-------KENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 718 iG~G~~g~Vy~~~-~~~~~~vavK~i~~~~-------~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.+.|+.|.+..++ .-.|+.||+|.+.+.. .......+++.+|+++|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4666666666652 3358889999986432 22345567899999999999 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||++|++|.+++...+. ++.. +|+.||+.||+|+|+++ ||||||||+|||++++|.+||+|||+|+...
T Consensus 322 Eyv~G~~L~d~i~~~~~-----l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE-----IDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp ECCCSEEHHHHHHTTCC-----CCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred ecCCCCcHHHHHHhCCC-----CCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999976432 3432 58999999999999776 9999999999999999999999999998765
Q ss_pred CC-CCceeeccccCccccCcccccccC
Q 043136 869 SD-ESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 869 ~~-~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.. ....+.+||+.|||||++.+.+..
T Consensus 391 ~~~~~~~t~vGTp~YmAPE~l~g~~~~ 417 (569)
T 4azs_A 391 QDCSWPTNLVQSFFVFVNELFAENKSW 417 (569)
T ss_dssp ---CCSHHHHHHHHHHHHHHC------
T ss_pred CCCccccCceechhhccHHHhCCCCCC
Confidence 43 334567899999999999886543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-26 Score=248.78 Aligned_cols=180 Identities=27% Similarity=0.398 Sum_probs=141.8
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchh--hHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEe
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKE--NIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCS 779 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~--~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~ 779 (902)
++....|...+.||+|+||.||+|++ .+++.||+|++...... .......+.+|+++++++ +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45556778889999999999999976 56899999998533211 001112345677766665 5999999999997
Q ss_pred cCC-----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC
Q 043136 780 NRE-----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM 854 (902)
Q Consensus 780 ~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~ 854 (902)
... ..++||||+. |+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~ 157 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGG 157 (308)
T ss_dssp ECCSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTS
T ss_pred ccCCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCC
Confidence 654 5799999996 699999876432 23788899999999999999999776 99999999999999999
Q ss_pred CEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 855 EARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 855 ~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.+||+|||+|+...........+||+.|+|||++.+..
T Consensus 158 ~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 195 (308)
T 3g33_A 158 TVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQST 195 (308)
T ss_dssp CEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC
T ss_pred CEEEeeCccccccCCCcccCCccccccccCchHHcCCC
Confidence 99999999998776655566678999999999986654
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.5e-26 Score=249.43 Aligned_cols=180 Identities=28% Similarity=0.404 Sum_probs=135.5
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
|+....|...+.||+|+||.||+|+.. ..||+|++.... ......+.+.+|++++++++||||+++++++ .....+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 444556777899999999999999864 359999985443 2344567789999999999999999999965 456689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 96 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~ 168 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT 168 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred EEEEecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence 9999999999999986432 24778889999999999999999776 9999999999999999999999999998
Q ss_pred eccC---CCCceeeccccCccccCcccccccCce
Q 043136 866 LIQS---DESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 866 ~~~~---~~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
.... ........||+.|+|||++....+.++
T Consensus 169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (289)
T 3og7_A 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202 (289)
T ss_dssp ---------------CCCTTCCHHHHC----CCS
T ss_pred ccccccccccccccCCCccccCchhhcccCCCCC
Confidence 6543 222344679999999999975444443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=251.89 Aligned_cols=170 Identities=19% Similarity=0.216 Sum_probs=143.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|...+.||+|+||.||+|+. .+++.||||++..... .+.+.+|+++++++ +||||+++++++...+..++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 355678999999999999975 5789999999854322 23467899999999 8999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC-----EEEeeccc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME-----ARVADFGV 863 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~-----~kl~DFGl 863 (902)
||+ +++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~ 156 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156 (330)
T ss_dssp ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred EeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence 999 999999997642 24788899999999999999999776 999999999999998887 99999999
Q ss_pred ceeccCCCC--------ceeeccccCccccCccccccc
Q 043136 864 AKLIQSDES--------MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 864 a~~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~ 893 (902)
|+.+..... ....+||+.|+|||++.+...
T Consensus 157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 194 (330)
T 2izr_A 157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ 194 (330)
T ss_dssp CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred ceeeecCCCCccccccccCCcCCCccccChHHHcCCCC
Confidence 997644322 245789999999999987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.93 E-value=5.8e-26 Score=242.14 Aligned_cols=174 Identities=29% Similarity=0.449 Sum_probs=132.7
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhh-HHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN-IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.+ .++.||||++....... ....+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (271)
T 3dtc_A 8 ELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVME 86 (271)
T ss_dssp SEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEE
T ss_pred heeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEE
Confidence 345678999999999999987 48899999985433222 2234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--------CCCEEEeec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--------EMEARVADF 861 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--------~~~~kl~DF 861 (902)
|+++++|.+++... .+++..++.++.|+++|++|||+++..+|+||||||+||+++. ++.+||+||
T Consensus 87 ~~~~~~L~~~~~~~------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 87 FARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp CCTTEEHHHHHTSS------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred cCCCCCHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 99999999988532 4678888999999999999999765445999999999999986 678999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|.++....... ....||+.|+|||++.+..
T Consensus 161 g~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~ 190 (271)
T 3dtc_A 161 GLAREWHRTTK-MSAAGAYAWMAPEVIRASM 190 (271)
T ss_dssp CC--------------CCGGGSCHHHHHHCC
T ss_pred Ccccccccccc-cCCCCccceeCHHHhccCC
Confidence 99987654332 3467999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.93 E-value=9e-26 Score=248.91 Aligned_cols=168 Identities=24% Similarity=0.317 Sum_probs=140.3
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
...|...+.||+|+||.||+|... +++.||+|++.+.... ..+|++++.++ +||||+++++++.+.+..|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 345777789999999999999764 6889999998544322 34588888777 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC----CCEEEeecc
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE----MEARVADFG 862 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~----~~~kl~DFG 862 (902)
||||++||+|.+++...+ .+++.....++.||+.||+|||+++ |+||||||+||++.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQK-----FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHTCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 999999999999987543 3778888999999999999999776 9999999999998543 359999999
Q ss_pred cceeccCC-CCceeeccccCccccCccccc
Q 043136 863 VAKLIQSD-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+++..... ......+||+.|+|||++.+.
T Consensus 166 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 195 (342)
T 2qr7_A 166 FAKQLRAENGLLMTPCYTANFVAPEVLERQ 195 (342)
T ss_dssp TCEECBCTTCCBCCSSCCSSCCCHHHHHHH
T ss_pred CcccCcCCCCceeccCCCccccCHHHhcCC
Confidence 99976543 334567899999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.2e-25 Score=241.55 Aligned_cols=173 Identities=26% Similarity=0.373 Sum_probs=146.0
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 15 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 94 (284)
T 2vgo_A 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLE 94 (284)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEE
Confidence 3566789999999999999765 578899999854322222224568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++.... .+++.....++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 95 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 95 FAPRGELYKELQKHG-----RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999997653 3677888999999999999999665 99999999999999999999999999976543
Q ss_pred CCCceeeccccCccccCcccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 167 ~-~~~~~~~~~~y~aPE~~~~~~ 188 (284)
T 2vgo_A 167 L-RRRTMCGTLDYLPPEMIEGKT 188 (284)
T ss_dssp S-CBCCCCSCGGGCCHHHHTTCC
T ss_pred c-ccccccCCCCcCCHHHhccCC
Confidence 2 234567999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=5e-26 Score=249.37 Aligned_cols=179 Identities=23% Similarity=0.347 Sum_probs=131.9
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee-
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT- 784 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~- 784 (902)
..|...+.||+|+||.||+|++.... .||||++..... .....+.+.+|++++++++||||+++++++...+..
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 34667789999999999999765432 799999854322 223456788999999999999999999999877655
Q ss_pred -----EEEEEccCCCCHHHHHHhhccC-CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 785 -----MLLYEYMPNGNLDDLLHAKNKG-ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 785 -----~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEE
Confidence 9999999999999999765432 2235788899999999999999999776 999999999999999999999
Q ss_pred eecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 859 ADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 859 ~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+|||+|+....... .....||+.|+|||++.+..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 215 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL 215 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCC
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCC
Confidence 99999987644332 22345788999999987654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-24 Score=232.24 Aligned_cols=205 Identities=22% Similarity=0.287 Sum_probs=170.7
Q ss_pred CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc
Q 043136 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA 206 (902)
Q Consensus 127 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 206 (902)
+.+++++++|.++. +|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.++...+..|.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~~-ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLTA-IPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCCc-cCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 35556666666653 444433 456667777777766666677778888888888888876666667888889999999
Q ss_pred CCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec
Q 043136 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 207 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
+|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+++..+..|..+++|++|+|++|++++..
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 173 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVP 173 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeC
Confidence 99988776777888999999999999999888888999999999999999999877778999999999999999999887
Q ss_pred CCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccC
Q 043136 287 PVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEI 334 (902)
Q Consensus 287 p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 334 (902)
+..|..+++|++|+|++|++++..+..|..+++|+.|+|++|.+...-
T Consensus 174 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 221 (270)
T 2o6q_A 174 EGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTC 221 (270)
T ss_dssp TTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSS
T ss_pred hhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCC
Confidence 778999999999999999999877778999999999999999987654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=5.6e-26 Score=247.70 Aligned_cols=177 Identities=30% Similarity=0.466 Sum_probs=147.1
Q ss_pred hccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~ 783 (902)
.|...+.||+|+||.||+|+. .+++.||+|++..... ....+.+.+|+++++++ +||||+++++++.+.+.
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 456778999999999999974 3468899999864432 34456788999999999 89999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC-------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG-------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
.++||||+++|+|.+++...... ....+++..++.++.|+++||+|||+++ |+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEE
Confidence 99999999999999999765421 1234788899999999999999999776 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCCc---eeeccccCccccCcccccc
Q 043136 851 DGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~~ 892 (902)
+.++.+||+|||+++........ ....||+.|+|||++.+..
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 223 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC
Confidence 99999999999999877544332 2345788999999886543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.4e-26 Score=249.74 Aligned_cols=174 Identities=25% Similarity=0.382 Sum_probs=141.0
Q ss_pred HHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchh-----hHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKE-----NIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN 780 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~-----~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~ 780 (902)
.....|.+.+.||+|+||.||+|... +++.||||++...... .......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34556788899999999999999764 5889999998643221 11223457889999999999999999999976
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC---EE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME---AR 857 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~---~k 857 (902)
.+ .|+||||+++++|.+++.... .+++.....++.|++.||+|||+++ |+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK-----RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEE
Confidence 65 899999999999999886432 4678888899999999999999776 999999999999987654 99
Q ss_pred EeecccceeccCCCCceeeccccCccccCccc
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
|+|||+++............||+.|+|||++.
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHH
T ss_pred EccCccceecccccccccccCCcCccCchhhc
Confidence 99999998875544445567999999999974
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.2e-26 Score=257.85 Aligned_cols=173 Identities=17% Similarity=0.195 Sum_probs=138.0
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHH---HHHhcCCcCeeEeEE-------eEEec
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEV---DVLGNVRHRNIVRLL-------GCCSN 780 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei---~il~~l~h~nIv~l~-------~~~~~ 780 (902)
|...+.||+|+||.||+|++ .+++.||||++...........+.+.+|+ +++++++|||||+++ +++.+
T Consensus 75 y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~ 154 (377)
T 3byv_A 75 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKD 154 (377)
T ss_dssp EEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEEC
T ss_pred EEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhc
Confidence 45568999999999999986 56899999998654333334556788999 455566899999998 66665
Q ss_pred CCe-----------------eEEEEEccCCCCHHHHHHhhccCC--CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEc
Q 043136 781 REC-----------------TMLLYEYMPNGNLDDLLHAKNKGE--NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHR 841 (902)
Q Consensus 781 ~~~-----------------~~lv~e~~~~gsL~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHr 841 (902)
.+. .|+||||+ +|+|.+++....... ...+++..++.|+.||+.||+|||+++ |+||
T Consensus 155 ~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHr 230 (377)
T 3byv_A 155 PQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHT 230 (377)
T ss_dssp TTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECS
T ss_pred cCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 532 78999999 689999998654321 123446778889999999999999776 9999
Q ss_pred CCCCCCEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 842 DLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 842 DlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||||+|||++.++.+||+|||+|+... ......+| +.|+|||++.+.
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhccc
Confidence 999999999999999999999998643 23455678 999999999876
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.3e-26 Score=254.03 Aligned_cols=169 Identities=22% Similarity=0.312 Sum_probs=140.7
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|.+.+.||+|+||.||+|...+++.||||++..... .....+.+.+|++++++++ ||||+++++++...+..|+||
T Consensus 57 ~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred ceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 3666789999999999999888899999999854432 3345677899999999996 599999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
| +.+++|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ ++.+||+|||+|+.+.
T Consensus 136 E-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~ 205 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 205 (390)
T ss_dssp E-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred e-cCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence 9 55889999997643 3677788899999999999999665 99999999999995 5899999999998765
Q ss_pred CCCC---ceeeccccCccccCcccc
Q 043136 869 SDES---MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~~---~~~~~Gt~~y~APE~~~~ 890 (902)
.... ....+||+.|||||++.+
T Consensus 206 ~~~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 206 PDTTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp --------CCSCCCGGGCCHHHHHC
T ss_pred CCCccccCCCCCcCCCccChHHhhh
Confidence 4322 245679999999999976
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.93 E-value=3.8e-25 Score=233.03 Aligned_cols=192 Identities=21% Similarity=0.268 Sum_probs=144.1
Q ss_pred CCCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 64 ~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
+||.|.|++|.. ..+.+++++++++ .+|..+. ++|++|+|++|++++..+..|.++++|++|+|++|.+++..|
T Consensus 3 ~Cp~~~gC~C~~---~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~ 76 (251)
T 3m19_A 3 TCETVTGCTCNE---GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSA 76 (251)
T ss_dssp -CHHHHSSEEEG---GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCT
T ss_pred cCCCCCceEcCC---CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCH
Confidence 388999999964 3456899999998 5676655 688999999999998888888888999999999988888777
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ 223 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 223 (902)
..|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|+.+++
T Consensus 77 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 156 (251)
T 3m19_A 77 GVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTN 156 (251)
T ss_dssp TTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred hHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcC
Confidence 77788888888888888777776677777777777777777777666666677777777777777777555556666667
Q ss_pred CcEEEeeCcccCCCCChhccCCCCCCEEEccCccCccc
Q 043136 224 LERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGT 261 (902)
Q Consensus 224 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 261 (902)
|++|+|++|+|++..+..|..+++|++|+|++|.+++.
T Consensus 157 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 157 LQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 77777777776666666666666666666666666543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.7e-25 Score=240.47 Aligned_cols=172 Identities=32% Similarity=0.438 Sum_probs=148.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccc------hhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCC
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKH------KENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRE 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~------~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~ 782 (902)
.|...+.||+|+||.||+|... +++.||+|++.... .......+.+.+|+++++++. ||||+++++++...+
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (298)
T 1phk_A 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 97 (298)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred ccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCC
Confidence 4566789999999999999764 68999999985432 122334567889999999995 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 98 ~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 98 FFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccCCCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999997643 3678888999999999999999776 9999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCcccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.++............||+.|+|||++.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (298)
T 1phk_A 170 FSCQLDPGEKLREVCGTPSYLAPEIIEC 197 (298)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHH
T ss_pred chhhcCCCcccccccCCccccCHHHhcc
Confidence 9998766665666789999999999863
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=257.37 Aligned_cols=167 Identities=29% Similarity=0.401 Sum_probs=138.9
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC-eeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE-CTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~-~~~lv~e~ 790 (902)
+...+.||+|+||.||+|+.. ++.||||++.... ..+.+.+|++++++++||||+++++++...+ ..|+||||
T Consensus 195 ~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 195 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp EEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred eEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 455689999999999999874 7899999985432 2356889999999999999999999987655 78999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp CTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 999999999986532 23577888999999999999999776 999999999999999999999999999865332
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+++.|+|||++.+..
T Consensus 343 --~~~~~~~~~y~aPE~~~~~~ 362 (450)
T 1k9a_A 343 --QDTGKLPVKWTAPEALREKK 362 (450)
T ss_dssp ------CCCTTTSCHHHHHSSC
T ss_pred --ccCCCCCcceeCHHHhcCCC
Confidence 22346789999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=249.02 Aligned_cols=177 Identities=29% Similarity=0.407 Sum_probs=143.6
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~ 782 (902)
..|...+.||+|+||.||+|++ .+++.||+|++.... .....+.+.+|+++++++ +||||+++++++...+
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 3456778999999999999975 246789999986432 223456788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCC
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKG------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLK 844 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlK 844 (902)
..|+||||+++|+|.+++...... ....+++..++.++.|+++||+|||+++ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999764321 0123688889999999999999999776 9999999
Q ss_pred CCCEEEcCCCCEEEeecccceeccCCCCc---eeeccccCccccCccccc
Q 043136 845 PSNILLDGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 845 p~NILl~~~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
|+||+++.++.+||+|||+++........ ....||+.|+|||++.+.
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 249 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 249 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC
Confidence 99999999999999999999877544332 235678899999998654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=250.48 Aligned_cols=169 Identities=22% Similarity=0.317 Sum_probs=139.8
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc--CeeEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--~nIv~l~~~~~~~~~~~lv~ 788 (902)
.|.+.+.||+|+||.||+|...+++.||||++.... ......+.+.+|++++++++| |||+++++++.+.+..|+||
T Consensus 10 ~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 88 (343)
T 3dbq_A 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 88 (343)
T ss_dssp EEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEE
Confidence 456678999999999999988889999999985433 233455778899999999976 99999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|+ .+++|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+|+...
T Consensus 89 e~-~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 89 EC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp CC-CSEEHHHHHHHSC-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred eC-CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 95 5889999997643 3677888999999999999999776 99999999999997 6789999999998765
Q ss_pred CCCC---ceeeccccCccccCcccc
Q 043136 869 SDES---MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 869 ~~~~---~~~~~Gt~~y~APE~~~~ 890 (902)
.... ....+||+.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp -----------CCCCSSCCHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhh
Confidence 4332 235679999999999865
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=238.59 Aligned_cols=173 Identities=26% Similarity=0.390 Sum_probs=143.1
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~l 786 (902)
+.+.+.||+|+||.||+|.+ .++..||+|++..... .....+.+.+|++++++++||||+++++++.. ....++
T Consensus 28 ~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 45667899999999999976 4678899999854332 33456778899999999999999999999865 456899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCCEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEMEARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~ 865 (902)
||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ .+|+||||||+||+++ .++.+||+|||+++
T Consensus 107 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEecCCCCHHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 999999999999997643 3677888999999999999999542 2499999999999997 78999999999997
Q ss_pred eccCCCCceeeccccCccccCcccccc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.... .......||+.|+|||++.+.+
T Consensus 181 ~~~~-~~~~~~~~t~~y~aPE~~~~~~ 206 (290)
T 1t4h_A 181 LKRA-SFAKAVIGTPEFMAPEMYEEKY 206 (290)
T ss_dssp GCCT-TSBEESCSSCCCCCGGGGGTCC
T ss_pred cccc-cccccccCCcCcCCHHHHhccC
Confidence 5433 3345567999999999987643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=245.17 Aligned_cols=171 Identities=28% Similarity=0.392 Sum_probs=143.8
Q ss_pred hccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe--cCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS--NREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~--~~~~ 783 (902)
.|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++. +...
T Consensus 24 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 456678999999999999973 468899999985442 334566889999999999999999999886 4567
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRA----RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence 8999999999999999976432 4788899999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCC----ceeeccccCccccCccccc
Q 043136 864 AKLIQSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
++....... .....||+.|+|||++.+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHC
T ss_pred ceecccCCccceeeccCCccccccCHHHhccC
Confidence 987754332 2234588889999998654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=241.33 Aligned_cols=173 Identities=20% Similarity=0.300 Sum_probs=132.5
Q ss_pred HhccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..|...+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. .+..|
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 356677899999999999997643 4579999875432 2345667889999999999999999999984 56789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999997543 24778889999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC--ceeeccccCccccCcccccc
Q 043136 866 LIQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....||+.|+|||++.+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 193 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRR 193 (281)
T ss_dssp --------------CCGGGCCHHHHHHCC
T ss_pred ccCcccccccccCCCcccccChhhcccCC
Confidence 7654332 23345788999999986543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=244.10 Aligned_cols=178 Identities=20% Similarity=0.332 Sum_probs=138.3
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+.+|++++++++||||+++++++...+..++|||
T Consensus 33 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 112 (310)
T 2wqm_A 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 112 (310)
T ss_dssp GEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEe
Confidence 356678999999999999976 5789999999865444445566778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++..... ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 113 ~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 113 LADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp CCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred cCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999875432 2234778888999999999999999776 99999999999999999999999999987643
Q ss_pred CC-CceeeccccCccccCcccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......||+.|+|||++.+..
T Consensus 189 ~~~~~~~~~~~~~y~aPE~~~~~~ 212 (310)
T 2wqm_A 189 KTTAAHSLVGTPYYMSPERIHENG 212 (310)
T ss_dssp ----------CCSSCCHHHHTTCC
T ss_pred CCccccccCCCeeEeChHHhCCCC
Confidence 32 234467999999999987653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-26 Score=255.82 Aligned_cols=173 Identities=24% Similarity=0.258 Sum_probs=143.5
Q ss_pred hccCCcEeeecCceEEEEEEe----CCCcEEEEEEecccchh-hHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHKE-NIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~~-~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
.|...+.||+|+||.||+|+. .+++.||||++.+.... .....+.+.+|+++++++ +||||+++++++...+..
T Consensus 55 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 134 (355)
T 1vzo_A 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL 134 (355)
T ss_dssp GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred ceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceE
Confidence 355678999999999999976 36899999998643210 111223456799999999 699999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+++|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 135 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 135 HLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEeecCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999997653 3677888899999999999999776 999999999999999999999999999
Q ss_pred eeccCCC--CceeeccccCccccCccccc
Q 043136 865 KLIQSDE--SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~--~~~~~~Gt~~y~APE~~~~~ 891 (902)
+.+.... .....+||+.|+|||++.+.
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGG 235 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred eecccCCCCcccCcccCcCccChhhhcCC
Confidence 8764322 23446899999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=247.63 Aligned_cols=177 Identities=25% Similarity=0.372 Sum_probs=145.2
Q ss_pred HhccCCcEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~ 780 (902)
..|...+.||+|+||.||+|++. +++.||+|++.... .....+.+.+|+++++++ +||||+++++++.+
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 35667789999999999999763 46789999985433 234556788999999999 89999999999999
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NIL 849 (902)
.+..|+||||+++|+|.+++...... ....+++..++.++.|+++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999865421 1224788889999999999999999776 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCCC---ceeeccccCccccCccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~ 891 (902)
++.++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 234 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR 234 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC
Confidence 99999999999999987654332 2234578899999998654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=6e-26 Score=260.67 Aligned_cols=169 Identities=25% Similarity=0.433 Sum_probs=141.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+...+.||+|+||.||+|...++..||||++..... ..+.+.+|++++++++||||+++++++. .+..|+||||+
T Consensus 190 ~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~ 264 (454)
T 1qcf_A 190 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFM 264 (454)
T ss_dssp EEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCC
T ss_pred eEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeec
Confidence 445689999999999999988889999999864332 2456889999999999999999999986 56789999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.++++.... ...++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 265 ~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 265 AKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp TTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 99999999975432 13567788899999999999999776 9999999999999999999999999998764321
Q ss_pred --CceeeccccCccccCccccc
Q 043136 872 --SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 --~~~~~~Gt~~y~APE~~~~~ 891 (902)
......+|+.|+|||++.+.
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~ 360 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFG 360 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHC
T ss_pred eeccCCCcccccccCHHHhccC
Confidence 12234567899999998654
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.1e-27 Score=259.89 Aligned_cols=257 Identities=20% Similarity=0.214 Sum_probs=190.7
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCc----hhhhccC-CCcEEEccCCCCCCCCCcccccc-----cc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQ----PAILELT-KLRTIDISHNSFNSTFPPGISKL-----RF 151 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~----~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 151 (902)
.++|+.|+++|.+|..+...++|++|+|++|.+++..+ ..+..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35788999999988888888889999999999998777 7778888 89999999999988877777775 88
Q ss_pred cceeccccccccCCCchhhhcc-----cCCcEEeccCccCcCCCCccc----CC-CCCCCEEEccCCCccCCCC----cc
Q 043136 152 LRIFNAYSNSFTGPLPLEFVQL-----NSLQQLNLGGSYFDGEIPSDY----RN-LSSLRFLDLAGNSLTGSLP----PQ 217 (902)
Q Consensus 152 L~~L~L~~N~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~----~~-l~~L~~L~L~~N~l~~~~p----~~ 217 (902)
|++|+|++|.+++..+..++.. ++|++|+|++|++++..+..+ .. .++|++|+|++|++++..+ ..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 9999999999988887766554 789999999999887665543 33 2588899999988885333 33
Q ss_pred ccCCC-CCcEEEeeCcccCCCCChhcc----CC-CCCCEEEccCccCccc----CCccccC-CCCccEEecCCCccceec
Q 043136 218 LGLLT-QLERIEIGYNNLQGEVPVEFA----SL-VNLKYMDISACNLSGT----LPSEISN-LTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 218 ~~~l~-~L~~L~L~~N~l~~~~p~~~~----~l-~~L~~L~Ls~N~l~~~----~p~~~~~-l~~L~~L~L~~N~l~~~~ 286 (902)
+..++ +|++|+|++|+|++..+..+. .+ ++|++|||++|.+++. ++..+.. .++|++|+|++|++++..
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~ 241 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCC
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHH
Confidence 44554 888888888888877665444 34 5888888888888752 3444544 347888888888887543
Q ss_pred C----CCCCCcCcCcEEecccCCCccc-------cCccccccCCCCEEEccCccccccCChhh
Q 043136 287 P----VSYGNLQALQVLDLSDNQLSGP-------IPASLASLKGLTRLSLMNNVLFGEIPQDI 338 (902)
Q Consensus 287 p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 338 (902)
+ ..+..+++|++|+|++|.+.+. ++..+..+++|++||+++|.+.+..+..+
T Consensus 242 ~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~ 304 (362)
T 3goz_A 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPI 304 (362)
T ss_dssp HHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHH
T ss_pred HHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHH
Confidence 3 3346677788888888874432 23355666777777777777766544443
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.3e-26 Score=251.59 Aligned_cols=175 Identities=15% Similarity=0.197 Sum_probs=139.1
Q ss_pred hccCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHH--------HHHHHHHHHHHhcCCcCeeEeEEe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRR--------RRGVLAEVDVLGNVRHRNIVRLLG 776 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~--------~~~~~~Ei~il~~l~h~nIv~l~~ 776 (902)
.|.+.+.||+|+||.||+|.+.. ++.||||++.........+ ......|+..+..++||||+++++
T Consensus 36 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~ 115 (364)
T 3op5_A 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWG 115 (364)
T ss_dssp EEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEE
T ss_pred eEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEe
Confidence 56677899999999999997754 4789999986543221111 123455777888899999999999
Q ss_pred EEecC----CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-
Q 043136 777 CCSNR----ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD- 851 (902)
Q Consensus 777 ~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~- 851 (902)
++... ...|+||||+ +++|.+++.... ..+++..+..|+.||+.||+|||+++ |+||||||+||+++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 116 SGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY 187 (364)
T ss_dssp EEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred eeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence 98764 4589999999 999999997642 24788999999999999999999776 99999999999998
Q ss_pred -CCCCEEEeecccceeccCCCC--------ceeeccccCccccCccccccc
Q 043136 852 -GEMEARVADFGVAKLIQSDES--------MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 852 -~~~~~kl~DFGla~~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.++.+||+|||+|+.+..... ....+||+.|||||++.+...
T Consensus 188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 238 (364)
T 3op5_A 188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP 238 (364)
T ss_dssp SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC
T ss_pred CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC
Confidence 889999999999987643211 134569999999999977643
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-26 Score=246.00 Aligned_cols=168 Identities=18% Similarity=0.345 Sum_probs=141.5
Q ss_pred HhccCCcEeeecCceEEEEEEeCC-C-------cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG-G-------EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR 781 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~-~-------~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~ 781 (902)
..|.+.+.||+|+||.||+|.... + ..||+|++..... ...+.+.+|++++++++||||+++++++.+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG---GGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 345677899999999999996543 3 5799999854332 2345688999999999999999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC------
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME------ 855 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~------ 855 (902)
+..++||||+++|+|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHTGG----GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccc
Confidence 999999999999999999976432 3678888999999999999999776 999999999999998887
Q ss_pred --EEEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 856 --ARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 856 --~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
+||+|||.++.... .....||+.|+|||++.+
T Consensus 158 ~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 158 PFIKLSDPGISITVLP---KDILQERIPWVPPECIEN 191 (289)
T ss_dssp CEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHC
T ss_pred ceeeeccCcccccccC---ccccCCcCcccCHHHhCC
Confidence 99999999875432 234568999999999976
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-26 Score=255.39 Aligned_cols=267 Identities=18% Similarity=0.224 Sum_probs=157.1
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
|.+|.++.|++. .++.++++++.+. +..+..+ ..++++.|++++|.+.+..+.
T Consensus 36 c~~W~~~~~~~~--~~~~l~l~~~~~~---~~~~~~~----------------------~~~~l~~L~l~~n~l~~~~~~ 88 (336)
T 2ast_B 36 CKRWYRLASDES--LWQTLDLTGKNLH---PDVTGRL----------------------LSQGVIAFRCPRSFMDQPLAE 88 (336)
T ss_dssp CHHHHHHHTCST--TSSEEECTTCBCC---HHHHHHH----------------------HHTTCSEEECTTCEECSCCCS
T ss_pred HHHHHHHhcCch--hheeeccccccCC---HHHHHhh----------------------hhccceEEEcCCccccccchh
Confidence 668999988643 4556666655544 2333333 004445555555544444333
Q ss_pred ccccccccceeccccccccCC-CchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCC-CccCC-CCccccCC
Q 043136 145 GISKLRFLRIFNAYSNSFTGP-LPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGN-SLTGS-LPPQLGLL 221 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l 221 (902)
+..+++|++|++++|.+++. +|..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+..+
T Consensus 89 -~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~ 167 (336)
T 2ast_B 89 -HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 167 (336)
T ss_dssp -CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHC
T ss_pred -hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcC
Confidence 33455555555555555443 5555666666666666666666555556666666666666666 45532 44555666
Q ss_pred CCCcEEEeeCc-ccCCC-CChhccCCC-CCCEEEccCc--cCc-ccCCccccCCCCccEEecCCCc-cceecCCCCCCcC
Q 043136 222 TQLERIEIGYN-NLQGE-VPVEFASLV-NLKYMDISAC--NLS-GTLPSEISNLTKLEMLLLFKNH-FTGEIPVSYGNLQ 294 (902)
Q Consensus 222 ~~L~~L~L~~N-~l~~~-~p~~~~~l~-~L~~L~Ls~N--~l~-~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~ 294 (902)
++|++|++++| ++++. ++..+..++ +|++|+|++| .++ +.+|..+.++++|++|++++|. +++..+..+..++
T Consensus 168 ~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~ 247 (336)
T 2ast_B 168 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 247 (336)
T ss_dssp TTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCT
T ss_pred CCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCC
Confidence 66677777666 66643 455566677 7777777777 444 3455566667777777777777 5555666677777
Q ss_pred cCcEEecccCC-CccccCccccccCCCCEEEccCccccccCChhhhhcc-ccceEEecCceeccccCcccc
Q 043136 295 ALQVLDLSDNQ-LSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLA-DLDTLLLWNNHLTGVLPQKLG 363 (902)
Q Consensus 295 ~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~~~~~~ 363 (902)
+|++|++++|. +.......+..+++|+.|++++| +. ...+..+. .+..|++++|++++..|..++
T Consensus 248 ~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 248 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp TCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCccc
Confidence 77777777774 22222225667777777777777 32 12333332 355666666666666555544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=252.92 Aligned_cols=170 Identities=24% Similarity=0.313 Sum_probs=139.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-------- 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-------- 780 (902)
..|...+.||+|+||.||+|++ .+++.||||++...... ..+|+++++.++||||+++++++..
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 3566779999999999999975 57899999998543222 2369999999999999999999843
Q ss_pred ------------------------------CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHH
Q 043136 781 ------------------------------RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830 (902)
Q Consensus 781 ------------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~L 830 (902)
....++||||++ |+|.+.+..... ....+++..+..++.|+++||+||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334889999997 588888765322 223577888999999999999999
Q ss_pred HhCCCCCeEEcCCCCCCEEEc-CCCCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 831 HHDCDPVIVHRDLKPSNILLD-GEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 831 H~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++ |+||||||+||+++ .++.+||+|||+|+............||+.|+|||++.+.
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC
Confidence 9665 99999999999997 6889999999999987666666677899999999998764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.92 E-value=7.1e-26 Score=243.98 Aligned_cols=173 Identities=24% Similarity=0.332 Sum_probs=130.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+. .+++.||+|++..... .....+.+..+...++.++||||+++++++.+.+..++|||
T Consensus 8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred hhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 456678999999999999976 5789999999854322 22333444455556788899999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|++ |++.+++..... ....+++..+..++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 87 LMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp CCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred hhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 996 588888765322 223578889999999999999999976 6 9999999999999999999999999998876
Q ss_pred CCCCceeeccccCccccCccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~ 889 (902)
.........||+.|+|||++.
T Consensus 162 ~~~~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 162 DDVAKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp --------CCCCCCSCHHHHS
T ss_pred ccccccccCCCccccChhhcC
Confidence 655555668999999999974
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=251.81 Aligned_cols=173 Identities=26% Similarity=0.372 Sum_probs=145.7
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...|...+.||+|+||.||+|++. +++.||+|++.... .....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 109 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 109 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence 345666789999999999999765 68999999986442 234456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
|||+++++|.+++.... ..++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.
T Consensus 110 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 110 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ECCCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred EECCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999997653 367788889999999999999974 5 99999999999999999999999999976
Q ss_pred ccCCCCceeeccccCccccCcccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.... ......||+.|+|||++.+..
T Consensus 182 ~~~~-~~~~~~gt~~y~aPE~~~~~~ 206 (360)
T 3eqc_A 182 LIDS-MANSFVGTRSYMSPERLQGTH 206 (360)
T ss_dssp HHHH-C----CCCCTTCCHHHHTTCC
T ss_pred cccc-cccCCCCCCCeECHHHHcCCC
Confidence 5432 234468999999999997653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=239.88 Aligned_cols=171 Identities=27% Similarity=0.455 Sum_probs=137.7
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-------- 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-------- 780 (902)
..|...+.||+|+||.||+|+. .+++.||+|++.. .....+.+.+|++++++++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 3466778999999999999976 4789999999843 22345678899999999999999999998854
Q ss_pred -----CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 781 -----RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 781 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
.+..|+||||+++|+|.+++.... ...++..++.++.|+++||+|||+++ |+||||||+||+++.++.
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~ 154 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRN 154 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCC
Confidence 356899999999999999997532 24667788899999999999999776 999999999999999999
Q ss_pred EEEeecccceeccCC---------------CCceeeccccCccccCccccc
Q 043136 856 ARVADFGVAKLIQSD---------------ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 856 ~kl~DFGla~~~~~~---------------~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+||+|||+++..... .......||+.|+|||++.+.
T Consensus 155 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 155 VKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp EEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred EEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 999999999876421 123446799999999998753
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=249.12 Aligned_cols=170 Identities=26% Similarity=0.310 Sum_probs=131.9
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~ 783 (902)
.|...+.||+|+||.||+|.. .+++.||||++.... ......+.+.+|+++++.++||||+++++++...+ .
T Consensus 26 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred heeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 355678999999999999976 468899999986432 23345567889999999999999999999997654 7
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||++ |++.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 899999996 578888752 2677888899999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+...........+||+.|+|||++.+..
T Consensus 174 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 202 (371)
T 2xrw_A 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMG 202 (371)
T ss_dssp ----------------CTTCCHHHHTTCC
T ss_pred ccccccccccCCceecCCccCHHHhcCCC
Confidence 98776554455678999999999997753
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3.3e-25 Score=240.61 Aligned_cols=172 Identities=27% Similarity=0.400 Sum_probs=144.2
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 456778899999999999999764 689999999854322 2335678999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVA 864 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla 864 (902)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILERG-----VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 99999999999987643 3677888999999999999999776 9999999999999 77889999999999
Q ss_pred eeccCCCCceeeccccCccccCcccccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+..... ......||+.|+|||++.+..
T Consensus 157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~ 183 (304)
T 2jam_A 157 KMEQNG-IMSTACGTPGYVAPEVLAQKP 183 (304)
T ss_dssp CCCCCB-TTHHHHSCCCBCCTTTBSSCS
T ss_pred eecCCC-ccccccCCCCccChHHhccCC
Confidence 765332 334467999999999997653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=238.05 Aligned_cols=174 Identities=26% Similarity=0.351 Sum_probs=144.7
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~lv~ 788 (902)
.|...+.||+|+||.||+|++ +++.||+|++.... ......+.+.+|++++++++||||+++++++.+. +..++||
T Consensus 11 ~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 11 QLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTT-CCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 345668999999999999988 48889999986543 2334456789999999999999999999999877 7889999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp ECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred cccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 9999999999997542 224788899999999999999999542 339999999999999999999999999876533
Q ss_pred CCCCceeeccccCccccCcccccccC
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
. ....||+.|+|||++.+....
T Consensus 165 ~----~~~~~t~~y~aPE~~~~~~~~ 186 (271)
T 3kmu_A 165 S----PGRMYAPAWVAPEALQKKPED 186 (271)
T ss_dssp C----TTCBSCGGGSCHHHHHSCGGG
T ss_pred c----cCccCCccccChhhhccCCCC
Confidence 2 235789999999999875443
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=247.47 Aligned_cols=172 Identities=24% Similarity=0.336 Sum_probs=134.6
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|...+.||+|+||.||+|.+ .+++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 3567778999999999999975 4689999999854432 2334556779999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-----CCCCEEEeeccc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-----GEMEARVADFGV 863 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-----~~~~~kl~DFGl 863 (902)
||++ |+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 113 e~~~-~~L~~~~~~~~-----~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 113 EYAE-NDLKKYMDKNP-----DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp ECCS-EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred ecCC-CCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9997 59999987543 3678888999999999999999776 99999999999994 455699999999
Q ss_pred ceeccCC-CCceeeccccCccccCccccc
Q 043136 864 AKLIQSD-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+..... ......+||+.|+|||++.+.
T Consensus 184 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 212 (329)
T 3gbz_A 184 ARAFGIPIRQFTHEIITLWYRPPEILLGS 212 (329)
T ss_dssp HHHHC-----------CCTTCCHHHHTTC
T ss_pred ccccCCcccccCCCcCCccccCHHHhcCC
Confidence 9876432 233456789999999999763
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=4e-25 Score=236.23 Aligned_cols=172 Identities=26% Similarity=0.343 Sum_probs=145.7
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||.||+|... +++.||+|++...... ...+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 34667789999999999999765 6899999998543322 23466889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++...
T Consensus 85 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 156 (276)
T 2yex_A 85 EYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (276)
T ss_dssp ECCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccC
Confidence 999999999887543 24778888999999999999999776 9999999999999999999999999998764
Q ss_pred CCC---CceeeccccCccccCccccc
Q 043136 869 SDE---SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 869 ~~~---~~~~~~Gt~~y~APE~~~~~ 891 (902)
... ......||+.|+|||++.+.
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~ 182 (276)
T 2yex_A 157 YNNRERLLNKMCGTLPYVAPELLKRR 182 (276)
T ss_dssp ETTEECCBCCCCSCGGGCCGGGGTCS
T ss_pred CCcchhcccCCccccCccChHHHhcC
Confidence 322 23456799999999999764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-26 Score=264.28 Aligned_cols=170 Identities=27% Similarity=0.416 Sum_probs=143.2
Q ss_pred ccCCcEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+...+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|++++++++||||+++++++...+..|+||||
T Consensus 222 ~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 222 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp EEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 4556889999999999997754 88999999854332 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 298 ~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 298 MTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred cCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 999999999976432 24778888999999999999999776 999999999999999999999999999876443
Q ss_pred CC--ceeeccccCccccCccccc
Q 043136 871 ES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....+++.|+|||++.+.
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~ 394 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYN 394 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHC
T ss_pred ceeecCCCcCCcceeCHhHHhcC
Confidence 22 1223467889999998654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.9e-25 Score=244.02 Aligned_cols=175 Identities=24% Similarity=0.304 Sum_probs=142.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe----cCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS----NRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~----~~~~~~ 785 (902)
.|.+.+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++. .....|
T Consensus 30 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred EEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 456678999999999999976 57899999988543 2345567889999999999999999999986 345789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++..... ....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.++
T Consensus 107 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 99999999999999976432 2235788899999999999999999776 9999999999999999999999999987
Q ss_pred eccCCCC----------ceeeccccCccccCcccccc
Q 043136 866 LIQSDES----------MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~----------~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....||+.|+|||++.+..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 219 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQS 219 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCS
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCC
Confidence 6532110 12345799999999987643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=252.46 Aligned_cols=169 Identities=25% Similarity=0.341 Sum_probs=136.9
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------ee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------CT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~~ 784 (902)
.|...+.||+|+||.||+|+...+..||+|++...... ..+|+++++.++||||+++++++...+ ..
T Consensus 41 ~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 41 AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred eEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 45667899999999999999877777999998543322 236999999999999999999985433 37
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEMEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGl 863 (902)
++||||+++ ++.+.+..... ....+++..+..++.|+++||+|||+++ |+||||||+||+++ .++.+||+|||+
T Consensus 114 ~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 114 NLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCC
Confidence 899999976 44444432221 1224778888899999999999999776 99999999999999 789999999999
Q ss_pred ceeccCCCCceeeccccCccccCccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+...........+||+.|+|||++.+.
T Consensus 189 a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 216 (394)
T 4e7w_A 189 AKILIAGEPNVSYICSRYYRAPELIFGA 216 (394)
T ss_dssp CEECCTTCCCCSSCSCGGGCCHHHHTTC
T ss_pred cccccCCCCCcccccCcCccCHHHHcCC
Confidence 9987666666667899999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-26 Score=247.24 Aligned_cols=169 Identities=25% Similarity=0.418 Sum_probs=134.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|+.. +++.||+|++...... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred eEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 556689999999999999765 6899999998533211 1222355799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++ |+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN----IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp CS-EEHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred cc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 96 599998876432 4778888899999999999999776 999999999999999999999999999865432
Q ss_pred -CCceeeccccCccccCcccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~ 890 (902)
......+||+.|+|||++.+
T Consensus 154 ~~~~~~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 154 TKTYDNEVVTLWYRPPDILLG 174 (324)
T ss_dssp ---------CGGGCCHHHHTT
T ss_pred ccccccccCcccccChhhhcC
Confidence 23345678999999999876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.8e-25 Score=243.58 Aligned_cols=174 Identities=26% Similarity=0.393 Sum_probs=146.8
Q ss_pred CCHHHHHHHhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhc--CCcCeeEeEEeEEe
Q 043136 702 FTADDVLECLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN--VRHRNIVRLLGCCS 779 (902)
Q Consensus 702 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~--l~h~nIv~l~~~~~ 779 (902)
+...+.+...|...+.||+|+||.||+|+. +++.||||++.... .+.+.+|++++.. ++||||+++++++.
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 445566777888899999999999999987 58999999984322 2346678888876 78999999999998
Q ss_pred cCC----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEcCCCCCC
Q 043136 780 NRE----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH--------HDCDPVIVHRDLKPSN 847 (902)
Q Consensus 780 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--------~~~~~~ivHrDlKp~N 847 (902)
... ..|+||||+++|+|.+++... .+++..++.++.|+++||+||| +.+ |+||||||+|
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~N 177 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKN 177 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGG
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHH
Confidence 775 789999999999999999653 3778889999999999999999 554 9999999999
Q ss_pred EEEcCCCCEEEeecccceeccCCCC-----ceeeccccCccccCccccc
Q 043136 848 ILLDGEMEARVADFGVAKLIQSDES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 848 ILl~~~~~~kl~DFGla~~~~~~~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
|+++.++.+||+|||+++....... .....||+.|+|||++.+.
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 226 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSC
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccc
Confidence 9999999999999999987755432 2345799999999999765
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=238.20 Aligned_cols=171 Identities=25% Similarity=0.422 Sum_probs=144.2
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|...+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 9 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 9 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred heeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 35566899999999999999888899999998654322 24678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ..++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 85 MEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CTTCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred CCCCcHHHHHhhCcc----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccc
Confidence 999999999975432 4678888999999999999999776 999999999999999999999999999865322
Q ss_pred C--CceeeccccCccccCcccccc
Q 043136 871 E--SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~--~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. ......||+.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~ 181 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSFSR 181 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHHCC
T ss_pred cccccccccccccccChhhhcCCC
Confidence 1 122345788999999986543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-25 Score=245.25 Aligned_cols=178 Identities=24% Similarity=0.346 Sum_probs=146.3
Q ss_pred HhccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..|...+.||+|+||.||+|.+. +++.||+|++.... .......+.+|++++++++||||+++++++.+.+.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 102 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 102 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCc
Confidence 45667799999999999999654 36789999986433 23445678899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNK-----GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl 858 (902)
.++||||+++|+|.+++...+. ......++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||
T Consensus 103 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEE
Confidence 9999999999999999976432 11124578888999999999999999776 999999999999999999999
Q ss_pred eecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 859 ADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 859 ~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+|||+++....... .....||+.|+|||++.+..
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCC
Confidence 99999987643322 12345788999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=249.47 Aligned_cols=167 Identities=26% Similarity=0.387 Sum_probs=135.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~ 783 (902)
.|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+++++.++||||+++++++...+ .
T Consensus 26 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred eEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 355668899999999999976 468999999985432 23345567889999999999999999999997653 4
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+ +++|.+++... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 105 ~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 69999999 88999998752 3677888899999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+.... .....+||+.|+|||++.+
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHT
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhC
Confidence 987643 2345689999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=238.78 Aligned_cols=171 Identities=32% Similarity=0.504 Sum_probs=139.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHH----HHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRR----RRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~----~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.|...+.||+|+||.||+|++ .+++.||+|++.......... .+.+.+|++++++++||||+++++++.+.. +
T Consensus 20 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~ 97 (287)
T 4f0f_A 20 EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--R 97 (287)
T ss_dssp TEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--E
T ss_pred cceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--e
Confidence 455678999999999999976 468999999986443322111 156889999999999999999999997655 6
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC-----EEEee
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME-----ARVAD 860 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~-----~kl~D 860 (902)
+||||+++|+|.+.+.... ..+++..++.++.|++.|++|||+++ .+|+||||||+||+++.++. +||+|
T Consensus 98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 98 MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred EEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 9999999999999886543 24788889999999999999999542 23999999999999988776 99999
Q ss_pred cccceeccCCCCceeeccccCccccCcccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
||+++.... ......||+.|+|||++.+
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~ 200 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGA 200 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSC
T ss_pred CCccccccc--cccccCCCccccCchhhcc
Confidence 999985433 3455689999999999843
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=248.23 Aligned_cols=174 Identities=31% Similarity=0.423 Sum_probs=138.8
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhh--HHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKEN--IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~--~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
..|...+.||+|+||.||+|.+. +++.||+|++....... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 10 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 89 (346)
T 1ua2_A 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISL 89 (346)
T ss_dssp ---CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEE
T ss_pred cccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEE
Confidence 34667789999999999999774 58999999985432221 1123457789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++ ++.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 90 v~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 90 VFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp EEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred EEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999975 8888886532 23556677899999999999999776 99999999999999999999999999987
Q ss_pred ccCC-CCceeeccccCccccCccccc
Q 043136 867 IQSD-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... ......+||+.|+|||++.+.
T Consensus 162 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 187 (346)
T 1ua2_A 162 FGSPNRAYTHQVVTRWYRAPELLFGA 187 (346)
T ss_dssp TTSCCCCCCCSCCCCTTCCHHHHTTC
T ss_pred ccCCcccCCcccccccccCchHhhCC
Confidence 6433 234456899999999998653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=242.50 Aligned_cols=170 Identities=18% Similarity=0.206 Sum_probs=143.1
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv 787 (902)
..|...+.||+|+||.||+|.. .+++.||+|++..... .+.+.+|+++++++ +|++++++++++.+....++|
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 4566778999999999999975 5789999998853322 23467899999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC-----EEEeecc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME-----ARVADFG 862 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~-----~kl~DFG 862 (902)
|||+ +++|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 9999999976432 4788899999999999999999665 999999999999987776 9999999
Q ss_pred cceeccCCCC--------ceeeccccCccccCcccccc
Q 043136 863 VAKLIQSDES--------MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 863 la~~~~~~~~--------~~~~~Gt~~y~APE~~~~~~ 892 (902)
+++....... .....||+.|+|||++.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 194 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 194 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCC
Confidence 9987754322 34567999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=248.89 Aligned_cols=177 Identities=28% Similarity=0.437 Sum_probs=145.0
Q ss_pred HhccCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~ 782 (902)
..|...+.||+|+||.||+|.... .+.||+|++.... .....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 345667899999999999997642 2479999985433 234456788999999999 8999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccC---------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKG---------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE 853 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~ 853 (902)
..|+||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCC
Confidence 999999999999999999764321 1224678889999999999999999776 9999999999999999
Q ss_pred CCEEEeecccceeccCCCCc---eeeccccCccccCccccc
Q 043136 854 MEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 854 ~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
+.+||+|||+++........ ....||+.|+|||++.+.
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 241 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC 241 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccC
Confidence 99999999999876543322 234578899999988654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2e-25 Score=243.80 Aligned_cols=165 Identities=26% Similarity=0.387 Sum_probs=134.9
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
++.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.++ +||||+++++++.+.+..|+||||++
T Consensus 18 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 94 (316)
T 2ac3_A 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94 (316)
T ss_dssp CCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCC
Confidence 57899999999999975 46899999998544322 245678899999885 79999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC---EEEeecccceeccC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME---ARVADFGVAKLIQS 869 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~---~kl~DFGla~~~~~ 869 (902)
+|+|.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++. +||+|||+++....
T Consensus 95 ~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 95 GGSILSHIHKRR-----HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp TCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred CCcHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999997653 3677888899999999999999776 999999999999988776 99999999986532
Q ss_pred CC--------CceeeccccCccccCcccc
Q 043136 870 DE--------SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~--------~~~~~~Gt~~y~APE~~~~ 890 (902)
.. .....+||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp ---------------CCSGGGCCHHHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhc
Confidence 11 1234569999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-26 Score=244.28 Aligned_cols=173 Identities=27% Similarity=0.394 Sum_probs=145.8
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|...+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST----HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34566789999999999999775 488899999854322 3456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
||+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.++...
T Consensus 89 e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp ECCTTEEHHHHHHHCCT---TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EcCCCCcHHHHHHhccc---CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 99999999999976432 34778888999999999999999776 9999999999999999999999999998765
Q ss_pred CCCCc--eeeccccCccccCcccccc
Q 043136 869 SDESM--SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 869 ~~~~~--~~~~Gt~~y~APE~~~~~~ 892 (902)
..... ....||+.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~ 188 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNK 188 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCccccccCCccccCcCChhhhccCC
Confidence 43322 2345788999999986543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=240.01 Aligned_cols=172 Identities=26% Similarity=0.384 Sum_probs=139.1
Q ss_pred ccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe-cCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS-NRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~-~~~~~~l 786 (902)
|.+.+.||+|+||.||+|...+ ...+|+|++.... .....+.+.+|++++++++||||+++++++. .++..++
T Consensus 27 y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 27 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred hhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4566899999999999997532 2358999885432 3345567889999999999999999999864 5567899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++.... ...++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 105 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~ 177 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 177 (298)
T ss_dssp EEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred EEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccc
Confidence 999999999999997532 24677888999999999999999776 99999999999999999999999999987
Q ss_pred ccCCC-----CceeeccccCccccCcccccc
Q 043136 867 IQSDE-----SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~-----~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..... ......||+.|+|||++.+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 208 (298)
T 3f66_A 178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQK 208 (298)
T ss_dssp CSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred ccccchhccccccCCCCCccccChHHhcCCC
Confidence 64322 223456788999999986654
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=233.27 Aligned_cols=161 Identities=26% Similarity=0.253 Sum_probs=86.4
Q ss_pred chhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCC
Q 043136 167 PLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246 (902)
Q Consensus 167 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 246 (902)
|..|..+++|++|+|++|.+++..+ . +.+++|++|+|++|+++ .+|..+..+++|++|++++|+|++..|..|..++
T Consensus 48 ~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~ 124 (290)
T 1p9a_G 48 LATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124 (290)
T ss_dssp GGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCT
T ss_pred HHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCC
Confidence 3334444444444444444432211 1 34455555555555554 3444555555555555555555554455555555
Q ss_pred CCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEcc
Q 043136 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326 (902)
Q Consensus 247 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 326 (902)
+|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+.+|+.|+|+
T Consensus 125 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~ 203 (290)
T 1p9a_G 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLH 203 (290)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECC
T ss_pred CCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeC
Confidence 5555555555555544455555566666666666665444444555666666666666665 455555555666666666
Q ss_pred Ccccc
Q 043136 327 NNVLF 331 (902)
Q Consensus 327 ~N~l~ 331 (902)
+|.+.
T Consensus 204 ~Np~~ 208 (290)
T 1p9a_G 204 GNPWL 208 (290)
T ss_dssp SCCBC
T ss_pred CCCcc
Confidence 66654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=6.6e-25 Score=239.91 Aligned_cols=168 Identities=29% Similarity=0.462 Sum_probs=141.2
Q ss_pred cCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC--CeeE
Q 043136 713 MSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR--ECTM 785 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~--~~~~ 785 (902)
...+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++.+. ...+
T Consensus 34 ~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred hhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 6678999999999998854 258899999986442 234566788999999999999999999999874 6789
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 112 lv~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 999999999999998653 2678889999999999999999776 9999999999999999999999999999
Q ss_pred eccCCCC----ceeeccccCccccCccccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
....... .....||+.|+|||++.+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 212 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHC
T ss_pred cccccccccccccCCCCCceeeChHHhcCC
Confidence 8755432 2335688899999998764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.3e-25 Score=246.54 Aligned_cols=173 Identities=28% Similarity=0.416 Sum_probs=135.6
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.|...+.||+|+||.||+|++. +++ +||+|.+.... .....+.+.+|++++++++||||+++++++.+.. .+
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 4556789999999999999753 344 35777764322 2234567889999999999999999999998755 78
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+|+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCccee
Confidence 99999999999999976432 4778888999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC---ceeeccccCccccCccccccc
Q 043136 866 LIQSDES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 866 ~~~~~~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....... .....||+.|+|||++.+...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3poz_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp HHTTTCC-------CCCGGGSCHHHHHHCCC
T ss_pred EccCCcccccccCCCccccccChHHhccCCC
Confidence 7654332 233456889999999876543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-26 Score=259.48 Aligned_cols=169 Identities=28% Similarity=0.424 Sum_probs=137.0
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+...+.||+|+||.||+|.+.++..||||++..... ..+.+.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 186 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 186 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred ceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 455688999999999999988888899999864332 23568899999999999999999999876 6789999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++..... ..+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++......
T Consensus 261 ~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 261 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp TTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999975422 23678888999999999999999776 9999999999999999999999999998765332
Q ss_pred C--ceeeccccCccccCccccc
Q 043136 872 S--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~--~~~~~Gt~~y~APE~~~~~ 891 (902)
. .....+|+.|+|||++.+.
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~ 356 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYG 356 (452)
T ss_dssp --------CCGGGSCHHHHHHC
T ss_pred eecccCCcccccccCHhHHhcC
Confidence 2 2334578899999998654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.9e-25 Score=238.77 Aligned_cols=224 Identities=20% Similarity=0.218 Sum_probs=160.3
Q ss_pred CCCCEEEccCCCCcccCch---hhhccCCCcEEEccCCCCCCCCCccc--ccccccceeccccccccCCCc----hhhhc
Q 043136 102 TSLTHLNLSANAFDGPLQP---AILELTKLRTIDISHNSFNSTFPPGI--SKLRFLRIFNAYSNSFTGPLP----LEFVQ 172 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~ 172 (902)
..++.|.++++.++...-. .+..+++|++|+|++|++++..|..+ +.+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4578888888887642111 23356779999999999999888888 889999999999999987655 44567
Q ss_pred ccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCC--C--CccccCCCCCcEEEeeCcccCCCCCh----hccC
Q 043136 173 LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGS--L--PPQLGLLTQLERIEIGYNNLQGEVPV----EFAS 244 (902)
Q Consensus 173 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~ 244 (902)
+++|++|+|++|++.+..|..|+++++|++|+|++|++++. + +..++.+++|++|+|++|+++. ++. .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~ 222 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAA 222 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHH
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhc
Confidence 88888888888888877778888888888888888887642 1 2234677778888888887763 222 2456
Q ss_pred CCCCCEEEccCccCcccCCccccCC---CCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCC
Q 043136 245 LVNLKYMDISACNLSGTLPSEISNL---TKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLT 321 (902)
Q Consensus 245 l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 321 (902)
+++|++|||++|++++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|++|+|++|+|++. |. +..+++|+
T Consensus 223 l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~ 297 (310)
T 4glp_A 223 GVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVD 297 (310)
T ss_dssp TCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCS
T ss_pred CCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCcc
Confidence 6777777777777776666666655 47777777777777 4555553 5677777777777643 32 45566666
Q ss_pred EEEccCcccc
Q 043136 322 RLSLMNNVLF 331 (902)
Q Consensus 322 ~L~L~~N~l~ 331 (902)
.|+|++|+++
T Consensus 298 ~L~L~~N~l~ 307 (310)
T 4glp_A 298 NLTLDGNPFL 307 (310)
T ss_dssp CEECSSTTTS
T ss_pred EEECcCCCCC
Confidence 7777766664
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-25 Score=252.87 Aligned_cols=168 Identities=27% Similarity=0.384 Sum_probs=135.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Cee
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------ECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~~ 784 (902)
|...+.||+|+||.||+|++. +++.||||++..... ...+|++++++++||||+++++++... .+.
T Consensus 56 y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred EEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 455688999999999999774 589999999854322 134699999999999999999988432 246
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DFGl 863 (902)
++||||+++ ++.+.+..... ....+++..++.++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred Eeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchh
Confidence 799999965 77776654322 2235788888999999999999999665 9999999999999965 5689999999
Q ss_pred ceeccCCCCceeeccccCccccCccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+...........+||+.|+|||++.+.
T Consensus 204 a~~~~~~~~~~~~~~t~~y~aPE~~~~~ 231 (420)
T 1j1b_A 204 AKQLVRGEPNVSYICSRYYRAPELIFGA 231 (420)
T ss_dssp CEECCTTCCCCSCCSCTTSCCHHHHTTC
T ss_pred hhhcccCCCceeeeeCCCcCCHHHHcCC
Confidence 9987665555667899999999998653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.9e-25 Score=244.78 Aligned_cols=169 Identities=27% Similarity=0.462 Sum_probs=131.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-----CCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-----RECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-----~~~~~l 786 (902)
|...+.||+|+||.||+|+. +++.||||++...... ......|+..+..++||||+++++++.. ....|+
T Consensus 15 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l 89 (336)
T 3g2f_A 15 LKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ----NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL 89 (336)
T ss_dssp EEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred hheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh----hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence 45668999999999999976 7899999998533211 1112234444556899999999986532 336789
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC------DPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~------~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
||||+++|+|.+++.... .++..+..++.|+++||+|||+.. ..+|+||||||+||+++.++.+||+|
T Consensus 90 v~e~~~~g~L~~~l~~~~------~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 90 VMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EECCCTTCBHHHHHHHCC------BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEecCCCCcHHHHHhhcc------cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 999999999999996542 467888899999999999999660 01599999999999999999999999
Q ss_pred cccceeccCCC---------CceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSDE---------SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~~---------~~~~~~Gt~~y~APE~~~~~ 891 (902)
||+|+.+.... .....+||+.|+|||++.+.
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGA 203 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCC
Confidence 99998764321 12245799999999999763
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=244.77 Aligned_cols=172 Identities=28% Similarity=0.438 Sum_probs=140.2
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+.. +++.||+|++.... ......+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 26 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 3556689999999999999765 58999999985443 233445667899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++++++.++..... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 105 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELFPN-----GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHSTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 999988888765432 3778889999999999999999776 99999999999999999999999999987643
Q ss_pred C-CCceeeccccCccccCccccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
. .......||+.|+|||++.+.
T Consensus 177 ~~~~~~~~~~t~~y~aPE~~~~~ 199 (331)
T 4aaa_A 177 PGEVYDDEVATRWYRAPELLVGD 199 (331)
T ss_dssp -------CCCCCTTCCHHHHTTC
T ss_pred CccccCCCcCCccccCcccccCC
Confidence 2 233456799999999998764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-25 Score=238.16 Aligned_cols=178 Identities=28% Similarity=0.379 Sum_probs=149.9
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~ 784 (902)
+.+...|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+.+..
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 445567888899999999999999775 6899999998543221 22345688999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC---CCEEEeec
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE---MEARVADF 861 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~---~~~kl~DF 861 (902)
|+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKRK-----RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEecc
Confidence 99999999999999887543 3678889999999999999999776 9999999999999754 47999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++............||+.|+|||++.+.+
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 199 (287)
T 2wei_A 169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY 199 (287)
T ss_dssp TGGGTBCCCSSCSCHHHHHTTCCHHHHTTCC
T ss_pred CcceeecCCCccccccCcccccChHHhcCCC
Confidence 9998776555555667999999999987653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-25 Score=249.94 Aligned_cols=168 Identities=11% Similarity=0.023 Sum_probs=124.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHH---HHHhcCCcCeeEeEE-------eEEec
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEV---DVLGNVRHRNIVRLL-------GCCSN 780 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei---~il~~l~h~nIv~l~-------~~~~~ 780 (902)
|...+.||+|+||.||+|++. +++.||||++...........+.+.+|+ ++++. +||||++++ +++..
T Consensus 64 y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 64 LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEE
T ss_pred eeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheec
Confidence 445689999999999999764 7899999999766554555566777785 45555 799988855 44433
Q ss_pred C-----------------CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHH------HHHHHHHHHHHHHHHhCCCCC
Q 043136 781 R-----------------ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR------YKIALGVAQGICYLHHDCDPV 837 (902)
Q Consensus 781 ~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~------~~i~~qi~~~L~~LH~~~~~~ 837 (902)
. ...|+||||++ |+|.+++...... .++..+ ..++.||++||+|||+++
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~----~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV----YVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc----cchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 2 33799999998 8999999865331 222333 677799999999999776
Q ss_pred eEEcCCCCCCEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 838 IVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 838 ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+||||||+|||++.++.+||+|||+|+.... ......||+.|+|||++.+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNA 265 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccC
Confidence 99999999999999999999999999987632 2224567899999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=251.47 Aligned_cols=172 Identities=25% Similarity=0.376 Sum_probs=130.8
Q ss_pred ccCCcEeeecCceEEEEEEeC--C--CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP--G--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~--~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~l 786 (902)
+...+.||+|+||.||+|+.. + +..||+|.+.... .....+.+.+|++++++++||||+++++++.. ++..|+
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 345688999999999999653 2 2468999875322 22445678899999999999999999998754 567899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++..... ..++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccc
Confidence 9999999999999975432 3677888899999999999999776 99999999999999999999999999987
Q ss_pred ccCCCC-----ceeeccccCccccCcccccc
Q 043136 867 IQSDES-----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~-----~~~~~Gt~~y~APE~~~~~~ 892 (902)
...... .....||+.|+|||++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 272 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK 272 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCC
T ss_pred ccccccccccccCCCCCcccccChHHhcCCC
Confidence 643221 23356788999999987643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.3e-25 Score=242.16 Aligned_cols=169 Identities=32% Similarity=0.487 Sum_probs=133.0
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|...+.||+|+||.||+|+. .++.||+|++... ...+.+.+|++++++++||||+++++++.+ ..++||||+
T Consensus 10 ~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 10 IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred eeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 45668999999999999987 4788999998432 234568899999999999999999998864 489999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC-EEEeecccceeccCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME-ARVADFGVAKLIQSD 870 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~-~kl~DFGla~~~~~~ 870 (902)
++|+|.+++..... ....++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp TTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred CCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 99999999975432 223567888899999999999999743356999999999999998886 799999999865432
Q ss_pred CCceeeccccCccccCcccccc
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....||+.|+|||++.+..
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~ 179 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSN 179 (307)
T ss_dssp -------CCTTSSCHHHHTCCC
T ss_pred --cccCCCCCceEChhhhCCCC
Confidence 23457999999999997653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=232.15 Aligned_cols=204 Identities=21% Similarity=0.199 Sum_probs=161.4
Q ss_pred cccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCC
Q 043136 97 EIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176 (902)
Q Consensus 97 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 176 (902)
.++++++++++++++|+++. +|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|.+++..+. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~~-ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred cccccCCccEEECCCCCCCc-CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence 46778888888888888874 454443 6788888888888877777888888888888888888765442 677888
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
++|+|++|+++ .+|..+.++++|++|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 158 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCC
Confidence 88888888887 66777788888888888888888766677888888888888888888777777888888888888888
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++++..+..|.++++|++|+|++|+|+ .+|..+..+.+|+.|+|++|.+.
T Consensus 159 ~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~ 208 (290)
T 1p9a_G 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (290)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCcc
Confidence 888666666777888888888888888 56777777778888888888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=243.02 Aligned_cols=173 Identities=30% Similarity=0.475 Sum_probs=137.1
Q ss_pred hccCCcEeeecCceEEEEEEeCC-----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG-----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~-----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.+...+.||+|+||.||+|.... +..||+|++.... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 45 ~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 34456899999999999996542 3469999986433 2344567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSR 195 (333)
T ss_dssp EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcch
Confidence 9999999999999997542 24778889999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC----ceeeccccCccccCcccccc
Q 043136 866 LIQSDES----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 866 ~~~~~~~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
....... .....||+.|+|||++.+..
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 226 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRK 226 (333)
T ss_dssp ---------------CCCGGGSCHHHHHSCC
T ss_pred hhccccccccccCCCCccccccCchhcccCC
Confidence 7643321 12234678999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-25 Score=247.71 Aligned_cols=173 Identities=24% Similarity=0.321 Sum_probs=135.3
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccch--------hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK--------ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN- 780 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~--------~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~- 780 (902)
..|...+.||+|+||.||+|...+++.||||++..... ......+.+.+|++++++++||||+++++++..
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 101 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHF 101 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEEC
T ss_pred cceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEec
Confidence 45667799999999999999888899999999854322 223345678999999999999999999999843
Q ss_pred ----CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCE
Q 043136 781 ----RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEA 856 (902)
Q Consensus 781 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~ 856 (902)
....|+||||++ |++.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 102 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~ 173 (362)
T 3pg1_A 102 EEPAMHKLYLVTELMR-TDLAQVIHDQR----IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDI 173 (362)
T ss_dssp CTTTCCEEEEEEECCS-EEHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCE
T ss_pred cCCCcceEEEEEccCC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCE
Confidence 346899999996 68888887432 24788889999999999999999776 9999999999999999999
Q ss_pred EEeecccceeccCCCCceeeccccCccccCcccc
Q 043136 857 RVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 857 kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
||+|||+++............||+.|+|||++.+
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTT
T ss_pred EEEecCcccccccccccceecccceecCcHHhcC
Confidence 9999999987665555566789999999999876
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-25 Score=228.33 Aligned_cols=203 Identities=20% Similarity=0.206 Sum_probs=121.2
Q ss_pred ccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCC-CCCCCCcccccccccceecccc-ccccCCCchhh
Q 043136 93 PIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS-FNSTFPPGISKLRFLRIFNAYS-NSFTGPLPLEF 170 (902)
Q Consensus 93 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~ 170 (902)
.+|. +. ++|++|+|++|++++..+..|..+++|++|+|++|+ +++..+..|+++++|++|++++ |++++..+..|
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f 101 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDAL 101 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSE
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHh
Confidence 4555 33 378888888888887777778888888888888886 6655444555555555555555 55554444444
Q ss_pred hcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc---EEEeeCc-ccCCCCChhccCCC
Q 043136 171 VQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE---RIEIGYN-NLQGEVPVEFASLV 246 (902)
Q Consensus 171 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~l~ 246 (902)
.++++|++|+|++|+ +++ +|. |..+++|+ +|++++| ++++..+..|..++
T Consensus 102 ~~l~~L~~L~l~~n~------------------------l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~ 155 (239)
T 2xwt_C 102 KELPLLKFLGIFNTG------------------------LKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC 155 (239)
T ss_dssp ECCTTCCEEEEEEEC------------------------CCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTB
T ss_pred CCCCCCCEEeCCCCC------------------------Ccc-ccc-cccccccccccEEECCCCcchhhcCcccccchh
Confidence 444445555554444 443 333 44444444 5555555 55555555566666
Q ss_pred CCC-EEEccCccCcccCCccccCCCCccEEecCCCc-cceecCCCCCCc-CcCcEEecccCCCccccCccccccCCCCEE
Q 043136 247 NLK-YMDISACNLSGTLPSEISNLTKLEMLLLFKNH-FTGEIPVSYGNL-QALQVLDLSDNQLSGPIPASLASLKGLTRL 323 (902)
Q Consensus 247 ~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 323 (902)
+|+ +|++++|+++...+..|.. ++|++|+|++|+ +++..+..|.++ ++|++|++++|++++. |.. .+++|+.|
T Consensus 156 ~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L 231 (239)
T 2xwt_C 156 NETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKEL 231 (239)
T ss_dssp SSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEE
T ss_pred cceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCcee
Confidence 666 6666666666322233333 566666666663 665555566666 6677777777776643 332 45566666
Q ss_pred EccCc
Q 043136 324 SLMNN 328 (902)
Q Consensus 324 ~L~~N 328 (902)
+++++
T Consensus 232 ~l~~~ 236 (239)
T 2xwt_C 232 IARNT 236 (239)
T ss_dssp ECTTC
T ss_pred eccCc
Confidence 66654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=247.29 Aligned_cols=172 Identities=23% Similarity=0.361 Sum_probs=140.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------C
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--------R 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--------~ 781 (902)
.|...+.||+|+||.||+|+. .+++.||+|++...... ......+.+|++++++++||||+++++++.. .
T Consensus 18 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCS-SSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred ceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEeccccc-ccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 466678999999999999977 56899999998544322 1223456789999999999999999999876 3
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
+..|+||||++ |++.+.+..... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVLV----KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999996 488777764322 3778889999999999999999776 999999999999999999999999
Q ss_pred ccceeccC-----CCCceeeccccCccccCccccc
Q 043136 862 GVAKLIQS-----DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~-----~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+|+.+.. .......+||+.|+|||++.+.
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 203 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 203 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCC
Confidence 99987642 2223446789999999998663
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.7e-25 Score=238.66 Aligned_cols=172 Identities=25% Similarity=0.354 Sum_probs=146.2
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|.. .+++.||+|++...... ...+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 23 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 355678899999999999975 46889999998544322 234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 101 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 171 (303)
T 3a7i_A 101 YLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171 (303)
T ss_dssp CCTTEEHHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred eCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCc
Confidence 99999999998642 3678889999999999999999776 99999999999999999999999999987654
Q ss_pred CC-CceeeccccCccccCccccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.. ......||+.|+|||++.+...
T Consensus 172 ~~~~~~~~~~~~~y~aPE~~~~~~~ 196 (303)
T 3a7i_A 172 TQIKRNTFVGTPFWMAPEVIKQSAY 196 (303)
T ss_dssp TBCCBCCCCSCGGGCCHHHHTTCCB
T ss_pred cccccCccCCCcCccCHHHHhcCCC
Confidence 32 2345679999999999976543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=242.88 Aligned_cols=176 Identities=28% Similarity=0.417 Sum_probs=140.0
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcE--EEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEI--IAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~--vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~l 786 (902)
.|...+.||+|+||.||+|+.. ++.. +|+|++.... .....+.+.+|+++++++ +||||+++++++.+.+..|+
T Consensus 26 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 26 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 3456789999999999999654 4554 4889875322 223456688999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC
Q 043136 787 LYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME 855 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~ 855 (902)
||||+++|+|.+++..... .....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCe
Confidence 9999999999999976431 12235788899999999999999999776 999999999999999999
Q ss_pred EEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 856 ARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 856 ~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+||+|||+++............+|+.|+|||++.+.
T Consensus 181 ~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 216 (327)
T 1fvr_A 181 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS 216 (327)
T ss_dssp EEECCTTCEESSCEECCC----CCTTTCCHHHHHHC
T ss_pred EEEcccCcCccccccccccCCCCCccccChhhhccc
Confidence 999999999855433333445678999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=237.54 Aligned_cols=170 Identities=27% Similarity=0.444 Sum_probs=141.8
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.|...+.||+|+||.||+|...+++.||+|++..... ..+.+.+|++++++++||||+++++++.. +..++||||
T Consensus 14 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred hhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 4566789999999999999988888999999854332 23567899999999999999999999864 568999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.++.....
T Consensus 89 ~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 89 MENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999865421 23678888999999999999999776 999999999999999999999999999877543
Q ss_pred CC--ceeeccccCccccCccccc
Q 043136 871 ES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
.. .....||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~y~aPE~~~~~ 185 (279)
T 1qpc_A 163 EYTAREGAKFPIKWTAPEAINYG 185 (279)
T ss_dssp CEECCTTCCCCTTTSCHHHHHHC
T ss_pred ccccccCCCCccCccChhhhccC
Confidence 22 1234567899999998654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=251.83 Aligned_cols=169 Identities=25% Similarity=0.394 Sum_probs=125.6
Q ss_pred CCcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe--cCCeeEEEE
Q 043136 714 SDKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS--NRECTMLLY 788 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~--~~~~~~lv~ 788 (902)
..++||+|+||.||+|+.. +++.||+|++...... +.+.+|++++++++||||+++++++. .....|+||
T Consensus 25 ~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp SSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred cCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 3678999999999999864 5788999998543221 34678999999999999999999995 467899999
Q ss_pred EccCCCCHHHHHHhhcc----CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE----cCCCCEEEee
Q 043136 789 EYMPNGNLDDLLHAKNK----GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL----DGEMEARVAD 860 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl----~~~~~~kl~D 860 (902)
||++ |+|.+++..... .....+++..++.++.||+.||+|||+.+ |+||||||+||++ +.++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9995 588888764332 12224788889999999999999999776 9999999999999 6778999999
Q ss_pred cccceeccCC----CCceeeccccCccccCccccc
Q 043136 861 FGVAKLIQSD----ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 861 FGla~~~~~~----~~~~~~~Gt~~y~APE~~~~~ 891 (902)
||+|+..... ......+||+.|+|||++.+.
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 210 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGA 210 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTTC
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcCC
Confidence 9999876432 223457899999999999763
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-25 Score=236.44 Aligned_cols=168 Identities=28% Similarity=0.395 Sum_probs=139.7
Q ss_pred CCcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 714 SDKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
.++.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++. .+..++||||
T Consensus 14 ~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~ 90 (287)
T 1u59_A 14 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEM 90 (287)
T ss_dssp EEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEEC
T ss_pred hhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcEEEEEe
Confidence 3458999999999999753 57889999986542 2345667889999999999999999999994 5568999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 91 AGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp CTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred CCCCCHHHHHHhCC----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 99999999986432 24778889999999999999999776 999999999999999999999999999877543
Q ss_pred CCc----eeeccccCccccCccccc
Q 043136 871 ESM----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 871 ~~~----~~~~Gt~~y~APE~~~~~ 891 (902)
... ....||+.|+|||++.+.
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~ 188 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFR 188 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHC
T ss_pred cceeeccccccccccccCHHHhccC
Confidence 321 223568899999998653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=237.54 Aligned_cols=173 Identities=26% Similarity=0.349 Sum_probs=141.5
Q ss_pred ccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee-EE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT-ML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~-~l 786 (902)
+...+.||+|+||.||+|.+.+ +..||+|++.... .....+.+.+|++++++++||||+++++++.+.+.. ++
T Consensus 23 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 23 THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 3445889999999999996532 3379999985432 234566788999999999999999999999876654 99
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+.+|+|.+++.... ...++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 999999999999997532 24677888999999999999999776 99999999999999999999999999986
Q ss_pred ccCC-----CCceeeccccCccccCccccccc
Q 043136 867 IQSD-----ESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 867 ~~~~-----~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.... .......||+.|+|||++.+...
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 205 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRF 205 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCC
Confidence 5332 22234568899999999976543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-26 Score=255.26 Aligned_cols=261 Identities=17% Similarity=0.154 Sum_probs=153.8
Q ss_pred EEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCC----hhccCCC-CCCEEEccCccCcccCCccccCC-----CC
Q 043136 202 FLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP----VEFASLV-NLKYMDISACNLSGTLPSEISNL-----TK 271 (902)
Q Consensus 202 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p----~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l-----~~ 271 (902)
+++|+.|.+++.+|..+...++|++|+|++|+|++..+ ..|..++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 45677777777777666666667777777777776655 5666666 67777777777776655555554 66
Q ss_pred ccEEecCCCccceecCCCCCC----c-CcCcEEecccCCCccccCccccc-----cCCCCEEEccCccccccCChhh---
Q 043136 272 LEMLLLFKNHFTGEIPVSYGN----L-QALQVLDLSDNQLSGPIPASLAS-----LKGLTRLSLMNNVLFGEIPQDI--- 338 (902)
Q Consensus 272 L~~L~L~~N~l~~~~p~~~~~----l-~~L~~L~Ls~N~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~~p~~~--- 338 (902)
|++|+|++|++++..+..+.. + ++|++|+|++|++++..+..+.. .++|++|+|++|.+++..+..+
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 777777777766544443322 2 56666666666666554444332 2466666666666654333322
Q ss_pred -hhcc-ccceEEecCceeccccCcccc----CC-CceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccc
Q 043136 339 -ELLA-DLDTLLLWNNHLTGVLPQKLG----SN-GKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411 (902)
Q Consensus 339 -~~l~-~L~~L~L~~N~l~~~~~~~~~----~~-~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~ 411 (902)
..++ +|++|+|++|++++..+..+. .+ ++|+.|||++|++++... ..++..+.
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~--------------------~~l~~~l~ 221 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY--------------------AELAYIFS 221 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH--------------------HHHHHHHH
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH--------------------HHHHHHHh
Confidence 2232 555555555555544443222 12 344444444444442100 02444454
Q ss_pred c-cCCCcEEEccCCccCCCCC----cccCCCCCCcEEEccCcccCCC-------CCCcCcccCcCceecccccccCCCcC
Q 043136 412 N-CSSLSRLRIQDNQLNGSIP----QGFGLLPNLTFMDMSRNSLSGE-------IPRDLGNAQKLEYLNISENSFQTSLP 479 (902)
Q Consensus 412 ~-l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~-------~p~~~~~l~~L~~L~Ls~N~l~~~~p 479 (902)
. .++|++|+|++|+|++..+ ..+..+++|++|+|++|.+.+. ++..+..+++|+.||+++|.+....+
T Consensus 222 ~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 222 SIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred cCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 4 3478888888888875443 3456677788888888875533 23456667777777777777765544
Q ss_pred hhh
Q 043136 480 SNI 482 (902)
Q Consensus 480 ~~~ 482 (902)
..+
T Consensus 302 ~~~ 304 (362)
T 3goz_A 302 IPI 304 (362)
T ss_dssp HHH
T ss_pred HHH
Confidence 443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=239.62 Aligned_cols=163 Identities=23% Similarity=0.341 Sum_probs=140.9
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEec--CCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSN--RECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~--~~~~~l 786 (902)
.|...+.||+|+||.||+|.. .+++.||+|++.... .+.+.+|++++++++ ||||+++++++.+ ....++
T Consensus 37 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred ceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 456678999999999999965 568999999985332 245778999999997 9999999999987 567899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~ 865 (902)
||||+++++|.+++.. ++...+..++.|++.||+|||+++ |+||||||+||+++.++ .+||+|||+|+
T Consensus 111 v~e~~~~~~l~~~~~~--------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQT--------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGGG--------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHHh--------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 9999999999998742 567788899999999999999776 99999999999999777 89999999999
Q ss_pred eccCCCCceeeccccCccccCcccc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
............||+.|+|||++.+
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 180 FYHPGQEYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTT
T ss_pred EcCCCCccccccccccccChhhhcC
Confidence 8766666666789999999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.7e-25 Score=236.96 Aligned_cols=169 Identities=28% Similarity=0.435 Sum_probs=140.1
Q ss_pred CcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 715 DKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
...||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp BCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred cEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 35899999999999976 4688999999854432 3345688999999999999999999999999999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-CCCEEEeecccceeccCCC-
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-EMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-~~~~kl~DFGla~~~~~~~- 871 (902)
++|.+++..... ....++..+..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++......
T Consensus 104 ~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 104 GSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999976432 234567788889999999999999776 999999999999987 8999999999998764322
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
......||+.|+|||++.+.
T Consensus 179 ~~~~~~~~~~y~aPE~~~~~ 198 (295)
T 2clq_A 179 CTETFTGTLQYMAPEIIDKG 198 (295)
T ss_dssp --CCCCCCGGGCCHHHHHHG
T ss_pred cccccCCCccccChhhhcCC
Confidence 23456799999999998654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-25 Score=239.12 Aligned_cols=179 Identities=27% Similarity=0.387 Sum_probs=135.4
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC---
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--- 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--- 782 (902)
..|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 112 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQG 112 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-----
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccC
Confidence 34567789999999999999653 355899999854322 2344567889999999999999999999997654
Q ss_pred --eeEEEEEccCCCCHHHHHHhhcc-CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEe
Q 043136 783 --CTMLLYEYMPNGNLDDLLHAKNK-GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA 859 (902)
Q Consensus 783 --~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 859 (902)
..++||||+++|+|.+++..... .....+++..++.++.|+++||+|||+++ |+||||||+||+++.++.+||+
T Consensus 113 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 113 IPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp --CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEEC
T ss_pred CcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEe
Confidence 35999999999999999864332 22345788999999999999999999665 9999999999999999999999
Q ss_pred ecccceeccCCC---CceeeccccCccccCcccccc
Q 043136 860 DFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 860 DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|||+++...... ......|++.|+|||++.+..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCC
Confidence 999998764332 123356788999999987653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-25 Score=245.44 Aligned_cols=172 Identities=30% Similarity=0.429 Sum_probs=134.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcE----EEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEI----IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
|...+.||+|+||.||+|.+. +++. ||+|.+..... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 15 y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 15 LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp EEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred ceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 455689999999999999764 3443 77777643221 112234667999999999999999999986 456889
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|+|.+++..... .+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.
T Consensus 92 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHRG----ALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEECCTTCBSHHHHHSSGG----GSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEeCCCCCHHHHHHHccc----cCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 9999999999999875422 4666778899999999999999776 99999999999999999999999999987
Q ss_pred ccCCC---CceeeccccCccccCccccccc
Q 043136 867 IQSDE---SMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 867 ~~~~~---~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..... ......||+.|+|||++.+...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 194 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKY 194 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCC
T ss_pred cCcccccccccCCCCcccccChHHhccCCC
Confidence 64432 2344668889999999975543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=237.86 Aligned_cols=173 Identities=27% Similarity=0.378 Sum_probs=141.5
Q ss_pred HHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
....|...+.||+|+||.||+|... +++.||+|++.... ..+.+.+|++++++++||||+++++++...+..|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 3445667789999999999999765 58999999985432 13457789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.++.
T Consensus 102 v~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNK----TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHHTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999874322 4778889999999999999999776 99999999999999999999999999987
Q ss_pred ccCCC-CceeeccccCccccCcccccc
Q 043136 867 IQSDE-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..... ......||+.|+|||++.+..
T Consensus 175 ~~~~~~~~~~~~~~~~y~aPE~~~~~~ 201 (314)
T 3com_A 175 LTDTMAKRNTVIGTPFWMAPEVIQEIG 201 (314)
T ss_dssp CBTTBSCBCCCCSCGGGCCHHHHSSSC
T ss_pred hhhhccccCccCCCCCccChhhcCCCC
Confidence 65432 234567999999999987653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=236.54 Aligned_cols=174 Identities=24% Similarity=0.315 Sum_probs=140.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhh-HHHHHHHHHHHHHHhcCCcCeeEeEEeEEe--cCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKEN-IRRRRGVLAEVDVLGNVRHRNIVRLLGCCS--NRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~-~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~--~~~~~~l 786 (902)
.|.+.+.||+|+||.||+|... +++.||+|++....... ....+.+.+|++++++++||||+++++++. +.+..|+
T Consensus 6 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (305)
T 2wtk_C 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYM 85 (305)
T ss_dssp CBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEE
T ss_pred ceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEE
Confidence 4677899999999999999764 68899999985432211 233567889999999999999999999984 4557899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||++++ +.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||.++.
T Consensus 86 v~e~~~~~-l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 86 VMEYCVCG-MQEMLDSVPE---KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEECCSEE-HHHHHHHSTT---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EehhccCC-HHHHHHhCcc---cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 99999776 7777765322 24778889999999999999999776 99999999999999999999999999987
Q ss_pred ccCC---CCceeeccccCccccCccccc
Q 043136 867 IQSD---ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~---~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... .......||+.|+|||++.+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCC
T ss_pred cCccccccccccCCCCCCCcChhhccCc
Confidence 6432 222345799999999998763
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.4e-25 Score=239.67 Aligned_cols=177 Identities=28% Similarity=0.369 Sum_probs=144.4
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~ 782 (902)
..|.+.+.||+|+||.||+|++ .+++.||||++.... .....+.+.+|++++.++ +||||+++++++...+
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 104 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 104 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence 4566779999999999999964 356899999986443 234456788999999999 7999999999987654
Q ss_pred -eeEEEEEccCCCCHHHHHHhhccCC-----------CcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 783 -CTMLLYEYMPNGNLDDLLHAKNKGE-----------NLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 783 -~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
..++||||+++|+|.+++....... ...+++..++.++.|+++||+|||+.+ |+||||||+||++
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~ 181 (316)
T 2xir_A 105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 181 (316)
T ss_dssp SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEE
Confidence 5899999999999999997643210 122778889999999999999999776 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCCc---eeeccccCccccCccccc
Q 043136 851 DGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~ 891 (902)
+.++.+||+|||+++........ ....||+.|+|||++.+.
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 225 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR 225 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc
Confidence 99999999999999876543322 235688999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-25 Score=246.87 Aligned_cols=173 Identities=22% Similarity=0.339 Sum_probs=145.1
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhH--------------HHHHHHHHHHHHHhcCCcCeeEeEEe
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENI--------------RRRRGVLAEVDVLGNVRHRNIVRLLG 776 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~--------------~~~~~~~~Ei~il~~l~h~nIv~l~~ 776 (902)
.|...+.||+|+||.||+|+. +++.||+|++........ ...+.+.+|++++++++||||+++++
T Consensus 32 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 110 (348)
T 2pml_X 32 DYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG 110 (348)
T ss_dssp TEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred ceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 455678999999999999988 999999999853321110 01166889999999999999999999
Q ss_pred EEecCCeeEEEEEccCCCCHHHH------HHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-CCCCCeEEcCCCCCCEE
Q 043136 777 CCSNRECTMLLYEYMPNGNLDDL------LHAKNKGENLVADWVTRYKIALGVAQGICYLHH-DCDPVIVHRDLKPSNIL 849 (902)
Q Consensus 777 ~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~-~~~~~ivHrDlKp~NIL 849 (902)
++.+.+..|+||||+++|+|.++ +... ....+++..++.++.|++.||+|||+ .+ |+||||||+||+
T Consensus 111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp EEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 99999999999999999999988 4321 13457889999999999999999997 65 999999999999
Q ss_pred EcCCCCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 850 LDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 850 l~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
++.++.+||+|||.++..... ......||+.|+|||++.+.
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSC
T ss_pred EcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCC
Confidence 999999999999999876443 33456799999999999765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=241.01 Aligned_cols=171 Identities=28% Similarity=0.456 Sum_probs=141.9
Q ss_pred hccCCcEeeecCceEEEEEEe-----CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC--e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-----PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE--C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-----~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~--~ 783 (902)
.|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+.+|++++++++||||+++++++...+ .
T Consensus 42 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 456678999999999999973 468899999986432 234567889999999999999999999987654 7
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.++||||+++++|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~ 191 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE----RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGL 191 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT----SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTT
T ss_pred eEEEEECCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcc
Confidence 8999999999999999976432 4778888999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCc----eeeccccCccccCccccc
Q 043136 864 AKLIQSDESM----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~~----~~~~Gt~~y~APE~~~~~ 891 (902)
++........ ....|+..|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 223 (326)
T 2w1i_A 192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223 (326)
T ss_dssp CEECCSSCSEEECSSCCSCCGGGCCHHHHHHC
T ss_pred hhhccccccccccccCCCCceeEECchhhcCC
Confidence 9887544321 224577889999998654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-25 Score=263.80 Aligned_cols=168 Identities=30% Similarity=0.415 Sum_probs=135.5
Q ss_pred CcEeeecCceEEEEEEe---CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 715 DKILGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
++.||+|+||.||+|.+ ..++.||||++..... .....+++.+|++++++++|||||++++++.. +..++||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEcc
Confidence 45899999999999954 2468899999854322 22335678899999999999999999999975 4588999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++.... .+++..+..|+.||+.||+|||+++ ||||||||+||+++.++.+||+|||+|+.+....
T Consensus 452 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 452 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 523 (635)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred CCCCHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence 9999999997543 3678889999999999999999776 9999999999999999999999999998765432
Q ss_pred C----ceeeccccCccccCcccccc
Q 043136 872 S----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~----~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .....||+.|+|||++.+..
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~~~ 548 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINYYK 548 (635)
T ss_dssp -----------CGGGSCHHHHHHCC
T ss_pred cccccccCCCCceeeeChhhhcCCC
Confidence 2 23345788999999996643
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-25 Score=236.67 Aligned_cols=179 Identities=25% Similarity=0.383 Sum_probs=143.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe--cCCeeEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS--NRECTMLL 787 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~--~~~~~~lv 787 (902)
.|...+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|++++++++||||+++++++. .....|+|
T Consensus 7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred heeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 3556789999999999999764 689999999854332 2345677899999999999999999999874 45689999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--DPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
|||+++++|.+++..... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||.++
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999976543 2234788899999999999999999754 1339999999999999999999999999998
Q ss_pred eccCCCC-ceeeccccCccccCccccc
Q 043136 866 LIQSDES-MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~-~~~~~Gt~~y~APE~~~~~ 891 (902)
....... .....||+.|+|||++.+.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~ 191 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRM 191 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC
T ss_pred eeccccccccccCCCccccChHHhccC
Confidence 7643322 2345799999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-25 Score=234.33 Aligned_cols=172 Identities=25% Similarity=0.402 Sum_probs=138.7
Q ss_pred hccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.|...+.||+|+||.||+|.... +..||+|++.... .....+.+.+|++++++++||||+++++++.+ +..|+
T Consensus 13 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 45567899999999999997532 3469999986442 23445678899999999999999999999865 45789
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 90 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT----TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 9999999999999976432 3678888999999999999999776 99999999999999999999999999987
Q ss_pred ccCCCC--ceeeccccCccccCcccccc
Q 043136 867 IQSDES--MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 867 ~~~~~~--~~~~~Gt~~y~APE~~~~~~ 892 (902)
...... .....||+.|+|||++.+..
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 190 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRR 190 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCC
T ss_pred cccccccccccCCCCcceeCchhhccCC
Confidence 644322 23346788999999986543
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=4.5e-25 Score=244.17 Aligned_cols=174 Identities=16% Similarity=0.174 Sum_probs=136.6
Q ss_pred HhccCCcEeeecCceEEEEEEeC----CCcEEEEEEecccchhhHH--------HHHHHHHHHHHHhcCCcCeeEeEEeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP----GGEIIAVKKLWGKHKENIR--------RRRGVLAEVDVLGNVRHRNIVRLLGC 777 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~----~~~~vavK~i~~~~~~~~~--------~~~~~~~Ei~il~~l~h~nIv~l~~~ 777 (902)
..|.+.+.||+|+||.||+|... ++..||+|++......... ..+.+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 45667789999999999999775 5788999998654322111 12346688999999999999999999
Q ss_pred Eec----CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC
Q 043136 778 CSN----RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE 853 (902)
Q Consensus 778 ~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~ 853 (902)
+.. ....|+||||+ +++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 987 67899999999 999999987543 4788899999999999999999776 9999999999999888
Q ss_pred C--CEEEeecccceeccCCC--------CceeeccccCccccCcccccc
Q 043136 854 M--EARVADFGVAKLIQSDE--------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 854 ~--~~kl~DFGla~~~~~~~--------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+ .+||+|||+|+.+.... ......||+.|+|||++.+..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 236 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA 236 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC
Confidence 7 99999999998764321 114457999999999998753
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=234.10 Aligned_cols=170 Identities=28% Similarity=0.400 Sum_probs=137.2
Q ss_pred ccCCc-EeeecCceEEEEEEe---CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDK-ILGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~-~iG~G~~g~Vy~~~~---~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|.+.+ .||+|+||.||+|.+ .+++.||||++..... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus 18 y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv 95 (291)
T 1xbb_A 18 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLV 95 (291)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEE
T ss_pred hhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEE
Confidence 33444 899999999999954 2468899999854422 223456788999999999999999999999 55678999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 96 MEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EECCTTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEeCCCCCHHHHHHhCc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999997643 3677888999999999999999776 999999999999999999999999999877
Q ss_pred cCCCCc----eeeccccCccccCccccc
Q 043136 868 QSDESM----SVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 868 ~~~~~~----~~~~Gt~~y~APE~~~~~ 891 (902)
...... ....||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 195 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYY 195 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred ccCCCcccccccCCCCceeeChHHhccC
Confidence 544332 223467889999998654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-25 Score=261.81 Aligned_cols=169 Identities=28% Similarity=0.430 Sum_probs=141.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||.||+|++.++..||||++..... ..+.+.+|++++++++||||+++++++.+ +..|+||||+
T Consensus 269 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~ 343 (535)
T 2h8h_A 269 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343 (535)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehh
Confidence 456689999999999999988888899999864332 23568899999999999999999999876 6789999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.++++.... ..+++..++.|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+++......
T Consensus 344 ~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 344 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp TTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred cCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence 99999999975422 13678888999999999999999776 9999999999999999999999999998764321
Q ss_pred --CceeeccccCccccCccccc
Q 043136 872 --SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 --~~~~~~Gt~~y~APE~~~~~ 891 (902)
......++..|+|||++.+.
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~ 439 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYG 439 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHC
T ss_pred eecccCCcCcccccCHHHhccC
Confidence 11234567899999998654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=246.33 Aligned_cols=171 Identities=26% Similarity=0.281 Sum_probs=141.0
Q ss_pred HHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC------CcCeeEeEEeEEecC
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV------RHRNIVRLLGCCSNR 781 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l------~h~nIv~l~~~~~~~ 781 (902)
..+|.+.+.||+|+||.||+|... +++.||||++.... ...+.+.+|+++++.+ .|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 345777899999999999999664 58999999985432 2344566777777665 578999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC--EEEe
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME--ARVA 859 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~--~kl~ 859 (902)
+..++||||+. ++|.+++..... ..+++..+..++.||++||+|||+++ ||||||||+|||++.++. +||+
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~ 244 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVI 244 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEEC
T ss_pred CeEEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEe
Confidence 99999999995 699999876532 23778888999999999999999776 999999999999999987 9999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|||+|+.... .....+||+.|+|||++.+..
T Consensus 245 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~ 275 (429)
T 3kvw_A 245 DFGSSCYEHQ--RVYTYIQSRFYRAPEVILGAR 275 (429)
T ss_dssp CCTTCEETTC--CCCSSCSCGGGCCHHHHHTBC
T ss_pred ecccceecCC--cccccCCCCCccChHHHhCCC
Confidence 9999976533 234568999999999997654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=241.88 Aligned_cols=169 Identities=24% Similarity=0.342 Sum_probs=141.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
.|...+.||+|+||.||+|... +++.||+|++.... .....+.+.+|++++++++||||+++++++... ...
T Consensus 28 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4667789999999999999764 68899999985432 234456788999999999999999999999654 368
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcce
Confidence 99999996 5999988653 3677888999999999999999776 999999999999999999999999999
Q ss_pred eeccCCCC----ceeeccccCccccCccccc
Q 043136 865 KLIQSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
+....... ....+||+.|+|||++.+.
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTB
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCC
Confidence 87643221 2446899999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-24 Score=236.49 Aligned_cols=172 Identities=26% Similarity=0.343 Sum_probs=123.2
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHH-HHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVD-VLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~-il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|...+.||+|+||.||+|... +++.||||++..... .....++.+|+. +++.++||||+++++++...+..++|||
T Consensus 24 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp EEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 455688999999999999774 689999999864432 223344556666 6777899999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|++ |++.+++..........+++..+..++.|++.|++|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 997 4888887653332334578888899999999999999976 6 9999999999999999999999999998776
Q ss_pred CCCCceeeccccCccccCccc
Q 043136 869 SDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~ 889 (902)
.........||+.|+|||++.
T Consensus 178 ~~~~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 178 DSIAKTRDAGCRPYMAPERID 198 (327)
T ss_dssp ---------------------
T ss_pred cccccccCCCCccccCceeec
Confidence 554445568999999999984
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.7e-25 Score=261.14 Aligned_cols=167 Identities=27% Similarity=0.379 Sum_probs=134.6
Q ss_pred cEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
..||+|+||.||+|.+. ++..||||++...... ...+.+.+|++++++++|||||++++++.. +..|+||||++
T Consensus 342 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~ 418 (613)
T 2ozo_A 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAG 418 (613)
T ss_dssp EEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSS--TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred cEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCC
Confidence 47999999999999653 4667999998643222 235668899999999999999999999976 56899999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|+|.+++.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 419 ~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 419 GGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp TCBHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred CCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999986532 24788889999999999999999776 99999999999999999999999999987643322
Q ss_pred ----ceeeccccCccccCcccccc
Q 043136 873 ----MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 873 ----~~~~~Gt~~y~APE~~~~~~ 892 (902)
.....+|+.|+|||++.+..
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~ 515 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRK 515 (613)
T ss_dssp ----------CCTTSCHHHHHHCC
T ss_pred eeeeccCCCCccceeCHhhhcCCC
Confidence 12234568999999986543
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-26 Score=258.30 Aligned_cols=242 Identities=19% Similarity=0.189 Sum_probs=153.6
Q ss_pred ccCccccCCCCCCEEEccCCCCcccCchh----hhccCCCcEEEccCC---CCCCCCCccc-------ccccccceeccc
Q 043136 93 PIPPEIRYLTSLTHLNLSANAFDGPLQPA----ILELTKLRTIDISHN---SFNSTFPPGI-------SKLRFLRIFNAY 158 (902)
Q Consensus 93 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~----~~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~L~ 158 (902)
.++..+..+++|++|+|++|.+++..+.. +..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 35566777788888888888887654433 557788888888875 4445555544 566777777777
Q ss_pred cccccC----CCchhhhcccCCcEEeccCccCcCCCCccc----CCC---------CCCCEEEccCCCcc-CCCC---cc
Q 043136 159 SNSFTG----PLPLEFVQLNSLQQLNLGGSYFDGEIPSDY----RNL---------SSLRFLDLAGNSLT-GSLP---PQ 217 (902)
Q Consensus 159 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~l~-~~~p---~~ 217 (902)
+|.+++ .+|..+..+++|++|+|++|.+++..+..+ ..+ ++|++|+|++|+++ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777766 356666777777777777777653333222 222 67777777777766 3333 34
Q ss_pred ccCCCCCcEEEeeCcccC--C---CCChhccCCCCCCEEEccCccCc----ccCCccccCCCCccEEecCCCcccee---
Q 043136 218 LGLLTQLERIEIGYNNLQ--G---EVPVEFASLVNLKYMDISACNLS----GTLPSEISNLTKLEMLLLFKNHFTGE--- 285 (902)
Q Consensus 218 ~~~l~~L~~L~L~~N~l~--~---~~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~L~~N~l~~~--- 285 (902)
+..+++|++|++++|+|+ | ..|..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|++++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 556666777777777665 2 23335666667777777777764 45566666666777777777766654
Q ss_pred -cCCCC--CCcCcCcEEecccCCCcc----ccCccc-cccCCCCEEEccCccccccC
Q 043136 286 -IPVSY--GNLQALQVLDLSDNQLSG----PIPASL-ASLKGLTRLSLMNNVLFGEI 334 (902)
Q Consensus 286 -~p~~~--~~l~~L~~L~Ls~N~l~~----~~p~~l-~~l~~L~~L~L~~N~l~~~~ 334 (902)
++..+ +.+++|++|+|++|.+++ .+|..+ .++++|++|++++|.+++..
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 33444 336667777777777665 355555 44666777777777666555
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=9e-25 Score=240.65 Aligned_cols=173 Identities=25% Similarity=0.338 Sum_probs=126.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEe--------c
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCS--------N 780 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~--------~ 780 (902)
.|...+.||+|+||.||+|++ .+++.||+|++.... ....+.+.+|+.+++++. ||||+++++++. .
T Consensus 29 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred eEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 456778999999999999976 468999999985432 334566889999999995 999999999983 3
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
....++||||+. |+|.+++...... ..+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESR--GPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTT--CSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 445899999995 7999998764322 24788899999999999999999542 2399999999999999999999999
Q ss_pred cccceeccCCCCc-------------eeeccccCccccCcccc
Q 043136 861 FGVAKLIQSDESM-------------SVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 861 FGla~~~~~~~~~-------------~~~~Gt~~y~APE~~~~ 890 (902)
||+++........ ....||+.|+|||++..
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDL 224 (337)
T ss_dssp CTTCBCCSSCC-------------------------------C
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhc
Confidence 9999876543221 14569999999999843
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=234.78 Aligned_cols=173 Identities=26% Similarity=0.340 Sum_probs=132.5
Q ss_pred hccCCcEeeecCceEEEEEEeC--CC--cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP--GG--EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~--~~--~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.|...+.||+|+||.||+|++. ++ ..||+|++...........+.+.+|++++++++||||+++++++.... .++
T Consensus 19 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~ 97 (291)
T 1u46_A 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKM 97 (291)
T ss_dssp GEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEE
T ss_pred HeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-cee
Confidence 4566789999999999999752 23 368999986543333345677889999999999999999999998765 899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++++|.+++..... .+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 98 v~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 98 VTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eEecccCCCHHHHHHhccC----CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 9999999999999976432 4678888999999999999999776 99999999999999999999999999988
Q ss_pred ccCCCC----ceeeccccCccccCccccc
Q 043136 867 IQSDES----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~----~~~~~Gt~~y~APE~~~~~ 891 (902)
...... .....||+.|+|||++.+.
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTR 199 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHC
T ss_pred ccccccchhhhccCCCCceeeCchhhcCC
Confidence 754332 2234678899999998654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=4.8e-25 Score=245.60 Aligned_cols=167 Identities=25% Similarity=0.376 Sum_probs=123.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC------Ce
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR------EC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~------~~ 783 (902)
.|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+++++.++||||+++++++... ..
T Consensus 30 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 455668999999999999975 568999999985432 2334556788999999999999999999998654 56
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 109 ~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CEEEEECC-CEECC-----C------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred EEEEeccc-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 79999999 78999888642 3778888999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+..... ....+||+.|+|||++.+
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp --------------CCCTTCCHHHHTT
T ss_pred ccccccc--CCCcCcCcCccChHHHcC
Confidence 9875432 345689999999999876
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-25 Score=265.63 Aligned_cols=168 Identities=23% Similarity=0.291 Sum_probs=140.0
Q ss_pred HHhccCCcEeeecCceEEEEEEeC--CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe---
Q 043136 709 ECLSMSDKILGMGSTGTVYKAEMP--GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC--- 783 (902)
Q Consensus 709 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~--- 783 (902)
...|.+.+.||+|+||.||+|.+. +++.||||++.... .....+.+.+|++++++++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 156 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD 156 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence 345777889999999999999775 58999999885432 23445678899999999999999999999987654
Q ss_pred --eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 784 --TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 784 --~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
.|+||||++|++|.+++.. .+++..++.|+.||+.||+|||+++ ||||||||+||+++.+ .+||+||
T Consensus 157 ~~~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DF 225 (681)
T 2pzi_A 157 PVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDL 225 (681)
T ss_dssp EEEEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCC
T ss_pred ceeEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEec
Confidence 6999999999999887643 3788899999999999999999776 9999999999999986 8999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+++..... ...+||+.|||||++.+.+
T Consensus 226 G~a~~~~~~---~~~~gt~~y~aPE~~~~~~ 253 (681)
T 2pzi_A 226 GAVSRINSF---GYLYGTPGFQAPEIVRTGP 253 (681)
T ss_dssp TTCEETTCC---SCCCCCTTTSCTTHHHHCS
T ss_pred ccchhcccC---CccCCCccccCHHHHcCCC
Confidence 999876543 4467999999999987654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=239.22 Aligned_cols=175 Identities=25% Similarity=0.323 Sum_probs=144.1
Q ss_pred HHHHHHhccCCcEeeecCceEEEEEEe--CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe------eEeEEe
Q 043136 705 DDVLECLSMSDKILGMGSTGTVYKAEM--PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN------IVRLLG 776 (902)
Q Consensus 705 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n------Iv~l~~ 776 (902)
++++...|.+.+.||+|+||.||+|.+ .+++.||+|++... ....+.+.+|+++++.++|++ ++++++
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~ 84 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE 84 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence 334445677789999999999999976 36889999998432 234556778999988887654 999999
Q ss_pred EEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC----
Q 043136 777 CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---- 852 (902)
Q Consensus 777 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---- 852 (902)
++...+..++||||+ +++|.+++..... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.
T Consensus 85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 85 WFEHHGHICIVFELL-GLSTYDFIKENGF---LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEE
T ss_pred ccccCCcEEEEEcCC-CCCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccc
Confidence 999999999999999 8899999876432 24678888999999999999999776 999999999999987
Q ss_pred ---------------CCCEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 853 ---------------EMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 853 ---------------~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
++.+||+|||+++..... ....+||+.|+|||++.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 210 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALG 210 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCC
Confidence 668999999999875432 34568999999999997653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=8.1e-25 Score=246.93 Aligned_cols=178 Identities=24% Similarity=0.277 Sum_probs=144.5
Q ss_pred CCHHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC--------cCeeE
Q 043136 702 FTADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR--------HRNIV 772 (902)
Q Consensus 702 ~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--------h~nIv 772 (902)
+..++++...|.+.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|++++++++ |+||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 344555566788889999999999999975 46889999998532 234556788999998885 78899
Q ss_pred eEEeEEe----cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCC
Q 043136 773 RLLGCCS----NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSN 847 (902)
Q Consensus 773 ~l~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~N 847 (902)
++++++. .....|+||||+ ++++.+.+..... ..+++..++.++.||+.||+|||++ + |+||||||+|
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~N 177 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNY---QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPEN 177 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGG
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHH
Confidence 9999987 556899999999 6677777654321 2477888999999999999999976 5 9999999999
Q ss_pred EEEcCCC-------------------------------------------------CEEEeecccceeccCCCCceeecc
Q 043136 848 ILLDGEM-------------------------------------------------EARVADFGVAKLIQSDESMSVIAG 878 (902)
Q Consensus 848 ILl~~~~-------------------------------------------------~~kl~DFGla~~~~~~~~~~~~~G 878 (902)
||++.++ .+||+|||.|+..... ....+|
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence 9999775 7999999999876543 344579
Q ss_pred ccCccccCcccccc
Q 043136 879 SYGYIAPGTFCFCF 892 (902)
Q Consensus 879 t~~y~APE~~~~~~ 892 (902)
|+.|+|||++.+..
T Consensus 256 t~~y~aPE~~~~~~ 269 (397)
T 1wak_A 256 TRQYRSLEVLIGSG 269 (397)
T ss_dssp CGGGCCHHHHHTSC
T ss_pred CCcccCChhhcCCC
Confidence 99999999997754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-25 Score=238.37 Aligned_cols=175 Identities=24% Similarity=0.337 Sum_probs=127.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 16 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 4556789999999999999754 688999998854322 2345568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhcc---CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 790 YMPNGNLDDLLHAKNK---GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~---~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
|+++++|.+++..... .....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 9999999999875321 12235788899999999999999999776 99999999999999999999999999876
Q ss_pred ccCCC------CceeeccccCccccCcccc
Q 043136 867 IQSDE------SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 867 ~~~~~------~~~~~~Gt~~y~APE~~~~ 890 (902)
..... ......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp CC---------------CCCTTCCHHHHHH
T ss_pred eccCCCccchhhhcccCCCccccCHHHhcc
Confidence 54321 1234579999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-25 Score=241.23 Aligned_cols=178 Identities=25% Similarity=0.335 Sum_probs=141.4
Q ss_pred HhccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~ 783 (902)
..|.+.+.||+|+||.||+|+. .+++.||||++.... .......+.+|+.++++++||||+++++++.+.+.
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 4566778999999999999974 346789999985332 23445578899999999999999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC--CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG--ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARV 858 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl 858 (902)
.|+||||+++|+|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999865431 2234788889999999999999999776 999999999999984 446999
Q ss_pred eecccceeccCCCC---ceeeccccCccccCcccccc
Q 043136 859 ADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 859 ~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~ 892 (902)
+|||+++....... .....||+.|+|||++.+..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 221 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCC
Confidence 99999986543221 23356899999999986543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=238.11 Aligned_cols=169 Identities=26% Similarity=0.385 Sum_probs=137.7
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 20 ~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp TEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4566789999999999999775 588999999854322 234568889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++++|.+++..... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR----GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK 169 (302)
T ss_dssp CCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999875432 3778889999999999999999776 99999999999999999999999999764321
Q ss_pred -CCCceeeccccCccccCccc
Q 043136 870 -DESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 870 -~~~~~~~~Gt~~y~APE~~~ 889 (902)
........||+.|+|||++.
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp HHHC-----CCGGGCCHHHHH
T ss_pred cccccccccCChhhcCCeeec
Confidence 11223467999999999984
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=232.92 Aligned_cols=167 Identities=29% Similarity=0.398 Sum_probs=132.6
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-CeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-ECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-~~~~lv~e 789 (902)
.|...+.||+|+||.||+|+. .++.||+|++.... ..+.+.+|++++++++||||+++++++... +..|+|||
T Consensus 22 ~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 22 ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 355678999999999999987 58899999985432 345688999999999999999999997554 47899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++..... ..+++..+..++.|+++|++|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 96 ~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred cCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999976432 23677888899999999999999776 99999999999999999999999999986543
Q ss_pred CCCceeeccccCccccCccccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
. .....+++.|+|||++.+.
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~ 189 (278)
T 1byg_A 170 T--QDTGKLPVKWTAPEALREK 189 (278)
T ss_dssp --------CCTTTSCHHHHHHC
T ss_pred c--ccCCCccccccCHHHhCCC
Confidence 3 2334688999999998654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-25 Score=239.10 Aligned_cols=224 Identities=15% Similarity=0.160 Sum_probs=189.0
Q ss_pred CEEEEEcCCCCcccccCc---cccCCCCCCEEEccCCCCcccCchhh--hccCCCcEEEccCCCCCCCCC----cccccc
Q 043136 79 QITSLDLSRRSLSGPIPP---EIRYLTSLTHLNLSANAFDGPLQPAI--LELTKLRTIDISHNSFNSTFP----PGISKL 149 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~~~~---~~~~l~~L~~L~Ls~n~l~~~~~~~~--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 149 (902)
+++.|.+.+..++...-. .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 467788888777532111 22345779999999999999999988 899999999999999998666 345679
Q ss_pred cccceeccccccccCCCchhhhcccCCcEEeccCccCcCC--C--CcccCCCCCCCEEEccCCCccCCCCc----cccCC
Q 043136 150 RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE--I--PSDYRNLSSLRFLDLAGNSLTGSLPP----QLGLL 221 (902)
Q Consensus 150 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~--~--p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l 221 (902)
++|++|+|++|++++..|..|+.+++|++|+|++|++.+. + +..+.++++|++|+|++|+++. +|. .++.+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l 223 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAAAG 223 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHHHT
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHhcC
Confidence 9999999999999999999999999999999999998752 2 2334789999999999999983 343 25788
Q ss_pred CCCcEEEeeCcccCCCCChhccCC---CCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcE
Q 043136 222 TQLERIEIGYNNLQGEVPVEFASL---VNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQV 298 (902)
Q Consensus 222 ~~L~~L~L~~N~l~~~~p~~~~~l---~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 298 (902)
++|++|+|++|+|++..|..+..+ ++|++|+|++|+++ .+|..+. ++|++|+|++|+|++. |. +..+++|+.
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~ 298 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDN 298 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSC
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccE
Confidence 999999999999999888888777 69999999999999 6777764 8999999999999964 43 678899999
Q ss_pred EecccCCCcc
Q 043136 299 LDLSDNQLSG 308 (902)
Q Consensus 299 L~Ls~N~l~~ 308 (902)
|+|++|+|+.
T Consensus 299 L~L~~N~l~~ 308 (310)
T 4glp_A 299 LTLDGNPFLV 308 (310)
T ss_dssp EECSSTTTSC
T ss_pred EECcCCCCCC
Confidence 9999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=238.09 Aligned_cols=173 Identities=28% Similarity=0.415 Sum_probs=132.8
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcE----EEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEI----IAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~----vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.|...+.||+|+||.||+|++. +++. ||+|.+..... ....+.+.+|++++++++||||+++++++.... .+
T Consensus 16 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 16 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 3556789999999999999753 4443 57776643221 123456889999999999999999999998765 78
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+|+||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred EEEEecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 99999999999999976432 4778888999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC---ceeeccccCccccCccccccc
Q 043136 866 LIQSDES---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 866 ~~~~~~~---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....... .....||+.|+|||++.+...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 196 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIY 196 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCC
T ss_pred EccCccccccccCCCccccccCHHHHcCCCC
Confidence 7643322 233456889999999876543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.91 E-value=1e-24 Score=239.20 Aligned_cols=174 Identities=27% Similarity=0.422 Sum_probs=140.0
Q ss_pred hccCCcEeeecCceEEEEEEe--CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEe-----c
Q 043136 711 LSMSDKILGMGSTGTVYKAEM--PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCS-----N 780 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~--~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~-----~ 780 (902)
.|...+.||+|+||.||+|+. .+++.||+|++....... .....+.+|+++++.+ +||||+++++++. .
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred ceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 466778999999999999987 468899999986432211 1112345677666655 8999999999987 5
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
....++||||++ |+|.+++..... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 91 ~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 91 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp EEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 567899999997 699999876432 23678888999999999999999776 99999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+++............||+.|+|||++.+..
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 195 (326)
T 1blx_A 164 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSS 195 (326)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC
T ss_pred CcccccccCCCCccccccccceeCHHHHhcCC
Confidence 99998765544455678999999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=237.10 Aligned_cols=168 Identities=25% Similarity=0.377 Sum_probs=138.3
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
.|...+.||+|+||.||+|++. +++.||||++.... .......+.+|++++++++||||+++++++... ...
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 3556789999999999999764 68999999985432 234455678999999999999999999987654 678
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+. |+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 90 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ------MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEeccC-ccHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccc
Confidence 99999996 6999988652 3678888999999999999999776 999999999999999999999999999
Q ss_pred eeccCCCC-----------ceeeccccCccccCcccc
Q 043136 865 KLIQSDES-----------MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 865 ~~~~~~~~-----------~~~~~Gt~~y~APE~~~~ 890 (902)
+....... ....+||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHS
T ss_pred cccccccccccCccccccchhhccccccccCCeeecc
Confidence 87643211 223578999999998754
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-25 Score=252.07 Aligned_cols=241 Identities=22% Similarity=0.255 Sum_probs=140.6
Q ss_pred cCchhhhccCCCcEEEccCCCCCCCCC----cccccccccceeccccc---cccCCCchhh-------hcccCCcEEecc
Q 043136 117 PLQPAILELTKLRTIDISHNSFNSTFP----PGISKLRFLRIFNAYSN---SFTGPLPLEF-------VQLNSLQQLNLG 182 (902)
Q Consensus 117 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~L~~N---~l~~~~p~~~-------~~l~~L~~L~L~ 182 (902)
.++..+..+++|++|+|++|.++...+ ..+..+++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 366778889999999999999887643 34667888888888885 4556666655 566777777777
Q ss_pred CccCcC----CCCcccCCCCCCCEEEccCCCccCCCCccc----cCC---------CCCcEEEeeCcccC-CCCC---hh
Q 043136 183 GSYFDG----EIPSDYRNLSSLRFLDLAGNSLTGSLPPQL----GLL---------TQLERIEIGYNNLQ-GEVP---VE 241 (902)
Q Consensus 183 ~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l---------~~L~~L~L~~N~l~-~~~p---~~ 241 (902)
+|.+++ .+|..+.++++|++|+|++|.++...+..+ ..+ ++|++|+|++|+++ +.+| ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 777765 355566666777777777777653322222 222 56666666666665 2333 24
Q ss_pred ccCCCCCCEEEccCccCc--c---cCCccccCCCCccEEecCCCccc----eecCCCCCCcCcCcEEecccCCCccc---
Q 043136 242 FASLVNLKYMDISACNLS--G---TLPSEISNLTKLEMLLLFKNHFT----GEIPVSYGNLQALQVLDLSDNQLSGP--- 309 (902)
Q Consensus 242 ~~~l~~L~~L~Ls~N~l~--~---~~p~~~~~l~~L~~L~L~~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~--- 309 (902)
+..+++|++|+|++|+++ | ..|..+..+++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++.
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 445556666666666555 2 22334555555555555555553 34444455555555555555555443
Q ss_pred -cCccccc--cCCCCEEEccCccccc----cCChhh-hhccccceEEecCceeccc
Q 043136 310 -IPASLAS--LKGLTRLSLMNNVLFG----EIPQDI-ELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 310 -~p~~l~~--l~~L~~L~L~~N~l~~----~~p~~~-~~l~~L~~L~L~~N~l~~~ 357 (902)
++..+.. +++|+.|+|++|.+++ .+|..+ ..+++|++|++++|++++.
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~ 318 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcc
Confidence 3333322 4555555555555544 244444 3345555555555555433
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=240.80 Aligned_cols=166 Identities=25% Similarity=0.377 Sum_probs=135.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCee-----
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECT----- 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~----- 784 (902)
.|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|++++++++||||+++++++...+..
T Consensus 43 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 43 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred cEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 455668999999999999976 468999999986433 2334556788999999999999999999999877654
Q ss_pred -EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 785 -MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 785 -~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
|+||||+. ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 122 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688877632 2678888999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++..... ....+||+.|+|||++.+
T Consensus 191 a~~~~~~--~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 191 ARHADAE--MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp C----------CTTCCCTTSCHHHHSC
T ss_pred ccccccC--cCCcccCccccCHHHhcC
Confidence 9865432 345679999999999876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-24 Score=246.98 Aligned_cols=166 Identities=27% Similarity=0.381 Sum_probs=129.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...++||+|+||+||.....+++.||||++...... .+.+|+++++++ +|||||++++++.+.+..|+||||
T Consensus 26 y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 4456889999999977665668999999998543222 245799999998 799999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCCEEEeecccce
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-----EMEARVADFGVAK 865 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-----~~~~kl~DFGla~ 865 (902)
++ |+|.+++...... ......+.++.||++||+|||+++ |+||||||+||+++. ...+||+|||+|+
T Consensus 100 ~~-g~L~~~l~~~~~~----~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 100 CA-ATLQEYVEQKDFA----HLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CS-EEHHHHHHSSSCC----CCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CC-CCHHHHHHhcCCC----ccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 95 6999999764321 222334579999999999999776 999999999999953 2368899999998
Q ss_pred eccCCC----CceeeccccCccccCccccc
Q 043136 866 LIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
...... .....+||+.|+|||++.+.
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~ 201 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSED 201 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcc
Confidence 765332 23456799999999999754
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-24 Score=248.28 Aligned_cols=170 Identities=31% Similarity=0.431 Sum_probs=129.4
Q ss_pred hccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.+..++.||+|+||+||.+...+|+.||||++.... .+.+.+|+++++++ +||||+++++++.+.+..|+|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 445568999999999988777789999999984322 23467899999876 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCc--ccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-------------C
Q 043136 790 YMPNGNLDDLLHAKNKGENL--VADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-------------M 854 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-------------~ 854 (902)
|+. |+|.+++......... ...+..++.++.||+.||+|||+++ |+||||||+||+++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence 995 6999999765432111 1122234679999999999999776 9999999999999754 4
Q ss_pred CEEEeecccceeccCCCC-----ceeeccccCccccCcccc
Q 043136 855 EARVADFGVAKLIQSDES-----MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 855 ~~kl~DFGla~~~~~~~~-----~~~~~Gt~~y~APE~~~~ 890 (902)
.+||+|||+|+....... ....+||+.|+|||++.+
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 899999999998754322 234679999999999976
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.4e-25 Score=243.63 Aligned_cols=167 Identities=17% Similarity=0.189 Sum_probs=137.2
Q ss_pred hccCCcEeeecCceEEEEEEeCC---------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEe--------
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG---------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR-------- 773 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~---------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~-------- 773 (902)
.|.+.+.||+|+||.||+|+... ++.||+|++... +.+.+|++++++++||||++
T Consensus 43 ~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred eEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 45667899999999999997753 789999998533 24678999999999999887
Q ss_pred -------EEeEEec-CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCC
Q 043136 774 -------LLGCCSN-RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKP 845 (902)
Q Consensus 774 -------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp 845 (902)
+++++.. .+..|+||||+ +++|.+++.... ...+++..++.++.|++.||+|||+++ |+||||||
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp 187 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTA 187 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCG
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCH
Confidence 6677765 67899999999 999999998642 124788999999999999999999776 99999999
Q ss_pred CCEEEcCCC--CEEEeecccceeccCCC--------CceeeccccCccccCcccccc
Q 043136 846 SNILLDGEM--EARVADFGVAKLIQSDE--------SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 846 ~NILl~~~~--~~kl~DFGla~~~~~~~--------~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+||+++.++ .+||+|||+++.+.... ......||+.|+|||++.+..
T Consensus 188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 244 (352)
T 2jii_A 188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG 244 (352)
T ss_dssp GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC
T ss_pred HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC
Confidence 999999998 89999999998764322 113347999999999997753
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=236.40 Aligned_cols=170 Identities=24% Similarity=0.393 Sum_probs=136.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec------CC
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN------RE 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~------~~ 782 (902)
.|.+.+.||+|+||.||+|++ .+++.||+|++...... .+.+.+|+++++++ +||||+++++++.. .+
T Consensus 25 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 25 IFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred cEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 456678999999999999976 46899999998543322 34577899999998 79999999999976 46
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg 174 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 174 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCT
T ss_pred eEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCc
Confidence 78999999999999999976432 24677888899999999999999776 9999999999999999999999999
Q ss_pred cceeccCCC-CceeeccccCccccCcccc
Q 043136 863 VAKLIQSDE-SMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 863 la~~~~~~~-~~~~~~Gt~~y~APE~~~~ 890 (902)
+++...... ......||+.|+|||++.+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (326)
T 2x7f_A 175 VSAQLDRTVGRRNTFIGTPYWMAPEVIAC 203 (326)
T ss_dssp TTC-------------CCGGGCCHHHHC-
T ss_pred CceecCcCccccccccCCccccChhhhcc
Confidence 998764322 2345679999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=232.83 Aligned_cols=171 Identities=22% Similarity=0.293 Sum_probs=137.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEe-EEecCCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG-CCSNRECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~-~~~~~~~~~lv 787 (902)
..|...+.||+|+||.||+|++ .+++.||||++..... .+.+.+|++++++++|++++..++ ++...+..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4577789999999999999976 5789999998643322 234678999999998777665555 44677888999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVA 864 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla 864 (902)
|||+ +++|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||++
T Consensus 84 ~e~~-~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a 155 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155 (296)
T ss_dssp EECC-CCBHHHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred EEcc-CCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence 9999 9999999875332 3788899999999999999999776 9999999999999 78899999999999
Q ss_pred eeccCCCC--------ceeeccccCccccCccccccc
Q 043136 865 KLIQSDES--------MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 865 ~~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+....... .....||+.|+|||++.+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 4hgt_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC
T ss_pred eeccCcccCccCCCCcccccCCCccccchHHhcCCCC
Confidence 87754322 235679999999999977543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-24 Score=221.00 Aligned_cols=196 Identities=16% Similarity=0.214 Sum_probs=158.3
Q ss_pred cceeccccccccCCCchhhhcccCCcEEeccCcc-CcCCCCcccCCCCCCCEEEccC-CCccCCCCccccCCCCCcEEEe
Q 043136 152 LRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY-FDGEIPSDYRNLSSLRFLDLAG-NSLTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 152 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L 229 (902)
|++|++++|++++..+..|.++++|++|+|++|+ +++..+..|.++++|++|+|++ |++++..+..|..+++|++|++
T Consensus 33 l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l 112 (239)
T 2xwt_C 33 TQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGI 112 (239)
T ss_dssp CCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEE
T ss_pred ccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeC
Confidence 3334444444444444556666777777777775 6655566788889999999998 9999777788999999999999
Q ss_pred eCcccCCCCChhccCCCCCC---EEEccCc-cCcccCCccccCCCCcc-EEecCCCccceecCCCCCCcCcCcEEecccC
Q 043136 230 GYNNLQGEVPVEFASLVNLK---YMDISAC-NLSGTLPSEISNLTKLE-MLLLFKNHFTGEIPVSYGNLQALQVLDLSDN 304 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~---~L~Ls~N-~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 304 (902)
++|++++ +|. |..+++|+ +|++++| ++++..+..|.++++|+ +|++++|+++...+..|.. ++|++|+|++|
T Consensus 113 ~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n 189 (239)
T 2xwt_C 113 FNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKN 189 (239)
T ss_dssp EEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTTTTT-CEEEEEECTTC
T ss_pred CCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCC
Confidence 9999997 665 88999998 9999999 99988888899999999 9999999999544445555 89999999999
Q ss_pred C-CccccCcccccc-CCCCEEEccCccccccCChhhhhccccceEEecCce
Q 043136 305 Q-LSGPIPASLASL-KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNH 353 (902)
Q Consensus 305 ~-l~~~~p~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 353 (902)
+ +++..+..|..+ ++|++|++++|++++. |.. .+++|+.|+++++.
T Consensus 190 ~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~~ 237 (239)
T 2xwt_C 190 KYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNTW 237 (239)
T ss_dssp TTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC-
T ss_pred CCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCcc
Confidence 5 998778899999 9999999999999854 443 67789999988763
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=230.23 Aligned_cols=170 Identities=22% Similarity=0.298 Sum_probs=138.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEe-EEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLG-CCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~-~~~~~~~~~lv~ 788 (902)
.|...+.||+|+||.||+|++ .+++.||+|++...... +.+.+|++++++++|++++..+. ++...+..++||
T Consensus 10 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 456678999999999999976 57899999998543322 34678999999998877655554 446677889999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccce
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVAK 865 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla~ 865 (902)
||+ +++|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+||++ +.++.+||+|||+++
T Consensus 85 e~~-~~~L~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~ 156 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp ECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence 999 9999999974332 4788899999999999999999776 9999999999999 478899999999998
Q ss_pred eccCCCC--------ceeeccccCccccCccccccc
Q 043136 866 LIQSDES--------MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 866 ~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....... .....||+.|+|||++.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 192 (296)
T 3uzp_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ 192 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC
T ss_pred cccccccccccccccccccccccccCChhhhcCCCC
Confidence 7754322 245679999999999977543
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.4e-23 Score=221.08 Aligned_cols=180 Identities=20% Similarity=0.208 Sum_probs=121.1
Q ss_pred CcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCC
Q 043136 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASS 495 (902)
Q Consensus 416 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 495 (902)
.++++++++.++ .+|..+. ++|+.|+|++|++++..|..|.++++|++|+|++|++++..|..+..+++|++|++++
T Consensus 16 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 16 KKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp GTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 445555555555 3444332 4555555555555555555555555555555555555555555555555566666666
Q ss_pred CccCCCccccc-ccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCC
Q 043136 496 SKLTGKIPDFI-GCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574 (902)
Q Consensus 496 N~l~~~~p~~~-~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 574 (902)
|++++..+..+ ++++|++|+|++|++++..+..++.+++|+.|+|++|+|++..|..|+.+++|+.|||++|++++..|
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 66555444433 25666666677777765555567788888888888888888777788888888888888888887777
Q ss_pred CCCcCCccceeecccCCcccccCC
Q 043136 575 SNFENCSTLESFNVSYNLLTGPIP 598 (902)
Q Consensus 575 ~~~~~l~~L~~l~ls~N~l~g~ip 598 (902)
..|..+++|+.|+|++|++++..+
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTST
T ss_pred HHHhCCCCCCEEEeeCCceeCCcc
Confidence 788888888888888888887644
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-24 Score=236.34 Aligned_cols=179 Identities=25% Similarity=0.296 Sum_probs=138.1
Q ss_pred HHHHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhH---HHHHHHHHHHHHHhcC----CcCeeEeEE
Q 043136 704 ADDVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENI---RRRRGVLAEVDVLGNV----RHRNIVRLL 775 (902)
Q Consensus 704 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~---~~~~~~~~Ei~il~~l----~h~nIv~l~ 775 (902)
..+.+...|...+.||+|+||.||+|+. .+++.||+|++........ .....+.+|++++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 3455666788889999999999999976 4688999999864432211 1233456788888888 899999999
Q ss_pred eEEecCCeeEEEEEc-cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CC
Q 043136 776 GCCSNRECTMLLYEY-MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GE 853 (902)
Q Consensus 776 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~ 853 (902)
+++...+..++|||| +.+++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ .+
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 176 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-----PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR 176 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCC
Confidence 999999999999999 78999999997643 3778889999999999999999776 99999999999999 88
Q ss_pred CCEEEeecccceeccCCCCceeeccccCccccCccccc
Q 043136 854 MEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 854 ~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+.+||+|||+++..... ......||+.|+|||++.+.
T Consensus 177 ~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~ 213 (312)
T 2iwi_A 177 GCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRH 213 (312)
T ss_dssp TEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHS
T ss_pred CeEEEEEcchhhhcccC-cccccCCcccccCceeeecC
Confidence 99999999999877543 33456799999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5e-24 Score=254.60 Aligned_cols=172 Identities=20% Similarity=0.313 Sum_probs=139.2
Q ss_pred HhccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
..|...+.||+|+||.||+|.+.. +..||+|++.... .....+.+.+|+.++++++||||+++++++. ++..|
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 466 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 466 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence 345667899999999999997632 4679999875432 3345567899999999999999999999985 45689
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 467 lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 9999999999999997543 24778888999999999999999776 9999999999999999999999999998
Q ss_pred eccCCCC--ceeeccccCccccCccccc
Q 043136 866 LIQSDES--MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~--~~~~~Gt~~y~APE~~~~~ 891 (902)
....... .....||+.|||||++.+.
T Consensus 540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 567 (656)
T 2j0j_A 540 YMEDSTYYKASKGKLPIKWMAPESINFR 567 (656)
T ss_dssp SCCC----------CCGGGCCHHHHHHC
T ss_pred ecCCCcceeccCCCCCcceeCHHHhcCC
Confidence 7654332 2234577899999998654
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.7e-24 Score=243.75 Aligned_cols=171 Identities=20% Similarity=0.268 Sum_probs=140.8
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc-CeeEeEEeEEecCCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-~nIv~l~~~~~~~~~~~lv 787 (902)
..|.+.+.||+|+||.||+|++ .+++.||||++...... +++.+|+++++.++| ++|+.+..++...+..++|
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 3466788999999999999976 56899999987543322 236789999999976 6666777777888899999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE---cCCCCEEEeecccc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL---DGEMEARVADFGVA 864 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl---~~~~~~kl~DFGla 864 (902)
|||+ +++|.+++..... .+++..++.|+.||+.||+|||+++ ||||||||+|||+ +.++.+||+|||+|
T Consensus 82 me~~-g~sL~~ll~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla 153 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSR----KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153 (483)
T ss_dssp EECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred EECC-CCCHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence 9999 9999999975332 4788999999999999999999776 9999999999999 68899999999999
Q ss_pred eeccCCCC--------ceeeccccCccccCccccccc
Q 043136 865 KLIQSDES--------MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 865 ~~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~ 893 (902)
+.+..... ....+||+.|+|||++.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~ 190 (483)
T 3sv0_A 154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ 190 (483)
T ss_dssp EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC
T ss_pred eeccCCccccccccccccccCCCccccCHHHhcCCCC
Confidence 98754332 125689999999999977543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.5e-24 Score=232.04 Aligned_cols=170 Identities=22% Similarity=0.301 Sum_probs=138.2
Q ss_pred HhccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecCCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~~~~~lv 787 (902)
..|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+.+|++++++++ ||||+++++++...+..|+|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 34566789999999999999988899999999854332 3345677889999999997 59999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|| +.+++|.+++.... .+++..+..++.|+++||+|||+.+ |+||||||+||++++ +.+||+|||+++..
T Consensus 107 ~e-~~~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EC-CCSEEHHHHHHHCS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred Ee-cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 99 55889999997643 3677888899999999999999776 999999999999964 89999999999876
Q ss_pred cCCCC---ceeeccccCccccCcccc
Q 043136 868 QSDES---MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~---~~~~~Gt~~y~APE~~~~ 890 (902)
..... .....||+.|+|||++.+
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp -------------CCGGGCCHHHHTT
T ss_pred cCccccccccCCCCCCCcCCHHHHhh
Confidence 43322 234579999999999976
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=6.8e-24 Score=231.81 Aligned_cols=167 Identities=23% Similarity=0.382 Sum_probs=131.4
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe----------
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS---------- 779 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~---------- 779 (902)
.|...+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++++++||||+++++++.
T Consensus 12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred ceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 4566789999999999999775 48999999985432 344567889999999999999999999874
Q ss_pred ----cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCC
Q 043136 780 ----NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEM 854 (902)
Q Consensus 780 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~ 854 (902)
+....|+||||++ |+|.+++... .+++..+..++.|+++||+|||+++ |+||||||+||+++ +++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 158 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG------PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDL 158 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTT
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC------CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCC
Confidence 3467899999997 6999988542 3677888899999999999999776 99999999999997 567
Q ss_pred CEEEeecccceeccCC----CCceeeccccCccccCcccc
Q 043136 855 EARVADFGVAKLIQSD----ESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 855 ~~kl~DFGla~~~~~~----~~~~~~~Gt~~y~APE~~~~ 890 (902)
.+||+|||+++..... .......||+.|+|||++.+
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred eEEEccCccccccCCCcccccccccccccccccCcHHhcC
Confidence 9999999999876432 12234567999999998854
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-24 Score=251.76 Aligned_cols=159 Identities=17% Similarity=0.239 Sum_probs=123.0
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccch-----hhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK-----ENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
...+.||+|+||.||+|+. .++.+|+|+...+.. ......+++.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 578889988654322 1222356689999999999999999665555567778999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+||+++. .+||+|||+|+..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999864 3378999999999999776 999999999999998 9999999999987
Q ss_pred cCCCC--------ceeeccccCccccCcccc
Q 043136 868 QSDES--------MSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~--------~~~~~Gt~~y~APE~~~~ 890 (902)
..... ....+||+.|||||++.+
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHH
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHH
Confidence 54322 135789999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-24 Score=237.09 Aligned_cols=166 Identities=25% Similarity=0.374 Sum_probs=135.3
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCe------
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNREC------ 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~------ 783 (902)
.|...+.||+|+||.||+|.+ .+++.||||++.... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 25 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred eEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 355678999999999999976 468999999985432 233445678899999999999999999999987654
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred EEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 688776632 2678888999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCcccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
++..... .....||+.|+|||++.+
T Consensus 173 ~~~~~~~--~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 173 ARHADAE--MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp TTC----------CCSBCCSCHHHHSC
T ss_pred ccCCCCC--ccccccCcCcCCHHHHhC
Confidence 9875432 345679999999999876
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=239.97 Aligned_cols=173 Identities=24% Similarity=0.298 Sum_probs=127.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------ 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------ 782 (902)
..|.+.+.||+|+||.||+|+. .+++.||||++...... .....+|++.+..++||||+++++++...+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp TTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 3567788999999999999977 46899999988543222 223456777888889999999999986533
Q ss_pred -eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEcCCCCCCEEEcC-CCCEEE
Q 043136 783 -CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH--HDCDPVIVHRDLKPSNILLDG-EMEARV 858 (902)
Q Consensus 783 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH--~~~~~~ivHrDlKp~NILl~~-~~~~kl 858 (902)
..++||||+++ ++.+.+..... .....++..+..++.|++.|++|+| +.+ |+||||||+||+++. ++.+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 99 IYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp EEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEE
T ss_pred eeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEE
Confidence 37899999975 66555543221 2234677888899999999999999 555 999999999999997 899999
Q ss_pred eecccceeccCCCCceeeccccCccccCccccc
Q 043136 859 ADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 859 ~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+|||+++............||+.|+|||++.+.
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 206 (360)
T 3e3p_A 174 CDFGSAKKLSPSEPNVAYICSRYYRAPELIFGN 206 (360)
T ss_dssp CCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTC
T ss_pred eeCCCceecCCCCCcccccCCcceeCHHHHcCC
Confidence 999999987666555667899999999998653
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-25 Score=244.48 Aligned_cols=252 Identities=19% Similarity=0.243 Sum_probs=141.9
Q ss_pred CcEEEccCCCCCCCCCcccccc--cccceeccccccccCCCchhhhcccCCcEEeccCccCcCC-CCcccCCCCCCCEEE
Q 043136 128 LRTIDISHNSFNSTFPPGISKL--RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGE-IPSDYRNLSSLRFLD 204 (902)
Q Consensus 128 L~~L~Ls~N~l~~~~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~ 204 (902)
++.|++++|.+. |..+..+ ++++.|++++|.+.+..+. +..+++|++|+|++|.+++. +|..+..+++|++|+
T Consensus 49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~ 124 (336)
T 2ast_B 49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLS 124 (336)
T ss_dssp SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEE
T ss_pred heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEe
Confidence 666777776665 3445555 6666666666666665554 34566666666666666544 555566666666666
Q ss_pred ccCCCccCCCCccccCCCCCcEEEeeCc-ccCCC-CChhccCCCCCCEEEccCc-cCccc-CCccccCCC-CccEEecCC
Q 043136 205 LAGNSLTGSLPPQLGLLTQLERIEIGYN-NLQGE-VPVEFASLVNLKYMDISAC-NLSGT-LPSEISNLT-KLEMLLLFK 279 (902)
Q Consensus 205 L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~-~p~~~~~l~-~L~~L~L~~ 279 (902)
|++|.+++..|..++.+++|++|++++| .+++. ++..+..+++|++|++++| .+++. ++..+..++ +|++|+|++
T Consensus 125 L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~ 204 (336)
T 2ast_B 125 LEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG 204 (336)
T ss_dssp CTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCS
T ss_pred CcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCC
Confidence 6666666555566666666666666666 45542 4445566666666666666 66543 345555666 666666666
Q ss_pred C--ccc-eecCCCCCCcCcCcEEecccCC-CccccCccccccCCCCEEEccCcc-ccccCChhhhhccccceEEecCcee
Q 043136 280 N--HFT-GEIPVSYGNLQALQVLDLSDNQ-LSGPIPASLASLKGLTRLSLMNNV-LFGEIPQDIELLADLDTLLLWNNHL 354 (902)
Q Consensus 280 N--~l~-~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~L~~N~l 354 (902)
| .++ +.+|..+..+++|++|++++|. +++..+..+..+++|++|++++|. +.......+..+++|+.|++++| +
T Consensus 205 ~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i 283 (336)
T 2ast_B 205 YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-V 283 (336)
T ss_dssp CGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-S
T ss_pred CcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-c
Confidence 6 333 2344445556666666666666 555555556666666666666663 21111123455556666666655 2
Q ss_pred ccccCccccCC-CceeEEEecCCcccCCCCCCcc
Q 043136 355 TGVLPQKLGSN-GKLLTVDVSSNSLTGPIPPTIC 387 (902)
Q Consensus 355 ~~~~~~~~~~~-~~L~~L~Ls~N~l~~~~p~~~~ 387 (902)
+. ..+..+ ..+..|+++.|++++..|+.++
T Consensus 284 ~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~~~ 314 (336)
T 2ast_B 284 PD---GTLQLLKEALPHLQINCSHFTTIARPTIG 314 (336)
T ss_dssp CT---TCHHHHHHHSTTSEESCCCSCCTTCSSCS
T ss_pred CH---HHHHHHHhhCcceEEecccCccccCCccc
Confidence 21 122222 1244444555555555555443
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=235.04 Aligned_cols=172 Identities=27% Similarity=0.259 Sum_probs=139.6
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cC-----eeEeEEeEEecCC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HR-----NIVRLLGCCSNRE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~-----nIv~l~~~~~~~~ 782 (902)
..|.+.+.||+|+||.||+|... +++.||||++... ......+.+|+++++.++ |+ +|+++++++...+
T Consensus 54 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 45677789999999999999764 6889999998532 223455667888887774 44 5999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCCEEEee
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD--GEMEARVAD 860 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~--~~~~~kl~D 860 (902)
..|+||||++ |+|.+++..... ..+++..+..++.|++.||+|||++ +.+||||||||+||+++ .++.+||+|
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNF---RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred ceEEEEecCC-CCHHHHHhhcCc---CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEe
Confidence 9999999995 599999976532 2367888899999999999999953 34699999999999994 478899999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccc
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
||+|+..... ....+||+.|+|||++.+..
T Consensus 205 FG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~ 234 (382)
T 2vx3_A 205 FGSSCQLGQR--IYQYIQSRFYRSPEVLLGMP 234 (382)
T ss_dssp CTTCEETTCC--CCSSCSCGGGCCHHHHTTCC
T ss_pred ccCceecccc--cccccCCccccChHHHcCCC
Confidence 9999876432 34568999999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=231.80 Aligned_cols=163 Identities=24% Similarity=0.379 Sum_probs=114.1
Q ss_pred CcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~lv~e 789 (902)
.++||+|+||.||+|.+. +++.||+|++.... ...++ ....++.++||||+++++++.. ....++|||
T Consensus 34 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e---~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e 106 (336)
T 3fhr_A 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQE---VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIME 106 (336)
T ss_dssp EEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHH---HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred ceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHH---HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEe
Confidence 567999999999999775 68999999984321 11221 2223455689999999999876 456899999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEEeeccccee
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARVADFGVAKL 866 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla~~ 866 (902)
|+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+||+|||+++.
T Consensus 107 ~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 107 CMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp CCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 9999999999976432 24788899999999999999999776 999999999999976 45599999999987
Q ss_pred ccCCCCceeeccccCccccCccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.... .....+||+.|+|||++.+.
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~ 204 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPE 204 (336)
T ss_dssp C-----------------------C
T ss_pred cccc-ccccCCCCcCccChhhhCCC
Confidence 6433 33456799999999998543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=251.03 Aligned_cols=176 Identities=24% Similarity=0.329 Sum_probs=146.2
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec------CC
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN------RE 782 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~------~~ 782 (902)
..|.+.+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++++++||||+++++++.. .+
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 4577889999999999999976 468999999985432 33456678899999999999999999998765 66
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCC---EEEe
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEME---ARVA 859 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~---~kl~ 859 (902)
..|+||||+++|+|.+++...... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~--~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENC--CGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCT--TCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEc
Confidence 789999999999999999764322 23566777899999999999999776 999999999999997765 9999
Q ss_pred ecccceeccCCCCceeeccccCccccCcccccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|||.++............||+.|+|||++.+..
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~ 199 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQKK 199 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSC
T ss_pred ccccccccccccccccccCCcccCChHHhccCC
Confidence 999999876666566678999999999997644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-23 Score=229.23 Aligned_cols=170 Identities=25% Similarity=0.347 Sum_probs=122.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|++. +++.||||++...... ....+.+..+..+++.++||||+++++++.+.+..|+||||
T Consensus 27 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 105 (318)
T 2dyl_A 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMEL 105 (318)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEec
Confidence 445678999999999999774 6899999998644322 22333444555678888999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
+ ++.+..+..... ..+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||+++....
T Consensus 106 ~-~~~~~~l~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 106 M-GTCAEKLKKRMQ----GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp C-SEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred c-CCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 9 556666554322 2467888899999999999999974 5 99999999999999999999999999987765
Q ss_pred CCCceeeccccCccccCcccc
Q 043136 870 DESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~ 890 (902)
........||+.|+|||++.+
T Consensus 178 ~~~~~~~~~~~~y~aPE~~~~ 198 (318)
T 2dyl_A 178 DKAKDRSAGCAAYMAPERIDP 198 (318)
T ss_dssp ---------CCTTCCHHHHC-
T ss_pred CccccccCCCccccChhhccc
Confidence 555556789999999999854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=237.76 Aligned_cols=175 Identities=23% Similarity=0.322 Sum_probs=143.4
Q ss_pred HHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhh---HHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecC
Q 043136 708 LECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNR 781 (902)
Q Consensus 708 ~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~ 781 (902)
....|.+.+.||+|+||.||+|.. .+++.||||++....... ....+.+.+|++++++++ ||||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 334567778999999999999965 568999999985432211 011234567999999985 59999999999999
Q ss_pred CeeEEEEEccCC-CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCCEEEe
Q 043136 782 ECTMLLYEYMPN-GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEMEARVA 859 (902)
Q Consensus 782 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~ 859 (902)
+..++|||++.+ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.+||+
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred CcEEEEEEcCCCCccHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 999999999976 89999987643 3677888899999999999999776 99999999999999 78999999
Q ss_pred ecccceeccCCCCceeeccccCccccCccccc
Q 043136 860 DFGVAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 860 DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|||+++..... ......||+.|+|||++.+.
T Consensus 193 Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 223 (320)
T 3a99_A 193 DFGSGALLKDT-VYTDFDGTRVYSPPEWIRYH 223 (320)
T ss_dssp CCTTCEECCSS-CBCCCCSCGGGSCHHHHHHS
T ss_pred eCccccccccc-cccCCCCCccCCChHHhccC
Confidence 99999877543 33456799999999998654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.1e-23 Score=233.78 Aligned_cols=174 Identities=23% Similarity=0.280 Sum_probs=141.2
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEeC-CC-cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe------eEeEEeE
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEMP-GG-EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN------IVRLLGC 777 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~-~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n------Iv~l~~~ 777 (902)
+++...|.+.+.||+|+||.||+|... ++ +.||+|++... ....+.+.+|++++++++|++ ++.++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 15 DWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred ceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence 334456777899999999999999764 34 68999998532 234456778999999887765 9999999
Q ss_pred EecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE-------
Q 043136 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL------- 850 (902)
Q Consensus 778 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl------- 850 (902)
+...+..++||||+ ++++.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+||++
T Consensus 91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 91 FNFHGHMCIAFELL-GKNTFEFLKENNF---QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp EEETTEEEEEEECC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEE
T ss_pred eeeCCeEEEEEecc-CCChHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccc
Confidence 99999999999999 6778777765432 24778889999999999999999665 9999999999999
Q ss_pred ------------cCCCCEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 851 ------------DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 851 ------------~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
+.++.+||+|||+++..... ....+||+.|+|||++.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 215 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELG 215 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCC
T ss_pred cccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCC
Confidence 56789999999999875432 34468999999999997654
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-24 Score=247.72 Aligned_cols=195 Identities=24% Similarity=0.358 Sum_probs=125.8
Q ss_pred ccccE-EecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcc
Q 043136 67 SWSGI-KCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPG 145 (902)
Q Consensus 67 ~w~Gv-~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 145 (902)
.|.|+ .|.. ++++.|+|++|+|++ +|+.+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|.
T Consensus 49 ~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~- 117 (571)
T 3cvr_A 49 AVSLLKECLI--NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE- 117 (571)
T ss_dssp HHHHHHHHHH--TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-
T ss_pred hhhhcccccc--CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-
Confidence 79999 7864 379999999999987 777663 78999999999988 455 457888888888888887 665
Q ss_pred cccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc
Q 043136 146 ISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE 225 (902)
Q Consensus 146 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 225 (902)
+.+ +|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|+
T Consensus 118 l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~ 183 (571)
T 3cvr_A 118 LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLE 183 (571)
T ss_dssp CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCC
T ss_pred hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCC
Confidence 554 77777777777776 444 46667777777777664 444 45666666666666664 554 44 5666
Q ss_pred EEEeeCcccCCCCChhccCCCCC-------CEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCC
Q 043136 226 RIEIGYNNLQGEVPVEFASLVNL-------KYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYG 291 (902)
Q Consensus 226 ~L~L~~N~l~~~~p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 291 (902)
+|+|++|+|+ .+|. |.. +| ++|+|++|+|+ .+|..+..+++|++|+|++|.+++.+|..+.
T Consensus 184 ~L~Ls~N~L~-~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 251 (571)
T 3cvr_A 184 ALDVSTNLLE-SLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLS 251 (571)
T ss_dssp EEECCSSCCS-SCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHH
T ss_pred EEECcCCCCC-chhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHH
Confidence 6666666666 3443 332 44 55555555555 3444444455555555555555444444433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=234.44 Aligned_cols=170 Identities=21% Similarity=0.319 Sum_probs=139.2
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-----------cCeeEeEEeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-----------HRNIVRLLGC 777 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------h~nIv~l~~~ 777 (902)
..|.+.+.||+|+||.||+|++ .+++.||||++... ....+.+.+|++++++++ ||||++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC----ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3566778999999999999976 56899999998532 233456778999988876 8999999999
Q ss_pred EecCC----eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEc-
Q 043136 778 CSNRE----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLD- 851 (902)
Q Consensus 778 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~- 851 (902)
+...+ ..++||||+ +++|.+++..... ..+++..+..++.||+.||+|||++ + |+||||||+||+++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEec
Confidence 87654 789999999 8999999976432 2367888899999999999999976 5 99999999999994
Q ss_pred -----CCCCEEEeecccceeccCCCCceeeccccCccccCcccccc
Q 043136 852 -----GEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 852 -----~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
..+.+||+|||+|+..... .....||+.|+|||++.+..
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~ 211 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP 211 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC
T ss_pred cCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC
Confidence 4457999999999876543 33457999999999997754
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=4.7e-23 Score=228.24 Aligned_cols=202 Identities=16% Similarity=0.105 Sum_probs=118.2
Q ss_pred CccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCc-
Q 043136 66 CSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP- 144 (902)
Q Consensus 66 C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~- 144 (902)
|+|..|.|+. ++++ .+|..+ .+++++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+|.
T Consensus 9 C~~~~v~C~~------------~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~ 73 (350)
T 4ay9_X 9 CSNRVFLCQE------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73 (350)
T ss_dssp EETTEEEEES------------TTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTT
T ss_pred eeCCEEEecC------------CCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChh
Confidence 6787788853 3444 467655 36889999999999877667888899999999999988766554
Q ss_pred ccccccccce-eccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccC-CCccCCCCccccCCC
Q 043136 145 GISKLRFLRI-FNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAG-NSLTGSLPPQLGLLT 222 (902)
Q Consensus 145 ~l~~l~~L~~-L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~ 222 (902)
.|.++++|+. +.++.|++++..|..|..+++|++|++++|+++...+..+....++..|++.+ |+++...+..|..+.
T Consensus 74 ~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~ 153 (350)
T 4ay9_X 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 153 (350)
T ss_dssp SBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred HhhcchhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcc
Confidence 4666666543 45555666666666666666666666666666655444455555555555543 344433333444432
Q ss_pred -CCcEEEeeCcccCCCCChhccCCCCCCEEEccC-ccCcccCCccccCCCCccEEecCCCccc
Q 043136 223 -QLERIEIGYNNLQGEVPVEFASLVNLKYMDISA-CNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 223 -~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
.++.|+|++|+|+.+ |.......+|++|++++ |.++...++.|.++++|++|+|++|+|+
T Consensus 154 ~~l~~L~L~~N~i~~i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~ 215 (350)
T 4ay9_X 154 FESVILWLNKNGIQEI-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 215 (350)
T ss_dssp SSCEEEECCSSCCCEE-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC
T ss_pred hhhhhhccccccccCC-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC
Confidence 345555555555532 22222334455555543 3333222234445555555555555554
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-23 Score=222.60 Aligned_cols=193 Identities=21% Similarity=0.325 Sum_probs=95.1
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
..+++|++|++++|.++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|++++|++++. ..+..+++|++
T Consensus 38 ~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~--~~~~~l~~L~~ 111 (308)
T 1h6u_A 38 ADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV--SAIAGLQSIKT 111 (308)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC--GGGTTCTTCCE
T ss_pred HHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc--hhhcCCCCCCE
Confidence 345566666666666654 22 45566666666666666654332 55555555555555555542 23555555555
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
|+|++|++++. +. +..+++|++|+|++|++++..+ ++.+++|++|++++|++++..+ +..+++|++|+|++|++
T Consensus 112 L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l 185 (308)
T 1h6u_A 112 LDLTSTQITDV-TP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKI 185 (308)
T ss_dssp EECTTSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EECCCCCCCCc-hh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--hcCCCCCCEEECCCCcc
Confidence 55555555532 21 4555555555555555553221 4445555555555555543222 44445555555555554
Q ss_pred cccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc
Q 043136 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++..+ +..+++|++|+|++|++++..+ +..+++|+.|+|++|.++
T Consensus 186 ~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~ 230 (308)
T 1h6u_A 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTIT 230 (308)
T ss_dssp CCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEE
T ss_pred CcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeee
Confidence 43222 4444444444444444443321 344444444444444443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-24 Score=235.80 Aligned_cols=169 Identities=22% Similarity=0.378 Sum_probs=135.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|...+.||+|+||.||+|+..+ .+|+|++...... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 35 ~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~ 111 (319)
T 2y4i_B 35 LEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLC 111 (319)
T ss_dssp EECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCC
T ss_pred eEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecc
Confidence 5567899999999999998744 4899988543221 122344678999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC--
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS-- 869 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~-- 869 (902)
++++|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+||+++ ++.+||+|||+++....
T Consensus 112 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 112 KGRTLYSVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp CSEEHHHHTTSSC----CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred cCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999986532 24677888899999999999999776 99999999999998 67999999999876531
Q ss_pred ----CCCceeeccccCccccCccccc
Q 043136 870 ----DESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ----~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
........||+.|+|||++.+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~ 209 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQL 209 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCB
T ss_pred ccccccccccCCCcccccChHHhhhc
Confidence 1223345699999999999763
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=208.76 Aligned_cols=157 Identities=23% Similarity=0.249 Sum_probs=94.9
Q ss_pred CCCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 64 ~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
..|.|.+|.|+... ++ .+|..+ .++|++|+|++|++++..+..|..+++|++|+|++|++++..+
T Consensus 5 C~C~~~~v~c~~~~------------l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 69 (208)
T 2o6s_A 5 CSCSGTTVECYSQG------------RT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPN 69 (208)
T ss_dssp CEEETTEEECCSSC------------CS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCT
T ss_pred CEECCCEEEecCCC------------cc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccCh
Confidence 35899999997542 22 244333 4578888888888887666677788888888888887776555
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ 223 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 223 (902)
..|+.+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++
T Consensus 70 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 149 (208)
T 2o6s_A 70 GVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTS 149 (208)
T ss_dssp TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred hhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCC
Confidence 55566666666666666666555545555555555555555555444444555555555555555555433333444444
Q ss_pred CcEEEeeCcccC
Q 043136 224 LERIEIGYNNLQ 235 (902)
Q Consensus 224 L~~L~L~~N~l~ 235 (902)
|++|++++|.+.
T Consensus 150 L~~L~l~~N~~~ 161 (208)
T 2o6s_A 150 LQYIWLHDNPWD 161 (208)
T ss_dssp CCEEECCSCCBC
T ss_pred ccEEEecCCCee
Confidence 444444444433
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-22 Score=220.72 Aligned_cols=195 Identities=25% Similarity=0.360 Sum_probs=102.3
Q ss_pred hhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCC
Q 043136 122 ILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLR 201 (902)
Q Consensus 122 ~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 201 (902)
+..+++|++|++++|.++. +| .+..+++|++|++++|.+++..+ +..+++|++|+|++|++++. + .+.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCC
Confidence 4556677777777776654 23 35555555555555555554333 55555555555555555432 2 344555555
Q ss_pred EEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCc
Q 043136 202 FLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNH 281 (902)
Q Consensus 202 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 281 (902)
+|+|++|++++ +| . +..+++|++|++++|++++..+ +..+++|++|+|++|+
T Consensus 111 ~L~l~~n~l~~-~~-~------------------------l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~ 162 (308)
T 1h6u_A 111 TLDLTSTQITD-VT-P------------------------LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQ 162 (308)
T ss_dssp EEECTTSCCCC-CG-G------------------------GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEECCCCCCCC-ch-h------------------------hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCc
Confidence 55555555543 22 1 4444555555555555543322 4445555555555555
Q ss_pred cceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceecc
Q 043136 282 FTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356 (902)
Q Consensus 282 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 356 (902)
+++..+ +..+++|+.|+|++|++++..+ +..+++|++|+|++|++.+..+ +..+++|+.|++++|.+++
T Consensus 163 l~~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 163 VSDLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEEC
T ss_pred CCCChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeec
Confidence 543222 4555555555555555554322 5555556666666666554332 5556666666666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.88 E-value=6.7e-23 Score=220.09 Aligned_cols=154 Identities=11% Similarity=0.041 Sum_probs=130.8
Q ss_pred CCHHH-HHHHhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEe
Q 043136 702 FTADD-VLECLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCS 779 (902)
Q Consensus 702 ~~~~~-~~~~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~ 779 (902)
+..++ ++...|.+.+.||+|+||.||+|++. +++.||+|++...........+.+.+|++++.+++||||+++++++.
T Consensus 22 ~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 101 (286)
T 3uqc_A 22 LVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH 101 (286)
T ss_dssp CCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE
Confidence 34444 55566778899999999999999775 48999999997655444556677899999999999999999999999
Q ss_pred cCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEe
Q 043136 780 NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVA 859 (902)
Q Consensus 780 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~ 859 (902)
+.+..|+||||++|++|.++++.. .......+|+.|++.||+|||+++ |+||||||+||+++.++.+||+
T Consensus 102 ~~~~~~lv~e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~ 171 (286)
T 3uqc_A 102 TRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLA 171 (286)
T ss_dssp ETTEEEEEEECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEEC
T ss_pred ECCcEEEEEEecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEE
Confidence 999999999999999999998532 133456789999999999999776 9999999999999999999999
Q ss_pred ecccce
Q 043136 860 DFGVAK 865 (902)
Q Consensus 860 DFGla~ 865 (902)
++|...
T Consensus 172 ~~~~~~ 177 (286)
T 3uqc_A 172 YPATMP 177 (286)
T ss_dssp SCCCCT
T ss_pred eccccC
Confidence 887653
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.6e-22 Score=218.98 Aligned_cols=240 Identities=14% Similarity=0.086 Sum_probs=139.8
Q ss_pred CEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCc-hhhhcccCCcE-Eecc
Q 043136 105 THLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLP-LEFVQLNSLQQ-LNLG 182 (902)
Q Consensus 105 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L~ 182 (902)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|+++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 45677777777 355544 3567888888888876555567777777777777777765544 35666666554 4555
Q ss_pred CccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeC-cccCCCCChhccCCC-CCCEEEccCccCcc
Q 043136 183 GSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLV-NLKYMDISACNLSG 260 (902)
Q Consensus 183 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~ 260 (902)
+|+++...|..|.++++|++|++++|++++..+..+....++..|++.+ |++....+..|..+. .+++|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 6677666666677777777777777777655555555556666666654 455544455555553 46666666666663
Q ss_pred cCCccccCCCCccEEecCC-CccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhh
Q 043136 261 TLPSEISNLTKLEMLLLFK-NHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE 339 (902)
Q Consensus 261 ~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 339 (902)
. |......++|++|++++ |.++...+..|.++++|++|||++|+|+...+..|. +|+.|.+.++.-...+| .+.
T Consensus 169 i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~l~~~~l~~lP-~l~ 243 (350)
T 4ay9_X 169 I-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRARSTYNLKKLP-TLE 243 (350)
T ss_dssp E-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEECTTCTTCCCCC-CTT
T ss_pred C-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhhccCCCcCcCC-Cch
Confidence 3 33333445666666653 445433334556666666666666666643333333 33344433332223334 244
Q ss_pred hccccceEEecCc
Q 043136 340 LLADLDTLLLWNN 352 (902)
Q Consensus 340 ~l~~L~~L~L~~N 352 (902)
.+++|+.++++++
T Consensus 244 ~l~~L~~l~l~~~ 256 (350)
T 4ay9_X 244 KLVALMEASLTYP 256 (350)
T ss_dssp TCCSCCEEECSCH
T ss_pred hCcChhhCcCCCC
Confidence 4455555554443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.2e-22 Score=227.95 Aligned_cols=169 Identities=21% Similarity=0.233 Sum_probs=124.4
Q ss_pred CCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc-Ce---------------eEe---
Q 043136 714 SDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RN---------------IVR--- 773 (902)
Q Consensus 714 ~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-~n---------------Iv~--- 773 (902)
..+.||+|+||.||+|++ .+++.||||++...........+.+.+|+.+++.++| ++ ++.
T Consensus 82 ~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (413)
T 3dzo_A 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161 (413)
T ss_dssp EEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC
T ss_pred EecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCC
Confidence 457899999999999975 5689999999864444443445678899999999976 21 111
Q ss_pred ---EEeEEec-----CCeeEEEEEccCCCCHHHHHHhhc--cCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCC
Q 043136 774 ---LLGCCSN-----RECTMLLYEYMPNGNLDDLLHAKN--KGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDL 843 (902)
Q Consensus 774 ---l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDl 843 (902)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.|+++||+|||+++ ||||||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDi 237 (413)
T 3dzo_A 162 KKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYL 237 (413)
T ss_dssp ---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCC
T ss_pred CCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCc
Confidence 1111111 12456777766 789999985321 112335677888999999999999999776 999999
Q ss_pred CCCCEEEcCCCCEEEeecccceeccCCCCceeeccccCccccCccc
Q 043136 844 KPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFC 889 (902)
Q Consensus 844 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~ 889 (902)
||+|||++.++.+||+|||+++..... ....+| +.|||||++.
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHH
T ss_pred ccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhh
Confidence 999999999999999999999875433 445678 9999999994
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.2e-21 Score=228.31 Aligned_cols=189 Identities=23% Similarity=0.343 Sum_probs=120.9
Q ss_pred CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc
Q 043136 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA 206 (902)
Q Consensus 127 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 206 (902)
+|++|+|++|.+++ +|..+. ++|++|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 56666666666654 444432 45666666666655 344 335666666777666665 555 444 67777777
Q ss_pred CCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec
Q 043136 207 GNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 207 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
+|+|++ +|. .+++|++|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |. ++|++|+|++|+|+ .+
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~-~l 195 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLE-SL 195 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCS-SC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCC-ch
Confidence 777765 554 46667777777777765 443 45677777777777775 555 44 67777777777777 45
Q ss_pred CCCCCCcCcC-------cEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccc
Q 043136 287 PVSYGNLQAL-------QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLAD 343 (902)
Q Consensus 287 p~~~~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 343 (902)
|. +.. +| +.|+|++|+|+ .+|..+..+++|+.|+|++|.+++.+|..+..+..
T Consensus 196 p~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 196 PA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp CC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 54 443 55 78888888887 46776777888888888888887777777766543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.8e-21 Score=198.66 Aligned_cols=152 Identities=21% Similarity=0.193 Sum_probs=78.6
Q ss_pred CEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCc
Q 043136 105 THLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGS 184 (902)
Q Consensus 105 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 184 (902)
+.++++++.++. +|..+ .++|++|+|++|++++..+..|+.+++|++|++++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRTS-VPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCSS-CCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCccC-CCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 355666666653 23222 346666666666666554445555555555555555555544444555555555555555
Q ss_pred cCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCc
Q 043136 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 185 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
++++..+..|.++++|++|+|++|++++..+..|..+++|++|++++|++++..+..|..+++|++|+|++|.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 161 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWD 161 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCee
Confidence 555444444455555555555555555443334444445555555555444444434444444444444444433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=9.2e-22 Score=212.90 Aligned_cols=150 Identities=25% Similarity=0.403 Sum_probs=124.6
Q ss_pred HHHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHH-hcCCcCeeEeEEeEEec---
Q 043136 706 DVLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVL-GNVRHRNIVRLLGCCSN--- 780 (902)
Q Consensus 706 ~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il-~~l~h~nIv~l~~~~~~--- 780 (902)
++...++...+.||+|+||.||+|.. .+++.||+|++... ..+.+|++++ +..+||||+++++++..
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 34444445558899999999999976 56899999998421 2355788887 55689999999999876
Q ss_pred -CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCE
Q 043136 781 -RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEA 856 (902)
Q Consensus 781 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~ 856 (902)
....|+||||+++|+|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++. ++.+
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCE
T ss_pred CCceEEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcE
Confidence 6778999999999999999976432 24788889999999999999999776 999999999999998 7899
Q ss_pred EEeecccceeccC
Q 043136 857 RVADFGVAKLIQS 869 (902)
Q Consensus 857 kl~DFGla~~~~~ 869 (902)
||+|||+|+....
T Consensus 160 kl~Dfg~a~~~~~ 172 (299)
T 3m2w_A 160 KLTDFGFAKETTG 172 (299)
T ss_dssp EECCCTTCEECTT
T ss_pred EEecccccccccc
Confidence 9999999987654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-22 Score=244.51 Aligned_cols=221 Identities=17% Similarity=0.196 Sum_probs=92.7
Q ss_pred CCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCCccccEEecCCCCCEEEEEcCCCCcccccCccccC
Q 043136 21 NTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRY 100 (902)
Q Consensus 21 ~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~ 100 (902)
+....+++||+++..+...+....-..|.... +..+.|.++.++. .+++.|+|.++.+.. ++..+
T Consensus 128 s~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~s~--~~~~~l~L~~n~~~~-~~~~~-- 192 (727)
T 4b8c_D 128 SLVDCTKQALMEMADTLTDSKTAKKQQPTGDS----------TPSGTATNSAVST--PLTPKIELFANGKDE-ANQAL-- 192 (727)
T ss_dssp ----CCCHHHHHHHHHHHHHHTTC--------------------------------------------------------
T ss_pred hccccchhhhhhhhhhcccccCcccCCCcCCC----------CccccCCCceecC--CccceEEeeCCCCCc-chhhH--
Confidence 45667899999999887432111223443321 2357899998875 489999999999886 34333
Q ss_pred CCCCCEEEccCCCCcc---------cCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhh
Q 043136 101 LTSLTHLNLSANAFDG---------PLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFV 171 (902)
Q Consensus 101 l~~L~~L~Ls~n~l~~---------~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 171 (902)
|+.++|+.|.|.+ ..+..+..+++|++|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+
T Consensus 193 ---l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~ 267 (727)
T 4b8c_D 193 ---LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIK 267 (727)
T ss_dssp --------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGG
T ss_pred ---hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhh
Confidence 3444555554443 33555666666666666666665 45555556666666666666666 5555666
Q ss_pred cccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCC-CCE
Q 043136 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVN-LKY 250 (902)
Q Consensus 172 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~ 250 (902)
.+++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+.+++|++|+|++|.|++.+|..+..+.. +..
T Consensus 268 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~ 345 (727)
T 4b8c_D 268 NLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLI 345 (727)
T ss_dssp GGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHH
T ss_pred CCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhH
Confidence 6666666666666665 45555666666666666666665 45555555666666666666665555555543221 122
Q ss_pred EEccCccCcccCC
Q 043136 251 MDISACNLSGTLP 263 (902)
Q Consensus 251 L~Ls~N~l~~~~p 263 (902)
|+|++|.+++.+|
T Consensus 346 l~l~~N~l~~~~p 358 (727)
T 4b8c_D 346 FYLRDNRPEIPLP 358 (727)
T ss_dssp HHHHHCCCCCCCC
T ss_pred HhhccCcccCcCc
Confidence 4555555555444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-21 Score=208.06 Aligned_cols=146 Identities=17% Similarity=0.103 Sum_probs=113.9
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhH---------------HHHHHHHHHHHHHhcCCcCeeEeEEeE
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENI---------------RRRRGVLAEVDVLGNVRHRNIVRLLGC 777 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~---------------~~~~~~~~Ei~il~~l~h~nIv~l~~~ 777 (902)
.+.+.||+|+||.||+|...+++.||+|++........ .....+.+|++++++++| +++.++
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~~~ 169 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVPKV 169 (282)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSCCE
T ss_pred EecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcCeE
Confidence 34589999999999999887799999999853221100 245678899999999984 555555
Q ss_pred EecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEE
Q 043136 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857 (902)
Q Consensus 778 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~k 857 (902)
+.. +..|+||||++||+|.+ +.. + ....++.|+++|++|||+++ |+||||||+||+++ ++.+|
T Consensus 170 ~~~-~~~~lvmE~~~g~~L~~-l~~---------~--~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vk 232 (282)
T 1zar_A 170 YAW-EGNAVLMELIDAKELYR-VRV---------E--NPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIW 232 (282)
T ss_dssp EEE-ETTEEEEECCCCEEGGG-CCC---------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEE
T ss_pred Eec-cceEEEEEecCCCcHHH-cch---------h--hHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEE
Confidence 433 55799999999999988 421 1 12368999999999999776 99999999999999 99999
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccc
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
|+|||+|+. +..|+|||++..
T Consensus 233 l~DFG~a~~------------~~~~~a~e~l~r 253 (282)
T 1zar_A 233 IIDFPQSVE------------VGEEGWREILER 253 (282)
T ss_dssp ECCCTTCEE------------TTSTTHHHHHHH
T ss_pred EEECCCCeE------------CCCCCHHHHHHH
Confidence 999999864 345788988753
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=3.7e-23 Score=242.40 Aligned_cols=216 Identities=21% Similarity=0.196 Sum_probs=109.6
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
..+++|+.|+|++|+++ .+|..++.|++|+.|++++|......|. .+..+.+.+.+|..++.+++|+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------ll~~~~~~~~~~~~l~~l~~L~~ 413 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------LMRALDPLLYEKETLQYFSTLKA 413 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------HHHHHCTGGGHHHHHHHHHHHHH
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------HHHhcccccCCHHHHHHHHhccc
Confidence 34555555555555554 3455555555555555544431000000 00001144555666666666666
Q ss_pred Ee-ccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCcc
Q 043136 179 LN-LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257 (902)
Q Consensus 179 L~-L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 257 (902)
|+ ++.|.+. +|+.+.+++|.++.. |. ..|+.|+|++|+|++ +|. |+.+++|++|+|++|+
T Consensus 414 L~~l~~n~~~-----------~L~~l~l~~n~i~~l-~~-----~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 414 VDPMRAAYLD-----------DLRSKFLLENSVLKM-EY-----ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp HCGGGHHHHH-----------HHHHHHHHHHHHHHH-HH-----TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred Ccchhhcccc-----------hhhhhhhhccccccc-Cc-----cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 66 5555432 333444444444421 11 124555555555553 333 5555555555555555
Q ss_pred CcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcccc-CccccccCCCCEEEccCccccccCCh
Q 043136 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPI-PASLASLKGLTRLSLMNNVLFGEIPQ 336 (902)
Q Consensus 258 l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (902)
|+ .+|..|+++++|++|+|++|+|++ +| .++++++|++|+|++|+|++.. |..+..+++|+.|+|++|.+++.+|.
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~ 551 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI 551 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred cc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence 55 445555555555555555555554 33 5555666666666666665554 55666666666666666666554432
Q ss_pred ---hhhhccccceEE
Q 043136 337 ---DIELLADLDTLL 348 (902)
Q Consensus 337 ---~~~~l~~L~~L~ 348 (902)
.+..+++|+.|+
T Consensus 552 ~~~l~~~lp~L~~L~ 566 (567)
T 1dce_A 552 QERLAEMLPSVSSIL 566 (567)
T ss_dssp TTHHHHHCTTCSEEE
T ss_pred HHHHHHHCcccCccC
Confidence 233456666664
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.6e-20 Score=189.87 Aligned_cols=157 Identities=21% Similarity=0.237 Sum_probs=96.9
Q ss_pred CCCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC
Q 043136 64 VWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP 143 (902)
Q Consensus 64 ~~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 143 (902)
..|+|.+|.|+.. +++ .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|+...+
T Consensus 17 ~~Cs~~~v~c~~~------------~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~ 81 (229)
T 3e6j_A 17 CSCSGTTVDCRSK------------RHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPV 81 (229)
T ss_dssp CEEETTEEECTTS------------CCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT
T ss_pred CEEeCCEeEccCC------------CcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcCh
Confidence 3799999999643 232 4555443 778888888888887777777777777777777777765444
Q ss_pred cccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCC
Q 043136 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQ 223 (902)
Q Consensus 144 ~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 223 (902)
..|..+++|++|+|++|+|++. .+..|..+++|++|+|++|+|+ .+|..+..+++
T Consensus 82 ~~~~~l~~L~~L~Ls~N~l~~l------------------------~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~ 136 (229)
T 3e6j_A 82 GVFDSLTQLTVLDLGTNQLTVL------------------------PSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH 136 (229)
T ss_dssp TTTTTCTTCCEEECCSSCCCCC------------------------CTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTT
T ss_pred hhcccCCCcCEEECCCCcCCcc------------------------ChhHhCcchhhCeEeccCCccc-ccCcccccCCC
Confidence 4455555555555555555444 4444455555555555555555 44555555555
Q ss_pred CcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcc
Q 043136 224 LERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG 260 (902)
Q Consensus 224 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 260 (902)
|++|+|++|+|++..+..|..+++|++|+|++|.+..
T Consensus 137 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp CSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 5555555555555545556666666666666666654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=199.80 Aligned_cols=172 Identities=23% Similarity=0.340 Sum_probs=87.8
Q ss_pred cCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcE
Q 043136 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQ 178 (902)
Q Consensus 99 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 178 (902)
..+++|++|++++|.++.. +.+..+++|++|+|++|++++..+ +..+++|++|++++|.+++
T Consensus 43 ~~l~~L~~L~l~~~~i~~~--~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-------------- 104 (291)
T 1h6t_A 43 NELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-------------- 104 (291)
T ss_dssp HHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC--------------
T ss_pred hhcCcccEEEccCCCcccC--hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC--------------
Confidence 3455555555555555533 235555555555555555554322 4444444444444444443
Q ss_pred EeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 179 LNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 179 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
+| .+.++++|++|+|++|++++. +.+..+++|++|++++|++++. ..+..+++|++|+|++|++
T Consensus 105 -----------~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l 168 (291)
T 1h6t_A 105 -----------LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQI 168 (291)
T ss_dssp -----------GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCC
T ss_pred -----------Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCcc
Confidence 11 244455555555555555432 2344555555555555555543 3455555555555555555
Q ss_pred cccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcc
Q 043136 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 259 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
++..| +..+++|++|+|++|++++. | .+..+++|+.|++++|+++.
T Consensus 169 ~~~~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 169 SDIVP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp CCCGG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred ccchh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 54333 55555555555555555532 2 25556666666666666553
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=5.3e-20 Score=216.87 Aligned_cols=170 Identities=26% Similarity=0.373 Sum_probs=73.6
Q ss_pred ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEE
Q 043136 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203 (902)
Q Consensus 124 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 203 (902)
.|++|+.|+|++|.+... | .++.+++|+.|+|++|++++..| +..+++|+.|+|++|.+++ +| .+..+++|++|
T Consensus 41 ~L~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~~L 114 (605)
T 1m9s_A 41 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLKSL 114 (605)
T ss_dssp HHTTCCCCBCTTCCCCCC-T-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCCEE
T ss_pred cCCCCCEEECcCCCCCCC-h-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCCEE
Confidence 344444444444444321 1 23344444444444444443322 4444444444444444443 11 34444444444
Q ss_pred EccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 204 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
+|++|++++ + +.+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+++..| +..+++|+.|+|++|+|+
T Consensus 115 ~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~ 188 (605)
T 1m9s_A 115 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS 188 (605)
T ss_dssp ECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred EecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCC
Confidence 444444443 1 2344444444444444444432 334444444444444444443333 444444444444444444
Q ss_pred eecCCCCCCcCcCcEEecccCCCc
Q 043136 284 GEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 284 ~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
+. ..+..+++|+.|+|++|+++
T Consensus 189 ~l--~~l~~l~~L~~L~L~~N~l~ 210 (605)
T 1m9s_A 189 DL--RALAGLKNLDVLELFSQECL 210 (605)
T ss_dssp BC--GGGTTCTTCSEEECCSEEEE
T ss_pred CC--hHHccCCCCCEEEccCCcCc
Confidence 32 12444444444444444444
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.7e-20 Score=199.14 Aligned_cols=188 Identities=24% Similarity=0.318 Sum_probs=152.6
Q ss_pred EEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCc
Q 043136 131 IDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSL 210 (902)
Q Consensus 131 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 210 (902)
+.+..+.+++.. .+..+++|+.|++++|.++.. + .+..+++|++|+|++|++++..+ +.++++|++|+|++|++
T Consensus 29 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCccccc--chhhcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcC
Confidence 344444444321 234555566666666666543 2 47778889999999999986554 89999999999999999
Q ss_pred cCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCC
Q 043136 211 TGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY 290 (902)
Q Consensus 211 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 290 (902)
++ + +.+..+++|++|++++|++++. ..+..+++|++|++++|++++. ..+..+++|++|+|++|++++..| +
T Consensus 103 ~~-~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l 174 (291)
T 1h6t_A 103 KD-L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--L 174 (291)
T ss_dssp CC-G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--G
T ss_pred CC-C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--h
Confidence 85 3 3599999999999999999974 5689999999999999999965 678999999999999999997655 8
Q ss_pred CCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccC
Q 043136 291 GNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEI 334 (902)
Q Consensus 291 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 334 (902)
..+++|++|+|++|++++ ++ .+..+++|+.|++++|++....
T Consensus 175 ~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~ 216 (291)
T 1h6t_A 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKP 216 (291)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCC
T ss_pred cCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCc
Confidence 999999999999999986 44 4899999999999999997643
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.82 E-value=3.1e-20 Score=218.85 Aligned_cols=173 Identities=28% Similarity=0.353 Sum_probs=85.7
Q ss_pred hcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCE
Q 043136 171 VQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKY 250 (902)
Q Consensus 171 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 250 (902)
..+++|+.|+|++|.+.. +| .+..+++|+.|+|++|++++..| +..+++|+.|+|++|+|++. | .+..+++|++
T Consensus 40 ~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~ 113 (605)
T 1m9s_A 40 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKS 113 (605)
T ss_dssp HHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCE
T ss_pred hcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCE
Confidence 344444444444444442 12 24444555555555555543222 44455555555555555431 2 3455555555
Q ss_pred EEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccc
Q 043136 251 MDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 251 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 330 (902)
|+|++|++++. ..+..+++|+.|+|++|++++. ..+..+++|+.|+|++|+|++..| +..+++|+.|+|++|++
T Consensus 114 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i 187 (605)
T 1m9s_A 114 LSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHI 187 (605)
T ss_dssp EECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCC
T ss_pred EEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCC
Confidence 55555555532 2345555555555555555533 344555555555555555554444 55555555555555555
Q ss_pred cccCChhhhhccccceEEecCceeccc
Q 043136 331 FGEIPQDIELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 331 ~~~~p~~~~~l~~L~~L~L~~N~l~~~ 357 (902)
.+. +.+..+++|+.|+|++|.+++.
T Consensus 188 ~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 188 SDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCC--hHHccCCCCCEEEccCCcCcCC
Confidence 432 2355555555555555555543
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=185.42 Aligned_cols=152 Identities=24% Similarity=0.247 Sum_probs=102.8
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCc-hhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQ-PAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 160 (902)
.+++++|+++. +|..+. +.+++|+|++|+|++..+ ..|..+++|++|+|++|+|++..+..|+.+++|++|+|++|
T Consensus 15 ~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 56777778774 676553 456889999988887754 45778888888888888888766666777777777777777
Q ss_pred cccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCC
Q 043136 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG 236 (902)
Q Consensus 161 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 236 (902)
++++..|..|..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++
T Consensus 92 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c 167 (220)
T 2v70_A 92 RLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNC 167 (220)
T ss_dssp CCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEEC
T ss_pred ccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcC
Confidence 7766666666666666666666666666556666666666666666666665555555555555555555555543
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=187.03 Aligned_cols=149 Identities=25% Similarity=0.271 Sum_probs=88.0
Q ss_pred EcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceecccccccc
Q 043136 84 DLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFT 163 (902)
Q Consensus 84 ~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 163 (902)
++++++++ .+|..+. ++|++|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++|+|+
T Consensus 17 ~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~ 93 (220)
T 2v9t_B 17 DCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93 (220)
T ss_dssp ECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSCCC
T ss_pred EcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCcCC
Confidence 33445555 4565543 67888888888887766667777777777777777777665666666665555555555555
Q ss_pred CCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhcc
Q 043136 164 GPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFA 243 (902)
Q Consensus 164 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 243 (902)
+..+..|..+++|++|+|++|+ +++..|..|..+++|++|+|++|+|++..+..|.
T Consensus 94 ~l~~~~f~~l~~L~~L~L~~N~------------------------l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 149 (220)
T 2v9t_B 94 ELPKSLFEGLFSLQLLLLNANK------------------------INCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149 (220)
T ss_dssp CCCTTTTTTCTTCCEEECCSSC------------------------CCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ccCHhHccCCCCCCEEECCCCC------------------------CCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh
Confidence 4444444444445555554444 4444444455555555555555555544444555
Q ss_pred CCCCCCEEEccCccCc
Q 043136 244 SLVNLKYMDISACNLS 259 (902)
Q Consensus 244 ~l~~L~~L~Ls~N~l~ 259 (902)
.+++|++|+|++|.+.
T Consensus 150 ~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 150 PLRAIQTMHLAQNPFI 165 (220)
T ss_dssp TCTTCCEEECCSSCEE
T ss_pred CCCCCCEEEeCCCCcC
Confidence 5555555555555554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.7e-19 Score=200.51 Aligned_cols=176 Identities=28% Similarity=0.301 Sum_probs=122.8
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCcccc-CCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG-LLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 255 (902)
+.+++++|.++ .+|..+. +.++.|+|++|+|++..+..|. .+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46666666666 3555443 3467777777777766666666 777777777777777766667777777777777777
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccc---cccCCCCEEEccCccccc
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASL---ASLKGLTRLSLMNNVLFG 332 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l---~~l~~L~~L~L~~N~l~~ 332 (902)
|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..| ..+++|+.|+|++|+|++
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 77776666677777777777777777777777777777788888888887775444444 457777777777777776
Q ss_pred cCChhhhhccc--cceEEecCceec
Q 043136 333 EIPQDIELLAD--LDTLLLWNNHLT 355 (902)
Q Consensus 333 ~~p~~~~~l~~--L~~L~L~~N~l~ 355 (902)
..+..+..++. ++.|+|++|.+.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred cCHHHhhhccHhhcceEEecCCCcc
Confidence 55556666655 366666666664
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=184.00 Aligned_cols=156 Identities=21% Similarity=0.247 Sum_probs=110.0
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCC-ccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLP-PQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 255 (902)
+.+++++|.++ .+|..+. ..+++|+|++|++++..| ..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 46666666665 3454442 345677777777775544 3467777777777777777766666777777777777777
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCC
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIP 335 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (902)
|++++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+..+
T Consensus 91 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 170 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY 170 (220)
T ss_dssp SCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred CccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence 77776666667777777777777777777767777777777777777777777777777777777777777777765443
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.80 E-value=5.5e-22 Score=232.47 Aligned_cols=202 Identities=21% Similarity=0.148 Sum_probs=157.5
Q ss_pred ccccceeccccccccCCCchhhhcccCCcEEeccCcc-------------CcCCCCcccCCCCCCCEEE-ccCCCccCCC
Q 043136 149 LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSY-------------FDGEIPSDYRNLSSLRFLD-LAGNSLTGSL 214 (902)
Q Consensus 149 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~~~~ 214 (902)
++.|+.|+|++|+++ .+|..++.+++|+.|++++|. +.+.+|..++++++|+.|+ ++.|.+.
T Consensus 348 ~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~--- 423 (567)
T 1dce_A 348 DEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD--- 423 (567)
T ss_dssp TTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH---
T ss_pred CccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc---
Confidence 344444444444443 344445555555555544443 4566777788888888888 6666543
Q ss_pred CccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcC
Q 043136 215 PPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQ 294 (902)
Q Consensus 215 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 294 (902)
+|..+.+++|.|+...+ ..|++|+|++|+|++ +|. |.++++|++|+|++|+|+ .+|..+++++
T Consensus 424 --------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 486 (567)
T 1dce_A 424 --------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALR 486 (567)
T ss_dssp --------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCT
T ss_pred --------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCC
Confidence 46667778888874332 248999999999996 676 999999999999999999 7899999999
Q ss_pred cCcEEecccCCCccccCccccccCCCCEEEccCccccccC-ChhhhhccccceEEecCceeccccCcc---ccCCCceeE
Q 043136 295 ALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEI-PQDIELLADLDTLLLWNNHLTGVLPQK---LGSNGKLLT 370 (902)
Q Consensus 295 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~~~~---~~~~~~L~~ 370 (902)
+|+.|+|++|+|++ +| .+..+++|+.|+|++|++++.+ |..++.+++|+.|+|++|.|++.+|.. +..+++|+.
T Consensus 487 ~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~ 564 (567)
T 1dce_A 487 CLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSS 564 (567)
T ss_dssp TCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSE
T ss_pred CCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCc
Confidence 99999999999997 67 8999999999999999999887 999999999999999999999876643 334788888
Q ss_pred EEe
Q 043136 371 VDV 373 (902)
Q Consensus 371 L~L 373 (902)
|++
T Consensus 565 L~l 567 (567)
T 1dce_A 565 ILT 567 (567)
T ss_dssp EEC
T ss_pred cCC
Confidence 874
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.80 E-value=9.6e-20 Score=202.44 Aligned_cols=174 Identities=21% Similarity=0.227 Sum_probs=88.8
Q ss_pred EEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhh-ccCCCcEEEccCCCCCCCCCcccccccccceeccccc
Q 043136 82 SLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAIL-ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160 (902)
Q Consensus 82 ~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N 160 (902)
.+++++++|+. +|..+. +.++.|+|++|+|++..+..+. .+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 22 ~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 46667777763 565443 3467777777777766666665 6666666666666666554444555555555554444
Q ss_pred cccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCCh
Q 043136 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPV 240 (902)
Q Consensus 161 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 240 (902)
+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+.
T Consensus 99 ~l~~~~~~------------------------~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~ 154 (361)
T 2xot_A 99 HLHTLDEF------------------------LFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVE 154 (361)
T ss_dssp CCCEECTT------------------------TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGG
T ss_pred cCCcCCHH------------------------HhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHH
Confidence 44443333 344444444444444444444444444444444444444444433223
Q ss_pred hc---cCCCCCCEEEccCccCcccCCccccCCCC--ccEEecCCCcc
Q 043136 241 EF---ASLVNLKYMDISACNLSGTLPSEISNLTK--LEMLLLFKNHF 282 (902)
Q Consensus 241 ~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~--L~~L~L~~N~l 282 (902)
.| ..+++|++|+|++|+|++..+..+..++. |+.|+|++|.+
T Consensus 155 ~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~ 201 (361)
T 2xot_A 155 LIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201 (361)
T ss_dssp GTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCE
T ss_pred HhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCc
Confidence 33 33455555555555555333334444433 23344444433
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.80 E-value=3.6e-19 Score=183.05 Aligned_cols=152 Identities=21% Similarity=0.333 Sum_probs=92.9
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+.+++++|.++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 34555555555 3444332 45666666666666555555666666666666666666555666666666666666666
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (902)
+|+...+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 91 ~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred cCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 666544445566666666666666666665666666666666666666666655556666666666666666654
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.3e-18 Score=178.22 Aligned_cols=156 Identities=24% Similarity=0.276 Sum_probs=108.1
Q ss_pred CcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC
Q 043136 176 LQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255 (902)
Q Consensus 176 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 255 (902)
.+.++.+++.+. .+|..+. ++|++|+|++|++++..|..|..+++|++|+|++|+|+...+..|..+++|++|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 345666666665 4444332 6677777777777766666677777777777777777655556667777777777777
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCC
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIP 335 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (902)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+..+
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 7777666666677777777777777777 566677777777777777777776666667777777777777777765443
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-19 Score=190.19 Aligned_cols=167 Identities=24% Similarity=0.288 Sum_probs=72.7
Q ss_pred cccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEe
Q 043136 150 RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 150 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 229 (902)
.++..++++.|.+++.. .+..+++|++|++++|.++. +| .+..+++|++|+|++|++++.. . +..+++|++|++
T Consensus 19 ~~l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~-~-l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLS-P-LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCG-G-GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCccccc--chhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCCh-h-hccCCCCCEEEC
Confidence 33444444444443222 34444444444444444442 22 3444444444444444444322 2 444444444444
Q ss_pred eCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccc
Q 043136 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 309 (902)
++|++++. |. +.. ++|++|+|++|++++. + .+..+++|++|+|++|++++. + .+..+++|++|+|++|++++.
T Consensus 93 ~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~~-~-~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~ 165 (263)
T 1xeu_A 93 NRNRLKNL-NG-IPS-ACLSRLFLDNNELRDT-D-SLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT 165 (263)
T ss_dssp CSSCCSCC-TT-CCC-SSCCEEECCSSCCSBS-G-GGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred CCCccCCc-Cc-ccc-CcccEEEccCCccCCC-h-hhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence 44444432 11 111 4444555555544432 1 244444444444444444432 1 344444444444444444433
Q ss_pred cCccccccCCCCEEEccCcccc
Q 043136 310 IPASLASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~ 331 (902)
..+..+++|+.|++++|.+.
T Consensus 166 --~~l~~l~~L~~L~l~~N~~~ 185 (263)
T 1xeu_A 166 --GGLTRLKKVNWIDLTGQKCV 185 (263)
T ss_dssp --TTSTTCCCCCEEEEEEEEEE
T ss_pred --HHhccCCCCCEEeCCCCccc
Confidence 33444444444444444443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.8e-20 Score=223.65 Aligned_cols=200 Identities=21% Similarity=0.259 Sum_probs=83.1
Q ss_pred EecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccC
Q 043136 372 DVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451 (902)
Q Consensus 372 ~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 451 (902)
+++.|++. ..|..+..+..|+.|+|++|++. .+|..+..+++|+.|+|++|.|+ .+|..|+.+++|++|||++|+|+
T Consensus 207 ~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~ 283 (727)
T 4b8c_D 207 DDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT 283 (727)
T ss_dssp ----------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS
T ss_pred ccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC
Confidence 33444444 34455555555666666666555 45555556666666666666666 56666666666666666666666
Q ss_pred CCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCccCCCcccccccc--cccEEeccCccccccCCccc
Q 043136 452 GEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCK--SIYKIELHNNLLNGSIPWDI 529 (902)
Q Consensus 452 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~--~l~~l~Ls~N~l~g~ip~~~ 529 (902)
.+|..|+++++|++|+|++|.|+ .+|..|+.+++|+.|+|++|++++.+|..+... ....++|++|.++|.+|.+
T Consensus 284 -~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~- 360 (727)
T 4b8c_D 284 -SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE- 360 (727)
T ss_dssp -SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC-
T ss_pred -ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCccc-
Confidence 55666666666666666666664 455556666666666666666665555544311 1122445555555544432
Q ss_pred cccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCC
Q 043136 530 GHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIP 598 (902)
Q Consensus 530 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip 598 (902)
|..|++++|.- . ....+.|++.++..+.++..+....+++|-+.+...
T Consensus 361 -----l~~l~l~~n~~---~-------------~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~~~~~ 408 (727)
T 4b8c_D 361 -----RRFIEINTDGE---P-------------QREYDSLQQSTEHLATDLAKRTFTVLSYNTLCQHYA 408 (727)
T ss_dssp --------------------------------------------------------------CCCGGGC
T ss_pred -----cceeEeecccc---c-------------ccccCCccccccchhhcccccceeeeeccccccccC
Confidence 23333443300 0 000114444455556666677777778887765444
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=2.5e-19 Score=189.55 Aligned_cols=151 Identities=23% Similarity=0.287 Sum_probs=87.4
Q ss_pred cccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc
Q 043136 146 ISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE 225 (902)
Q Consensus 146 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 225 (902)
+..+++|+.|++++|.++. +| .+..+++|++|+|++|++++..+ +.++++|++|+|++|++++ +|... . ++|+
T Consensus 37 ~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~-~-~~L~ 109 (263)
T 1xeu_A 37 QKELSGVQNFNGDNSNIQS-LA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIP-S-ACLS 109 (263)
T ss_dssp HHHHTTCSEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCC-C-SSCC
T ss_pred hhhcCcCcEEECcCCCccc-ch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCccc-c-Cccc
Confidence 3334444444444444432 22 34555555555555555554333 5556666666666666653 33222 2 5666
Q ss_pred EEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCC
Q 043136 226 RIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305 (902)
Q Consensus 226 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 305 (902)
+|++++|+|++. ..+..+++|++|+|++|++++. + .+..+++|++|+|++|++++. ..+..+++|+.|++++|.
T Consensus 110 ~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~ 183 (263)
T 1xeu_A 110 RLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQK 183 (263)
T ss_dssp EEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEE
T ss_pred EEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCc
Confidence 666666666643 2466667777777777777643 3 566677777777777777654 556677777777777777
Q ss_pred Cccc
Q 043136 306 LSGP 309 (902)
Q Consensus 306 l~~~ 309 (902)
+++.
T Consensus 184 ~~~~ 187 (263)
T 1xeu_A 184 CVNE 187 (263)
T ss_dssp EECC
T ss_pred ccCC
Confidence 7654
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.77 E-value=1.6e-18 Score=174.98 Aligned_cols=152 Identities=19% Similarity=0.271 Sum_probs=92.0
Q ss_pred hcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCE
Q 043136 171 VQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKY 250 (902)
Q Consensus 171 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 250 (902)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .++.+..+++|++|++++|++++..|..|..+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 55666666666666666 344 4666666666666666554 2335666666666666666666655666666666666
Q ss_pred EEccCccCcccCCccccCCCCccEEecCCCc-cceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcc
Q 043136 251 MDISACNLSGTLPSEISNLTKLEMLLLFKNH-FTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329 (902)
Q Consensus 251 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (902)
|+|++|++++..|..+..+++|++|+|++|+ ++ .+| .+..+++|++|++++|++++ ++ .+..+++|+.|++++|+
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~ 192 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQT 192 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC-
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcc
Confidence 6666666665555666666666666666665 43 333 45556666666666666654 22 45555666666666665
Q ss_pred c
Q 043136 330 L 330 (902)
Q Consensus 330 l 330 (902)
+
T Consensus 193 i 193 (197)
T 4ezg_A 193 I 193 (197)
T ss_dssp -
T ss_pred c
Confidence 5
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.76 E-value=1.7e-18 Score=174.85 Aligned_cols=132 Identities=16% Similarity=0.212 Sum_probs=67.5
Q ss_pred hhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCC
Q 043136 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249 (902)
Q Consensus 170 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 249 (902)
+..+++|++|++++|.++ .++.+..+++|++|++++|++++..|..++.+++|++|++++|++++..|..+..+++|+
T Consensus 62 l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~ 139 (197)
T 4ezg_A 62 IEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVN 139 (197)
T ss_dssp GGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCC
T ss_pred HhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCC
Confidence 333444444444444332 122344455555555555555544455555555555555555555555555555555566
Q ss_pred EEEccCcc-CcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc
Q 043136 250 YMDISACN-LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 250 ~L~Ls~N~-l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
+|+|++|. ++ .+| .+..+++|++|++++|++++ ++ .+..+++|++|++++|++.
T Consensus 140 ~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 140 SIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp EEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC---
T ss_pred EEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCcccC
Confidence 66666555 33 333 45556666666666666653 22 4555666666666666654
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.73 E-value=1.1e-17 Score=168.12 Aligned_cols=132 Identities=20% Similarity=0.222 Sum_probs=71.3
Q ss_pred cEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCC-cCcccCcCceecccccccCCCcChhhhcccccceeccCC
Q 043136 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPR-DLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASS 495 (902)
Q Consensus 417 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 495 (902)
+.+++++|+++ .+|..+.. +|++|+|++|++++..+. .|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56666666664 45554432 566666666666544443 255555555555555555544444444444333333333
Q ss_pred CccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCC
Q 043136 496 SKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIP 574 (902)
Q Consensus 496 N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip 574 (902)
|+|++..|..|+.+++|++|+|++|+|++.+|..++.+++|+.|+|++|.+++..+
T Consensus 88 -----------------------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~ 143 (192)
T 1w8a_A 88 -----------------------NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH 143 (192)
T ss_dssp -----------------------CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred -----------------------CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence 33333444445555666666666666666666666666666666666666665443
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=6.3e-18 Score=178.23 Aligned_cols=140 Identities=19% Similarity=0.169 Sum_probs=104.8
Q ss_pred cCCcEeeecCceEEEEEEe-CCCcE--EEEEEecccchh---------------------hHHHHHHHHHHHHHHhcCCc
Q 043136 713 MSDKILGMGSTGTVYKAEM-PGGEI--IAVKKLWGKHKE---------------------NIRRRRGVLAEVDVLGNVRH 768 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~-~~~~~--vavK~i~~~~~~---------------------~~~~~~~~~~Ei~il~~l~h 768 (902)
.+.+.||+|+||.||+|.. .+|+. ||||++...... .......+.+|++++.++.|
T Consensus 50 ~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 129 (258)
T 1zth_A 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKE 129 (258)
T ss_dssp EEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHH
T ss_pred hhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHh
Confidence 4568899999999999987 67888 999987432111 11223467889999999987
Q ss_pred Cee--EeEEeEEecCCeeEEEEEccCC-C----CHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHH-hCCCCCeEE
Q 043136 769 RNI--VRLLGCCSNRECTMLLYEYMPN-G----NLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH-HDCDPVIVH 840 (902)
Q Consensus 769 ~nI--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH 840 (902)
+++ +..+++ +..++||||+.+ | +|.++.... ++.....++.|++.|++||| +.+ |||
T Consensus 130 ~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~~--------~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 130 AGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGREL--------KELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp TTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGGG--------GGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred CCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhcc--------ChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 753 444443 357899999942 3 676654321 12234578999999999999 776 999
Q ss_pred cCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 841 RDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 841 rDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|||||+|||++. .++|+|||+|.....
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEETTS
T ss_pred CCCCHHHEEEcC--cEEEEECcccccCCC
Confidence 999999999998 999999999987643
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.73 E-value=1.6e-18 Score=190.07 Aligned_cols=292 Identities=16% Similarity=0.136 Sum_probs=174.2
Q ss_pred cccCcccc--CCCCCCEEEccCCCCcccCchhhhc-cCCCcEEEccCCCCC--CCCCcccccccccceeccccccccCCC
Q 043136 92 GPIPPEIR--YLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISHNSFN--STFPPGISKLRFLRIFNAYSNSFTGPL 166 (902)
Q Consensus 92 g~~~~~~~--~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~Ls~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~~~~ 166 (902)
|.++..+. .+.++++|.++++ +....-..+.. +++|++|||++|++. ...+. .++.++.+.+..|.+ .
T Consensus 13 g~l~~~l~~~~~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~---~~~~~~~~~~~~~~I---~ 85 (329)
T 3sb4_A 13 GTLISMMTEEEANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAG---TYPNGKFYIYMANFV---P 85 (329)
T ss_dssp TCGGGGSCHHHHHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSS---SSGGGCCEEECTTEE---C
T ss_pred CcHHhhccchhhCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCccc---ccccccccccccccc---C
Confidence 33444444 3678888888864 22222234444 788999999999887 22222 222345555555533 2
Q ss_pred chhhhc--------ccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcc----c
Q 043136 167 PLEFVQ--------LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNN----L 234 (902)
Q Consensus 167 p~~~~~--------l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~----l 234 (902)
+..|.+ +++|++|+|.+ .++..-+.+|.++++|+.|++++|.++...+.+|..+.++..+.++.+. .
T Consensus 86 ~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~ 164 (329)
T 3sb4_A 86 AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFK 164 (329)
T ss_dssp TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTS
T ss_pred HHHhcccccccccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcc
Confidence 345666 88888888888 7776666778888888888888888876777778877777776665532 2
Q ss_pred CCCCChhccCCCCCC-EEEccCccCcccCCccc----cCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccc
Q 043136 235 QGEVPVEFASLVNLK-YMDISACNLSGTLPSEI----SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309 (902)
Q Consensus 235 ~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 309 (902)
......+|.++..|+ .+++.... .++..+ ....+++.+.+.++-...........+++|+.|+|++|+++.+
T Consensus 165 ~~i~~~~f~~~~~L~~~i~~~~~~---~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I 241 (329)
T 3sb4_A 165 NRWEHFAFIEGEPLETTIQVGAMG---KLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTI 241 (329)
T ss_dssp TTTTTSCEEESCCCEEEEEECTTC---CHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEE
T ss_pred ccccccccccccccceeEEecCCC---cHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCccee
Confidence 333344566666666 44443321 111111 1233444444443311110000011256666666666666655
Q ss_pred cCccccccCCCCEEEccCccccccCChhhhhccccc-eEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccC
Q 043136 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLD-TLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388 (902)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 388 (902)
.+..|.++++|+.|+|.+| +....+..|..+.+|+ .+++.+ +++.+.+..|..+.+|+.++++.|+++...+..|.+
T Consensus 242 ~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~ 319 (329)
T 3sb4_A 242 PDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGN 319 (329)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCT
T ss_pred cHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcC
Confidence 5556666666666666666 5545555666666676 677666 566566667777777777777777777666667777
Q ss_pred CCCccEEe
Q 043136 389 GDRLFKLI 396 (902)
Q Consensus 389 ~~~L~~L~ 396 (902)
+.+|+.++
T Consensus 320 ~~~L~~ly 327 (329)
T 3sb4_A 320 GVPSKLIY 327 (329)
T ss_dssp TCCCCEEE
T ss_pred Ccchhhhc
Confidence 77777665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.72 E-value=6.7e-18 Score=185.05 Aligned_cols=103 Identities=17% Similarity=0.159 Sum_probs=66.7
Q ss_pred CCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCc-EEEccCCccCCCCCcccCCCCCCcEE
Q 043136 365 NGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLS-RLRIQDNQLNGSIPQGFGLLPNLTFM 443 (902)
Q Consensus 365 ~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L 443 (902)
+++|+.+++++|+++...+..|.++.+|+.+++.+| ++..-+..|.+|++|+ .+++.+ +++..-+.+|.++++|+.|
T Consensus 225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l 302 (329)
T 3sb4_A 225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV 302 (329)
T ss_dssp CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence 344555555555555444444555555555555554 4444455677777777 777777 6665556778888888888
Q ss_pred EccCcccCCCCCCcCcccCcCceecc
Q 043136 444 DMSRNSLSGEIPRDLGNAQKLEYLNI 469 (902)
Q Consensus 444 ~Ls~N~l~~~~p~~~~~l~~L~~L~L 469 (902)
++++|+++...+.+|.++++|+.++.
T Consensus 303 ~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 303 LATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred EeCCCccCccchhhhcCCcchhhhcc
Confidence 88888887666677888888877753
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.6e-17 Score=164.23 Aligned_cols=131 Identities=28% Similarity=0.336 Sum_probs=65.7
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCc-cccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccC
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPP-QLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISA 255 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 255 (902)
+++++++|.++ .+|..+.. +|++|+|++|++++..+. .|+.+++|++|+|++|+|++..|..|.+++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--------- 78 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGAS--------- 78 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCT---------
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcc---------
Confidence 45566666554 44443322 555555555555543332 244455555555555555544444444444
Q ss_pred ccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccC
Q 043136 256 CNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEI 334 (902)
Q Consensus 256 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 334 (902)
+|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+.+..
T Consensus 79 ---------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c 142 (192)
T 1w8a_A 79 ---------------HIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC 142 (192)
T ss_dssp ---------------TCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred ---------------cCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence 4444444444444444444555555555555555555555555555555555555555554443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.69 E-value=6.5e-17 Score=158.64 Aligned_cols=133 Identities=22% Similarity=0.234 Sum_probs=77.8
Q ss_pred CCCCCEEEccCCCCc-ccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEE
Q 043136 101 LTSLTHLNLSANAFD-GPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQL 179 (902)
Q Consensus 101 l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 179 (902)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|++++.+|..+..+++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 366777777777776 56666667777777777777777654 556666666666666666666566666666666666
Q ss_pred eccCccCcCCC-CcccCCCCCCCEEEccCCCccCCCC---ccccCCCCCcEEEeeCcccC
Q 043136 180 NLGGSYFDGEI-PSDYRNLSSLRFLDLAGNSLTGSLP---PQLGLLTQLERIEIGYNNLQ 235 (902)
Q Consensus 180 ~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L~~N~l~ 235 (902)
+|++|.+++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 66666665432 1445555555555555555553222 23444444444444444433
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=1.1e-16 Score=156.86 Aligned_cols=131 Identities=24% Similarity=0.283 Sum_probs=64.1
Q ss_pred CCcEEeccCccCc-CCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEc
Q 043136 175 SLQQLNLGGSYFD-GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253 (902)
Q Consensus 175 ~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 253 (902)
+|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|++++|++++.+|..+..+++|++|+|
T Consensus 25 ~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 25 AVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp SCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred cCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 4444444444444 34444444444555555555554432 44444555555555555555444444444555555555
Q ss_pred cCccCcccC-CccccCCCCccEEecCCCccceecC---CCCCCcCcCcEEecccCCCc
Q 043136 254 SACNLSGTL-PSEISNLTKLEMLLLFKNHFTGEIP---VSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 254 s~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++|++++.. +..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+.
T Consensus 103 s~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 103 SGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp BSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred cCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence 555554321 1445555555555555555553322 24555555555555555554
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.66 E-value=3.4e-16 Score=154.88 Aligned_cols=132 Identities=27% Similarity=0.319 Sum_probs=78.5
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
.|+|.+|.|+.. +++ .+|..+ .++|++|++++|++++..+..|..+++|++|+|++|++++..+.
T Consensus 6 ~C~~~~l~~~~~------------~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 70 (177)
T 2o6r_A 6 SCSGTEIRCNSK------------GLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDG 70 (177)
T ss_dssp EEETTEEECCSS------------CCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTT
T ss_pred EeCCCEEEecCC------------CCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChh
Confidence 478888888543 333 344333 36788888888888776666677777777777777777765555
Q ss_pred ccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCcc
Q 043136 145 GISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 211 (902)
.++.+++|++|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|++|.++
T Consensus 71 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 71 VFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp TTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred HccCCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 5555555555555555555544444455555555555555554433333444444444444444444
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1e-16 Score=153.75 Aligned_cols=109 Identities=22% Similarity=0.287 Sum_probs=63.0
Q ss_pred CCCCEEEccCCCCc-ccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEe
Q 043136 102 TSLTHLNLSANAFD-GPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 180 (902)
++|++|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|++++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666666 55666666666666666666666654 4555556666666666666555555555566666666
Q ss_pred ccCccCcCC-CCcccCCCCCCCEEEccCCCccC
Q 043136 181 LGGSYFDGE-IPSDYRNLSSLRFLDLAGNSLTG 212 (902)
Q Consensus 181 L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 212 (902)
+++|++++. .+..++++++|++|++++|.+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~ 127 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN 127 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc
Confidence 666655542 22444555555555555555543
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.65 E-value=1.7e-16 Score=152.23 Aligned_cols=126 Identities=23% Similarity=0.289 Sum_probs=64.5
Q ss_pred cCCcEEeccCccCc-CCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEE
Q 043136 174 NSLQQLNLGGSYFD-GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252 (902)
Q Consensus 174 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 252 (902)
++|++|++++|.++ +.+|..+..+++|++|+|++|++++. ..++.+++|++|++++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 45556666666655 45555555566666666666665543 4455555555555555555554555555555555555
Q ss_pred ccCccCccc-CCccccCCCCccEEecCCCccceecC---CCCCCcCcCcEEec
Q 043136 253 ISACNLSGT-LPSEISNLTKLEMLLLFKNHFTGEIP---VSYGNLQALQVLDL 301 (902)
Q Consensus 253 Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p---~~~~~l~~L~~L~L 301 (902)
+++|.+++. .+..+..+++|++|++++|++++..+ ..+..+++|++|++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l 147 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDG 147 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETT
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccC
Confidence 555555532 12344444444444444444443322 23334444444444
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.2e-15 Score=152.98 Aligned_cols=108 Identities=25% Similarity=0.378 Sum_probs=50.3
Q ss_pred CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecc
Q 043136 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302 (902)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 302 (902)
+|++|++++|+|+ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus 32 ~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L~ 110 (193)
T 2wfh_A 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLH 110 (193)
T ss_dssp TCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECC
T ss_pred CCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEECC
Confidence 3444444444443 233344444444444444444444434444444444444444444444444444445555555555
Q ss_pred cCCCccccCccccccCCCCEEEccCcccc
Q 043136 303 DNQLSGPIPASLASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 303 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (902)
+|+|++..+..|..+++|+.|+|++|.+.
T Consensus 111 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 111 GNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 55554444444555555555555555554
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-15 Score=152.96 Aligned_cols=128 Identities=21% Similarity=0.275 Sum_probs=108.8
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+.+++++|.++ .+|..+. ++|++|+|++|+++ .+|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 67888888887 5666543 58899999999998 67788888999999999999999888888899999999999999
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcc
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+..
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 9988888888889999999999999987666678888999999999998864
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.63 E-value=5.8e-15 Score=165.33 Aligned_cols=264 Identities=11% Similarity=0.044 Sum_probs=127.9
Q ss_pred CCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEe
Q 043136 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLN 180 (902)
Q Consensus 101 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 180 (902)
+..++.+.+.+ .++.+...+|.++ +|+.++|..| ++..-...|.+ .+|+.+.+.. .++...+.+|.++++|+.++
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~ 186 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD 186 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence 35566666643 3444445555553 5666666554 44333334444 2355555443 33333344444444444444
Q ss_pred ccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcc
Q 043136 181 LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG 260 (902)
Q Consensus 181 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 260 (902)
|++|.++......|. .++|+.+.+.. .++.+...+|.++++|+.+++..| ++.
T Consensus 187 l~~n~l~~I~~~aF~-------------------------~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~~ 239 (401)
T 4fdw_A 187 LSKTKITKLPASTFV-------------------------YAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VST 239 (401)
T ss_dssp CTTSCCSEECTTTTT-------------------------TCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CCE
T ss_pred cCCCcceEechhhEe-------------------------ecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-ccC
Confidence 444444433333333 34444444442 243333444445555555555442 332
Q ss_pred cCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc-----cccCccccccCCCCEEEccCccccccCC
Q 043136 261 TLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS-----GPIPASLASLKGLTRLSLMNNVLFGEIP 335 (902)
Q Consensus 261 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (902)
+...+|.+ .+|+.+.+ .|.++...+..|.++++|+.+++.+|.+. ...+..|.++++|+.++|.+ .+.....
T Consensus 240 I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~~ 316 (401)
T 4fdw_A 240 IGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILGQ 316 (401)
T ss_dssp ECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEECT
T ss_pred cccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEhh
Confidence 33334444 44555555 23344344444555555555555554443 23344555555555555552 3444444
Q ss_pred hhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCC-CccEEeccCCc
Q 043136 336 QDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGD-RLFKLILFSNN 401 (902)
Q Consensus 336 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~-~L~~L~l~~N~ 401 (902)
..|..+.+|+.+.|..| ++.+....|..+ +|+.+++++|.+....+..|..++ .+..+++-.+.
T Consensus 317 ~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 317 GLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp TTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred hhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence 45555555666655433 444555556666 666666666665544444454442 45566555544
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.6e-15 Score=149.99 Aligned_cols=132 Identities=24% Similarity=0.289 Sum_probs=75.1
Q ss_pred CEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCC
Q 043136 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280 (902)
Q Consensus 201 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 280 (902)
+.+++++|+++ .+|..+. ++|++|++++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|
T Consensus 10 ~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 86 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN 86 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence 34444455444 2333222 35555555555555444445555566666666666665444445556666666666666
Q ss_pred ccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCC
Q 043136 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIP 335 (902)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 335 (902)
++++..+..+..+++|++|+|++|++++..+..+..+++|++|++++|.+.+..|
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 6665555555666666666666666665555555666666666776666665443
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.62 E-value=9.2e-15 Score=163.74 Aligned_cols=253 Identities=9% Similarity=0.049 Sum_probs=187.6
Q ss_pred cccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchh
Q 043136 90 LSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLE 169 (902)
Q Consensus 90 l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 169 (902)
++..-..+|.+. +|+.++|..| ++.+...+|.++ +|+.++|.. .++..-+..|.++++|+.++++.|+++......
T Consensus 124 i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~a 199 (401)
T 4fdw_A 124 VKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPAST 199 (401)
T ss_dssp CCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTT
T ss_pred cCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhh
Confidence 333334467775 7999999876 777777888884 799999986 777777788999999999999999999877777
Q ss_pred hhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCC
Q 043136 170 FVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLK 249 (902)
Q Consensus 170 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 249 (902)
|. ..+|+.+.|..+ +...-..+|.++++|+.+++..| ++..-..+|.+ .+|+.+.+ .|.++.+.+.+|.++++|+
T Consensus 200 F~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~ 274 (401)
T 4fdw_A 200 FV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELA 274 (401)
T ss_dssp TT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCC
T ss_pred Ee-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCC
Confidence 87 689999999855 76666778999999999999875 66555667777 78999998 4557666678888888899
Q ss_pred EEEccCccCc-----ccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEE
Q 043136 250 YMDISACNLS-----GTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLS 324 (902)
Q Consensus 250 ~L~Ls~N~l~-----~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 324 (902)
.+++.+|.+. ...+.+|.++++|+.++|. +.++......|.++++|+.++|..| ++..-+.+|.++ +|+.++
T Consensus 275 ~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~ 351 (401)
T 4fdw_A 275 EVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVK 351 (401)
T ss_dssp EEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEE
T ss_pred EEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEE
Confidence 9888887765 3445677777778887777 4466566667777777777777544 555556677777 777777
Q ss_pred ccCccccccCChhhhhcc-ccceEEecCcee
Q 043136 325 LMNNVLFGEIPQDIELLA-DLDTLLLWNNHL 354 (902)
Q Consensus 325 L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l 354 (902)
+++|.+....+..|..++ .+..|++..+.+
T Consensus 352 l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~ 382 (401)
T 4fdw_A 352 VEGTTPPQVFEKVWYGFPDDITVIRVPAESV 382 (401)
T ss_dssp ECCSSCCBCCCSSCCCSCTTCCEEEECGGGH
T ss_pred EcCCCCcccccccccCCCCCccEEEeCHHHH
Confidence 777766544444444442 455555555443
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=1.9e-17 Score=167.19 Aligned_cols=127 Identities=24% Similarity=0.353 Sum_probs=58.3
Q ss_pred hhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCC
Q 043136 169 EFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNL 248 (902)
Q Consensus 169 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 248 (902)
.|..+++|++|+|++|++++ +| .+.++++|++|+|++|+++ .+|..+..+++|++|++++|++++ +| .+..+++|
T Consensus 43 ~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L 117 (198)
T 1ds9_A 43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL 117 (198)
T ss_dssp HHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHS
T ss_pred HHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCC
Confidence 44444444444444444443 33 4444444444444444444 344444444445555555554443 22 34444455
Q ss_pred CEEEccCccCcccCC-ccccCCCCccEEecCCCccceecCCC----------CCCcCcCcEEe
Q 043136 249 KYMDISACNLSGTLP-SEISNLTKLEMLLLFKNHFTGEIPVS----------YGNLQALQVLD 300 (902)
Q Consensus 249 ~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~~L~~L~ 300 (902)
++|+|++|++++..+ ..+..+++|++|++++|.+++..|.. +..+++|+.||
T Consensus 118 ~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp SEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC
T ss_pred CEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC
Confidence 555555555543211 23444555555555555554443332 44555555554
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.9e-17 Score=165.90 Aligned_cols=154 Identities=21% Similarity=0.229 Sum_probs=102.9
Q ss_pred hcccCCcEEeccCccCcCCCCc------ccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccC
Q 043136 171 VQLNSLQQLNLGGSYFDGEIPS------DYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFAS 244 (902)
Q Consensus 171 ~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 244 (902)
.....++.++++.+.++|.+|. .|..+++|++|+|++|++++ +| .+..+++|++|++++|+|+ .+|..+..
T Consensus 15 ~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~ 91 (198)
T 1ds9_A 15 EERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAV 91 (198)
T ss_dssp HHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHH
T ss_pred HhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhc
Confidence 3344455555555555555444 67777777777777777775 55 6777777777777777777 45666666
Q ss_pred CCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecC-CCCCCcCcCcEEecccCCCccccCcc----------
Q 043136 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSGPIPAS---------- 313 (902)
Q Consensus 245 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~---------- 313 (902)
+++|++|+|++|++++ +| .+..+++|++|+|++|++++..+ ..+..+++|++|++++|.+++.+|..
T Consensus 92 ~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~ 169 (198)
T 1ds9_A 92 ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169 (198)
T ss_dssp HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHH
T ss_pred CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHH
Confidence 6777777777777775 34 56677777777777777774322 35667777777777777776665542
Q ss_pred ccccCCCCEEEccCcccc
Q 043136 314 LASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 314 l~~l~~L~~L~L~~N~l~ 331 (902)
+..+++|+.|| +|.++
T Consensus 170 ~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 170 VKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp HHHCSSCSEEC--CGGGT
T ss_pred HHhCCCcEEEC--CcccC
Confidence 66777777776 55554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.57 E-value=2.4e-15 Score=164.39 Aligned_cols=139 Identities=11% Similarity=0.096 Sum_probs=99.6
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccch-----------------hhH--HHHHHHHHHHHHHhcCCcCee-
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK-----------------ENI--RRRRGVLAEVDVLGNVRHRNI- 771 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~-----------------~~~--~~~~~~~~Ei~il~~l~h~nI- 771 (902)
|.+.+.||+|+||.||+|...+|+.||||++..... ... ..+....+|...+.++.+..+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 566789999999999999988999999998742110 000 011223467777777754443
Q ss_pred -EeEEeEEecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 772 -VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 772 -v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
.+.+++. ..++||||++|+++.++... + ....++.|++.++.|+|.++ ||||||||.|||+
T Consensus 177 vp~p~~~~----~~~LVME~i~G~~L~~l~~~---------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 177 VPEPIAQS----RHTIVMSLVDALPMRQVSSV---------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp CCCEEEEE----TTEEEEECCSCEEGGGCCCC---------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCeeeecc----CceEEEEecCCccHhhhccc---------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 3333322 24799999998887654211 1 12367889999999999776 9999999999999
Q ss_pred cCCC----------CEEEeecccceecc
Q 043136 851 DGEM----------EARVADFGVAKLIQ 868 (902)
Q Consensus 851 ~~~~----------~~kl~DFGla~~~~ 868 (902)
++++ .+.|+||+-+....
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred eCCCCcccccccccceEEEEeCCcccCC
Confidence 8776 38999999887654
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.1e-15 Score=147.81 Aligned_cols=111 Identities=20% Similarity=0.164 Sum_probs=64.3
Q ss_pred ccccCCCCCCEEEccCCCCcccCchhhhccC-CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhccc
Q 043136 96 PEIRYLTSLTHLNLSANAFDGPLQPAILELT-KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLN 174 (902)
Q Consensus 96 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 174 (902)
+.+.++++|++|+|++|+++.. +. +..+. +|++|+|++|.+++. ..++.+++|++|++++|+|++..+..|..++
T Consensus 13 ~~~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 13 AQYTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HhcCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 3456677777777777777743 33 44444 777777777777653 4556666666666666666554444445555
Q ss_pred CCcEEeccCccCcCCCCc--ccCCCCCCCEEEccCCCcc
Q 043136 175 SLQQLNLGGSYFDGEIPS--DYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 175 ~L~~L~L~~N~l~~~~p~--~~~~l~~L~~L~L~~N~l~ 211 (902)
+|++|+|++|+++ .+|. .+.++++|++|++++|.++
T Consensus 89 ~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~ 126 (176)
T 1a9n_A 89 DLTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT 126 (176)
T ss_dssp TCCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC
Confidence 5555555555553 2333 4444455555555555444
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.55 E-value=1.4e-13 Score=154.51 Aligned_cols=330 Identities=14% Similarity=0.071 Sum_probs=174.7
Q ss_pred CccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhccc
Q 043136 95 PPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLN 174 (902)
Q Consensus 95 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 174 (902)
..+|.++++|+++.|.. .++.+...+|.++++|+.++|..+ ++......|..++.|+.+.+..+ +......+|.++.
T Consensus 64 ~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~ 140 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCD 140 (394)
T ss_dssp TTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCC
T ss_pred HHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecceeeeccc
Confidence 34677777788887764 366556667777777777777654 44444455666666666655433 3333344555554
Q ss_pred CCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEcc
Q 043136 175 SLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254 (902)
Q Consensus 175 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 254 (902)
.++......... .-..+|.++++|+.+.+.++..+ .-...|..+++|+.+++..| ++.+...+|.++..|+.+.+.
T Consensus 141 ~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~ 216 (394)
T 4fs7_A 141 FKEITIPEGVTV--IGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFP 216 (394)
T ss_dssp CSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCC
T ss_pred ccccccCccccc--cchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecC
Confidence 333333222221 12344555566666666544322 33344555555555555443 333334445555555555544
Q ss_pred CccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccC
Q 043136 255 ACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEI 334 (902)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 334 (902)
.+... +.+.+...++|+.+.+..+ ++......|.++..|+.+.+..+..+ .....|..+..++.+..
T Consensus 217 ~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~--------- 283 (394)
T 4fs7_A 217 NSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIY--------- 283 (394)
T ss_dssp TTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEE---------
T ss_pred CCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcce-eeccccccccccceecc---------
Confidence 43322 1222233344555544332 22222334444455555555444322 33334444444444444
Q ss_pred ChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccC
Q 043136 335 PQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCS 414 (902)
Q Consensus 335 p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~ 414 (902)
..+.+. ...|..+.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.+|+
T Consensus 284 ---------------~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~ 343 (394)
T 4fs7_A 284 ---------------GSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCT 343 (394)
T ss_dssp ---------------CSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCT
T ss_pred ---------------Cceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCC
Confidence 433321 233444555555555433 33333444555556666665432 4434456678888
Q ss_pred CCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCcee
Q 043136 415 SLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYL 467 (902)
Q Consensus 415 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 467 (902)
+|+.+++..| ++..-..+|.++++|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 344 ~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 344 SLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 8888888776 66555668888888998888755 33 345678888888764
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.54 E-value=6.4e-15 Score=145.55 Aligned_cols=130 Identities=21% Similarity=0.219 Sum_probs=56.4
Q ss_pred CCCCCCCEEEccCCCccCCCCccccCCC-CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCcc
Q 043136 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLT-QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273 (902)
Q Consensus 195 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 273 (902)
.++++|++|+|++|+++. +|. +..+. +|++|++++|+|++. ..|..+++|++|+|++|++++..+..|..+++|+
T Consensus 16 ~~~~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 91 (176)
T 1a9n_A 16 TNAVRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 91 (176)
T ss_dssp ECTTSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred CCcCCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCC
Confidence 334444444444444442 222 22222 444444444444432 3344444555555555554433333334444444
Q ss_pred EEecCCCccceecCC--CCCCcCcCcEEecccCCCccccCc----cccccCCCCEEEccCccc
Q 043136 274 MLLLFKNHFTGEIPV--SYGNLQALQVLDLSDNQLSGPIPA----SLASLKGLTRLSLMNNVL 330 (902)
Q Consensus 274 ~L~L~~N~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~p~----~l~~l~~L~~L~L~~N~l 330 (902)
+|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|. .+..+++|++||+++|.+
T Consensus 92 ~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 92 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred EEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 4444444443 2222 3444444445555554444 2232 244444444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.53 E-value=2.5e-13 Score=152.49 Aligned_cols=335 Identities=13% Similarity=0.063 Sum_probs=213.9
Q ss_pred CcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcc
Q 043136 114 FDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD 193 (902)
Q Consensus 114 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 193 (902)
++.+...+|.++++|+.+.|..+ ++..-...|.++++|+.+++.++ ++..-..+|
T Consensus 59 VtsIg~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF----------------------- 113 (394)
T 4fs7_A 59 VVSIGYAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTF----------------------- 113 (394)
T ss_dssp EEEECTTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTT-----------------------
T ss_pred EeEhHHHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhh-----------------------
Confidence 34444566777777777777533 44433444555555555555433 332333344
Q ss_pred cCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCcc
Q 043136 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273 (902)
Q Consensus 194 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 273 (902)
.++++|+.+.+..+ ++..-..+|.....++..... .+......+|.++++|+.+.+..+. .......|.++++|+
T Consensus 114 -~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~~~~~~~--~~~~i~~~aF~~c~~L~~i~l~~~~-~~I~~~~F~~c~~L~ 188 (394)
T 4fs7_A 114 -SGCYALKSILLPLM-LKSIGVEAFKGCDFKEITIPE--GVTVIGDEAFATCESLEYVSLPDSM-ETLHNGLFSGCGKLK 188 (394)
T ss_dssp -TTCTTCCCCCCCTT-CCEECTTTTTTCCCSEEECCT--TCCEECTTTTTTCTTCCEEECCTTC-CEECTTTTTTCTTCC
T ss_pred -cccccchhhcccCc-eeeecceeeecccccccccCc--cccccchhhhcccCCCcEEecCCcc-ceeccccccCCCCce
Confidence 44444444444332 222223334443322222211 1222334566777777777776543 324455677777777
Q ss_pred EEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCce
Q 043136 274 MLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNH 353 (902)
Q Consensus 274 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 353 (902)
.+.+..| ++......|.++..|+.+.+..+... +........+|+.+.+..+ ++......|.....|+.+.+..+.
T Consensus 189 ~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~ 264 (394)
T 4fs7_A 189 SIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNK 264 (394)
T ss_dssp BCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTT
T ss_pred EEEcCCC-ceEeCchhhccccccceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCc
Confidence 7777665 44455566777777777777666543 3333444567777777643 233344566777888888887765
Q ss_pred eccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcc
Q 043136 354 LTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQG 433 (902)
Q Consensus 354 l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 433 (902)
.+ .....|..+..++.+....+.+. ...+..+.+|+.+.+..+ ++..-...|.++++|+.++|.++ ++..-..+
T Consensus 265 ~~-i~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~a 338 (394)
T 4fs7_A 265 LR-IGGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRS 338 (394)
T ss_dssp CE-ECSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred ce-eeccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHh
Confidence 43 56677888899999988877543 356778889999998765 66555677999999999999755 76555679
Q ss_pred cCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhccccccee
Q 043136 434 FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKIL 491 (902)
Q Consensus 434 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 491 (902)
|.++.+|+.+++..| ++..-..+|.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus 339 F~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 339 FRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred ccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 999999999999877 77666789999999999999866 32 345678888888764
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=8e-14 Score=136.69 Aligned_cols=108 Identities=20% Similarity=0.202 Sum_probs=85.5
Q ss_pred ceeccCCCccCCCcccccccccccEEeccCccccccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCc
Q 043136 489 KILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNF 568 (902)
Q Consensus 489 ~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~ 568 (902)
+.+++++|+++. +|..+ ..+++.|+|++|+|++..|..|+.+++|++|+|++|+|+++.|..|..+++|++|+|++|+
T Consensus 12 ~~l~~s~n~l~~-ip~~~-~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~ 89 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGI-PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDNQ 89 (170)
T ss_dssp TEEECTTSCCSS-CCSCC-CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred CEEEeCCCCcCc-cCccC-CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCCc
Confidence 445555555553 33322 2567778888888887778888899999999999999998888888999999999999999
Q ss_pred ccccCCCCCcCCccceeecccCCcccccCC
Q 043136 569 LTGTIPSNFENCSTLESFNVSYNLLTGPIP 598 (902)
Q Consensus 569 l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip 598 (902)
|++..|..|.++++|++|+|++|++++..+
T Consensus 90 l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~ 119 (170)
T 3g39_A 90 LKSIPRGAFDNLKSLTHIWLLNNPWDCACS 119 (170)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred cCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence 997777779999999999999999887655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.47 E-value=1.7e-13 Score=134.35 Aligned_cols=104 Identities=24% Similarity=0.288 Sum_probs=49.3
Q ss_pred CEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCC
Q 043136 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280 (902)
Q Consensus 201 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 280 (902)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 12 ~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 44555555554 2443332 44455555555555444444555555555555555555444444444444444444444
Q ss_pred ccceecCCCCCCcCcCcEEecccCCCc
Q 043136 281 HFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
+|++..+..|..+++|++|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 444433334444444444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.44 E-value=4e-13 Score=132.17 Aligned_cols=104 Identities=24% Similarity=0.319 Sum_probs=49.0
Q ss_pred CEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCC
Q 043136 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280 (902)
Q Consensus 201 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 280 (902)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 44555555554 3444332 44555555555555444445555555555555555555433333444444444444444
Q ss_pred ccceecCCCCCCcCcCcEEecccCCCc
Q 043136 281 HFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 444333333444444444444444443
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.43 E-value=5.5e-13 Score=131.16 Aligned_cols=104 Identities=20% Similarity=0.280 Sum_probs=61.5
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+.+++++|+++ .+|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N 91 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDN 91 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCC
Confidence 45555555554 4444432 55666666666666555556666666666666666666555555566666666666666
Q ss_pred cCcccCCccccCCCCccEEecCCCccc
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
+|++..+..|..+++|++|+|++|.+.
T Consensus 92 ~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 92 HLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred ccceeCHHHhccccCCCEEEeCCCCcc
Confidence 666544445666666666666666655
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.35 E-value=2.7e-14 Score=158.37 Aligned_cols=186 Identities=15% Similarity=0.137 Sum_probs=85.1
Q ss_pred CCCCEEEccCCCCcccCchhhhcc-----CCCcEEEccCCCCCCCCCccc-ccccccceeccccccccCCCchhhh----
Q 043136 102 TSLTHLNLSANAFDGPLQPAILEL-----TKLRTIDISHNSFNSTFPPGI-SKLRFLRIFNAYSNSFTGPLPLEFV---- 171 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l-----~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~N~l~~~~p~~~~---- 171 (902)
++|++|+|++|.++......+... ++|++|+|++|.++......+ ..+++|+.|+|++|.++......++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 456677777777665444444333 566666666666654322222 2334555555555555433222222
Q ss_pred -cccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCC----CChhccCCC
Q 043136 172 -QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGE----VPVEFASLV 246 (902)
Q Consensus 172 -~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~ 246 (902)
..++|++|+|++|.|+..-.. .++..+...++|++|+|++|.|+.. ++..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~--------------------~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~ 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVA--------------------VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHH--------------------HHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS
T ss_pred hcCCccceeeCCCCCCChHHHH--------------------HHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC
Confidence 123444444444444321000 1222233444455555555554421 133444455
Q ss_pred CCCEEEccCccCccc----CCccccCCCCccEEecCCCccceecCCCCCC---cC--cCcEEe--cccCCCc
Q 043136 247 NLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGEIPVSYGN---LQ--ALQVLD--LSDNQLS 307 (902)
Q Consensus 247 ~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~---l~--~L~~L~--Ls~N~l~ 307 (902)
+|++|+|++|.|+.. ++..+...++|++|+|++|.|+......+.. .. .|+.+. +..|.++
T Consensus 212 ~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 212 QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 566666666666532 2233344566666666666665432222211 11 166666 6666665
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.34 E-value=1.1e-12 Score=144.67 Aligned_cols=108 Identities=19% Similarity=0.214 Sum_probs=80.7
Q ss_pred CccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccC-CCCcccCchhhhccCCCcEEEccCCCCCCCCCc
Q 043136 66 CSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSA-NAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 66 C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
|.|.+|.|+.. |+|++ +|. |..+++|++|+|++ |.|++..+..|..|++|++|+|++|+|++..|.
T Consensus 8 C~~~~v~~~~~-----------n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~ 74 (347)
T 2ifg_A 8 HGSSGLRCTRD-----------GALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD 74 (347)
T ss_dssp SSSSCEECCSS-----------CCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTT
T ss_pred ccCCEEEcCCC-----------CCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHH
Confidence 88877777432 15663 777 88889999999986 888888888888888888888888888887777
Q ss_pred ccccccccceeccccccccCCCchhhhcccCCcEEeccCccCc
Q 043136 145 GISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFD 187 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 187 (902)
.|++|++|+.|+|++|+|++..+..|..++ |+.|+|.+|.+.
T Consensus 75 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 75 AFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp GGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred HhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777777777777777777765555555554 666666666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.33 E-value=2e-14 Score=159.35 Aligned_cols=184 Identities=17% Similarity=0.118 Sum_probs=112.4
Q ss_pred cCCCcEEEccCCCCCCCCCcccccc-----cccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCC
Q 043136 125 LTKLRTIDISHNSFNSTFPPGISKL-----RFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSS 199 (902)
Q Consensus 125 l~~L~~L~Ls~N~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 199 (902)
++.|++|+|++|.++......+... ++|+.|+|++|.++......+. ..+++
T Consensus 71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~-----------------------~~L~~ 127 (372)
T 3un9_A 71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLL-----------------------PVFLR 127 (372)
T ss_dssp HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTH-----------------------HHHHT
T ss_pred HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHH-----------------------HHHHh
Confidence 4567777777777764333222221 3455555555544322211111 22345
Q ss_pred CCEEEccCCCccCCCCccc-----cCCCCCcEEEeeCcccCC----CCChhccCCCCCCEEEccCccCccc----CCccc
Q 043136 200 LRFLDLAGNSLTGSLPPQL-----GLLTQLERIEIGYNNLQG----EVPVEFASLVNLKYMDISACNLSGT----LPSEI 266 (902)
Q Consensus 200 L~~L~L~~N~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~ 266 (902)
|++|+|++|.|+..-...+ ...++|++|+|++|.|+. .++..+...++|++|+|++|.|+.. ++..+
T Consensus 128 L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L 207 (372)
T 3un9_A 128 ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQL 207 (372)
T ss_dssp EEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHG
T ss_pred ccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHH
Confidence 5566666665553222222 234667788888887764 2345567889999999999999853 35567
Q ss_pred cCCCCccEEecCCCccceec----CCCCCCcCcCcEEecccCCCccccCccccccCC-----CCEEE--ccCcccc
Q 043136 267 SNLTKLEMLLLFKNHFTGEI----PVSYGNLQALQVLDLSDNQLSGPIPASLASLKG-----LTRLS--LMNNVLF 331 (902)
Q Consensus 267 ~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~-----L~~L~--L~~N~l~ 331 (902)
...++|++|+|++|.|+... +..+...++|++|+|++|.|+......+..+.. |+.+. +..|.+.
T Consensus 208 ~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 208 DRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp GGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred hcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 78889999999999998532 334445689999999999998665555544322 66676 6666664
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.29 E-value=2.2e-10 Score=128.44 Aligned_cols=331 Identities=12% Similarity=0.101 Sum_probs=176.6
Q ss_pred ccccCCC-CCCEEEccCCCCcccCchhhhccCCCcEEEccCCC---CCCCCCcccccccccceeccccccccCCCchhhh
Q 043136 96 PEIRYLT-SLTHLNLSANAFDGPLQPAILELTKLRTIDISHNS---FNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFV 171 (902)
Q Consensus 96 ~~~~~l~-~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~ 171 (902)
.+|.+.+ .|+.+.+..+ ++.+...+|.++++|+.+.++.|. ++..-...|..+..|+.+.+..+ ++......|.
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~ 134 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFH 134 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhh
Confidence 4566664 5888888754 776777888899999999888764 55444566777788887777654 4445556777
Q ss_pred cccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEE
Q 043136 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251 (902)
Q Consensus 172 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 251 (902)
.+.+|+.+.+..+ +.......|.++.+|+.+.+..+ ++..-..+|.. .+|+.+.+..+-.. ....+|..+.+++..
T Consensus 135 ~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~ 210 (394)
T 4gt6_A 135 HCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTI 210 (394)
T ss_dssp TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEE
T ss_pred hhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhcccccee
Confidence 8888888888644 33344556777788888887655 44333344543 56777777654332 445667777777776
Q ss_pred EccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc
Q 043136 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 252 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (902)
....+.... +...+..........+ ..+.....+..+.+. +.++..-..+|.++..|+.+.+..+..
T Consensus 211 ~~~~~~~~~-~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~- 277 (394)
T 4gt6_A 211 TSDSESYPA-IDNVLYEKSANGDYAL----------IRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVV- 277 (394)
T ss_dssp EECCSSSCB-SSSCEEEECTTSCEEE----------EECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCC-
T ss_pred ccccccccc-ccceeecccccccccc----------cccccccccceEEcC-CcceEcccceeeecccccEEecccccc-
Confidence 665554431 1111111000000000 000011112222221 112222233444444455554443322
Q ss_pred ccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCccccccccc
Q 043136 332 GEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411 (902)
Q Consensus 332 ~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~ 411 (902)
......|..+..|+.+.+. +.++......|..+.+|+.+++..+ ++..-...|.++.+|+.+.+..+ ++..-...|.
T Consensus 278 ~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~ 354 (394)
T 4gt6_A 278 SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFS 354 (394)
T ss_dssp EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGT
T ss_pred eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhh
Confidence 1223334444555555543 3333344455555556666665543 44334455555666666666433 4444456788
Q ss_pred ccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccC
Q 043136 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451 (902)
Q Consensus 412 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 451 (902)
+|++|+.+++.+|.... ..|....+|+.+.+..|.+.
T Consensus 355 ~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~~ 391 (394)
T 4gt6_A 355 NCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSID 391 (394)
T ss_dssp TCTTCCEEEESSCHHHH---HTCBCCCCC-----------
T ss_pred CCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence 88888888888876531 45667778888887766553
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.26 E-value=1.4e-11 Score=135.73 Aligned_cols=103 Identities=25% Similarity=0.166 Sum_probs=60.3
Q ss_pred EEEccCC-CccCCCCccccCCCCCcEEEeeC-cccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCC
Q 043136 202 FLDLAGN-SLTGSLPPQLGLLTQLERIEIGY-NNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFK 279 (902)
Q Consensus 202 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 279 (902)
.++++++ +|+ .+|. +..+++|++|+|++ |+|++..+..|.++++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 12 ~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4566666 666 3555 66666666666664 666655556666666666666666666665555566666666666666
Q ss_pred CccceecCCCCCCcCcCcEEecccCCCc
Q 043136 280 NHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 280 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
|+|++..+..|..++ |+.|+|++|.+.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 666544444444333 555555555544
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.25 E-value=3.9e-10 Score=126.36 Aligned_cols=335 Identities=10% Similarity=0.056 Sum_probs=152.7
Q ss_pred cccCchhhhccC-CCcEEEccCCCCCCCCCcccccccccceecccccc---ccCCCchhhhcccCCcEEeccCccCcCCC
Q 043136 115 DGPLQPAILELT-KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNS---FTGPLPLEFVQLNSLQQLNLGGSYFDGEI 190 (902)
Q Consensus 115 ~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~---l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 190 (902)
+.+...+|.++. .|+.+.+-.+ ++..-...|.++++|+.+.+..|. ++..-..+|
T Consensus 52 t~Ig~~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF-------------------- 110 (394)
T 4gt6_A 52 SKIGDRVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAF-------------------- 110 (394)
T ss_dssp EEECTTTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTT--------------------
T ss_pred eEcCHhhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhc--------------------
Confidence 334455666663 4777777543 444444445555555555554442 332233344
Q ss_pred CcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCC
Q 043136 191 PSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLT 270 (902)
Q Consensus 191 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 270 (902)
.++.+|+.+.+..+ ++..-...|..+.+|+.+.+..+ +..+....|..+.+|+.+.+..+ ++..-..+|. ..
T Consensus 111 ----~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~-~~ 182 (394)
T 4gt6_A 111 ----MFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFT-GT 182 (394)
T ss_dssp ----TTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTT-TC
T ss_pred ----hhcccceeeccCCc-cceehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEecccccc-cc
Confidence 44444444444332 22223334444555555555422 22233344555555555555433 2222223333 24
Q ss_pred CccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEec
Q 043136 271 KLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLW 350 (902)
Q Consensus 271 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 350 (902)
+|+.+.+..+-.. .....|.++.+++......+......-..+........-... +.....+..+.+.
T Consensus 183 ~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~ip 250 (394)
T 4gt6_A 183 ALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGDYALIR-----------YPSQREDPAFKIP 250 (394)
T ss_dssp CCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSCEEEEE-----------CCTTCCCSEEECC
T ss_pred ceeEEEECCcccc-cccchhhhccccceecccccccccccceeecccccccccccc-----------cccccccceEEcC
Confidence 4555555443222 333445555555555554443321111111110000000000 0000111122211
Q ss_pred CceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCC
Q 043136 351 NNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSI 430 (902)
Q Consensus 351 ~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 430 (902)
+.++......|..+..|+.+.+..+..+ .....|.++..|+.+.+. +.++..-...|.+|.+|+.++|.++ ++..-
T Consensus 251 -~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~ 326 (394)
T 4gt6_A 251 -NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQIL 326 (394)
T ss_dssp -TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEEC
T ss_pred -CcceEcccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEeh
Confidence 1222233445555555665555543322 333445555666666654 3344344455677777777777654 54344
Q ss_pred CcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhcccccceeccCCCcc
Q 043136 431 PQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKL 498 (902)
Q Consensus 431 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l 498 (902)
..+|.++.+|+.+.+..+ ++..-..+|.++.+|+.+++.+|... -..+....+|+.+.+..|.+
T Consensus 327 ~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~---~~~~~~~~~L~~i~i~~~~~ 390 (394)
T 4gt6_A 327 DDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ---WNAISTDSGLQNLPVAPGSI 390 (394)
T ss_dssp TTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH---HHTCBCCCCC----------
T ss_pred HhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee---hhhhhccCCCCEEEeCCCCE
Confidence 556777777777777543 55444567777777777777776542 13455666677776655543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.07 E-value=1.2e-10 Score=122.75 Aligned_cols=142 Identities=20% Similarity=0.075 Sum_probs=106.4
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.....++.|+.+.||+++.. ++.+++|+....... ....+.+|+++++.+. +..++++++++...+..|+||||
T Consensus 16 ~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 16 YRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp SEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 334566777888999999754 688999998542211 1224678999988874 67888999999888899999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-------------------------------------
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD------------------------------------- 833 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------- 833 (902)
++|.++.+..... .....++.++++++..||+.
T Consensus 92 i~G~~l~~~~~~~----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 92 ADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CSSEEHHHHCCTT----------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred cCCeehhhccCCc----------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999987753110 11236788999999999971
Q ss_pred -------------------CCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 834 -------------------CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 834 -------------------~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
....++|+|++|.||+++++..+.|+||+.+...
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~g 214 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRA 214 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccC
Confidence 0144899999999999987666789999987643
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.05 E-value=4.1e-11 Score=131.61 Aligned_cols=205 Identities=18% Similarity=0.205 Sum_probs=112.3
Q ss_pred CCCEEEEEcCCCCccc-c-------cCccccCCCCCCEEEccCCCCc---------ccCchhhhccCCCcEEEccCCCCC
Q 043136 77 SSQITSLDLSRRSLSG-P-------IPPEIRYLTSLTHLNLSANAFD---------GPLQPAILELTKLRTIDISHNSFN 139 (902)
Q Consensus 77 ~~~v~~L~L~~~~l~g-~-------~~~~~~~l~~L~~L~Ls~n~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~ 139 (902)
..+|+.|.+...+..| . +.+++..+++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 106 ~~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l 185 (362)
T 2ra8_A 106 LPSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL 185 (362)
T ss_dssp GGGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC
T ss_pred chhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc
Confidence 3478888887766553 2 2345667889999998765431 235566678889999999887311
Q ss_pred CCCCcccccccccceeccccccccCCCchhhh--cccCCcEEeccC--ccCcCCCCcccCCCCCCCEEEccCCCccCCCC
Q 043136 140 STFPPGISKLRFLRIFNAYSNSFTGPLPLEFV--QLNSLQQLNLGG--SYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLP 215 (902)
Q Consensus 140 ~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 215 (902)
.++. + .+++|+.|+|..+.++......++ .+++|++|+|+. |...+... +.. +.
T Consensus 186 -~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~--~~~-----------------l~ 243 (362)
T 2ra8_A 186 -SIGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD--MNV-----------------FR 243 (362)
T ss_dssp -BCCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC--GGG-----------------TG
T ss_pred -eecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh--HHH-----------------HH
Confidence 2333 3 267788888877776544333444 567777777752 22111100 000 00
Q ss_pred ccc--cCCCCCcEEEeeCcccCCCCChhcc---CCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCccceec
Q 043136 216 PQL--GLLTQLERIEIGYNNLQGEVPVEFA---SLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFTGEI 286 (902)
Q Consensus 216 ~~~--~~l~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~ 286 (902)
..+ ..+++|++|+|++|.++...+..+. .+++|++|+|+.|.+++. ++..+.++++|+.|+|++|.|+...
T Consensus 244 ~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~ 323 (362)
T 2ra8_A 244 PLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEM 323 (362)
T ss_dssp GGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHH
T ss_pred HHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHH
Confidence 011 1245555555555555433222222 355677777777766643 2333345667777777777665432
Q ss_pred CCCCCC-cCcCcEEecccCC
Q 043136 287 PVSYGN-LQALQVLDLSDNQ 305 (902)
Q Consensus 287 p~~~~~-l~~L~~L~Ls~N~ 305 (902)
-..+.. + ...+++++++
T Consensus 324 ~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 324 KKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp HHHHHHHC--CSEEECCSBC
T ss_pred HHHHHHHc--CCEEEecCCc
Confidence 222221 1 2456777766
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=99.01 E-value=1.4e-10 Score=127.44 Aligned_cols=213 Identities=14% Similarity=0.171 Sum_probs=103.5
Q ss_pred CCCCEEEccCCCCcc-cC-------chhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcc
Q 043136 102 TSLTHLNLSANAFDG-PL-------QPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL 173 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~-~~-------~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 173 (902)
..++.|.+....+.| .. ..++..+++|+.|.+..+..... +++... .+.+...+..+
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~--------------~is~~~-~~~L~~ll~~~ 171 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQ--------------EISWIE-QVDLSPVLDAM 171 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTC--------------CGGGCB-CCBCHHHHHTC
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhc--------------cccccc-ccCHHHHHhcC
Confidence 356777777655542 11 23345667777777765432110 000000 12344556667
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCcccc--CCCCCcEEEeeC--cccCCCCChhccCCCCCC
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLG--LLTQLERIEIGY--NNLQGEVPVEFASLVNLK 249 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~p~~~~~l~~L~ 249 (902)
++|+.|+|++|.-. .++. +. +++|++|+|..|.++......+. .+++|++|+|+. |...+...
T Consensus 172 P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~---------- 238 (362)
T 2ra8_A 172 PLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD---------- 238 (362)
T ss_dssp TTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC----------
T ss_pred CCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh----------
Confidence 77777777766211 1222 22 56677777766665432222222 456666666642 22111100
Q ss_pred EEEccCccCcccCCccc--cCCCCccEEecCCCccceecCCCC---CCcCcCcEEecccCCCccc----cCccccccCCC
Q 043136 250 YMDISACNLSGTLPSEI--SNLTKLEMLLLFKNHFTGEIPVSY---GNLQALQVLDLSDNQLSGP----IPASLASLKGL 320 (902)
Q Consensus 250 ~L~Ls~N~l~~~~p~~~--~~l~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L 320 (902)
+. .+...+ ..+++|++|+|++|.+.+..+..+ ..+++|++|+|+.|.+++. ++..+..+++|
T Consensus 239 --------~~-~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L 309 (362)
T 2ra8_A 239 --------MN-VFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHL 309 (362)
T ss_dssp --------GG-GTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTC
T ss_pred --------HH-HHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcc
Confidence 00 000011 124555555555555543221111 2356677777777776643 33344556777
Q ss_pred CEEEccCccccccCChhhhh-ccccceEEecCce
Q 043136 321 TRLSLMNNVLFGEIPQDIEL-LADLDTLLLWNNH 353 (902)
Q Consensus 321 ~~L~L~~N~l~~~~p~~~~~-l~~L~~L~L~~N~ 353 (902)
+.|+|++|.++...-..+.. + ...+++++++
T Consensus 310 ~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 310 KFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp SEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred eEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 77777777765433233322 1 2556777766
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.97 E-value=1.8e-11 Score=127.58 Aligned_cols=22 Identities=9% Similarity=-0.106 Sum_probs=16.8
Q ss_pred CCccccEEecCCCCCEEEEEcC
Q 043136 65 WCSWSGIKCNPKSSQITSLDLS 86 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~ 86 (902)
.|+|.|+.|+....+|+.+...
T Consensus 77 l~~~~g~i~~~~~~ki~~~v~~ 98 (267)
T 3rw6_A 77 LKAVNYKILDRENRRISIIINS 98 (267)
T ss_dssp HHHTTSSCBCTTSCBCCCEEEE
T ss_pred HHhcCcEEECCCCCEEEEEEec
Confidence 5899999999877677665443
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.96 E-value=4.2e-08 Score=109.11 Aligned_cols=316 Identities=11% Similarity=0.056 Sum_probs=139.1
Q ss_pred cccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCC
Q 043136 97 EIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176 (902)
Q Consensus 97 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 176 (902)
++....+|+.+.+.. .++.+...+|.++++|+.++|..+ ++..-...|.+. .|+.+.+..+ ++.....+|... +|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 344455666666642 345445556666666666666533 443333445444 3444444322 222223334332 56
Q ss_pred cEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 177 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+.+.+..+... .-...|.+. +|+.+.+..+ ++..-...|....+++.+.+..+.........+. . +
T Consensus 116 ~~i~lp~~~~~-i~~~~F~~~-~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~-~----------~ 181 (379)
T 4h09_A 116 DDFEFPGATTE-IGNYIFYNS-SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVL-Y----------N 181 (379)
T ss_dssp SEEECCTTCCE-ECTTTTTTC-CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEE-E----------E
T ss_pred ccccCCCcccc-ccccccccc-eeeeeeccce-eeccccchhcccccccccccccccceeeccccee-c----------c
Confidence 66655543211 222233332 3444444332 2223334455555555555543332110000000 0 0
Q ss_pred cCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCCh
Q 043136 257 NLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ 336 (902)
Q Consensus 257 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 336 (902)
. .......+.....+..+.+..+.- ......+.....|+.+.+..+ +.......|.++..|+.+.+..+ ++.....
T Consensus 182 ~-~~~~~~~~~~~~~~~~~~~~~~~~-~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~ 257 (379)
T 4h09_A 182 K-NKTILESYPAAKTGTEFTIPSTVK-TVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSF 257 (379)
T ss_dssp T-TSSEEEECCTTCCCSEEECCTTCC-EECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTT
T ss_pred c-ccceecccccccccccccccccee-EEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcc
Confidence 0 000111222233333333322211 122333444444444444333 22233344444555555555443 3323333
Q ss_pred hhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCC
Q 043136 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSL 416 (902)
Q Consensus 337 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L 416 (902)
.|..+.+|+.+.+..+ ++......|..+.+|+.+++.++.++..-...|.++.+|+.+.+..+ ++..-...|.+|++|
T Consensus 258 aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L 335 (379)
T 4h09_A 258 LLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKAL 335 (379)
T ss_dssp TTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTC
T ss_pred ccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCC
Confidence 4444555555555332 33344445555555555555555555444455555566666665433 443344567777777
Q ss_pred cEEEccCCccCCCCCcccCCCC
Q 043136 417 SRLRIQDNQLNGSIPQGFGLLP 438 (902)
Q Consensus 417 ~~L~Ls~N~l~~~~p~~~~~l~ 438 (902)
+.+.+..+ ++..-..+|.+.+
T Consensus 336 ~~i~ip~~-v~~I~~~aF~~c~ 356 (379)
T 4h09_A 336 STISYPKS-ITLIESGAFEGSS 356 (379)
T ss_dssp CCCCCCTT-CCEECTTTTTTSS
T ss_pred CEEEECCc-cCEEchhHhhCCC
Confidence 77777654 5433345565543
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.96 E-value=7.4e-08 Score=107.16 Aligned_cols=130 Identities=12% Similarity=0.103 Sum_probs=61.6
Q ss_pred hhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCC
Q 043136 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSL 416 (902)
Q Consensus 337 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L 416 (902)
.+.....|+.+.+..+ ++......|..+..|+.+.+..+ ++..-...+.++.+|+.+.+..+ +...-...|.++++|
T Consensus 212 ~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L 288 (379)
T 4h09_A 212 GFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNL 288 (379)
T ss_dssp TTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTC
T ss_pred ccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccc
Confidence 3444445555555433 33333444555555555555443 33333334444444544444322 322223345555555
Q ss_pred cEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceeccc
Q 043136 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNIS 470 (902)
Q Consensus 417 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 470 (902)
+.+.+.++.++..-..+|.++.+|+.++|..+ ++.+-..+|.++.+|+.+.+.
T Consensus 289 ~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip 341 (379)
T 4h09_A 289 TKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYP 341 (379)
T ss_dssp CEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred ccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEEC
Confidence 55555555555333445555555555555432 433333455555555555554
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.91 E-value=8.3e-10 Score=115.96 Aligned_cols=132 Identities=17% Similarity=0.127 Sum_probs=95.6
Q ss_pred Eee-ecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe--eEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILG-MGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN--IVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG-~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n--Iv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.++ .|..+.||++...+|+.+++|...... ...+.+|+++++.+.+.. +++++++....+..++||||++|
T Consensus 26 ~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G 99 (264)
T 1nd4_A 26 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 99 (264)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred ecccCCCCceEEEEecCCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCC
Confidence 344 455699999987778889999874331 133567888888874333 66788888888889999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--------------------------------------- 834 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------- 834 (902)
.++. ... .+ ...++.++++.+..+|+..
T Consensus 100 ~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 100 QDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp EETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred cccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 8774 110 11 1245677777788887532
Q ss_pred ----------------CCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 835 ----------------DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 835 ----------------~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
...++|+|++|.||++++++.++|+|||.+...
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999987766789999998653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.7e-09 Score=117.97 Aligned_cols=141 Identities=16% Similarity=0.200 Sum_probs=102.4
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEec--ccchhhHHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecC---CeeEEEE
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLW--GKHKENIRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNR---ECTMLLY 788 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~--~~~~~~~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~---~~~~lv~ 788 (902)
+.++.|.++.||+++..+ ..+++|+.. ... .......+.+|+++++.+. +..+++++.++.+. +..|+||
T Consensus 44 ~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~--~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 44 EQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSK--LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EECCC-CCSCEEEEECSS-CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEcCCcccceEEEEEECC-ceEEEEeCCCCCCC--CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 568999999999998754 678888764 221 1122345778999998886 45688999988776 4589999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC---------------------------------- 834 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---------------------------------- 834 (902)
||++|..+.+.. ...++...+..++.+++++|+.||+..
T Consensus 121 e~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 121 EFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp ECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred EecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 999987764311 012445666788999999999999731
Q ss_pred ---------------------CCCeEEcCCCCCCEEEcCCCC--EEEeeccccee
Q 043136 835 ---------------------DPVIVHRDLKPSNILLDGEME--ARVADFGVAKL 866 (902)
Q Consensus 835 ---------------------~~~ivHrDlKp~NILl~~~~~--~kl~DFGla~~ 866 (902)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 246999999999999997753 69999998875
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.56 E-value=6.1e-09 Score=103.18 Aligned_cols=123 Identities=17% Similarity=0.176 Sum_probs=65.2
Q ss_pred ccCccccCCCCCCEEEccCC-CCccc----CchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCc
Q 043136 93 PIPPEIRYLTSLTHLNLSAN-AFDGP----LQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLP 167 (902)
Q Consensus 93 ~~~~~~~~l~~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 167 (902)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|.|....... +.
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~--------------------l~ 86 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFA--------------------LA 86 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHH--------------------HH
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHH--------------------HH
Confidence 44556677778888888887 77643 2334455677777777777775321111 11
Q ss_pred hhhhcccCCcEEeccCccCcCC----CCcccCCCCCCCEEEc--cCCCccCC----CCccccCCCCCcEEEeeCcccC
Q 043136 168 LEFVQLNSLQQLNLGGSYFDGE----IPSDYRNLSSLRFLDL--AGNSLTGS----LPPQLGLLTQLERIEIGYNNLQ 235 (902)
Q Consensus 168 ~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L--~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 235 (902)
..+...++|++|+|++|.|... +...+...++|++|+| ++|.++.. +...+...++|++|+|++|.+.
T Consensus 87 ~~L~~n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 87 EMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHhCCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 2223334444444444444321 2233444455566666 55555522 2233444456666666666654
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.44 E-value=1.4e-08 Score=105.59 Aligned_cols=65 Identities=20% Similarity=0.285 Sum_probs=26.8
Q ss_pred CCCCCEEEccCCCccC--CCCccccCCCCCcEEEeeCcccCCCCChhccCCC--CCCEEEccCccCcccCC
Q 043136 197 LSSLRFLDLAGNSLTG--SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV--NLKYMDISACNLSGTLP 263 (902)
Q Consensus 197 l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~p 263 (902)
+++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|
T Consensus 169 l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 169 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp CTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred CCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 3444444444444443 2223333444444444444444432 1122222 45555555555554333
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.41 E-value=6.1e-07 Score=96.40 Aligned_cols=136 Identities=21% Similarity=0.243 Sum_probs=94.1
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcC--eeEeEEeEEecCC---eeEEEEE
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHR--NIVRLLGCCSNRE---CTMLLYE 789 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~--nIv~l~~~~~~~~---~~~lv~e 789 (902)
+.++.|....||++. +.+++|+.... .....+.+|+++++.+ .+. -+++.+......+ ..|+|||
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 568999999999874 45888875321 2345678899998877 332 2455665544333 4589999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD------------------------------------ 833 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~------------------------------------ 833 (902)
+++|.++.+.... .++..++..++.++++.++.||+.
T Consensus 97 ~i~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 9999887653221 133445556677777777777751
Q ss_pred -------------------CCCCeEEcCCCCCCEEEcC--CCCEEEeecccceec
Q 043136 834 -------------------CDPVIVHRDLKPSNILLDG--EMEARVADFGVAKLI 867 (902)
Q Consensus 834 -------------------~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~ 867 (902)
....++|+|++|.||++++ ...+.|+||+.+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1235899999999999998 456899999988753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.32 E-value=1.1e-07 Score=94.04 Aligned_cols=42 Identities=12% Similarity=0.086 Sum_probs=19.1
Q ss_pred ccCCCCCcEEEeeCc-ccCCC----CChhccCCCCCCEEEccCccCc
Q 043136 218 LGLLTQLERIEIGYN-NLQGE----VPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 218 ~~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
+...++|++|+|++| .|... +...+...++|++|+|++|.+.
T Consensus 32 l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~ 78 (185)
T 1io0_A 32 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 78 (185)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCC
Confidence 344455555555555 44421 1222333444555555555543
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.6e-06 Score=88.82 Aligned_cols=136 Identities=18% Similarity=0.131 Sum_probs=88.7
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcC---eeEeEEeEEe-cCCeeEEEEEcc
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR---NIVRLLGCCS-NRECTMLLYEYM 791 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~---nIv~l~~~~~-~~~~~~lv~e~~ 791 (902)
+.++.|....||+. ++.+++|+-.. ......+.+|+++++.+.+. .|++.+.++. ..+..|+|||++
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 56888999999998 46688887421 12345678899999988642 4667777774 456678999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC--------------------------------------
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-------------------------------------- 833 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-------------------------------------- 833 (902)
+|..+.+..... .+......++.++++.++.||+.
T Consensus 96 ~G~~l~~~~~~~-------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGMAV-------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHHTT-------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhhhh-------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 998776531100 11122222333333333333321
Q ss_pred -------------------CCCCeEEcCCCCCCEEEcC---CCC-EEEeecccceec
Q 043136 834 -------------------CDPVIVHRDLKPSNILLDG---EME-ARVADFGVAKLI 867 (902)
Q Consensus 834 -------------------~~~~ivHrDlKp~NILl~~---~~~-~kl~DFGla~~~ 867 (902)
....++|+|++|.||+++. ++. +.|+||+.+..-
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2345799999999999987 455 489999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=6.2e-06 Score=86.76 Aligned_cols=136 Identities=18% Similarity=0.161 Sum_probs=96.2
Q ss_pred EeeecCce-EEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTG-TVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g-~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.+..|..| .||+.... ++..+++|+-... ....+.+|.++++.+. +--|.++++++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 45556555 69998664 4567888875321 2345677888887773 44477889999989999999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--------------------------------------- 834 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------- 834 (902)
.++.+...... .....+..++++.+..||...
T Consensus 105 ~~~~~~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (272)
T 4gkh_A 105 KTAFQVLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP 175 (272)
T ss_dssp EEHHHHHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred ccccccccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence 88877653211 112245666777777777421
Q ss_pred ----------------CCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 835 ----------------DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 835 ----------------~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
...++|+|+.+.||++++++.+-|+||+.+...
T Consensus 176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 113799999999999998877789999988653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=7.5e-06 Score=89.98 Aligned_cols=82 Identities=7% Similarity=-0.021 Sum_probs=53.1
Q ss_pred cEe-eecCceEEEEEEeC-------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-c--CeeEeEEeEEecC---
Q 043136 716 KIL-GMGSTGTVYKAEMP-------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H--RNIVRLLGCCSNR--- 781 (902)
Q Consensus 716 ~~i-G~G~~g~Vy~~~~~-------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--~nIv~l~~~~~~~--- 781 (902)
+.| +.|....+|+++.. +++.+++|+..............+.+|+++++.+. + ..|++++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 456 78889999998764 26678888764322000000123566888877773 3 3577888887655
Q ss_pred CeeEEEEEccCCCCHH
Q 043136 782 ECTMLLYEYMPNGNLD 797 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~ 797 (902)
+..|+||||++|..+.
T Consensus 106 g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPP 121 (357)
T ss_dssp SSCEEEEECCCCBCCC
T ss_pred CCceEEEEecCCCChh
Confidence 3578999999886543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.73 E-value=5e-05 Score=84.64 Aligned_cols=77 Identities=13% Similarity=0.035 Sum_probs=47.8
Q ss_pred cEeeecCceEEEEEEeC-CCcEEEEEEecccch-hhH---HHHHHHHHHHHHHhcCC---cCeeEeEEeEEecCCeeEEE
Q 043136 716 KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHK-ENI---RRRRGVLAEVDVLGNVR---HRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~-~~~---~~~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~~~~~lv 787 (902)
+.+|.|..+.||+++.. +++.+++|....... ... ...+++..|.++++.+. ...+++++.+. .+..++|
T Consensus 36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~lv 113 (397)
T 2olc_A 36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 113 (397)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEEE
Confidence 57899999999999654 467899998643221 000 01234566888887663 23455666543 4456899
Q ss_pred EEccCCC
Q 043136 788 YEYMPNG 794 (902)
Q Consensus 788 ~e~~~~g 794 (902)
||++++.
T Consensus 114 mE~l~g~ 120 (397)
T 2olc_A 114 MEDLSHL 120 (397)
T ss_dssp ECCCTTS
T ss_pred EEeCCCc
Confidence 9999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00013 Score=79.31 Aligned_cols=32 Identities=25% Similarity=0.424 Sum_probs=28.3
Q ss_pred CCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 835 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
...++|+|+++.||+++.++.+.|+||+.+..
T Consensus 221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 45699999999999998888999999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00019 Score=76.67 Aligned_cols=139 Identities=19% Similarity=0.195 Sum_probs=90.3
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC---cCeeEeEEeEEecCCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR---HRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~---h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+.|+.|....+|+++. +++.+++|+.... ....+.+|++.++.+. ...|++++.++...+..|+||||++
T Consensus 42 ~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 42 EKLYSGEMNEIWLIND-EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEECCSSSSEEEEEES-SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred EEeCCccceeeeEEEE-CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 5689999999999986 5677888876322 1345678888888773 3678899999888889999999999
Q ss_pred CCCHH--------HH---HHhhcc-C----------------CCcccCHHHHH---HHHHH----------------HHH
Q 043136 793 NGNLD--------DL---LHAKNK-G----------------ENLVADWVTRY---KIALG----------------VAQ 825 (902)
Q Consensus 793 ~gsL~--------~~---l~~~~~-~----------------~~~~~~~~~~~---~i~~q----------------i~~ 825 (902)
|..+. +. ++.... . ....-+|...+ ++..+ +++
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87541 11 222111 0 01122454321 11111 111
Q ss_pred H-HHHHHh-CCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 826 G-ICYLHH-DCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 826 ~-L~~LH~-~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
. ...+.. ...+.+||+|+.+.|++++.++ +.|+||.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 123321 2245699999999999999887 9999984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00027 Score=79.35 Aligned_cols=32 Identities=16% Similarity=0.287 Sum_probs=27.9
Q ss_pred CCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 835 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
...++|+|++|.||+++.++ ++++||+.+..-
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 45699999999999998876 999999988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.47 E-value=2.9e-05 Score=74.75 Aligned_cols=34 Identities=6% Similarity=0.045 Sum_probs=15.2
Q ss_pred CCCEEEccCCCCcccCchhhhccCCCcEEEccCC
Q 043136 103 SLTHLNLSANAFDGPLQPAILELTKLRTIDISHN 136 (902)
Q Consensus 103 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 136 (902)
.|++|||+++.++..--..+..+++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 3444444444444333333444444444444444
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.38 E-value=5.8e-05 Score=72.70 Aligned_cols=34 Identities=9% Similarity=0.165 Sum_probs=16.5
Q ss_pred CCcEEEeeCcccCCCCChhccCCCCCCEEEccCc
Q 043136 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISAC 256 (902)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 256 (902)
+|++||++++.|+..--..+.++++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555444333333444555555555555
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.18 E-value=4.1e-05 Score=75.15 Aligned_cols=122 Identities=15% Similarity=0.151 Sum_probs=61.8
Q ss_pred cCccccCCCCCCEEEccCC-CCccc----CchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCch
Q 043136 94 IPPEIRYLTSLTHLNLSAN-AFDGP----LQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPL 168 (902)
Q Consensus 94 ~~~~~~~l~~L~~L~Ls~n-~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 168 (902)
+...+.+-+.|++|+|++| +|... +-.++..-+.|+.|+|++|.|....-.. +-.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~a--------------------lA~ 92 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARG--------------------LIE 92 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTT--------------------HHH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHH--------------------HHH
Confidence 3334455567777777774 66532 2344555667777777777765322111 122
Q ss_pred hhhcccCCcEEeccCccCcCC----CCcccCCCCCCCEEEccCCC---ccC----CCCccccCCCCCcEEEeeCcccC
Q 043136 169 EFVQLNSLQQLNLGGSYFDGE----IPSDYRNLSSLRFLDLAGNS---LTG----SLPPQLGLLTQLERIEIGYNNLQ 235 (902)
Q Consensus 169 ~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~---l~~----~~p~~~~~l~~L~~L~L~~N~l~ 235 (902)
.+..-+.|++|+|+.|.|... +-..+..-+.|++|+|++|. +.. .+...+..-+.|++|+++.|.+.
T Consensus 93 aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 93 LIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHhcCCccCeEecCCCcCCHHHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 333334455555555555421 11223333456666666442 221 12233445566777777666543
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0023 Score=67.59 Aligned_cols=73 Identities=18% Similarity=0.114 Sum_probs=51.3
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-c--CeeEeEEeEEecCCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H--RNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h--~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
+.+|.|..+.||+++..+|+.|++|+....... ....+.+|++.|+.+. . --+++++++. ..++||||++
T Consensus 21 ~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~---~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~l~ 93 (288)
T 3f7w_A 21 AERGHSHRWHLYRVELADGTPLFVKALPDDAPA---LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEWVD 93 (288)
T ss_dssp EEEEEETTEEEEEEEETTSCEEEEEECCTTCCC---CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEECCC
T ss_pred EecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc---hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEeec
Confidence 568999999999999999999999986433221 1234667888887763 2 2355666543 2478999998
Q ss_pred CCC
Q 043136 793 NGN 795 (902)
Q Consensus 793 ~gs 795 (902)
++.
T Consensus 94 ~~~ 96 (288)
T 3f7w_A 94 ERP 96 (288)
T ss_dssp CCC
T ss_pred ccC
Confidence 764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0015 Score=70.68 Aligned_cols=33 Identities=45% Similarity=0.514 Sum_probs=28.0
Q ss_pred CCCeEEcCCCCCCEEEcCC----CCEEEeecccceec
Q 043136 835 DPVIVHRDLKPSNILLDGE----MEARVADFGVAKLI 867 (902)
Q Consensus 835 ~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~~ 867 (902)
...++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 4569999999999999875 67999999988653
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.89 E-value=0.00034 Score=68.67 Aligned_cols=15 Identities=7% Similarity=0.206 Sum_probs=6.7
Q ss_pred CCCCCEEEccCccCc
Q 043136 245 LVNLKYMDISACNLS 259 (902)
Q Consensus 245 l~~L~~L~Ls~N~l~ 259 (902)
-+.|+.|+|++|+|.
T Consensus 69 N~~L~~L~L~~n~ig 83 (197)
T 1pgv_A 69 SKHIEKFSLANTAIS 83 (197)
T ss_dssp CSCCCEEECTTSCCB
T ss_pred CCCcCEEEccCCCCC
Confidence 344444444444443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0042 Score=66.61 Aligned_cols=145 Identities=14% Similarity=0.166 Sum_probs=77.0
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-c-CeeEeEEeE------EecCCeeEEE
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-H-RNIVRLLGC------CSNRECTMLL 787 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h-~nIv~l~~~------~~~~~~~~lv 787 (902)
+.|+.|....+|+++..++ .+++|...... ..+.+..|++++..+. + -.+++++.. ....+..+++
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l 101 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAAL 101 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEE
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEE
Confidence 4566788899999987555 57889875421 1123445666665552 1 113333321 1224567899
Q ss_pred EEccCCCCHH-----H---------HHHhhccC-C-C-----cccCHHHHHH------------HHHHHHHHHHHHHhC-
Q 043136 788 YEYMPNGNLD-----D---------LLHAKNKG-E-N-----LVADWVTRYK------------IALGVAQGICYLHHD- 833 (902)
Q Consensus 788 ~e~~~~gsL~-----~---------~l~~~~~~-~-~-----~~~~~~~~~~------------i~~qi~~~L~~LH~~- 833 (902)
|+|++|..+. . .++..... . . ....|...+. +...+.+.+++++..
T Consensus 102 ~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~ 181 (322)
T 2ppq_A 102 ISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHW 181 (322)
T ss_dssp EECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHC
T ss_pred EEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhC
Confidence 9999875431 1 11211100 0 0 0011222100 011234445555532
Q ss_pred ---CCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 834 ---CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 834 ---~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
....++|+|+.+.||++++++.+.|+||+.+..
T Consensus 182 ~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 182 PKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 134599999999999999876668999988754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0034 Score=67.56 Aligned_cols=144 Identities=12% Similarity=0.117 Sum_probs=78.1
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc--CeeEeEEeE-----EecCCeeEEEE
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH--RNIVRLLGC-----CSNRECTMLLY 788 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h--~nIv~l~~~-----~~~~~~~~lv~ 788 (902)
+.++ |....||++...+|+.+++|....... ..+.+..|.+++..+.. -.+++++.. ....+..++||
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3466 888899999776777899998853211 12234456666665531 124444432 12245668899
Q ss_pred EccCCCCHH-----HH---------HHhhccC----CCcccCHHHH----HH---------------HHHHHHHHHHHHH
Q 043136 789 EYMPNGNLD-----DL---------LHAKNKG----ENLVADWVTR----YK---------------IALGVAQGICYLH 831 (902)
Q Consensus 789 e~~~~gsL~-----~~---------l~~~~~~----~~~~~~~~~~----~~---------------i~~qi~~~L~~LH 831 (902)
|+++|..+. .. ++..... .....++... .. +...+.+.++.+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999874321 11 1111110 0111121110 00 0111112233332
Q ss_pred hC----CCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 832 HD----CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 832 ~~----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
.. ....++|+|+++.||+++ + .+.++||+.+..
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 21 234589999999999999 4 899999987754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.61 E-value=0.0018 Score=68.92 Aligned_cols=70 Identities=11% Similarity=0.005 Sum_probs=41.4
Q ss_pred cEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEcc-CC
Q 043136 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYM-PN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~-~~ 793 (902)
+.|+.|....+|++ +.+++|+....... .....+|+++++.+. +.-.++++++. .+.-++|+||+ +|
T Consensus 24 ~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 24 LERLGGLTNLVFRA-----GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp EEEESCSSEEEEEE-----TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eEcCCcccccccee-----eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 67889999999999 45888876432111 111234666666553 21124555543 33457899999 66
Q ss_pred CCH
Q 043136 794 GNL 796 (902)
Q Consensus 794 gsL 796 (902)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.60 E-value=0.0018 Score=59.23 Aligned_cols=55 Identities=24% Similarity=0.274 Sum_probs=29.6
Q ss_pred EEeccCcccc-ccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcc
Q 043136 513 KIELHNNLLN-GSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFL 569 (902)
Q Consensus 513 ~l~Ls~N~l~-g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l 569 (902)
.++.+++.++ ..+|..+. .+|+.|+|++|+|+.+.+..|..+++|+.|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 5566666664 24554332 2455555555555555555555555555555555554
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.57 E-value=0.0032 Score=69.03 Aligned_cols=143 Identities=15% Similarity=0.182 Sum_probs=79.5
Q ss_pred cEeeecCceEEEEEEeC--------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEE
Q 043136 716 KILGMGSTGTVYKAEMP--------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~--------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~l 786 (902)
+.+..|-...+|++... +++.+++|+.-... .......+|.++++.+. +.-.+++++++.+ .+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 46777888899999864 24788888862211 11234557888887773 3334677776653 29
Q ss_pred EEEccCCCCHHH--------------HH---HhhccCCCcccC--HHHHHHHHHHHH-------------------HHHH
Q 043136 787 LYEYMPNGNLDD--------------LL---HAKNKGENLVAD--WVTRYKIALGVA-------------------QGIC 828 (902)
Q Consensus 787 v~e~~~~gsL~~--------------~l---~~~~~~~~~~~~--~~~~~~i~~qi~-------------------~~L~ 828 (902)
||||++|..+.. .+ +.....-..... +.+..++..++. +.++
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999998754421 11 111000001111 233333333321 1223
Q ss_pred HH----HhC-CCCCeEEcCCCCCCEEEcCC----CCEEEeeccccee
Q 043136 829 YL----HHD-CDPVIVHRDLKPSNILLDGE----MEARVADFGVAKL 866 (902)
Q Consensus 829 ~L----H~~-~~~~ivHrDlKp~NILl~~~----~~~kl~DFGla~~ 866 (902)
++ ... ....++|+|+.+.||+++.+ +.+.++||..|..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 33 221 23458999999999999876 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.50 E-value=0.0041 Score=69.69 Aligned_cols=71 Identities=14% Similarity=0.215 Sum_probs=46.5
Q ss_pred cEeeecCceEEEEEEeCC--------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEE
Q 043136 716 KILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~l 786 (902)
+.|+.|....||++...+ ++.+++|+...... .+.+.+|..+++.+. +.-.+++++.+.+ .+
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~-----~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET-----ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC-----HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc-----HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 567888899999998653 47888998733111 123446888887763 3334667776542 28
Q ss_pred EEEccCCCC
Q 043136 787 LYEYMPNGN 795 (902)
Q Consensus 787 v~e~~~~gs 795 (902)
||||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999997633
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0041 Score=56.86 Aligned_cols=55 Identities=24% Similarity=0.288 Sum_probs=28.5
Q ss_pred EEEccCCCcc-CCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccC
Q 043136 202 FLDLAGNSLT-GSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258 (902)
Q Consensus 202 ~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 258 (902)
.++.+++.|+ ..+|..+. ++|++|+|++|+|+...+..|..+++|++|+|++|.+
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~ 67 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW 67 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence 4555555554 23443322 2455555555555544445555555566666665554
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.21 E-value=0.011 Score=66.64 Aligned_cols=73 Identities=15% Similarity=0.063 Sum_probs=45.0
Q ss_pred cEeeecCceEEEEEEeCC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
+.|+.|-...+|++...+ ++.+++|+......... ...+|..+++.+. +.-.+++++++. + .+||||++|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i----dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII----NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS----CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc----CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 568888899999998755 47788887633211100 1136888887774 333467777763 2 259999987
Q ss_pred CCH
Q 043136 794 GNL 796 (902)
Q Consensus 794 gsL 796 (902)
..+
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.12 E-value=0.0032 Score=69.10 Aligned_cols=72 Identities=13% Similarity=0.121 Sum_probs=40.9
Q ss_pred cEeeecCceEEEEEEeCC---------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeE
Q 043136 716 KILGMGSTGTVYKAEMPG---------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~---------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~ 785 (902)
+.++.|..-.+|++...+ ++.+++|+........ .....|.++++.+. +.-++++++.. . -+
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~----~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL----YNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT----SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce----ecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 457788888999997654 2678888764321110 11245777776663 22245666554 2 36
Q ss_pred EEEEccCCCC
Q 043136 786 LLYEYMPNGN 795 (902)
Q Consensus 786 lv~e~~~~gs 795 (902)
+||||++|..
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999998753
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.00 E-value=0.0085 Score=64.81 Aligned_cols=32 Identities=25% Similarity=0.428 Sum_probs=28.1
Q ss_pred CCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 836 ~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
..++|+|+.+.||++++++.+.++||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.13 E-value=0.077 Score=58.83 Aligned_cols=72 Identities=11% Similarity=0.049 Sum_probs=44.8
Q ss_pred cEeeecCceEEEEEEeCC--------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEE
Q 043136 716 KILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~l 786 (902)
+.+..|-...+|++...+ ++.+++|+....... .....+|.++++.+. +.-.+++++.+. -++
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~----~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK----FYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C----CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch----hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456778888999997653 578888886432111 111235777776663 333456665442 368
Q ss_pred EEEccCCCC
Q 043136 787 LYEYMPNGN 795 (902)
Q Consensus 787 v~e~~~~gs 795 (902)
||||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999998855
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.40 E-value=0.92 Score=49.89 Aligned_cols=29 Identities=28% Similarity=0.437 Sum_probs=24.9
Q ss_pred eEEcCCCCCCEEE------cCCCCEEEeeccccee
Q 043136 838 IVHRDLKPSNILL------DGEMEARVADFGVAKL 866 (902)
Q Consensus 838 ivHrDlKp~NILl------~~~~~~kl~DFGla~~ 866 (902)
++|+|+.+.||++ +++..++++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4457799999998864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 902 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-43 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-42 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-40 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-39 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-39 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-39 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-39 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-39 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-38 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-38 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 9e-37 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-36 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-36 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-34 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-33 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-33 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-33 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-32 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-32 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-32 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-31 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 8e-31 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-30 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-30 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 9e-30 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-29 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-29 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-27 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-27 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-26 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-23 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-26 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-22 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-07 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-21 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-18 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-11 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 7e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.004 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 11/171 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G+ G V+K P G ++A K + + K IR + ++ E+ VL IV
Sbjct: 12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGF 69
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
G + + E+M G+LD +L + K+++ V +G+ YL
Sbjct: 70 YGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKH 124
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+KPSNIL++ E ++ DFGV+ + + S + G+ Y++P
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-GTRSYMSP 172
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 14/184 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G GS GTVYK + G +AVK L ++ + EV VL RH NI+ +
Sbjct: 14 QRIGSGSFGTVYKGKWHGD--VAVKMLN-VTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 70
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G + ++ ++ +L LH + + IA AQG+ YLH
Sbjct: 71 GYSTA-PQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQGMDYLHAKS- 124
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCF 892
I+HRDLK +NI L ++ ++ DFG+A + ++GS ++AP
Sbjct: 125 --IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182
Query: 893 SVPF 896
P+
Sbjct: 183 KNPY 186
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 4e-42
Identities = 46/172 (26%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ LG G G V+ G +AVK L K+ LAE +++ ++H+ +VRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLY 74
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
+ ++ EYM NG+L D L + + +A +A+G+ ++
Sbjct: 75 AVVTQEPI-YIITEYMENGSLVDFLKTPSGIKL---TINKLLDMAAQIAEGMAFIEERN- 129
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--MSVIAGSYGYIAP 885
+HRDL+ +NIL+ + ++ADFG+A+LI+ +E + AP
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 150 bits (381), Expect = 5e-41
Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 702 FTADDVLECLSMSDKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEV 760
F DD + S +I G GS G VY A + E++A+KK+ K++ + + ++ EV
Sbjct: 8 FFKDDPEKLFSDLREI-GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEV 66
Query: 761 DVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIA 820
L +RH N ++ GC L+ EY D L K V +
Sbjct: 67 RFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVT 121
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY 880
G QG+ YLH ++HRD+K NILL ++ DFG A ++ S G+
Sbjct: 122 HGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTP 175
Query: 881 GYIAP 885
++AP
Sbjct: 176 YWMAP 180
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 5e-40
Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 14/179 (7%)
Query: 712 SMSD----KILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
++ D + LG G G VY A I+A+K L+ E + EV++ ++
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
RH NI+RL G + L+ EY P G + L +K D +A
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANA 118
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ Y H ++HRD+KP N+LL E ++ADFG + S ++ G+ Y+ P
Sbjct: 119 LSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC-GTLDYLPP 173
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 8e-40
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 13/172 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
K LG G G V + G +A+K + KE + E V+ N+ H +V+L
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMI----KEGSMSEDEFIEEAKVMMNLSHEKLVQLY 65
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G C+ + ++ EYM NG L + L ++ V + + YL
Sbjct: 66 GVCTKQRPIFIITEYMANGCLLNYLREMRHRF----QTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV--IAGSYGYIAP 885
+HRDL N L++ + +V+DFG+++ + DE S + P
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 8e-40
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 12/172 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G+ G VYKA+ + A K + ++ + E+D+L + H NIV+L
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVI---DTKSEEELEDYMVEIDILASCDHPNIVKL 74
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
L +L E+ G +D ++ + + + YLH +
Sbjct: 75 LDAFYYENNLWILIEFCAGGAVDAVMLELERP----LTESQIQVVCKQTLDALNYLHDNK 130
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLI-QSDESMSVIAGSYGYIAP 885
I+HRDLK NIL + + ++ADFGV+ ++ + G+ ++AP
Sbjct: 131 ---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 1e-39
Identities = 49/200 (24%), Positives = 82/200 (41%), Gaps = 25/200 (12%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G G G V++ + G E +AVK + + + R AE+ +RH NI+ +
Sbjct: 9 ESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFRE----AEIYQTVMLRHENILGFI 63
Query: 776 GCCSNRECT----MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+ T L+ +Y +G+L D L+ K+AL A G+ +LH
Sbjct: 64 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTV------TVEGMIKLALSTASGLAHLH 117
Query: 832 HDC-----DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE-----SMSVIAGSYG 881
+ P I HRDLK NIL+ +AD G+A S + + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 882 YIAPGTFCFCFSVPFCWVDQ 901
Y+AP ++ +
Sbjct: 178 YMAPEVLDDSINMKHFESFK 197
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G GS G K G+I+ K+L ++ +++EV++L ++H NIVR
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRY 68
Query: 775 LGCCSNRECTML--LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH- 831
+R T L + EY G+L ++ K E D ++ + + H
Sbjct: 69 YDRIIDRTNTTLYIVMEYCEGGDLASVIT-KGTKERQYLDEEFVLRVMTQLTLALKECHR 127
Query: 832 -HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS-VIAGSYGYIAP 885
D ++HRDLKP+N+ LDG+ ++ DFG+A+++ D S + G+ Y++P
Sbjct: 128 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 3e-39
Identities = 48/173 (27%), Positives = 75/173 (43%), Gaps = 13/173 (7%)
Query: 715 DKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G G V+ G +A+K L K L E V+ +RH +V+L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
S ++ EYM G+L D L + +A +A G+ Y+
Sbjct: 78 YAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVERMN 133
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE--SMSVIAGSYGYIAP 885
VHRDL+ +NIL+ + +VADFG+A+LI+ +E + + AP
Sbjct: 134 ---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-39
Identities = 48/177 (27%), Positives = 77/177 (43%), Gaps = 14/177 (7%)
Query: 715 DKILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVR 773
D +G GS TVYK +A +L K R+ E ++L ++H NIVR
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 774 LLGCC----SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++C +L+ E M +G L L + +G+ +
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQF 127
Query: 830 LHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
LH P I+HRDLK NI + G ++ D G+A L ++ + +VI G+ ++AP
Sbjct: 128 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVI-GTPEFMAP 182
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 5e-39
Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 17/184 (9%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEM---PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
+ L ++D LG G+ G+V + +A+K L ++ ++ E ++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE--MMREAQIMHQ 65
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+ + IVRL+G C ML+ E G L L K + ++ V+
Sbjct: 66 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSM 120
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES----MSVIAGSYG 881
G+ YL VHRDL N+LL A+++DFG++K + +D+S S
Sbjct: 121 GMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 882 YIAP 885
+ AP
Sbjct: 178 WYAP 181
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (365), Expect = 5e-39
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 14/189 (7%)
Query: 701 NFTADDVLECLSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGV 756
F + + C+ + ++++G G G V + +A+K L + E RR
Sbjct: 18 EFAKEIDISCVKI-EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD--F 74
Query: 757 LAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTR 816
L+E ++G H N++ L G + M++ E+M NG+LD L + +
Sbjct: 75 LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQL 130
Query: 817 YKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVI 876
+ G+A G+ YL VHRDL NIL++ + +V+DFG+++ ++ D S
Sbjct: 131 VGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY 187
Query: 877 AGSYGYIAP 885
+ G P
Sbjct: 188 TSALGGKIP 196
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 144 bits (364), Expect = 6e-39
Identities = 50/173 (28%), Positives = 77/173 (44%), Gaps = 13/173 (7%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
LG G G VY+ +AVK L KE+ L E V+ ++H N+V+L
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQL 78
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
LG C+ ++ E+M GNL D L N+ E V +A ++ + YL
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK-- 133
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE--SMSVIAGSYGYIAP 885
+HRDL N L+ +VADFG+++L+ D + + + AP
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-39
Identities = 50/184 (27%), Positives = 85/184 (46%), Gaps = 17/184 (9%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPG---GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
+ L++ DK LG G+ GTV K + +AVK L + + + +LAE +V+
Sbjct: 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE-LLAEANVMQQ 64
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+ + IVR++G C ML+ E G L+ L ++ V+
Sbjct: 65 LDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSM 118
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE----SMSVIAGSYG 881
G+ YL VHRDL N+LL + A+++DFG++K +++DE + +
Sbjct: 119 GMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 882 YIAP 885
+ AP
Sbjct: 176 WYAP 179
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 37/172 (21%), Positives = 75/172 (43%), Gaps = 13/172 (7%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G G G V+ + +A+K + +E + E +V+ + H +V+L
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQLY 66
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
G C + L++E+M +G L D L + + T + L V +G + + +
Sbjct: 67 GVCLEQAPICLVFEFMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEG---MAYLEE 119
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--MSVIAGSYGYIAP 885
++HRDL N L+ +V+DFG+ + + D+ + + +P
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 2e-38
Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 28/208 (13%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K LG G+ G V +A G +AVK L K ++ R +++E+ VL + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--KPSAHLTEREALMSELKVLSYLGNH 86
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKG-------------ENLVADWVT 815
NIV LLG C+ T+++ EY G+L + L K + L D
Sbjct: 87 MNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146
Query: 816 RYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV 875
+ VA+G+ +L +HRDL NILL ++ DFG+A+ I++D + V
Sbjct: 147 LLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 876 ---IAGSYGYIAPGTFCFCFSVPFCWVD 900
++AP + C V
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVW 231
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 2e-38
Identities = 44/174 (25%), Positives = 73/174 (41%), Gaps = 14/174 (8%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G+ G V A E +AVK + K + + E+ + + H N+V+
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPEN--IKKEICINKMLNHENVVKF 68
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
G L EY G L D + + + G+ YLH
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAP 885
I HRD+KP N+LLD +++DFG+A + + + ++ + G+ Y+AP
Sbjct: 124 ---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 3e-38
Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 33/198 (16%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RH 768
K+LG G+ G V A G +AVK L K + R +++E+ ++ + H
Sbjct: 43 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA--LMSELKMMTQLGSH 100
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNK------------------GENLV 810
NIV LLG C+ L++EY G+L + L +K + + V
Sbjct: 101 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 160
Query: 811 ADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
+ A VA+G+ +L VHRDL N+L+ ++ DFG+A+ I SD
Sbjct: 161 LTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSD 217
Query: 871 ESMSV---IAGSYGYIAP 885
+ V ++AP
Sbjct: 218 SNYVVRGNARLPVKWMAP 235
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 3e-38
Identities = 50/180 (27%), Positives = 82/180 (45%), Gaps = 19/180 (10%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
L+M + + +G G G V + G +AVK + + + LAE V+ +
Sbjct: 4 LNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVKCI---KNDATAQA--FLAEASVMTQL 57
Query: 767 RHRNIVRLLGCC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
RH N+V+LLG + ++ EYM G+L D L ++ + V K +L V +
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCE 114
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ YL + VHRDL N+L+ + A+V+DFG+ K S + + AP
Sbjct: 115 AMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK--LPVKWTAP 169
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 9e-37
Identities = 50/198 (25%), Positives = 84/198 (42%), Gaps = 33/198 (16%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ +G G+ G V++A PG ++AVK L + +++ E ++ +
Sbjct: 19 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD--FQREAALMAEFDNP 76
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA------------------ 811
NIV+LLG C+ + LL+EYM G+L++ L + +
Sbjct: 77 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 136
Query: 812 -DWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870
+ IA VA G+ YL VHRDL N L+ M ++ADFG+++ I S
Sbjct: 137 LSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 193
Query: 871 ESMSV---IAGSYGYIAP 885
+ A ++ P
Sbjct: 194 DYYKADGNDAIPIRWMPP 211
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 9e-37
Identities = 48/174 (27%), Positives = 72/174 (41%), Gaps = 12/174 (6%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
KILG GS TV A E+ A+K L +H + V E DV+ + H V+L
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ E Y NG L + A+ + L +
Sbjct: 74 YFTFQDDEKLYFGLSYAKNGELLKYIRKIGS--------FDETCTRFYTAEIVSALEYLH 125
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAP 885
I+HRDLKP NILL+ +M ++ DFG AK++ + + G+ Y++P
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 138 bits (349), Expect = 2e-36
Identities = 46/197 (23%), Positives = 84/197 (42%), Gaps = 14/197 (7%)
Query: 692 WKLTAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENI 750
WK Q + D VL+ + + LG G+ G V++ E G A K + +
Sbjct: 9 WKQYYPQPVEIKHDHVLDHYDI-HEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHE 64
Query: 751 RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLV 810
+ V E+ + +RH +V L + +++YE+M G L + + ++
Sbjct: 65 SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK---- 120
Query: 811 ADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQ 868
+ V +G+C++H + VH DLKP NI+ + + DFG+ +
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177
Query: 869 SDESMSVIAGSYGYIAP 885
+S+ V G+ + AP
Sbjct: 178 PKQSVKVTTGTAEFAAP 194
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 9e-36
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 20/185 (10%)
Query: 716 KILGMGSTGTVYKAEMPGG---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNI 771
++G G+ G V KA + A+K++ ++ R E++VL + H NI
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD--FAGELEVLCKLGHHPNI 73
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA-----------DWVTRYKIA 820
+ LLG C +R L EY P+GNL D L E A A
Sbjct: 74 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 133
Query: 821 LGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSY 880
VA+G + + +HRDL NIL+ A++ADFG+++ + ++
Sbjct: 134 ADVARG---MDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 190
Query: 881 GYIAP 885
++A
Sbjct: 191 RWMAI 195
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 135 bits (341), Expect = 2e-35
Identities = 38/173 (21%), Positives = 76/173 (43%), Gaps = 13/173 (7%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G+ G V++ E G + K + + + V E+ ++ + H ++ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFI---NTPYPLDKYTVKNEISIMNQLHHPKLINL 91
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
++ +L+ E++ G L D + A++ +G+ ++H
Sbjct: 92 HDAFEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQACEGLKHMH--- 144
Query: 835 DPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
+ IVH D+KP NI+ + + + V DFG+A + DE + V + + AP
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-35
Identities = 41/172 (23%), Positives = 86/172 (50%), Gaps = 14/172 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G++GTVY A ++ G+ +A++++ + + ++ ++ E+ V+ ++ NIV
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
L + ++ EY+ G+L D++ D + Q + +LH +
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSNQ 136
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES-MSVIAGSYGYIAP 885
++HRD+K NILL + ++ DFG I ++S S + G+ ++AP
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 130 bits (327), Expect = 3e-34
Identities = 56/178 (31%), Positives = 79/178 (44%), Gaps = 16/178 (8%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKL------WGKHKENIRRRRGVLAEVDVLGNVR- 767
+ILG G + V + P + AVK + +E R L EVD+L V
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
H NI++L L+++ M G L D L K KI + + I
Sbjct: 69 HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVI 123
Query: 828 CYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
C LH IVHRDLKP NILLD +M ++ DFG + + E + + G+ Y+AP
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 6e-34
Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 16/178 (8%)
Query: 716 KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ LG GS G V + E +AVK L + EV+ + ++ HRN+
Sbjct: 14 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
+RL G ++ E P G+L D L + + ++RY A+ VA+G+ YL
Sbjct: 74 IRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRY--AVQVAEGMGYLE 128
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV----IAGSYGYIAP 885
+HRDL N+LL ++ DFG+ + + ++ V + + AP
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 1e-33
Identities = 33/175 (18%), Positives = 67/175 (38%), Gaps = 16/175 (9%)
Query: 716 KILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNI 771
+ +G G G V++ +A+K +++R + L E + H +I
Sbjct: 13 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK--FLQEALTMRQFDHPHI 70
Query: 772 VRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
V+L+G + ++ E G L L + D + A ++ + YL
Sbjct: 71 VKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSL----DLASLILYAYQLSTALAYLE 125
Query: 832 HDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM--SVIAGSYGYIA 884
VHRD+ N+L+ ++ DFG+++ ++ S ++A
Sbjct: 126 SKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 129 bits (326), Expect = 1e-33
Identities = 47/179 (26%), Positives = 74/179 (41%), Gaps = 15/179 (8%)
Query: 712 SMSD----KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV 766
S+ D + LG GS G V+ G A+K L + +++ E +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQG 826
H I+R+ G + + ++ +Y+ G L LL A+
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--------RFPNPVAKFYAAEV 113
Query: 827 ICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
L + I++RDLKP NILLD ++ DFG AK + + + G+ YIAP
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTYTLCGTPDYIAP 170
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 2e-33
Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 19/186 (10%)
Query: 709 ECLSMSDKILGMGSTGTVYKAEMPGGE-----IIAVKKLWGKHKENIRRRRGVLAEVDVL 763
C++ K++G G G VYK + +A+K L + E R L E ++
Sbjct: 7 SCVTR-QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD--FLGEAGIM 63
Query: 764 GNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGV 823
G H NI+RL G S + M++ EYM NG LD L K+ + + G+
Sbjct: 64 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGI 119
Query: 824 AQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE----SMSVIAGS 879
A G+ YL + VHRDL NIL++ + +V+DFG++++++ D + S
Sbjct: 120 AAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176
Query: 880 YGYIAP 885
+ AP
Sbjct: 177 IRWTAP 182
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (322), Expect = 3e-33
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 14/174 (8%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+LG G+ V AE +++A+K + K E + E+ VL ++H NIV L
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIAVLHKIKHPNIVAL 72
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ L+ + + G L D + K ++ V + YLH
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLHDLG 127
Query: 835 DPVIVHRDLKPSNILL---DGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
IVHRDLKP N+L D + + ++DFG++K+ +S G+ GY+AP
Sbjct: 128 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 4e-33
Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 19/181 (10%)
Query: 715 DKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
++++G G G VY + AVK L +I L E ++ + H N
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 771 IVRLLGCCSNRE-CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++ LLG C E +++ YM +G+L + + + L VA+G
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP----TVKDLIGFGLQVAKG--- 142
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSV-----IAGSYGYIA 884
+ VHRDL N +LD + +VADFG+A+ + E SV ++A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 885 P 885
Sbjct: 203 L 203
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-32
Identities = 43/184 (23%), Positives = 76/184 (41%), Gaps = 19/184 (10%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
+ LG GS G VY+ G +A+K + ++R R L E V+
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCH 83
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA-----DWVTRYKIALGVA 824
++VRLLG S + T+++ E M G+L L + ++A +A
Sbjct: 84 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 143
Query: 825 QGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---MSVIAGSYG 881
G+ YL+ + VHRDL N ++ + ++ DFG+ + I +
Sbjct: 144 DGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 200
Query: 882 YIAP 885
+++P
Sbjct: 201 WMSP 204
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-32
Identities = 33/173 (19%), Positives = 75/173 (43%), Gaps = 14/173 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ LG G G V++ E + K + K + + ++ E+ +L RHRNI+ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK----EISILNIARHRNILHL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ E ++++E++ ++ + ++ + V + + +LH
Sbjct: 67 HESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLH--- 119
Query: 835 DPVIVHRDLKPSNILLDGEMEARV--ADFGVAKLIQSDESMSVIAGSYGYIAP 885
I H D++P NI+ + + +FG A+ ++ ++ ++ + Y AP
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 126 bits (317), Expect = 5e-32
Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 17/182 (9%)
Query: 711 LSMSD----KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKH---KENIRRRRGVLAEVDV 762
L+M+D +I+G G G VY G++ A+K L K K+ + +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 763 LGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALG 822
+ IV + + + + M G+L L A
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAE 115
Query: 823 VAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGY 882
+ G+ ++H+ +V+RDLKP+NILLD R++D G+A + + + G++GY
Sbjct: 116 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGY 171
Query: 883 IA 884
+A
Sbjct: 172 MA 173
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 1e-31
Identities = 49/178 (27%), Positives = 83/178 (46%), Gaps = 18/178 (10%)
Query: 716 KILGMGSTGTVYKAE-MPGGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN 770
K+LG G+ GTVYK +P GE +A+K+L + + + + +L E V+ +V + +
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL--REATSPKANKEILDEAYVMASVDNPH 72
Query: 771 IVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
+ RLLG C L+ + MP G L D + + +A+G+ YL
Sbjct: 73 VCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYL 127
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAP 885
+VHRDL N+L+ ++ DFG+AKL+ ++E ++A
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 8e-31
Identities = 48/178 (26%), Positives = 80/178 (44%), Gaps = 20/178 (11%)
Query: 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K++G GS G VY+A++ GE++A+KK+ ++ + R E+ ++ + H NIVRL
Sbjct: 26 KVIGNGSFGVVYQAKLCDSGELVAIKKV---LQDKRFKNR----ELQIMRKLDHCNIVRL 78
Query: 775 LGCC------SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
+ L+ +Y+P H + L + + + +
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL--PVIYVKLYMYQLFRSLA 136
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y+H I HRD+KP N+LLD + ++ DFG AK + E S Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 1e-30
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 12/174 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRR--RRGVLAEVDVLGNVRHRNIV 772
LG G TVYKA +I+A+KK+ H+ + R L E+ +L + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 773 RLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH 832
LL ++ L++++M + L + Y + + L +
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAY-----MLMTLQGLEY 115
Query: 833 DCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD-ESMSVIAGSYGYIAP 885
I+HRDLKP+N+LLD ++ADFG+AK S + + + Y AP
Sbjct: 116 LHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 3e-30
Identities = 49/173 (28%), Positives = 74/173 (42%), Gaps = 11/173 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLG-NVRHRNIVR 773
K+LG GS G V+ AE + A+K L + E VL H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+ +E + EY+ G+L + + +K D A + G+ +LH
Sbjct: 68 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKF-----DLSRATFYAAEIILGLQFLHSK 122
Query: 834 CDPVIVHRDLKPSNILLDGEMEARVADFGVAK-LIQSDESMSVIAGSYGYIAP 885
IV+RDLK NILLD + ++ADFG+ K + D + G+ YIAP
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 7e-30
Identities = 41/175 (23%), Positives = 76/175 (43%), Gaps = 12/175 (6%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ G V A + +A+KK+ + +R L E+ +L RH NI+ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQR--TLREIKILLRFRHENIIGI 71
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ Y+ + L+ K ++L + +G+ Y+H
Sbjct: 72 NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHL--SNDHICYFLYQILRGLKYIHSAN 129
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES----MSVIAGSYGYIAP 885
++HRDLKPSN+LL+ + ++ DFG+A++ D ++ + Y AP
Sbjct: 130 ---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 9e-30
Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 23/180 (12%)
Query: 715 DKILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIV 772
++LG+G G V + E A+K L + RR EV++ + +IV
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML--QDCPKARR------EVELHWRASQCPHIV 68
Query: 773 RLLGCC----SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
R++ + R+C +++ E + G L + + + +I + + I
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQ 125
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEME---ARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
YLH I HRD+KP N+L + ++ DFG AK S S++ + Y+AP
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 695 TAFQRLNFTADDVLECLSMSDKILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRR- 752
T F++ N DD + + LG G V K E G A K + + ++ RR
Sbjct: 1 TVFRQENV--DDYYDTG----EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRG 54
Query: 753 --RRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLV 810
R + EV +L ++H N++ L N+ +L+ E + G L D L + E+L
Sbjct: 55 VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLT 111
Query: 811 ADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR----VADFGVAKL 866
+ T + + Q + +++ I H DLKP NI+L + + DFG+A
Sbjct: 112 EEEATEF-----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK 166
Query: 867 IQSDESMSVIAGSYGYIAP 885
I I G+ ++AP
Sbjct: 167 IDFGNEFKNIFGTPEFVAP 185
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-29
Identities = 51/195 (26%), Positives = 79/195 (40%), Gaps = 27/195 (13%)
Query: 716 KILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHR 769
K LG G+ G V +A+ G +AVK L K R +++E+ +L ++ H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHIGHH 76
Query: 770 -NIVRLLGCC-SNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA-----------DWVTR 816
N+V LLG C M++ E+ GNL L +K
Sbjct: 77 LNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136
Query: 817 YKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES---M 873
+ VA+G+ +L +HRDL NILL + ++ DFG+A+ I D
Sbjct: 137 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 193
Query: 874 SVIAGSYGYIAPGTF 888
++AP T
Sbjct: 194 GDARLPLKWMAPETI 208
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 115 bits (290), Expect = 3e-29
Identities = 38/179 (21%), Positives = 70/179 (39%), Gaps = 17/179 (9%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ILG G V+ A + +AVK L + E + H IV +
Sbjct: 13 EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72
Query: 775 LGCCSNRE----CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYL 830
++ EY+ L D++H + ++ Q + +
Sbjct: 73 YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 127
Query: 831 HHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES----MSVIAGSYGYIAP 885
H + I+HRD+KP+NI++ +V DFG+A+ I + + + G+ Y++P
Sbjct: 128 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 116 bits (290), Expect = 3e-29
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 9/158 (5%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLL 775
+ +G G+ G VYKA+ GE A+KK+ KE+ + E+ +L ++H NIV+L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 776 GCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCD 835
++ +L++E++ L + + VT L + GI Y H
Sbjct: 67 DVIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRR- 120
Query: 836 PVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESM 873
++HRDLKP N+L++ E E ++ADFG+A+
Sbjct: 121 --VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 4e-29
Identities = 45/181 (24%), Positives = 73/181 (40%), Gaps = 14/181 (7%)
Query: 711 LSMSD----KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGN 765
++M+D K+LG G+ G V G A+K L + + E VL N
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 766 VRHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
RH + L + + EY G L L + T + A+
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER--------VFTEERARFYGAE 113
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES-MSVIAGSYGYIA 884
+ L + +V+RD+K N++LD + ++ DFG+ K SD + M G+ Y+A
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLA 173
Query: 885 P 885
P
Sbjct: 174 P 174
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 7e-29
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 28/193 (14%)
Query: 716 KILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV- 766
K LG G+ G V AE G +AVK L E +++E++++ +
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD--LISEMEMMKMIG 76
Query: 767 RHRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVA-----------DWVT 815
+H+NI+ LLG C+ ++ EY GNL + L A+ +
Sbjct: 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136
Query: 816 RYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMS- 874
A VA+G + + +HRDL N+L+ + ++ADFG+A+ I +
Sbjct: 137 LVSCAYQVARG---MEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 875 --VIAGSYGYIAP 885
++AP
Sbjct: 194 TTNGRLPVKWMAP 206
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-27
Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 18/180 (10%)
Query: 716 KILGMGSTGTVYKAE--MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDV---LGNVRHRN 770
+G G+ G V+KA GG +A+K++ + EV V L H N
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVR-VQTGEEGMPLSTIREVAVLRHLETFEHPN 71
Query: 771 IVRLLGCCS-----NRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQ 825
+VRL C+ L++E++ L G T + + +
Sbjct: 72 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG----VPTETIKDMMFQLLR 127
Query: 826 GICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
G+ +LH +VHRDLKP NIL+ + ++ADFG+A++ +++ + + Y AP
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 111 bits (277), Expect = 5e-27
Identities = 42/171 (24%), Positives = 69/171 (40%), Gaps = 11/171 (6%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K LG GS G V + G A+K L + +++ L E +L V +V+L
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ ++ EY+ G + L + A + YLH
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLD 161
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+++RDLKP N+L+D + +V DFG AK + + G+ +AP
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAP 207
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 44/172 (25%), Positives = 77/172 (44%), Gaps = 10/172 (5%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G+ G VYKA GE++A+KK+ E + E+ +L + H NIV+L
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
L L++E++ + + G + + Y + Q + L
Sbjct: 67 LDVIHTENKLYLVFEFLHQDLKKFMDASALTG--IPLPLIKSY-----LFQLLQGLAFCH 119
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES-MSVIAGSYGYIAP 885
++HRDLKP N+L++ E ++ADFG+A+ + + Y AP
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAP 171
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 8e-27
Identities = 40/186 (21%), Positives = 78/186 (41%), Gaps = 10/186 (5%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G+ GTV+KA+ EI+A+K++ ++ L E+ +L ++H+NIVRL
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRL 66
Query: 775 LGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC 834
+ + L++E+ + + + Q + L
Sbjct: 67 HDVLHSDKKLTLVFEFCDQDLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCH 118
Query: 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894
++HRDLKP N+L++ E ++A+FG+A+ + P F +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 895 PFCWVD 900
+D
Sbjct: 179 YSTSID 184
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 1e-26
Identities = 41/191 (21%), Positives = 76/191 (39%), Gaps = 21/191 (10%)
Query: 710 CLSMSD----KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLG 764
C +S +G G+ G V+KA G+ +A+KK+ E L E+ +L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQ 64
Query: 765 NVRHRNIVRLLGCCSNR-----ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKI 819
++H N+V L+ C + C +Y D N + R
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-- 122
Query: 820 ALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES-----MS 874
+ + L++ I+HRD+K +N+L+ + ++ADFG+A+ ++ +
Sbjct: 123 ---MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 179
Query: 875 VIAGSYGYIAP 885
+ Y P
Sbjct: 180 NRVVTLWYRPP 190
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 3e-26
Identities = 37/177 (20%), Positives = 65/177 (36%), Gaps = 15/177 (8%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKH---KENIRRRRGVLAEVDVLGNVR--HR 769
+LG G G+VY + +A+K + + V EV +L V
Sbjct: 10 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69
Query: 770 NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
++RLL + +L+ E + V + + +
Sbjct: 70 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA----LQEELARSFFWQVLEAVRH 125
Query: 830 LHHDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
H+ ++HRD+K NIL+D E ++ DFG L++ D + G+ Y P
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDFDGTRVYSPP 178
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 107 bits (268), Expect = 3e-26
Identities = 77/312 (24%), Positives = 129/312 (41%), Gaps = 18/312 (5%)
Query: 29 SLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSS--QITSLDLS 86
+LL IK L +P + W T N +W G+ C+ + ++ +LDLS
Sbjct: 10 ALLQIKKDLGNP--TTLSSWLPTTDCCN---------RTWLGVLCDTDTQTYRVNNLDLS 58
Query: 87 RRSLSG--PIPPEIRYLTSLTHLNLSANA-FDGPLQPAILELTKLRTIDISHNSFNSTFP 143
+L PIP + L L L + GP+ PAI +LT+L + I+H + + P
Sbjct: 59 GLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIP 118
Query: 144 PGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203
+S+++ L + N+ +G LP L +L + G+ G IP Y + S L
Sbjct: 119 DFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTS 178
Query: 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLP 263
+ P L +++ N L+G+ V F S N + + ++ +L+ L
Sbjct: 179 MTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG 238
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
+ + L N G +P L+ L L++S N L G IP +L+
Sbjct: 239 KVGLSKNLNGLDLRN-NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVS 296
Query: 324 SLMNNVLFGEIP 335
+ NN P
Sbjct: 297 AYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.1 bits (245), Expect = 3e-23
Identities = 59/276 (21%), Positives = 100/276 (36%), Gaps = 5/276 (1%)
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTG--PIPPTICDGDRLFKLILFSN-NFTYSIPENLV 411
GVL ++ +D+S +L PIP ++ + L L + N IP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
+ L L I ++G+IP + L +D S N+LSG +P + + L +
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 472 NSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGH 531
N ++P + S L S + + +
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 532 CEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYN 591
+K + ++ ++ +DL +N + GT+P L S NVS+N
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFN 278
Query: 592 LLTGPIPASGTIFPNLHPSSFIGNEGLCGRVLTKPC 627
L G IP G S++ N+ LCG L C
Sbjct: 279 NLCGEIPQGGN-LQRFDVSAYANNKCLCGSPL-PAC 312
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 108 bits (270), Expect = 3e-26
Identities = 41/175 (23%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVR 773
+ LG G V++A + E + VK L K+ I+R E+ +L N+R NI+
Sbjct: 41 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR------EIKILENLRGGPNIIT 94
Query: 774 LLGCCSNR--ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLH 831
L + L++E++ N + L + + + Y H
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT--------DYDIRFYMYEILKALDYCH 146
Query: 832 HDCDPVIVHRDLKPSNILLDGE-MEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
I+HRD+KP N+++D E + R+ D+G+A+ + +V S + P
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGP 198
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 3e-24
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 709 ECLSMSD----KILGMGSTGTVYKAE----MPGGEIIAVKKLWGKH-KENIRRRRGVLAE 759
E + + + K+LG G+ G V+ G++ A+K L + + E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 760 VDVLGNVRHR-NIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYK 818
VL ++R +V L L+ +Y+ G L L + + T ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--------FTEHE 130
Query: 819 IALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES--MSVI 876
+ + V + + L H I++RD+K NILLD + DFG++K +DE+
Sbjct: 131 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF 190
Query: 877 AGSYGYIAPGTFCFCFSVPFCWVDQ 901
G+ Y+AP S VD
Sbjct: 191 CGTIEYMAPDIVRGGDSGHDKAVDW 215
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 3e-24
Identities = 44/183 (24%), Positives = 76/183 (41%), Gaps = 19/183 (10%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
K +G G+ G V A + +A+KKL + +N + E+ ++ V H+NI+ L
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQNQTHAKRAYRELVLMKCVNHKNIISL 81
Query: 775 LGCCSNRECTM------LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L + ++ L+ E M + D + + GI
Sbjct: 82 LNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLYQMLCGIK 133
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAPGTF 888
+LH I+HRDLKPSNI++ + ++ DFG+A+ + M+ + Y AP
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 889 CFC 891
Sbjct: 191 LGM 193
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 5e-24
Identities = 46/177 (25%), Positives = 82/177 (46%), Gaps = 20/177 (11%)
Query: 716 KILGMGSTGTVYKA-EMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G G+ G V A + G +A+KKL+ + + +R E+ +L ++RH N++ L
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-AYRELRLLKHMRHENVIGL 82
Query: 775 LGCCSNRECT------MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
L + E L+ +M G L K + + +G+
Sbjct: 83 LDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK-----LGEDRIQFLVYQMLKGLR 135
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
Y+H I+HRDLKP N+ ++ + E ++ DFG+A+ Q+D M+ + Y AP
Sbjct: 136 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMTGYVVTRWYRAP 187
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.4 bits (244), Expect = 5e-23
Identities = 33/183 (18%), Positives = 65/183 (35%), Gaps = 26/183 (14%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+ +G GS G +Y + GE +A+K + + + E + ++ +
Sbjct: 13 RKIGSGSFGDIYLGTDIAAGEEVAIKLE---CVKTKHPQ--LHIESKIYKMMQGGVGIPT 67
Query: 775 LG-CCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+ C + + +++ E + D K T +A + I Y+H
Sbjct: 68 IRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKF-----SLKTVLLLADQMISRIEYIHSK 122
Query: 834 CDPVIVHRDLKPSNIL---LDGEMEARVADFGVAKLIQSDES--------MSVIAGSYGY 882
+HRD+KP N L + DFG+AK + + + G+ Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 883 IAP 885
+
Sbjct: 180 ASI 182
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.0 bits (240), Expect = 1e-22
Identities = 56/290 (19%), Positives = 104/290 (35%), Gaps = 25/290 (8%)
Query: 66 CSWSGIKCNPKS---------SQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDG 116
C ++C+ LDL ++ + + L +L L L N
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 117 PLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSL 176
A L KL + +S N L+ LR+ N T F LN +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE---NEITKVRKSVFNGLNQM 126
Query: 177 QQLNLGGSYFD--GEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNL 234
+ LG + G ++ + L ++ +A ++T ++P GL L + + N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKI 183
Query: 235 QGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQ 294
L NL + +S ++S ++N L L N+ ++P + +
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL-RELHLNNNKLVKVPGGLADHK 242
Query: 295 ALQVLDLSDNQLSG------PIPASLASLKGLTRLSLMNNVL-FGEIPQD 337
+QV+ L +N +S P + +SL +N + + EI
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.9 bits (232), Expect = 2e-21
Identities = 58/281 (20%), Positives = 105/281 (37%), Gaps = 34/281 (12%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
+LDL +N+++ +LK L L L+NN + P L L+ L L N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
LP+K+ + L V + + + + +L +
Sbjct: 93 E-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKK 151
Query: 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
LS +RI D + +IPQG L P+LT + + N ++ L L L +S NS
Sbjct: 152 LSYIRIADTNIT-TIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 476 TSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKL 535
++ + P+L+ L +++KL +P + + +
Sbjct: 209 AVDNGSLANTPHLRELHLNNNKLV------------------------KVPGGLADHKYI 244
Query: 536 LLLNLSRNSLTGI------IPWEISGLPSITDVDLSHNFLT 570
++ L N+++ I P + S + V L N +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 53/284 (18%), Positives = 103/284 (36%), Gaps = 14/284 (4%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNL 258
LR + + L +P L +++ N + +F +L NL + + +
Sbjct: 11 HLRVVQCSDLGLE-KVPK--DLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 67
Query: 259 SGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLK 318
S P + L KLE L L KN LQ L+V + ++ + L +
Sbjct: 68 SKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQM 126
Query: 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSL 378
+ L G + + L + + + ++T +PQ L + L + + N +
Sbjct: 127 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS--LTELHLDGNKI 183
Query: 379 TGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLP 438
T ++ + L KL L N+ + +L N L L + +N+L +P G
Sbjct: 184 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHK 242
Query: 439 NLTFMDMSRNSLSG------EIPRDLGNAQKLEYLNISENSFQT 476
+ + + N++S P +++ N Q
Sbjct: 243 YIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQY 286
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.8 bits (216), Expect = 2e-19
Identities = 49/262 (18%), Positives = 105/262 (40%), Gaps = 8/262 (3%)
Query: 237 EVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQAL 296
+VP + + +D+ ++ + NL L L+L N + P ++ L L
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 297 QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356
+ L LS NQL +L+ L + + + + ++ L +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSG 140
Query: 357 VLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSL 416
+ KL + ++ ++T IP + L +L L N T +L ++L
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 417 SRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQT 476
++L + N ++ P+L + ++ N L ++P L + + ++ + + N+ +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNI-S 255
Query: 477 SLPSNIWSAPNLKILSASSSKL 498
++ SN + P AS S +
Sbjct: 256 AIGSNDFCPPGYNTKKASYSGV 277
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 81.2 bits (199), Expect = 3e-17
Identities = 47/260 (18%), Positives = 92/260 (35%), Gaps = 11/260 (4%)
Query: 198 SSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACN 257
LDL N +T L L + + N + P FA LV L+ + +S
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
L L +L + + + N + L + + SG + +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVF-NGLNQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
K L+ + + + + IPQ L L L L N +T V L L + +S NS
Sbjct: 150 KKLSYIRIADTNI-TTIPQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 378 LTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG------SIP 431
++ ++ + L + + +NN +P L + + + + +N ++ P
Sbjct: 207 ISAVDNGSLANTPHLRE-LHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 432 QGFGLLPNLTFMDMSRNSLS 451
+ + + + N +
Sbjct: 266 GYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 75.5 bits (184), Expect = 3e-15
Identities = 42/224 (18%), Positives = 85/224 (37%), Gaps = 6/224 (2%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS 429
V S L +P + L L +N T + N +L L + +N+++
Sbjct: 14 VVQCSDLGLEK-VPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 430 IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLK 489
P F L L + +S+N L + Q+L + S+ + + ++
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 490 ILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGII 549
+ + + F G K + I + + + +IP + L L+L N +T +
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVD 187
Query: 550 PWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLL 593
+ GL ++ + LS N ++ + N L +++ N L
Sbjct: 188 AASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 3e-14
Identities = 31/181 (17%), Positives = 65/181 (35%), Gaps = 7/181 (3%)
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNL 488
+P+ P+ +D+ N ++ D N + L L + N P L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 489 KILSASSSKLTGKIPDFIGCKSIYKIELHNNLLN-GSIPWDIGHCEKLLLLNLSRNSLTG 547
+ L S ++L +P+ + N + ++ + ++ L + +G
Sbjct: 82 ERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 140
Query: 548 IIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNL 607
I G+ ++ + ++ +T TIP +L ++ N +T AS NL
Sbjct: 141 IENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197
Query: 608 H 608
Sbjct: 198 A 198
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 50.4 bits (119), Expect = 4e-07
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 2/93 (2%)
Query: 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583
+P D+ LL+L N +T I + L ++ + L +N ++ P F L
Sbjct: 24 KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 584 ESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNE 616
E +S N L L +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITK 114
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 6e-22
Identities = 75/385 (19%), Positives = 129/385 (33%), Gaps = 35/385 (9%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L L + +L ++ T+ S G+ L L N +N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPP---- 216
T PL+ L L + + + P + L + L
Sbjct: 77 QLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 217 --------QLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI-S 267
+ ++ L + G + L NL ++ + + + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 268 NLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMN 327
LT LE L+ N + P G L L L L+ NQL +LASL LT L L N
Sbjct: 195 KLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLAN 250
Query: 328 NVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTIC 387
N + P + L L L L N ++ + P + + N I
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTN----LELNENQLEDISPIS 304
Query: 388 DGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSR 447
+ L L L+ NN + P + + + L RL +N+++ L N+ ++
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 448 NSLSGEIPRDLGNAQKLEYLNISEN 472
N +S P L N ++ L +++
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 1e-21
Identities = 61/389 (15%), Positives = 128/389 (32%), Gaps = 52/389 (13%)
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
L + + +G N+ V L + + I ++ +E
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLG--------IKSIDGVE------- 63
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFGEIPQDIE 339
L L ++ S+NQL+ P +L L + + +
Sbjct: 64 -----------YLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNL 112
Query: 340 LLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFS 399
L + + L T+ S + G+++ L +
Sbjct: 113 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLA 172
Query: 400 NNFTYSIPENLVN----------CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNS 449
N T + N ++L L +NQ++ P G NL + ++ N
Sbjct: 173 NLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQ 230
Query: 450 LSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCK 509
L L + L L+++ N P + L L +++++ I G
Sbjct: 231 LKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISN-ISPLAGLT 285
Query: 510 SIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFL 569
++ +EL+ N I + + L L L N+++ I P +S L + + ++N +
Sbjct: 286 ALTNLELNEN--QLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV 341
Query: 570 TGTIPSNFENCSTLESFNVSYNLLTGPIP 598
+ S+ N + + + +N ++ P
Sbjct: 342 SD--VSSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 90.1 bits (222), Expect = 1e-19
Identities = 61/395 (15%), Positives = 125/395 (31%), Gaps = 32/395 (8%)
Query: 173 LNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN 232
L + LG + + +L + L + S+ + L L +I N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 233 NLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGN 292
L P +L L + ++ ++ P L + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 293 LQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNN 352
+ S I A + L ++ L + N
Sbjct: 135 NR--------LELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNK 186
Query: 353 HLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN 412
+ KL + L ++N ++ P I L +L L N L +
Sbjct: 187 VSDISVLAKLTNLESL---IATNNQISDITPLGILT--NLDELSLNGNQLK--DIGTLAS 239
Query: 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN 472
++L+ L + +NQ++ P L LT + + N +S P A LN ++
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 473 SFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHC 532
+ I + NL L+ + ++ P + ++ NN ++ + +
Sbjct: 298 EDIS----PISNLKNLTYLTLYFNNISDISP-VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 533 EKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHN 567
+ L+ N ++ + P ++ L IT + L+
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 67.3 bits (163), Expect = 2e-12
Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 12/168 (7%)
Query: 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE 124
I + +T LDL+ +S P + LT LT L L AN +
Sbjct: 228 GNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNI--SPLAG 283
Query: 125 LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGS 184
LT L ++++ N P S L+ L Y N+ + P+ L LQ+L +
Sbjct: 284 LTALTNLELNENQLEDISPI--SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANN 339
Query: 185 YFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN 232
S NL+++ +L N ++ P L LT++ ++ +
Sbjct: 340 KVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 1e-07
Identities = 18/102 (17%), Positives = 32/102 (31%), Gaps = 6/102 (5%)
Query: 59 SEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPL 118
+ E I +T L L ++S P + LT L L + N
Sbjct: 288 TNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDV- 344
Query: 119 QPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
++ LT + + HN + P ++ L +
Sbjct: 345 -SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 38/248 (15%), Positives = 81/248 (32%), Gaps = 52/248 (20%)
Query: 394 KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGE 453
K +L N T ++ + + ++ L+ + SI G L NLT ++ S N L+
Sbjct: 26 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTDI 81
Query: 454 IPRDLGNAQKLEYLNISENSFQT------------------------------------- 476
P L N KL + ++ N
Sbjct: 82 TP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 477 ---SLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCE 533
++ + + S + ++ ++++ +N S +
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN--KVSDISVLAKLT 197
Query: 534 KLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLL 593
L L + N ++ I P I ++ ++ L+ N L + + L +++ N +
Sbjct: 198 NLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQI 253
Query: 594 TGPIPASG 601
+ P SG
Sbjct: 254 SNLAPLSG 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 94.5 bits (234), Expect = 1e-21
Identities = 29/185 (15%), Positives = 63/185 (34%), Gaps = 28/185 (15%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN-IVR 773
+ +G GS G +++ + + +A+K + + + + E + I
Sbjct: 11 RRIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQ--LRDEYRTYKLLAGCTGIPN 65
Query: 774 LLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD 833
+ +L+ + + D L K T A + + +H
Sbjct: 66 VYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKF-----SVKTVAMAAKQMLARVQSIHEK 120
Query: 834 CDPVIVHRDLKPSNILLDGEM-----EARVADFGVAKLIQSDES--------MSVIAGSY 880
+V+RD+KP N L+ V DFG+ K + + ++G+
Sbjct: 121 S---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 881 GYIAP 885
Y++
Sbjct: 178 RYMSI 182
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.9 bits (227), Expect = 2e-20
Identities = 43/176 (24%), Positives = 86/176 (48%), Gaps = 18/176 (10%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRL 774
+G G+ G+V A G +AVKKL + ++I + E+ +L +++H N++ L
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGL 82
Query: 775 LGCCSNRECTM-----LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICY 829
L + L ++ +L++++ + ++ V + + +G+ Y
Sbjct: 83 LDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQ------FLIYQILRGLKY 136
Query: 830 LHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDESMSVIAGSYGYIAP 885
+H I+HRDLKPSN+ ++ + E ++ DFG+A +D+ M+ + Y AP
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA--RHTDDEMTGYVATRWYRAP 187
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (207), Expect = 2e-18
Identities = 56/285 (19%), Positives = 98/285 (34%), Gaps = 8/285 (2%)
Query: 73 CNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTID 132
C + + ++ L +P I + + L N + L +
Sbjct: 6 CVCYNEPKVTTSCPQQGLQA-VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILW 62
Query: 133 ISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPL-PLEFVQLNSLQQLNLGGSYFDGEIP 191
+ N + L L + N+ + P F L L L+L P
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGP 122
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251
+R L++L++L L N+L L L + + N + F L +L +
Sbjct: 123 GLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRL 182
Query: 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP 311
+ ++ P +L +L L LF N+ + + L+ALQ L L+DN
Sbjct: 183 LLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR 242
Query: 312 ASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTG 356
+ L + ++ + +PQ LA D L N L G
Sbjct: 243 -ARPLWAWLQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (191), Expect = 2e-16
Identities = 50/253 (19%), Positives = 92/253 (36%), Gaps = 4/253 (1%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
Q + L N++S AS + + LT L L +NVL LA L+ L L +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 356 GVL-PQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCS 414
+ P G+L T+ + L P L L L N + +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 415 SLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSF 474
+L+ L + N+++ + F L +L + + +N ++ P + +L L + N+
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 475 QTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEK 534
+ L+ L + + + K ++ + S+P +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLAG--- 270
Query: 535 LLLLNLSRNSLTG 547
L L+ N L G
Sbjct: 271 RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.2 bits (170), Expect = 1e-13
Identities = 52/273 (19%), Positives = 95/273 (34%), Gaps = 8/273 (2%)
Query: 346 TLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYS 405
T L V P + + + + + N ++ + L L L SN
Sbjct: 15 TTSCPQQGLQAV-PVGIPAASQRI--FLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 406 IPENLVNCSSLSRLRIQDNQLNGSI-PQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKL 464
+ L +L + DN S+ P F L L + + R L P L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 465 EYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHNNLLNG 523
+YL + +N+ Q NL L ++++ F G S+ ++ LH N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583
P +L+ L L N+L+ + ++ L ++ + L+ N + L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWL 250
Query: 584 ESFNVSYNLLTGPIPAS--GTIFPNLHPSSFIG 614
+ F S + + +P G L + G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.4 bits (134), Expect = 5e-09
Identities = 34/218 (15%), Positives = 65/218 (29%), Gaps = 13/218 (5%)
Query: 404 YSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQK 463
Y+ P+ +C L+ ++P G + + + N +S +
Sbjct: 9 YNEPKVTTSCPQQG-LQ--------AVPVG--IPAASQRIFLHGNRISHVPAASFRACRN 57
Query: 464 LEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD--FIGCKSIYKIELHNNLL 521
L L + N + L+ L S + + F G ++ + L L
Sbjct: 58 LTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGL 117
Query: 522 NGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCS 581
P L L L N+L + L ++T + L N ++ F
Sbjct: 118 QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177
Query: 582 TLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLC 619
+L+ + N + P + L N
Sbjct: 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 81.8 bits (201), Expect = 3e-18
Identities = 28/157 (17%), Positives = 48/157 (30%), Gaps = 19/157 (12%)
Query: 716 KILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKEN-------IRRRRGVLAEVDVLGNVRH 768
K++G G V+ VK H
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 769 RNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGIC 828
R + +L G +Y + N L +L+ AK V + ++ + + +
Sbjct: 66 RALQKLQGL-----AVPKVYAWEGNAVLMELIDAKELYRVRVENPD---EVLDMILEEVA 117
Query: 829 YLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865
+H IVH DL N+L+ E + DF +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.1 bits (209), Expect = 4e-18
Identities = 38/182 (20%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 716 KILGMGSTGTVYKAE-MPGGEIIAVKKLWGK--HKENIRRRRGVLAEVDVLGNVR----- 767
+ LG G TV+ A+ M +A+K + G + E +L V+ N +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 768 HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGI 827
+I++LL +++ + + ++LL K E+ + +I+ + G+
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 828 CYLHHDCDPVIVHRDLKPSNILLD----GEMEARVADFGVAKLIQSDESMSVIAGSYGYI 883
Y+H C I+H D+KP N+L++ E ++ + DE + + Y
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 884 AP 885
+P
Sbjct: 197 SP 198
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.0 bits (154), Expect = 1e-11
Identities = 46/287 (16%), Positives = 89/287 (31%), Gaps = 22/287 (7%)
Query: 81 TSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFN- 139
+LDL+ ++L + + + + D PL +++ +D+S++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEV 60
Query: 140 STFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSS 199
ST +S+ L+ + + P+ + ++L +LNL G E S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 200 LRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259
R +L + + + I NL G S ++
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV-- 178
Query: 260 GTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSD-NQLSGPIPASLASLK 318
+ L + + L LQ L LS + L +
Sbjct: 179 -------------HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 319 GLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSN 365
L L + V G + L L L + +H T + +G+
Sbjct: 226 TLKTLQVFGIVPDGTLQ---LLKEALPHLQINCSHFTTIARPTIGNK 269
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 46/275 (16%), Positives = 91/275 (33%), Gaps = 16/275 (5%)
Query: 251 MDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG-P 309
+D++ NL + + + + ++ + + + +Q +DLS++ +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLP--------QK 361
+ L+ L LSL L I + ++L L L +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRI 421
L D + + + +L N + + C +L L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 422 QDNQL-NGSIPQGFGLLPNLTFMDMSR-NSLSGEIPRDLGNAQKLEYLNISENSFQTSLP 479
D+ + Q F L L + +SR + E +LG L+ L + +L
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 480 SNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKI 514
+ P+L+I + S T IG K +I
Sbjct: 243 LLKEALPHLQI---NCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 32/255 (12%), Positives = 72/255 (28%), Gaps = 14/255 (5%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNG- 428
T+D++ +L + + + +F + + + + ++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 429 SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE--NSFQTSLPSNIWSAP 486
++ L + + LS I L L LN+S + +L + + S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLL--------NGSIPWDIGHCEKLLLL 538
L L+ S + + + + NL + + L
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 181
Query: 539 NLSRNSLTGIIPWEISGLPSITDVDLSH-NFLTGTIPSNFENCSTLESFNVSYNLLTGPI 597
L E L + + LS + TL++ V + G +
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTL 241
Query: 598 PASGTIFPNLHPSSF 612
P+L +
Sbjct: 242 QLLKEALPHLQINCS 256
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.0 bits (128), Expect = 3e-08
Identities = 39/253 (15%), Positives = 87/253 (34%), Gaps = 15/253 (5%)
Query: 77 SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILE-LTKLRTIDISH 135
S + + R + P+ + H++LS + + IL +KL+ + +
Sbjct: 22 SQGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80
Query: 136 NSFNSTFPPGISKLRFLRIFNAY--SNSFTGPLPLEFVQLNSLQQLNLGGSYFDG----- 188
+ ++K L N S L + L +LNL +
Sbjct: 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQ 140
Query: 189 -EIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN-NLQGEVPVEFASLV 246
+ ++ L N L + L +++ + L+ + EF L
Sbjct: 141 VAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLN 200
Query: 247 NLKYMDISACN-LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQ 305
L+++ +S C + E+ + L+ L +F G + + +AL L ++ +
Sbjct: 201 YLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLL---KEALPHLQINCSH 257
Query: 306 LSGPIPASLASLK 318
+ ++ + K
Sbjct: 258 FTTIARPTIGNKK 270
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.0 bits (123), Expect = 1e-07
Identities = 40/265 (15%), Positives = 84/265 (31%), Gaps = 15/265 (5%)
Query: 348 LLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIP 407
L N V + L ++ + + P+ R+ + L ++ S
Sbjct: 7 LTGKNLHPDVTGRLLSQG--VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEVSTL 63
Query: 408 ENLV-NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS--RNSLSGEIPRDLGNAQKL 464
++ CS L L ++ +L+ I NL +++S + L + +L
Sbjct: 64 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123
Query: 465 EYLNISENSFQTSLPSNIWSAP--------NLKILSASSSKLTGKIPDFIGCKSIYKIEL 516
+ LN+S T + A NL + K ++
Sbjct: 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183
Query: 517 HNNLLNGSIPWDIGHCEKLLLLNLSR-NSLTGIIPWEISGLPSITDVDLSHNFLTGTIPS 575
+ +L + L L+LSR + E+ +P++ + + GT+
Sbjct: 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQL 243
Query: 576 NFENCSTLESFNVSYNLLTGPIPAS 600
E L+ + + P +
Sbjct: 244 LKEALPHLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 2e-07
Identities = 30/286 (10%), Positives = 82/286 (28%), Gaps = 22/286 (7%)
Query: 177 QQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG 236
Q L+L G ++ + + + + L +++ +++ + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 60
Query: 237 E-VPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQA 295
+ + L+ + + LS + + ++ + L L L E +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
++ +L+ + + ++ L G N +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG---------------YRKNLQKS 165
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLIL-FSNNFTYSIPENLVNCS 414
+ + S L + L L L + L
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 415 SLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN 460
+L L++ +G++ LP+L ++ + + +GN
Sbjct: 226 TLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (100), Expect = 7e-05
Identities = 18/108 (16%), Positives = 42/108 (38%), Gaps = 3/108 (2%)
Query: 513 KIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG- 571
++L L+ + + + ++ R+ + + S + +DLS++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVS 61
Query: 572 TIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLHPSSFIGNEGLC 619
T+ CS L++ ++ L+ PI + NL + G G
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFS 109
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.0 bits (149), Expect = 5e-11
Identities = 51/211 (24%), Positives = 77/211 (36%), Gaps = 7/211 (3%)
Query: 265 EISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLS 324
E+S + + K + T +P +L LS+N L A+L LT+L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 325 LMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPP 384
L Q L L TL L +N L + + L +DVS N LT
Sbjct: 62 LDRA--ELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLG 118
Query: 385 TICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMD 444
+ L +L L N P L L +L + +N L L NL +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 445 MSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
+ NSL IP+ + L + + N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 2e-09
Identities = 39/207 (18%), Positives = 74/207 (35%), Gaps = 6/207 (2%)
Query: 385 TICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMD 444
+ ++ N T ++P +L + L + +N L LT ++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 445 MSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD 504
+ R L+ L L++S N Q+ + + + + +
Sbjct: 62 LDRAELTKLQVDG--TLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 505 FIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDL 564
G + ++ L N L P + KL L+L+ N+LT + ++GL ++ + L
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 565 SHNFLTGTIPSNFENCSTLESFNVSYN 591
N L TIP F L + N
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.9 bits (115), Expect = 1e-06
Identities = 47/207 (22%), Positives = 74/207 (35%), Gaps = 7/207 (3%)
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
+ + NL +P + + + +S L + + T+L L L +
Sbjct: 9 VASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNL--D 63
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIEL 340
G L L LDLS NQL +L LT L + N L +
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 341 LADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSN 400
L +L L L N L + P L KL + +++N+LT + + L L+L
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL-QE 181
Query: 401 NFTYSIPENLVNCSSLSRLRIQDNQLN 427
N Y+IP+ L + N
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 4e-06
Identities = 45/203 (22%), Positives = 64/203 (31%), Gaps = 7/203 (3%)
Query: 54 FSNPSSEQEPVWCSWSGIKCNPK--SSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSA 111
S +S E V C + P T L LS L + T LT LNL
Sbjct: 6 VSKVASHLE-VNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 112 NAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFV 171
L + ++ + P L L + + N T
Sbjct: 65 AELTKLQVDGTL---PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGY 231
L LQ+L L G+ P L L LA N+LT L L L+ + +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 232 NNLQGEVPVEFASLVNLKYMDIS 254
N+L +P F L + +
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLH 203
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 42/207 (20%), Positives = 69/207 (33%), Gaps = 30/207 (14%)
Query: 363 GSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQ 422
L V+ +LT +PP + L L N L+ + L++L +
Sbjct: 7 SKVASHLEVNCDKRNLTA-LPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 423 DNQLNGSIPQGFGLLPNLT-----------------------FMDMSRNSLSGEIPRDLG 459
+L G LP L +D+S N L+ L
Sbjct: 64 RAELTKLQVDGT--LPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 460 NAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPD-FIGCKSIYKIELHN 518
+L+ L + N +T P + P L+ LS +++ LT G +++ + L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 519 NLLNGSIPWDIGHCEKLLLLNLSRNSL 545
N L +IP L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 35/217 (16%), Positives = 63/217 (29%), Gaps = 22/217 (10%)
Query: 268 NLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMN 327
L + K++ T + + +L + L ++ I + L L L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT-IEG-VQYLNNLIGLELKD 72
Query: 328 NVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTIC 387
N + P L + LT ++ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 388 DGDRLFKLILFSNNFT--------------YSIPENLVNCSSLSRLRIQDNQLNGSIPQG 433
I + S L N S L+ L+ DN+++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 434 FGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNIS 470
LPNL + + N +S P L N L + ++
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.5 bits (127), Expect = 2e-08
Identities = 37/227 (16%), Positives = 71/227 (31%), Gaps = 18/227 (7%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L + + + + A +L + T+ + G+ L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
T PL+ + + +L+ I + + + L +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
L + L +S N + + ++NL+KL L N
Sbjct: 134 LYLDLNQITNISPLA----------GLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDN 183
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMN 327
+ P+ +L L + L +NQ+S P LA+ L ++L N
Sbjct: 184 KISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.2 bits (121), Expect = 1e-07
Identities = 39/223 (17%), Positives = 77/223 (34%), Gaps = 17/223 (7%)
Query: 367 KLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQL 426
+ + +++T + T D D + L F T +I E + ++L L ++DNQ+
Sbjct: 20 NAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQI 75
Query: 427 NGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAP 486
P + + I Q + + +
Sbjct: 76 TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST------QITDVTPLAGLS 129
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
NL++L +++T P Y S + + KL L N ++
Sbjct: 130 NLQVLYLDLNQITNISPLAGLTNLQYL---SIGNAQVSDLTPLANLSKLTTLKADDNKIS 186
Query: 547 GIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVS 589
I P ++ LP++ +V L +N ++ P N S L ++
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 28/218 (12%), Positives = 60/218 (27%), Gaps = 22/218 (10%)
Query: 74 NPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDI 133
+P + + + +++ + L +T L+ + L L +++
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLEL 70
Query: 134 SHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSD 193
N P + + S+
Sbjct: 71 KDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
Query: 194 YRNLSSLRFLDLAGNSLTG--------------SLPPQLGLLTQLERIEIGYNNLQGEVP 239
+ L + L G S L L++L ++ N + P
Sbjct: 131 LQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP 190
Query: 240 VEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277
ASL NL + + +S P ++N + L ++ L
Sbjct: 191 --LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 24/217 (11%), Positives = 63/217 (29%), Gaps = 17/217 (7%)
Query: 392 LFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLS 451
K+ +N T ++ + + ++ L + +I G L NL +++ N ++
Sbjct: 21 AIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQIT 76
Query: 452 GEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSI 511
P L+ + +++ + + + +
Sbjct: 77 DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYL 136
Query: 512 YKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTG 571
++ L LS + ++ L +T + N ++
Sbjct: 137 DLNQIT---------NISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187
Query: 572 TIPSNFENCSTLESFNVSYNLLTGPIPASGTIFPNLH 608
P + L ++ N ++ P + NL
Sbjct: 188 ISP--LASLPNLIEVHLKNNQISDVSPLAN--TSNLF 220
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 51.6 bits (123), Expect = 2e-08
Identities = 28/127 (22%), Positives = 47/127 (37%), Gaps = 9/127 (7%)
Query: 201 RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSG 260
R L LA LT L L + +++ +N L+ P A+L L+ + S
Sbjct: 1 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNA--L 55
Query: 261 TLPSEISNLTKLEMLLLFKNHFTG-EIPVSYGNLQALQVLDLSDNQLSGP---IPASLAS 316
++NL +L+ LLL N + L +L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 317 LKGLTRL 323
L ++ +
Sbjct: 116 LPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 2e-07
Identities = 26/123 (21%), Positives = 51/123 (41%), Gaps = 6/123 (4%)
Query: 443 MDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKI 502
+ ++ L+ + L + +L++S N +LP + + L++L AS + L
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALENVD 59
Query: 503 PDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI---IPWEISGLPSI 559
+ + +N L + + C +L+LLNL NSL LPS+
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 560 TDV 562
+ +
Sbjct: 120 SSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 15/107 (14%), Positives = 35/107 (32%), Gaps = 5/107 (4%)
Query: 466 YLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSI 525
L+++ ++ ++ + L S ++L P + + ++ +N L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD 59
Query: 526 PWDIGHCEKLLLLNLSRNSLTGI-IPWEISGLPSITDVDLSHNFLTG 571
+ L L N L + P + ++L N L
Sbjct: 60 GVANLPRLQEL--LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.5 bits (107), Expect = 2e-06
Identities = 29/125 (23%), Positives = 48/125 (38%), Gaps = 9/125 (7%)
Query: 107 LNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPL 166
L+L+ + +L + +D+SHN PP ++ LR L + A N+
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRL-RALPPALAALRCLEVLQASDNALENVD 59
Query: 167 PLEFVQLNSLQQLNLGGSYF-DGEIPSDYRNLSSLRFLDLAGNSLTG--SLPPQL-GLLT 222
L LQ+L L + + L L+L GNSL + +L +L
Sbjct: 60 G--VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 223 QLERI 227
+ I
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.9 bits (95), Expect = 8e-05
Identities = 22/123 (17%), Positives = 44/123 (35%), Gaps = 8/123 (6%)
Query: 489 KILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGI 548
++L + LT + + ++L +N L P + L +L S N+L +
Sbjct: 1 RVLHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 549 IPWEISGLPSITDVDLSHNFLTGT-IPSNFENCSTLESFNVSYNLLTGP---IPASGTIF 604
P + ++ L +N L + +C L N+ N L +
Sbjct: 59 DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 605 PNL 607
P++
Sbjct: 117 PSV 119
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 25/109 (22%), Positives = 44/109 (40%), Gaps = 6/109 (5%)
Query: 346 TLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYS 405
L L + LT + L + +D+S N L PP + L +L +++
Sbjct: 2 VLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLRAL-PPALAALRCLE--VLQASDNALE 56
Query: 406 IPENLVNCSSLSRLRIQDNQLNG-SIPQGFGLLPNLTFMDMSRNSLSGE 453
+ + N L L + +N+L + Q P L +++ NSL E
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 23/109 (21%), Positives = 37/109 (33%), Gaps = 4/109 (3%)
Query: 249 KYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308
+ + ++ +L T+ + L + L L N P + L+ L+VL SDN L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 309 PIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357
+ L N + Q + L L L N L
Sbjct: 58 VDGVANLPRLQELLLC-NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 17/94 (18%), Positives = 36/94 (38%), Gaps = 13/94 (13%)
Query: 412 NCSSLSRLRIQDNQLNG----SIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQK---- 463
S L L + D ++ S+ +L +D+S N L L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 464 -LEYLNISENSFQTSLPSNIWSA----PNLKILS 492
LE L + + + + + + P+L+++S
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 15/85 (17%), Positives = 31/85 (36%), Gaps = 5/85 (5%)
Query: 246 VNLKYMDISACNLSGTLPSEI-SNLTKLEMLLLFKNHFTGE----IPVSYGNLQALQVLD 300
++++ +DI LS +E+ L + +++ L T I + AL L+
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 301 LSDNQLSGPIPASLASLKGLTRLSL 325
L N+L + +
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKI 86
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 17/102 (16%), Positives = 30/102 (29%), Gaps = 15/102 (14%)
Query: 263 PSEISNLTKLEMLLLFKNHFTGE----IPVSYGNLQALQVLDLSDNQLSGPIPASLAS-- 316
+ L +L L + + + +L+ LDLS+N L L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 317 ---LKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLT 355
L +L L + E+ ++ L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQ------ALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 13/78 (16%), Positives = 23/78 (29%), Gaps = 5/78 (6%)
Query: 77 SSQITSLDLSRRSLSGPIPPEI-RYLTSLTHLNLSANAFDG----PLQPAILELTKLRTI 131
S I SLD+ LS E+ L + L + A+ L +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 132 DISHNSFNSTFPPGISKL 149
++ N + +
Sbjct: 61 NLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 17/95 (17%), Positives = 29/95 (30%), Gaps = 21/95 (22%)
Query: 296 LQVLDLSDNQLS-GPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHL 354
+Q LD+ +LS L L+ + L + L +D
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKD----------------- 46
Query: 355 TGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389
+ L N L +++ SN L + G
Sbjct: 47 ---ISSALRVNPALAELNLRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 21/129 (16%), Positives = 38/129 (29%), Gaps = 8/129 (6%)
Query: 415 SLSRLRIQDNQLNGS-IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA----QKLEYLNI 469
+ L IQ +L+ + + LL + + L+ +D+ +A L LN+
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 470 SENSFQTSLPSNIWSA---PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIP 526
N + P+ KI S S + L+ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 527 WDIGHCEKL 535
+L
Sbjct: 123 LLGDAGLQL 131
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 13/91 (14%), Positives = 24/91 (26%), Gaps = 5/91 (5%)
Query: 175 SLQQLNLGGSYF-DGEIPSDYRNLSSLRFLDLAGNSLTG----SLPPQLGLLTQLERIEI 229
+Q L++ D L + + L LT + L + L + +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSG 260
N L + I +L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 7e-04
Identities = 11/82 (13%), Positives = 25/82 (30%), Gaps = 9/82 (10%)
Query: 526 PWDIGHCEKLLLLNLSRNSLTGI----IPWEISGLPSITDVDLSHNFLTGTIPSNF---- 577
L +L L+ ++ + + S+ ++DLS+N L
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 578 -ENCSTLESFNVSYNLLTGPIP 598
+ LE + + +
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 14/117 (11%), Positives = 30/117 (25%), Gaps = 9/117 (7%)
Query: 43 NSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSG----PIPPEI 98
+ ++ E S + L L+ +S + +
Sbjct: 334 SVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATL 393
Query: 99 RYLTSLTHLNLSANAFDGPLQPAILE-----LTKLRTIDISHNSFNSTFPPGISKLR 150
SL L+LS N ++E L + + ++ + L
Sbjct: 394 LANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 8e-04
Identities = 13/102 (12%), Positives = 30/102 (29%), Gaps = 10/102 (9%)
Query: 392 LFKLILFSNNFTYS-IPENLVNCSSLSRLRIQDNQLNG----SIPQGFGLLPNLTFMDMS 446
+ L + + + E L +R+ D L I + P L +++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 447 RNSLSGEIPRDLGNA-----QKLEYLNISENSFQTSLPSNIW 483
N L + K++ L++ + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLS 105
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 9e-04
Identities = 14/92 (15%), Positives = 26/92 (28%), Gaps = 10/92 (10%)
Query: 224 LERIEIGYNNLQGEVPVE-FASLVNLKYMDISACNLSG----TLPSEISNLTKLEMLLLF 278
++ ++I L E L + + + C L+ + S + L L L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 279 KNHFTGEIPVSYG-----NLQALQVLDLSDNQ 305
N +Q L L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 22/121 (18%), Positives = 37/121 (30%), Gaps = 29/121 (23%)
Query: 191 PSDYRNLSSLRFLDLAGNSLTG----SLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV 246
+ S LR L LA ++ SL L L +++ N L ++ V
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 247 NLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQL 306
LE L+L+ +++ E+ LQ L+ L
Sbjct: 422 R-------------------QPGCLLEQLVLYDIYWSEEME------DRLQALEKDKPSL 456
Query: 307 S 307
Sbjct: 457 R 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 18/106 (16%), Positives = 32/106 (30%), Gaps = 27/106 (25%)
Query: 344 LDTLLLWNNHLTGV----LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFS 399
L L L + ++ L L +N L +D+S+N L + + R
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVR-------- 422
Query: 400 NNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLL----PNLT 441
L +L + D + + L P+L
Sbjct: 423 -----------QPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 9/85 (10%)
Query: 174 NSLQQLNLGGSYFDGE----IPSDYRNLSSLRFLDLAGNSLTGSLPPQLG-----LLTQL 224
+ L+ L L + + SLR LDL+ N L + QL L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 225 ERIEIGYNNLQGEVPVEFASLVNLK 249
E++ + E+ +L K
Sbjct: 429 EQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 9e-07
Identities = 21/90 (23%), Positives = 34/90 (37%), Gaps = 9/90 (10%)
Query: 231 YNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY 290
N E+ +L+ +++S L LP+ L +L NH E+P
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERLI---ASFNHLA-EVP--- 320
Query: 291 GNLQALQVLDLSDNQLSGPIPASLASLKGL 320
Q L+ L + N L P S++ L
Sbjct: 321 ELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 1e-06
Identities = 61/325 (18%), Positives = 99/325 (30%), Gaps = 26/325 (8%)
Query: 296 LQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELL--ADLDTLLLWN-N 352
L+L++ LS +P L L N L E+P+ + L +D L +
Sbjct: 40 AHELELNNLGLSS-LPELPPHL---ESLVASCNSL-TELPELPQSLKSLLVDNNNLKALS 94
Query: 353 HLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVN 412
L +L SN +L + NS I + + + S F + L
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 413 CSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN 472
L L + L+ + + E +L N L + N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 473 SFQTSLPSNI---------WSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNG 523
+T +L L S + L F G + + N +
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 524 SIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTL 583
I L LN+S N L + + P + + S N L +P +N L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLIEL----PALPPRLERLIASFNHLA-EVPELPQN---L 326
Query: 584 ESFNVSYNLLTGPIPASGTIFPNLH 608
+ +V YN L P +L
Sbjct: 327 KQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 24/97 (24%), Positives = 38/97 (39%), Gaps = 11/97 (11%)
Query: 422 QDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSN 481
N + I L P+L +++S N L E+P LE L S N +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL-AEVPEL 322
Query: 482 IWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHN 518
NLK L + L + PD S+ + +++
Sbjct: 323 P---QNLKQLHVEYNPLR-EFPDIPE--SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 8e-05
Identities = 17/119 (14%), Positives = 32/119 (26%), Gaps = 9/119 (7%)
Query: 38 KDPFNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPE 97
+ + + P + S + L++S L +P
Sbjct: 244 QSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL 302
Query: 98 IRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFN 156
L L S N L L+ + + +N FP + LR+ +
Sbjct: 303 P---PRLERLIASFNH----LAEVPELPQNLKQLHVEYNPL-REFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 43.3 bits (100), Expect = 8e-05
Identities = 26/92 (28%), Positives = 39/92 (42%), Gaps = 9/92 (9%)
Query: 277 LFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQ 336
+ N + EI +L+ L++S+N+L +PA L+ RL N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLE---RLIASFNHL-AEVP- 320
Query: 337 DIELLADLDTLLLWNNHLTGVLPQKLGSNGKL 368
EL +L L + N L P S L
Sbjct: 321 --ELPQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 24/98 (24%), Positives = 39/98 (39%), Gaps = 8/98 (8%)
Query: 442 FMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGK 501
N+ S EI LE LN+S N LP+ P L+ L AS + L +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKL-IELPALP---PRLERLIASFNHLA-E 318
Query: 502 IPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLN 539
+P+ ++ ++ + N L P E L + +
Sbjct: 319 VPELPQ--NLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 0.001
Identities = 19/137 (13%), Positives = 35/137 (25%), Gaps = 9/137 (6%)
Query: 41 FNNSFHDWDATPAFSNPSSEQEPVWCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRY 100
+ ++ + + S++ + S I
Sbjct: 223 PPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDL 282
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
SL LN+S N L +L + S N + P L+ L + N
Sbjct: 283 PPSLEELNVSNN----KLIELPALPPRLERLIASFNHL-AEVPELPQNLKQLHVEY---N 334
Query: 161 SFTGPLPLEFVQLNSLQ 177
P + L+
Sbjct: 335 PLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.002
Identities = 20/91 (21%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 208 NSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEIS 267
N+ + + L LE + + N L E+P A L+ + S +L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELP---ALPPRLERLIASFNHLA-EVPELPQ 324
Query: 268 NLTKLEMLLLFKNHFTGEIPVSYGNLQALQV 298
NL +L + N E P +++ L++
Sbjct: 325 NLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 39/222 (17%), Positives = 79/222 (35%), Gaps = 19/222 (8%)
Query: 372 DVSSNSLTGPIPPTICDGDRLF----KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLN 427
+ S ++T P P D F K L + T ++ +N +S+ ++ ++ +
Sbjct: 2 PLGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK 59
Query: 428 GSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPN 487
QG LPN+T + ++ N L+ P L+ L +
Sbjct: 60 S--VQGIQYLPNVTKLFLNGNKLTDIKPL-----ANLKNLGWLFLDENKVKDLSSLKDLK 112
Query: 488 LKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTG 547
+ I + + + L NN + + KL L+L N ++
Sbjct: 113 KLKSLSLEHNGISDINGLVHLPQLESLYLGNN--KITDITVLSRLTKLDTLSLEDNQISD 170
Query: 548 IIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVS 589
I+P ++GL + ++ LS N ++ L+ +
Sbjct: 171 IVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 4e-06
Identities = 35/204 (17%), Positives = 67/204 (32%), Gaps = 16/204 (7%)
Query: 292 NLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWN 351
+L ++ + + L + ++ N+ + I+ L ++ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAV--TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 352 NHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLV 411
N LT + L + D L + S LV
Sbjct: 78 NKLTDI------KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 412 NCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISE 471
+ L L + +N++ L L + + N +S +P L KL+ L +S+
Sbjct: 132 HLPQLESLYLGNNKITDITVLSR--LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 472 NSFQTSLPSNIWSAPNLKILSASS 495
N + L + + NL +L S
Sbjct: 188 NHI-SDLRA-LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 38/204 (18%), Positives = 65/204 (31%), Gaps = 24/204 (11%)
Query: 139 NSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLS 198
F N S T + +LNS+ Q+ S + L
Sbjct: 15 KQIFS--DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLP 68
Query: 199 SLRFLDLAGNSLTG---------------SLPPQLGLLTQLERIEIGYNNLQGEVPVEFA 243
++ L L GN LT L + + ++ +L+ +
Sbjct: 69 NVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 244 SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSD 303
LV+L ++ + + + L +++ +I L LQ L LS
Sbjct: 129 GLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSK 187
Query: 304 NQLSGPIPASLASLKGLTRLSLMN 327
N +S +LA LK L L L +
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 39/205 (19%), Positives = 69/205 (33%), Gaps = 17/205 (8%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
NL + + EL + I +++ S GI L + N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGN 78
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
T PL L G F E + + + + GL
Sbjct: 79 KLTDIKPLAN--------LKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 221 LTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280
+ + + N + + L L + + +S +P ++ LTKL+ L L KN
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 281 HFTGEIPVSYGNLQALQVLDLSDNQ 305
H + ++ + L+ L VL+L +Q
Sbjct: 189 HIS-DLR-ALAGLKNLDVLELF-SQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 11/69 (15%), Positives = 27/69 (39%), Gaps = 4/69 (5%)
Query: 533 EKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNL 592
+ + NL + S+T + + L SI + +++ + + + ++ N
Sbjct: 24 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNK 79
Query: 593 LTGPIPASG 601
LT P +
Sbjct: 80 LTDIKPLAN 88
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 47.2 bits (110), Expect = 5e-06
Identities = 34/304 (11%), Positives = 86/304 (28%), Gaps = 28/304 (9%)
Query: 285 EIPVSYGNLQALQVLDLSDNQLSGP----IPASLASLKGLTRLSLMNN---VLFGEIPQD 337
+ +++ + LS N + + ++AS K L + + EIP+
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 338 IELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLIL 397
+ LL + + + + L +S ++ + +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 398 FSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRD 457
++ + N L + N+L + + + + + I +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 458 LGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELH 517
LE L + L N ++ ++ ++ L+
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA----------LAIALKSWPNLRELGLN 251
Query: 518 NNLLNGSIPWDIGHC------EKLLLLNLSRNSLTGIIPWEI-----SGLPSITDVDLSH 566
+ LL+ + L L L N + + +P + ++L+
Sbjct: 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 311
Query: 567 NFLT 570
N +
Sbjct: 312 NRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 34/319 (10%), Positives = 86/319 (26%), Gaps = 29/319 (9%)
Query: 294 QALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGE----IPQDIELLADLDTLLL 349
++L++ ++ + A L + + L N + E + ++I DL+
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 350 WNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPEN 409
+ V + + LL + L G + ++ + +
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHL 126
Query: 410 LVNCSSLSRLRIQ---DNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEY 466
++ + L ++ + P L + RN L ++ +
Sbjct: 127 YLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHR 186
Query: 467 LNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIP 526
L + Q + L+ L + +L + ++
Sbjct: 187 LLHTVKMVQNGIRPEGIEHLLLEGL----------AYCQELKVLDLQDNTFTHLGSSALA 236
Query: 527 WDIGHCEKLLLLNLSRNSLTGIIPWEIS------GLPSITDVDLSHNFLTGTIPSN---- 576
+ L L L+ L+ + + + L +N +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 577 -FENCSTLESFNVSYNLLT 594
E L ++ N +
Sbjct: 297 IDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 7e-05
Identities = 32/298 (10%), Positives = 78/298 (26%), Gaps = 17/298 (5%)
Query: 189 EIPSDYRNLSSLRFLDLAGNSLTG----SLPPQLGLLTQLERIEIGYN---NLQGEVPVE 241
+ + S++ + L+GN++ L + LE E ++ E+P
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 242 FASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDL 301
L+ + + + + + L K+ + + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 302 SDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQK 361
+ + + L + N L ++ LL + + +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 362 LGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRI 421
+ L + + L + ++ L +C +R
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261
Query: 422 QDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNA-----QKLEYLNISENSF 474
L + + N + + R L L +L ++ N F
Sbjct: 262 AVVD-----AFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 7e-04
Identities = 41/300 (13%), Positives = 80/300 (26%), Gaps = 32/300 (10%)
Query: 76 KSSQITSLDLSRRSLSGP----IPPEIRYLTSLTHLNLSAN----------AFDGPLQPA 121
+ + + LS ++ + I L S L A
Sbjct: 29 EDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA 88
Query: 122 ILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNL 181
+L+ KL T+ +S N+F T + + L + + L
Sbjct: 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 148
Query: 182 GGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVE 241
+ P + L+ LL ++ ++ G E +
Sbjct: 149 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 208
Query: 242 FA------SLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGN--- 292
V + S L + + L L L + + +
Sbjct: 209 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 268
Query: 293 ---LQALQVLDLSDNQLSGPIPASLAS-----LKGLTRLSLMNNVLFGEIPQDIELLADL 344
LQ L L N++ +L + + L L L N F E ++ + ++
Sbjct: 269 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGN-RFSEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 34/340 (10%), Positives = 93/340 (27%), Gaps = 30/340 (8%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFA-------SLVNLKYM 251
SL+ + S+ L ++ I + N + E + L ++
Sbjct: 9 SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP 311
DI + +P + L + + + Q + LS + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 312 ASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTV 371
L + + + + + L +++ N L ++ + +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 372 DVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIP 431
+ + I P + + + + + ++
Sbjct: 188 LHTVKMVQNGIRPEGI-----------EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALA 236
Query: 432 QGFGLLPNLTFMDMSRNSLSGEIPRDLGNA------QKLEYLNISENSFQTSLPSNIWSA 485
PNL + ++ LS + +A L+ L + N + + +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTV 296
Query: 486 -----PNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNL 520
P+L L + ++ + + + ++ L
Sbjct: 297 IDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGEL 336
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.9 bits (104), Expect = 2e-05
Identities = 24/228 (10%), Positives = 49/228 (21%), Gaps = 9/228 (3%)
Query: 370 TVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGS 429
+ +T IP + +L L ++ I N +
Sbjct: 12 VFLCQESKVTE-IPSDLPR--NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 430 IPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISEN-----SFQTSLPSNIWS 484
I + + + + +
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 485 APNLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNS 544
L I + + + L+ N + + L N+
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 545 LTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNL 592
L + G +D+S + EN L + + YNL
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST-YNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 0.001
Identities = 12/57 (21%), Positives = 20/57 (35%)
Query: 272 LEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNN 328
E+ L N+ + +LD+S ++ L +LK L S N
Sbjct: 179 DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 15/86 (17%), Positives = 22/86 (25%), Gaps = 3/86 (3%)
Query: 395 LILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEI 454
L L N +N L F +D+SR +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 455 PRDLGNAQKLEYLNISENSFQTSLPS 480
L N +KL + LP+
Sbjct: 218 SYGLENLKKLRARSTYNL---KKLPT 240
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (97), Expect = 9e-05
Identities = 24/119 (20%), Positives = 42/119 (35%), Gaps = 7/119 (5%)
Query: 195 RNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254
R S + LDL G L + L R +++ + + ++ L +++S
Sbjct: 19 RYDGSQQALDLKGLRSDPDLV-AQNIDVVLNRR----SSMAATLRIIEENIPELLSLNLS 73
Query: 255 ACNLSGT--LPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIP 311
L + S + L++L L N E + L+ L L N LS
Sbjct: 74 NNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 7/128 (5%)
Query: 99 RYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAY 158
RY S L+L D P ++ ++ + +T + L N
Sbjct: 19 RYDGSQQALDLKGLRSD----PDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLS 73
Query: 159 SNSFTG--PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPP 216
+N + + +L+ LNL G+ E D L L L GNSL+ +
Sbjct: 74 NNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
Query: 217 QLGLLTQL 224
Q ++ +
Sbjct: 134 QSTYISAI 141
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (88), Expect = 0.001
Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 4/114 (3%)
Query: 487 NLKILSASSSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLT 546
+ + L PD + + +++ ++ + +LL LNLS N L
Sbjct: 21 DGSQQALDLKGLR-SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 547 GI--IPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIP 598
+ + + P++ ++LS N L + LE + N L+
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.004
Identities = 23/146 (15%), Positives = 42/146 (28%), Gaps = 26/146 (17%)
Query: 438 PNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSK 497
+ +D+ DL LN + +L + P L L+ S+++
Sbjct: 22 GSQQALDLKGLR----SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNR 76
Query: 498 LTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLP 557
L + + L +LNLS N L +
Sbjct: 77 LYR---------------------LDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGL 115
Query: 558 SITDVDLSHNFLTGTIPSNFENCSTL 583
+ ++ L N L+ T S +
Sbjct: 116 KLEELWLDGNSLSDTFRDQSTYISAI 141
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.7 bits (96), Expect = 1e-04
Identities = 34/182 (18%), Positives = 61/182 (33%), Gaps = 8/182 (4%)
Query: 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLV-NLKYMDISACN 257
+D G L +P + + + N L + +L +++
Sbjct: 9 EGTTVDCTGRGLK-EIPR--DIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQ 65
Query: 258 LSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASL 317
L+G P+ + ++ L L +N + L L+ L+L DNQ+S +P S L
Sbjct: 66 LTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHL 125
Query: 318 KGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNS 377
LT L+L +N L L P K+ + D+ +
Sbjct: 126 NSLTSLNLASNPFNCNCHLAW-FAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSE 181
Query: 378 LT 379
Sbjct: 182 FK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 38.6 bits (88), Expect = 0.001
Identities = 33/185 (17%), Positives = 65/185 (35%), Gaps = 8/185 (4%)
Query: 297 QVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIE-LLADLDTLLLWNNHLT 355
+D + L IP + T L L +N L + L L L L N LT
Sbjct: 11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 356 GVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSS 415
G+ P + + + N + +L L L+ N + +P + + +S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 416 LSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQ 475
L+ L + N N + L ++ + P + + ++ ++ + F+
Sbjct: 128 LTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183
Query: 476 TSLPS 480
S +
Sbjct: 184 CSSEN 188
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 31/189 (16%), Positives = 57/189 (30%), Gaps = 20/189 (10%)
Query: 101 LTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSN 160
L L + +L ++ T+ S G+ L L N +N
Sbjct: 17 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 72
Query: 161 SFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGL 220
T PL+ + +N + + F + + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 221 LTQLERI--------------EIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEI 266
L ++ +++ Q A+L L+ +DIS+ +S S +
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVL 190
Query: 267 SNLTKLEML 275
+ LT LE L
Sbjct: 191 AKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 39/201 (19%), Positives = 63/201 (31%), Gaps = 16/201 (7%)
Query: 267 SNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326
+ L + +L K + T + + +L + L + + L LT+++
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 70
Query: 327 NNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTI 386
NN L P L L + L + LT I
Sbjct: 71 NNQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 387 CDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMS 446
+ L ++ T S L +SL +L NQ+ P L L +D+S
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDIS 180
Query: 447 RNSLSGEIPRDLGNAQKLEYL 467
N +S L LE L
Sbjct: 181 SNKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 0.001
Identities = 31/192 (16%), Positives = 66/192 (34%), Gaps = 15/192 (7%)
Query: 394 KLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGE 453
K +L N T ++ + + ++ L+ + SI G L NLT ++ S N L+
Sbjct: 22 KTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDI 77
Query: 454 IPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYK 513
P +N ++ + T L + + + K + +
Sbjct: 78 TPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSS 137
Query: 514 IELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTI 573
+ + + N +T + P ++ L ++ +D+S N ++
Sbjct: 138 NTISDISALSGLTSLQQLNFS-------SNQVTDLKP--LANLTTLERLDISSNKVSD-- 186
Query: 574 PSNFENCSTLES 585
S + LES
Sbjct: 187 ISVLAKLTNLES 198
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (93), Expect = 2e-04
Identities = 10/100 (10%), Positives = 35/100 (35%), Gaps = 3/100 (3%)
Query: 495 SSKLTGKIPDFIGCKSIYKIELHNNLLNGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEIS 554
+++L + + +++L + I ++ ++ S N + + +
Sbjct: 4 TAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF--P 60
Query: 555 GLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLT 594
L + + +++N + + L ++ N L
Sbjct: 61 LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.9 bits (92), Expect = 4e-04
Identities = 24/136 (17%), Positives = 43/136 (31%), Gaps = 7/136 (5%)
Query: 192 SDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYM 251
+ Y N R LDL G + + L Q + I+ N ++ F L LK +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTL 68
Query: 252 DISACNLSGTLPSEISNLTKLEMLLLFKNHFTG-EIPVSYGNLQALQVLDLSD---NQLS 307
++ + L L L+L N +L++L L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 308 GPIPASLASLKGLTRL 323
+ + + L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 6e-04
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 3/94 (3%)
Query: 264 SEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRL 323
++ +N + L L I L +D SDN++ L+ L L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 324 SLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGV 357
+ NN + + L DL L+L NN L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 102
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 902 | |||
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.98 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.98 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.98 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.98 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.97 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.96 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.96 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.95 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.95 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.95 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.95 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.94 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.94 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.94 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.94 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.86 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.85 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.83 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.79 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.79 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.78 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.57 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.52 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.51 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.34 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.26 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.43 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.41 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.97 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.79 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.5 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.73 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.55 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.54 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.4 |
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.2e-44 Score=393.31 Aligned_cols=293 Identities=29% Similarity=0.493 Sum_probs=205.0
Q ss_pred CCChhhHHHHHHHHHhCCCCCCCCcCCCCCCCCCCCCCCCCCCCCC--ccccEEecCCC--CCEEEEEcCCCCccc--cc
Q 043136 21 NTLPLPLVSLLSIKASLKDPFNNSFHDWDATPAFSNPSSEQEPVWC--SWSGIKCNPKS--SQITSLDLSRRSLSG--PI 94 (902)
Q Consensus 21 ~~~~~~~~aLl~~k~~~~~~~~~~l~~W~~~~~~~~~~~~~~~~~C--~w~Gv~c~~~~--~~v~~L~L~~~~l~g--~~ 94 (902)
.|.|+|++||++||+++.+|. .+++|+.+ +| || .|.||+|+..+ .||++|||++++++| .+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~--~l~sW~~~------~d-----~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~l 68 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT--TLSSWLPT------TD-----CCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPI 68 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG--GGTTCCTT------SC-----TTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEEC
T ss_pred CCCHHHHHHHHHHHHHCCCCC--cCCCCCCC------CC-----CCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCC
Confidence 599999999999999999874 59999765 34 88 59999998764 489999999999998 47
Q ss_pred CccccCCCCCCEEEccC-CCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcc
Q 043136 95 PPEIRYLTSLTHLNLSA-NAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL 173 (902)
Q Consensus 95 ~~~~~~l~~L~~L~Ls~-n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 173 (902)
|+++++|++|++|+|++ |+++|.+|++|++|++|++|+|++|+|.+..+..+..+..|+.++++.|++.+.+|..+.++
T Consensus 69 p~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l 148 (313)
T d1ogqa_ 69 PSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSL 148 (313)
T ss_dssp CGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGC
T ss_pred ChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccC
Confidence 88899999999999986 88888888888888888888888888888777777777777777777777777777777777
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCC-CEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEE
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSL-RFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMD 252 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 252 (902)
+.|+++++++|++.+.+|..+..+.++ +.+++++|++++..|..+..+..+ .++++.|.+.+.+|..+..+++|+.++
T Consensus 149 ~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~ 227 (313)
T d1ogqa_ 149 PNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIH 227 (313)
T ss_dssp TTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred cccceeeccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccc
Confidence 777777777777776677666666554 666666666666666655555433 456666666555555555555566666
Q ss_pred ccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcc
Q 043136 253 ISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNV 329 (902)
Q Consensus 253 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (902)
+++|.+++.+| .+..+++|++|+|++|+++|.+|..|+++++|++|+|++|+|+|.+|. ++++++|+.+++++|+
T Consensus 228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 65555554433 344555555555555555555555555555555555555555554442 3444444444444443
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=5.3e-35 Score=316.80 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=229.3
Q ss_pred CceeEEEecCCcccC--CCCCCccCCCCccEEeccC-CcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcE
Q 043136 366 GKLLTVDVSSNSLTG--PIPPTICDGDRLFKLILFS-NNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTF 442 (902)
Q Consensus 366 ~~L~~L~Ls~N~l~~--~~p~~~~~~~~L~~L~l~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 442 (902)
.+++.|||++|.++| .+|+.++++++|++|++++ |+++|.+|..|.++++|++|+|++|++++..|..+..+..|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 357778888888877 4778888888888888876 7888888888889999999999999999888888888999999
Q ss_pred EEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhccccc-ceeccCCCccCCCcccccccccccEEeccCccc
Q 043136 443 MDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWSAPNL-KILSASSSKLTGKIPDFIGCKSIYKIELHNNLL 521 (902)
Q Consensus 443 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N~l 521 (902)
+++++|++.+.+|..+++++.|+.+++++|.+.+.+|..+..+..+ +.++++.|++++..|..++......+++++|.+
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~ 209 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999998899999999999999999999988899988888776 788999999998888877756667899999999
Q ss_pred cccCCccccccccceEEEeeCCcceecCCCCCCCCCcccEEEccCCcccccCCCCCcCCccceeecccCCcccccCCCCC
Q 043136 522 NGSIPWDIGHCEKLLLLNLSRNSLTGIIPWEISGLPSITDVDLSHNFLTGTIPSNFENCSTLESFNVSYNLLTGPIPASG 601 (902)
Q Consensus 522 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~ip~~~ 601 (902)
.|.+|..++.+++|+.|++++|.+++.+| .++.+++|+.|||++|+|+|.+|..|.++++|++|||++|+|+|.||+.+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcc
Confidence 99999999999999999999999998776 68999999999999999999999999999999999999999999999876
Q ss_pred CcCcCCCCCcccCCcccCCCCcCCCCC
Q 043136 602 TIFPNLHPSSFIGNEGLCGRVLTKPCP 628 (902)
Q Consensus 602 ~~~~~~~~~~~~gn~~lcg~~~~~~c~ 628 (902)
.+.. ++..++.||+.+||.|+ ++|.
T Consensus 289 ~L~~-L~~l~l~~N~~l~g~pl-p~c~ 313 (313)
T d1ogqa_ 289 NLQR-FDVSAYANNKCLCGSPL-PACT 313 (313)
T ss_dssp TGGG-SCGGGTCSSSEEESTTS-SCCC
T ss_pred cCCC-CCHHHhCCCccccCCCC-CCCC
Confidence 6544 58899999999999994 5773
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-34 Score=301.21 Aligned_cols=174 Identities=28% Similarity=0.402 Sum_probs=150.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|++. +++.||+|++.+.........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEee
Confidence 556789999999999999774 6889999998644333333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 88 ~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 88 APLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred cCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999997653 3778888999999999999999776 999999999999999999999999999876543
Q ss_pred CCceeeccccCccccCcccccccC
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.....+||+.|||||++.+....
T Consensus 160 -~~~~~~Gt~~Y~APE~~~~~~~~ 182 (263)
T d2j4za1 160 -RRTTLCGTLDYLPPEMIEGRMHD 182 (263)
T ss_dssp -CCEETTEEGGGCCHHHHTTCCCC
T ss_pred -cccccCCCCcccCHHHHcCCCCC
Confidence 34567899999999999886544
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=302.49 Aligned_cols=171 Identities=26% Similarity=0.338 Sum_probs=144.4
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|++ .+++.||||++...... ...+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred eEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 45568999999999999976 46899999998644322 2345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|+|.+++.... .+++..+..++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+.....
T Consensus 85 ~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 85 CSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCcHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999886432 4778888999999999999999776 999999999999999999999999999976433
Q ss_pred C---CceeeccccCccccCcccccc
Q 043136 871 E---SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 ~---~~~~~~Gt~~y~APE~~~~~~ 892 (902)
. .....+||+.|||||++.+..
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~ 181 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRRE 181 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSS
T ss_pred CccccccceeeCcCccCHhHhcCCC
Confidence 2 235578999999999997653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=303.75 Aligned_cols=175 Identities=28% Similarity=0.350 Sum_probs=147.7
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|++ .+++.||||++.+.........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEc
Confidence 56678999999999999976 46899999998654333333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++||+|.+++...+ .+++..+..++.|++.||+|||+++ ||||||||+||++++++.+||+|||+|+.+...
T Consensus 90 ~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred cCCCCHHHhhhccC-----CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999987654 3778888999999999999999776 999999999999999999999999999987532
Q ss_pred C---CceeeccccCccccCcccccccC
Q 043136 871 E---SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~---~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
. .....+||+.|||||++.+....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~ 188 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSAC 188 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCC
T ss_pred CcccccccccCCccccCceeeccCCCC
Confidence 2 23456899999999999876543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-34 Score=304.84 Aligned_cols=176 Identities=28% Similarity=0.406 Sum_probs=150.3
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|...+.||+|+||+||+|+. .+++.||||++...........+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4566678899999999999975 568899999997655555566678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|||++|++..++...+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccC
Confidence 9999998876655432 4788899999999999999999776 9999999999999999999999999998754
Q ss_pred CCCCceeeccccCccccCcccccccCce
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCFSVPF 896 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~~~p~ 896 (902)
. ....+||+.|||||++.+....++
T Consensus 167 ~---~~~~~GT~~Y~APE~~~~~~~~~y 191 (309)
T d1u5ra_ 167 P---ANSFVGTPYWMAPEVILAMDEGQY 191 (309)
T ss_dssp S---BCCCCSCGGGCCHHHHTTTTSCCB
T ss_pred C---CCccccCccccCHHHHhccCCCCc
Confidence 3 345689999999999976433333
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=300.25 Aligned_cols=172 Identities=23% Similarity=0.367 Sum_probs=148.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||+||+|++ .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 21 ~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 466678999999999999976 46899999998644322 24568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|++||+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++++||+|||+|+.+..
T Consensus 98 y~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 99999999987643 3678888999999999999999776 99999999999999999999999999998754
Q ss_pred CC-CceeeccccCccccCcccccccC
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.. .....+||+.|||||++.+....
T Consensus 169 ~~~~~~~~~gt~~Y~aPE~~~~~~~~ 194 (293)
T d1yhwa1 169 EQSKRSTMVGTPYWMAPEVVTRKAYG 194 (293)
T ss_dssp TTCCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred ccccccccccCCCccChhhhcCCCCC
Confidence 33 34567899999999999876443
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-34 Score=300.19 Aligned_cols=181 Identities=24% Similarity=0.370 Sum_probs=137.7
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--CCeeEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--RECTMLLY 788 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--~~~~~lv~ 788 (902)
|.+.+.||+|+||+||+|+. .+|+.||||++..... .....+.+.+|++++++++|||||++++++.+ .+..|+||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred CEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEE
Confidence 44568999999999999976 4689999999865433 33456778999999999999999999999865 45689999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--DPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
|||++|+|.+++..... ....+++..++.++.|++.||+|||+++ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 85 Ey~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 85 EYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp ECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred ecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999875432 1235788899999999999999999754 24599999999999999999999999999998
Q ss_pred ccCCC-CceeeccccCccccCcccccccC
Q 043136 867 IQSDE-SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 867 ~~~~~-~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+..+. .....+||+.|||||++.+....
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~ 192 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYN 192 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCC
Confidence 75433 34567899999999999775443
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-33 Score=293.46 Aligned_cols=173 Identities=26% Similarity=0.393 Sum_probs=144.5
Q ss_pred cCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec----CCeeEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN----RECTMLL 787 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~----~~~~~lv 787 (902)
.+++.||+|+||+||+|.+. +++.||+|++..... .....+.+.+|++++++++|||||++++++.+ ....|+|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 45678999999999999764 688999999865432 33456778999999999999999999999864 3568999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc-CCCCEEEeeccccee
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD-GEMEARVADFGVAKL 866 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~-~~~~~kl~DFGla~~ 866 (902)
|||+++|+|.+++.... .+++..+..++.||++||+|||+++ .+||||||||+|||++ +++.+||+|||+|+.
T Consensus 91 mE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EeCCCCCcHHHHHhccc-----cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 99999999999997653 3778888899999999999999652 4499999999999996 578999999999986
Q ss_pred ccCCCCceeeccccCccccCccccccc
Q 043136 867 IQSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 867 ~~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.. .......+||+.|||||++.+.+.
T Consensus 165 ~~-~~~~~~~~GT~~Y~aPE~~~~~~~ 190 (270)
T d1t4ha_ 165 KR-ASFAKAVIGTPEFMAPEMYEEKYD 190 (270)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGTCCC
T ss_pred cc-CCccCCcccCccccCHHHhCCCCC
Confidence 43 334566789999999999987543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=310.21 Aligned_cols=173 Identities=27% Similarity=0.390 Sum_probs=147.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|...+.||+|+||+||+|++ .+++.||+|++...... ...+.+.+|++++++++|||||+++++|.+.+..|+|||
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 455668999999999999976 46899999998654322 334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-CCCCeEEcCCCCCCEEEcCCCCEEEeecccceecc
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-CDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQ 868 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~ 868 (902)
|++||+|.+++.+.+ .+++..+..++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+|+...
T Consensus 85 y~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp CCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred cCCCCcHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999997653 377888899999999999999974 5 9999999999999999999999999999765
Q ss_pred CCCCceeeccccCccccCcccccccC
Q 043136 869 SDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 869 ~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+.. ..+.+||+.|||||++.+....
T Consensus 157 ~~~-~~~~~GT~~Y~APEvl~~~~y~ 181 (322)
T d1s9ja_ 157 DSM-ANSFVGTRSYMSPERLQGTHYS 181 (322)
T ss_dssp HHT-C---CCSSCCCCHHHHHCSCCC
T ss_pred CCc-cccccCCccccCchHHcCCCCC
Confidence 432 3457899999999999876443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-33 Score=302.25 Aligned_cols=175 Identities=25% Similarity=0.250 Sum_probs=150.5
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|+. .+++.||||++.+.........+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceec
Confidence 45568999999999999976 57999999999654333333456688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC-
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS- 869 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~- 869 (902)
++||+|.+++...+ .+++.....++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 87 ~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 87 ANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred cCCCchhhhhhccc-----CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999988654 3667778899999999999999776 99999999999999999999999999997643
Q ss_pred CCCceeeccccCccccCcccccccC
Q 043136 870 DESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.......+||+.|||||++.+....
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~ 183 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYG 183 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBC
T ss_pred CcccccceeCHHHhhhhhccCCCCC
Confidence 3445668999999999999876443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-33 Score=297.24 Aligned_cols=175 Identities=29% Similarity=0.420 Sum_probs=141.6
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||+||+|+.. ..||||++..... .....+.+.+|++++++++|||||++++++.+ +..++||||+
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~ 85 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC 85 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred EEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence 456789999999999999864 3599999854332 23456778999999999999999999998754 5689999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++...+. .+++..+..|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 86 EGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999975432 4788899999999999999999766 9999999999999999999999999998764322
Q ss_pred ---CceeeccccCccccCcccccccCcee
Q 043136 872 ---SMSVIAGSYGYIAPGTFCFCFSVPFC 897 (902)
Q Consensus 872 ---~~~~~~Gt~~y~APE~~~~~~~~p~~ 897 (902)
.....+||+.|||||++.+....+++
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~ 187 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYS 187 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCC
Confidence 23456899999999999876544443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.98 E-value=1.1e-33 Score=303.50 Aligned_cols=176 Identities=27% Similarity=0.366 Sum_probs=132.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
..|.+.+.||+|+||+||+|++. +++.||||++.+.... ...+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45777899999999999999764 6899999998654332 23456789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc---CCCCEEEeecccce
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD---GEMEARVADFGVAK 865 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~---~~~~~kl~DFGla~ 865 (902)
|||+||+|.+++...+ .+++.....++.||+.||+|||+++ ||||||||+||++. +++.+||+|||+|+
T Consensus 87 E~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp CCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred eccCCCcHHHhhhccc-----CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeE
Confidence 9999999999997543 4788889999999999999999776 99999999999994 57899999999999
Q ss_pred eccCCCCceeeccccCccccCcccccccCc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
.........+.+||+.|||||++.+....+
T Consensus 159 ~~~~~~~~~~~~GT~~y~APE~~~~~~~~~ 188 (307)
T d1a06a_ 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSK 188 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCT
T ss_pred EccCCCeeeeeeeCccccCcHHHcCCCCCc
Confidence 876666666788999999999998764443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=6.7e-33 Score=298.59 Aligned_cols=173 Identities=28% Similarity=0.343 Sum_probs=147.8
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|.+.+.||+|+||+||+|++ .+|+.||||++.+.........+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred eEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeee
Confidence 45568999999999999976 46899999998644333333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
++||++.+++..... .++.....++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~~~~-----~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQR-----FPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCSCBHHHHHHHTSS-----CCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred cCCcccccccccccc-----ccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 999999998876543 566777789999999999999665 999999999999999999999999999986543
Q ss_pred CCceeeccccCccccCcccccccC
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
..+.+||+.|||||++.+....
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~ 179 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYN 179 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBC
T ss_pred --cccccCcccccCHHHHcCCCCC
Confidence 3457899999999999876443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.6e-33 Score=294.48 Aligned_cols=172 Identities=24% Similarity=0.423 Sum_probs=138.0
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.+.||+|+||+||+|++.+++.||||++...... .+++.+|++++++++|||||++++++.+.+..|+||||++
T Consensus 8 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 8 TFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 345789999999999999888899999998643322 3568899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|+|.+++.... ...++..+..++.|+|+||+|+|+++ |+||||||+||+++.++.+||+|||+|+.......
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999987543 24778888999999999999999776 99999999999999999999999999987754332
Q ss_pred --ceeeccccCccccCcccccccCc
Q 043136 873 --MSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 873 --~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
.....||+.|||||++.+....+
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~ 181 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSS 181 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCH
T ss_pred eeecceecCcccCChHHhcCCCCCc
Confidence 23467999999999998765443
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.98 E-value=1.3e-32 Score=300.25 Aligned_cols=173 Identities=24% Similarity=0.365 Sum_probs=151.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 466778999999999999976 4689999999864432 345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC--CCCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG--EMEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~--~~~~kl~DFGla~~~ 867 (902)
||+||+|.+++.... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.+
T Consensus 104 ~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 104 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp CCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred cCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 999999999986432 24788899999999999999999776 999999999999954 578999999999988
Q ss_pred cCCCCceeeccccCccccCccccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
.........+||+.|||||++.+...
T Consensus 177 ~~~~~~~~~~gT~~Y~aPEv~~~~~~ 202 (350)
T d1koaa2 177 DPKQSVKVTTGTAEFAAPEVAEGKPV 202 (350)
T ss_dssp CTTSCEEEECSCTTTCCHHHHHTCCB
T ss_pred ccccccceecCcccccCHHHHcCCCC
Confidence 77777778899999999999987543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=8.5e-33 Score=295.53 Aligned_cols=177 Identities=25% Similarity=0.334 Sum_probs=152.6
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhh---HHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
.+|.+.+.||+|+||+||+|++ .+|+.||||++.+..... ....+.+.+|++++++++|||||++++++.+.+..|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4677789999999999999976 468999999986433221 123567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC----CEEEeec
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM----EARVADF 861 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~----~~kl~DF 861 (902)
+|||||++|+|.+++...+ .+++..+..++.|++.||+|||+++ ||||||||+||+++.++ .+|++||
T Consensus 90 iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEcCCCccccchhcccc-----ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecch
Confidence 9999999999999997653 3788888999999999999999776 99999999999998876 4999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccccC
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
|+|+............||+.|||||++.+....
T Consensus 162 G~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~ 194 (293)
T d1jksa_ 162 GLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLG 194 (293)
T ss_dssp TTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBC
T ss_pred hhhhhcCCCccccccCCCCcccCHHHHcCCCCC
Confidence 999988766666778899999999999876443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.5e-33 Score=296.64 Aligned_cols=171 Identities=26% Similarity=0.361 Sum_probs=145.6
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||+||+|++ .+++.||||++...... ..+.+.+|++++++++|||||++++++.+.+..|+|||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 355668899999999999976 46899999998654322 34567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||++|+|.+++..... .+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 9999999999865432 4788888999999999999999776 99999999999999999999999999987643
Q ss_pred C-CCceeeccccCccccCccccc
Q 043136 870 D-ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 870 ~-~~~~~~~Gt~~y~APE~~~~~ 891 (902)
. ......+||+.|||||++.+.
T Consensus 163 ~~~~~~~~~Gt~~y~APE~l~~~ 185 (288)
T d2jfla1 163 TIQRRDSFIGTPYWMAPEVVMCE 185 (288)
T ss_dssp HHHHHTCCCSCCTTCCHHHHTTC
T ss_pred CcccccccccccccCCHHHHhhc
Confidence 2 223457899999999998643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2.8e-32 Score=297.78 Aligned_cols=173 Identities=21% Similarity=0.314 Sum_probs=151.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 466778999999999999976 5699999999864432 334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc--CCCCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD--GEMEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~--~~~~~kl~DFGla~~~ 867 (902)
||+||+|.+++.... ..+++..+..|+.||+.||+|||+++ ||||||||+|||++ .++.+||+|||+|+.+
T Consensus 107 ~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 107 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred cCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceec
Confidence 999999998875432 24788899999999999999999776 99999999999997 5789999999999998
Q ss_pred cCCCCceeeccccCccccCccccccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..........||+.|||||++.+...
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (352)
T d1koba_ 180 NPDEIVKVTTATAEFAAPEIVDREPV 205 (352)
T ss_dssp CTTSCEEEECSSGGGCCHHHHTTCCB
T ss_pred CCCCceeeccCcccccCHHHHcCCCC
Confidence 87777778899999999999987643
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-33 Score=296.34 Aligned_cols=171 Identities=27% Similarity=0.434 Sum_probs=144.3
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||+||+|++++++.||||++..... ..+.+.+|++++++++|||||++++++.+ +..|+||||+
T Consensus 15 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 15 LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred eEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 456688999999999999998889999999854322 23568899999999999999999998854 5679999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++..... ..+++..+.+|+.||++||+|||+++ |+||||||+||++++++.+||+|||+|+......
T Consensus 90 ~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999998765432 24788999999999999999999766 9999999999999999999999999999875433
Q ss_pred C--ceeeccccCccccCccccccc
Q 043136 872 S--MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 872 ~--~~~~~Gt~~y~APE~~~~~~~ 893 (902)
. .....||+.|||||++.+...
T Consensus 164 ~~~~~~~~gt~~y~APE~~~~~~~ 187 (272)
T d1qpca_ 164 YTAREGAKFPIKWTAPEAINYGTF 187 (272)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEE
T ss_pred cccccccCCcccccChHHHhCCCC
Confidence 2 234578999999999976543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=1e-32 Score=295.17 Aligned_cols=174 Identities=26% Similarity=0.452 Sum_probs=135.1
Q ss_pred ccCCcEeeecCceEEEEEEeCC-C---cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG-G---EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~-~---~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
+...+.||+|+||+||+|++.. + ..||||++.... .....+++.+|++++++++|||||++++++.+.+..|+|
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred cEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 4556899999999999997643 2 358899875433 234556799999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
||||++|+|.+++..... .+++.++..++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEecCCCcceeeeccccC----CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEc
Confidence 999999999998875432 4788999999999999999999766 999999999999999999999999999877
Q ss_pred cCCCCc------eeeccccCccccCcccccccC
Q 043136 868 QSDESM------SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 868 ~~~~~~------~~~~Gt~~y~APE~~~~~~~~ 894 (902)
...... ....||+.|||||++.+....
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 211 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCC
T ss_pred cCCCCcceeeecccccCCccccCHHHHhcCCCC
Confidence 543221 224579999999999765443
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=2e-33 Score=298.76 Aligned_cols=173 Identities=27% Similarity=0.391 Sum_probs=146.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
+.+.+.||+|+||+||+|.+. +++.||||++..... ..+++.+|++++++++|||||++++++.+.+..|+||||
T Consensus 19 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~ 94 (287)
T d1opja_ 19 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 94 (287)
T ss_dssp EEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred eEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence 455688999999999999765 588999999854332 245688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+++|++.+++.... ...+++..+..|+.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+....+
T Consensus 95 ~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 95 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 99999999987543 235788889999999999999999776 999999999999999999999999999876544
Q ss_pred CCc--eeeccccCccccCcccccccC
Q 043136 871 ESM--SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~~~--~~~~Gt~~y~APE~~~~~~~~ 894 (902)
... ....||+.|||||++.+....
T Consensus 169 ~~~~~~~~~g~~~y~aPE~~~~~~~~ 194 (287)
T d1opja_ 169 TYTAHAGAKFPIKWTAPESLAYNKFS 194 (287)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred CceeeccccccccccChHHHcCCCCC
Confidence 332 234689999999999765443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=289.59 Aligned_cols=168 Identities=29% Similarity=0.411 Sum_probs=138.1
Q ss_pred CcEeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 715 DKILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
++.||+|+||+||+|.+. .++.||||++.... ......+++.+|++++++++|||||++++++.++ ..|+||||+
T Consensus 12 ~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcC
Confidence 467999999999999653 35789999985432 2234456799999999999999999999999754 578999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.++++... .+++..+..++.||++||+|||+++ ||||||||+||+++.++.+||+|||+|+......
T Consensus 90 ~~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~ 161 (277)
T d1xbba_ 90 ELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADE 161 (277)
T ss_dssp TTEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred CCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccc
Confidence 9999999987543 4788999999999999999999766 9999999999999999999999999999875443
Q ss_pred Cc----eeeccccCccccCcccccc
Q 043136 872 SM----SVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 872 ~~----~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ....||+.|||||++.+..
T Consensus 162 ~~~~~~~~~~gt~~y~APE~l~~~~ 186 (277)
T d1xbba_ 162 NYYKAQTHGKWPVKWYAPECINYYK 186 (277)
T ss_dssp SEEEC----CCCGGGCCHHHHHHCE
T ss_pred cccccccccCCCceecCchhhcCCC
Confidence 32 2356899999999986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=5.2e-32 Score=295.68 Aligned_cols=173 Identities=24% Similarity=0.248 Sum_probs=149.5
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||.||+|++ .+|+.||||++.+.........+.+.+|+++++.++|||||++++++.+.+..++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred eEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccc
Confidence 45568999999999999976 46999999998644333333456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+.+|++.+++...+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 123 ~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccchhhhHhhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999997654 3678888999999999999999776 999999999999999999999999999987543
Q ss_pred CCceeeccccCccccCcccccccC
Q 043136 871 ESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 871 ~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
....+||+.|||||++.+....
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~ 216 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYN 216 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBC
T ss_pred --cccccCccccCCHHHHcCCCCC
Confidence 3457899999999999876543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5e-32 Score=283.06 Aligned_cols=171 Identities=23% Similarity=0.346 Sum_probs=147.0
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
.+.++||+|+||+||+|++++++.||||++.+.... .+++.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred EEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 456889999999999999988889999998654332 3468899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES 872 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 872 (902)
+|++.+++..... ..++..+++++.|+++||+|||+++ |+||||||+||++++++.+||+|||+|+.......
T Consensus 83 ~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 83 NGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp TEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCcHHHhhhcccc----CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence 9999999765433 4677888999999999999999766 99999999999999999999999999987654332
Q ss_pred --ceeeccccCccccCcccccccC
Q 043136 873 --MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 873 --~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.....||+.|||||++.+....
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~ 179 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFS 179 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCC
T ss_pred eeecccCCCCCcCCcHHhcCCCCC
Confidence 2346789999999999765544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.97 E-value=1.2e-31 Score=282.94 Aligned_cols=173 Identities=32% Similarity=0.447 Sum_probs=151.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccch------hhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCC
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHK------ENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRE 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~------~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~ 782 (902)
.|.+.+.||+|+||+||+|+. .+++.||||++.+... ......+.+.+|++++++++ |||||++++++.+++
T Consensus 4 ~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~ 83 (277)
T d1phka_ 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNT 83 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCc
Confidence 356678999999999999976 5789999999865432 12334567889999999996 999999999999999
Q ss_pred eeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
..|+||||+++|+|.++++..+ .+++..+..++.||++||+|||+++ ||||||||+||+++.++.+||+|||
T Consensus 84 ~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 84 FFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEcCCCchHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 9999999999999999997653 4788999999999999999999776 9999999999999999999999999
Q ss_pred cceeccCCCCceeeccccCccccCccccc
Q 043136 863 VAKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
+|+.+.........+||+.|+|||++.+.
T Consensus 156 ~a~~~~~~~~~~~~~gt~~y~~PE~~~~~ 184 (277)
T d1phka_ 156 FSCQLDPGEKLREVCGTPSYLAPEIIECS 184 (277)
T ss_dssp TCEECCTTCCBCCCCSCGGGCCHHHHHHH
T ss_pred heeEccCCCceeeeeccCCCCCHHHhhcc
Confidence 99988766666678899999999999754
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.7e-32 Score=287.39 Aligned_cols=175 Identities=30% Similarity=0.476 Sum_probs=139.0
Q ss_pred ccCCcEeeecCceEEEEEEeCCC-----cEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGG-----EIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~-----~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
+...++||+|+||.||+|.+..+ ..||||++..... .....++.+|++++++++|||||++++++.+.+..++
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred eEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 44568999999999999976432 4799999854332 3445678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+.+|++.+++..... .+++..+.+++.|++.|++|||+++ |+||||||+|||++.++.+||+|||+|+.
T Consensus 87 v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEecccCcchhhhhcccc----cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhc
Confidence 9999999999998765432 4788899999999999999999766 99999999999999999999999999987
Q ss_pred ccCCCC----ceeeccccCccccCcccccccCc
Q 043136 867 IQSDES----MSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 867 ~~~~~~----~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
...... .....||+.|||||++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~ 192 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTS 192 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCH
T ss_pred ccCCCccceEeccCCCCccccCHHHHccCCCCC
Confidence 644322 23356899999999997765443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.9e-32 Score=285.30 Aligned_cols=167 Identities=28% Similarity=0.375 Sum_probs=139.6
Q ss_pred EeeecCceEEEEEEeC---CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGSTGTVYKAEMP---GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~g~Vy~~~~~---~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.||+|+||+||+|.+. ++..||||++.... .....+++.+|++++++++|||||++++++.+ +..|+||||+++
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~ 92 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG 92 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred EEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCC
Confidence 4999999999999653 35579999985433 23456778999999999999999999999975 457999999999
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCCC-
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDES- 872 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~- 872 (902)
|+|.+++...+ ..+++..+..++.||++||+|||+++ ||||||||+||+++.++.+||+|||+|+.+.....
T Consensus 93 g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 93 GPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred CcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 99999875432 24788899999999999999999776 99999999999999999999999999998754332
Q ss_pred ---ceeeccccCccccCccccccc
Q 043136 873 ---MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 873 ---~~~~~Gt~~y~APE~~~~~~~ 893 (902)
....+||+.|||||++.+...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~ 189 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKF 189 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred cccccccccCccccChHHHhCCCC
Confidence 233568999999999876543
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.6e-32 Score=292.27 Aligned_cols=179 Identities=29% Similarity=0.423 Sum_probs=144.2
Q ss_pred ccCCcEeeecCceEEEEEEeCC------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCee
Q 043136 712 SMSDKILGMGSTGTVYKAEMPG------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~ 784 (902)
+.+.+.||+|+||+||+|++.. ...||+|++.... .......+.+|++++.++ +|||||++++++.+.+..
T Consensus 39 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 39 LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred eEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 4567899999999999997542 2368999885432 223456788999999998 899999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhhccC------------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKG------------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~ 846 (902)
|+|||||++|+|.++++..+.. ....+++..++.++.||++||+|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 9999999999999999765321 1234788889999999999999999776 999999999
Q ss_pred CEEEcCCCCEEEeecccceeccCCCCc---eeeccccCccccCcccccccCc
Q 043136 847 NILLDGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 847 NILl~~~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~~~~p 895 (902)
||+++.++.+||+|||+|+........ ....||+.|||||++.+....+
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~ 245 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCc
Confidence 999999999999999999887554432 3456899999999997655443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.97 E-value=1.9e-31 Score=292.75 Aligned_cols=170 Identities=24% Similarity=0.300 Sum_probs=141.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHH---HHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRR---GVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~---~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|.+.+.||+|+||.||+|++. +|+.||||++.+.......... ...+|+++++.++|||||++++++.+.+..|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEE
Confidence 456689999999999999764 6899999998543322211122 233457788888999999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||++||+|.+++.... ..++..+..++.||+.||+|||+++ ||||||||+|||++.+|.+||+|||+|+.+
T Consensus 86 mE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp ECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999997653 3567888899999999999999776 999999999999999999999999999977
Q ss_pred cCCCCceeeccccCccccCcccc
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCF 890 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~ 890 (902)
.... ....+||+.|||||++..
T Consensus 158 ~~~~-~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 158 SKKK-PHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp SSSC-CCSCCSCGGGCCHHHHST
T ss_pred CCCc-ccccccccccchhHHhhc
Confidence 5443 345689999999999964
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=1.3e-29 Score=282.08 Aligned_cols=355 Identities=22% Similarity=0.267 Sum_probs=175.0
Q ss_pred cCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccC
Q 043136 85 LSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTG 164 (902)
Q Consensus 85 L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 164 (902)
+....+++.++ ...+.+|++|++++++|+.. +.+..+++|++|+|++|+|++..| ++++++|++|++++|++++
T Consensus 29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred hCCCCCCCccC--HHHhCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc
Confidence 33444444333 23445556666666655532 235555566666666665554321 4455555555555555443
Q ss_pred CCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccC
Q 043136 165 PLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFAS 244 (902)
Q Consensus 165 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 244 (902)
..| ++.+++|+.|++++|.+++..+ ......+..+....|.+....+.....
T Consensus 103 i~~--l~~l~~L~~L~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~~~~~~~~ 154 (384)
T d2omza2 103 ITP--LANLTNLTGLTLFNNQITDIDP--------------------------LKNLTNLNRLELSSNTISDISALSGLT 154 (384)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--------------------------GTTCTTCSEEEEEEEEECCCGGGTTCT
T ss_pred ccc--cccccccccccccccccccccc--------------------------ccccccccccccccccccccccccccc
Confidence 321 4444444444444444443221 222333444444444443332222222
Q ss_pred CCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEE
Q 043136 245 LVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLS 324 (902)
Q Consensus 245 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 324 (902)
.............+ ..+...+.........|... ....+..+++++.+++++|.+++..| +...++|+.|+
T Consensus 155 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~ 225 (384)
T d2omza2 155 SLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS--DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELS 225 (384)
T ss_dssp TCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEE
T ss_pred cccccccccccchh-----hhhccccccccccccccccc--cccccccccccceeeccCCccCCCCc--ccccCCCCEEE
Confidence 22222211111111 12222333333333333322 12223344444455555554443322 23334455555
Q ss_pred ccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcc
Q 043136 325 LMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTY 404 (902)
Q Consensus 325 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~ 404 (902)
+++|.++. ++.+..+++|+.|++++|++++..+ +..+++|+.|++++|++++.. .+..+..++.+.+..|++.+
T Consensus 226 l~~n~l~~--~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~ 299 (384)
T d2omza2 226 LNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED 299 (384)
T ss_dssp CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC
T ss_pred CCCCCCCC--cchhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCC--cccccccccccccccccccc
Confidence 55554432 1234444555555555555544332 444555555555555555332 24445555666666666554
Q ss_pred cccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceecccccccCCCcChhhhc
Q 043136 405 SIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLNISENSFQTSLPSNIWS 484 (902)
Q Consensus 405 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 484 (902)
. ..+..+++++.|++++|++++.. .+..+++|++|++++|++++ +| .+.++++|++|++++|++++..| +.+
T Consensus 300 ~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~ 371 (384)
T d2omza2 300 I--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LAN 371 (384)
T ss_dssp C--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTT
T ss_pred c--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hcc
Confidence 2 23566677777777777777543 26677777777777777764 33 47777777777777777776544 677
Q ss_pred ccccceeccCCC
Q 043136 485 APNLKILSASSS 496 (902)
Q Consensus 485 l~~L~~L~ls~N 496 (902)
+++|+.|++++|
T Consensus 372 l~~L~~L~L~~N 383 (384)
T d2omza2 372 LTRITQLGLNDQ 383 (384)
T ss_dssp CTTCSEEECCCE
T ss_pred CCCCCEeeCCCC
Confidence 777777777776
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.97 E-value=2.2e-29 Score=280.30 Aligned_cols=341 Identities=23% Similarity=0.295 Sum_probs=262.2
Q ss_pred ccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEE
Q 043136 149 LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228 (902)
Q Consensus 149 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 228 (902)
+.+|++|++++|.|+.. +.+..+++|++|+|++|+|++.. .++++++|++|++++|++++. + .++.+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCCc--cccCCcccccccccccccccc-c-cccccccccccc
Confidence 34444444444444432 24566777777777777777543 278888888888888888853 3 378899999999
Q ss_pred eeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcc
Q 043136 229 IGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 229 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
+++|.+++..+ ......+..+....|.+....+..................+ ..+...+.........|...
T Consensus 117 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~- 188 (384)
T d2omza2 117 LFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNKVS- 188 (384)
T ss_dssp CCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSCCC-
T ss_pred ccccccccccc--ccccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccccc-
Confidence 99999886544 44567788888888888755443333333333333322222 23445566677777777664
Q ss_pred ccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccC
Q 043136 309 PIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICD 388 (902)
Q Consensus 309 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~ 388 (902)
....+..+++++.+++++|.+++..| +...++|+.|++++|+++.. ..+..+++|+.+++++|++++..+ +..
T Consensus 189 -~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~ 261 (384)
T d2omza2 189 -DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSG 261 (384)
T ss_dssp -CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred -cccccccccccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCCc--chhhcccccchhccccCccCCCCc--ccc
Confidence 45667889999999999999987654 56678999999999999864 367889999999999999997543 778
Q ss_pred CCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcccCcCceec
Q 043136 389 GDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGNAQKLEYLN 468 (902)
Q Consensus 389 ~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 468 (902)
+++|+.+++++|++++..+ +..+..++.++++.|++++. ..+..+++++.|++++|++++.. .+..+++|++|+
T Consensus 262 ~~~L~~L~l~~~~l~~~~~--~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~ 335 (384)
T d2omza2 262 LTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLF 335 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEE
T ss_pred cccCCEeeccCcccCCCCc--cccccccccccccccccccc--cccchhcccCeEECCCCCCCCCc--ccccCCCCCEEE
Confidence 8999999999999986543 77889999999999999853 45888999999999999999764 388999999999
Q ss_pred ccccccCCCcChhhhcccccceeccCCCccCCCcccccccccccEEeccCc
Q 043136 469 ISENSFQTSLPSNIWSAPNLKILSASSSKLTGKIPDFIGCKSIYKIELHNN 519 (902)
Q Consensus 469 Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~~~l~~l~Ls~N 519 (902)
+++|++++ ++ .+..+++|++|++++|++++.+| +.++++|+.|+|++|
T Consensus 336 L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~-l~~l~~L~~L~L~~N 383 (384)
T d2omza2 336 FANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383 (384)
T ss_dssp CCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG-GTTCTTCSEEECCCE
T ss_pred CCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh-hccCCCCCEeeCCCC
Confidence 99999975 44 68999999999999999997655 667999999999998
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-32 Score=291.91 Aligned_cols=174 Identities=25% Similarity=0.355 Sum_probs=144.1
Q ss_pred HHHHhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEec----
Q 043136 707 VLECLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSN---- 780 (902)
Q Consensus 707 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~---- 780 (902)
+.+.++...++||+|+||.||+|++ .+++.||||++... +.+.+|++++.++ +|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 3334444557899999999999976 56899999998432 2356799887654 89999999999865
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEE
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEAR 857 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~k 857 (902)
+...|+|||||+||+|.+++..+. ...+++..+..|+.||+.||+|||+++ |+||||||+|||++. ++.+|
T Consensus 81 ~~~~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~K 154 (335)
T d2ozaa1 81 RKCLLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILK 154 (335)
T ss_dssp EEEEEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEE
T ss_pred CCEEEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccc
Confidence 457899999999999999997542 225788889999999999999999776 999999999999975 56799
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccccC
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
|+|||+|+...........+||+.|||||++.+....
T Consensus 155 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~ 191 (335)
T d2ozaa1 155 LTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191 (335)
T ss_dssp ECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGS
T ss_pred ccccceeeeccCCCccccccCCcccCCcHHHcCCCCC
Confidence 9999999988776667778999999999999876544
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=286.54 Aligned_cols=176 Identities=28% Similarity=0.340 Sum_probs=147.3
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHh-cCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLG-NVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~-~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
|.+.+.||+|+||+||+|++. +++.||||++.+.........+.+.+|+.++. .++|||||++++++.+++..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred eEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEe
Confidence 456789999999999999764 68999999996443222233455667777765 6899999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
|+++|+|.+++..... .++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~i~~~~~-----~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp CCTTCBHHHHHHHHSS-----CCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred ecCCCcHHHHhhccCC-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 9999999999976543 667788899999999999999776 99999999999999999999999999987643
Q ss_pred -CCCceeeccccCccccCcccccccCc
Q 043136 870 -DESMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 870 -~~~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
.......+||+.|||||++.+....+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ 182 (320)
T d1xjda_ 156 GDAKTNTFCGTPDYIAPEILLGQKYNH 182 (320)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred ccccccccCCCCCcCCHHHHcCCCCCc
Confidence 33345578999999999998865544
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.8e-32 Score=286.00 Aligned_cols=173 Identities=28% Similarity=0.404 Sum_probs=140.6
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
+.+.+.||+|+||+||+|++.+++.||||++..... ..+.+.+|+.++++++|||||++++++.+ +..|+||||+
T Consensus 19 ~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 19 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred EEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 567789999999999999998888999999854332 23568899999999999999999999854 5689999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|++.+++..... ..+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 94 ~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 94 SKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999998875432 24789999999999999999999776 9999999999999999999999999998764333
Q ss_pred --CceeeccccCccccCcccccccCc
Q 043136 872 --SMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 872 --~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
......||+.|||||++......+
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ 193 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTI 193 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCH
T ss_pred ceeeccccccccccChHHHhCCCCCc
Confidence 234467999999999997665443
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.7e-31 Score=286.76 Aligned_cols=173 Identities=20% Similarity=0.285 Sum_probs=149.1
Q ss_pred hccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
.|.+.+.||+|+||+||+|.+. +++.||||++..... ....+.+|++++++++|||||++++++++++..|+|||
T Consensus 6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3567789999999999999764 688999999965432 23457899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC--CCEEEeecccceec
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE--MEARVADFGVAKLI 867 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~--~~~kl~DFGla~~~ 867 (902)
||+||+|.+++...+ ..+++..+..++.||++||+|||+++ |+||||||+|||++.+ +.+||+|||+++..
T Consensus 82 ~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~ 154 (321)
T d1tkia_ 82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQL 154 (321)
T ss_dssp CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcc
Confidence 999999999996543 24788889999999999999999776 9999999999999854 58999999999988
Q ss_pred cCCCCceeeccccCccccCcccccccC
Q 043136 868 QSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 868 ~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.........+||+.|+|||.+.+....
T Consensus 155 ~~~~~~~~~~~t~~y~ape~~~~~~~~ 181 (321)
T d1tkia_ 155 KPGDNFRLLFTAPEYYAPEVHQHDVVS 181 (321)
T ss_dssp CTTCEEEEEESCGGGSCHHHHTTCEEC
T ss_pred ccCCcccccccccccccchhccCCCCC
Confidence 766666778899999999999776544
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.97 E-value=4.1e-31 Score=280.18 Aligned_cols=177 Identities=21% Similarity=0.286 Sum_probs=143.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC----eeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE----CTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~----~~~ 785 (902)
+|.+.+.||+|+||.||+|++ .+++.||||++.+.........+.+.+|++++++++|||||++++++...+ ..|
T Consensus 8 rY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~ 87 (277)
T d1o6ya_ 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPY 87 (277)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred eeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEE
Confidence 466778999999999999976 579999999997655555566678999999999999999999999987643 479
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||++||+|.+++...+ .+++..+..++.||+.||+|||+++ ||||||||+||+++.++.++++|||.++
T Consensus 88 lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 88 IVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEECCCCCEehhhhcccC-----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 9999999999999887654 3778889999999999999999776 9999999999999999999999999987
Q ss_pred eccCCC----CceeeccccCccccCcccccccCc
Q 043136 866 LIQSDE----SMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 866 ~~~~~~----~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
...... .....+||+.|||||++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 193 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDA 193 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCH
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCc
Confidence 653322 234568999999999998765443
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.8e-30 Score=278.36 Aligned_cols=169 Identities=28% Similarity=0.376 Sum_probs=137.2
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC----eeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE----CTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~----~~~lv 787 (902)
+...+.||+|+||.||+|+. +|+.||||++..... .....+.|+..+.+++|||||++++++.+.+ ..|+|
T Consensus 5 ~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 5 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp EEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 45668899999999999987 688999999853321 1222334666667789999999999997643 67999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhC-----CCCCeEEcCCCCCCEEEcCCCCEEEeecc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHD-----CDPVIVHRDLKPSNILLDGEMEARVADFG 862 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-----~~~~ivHrDlKp~NILl~~~~~~kl~DFG 862 (902)
|||+++|+|.++++.. ..++..+..++.|+|.|++|+|+. ++.+||||||||+|||++.++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999753 378899999999999999999964 23579999999999999999999999999
Q ss_pred cceeccCCCC-----ceeeccccCccccCccccc
Q 043136 863 VAKLIQSDES-----MSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 863 la~~~~~~~~-----~~~~~Gt~~y~APE~~~~~ 891 (902)
+++....... ....+||+.|||||++.+.
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 187 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTC
T ss_pred ccccccCCCcceeccccceecccCcCChhhcccc
Confidence 9998754332 3446799999999998764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.6e-31 Score=282.55 Aligned_cols=168 Identities=32% Similarity=0.420 Sum_probs=135.8
Q ss_pred cEeeecCceEEEEEEe-CCCcEEEEEEecccchhhH--HHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEccC
Q 043136 716 KILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENI--RRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYMP 792 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~--~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~~ 792 (902)
++||+|+||+||+|++ .+++.||||++........ ...+.+.+|++++++++|||||++++++.+++..|+||||++
T Consensus 4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~ 83 (299)
T d1ua2a_ 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME 83 (299)
T ss_dssp EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence 5799999999999976 4689999999854332211 123568899999999999999999999999999999999998
Q ss_pred CCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC-
Q 043136 793 NGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE- 871 (902)
Q Consensus 793 ~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~- 871 (902)
++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 84 TDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp EEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred chHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence 87766555422 23556677899999999999999776 9999999999999999999999999998765433
Q ss_pred CceeeccccCccccCccccc
Q 043136 872 SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~ 891 (902)
.....+||+.|||||++.+.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGA 175 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTC
T ss_pred cccceecChhhccHHHHccC
Confidence 34456899999999998653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.4e-30 Score=277.49 Aligned_cols=179 Identities=27% Similarity=0.409 Sum_probs=146.6
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+.+.+.||+|+||+||+|+.. +++.||||++.... .....+++.+|++++++++||||+++++++.+.+..+
T Consensus 15 ~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 15 IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred cEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceE
Confidence 455688999999999999753 35789999986433 2345667899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhcc-------------------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCC
Q 043136 786 LLYEYMPNGNLDDLLHAKNK-------------------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPS 846 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~ 846 (902)
+||||+++|+|.++++.... .....+++..+..|+.|++.||+|||+++ ||||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEccc
Confidence 99999999999999975332 11234788889999999999999999766 999999999
Q ss_pred CEEEcCCCCEEEeecccceeccCCC---CceeeccccCccccCcccccccCc
Q 043136 847 NILLDGEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 847 NILl~~~~~~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
|||++.++.+||+|||+|+...+.. .....+||+.|||||++.+...++
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCCh
Confidence 9999999999999999998764332 234567899999999998765443
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-30 Score=275.48 Aligned_cols=175 Identities=20% Similarity=0.297 Sum_probs=133.9
Q ss_pred hccCCcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
.|.+.+.||+|+||+||+|.+.. +..||||++.... .....+.+.+|++++++++|||||++++++. ++..|+
T Consensus 8 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 45567899999999999997643 3568899874332 3345677899999999999999999999996 467899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
||||+++|++.+++..... .+++..+..++.||++||+|||+++ ||||||||+||+++.++.+||+|||+|+.
T Consensus 85 v~E~~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEeccCCcHHhhhhccCC----CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 9999999999998765432 4788889999999999999999776 99999999999999999999999999987
Q ss_pred ccCCC--CceeeccccCccccCcccccccCc
Q 043136 867 IQSDE--SMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 867 ~~~~~--~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
..... ......||+.|||||++.+....+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~ 188 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTS 188 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCC
Confidence 65332 234457899999999997655443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2e-30 Score=278.17 Aligned_cols=179 Identities=27% Similarity=0.358 Sum_probs=136.0
Q ss_pred hccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC-C
Q 043136 711 LSMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR-E 782 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~-~ 782 (902)
.|.+.+.||+|+||+||+|++. +++.||||++.... .....+.+.+|++++.++ +|+||+++++++... .
T Consensus 14 ~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 4566789999999999999753 35689999985332 223455677888888776 689999999988654 5
Q ss_pred eeEEEEEccCCCCHHHHHHhhccC-----------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEc
Q 043136 783 CTMLLYEYMPNGNLDDLLHAKNKG-----------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLD 851 (902)
Q Consensus 783 ~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~ 851 (902)
..++|||||++|+|.++++..+.. ....+++..+..++.||++||+|||+++ ||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 689999999999999999765321 1234788899999999999999999776 99999999999999
Q ss_pred CCCCEEEeecccceeccCCC---CceeeccccCccccCcccccccC
Q 043136 852 GEMEARVADFGVAKLIQSDE---SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 852 ~~~~~kl~DFGla~~~~~~~---~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.++.+||+|||+|+...... .....+||+.|||||++.+....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 214 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 214 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC
Confidence 99999999999998764332 23446799999999999765443
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3e-30 Score=272.05 Aligned_cols=174 Identities=25% Similarity=0.317 Sum_probs=133.2
Q ss_pred ccCCcEeeecCceEEEEEEeC--C--CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP--G--GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~--~--~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv 787 (902)
|.+.+.||+|+||+||+|+.. + ...||||++.+.........+++.+|++++++++|||||++++++.+ +..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchhee
Confidence 345678999999999999653 2 24789999865544444556779999999999999999999999975 467899
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceec
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLI 867 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~ 867 (902)
|||+++|++.+.+..... .+++..+..++.|+|+||+|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeecCcchhhhhhcccC----CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 999999999998876532 4788899999999999999999766 999999999999999999999999999987
Q ss_pred cCCCC----ceeeccccCccccCccccccc
Q 043136 868 QSDES----MSVIAGSYGYIAPGTFCFCFS 893 (902)
Q Consensus 868 ~~~~~----~~~~~Gt~~y~APE~~~~~~~ 893 (902)
..... .....||+.|||||++.+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~ 191 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEE
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCC
Confidence 54432 233567889999999976543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=277.63 Aligned_cols=173 Identities=28% Similarity=0.412 Sum_probs=136.8
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCc----EEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGE----IIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~----~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~l 786 (902)
|...++||+|+||+||+|.+. +|+ +||+|++.... .....+++.+|++++++++|||||++++++.+. ..++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred CEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 445689999999999999764 343 58888874322 223456789999999999999999999999865 5678
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
+|||+.+|+|.+.+.... ..+++..+..++.|||+||+|||+++ ||||||||+||+++.++.+||+|||+|+.
T Consensus 88 v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp EEECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred EEEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeecccccee
Confidence 889999999999887643 25788889999999999999999766 99999999999999999999999999997
Q ss_pred ccCCCC---ceeeccccCccccCcccccccC
Q 043136 867 IQSDES---MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 867 ~~~~~~---~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
...... .....||+.|||||++.+....
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~ 191 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYT 191 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCC
T ss_pred cccccccccccccccCccccChHHHhcCCCC
Confidence 754332 2335689999999999766443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.7e-30 Score=276.16 Aligned_cols=177 Identities=28% Similarity=0.424 Sum_probs=142.0
Q ss_pred cCCcEeeecCceEEEEEEeC-CCc--EEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCeeEEEE
Q 043136 713 MSDKILGMGSTGTVYKAEMP-GGE--IIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~-~~~--~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~~~lv~ 788 (902)
.+.+.||+|+||+||+|++. ++. .||||++.... .....+.+.+|+++++++ +|||||++++++.+++..|+||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ 90 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAI 90 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEE
Confidence 34688999999999999764 344 47778764322 223456789999999998 7999999999999999999999
Q ss_pred EccCCCCHHHHHHhhc-----------cCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEE
Q 043136 789 EYMPNGNLDDLLHAKN-----------KGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~k 857 (902)
||+++|+|.++++... ......+++..+..++.|||+|++|+|+++ ||||||||+|||++.++.+|
T Consensus 91 ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 91 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp CCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEE
T ss_pred EecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceE
Confidence 9999999999997542 122345889999999999999999999766 99999999999999999999
Q ss_pred EeecccceeccCCCCceeeccccCccccCcccccccC
Q 043136 858 VADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 858 l~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
|+|||+|+............||+.|+|||.+.+....
T Consensus 168 l~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 204 (309)
T d1fvra_ 168 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYT 204 (309)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEEC
T ss_pred EccccccccccccccccceecCCcccchHHhccCCCC
Confidence 9999999876555555566799999999999765443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.1e-30 Score=274.02 Aligned_cols=173 Identities=27% Similarity=0.411 Sum_probs=140.6
Q ss_pred ccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEc
Q 043136 712 SMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEY 790 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~ 790 (902)
|...+.||+|+||+||+|++ .+++.||||++.... ......+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEee
Confidence 44558899999999999976 568999999985432 2223356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCC
Q 043136 791 MPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSD 870 (902)
Q Consensus 791 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~ 870 (902)
+.+ ++.+++.... ...+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|||.|+.....
T Consensus 83 ~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred cCC-chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 965 5555554332 224788899999999999999999776 999999999999999999999999999876533
Q ss_pred -CCceeeccccCccccCcccccc
Q 043136 871 -ESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 871 -~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
......+||+.|+|||++....
T Consensus 156 ~~~~~~~~gt~~y~apE~~~~~~ 178 (298)
T d1gz8a_ 156 VRTYTHEVVTLWYRAPEILLGCK 178 (298)
T ss_dssp SBCTTCCBCCCTTCCHHHHTTCS
T ss_pred cccceeecccceeeehhhhcccc
Confidence 3345568999999999986654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-30 Score=273.78 Aligned_cols=174 Identities=22% Similarity=0.295 Sum_probs=142.5
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhh---HHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecCCe
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKEN---IRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNREC 783 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~---~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~~~ 783 (902)
..|.+.+.||+|+||+||+|+. .+++.||||++.+..... .....++.+|++++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 3567789999999999999976 468999999985432111 111233567999999886 8999999999999999
Q ss_pred eEEEEEccCC-CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCC-CCEEEeec
Q 043136 784 TMLLYEYMPN-GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGE-MEARVADF 861 (902)
Q Consensus 784 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~-~~~kl~DF 861 (902)
.|+||||+.+ +++.+++.... .+++..+..++.|+++||+|||+++ |+||||||+||+++.+ +.+||+||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEeccCcchHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcc
Confidence 9999999976 57888876543 3778888899999999999999776 9999999999999854 79999999
Q ss_pred ccceeccCCCCceeeccccCccccCcccccc
Q 043136 862 GVAKLIQSDESMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 862 Gla~~~~~~~~~~~~~Gt~~y~APE~~~~~~ 892 (902)
|+|+..... ...+.+||+.|||||++.+..
T Consensus 156 G~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~ 185 (273)
T d1xwsa_ 156 GSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185 (273)
T ss_dssp TTCEECCSS-CBCCCCSCGGGSCHHHHHHSC
T ss_pred ccceecccc-cccccccCCCcCCHHHHcCCC
Confidence 999875433 345678999999999997653
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.1e-30 Score=268.92 Aligned_cols=169 Identities=28% Similarity=0.393 Sum_probs=134.1
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeEEEEEcc
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTMLLYEYM 791 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~lv~e~~ 791 (902)
.+.+.||+|+||.||+|++ .|+.||||++.+.. ..+.+.+|++++++++||||+++++++.+ .+..|+||||+
T Consensus 10 ~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 10 KLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred EEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 3457899999999999988 57889999985432 23568899999999999999999999854 46689999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
++|+|.+++..+.. ..+++..+++|+.||+.||+|||+.+ ||||||||+||+++.++.+|++|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp TTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 99999999976432 24788999999999999999999766 999999999999999999999999999876433
Q ss_pred CceeeccccCccccCcccccccCc
Q 043136 872 SMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 872 ~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
.....+|+.|||||++.+...++
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~ 179 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFST 179 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCH
T ss_pred -CccccccccCCChHHHhCCCCCh
Confidence 34457899999999997655443
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=272.37 Aligned_cols=179 Identities=30% Similarity=0.458 Sum_probs=148.8
Q ss_pred hccCCcEeeecCceEEEEEEe------CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecCCe
Q 043136 711 LSMSDKILGMGSTGTVYKAEM------PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNREC 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~------~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~~~ 783 (902)
.+.+.+.||+|+||.||+|++ .+++.||||++..... .....++.+|+.+++++ +|||||++++++.+.+.
T Consensus 24 ~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 345668999999999999975 3467899999865432 34456788999999998 69999999999999999
Q ss_pred eEEEEEccCCCCHHHHHHhhccC-------------CCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKG-------------ENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
.|+|||||++|+|.++++..... ....+++..+..++.||++|++|||+++ +|||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 99999999999999999865421 2335788899999999999999999776 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCCc---eeeccccCccccCcccccccC
Q 043136 851 DGEMEARVADFGVAKLIQSDESM---SVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~~---~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+.++.+|++|||.++........ ...+||+.|||||++.+....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 225 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC
Confidence 99999999999999987543322 335789999999999765543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.1e-29 Score=270.55 Aligned_cols=171 Identities=25% Similarity=0.383 Sum_probs=141.1
Q ss_pred CcEeeecCceEEEEEEeCC----CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec-CCeeEEEEE
Q 043136 715 DKILGMGSTGTVYKAEMPG----GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN-RECTMLLYE 789 (902)
Q Consensus 715 ~~~iG~G~~g~Vy~~~~~~----~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~-~~~~~lv~e 789 (902)
+++||+|+||+||+|++.. ...||||++... ......+++.+|++++++++|||||++++++.. ++..++|||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 5789999999999997643 235899998532 234556779999999999999999999999765 568999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
||++|++.+++..... ..++..+..++.|++.||.|+|+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 110 ~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp CCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred EeecCchhhhhccccc----cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 9999999999875432 4567788899999999999999766 99999999999999999999999999987643
Q ss_pred CCC-----ceeeccccCccccCcccccccC
Q 043136 870 DES-----MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 870 ~~~-----~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
... .....||+.|+|||++......
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 212 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFT 212 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCC
T ss_pred cccccceecccccccccccChHHHhcCCCC
Confidence 322 2335689999999998765433
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=271.94 Aligned_cols=179 Identities=23% Similarity=0.349 Sum_probs=148.1
Q ss_pred ccCCcEeeecCceEEEEEEeC------CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEMP------GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~------~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~ 785 (902)
+...+.||+|+||.||+|.+. +++.||||++.... .......+.+|++++++++|||||++++++..++..+
T Consensus 22 ~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~ 99 (308)
T d1p4oa_ 22 ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL 99 (308)
T ss_dssp EEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred eEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence 345688999999999999653 35789999985432 3345567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhcc-----CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 786 LLYEYMPNGNLDDLLHAKNK-----GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
+||||+++|+|.+++...+. ......++..+.+++.|+|+||.|||+++ |+||||||+|||++.++++||+|
T Consensus 100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEee
Confidence 99999999999999875432 12234678889999999999999999765 99999999999999999999999
Q ss_pred cccceeccCCCC---ceeeccccCccccCcccccccCc
Q 043136 861 FGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 861 FGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
||+|+....... ....+||+.|||||.+.+....+
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~ 214 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTT 214 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCH
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCCc
Confidence 999987654332 23346899999999998765543
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=1.7e-29 Score=269.20 Aligned_cols=171 Identities=27% Similarity=0.375 Sum_probs=140.3
Q ss_pred ccCCcEeeecCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEEcc
Q 043136 712 SMSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYEYM 791 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e~~ 791 (902)
|..-+.||+|+||+||+|++.+++.||||++..... .....+.+.+|+.++++++|||||++++++.+.+..|++|||+
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~ 82 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECC
T ss_pred ceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEee
Confidence 445678999999999999988999999999865432 2233466889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccCCC
Q 043136 792 PNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQSDE 871 (902)
Q Consensus 792 ~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 871 (902)
.++.+..+.... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+|++|||.|.......
T Consensus 83 ~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 83 DQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp SEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred hhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 776666555433 24788889999999999999999766 9999999999999999999999999998765432
Q ss_pred -CceeeccccCccccCccccc
Q 043136 872 -SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 872 -~~~~~~Gt~~y~APE~~~~~ 891 (902)
......|++.|+|||++.+.
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~ 175 (286)
T d1ob3a_ 155 RKYTHEIVTLWYRAPDVLMGS 175 (286)
T ss_dssp -------CCCTTCCHHHHTTC
T ss_pred cccceecccchhhhHHHHhCC
Confidence 34556799999999999654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=3.4e-29 Score=268.05 Aligned_cols=179 Identities=27% Similarity=0.382 Sum_probs=142.7
Q ss_pred hccCCcEeeecCceEEEEEEeCC--------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC-CcCeeEeEEeEEecC
Q 043136 711 LSMSDKILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV-RHRNIVRLLGCCSNR 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l-~h~nIv~l~~~~~~~ 781 (902)
.|.+.+.||+|+||.||+|+... +..||||++.+... .....++.+|+..+.++ +|||||+++++|.++
T Consensus 14 ~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 34566899999999999996532 34799999865432 34456788899999888 899999999999999
Q ss_pred CeeEEEEEccCCCCHHHHHHhhcc-----------CCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEE
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNK-----------GENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILL 850 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl 850 (902)
+..|+||||+++|+|.+++..+.. .....+++.+++.++.||+.||+|||+++ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999976542 12345789999999999999999999766 9999999999999
Q ss_pred cCCCCEEEeecccceeccCCCC---ceeeccccCccccCcccccccC
Q 043136 851 DGEMEARVADFGVAKLIQSDES---MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 851 ~~~~~~kl~DFGla~~~~~~~~---~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+.++.+||+|||+++....... .....||+.|||||++.+....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~ 215 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC
Confidence 9999999999999998754432 2346789999999999765443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=7.7e-29 Score=271.64 Aligned_cols=168 Identities=27% Similarity=0.375 Sum_probs=135.9
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec------CCee
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN------RECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~------~~~~ 784 (902)
|...++||+|+||+||+|++. +++.||||++...... ..+|++++++++||||+++++++.. ..+.
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred cEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 445578999999999999774 6899999998644322 3469999999999999999999853 2357
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeeccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGV 863 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGl 863 (902)
|+||||++++....+..... ....+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccc
Confidence 89999997654443333222 2235788889999999999999999665 99999999999999775 899999999
Q ss_pred ceeccCCCCceeeccccCccccCccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+.........+.+||+.|+|||.+.+.
T Consensus 170 a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 170 AKQLVRGEPNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp CEECCTTSCCCSCCSCTTSCCHHHHTTC
T ss_pred hhhccCCcccccccccccccChHHhhcc
Confidence 9988766666778899999999988653
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4.3e-29 Score=268.76 Aligned_cols=176 Identities=26% Similarity=0.373 Sum_probs=137.5
Q ss_pred hccCCcEeeecCceEEEEEEe-CC-CcEEEEEEecccchhhHHHHHHHHHHHHHHhcC---CcCeeEeEEeEEec-----
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PG-GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNV---RHRNIVRLLGCCSN----- 780 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~-~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l---~h~nIv~l~~~~~~----- 780 (902)
.|.+.+.||+|+||+||+|++ .+ ++.||||++....... .....+.+|+++++.+ +||||+++++++..
T Consensus 8 ~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 456678999999999999976 34 6679999985432221 1122345677766554 79999999999853
Q ss_pred CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEee
Q 043136 781 RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVAD 860 (902)
Q Consensus 781 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~D 860 (902)
....+++|||++++.+....... ....++..+..++.|++.||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecc
Confidence 34689999999887665444322 224677888899999999999999776 99999999999999999999999
Q ss_pred cccceeccCCCCceeeccccCccccCcccccccC
Q 043136 861 FGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 861 FGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
||+++...........+||+.|||||++.+....
T Consensus 160 fg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~ 193 (305)
T d1blxa_ 160 FGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 193 (305)
T ss_dssp CCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCC
T ss_pred hhhhhhhcccccCCCcccChhhcCcchhcCCCCC
Confidence 9999877666666778999999999999775443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.95 E-value=2.5e-28 Score=265.47 Aligned_cols=164 Identities=23% Similarity=0.337 Sum_probs=139.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEec--CCeeEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSN--RECTML 786 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~--~~~~~l 786 (902)
.|.+.++||+|+||+||+|++ .+++.||||++.+.. .+++.+|++++++++ ||||+++++++.. ....++
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 466778999999999999976 568999999985432 245778999999995 9999999999974 356899
Q ss_pred EEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-CEEEeecccce
Q 043136 787 LYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM-EARVADFGVAK 865 (902)
Q Consensus 787 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~-~~kl~DFGla~ 865 (902)
||||+++++|.++.+ .+++..+..++.||+.||+|||+++ ||||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccce
Confidence 999999999876532 3677888899999999999999776 99999999999998765 59999999999
Q ss_pred eccCCCCceeeccccCccccCccccc
Q 043136 866 LIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
...........+||+.|+|||++.+.
T Consensus 179 ~~~~~~~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 179 FYHPGQEYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp ECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred eccCCCcccccccCccccCcccccCC
Confidence 88776666778899999999998764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.5e-28 Score=267.01 Aligned_cols=170 Identities=24% Similarity=0.321 Sum_probs=137.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC----eeE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE----CTM 785 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~----~~~ 785 (902)
+|...+.||+|+||+||+|.+ .+++.||||++.+.. .....+.+.+|++++++++||||+++++++.... ..+
T Consensus 9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 455668999999999999965 579999999986433 2344567889999999999999999999996543 234
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
++++|+.+|+|.+++... .+++..+..++.|+++||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCcee
Confidence 555566799999999643 3678888999999999999999776 9999999999999999999999999998
Q ss_pred eccCCC----CceeeccccCccccCccccc
Q 043136 866 LIQSDE----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~~----~~~~~~Gt~~y~APE~~~~~ 891 (902)
...... .....+||+.|+|||++...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 187 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNS 187 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTB
T ss_pred eccCCCccceeeccccccceechHHHhhcC
Confidence 764322 23556799999999998654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.95 E-value=1.2e-28 Score=262.97 Aligned_cols=172 Identities=18% Similarity=0.197 Sum_probs=140.9
Q ss_pred HhccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCc-CeeEeEEeEEecCCeeEEE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRH-RNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h-~nIv~l~~~~~~~~~~~lv 787 (902)
..|.+.+.||+|+||+||+|++. +++.||||++..... .+.+.+|+++++.++| +||+.+++++......|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 45677899999999999999764 689999998754322 1235678888888864 8999999999999999999
Q ss_pred EEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC-----CCCEEEeecc
Q 043136 788 YEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG-----EMEARVADFG 862 (902)
Q Consensus 788 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~-----~~~~kl~DFG 862 (902)
|||+ +++|.+++..... .++..+...++.|++.||+|||+++ ||||||||+||+++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhhcc----chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 7899998865432 4678888999999999999999665 999999999999964 5789999999
Q ss_pred cceeccCCC--------CceeeccccCccccCcccccccC
Q 043136 863 VAKLIQSDE--------SMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 863 la~~~~~~~--------~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
+|+...... .....+||+.|||||++.+....
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~ 191 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS 191 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCC
Confidence 999864321 23456899999999999876443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.2e-28 Score=267.93 Aligned_cols=168 Identities=26% Similarity=0.387 Sum_probs=136.4
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCC------e
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRE------C 783 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~------~ 783 (902)
+|...+.||+|+||+||+|.+ .+++.||||++.+.. ......+.+.+|++++++++|||||+++++|...+ .
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred cEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 455668899999999999976 469999999996433 33445677889999999999999999999997654 5
Q ss_pred eEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeeccc
Q 043136 784 TMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGV 863 (902)
Q Consensus 784 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGl 863 (902)
.|+||||+ +.++..+.+.. .+++..+..++.|++.||+|||+++ ||||||||+|||++.++.+|++|||.
T Consensus 98 ~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-cccHHHHHHhc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 79999999 67888877542 3788889999999999999999776 99999999999999999999999999
Q ss_pred ceeccCCCCceeeccccCccccCccccc
Q 043136 864 AKLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 864 a~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+..... ....+||+.|||||++.+.
T Consensus 168 a~~~~~~--~~~~~~t~~y~aPE~~~~~ 193 (346)
T d1cm8a_ 168 ARQADSE--MTGYVVTRWYRAPEVILNW 193 (346)
T ss_dssp CEECCSS--CCSSCSCGGGCCTHHHHTT
T ss_pred eeccCCc--cccccccccccCHHHHcCC
Confidence 9876433 3456899999999998664
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.95 E-value=3e-26 Score=246.48 Aligned_cols=281 Identities=20% Similarity=0.245 Sum_probs=188.2
Q ss_pred CCccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCc
Q 043136 65 WCSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPP 144 (902)
Q Consensus 65 ~C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~ 144 (902)
-|.|.+|.|+.. +++ .+|+.+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|.
T Consensus 9 ~c~~~~~~C~~~------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~ 73 (305)
T d1xkua_ 9 QCHLRVVQCSDL------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPG 73 (305)
T ss_dssp EEETTEEECTTS------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTT
T ss_pred EecCCEEEecCC------------CCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchh
Confidence 478999999643 333 4555542 5677777777777766556677777777777777777766666
Q ss_pred ccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCcc--CCCCccccCCC
Q 043136 145 GISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLT--GSLPPQLGLLT 222 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~ 222 (902)
.|.++++|++|++++|+++.. |.. ....++.|+++.|.+.+..+..+.....++.++...|... ...+..+..++
T Consensus 74 ~f~~l~~L~~L~l~~n~l~~l-~~~--~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~ 150 (305)
T d1xkua_ 74 AFAPLVKLERLYLSKNQLKEL-PEK--MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMK 150 (305)
T ss_dssp TTTTCTTCCEEECCSSCCSBC-CSS--CCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCT
T ss_pred hhhCCCccCEecccCCccCcC-ccc--hhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCcccccccc
Confidence 777777777777777777643 322 2245677777777777665555666667777777766443 33455666777
Q ss_pred CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecc
Q 043136 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLS 302 (902)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 302 (902)
+|+.+++++|+++. +|..+ +++|+.|++++|..++..+..|.+++.+++|++++|++++..+..+.++++|++|+|+
T Consensus 151 ~L~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~ 227 (305)
T d1xkua_ 151 KLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227 (305)
T ss_dssp TCCEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECC
T ss_pred ccCccccccCCccc-cCccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeecc
Confidence 77777777777763 34332 4677777777777777777777777777777777777777767777777777777777
Q ss_pred cCCCccccCccccccCCCCEEEccCccccccCChhh------hhccccceEEecCceec--cccCccccCCCc
Q 043136 303 DNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDI------ELLADLDTLLLWNNHLT--GVLPQKLGSNGK 367 (902)
Q Consensus 303 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~------~~l~~L~~L~L~~N~l~--~~~~~~~~~~~~ 367 (902)
+|+|+ .+|..|..+++|++|+|++|+|+......| ..+.+|+.|+|++|.++ ...|..|..+..
T Consensus 228 ~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~ 299 (305)
T d1xkua_ 228 NNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299 (305)
T ss_dssp SSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCC
T ss_pred ccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhccccc
Confidence 77776 456677777777777777777764433332 34567778888888764 345555554433
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=3.7e-26 Score=245.71 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=150.4
Q ss_pred CCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCC
Q 043136 200 LRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFK 279 (902)
Q Consensus 200 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 279 (902)
++.+|-++++|+ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|.+....|..|.++++|++|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccC
Confidence 445555555555 4454442 4566666666666544444566666666666666666655555566666666666666
Q ss_pred CccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc--ccCChhhhhccccceEEecCceeccc
Q 043136 280 NHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF--GEIPQDIELLADLDTLLLWNNHLTGV 357 (902)
Q Consensus 280 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~ 357 (902)
|+++. +|..+ ...++.|++++|.+.+..+..+.....+..++...|... ...+..+..+++|+.+++++|.++..
T Consensus 89 n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l 165 (305)
T d1xkua_ 89 NQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI 165 (305)
T ss_dssp SCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC
T ss_pred CccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcccc
Confidence 66652 33322 235566666666666555555555556666666655432 22334455555666666666665532
Q ss_pred cCccccCCCceeEEEecCCcccCCCCCCccCCCCccEEeccCCcCcccccccccccCCCcEEEccCCccCCCCCcccCCC
Q 043136 358 LPQKLGSNGKLLTVDVSSNSLTGPIPPTICDGDRLFKLILFSNNFTYSIPENLVNCSSLSRLRIQDNQLNGSIPQGFGLL 437 (902)
Q Consensus 358 ~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 437 (902)
|..+ .++|+.|++++|..++..+..+..++.+++|++++|.+.+..+..+.++++|++|+|++|+|+ .+|.+|..+
T Consensus 166 -~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l 241 (305)
T d1xkua_ 166 -PQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADH 241 (305)
T ss_dssp -CSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTC
T ss_pred -Cccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccc
Confidence 2221 345566666666666555555555555666666666666555566666666666666666666 456666666
Q ss_pred CCCcEEEccCcccCCCCCCcC------cccCcCceecccccccC
Q 043136 438 PNLTFMDMSRNSLSGEIPRDL------GNAQKLEYLNISENSFQ 475 (902)
Q Consensus 438 ~~L~~L~Ls~N~l~~~~p~~~------~~l~~L~~L~Ls~N~l~ 475 (902)
++|++|+|++|+|+......| ..+.+|+.|+|++|.++
T Consensus 242 ~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 242 KYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp SSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 666666666666664322222 23455555566655553
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.8e-27 Score=251.78 Aligned_cols=268 Identities=21% Similarity=0.229 Sum_probs=169.4
Q ss_pred EEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccc
Q 043136 83 LDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSF 162 (902)
Q Consensus 83 L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l 162 (902)
++.++++++ .+|..+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+....+..+..+..++.++...
T Consensus 16 v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~--- 89 (284)
T d1ozna_ 16 TSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD--- 89 (284)
T ss_dssp EECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS---
T ss_pred EEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccc---
Confidence 355666776 5666553 5678888888888876667788888888888888877766555555555555554331
Q ss_pred cCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhc
Q 043136 163 TGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEF 242 (902)
Q Consensus 163 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 242 (902)
.|.++...+..|.++++|++|++++|.+....+..+...++|+.+++++|+|+++.+.+|
T Consensus 90 --------------------~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f 149 (284)
T d1ozna_ 90 --------------------NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149 (284)
T ss_dssp --------------------CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred --------------------ccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHh
Confidence 233333334445555555555555555554444555555566666666666665555566
Q ss_pred cCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCE
Q 043136 243 ASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTR 322 (902)
Q Consensus 243 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 322 (902)
..+++|++|++++|++++..+..|.++++|+++++++|++++..|..|.++++|++|++++|++++..+..|..+++|++
T Consensus 150 ~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~ 229 (284)
T d1ozna_ 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY 229 (284)
T ss_dssp TTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCE
T ss_pred ccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCE
Confidence 66666777777777776666666677777777777777777666777777777777777777777766677777777777
Q ss_pred EEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccC
Q 043136 323 LSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTG 380 (902)
Q Consensus 323 L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~ 380 (902)
|++++|.+.+.-+ .......++.+....+++....|..+.+ ....+++.+.|+|
T Consensus 230 L~l~~N~l~C~C~-~~~l~~~l~~~~~~~~~~~C~~p~~l~g---~~l~~l~~~~l~g 283 (284)
T d1ozna_ 230 LRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283 (284)
T ss_dssp EECCSSCEECSGG-GHHHHHHHHHCCSEECCCBEEESGGGTT---CBGGGSCGGGSCC
T ss_pred EEecCCCCCCCcc-chHHHHHHHhCcCCCCceEeCCchHHcC---CccccCCHHHCCC
Confidence 7777777765432 1122234555666667777666666543 2333455555543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7.7e-28 Score=260.43 Aligned_cols=172 Identities=22% Similarity=0.343 Sum_probs=135.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec--------C
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN--------R 781 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~--------~ 781 (902)
+|.+.+.||+|+||+||+|++ .+++.||||++..... .....+++.+|++++++++||||+++++++.. +
T Consensus 11 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 456678999999999999976 5799999999854322 22234567899999999999999999998855 3
Q ss_pred CeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeec
Q 043136 782 ECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADF 861 (902)
Q Consensus 782 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DF 861 (902)
+..|+||||++++.+....... ...+....+.++.|++.||+|||+++ ||||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 4689999999776655443322 23667778899999999999999766 999999999999999999999999
Q ss_pred ccceeccCCC-----CceeeccccCccccCccccc
Q 043136 862 GVAKLIQSDE-----SMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 862 Gla~~~~~~~-----~~~~~~Gt~~y~APE~~~~~ 891 (902)
|+|+.+.... .....+||+.|+|||++.+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCC
Confidence 9998764322 23446799999999998764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-27 Score=253.21 Aligned_cols=173 Identities=24% Similarity=0.323 Sum_probs=145.8
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecCCeeEEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNRECTMLLYE 789 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~~~~~lv~e 789 (902)
+|...+.||+|+||+||+|++ .+++.||||++..... .....+++.+|+++++.++||||+++++++.+....++|+|
T Consensus 3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 355668999999999999976 5689999999854432 23456678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccceeccC
Q 043136 790 YMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAKLIQS 869 (902)
Q Consensus 790 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 869 (902)
++.++++..++...+ ..++..+..++.|+++||+|||+++ ||||||||+|||++.++.+||+|||.|+....
T Consensus 82 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccccc-----ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccC
Confidence 999988888776443 3667888899999999999999776 99999999999999999999999999998754
Q ss_pred CC-CceeeccccCccccCcccccc
Q 043136 870 DE-SMSVIAGSYGYIAPGTFCFCF 892 (902)
Q Consensus 870 ~~-~~~~~~Gt~~y~APE~~~~~~ 892 (902)
.. ......+++.|+|||++.+..
T Consensus 154 ~~~~~~~~~~~~~~~~pe~~~~~~ 177 (292)
T d1unla_ 154 PVRCYSAEVVTLWYRPPDVLFGAK 177 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred CCccceeeccccchhhhhHhccCC
Confidence 33 334456788999999987653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=3.4e-28 Score=262.47 Aligned_cols=172 Identities=24% Similarity=0.290 Sum_probs=143.2
Q ss_pred ccCCcEeeecCceEEEEEEe----CCCcEEEEEEecccch-hhHHHHHHHHHHHHHHhcCCc-CeeEeEEeEEecCCeeE
Q 043136 712 SMSDKILGMGSTGTVYKAEM----PGGEIIAVKKLWGKHK-ENIRRRRGVLAEVDVLGNVRH-RNIVRLLGCCSNRECTM 785 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~----~~~~~vavK~i~~~~~-~~~~~~~~~~~Ei~il~~l~h-~nIv~l~~~~~~~~~~~ 785 (902)
|.+.+.||+|+||+||+|+. .+|+.||||++.+... ......+.+.+|++++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred eEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCcee
Confidence 56678999999999999965 2478999999864321 111223457789999999976 89999999999999999
Q ss_pred EEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccce
Q 043136 786 LLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVAK 865 (902)
Q Consensus 786 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~ 865 (902)
+||||+.+|+|.+++...+. ........++.|++.|++|+|+++ ||||||||+||+++.++.+||+|||+|+
T Consensus 106 ~v~e~~~~~~L~~~i~~~~~-----~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEECCCCSCBHHHHHHHHSC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeecccccHHHHHHHhccc-----ccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 99999999999999976643 456677889999999999999776 9999999999999999999999999998
Q ss_pred eccCC--CCceeeccccCccccCccccc
Q 043136 866 LIQSD--ESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 866 ~~~~~--~~~~~~~Gt~~y~APE~~~~~ 891 (902)
.+... .......||+.|+|||.+.+.
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~ 205 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGG 205 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTC
T ss_pred hhcccccccccccccccccchhHHhhcC
Confidence 76432 223457899999999999764
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.8e-26 Score=245.36 Aligned_cols=249 Identities=20% Similarity=0.178 Sum_probs=205.9
Q ss_pred ccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc-CCCccCCCCccccCCCCCcEEEe
Q 043136 151 FLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA-GNSLTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 151 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L 229 (902)
.+++|+|++|+|++..+..|.++++|++|++++|++.+..+..+.++..++.++.. .|.++...|..|.++++|++|++
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 34556666666665556677888888888888888888888888889999998765 67788777889999999999999
Q ss_pred eCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCccc
Q 043136 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSGP 309 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 309 (902)
++|.+....+..+....+|+.+++++|++++..+..|..+++|++|++++|++++..+..|.++++|+++++++|++++.
T Consensus 113 ~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i 192 (284)
T d1ozna_ 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192 (284)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEE
T ss_pred CCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhcccccc
Confidence 99999988888899999999999999999987788899999999999999999998899999999999999999999999
Q ss_pred cCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCCCCCccCC
Q 043136 310 IPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPIPPTICDG 389 (902)
Q Consensus 310 ~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~ 389 (902)
.|..|..+++|++|++++|++.+..+..|+.+++|++|++++|.+...-+. ..-...++.+....+++....|..+..
T Consensus 193 ~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~-~~l~~~l~~~~~~~~~~~C~~p~~l~g- 270 (284)
T d1ozna_ 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAG- 270 (284)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGG-HHHHHHHHHCCSEECCCBEEESGGGTT-
T ss_pred ChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccc-hHHHHHHHhCcCCCCceEeCCchHHcC-
Confidence 999999999999999999999998889999999999999999999864331 111224555666677777666665543
Q ss_pred CCccEEeccCCcCc
Q 043136 390 DRLFKLILFSNNFT 403 (902)
Q Consensus 390 ~~L~~L~l~~N~l~ 403 (902)
....++..+.++
T Consensus 271 --~~l~~l~~~~l~ 282 (284)
T d1ozna_ 271 --RDLKRLAANDLQ 282 (284)
T ss_dssp --CBGGGSCGGGSC
T ss_pred --CccccCCHHHCC
Confidence 233334444444
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-27 Score=259.96 Aligned_cols=172 Identities=27% Similarity=0.304 Sum_probs=130.7
Q ss_pred ccCCcEeeecCceEEEEEEeC-CCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEec------CCee
Q 043136 712 SMSDKILGMGSTGTVYKAEMP-GGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSN------RECT 784 (902)
Q Consensus 712 ~~~~~~iG~G~~g~Vy~~~~~-~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~------~~~~ 784 (902)
|...++||+|+||+||+|++. +|+.||||++.+... ......++.+|+.++++++|||||++++++.. ....
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~ 97 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDV 97 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEE
T ss_pred eEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCcee
Confidence 555689999999999999764 699999999964432 34455678899999999999999999999964 3678
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
|+||||+.+ ++.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 98 ~iv~Ey~~~-~l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 98 YLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeccch-HHHHhhhc-------CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 999999965 45444432 3677888999999999999999776 999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCcccccccCc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFCFSVP 895 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~p 895 (902)
+...........+||+.|+|||++.+....+
T Consensus 167 ~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~ 197 (355)
T d2b1pa1 167 RTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCT
T ss_pred hccccccccccccccccccChhhhcCCCCCC
Confidence 8876666667778999999999998765544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.94 E-value=3.5e-27 Score=252.74 Aligned_cols=171 Identities=22% Similarity=0.288 Sum_probs=136.1
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe-eEeEEeEEecCCeeEEEE
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN-IVRLLGCCSNRECTMLLY 788 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n-Iv~l~~~~~~~~~~~lv~ 788 (902)
+|.+.+.||+|+||+||+|++ .+++.||||++...... +++.+|++++++++|++ |+.+.+++.+.+..++||
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 466778999999999999976 56899999987543322 34678999999997665 555666677888999999
Q ss_pred EccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcC---CCCEEEeecccce
Q 043136 789 EYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDG---EMEARVADFGVAK 865 (902)
Q Consensus 789 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~---~~~~kl~DFGla~ 865 (902)
||+ ++++.+.+..... .+++..+..++.|++.||+|||+++ ||||||||+||+++. +..+|++|||+|+
T Consensus 83 e~~-~~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp ECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred EEc-CCchhhhhhhccC----CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcce
Confidence 999 6677776654332 4778889999999999999999776 999999999999854 4579999999999
Q ss_pred eccCCCC--------ceeeccccCccccCcccccccC
Q 043136 866 LIQSDES--------MSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 866 ~~~~~~~--------~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.+..... ....+||+.|||||++.+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 191 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS 191 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCC
Confidence 8754321 2446799999999999876544
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4e-27 Score=258.25 Aligned_cols=169 Identities=24% Similarity=0.348 Sum_probs=137.0
Q ss_pred hccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCeeEeEEeEEecC-----Cee
Q 043136 711 LSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRNIVRLLGCCSNR-----ECT 784 (902)
Q Consensus 711 ~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~~~~~-----~~~ 784 (902)
+|...+.||+|+||+||+|++ .+++.||||++.+.. ......+.+.+|++++++++|||||++++++... ...
T Consensus 19 rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 355668899999999999976 579999999986443 3334556788999999999999999999998643 344
Q ss_pred EEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEEEeecccc
Q 043136 785 MLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEARVADFGVA 864 (902)
Q Consensus 785 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~kl~DFGla 864 (902)
+++|||+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||.|
T Consensus 98 ~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred EEEEEeecCCchhhhcccc------cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 6677778899999998543 3778889999999999999999776 999999999999999999999999999
Q ss_pred eeccCCCCceeeccccCccccCccccc
Q 043136 865 KLIQSDESMSVIAGSYGYIAPGTFCFC 891 (902)
Q Consensus 865 ~~~~~~~~~~~~~Gt~~y~APE~~~~~ 891 (902)
..... ...+..||+.|+|||++.+.
T Consensus 169 ~~~~~--~~~~~~g~~~y~apE~~~~~ 193 (348)
T d2gfsa1 169 RHTDD--EMTGYVATRWYRAPEIMLNW 193 (348)
T ss_dssp -CCTG--GGSSSCHHHHTSCHHHHTTC
T ss_pred cccCc--ccccccccccccCchhhcCC
Confidence 76532 33456799999999997664
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=2.2e-23 Score=218.82 Aligned_cols=203 Identities=21% Similarity=0.265 Sum_probs=129.4
Q ss_pred ecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCccccccccc
Q 043136 73 CNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFL 152 (902)
Q Consensus 73 c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 152 (902)
|...+ ...++|.++++|+ .+|+.+. ++|++|+|++|+|++..+.+|.++++|++|+|++|+|+. +| .++.+++|
T Consensus 6 ~~~~~-~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L 79 (266)
T d1p9ag_ 6 VSKVA-SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVL 79 (266)
T ss_dssp EECST-TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTC
T ss_pred EcccC-CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccc
Confidence 44444 3344588888888 4777664 578899999999988777788888888888888888864 22 23445555
Q ss_pred ceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCc
Q 043136 153 RIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN 232 (902)
Q Consensus 153 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 232 (902)
++|+|++|++++ ++..+.++++|++|++++|.+.+..+..+..+.++++|++++|
T Consensus 80 ~~L~Ls~N~l~~-------------------------~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n 134 (266)
T d1p9ag_ 80 GTLDLSHNQLQS-------------------------LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (266)
T ss_dssp CEEECCSSCCSS-------------------------CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred cccccccccccc-------------------------cccccccccccccccccccccceeecccccccccccccccccc
Confidence 555555555443 2344555555555555555555545555555556666666666
Q ss_pred ccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc
Q 043136 233 NLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 233 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
.++...+..+..+++|++|++++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 135 ~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred ccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 665555555566666666666666666555556666666666666666666 55656666666777777777654
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3e-23 Score=217.86 Aligned_cols=200 Identities=23% Similarity=0.243 Sum_probs=155.9
Q ss_pred cCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEE
Q 043136 125 LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLD 204 (902)
Q Consensus 125 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 204 (902)
...+.+.|.+++.++. +|+.+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+. +| .++.+++|++|+
T Consensus 9 ~~~~~~v~C~~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~ 83 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLD 83 (266)
T ss_dssp STTCCEEECTTSCCSS-CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEE
T ss_pred cCCCeEEEccCCCCCe-eCcCcC--cCCCEEECcCCcCCCcCHHHhhccccccccccccccccc-cc-cccccccccccc
Confidence 3344445555555553 454442 356666666676666666677788888888888888873 34 357788999999
Q ss_pred ccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccce
Q 043136 205 LAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTG 284 (902)
Q Consensus 205 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 284 (902)
|++|+++ ..+..+..+++|++|++++|.+.+..+..+..+.++++|++++|.++...+..+..+++|+.|++++|++++
T Consensus 84 Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~ 162 (266)
T d1p9ag_ 84 LSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE 162 (266)
T ss_dssp CCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred ccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhcccccccccc
Confidence 9999998 457788888999999999999888888888888899999999999887777778888888899999998887
Q ss_pred ecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCcccc
Q 043136 285 EIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLF 331 (902)
Q Consensus 285 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 331 (902)
..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 163 ~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 163 LPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred cCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 77778888888888888888888 67777778888888888888775
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.87 E-value=1.5e-22 Score=222.70 Aligned_cols=175 Identities=21% Similarity=0.225 Sum_probs=131.2
Q ss_pred HhccCCcEeeecCceEEEEEEe-CCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-----------cCeeEeEEeE
Q 043136 710 CLSMSDKILGMGSTGTVYKAEM-PGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-----------HRNIVRLLGC 777 (902)
Q Consensus 710 ~~~~~~~~iG~G~~g~Vy~~~~-~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-----------h~nIv~l~~~ 777 (902)
.+|.+.++||+|+||+||+|+. .+|+.||||++.+.. ...+.+.+|+++++.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 3577789999999999999976 579999999985432 22345677888887764 5789999988
Q ss_pred Eec--CCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCC-
Q 043136 778 CSN--RECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEM- 854 (902)
Q Consensus 778 ~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~- 854 (902)
+.. ....+++|+++..+.......... .....++..+..++.||+.|++|||+. .+|+||||||+|||++.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEET
T ss_pred eeeccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCc
Confidence 754 345667777665554333332222 233467778889999999999999971 3499999999999998665
Q ss_pred -----CEEEeecccceeccCCCCceeeccccCccccCcccccccC
Q 043136 855 -----EARVADFGVAKLIQSDESMSVIAGSYGYIAPGTFCFCFSV 894 (902)
Q Consensus 855 -----~~kl~DFGla~~~~~~~~~~~~~Gt~~y~APE~~~~~~~~ 894 (902)
.+|++|||.|+..... ....+||+.|+|||++.+....
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~ 207 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG 207 (362)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred ccccceeeEeecccccccccc--cccccccccccChhhccccCCC
Confidence 3999999999875432 3456899999999999875443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.86 E-value=7.2e-20 Score=199.72 Aligned_cols=96 Identities=25% Similarity=0.323 Sum_probs=53.9
Q ss_pred cCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEc
Q 043136 174 NSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDI 253 (902)
Q Consensus 174 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 253 (902)
.+|++|||++|.++ .+|+. +++|++|+|++|+|+ .+|..+ .+|++|++++|+++. ++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence 35777777777776 45543 356777777777777 455543 356666666666652 2211 124555555
Q ss_pred cCccCcccCCccccCCCCccEEecCCCccc
Q 043136 254 SACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 254 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
++|.++ .+|. ++.+++|++|++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp CSSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hhhhccceeecccccccc
Confidence 555555 2332 344555555555555544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.85 E-value=8.6e-20 Score=199.10 Aligned_cols=137 Identities=24% Similarity=0.301 Sum_probs=71.3
Q ss_pred CCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcc-cCCcEEe
Q 043136 102 TSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQL-NSLQQLN 180 (902)
Q Consensus 102 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~ 180 (902)
.++++|||++|.++. +|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++.. + .+ +.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~l-~----~lp~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKAL-S----DLPPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSCC-C----SCCTTCCEEE
T ss_pred cCCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccchh-h----hhcccccccc
Confidence 367788888888874 5542 467788888888877 456543 3455566666665522 1 11 2355555
Q ss_pred ccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCc
Q 043136 181 LGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 181 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
|++|.+. .+|. ++.+++|++|++++|.++. .|.. ...+..+.+..+... .+..+..++.++.|++++|.+.
T Consensus 105 L~~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 105 VSNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred ccccccc-cccc-hhhhccceeeccccccccc-cccc---cccccchhhcccccc--ccccccccccceeccccccccc
Confidence 5555555 2332 3455555555555555542 2211 233444444433332 1223444444445555544443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.83 E-value=9.6e-21 Score=187.81 Aligned_cols=137 Identities=18% Similarity=0.172 Sum_probs=105.1
Q ss_pred cCCcEeeecCceEEEEEEeCCCcEEEEEEecccch---------------hhHHHHHHHHHHHHHHhcCCcCeeEeEEeE
Q 043136 713 MSDKILGMGSTGTVYKAEMPGGEIIAVKKLWGKHK---------------ENIRRRRGVLAEVDVLGNVRHRNIVRLLGC 777 (902)
Q Consensus 713 ~~~~~iG~G~~g~Vy~~~~~~~~~vavK~i~~~~~---------------~~~~~~~~~~~Ei~il~~l~h~nIv~l~~~ 777 (902)
.+.++||+|+||.||+|...+|+.||||++..... ..........+|...+.++.|+++++.+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999988899999998642110 011223445678999999999999998876
Q ss_pred EecCCeeEEEEEccCCCCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCCCCCeEEcCCCCCCEEEcCCCCEE
Q 043136 778 CSNRECTMLLYEYMPNGNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHHDCDPVIVHRDLKPSNILLDGEMEAR 857 (902)
Q Consensus 778 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~ivHrDlKp~NILl~~~~~~k 857 (902)
.. .+++|||+++....++ +......++.|+++|++|||+++ |+||||||+|||++++ .++
T Consensus 83 ~~----~~lvme~~~~~~~~~l------------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 EG----NAVLMELIDAKELYRV------------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ET----TEEEEECCCCEEGGGC------------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred cC----CEEEEEeeccccccch------------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 42 3799999987544321 11223468999999999999776 9999999999999966 489
Q ss_pred EeecccceeccC
Q 043136 858 VADFGVAKLIQS 869 (902)
Q Consensus 858 l~DFGla~~~~~ 869 (902)
++|||.|+....
T Consensus 143 liDFG~a~~~~~ 154 (191)
T d1zara2 143 IIDFPQSVEVGE 154 (191)
T ss_dssp ECCCTTCEETTS
T ss_pred EEECCCcccCCC
Confidence 999999987643
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=4.4e-22 Score=225.69 Aligned_cols=109 Identities=18% Similarity=0.263 Sum_probs=65.1
Q ss_pred CEEEEEcCCCCcccc-cCccccCCCCCCEEEccCCCCcc----cCchhhhccCCCcEEEccCCCCCCC----CCcccc-c
Q 043136 79 QITSLDLSRRSLSGP-IPPEIRYLTSLTHLNLSANAFDG----PLQPAILELTKLRTIDISHNSFNST----FPPGIS-K 148 (902)
Q Consensus 79 ~v~~L~L~~~~l~g~-~~~~~~~l~~L~~L~Ls~n~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~-~ 148 (902)
.+++||++++++++. +.+.+..++++++|+|++|.++. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 577888888888753 23345567777788888887763 2344566777788888887776421 111221 1
Q ss_pred ccccceeccccccccCC----CchhhhcccCCcEEeccCccCc
Q 043136 149 LRFLRIFNAYSNSFTGP----LPLEFVQLNSLQQLNLGGSYFD 187 (902)
Q Consensus 149 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 187 (902)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccch
Confidence 23566666666666543 2334445556666666666554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=3.7e-19 Score=183.49 Aligned_cols=221 Identities=17% Similarity=0.137 Sum_probs=121.7
Q ss_pred CccccEEecCCCCCEEEEEcCCCCcccccCccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCC-c
Q 043136 66 CSWSGIKCNPKSSQITSLDLSRRSLSGPIPPEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFP-P 144 (902)
Q Consensus 66 C~w~Gv~c~~~~~~v~~L~L~~~~l~g~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~ 144 (902)
|.+..|.|.. .+++ .+|+.+. +++++|+|++|.|+...+.+|.++++|++|+|++|.+...++ .
T Consensus 8 C~~~~i~c~~------------~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~ 72 (242)
T d1xwdc1 8 CSNRVFLCQE------------SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72 (242)
T ss_dssp ECSSEEEEES------------CSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSS
T ss_pred CcCCEEEEeC------------CCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecc
Confidence 5556666643 3455 5666553 578999999999987777788889999999999998876544 3
Q ss_pred ccccccccceeccc-cccccCCCchhhhcccCCcEEeccCccCcCCCCc-ccCCCCCCCEEEccCCCccCCCCccccCCC
Q 043136 145 GISKLRFLRIFNAY-SNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPS-DYRNLSSLRFLDLAGNSLTGSLPPQLGLLT 222 (902)
Q Consensus 145 ~l~~l~~L~~L~L~-~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 222 (902)
.|..++.++++++. .|++....+..|.++++|++|++++|++....+. .+..+..++.+..++++++...+..|..++
T Consensus 73 ~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~ 152 (242)
T d1xwdc1 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLS 152 (242)
T ss_dssp SEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSB
T ss_pred ccccccccccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccc
Confidence 46667777766654 3556555555666666666666666665432221 223344444444444454433333333332
Q ss_pred CCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEE-ecCCCccceecCCCCCCcCcCcEEec
Q 043136 223 QLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEML-LLFKNHFTGEIPVSYGNLQALQVLDL 301 (902)
Q Consensus 223 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L-~L~~N~l~~~~p~~~~~l~~L~~L~L 301 (902)
..++.|++++|+++...+..+ +.++++.+ ++++|+++...+..|.++++|++|+|
T Consensus 153 -----------------------~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~L 208 (242)
T d1xwdc1 153 -----------------------FESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208 (242)
T ss_dssp -----------------------SSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEEC
T ss_pred -----------------------ccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEEC
Confidence 144445555555543322222 22332222 34444554333334555555555555
Q ss_pred ccCCCccccCccccccCCCCEEEc
Q 043136 302 SDNQLSGPIPASLASLKGLTRLSL 325 (902)
Q Consensus 302 s~N~l~~~~p~~l~~l~~L~~L~L 325 (902)
++|+|+...+..|.++++|+.+++
T Consensus 209 s~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 209 SRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTSCCCCCCSSSCTTCCEEESSSE
T ss_pred CCCcCCccCHHHHcCCcccccCcC
Confidence 555555433444455544444444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=7.3e-22 Score=223.88 Aligned_cols=389 Identities=18% Similarity=0.181 Sum_probs=254.1
Q ss_pred CCCEEEccCCCCcccC-chhhhccCCCcEEEccCCCCCC----CCCcccccccccceeccccccccCCCchhhh-----c
Q 043136 103 SLTHLNLSANAFDGPL-QPAILELTKLRTIDISHNSFNS----TFPPGISKLRFLRIFNAYSNSFTGPLPLEFV-----Q 172 (902)
Q Consensus 103 ~L~~L~Ls~n~l~~~~-~~~~~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~-----~ 172 (902)
+|++||+++|++++.. ...+..+++|++|+|++|.++. .+...+..+++|+.|||++|.|+......+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5899999999998643 4456789999999999999873 3445577889999999999998632222222 2
Q ss_pred ccCCcEEeccCccCcCC----CCcccCCCCCCCEEEccCCCccCCCCcc----c-cCCCCCcEEEeeCcccCCCC----C
Q 043136 173 LNSLQQLNLGGSYFDGE----IPSDYRNLSSLRFLDLAGNSLTGSLPPQ----L-GLLTQLERIEIGYNNLQGEV----P 239 (902)
Q Consensus 173 l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~----~-~~l~~L~~L~L~~N~l~~~~----p 239 (902)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++..-... + ...............+.... -
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 35799999999999754 4556788999999999999987321111 1 12223444444444333111 1
Q ss_pred hhccCCCCCCEEEccCccCcccC----Cccc-cCCCCccEEecCCCccceec----CCCCCCcCcCcEEecccCCCcc--
Q 043136 240 VEFASLVNLKYMDISACNLSGTL----PSEI-SNLTKLEMLLLFKNHFTGEI----PVSYGNLQALQVLDLSDNQLSG-- 308 (902)
Q Consensus 240 ~~~~~l~~L~~L~Ls~N~l~~~~----p~~~-~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~Ls~N~l~~-- 308 (902)
..+.....++.++++.+...... ...+ ........+++..+.+.... ...+...+.++.+++++|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 22344567888888887765211 0111 12235667777777654211 1123345678888888887642
Q ss_pred ---ccCccccccCCCCEEEccCccccccC----ChhhhhccccceEEecCceeccccCccc-----cCCCceeEEEecCC
Q 043136 309 ---PIPASLASLKGLTRLSLMNNVLFGEI----PQDIELLADLDTLLLWNNHLTGVLPQKL-----GSNGKLLTVDVSSN 376 (902)
Q Consensus 309 ---~~p~~l~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~~~~L~~L~Ls~N 376 (902)
..+........++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 22334445677888888888775432 2234556778888888888864322221 23457888889988
Q ss_pred cccCCCCCC----ccCCCCccEEeccCCcCccc----cccccc-ccCCCcEEEccCCccCCC----CCcccCCCCCCcEE
Q 043136 377 SLTGPIPPT----ICDGDRLFKLILFSNNFTYS----IPENLV-NCSSLSRLRIQDNQLNGS----IPQGFGLLPNLTFM 443 (902)
Q Consensus 377 ~l~~~~p~~----~~~~~~L~~L~l~~N~l~~~----~p~~l~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L 443 (902)
.++...... +....+|++|+|++|+++.. +++.+. ..+.|++|+|++|+|+.. ++..+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred chhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEE
Confidence 887542222 23445789999999988753 334443 456799999999999742 44556678999999
Q ss_pred EccCcccCCCCCCc----Cc-ccCcCceecccccccCCCcChhh----hccccccee
Q 043136 444 DMSRNSLSGEIPRD----LG-NAQKLEYLNISENSFQTSLPSNI----WSAPNLKIL 491 (902)
Q Consensus 444 ~Ls~N~l~~~~p~~----~~-~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L 491 (902)
||++|+|+...... +. +..+|+.|++++|.+.......+ ...|+|++|
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l~~l~~~~~~l~~~ 459 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHHHHHHHHCTTSEEE
T ss_pred ECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHHHHHHHHHHhCCCCEEe
Confidence 99999997532222 22 33479999999999875555444 245667665
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=7.9e-19 Score=179.08 Aligned_cols=187 Identities=25% Similarity=0.363 Sum_probs=96.6
Q ss_pred ccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEE
Q 043136 124 ELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFL 203 (902)
Q Consensus 124 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 203 (902)
.+.+|++|++++|.++. + +.+..+++|++|++++|++++..| +..+++|+++++++|.++. ++ .+.++++|+++
T Consensus 39 ~l~~L~~L~l~~~~i~~-l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l 112 (227)
T d1h6ua2 39 DLDGITTLSAFGTGVTT-I-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTL 112 (227)
T ss_dssp HHHTCCEEECTTSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEE
T ss_pred HcCCcCEEECCCCCCCc-c-hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccccc-cc-ccccccccccc
Confidence 33444444444444432 1 123444444444444444443322 4445555555555555442 22 34455555555
Q ss_pred EccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 204 DLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 204 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
+++++..++. ..+...+.++.+.++.+.+.... .+...++|++|++++|.+++.. .+.++++|++|+|++|+++
T Consensus 113 ~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 113 DLTSTQITDV--TPLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp ECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCC
T ss_pred cccccccccc--chhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hhcccccceecccCCCccC
Confidence 5555555432 22444555566666655554322 2455566666666666665322 2556666666666666666
Q ss_pred eecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEcc
Q 043136 284 GEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLM 326 (902)
Q Consensus 284 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 326 (902)
+. + .++++++|++|+|++|++++..| +.++++|++|+++
T Consensus 187 ~l-~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 187 DI-S-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp CC-G-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred CC-h-hhcCCCCCCEEECcCCcCCCCcc--cccCCCCCEEEee
Confidence 42 2 25666667777777777664322 6666777777765
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.78 E-value=8.5e-19 Score=178.84 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=97.0
Q ss_pred EEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCc
Q 043136 131 IDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSL 210 (902)
Q Consensus 131 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 210 (902)
++++.+++++.+ .++.+.+|+.|++++|.|+.. ..+..+++|++|++++|++++..| +..+++|+++++++|.+
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~ 97 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL 97 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCcc--hhHhcCCCCcEeecCCceeecccc--ccccccccccccccccc
Confidence 344444444322 234455555555555555432 235555555555555555553322 45555555555555555
Q ss_pred cCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCC
Q 043136 211 TGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSY 290 (902)
Q Consensus 211 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 290 (902)
+. + +.+..+++|+.++++++...+.. .+...+.++.++++.+.+.... .+.++++|++|++++|.+.+.. .+
T Consensus 98 ~~-i-~~l~~l~~L~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~n~~~~~~--~l 169 (227)
T d1h6ua2 98 KN-V-SAIAGLQSIKTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNIS--PLAGLTNLQYLSIGNAQVSDLT--PL 169 (227)
T ss_dssp SC-C-GGGTTCTTCCEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECCSSCCCCCG--GG
T ss_pred cc-c-ccccccccccccccccccccccc--hhccccchhhhhchhhhhchhh--hhccccccccccccccccccch--hh
Confidence 42 2 23445555555555555544321 2344455555555555554221 2444555555555555554321 24
Q ss_pred CCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEec
Q 043136 291 GNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLW 350 (902)
Q Consensus 291 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 350 (902)
+++++|++|+|++|++++. + .++++++|++|+|++|++++.. .++.+++|+.|+++
T Consensus 170 ~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i~--~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 170 ANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLT 225 (227)
T ss_dssp TTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEE
T ss_pred cccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCCc--ccccCCCCCEEEee
Confidence 4555555555555555432 2 2455555555555555554322 14455555555554
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.5e-18 Score=176.07 Aligned_cols=218 Identities=17% Similarity=0.115 Sum_probs=108.4
Q ss_pred cEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceec-CCCCCCcCcCcEEeccc
Q 043136 225 ERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEI-PVSYGNLQALQVLDLSD 303 (902)
Q Consensus 225 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 303 (902)
+.++.++++++ .+|..+. +++++|||++|+|+...+..|.++++|++|++++|.+...+ +..|.+++.++++++..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 46667766666 4554432 45677777777776554556666777777777777665433 33456666666666543
Q ss_pred -CCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCccccCCCceeEEEecCCcccCCC
Q 043136 304 -NQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQKLGSNGKLLTVDVSSNSLTGPI 382 (902)
Q Consensus 304 -N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~Ls~N~l~~~~ 382 (902)
|++....+..|.++++|+.|++++|.+....+.. .+..+..+..+..+++++....
T Consensus 88 ~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~-----------------------~~~~l~~l~~~~~~n~~l~~i~ 144 (242)
T d1xwdc1 88 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVH-----------------------KIHSLQKVLLDIQDNINIHTIE 144 (242)
T ss_dssp CTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCT-----------------------TTCBSSCEEEEEESCTTCCEEC
T ss_pred cccccccccccccccccccccccchhhhccccccc-----------------------cccccccccccccccccccccc
Confidence 5555555566666666666666666654322111 1122233333333333333222
Q ss_pred CCCccCCC-CccEEeccCCcCcccccccccccCCCcE-EEccCCccCCCCCcccCCCCCCcEEEccCcccCCCCCCcCcc
Q 043136 383 PPTICDGD-RLFKLILFSNNFTYSIPENLVNCSSLSR-LRIQDNQLNGSIPQGFGLLPNLTFMDMSRNSLSGEIPRDLGN 460 (902)
Q Consensus 383 p~~~~~~~-~L~~L~l~~N~l~~~~p~~l~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 460 (902)
+..+..+. .++.+++.+|+++...+..+ ...++.+ +++++|+|+...+..|.++++|++|||++|+|+...+..|.+
T Consensus 145 ~~~~~~~~~~l~~L~l~~n~l~~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 145 RNSFVGLSFESVILWLNKNGIQEIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp TTSSTTSBSSCEEEECCSSCCCEECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred ccccccccccceeeecccccccccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 22222221 23333333333332222212 2223222 234555555333334555566666666666655433444555
Q ss_pred cCcCceecc
Q 043136 461 AQKLEYLNI 469 (902)
Q Consensus 461 l~~L~~L~L 469 (902)
+++|++|++
T Consensus 224 l~~L~~l~~ 232 (242)
T d1xwdc1 224 LKKLRARST 232 (242)
T ss_dssp CCEEESSSE
T ss_pred CcccccCcC
Confidence 555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.1e-18 Score=172.96 Aligned_cols=171 Identities=21% Similarity=0.254 Sum_probs=98.5
Q ss_pred EEEccCCCccCCCCccccCCCCCcEEEeeCcccCC-CCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCC
Q 043136 202 FLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQG-EVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKN 280 (902)
Q Consensus 202 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 280 (902)
.+++++++|+ .+|..+. +++++|+|++|+|++ ..+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|
T Consensus 12 ~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N 88 (192)
T d1w8aa_ 12 TVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccc
Confidence 4555555555 3444432 455555566665554 22444566666666666666666666666666666666666666
Q ss_pred ccceecCCCCCCcCcCcEEecccCCCccccCccccccCCCCEEEccCccccccCChhhhhccccceEEecCceeccccCc
Q 043136 281 HFTGEIPVSYGNLQALQVLDLSDNQLSGPIPASLASLKGLTRLSLMNNVLFGEIPQDIELLADLDTLLLWNNHLTGVLPQ 360 (902)
Q Consensus 281 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~ 360 (902)
+|+...|..|.++++|++|+|++|+|++..|..|..+++|++|+|++|.+....+. ......++.+.+..|.++...|.
T Consensus 89 ~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~ 167 (192)
T d1w8aa_ 89 KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPS 167 (192)
T ss_dssp CCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSST
T ss_pred cccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCCh
Confidence 66655566666666666666666666666666666666677777777666543221 11123345555666666655554
Q ss_pred cccCCCceeEEEecCCccc
Q 043136 361 KLGSNGKLLTVDVSSNSLT 379 (902)
Q Consensus 361 ~~~~~~~L~~L~Ls~N~l~ 379 (902)
.+ ..++.++|+.|.+.
T Consensus 168 ~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 168 KV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp TT---TTSBGGGSCTTTCC
T ss_pred hh---cCCEeeecCHhhCc
Confidence 43 33445566666654
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=3.7e-18 Score=171.59 Aligned_cols=101 Identities=29% Similarity=0.395 Sum_probs=44.2
Q ss_pred ccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCc
Q 043136 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQ 297 (902)
Q Consensus 218 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 297 (902)
+..+++|+.|++++|.+.. + ..+..+++|+.+++++|.+++ +..+..+++|+++++++|++++.. .++++++|+
T Consensus 108 l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~ 181 (210)
T d1h6ta2 108 LKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQ 181 (210)
T ss_dssp GTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCC
T ss_pred ccccccccccccccccccc-c-ccccccccccccccccccccc--cccccccccccccccccccccccc--cccCCCCCC
Confidence 3334444444444444331 1 123444444444444444432 122334444555555555444321 144455555
Q ss_pred EEecccCCCccccCccccccCCCCEEEcc
Q 043136 298 VLDLSDNQLSGPIPASLASLKGLTRLSLM 326 (902)
Q Consensus 298 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 326 (902)
+|+|++|+++. +| .+.++++|++|+|+
T Consensus 182 ~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 182 NLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp EEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred EEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 55555555542 22 34555555555554
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=1.1e-18 Score=172.85 Aligned_cols=153 Identities=17% Similarity=0.144 Sum_probs=81.8
Q ss_pred ccceeccccccccCC-CchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEe
Q 043136 151 FLRIFNAYSNSFTGP-LPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEI 229 (902)
Q Consensus 151 ~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 229 (902)
++++|+|++|+|++. .+..|.++++|++|+|++|.+.+..+..|..+++|++|+|++|+|++..|.+|.++++|++|+|
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L 109 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCccccccc
Confidence 344444444444432 2334555566666666666666555566666666666666666666555555666666666666
Q ss_pred eCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCc
Q 043136 230 GYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLS 307 (902)
Q Consensus 230 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 307 (902)
++|+|++..|.+|..+++|++|+|++|.+....+. ..-...++.+.+..|.++...|..+ ..++.++|+.|.+.
T Consensus 110 ~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~-~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~ 183 (192)
T d1w8aa_ 110 YDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFK 183 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG-HHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCC
T ss_pred CCccccccCHHHhcCCcccccccccccccccccch-HHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCc
Confidence 66666655566666666666666666666532211 1111224444455555554444332 33445555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=5.7e-18 Score=170.19 Aligned_cols=165 Identities=25% Similarity=0.336 Sum_probs=97.8
Q ss_pred cCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEE
Q 043136 125 LTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLD 204 (902)
Q Consensus 125 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 204 (902)
+.+|++|++++|.++... .+..+++|++|++++|+|++.. .++.+++|++|++++|++++ +| .+.++++|+.|+
T Consensus 45 L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~ 118 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS 118 (210)
T ss_dssp HHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred hcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence 444444555555444321 2444555555555555554432 24556666666666666653 33 356666677777
Q ss_pred ccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccce
Q 043136 205 LAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTG 284 (902)
Q Consensus 205 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 284 (902)
+++|.++. ...+..+++++.+++++|.+++ +..+..+++|+++++++|++++. + .+.++++|++|+|++|+|+.
T Consensus 119 l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 119 LEHNGISD--INGLVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp CTTSCCCC--CGGGGGCTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB
T ss_pred cccccccc--cccccccccccccccccccccc--ccccccccccccccccccccccc-c-cccCCCCCCEEECCCCCCCC
Confidence 76666652 2346666677777777777663 23456667777777777777643 2 26677777777777777764
Q ss_pred ecCCCCCCcCcCcEEeccc
Q 043136 285 EIPVSYGNLQALQVLDLSD 303 (902)
Q Consensus 285 ~~p~~~~~l~~L~~L~Ls~ 303 (902)
+| .+.++++|++|+|++
T Consensus 193 -l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 193 -LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp -CG-GGTTCTTCSEEEEEE
T ss_pred -Ch-hhcCCCCCCEEEccC
Confidence 33 467777777777764
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=1.4e-17 Score=165.91 Aligned_cols=142 Identities=26% Similarity=0.359 Sum_probs=69.3
Q ss_pred cccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCc
Q 043136 146 ISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLE 225 (902)
Q Consensus 146 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 225 (902)
+..+++|++|++++|++++..| ++++++|++|++++|.+.. ++ .+.++++|++|++++|.+... ..+..+++|+
T Consensus 58 l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~ 131 (199)
T d2omxa2 58 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLN 131 (199)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCS
T ss_pred cccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-ccccccccccccccccccccc--cccchhhhhH
Confidence 3334444444444444443222 4444555555555554442 22 244555555555555555421 2344555555
Q ss_pred EEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEE
Q 043136 226 RIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVL 299 (902)
Q Consensus 226 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 299 (902)
.|++++|++.. + +.+..+++|++|++++|++++.. .++++++|++|++++|++++ ++ .++.+++|++|
T Consensus 132 ~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 132 RLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp EEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred Hhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 55555555542 2 23555555666666666555321 25555666666666666553 22 34555555544
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=2.3e-17 Score=164.21 Aligned_cols=161 Identities=27% Similarity=0.349 Sum_probs=100.0
Q ss_pred ccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEE
Q 043136 149 LRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIE 228 (902)
Q Consensus 149 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 228 (902)
+.++++|++++|.++.. +.+..+++|++|+|++|++++..| ++++++|++|++++|.++. ++ .+..+++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence 34444444444444422 235666777777777777765432 6677777777777777663 33 366777777777
Q ss_pred eeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCcCcEEecccCCCcc
Q 043136 229 IGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQALQVLDLSDNQLSG 308 (902)
Q Consensus 229 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 308 (902)
+++|.+... ..+..+++|++|++++|++.. + ..+..+++|++|++++|++++.. .++++++|++|++++|++++
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cccCCCCCCEEECCCCCCCC
Confidence 777766643 236667777777777777653 2 24666777777777777776432 36667777777777777764
Q ss_pred ccCccccccCCCCEE
Q 043136 309 PIPASLASLKGLTRL 323 (902)
Q Consensus 309 ~~p~~l~~l~~L~~L 323 (902)
++ .++++++|+.|
T Consensus 187 -i~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 -IS-VLAKLTNLESL 199 (199)
T ss_dssp -CG-GGGGCTTCSEE
T ss_pred -Cc-cccCCCCCCcC
Confidence 32 36666666654
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.57 E-value=6.7e-16 Score=162.54 Aligned_cols=200 Identities=18% Similarity=0.195 Sum_probs=111.7
Q ss_pred CcEEEccCCCCCCCCCcccccccccceeccccccccCC-CchhhhcccCCcEEeccCccCcCCCCcccCCCCCCCEEEcc
Q 043136 128 LRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGP-LPLEFVQLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLA 206 (902)
Q Consensus 128 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 206 (902)
+..+.++...+...+.. .....+|++||++++.++.. ++..+.++++|++|+|+++.+++..+..+..+++|++|+|+
T Consensus 25 ~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls 103 (284)
T d2astb2 25 VIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 103 (284)
T ss_dssp CSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECT
T ss_pred ceEeeccccccccchhh-hccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCcccc
Confidence 34455554444322222 22334566666666665533 23445666777777777776666556666666777777777
Q ss_pred CC-CccCC-CCccccCCCCCcEEEeeCc-ccCCC-CChhccC-CCCCCEEEccCc--cCccc-CCccccCCCCccEEecC
Q 043136 207 GN-SLTGS-LPPQLGLLTQLERIEIGYN-NLQGE-VPVEFAS-LVNLKYMDISAC--NLSGT-LPSEISNLTKLEMLLLF 278 (902)
Q Consensus 207 ~N-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~-l~~L~~L~Ls~N--~l~~~-~p~~~~~l~~L~~L~L~ 278 (902)
++ .++.. +...+..+++|++|+++++ +++.. +...+.. .++|+.|+++++ .++.. +...+.++++|++|+++
T Consensus 104 ~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~ 183 (284)
T d2astb2 104 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLS 183 (284)
T ss_dssp TCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECT
T ss_pred ccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccc
Confidence 64 44421 1112345667777777664 34321 1122222 356777777754 23321 22233456777777777
Q ss_pred CC-ccceecCCCCCCcCcCcEEeccc-CCCccccCccccccCCCCEEEccCc
Q 043136 279 KN-HFTGEIPVSYGNLQALQVLDLSD-NQLSGPIPASLASLKGLTRLSLMNN 328 (902)
Q Consensus 279 ~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L~~N 328 (902)
+| .+++.....+..+++|++|+|++ +.+++.....++++++|+.|+++++
T Consensus 184 ~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 184 DSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp TCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred cccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 64 45555555666677777777777 3565555556666777777777665
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.54 E-value=3.4e-16 Score=170.00 Aligned_cols=190 Identities=16% Similarity=0.128 Sum_probs=93.0
Q ss_pred cCccccCCCCCCEEEccCCCCcccC----chhhhccCCCcEEEccCCCCCCCC---C-------cccccccccceecccc
Q 043136 94 IPPEIRYLTSLTHLNLSANAFDGPL----QPAILELTKLRTIDISHNSFNSTF---P-------PGISKLRFLRIFNAYS 159 (902)
Q Consensus 94 ~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~~~---p-------~~l~~l~~L~~L~L~~ 159 (902)
+...+.+.+.|++|+|++|.+.... ...+...++|+.|+++++.+.... | ..+...++|+.|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 3445666777888888887775432 233456677778887776543221 1 1233445566666666
Q ss_pred ccccCCC----chhhhcccCCcEEeccCccCcCCCCcc-------------cCCCCCCCEEEccCCCccCC----CCccc
Q 043136 160 NSFTGPL----PLEFVQLNSLQQLNLGGSYFDGEIPSD-------------YRNLSSLRFLDLAGNSLTGS----LPPQL 218 (902)
Q Consensus 160 N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~-------------~~~l~~L~~L~L~~N~l~~~----~p~~~ 218 (902)
|.+...- ...+...++|++|++++|.+...-... ....+.|+.|++++|+++.. +...+
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l 182 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHH
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchh
Confidence 6555432 223344556666666666553110000 12334555555555555421 11223
Q ss_pred cCCCCCcEEEeeCcccCCC-----CChhccCCCCCCEEEccCccCccc----CCccccCCCCccEEecCCCccc
Q 043136 219 GLLTQLERIEIGYNNLQGE-----VPVEFASLVNLKYMDISACNLSGT----LPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 219 ~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
...+.|++|+|++|+|+.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|++|.|+
T Consensus 183 ~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~ 256 (344)
T d2ca6a1 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256 (344)
T ss_dssp HHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred hhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccC
Confidence 3444555555555554421 112234444555555555554321 1223344445555555555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=6.3e-15 Score=140.58 Aligned_cols=128 Identities=20% Similarity=0.195 Sum_probs=63.5
Q ss_pred cCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCcc
Q 043136 194 YRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLE 273 (902)
Q Consensus 194 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 273 (902)
|.+..+|++|+|++|+|+ .+|..+..+++|+.|+|++|+|+. ++ .|..+++|++|++++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 344455555555555555 334444455555555555555552 22 255555555555555555544444444555555
Q ss_pred EEecCCCccceecC-CCCCCcCcCcEEecccCCCcccc---CccccccCCCCEEE
Q 043136 274 MLLLFKNHFTGEIP-VSYGNLQALQVLDLSDNQLSGPI---PASLASLKGLTRLS 324 (902)
Q Consensus 274 ~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~---p~~l~~l~~L~~L~ 324 (902)
+|++++|+|+.... ..+..+++|++|++++|.++... +..+..+++|++||
T Consensus 91 ~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 91 ELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp EEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 55555555542211 23444555555555555554211 11344455555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=7.3e-15 Score=140.11 Aligned_cols=113 Identities=19% Similarity=0.125 Sum_probs=71.3
Q ss_pred ccccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccC
Q 043136 96 PEIRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNS 175 (902)
Q Consensus 96 ~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 175 (902)
+.+.++..|++|||++|+|+.+ +..+..+++|++|||++|+|+.. +.|..+++|++|++++|+++...+..+..+++
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred HhccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCccccccccc
Confidence 3466777788888888888754 55567778888888888887743 24666666666666666666555555556666
Q ss_pred CcEEeccCccCcCCCC-cccCCCCCCCEEEccCCCcc
Q 043136 176 LQQLNLGGSYFDGEIP-SDYRNLSSLRFLDLAGNSLT 211 (902)
Q Consensus 176 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 211 (902)
|++|+|++|+++.... ..+..+++|++|++++|.++
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred cccceeccccccccccccccccccccchhhcCCCccc
Confidence 6666666666653211 23445555555555555554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.3e-15 Score=160.35 Aligned_cols=181 Identities=19% Similarity=0.220 Sum_probs=93.4
Q ss_pred cccCCcEEeccCccCcCC-CCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCc-ccCCC-CChhccCCCCC
Q 043136 172 QLNSLQQLNLGGSYFDGE-IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN-NLQGE-VPVEFASLVNL 248 (902)
Q Consensus 172 ~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~l~~L 248 (902)
...+|++|||+++.++.. ++..+.++++|++|+|++|.+++..+..++.+++|++|+++++ .++.. +...+.++++|
T Consensus 44 ~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L 123 (284)
T d2astb2 44 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRL 123 (284)
T ss_dssp CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTC
T ss_pred cCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhc
Confidence 344666677766665532 2333556666666666666666555555666666666666663 34421 11223445666
Q ss_pred CEEEccCc-cCccc-CCccccC-CCCccEEecCCC--cccee-cCCCCCCcCcCcEEecccC-CCccccCccccccCCCC
Q 043136 249 KYMDISAC-NLSGT-LPSEISN-LTKLEMLLLFKN--HFTGE-IPVSYGNLQALQVLDLSDN-QLSGPIPASLASLKGLT 321 (902)
Q Consensus 249 ~~L~Ls~N-~l~~~-~p~~~~~-l~~L~~L~L~~N--~l~~~-~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~ 321 (902)
++|+++++ .++.. +...+.. .++|+.|++++. .++.. +...+.++++|++|++++| .+++.....+..+++|+
T Consensus 124 ~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~ 203 (284)
T d2astb2 124 DELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQ 203 (284)
T ss_dssp CEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCC
T ss_pred cccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCC
Confidence 66666664 33311 1112222 345666666543 23221 1111234556666666654 35545555555566666
Q ss_pred EEEccC-ccccccCChhhhhccccceEEecCc
Q 043136 322 RLSLMN-NVLFGEIPQDIELLADLDTLLLWNN 352 (902)
Q Consensus 322 ~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N 352 (902)
+|+|++ +.+++.....+..+++|+.|+++++
T Consensus 204 ~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 204 HLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred EEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 666665 3444444444555555666665554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.51 E-value=1.1e-15 Score=165.79 Aligned_cols=251 Identities=18% Similarity=0.199 Sum_probs=130.4
Q ss_pred CchhhhccCCCcEEEccCCCCCCC----CCcccccccccceeccccccccCC---Cc-------hhhhcccCCcEEeccC
Q 043136 118 LQPAILELTKLRTIDISHNSFNST----FPPGISKLRFLRIFNAYSNSFTGP---LP-------LEFVQLNSLQQLNLGG 183 (902)
Q Consensus 118 ~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~---~p-------~~~~~l~~L~~L~L~~ 183 (902)
+...+...+.|+.|+|++|.+... +...+...+.|+.|+++++.+... .| ..+..+++|++|+|++
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~ 102 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD 102 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCS
T ss_pred HHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccc
Confidence 456677889999999999988643 223456667788888776654322 11 1233455666666666
Q ss_pred ccCcCC----CCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCc
Q 043136 184 SYFDGE----IPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLS 259 (902)
Q Consensus 184 N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 259 (902)
|.+... +...+...++|++|++++|.++..-...+.. .+..+ .........+.|+.+++++|.++
T Consensus 103 n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~--~l~~~---------~~~~~~~~~~~L~~l~l~~n~i~ 171 (344)
T d2ca6a1 103 NAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR--ALQEL---------AVNKKAKNAPPLRSIICGRNRLE 171 (344)
T ss_dssp CCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH--HHHHH---------HHHHHHHTCCCCCEEECCSSCCT
T ss_pred cccccccccchhhhhcccccchheecccccccccccccccc--ccccc---------ccccccccCcccceeeccccccc
Confidence 665533 1122334455666666655543110000000 00000 00001123445556666655554
Q ss_pred cc----CCccccCCCCccEEecCCCcccee-----cCCCCCCcCcCcEEecccCCCccc----cCccccccCCCCEEEcc
Q 043136 260 GT----LPSEISNLTKLEMLLLFKNHFTGE-----IPVSYGNLQALQVLDLSDNQLSGP----IPASLASLKGLTRLSLM 326 (902)
Q Consensus 260 ~~----~p~~~~~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~ 326 (902)
.. +...+...+.|++|+|++|+++.. +...+..+++|+.|+|++|.++.. +...+..+++|++|+|+
T Consensus 172 ~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls 251 (344)
T d2ca6a1 172 NGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN 251 (344)
T ss_dssp GGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT
T ss_pred ccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhh
Confidence 21 122334455666666666665421 223345556666666666666422 23445566667777777
Q ss_pred CccccccCChhh----hh--ccccceEEecCceecccc----Ccccc-CCCceeEEEecCCccc
Q 043136 327 NNVLFGEIPQDI----EL--LADLDTLLLWNNHLTGVL----PQKLG-SNGKLLTVDVSSNSLT 379 (902)
Q Consensus 327 ~N~l~~~~p~~~----~~--l~~L~~L~L~~N~l~~~~----~~~~~-~~~~L~~L~Ls~N~l~ 379 (902)
+|.+++.....+ .. ...|++|++++|+|+... ...+. ..++|+.|++++|++.
T Consensus 252 ~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 252 DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred cCccCchhhHHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 776654322222 22 235677777777765422 22222 3566777788887775
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=3.6e-14 Score=128.60 Aligned_cols=63 Identities=27% Similarity=0.440 Sum_probs=25.5
Q ss_pred ccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccc
Q 043136 218 LGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFT 283 (902)
Q Consensus 218 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 283 (902)
++.+++|++|++++|+|+ .+|..|+.+++|++|++++|.|++ +| .+.++++|++|++++|+|+
T Consensus 16 l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~ 78 (124)
T d1dcea3 16 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQ 78 (124)
T ss_dssp GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCC
T ss_pred cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccC
Confidence 344444444444444443 233334444444444444444442 12 2334444444444444443
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=5.6e-14 Score=127.26 Aligned_cols=85 Identities=21% Similarity=0.319 Sum_probs=33.7
Q ss_pred cccCCcEEeccCccCcCCCCcccCCCCCCCEEEccCCCccCCCCccccCCCCCcEEEeeCcccCCCCC-hhccCCCCCCE
Q 043136 172 QLNSLQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYNNLQGEVP-VEFASLVNLKY 250 (902)
Q Consensus 172 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~ 250 (902)
++++|++|++++|+|+ .+|+.|+.+++|++|++++|+++. +| .++.+++|++|++++|+|+.... ..+..+++|++
T Consensus 18 ~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~ 94 (124)
T d1dcea3 18 QLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94 (124)
T ss_dssp GGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCE
T ss_pred cCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCCccCCCCCchhhcCCCCCCE
Confidence 3333334444444333 223333444444444444444432 22 23444444444444444432211 23444444444
Q ss_pred EEccCccCc
Q 043136 251 MDISACNLS 259 (902)
Q Consensus 251 L~Ls~N~l~ 259 (902)
|++++|.++
T Consensus 95 L~l~~N~i~ 103 (124)
T d1dcea3 95 LNLQGNSLC 103 (124)
T ss_dssp EECTTSGGG
T ss_pred EECCCCcCC
Confidence 444444443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.34 E-value=1.5e-14 Score=143.01 Aligned_cols=19 Identities=16% Similarity=0.321 Sum_probs=7.6
Q ss_pred hhhcccCCcEEeccCccCc
Q 043136 169 EFVQLNSLQQLNLGGSYFD 187 (902)
Q Consensus 169 ~~~~l~~L~~L~L~~N~l~ 187 (902)
.+..+++|++|+|++|+|+
T Consensus 43 sl~~L~~L~~L~Ls~n~I~ 61 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIE 61 (198)
T ss_dssp HHHHTTTCCEEECSEEEES
T ss_pred HHhcccccceeECcccCCC
Confidence 3334444444444444433
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=2.9e-14 Score=140.85 Aligned_cols=112 Identities=21% Similarity=0.298 Sum_probs=52.2
Q ss_pred ccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEecCCCccceecCCCCCCcCc
Q 043136 216 PQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLLFKNHFTGEIPVSYGNLQA 295 (902)
Q Consensus 216 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 295 (902)
.++..+++|++|+|++|+|+. ++ .+..+++|++|+|++|.++ .+|..+..+++|++|++++|+++.. ..+..+++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~~ 116 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIASL--SGIEKLVN 116 (198)
T ss_dssp HHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCCH--HHHHHHHH
T ss_pred hHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccccccccccccccccccccc--cccccccc
Confidence 334444445555555555442 22 2444455555555555544 2333333334455555555555432 12444555
Q ss_pred CcEEecccCCCccccC-ccccccCCCCEEEccCccccc
Q 043136 296 LQVLDLSDNQLSGPIP-ASLASLKGLTRLSLMNNVLFG 332 (902)
Q Consensus 296 L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~ 332 (902)
|++|+|++|+|+.... ..+..+++|+.|+|++|.+..
T Consensus 117 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 117 LRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp SSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred ccccccccchhccccccccccCCCccceeecCCCcccc
Confidence 5555555555543211 234555555555555555543
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=1.1e-11 Score=116.81 Aligned_cols=106 Identities=21% Similarity=0.094 Sum_probs=57.6
Q ss_pred CCCEEEccCCCccCCCCccccCCCCCcEEEeeCc-ccCCCCChhccCCCCCCEEEccCccCcccCCccccCCCCccEEec
Q 043136 199 SLRFLDLAGNSLTGSLPPQLGLLTQLERIEIGYN-NLQGEVPVEFASLVNLKYMDISACNLSGTLPSEISNLTKLEMLLL 277 (902)
Q Consensus 199 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 277 (902)
..+.++++++.++ ..|..+..+++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+.+.|.+|..+++|++|+|
T Consensus 9 ~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L 87 (156)
T d2ifga3 9 GSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (156)
T ss_dssp SSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceec
Confidence 3455666666666 35555666666666666544 355544555666666666666666665555555555555555555
Q ss_pred CCCccceecCCCCCCcCcCcEEecccCCC
Q 043136 278 FKNHFTGEIPVSYGNLQALQVLDLSDNQL 306 (902)
Q Consensus 278 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 306 (902)
++|+|+...+..|.. .+|+.|+|++|.+
T Consensus 88 s~N~l~~l~~~~~~~-~~l~~L~L~~Np~ 115 (156)
T d2ifga3 88 SFNALESLSWKTVQG-LSLQELVLSGNPL 115 (156)
T ss_dssp CSSCCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred cCCCCcccChhhhcc-ccccccccCCCcc
Confidence 555555332223322 2355555555544
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.26 E-value=5.3e-12 Score=119.10 Aligned_cols=105 Identities=17% Similarity=0.071 Sum_probs=49.3
Q ss_pred CcEEeccCccCcCCCCcccCCCCCCCEEEccCC-CccCCCCccccCCCCCcEEEeeCcccCCCCChhccCCCCCCEEEcc
Q 043136 176 LQQLNLGGSYFDGEIPSDYRNLSSLRFLDLAGN-SLTGSLPPQLGLLTQLERIEIGYNNLQGEVPVEFASLVNLKYMDIS 254 (902)
Q Consensus 176 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 254 (902)
.+.++.+++.+. .+|..+..+++|++|++++| .|+...+.+|..+++|+.|+|++|+|+.+.|.+|..+++|++|+|+
T Consensus 10 ~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 10 SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 344444444444 33444444555555555433 2443333445555555555555555554444555555555555555
Q ss_pred CccCcccCCccccCCCCccEEecCCCcc
Q 043136 255 ACNLSGTLPSEISNLTKLEMLLLFKNHF 282 (902)
Q Consensus 255 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l 282 (902)
+|+|+...+..|.. .+|+.|+|++|.+
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~ 115 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPL 115 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred CCCCcccChhhhcc-ccccccccCCCcc
Confidence 55555322222322 2455555555544
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=1e-08 Score=96.68 Aligned_cols=80 Identities=20% Similarity=0.231 Sum_probs=39.7
Q ss_pred CCcEEEccCCCCCCCCCcccccccccceeccccccccCCCchhhhcccCCcEEeccCccCcCCC--CcccCCCCCCCEEE
Q 043136 127 KLRTIDISHNSFNSTFPPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNSLQQLNLGGSYFDGEI--PSDYRNLSSLRFLD 204 (902)
Q Consensus 127 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ 204 (902)
..+.||+++++.. ..+..+..+..++...+... .++..+..+++|++|+|++|+|+..- +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3445555554321 12333444444444444332 23444455666666666666666432 23344555555555
Q ss_pred ccCCCcc
Q 043136 205 LAGNSLT 211 (902)
Q Consensus 205 L~~N~l~ 211 (902)
|++|.++
T Consensus 98 Ls~N~i~ 104 (162)
T d1koha1 98 LSGNELK 104 (162)
T ss_dssp CTTSCCC
T ss_pred cccCccc
Confidence 5555555
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.41 E-value=8.8e-09 Score=97.19 Aligned_cols=90 Identities=18% Similarity=0.167 Sum_probs=45.7
Q ss_pred ccCCCCCCEEEccCCCCcccCchhhhccCCCcEEEccCCCCCCCC--CcccccccccceeccccccccCCCchhhhcccC
Q 043136 98 IRYLTSLTHLNLSANAFDGPLQPAILELTKLRTIDISHNSFNSTF--PPGISKLRFLRIFNAYSNSFTGPLPLEFVQLNS 175 (902)
Q Consensus 98 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 175 (902)
+..+..+..++..++.. ..++..+..+++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+...+-.+....+
T Consensus 38 l~~~~~~~~l~~~~~~~-~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~ 116 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMA-ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK 116 (162)
T ss_dssp TTTTTCCCCTTSHHHHH-HHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred hhhccchhhcchhhhHh-hhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence 33333444444433322 223444456777777777777776532 233455556666666666655443333333344
Q ss_pred CcEEeccCccCcC
Q 043136 176 LQQLNLGGSYFDG 188 (902)
Q Consensus 176 L~~L~L~~N~l~~ 188 (902)
|+.|+|++|.+..
T Consensus 117 L~~L~L~~Npl~~ 129 (162)
T d1koha1 117 LEELWLDGNSLSD 129 (162)
T ss_dssp CSSCCCTTSTTSS
T ss_pred cceeecCCCCcCc
Confidence 5555555555543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.97 E-value=4.5e-06 Score=84.76 Aligned_cols=132 Identities=20% Similarity=0.116 Sum_probs=88.3
Q ss_pred cCceEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEEEEEccCCCCHHHH
Q 043136 721 GSTGTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTMLLYEYMPNGNLDDL 799 (902)
Q Consensus 721 G~~g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~lv~e~~~~gsL~~~ 799 (902)
++.+.||++.. +++.+++|+........ ...+.+|...+..+. +--+++++++....+..|+||++++|..+.+.
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCcEEEEEe-CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 33468999875 55667888875332221 223456777766553 44467888888888899999999999887654
Q ss_pred HHhhccCCCcccCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------------
Q 043136 800 LHAKNKGENLVADWVTRYKIALGVAQGICYLHHDC--------------------------------------------- 834 (902)
Q Consensus 800 l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--------------------------------------------- 834 (902)
.... .. ...++.++++.++.+|+..
T Consensus 101 ~~~~-------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 101 YEDE-------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp TTTC-------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred cccc-------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHH
Confidence 3211 11 1234555666666666421
Q ss_pred -----------CCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 835 -----------DPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 835 -----------~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
...++|+|+.|.||++++++.+.|+||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11379999999999999876678999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.79 E-value=2.2e-05 Score=79.10 Aligned_cols=131 Identities=18% Similarity=0.155 Sum_probs=83.5
Q ss_pred EeeecCc-eEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC--cCeeEeEEeEEecCCeeEEEEEccCC
Q 043136 717 ILGMGST-GTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR--HRNIVRLLGCCSNRECTMLLYEYMPN 793 (902)
Q Consensus 717 ~iG~G~~-g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~--h~nIv~l~~~~~~~~~~~lv~e~~~~ 793 (902)
.+..|.. +.||+++..++..+++|........ .+..|++.++.+. .--+++++++..+.+..++|||+++|
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 3445553 6799998878888889986443322 2445666665552 33467788888888889999999987
Q ss_pred CCHHHHHHhhccCCCcccCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 043136 794 GNLDDLLHAKNKGENLVADWVTRYKIALGVAQGICYLHH----------------------------------------- 832 (902)
Q Consensus 794 gsL~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~----------------------------------------- 832 (902)
.++.+.. ... ..++.++++.+.-||+
T Consensus 91 ~~~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (255)
T d1nd4a_ 91 QDLLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 157 (255)
T ss_dssp EETTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ccccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhH
Confidence 6542210 000 0112223333333332
Q ss_pred ----------C----CCCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 833 ----------D----CDPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 833 ----------~----~~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
. ....++|+|+.|.||+++++..+.|+||+.+..
T Consensus 158 ~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 158 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112379999999999999876678999998765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.50 E-value=1.6e-05 Score=74.41 Aligned_cols=40 Identities=13% Similarity=0.198 Sum_probs=20.1
Q ss_pred CCCCCCEEEccC-CCCccc----CchhhhccCCCcEEEccCCCCC
Q 043136 100 YLTSLTHLNLSA-NAFDGP----LQPAILELTKLRTIDISHNSFN 139 (902)
Q Consensus 100 ~l~~L~~L~Ls~-n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 139 (902)
+.+.|++|+|++ +.++.. +-.++...+.|++|+|++|.+.
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccc
Confidence 345566666665 234322 1223444555666666666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=4e-05 Score=71.67 Aligned_cols=85 Identities=12% Similarity=0.158 Sum_probs=58.5
Q ss_pred CCEEEEEcCCC-Ccccc----cCccccCCCCCCEEEccCCCCccc----CchhhhccCCCcEEEccCCCCCCCCC----c
Q 043136 78 SQITSLDLSRR-SLSGP----IPPEIRYLTSLTHLNLSANAFDGP----LQPAILELTKLRTIDISHNSFNSTFP----P 144 (902)
Q Consensus 78 ~~v~~L~L~~~-~l~g~----~~~~~~~l~~L~~L~Ls~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p----~ 144 (902)
.++++|+|+++ .++.. +...+...+.|++|+|++|.+... +...+...+.|++|+|++|.++.... .
T Consensus 15 ~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~ 94 (167)
T d1pgva_ 15 TDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLR 94 (167)
T ss_dssp SSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHH
T ss_pred CCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHH
Confidence 37999999974 46532 445678889999999999999743 23455667889999999998875321 1
Q ss_pred ccccccccceeccccccc
Q 043136 145 GISKLRFLRIFNAYSNSF 162 (902)
Q Consensus 145 ~l~~l~~L~~L~L~~N~l 162 (902)
.+..-+.|++|++++|++
T Consensus 95 aL~~n~sL~~L~l~~n~~ 112 (167)
T d1pgva_ 95 STLVTQSIVEFKADNQRQ 112 (167)
T ss_dssp HTTTTCCCSEEECCCCSS
T ss_pred HHHhCCcCCEEECCCCcC
Confidence 233444555555555543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.00026 Score=75.93 Aligned_cols=78 Identities=13% Similarity=0.036 Sum_probs=47.1
Q ss_pred cEeeecCceEEEEEEeCC-CcEEEEEEecccchhh----HHHHHHHHHHHHHHhcC-C--cCeeEeEEeEEecCCeeEEE
Q 043136 716 KILGMGSTGTVYKAEMPG-GEIIAVKKLWGKHKEN----IRRRRGVLAEVDVLGNV-R--HRNIVRLLGCCSNRECTMLL 787 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~-~~~vavK~i~~~~~~~----~~~~~~~~~Ei~il~~l-~--h~nIv~l~~~~~~~~~~~lv 787 (902)
+.||.|..-.||+++..+ ++.++||.-....... ....++...|.++++.+ . ...+++++.+. .+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEEE
Confidence 568999999999997654 6788898653211110 00112234577776654 2 34567777653 4456799
Q ss_pred EEccCCCC
Q 043136 788 YEYMPNGN 795 (902)
Q Consensus 788 ~e~~~~gs 795 (902)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997644
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.73 E-value=7.3e-05 Score=69.76 Aligned_cols=42 Identities=19% Similarity=0.140 Sum_probs=22.2
Q ss_pred ccCCCCCCEEEccC-CCCccc----CchhhhccCCCcEEEccCCCCC
Q 043136 98 IRYLTSLTHLNLSA-NAFDGP----LQPAILELTKLRTIDISHNSFN 139 (902)
Q Consensus 98 ~~~l~~L~~L~Ls~-n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~ 139 (902)
..+.+.|++|+|++ +.++.. +-.++...++|++|+|++|.++
T Consensus 13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCccc
Confidence 34456666666665 345422 1223345566666666666554
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.55 E-value=0.00041 Score=64.37 Aligned_cols=63 Identities=10% Similarity=0.272 Sum_probs=48.5
Q ss_pred CCEEEEEcCC-CCcccc----cCccccCCCCCCEEEccCCCCcccC----chhhhccCCCcEEEccCCCCCC
Q 043136 78 SQITSLDLSR-RSLSGP----IPPEIRYLTSLTHLNLSANAFDGPL----QPAILELTKLRTIDISHNSFNS 140 (902)
Q Consensus 78 ~~v~~L~L~~-~~l~g~----~~~~~~~l~~L~~L~Ls~n~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~ 140 (902)
..+++|+|++ +.++.. +...+...++|++|+|++|.++... -..+...+.|+.|++++|.++.
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~ 88 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISG 88 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccc
Confidence 3789999997 456532 4456778999999999999997543 3345677899999999998864
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.29 E-value=0.0025 Score=65.97 Aligned_cols=67 Identities=9% Similarity=0.063 Sum_probs=41.1
Q ss_pred eEEEEEEeCCCcEEEEEEecccchhhHHHHHHHHHHHHHHhcCCcCe--eEeEE-----eEEecCCeeEEEEEccCCC
Q 043136 724 GTVYKAEMPGGEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVRHRN--IVRLL-----GCCSNRECTMLLYEYMPNG 794 (902)
Q Consensus 724 g~Vy~~~~~~~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~h~n--Iv~l~-----~~~~~~~~~~lv~e~~~~g 794 (902)
=.||+++..+|+.|++|+..+... ..+++..|.+.+..+.... ++..+ ..+...+..+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCC----CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 479999998999999999754321 1233555776665553211 11111 1234466788899998763
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.54 E-value=0.011 Score=62.80 Aligned_cols=71 Identities=14% Similarity=0.203 Sum_probs=46.1
Q ss_pred cEeeecCceEEEEEEeCC--------CcEEEEEEecccchhhHHHHHHHHHHHHHHhcCC-cCeeEeEEeEEecCCeeEE
Q 043136 716 KILGMGSTGTVYKAEMPG--------GEIIAVKKLWGKHKENIRRRRGVLAEVDVLGNVR-HRNIVRLLGCCSNRECTML 786 (902)
Q Consensus 716 ~~iG~G~~g~Vy~~~~~~--------~~~vavK~i~~~~~~~~~~~~~~~~Ei~il~~l~-h~nIv~l~~~~~~~~~~~l 786 (902)
+.|+-|-.=.+|+++..+ .+.|.+++.- .... . ....+|.++++.+. +.-.+++++++.+ .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-E---SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-H---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-h---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 568888889999997643 3456666653 2111 1 12346888887773 4445678887753 58
Q ss_pred EEEccCCCC
Q 043136 787 LYEYMPNGN 795 (902)
Q Consensus 787 v~e~~~~gs 795 (902)
||||++|..
T Consensus 119 I~efi~g~~ 127 (395)
T d1nw1a_ 119 LEEYIPSRP 127 (395)
T ss_dssp EECCCCEEE
T ss_pred EEEEecccc
Confidence 899998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.40 E-value=0.24 Score=50.00 Aligned_cols=32 Identities=25% Similarity=0.319 Sum_probs=27.8
Q ss_pred CCCeEEcCCCCCCEEEcCCCCEEEeeccccee
Q 043136 835 DPVIVHRDLKPSNILLDGEMEARVADFGVAKL 866 (902)
Q Consensus 835 ~~~ivHrDlKp~NILl~~~~~~kl~DFGla~~ 866 (902)
..++||+|+.++||+++.+...-|+||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 34699999999999999987779999998753
|